PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Lucke-Wold, BP; Logsdon, AF; Turner, RC; Huber, JD; Rosen, CL				Lucke-Wold, Brandon P.; Logsdon, Aric F.; Turner, Ryan C.; Huber, Jason D.; Rosen, Charles L.			Endoplasmic Reticulum Stress Modulation as a Target for Ameliorating Effects of Blast Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bTBI; ER stress; iron toxicity; salubrinal; tauopathy	ENCEPHALOPATHY; MODEL; NEURODEGENERATION; PATHOLOGY; DEFICITS; IRON; TAU	Blast traumatic brain injury (bTBI) has been shown to contribute to progressive neurodegenerative disease. Recent evidence suggests that endoplasmic reticulum (ER) stress is a mechanistic link between acute neurotrauma and progressive tauopathy. We propose that ER stress contributes to extensive behavioral changes associated with a chronic traumatic encephalopathy (CTE)-like phenotype. Targeting ER stress is a promising option for the treatment of neurotrauma-related neurodegeneration, which warrants investigation. Utilizing our validated and clinically relevant Sprague-Dawley blast model, we investigated a time course of mechanistic changes that occur following bTBI (50 psi) including: ER stress activation, iron-mediated toxicity, and tauopathy via Western blot and immunohistochemistry. These changes were associated with behavioral alterations measured by the Elevated Plus Maze (EPM), Forced Swim Test (FST), and Morris Water Maze (MWM). Following characterization, salubrinal, an ER stress modulator, was given at a concentration of 1mg/kg post-blast, and its mechanism of action was determined in vitro. bTBI significantly increased markers of injury in the cortex of the left hemisphere: p-PERK and p-eIF2 at 30min, p-T205 tau at 6h, and iron at 24h. bTBI animals spent more time immobile on the FST at 72h and more time in the open arm of the EPM at 7 days. Further, bTBI caused a significant learning disruption measured with MWM at 21 days post-blast, with persistent tau changes. Salubrinal successfully reduced ER stress markers in vivo and in vitro while significantly improving performance on the EPM. bTBI causes robust biochemical changes that contribute to neurodegeneration, but these changes may be targeted with ER stress modulators.	[Lucke-Wold, Brandon P.; Turner, Ryan C.; Rosen, Charles L.] West Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; [Logsdon, Aric F.; Huber, Jason D.] West Virginia Univ, Dept Basic Pharmaceut Sci, Sch Pharm, Morgantown, WV 26506 USA		Rosen, CL (corresponding author), West Virginia Univ, Sch Med, Dept Neurosurg, Hlth Sci Ctr, One Med Ctr Dr Suite 4300,POB 9183, Morgantown, WV 26506 USA.	crosen@hsc.wvu.edu	Lucke-Wold, Brandon/AAW-1881-2021; Lucke-Wold, Brandon/AAW-3525-2021	Lucke-Wold, Brandon/0000-0001-6577-4080; Turner, Ryan/0000-0001-5523-0645	American Foundation of Pharmaceutical Education; Sigma Xi Grants in Aid of Research; Neurosurgery Research and Education Foundation Medical Student Summer Fellowship; American Association of Pharmaceutical Scientists Pre-doctoral Fellowship; American Medical Association Foundation Seed Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER	Aric Logsdon and Brandon Lucke-Wold thank the American Foundation of Pharmaceutical Education for awarding pre-doctoral fellowships. Brandon Lucke-Wold also received funding from Sigma Xi Grants in Aid of Research, Neurosurgery Research and Education Foundation Medical Student Summer Fellowship, American Association of Pharmaceutical Scientists Pre-doctoral Fellowship, and the American Medical Association Foundation Seed Grant.	Chen H., 2015, BRAIN NEUROTRAUMA MO; Chen-Roetling J, 2011, FREE RADICAL BIO MED, V51, P1966, DOI 10.1016/j.freeradbiomed.2011.08.021; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Galgano MA, 2016, CUREUS, V8, DOI 10.7759/cureus.532; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lucke-Wold B. P., 2014, MOL NEUROBIOL; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Tucker L. B., 2016, J NEUROTRAUMA; Turner R. C, 2016, BRAIN INJURY, P1, DOI [10.1080/02699052.2016, DOI 10.1080/02699052.2016]; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489	27	12	12	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34			1			S62	S70		10.1089/neu.2016.4680			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI2DA	WOS:000411746000008	28077004	Green Published, Bronze			2022-02-06	
J	Rao, A; Lin, A; Hilliard, C; Fu, RW; Lennox, T; Barbosa, R; Schreiber, M; Rowell, S				Rao, Abigail; Lin, Amber; Hilliard, Cole; Fu, Rongwei; Lennox, Tori; Barbosa, Ronald; Schreiber, Martin; Rowell, Susan			The Utility of Thromboelastography for Predicting The Risk of Progression of Intracranial Hemorrhage in Traumatic Brain Injury Patients	NEUROSURGERY			English	Article; Proceedings Paper	64th Annual Meeting of the Congress-of-Neurological-Surgeons (CNS)	SEP 24-28, 2016	San Diego, CA	Cong Neurol Surg			HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; COAGULOPATHY; COAGULATION; THROMBELASTOGRAPHY; MORTALITY		[Rao, Abigail] OHSU, Dept Neurol Surg, Mail Code CH8N,3303 SW Bond Ave, Portland, OR 97239 USA; [Lin, Amber; Fu, Rongwei] OHSU, Sch Publ Hlth, Portland, OR USA; [Lin, Amber; Fu, Rongwei] OHSU, Ctr Policy Res, Portland, OR USA; [Hilliard, Cole; Schreiber, Martin; Rowell, Susan] OHSU, Div Trauma Crit Care & Acute Care Surg, Dept Surg, Portland, OR USA; [Lennox, Tori] Univ Washington, Div Cardiothorac Surg, Seattle, WA 98195 USA; [Barbosa, Ronald] Legacy Emanuel Hosp & Hlth Serv, Trauma Serv, Portland, OR USA		Rao, A (corresponding author), OHSU, Dept Neurol Surg, Mail Code CH8N,3303 SW Bond Ave, Portland, OR 97239 USA.	abigail.rao@gmail.com	Rowell, Susan/S-7480-2019		National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5K12HL108974-05]; American Association for the Surgery of Trauma; Oregon Clinical and Translational Research Institute from the National Center for Advancing Translational Sciences at the NIH [1UL1 RR02414001]	This project was supported by Award Number 5K12HL108974-05 from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the NIH. The project also was supported by the American Association for the Surgery of Trauma (no grant number). This publication was supported by Oregon Clinical and Translational Research Institute, grant number (1UL1 RR02414001) from the National Center for Advancing Translational Sciences at the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Reikvam H, 2009, TRANSFUS APHER SCI, V40, P119, DOI 10.1016/j.transci.2009.01.019; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	23	12	14	2	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2017	64			1			182	187		10.1093/neuros/nyx210			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	GO9ZV	WOS:000440467800029	28899039	Green Published			2022-02-06	
J	Buunk, AM; Spikrnan, JM; Veenstra, WS; van Laar, PJ; Metzemaekers, JDM; van Dijk, JMC; Meiners, LC; Groen, RJM				Buunk, Anne M.; Spikrnan, Jacoba M.; Veenstra, Wencke S.; van Laar, Peter Jan; Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Meiners, Linda C.; Groen, Rob J. M.			Social cognition impairments after aneurysmal subarachnoid haemorrhage: Associations with deficits in interpersonal behaviour, apathy, and impaired self-awareness	NEUROPSYCHOLOGIA			English	Article						Social cognition; Subarachnoid haemorrhage; Apathy; Self-awareness; Magnetic resonance imaging	TRAUMATIC BRAIN-INJURY; DELAYED CEREBRAL-ISCHEMIA; QUALITY-OF-LIFE; EMOTION RECOGNITION; PREFRONTAL LESIONS; ASPERGER-SYNDROME; MIND IMPAIRMENTS; CLINICAL-TRIALS; ACQUIRED THEORY; OUTCOME EVENT	Behavioural disturbances are frequently found after aneurysmal subarachnoid haemorrhage (aSAH). Social cognition impairments have been suggested as a possible underlying mechanism for behavioural problems. Also, aSAH is likely to result in damage affecting frontal-subcortical circuits underlying social cognition. Therefore, we aimed to investigate social cognition after aSAH and its associations with behavioural problems (deficits in interpersonal behaviour, apathy, and impaired self-awareness) and focal as well as diffuse brain damage. 88 aSAH patients (in the subacute phase post-aSAH) and 60 age-, sex- and education-matched healthy controls participated. Tasks for emotion recognition, Theory of Mind (ToM), and empathy as well as questionnaires were used. Cortical infarctions in frontal and non-frontal areas on MRI, aneurysm circulation and aSAH-related events were taken into account. Compared to healthy controls, aSAH patients performed significantly worse on tasks for emotion recognition, ToM and empathy. Poor performance on ToM and emotion recognition was associated with proxy-ratings indicating impaired interpersonal behaviour and apathy and with indications of impaired self-awareness. No associations were found between deficits in social cognition and frontal or non-frontal cortical lesions on MRI. Also, aneurysm circulation and aSAH-related events such as hydrocephalus, vasospasm, and treatment method did not explain why and how social cognitive deficits did occur after aSAH. In conclusion, emotion recognition, ToM and empathy were clearly impaired in aSAH patients and these deficits were related to apathy and deficits in interpersonal behaviour as reported by proxies and to impaired self-awareness. This association strengthens the assumption of impaired social cognition as an underlying construct of behavioural problems after aSAH. Consequently, social cognition tests and proxy-ratings should be used in clinical practice, irrespective of lesion location on MRI or aneurysm circulation, to improve the detection and treatment of apathy and deficits in interpersonal behaviour after aSAH.	[Buunk, Anne M.; Spikrnan, Jacoba M.; Veenstra, Wencke S.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Subdept Neuropsychol, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands; [Buunk, Anne M.; Spikrnan, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Hanzepl 1,POB 30-001,Poortweg 4,2nd Floor, NL-9700 RB Groningen, Netherlands; [van Laar, Peter Jan; Meiners, Linda C.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands; [Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Groen, Rob J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands		Buunk, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Subdept Neuropsychol,Dept Clin & Dev Neuropsychol, Hanzepl 1,Poortweg 4,2nd Floor,Room V2-214, NL-9700 RB Groningen, Netherlands.	a.m.buunk@umcg.nl	van Dijk, J. Marc C./C-1078-2013	van Dijk, J. Marc C./0000-0002-0814-5680; Spikman, Jacoba/0000-0002-6477-0763; Groen, Rob J.M./0000-0003-3067-763X	charitable foundation Stichting Catharina Heerdt	This work was supported by the charitable foundation Stichting Catharina Heerdt. The funder had no involvement other than financial support. The authors declare no competing financial interests.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Al Banna M, 2016, J NEUROL NEUROSUR PS, V87, P161, DOI 10.1136/jnnp-2015-310305; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Bottger S, 1998, J NEUROL NEUROSUR PS, V65, P93, DOI 10.1136/jnnp.65.1.93; Brand S., 2014, WORLD J BIOL PSYCHIA; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; Buunk AM, 2016, NEUROPSYCHOLOGY; Buunk AM, 2015, BRAIN INJURY, V29, P1589, DOI 10.3109/02699052.2015.1073789; Caeiro L, 2011, EUR J NEUROL, V18, P857, DOI 10.1111/j.1468-1331.2010.03271.x; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Cox SR, 2016, NEUROPSYCHOLOGIA, V91, P299, DOI 10.1016/j.neuropsychologia.2016.08.029; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Fleming JM, 1996, BRAIN INJURY, V10, P1; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Hutter BO, 2014, J NEUROSURG, V120, P923, DOI 10.3171/2013.11.JNS121552; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; HUTTER BO, 1995, J CLIN EXP NEUROPSYC, V17, P499, DOI 10.1080/01688639508405141; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Leung DPK, 2011, INT J REHABIL RES, V34, P187, DOI 10.1097/MRR.0b013e3283487f31; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Liu SF, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3552; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Martin J. H., 2003, NEUROANATOMY; Martory MD, 2015, EUR NEUROL, V74, P288, DOI 10.1159/000442412; May M., 2017, J INT NEUROPSYCHOL S; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mees SMD, 2012, J NEUROL, V259, P679, DOI 10.1007/s00415-011-6243-2; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Naik D, 2014, ANN INDIAN ACAD NEUR, V17, P58, DOI 10.4103/0972-2327.128555; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Njomboro P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-18; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pijnenborg GHM, 2013, EUR ARCH PSY CLIN N, V263, P299, DOI 10.1007/s00406-012-0373-0; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Robert G, 2014, J NEUROL NEUROSUR PS, V85, P1153, DOI 10.1136/jnnp-2013-307025; Rosenberg H., 2016, J NEUROPSYCHOL; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Stienen MN, 2014, WORLD NEUROSURG; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; STOREY PB, 1970, BRIT J PSYCHIAT, V117, P129, DOI 10.1192/S0007125000192815; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; van der Hulst EJ, 2015, J NEUROL NEUROSUR PS, V86, P1208, DOI 10.1136/jnnp-2014-309290; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Verhage F, 1964, INTELLIGENTIE LEEFTI; Wallace CA, 2000, BRAIN INJURY, V14, P549; Wilkos Ewelina, 2015, Neuropsychiatr Dis Treat, V11, P1031, DOI 10.2147/NDT.S78037; Young A., 2002, FACIAL EXPRESSIONS E; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440; Zweifel-Zehnder AE, 2015, ACTA NEUROCHIR, V157, P1449, DOI 10.1007/s00701-015-2480-y	101	12	12	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	AUG	2017	103						131	139		10.1016/j.neuropsychologia.2017.07.015			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	FF3IR	WOS:000408789200015	28723344	Green Submitted			2022-02-06	
J	Miller, DR; Hayes, JP; Lafleche, G; Salat, DH; Verfaellie, M				Miller, Danielle R.; Hayes, Jasmeet P.; Lafleche, Ginette; Salat, David H.; Verfaellie, Mieke			White matter abnormalities are associated with overall cognitive status in blast-related mTBI	BRAIN IMAGING AND BEHAVIOR			English	Article						mTBI; Loss of consciousness; White matter integrity; Cognitive impairment; DTI	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; OEF/OIF VETERANS; PROCESSING SPEED; SYMPTOMS; CONCUSSION; EXPOSURE; PTSD; PERFORMANCE; COMBAT	Blast-related mild traumatic brain injury (mTBI) is a common injury of the Iraq and Afghanistan Wars. Research has suggested that blast-related mTBI is associated with chronic white matter abnormalities, which in turn are associated with impairment in neurocognitive function. However, findings are inconsistent as to which domains of cognition are affected by TBI-related white matter disruption. Recent evidence that white matter abnormalities associated with blast-related mTBI are spatially variable raises the possibility that the associated cognitive impairment is also heterogeneous. Thus, the goals of this study were to examine (1) whether mTBI-related white matter abnormalities are associated with overall cognitive status and (2) whether white matter abnormalities provide a mechanism by which mTBI influences cognition. Ninety-six Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OEF) veterans were assigned to one of three groups: no-TBI, mTBI without loss of consciousness (LOC) (mTBI-LOC), and mTBI with LOC (mTBI + LOC). Participants were given a battery of neuropsychological tests that were selected for their sensitivity to mTBI. Results showed that number of white matter abnormalities was associated with the odds of having clinically significant cognitive impairment. A mediation analysis revealed that mTBI + LOC was indirectly associated with cognitive impairment through its effect on white matter integrity. These results suggest that cognitive difficulties in blast-related mTBI can be linked to injury-induced neural changes when taking into account the variability of injury as well as the heterogeneity in cognitive deficits across individuals.	[Miller, Danielle R.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Miller, Danielle R.; Lafleche, Ginette; Verfaellie, Mieke] VA Boston Healthcare Syst, Memory Disorders Res Ctr, Boston, MA 02130 USA; [Hayes, Jasmeet P.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Hayes, Jasmeet P.; Lafleche, Ginette; Verfaellie, Mieke] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Hayes, Jasmeet P.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA; [Salat, David H.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Salat, David H.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA		Miller, DR (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.; Miller, DR (corresponding author), VA Boston Healthcare Syst, Memory Disorders Res Ctr, Boston, MA 02130 USA.	dmiller3@bu.edu	Hayes, Jasmeet/AAN-4150-2020	Hayes, Jasmeet/0000-0002-5157-0666; Verfaellie, Mieke/0000-0001-5535-4584; Sullivan, Danielle R./0000-0002-0141-5887	VA Rehabilitation Research Development [I01RX000216, I21RX001594]; VA Clinical Science Research and Development Service; National Center for PTSD; Veterans AffairsUS Department of Veterans Affairs [I01RX000216, I21RX001594] Funding Source: NIH RePORTER	The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. This work was supported by VA Rehabilitation Research & Development grant I01RX000216 and I21RX001594, the VA Clinical Science Research and Development Service, and the National Center for PTSD. The authors would like to acknowledge Kathryn Bousquet, Keely Burke, and Aubrey Wank for assistance with imaging data collection.	Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bigler E. D., 2006, BRAIN INJURY MED PRI; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Hayes, 2018, INTRO MEDIATION MODE; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers F.W., 1993, ANN CONV INT SOC TRA; WechslerD, 2001, WECHSLER TEST ADULT	36	12	12	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	AUG	2017	11	4					1129	1138		10.1007/s11682-016-9593-7			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FD9KF	WOS:000407840500020	27704406	Green Accepted			2022-02-06	
J	Chen, Y; Cai, ZY; Ke, ZY				Chen, Yi; Cai, Zhiyou; Ke, Zunyu			Antineuroinflammation of Minocycline in Stroke	NEUROLOGIST			English	Article						minocycline; neuroinflammation; stroke	ACUTE ISCHEMIC-STROKE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS	Accumulating research substantiates the statement that inflammation plays an important role in the development of stroke. Both proinflammatory and anti-inflammatory mediators are involved in the pathogenesis of stroke, an imbalance of which leads to inflammation. Anti-inflammation is a kind of hopeful strategy for the prevention and treatment of stroke. Substantial studies have demonstrated that minocycline, a second-generation semisynthetic antibiotic belonging to the tetracycline family, can inhibit neuroinflammation, inflammatory mediators and microglia activation, and improve neurological outcome. Experimental and clinical data have found the preclinical and clinical potential of minocycline in the treatment of stroke due to its anti-inflammation properties and anti-inflammation-induced pathogeneses, including antioxidative stress, antiapoptosis, inhibiting leukocyte migration and microglial activation, and decreasing matrix metalloproteinases activity. Hence, it suggests a great future for minocycline in the therapeutics of stroke that diminish the inflammatory progress of stroke.	[Chen, Yi; Cai, Zhiyou; Ke, Zunyu] Hubei Univ Med, Shiyan Renmin Hosp, Renmin Hosp, Dept Neurol, 39 Chaoyang Middle Rd, Shiyan 442000, Hubei Province, Peoples R China		Cai, ZY (corresponding author), Hubei Univ Med, Shiyan Renmin Hosp, Renmin Hosp, Dept Neurol, 39 Chaoyang Middle Rd, Shiyan 442000, Hubei Province, Peoples R China.	c0909@hotmail.com	Cai, Zhiyou/K-2206-2019	Cai, Zhiyou/0000-0002-9552-4020	Natural Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [2015CFB260]; Hubei Province Health and Family Planning Scientific Research Project [WJ2015MB219]; Shiyan Natural Science Foundation [15K70]; Renmin Hospital, Hubei University of Medicine	Supported by grants from the Natural Science Foundation of Hubei Province (2015CFB260), and the Hubei Province Health and Family Planning Scientific Research Project (WJ2015MB219), and the Shiyan Natural Science Foundation (15K70) and Renmin Hospital, Hubei University of Medicine to Z.C.	Abraham J, 2012, NEUROBIOL DIS, V46, P425, DOI 10.1016/j.nbd.2012.02.006; Adembri C, 2014, CRIT CARE MED, V42, pE570, DOI 10.1097/CCM.0000000000000414; Ahmad M, 2016, PHARMACOL BIOCHEM BE, V145, P45, DOI 10.1016/j.pbb.2016.04.003; Amiri-Nikpour MR, 2015, ACTA NEUROL SCAND, V131, P45, DOI 10.1111/ane.12296; Arnold SM, 2015, J STROKE CEREBROVASC, V24, P1168, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.007; Austin V, 2016, CLIN SCI, V130, P1039, DOI 10.1042/CS20160043; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Beer C, 2011, MED SCI MONITOR, V17, pCR467, DOI 10.12659/MSM.881931; Bernier C, 2001, ANN DERMATOL VENER, V128, P627; Blacker DJ, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/362961; Boridy S, 2012, NANOMEDICINE-UK, V7, P1149, DOI 10.2217/nnm.12.16; Brewer L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0466-2; Buijs JE, 2016, J STROKE CEREBROVASC, V25, P312, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.035; Cai Z, 2006, NEUROSCIENCE, V137, P425, DOI 10.1016/j.neuroscience.2005.09.023; Cai ZY, 2010, NEUROSCI BULL, V26, P28, DOI 10.1007/s12264-010-0818-2; Cai Zhi-You, 2008, Neurosci Bull, V24, P305, DOI 10.1007/s12264-008-0324-y; Cai ZY, 2013, CLIN INTERV AGING, V8, P1089, DOI 10.2147/CIA.S46536; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Cerami C, 2015, CURR VASC PHARMACOL, V13, P218, DOI 10.2174/15701611113116660168; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chen CY, 2015, SLEEP MED, V16, P113, DOI 10.1016/j.sleep.2014.07.027; Chen G, 2016, REGUL TOXICOL PHARM, V81, P480, DOI 10.1016/j.yrtph.2016.09.027; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen XH, 2011, J NEUROIMMUNOL, V235, P1, DOI 10.1016/j.jneuroim.2011.04.006; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Simao ANC, 2015, METAB BRAIN DIS, V30, P1409, DOI 10.1007/s11011-015-9720-y; Dalm D, 2010, J MOL BIOL, V398, P83, DOI 10.1016/j.jmb.2010.02.049; Fan X, 2013, STROKE, V44, P745, DOI 10.1161/STROKEAHA.111.000309; Ferretti MT, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-62; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Good ML, 2003, BRIT J DERMATOL, V149, P237, DOI 10.1046/j.1365-2133.2003.05497.x; Grienberger HJ, 2010, EXP BRAIN RES, V206, P311, DOI 10.1007/s00221-010-2410-4; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hahn JN, 2016, J IMMUNOL, V197, P3850, DOI 10.4049/jimmunol.1600436; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Huang SP, 2015, J BIOL CHEM, V290, P20782, DOI 10.1074/jbc.M114.635870; Inta D, 2016, SCHIZOPHR B; Ishioka K, 2013, J VET MED SCI, V75, P173, DOI 10.1292/jvms.12-0169; Janssen B, 2016, BBA-MOL BASIS DIS, V1862, P425, DOI 10.1016/j.bbadis.2015.11.011; Jin ZQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0264-1; JONAS M, 1982, THER DRUG MONIT, V4, P137; Jura J, 2012, BBA-MOL CELL RES, V1823, P1905, DOI 10.1016/j.bbamcr.2012.06.029; Karachitos A, 2013, CURR DRUG TARGETS, V14, P47, DOI 10.2174/138945013804806442; Kim E, 2016, NEUROTHERAPEUTICS, V13, P702, DOI 10.1007/s13311-016-0463-1; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kim WK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072108; Kohler E, 2013, STROKE, V44, P2493, DOI 10.1161/STROKEAHA.113.000780; Kokaia Z, 2015, Georgian Med News, P84; Kono S, 2015, J STROKE CEREBROVASC, V24, P537, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.037; Krishnamurthi RV, 2015, NEUROEPIDEMIOLOGY, V45, P177, DOI 10.1159/000441087; Krishnan A, 2010, J THROMB THROMBOLYS, V29, P368, DOI 10.1007/s11239-010-0439-7; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lee HS, 2007, PHARMAZIE, V62, P937, DOI 10.1691/ph.2007.12.7563; Lee H, 2012, AM J OPHTHALMOL, V154, P949, DOI 10.1016/j.ajo.2012.06.009; Li CY, 2013, REV NEUROSCIENCE, V24, P553, DOI 10.1515/revneuro-2013-0040; Liao TV, 2013, CURR TOP MED CHEM, V13, P2283, DOI 10.2174/15680266113136660160; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Morimoto N, 2005, BRAIN RES, V1044, P8, DOI 10.1016/j.brainres.2005.02.062; Nikodemova M, 2006, J NEUROCHEM, V96, P314, DOI 10.1111/j.1471-4159.2005.03520.x; Orhan G, 2016, NEUROL SCI, V37, P955, DOI 10.1007/s10072-016-2524-y; Orsucci D, 2009, CNS NEUROL DISORD-DR, V8, P222; Pae CU, 2008, BIOMED PHARMACOTHER, V62, P308, DOI 10.1016/j.biopha.2007.12.005; Pancioli AM, 2004, CNS DRUGS, V18, P981, DOI 10.2165/00023210-200418140-00003; Papa S, 2016, BIOMATERIALS, V75, P13, DOI 10.1016/j.biomaterials.2015.10.015; Parachikova A, 2010, J ALZHEIMERS DIS, V21, P527, DOI 10.3233/JAD-2010-100204; Park CH, 2011, KOREAN J PHYSIOL PHA, V15, P115, DOI 10.4196/kjpp.2011.15.2.115; Peng J, 2006, J NEUROSCI, V26, P11644, DOI 10.1523/JNEUROSCI.3447-06.2006; Pfau ML, 2016, TRENDS NEUROSCI, V39, P353, DOI 10.1016/j.tins.2016.04.004; Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092; Qi DF, 2011, J BIOL CHEM, V286, P41692, DOI 10.1074/jbc.M111.276006; Quach ET, 2015, J CLIN NEUROSCI, V22, P1515, DOI 10.1016/j.jocn.2015.03.022; Quintero EM, 2006, BRAIN RES, V1093, P198, DOI 10.1016/j.brainres.2006.03.104; Rennaker RL, 2007, J NEURAL ENG, V4, pL1, DOI 10.1088/1741-2560/4/2/L01; Roy A, 2012, CELL SIGNAL, V24, P2123, DOI 10.1016/j.cellsig.2012.07.014; Rubio-Perez J. M., 2012, THESCIENTIFICWORLDJO, V2012, P2012, DOI DOI 10.1100/2012/756357; Rull A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/326580; Sacktor N, 2014, J NEUROVIROL, V20, P620, DOI 10.1007/s13365-014-0292-0; Sakata H, 2012, J NEUROSCI, V32, P3462, DOI 10.1523/JNEUROSCI.5686-11.2012; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Savitz SI, 2016, STEM CELLS, V34, P537, DOI 10.1002/stem.2253; Schaefer PW, 2015, AM J NEURORADIOL, V36, P259, DOI 10.3174/ajnr.A4103; Schaller B, 2005, FREE RADICAL BIO MED, V38, P411, DOI 10.1016/j.freeradbiomed.2004.10.032; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Soliman S, 2015, TRANSL STROKE RES, V6, P309, DOI 10.1007/s12975-015-0408-8; Sonmez E, 2013, SPINE, V38, P1253, DOI 10.1097/BRS.0b013e3182895587; Sorensen PS, 2016, EUR J NEUROL, V23, P861, DOI 10.1111/ene.12953; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; Steiner N, 2016, NEUROCHEM INT, V95, P46, DOI 10.1016/j.neuint.2015.10.013; Suk K, 2004, NEUROSCI LETT, V366, P167, DOI 10.1016/j.neulet.2004.05.038; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Suzumura A, 2013, CURR PROTEIN PEPT SC, V14, P16, DOI 10.2174/1389203711314010004; Switzer JA, 2012, TRANSL STROKE RES, V3, P364, DOI 10.1007/s12975-012-0150-4; Takada Y, 2010, J IMMUNOL, V184, P2671, DOI 10.4049/jimmunol.0804012; Takatsuna H, 2005, BIOMED PHARMACOTHER, V59, P318, DOI 10.1016/j.biopha.2005.01.011; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Vay SU, 2016, J NEUROSCI RES, V94, P149, DOI 10.1002/jnr.23686; Wakita H, 2003, BRAIN RES, V992, P53, DOI 10.1016/j.brainres.2003.08.028; Wallentin L, 2014, CIRCULATION, V130, P1847, DOI 10.1161/CIRCULATIONAHA.114.011204; Walter HL, 2015, NEUROSCIENCE, V292, P71, DOI 10.1016/j.neuroscience.2015.02.024; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Wang HL, 2016, J CELL MOL MED, V20, P1632, DOI 10.1111/jcmm.12854; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wang ZC, 2017, BIOMATERIALS, V112, P62, DOI 10.1016/j.biomaterials.2016.10.002; Worlitzer MMA, 2013, EUR J NEUROSCI, V38, P2684, DOI 10.1111/ejn.12269; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yan AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35885; Yang LC, 2003, J NEUROSCI RES, V74, P278, DOI 10.1002/jnr.10709; Yang LP, 2007, MOL VIS, V13, P1083; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zendedel A, 2015, J NEUROIMMUNOL, V278, P200, DOI 10.1016/j.jneuroim.2014.11.007; Zhang LY, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0281-8; Zhang Q, 2009, MED HYPOTHESES, V73, P744, DOI 10.1016/j.mehy.2009.04.028; Zhang Y, 2008, CAN J NEUROL SCI, V35, P185, DOI 10.1017/S0317167100008611; Zhao DL, 2016, ECHOCARDIOGR-J CARD, V33, P1735, DOI 10.1111/echo.13326; Zhu SZ, 2016, BIOCHEM BIOPH RES CO, V474, P175, DOI 10.1016/j.bbrc.2016.04.095; Zitnanova I, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9761697	125	12	12	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	JUL	2017	22	4					120	126		10.1097/NRL.0000000000000136			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY6SA	WOS:000404112300004	28644252				2022-02-06	
J	Muradashvili, N; Tyagi, SC; Lominadze, D				Muradashvili, Nino; Tyagi, Suresh C.; Lominadze, David			Localization of Fibrinogen in the Vasculo-Astrocyte Interface after Cortical Contusion Injury in Mice	BRAIN SCIENCES			English	Article						astrocyte endfeet; cerebral vessels; neuronal degeneration; short-term memory	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; SPATIAL MEMORY; PRION PROTEIN; BETA; PERMEABILITY; MATRIX-METALLOPROTEINASE-9; PLASMINOGEN; IMPAIRMENT; EXPRESSION	Besides causing neuronal damage, traumatic brain injury (TBI) is involved in memory reduction, which can be a result of alterations in vasculo-neuronal interactions. Inflammation following TBI is involved in elevation of blood content of fibrinogen (Fg), which is known to enhance cerebrovascular permeability, and thus, enhance its deposition in extravascular space. However, the localization of Fg in the extravascular space and its possible interaction with nonvascular cells are not clear. The localization of Fg deposition in the extravascular space was defined in brain samples of mice after cortical contusion injury (CCI) and sham-operation (control) using immunohistochemistry and laser-scanning confocal microscopy. Memory changes were assessed with new object recognition and Y-maze tests. Data showed a greater deposition of Fg in the vascular and astrocyte endfeet interface in mice with CCI than in control animals. This effect was accompanied by enhanced neuronal degeneration and reduction in short-term memory in mice with CCI. Thus, our results suggest that CCI induces increased deposition of Fg in the vasculo-astrocyte interface, and is accompanied by neuronal degeneration, which may result in reduction of short-term memory.	[Muradashvili, Nino; Tyagi, Suresh C.; Lominadze, David] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA		Lominadze, D (corresponding author), Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA.	n0mura01@louisville.edu; s0tyag01@louisville.edu; dglomi01@louisville.edu		Lominadze, David/0000-0002-9911-4539	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 GM-103507, NS-084823, HL-074185, HL-107640, DK-104653]; American Heart AssociationAmerican Heart Association [17SDG33670372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL074185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK104653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084823] Funding Source: NIH RePORTER	This work was in part supported by the National Institutes of Health (grants P30 GM-103507, NS-084823, HL-074185, HL-107640 and DK-104653) and American Heart Association (17SDG33670372).	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; AKIYAMA H, 1993, ACTA NEUROPATHOL, V85, P628, DOI 10.1007/BF00334673; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Conrad CD, 1997, BRAIN RES, V759, P76, DOI 10.1016/S0006-8993(97)00236-9; Cortes-Canteli M, 2009, J THROMB HAEMOST, V7, P146, DOI 10.1111/j.1538-7836.2009.03376.x; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hsiao TW, 2013, ACTA BIOMATER, V9, P7200, DOI 10.1016/j.actbio.2013.02.047; Jadavji NM, 2015, NEUROSCIENCE, V300, P1, DOI 10.1016/j.neuroscience.2015.04.067; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kutiyanawalla A, 2012, INT J NEUROPSYCHOPH, V15, P1073, DOI 10.1017/S1461145711001180; Lominadze D, 2005, AM J PHYSIOL-HEART C, V288, pH1257, DOI 10.1152/ajpheart.00856.2004; MAURICE T, 1994, BRAIN RES, V647, P44, DOI 10.1016/0006-8993(94)91397-8; Muradashvili N, 2016, J PHYSIOL-LONDON, V594, P5941, DOI 10.1113/JP272558; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2014, J CEREBR BLOOD F MET, V34, P1472, DOI 10.1038/jcbfm.2014.102; Muradashvili N, 2014, CELL BIOCHEM BIOPHYS, V69, P283, DOI 10.1007/s12013-013-9797-z; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Muradashvili N, 2012, J CEREBR BLOOD F MET, V32, P150, DOI 10.1038/jcbfm.2011.144; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Yamada K, 1996, NEUROSCIENCE, V74, P365, DOI 10.1016/0306-4522(96)00161-3; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668	30	12	12	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-3425			BRAIN SCI	Brain Sci.	JUL	2017	7	7							77	10.3390/brainsci7070077			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD3PH	WOS:000407444400008	28684673	gold, Green Submitted, Green Published			2022-02-06	
J	Povysheva, T; Shmarov, M; Logunov, D; Naroditsky, B; Shulman, I; Ogurcov, S; Kolesnikov, P; Islamov, R; Chelyshev, Y				Povysheva, Tatyana; Shmarov, Maksim; Logunov, Denis; Naroditsky, Boris; Shulman, Ilya; Ogurcov, Sergey; Kolesnikov, Pavel; Islamov, Rustem; Chelyshev, Yuri			Post-spinal cord injury astrocyte-mediated functional recovery in rats after intraspinal injection of the recombinant adenoviral vectors Ad5-VEGF and Ad5-ANG	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal cord injury; adenovirus vector; angiogenin; vascular endothelial growth factor; VEGF; astrocyte	AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOTHELIAL GROWTH-FACTOR; GENE-THERAPY; VEGF-A; ANGIOGENIN; BRAIN; CELLS; REGENERATION; DISORDERS; OUTGROWTH	OBJECTIVE The most actively explored therapeutic strategy for overcoming spinal cord injury (SCI) is the delivery of genes encoding molecules that stimulate regeneration. In a mouse model of amyotrophic lateral sclerosis and in preliminary clinical trials in patients with amyotrophic lateral sclerosis, the combined administration of recombinant adenoviral vectors (Ad5-VEGF+Ad5-ANG) encoding the neurotrophic/angiogenic factors vascular endothelial growth factor (VEGF) and angiogenin (ANG) was found to slow the development of neurological deficits. These results suggest that there may be positive effects of this combination of genes in posttraumatic spinal cord regeneration. The objective of the present study was to determine the effects of Ad5-VEGF+Ad5-ANG combination therapy on motor function recovery and reactivity of astrocytes in a rat model of SCI. METHODS Spinal cord injury was induced in adult Wistar rats by the weight-drop method. Rats (n = 51) were divided into 2 groups: the experimental group (Ad5-VEGF+Ad5-ANG) and the control group (Ad5-GFP [green fluorescent protein]). Recovery of motor function was assessed using the Basso, Beattie, and Bresnahan scale. The duration and intensity of infectivity and gene expression from the injected vectors were assessed by immunofluorescent detection of GFP. Reactivity of glial cells was assessed by changes in the number of immunopositive cells expressing glial fibrillary acidic protein (GFAP), S100B, aquaporin 4 (AQP4), oligodendrocyte transcription factor 2, and chondroitin sulfate proteoglycan 4. The level of S100/3 mRNA expression in the spinal cord was estimated by real-time polymerase chain reaction. RESULTS Partial recovery of motor function was observed 30 days after surgery in both groups. However, Basso, Beattie, and Bresnahan scores were 35.9% higher in the Ad5-VEGF+Ad5-ANG group compared with the control group. Specific GFP signal was observed at distances of up to 5 mm in the rostra! and caudal directions from the points of injection. A 1.5 to 2.0 fold increase in the number of GFAP+, S10013+, and AQP4+ cells was observed in the white and gray matter at a distance of up to 5 mm from the center of the lesion site in the caudal and rostral directions. At 30 days after injury, a 2-fold increase in S100/3 transcripts was observed in the Ad5-VEGF+Ad5-ANG group compared with the control group. CONCLUSIONS Intraspinal injection of recombinant adenoviral vectors encoding VEGF and ANG stimulates functional recovery after traumatic SCI. The increased number of S10013+ astrocytes induced by this approach may be a beneficial factor for maintaining the survival and function of neurons. Therefore, gene therapy with Ad5-VEGF+Ad5-ANG vectors is an effective therapeutic method for SCI treatment.	[Povysheva, Tatyana; Kolesnikov, Pavel; Islamov, Rustem; Chelyshev, Yuri] Kazan State Med Univ, 49 Butlerova Str, Kazan 420009, Russia; [Shmarov, Maksim; Logunov, Denis; Naroditsky, Boris] Republican Clin Hosp, Dept Neurosurg, Kazan, Russia; [Shulman, Ilya; Ogurcov, Sergey] Gamaleya Res Inst Epidemiol & Microbiol, Moscow, Russia		Povysheva, T (corresponding author), Kazan State Med Univ, 49 Butlerova Str, Kazan 420009, Russia.	t.povysheva@gmail.com	Chelyshev, Yuri/P-9412-2015; Povysheva, Tatyana/R-1086-2016; Islamov, Rustem R/A-3581-2019; Islamov, Rustem R/H-8722-2015; Logunov, Denis/E-8300-2014	Povysheva, Tatyana/0000-0002-3384-1450; Islamov, Rustem R/0000-0002-6632-4636; Shmarov, Maxim/0000-0002-5268-1296; Naroditsky, Boris/0000-0001-5522-8238; Logunov, Denis/0000-0003-4035-6581	Russian Science FoundationRussian Science Foundation (RSF) [16-15-00010]	We thank Y. O. Mukhamedshina and E. E. Cherenkova (Open lab Gene and Cell Technologies, Kazan [Volga Region] Federal University, Kazan, Russia) for their assistance in some experiments. The study was supported by grant no. 16-15-00010 from the Russian Science Foundation.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Aparicio-Erriu IM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00167; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; CHAMOUX M, 1991, BIOCHEM BIOPH RES CO, V176, P833, DOI 10.1016/S0006-291X(05)80261-X; Chelyshev YA, 2014, NEUROSCIENCE, V280, P328, DOI 10.1016/j.neuroscience.2014.09.004; Costa S, 2002, GLIA, V37, P105, DOI 10.1002/glia.10015; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Figley SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096137; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Islamov RR, 2004, NEUROREPORT, V15, P2117, DOI 10.1097/00001756-200409150-00024; Ismailov SM, 2014, RUSS J GENET+, V50, P518, DOI 10.1134/S1022795414050056; Iwasaki Y, 1997, J NEUROL SCI, V151, P7, DOI 10.1016/S0022-510X(97)00073-7; Jin H, 2009, SPINE, V34, pE952, DOI 10.1097/BRS.0b013e3181c4af80; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Lebedev SV, 2008, B EXP BIOL MED+, V146, P489, DOI 10.1007/s10517-009-0328-2; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; MACMILLAN M, 1991, J SPINAL DISORD, V4, P449; Nesic O, 2010, NEUROSCIENCE, V168, P1019, DOI 10.1016/j.neuroscience.2010.01.037; Qiang Hui, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P724; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Shaymardanova GF, 2013, B EXP BIOL MED+, V154, P544, DOI 10.1007/s10517-013-1996-5; Skorupa A, 2013, J PROTEOMICS, V91, P274, DOI 10.1016/j.jprot.2013.07.028; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Sorci Guglielmo, 2013, World J Biol Chem, V4, P1, DOI 10.4331/wjbc.v4.i1.1; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Tsai MC, 2008, MOL CELL PROTEOMICS, V7, P1668, DOI 10.1074/mcp.M800076-MCP200; Wang XF, 2011, J NEUROTRAUM, V28, P635, DOI 10.1089/neu.2010.1566; Zavalishin IA, 2008, B EXP BIOL MED+, V145, P483, DOI 10.1007/s10517-008-0124-4	36	12	15	0	19	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JUL	2017	27	1					105	115		10.3171/2016.9.SPINE15959			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EY6IY	WOS:000404087200015	28452633	Bronze			2022-02-06	
J	Saar, S; Lomp, A; Laos, J; Mihnovits, V; Salkauskas, R; Lustenberger, T; Vali, M; Lepner, U; Talving, P				Saar, S.; Lomp, A.; Laos, J.; Mihnovits, V.; Salkauskas, R.; Lustenberger, T.; Vali, M.; Lepner, U.; Talving, P.			Population-Based Autopsy Study of Traumatic Fatalities	WORLD JOURNAL OF SURGERY			English	Article							CARDIAC TRAUMA; EPIDEMIOLOGY; BLUNT	Background Injuries result in 5.8 million global fatalities annually and are the leading cause of death in younger individuals. Nevertheless, population-based autopsy investigations on traumatic deaths are scarce. We set out to study all consecutive autopsies on traumatic fatalities performed in a 5-year time segment in Estonia. Methods After the ethics review board approval, all consecutive autopsies after blunt or penetrating deaths occurring in prehospital or in-hospital settings between January 1, 2009, and December 31, 2013, were retrospectively reviewed using the National Forensic Medicine Database. Fatalities due to suffocation, intoxication, burns, or freezing were excluded. Data collection included demographics, mechanism of injuries, cause of death, and a detailed injury profile. Primary outcome was cause of death. Secondary outcomes included injury patterns. Results Overall, 1344 autopsies were included. 75.7% of deaths were following blunt trauma. Mean age was 50.4 +/- 18.5 years, and 77.1% were male. A total of 71.8% of deaths occurred in the prehospital setting. Accidents, assaults, and suicides constituted 64.4, 20.5, and 15.2% of deaths, respectively. A total of 51.1% of injury fatalities had a positive blood alcohol level (BAL). Mean injury severity score was 39.7 +/- 23.9. Most common cause of death was due to head injuries at 50.5% followed by hemorrhage at 30.4%. Cardiac and aortic injuries were the predominant cause of hemorrhage-related fatalities. Conclusions The current population-based investigation documented brain injury as the predominant cause of death followed by cardiac and aortic injuries. High incidence of positive BAL among injury fatalities requires national initiatives for alcohol harm reduction and law enforcement efforts.	[Saar, S.; Lomp, A.; Laos, J.; Mihnovits, V.; Salkauskas, R.; Vali, M.; Lepner, U.; Talving, P.] Univ Tartu, Sch Med, Tartu, Estonia; [Saar, S.; Laos, J.; Talving, P.] North Estonia Med Ctr, Div Acute Care Surg, Dept Surg, Tallinn, Estonia; [Salkauskas, R.; Lepner, U.; Talving, P.] Tartu Univ Hosp, Dept Surg, Ulikooli 18, EE-50090 Tartu, Estonia; [Lustenberger, T.] Goethe Univ Hosp, Div Trauma, Frankfurt, Germany; [Vali, M.] Univ Tartu, Dept Pathol Anat & Forens Med, Tartu, Estonia		Talving, P (corresponding author), Univ Tartu, Sch Med, Tartu, Estonia.; Talving, P (corresponding author), North Estonia Med Ctr, Div Acute Care Surg, Dept Surg, Tallinn, Estonia.; Talving, P (corresponding author), Tartu Univ Hosp, Dept Surg, Ulikooli 18, EE-50090 Tartu, Estonia.	peep.talving@ut.ee		Mihnovits, Vladislav/0000-0003-3897-7311			Balogh Z, 2007, J TRAUMA, V63, P1066, DOI 10.1097/TA.0b013e3181589fa4; Campbell NC, 1997, BRIT J SURG, V84, P1737, DOI 10.1046/j.1365-2168.1997.02819.x; Center for Disease Control and Prevention, 2011, INJ PREV CONTR DAT S; Demetriades D, 1998, J AM COLL SURGEONS, V187, P373, DOI 10.1016/S1072-7515(98)00209-9; Dosios TJ, 2000, J TRAUMA, V49, P696, DOI 10.1097/00005373-200010000-00018; EuroSafe, 2014, INJ EUR UN; Eurosafe, 2016, INJ EUR UN; EuroSafe, 2013, INJ EUR UN; He M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131309; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Shackelford Stacy, 2011, Am J Disaster Med, V6, P127; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sharma Gyanendra, 2006, Int J Inj Contr Saf Promot, V13, P197, DOI 10.1080/17457300500373523; Teixeira PGR, 2009, J TRAUMA, V67, P1259, DOI 10.1097/TA.0b013e318187a2d2	15	12	17	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUL	2017	41	7					1790	1795		10.1007/s00268-017-3929-3			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EX2KY	WOS:000403056400018	28255632				2022-02-06	
J	Ulbrich, F; Hagmann, C; Buerkle, H; Romao, CC; Schallner, N; Goebel, U; Biermann, J				Ulbrich, Felix; Hagmann, Claus; Buerkle, Hartmut; Romao, Carlos C.; Schallner, Nils; Goebel, Ulrich; Biermann, Julia			The Carbon monoxide releasing molecule ALF-186 mediates anti-inflammatory and neuroprotective effects via the soluble guanylate cyclase beta 1 in rats' retinal ganglion cells after ischemia and reperfusion injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Ischemia/reperfusion injury; Carbon monoxide; Neuro-inflammation; Neuroprotection; sGC-beta(1); Heat shock proteins	HEPATIC ISCHEMIA/REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; PROTECTION; PATHWAY; POPULATION; INHALATION; APOPTOSIS; IMPACT	Background: The endogenously produced gaseous molecule carbon monoxide is able to promote organ protection after ischemia-reperfusion injuries (IRI). The impact of carbon monoxide releasing molecules (CORM) regarding inflammation in neuronal tissues has not been studied in detail. In this investigation, we aimed to analyze the effects of the CORM ALF-186 on neuro-inflammation and hypothesized that the soluble guanylate cyclase (sGC) is playing a decisive role. Methods: Retinal ischemia-reperfusion injury was performed for 60 min in Sprague-Dawley rats. Thereafter, the CORM ALF-186 (10 mg/kg) in the presence or absence of the sGC inhibitor ODQ was injected via a tail vein. Retinal tissue was harvested 24 h later to analyze mRNA or protein expression of sGC-B1 subunit, transcription factors NF-.B and CREB, the inflammatory cytokines TNF-alpha and IL-6, as well as the heat shock proteins (HSP) HSP-70 and HSP-90. Immunohistochemistry was performed on frozen sections of the retina. The overall neuroprotective effect of ALF-186 was assessed by counting fluorogold-pre-labeled retinal ganglion cells (RGC) 7 days after IRI. Results: Ischemia-reperfusion mediated loss of vital RGC was attenuated by the administration of ALF-186 after injury. ALF-186 treatment after IRI induced sGC-beta 1 leading to a decreased NF-beta 1 and CREB phosphorylation. Consecutively, ALF-186 mitigated IRI induced TNF-a and IL-6 expression in the retina and in the rats' serum. Moreover, ALF-186 attenuated heat shock protein 70 (Hsp-70) while increasing Hsp-90. The sGC-inhibitor ODQ attenuated the antiinflammatory effects of ALF-186 and increased retinal loss of ganglion cells. These results were confirmed by immunohistochemistry. Conclusion: The CORM ALF-186 protected RGC from IRI induced loss. Furthermore, ALF-186 reduced IRI mediated neuroinflammation in the retina and in the serum by activating sGC. Inhibition of sGC stopped the beneficial and protective effects of ALF-186. ALF-186 may present a promising therapeutic alternative in treating inflammation after neuronal IRI.	[Ulbrich, Felix; Hagmann, Claus; Buerkle, Hartmut; Schallner, Nils; Goebel, Ulrich] Univ Freiburg, Med Ctr, Dept Anesthesiol & Crit Care, Fac Med, Hugstetter Str 55, D-79106 Freiburg, Germany; [Biermann, Julia] Univ Freiburg, Fac Med, Med Ctr, Eye Ctr, Freiburg, Germany; [Romao, Carlos C.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Romao, Carlos C.] Alfama Ltd, IBET, Oeiras, Portugal		Goebel, U (corresponding author), Univ Freiburg, Med Ctr, Dept Anesthesiol & Crit Care, Fac Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	ulrich.goebel@uniklinik-freiburg.de	Goebel, Ulrich/Q-7613-2016	Goebel, Ulrich/0000-0002-9991-3226; Romao, Carlos C./0000-0001-5061-3743	German Research Foundation (DFG)German Research Foundation (DFG) [Go 2158/3-1, Bi 1567/2-1]	This work was conducted at the Department of Anesthesiology and Intensive Care and the Eye Center, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany and granted by The German Research Foundation (DFG, Grants: for Ulrich Goebel Go 2158/3-1 and for Julia Biermann Bi 1567/2-1). The funder (DFG) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida AS, 2016, J NEUROCHEM, V138, P423, DOI 10.1111/jnc.13653; Banecka-Majkutewicz Z, 2014, ACTA BIOCHIM POL, V61, P379; Bettaga N, 2015, ANGIOGENESIS, V18, P245, DOI 10.1007/s10456-015-9463-8; Biermann J, 2011, MOL VIS, V17, P1275; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Costa NRD, 2013, EUR J PHARMACOL, V700, P51, DOI 10.1016/j.ejphar.2012.12.007; Dasgupta A, 2015, CLIN PHARMACOL THER, V97, P88, DOI 10.1002/cpt.10; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fujimoto H, 2004, ARTERIOSCL THROM VAS, V24, P1848, DOI 10.1161/01.ATV.0000142364.85911.0e; He DK, 2015, BRAIN RES, V1599, P150, DOI 10.1016/j.brainres.2014.12.019; Kaizu T, 2008, AM J PHYSIOL-GASTR L, V294, pG236, DOI 10.1152/ajpgi.00144.2007; Kelly Stephen, 2002, Curr Med Res Opin, V18 Suppl 2, ps55, DOI 10.1185/030079902125000732; Kim N, 2012, SP BIRKHAUSER VERLAG, V20, P177; Kohmoto J, 2006, J SURG RES, V130, P208; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mahan VL, 2012, PLOS ONE, P7; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Mori A, 2015, EUR J PHARMACOL, V764, P249, DOI 10.1016/j.ejphar.2015.07.009; Nakao A, 2006, TRANSPLANTATION, V81, P220, DOI 10.1097/01.tp.0000188637.80695.7f; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Neto JS, 2004, AM J PHYSIOL-RENAL, V287, pF979, DOI 10.1152/ajprenal.00158.2004; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Qin WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075840; Queiroga CSF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042632; Ruan YL, 2014, KIDNEY INT, V86, P525, DOI 10.1038/ki.2014.80; Sandouka A, 2006, KIDNEY INT, V69, P239, DOI 10.1038/sj.ki.5000016; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Tomiyama K, 2008, HEPATOLOGY, V48, P1608, DOI 10.1002/hep.22482; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wei YW, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-42; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007	35	12	13	1	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUN 27	2017	14								130	10.1186/s12974-017-0905-7			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EZ8UH	WOS:000405003100001	28655348	Green Published, gold			2022-02-06	
J	Guo, XB; Deng, X; Wei, Y				Guo, Xin-bin; Deng, Xin; Wei, Ying			Homing of Cultured Endothelial Progenitor Cells and Their Effect on Traumatic Brain Injury in Rat Model	SCIENTIFIC REPORTS			English	Article							ENHANCES NEUROGENESIS; CEREBRAL-ISCHEMIA; CD34(+) CELLS; ANGIOGENESIS; TRANSPLANTATION; STROKE; DISEASE	Transplanted endothelial progenitor cells (EPCs) may play an important role in reestablishing the endothelial integrity of the vessels after brain injury, and contribute to neurogenesis. We, therefore, tested the homing of ex vivo cultured peripheral blood-derived EPCs and their effect on injured brain tissue after intravenous administration. To track the homing of implanted EPCs in injured brain tissues, EPCs were labeled with DAPI and BrdU in vitro before transplantation. EPCs were transplanted into the host animal through peripheral administration through the femoral vein, and homing of EPCs was evaluated. The integration of intravenously injected EPCs into the injured brain tissue was demonstrated. Immunohistochemical staining showed that microvessel density in the perifocal region of EPCs-transplanted rats was significantly increased, and the numbers of BrdU+ cells in the DG of subventricular zone were increased in EPCs-transplanted rats as compared to the control group. Transplanted EPCs may play an important role in reestablishing the endothelial integrity in the vessels after brain injury and further contribute to neurogenesis. EPCs enhanced recovery following brain injury in a rat model of TBI.	[Guo, Xin-bin; Deng, Xin; Wei, Ying] Zhengzhou Univ, Dept Neurointervent Radiol, Affiliated Hosp 1, 1 Jianshe Rd, Zhengzhou 450052, Peoples R China		Guo, XB (corresponding author), Zhengzhou Univ, Dept Neurointervent Radiol, Affiliated Hosp 1, 1 Jianshe Rd, Zhengzhou 450052, Peoples R China.	gxb3906080@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100928]; Henan Medical Science Research Project [2011020010]	The work is supported by National Natural Science Foundation of China 81100928, and Henan Medical Science Research Project 2011020010.	Adamczak J, 2015, STROKE, V46, pE103, DOI 10.1161/STROKEAHA.114.007642; Alphonse RS, 2015, NAT PROTOC, V10, P1697, DOI 10.1038/nprot.2015.107; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bennis Y, 2012, J THROMB HAEMOST, V10, P1914, DOI 10.1111/j.1538-7836.2012.04835.x; Chong MSK, 2016, STEM CELL TRANSL MED, V5, P530, DOI 10.5966/sctm.2015-0227; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hecht N, 2014, J CEREBR BLOOD F MET, V34, P1297, DOI 10.1038/jcbfm.2014.78; Hou LQ, 2016, AM J PHYSIOL-HEART C, V310, pH455, DOI 10.1152/ajpheart.00726.2015; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Long JT, 2013, J VASC SURG, V58, P756, DOI 10.1016/j.jvs.2012.11.096; Ma FF, 2015, BRAIN RES, V1623, P150, DOI 10.1016/j.brainres.2015.02.010; Nguyen MP, 2015, ONCOTARGET, V6, P16588, DOI 10.18632/oncotarget.3752; Morancho A, 2015, J CEREBR BLOOD F MET, V35, P1547, DOI 10.1038/jcbfm.2015.180; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Rodrigues HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165115; Seki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12152; Subramaniyam V, 2009, AM HEART J, V158, P53, DOI 10.1016/j.ahj.2009.04.014; Sun K, 2016, CURR STEM CELL RES T, V11, P265, DOI 10.2174/1574888X1103160303181155; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tan Y, 2016, ONCOTARGET, V7, P87100, DOI 10.18632/oncotarget.13527; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xu XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11456; Yang J, 2015, BRAIN RES, V1625, P189, DOI 10.1016/j.brainres.2015.09.001	26	12	13	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 23	2017	7								4164	10.1038/s41598-017-04153-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UL	WOS:000404118700055	28646184	Green Published, gold			2022-02-06	
J	Ogundele, OM; Ebenezer, PJ; Lee, CC; Francis, J				Ogundele, Olalekan M.; Ebenezer, Philip J.; Lee, Charles C.; Francis, Joseph			STRESS-ALTERED SYNAPTIC PLASTICITY AND DAMP SIGNALING IN THE HIPPOCAMPUS-PFC AXIS; ELUCIDATING THE SIGNIFICANCE OF IGF-1/IGF-1R/CAMKII alpha EXPRESSION IN NEURAL CHANGES ASSOCIATED WITH A PROLONGED EXPOSURE THERAPY	NEUROSCIENCE			English	Article						IGF-1R; CaMKII alpha; IGF-1; synaptic morphology; DAMP; traumatic stress	GROWTH-FACTOR-I; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; SMALL-CONDUCTANCE; GENE-EXPRESSION; IGF-I; ALZHEIMERS-DISEASE; POTASSIUM CHANNELS; CONTEXTUAL MEMORY; AROUSAL SYMPTOMS	Traumatic stress patients showed significant improvement in behavior after a prolonged exposure to an unrelated stimulus. This treatment method attempts to promote extinction of the fear memory associated with the initial traumatic experience. However, the subsequent prolonged exposure to such stimulus creates an additional layer of neural stress. Although the mechanism remains unclear, prolonged exposure therapy (PET) likely involves changes in synaptic plasticity, neurotransmitter function and inflammation; especially in parts of the brain concerned with the formation and retrieval of fear memory (Hippocampus and Prefrontal Cortex: PFC). Since certain synaptic proteins are also involved in danger-associated molecular pattern signaling (DAMP), we identified the significance of IGF-1/IGF-1R/CaMKII alpha expression as a potential link between the concurrent progression of synaptic and inflammatory changes in stress. Thus, a comparison between IGF-1/IGF-1R/CaMKII alpha, synaptic and DAMP proteins in stress and PET may highlight the significance of PET on synaptic morphology and neuronal inflammatory response. In behaviorally characterized Sprague-Dawley rats, there was a significant decline in neural IGF-1 (p < 0.001), hippocampal (p < 0.001) and cortical (p < 0.05) IGF-1R expression. These animals showed a significant loss of presynaptic markers (synaptophysin; p < 0.001), and changes in neurotransmitters (VGLUT2, Tyrosine hydroxylase, GABA, ChAT). Furthermore, naive stressed rats recorded a significant decrease in post synaptic marker (PSD-95; p < 0.01) and synaptic regulator (CaMKII alpha; p < 0.001). As part of the synaptic response to a decrease in brain CaMKII alpha, small ion conductance channel (KCa2.2) was upregulated in the brain of naive stressed rats (p < 0.01). After a PET, an increase in IGF-1 (p < 0.05) and IGF-1R was recorded in the Stress-PET group (p < 0.001). As such, hippocampal (p < 0.001), but not cortical (ns) synaptophysin expression increased in Stress-PET. Although PSD-95 was relatively unchanged in the hippocampus and PFC, CaMKII alpha (p < 0.001) and KCa2.2 (p < 0.01) were upregulated in Stress-PET, and may be involved in extinction of fear memory-related synaptic potentials. These changes were also associated with a normalized neurotransmitter function, and a significant reduction in open space avoidance; when the animals were assessed in elevated plus maze (EPM). In addition to a decrease in IGF-1/IGF-1R, an increase in activated hippocampal and cortical microglia was seen in stress (p < 0.05) and after a PET (Stress-PET; p < 0.001). Furthermore, this was linked with a significant increase in HMGB1 (Hippocampus: p < 0.001, PFC: p < 0.05) and TLR4 expression (Hippocampus: p < 0.01; PFC: ns) in the neurons. Taken together, this study showed that traumatic stress and subsequent PET involves an event dependent alteration of IGF1/IGF-1R/CaMKII alpha. Firstly, we showed a direct relationship between IGF-1/IGF-1R expression, presynaptic function (synaptophysin) and neurotransmitter activity in stress and PET. Secondly, we identified the possible role of CaMKII alpha in post-synaptic function and regulation of small ion conductance channels. Lastly, we highlighted some of the possible links between IGF1/IGF1R/CaMKII alpha, the expression of DAMP proteins, Microglia activation, and its implication on synaptic plasticity during stress and PET. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Ogundele, Olalekan M.; Ebenezer, Philip J.; Lee, Charles C.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA		Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu		Lee, Charles/0000-0001-6938-1604	IBRO-ISN Fellowship; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 MH 104851]; Louisiana Board of Regents RCS Grant [RD-A-09]; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-15-1-10061]; SVM CORP Funds; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH104851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG052120] Funding Source: NIH RePORTER	This study was supported by the IBRO-ISN Fellowship 2015 awarded to OOM. NIH Grant R03 MH 104851 and Louisiana Board of Regents RCS Grant RD-A-09 awarded to CCL. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program 2014 under Award No. W81XWH-15-1-10061 and SVM CORP Funds awarded to JF. The opinions, interpretations, conclusions and recommendation are those of the authors and are not necessary endorsed by the Department of Defense or other agencies listed above.	Abraham AD, 2016, NEUROPSYCHOPHARMACOL; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bouallegue A, 2009, FREE RADICAL BIO MED, V47, P858, DOI 10.1016/j.freeradbiomed.2009.06.022; Castillo DT, 2016, PSYCHOL TRAUMA; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Dall'Igna OP, 2013, INT J DEV NEUROSCI, V31, P482, DOI 10.1016/j.ijdevneu.2013.06.002; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Dong YJ, 2015, J CLIN SLEEP MED, V11, P1243, DOI 10.5664/jcsm.5106; Doyle S, 2010, J BIOL CHEM; Doyle S, 2010, J BIOL CHEM, V285, P14366, DOI 10.1074/jbc.M109.080069; Duan YQ, 2014, FOOD FUNCT, V5, P2289, DOI [10.1039/c4fo00250d, 10.1039/C4FO00250D]; Finsterwald C, 2015, J NEUROSCI, V35, P15903, DOI 10.1523/JNEUROSCI.0771-15.2015; Fiorenza NG, 2012, BEHAV BRAIN RES, V232, P210, DOI 10.1016/j.bbr.2012.04.015; Franklin K., 1997, MOUSE BRAIN STEREOTA, P45; Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527; Furini C, 2014, NEUROSCI BIOBEHAV R, V47, P670, DOI 10.1016/j.neubiorev.2014.10.016; Gao L, 2014, ONCOTARGET, V5, P2562, DOI 10.18632/oncotarget.1812; Gazit N, 2016, NEURON, V89, P583, DOI 10.1016/j.neuron.2015.12.034; Gontier G, 2015, J NEUROSCI, V35, P11500, DOI 10.1523/JNEUROSCI.0343-15.2015; Gonzalez C, 2012, COMPR PHYSL; Grunnet M, 2010, KCA1 KCA5 FAMILIES I, P403; GuevaraAguirre J, 1996, NEW ENGL J MED, V335, P1389, DOI 10.1056/NEJM199610313351810; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hu AK, 2016, BRAIN RES, V1631, P204, DOI 10.1016/j.brainres.2015.11.010; Huang GB, 2013, INT J NEUROPSYCHOPH, V16, P1635, DOI 10.1017/S1461145713000060; Hwa V, 2013, NESTLE NUTR WORKS SE, V71, P43, DOI 10.1159/000342548; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jerud AB, 2016, BEHAV RES THER, V77, P62, DOI 10.1016/j.brat.2015.12.002; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kuiper EFE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00107; la Cour CM, 2011, MOL PHARMACOL, V79, P91, DOI 10.1124/mol.110.065409; Lam J, 2013, EXPERT OPIN THER TAR, V17, P1203, DOI 10.1517/14728222.2013.823161; Larsen SE, 2016, BEHAV RES THER, V77, P68, DOI 10.1016/j.brat.2015.12.009; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Ma Lijuan, 2012, Immune Netw, V12, P148, DOI 10.4110/in.2012.12.4.148; Makkar SR, 2010, NEUROPSYCHOPHARMACOL, V35, P1625, DOI 10.1038/npp.2010.53; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mattson MP, 1990, ADV EXP MED BIOL, V1990, P211; McKay BM, 2012, J NEUROPHYSIOL, V108, P863, DOI 10.1152/jn.00025.2012; MELANDER T, 1985, BRAIN RES, V360, P130, DOI 10.1016/0006-8993(85)91228-4; Mpari B, 2010, HIPPOCAMPUS, V20, P352, DOI 10.1002/hipo.20622; Murthy SRK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127264; Novick AM, 2016, BEHAV BRAIN RES, V304, P51, DOI 10.1016/j.bbr.2016.02.013; Pan YW, 2013, NEUROBIOL LEARN MEM, V105, P81, DOI 10.1016/j.nlm.2013.07.011; Pang EW, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00170; Pavlovsky L, 2012, BRAIN RES, V1472, P99, DOI 10.1016/j.brainres.2012.05.057; Pehar M, 2010, AGING CELL, V9, P174, DOI 10.1111/j.1474-9726.2010.00547.x; Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609; Rosso SB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00103; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Rusch HL, 2015, J CLIN SLEEP MED, V11, P615, DOI 10.5664/jcsm.4770; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stackman RW, 2008, LEARN MEMORY, V15, P208, DOI 10.1101/lm.906808; Su SS, 2015, PSYCHIAT RES, V229, P365, DOI 10.1016/j.psychres.2015.06.038; Sun HY, 2016, EPILEPSY RES, V119, P30, DOI 10.1016/j.eplepsyres.2015.11.006; Takeuchi Y, 2002, J NEUROCHEM, V82, P316, DOI 10.1046/j.1471-4159.2002.00967.x; Trimmer JS, 2015, NEURON, V85, P238, DOI 10.1016/j.neuron.2014.12.042; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Wilson CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089104; YAMAGUCHI F, 1990, BRAIN RES, V533, P344, DOI 10.1016/0006-8993(90)91361-J; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Yehuda R, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0048; Yu XF, 2012, ACTA BIOCH BIOPH SIN, V44, P746, DOI 10.1093/abbs/gms059; Zhang SF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06811; Zhao H, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-12; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613	78	12	12	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 14	2017	353						147	165		10.1016/j.neuroscience.2017.04.008			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EW1CV	WOS:000402228400013	28438613	Green Accepted			2022-02-06	
J	Ang, D; Kurek, S; McKenney, M; Norwood, S; Kimbrell, B; Barquist, E; Liu, HZ; O'Dell, A; Ziglar, M; Hurst, J				Ang, Darwin; Kurek, Stan; McKenney, Mark; Norwood, Scott; Kimbrell, Brian; Barquist, Erik; Liu, Huazhi; O'Dell, Annette; Ziglar, Michele; Hurst, James			Outcomes of Geriatric Trauma Patients on Preinjury Anticoagulation: A Multicenter Study	AMERICAN SURGEON			English	Article							PRESCRIPTION ANTIPLATELET AGENTS; INTRACRANIAL HEMORRHAGE; BRAIN-INJURY; WARFARIN USE; HEAD TRAUMA; IMPACT; CLOPIDOGREL; DISEASE; RISK; PREVENTION	Outpatient anticoagulation in the geriatric trauma patient is a challenging clinical problem. The aim of this study is to determine clinical outcomes associated with class of preinjury anticoagulants (PA) used by this population. This is a multicenter retrospective cohort study among four Level II trauma centers. A total of 1642 patients were evaluated; 684 patients were on anticoagulation and 958 patients were not. Patients on PAwere compared with those who were not. Drug classes were divided into thromboxane A2 inhibitors, vitamin K factor-dependent inhibitors, antithrombin III activation, platelet P2Y12 inhibitors, and thrombin inhibitors. Multivariate regression was used to adjust for age, gender, race, mechanism of injury, and Injury Severity Score. No single or combination of anticoagulation agents had a significant association with mortality; however, there were positive trends toward increased mortality were noted for all antiplatelet groups involving thromboxane A2 inhibitors and platelet P2Y12 inhibitors classes. The likelihood of complications was significantly higher with platelet P2Y12 inhibitors adjusted odds ratio (aOR) 2.39 [95% confidence interval (CI) 1.32, 4.3]. The likelihood of blood transfusion was increased with vitamin K inhibitors aOR 2.89 (95% CI 1.3, 6.5), P2Y12 inhibitors aOR 2.76 ( 95% CI 1.12, 6.76), and combined thromboxane A2 and P2Y12 inhibitors aOR 2.89 (95% CI 1.13, 7.46). P2Y12 inhibitors were also more likely associated with traumatic brain injury aOR 2.16 (95% CI 1.01, 4.6). All classes of PA were associated with solid organ injury. There were no significant differences in the use of antiplatelet agents between patients with major indications for PA and those without major indications. Geriatric trauma patients on outpatient anticoagulants have a higher likelihood of developing complications, packed red blood cell transfusions, traumatic brain injury, and solid organ injury. Attention should be paid to patients on platelet P2Y12 inhibitors, vitamin Kinhibitors, and thromboxane A2 inhibitor agents combined with platelet P2Y12 inhibitors. Opportunities exist to address the use of antiplatelet agents among patients without major indications to improve patient outcomes.	[Ang, Darwin; Kurek, Stan; McKenney, Mark; Norwood, Scott; Barquist, Erik; Liu, Huazhi; O'Dell, Annette; Hurst, James] Univ S Florida, Dept Surg, Tampa, FL USA; [Ang, Darwin; Liu, Huazhi] Ocala Hlth Syst, Ocala, FL USA; [McKenney, Mark] Kendall Reg Med Ctr, Miami, FL USA; [Kurek, Stan] Lawnwood Med Ctr, Ft Pierce, FL USA; [Barquist, Erik] Cent Florida Med Ctr, Sanford, FL USA; [Norwood, Scott] Bayonet Point Med Ctr, Hudson, FL USA; Blake Med Ctr, Bradenton, FL USA; [Ziglar, Michele] Hosp Corp America, Bradenton, FL USA		Ang, D (corresponding author), 1234 SE Magnolia Ext,Unit 1, Ocala, FL 34471 USA.	darwinang@usf.edu					Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Bowry ADK, 2008, AM J CARDIOL, V101, P960, DOI 10.1016/j.amjcard.2007.11.057; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Byrnes MC, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-25; Ciesla DJ, 2013, SURGERY, V154, P291, DOI 10.1016/j.surg.2013.04.025; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hackam DG, 2005, CIRCULATION, V111, P2250, DOI 10.1161/01.CIR.0000163548.38396.E7; Hankey GJ, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0480-9; Inui TS, 2014, J TRAUMA ACUTE CARE, V76, P642, DOI 10.1097/TA.0000000000000138; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Lowe G, 2014, DIABETES, V63, P1115, DOI 10.2337/db12-1625; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Shoob HD, 2007, PREV MED, V44, P447, DOI 10.1016/j.ypmed.2006.12.013; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	29	12	12	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUN	2017	83	6					527	535					9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FA2VS	WOS:000405299900014	28637551				2022-02-06	
J	Grando, MA; Murcko, A; Mahankali, S; Saks, M; Zent, M; Chern, D; Dye, C; Sharp, R; Young, L; Davis, P; Hiestand, M; Hassanzadeh, N				Grando, Maria Adela; Murcko, Anita; Mahankali, Srividya; Saks, Michael; Zent, Michael; Chern, Darwyn; Dye, Christy; Sharp, Richard; Young, Laura; Davis, Patricia; Hiestand, Megan; Hassanzadeh, Neda			A Study to Elicit Behavioral Health Patients' and Providers' Opinions on Health Records Consent	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							MANAGEMENT PRACTICE PATTERNS; ATHLETIC TRAINERS; CONCUSSION		[Grando, Maria Adela; Murcko, Anita] Arizona State Univ, Dept Biomed Informat, Tempe, AZ 85287 USA; [Grando, Maria Adela] Mayo Clin, Coll Med, Med, Rochester, MN 55905 USA; [Mahankali, Srividya; Davis, Patricia; Hiestand, Megan; Hassanzadeh, Neda] Arizona State Univ, Tempe, AZ 85287 USA; [Saks, Michael] Arizona State Univ, Sandra Day OConnor Coll Law, Law & Psychol, Tempe, AZ 85287 USA; [Zent, Michael] Topaz Informat Solut LLC, Phoenix, AZ USA; [Zent, Michael] Jewish Family & Childrens Serv Phoenix, Phoenix, AZ USA; [Zent, Michael] Behav Hlth Informat Network Arizona BHINAZ, Phoenix, AZ USA; [Chern, Darwyn] Partners Recovery LLC, Clin Serv, Phoenix, AZ USA; [Chern, Darwyn; Dye, Christy] Partners Recovery LLC, Phoenix, AZ USA; [Sharp, Richard] Mayo Clin, Biomed Eth Program, Rochester, MN USA; [Sharp, Richard] Ctr Individualized Med Bioeth Program, Rochester, MN USA; [Sharp, Richard] Clin & Translat Res Eth Program, Rochester, MN USA; [Young, Laura] BHINAZ, Phoenix, AZ USA		Grando, MA (corresponding author), Arizona State Univ, Dept Biomed Informat, Tempe, AZ 85287 USA.; Grando, MA (corresponding author), Mayo Clin, Coll Med, Med, Rochester, MN 55905 USA.		Murcko, Anita/U-2404-2019	Murcko, Anita/0000-0002-2424-0987	National Institute for Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1 R01 MH108992-01]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH108992] Funding Source: NIH RePORTER	This research has been supported by "My Data Choices, evaluation of effective consent strategies for patients with behavioral health conditions" (1 R01 MH108992-01), funded by the National Institute for Mental Health.	Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Hainline B., 2015, MEMORANDUM AUTONOMOU; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kroshus E., 2016, HEALTH EDUC BEHAV, V43, P66; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lowery K., 2016, J HLTH CARE LAW POLI, V19, P99; NCAA, CONC GUID DIAGN MAN; NCAA, 2013, 2013 2014 NCAA SPORT, P56; Saldana J, 2012, CODING MANUAL QUALIT; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290	12	12	12	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	JUN	2017	45	2					238	259		10.1177/1073110517720653			22	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	FA6SL	WOS:000405574300010	30976154	Green Accepted			2022-02-06	
J	Hirst, RB; Han, CS; Teague, AM; Rosen, AS; Gretler, J; Quittner, Z				Hirst, Rayna B.; Han, Cecilia S.; Teague, Anna M.; Rosen, Alexis S.; Gretler, Julie; Quittner, Zoe			Adherence to Validity Testing Recommendations in Neuropsychological Assessment: A Survey of INS and NAN Members	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Forensic neuropsychology; Malingering/symptom validity testing; Professional issues	TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; SYMPTOM VALIDITY; SUBOPTIMAL EFFORT; INADEQUATE EFFORT; TEST FAILURE; BASE-RATE; MILD TBI; PERFORMANCE; MOTIVATION	Objective: The National Academy of Neuropsychology (NAN) has published recommendations for best validity testing practices, as has the American Academy of Clinical Neuropsychologists (AACN) in their review of critical issues in the field. However, surveys show not all neuropsychologists follow these recommendations consistently. Examiner characteristics (e.g., training history) and current practice characteristics (e.g., type of practice setting) may affect systematic adherence to these recommendations. Further, previous surveys focused on distinct countries or continents rather than an international sample. This study sought to provide better understanding of examiner factors that contribute to recommendation adherence and identify opportunities for improving validity testing training and practice. Method: A sample of 654 NAN and International Neuropsychological Society (INS) neuropsychologists responded to online survey questions about their demographic, training, and practice characteristics, as well as validity testing practices. Results: Findings indicate that neuropsychologists from other countries generally adhere to NAN and AACN recommendations as closely as United States neuropsychologists. Across all neuropsychologists, those who work with pediatric and geriatric populations do not follow recommendations as consistently as those who work with adults, despite research supporting that recommendations should be followed with all patients. Neuropsychologists who have been practicing longer were also less likely to adhere to recommendations, suggesting that continuing education would be beneficial even for more experienced neuropsychologists. Conclusions: Results highlight the need for continued training on the importance of validity testing practices across different countries and all assessment settings, and identify groups of neuropsychologists to whom training could be targeted to maximize effectiveness.	[Hirst, Rayna B.; Han, Cecilia S.; Teague, Anna M.; Rosen, Alexis S.; Gretler, Julie; Quittner, Zoe] Palo Alto Univ, 1791 Arastradero Rd, Palo Alto, CA 94304 USA		Hirst, RB (corresponding author), Palo Alto Univ, 1791 Arastradero Rd, Palo Alto, CA 94304 USA.	rhirst@paloaltou.edu	Teague, Anna M./U-4694-2019	Rosen, Alexis/0000-0001-6925-5763; Teague, Anna/0000-0002-0651-151X			An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; British Psychological Society, 2009, ASS EFF CLIN TEST CO; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone D. A., 2013, CLIN NEUROPSYCHOL, P1; Carone DA, 2014, APPL NEUROPSYCH-ADUL, V21, P155, DOI 10.1080/09084282.2012.755533; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Chafetz MD, 2011, ARCH CLIN NEUROPSYCH, V26, P306, DOI 10.1093/arclin/acr030; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Dean A. C., 2007, CLIN NEUROPSYCHOL, V23, P133; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Guilmette T. J., 2012, MILD TRAUMATIC BRAIN; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Macher RB, 2012, J CLIN EXP NEUROPSYC, V34, P405, DOI 10.1080/13803395.2011.646957; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCarter RJ, 2009, CLIN NEUROPSYCHOL, V23, P1050, DOI 10.1080/13854040802665790; Merten T, 2010, Versicherungsmedizin, V62, P126; Ploetz DM, 2016, CHILD NEUROPSYCHOL, V22, P133, DOI 10.1080/09297049.2014.986446; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Sauermann H, 2013, RES POLICY, V42, P273, DOI 10.1016/j.respol.2012.05.003; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sherman E. M. S., 2015, VALIDITY TESTING CHI, P22; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stulemeijer M, 2007, BRAIN INJURY, V21, P309, DOI 10.1080/02699050701209980; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X	37	12	12	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2017	32	4					456	471		10.1093/arclin/acx009			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EY2LX	WOS:000403800800008	28184453				2022-02-06	
J	Juengst, SB; Myrga, JM; Fann, JR; Wagner, AK				Juengst, Shannon B.; Myrga, John M.; Fann, Jesse R.; Wagner, Amy K.			Cross-Lagged Panel Analysis of Depression and Behavioral Dysfunction in the First Year After Moderate-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							CHALLENGING BEHAVIOR; AGGRESSIVE-BEHAVIOR; SCALE FRSBE; SEQUELAE; SYSTEMS; MULTICENTER; IMPULSIVITY; SERTRALINE; PREDICTOR; DOPAMINE	Timely treatment of depression and behavioral dysfunction after moderate-to-severe traumatic brain injury (TBI) could improve health, function, and quality of life. The authors hypothesized that 6-month depression would be the stronger contributor to later depression and behavioral dysfunction in a sample of 88 adults with moderate-to-severe TBI. A structural equation modeling cross-lagged panel analysis, adjusting for all 6-month predictors, revealed that 6-month depression had a stronger relationship to 12-month depression (beta(stand)=0.55, p=0.002) and behavioral dysfunction (beta(stand)=0.41, p=0.004) than did 6-month behavioral dysfunction (beta(stand)=0.17, p=0.270, beta(stand)=0.30, p=0.035). Depression may be in the developmental pathway to behavioral dysfunction, triggering a cycle of reciprocal causality.	[Juengst, Shannon B.; Myrga, John M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Juengst, SB (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	Shannon.Juengst@UTSouthwestern.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [NIDILRR: 90DP0041]; Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [CDC: R49 CCR 323155]; National Science FoundationNational Science Foundation (NSF) [NSF-DGE-0549352]; Department of DefenseUnited States Department of Defense [DOD: W81XWH-071-0701]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000041] Funding Source: NIH RePORTER	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR: 90DP0041), the Centers for Disease Control (CDC: R49 CCR 323155), the National Science Foundation (NSF-DGE-0549352), and the Department of Defense (DOD: W81XWH-071-0701). NIDILRR is a Center within the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS).	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; Chan KL, 2006, ARCH PHYS MED REHAB, V87, P793, DOI 10.1016/j.apmr.2006.02.016; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Economidou D, 2012, NEUROPSYCHOPHARMACOL, V37, P2057, DOI 10.1038/npp.2012.53; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Grace J, 2001, FRSBE FRONTAL SYSTEM; Heller AS, 2013, JAMA PSYCHIAT, V70, P1181, DOI 10.1001/jamapsychiatry.2013.2430; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Judd LL, 2013, JAMA PSYCHIAT, V70, P1171, DOI 10.1001/jamapsychiatry.2013.1957; Juengst SB, 2015, ARCH PHYS M IN PRESS; Juengst SB, 2016, J CLIN EXP NEUROPSYC; Juengst SB, REHABIL PSY IN PRESS; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kim KH, 2005, STRUCT EQU MODELING, V12, P368, DOI 10.1207/s15328007sem1203_2; Kline RB., 2004, PRINCIPLES PRACTICE, V2nd; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; Miller MC, 2013, JAMA PSYCHIAT, V70, P1131, DOI 10.1001/jamapsychiatry.2013.3493; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Selig J. P., 2012, HDB DEV RES METHODS; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Smi CK, 2006, STROKE, V37, P156, DOI 10.1161/01.STR.0000190892.93663.e2; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	42	12	12	0	2	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2017	29	3					260	266		10.1176/appi.neuropsych.16100217			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	FE5CN	WOS:000408229700009	28294709	Bronze, Green Accepted			2022-02-06	
J	Karri, J; Mas, MF; Francisco, GE; Li, S				Karri, Jay; Mas, Manuel F.; Francisco, Gerard E.; Li, Sheng			PRACTICE PATTERNS FOR SPASTICITY MANAGEMENT WITH PHENOL NEUROLYSIS	JOURNAL OF REHABILITATION MEDICINE			English	Article						phenol; neurolysis; spasticity	PERIPHERAL-NERVE BLOCKADE; BRACHIAL-PLEXUS BLOCK; POSTSTROKE SPASTICITY; BOTULINUM-TOXIN; ULTRASOUND; MUSCLE; INJECTION; GUIDANCE; INJURY; SAFETY	Objective: To present practice patterns for phenol neurolysis procedures conducted for spasticity management. Design: A retrospective review of 185 persons with spasticity who underwent phenol neurolysis procedures (n = 293) at an academic rehabilitation hospital and clinic. Patient demographics, concomitant spasticity treatments, and procedure relevant information were collected. Results: The cohort included 71.9% males and 61.6% inpatient procedures. Neurological diagnoses included stroke (41.0%), traumatic brain injury (28.6%) and spinal cord injury (24.3%). Musculoskeletal diagnoses included spastic hemiplegia or paresis (51.3%), tetraplegia (38.4) and paraplegia (9.2%). At the time of phenol neurolysis, most patients (77.5%) received concomitant pharmacological treatments for spasticity. Injection guidance modalities included electrical stimulation and ultrasound (69.3%) or ultrasound only (27.3%). A mean of 3.48 ml of phenol were injected per nerve and 10.95 ml of phenol were used per procedure. Most commonly injected nerves included the obturator nerve (35.8%) and sciatic branches to the hamstrings and adductor magnus (27.0%). Post-phenol neurolysis assessment was recorded in 54.9% of encounters, in which 84.5% reported subjective benefit. Post-procedure adverse events included pain (4.0%), swelling and inflammation (2.7%), dysaesthesia (0.7%) and hypotension (0.7%). Conclusion: Phenol neurolysis is currently used to reduce spasticity for various functional goals, including preventing contractures and improving gait. Depending on the pattern of spasticity displayed, numerous peripheral nerves in the upper and lower extremities can be targeted for treatment with phenol neurolysis. Further research into its role in spasticity management, including studies exploring its cost-effectiveness and pharmacological and side-effects compared with other treatment options are needed.	[Li, Sheng] Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Phys Med & Rehabil, McGovern Med Sch, Houston, TX 77030 USA; TIRR Mem Hermann, NeuroRecovery Res Ctr, Houston, TX USA		Li, S (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Phys Med & Rehabil, McGovern Med Sch, Houston, TX 77030 USA.	sheng.li@uth.tmc.edu	Li, Sheng/ABC-5392-2021		NIH/NICHD/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD087128]	The study was in part supported by an NIH/NICHD/NCMRR grant (R21HD087128).	Awaad Y, 2012, ISRN NEUROL; Bakheit A., 1996, CLIN REHABIL, V10, P40, DOI [10.1177/026921559601000108, DOI 10.1177/026921559601000108]; Bensmail Djamel, 2014, J Med Econ, V17, P618, DOI 10.3111/13696998.2014.925462; Brull R, 2008, ANESTHESIOLOGY, V109, P1142, DOI 10.1097/ALN.0b013e31818dd8aa; Casati A, 2007, ANESTHESIOLOGY, V106, P992, DOI 10.1097/01.anes.0000265159.55179.e1; Childers Martin K, 2003, Phys Med Rehabil Clin N Am, V14, P781, DOI 10.1016/S1047-9651(03)00047-0; Chin KJ, 2008, CURR OPIN ANESTHESIO, V21, P624, DOI 10.1097/ACO.0b013e32830815d1; Dhir S, 2008, ACTA ANAESTH SCAND, V52, P1158, DOI 10.1111/j.1399-6576.2008.01736.x; Dufour E, 2008, ANESTH ANALG, V106, P1553, DOI 10.1213/ane.0b013e3181684b42; Elovic EP, 2009, PM&R, V1, P842, DOI 10.1016/j.pmrj.2009.08.001; Francisco GE, 2016, PHYS MED REHABILITAT, P487; Francisco GE, 2012, STROKE, V43, P3132, DOI 10.1161/STROKEAHA.111.639831; Fu J, 2013, SUPPORT CARE CANCER, V21, P1227, DOI 10.1007/s00520-012-1651-0; Furr-Stimming E, 2014, SEMIN NEUROL, V34, P591, DOI 10.1055/s-0034-1396012; Gordon MF, 2004, NEUROLOGY, V63, P1971, DOI 10.1212/01.WNL.0000144349.95487.91; GRACIES JM, 1997, MUSCLE NERVE       S, V6, pS61; HALPERN D, 1967, J AMER MED ASSOC, V200, P1152, DOI 10.1001/jama.200.13.1152; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Kocabas H, 2010, EUR J PHYS REHAB MED, V46, P5; Kolaski K, 2008, AM J PHYS MED REHAB, V87, P556, DOI 10.1097/PHM.0b013e31817c115b; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lim ECH, 2006, PARKINSONISM RELAT D, V12, P43, DOI 10.1016/j.parkreldis.2005.06.008; Lindsay C, 2016, COCHRANE DB SYST REV, V10; O'Brien CF, 1997, MUSCLE NERVE, pS176; Pierson SH, 1997, MUSCLE NERVE, V6, pS37; Ploypetch T, 2015, PM&R, V7, P1073, DOI 10.1016/j.pmrj.2015.05.020; Rosales RL, 2008, J NEURAL TRANSM, V115, P617, DOI 10.1007/s00702-007-0869-3; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Stevenson Valerie L, 2016, SPASTICITY MANAGEMEN; SUPERVILLESOVAK B, 1975, ARCH NEUROL-CHICAGO, V32, P226, DOI 10.1001/archneur.1975.00490460042004; Viel E, 2003, NEUROCHIRURGIE, V49, P256; Watanabe T, 2011, SPASTICITY: DIAGNOSIS AND MANAGEMENT, P71	32	12	13	1	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUN	2017	49	6					482	488		10.2340/16501977-2239			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EZ6QQ	WOS:000404843000005	28537343	Green Submitted, gold			2022-02-06	
J	McDonald, S; Fisher, A; Flanagan, S; Honan, CA				McDonald, Skye; Fisher, Alana; Flanagan, Sharon; Honan, Cynthia A.			Impaired perception of sincerity after severe traumatic brain injury	JOURNAL OF NEUROPSYCHOLOGY			English	Article							ASSESSING SOCIAL-PERCEPTION; CLOSED HEAD-INJURY; EMOTION RECOGNITION; AFFECTIVE RESPONSIVITY; INFERENCE TEST; MIND DEFICITS; COGNITION; EMPATHY; AWARENESS; MIMICRY	Background. People with a severe traumatic brain injury (TBI) often experience problems understanding non-literal utterances such as sarcasm and lies in dyadic exchanges. This study aimed to investigate whether these problems extend to settings where speakers vary in their degree of sincerity and whether such problems are associated with deficits in social cognitive abilities (emotion perception, theory of mind, and self-reported empathy) or cognitive abilities (abstract reasoning, working memory, processing speed, attentional switching). Methods. Thirty-one adults with severe TBI (24 males) and 25 demographically matched controls (20 males) participated. They watched video vignettes depicting four actors volunteering for additional duties. Each speaker made a limited verbal response which literally suggested a willingness to be involved, but the sincerity with which the response was made was tempered by the actor's emotional demeanour. Participants rated each speaker in the vignettes for degree of sincerity (0-100%). Standardized measures of cognitive and social cognitive function were also taken. Results. Control participants had excellent agreement (a =.90) in their rankings of actors according to sincerity. TBI participants were less consistent (a =.65). Overall, they were sensitive to decreasing sincerity but generally less accurate than control participants. They were poorer at differentiating between levels of sincerity and rated insincere expressions as more sincere, although they rated sincere expressions similarly. Poorer working memory and poorer social cognition were associated with poorer sincerity/sarcasm detection in the participants with TBI, but only social cognition was uniquely associated. Conclusions. Some adults with TBI have difficulty assessing the level of sincerity of speakers. Moreover, poorer social cognition abilities are associated with this difficulty.	[McDonald, Skye; Fisher, Alana; Flanagan, Sharon; Honan, Cynthia A.] UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), UNSW Australia, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Fisher, Alana/T-1869-2019; Honan, Cynthia/O-6332-2017; McDonald, Skye/G-4118-2014	Honan, Cynthia/0000-0001-5735-4270; McDonald, Skye/0000-0003-0723-6094; Fisher, Alana/0000-0002-6027-659X	Australian Research CouncilAustralian Research Council	This study was funded by a grant from the Australian Research Council. We are indebted to our volunteers with brain injuries and their families. They have given their time so generously to help us learn more about the consequences of their injuries and possible paths forward for remediation and improving quality of life. We are also indebted to our community control participants.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Austin JL., 1962, DO THINGS WORDS, V2; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; GRICE HP, 1957, PHILOS REV, V66, P377, DOI 10.2307/2182440; Grice P., 1989, STUDIES WAY WORDS; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Mehrabian A., 2000, MANUAL BALANCED EMOT; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Perry J, 2012, STANFORD ENCY PHILOS; Powell J., 2000, COGNITIVE NEUROPSYCH, V5, P175, DOI [DOI 10.1080/13546800050083520, 10.1080/13546800050083520]; Reitan RM, 1992, TRAIL MAKING TEST; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SEARLE JR, 1976, LANG SOC, V5, P1, DOI 10.1017/S0047404500006837; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326	49	12	12	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	JUN	2017	11	2					291	304		10.1111/jnp.12086			14	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FF4BY	WOS:000408874400008	26482440				2022-02-06	
J	Ryu, JA; Yang, JH; Chung, CR; Suh, GY; Hong, SC				Ryu, Jeong-Am; Yang, Jeong Hoon; Chung, Chi Ryang; Suh, Gee Young; Hong, Seung-Chyul			Impact of Neurointensivist Co-management on the Clinical Outcomes of Patients Admitted to a Neurosurgical Intensive Care Unit	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Neurosurgery; Intensive Care Unit; Critical Care Outcomes	TRAUMATIC BRAIN-INJURY; NEUROCRITICAL CARE; STROKE PATIENTS; ILL PATIENTS; TEAM; MANAGEMENT; MORTALITY; KOREA	Limited data are available on improved outcomes after initiation of neurointensivist co-management in neurosurgical intensive care units (NSICUs) in Korea. We evaluated the impact of a newly appointed neurointensivist on the outcomes of neurosurgical patients admitted to an intensive care unit (ICU). This retrospective observational study involved neurosurgical patients admitted to the NSICU at Samsung Medical Center between March 2013 and May 2016. Neurointensivist co-management was initiated in October 1 2014. We compared the outcomes of neurosurgical patients before and after neurointensivist co-management. The primary outcome was ICU mortality. A total of 571 patients were admitted to the NSICU during the study period, 291 prior to the initiation of neurointensivist co-management and 280 thereafter. Intracranial hemorrhage (29.6%) and traumatic brain injury (TBI) (26.6%) were the most frequent reasons for ICU admission. TBI was the most common cause of death (39.0%). There were no significant differences in mortality rates and length of ICU stay before and after co-management. However, the rates of ICU and 30-day mortality among the TBI patients were significantly lower after compared to before initiation of neurointensivist co-management (8.5% vs. 22.9%; P = 0.014 and 11.0% vs. 27.1%; P = 0.010, respectively). Although overall outcomes were not different after neurointensivist co-management, initiation of a strategy of routine involvement of a neurointensivist significantly reduced the ICU and 30-day mortality rates of TBI patients.	[Ryu, Jeong-Am; Yang, Jeong Hoon; Chung, Chi Ryang; Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea; [Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Hong, Seung-Chyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, 81 Irwon Ro, Seoul 06351, South Korea		Hong, SC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, 81 Irwon Ro, Seoul 06351, South Korea.	nsschong@skku.edu	Suh, Gee Young/O-3676-2019	Suh, Gee Young/0000-0001-5473-1712; Yang, Jeong Hoon/0000-0001-8138-1367; Chung, Chi Ryang/0000-0003-1830-307X			Bershad EM, 2008, NEUROCRIT CARE, V9, P287, DOI 10.1007/s12028-008-9051-5; Bithal PK, 2016, J NEUROANAESTHESIOL, V3, P1, DOI DOI 10.4103/2348-0548.173249; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Jarquin-Valdivia AA, 2003, SEMIN NEUROSURG, V14, P131; Josephson SA, 2010, J NEUROSURG, V112, P626, DOI 10.3171/2009.8.JNS09441; Knopf L, 2012, NEUROCRIT CARE, V16, P63, DOI 10.1007/s12028-011-9620-x; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Kwak SH, 2014, J KOREAN MED SCI, V29, P431, DOI 10.3346/jkms.2014.29.3.431; Lim CM, 2015, J KOREAN MED SCI, V30, P1540, DOI 10.3346/jkms.2015.30.11.1540; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0; Park CM, 2014, ANN SURG TREAT RES, V86, P319, DOI 10.4174/astr.2014.86.6.319; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Song HK, 2013, J NEUROCRIT CARE, V6, P82; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Varelas PN, 2004, CRIT CARE MED, V32, P2191, DOI 10.1097/01.CCM.0000146131.03578.21; Wijayatilake DS, 2012, CURR OPIN ANESTHESIO, V25, P540, DOI 10.1097/ACO.0b013e328357960a	22	12	13	0	1	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUN	2017	32	6					1024	1030		10.3346/jkms.2017.32.6.1024			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3VP	WOS:000403162400020	28480662	Green Submitted, gold, Green Published			2022-02-06	
J	Seifert, T; Sufrinko, A; Cowan, R; Black, WS; Watson, D; Edwards, B; Livingston, S; Webster, K; Akers, D; Lively, M; Kontos, AP				Seifert, Tad; Sufrinko, Alicia; Cowan, Robert; Black, W. Scott; Watson, Dave; Edwards, Bill; Livingston, Scott; Webster, Keith; Akers, David; Lively, Mathew; Kontos, Anthony P.			Comprehensive Headache Experience in Collegiate Student-Athletes: An Initial Report From the NCAA Headache Task Force	HEADACHE			English	Article						headache; college; NCAA; concussion; migraine	MILD TRAUMATIC BRAIN; QUALITY-OF-LIFE; UNITED-STATES; POSTTRAUMATIC HEADACHE; CHRONIC MIGRAINE; PREVALENCE; PAIN; CONCUSSION; BURDEN; IMPACT	BackgroundThe prevalence of primary headache disorders in the general population provides a unique challenge in the evaluation of headache occurring in the context of sport. Despite a wealth of studies exploring the epidemiology of headache in the layperson, little is known about the prevalence and nature of headaches in collegiate student-athletes. These scenarios are challenging in the return to play context, as it is often unclear whether an athlete has an exacerbation of a primary headache disorder, new onset headache unrelated to trauma, or has suffered a concussive injury. PurposeTo establish the prevalence and nature of headaches in collegiate student-athletes. Study DesignRetrospective cross-sectional survey. MethodsThis cross-sectional survey evaluated the characteristics and prevalence of headache in 834 student-athletes from four NCAA Division-I institutions. Because headache occurrence may vary by sport (collision, contact, non-contact), by sex, and medical history, our sample included male and female athletes in a variety of sports, with differing degrees of contact exposure. The 20 question survey collected data on personal and family history of headache, as well as concussion history. ResultsA total of 23.7% (n=198) of participants reported having a personal history of migraine, 25.2% (n=210) history of sinus headache, and 12.3% (n=103) history of tension type headache. Among athletes with a prior history of concussion, 46.3% (n=25) of females reported a history of migraine, while only 32.2% of males reported history of migraine ((2)=3.421, P=.064). ConclusionsThe etiology of increased prevalence of migraine in our study is unclear. Whether this is due to increased awareness of headache disorders, a consequence of contact exposure, or a predisposition for migraine development in this age group remains unclear. Further studies are indicated.	[Seifert, Tad] Norton Healthcare, Louisville, KY USA; [Sufrinko, Alicia; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Cowan, Robert] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Black, W. Scott] Univ Kentucky, Dept Family & Commun Med, Lexington, KY 40506 USA; [Watson, Dave] West Virginia Univ, Dept Neurol, Morgantown, WV USA; [Edwards, Bill] Western Kentucky Univ, Dept Athlet, Bowling Green, KY 42101 USA; [Livingston, Scott] Univ Kentucky, Def & Vet Brain Injury Ctr, Lexington, KY 40506 USA; [Webster, Keith] Univ Kentucky, Dept Athlet, Lexington, KY 40506 USA; [Akers, David] Univ Kentucky, Dept Stat, Lexington, KY 40506 USA; [Lively, Mathew] West Virginia Univ, Dept Med & Pediat, Morgantown, WV USA		Seifert, T (corresponding author), 3991 Dutchmans Lane,Suite 310, Louisville, KY 40222 USA.	Tad.Seifert@nortonhealthcare.org		Kontos, Anthony/0000-0002-3749-4310			American Headache Society, 2014, EP IMP HEAD MIGR; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aurora SK, 2007, HEADACHE, V47, P996, DOI 10.1111/j.1526-4610.2007.00853.x; Bigal ME, 2001, HEADACHE, V41, P710, DOI 10.1046/j.1526-4610.2001.041007710.x; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; de Tommaso M, 2012, CNS NEUROL DISORD-DR, V11, P110, DOI 10.2174/187152712800269759; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Dick R, 2007, J ATHL TRAINING, V42, P173; Eross E, 2007, HEADACHE, V47, P213, DOI 10.1111/j.1526-4610.2006.00688.x; Evers S, 2010, LANCET NEUROL, V9, P391, DOI 10.1016/S1474-4422(10)70008-9; Fumal A, 2006, BRAIN, V129, P543, DOI 10.1093/brain/awh691; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Haque B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-82; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hussain A, 2010, HEADACHE, V50, P669, DOI 10.1111/j.1526-4610.2009.01436.x; Kelman L, 2007, CEPHALALGIA, V27, P394, DOI 10.1111/j.1468-2982.2007.01303.x; Kinart CM, 2002, HEADACHE, V42, P620, DOI 10.1046/j.1526-4610.2002.02149.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Levine H, 2014, OTOLARYNG CLIN N AM, V47, P169, DOI 10.1016/j.otc.2013.11.003; Lipton RB, 2003, CEPHALALGIA, V23, P429, DOI 10.1046/j.1468-2982.2003.00543.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Lund N, 2014, CEPHALALGIA; MacGregor EA, 2011, HEADACHE, V51, P843, DOI 10.1111/j.1526-4610.2011.01904.x; Matheson GO, 2015, AM J SPORT MED, V43, P1518, DOI 10.1177/0363546515572144; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Nahman-Averbuch H, 2013, HEADACHE, V53, P1104, DOI 10.1111/head.12117; National Institute of Neurological Disorders and Stroke, 2016, COMM DAT EL; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Piovesan Elcio J, 2003, Curr Pain Headache Rep, V7, P377, DOI 10.1007/s11916-003-0037-x; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Seifert T, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0448-x; Sjaastad O, 2002, CEPHALALGIA, V22, P784, DOI 10.1046/j.1468-2982.2002.00466.x; Smitherman TA, 2011, HEADACHE, V51, P581, DOI 10.1111/j.1526-4610.2011.01857.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; WILLIAMS SJ, 1994, BRIT J SPORT MED, V28, P96, DOI 10.1136/bjsm.28.2.96	50	12	12	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2017	57	6					877	886		10.1111/head.13104			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX2II	WOS:000403049200006	28480575				2022-02-06	
J	Yasen, AL; Howell, DR; Chou, LS; Pazzaglia, AM; Christie, AD				Yasen, Alia L.; Howell, David R.; Chou, Li-Shan; Pazzaglia, Angela M.; Christie, Anita D.			Cortical and Physical Function after Mild Traumatic Brain Injury	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						MILD TRAUMATIC BRAIN INJURY; GAIT; TRANSCRANIAL MAGNETIC STIMULATION	TRANSCRANIAL MAGNETIC STIMULATION; COLLEGIATE FOOTBALL PLAYERS; GAIT BALANCE CONTROL; SILENT PERIOD; PARKINSONS-DISEASE; SPORTS CONCUSSION; LONG-TERM; MOTOR; INHIBITION; ATTENTION	Purpose The aim of this study was to prospectively examine the association between intracortical inhibition and functional recovery after mild traumatic brain injury (mTBI). Methods Twenty individuals with mTBI and 20 matched control participants were assessed using transcranial magnetic stimulation, the Attentional Network Test, and gait analysis. Hierarchical linear modeling was used to longitudinally examine potential differences between groups and relationships in the pattern of recovery in cortical silent period (CSP) duration, cognitive reaction time, and single- and dual-task walking speeds across five testing time points. Individuals with mTBI were assessed within 72 h of injury, and again at 1 wk, 2 wk, 1 month, and 2 months postinjury. After initial testing, control participants followed a similar timeline. Results At the 72-h time point, the group with mTBI had longer reaction time (b = -91.76, P = 0.01), similar single-task walking speed (b = 0.055, P = 0.10), and slower dual-task walking speed (b = 0.10, P = 0.012) compared with control participants. The CSP duration also tended to be longer in individuals with mTBI than controls at the 72-h time point (b = -16.34, P = 0.062). The change is CSP duration over time was not significantly associated with the change in reaction time (b = -0.19, P = 0.47), single-task walking speed (b = 0.0001, P = 0.53), or dual-task walking speed (b < 0.001, P = 0.68). Conclusion Although cognitive and motor functions were significantly impaired in the mTBI group acutely after injury, levels of intracortical inhibition were not associated with recovery in either functional domain.	[Yasen, Alia L.; Howell, David R.; Chou, Li-Shan; Christie, Anita D.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Howell, David R.] Childrens Hosp Boston, Dept Orthoped, Div Sports Med, Boston, MA USA; [Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Pazzaglia, Angela M.] Educ Dev Ctr Inc, Waltham, MA USA		Christie, AD (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	adc1@uoregon.edu					[Anonymous], 1995, GAIT POSTURE; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bryk AS, 1996, HLM 4 FOR WINDOWS; CANTELLO R, 1991, NEUROLOGY, V41, P1449, DOI 10.1212/WNL.41.9.1449; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.4, DOI 10.3171/FOC.2006.21.4.4]; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chou LS, 2003, GAIT POSTURE, V18, P125, DOI 10.1016/S0966-6362(02)00067-X; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Holste KG, 2014, MED SCI SPORT EXER, V46, P672, DOI 10.1249/01.mss.0000495489.69232.e0; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Ives JC, 2003, CLIN BIOMECH, V18, P543, DOI 10.1016/S0268-0033(03)00089-5; Kimberley TJ, 2009, NEUROSCI LETT, V464, P84, DOI 10.1016/j.neulet.2009.08.029; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Martini D, 2011, BRIT J SPORT MED, V45, P361; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Miller NR, 2014, BRAIN INJURY, P1; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; PRIORI A, 1994, BRAIN, V117, P317, DOI 10.1093/brain/117.2.317; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x	34	12	12	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2017	49	6					1066	1071		10.1249/MSS.0000000000001217			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EV0KI	WOS:000401427800002	28509819				2022-02-06	
J	von Steinbuchel, N; Real, RGL; Sasse, N; Wilson, L; Otto, C; Mullins, R; Behr, R; Deinsberger, W; Martinez-Olivera, R; Puschendorf, W; Petereit, W; Rohde, V; Schmidt, H; Sehmisch, S; Sturmer, KM; von Wild, K; Gibbons, H				von Steinbuechel, Nicole; Real, Ruben G. L.; Sasse, Nadine; Wilson, Lindsay; Otto, Christiane; Mullins, Ryan; Behr, Robert; Deinsberger, Wolfgang; Martinez-Olivera, Ramon; Puschendorf, Wolfgang; Petereit, Werner; Rohde, Veit; Schmidt, Holger; Sehmisch, Stephan; Stuermer, Klaus Michael; von Wild, Klaus; Gibbons, Henning			German validation of Quality of Life after Brain Injury (QOLIBRI) assessment and associated factors	PLOS ONE			English	Article							NEUROREHABILITATION UNIT; OUTCOME MEASURES; HEALTH; SATISFACTION; DISABILITY; SCALE; REHABILITATION; TBI; SYMPTOMATOLOGY; DEPRESSION	The consequences of traumatic brain injury (TBI) for health-related quality of life (HRQoL) are still poorly understood, and no TBI-specific instrument has hitherto been available. This paper describes in detail the psychometrics and validity of the German version of an internationally developed, self-rated HRQoL tool after TBI-the QOLIBRI (Quality of Life after Brain Injury). Factors associated with HRQoL, such as the impact of cognitive status and awareness, are specifically reported. One-hundred seventy-two participants after TBI were recruited from the records of acute clinics, most of whom having a Glasgow Coma Scale (GCS) 24-hour worst score and a Glasgow Outcome Scale (GOSE) score. Participants had severe (24%), moderate (11%) and mild (56%) injuries as assessed on the GCS, 3 months to 15 years post-injury. The QOLIBRI uses 37 items to measure "satisfaction" in the areas of "Cognition", "Self", "Daily Life and Autonomy", and "Social Relationships", and "feeling bothered" by "Emotions" and "Physical Problems". The scales meet standard psychometric criteria (alpha =.84 to.96; intra-class correlation-ICC =.72 to.91). ICCs (0.68 to 0.90) and as (. 83 to.96) were also good in a subgroup of participants with lower cognitive performance. The six-subscale structure of the international sample was reproduced for the German version using confirmatory factor analyses and Rasch analysis. Scale validity was supported by systematic relationships observed between the QOLIBRI and the GOSE, Patient Competency Rating Scale for Neurorehabilitation (PCRS-NR), Hospital Anxiety and Depression Scale HADS), Profile of Mood States (POMS), Short Form 36 (SF-36), and Satisfaction with Life Scale (SWLS). The German QOLIBRI contains novel information not provided by other currently available measures and has good psychometric criteria. It is potentially useful for clinicians and researchers, in post-acute and rehabilitation studies, on a group and individual level.	[von Steinbuechel, Nicole; Real, Ruben G. L.; Sasse, Nadine; Otto, Christiane; Mullins, Ryan; Schmidt, Holger; Gibbons, Henning] Univ Med Ctr Goettingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling, Scotland; [Otto, Christiane] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat, Psychotherapy & Psychosomat, Hamburg, Germany; [Behr, Robert] Clin Ctr Fulda, Dept Neurosurg, Fulda, Germany; [Deinsberger, Wolfgang] Clin Ctr Kassel, Dept Neurosurg, Kassel, Germany; [Martinez-Olivera, Ramon] Bergmannsheil Univ Hosp Bochum, Dept Neurosurg & Neurotraumatol, Bochum, Germany; [Puschendorf, Wolfgang] Westend Neurol Clin, Bad Wildungen, Germany; [Petereit, Werner] Clin Ctr Bernburg, Dept Neurosurg, Bernburg, Germany; [Rohde, Veit] Univ Med Ctr Goettingen, Dept Neurosurg, Gottingen, Germany; [Schmidt, Holger] Univ Med Ctr Goettingen, Dept Neurol, Gottingen, Germany; [Sehmisch, Stephan; Stuermer, Klaus Michael] Univ Med Ctr Goettingen, Trauma Surg Plast & Reconstruct Surg, Gottingen, Germany; [von Wild, Klaus] KvW Neurosci Consulting, Munster, Germany; [Gibbons, Henning] Univ Bonn, Dept Psychol, Bonn, Germany		Real, RGL (corresponding author), Univ Med Ctr Goettingen, Inst Med Psychol & Med Sociol, Gottingen, Germany.	ruben.real@med.uni-goettingen.de	Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Schmidt, Hartmut/0000-0002-2402-7764	ZNS Hannelore Kohl Foundation [2008014]; German Research FoundationGerman Research Foundation (DFG); Open Access Publication Funds of the Gottingen University	This project was funded by the ZNS Hannelore Kohl Foundation (project number 2008014; www.hannelore-kohl-stiftung.de), the German Research Foundation, and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by ZNS Hannelore Kohl Foundation (project number 2008014; www.hannelore-kohl-stifiung.de). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Acquadro C, 1996, QUALITY LIFE PHARMAC, P575; Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; Albani C, 2005, PSYCHOTHER PSYCH MED, V55, P324, DOI 10.1055/s-2004-834727; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bentler P. M., 1995, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bergner M., 1988, QUALITY LIFE ASSESSM, P79; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Brown M, 2004, ARCH PHYS MED REHAB, V85, pS13, DOI 10.1016/j.apmr.2003.08.110; Brown M.W., 1993, SOCIOL METHOD RES, P136; BULLINGER M, 1993, QUAL LIFE RES, V2, P451, DOI 10.1007/BF00422219; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Folstein M., 2003, TELEPHONE INTERVIEW; Formisano R, 2017, NEUROL SCI, V38, P279, DOI 10.1007/s10072-016-2755-y; Gladis MM, 1999, J CONSULT CLIN PSYCH, V67, P320, DOI 10.1037/0022-006X.67.3.320; Guillamondegui OD., 2011, TRAUMATIC BRAIN INJU; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hofer S, 2005, PSYCHOSOMATICS, V46, P212, DOI 10.1176/appi.psy.46.3.212; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hu L.T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hutter BO, 2001, ZBL NEUROCHIR, V62, P37, DOI 10.1055/s-2002-19476; JENNETT B, 1975, LANCET, V1, P480; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Lane AK, 2011, NEUROREHABILITATION, V28, P221, DOI 10.3233/NRE-2011-0651; Laxe S, 2011, NEUROREHABILITATION, V29, P99, DOI 10.3233/NRE-2011-0683; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Moosbrugger H., 2007, TESTTHEORIE FRAGEBOG, V2; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Novella JL, 2001, AGING CLIN EXP RES, V13, P362, DOI 10.1007/BF03351504; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Riemsma R P, 2001, Health Technol Assess, V5, P1; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stucki G, 1997, Z RHEUMATOL, V56, P266, DOI 10.1007/s003930050041; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; von Steinbuchel N, 2002, STUDY PROTOCOL COGNI; von Steinbuchel N., 1996, THESIS LEOPOLD FRANZ; von Steinbuchel Nicole, 2006, Eur J Ageing, V3, P116, DOI 10.1007/s10433-006-0024-2; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whiting M.D., 2006, ANIMAL MODELCOGNIT; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson L, 1998, STRUCTURED INTERVIEW, V15, P573; Wlodarczyk JH, 2004, ARCH GERONTOL GERIAT, V39, P25, DOI 10.1016/j.archger.2003.12.004; World Medical Association, 2009, DECL HELS ETH PRINC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	82	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176668	10.1371/journal.pone.0176668			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	WOS:000402061500007	28542226	Green Published, gold			2022-02-06	
J	Wilson, NM; Gurney, ME; Dietrich, WD; Atkins, CM				Wilson, Nicole M.; Gurney, Mark E.; Dietrich, W. Dalton; Atkins, Coleen M.			Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury	PLOS ONE			English	Article							CYCLIC-AMP-PHOSPHODIESTERASE; SELECTIVE PDE4B; LEUKOCYTE ACCUMULATION; SYNAPTIC PLASTICITY; BARRIER DISRUPTION; SIGNALING PATHWAY; RESPONSE ELEMENT; NEURONAL INJURY; GENE-EXPRESSION; PROTEIN-LEVELS	Traumatic brain injury (TBI) initiates a deleterious inflammatory response that exacerbates pathology and worsens outcome. This inflammatory response is partially mediated by a reduction in cAMP and a concomitant upregulation of cAMP-hydrolyzing phosphodiesterases (PDEs) acutely after TBI. The PDE4B subfamily, specifically PDE4B2, has been found to regulate cAMP in inflammatory cells, such as neutrophils, macrophages and microglia. To determine if PDE4B regulates inflammation and subsequent pathology after TBI, adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury (2 +/- 0.2 atm) and were then treated with a PDE4B - selective inhibitor, A33, or vehicle for up to 3 days post-surgery. Treatment with A33 reduced markers of microglial activation and neutrophil infiltration at 3 and 24 hrs after TBI, respectively. A33 treatment also reduced cortical contusion volume at 3 days post-injury. To determine whether this treatment paradigm attenuated TBI-induced behavioral deficits, animals were evaluated over a period of 6 weeks after surgery for forelimb placement asymmetry, contextual fear conditioning, water maze performance and spatial working memory. A33 treatment significantly improved contextual fear conditioning and water maze retention at 24 hrs post-training. However, this treatment did not rescue sensorimotor or working memory deficits. At 2 months after surgery, atrophy and neuronal loss were measured. A33 treatment significantly reduced neuronal loss in the pericontusional cortex and hippocampal CA3 region. This treatment paradigm also reduced cortical, but not hippocampal, atrophy. Overall, these results suggest that acute PDE4B inhibition may be a viable treatment to reduce inflammation, pathology and memory deficits after TBI.	[Wilson, Nicole M.; Dietrich, W. Dalton; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Gurney, Mark E.] Tetra Discovery Partners, Grand Rapids, MI USA		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA.	catkins@med.miami.edu			National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS056072]; WDD [F31 NS089351]; Miami Project to Cure Paralysis; National Institutes of Health/National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R44 MH091791]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R44MH091791, R43MH091791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS089351, R25NS083064, R01NS056072] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke RO1 NS056072 to CMA and WDD, F31 NS089351 to NMW, and The Miami Project to Cure Paralysis. MEG acknowledges support by the National Institutes of Health/National Institute of Mental Health R44 MH091791. The funder, Tetra Discovery Partners, provided support in the form of salary for MEG, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'authors contributions' section.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Blackman BE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203604; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chang CI, 2000, J IMMUNOL, V165, P2134, DOI 10.4049/jimmunol.165.4.2134; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corraliza IM, 1995, BIOCHEM BIOPH RES CO, P206; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DETMERS PA, 1994, J IMMUNOL, V153, P2137; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Erdely A, 2006, AM J PHYSIOL-LUNG C, V290, pL534, DOI 10.1152/ajplung.00326.2005; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; FitzGerald O, 2014, NAT REV RHEUMATOL, V10, P385, DOI 10.1038/nrrheum.2014.77; Flora G, 2013, CELL TRANSPLANT, V22, P2203, DOI 10.3727/096368912X658872; Fox D, 2014, CELL SIGNAL, V26, P657, DOI 10.1016/j.cellsig.2013.12.003; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Ghosh M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0463-9; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Ghosh M, 2010, TRANSL NEUROSCI, V1, P101, DOI 10.2478/v10134-010-0012-0; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GOTOH S, 1986, J IMMUNOL, V137, P643; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hagen TJ, 2014, BIOORG MED CHEM LETT, V24, P4031, DOI 10.1016/j.bmcl.2014.06.002; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; Havekes R, 2016, J NEUROSCI, V36, P8936, DOI 10.1523/JNEUROSCI.0248-16.2016; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Houslay MD, 2010, NAT BIOTECHNOL, V28, P38, DOI 10.1038/nbt0110-38; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYNN WA, 1991, J IMMUNOL, V147, P3072; Ma DM, 1999, MOL PHARMACOL, V55, P50, DOI 10.1124/mol.55.1.50; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Moretti L, 2012, LANCET NEUROL, P11; Moy AB, 1998, AM J PHYSIOL-LUNG C, V274, pL1024, DOI 10.1152/ajplung.1998.274.6.L1024; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P91, DOI 10.1038/nrd3657; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Reyes-Irisarri E, 2008, SYNAPSE, V62, P74, DOI 10.1002/syn.20459; Reyes-Irisarri E, 2007, J NEUROPATH EXP NEUR, V66, P923, DOI 10.1097/nen.0b013e3181567c31; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHWABE U, 1976, MOL PHARMACOL, V12, P900; Sheldon KE, 2013, J IMMUNOL, V191, P2290, DOI 10.4049/jimmunol.1202102; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; SHEPPARD H, 1975, J CYCLIC NUCL PROT, V1, P237; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Siegmund B, 1997, EUR J PHARMACOL, V321, P231, DOI 10.1016/S0014-2999(96)00947-8; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soares HD, 1995, J NEUROSCI, V15, P8223; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sugerman DE, 2012, J TRAUMA ACUTE CARE, P73; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Truettner JS, 2016, J CEREB BLOOD FLOW M; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vander Top EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-61; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang P, 1999, MOL PHARMACOL, V56, P170, DOI 10.1124/mol.56.1.170; Wei LH, 2000, AM J PHYSIOL-CELL PH, V279, pC248, DOI 10.1152/ajpcell.2000.279.1.C248; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40115; Zhou XM, 2005, AM J PHYSIOL-LUNG C, V288, pL655, DOI 10.1152/ajplung.00327.2004; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	128	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178013	10.1371/journal.pone.0178013			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	WOS:000401672600042	28542295	gold, Green Published, Green Submitted			2022-02-06	
J	Straudi, S; Severini, G; Charabati, AS; Pavarelli, C; Gamberini, G; Scotti, A; Basaglia, N				Straudi, Sofia; Severini, Giacomo; Charabati, Amira Sabbagh; Pavarelli, Claudia; Gamberini, Giulia; Scotti, Anna; Basaglia, Nino			The effects of video game therapy on balance and attention in chronic ambulatory traumatic brain injury: an exploratory study	BMC NEUROLOGY			English	Article						Gaming; Traumatic brain injury; Balance; Attention deficit; Mobility	VIRTUAL-REALITY GAME; EXERCISE PROGRAMS; PHYSICAL-THERAPY; REHABILITATION; INDIVIDUALS; DEFICITS; SCALE; GAIT; COMMUNITY; MOBILITY	Background: Patients with traumatic brain injury often have balance and attentive disorders. Video game therapy (VGT) has been proposed as a new intervention to improve mobility and attention through a reward-learning approach. In this pilot randomized, controlled trial, we tested the effects of VGT, compared with a balance platform therapy (BPT), on balance, mobility and selective attention in chronic traumatic brain injury patients. Methods: We enrolled chronic traumatic brain injury patients (n = 21) that randomly received VGT or BPT for 3 sessions per week for 6 weeks. The clinical outcome measures included: i) the Community Balance & Mobility Scale (CB & ii) the Unified Balance Scale (UBS); iii) the Timed Up and Go test (TUG); iv) static balance and v) selective visual attention evaluation (Go/Nogo task). Results: Both groups improved in CB&M scores, but only the VGT group increased on the UBS and TUG with a between-group significance (p < 0.05). Selective attention improved significantly in the VGT group (p < 0.01). Conclusions: Video game therapy is an option for the management of chronic traumatic brain injury patients to ameliorate balance and attention deficits.	[Straudi, Sofia; Charabati, Amira Sabbagh; Pavarelli, Claudia; Gamberini, Giulia; Scotti, Anna; Basaglia, Nino] Ferrara Univ Hosp, Neurosci & Rehabil Dept, Ferrara, Italy; [Severini, Giacomo] Univ Coll Dublin, Sch Elect & Elect Engn, Dublin, Ireland		Straudi, S (corresponding author), Ferrara Univ Hosp, Neurosci & Rehabil Dept, Ferrara, Italy.	s.straudi@ospfe.it	Straudi, Sofia/AAI-6971-2021	Straudi, Sofia/0000-0002-2061-9922; Severini, Giacomo/0000-0002-2289-9331	ER [1/86/2012]	ASC and CP were supported by ER Grant 1/86/2012.	Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Bucker B, 2017, ATTEN PERCEPT PSYCHO, V79, P415, DOI 10.3758/s13414-016-1241-1; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Caplovitz GP, 2009, NAT NEUROSCI, V12, P527, DOI 10.1038/nn0509-527; Chisholm JD, 2010, ATTEN PERCEPT PSYCHO, V72, P667, DOI 10.3758/APP.72.3.667; Cinnera AM, 2016, FUNCT NEUROL, V31, P117; Clark K, 2011, ACTA PSYCHOL, V136, P67, DOI 10.1016/j.actpsy.2010.10.003; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Cuthbert JP, 2014, BRAIN INJURY, V28, P181, DOI 10.3109/02699052.2013.860475; Dobkin BH, 2016, CURR OPIN NEUROL, V29, P693, DOI 10.1097/WCO.0000000000000380; Eftekharsadat B, 2015, NEUROL RES, V37, P539, DOI 10.1179/1743132815Y.0000000013; Esquenazi A, 2017, COMPARISON LOCOMOTOR; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2012, CURR BIOL, V22, pR197, DOI 10.1016/j.cub.2012.02.012; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Kiss M, 2009, PSYCHOL SCI, V20, P245, DOI 10.1111/j.1467-9280.2009.02281.x; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; La Porta F, 2011, J REHABIL MED, V43, P445, DOI 10.2340/16501977-0800; La Porta F, 2011, J REHABIL MED, V43, P435, DOI 10.2340/16501977-0797; Lauber B, 2014, EUR J SPORT SCI, V14, P36, DOI 10.1080/17461391.2012.725104; Laver KE, 2015, COCHRANE DB SYST REV, V12; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; O'Neil RL, 2013, NEUROREHABILITATION, V33, P667, DOI 10.3233/NRE-130985; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Pilkar R, 2016, IEEE ENG MED BIO, P25, DOI 10.1109/EMBC.2016.7590631; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rizzo AS, 2002, DISABIL REHABIL, V24, P567, DOI 10.1080/09638280110111315; Russell C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00230; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Tran DA, 2016, AM J PHYS MED REHAB, V95, P459, DOI 10.1097/PHM.0000000000000438; Ustinova KI, 2014, BRAIN INJURY, V28, P486, DOI 10.3109/02699052.2014.888593; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams GP, 2011, PHYSIOTHER CAN, V63, P58, DOI 10.3138/ptc.2009-53; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zimmermann P., 1992, TESTBATTERIE AUFMERK	49	12	15	3	14	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	MAY 10	2017	17								86	10.1186/s12883-017-0871-9			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EV4KT	WOS:000401729200001	28490322	Green Published, gold			2022-02-06	
J	Bauman, ZM; Ruggero, JM; Squindo, S; Mceachin, C; Jaskot, M; Ngo, W; Barnes, S; Lopez, PP				Bauman, Zachary M.; Ruggero, John M.; Squindo, Sunny; Mceachin, Chris; Jaskot, Michelle; Ngo, Will; Barnes, Scott; Lopez, Peter P.			Repeat Head CT? Not Necessary for Patients with a Negative Initial Head CT on Anticoagulation or Antiplatelet Therapy Suffering Low-Altitude Falls	AMERICAN SURGEON			English	Article							TRAUMATIC BRAIN-INJURY; PREINJURY WARFARIN USE; INTRACRANIAL HEMORRHAGE; ELDERLY-PATIENTS; OUTCOMES; AGENTS; RISK	Anticoagulation and antiplatelet (ACAP) medications are increasingly prescribed to patients at high risk for falls. Many trauma centers have developed protocols for obtaining repeat head CT (HCT) for patients with low-altitude falls on ACAP therapy. We assess the need for routine scheduled repeat HCT in this population. Prospective, observational analysis of all low-altitude fall (< 6 feet) patients on ACAP therapy evaluated at a Level II trauma center. All low-altitude fall patients with visible or suspected head trauma received an initial HCT. Patients were admitted and repeat HCT was obtained 12 hours later or earlier if acute neurologic decline developed. Chi-squared, Fischer exact, t, and Wilcoxon rank-sum tests were used. Statistical significance was defined as P < 0.05. Total of 1501 patients enrolled suffering low-altitude falls with initial HCT. Among them 1379(91.2%) were negative and 122(8.1%) were initially positive for intracranial hemorrhage. Mean age was 79.9 +/- 11.4 years, 61 per cent were female and 85 per cent had visible head trauma at presentation. One hundred ninety-nine were excluded secondary to not receiving repeat HCT. Of the 1180 patients with normal initial HCT who underwent repeat HCT, only 7 (0.51%) had delayed intracranial hemorrhage. None of these patients required surgery, major changes in medical management or suffered head trauma-related mortality; 69 per cent were taking aspirin (acetylsalicylic acid, ASA), 19 per cent warfarin, 17 per cent clopidogrel, 6 per cent other anticoagulants, and 11 per cent were on combination therapy. Repeat HCT for patients on any ACAP therapy after low-altitude fall with a negative initial HCT is not necessary. Thorough neurologic examination and close monitoring is as effective as obtaining a repeat HCT.	[Bauman, Zachary M.; Ruggero, John M.; Squindo, Sunny; Mceachin, Chris; Jaskot, Michelle; Ngo, Will; Barnes, Scott; Lopez, Peter P.] Henry Ford Macomb Hosp, Dept Trauma, Clinton Township, MI USA		Bauman, ZM (corresponding author), Henry Ford Macomb Hosp, Div Trauma Surg, 15855 19 Mile Rd, Clinton Township, MI 48038 USA.	zmbauman@gmail.com					Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Cohn B, 2014, J EMERG MED, V46, P410, DOI 10.1016/j.jemermed.2013.08.107; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Faul M, 2010, TRAUMATIC BRAIN INJU; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Grandhi R, 2008, AM SURGEON, V74, P802; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; HIRSH J, 1995, CHEST, V108, pS231, DOI 10.1378/chest.108.4_Supplement.231S; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2014, J SURG RES, V186, P287, DOI 10.1016/j.jss.2013.08.009; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Karni A, 2001, AM SURGEON, V67, P1098; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Luchette F, 2010, SURGERY, V148, P729; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Reddy S, 2014, AM SURGEON, V80, P975; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	25	12	12	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAY	2017	83	5					429	435					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EV7RC	WOS:000401976800014	28541850				2022-02-06	
J	Fabri, TL; Wilson, KE; Holland, N; Hickling, A; Murphy, J; Fait, P; Reed, N				Fabri, Tracy L.; Wilson, Katherine E.; Holland, Nicole; Hickling, Andrea; Murphy, James; Fait, Philippe; Reed, Nick			Using a dual-task protocol to investigate motor and cognitive performance in healthy children and youth	GAIT & POSTURE			English	Article						Dual-task; Attention; Postural stability; Concussion; Pediatrics; Rehabilitation	TRAUMATIC BRAIN-INJURY; POSTURAL STABILITY; CONCUSSION; ADOLESCENTS; BALANCE	Objectives: Mild traumatic brain injury (or concussion) is a prevalent yet understudied health concern in children and youth. This injury can cause dysfunction in both motor and cognitive domains; however, most literature focuses on single-task neuropsychological tests which only assess cognition. Although dual-task research on concussed children and youth is needed as many daily activities require both motor and cognitive domains, we must first investigate whether performing simultaneous motor and cognitive tasks of varied complexity impact these domains in healthy children and youth. Participants and design: Data collected from 106 healthy children and youth (5-18 years) created a normative dataset. Participants performed motor (postural stability) and cognitive (visual attention) tasks under single- and dual-task conditions. The cognitive task difficulty remained constant while the motor task had four conditions of increasing difficulty. The relationship between the number of correct responses (cognitive performance) and sway index (motor performance) was determined using two repeated measures ANOVAs (p < 0.05). Results: Dual-task conditions resulted in reduced postural stability, with greater differences on the foam surface (F-2,F-206 = 16.070, p < 0.0005). No statistically significant differences were observed in attention (F-4,F-101 = 0.713, p = 0.584). Conclusions: Postural stability decreased under dual-task conditions, but attention was maintained or improved. Consequently, attention took precedence over postural control when performing tasks concurrently, demonstrating the ability for dual-task methodology to isolate specific processes. This study provides a normative dataset to be used during clinical management to identify functional deficits following concussion and acts as a starting point to explore dual-task protocols in children and youth following concussion. (C) 2017 Elsevier B.V. All rights reserved.	[Fabri, Tracy L.; Wilson, Katherine E.; Holland, Nicole; Hickling, Andrea; Murphy, James; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Human Kinet, 3351 Blvd Forges, Trois Rivieres, PQ G9A 5H7, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Res Grp Neuromusculoskeletal Dysfunct GRAN, 3351 Blvd Forges, Trois Rivieres, PQ G9A 5H7, Canada; [Fait, Philippe] Cortex Med & Readaptat Concuss Clin, 205-1035 Ave Wilfrid Pelletier, Quebec City, PQ G1W 0CS, Canada; [Reed, Nick] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Reed, Nick] Univ Toronto, Fac Med, Rehabil Sci Inst, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada		Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	nreed@hollandbloorview.ca	Fabri, Tracy/AAR-8791-2021	Hickling, Andrea/0000-0001-6251-6369	Trillium Automobile Dealers Association (TADA)	Support for this research was given by the Trillium Automobile Dealers Association (TADA), and undergraduate student support was provided by the Ward Family Summer Student Research Program at Holland Bloorview Kids Rehabilitation Hospital (Toronto, Canada). We would like to thank the Ontario Science Centre, in particular Karen Hager and Mathieu Ranger, and the Holland Bloorview Concussion Centre for their collaboration on this project.	Abbruzzese LD, 2014, GAIT POSTURE, V40, P658, DOI 10.1016/j.gaitpost.2014.07.017; Biodex Medical systems Inc, 2014, BIOSW PORT BAL SYST; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; CogniSens Athletics, NEUR SUPP IND RTP DE; Demura S., 2006, SPORT SCI HLTH, V1, P158, DOI [10.1007/s11332-006-0028-5, DOI 10.1007/S11332-006-0028-5]; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Polskaia N, 2015, GAIT POSTURE, V41, P454, DOI 10.1016/j.gaitpost.2014.11.009; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Ruffieux J, 2015, SPORTS MED, V45, P1739, DOI 10.1007/s40279-015-0369-9; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	23	12	13	0	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAY	2017	54						154	159		10.1016/j.gaitpost.2017.03.002			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	EZ9IT	WOS:000405044400024	28301824				2022-02-06	
J	Surmeli, T; Eralp, E; Mustafazade, I; Kos, IH; Ozer, GE; Surmeli, OH				Surmeli, Tanju; Eralp, Emin; Mustafazade, Ilham; Kos, Ismet Hadi; Ozer, Gul Elif; Surmeli, Orkun H.			Quantitative EEG Neurometric Analysis-Guided Neurofeedback Treatment in Postconcussion Syndrome (PCS): Forty Cases. How Is Neurometric Analysis Important for the Treatment of PCS and as a Biomarker?	CLINICAL EEG AND NEUROSCIENCE			English	Article						postconcussion syndrome (PCS); traumatic brain injury; neurofeedback; QEEG; neurometric analysis; EEG biofeedback; Traumatic Brain Index; TBI	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; AXIS-I; BIOFEEDBACK; EFFICACY; QEEG; REHABILITATION	Postconcussion syndrome (PCS) has been used to describe a range of residual symptoms that persist 12 months or more after the injury, often despite a lack of evidence of brain abnormalities on magnetic resonance imaging and computed tomography scans. In this clinical case series, the efficacy of quantitative EEG-guided neurofeedback in 40 subjects diagnosed with PCS was investigated. Overall improvement was seen in all the primary (Symptom Assessment-45 Questionnaire, Clinical Global Impressions Scale, Hamilton Depression Scale) and secondary measures (Minnesota Multiphasic Personality Inventory, Test of Variables for Attention). The Neuroguide Traumatic Brain Index for the group also showed a decrease. Thirty-nine subjects were followed up long term with an average follow-up length of 3.1 years (CI = 2.7-3.3). All but 2 subjects were stable and were off medication. Overall neurofeedback treatment was shown to be effective in this group of subjects studied.	[Surmeli, Tanju; Mustafazade, Ilham; Kos, Ismet Hadi] Living Hlth Ctr Res & Educ, Kore Sehitleri Cad 49, TR-34394 Istanbul, Turkey; [Eralp, Emin; Ozer, Gul Elif; Surmeli, Orkun H.] Brain Power Inst, Istanbul, Turkey		Surmeli, T (corresponding author), Living Hlth Ctr Res & Educ, Kore Sehitleri Cad 49, TR-34394 Istanbul, Turkey.	neuropsychiatry@yahoo.com	Surmeli, Tanju/H-8474-2017				Andersson E, 2011, J REHABIL MED, V67, P1; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Ayers M. E., 1991, NAT HEAD INJ FDN LOS; Baehr E, 1998, J NEUROTHER, V2, P12; Baehr E, 2001, J NEUROTHERAPY, V4, P11, DOI [10.1300/J184v04n04_03, DOI 10.1300/J184V04N04_03]; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Carmody, 2013, J NEUROTHERAPY INVES, V17, P116, DOI [10.1080/10874208, DOI 10.1080/10874208.2013.785183]; Choi SW, 2011, NEUROPSYCHOBIOLOGY, V63, P43, DOI 10.1159/000322290; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; d'Alfonso AAL, 2002, J NEUROPSYCH CLIN N, V14, P77, DOI 10.1176/appi.neuropsych.14.1.77; Deb S, 1999, AM J PSYCHIAT, V156, P374; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; ELKIND AH, 1989, OTOLARYNG CLIN N AM, V22, P1251; Emre R., 2012, EXPERT REV NEUROTHER, V12, P475; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Ghaziri J, 2013, CLIN EEG NEUROSCI, V44, P265, DOI 10.1177/1550059413476031; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Guillamondegui O, 2011, 2902007100651 AG HEA; Hammond DC, 2005, CHILD ADOL PSYCH CL, V14, P105, DOI 10.1016/j.chc.2004.07.008; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoffman RE, 2003, ARCH GEN PSYCHIAT, V60, P49, DOI 10.1001/archpsyc.60.1.49; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; John E.R., 1987, HDB ELECTROENCEPHALO, P449; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; Johnstone J, 2005, CLIN EEG NEUROSCI, V36, P99, DOI 10.1177/155005940503600209; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Keller I, 2001, J NEUROTHERAPY, V5, P19; Knott V, 2001, PSYCHIAT RES-NEUROIM, V106, P123, DOI 10.1016/S0925-4927(00)00080-9; Koberda JL, 2015, J NEUROL NEUROBIOL, V1; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koprivova J, 2013, NEUROPSYCHOBIOLOGY, V67, P210, DOI 10.1159/000347087; La Vaque TJ, 2002, APPL PSYCHOPHYS BIOF, V27, P273, DOI 10.1023/A:1021061318355; Leark RA., 2007, PROFESSIONAL MANUAL; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Moss D, 2002, APPL PSYCHOPHYS BIOF, V27, P261; Munivenkatappa A, 2014, NEUROREHABILITATION, V35, P481, DOI 10.3233/NRE-141140; Ochs L., 2006, J NEUROTHER, V10, P5; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Prichep L. S., 1986, CLIN APPL COMPUTER A, V2, P153; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reddy RP, 2014, INDIAN J PSYCHOL MED, V36, P40, DOI 10.4103/0253-7176.127246; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Schoenberger N, 2011, J HEAD TRAUMA REHAB, V16, P260; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; Sterman MB, 1996, BIOFEEDBACK SELF-REG, V21, P3, DOI 10.1007/BF02214147; Stevens M M, 1982, J Neurosurg Nurs, V14, P239; Stokes DA, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-9; Surmeli T, 2012, CLIN EEG NEUROSCI, V43, P133, DOI 10.1177/1550059411429531; Surmeli T, 2011, CLIN EEG NEUROSCI, V42, P195, DOI 10.1177/155005941104200310; Tan G, 2009, CLIN EEG NEUROSCI, V73, P93; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Texas Department of Insurance, TRAD PRACT; Thatcher R., 1998, NEUROTHERAPY, V2, P8, DOI DOI 10.1300/J184V02N04_; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thornton K, 2000, J HEAD TRAUMA REHAB, V15, P1285, DOI 10.1097/00001199-200012000-00008; Thornton K., 2014, NEUROREGULATION, V1, P209; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Thornton KE, 2008, APPL PSYCHOPHYS BIOF, V33, P101, DOI 10.1007/s10484-008-9056-z; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Tinius T, 2001, J NEUROTHER, V1, P27; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Walker J. E., 2007, J NEUROTHERAPY, V11, P25; Walker J. E., 2002, J NEUROTHER, V6, P31, DOI DOI 10.1300/J184v06n02_05; Yucha C., 2004, EVIDENCE BASED PRACT; Zwil A S, 1993, New Dir Ment Health Serv, P109	98	12	12	0	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	MAY	2017	48	3					217	230		10.1177/1550059416654849			14	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	EX5LA	WOS:000403282400007	27354361				2022-02-06	
J	Urbach, A; Baum, E; Braun, F; Witte, OW				Urbach, Anja; Baum, Eileen; Braun, Falko; Witte, Otto W.			Cortical spreading depolarization increases adult neurogenesis, and alters behavior and hippocampus-dependent memory in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Adult neurogenesis; cortical spreading depression; hippocampus; spatial memory	TRAUMATIC BRAIN-INJURY; RAT DENTATE GYRUS; SPATIAL MEMORY; ENTORHINAL CORTEX; BARNES MAZE; LEARNING INCREASES; PROGENITOR CELLS; GRANULE CELLS; NEURONS BORN; DEPRESSION	Cortical spreading depolarizations are an epiphenomenon of human brain pathologies and associated with extensive but transient changes in ion homeostasis, metabolism, and blood flow. Previously, we have shown that cortical spreading depolarization have long-lasting consequences on the brains transcriptome and structure. In particular, we found that cortical spreading depolarization stimulate hippocampal cell proliferation resulting in a sustained increase in adult neurogenesis. Since the hippocampus is responsible for explicit memory and adult-born dentate granule neurons contribute to this function, cortical spreading depolarization might influence hippocampus-dependent cognition. To address this question, we induced cortical spreading depolarization in C57Bl/6J mice by epidural application of 1.5mol/L KCl and evaluated neurogenesis and behavior at two, four, or six weeks thereafter. Congruent with our previous findings in rats, we found that cortical spreading depolarization increases numbers of newborn dentate granule neurons. Moreover, exploratory behavior and object location memory were consistently enhanced. Reference memory in the water maze was virtually unaffected, whereas memory formation in the Barnes maze was impaired with a delay of two weeks and facilitated after four weeks. These data show that cortical spreading depolarization produces lasting changes in psychomotor behavior and complex, delay- and task-dependent changes in spatial memory, and suggest that cortical spreading depolarization-like events affect the emotional and cognitive outcomes of associated brain pathologies.	[Urbach, Anja; Baum, Eileen; Braun, Falko; Witte, Otto W.] Jena Univ Hosp, Hans Berger Dept Neurol, Erlanger Allee 101 FZL, D-07747 Jena, Germany		Urbach, A (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Erlanger Allee 101 FZL, D-07747 Jena, Germany.	anja.urbach@med.uni-jena.de	Witte, Otto/P-4127-2018	Witte, Otto/0000-0003-2101-4105	German Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01GI9905, 01GZ0306]; German Research foundation (DFG)German Research Foundation (DFG) [WI830/10-1]; Interdisciplinary Centre for Clinical Research (IZKF) [J15]; Leibniz Graduate School on Ageing and Age-Related Diseases (LGSA)	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this project was provided by the German Federal Ministry of Education and Research (BMBF, grant no. 01GI9905 and no. 01GZ0306), the German Research foundation (DFG, grant no. WI830/10-1), the Interdisciplinary Centre for Clinical Research (IZKF; grant no. J15) and the Leibniz Graduate School on Ageing and Age-Related Diseases (LGSA).	Aasebo IEJ, 2011, EUR J NEUROSCI, V33, P1094, DOI 10.1111/j.1460-9568.2011.07608.x; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Bures J, 1974, MECH APPL LEAOS SPRE; BURESOVA O, 1969, Journal of Neurobiology, V1, P135, DOI 10.1002/neu.480010202; BURESOVA O, 1971, PSYCHOPHARMACOLOGIA, V20, P57, DOI 10.1007/BF00404059; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Deutsch JA, 1983, PHYSIOLOGICAL BASIS; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Epp JR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00057; Epp JR, 2010, HIPPOCAMPUS, V20, P866, DOI 10.1002/hipo.20692; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Hallbergson A, 2005, SOC NEUROSCIENCE; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Kawahara N, 1997, NEUROSCI RES, V29, P37, DOI 10.1016/S0168-0102(97)00069-2; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kilic E, 2008, J PINEAL RES, V45, P142, DOI 10.1111/j.1600-079X.2008.00568.x; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Li B, 2012, NEUROIMAGE, V63, P1171, DOI 10.1016/j.neuroimage.2012.08.024; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; PANAKHOVA E, 1985, BEHAV PROCESS, V10, P387, DOI 10.1016/0376-6357(85)90039-7; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Robinson RG, 1997, ANNU REV MED, V48, P217; Scharfman H.E., 2007, DENTATE GYRUS COMPRE, V163; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tamura Y, 2012, J CEREBR BLOOD F MET, V32, P1879, DOI 10.1038/jcbfm.2012.98; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Unekawa M, 2013, J NEUROSCI RES, V91, P578, DOI 10.1002/jnr.23184; Urbach A, 2008, STROKE, V39, P3064, DOI 10.1161/STROKEAHA.108.518076; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; Urbach A, 2015, J CEREBR BLOOD F MET, V35, P576, DOI 10.1038/jcbfm.2014.232; Urbach A, 2013, BEHAV NEUROSCI, V127, P1, DOI 10.1037/a0031222; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Wernsmann B, 2006, EUR J NEUROSCI, V23, P1103, DOI 10.1111/j.1460-9568.2006.04643.x; Winter B, 2005, BIOL PSYCHIAT, V57, P1166, DOI 10.1016/j.biopsych.2005.02.010; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	63	12	12	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1776	1790		10.1177/0271678X16643736			15	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200016	27189903	Green Published, Bronze			2022-02-06	
J	Das, SK; Shetty, SP; Sen, KK				Das, Sudha Kiran; Shetty, Sachin P.; Sen, Kamal Kumar			Novel Triage Tool: Optic Nerve Sheath Diameter in Traumatic Brain Injury and its Correlation to Rotterdam Computed Tomography (CT) Scoring	POLISH JOURNAL OF RADIOLOGY			English	Article						Brain Injuries; Optic Nerve; Tomography, Spiral Computed	INTRACRANIAL-PRESSURE; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; SCAN CHARACTERISTICS; IMPACT	Background: Optic nerve sheath diameter (ONSD) evaluated in CT imaging as well as Rotterdam CT Score (RCTS) are proven independent predictors of outcome in patients with traumatic brain injury (TBI). To date, no study has correlated ONSD on admission CT scan with RCTS. Material/Methods: Retrospective cohort study comprised of consecutive patients undergoing CT imaging for traumatic brain injury recruited between January and October 2015. Bilateral ONSD was measured 3 mm behind the eyeball in axial and sagittal planes and mean value was calculated. RCTS was assessed on the same CT images, bias was eliminated by blinding RCTS to ONSD measurement. Results: 150 patients were included; mean age in the group was 42.94 +/- 16.7 years. ONSD in mild TBI, RCTS 2 and 3 were 3.3 mm (SD 0.39 mm) and 4.1 mm (0.047 mm), respectively. Mean ONSD in moderate and severe TBI (RCTS score 4 and above) was 4.83 mm and above, SD 0.4 mm. Mean ONSD correlated with occurrence of diffuse cerebral oedema, presence of subdural and extradural hematoma; however in isolation there was no statistical significance. Conclusions: Higher ONSD was observed in patients with moderate and severe TBI, correlating with admission RCTS of 4 and above. Subsequent increase in ONSD was also found with increase in RCTS. ONSD could serve as an initial triage tool in the emergency department as well as a method of determining the need for sequential CT in patients	[Das, Sudha Kiran; Shetty, Sachin P.; Sen, Kamal Kumar] JSS Univ, JSS Med Coll & Hosp, Dept Radiodiag & Imaging, MG Rd, Mysore 570004, Karnataka, India		Das, SK (corresponding author), JSS Univ, JSS Med Coll & Hosp, Dept Radiodiag & Imaging, MG Rd, Mysore 570004, Karnataka, India.	sudha7492@gmail.com	Das, Sudha/ABB-1662-2020	Das, Sudha/0000-0002-1289-2953			BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Goel RS, 2008, INJURY, V39, P519, DOI 10.1016/j.injury.2007.09.029; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HANSEN HC, 1994, NEURO-OPHTHALMOLOGY, V14, P345, DOI 10.3109/01658109409024061; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Samabasivan, 1991, NEUROL INDIA S, V43, P9; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Waqas M, 2016, J NEURORADIOLOGY, V43, P25, DOI 10.1016/j.neurad.2015.07.003; World Health Organization, 2002, PROJ MORT BURD DIS 2	21	12	12	1	3	INT SCIENTIFIC INFORMATION INC	SMITHTOWN	361 FOREST LN, SMITHTOWN, NY 11787 USA	0137-7183	1899-0967		POL J RADIOL	Pol. J. Radiol.	APR 28	2017	82						240	243		10.12659/PJR.900196			4	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	EU7FF	WOS:000401200000001	28533826	Green Published			2022-02-06	
J	Rodriguez-Perez, M; Abreu-Sanchez, A; Rojas-Ocana, MJ; del-Pino-Casado, R				Rodriguez-Perez, Margarita; Abreu-Sanchez, Ana; Rojas-Ocana, Maria Jesus; del-Pino-Casado, Rafael			Coping strategies and quality of life in caregivers of dependent elderly relatives	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Caregivers; Elderly; Coping; Quality of life; Nursing	TRAUMATIC BRAIN-INJURY; SOCIAL SUPPORT; STRESS PROCESS; PSYCHOLOGICAL HEALTH; DEMENTIA CAREGIVERS; ALZHEIMERS-DISEASE; FAMILY CAREGIVERS; BURDEN; STROKE; INTERVENTION	Background: Despite the importance of coping in caregiving, there are few studies on the relationship between coping and quality of life in caregivers of the frail dependent elderly. Thus, this study aims to analyze the relationship between coping strategies and quality of life dimensions in primary caregivers of dependent elderly relatives. Methods: A cross-sectional study was conducted from 86 caregivers. Predictive variables were coping strategies (problem-focused, emotion-focused, socially-supported, and dysfunctional); dependent variables were quality of life dimensions (psychological, physical, relational, and environmental); and potential confounding variables were age, gender, perceived health and burden of caregiver, and functional capacity of care receiver. Correlation coefficients were calculated and multiple linear regression analysis was performed. Results: After controlling for potential confounders, dysfunctional coping was related to worse quality of life in the psychological dimension, while emotion-focused and socially-supported coping were related to superior psychological and environmental dimensions of quality of life. The physical and relational dimensions of quality of life were not related to coping strategies. Conclusions: 1) it is important to consider coping strategies in the assessment of primary caregivers of dependent elderly relatives; 2) the quality of life of caregivers is related to their coping strategies, 3) their quality of life can be worsened by avoidance-type coping, and 4) their quality of life can be improved by active emotion-focused coping and socially-supported coping.	[Rodriguez-Perez, Margarita; Abreu-Sanchez, Ana; Rojas-Ocana, Maria Jesus] Univ Huelva, Sch Hlth Sci, Dept Nursing, Huelva, Spain; [del-Pino-Casado, Rafael] Univ Jaen, Sch Hlth Sci, Dept Nursing, Jaen, Spain		del-Pino-Casado, R (corresponding author), Univ Jaen, Sch Hlth Sci, Dept Nursing, Jaen, Spain.	rdelpino@ujaen.es	Abreu-Sanchez, Ana/AAG-7393-2020; Rodriguez, Margarita/AAD-7041-2021; Ocana, Maria Jesus Rojas/AAE-1739-2020; del-Pino-Casado, Rafael/L-3733-2018	Abreu-Sanchez, Ana/0000-0003-1240-4611; Rodriguez, Margarita/0000-0002-0105-6001; Ocana, Maria Jesus Rojas/0000-0003-1781-4548; del-Pino-Casado, Rafael/0000-0003-2263-2415			Alonso, 2002, MEDIDA SALUD GUIA ES; BASS DM, 2002, CONTENT IMPLEMENTATI; Baztan Juan J., 1993, Revista Espanola de Geriatria y Gerontologia, V28, P32; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cheng ST, 2014, GERONTOLOGIST, V54, P1049, DOI 10.1093/geront/gnu018; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cohen J., 2013, STAT POWER ANAL BEHA; Crespo M., 1997, ANAL MODIF CONDUCTA, V23, P797, DOI DOI 10.6018/ANALESPS.29.1.124531; del-Pino-Casado R, 2011, J ADV NURS, V67, P2311, DOI 10.1111/j.1365-2648.2011.05725.x; Folkman S., 1984, STRESS; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; Goldzweig G, 2012, J GERIATR ONCOL, V3, P376, DOI 10.1016/j.jgo.2012.07.003; Grassel E, 2011, GEROPSYCH, V24, P143, DOI 10.1024/1662-9647/a000042; Green M. A., 2009, THESIS; Greenglass E.R., 2002, COPING M GOALS VISIO, P37, DOI 10.1093/med:psych/9780198508144.003.0003; HALEY WE, 1987, PSYCHOL AGING, V2, P323, DOI 10.1037/0882-7974.2.4.323; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Helder DI, 2002, INT J BEHAV MED, V9, P37, DOI 10.1207/S15327558IJBM0901_03; Kate N, 2014, INT J SOC PSYCHIATR, V60, P107, DOI 10.1177/0020764012467598; Kershaw TS, 2008, ANN BEHAV MED, V36, P117, DOI 10.1007/s12160-008-9058-3; Kinsella G, 1998, J PALLIATIVE CARE, V14, P37, DOI 10.1177/082585979801400206; Klum MA, 2012, THESIS; Ekwall AK, 2007, J ADV NURS, V57, P584, DOI 10.1111/j.1365-2648.2006.03994.x; Li R, J AFFECT DISORD; Litman JA, 2006, PERS INDIV DIFFER, V41, P273, DOI 10.1016/j.paid.2005.11.032; Losada A, 2015, J CONSULT CLIN PSYCH, V83, P760, DOI 10.1037/ccp0000028; MAHONEY F I, 1965, Md State Med J, V14, P61; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Meyers FJ, 2011, J PALLIAT MED, V14, P465, DOI 10.1089/jpm.2010.0416; Mittelman MS, 2004, J GERONTOL B-PSYCHOL, V59, pP27, DOI 10.1093/geronb/59.1.P27; Montorio I, 1998, ANALES PSICOLOGIA, V14, P229; MOOS RH, 1990, PSYCHOL AGING, V5, P31, DOI 10.1037/0882-7974.5.1.31; Myaskovsky L, 2005, SOC SCI MED, V60, P2321, DOI 10.1016/j.socscimed.2004.10.001; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; OECD, 2013, HLTH GLANC 2013; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; PRUCHNO RA, 1989, PSYCHOL AGING, V4, P454, DOI 10.1037/0882-7974.4.4.454; Riedijk SR, 2006, DEMENT GERIATR COGN, V22, P405, DOI 10.1159/000095750; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; van Andel J, 2011, J NEUROL, V258, P1788, DOI 10.1007/s00415-011-6013-1; Wartella JE, 2009, J PSYCHOSOM RES, V66, P503, DOI 10.1016/j.jpsychores.2008.12.005; Webb C, 1998, SCHIZOPHR RES, V34, P169; White CL, 2003, RES NURS HEALTH, V26, P177, DOI 10.1002/nur.10084; *WHOQOL GROUP, 1993, QUAL LIFE RES, V2, P153, DOI DOI 10.1007/BF00435734; Yang XS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-143; Yu YH, 2013, J CLIN NURS, V22, P2160, DOI 10.1111/jocn.12251; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; [No title captured]	51	12	13	4	39	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1477-7525			HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	APR 14	2017	15								71	10.1186/s12955-017-0634-8			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	ER9ZE	WOS:000399184900001	28407778	Green Published, gold			2022-02-06	
J	DeBoussard, CN; Lannsjo, M; Stenberg, M; Stalnacke, BM; Godbolt, AK				DeBoussard, Catharina Nygren; Lannsjo, Marianne; Stenberg, Maud; Stalnacke, Britt-Marie; Godbolt, Alison K.			Behavioural problems in the first year after Severe traumatic brain injury: a prospective multicentre study	CLINICAL REHABILITATION			English	Article						Severe traumatic brain injury; prognosis; agitation; behaviour; outcome; assessment	GLASGOW OUTCOME SCALE; HOSPITAL ANXIETY; DEPRESSION SCALE; CARE PATHWAYS; AGITATION; CONSCIOUSNESS; SYMPTOMS; VALIDITY; SEQUELAE; MODERATE	Objective: To investigate the occurrence of behavioural problems in patients with severe traumatic brain injury during the first year after injury and potential associations with outcome. An additional post hoc objective was to analyse the frequency of behaviours with need for intervention from staff. Design and setting: In a prospective population based cohort study 114 patients with severe traumatic brain injury were assessed at three weeks, three months and one year after injury. Main measures: Assessments included clinical examination and standardised instruments. Agitation was assessed with the Agitated Behaviour Scale, the course of recovery by the Rancho Los Amigo Scale and outcome by Glasgow Outcome Scale Extended. Results: Agitation were most common at 3 weeks post injury and 28% (n=68) of the patients showed at least one agitated behaviour requiring intervention from staff. Presence of significant agitation at 3 weeks after injury was not associated with poor outcome. At 3 months agitation was present in 11% (n=90) and apathy in 26 out of 81 assessed patients. At 3 months agitation and apathy were associated with poor outcome at one year. Conclusions: Most agitated behaviours in the early phase are transient and are not associated with poor outcome. Agitation and apathy are uncommon at three months but when present are associated with poor outcome at one year after injury. In the early phase after a severe traumatic brain injury agitated behaviour in need of interventions from staff occur in a substantial proportion of patients.	[DeBoussard, Catharina Nygren; Godbolt, Alison K.] Karolinska Inst, Dept Clin Sci, SE-18288 Stockholm, Sweden; [DeBoussard, Catharina Nygren; Godbolt, Alison K.] Danderyd Hosp, Univ Dept Rehabil Med Stockholm, SE-18288 Stockholm, Sweden; [Lannsjo, Marianne] Sandviken Hosp, Sandviken, Sweden; [Lannsjo, Marianne; Godbolt, Alison K.] Uppsala Univ, Uppsala, Sweden; [Lannsjo, Marianne] Uppsala Univ, Ctr Res & Dev, Cty Council Gavleborg Gavle, Uppsala, Sweden; [Stenberg, Maud; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Rehabil Med, Umea, Sweden; [Godbolt, Alison K.] Univ Hosp Uppsala, Dept Rehabil Med, Uppsala, Sweden		DeBoussard, CN (corresponding author), Danderyd Hosp, Dept Rehabil Med, S-18288 Stockholm, Sweden.	catharina.nygren-deboussard@ds.se	Stenberg, Maud/AAX-4366-2021		AFA insurance [060833, 130095]; Uppsala University Hospital; Danderyd Hospital; Regional Research Council in the Region of Uppsala-Orebro; Umea University; Umea University Hospital	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by grant 060833 and 130095 from AFA insurance. AKG has received support from ALF-grants from Uppsala University Hospital and Danderyd Hospital. ML has received ALF-grants from Regional Research Council in the Region of Uppsala-Orebro, MS has received support from ALF-grants from Umea University and Umea University Hospital.	American Psychiatric Publishing, 2013, DIAGN STAT MAN MENT; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Bailey M, 2009, REHABIL NURS, V34, P11, DOI 10.1002/j.2048-7940.2009.tb00242.x; Becker C, 2012, REHABIL NURS, V37, P171, DOI 10.1002/rnj.50; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Hagen C., RANCHO AMIGO SCALE C; Hung CI, 2012, INT J PSYCHIAT CLIN, V16, P33, DOI 10.3109/13651501.2011.617456; International Classification of Diseases, INT CLASS DIS 10 REV; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Schwarzbold ML, 2014, REV BRAS PSIQUIATR, V36, P206, DOI 10.1590/1516-4446-2013-1308; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308; TEASDALE G, 1974, LANCET, V2, P81; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	12	12	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	APR	2017	31	4					555	566		10.1177/0269215516652184			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	ET2IA	WOS:000400092500013	27277217	Green Published			2022-02-06	
J	Jin, YC; Wang, R; Yang, SF; Zhang, XH; Dai, J				Jin, Yichao; Wang, Ran; Yang, Shaofeng; Zhang, Xiaohua; Dai, Jiong			Role of Microglia Autophagy in Microglia Activation After Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Apoptosis; Autophagy; Microglia; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; NECROSIS-FACTOR-ALPHA; MODERATE HYPOTHERMIA; CELL-DEATH; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; EXPRESSION; RAPAMYCIN; MICE; INTERLEUKIN-1	OBJECTIVE: We evaluated the role of microglia autophagy in microglia activation after traumatic brain injury (TBI) in rats. METHODS: TBI was induced by a fluid percussion TBI device. All rats were killed 24 hours after TBI. The ipsilateral hippocampus in all rats was analyzed with hematoxylin-eosin staining. Immunohistochemistry and Western blotting of ionized calcium-binding adapter molecule 1 was used to determine changes in microglia activation. Double staining of microtubule-associated protein light chain 3, Beclin-1, and ionized calcium-binding adapter molecule 1 was used to assess changes of microglia autophagy. Enzyme-linked immunosorbent assay of tumor necrosis factor-alpha and interleukin-1 beta was used to evaluate changes in inflammatory responses. Terminal deoxyribonucleotidyl transferase-mediated deoxyuridine 5'-triphosphate nick-end labeling staining was used to determine cell death in the ipsilateral hippocampus. RESULTS: At 24 hours after TBI, microglial cells became activated, and the autophagy inhibitor 3-methyladenine (3-MA) further promoted microglia activation. Protein light chain 3- and Beclin-1-positive microglial cells were increased after TBI, whereas 3-MA decreased the number of positive microglial cells, increasing the expression of tumor necrosis factor-alpha and interleukin-1b; terminal deoxyribonucleotidyl transferase-mediated deoxyuridine 5'-triphosphate nick-end labeling staining demonstrated that 3-MA could increase the number of terminal deoxyribonucleotidyl transferase-mediated deoxyuridine 5'-triphosphate nick-end labeling-positive cells (16.83 +/- 0.83 vs. 11 +/- 0.82, P < 0.001). CONCLUSIONS: Our data demonstrated that TBI induced microglia activation and microglia autophagy. Inhibition of microglia autophagy with 3-MA increased microglia activation and neural apoptosis. These findings indicate that targeting microglia autophagy may be a therapeutic strategy for TBI.	[Jin, Yichao; Wang, Ran; Yang, Shaofeng; Zhang, Xiaohua; Dai, Jiong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China		Zhang, XH; Dai, J (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China.	zhangxh1969@hotmail.com; jiongdai@hotmail.com			National Science and Nature [81601061, 81671203, 81300996]	This work was supported by grants from National Science and Nature (81601061, 81671203, 81300996).	Basu A, 2002, J NEUROSCI, V22, P6071; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Francois A, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-151; Heckmann BL, 2013, BRIT J PHARMACOL, V168, P163, DOI 10.1111/j.1476-5381.2012.02110.x; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Jin YC, 2016, WORLD NEUROSURG, V88, P433, DOI 10.1016/j.wneu.2015.10.055; Jin YC, 2015, WORLD NEUROSURG, V84, P420, DOI 10.1016/j.wneu.2015.03.039; Jin YC, 2015, J NEUROTRAUM, V32, P1090, DOI 10.1089/neu.2014.3649; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang Z, 2015, EXP MOL PATHOL, V98, P219, DOI 10.1016/j.yexmp.2015.02.003; Yang Z, 2014, CURR NEUROVASC RES, V11, P223, DOI 10.2174/1567202611666140520124407; Yang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096509; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	41	12	15	3	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2017	100						351	360		10.1016/j.wneu.2017.01.033			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7BT	WOS:000401930000047	28108422				2022-02-06	
J	Picetti, E; Caspani, ML; Iaccarino, C; Pastorello, G; Salsi, P; Viaroli, E; Servadei, F				Picetti, Edoardo; Caspani, Maria Luisa; Iaccarino, Corrado; Pastorello, Giulia; Salsi, Pierpaolo; Viaroli, Edoardo; Servadei, Franco			Intracranial pressure monitoring after primary decompressive craniectomy in traumatic brain injury: a clinical study	ACTA NEUROCHIRURGICA			English	Article						Intracranial pressure; Cerebral perfusion pressure; Monitoring; Primary decompressive craniectomy; Traumatic brain injury; Outcome	HYPERTENSION; HEMICRANIECTOMY; IMPACT; SCORE; TIME	Background Intracranial pressure (ICP) monitoring represents an important tool in the management of traumatic brain injury (TBI). Although current information exists regarding ICP monitoring in secondary decompressive craniectomy (DC), little is known after primary DC following emergency hematoma evacuation. Methods Retrospective analysis of prospectively collected data. Inclusion criteria were age >= 18 years and admission to the intensive care unit (ICU) for TBI and ICP monitoring after primary DC. Exclusion criteria were ICU length of stay (LOS) < 1 day and pregnancy. Major objectives were: (1) to analyze changes in ICP/cerebral perfusion pressure (CPP) after primary DC, (2) to evaluate the relationship between ICP/CPP and neurological outcome and (3) to characterize and evaluate ICP-driven therapies after DC. Results A total of 34 patients were enrolled. Over 308 days of ICP/CPP monitoring, 130 days with at least one episode of intracranial hypertension (26 patients, 76.5%) and 57 days with at least one episode of CPP < 60 mmHg (22 patients, 64.7%) were recorded. A statistically significant relationship was discovered between the Glasgow Outcome Scale (GOS) scores and mean post-decompression ICP (p < 0.04) and between GOS and CPP minimum (CPPmin) (p < 0.04). After DC, persisting intracranial hypertension was treated with: barbiturate coma (n = 7, 20.6%), external ventricular drain (EVD) (n = 4, 11.8%), DC diameter widening (n = 1, 2.9%) and removal of newly formed hematomas (n = 3, 8.8%). Conclusion Intracranial hypertension and/or low CPP occurs frequently after primary DC; their occurence is associated with an unfavorable neurological outcome. ICP monitoring appears useful in guiding therapy after primary DC.	[Picetti, Edoardo; Caspani, Maria Luisa] Azienda Osped Univ Parma, Serv Anestesia Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Azienda Osped Univ Parma, Neurochirugia & Neurotraumatol, Parma, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Arcispedale Santa Maria Nuova Reggio Emilia, Parma, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Azienda Osped Univ Parma, Neurochirugia & Neurotraumatol, Reggio Emilia, Italy; [Iaccarino, Corrado; Pastorello, Giulia; Viaroli, Edoardo; Servadei, Franco] Arcispedale Santa Maria Nuova Reggio Emilia, Reggio Emilia, Italy; [Salsi, Pierpaolo] Arcispedale Santa Maria Nuova Reggio Emilia, Serv Anestesia & Rianimaz, Reggio Emilia, Italy		Picetti, E (corresponding author), Azienda Osped Univ Parma, Serv Anestesia Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Iaccarino, Corrado/L-3190-2013; Viaroli, Edoardo/AAB-1988-2021	Iaccarino, Corrado/0000-0002-5133-6327; Servadei, Franco/0000-0002-3595-3464			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P74, DOI 10.1111/nyas.12482; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; Huang YH, 2016, WORLD NEUROSURG, V88, P59, DOI 10.1016/j.wneu.2015.12.041; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; JENNETT B, 1975, LANCET, V1, P480; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; TEASDALE G, 1974, LANCET, V2, P81; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131	34	12	13	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2017	159	4					615	622		10.1007/s00701-017-3118-z			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EQ6AP	WOS:000398164500004	28236181				2022-02-06	
J	Portbury, SD; Hare, DJ; Sgambelloni, CJ; Bishop, DP; Finkelstein, DI; Doble, PA; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Sgambelloni, Charlotte J.; Bishop, David P.; Finkelstein, David I.; Doble, Philip A.; Adlard, Paul A.			Age modulates the injury-induced metallomic profile in the brain	METALLOMICS			English	Article							LA-ICP-MS; ALZHEIMERS-DISEASE; REGIONAL-DISTRIBUTION; TRACE-ELEMENTS; HEAD-INJURY; ZINC; IRON; COPPER; NEUROPROTECTION; ABLATION	The biological transition metals iron (Fe), copper (Cu) and zinc (Zn) are thought to contribute to the neuronal pathologies that occur following traumatic brain injury (TBI), and indeed our previously published work in young (3 month-old) mice clearly demonstrates a significant spatiotemporal modulation of metals following TBI. Of note, however, is the literature observation that there is both an apparent detrimental effect of aging on TBI outcomes and an alteration in metals and their various transporters with normal advancing age. Therefore, to determine whether there was an interaction between aging, metals and TBI, we have utilised laser ablation-inductively coupled plasma-mass spectrometry to examine the spatial and temporal distribution of Fe, Zn and Cu following an acute controlled cortical impact brain injury in aged (24 months) rodents. The relative abundance of metals in corresponding regions within the ipsilateral and contralateral hemispheres as well as the hippocampus was assessed. Substantial region and time point specific alterations in Fe, Zn and Cu were identified immediately and up to 28 days post-TBI. The data from this follow-up study has also been compared to our previous data from young animals, and aged mice exhibit an appreciably enhanced and persistent elevation of all metals in every region surveyed, with individual metal disparities at various time points observed post-injury. This may potentially contribute to the acceleration in the onset of cognitive decline and neurological disease that has been observed in the aged population following head trauma.	[Portbury, Stuart D.; Hare, Dominic J.; Sgambelloni, Charlotte J.; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3052, Australia; [Hare, Dominic J.; Bishop, David P.; Doble, Philip A.] Univ Technol Sydney, Elemental Bioimaging Facil, Thomas St, Broadway, NSW 2007, Australia		Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3052, Australia.	paul.adlard@florey.edu.au	Doble, Philip/A-8812-2012; Finkelstein, David/B-9617-2009; Hare, Dominic/H-2481-2011; Bishop, David P/F-2891-2019	Doble, Philip/0000-0002-8472-1301; Finkelstein, David/0000-0002-8167-4917; Hare, Dominic/0000-0002-5922-7643; Bishop, David P/0000-0002-6533-4410; Portbury, Stuart/0000-0002-5470-6100	Australian Research Council (ARC)Australian Research Council; Ramaciotti Foundation; ARCAustralian Research Council; Agilent Technologies; Operational Infrastructure Support Grant; ESI Ltd.	PAA is supported by Australian Research Council (ARC) Future Fellowship. DJH wishes to acknowledge support from the Ramaciotti Foundation. DJH and PAD were also supported by an ARC Linkage Project with Agilent Technologies and ESI Ltd. In addition, the Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; [Anonymous], 2004, WORLD REP TRAFF INJ; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bolognin S, 2009, NEUROMOL MED, V11, P223, DOI 10.1007/s12017-009-8102-1; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hare DJ, 2016, ANAL METHODS-UK, V8, P7552, DOI 10.1039/c6ay02545e; Hare DJ, 2013, ANAL METHODS-UK, V5, P1915, DOI 10.1039/c3ay26248k; Hare DJ, 2012, ANAL CHEM, V84, P3990, DOI 10.1021/ac300374x; Hare DJ, 2010, METALLOMICS, V2, P745, DOI 10.1039/c0mt00039f; Hegde ML, 2006, ARCH BIOCHEM BIOPHYS, V449, P143, DOI 10.1016/j.abb.2006.02.018; Hellmich HL, 2004, NEUROSCI LETT, V355, P221, DOI 10.1016/j.neulet.2003.10.074; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Lear J, 2012, ANAL CHEM, V84, P6707, DOI 10.1021/ac301156f; Lear J, 2012, J ANAL ATOM SPECTROM, V27, P159, DOI 10.1039/c1ja10301f; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Lu L., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/470676; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; Mason PRD, 2002, J ANAL ATOM SPECTROM, V17, P858, DOI 10.1039/b202964b; MASSIE HR, 1979, MECH AGEING DEV, V10, P93, DOI 10.1016/0047-6374(79)90073-3; Matusch A, 2010, J AM SOC MASS SPECTR, V21, P161, DOI 10.1016/j.jasms.2009.09.022; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; PLANTIN LO, 1987, BIOL TRACE ELEM RES, V13, P69, DOI 10.1007/BF02796622; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Suram A, 2002, NEUROMOL MED, V2, P289, DOI 10.1385/NMM:2:3:289; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Takahashi S, 2001, BIOL TRACE ELEM RES, V80, P145, DOI 10.1385/BTER:80:2:145; Tarohda T, 2004, ANAL BIOANAL CHEM, V380, P240, DOI 10.1007/s00216-004-2697-8; Tatton WG, 1999, BBA-BIOENERGETICS, V1410, P195, DOI 10.1016/S0005-2728(98)00167-4; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vasudevaraju P, 2010, Indian J Psychiatry, V52, P140, DOI 10.4103/0019-5545.64590; Zecca L, 2001, J NEUROCHEM, V76, P1766, DOI 10.1046/j.1471-4159.2001.00186.x; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	80	12	12	0	12	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1756-5901	1756-591X		METALLOMICS	Metallomics	APR 1	2017	9	4					402	410		10.1039/c6mt00260a			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ES8AA	WOS:000399771300007	28170006	hybrid, Green Published			2022-02-06	
J	Salottolo, K; Carrick, M; Levy, AS; Morgan, BC; Slone, DS; Bar-Or, D				Salottolo, Kristin; Carrick, Matthew; Levy, A. Stewart; Morgan, Brent C.; Slone, Denetta S.; Bar-Or, David			The epidemiology, prognosis, and trends of severe traumatic brain injury with presenting Glasgow Coma Scale of 3	JOURNAL OF CRITICAL CARE			English	Article						Glasgow Coma Scale; Mortality; Traumatic brain injury; Epidemiology	UNITED-STATES; ADMISSION; SCORE; PERSPECTIVE; MORTALITY; MODERATE; OUTCOMES; CHANCE; ADULTS; IMPACT	Purpose: To characterize trends and prognosis of severe traumatic brain injury (TBI). Methods: This 5-year multicenter retrospective study included patients with TBI and Glasgow Coma Scale of 3. We analyzed demographic and clinical characteristics and mortality using Pearson chi 2 tests, Cochran-Armitage trend tests, and stepwise logistic regression. Analyses were stratified by vehicular and fall etiologies; other etiologies were excluded (24%). Results: Included were 481 patients. Fall-related injuries increased 58% (P = .001) but vehicular etiology did not change (P = .63). The characteristics of the populations changed over time; with falls, the population became older and increasingly presented with normal vital signs, whereas with vehicular etiology, the population became younger, with more alcohol-related injury (P < .05 for all). Mortality from falls increased substantially from 25% to 63% (P < .001), whereas death from vehicular injures remained statistically unchanged but with a downward trend (50%-38%, P = .28). Predictors of mortality included injury severity and age at least 65 years for both groups. Additional variables that were prognostic were abnormal vital signs and subdural hematoma for vehicular injuries, and sex for fall injuries. Conclusions: The epidemiology of severe TBI is changing. These epidemiologic data may be used for management and resource decisions, monitoring, and directing injury prevention measures. (C) 2016 Elsevier Inc. All rights reserved.	[Salottolo, Kristin; Carrick, Matthew; Bar-Or, David] Med Ctr Plano, Dept Trauma Res, 3901 West 15th St, Plano, TX 75075 USA; [Salottolo, Kristin; Slone, Denetta S.; Bar-Or, David] Swedish Med Ctr, Dept Trauma Res, 501 E Hampden Ave, Englewood, CO 80113 USA; [Salottolo, Kristin; Bar-Or, David] St Anthony Hosp, Dept Trauma Res, 11600 W 2nd Pl, Lakewood, CO 80228 USA; [Salottolo, Kristin; Bar-Or, David] Penrose Community Hosp, Dept Trauma Res, 2222 N Nevada Ave, Colorado Springs, CO 80907 USA; [Levy, A. Stewart] Intermt Neurosurg, 11700 W 2nd Pl, Lakewood, CO 80228 USA; [Carrick, Matthew; Morgan, Brent C.] Med Ctr PIano, Trauma Serv Dept, 3901 W 15th St, Plano, TX 75075 USA; [Levy, A. Stewart] St Anthony Hosp, Trauma Serv Dept, 11600 West 2nd Pl, Lakewood, CO 80228 USA; [Slone, Denetta S.] Swedish Med Ctr, Trauma Serv Dept, 499 E Hampden Ave, Englewood, CO 80113 USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Serv Dept, 501 E Hampden Ave,Rm 4-454, Englewood, CO 80113 USA.	ksalottolo@ampiopharma.com; matt.carrick@acutesurgical.com; stewartevy@centura.org; brentandang@me.com; sue.slone@healthonecares.com; dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Faul M, 2010, TRAUMATIC BRAIN INJU; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irvin CB, 2010, PREHOSP DISASTER MED, V25, P541, DOI 10.1017/S1049023X00008736; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Ley EJ, 2011, AM SURGEON, V77, P1342; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pryor JP, 2003, J TRAUMA, V55, P442; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salottolo KM, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-7; Sanchez AI, 2012, J HEAD TRAUMA REHAB, V27, P159, DOI 10.1097/HTR.0b013e3182074c41; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4	25	12	15	1	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2017	38						197	201		10.1016/j.jcrc.2016.11.034			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU5UU	WOS:000401100300035	27940095				2022-02-06	
J	Shi, WZ; Ju, JY; Xiao, HJ; Xue, F; Wu, J; Pan, MM; Ni, WF				Shi, Wei-Zhe; Ju, Jin-Yong; Xiao, Hai-Jun; Xue, Feng; Wu, Jiang; Pan, Ming-Mang; Ni, Wei-Feng			Dynamics of MMP-9, MMP-2 and TIMP-1 in a rat model of brain injury combined with traumatic heterotopic ossification	MOLECULAR MEDICINE REPORTS			English	Article						heterotopic ossification; brain injury; matrix metalloproteinase-9; matrix metalloproteinase-2; tissue inhibitor of metalloproteinase-1	MATRIX METALLOPROTEINASES; EXPRESSION; TISSUE	The present study aimed to detect early changes in the concentration of matrix metalloproteinase-9 (MMP-9), matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in a rat model of brain injury combined with traumatic heterotopic ossification (HO). A total of 132male Sprague-Dawley rats were used to establish the experimental and control groups. Anatomy and sample collection were conducted on postoperative days 1, 2, 3, 4, 5, 6 and 7. Hematoxylin and eosin and immunohistochemical staining were performed for local tissues. MMP-9, MMP-2 and TIMP-1 levels and gene expression level were measured by ELISA and reverse transcription-quantitative polymerase chain reaction. Radiological investigation of the rat lower limbs was conducted at weeks 5 and 10 following modeling to observe the occurrence of HO. The incidence of HO for rats in the experimental group was higher compared with the control group. The serum MMP-9 levels of the experimental group were notably higher on postoperative days 5-7 compared with the control group. The MMP-9 gene expression of the experimental group was higher on postoperative days 3-7 compared with the control group. The TIMP-1 gene expression levels were markedly higher compared with the control group at each time point. Thus, an increase in inflammatory response is closely associated with brain injury, in addition to an increase in the number of inflammatory cells with the incidence of HO. The pathological elevation of MMP-9 and the altered dynamic equilibrium between MMP-9 and TIMP-1 contributed to the degradation, remodeling and calcification of the extracellular matrix, resulting in the induction of osteoblast precursor cells in HO. MMP-9 is a predictive marker of HO.	[Shi, Wei-Zhe; Xiao, Hai-Jun; Pan, Ming-Mang] Southern Med Univ Affiliated Fengxian Hosp, Dept Orthoped, 6600 Nanfeng St, Shanghai 200000, Peoples R China; [Shi, Wei-Zhe] Guangzhou Huadu Dist Peoples Hosp, Dept Orthoped, Guangzhou 440000, Guangdong, Peoples R China; [Ju, Jin-Yong] Liaoning Med Univ, Fengxian Cent Hosp Grad Training Base, Dept Orthoped, Jinzhou, Liaoning, Peoples R China; [Xue, Feng; Ni, Wei-Feng] Shanghai Fengxian Dist Cent Hosp, Dept Orthoped, Shanghai 310000, Peoples R China; [Wu, Jiang] Changsha Eighth Hosp, Dept Orthoped, Changsha 430000, Hunan, Peoples R China		Xiao, HJ (corresponding author), Southern Med Univ Affiliated Fengxian Hosp, Dept Orthoped, 6600 Nanfeng St, Shanghai 200000, Peoples R China.	xiaohaijun89@126.com			Shanghai Municipal Commission of Health and Family Planning [20134204]	The present study was supported by the Shanghai Municipal Commission of Health and Family Planning (grant no. 20134204).	Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Caron A, 2005, CAN J PHYSIOL PHARM, V83, P287, DOI 10.1139/Y05-011; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen HC, 2009, BURNS, V35, P857, DOI 10.1016/j.burns.2008.03.002; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; EVANS EB, 1991, CLIN ORTHOP RELAT R, P94; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gupta K, 2007, ARTHRITIS RHEUM-US, V56, P3326, DOI 10.1002/art.22879; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; HILL PA, 1994, J CELL SCI, V107, P3055; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; Lin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088550; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Naraghi FF, 1996, ORTHOPEDICS, V19, P145; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Rodenberg E, 2011, TISSUE ENG PT A, V17, P2487, DOI [10.1089/ten.tea.2011.0007, 10.1089/ten.TEA.2011.0007]; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Xu JC, 2009, SAUDI MED J, V30, P605	27	12	15	0	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2017	15	4					2129	2135		10.3892/mmr.2017.6275			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	EP2HE	WOS:000397203200086	28259914	hybrid, Green Published, Green Submitted			2022-02-06	
J	Shun, PLW; Bottari, C; Ogourtsova, T; Swaine, B				Shun, Priscilla Lam Wai; Bottari, Carolina; Ogourtsova, Tatiana; Swaine, Bonnie			Exploring factors influencing occupational therapists' perception of patients' rehabilitation potential after acquired brain injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						acute care; qualitative research; stroke; traumatic brain injury	STROKE REHABILITATION; CARE; MODEL; RECOMMENDATIONS; QUESTIONNAIRE; AUSTRALIA; SELECTION; SERVICES; DECISION	Background/aim: Clinical practice guidelines advocate for early involvement of rehabilitation professionals in screening acquired brain injury patients' rehabilitation needs and determining the required rehabilitation services. Little is yet known about the nature of occupational therapists' role in this context. This exploratory study sought to identify factors influencing occupational therapists' perception of acquired brain injury patients' rehabilitation potential for inpatient rehabilitation. Methods: A qualitative approach was used to analyse data from a focus group involving 12 occupational therapists working in acute care and inpatient rehabilitation. A consensus-seeking technique was used to identify patient-related factors participants perceived as most important to consider when assessing rehabilitation potential. The transcription of the group discussion was analysed using an interpretive description approach to identify additional factors influencing occupational therapists' perception. Results: Participants agreed on 11 patient-related factors most important to consider: age, behaviour, cognitive abilities, endurance, home environment, medical status, observed improvement in acute care post-injury, physical abilities, post-injury functional status, pre-injury functional status, patient and family expectations. Additional factors included the influence of the organisational context (i.e. acute care and broader health care context) as well as occupational therapists' professional expertise, knowledge of scientific evidence, concerns for ethical decisions and interpretive activities (i.e. clinician's interpretation of patients' characteristics in light of all other factors). Conclusions: Findings suggest that assessing rehabilitation potential is a complex process that goes beyond strictly appraising patients' characteristics. Additional factors influence clinicians' perception of patients' rehabilitation potential. Clinicians should pay more attention to these factors when making evidence-based decisions regarding patients' potential to benefit from rehabilitation.	[Shun, Priscilla Lam Wai; Bottari, Carolina; Swaine, Bonnie] Univ Montreal, Fac Med, Sch Rehabil, Occupat Therapy, Montreal, PQ, Canada; [Shun, Priscilla Lam Wai; Bottari, Carolina; Ogourtsova, Tatiana; Swaine, Bonnie] Lucie Bruneau Rehabil Ctr, Ctr Interdisciplinary Res Rehabil Greater Montrea, 2275 Laurier Ave East,Room 106-40, Montreal, PQ H2H 2N8, Canada; [Ogourtsova, Tatiana] McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ, Canada		Shun, PLW (corresponding author), Lucie Bruneau Rehabil Ctr, Ctr Interdisciplinary Res Rehabil Greater Montrea, 2275 Laurier Ave East,Room 106-40, Montreal, PQ H2H 2N8, Canada.			Lam Wai Shun, Priscilla/0000-0001-5642-7490	Ordre des ergotherapeutes du Quebec; Quebec Rehabilitation Research Network	The authors thank the participants involved in this study and their institutions as well as the research assistants who participated in data analysis. This study received financial support from the "Ordre des ergotherapeutes du Quebec" and the Quebec Rehabilitation Research Network.	ABIKUS Guideline Development Group, 2007, ABIKUS EV BAS REC RE; Beauchamp T., 2001, PRINCIPLES BIOMEDICA, V5th; Britton L, 2015, AUST OCCUP THER J, V62, P370, DOI 10.1111/1440-1630.12227; Burton CR, 2015, DISABIL REHABIL, V37, P1955, DOI 10.3109/09638288.2014.991454; Carrier A, 2010, AUST OCCUP THER J, V57, P356, DOI 10.1111/j.1440-1630.2010.00875.x; Casaubon LK, 2016, INT J STROKE, V11, P239, DOI 10.1177/1747493015622461; Chabon Shelly, 2011, Seminars in Speech and Language, V32, P298, DOI 10.1055/s-0031-1292755; Conroy BE, 2009, TOP STROKE REHABIL, V16, P34, DOI 10.1310/tsr1601-34; Crennan M, 2010, PHYS OCCUP THER GERI, V28, P33, DOI 10.3109/02703180903381060; Cullen N, 2014, EFFICACY MODELS CARE; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; Fleming J, 1999, BRAIN INJURY, V13, P417; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Government of South Australia, 2012, ACQ BRAIN INJ MOD RE; Hakkennes SJ, 2011, ARCH PHYS MED REHAB, V92, P2057, DOI 10.1016/j.apmr.2011.07.189; Hayward KS, 2014, BRAIN IMPAIR, V15, P88, DOI 10.1017/BrImp.2014.12; Ilet PA, 2010, ARCH PHYS MED REHAB, V91, P788, DOI 10.1016/j.apmr.2009.11.028; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kennedy GM, 2012, ARCH PHYS MED REHAB, V93, P1457, DOI 10.1016/j.apmr.2011.11.036; Lamontagne ME, 2013, AUGMENT ALTERN COMM, V29, P182, DOI 10.3109/07434618.2013.784927; Lindsay M.P., 2010, CANADIAN BEST PRACTI; National Stroke Foundation, 2015, AC STROK SERV FRAM 2; P?pin G., 2002, EVAL J AUST, V2, P45, DOI [10.1177/1035719X0200200212, DOI 10.1177/1035719X0200200212]; Pereira S, 2012, TOP STROKE REHABIL, V19, P122, DOI 10.1310/tsr1902-122; Provalis Research, 2011, QDA MIN VERS 4 0; Putnam K., 2007, J REHABILITATION MED, V39, P21, DOI [10.2340/16501977-0006, DOI 10.2340/16501977-0006]; Rentz DM, 1991, PSYCHOL ASPECTS GERI, P97; Satterfield JM, 2009, MILBANK Q, V87, P368, DOI 10.1111/j.1468-0009.2009.00561.x; Schwamm LH, 2005, CIRCULATION, V111, P1078, DOI 10.1161/01.CIR.0000154252.62394.1E; Swaine B., 2011, ANN PHYS REHABILIT S, V54, pe278, DOI [10.1016/j.rehab.2011.07.214, DOI 10.1016/J.REHAB.2011.07.214]; Swaine BR, 2003, BRAIN INJURY, V17, P575, DOI 10.1080/0269905031000088568; Thorne S., 2008, INTERPRETIVE DESCRIP; Veillette N, 2009, ARCH GERONTOL GERIAT, V48, P205, DOI 10.1016/j.archger.2008.01.009; WHO, 2003, WORLD HLTH REP 2003	35	12	12	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	APR	2017	64	2					149	158		10.1111/1440-1630.12327			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	ET9BZ	WOS:000400602000007	27654022	Green Accepted			2022-02-06	
J	Tasker, RC; Vonberg, FW; Ulano, ED; Akhondi-Asl, A				Tasker, Robert C.; Vonberg, Frederick W.; Ulano, Elizabeth D.; Akhondi-Asl, Alireza			Updating Evidence for Using Hypothermia in Pediatric Severe Traumatic Brain Injury: Conventional and Bayesian Meta-Analytic Perspectives	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						Bayesian analysis; meta-analysis; therapeutic hypothermia; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; MODERATE HYPOTHERMIA; CLINICAL-TRIAL; THERAPEUTIC HYPOTHERMIA; PRIOR ELICITATION; CARDIAC-ARREST; PRIOR BELIEFS; CHILDREN; CARE; ASSOCIATION	Objective: To evaluate clinical trials of hypothermia management on outcome in pediatric patients with severe traumatic brain injury using conventional and Bayesian meta-analyses. Data Sources: Screening of PubMed and other databases to identify randomized controlled trials of hypothermia for pediatric severe traumatic brain injury published before September 2016. Study Selection: Four investigators assessed and reviewed randomized controlled trial data. Data Extraction: Details of trial design, patient number, Glasgow Coma Scale score, hypothermia and control normothermia therapy, and outcome of mortality were collated. Data Synthesis: In conventional meta-analysis, random-effects models were expressed as odds ratio (odds ratio with 95% credible-interval). Bayesian outcome probabilities were calculated as probability of odds ratio greater than or equal to 1. In seven randomized controlled trials (n = 472, patients 0-17 yr old), there was no difference in mortality (hypothermia vs normothermia) with pooled estimate 1.42 (credible-interval, 0.77-2.61; p = 0.26). Duration of hypothermia (24, 48, or 72 hr) did not show difference in mortality. (Similar results were found using poor outcome.) Bayesian analyses of randomized controlled trials ordered by time of study completed recruitment showed, after the seventh trial, chance of relative risk reduction of death by greater than 20% is 1-in-3. An optimistic belief (0.90 probability that relative risk reduction of death > 20% hypothermia vs normothermia) gives a chance of relative risk reduction of death by greater than 20% of 1-in-2. Conclusions: Conventional meta-analysis shows the null hypothesis-no difference between hypothermia versus normothermia on mortality and poor outcome-cannot be rejected. However, Bayesian meta-analysis shows chance of relative risk reduction of death greater than 20% with hypothermia versus normothermia is 1-in-3, which may be further altered by one's optimistic or skeptical belief about a patient.	[Tasker, Robert C.; Vonberg, Frederick W.; Ulano, Elizabeth D.; Akhondi-Asl, Alireza] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA 02115 USA; [Tasker, Robert C.; Vonberg, Frederick W.; Ulano, Elizabeth D.; Akhondi-Asl, Alireza] Harvard Med Sch, Boston, MA 02115 USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA		Tasker, RC (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA 02115 USA.; Tasker, RC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Tasker, RC (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.	Robert.tasker@childrens.harvard.edu	Tasker, Robert C/R-5837-2019; Akhondi-Asl, Alireza/I-3664-2018	Tasker, Robert/0000-0003-3647-8113			Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Boylan JF, 2011, J ROY COLL PHYS EDIN, V41, P126, DOI 10.4997/JRCPE.2011.216; CHALONER K, 1993, J ROY STAT SOC D-STA, V42, P341; Cumming G., 2013, UNDERSTANDING NEW ST; Diamond GA, 2004, J AM COLL CARDIOL, V43, P1929, DOI 10.1016/j.jacc.2004.01.035; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Harrell FE, 2001, INT J TECHNOL ASSESS, V17, P17, DOI 10.1017/S0266462301104034; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hiance A, 2009, J CLIN EPIDEMIOL, V62, P431, DOI 10.1016/j.jclinepi.2008.04.009; Higgins JPT, 2002, INT J EPIDEMIOL, V31, P96, DOI 10.1093/ije/31.1.96; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2013, LANCET NEUROL, V12, P527, DOI 10.1016/S1474-4422(13)70058-9; JENNETT B, 1975, LANCET, V1, P480; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P355, DOI 10.1016/j.jclinepi.2009.06.003; Kalil AC, 2014, CRIT CARE MED, V42, P2267, DOI 10.1097/CCM.0000000000000576; Kalil AC, 2011, INTENS CARE MED, V37, P420, DOI 10.1007/s00134-010-2121-0; Kalil AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002291; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Korner-Nievergelt F., 2015, BAYESIAN DATA ANAL E; Lazaridis C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0681-2; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI [10.1089/neu.2008.0828, 10.1089/neu.2008-0828]; Ma CK, 2013, CHILD NERV SYST, V29, P979, DOI 10.1007/s00381-013-2076-x; Meert KL, 2016, PEDIATR CRIT CARE ME, V17, pE543, DOI 10.1097/PCC.0000000000000969; Moatti M, 2013, CLIN TRIALS, V10, P505, DOI 10.1177/1740774513493528; Morrison LJ, 2015, CIRCULATION, V132, pS368, DOI 10.1161/CIR.0000000000000253; Pedroza C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1480-4; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Salpeter SR, 2009, AM J MED, V122, P1016, DOI 10.1016/j.amjmed.2009.05.021; Schoenfeld DA, 2009, CLIN TRIALS, V6, P297, DOI 10.1177/1740774509339238; See CW, 2012, OPHTHAL EPIDEMIOL, V19, P407, DOI 10.3109/09286586.2012.735332; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES; Stangl D.K., 2000, METAANALYSIS MED HLT; Sun CQ, 2013, INVEST OPHTH VIS SCI, V54, P4167, DOI 10.1167/iovs.13-11716; Sutton A.J., 2000, METHODS METAANALYSIS; Tasker RC, 2016, PEDIATR CRIT CARE ME, V17, P789, DOI 10.1097/PCC.0000000000000799; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010	45	12	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	APR	2017	18	4					355	362		10.1097/PCC.0000000000001098			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	ES2EJ	WOS:000399339000006	28230712				2022-02-06	
J	Turgeon, AF; Lauzier, F; Zarychanski, R; Fergusson, DA; Leger, C; McIntyre, LA; Bernard, F; Rigamonti, A; Burns, K; Griesdale, DE; Green, R; Scales, DC; Meade, MO; Savard, M; Shemilt, M; Paquet, J; Gariepy, JL; Lavoie, A; Reddy, K; Jichici, D; Pagliarello, G; Zygun, D; Moore, L				Turgeon, Alexis F.; Lauzier, Francois; Zarychanski, Ryan; Fergusson, Dean A.; Leger, Caroline; McIntyre, Lauralyn A.; Bernard, Francis; Rigamonti, Andrea; Burns, Karen; Griesdale, Donald E.; Green, Robert; Scales, Damon C.; Meade, Maureen O.; Savard, Martin; Shemilt, Michele; Paquet, Jerome; Gariepy, Jean-Luc; Lavoie, Andre; Reddy, Kesh; Jichici, Draga; Pagliarello, Giuseppe; Zygun, David; Moore, Lynne		TBI-Prognosis Study Team; Canadian Critical Care Trials Grp	Prognostication in critically ill patients with severe traumatic brain injury: the TBI-Prognosis multicentre feasibility study	BMJ OPEN			English	Article							SEVERE HEAD-INJURY; RANDOMIZED CONTROLLED-TRIAL; LIFE-SUSTAINING THERAPY; NEUROCRITICAL CARE; DECISION-MAKING; INTENSIVE-CARE; WITHDRAWAL; SCALE; VARIABLES; COHORT	Objective: Severe traumatic brain injury is a significant cause of morbidity and mortality in young adults. Assessing long-term neurological outcome after such injury is difficult and often characterised by uncertainty. The objective of this feasibility study was to establish the feasibility of conducting a large, multicentre prospective study to develop a prognostic model of long-term neurological outcome in critically ill patients with severe traumatic brain injury. Design: A prospective cohort study. Setting: 9 Canadian intensive care units enrolled patients suffering from acute severe traumatic brain injury. Clinical, biological, radiological and electrophysiological data were systematically collected during the first week in the intensive care unit. Mortality and functional outcome (Glasgow Outcome Scale extended) were assessed on hospital discharge, and then 3, 6 and 12 months following injury. Outcomes: The compliance to protocolised test procedures was the primary outcome. Secondary outcomes were enrolment rate and compliance to follow-up. Results: We successfully enrolled 50 patients over a 12-month period. Most patients were male (80%), with a median age of 45 years (IQR 29.0-60.0), a median Injury Severity Score of 38 (IQR 25-50) and a Glasgow Coma Scale of 6 (IQR 3-7). Mortality was 38% (19/50) and most deaths occurred following a decision to withdraw life-sustaining therapies (18/19). The main reasons for non-enrolment were the time window for inclusion being after regular working hours (35%, n=23) and oversight (24%, n=16). Compliance with protocolised test procedures ranged from 92% to 100% and enrolment rate was 43%. No patients were lost to follow-up at 6 months and 2 were at 12 months. Conclusions: In this multicentre prospective feasibility study, we achieved feasibility objectives pertaining to compliance to test, enrolment and follow-up. We conclude that the TBI-Prognosis prospective multicentre study in severe traumatic brain injury patients in Canada is feasible.	[Turgeon, Alexis F.; Lauzier, Francois; Leger, Caroline; Shemilt, Michele; Lavoie, Andre; Moore, Lynne] Univ Laval, Res Ctr, CHU Quebec, Populat Hlth & Optimal Hlth Practices Res Unit Tr, Quebec City, PQ, Canada; [Turgeon, Alexis F.; Lauzier, Francois; Savard, Martin] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Crit Care & Haematol & Med Oncol, Winnipeg, MB, Canada; [Fergusson, Dean A.; McIntyre, Lauralyn A.] Univ Ottawa, Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ctr Transfus & Crit Care Res, Ottawa, ON, Canada; [McIntyre, Lauralyn A.; Pagliarello, Giuseppe] Univ Ottawa, Ottawa Hosp, Dept Crit Care Med, Ottawa, ON, Canada; [Bernard, Francis] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Rigamonti, Andrea; Burns, Karen] Univ Toronto, St Michaels Hosp, Interdepat Div Crit Care Med, Toronto, ON, Canada; [Griesdale, Donald E.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Green, Robert] Dalhousie Univ, Dept Emergency Med, Dept Crit Care Med, Halifax, NS, Canada; [Scales, Damon C.] Univ Toronto, Sunnybrook Hosp, Interdept Div Crit Care Med, Toronto, ON, Canada; [Meade, Maureen O.; Jichici, Draga] McMaster Univ, Div Crit Care Med, Dept Med, Hamilton, ON, Canada; [Savard, Martin] Univ Laval, Div Neurol, Dept Med, Quebec City, PQ, Canada; [Paquet, Jerome] Univ Laval, Div Neurosurg, Dept Surg, Quebec City, PQ, Canada; [Paquet, Jerome; Gariepy, Jean-Luc] Univ Laval, Dept Radiol & Nucl Med, Quebec City, PQ, Canada; [Reddy, Kesh] McMaster Univ, Div Neurosurg, Dept Surg, Hamilton, ON, Canada; [Zygun, David] Univ Alberta, Dept Crit Care Med, Edmonton, AB, Canada; [Moore, Lynne] Univ Laval, Dept Prevent & Social Med, Quebec City, PQ, Canada		Turgeon, AF (corresponding author), Univ Laval, Res Ctr, CHU Quebec, Populat Hlth & Optimal Hlth Practices Res Unit Tr, Quebec City, PQ, Canada.; Turgeon, AF (corresponding author), Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada.	alexis.turgeon@fmed.ulaval.ca	Zarychanski, Ryan/AAB-6369-2022; McIntyre, Lauralyn/AAR-7710-2021; Savard, Martin/O-2549-2019; Lauzier, Francois/B-9237-2015; Griesdale, Donald/AAT-7762-2021	McIntyre, Lauralyn/0000-0001-7421-1407; Lauzier, Francois/0000-0002-6530-5513; Griesdale, Donald/0000-0001-5985-8624; Turgeon, Alexis/0000-0001-5675-8791; Fergusson, Dean/0000-0002-3389-2485; Zarychanski, Ryan/0000-0001-9455-6138	Fonds de la Recherche du Quebec-Sante (FRQS) [5888]; Canadian Intensive Care Foundation (CICF); New Investigator Awards from the Canadian Institutes of Health Research (CIHR); Traumatology Research Consortium of the FRQS	This study was funded by the Fonds de la Recherche du Quebec-Sante (FRQS) (grant #5888) and the Canadian Intensive Care Foundation (CICF). AFT is the Canada Research Chair in Critical Care Neurology and Trauma. LM, LAM, AFT and RZ are or were recipients of New Investigator Awards from the Canadian Institutes of Health Research (CIHR) during the conduction of the study. AFT and FL are supported by the Traumatology Research Consortium of the FRQS. FL is a recipient of a salary support Award from the FRQS.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Blanton S, 2006, PHYS THER, V86, P1520, DOI 10.2522/ptj.20060091; Brain Trauma Foundation American Association of Neurological Surgeons, 2000, MANAGEMENT PROGNOSIS; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Dickson S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-389; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fletcher B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000496; Gamble T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035982, 10.1371/journal.pone.0039429]; Gardner G, 2003, INT J NURS STUD, V40, P719, DOI 10.1016/S0020-7489(03)00011-7; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hsu MH, 2005, STUD HEALTH TECHNOL, V116, P241; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Huynh TN, 2013, J PALLIAT MED, V16, P1368, DOI 10.1089/jpm.2013.0142; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Lai Y. C., 1998, Annals Academy of Medicine Singapore, V27, P326; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; McIntyre LA, 2008, CAN J ANAESTH, V55, P819, DOI 10.1007/BF03034053; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; National Scientific Advisory Committee, 2004, LIST DIR INJ FIN REP; OCALLAHAN JG, 1995, CRIT CARE MED, V23, P1567, DOI 10.1097/00003246-199509000-00018; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Potter JE, 2013, INTENS CARE MED, V39, P472, DOI 10.1007/s00134-012-2732-8; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Turgeon A, 2009, CRIT CARE MED, V37, pA435; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Tyson SF, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0588-2; van Beinum A, 2016, J INTENSIVE CARE MED, V31, P243, DOI 10.1177/0885066615571529; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	43	12	13	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	APR	2017	7	4							e013779	10.1136/bmjopen-2016-013779			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW5EE	WOS:000402527200048	28416497	Green Published, gold			2022-02-06	
J	Zhao, CC; Wang, CF; Li, WP; Lin, Y; Tang, QL; Feng, JF; Mao, Q; Gao, GY; Jiang, JY				Zhao, Cheng-Cheng; Wang, Chuan-Fang; Li, Wei-Ping; Lin, Yong; Tang, Qi-Lin; Feng, Jun-Feng; Mao, Qing; Gao, Guo-Yi; Jiang, Ji-Yao			Mild Hypothermia Promotes Pericontusion Neuronal Sprouting via Suppressing Suppressor of Cytokine Signaling 3 Expression after Moderate Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; axonal regeneration; hypothermia; neuroplasticity; TBI	AXON REGENERATION; GAP-43; INHIBITION; SOCS3; PLASTICITY; PROTECTION; PTEN/MTOR; PTEN; NOGO	Mild therapeutic hypothermia is a candidate for the treatment of traumatic brain injury (TBI). However, the role of mild hypothermia in neuronal sprouting after TBI remains obscure. We used a fluid percussion injury (FPI) model to assess the effect of mild hypothermia on pericontusion neuronal sprouting after TBI in rats. Male Sprague-Dawley rats underwent FPI or sham surgery, followed by mild hypothermia treatment (33 degrees C) or normothermia treatment (37 degrees C) for 3 h. All the rats were euthanized at 7 days after FPI. Neuronal sprouting that was confirmed by an increase in growth associated protein-43 (GAP-43) expression was evaluated using immunofluorescence and Western blot assays. The expression levels of several intrinsic and extrinsic sprouting-associated genes such as neurite outgrowth inhibitor A (NogoA), phosphatase and tensin homolog (PTEN), and suppressor of cytokine signaling 3 (SOCS3) were analyzed by quantitative real-time polymerase chain reaction (RT-PCR). Our results revealed that mild hypothermia significantly increased the expression level of GAP-43 and dramatically suppressed the expression level of interleukin-6 (IL-6) and SOCS3 at 7 days after FPI in the ipsilateral cortex compared with that of the normothermia TBI group. These data suggest that post-traumatic mild hypothermia promotes pericontusion neuronal sprouting after TBI. Moreover, the mechanism of hypothermia-induced neuronal sprouting might be partially associated with decreased levels of SOCS3.	[Zhao, Cheng-Cheng; Wang, Chuan-Fang; Lin, Yong; Tang, Qi-Lin; Feng, Jun-Feng; Mao, Qing; Gao, Guo-Yi; Jiang, Ji-Yao] Shanghai Jiao Tong Univ, Shanghai Inst Head Trauma, Sch Med, Dept Neurosurg,Ren Ji Hosp, Shanghai, Peoples R China; [Li, Wei-Ping] Shenzhen Univ, Shenzhen Peoples Hosp 2, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, 160 Pujian Rd, Shanghai 200127, Peoples R China.	jiyaojiang16@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271381, 81471856]; National Key Basic Research ProgramNational Basic Research Program of China [2012CB518100]; Program for Outstanding Medical Academic Leader of Shanghai [2014529]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [13ZR1424500]; Shanghai Municipal Health Bureau [XYQ201 3094]; SMC-Star Award for Young Scholars	This research was supported by the National Natural Science Foundation of China (No. 81271381 and 81471856), the National Key Basic Research Program (No. 2012CB518100), and the Program for Outstanding Medical Academic Leader of Shanghai (No. 2014529). J.F.F. has also received funding from the Science and Technology Commission of Shanghai Municipality (13ZR1424500), Shanghai Municipal Health Bureau (XYQ201 3094), and SMC-Star Award for Young Scholars (B).	Auernhammer CJ, 1998, MOL ENDOCRINOL, V12, P954, DOI 10.1210/me.12.7.954; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; DANI JW, 1991, NEUROSCIENCE, V40, P277, DOI 10.1016/0306-4522(91)90190-Y; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Fung SJ, 2011, BIOL PSYCHIAT, V69, P71, DOI 10.1016/j.biopsych.2010.09.036; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Huang X., 2013, J APPL MATH, V1, P1; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kadomatsu K, 2014, ARCH BIOCHEM BIOPHYS, V558, P36, DOI 10.1016/j.abb.2014.06.009; Krautstrunk M, 2002, ACTA NEUROPATHOL, V104, P592, DOI 10.1007/s00401-002-0589-6; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu XF, 2015, EXP NEUROL, V263, P364, DOI 10.1016/j.expneurol.2014.10.024; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Nguyen L, 2009, MOL CELL NEUROSCI, V41, P62, DOI 10.1016/j.mcn.2009.01.011; Park KW, 2014, EXP NEUROL, V261, P65, DOI 10.1016/j.expneurol.2014.06.013; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Popescu C, 2015, J Med Life, V8, P272; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schmitt KRL, 2006, NEUROSCI LETT, V404, P309, DOI 10.1016/j.neulet.2006.05.064; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Siewert E, 1999, EUR J BIOCHEM, V265, P251, DOI 10.1046/j.1432-1327.1999.00719.x; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wang CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep37063	38	12	17	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1636	1644		10.1089/neu.2016.4759			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500015	27923323				2022-02-06	
J	Chen, WQ; Sheng, JT; Guo, JF; Peng, GY; Hong, JF; Li, BB; Chen, XX; Li, KS; Wang, SS				Chen, Weiqiang; Sheng, Jiangtao; Guo, Jingfang; Peng, Guoyi; Hong, Jinfang; Li, Bingbing; Chen, Xiaoxuan; Li, Kangsheng; Wang, Shousen			Cytokine cascades induced by mechanical trauma injury alter voltage-gated sodium channel activity in intact cortical neurons	JOURNAL OF NEUROINFLAMMATION			English	Article						Mechanical brain injury; Inflammatory microenvironment; Cytokine cascades; Voltage-gated sodium channel; Nerve excitability; Brain-derived neurotrophic factor	P75 NEUROTROPHIN RECEPTOR; NECROSIS-FACTOR-ALPHA; BRAIN-INJURY; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; FEBRILE SEIZURES; GROWTH-FACTOR; NA+ CURRENTS; IN-VITRO; GLUTAMATE	Background: Traumatic brain injury (TBI) triggers both immediate (primary) and long-term (secondary) tissue damages. Secondary damages can last from hours to days or even a lifetime. Secondary damages implicate several mechanisms, including influence of inflammatory mediators, mainly cytokines, on excitability of ion channels. However, studies should further explore the effects of inflammatory cytokines on voltage-gated sodium channels (VGSCs) and excitability in distal intact neurons. Methods: Mixed cultures of mouse cortical astrocytes and neurons were subjected to mechanical injury (trauma) to mimic TBI in vitro. Expression of various cytokines in these cultures were measured by real-time polymerase chain reaction and enzyme-linked immunosorbent assay. A trauma-conditioned medium with or without brain-derived neurotrophic factor (BDNF) was added to mouse primary cortical neurons for 6 and 24 h to mimic combined effects of multiple inflammatory cytokines on VGSCs. Spike behaviors of distal intact neurons were examined by whole-cell patch-clamp recordings. Results: Mechanical injury in mixed cortical neuron-astrocyte cultures significantly increased expression levels of multiple cytokines, including interleukin (IL)-1 beta, IL-6, tumor necrosis factor-a, monocyte chemoattractant protein-1, chemokine (C-C motif) ligand-5, IL-10, and transforming growth factor-beta 1, at 6 and 24 h after injury. Incubation in trauma-conditioned medium increased functional VGSCs in neuronal membranes and Na+ currents. Enhanced VGSCs were almost completely abolished by BDNF, and reinforcement of Na+ currents was also reduced in a dose-dependent manner. BDNF (30 ng/mL) also significantly reversed reduced neuronal cell viability, which was induced by medium conditioned at 6 h. At 6 and 24 h, trauma-conditioned medium significantly increased spike frequency but not spike threshold. Conclusions: In TBI, the combined effect of inflammatory cytokines is directly involved in VGSC, Na+ current, and excitability dysfunction in distal intact neurons. BDNF may partly exert neuroprotective effects by maintaining balance of VGSC function in distal intact neurons.	[Chen, Weiqiang; Hong, Jinfang; Li, Bingbing; Wang, Shousen] Xiamen Univ, Coll Med, Fuzhou Gen Hosp, Dept Neurosurg, 156 North Rd,West Second Ring, Fuzhou 350025, Fujian, Peoples R China; [Guo, Jingfang; Peng, Guoyi] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China; [Sheng, Jiangtao; Chen, Xiaoxuan; Li, Kangsheng] Shantou Univ, Coll Med, Key Immunopathol Lab Guangdong Prov, Dept Microbiol & Immunol, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China		Wang, SS (corresponding author), Xiamen Univ, Coll Med, Fuzhou Gen Hosp, Dept Neurosurg, 156 North Rd,West Second Ring, Fuzhou 350025, Fujian, Peoples R China.; Li, KS (corresponding author), Shantou Univ, Coll Med, Key Immunopathol Lab Guangdong Prov, Dept Microbiol & Immunol, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.	ksli2013@yeah.net; wshsen@xmu.edu.cn		Li, Kangsheng/0000-0002-6981-9263	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170852, 31300761, 81001322, 81001340, 81172795, 81374040, 81471622]; Guangdong Natural Science FoundationNational Natural Science Foundation of Guangdong Province [S2012040007470]; Medical Scientific Research Foundation of Guangdong Province, China [A2015211]; Foundation for Distinguished Young Teachers in Higher Education of Guangdong [Yq2013077, Yq2013079]; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases [2015026]	This project was supported by the National Natural Science Foundation of China (31170852, 31300761, 81001322, 81001340, 81172795, 81374040, and 81471622), the Guangdong Natural Science Foundation (S2012040007470), the Medical Scientific Research Foundation of Guangdong Province, China (A2015211), the Foundation for Distinguished Young Teachers in Higher Education of Guangdong (Yq2013077 and Yq2013079), and the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases (2015026). The funding bodies did not participate in the design of the study; collection, analysis, and interpretation of data; and writing of manuscript.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen WQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0349-x; Chen WQ, 2014, BIOCHEM BIOPH RES CO, V450, P55, DOI 10.1016/j.bbrc.2014.05.081; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; Faist E, 1997, CHIRURG, V68, P1066, DOI 10.1007/s001040050324; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Hanell A, 2015, J NEUROTRAUM, V1598, P804; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hille B, 2001, ION CHANNELS EXCITAB, V3rd; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jabaudon D, 2000, P NATL ACAD SCI USA, V97, P5610, DOI 10.1073/pnas.97.10.5610; Juliet PAR, 2008, BRAIN RES, V1210, P230, DOI 10.1016/j.brainres.2008.02.099; Katano H, 1999, NEUROREPORT, V10, P2439, DOI 10.1097/00001756-199908200-00002; Kraus J, 1996, NEUROTRAUMA, P13; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Pntr BT, 2015, PHARMACOGENOMICS, V16, P997; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reid AY, 2009, CAN J NEUROL SCI, V36, P679, DOI 10.1017/S0317167100008246; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shen KF, 2013, EXP NEUROL, V247, P466, DOI 10.1016/j.expneurol.2013.01.018; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Sordillo PP, 2016, BRAIN INJURY, V9052, P1; Stoffel M, 2002, J NEUROTRAUM, V19, P467, DOI 10.1089/08977150252932415; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu XB, 2016, SCI REP-UK, V6, DOI 10.1038/srep34836; Yang F, 2015, J NEUROINFLAMM, V12, P1; Yin HZ, 2012, EXP NEUROL, V238, P93, DOI 10.1016/j.expneurol.2012.08.004; Zhou C, 2011, NEUROCHEM RES, V36, P1116, DOI 10.1007/s11064-011-0456-8	53	12	12	0	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAR 31	2017	14								73	10.1186/s12974-017-0847-0			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EQ4DS	WOS:000398024900004	28359334	gold, Green Published			2022-02-06	
J	Puhakka, N; Bot, AM; Vuokila, N; Debski, KJ; Lukasiuk, K; Pitkanen, A				Puhakka, Noora; Bot, Anna Maria; Vuokila, Niina; Debski, Konrad Jozef; Lukasiuk, Katarzyna; Pitkanen, Asla			Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury	PLOS ONE			English	Article							MICRORNA EXPRESSION; HIPPOCAMPUS; EPILEPSY; MODELS; CELLS; EPILEPTOGENESIS; EPIDEMIOLOGY; ACTIVATION; BIOMARKERS; PROFILES	Traumatic brain injury (TBI) can result in several dentate gyrus-regulated disabilities. Almost nothing is known about the chronic molecular changes after TBI, and their potential as treatment targets. We hypothesized that chronic transcriptional alterations after TBI are under microRNA (miRNA) control. Expression of miRNAs and their targets in the dentate gyrus was analyzed using microarrays at 3 months after experimental TBI. Of 305 miRNAs present on the miRNA-array, 12 were downregulated (p<0.05). In parallel, 75 of their target genes were upregulated (p<0.05). A bioinformatics analysis of miRNA targets highlighted the dysregulation of the transcription factor NOTCH1 and 39 of its target genes (NOTCH1 interactome). Validation assays confirmed downregulation of miR-139-5p, upregulation of Notch1 and its activated protein, and positive enrichment of NOTCH1 target gene expression. These findings demonstrate that miRNA-based transcriptional regulation can be present at chronic time points after TBI, and highlight the NOTCH1 interactome as one of the mechanisms behind the dentate gyrus pathology-related morbidities.	[Puhakka, Noora; Vuokila, Niina; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland; [Bot, Anna Maria; Debski, Konrad Jozef; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio, Finland.	asla.pitkanen@uef.fi		Lukasiuk, Katarzyna/0000-0002-1582-0920; Debski, Konrad/0000-0001-5949-9211	Academy of FinlandAcademy of FinlandEuropean Commission; FP7-HEALTH project [602102]; National Research CentreNational Research Centre (NRC) [2011/01/M/NZ3/02139]; Ministry of Science and Education [DNP/N119/ESF-EuroEPINOMICS/2012]	This study was supported by the Academy of Finland http://www.aka.fi/en (AP) and FP7-HEALTH project 602102 https://ec.europa.eu/research/fp7/index_en.cfm (EPITARGET), National Research Centre grant 2011/01/M/NZ3/02139 (KL), and Ministry of Science and Education grant DNP/N119/ESF-EuroEPINOMICS/2012.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Balaraman S, 2012, ALCOHOL CLIN EXP RES, V36, P1669, DOI 10.1111/j.1530-0277.2012.01793.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth JMI, 2014, MIOMED RES; Bekris LM, 2015, NEURODEGENER DIS MAN, V5, P61, DOI [10.2217/NMT.14.52, 10.2217/nmt.14.52]; Boese AS, 2016, MOL CELL NEUROSCI, V71, P13, DOI 10.1016/j.mcn.2015.12.001; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Brai E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00447; Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Debski KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25668; Deprez F, 2011, NEUROBIOL DIS, V44, P174, DOI 10.1016/j.nbd.2011.06.011; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Grasso M, 2014, MOLECULES, V19, P6891, DOI 10.3390/molecules19056891; Guo YJ, 2009, PROG NEURO-PSYCHOPH, V33, P688, DOI 10.1016/j.pnpbp.2009.03.022; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu L, 2014, ADV DIFFER EQU, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0103948; Liu X, 2015, PLOS ONE; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Liu Zhong, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P1, DOI 10.3724/SP.J.1011.2012.00001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Mi L, 2015, J CELL BIOCHEM, V116, P1195, DOI 10.1002/jcb.25065; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Naghavian R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124555; Nagy Gergely, 2002, Pathology and Oncology Research, V8, P115; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Qu Y, 2014, NEUROBIOL DIS, V63, P184, DOI 10.1016/j.nbd.2013.11.023; R Core Team, 2012, LANG ENV STAT COMP; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Roncon P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14143; Roopra A, 2012, EPILEPSIA, V53, P2, DOI 10.1111/epi.12030; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sha LZ, 2014, MOL NEUROBIOL, V49, P633, DOI 10.1007/s12035-013-8545-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimada IS, 2011, STROKE, V42, P3231, DOI 10.1161/STROKEAHA.111.623280; Sibbe M, 2012, EUR J NEUROSCI, V36, P3643, DOI 10.1111/j.1460-9568.2012.08279.x; Song MX, 2014, PROTEIN CELL, V5, P851, DOI 10.1007/s13238-014-0093-5; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanase C, 2015, FUTURE ONCOL, V11, P511, DOI 10.2217/fon.14.238; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tu J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/368082; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang J, 2014, EXP THER MED, V8, P1671, DOI 10.3892/etm.2014.2014; Wang S., 2010, SIGN SYST EL ISSSE 2, V1, P1, DOI DOI 10.1097/FBP.0B013E328334B677; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011; Zhang LJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-124; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhang Z, 2015, BRAIN RES BULL, V113, P8, DOI 10.1016/j.brainresbull.2015.02.003	85	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 8	2017	12	3							e0172521	10.1371/journal.pone.0172521			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN5VL	WOS:000396073700077	28273100	gold, Green Published, Green Submitted			2022-02-06	
J	Boutin, A; Moore, L; Lauzier, F; Chasse, M; English, S; Zarychanski, R; McIntyre, L; Griesdale, D; Fergusson, DA; Turgeon, AF				Boutin, Amelie; Moore, Lynne; Lauzier, Francois; Chasse, Michael; English, Shane; Zarychanski, Ryan; McIntyre, Lauralyn; Griesdale, Donald; Fergusson, Dean A.; Turgeon, Alexis F.			Transfusion of red blood cells in patients with traumatic brain injuries admitted to Canadian trauma health centres: a multicentre cohort study	BMJ OPEN			English	Article							LENGTH-OF-STAY; CRITICALLY-ILL; CLINICAL-PRACTICE; ACUTE-PHASE; ANEMIA; MORTALITY; MODERATE; COMPLICATIONS; METAANALYSIS; REGRESSION	Background: Optimisation of healthcare practices in patients sustaining a traumatic brain injury is of major concern given the high incidence of death and longterm disabilities. Considering the brain's susceptibility to ischaemia, strategies to optimise oxygenation to brain are needed. While red blood cell (RBC) transfusion is one such strategy, specific RBC strategies are debated. We aimed to evaluate RBC transfusion frequency, determinants of transfusions and associated clinical outcomes. Methods: We conducted a retrospective multicentre cohort study using data from the National Trauma Registry of Canada. Patients admitted with moderate or severe traumatic brain injury to participating hospitals between April 2005 and March 2013 were eligible. Patient information on blood products, comorbidities, interventions and complications from the Discharge Abstract Database were linked to the National Trauma Registry data. Relative weights analyses evaluated the contribution of each determinant. We conducted multivariate robust Poisson regression to evaluate the association between potential determinants, mortality, complications, hospital-to-home discharge and RBC transfusion. We also used proportional hazard models to evaluate length of stay for time to discharge from ICU and hospital. Results: Among the 7062 patients with traumatic brain injury, 1991 patients received at least one RBC transfusion during their hospital stay. Female sex, anaemia, coagulopathy, sepsis, bleeding, hypovolemic shock, other comorbid illnesses, serious extracerebral trauma injuries were all significantly associated with RBC transfusion. Serious extracerebral injuries altogether explained 61% of the observed variation in RBC transfusion. Mortality (risk ratio (RR) 1.23 (95% CI 1.13 to 1.33)), trauma complications (RR 1.38 (95% CI 1.32 to 1.44)) and discharge elsewhere than home (RR 1.88 (95% CI 1.75 to 2.04)) were increased in patients who received RBC transfusion. Discharge from ICU and hospital were also delayed in transfused patients. Conclusions: RBC transfusion is common in patients with traumatic brain injury and associated with unfavourable outcomes. Trauma severity is an important determinant of RBC transfusion. Prospective studies are needed to further evaluate optimal transfusion strategies in traumatic brain injury.	[Boutin, Amelie; Moore, Lynne; Lauzier, Francois; Chasse, Michael; Turgeon, Alexis F.] Univ Laval, CHU Quebec Univ Laval Res Ctr, Populat Hlth & Opt Hlth Practices Res Unit Trauma, Quebec City, PQ, Canada; [Boutin, Amelie; Moore, Lynne] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Lauzier, Francois; Chasse, Michael; Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [English, Shane; McIntyre, Lauralyn] Ottawa Hosp Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada; [Zarychanski, Ryan] Univ Manitoba, Sect Crit Care Med, Dept Internal Med, Haematol & Med Oncol, Winnipeg, MB, Canada; [Griesdale, Donald] Univ British Columbia, Dept Anesthesia, Vancouver, BC, Canada		Turgeon, AF (corresponding author), Univ Laval, CHU Quebec Univ Laval Res Ctr, Populat Hlth & Opt Hlth Practices Res Unit Trauma, Quebec City, PQ, Canada.; Turgeon, AF (corresponding author), Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada.	alexis.turgeon@fmed.ulaval.ca	McIntyre, Lauralyn/AAR-7710-2021; Griesdale, Donald/AAT-7762-2021; Lauzier, Francois/B-9237-2015; Chasse, Michael/L-7906-2017; English, Shane/P-9187-2019; Chasse, Michael/Y-7820-2019; Zarychanski, Ryan/AAB-6369-2022	McIntyre, Lauralyn/0000-0001-7421-1407; Griesdale, Donald/0000-0001-5985-8624; Lauzier, Francois/0000-0002-6530-5513; Chasse, Michael/0000-0001-7075-1924; English, Shane/0000-0002-9477-6146; Boutin, Amelie/0000-0003-1907-2920; Fergusson, Dean/0000-0002-3389-2485; Zarychanski, Ryan/0000-0001-9455-6138; Turgeon, Alexis/0000-0001-5675-8791	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); CIHRCanadian Institutes of Health Research (CIHR); Traumatology Research Consortium of the Fonds de Recherche du Quebec- Sante (FRQS); FRQS	AB is recipient of a Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award from the Canadian Institutes of Health Research (CIHR). LM, AFT and RZ are/were recipients of New Investigator Awards from the CIHR. AFT and FL are supported by the Traumatology Research Consortium of the Fonds de Recherche du Quebec- Sante (FRQS). FL is a recipient of a salary support Award from the FRQS. AFT is the Canada Research Chair in Critical Care Neurology and Trauma.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; ANDERSEN J, 1992, J TRAUMA, V33, P219, DOI 10.1097/00005373-199208000-00009; [Anonymous], 2012, CIHI DAT QUAL STUD 2; Bellapart J, 2012, J TRAUMA ACUTE CARE, V73, P997, DOI 10.1097/TA.0b013e318265cede; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Brock GN, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-144; Brown JB, 2015, ANN SURG, V261, P997, DOI 10.1097/SLA.0000000000000674; Canadian Insitute for Health Information, 2014, NAT TRAUM REG COMPR; Carson Jeffrey L, 2012, Cochrane Database Syst Rev, pCD002042, DOI 10.1002/14651858.CD002042.pub3; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chant C, 2006, CRIT CARE, V10, DOI 10.1186/cc5054; Charge S, 2013, CLIN GUIDE TRANSFUSI; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Hallet J, 2013, CRIT CARE MED, V41, P2800, DOI 10.1097/CCM.0b013e31829a6ecb; Halpern SD, 2012, ICU LENGTH STAY NEW; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institut National d'Excellence en Sante et en Services sociaux (INESSS), 2013, AV CRIT TRIAG PREH T, P1; Juffermans NP., 2015, TRANSFUSION INTENSIV; Korn EL, 2006, STAT SCI, V21, P310, DOI 10.1214/088342306000000286; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kuimi BLB, 2015, INJURY, V46, P595, DOI 10.1016/j.injury.2015.01.006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Marik PE, 2014, CHEST, V145, P1407, DOI 10.1378/chest.13-2104; McCullough J, 2012, TRANSFUSION MEDICINE, 3RD EDITION, P1; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Mirski MA, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0912-y; Moore L, 2008, ANN EMERG MED, V52, P356, DOI 10.1016/j.annemergmed.2007.09.007; Moore L, 2015, ANN SURG, V262, P1123, DOI 10.1097/SLA.0000000000000963; Moore L, 2014, J TRAUMA ACUTE CARE, V77, P322, DOI 10.1097/TA.0000000000000366; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Rawn J, 2008, CURR OPIN ANESTHESIO, V21, P664, DOI 10.1097/ACO.0b013e32830f1fd1; Roberts DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11489; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Spinelli E, 2016, J INTENSIVE CARE MED, V31, P295, DOI 10.1177/0885066615571901; Tonidandel S, 2010, ORGAN RES METHODS, V13, P767, DOI 10.1177/1094428109341993; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Veenith T, 2010, ANAESTHESIA, V65, P331, DOI 10.1111/j.1365-2044.2009.06225.x; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Yang CJ, 2011, J TRAUMA, V71, pE132, DOI 10.1097/TA.0b013e31820ea36b; Yucel N, 2006, J TRAUMA, V60, P1228, DOI 10.1097/01.ta.0000220386.84012.bf; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	62	12	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAR	2017	7	3							e014472	10.1136/bmjopen-2016-014472			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6ZO	WOS:000398959400154	28360248	Green Published, gold			2022-02-06	
J	Brabazon, F; Wilson, CM; Shukla, DK; Mathur, S; Jaiswal, S; Bermudez, S; Byrnes, KR; Selwyn, R				Brabazon, Fiona; Wilson, Colin; Shukla, Dinesh; Mathur, Sanjeev; Jaiswal, Shalini; Bermudez, Sara; Byrnes, Kimberly; Selwyn, Reed			[F-18]FDG-PET Combined with MRI Elucidates the Pathophysiology of Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; brain injury; FDG-PET; inflammation; microglia	CORTICAL IMPACT INJURY; POSITRON-EMISSION-TOMOGRAPHY; MICROGLIA ACTIVATION; NEURONAL DEATH; UNITED-STATES; GLUCOSE; PATHOLOGY; RECEPTOR; TIME	Non-invasive measurements of brain metabolism using F-18-fluorodeoxyglucose (FDG) with positron emission tomography (PET) may provide important information about injury severity following traumatic brain injury (TBI). There is growing interest in the potential of combining functional PET imaging with anatomical and functional magnetic resonance imaging (MRI). This study aimed to investigate the effectiveness of combining clinically available FDG-PET with T2 and diffusion MR imaging, with a particular focus on inflammation and the influence of glial alterations after injury. Adult male Sprague Dawley rats underwent a moderate controlled cortical impact (CCI) injury followed by FDG-PET, MRI, and histological evaluation. FDG uptake showed significant alterations in the corpus callosum, hippocampus, and amygdala after TBI, demonstrating that a relatively focal CCI injury can result in global alterations. Analysis of MRI T2 intensity and apparent diffusion coefficient (ADC) also showed significant alterations in these regions to include cytotoxic and vasogenic edema. Histology showed increased glial activation in the corpus callosum and hippocampus that was associated with increased FDG uptake at sub-acute time-points. Glial activation was not detected in the amygdala but neuronal damage was evident, as the amygdala was the only region to show a reduction in both FDG uptake and ADC at sub-acute time-points. Overall, FDG-PET detected glial activation but was confounded by the presence of cell damage, whereas MRI consistently detected cell damage but was confounded by glial activation. These results demonstrate that FDG-PET and MRI can be used together to improve our understanding of the complex alterations in the brain after TBI.	[Brabazon, Fiona; Byrnes, Kimberly] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Wilson, Colin; Shukla, Dinesh; Mathur, Sanjeev; Jaiswal, Shalini; Selwyn, Reed] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA; [Wilson, Colin; Shukla, Dinesh; Mathur, Sanjeev; Jaiswal, Shalini; Byrnes, Kimberly; Selwyn, Reed] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Bermudez, Sara; Byrnes, Kimberly] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Selwyn, Reed] Univ New Mexico, Dept Radiol, MSC10 5530,1 Univ New Mexico, Albuquerque, NM 87131 USA		Selwyn, R (corresponding author), Univ New Mexico, Dept Radiol, MSC10 5530,1 Univ New Mexico, Albuquerque, NM 87131 USA.	RSelwyn@salud.unm.edu		Brabazon, Fiona/0000-0003-1642-808X	Department of Defense (DoD) in the Center for Neuroscience and Regenerative Medicine	This study was funded by the Department of Defense (DoD) in the Center for Neuroscience and Regenerative Medicine. The opinions or assertions contained herein are the private ones of the author(s) and are not to be construed as official or reflecting the views of the DoD or the Uniformed Services University of the Health Sciences (USUHS).	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hagelthorn KM, 2000, DEV NEUROPSYCHOL, V18, P11, DOI 10.1207/S15326942DN1801_2; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; REIVICH M, 1979, CIRC RES, V44, P127, DOI 10.1161/01.RES.44.1.127; Reshef A, 2008, J NEUROTRAUM, V25, P569, DOI 10.1089/neu.2007.0341; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Vallez Garcia D, 2016, J NEUROTRAUMA; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	36	12	12	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1074	1085		10.1089/neu.2016.4540			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200012	27554593				2022-02-06	
J	Grady, MF; Master, CL				Grady, Matthew F.; Master, Christina L.			Return to School and Learning After Concussion: Tips for Pediatricians	PEDIATRIC ANNALS			English	Article							SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; EXERCISE; SYMPTOMS; MANAGEMENT; RECOVERY; REST	Concussion in children and adolescents is a common injury that is usually managed by the primary care provider. Students with a concussion may present with a variety of symptoms, and these symptoms interfere with regular school participation. Optimizing the timing and progression of return to school and learning is often challenging, but with a careful history and concussion-specific examination, the primary care provider can identify potential barriers to school reentry. This review focuses on developing a systematic approach to the initial concussion evaluation and developing customized school accommodations to aid in the school reentry process.	[Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Dept Orthoped Surg, Div Sports Med, Philadelphia, PA 19104 USA; [Grady, Matthew F.; Master, Christina L.] Univ Penn, Perelman Sch Med, Dept Pediat, Pediat Clin, Philadelphia, PA 19104 USA		Grady, MF (corresponding author), Childrens Hosp Philadelphia, Dept Orthoped Surg, 3401 Civ Ctr Blvd,2nd Floor Wood Bldg, Philadelphia, PA 19104 USA.	gradym@email.chop.edu		Master, Christina/0000-0002-6717-4270			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Children's Hospital of Philadelphia, PED EX CONCL EV; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Makki AY., 2016, GLOB PEDIAT HLTH, V3; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	27	12	12	0	4	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	MAR	2017	46	3					E93	E98		10.3928/19382359-20170220-04			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EQ5FQ	WOS:000398108200005	28287682				2022-02-06	
J	Jastifer, J; Kent, R; Crandall, J; Sherwood, C; Lessley, D; McCullough, KA; Coughlin, MJ; Anderson, RB				Jastifer, James; Kent, Richard; Crandall, Jeff; Sherwood, Chris; Lessley, David; McCullough, Kirk A.; Coughlin, Michael J.; Anderson, Robert B.			The Athletic Shoe in Football: Apparel or Protective Equipment?	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						athletic shoewear; footwear; cleated shoe	METATARSOPHALANGEAL JOINT SPRAINS; FOREFOOT BENDING STIFFNESS; CRUCIATE LIGAMENT INJURIES; PLAYING SURFACES; RISK-FACTORS; PLAYERS; ANKLE; ENERGY; CONCUSSION; PREVENTION	Background: Foot and ankle injuries are common in sports, particularly in cleated athletes. Traditionally, the athletic shoe has not been regarded as a piece of protective equipment but rather as a part of the uniform, with a primary focus on performance and subjective feedback measures of comfort. Changes in turf and shoe design have poorly understood implications on the health and safety of players. Evidence Acquisition: A literature search of the MEDLINE and PubMed databases was conducted. Keywords included athletic shoewear, cleated shoe, football shoes, and shoewear, and search parameters were between the years 2000 and 2016. Study Design: Clinical review. Results: The athletic shoe is an important piece of protective sports equipment. There are several important structural considerations of shoe design, including biomechanical compliance, cleat and turf interaction, and shoe sizing/fit, that affect the way an athlete engages with the playing surface and carry important potential implications regarding player safety if not understood and addressed. Conclusion: Athletic footwear should be considered an integral piece of protective equipment rather than simply an extension of the uniform apparel. More research is needed to define optimal shoe sizing, the effect that design has on mechanical load, and how cleat properties, including pattern and structure, interact with the variety of playing surfaces.	[Jastifer, James] Borgess Orthoped, 2490 South 11th St, Kalamazoo, MI 49009 USA; [Kent, Richard; Crandall, Jeff; Sherwood, Chris; Lessley, David] Biomech Consulting & Res Biocore, Charlottesville, VA USA; [Kent, Richard; Crandall, Jeff] Univ Virginia, Charlottesville, VA USA; [McCullough, Kirk A.] OSMCKC, Kansas City, KS USA; [Coughlin, Michael J.] St Alphonsus Coughlin Foot & Ankle Clin, Boise, ID USA; [Anderson, Robert B.] OrthoCarolina, Charlotte, NC USA		Jastifer, J (corresponding author), Borgess Orthoped, 2490 South 11th St, Kalamazoo, MI 49009 USA.	jrjast@gmail.com			University of Virginia; NFL	The following authors declared potential conflicts of interest: Richard Kent, PhD, is a paid consultant for the NFL. Jeff Crandall, PhD, is a paid consultant for the NFL and has grants/grants pending from the University of Virginia. David Lessley, PhD, is a paid consultant for Biocore. Robert B. Anderson, MD, is a paid consultant for Wright Medical, DJO, Zimmer Biomet, Amniox, and Arthrex; receives royalties from Wright Medical, Arthrex, and Zimmer Biomet; and had travel paid for and received an honorarium for committee chairman duties that included this project oversight from the NFL.	[Anonymous], 1994, ASTMF91185; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Boden BP, 2010, J AM ACAD ORTHOP SUR, V18, P520, DOI 10.5435/00124635-201009000-00003; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Brock E, 2014, SPORT BIOMECH, V13, P362, DOI 10.1080/14763141.2014.965727; Crandall J, 2015, FOOTWEAR SCI, V7, P139, DOI 10.1080/19424280.2015.1058427; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Drakos MC, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000118; Frederick E. C., 1989, THE SHOE IN SPORT, P26; Frimenko RE, 2013, MED SCI SPORT EXER, V45, P2144, DOI 10.1249/MSS.0b013e3182994a10; Galbusera F, 2013, SPORT BIOMECH, V12, P293, DOI 10.1080/14763141.2013.769277; Gorden JA, 2003, J ATHL TRAINING, V38, P209; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hershman EB, 2012, AM J SPORT MED, V40, P2200, DOI 10.1177/0363546512458888; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kent R, 2015, SPORT BIOMECH, V14, P246, DOI 10.1080/14763141.2015.1052749; Lambson RB, 1996, AM J SPORT MED, V24, P155, DOI 10.1177/036354659602400206; Lessley DJ, 2016, FOOTWEAR SCI, V8, P65, DOI 10.1080/19424280.2016.1165742; Lievers WB, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115581593; Mayer SW, 2014, SPORTS HEALTH, V6, P481, DOI 10.1177/1941738113486588; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; McGuine TA, 2012, AM J SPORT MED, V40, P49, DOI 10.1177/0363546511422332; MILGROM C, 1991, FOOT ANKLE, V12, P26, DOI 10.1177/107110079101200105; Oleson M, 2005, J BIOMECH, V38, P1886, DOI 10.1016/j.jbiomech.2004.08.014; Parham KR, 1985, ANTHROPOMETRY FOOT L; Pietrosimone BG, 2008, J ATHL TRAINING, V43, P409, DOI 10.4085/1062-6050-43.4.409; Riley PO, 2013, GAIT POSTURE, V38, P563, DOI 10.1016/j.gaitpost.2012.03.034; RODEO SA, 1990, AM J SPORT MED, V18, P280, DOI 10.1177/036354659001800311; Roy JPR, 2006, MED SCI SPORT EXER, V38, P562, DOI 10.1249/01.mss.0000193562.22001.e8; Simon J, 2013, J SPORT REHABIL, V22, P229, DOI 10.1123/jsr.22.3.229; Stefanyshyn DJ, 2000, SPORTVERLETZ SPORTSC, V14, P82, DOI 10.1055/s-2000-7867; Stefanyshyn DJ, 2000, MED SCI SPORT EXER, V32, P471, DOI 10.1097/00005768-200002000-00032; Takahashi KZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29870; Wannop JW, 2010, AM J SPORT MED, V38, P1221, DOI 10.1177/0363546509359065	34	12	12	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2017	9	2					126	131		10.1177/1941738117690717			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EY5WQ	WOS:000404052200004	28151702	Green Published			2022-02-06	
J	Klee, R; Brandt, C; Tollner, K; Loscher, W				Klee, Rebecca; Brandt, Claudia; Toellner, Kathrin; Loescher, Wolfgang			Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model	EPILEPSY & BEHAVIOR			English	Article						Kainic acid; Hippocampus; Electrographic seizures; EEG; Anesthesia; Isoflurane	KAINIC ACID INJECTION; HIPPOCAMPAL SCLEROSIS; RECURRENT SEIZURES; STATUS EPILEPTICUS; ACQUIRED EPILEPSY; ANIMAL-MODELS; EPILEPTOGENESIS; MICE; NEURONS; CONTRIBUTES	Temporal lobe epilepsy (TLE) is the most common type of acquired epilepsy in adults. TLE can develop after diverse brain insults, including traumatic brain injury, infections, stroke, or prolonged status epilepticus (SE). Post SE rodent models of TLE are widely used to understand mechanisms of epileptogenesis and develop treatments for epilepsy prevention. In this respect, the intrahippocampal kainate model of TLE in mice is of interest, because highly frequent spontaneous electrographic seizures develop in the kainate focus, allowing evaluation of both anti-seizure and anti-epileptogenic effects of novel drugs with only short EEG recording periods, which is not possible in any other model of TLE, including the intrahippocampal kainate model in rats. In the present study, we investigated whether the marked mouse-to-rat difference in occurrence and frequency of spontaneous seizures is due to a species difference or to technical variables, such as anesthesia during kainate injection, kainate dose, or location of kainate injection and EEG electrode in the hippocampus. When, as in the mouse model, anesthesia was used during kainate injection, only few rats developed epilepsy, although severity or duration of SE was not affected by isoflurane. In contrast, most rats developed epilepsy when kainate was injected without anesthesia. However, frequent electrographic seizures as observed in mice did not occur in rats, irrespective of location of kainate injection (CA1, CA3) or EEG recording electrode (CA1, CA3, dentate gyrus) or dose of kainate injected. These data indicate marked phenotypic differences between mice and rats in this model. Further studies should explore the mechanisms underlying this species difference. (C) 2016 Elsevier Inc. All rights reserved.	[Klee, Rebecca; Brandt, Claudia; Toellner, Kathrin; Loescher, Wolfgang] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Bunteweg 17, D-30559 Hannover, Germany; Ctr Syst Neurosci, Hannover, Germany		Loscher, W (corresponding author), Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Bunteweg 17, D-30559 Hannover, Germany.	wolfgang.loescher@tiho-hannover.de	Loscher, Wolfgang/G-9824-2016	Loscher, Wolfgang/0000-0002-9648-8973	European UnionEuropean Commission [602102]; FAZIT-Foundation (Frankfurt a.M., Germany)	We thank Edith Kaczmarek, Dr. Friederike Twele, and Philip Hampel for skillful technical assistance. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602102 (EPITARGET). R. Klee thanks the FAZIT-Foundation (Frankfurt a.M., Germany) for a PhD scholarship.	ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Balosso S, 2005, ANN NEUROL, V57, P804, DOI 10.1002/ana.20480; Bar-Klein G, 2016, ANN NEUROL, V80, P896, DOI 10.1002/ana.24804; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bishop KM, 1999, BRAIN RES, V815, P358, DOI 10.1016/S0006-8993(98)01088-9; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 2004, EPILEPSIA, V45, P1017, DOI 10.1111/j.0013-9580.2004.17004.x; CAVALHEIRO EA, 1982, ELECTROEN CLIN NEURO, V53, P581, DOI 10.1016/0013-4694(82)90134-1; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dudek FE, 2006, MODELS OF SEIZURES AND EPILEPSY, P415, DOI 10.1016/B978-012088554-1/50036-0; Gernert M, 2001, EUR J PHARMACOL, V432, P35, DOI 10.1016/S0014-2999(01)01458-3; Gouder N, 2003, EPILEPSIA, V44, P877, DOI 10.1046/j.1528-1157.2003.03603.x; Groticke I, 2008, EXP NEUROL, V213, P71, DOI 10.1016/j.expneurol.2008.04.036; Guillemain I, 2012, EPILEPTIC DISORD, V14, P217, DOI 10.1684/epd.2012.0528; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Jarrard LE, 2002, HIPPOCAMPUS, V12, P405, DOI 10.1002/hipo.10054; Karoly N, 2011, ACTA HISTOCHEM, V113, P656, DOI 10.1016/j.acthis.2010.08.005; Klee R, 2015, EPILEPSY RES, V118, P34, DOI 10.1016/j.eplepsyres.2015.11.003; Klein S, 2015, NEUROPHARMACOLOGY, V90, P53, DOI 10.1016/j.neuropharm.2014.11.008; Kucker S, 2010, NEUROBIOL DIS, V37, P661, DOI 10.1016/j.nbd.2009.12.002; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Loscher W, 2016, EPILEPSY RES, V126, P157, DOI 10.1016/j.eplepsyres.2016.05.016; Loscher W, 2015, EPILEPSY BEHAV, V52, P78, DOI 10.1016/j.yebeh.2015.08.037; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2009, EUR J PHARMACOL, V610, P1, DOI 10.1016/j.ejphar.2009.03.025; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mitsuya K, 2009, EPILEPSIA, V50, P1979, DOI 10.1111/j.1528-1167.2009.02055.x; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Potter KA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046020; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raedt R, 2009, ACTA NEUROL SCAND, V119, P293, DOI 10.1111/j.1600-0404.2008.01108.x; Rattka M, 2013, EPILEPSY RES, V103, P135, DOI 10.1016/j.eplepsyres.2012.09.015; Rattka M, 2012, EUR J NEUROSCI, V36, P2505, DOI 10.1111/j.1460-9568.2012.08143.x; Rattka M, 2011, NEUROPHARMACOLOGY, V60, P505, DOI 10.1016/j.neuropharm.2010.11.005; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; SUZUKI F, 1995, NEUROSCIENCE, V64, P665, DOI 10.1016/0306-4522(94)00463-F; Tollner K, 2014, ANN NEUROL, V75, P550, DOI 10.1002/ana.24124; Topfer M, 2014, EUR J NEUROSCI, V39, P673, DOI 10.1111/ejn.12424; Twele F, 2016, EPILEPSY BEHAV, V55, P47, DOI 10.1016/j.yebeh.2015.11.027; Twele F, 2015, NEUROPHARMACOLOGY, V95, P234, DOI 10.1016/j.neuropharm.2015.03.014; Vezzani A, 1999, J NEUROSCI, V19, P5054; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; Whishaw IQ, 2001, DEV PSYCHOBIOL, V39, P151, DOI 10.1002/dev.1041; Wlaz P., 2000, Naunyn-Schmiedeberg's Archives of Pharmacology, V362, pR49; Zattoni M, 2011, J NEUROSCI, V31, P4037, DOI 10.1523/JNEUROSCI.6210-10.2011	53	12	12	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2017	68						129	140		10.1016/j.yebeh.2016.11.035			12	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	EQ9TA	WOS:000398426900021	28167446				2022-02-06	
J	Markos, SM; Failla, MD; Ritter, AC; Dixon, CE; Conley, YP; Ricker, JH; Arenth, PM; Juengst, SB; Wagner, AK				Markos, Steven M.; Failla, Michelle D.; Ritter, Anne C.; Dixon, C. Edward; Conley, Yvette P.; Ricker, Joseph H.; Arenth, Patricia M.; Juengst, Shannon B.; Wagner, Amy K.			Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; depression; genetic polymorphism; traumatic brain injury; vesicular monoamine transporter type 2 (VMAT2); Rehabilomics	SEVERE TBI; GENDER-DIFFERENCES; DOPAMINE LEVELS; OLDER-ADULTS; DEPRESSION; VALIDITY; VMAT2; RECOVERY; MODERATE; VARIANTS	Introduction: Traumatic brain injury (TBI) frequently results in impaired cognition, a function that can be modulated by monoaminergic signaling. Genetic variation among monoaminergic genes may affect post-TBI cognitive performance. The vesicular monoamine transporter-2 (VMAT2) gene may be a novel source of genetic variation important for cognitive outcomes post-TBI given VMAT2's role in monoaminergic neurotransmission. Objective: To evaluate associations between VMAT2 variability and cognitive outcomes post-TBI. Methods: We evaluated 136 white adults with severe TBI for variation in VMAT2 using a tagging single nucleotide polymorphism (tSNP) approach (rs363223, rs363226, rs363251, and rs363341). We show genetic variation interacts with assessed cognitive impairment (cognitive composite [ Comp-Cog] T-scores) to influence functional cognition (functional independence measure cognitive [FIM-Cog] subscale] 6 and 12 months postinjury. Results: Multivariate analyses at 6 months postinjury showed rs363226 genotype was associated with Comp-Cog (P = .040) and interacted with Comp-Cog to influence functional cognition (P < .001). G-homozygotes had the largest cognitive impairment, and their cognitive impairment had the greatest adverse effect on functional cognition. Discussion: We provide the first evidence that genetic variation within VMAT2 is associated with cognitive outcomes after TBI. Further work is needed to validate this finding and elucidate mechanisms by which genetic variation affects monoaminergic signaling, mediating differences in cognitive outcomes.	[Markos, Steven M.; Failla, Michelle D.; Ritter, Anne C.; Dixon, C. Edward; Arenth, Patricia M.; Juengst, Shannon B.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Dixon, C. Edward] Pittsburgh VA Healthcare Syst, Pittsburgh, PA USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Ricker, Joseph H.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Hlth Promot & Dev, Pittsburgh, PA 15261 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021; Juengst, Shannon B/AAC-5891-2019	Failla, Michelle/0000-0001-9734-3373; Juengst, Shannon B/0000-0003-4709-545X; Ricker, Joseph/0000-0003-3415-991X; Conley, Yvette/0000-0002-1784-6067	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T35AT005933-02, R01 HD048162-02, R01NR008424, 5P01NS030318-16]; NIDILRRUnited States Department of Health & Human Services [90DP0041]; DODUnited States Department of Defense [W81XWH-071-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [T35AT005933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The project described was supported by NIH 5T35AT005933-02, NIH R01 HD048162-02, NIH R01NR008424, NIH 5P01NS030318-16, NIDILRR 90DP0041, and DOD W81XWH-071-0701. The authors thank the UPMC Trauma Registry for their support with some elements of data collection.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BARON JC, 1985, NEUROLOGY, V35, P16, DOI 10.1212/WNL.35.1.16; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brighina L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.020; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Crownover J, 2012, CURR GERIATR REP, V1, P149, DOI 10.1007/s13670-012-0021-6; Cruz-Muros I, 2008, NEUROBIOL AGING, V29, P1702, DOI 10.1016/j.neurobiolaging.2007.04.003; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eiden LE, 2011, ANN NY ACAD SCI, V1216, P86, DOI 10.1111/j.1749-6632.2010.05906.x; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Failla MD, J HEAD TRAU IN PRESS; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farace E, 2000, Neurosurg Focus, V8, pe6; Fehr C, 2013, J NEURAL TRANSM, V120, P1161, DOI 10.1007/s00702-013-0996-y; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hanson GR, 2004, ANN NY ACAD SCI, V1025, P146, DOI 10.1196/annals.1316.019; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Henry JM, 1997, J INVEST SURG, V10, P281, DOI 10.3109/08941939709032167; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kim ST, 2005, J NEUROCHEM, V95, P89, DOI 10.1111/j.1471-4159.2005.03342.x; Kramer UM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-150; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lin ZC, 2005, HUM MOL GENET, V14, P1393, DOI 10.1093/hmg/ddi148; Lin ZC, 2010, FASEB J, V24, P2191, DOI 10.1096/fj.09-140368; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Narendran R, 2012, AM J PSYCHIAT, V169, P55, DOI 10.1176/appi.ajp.2011.11010126; NCBI, RS3632260 NCBI; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; Nomura M, 2006, PSYCHOPHARMACOLOGY, V187, P30, DOI 10.1007/s00213-006-0398-z; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Pedroli E, 2013, STUD HEALTH TECHNOL, V191, P38, DOI 10.3233/978-1-61499-282-0-38; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reitan R, 1985, HALSTEAD REITAN NEUR; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; SEEMAN P, 1978, FED PROC, V37, P130; Stefanis NC, 2005, AM J PSYCHIAT, V162, P1752, DOI 10.1176/appi.ajp.162.9.1752; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; van Veelen NMJ, 2010, SCHIZOPHR RES, V120, P191, DOI 10.1016/j.schres.2010.04.011; Vergo S, 2007, BRAIN RES, V1185, P18, DOI 10.1016/j.brainres.2007.09.028; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wimalasena K, 2011, MED RES REV, V31, P483, DOI 10.1002/med.20187; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yang XL, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/903164; Zai CC, 2013, J PSYCHIATR RES, V47, P1760, DOI 10.1016/j.jpsychires.2013.07.025	92	12	12	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E24	E34		10.1097/HTR.0000000000000224			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700004	26828714	Green Accepted			2022-02-06	
J	Petrelli, T; Farrokhyar, F; McGrath, P; Sulowski, C; Sobhi, G; DeMatteo, C; Giglia, L; Singh, SK				Petrelli, Tina; Farrokhyar, Forough; McGrath, Patricia; Sulowski, Chris; Sobhi, Gita; DeMatteo, Carol; Giglia, Lucia; Singh, Sheila K.			The use of ibuprofen and acetaminophen for acute headache in the postconcussive youth: A pilot study	PAEDIATRICS & CHILD HEALTH			English	Article						Acetaminophen; Acute headache; Adolescents; Analgesia; Children; Concussion; Headache; Mild traumatic brain injury; Nonsteroidal anti-inflammatory drugs	TRAUMATIC BRAIN-INJURY; CONCUSSION; STATEMENT; SYMPTOMS; SPORT	Objective: Acute postconcussive headaches are problematic for children after mild traumatic brain injury. There are no evidence-based guidelines for their management. This pilot study aims to assess the feasibility and efficacy of routine analgesia administration. Methods: A four-arm open-label randomized controlled trial pilot/feasibility study was conducted: (i) acetaminophen, (ii) ibuprofen, (iii) alternating acetaminophen and ibuprofen and (iv) a control group. Children and youth 8 to 18 years of age presenting to emergency department with headache within 48 hours of their first concussion were recruited consecutively and sequentially randomized. Children with abnormal neuroimaging, history of previous concussions and bleeding disorder were excluded. A headache survey was administered at recruitment. All participants were provided with standard concussion management education and were also instructed on how to use the headache diary for the 1-week study follow-up period. The diary captures (i) headache days, (ii) number of headaches, (iii) headache intensity and (iv) return-to-school information. Feasibility was assessed based on study recruitment and compliance. Results: There were no feasibility concerns with the recruitment and no major compliance issues. Patients on acetaminophen, ibuprofen or both had significantly less headache days, episodes of headache and lower headache intensity than did the standard care group. Patients on both ibuprofen and acetaminophen (79.0%) and on ibuprofen alone (61.0%) were more likely to be back at school 1 week postinjury as compared with the acetaminophen group (33.3%) and the standard care group (21.1%). Conclusion: Results showed routine analgesia administration was feasible and effective for postconcussive headache management. A larger full-scale randomized controlled trial is required to further assess the efficacy with longer follow-up, a wider variety of patients and more concussion related outcomes.	[Petrelli, Tina; Farrokhyar, Forough; Singh, Sheila K.] McMaster Univ, Dept Surg, Hamilton, ON, Canada; [Petrelli, Tina; Sulowski, Chris; Sobhi, Gita; Singh, Sheila K.] McMaster Childrens Hosp, Hamilton, ON, Canada; [Farrokhyar, Forough] McMaster Univ, Dept Clin Epidemiol Biostat & Surg Res Methodo, Hamilton, ON, Canada; [McGrath, Patricia; Giglia, Lucia] Pain Innovat Inc, London, ON, Canada; [Sulowski, Chris] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci & CanChild Ctr Childhood Disabil, Hamilton, ON, Canada; [Singh, Sheila K.] McMaster Univ, Michael DeGroote Ctr Learning & Discovery, Stem Cell & Canc Res Inst, Hamilton, ON, Canada		Petrelli, T (corresponding author), McMaster Childrens Hosp, Div Neurosurg, 1280 Main St West, Hamilton, ON L8N 3Z5, Canada.	petrelli@hhsc.ca	Farrokhyar, Forough/AAQ-6005-2021; Singh, Sheila K/W-2799-2018; Sulowski, Christopher/ABB-2692-2021	Farrokhyar, Forough/0000-0001-9928-9016; Singh, Sheila K/0000-0003-1272-5300; Sulowski, Christopher/0000-0002-1445-3719	New Investigator Fund, Hamilton Health Sciences	All phases of this study were supported by a New Investigator Fund, Hamilton Health Sciences. All authors have no financial relationships relevant for this study and no conflicts of interest to disclose.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Lee H, 2006, AM J PHYS MED REHAB, V85, P619; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Purcell L., 2012, PAEDIAT CHILD HLTH, V17, P1; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Southey ER, 2009, CURR MED RES OPIN, V25, P2207, DOI 10.1185/03007990903116255; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	17	12	12	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	MAR 1	2017	22	1					2	6		10.1093/pch/pxw011			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EV0OR	WOS:000401441000002	29483787	Green Published, Bronze			2022-02-06	
J	Rhea, CK; Kuznetsov, NA; Ross, SE; Long, B; Jakiela, JT; Bailie, JM; Yanagi, MA; Haran, J; Wright, WG; Robins, RK; Sargent, PD; Duckworth, JL				Rhea, Christopher K.; Kuznetsov, Nikita A.; Ross, Scott E.; Long, Benjamin; Jakiela, Jason T.; Bailie, Jason M.; Yanagi, Matthew A.; Haran, Jay; Wright, W. Geoffrey; Robins, Rebecca K.; Sargent, Paul D.; Duckworth, Joshua L.			Development of a Portable Tool for Screening Neuromotor Sequelae From Repetitive Low-Level Blast Exposure	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE ASSESSMENT-TOOL; SUBCONCUSSIVE HEAD TRAUMA; INTERPRETING CHANGE; FOOTBALL PLAYERS; CONCUSSION; GAIT; DYNAMICS; DEFICITS; DEFENSE	Blast exposure is a prevalent cause of mild traumatic brain injury (mTBI) in military personnel in combat. However, it is more common for a service member to be exposed to a low-level blast (LLB) that does not result in a clinically diagnosable mTBI. Recent research suggests that repetitive LLB exposure can result in symptomology similar to symptoms observed after mTBI. This manuscript reports on the use of an Android-based smartphone application (AccWalker app) to capture changes in neuromotor functioning after blast exposure. Active duty U.S. Navy personnel (N = 59) performed a stepping-in-place task before repetitive LLB exposure (heavy weapons training), and again immediately after, 24 hours after, and 72 to 96 hours after the completion of the training. The AccWalker app revealed that there are changes in neuromotor functioning after LLB exposure (slower self-selected movement pace and increased stride time variability) in participants who experienced neurocognitive decline. These data suggest that neurocognitive and neuromotor decline can occur after repeated LLB exposure.	[Rhea, Christopher K.; Kuznetsov, Nikita A.; Ross, Scott E.; Long, Benjamin; Jakiela, Jason T.] Univ North Carolina Greensboro, 1400 Spring Garden St, Greensboro, NC 27412 USA; [Bailie, Jason M.] Def & Vet Brain Injury Ctr, 1335 East West Highway 600, Silver Spring, MD 20910 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, 200 Mercy Circle, Oceanside, CA 92058 USA; [Yanagi, Matthew A.] SPAWAR Syst Ctr Pacific, 53560 Hull St, San Diego, CA 92152 USA; [Haran, Jay] Naval Submarine Base New London, Naval Submarine Med Res Lab, Box 900, Groton, CT 06349 USA; [Wright, W. Geoffrey; Robins, Rebecca K.] Temple Univ, 1801 North Broad St, Philadelphia, PA 19122 USA; [Sargent, Paul D.] Naval Special Warfare Grp ONE, 2000 Trident Way, San Diego, CA 92155 USA; [Duckworth, Joshua L.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Rhea, CK (corresponding author), Univ North Carolina Greensboro, 1400 Spring Garden St, Greensboro, NC 27412 USA.				Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0094, HU0001-14-1-0022]	The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under award no. W81XWH-15-1-0094 to Christopher K. Rhea and HU0001-14-1-0022 to Joshua L. Duckworth.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brandt J, 2001, HOPKINS VERBAL LEARN, P17; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delignieres D, 2004, HUM MOVEMENT SCI, V23, P87, DOI 10.1016/j.humov.2004.07.001; Denis A. M., 2007, INTENS CARE MED, P1011; Department of Defense, 2012, DOD POL GUID MAN MIL; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Haran FJ, 1511 NEDU TR; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Laubscher J, 2006, AFR J PHYS HLTH ED R, V12, P468; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; O'Neil RL, 2013, NEUROREHABILITATION, V33, P667, DOI 10.3233/NRE-130985; Onge PS, 2011, US ARMY MED DEP J, P97; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2010, J MOTOR BEHAV, V42, P111, DOI 10.1080/00222890903566418; Rhea CK, 2014, J APPL BIOMECH, V30, P534, DOI 10.1123/jab.2013-0314; Rhea CK, 2014, GAIT BIOMETRICS BASI; Russo CR, 2015, APPL PSYCH MEAS, V39, P566, DOI 10.1177/0146621615577361; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stone JR, 2013, J NEUROTRAUM, V30, pA120; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tung WW, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046210; van Orden G. C., 2007, PSYCHOL SCI AGENDA, V22; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	55	12	12	0	3	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			147	154		10.7205/MILMED-D-16-00140			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6VN	WOS:000398947100024	28291466	Bronze			2022-02-06	
J	Sherman, DW; Maitra, K; Gordon, Y; Simon, S; Olenick, M; Barbara, S; Doherty-Restrepo, J; Hough, M; Randolph, M; Singh, A				Sherman, Deborah Witt; Maitra, Kinsuk; Gordon, Yhovana; Simon, Sharon; Olenick, Maria; Barbara, Salvatore; Doherty-Restrepo, Jennifer; Hough, Monica; Randolph, Marilys; Singh, Arvindar			Illustrating and Analyzing the Processes of Interprofessional Collaboration: A Lesson Learned from Palliative Care in Deconstructing the Concept	JOURNAL OF PALLIATIVE MEDICINE			English	Article						interprofessional assessment and plan; interprofessional collaboration; teamwork		Background: A basic tenet of palliative care is interprofessional collaboration. Palliative care educators and practitioners lead the way in responding to the Institute of Medicine's (2003) challenge to transform educational and health care systems through interprofessional collaboration. Through exemplary commitment to interprofessional collaboration, a college's academic and palliative care leader, in collaboration with Department Chairs and Directors of nursing and allied health professions, can illustrate and analyze the processes of interprofessional collaboration through the development of a simulated case study of a combat veteran with traumatic brain injury. Methods: Methodologic components: (1) interprofessional development of a palliative care case study and (2) debriefing interviews regarding the experience of collaboration of interprofessional team members. Results: The results provide the identification of steps of the interprofessional process and the shared and unique disciplinary competencies in determining a comprehensive health history, physical examination, identifying and prioritizing diagnoses, and determining collaborative discipline-specific interventions. Content analysis of debriefing team interviews provides a description of group composition, structure, process, development, and performance, as well as team member's perceptions of what fosters and challenges collaboration, benefits, and drawbacks, and what could have been done differently in developing an interprofessional initiative. Discussion: Transformative change in healthcare education and clinical practice involves interprofessional collaboration of colleagues within, across, and beyond universities/colleges and healthcare systems and agencies. Advocating for teamwork has to go beyond talking about being a team player or not to having the language and behaviors we need to observe and measure. This article not only provides key processes in interprofessional collaboration but also identifies key attitudes and behaviors critical to teamwork. It provides a starting point to determine observable and measurable outcomes for interprofessional education, practice, and research. This article highlights expert behavior to move professionals from being novices in interprofessional collaboration to mastering the skills.	[Sherman, Deborah Witt; Gordon, Yhovana] Grad Nursing FIU, Miami, FL USA; [Maitra, Kinsuk] Dept Occupat Therapy FIU, Atlanta, GA USA; [Simon, Sharon; Olenick, Maria] Undergrad Nursing FIU, Miami, FL USA; [Barbara, Salvatore] Heath Serv Adm FIU, Miami, FL USA; [Doherty-Restrepo, Jennifer] Dept Athlet Training, Miami, FL USA; [Hough, Monica] Commun Sci & Disorders, Miami, FL USA; [Randolph, Marilys] Phys Therapy FIU, Miami, FL USA; [Singh, Arvindar] FIU, Miami, FL USA		Sherman, DW (corresponding author), Florida Int Univ, Nicole Wertheim Coll Nursing & Hlth Sci, 11200 SW 8th St,ACH 3,Room 222, Miami, FL 33199 USA.	desherma@fiu.edu	Olenick, maria/AAM-9991-2020; Maitra, Kinsuk/AAE-4630-2021				Burzotta Louise, 2011, Br J Nurs, V20, P310; Ely M., 1991, DOING QUALITATIVE RE; Engel J, 2013, NURS ETHICS, V20, P426, DOI 10.1177/0969733012468466; Gaboury I, 2009, SOC SCI MED, V69, P707, DOI 10.1016/j.socscimed.2009.05.048; Institute of Medicine, 2003, I MED HLTH PROF ED B; Interprofessional Education Collaborative, 2016, COR COMP INT COLL PR; Karstadt Lyn, 2012, Br J Nurs, V21, P522; Milton CL, 2013, NURS SCI QUART, V26, P316, DOI 10.1177/0894318413500314; Olenick M, 2010, ADV MED EDUC PRACT, V1, P75, DOI 10.2147/AMEP.S13207; Park A, 2014, RURAL UNDERGRADUATE; Reeves S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub3; Rubenfeld MG, 2010, SCJEFFER BK CRITICAL; Sherman DW, 2015, PALLIATIVE CARE RESP, P21; World Health Organization (WHO), 2010, FRAM ACT INT ED COLL	14	12	12	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	MAR	2017	20	3					227	234		10.1089/jpm.2016.0332			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	EM6FC	WOS:000395407200007	28001457				2022-02-06	
J	Sinha, SP; Avcu, P; Spiegler, KM; Komaravolu, S; Kim, K; Cominski, T; Servatius, RJ; Pang, KCH				Sinha, Swamini P.; Avcu, Pelin; Spiegler, Kevin M.; Komaravolu, Sreeya; Kim, Kevin; Cominski, Tara; Servatius, Richard J.; Pang, Kevin C. H.			Startle suppression after mild traumatic brain injury is associated with an increase in pro-inflammatory cytokines, reactive gliosis and neuronal loss in the caudal pontine reticular nucleus	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Concussion; Post-concussion symptoms; Lateral fluid percussion; Glial activation; Interleukin-1; TNE-alpha; GFAP; IBA-1; Pons; ASR	TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; FACTOR-ALPHA; INTERLEUKIN-1; ACTIVATION; EXPRESSION; STRESS; NEUROPATHOLOGY; VETERANS; MODERATE	Mild traumatic brain injury (mTBI) can produce somatic symptoms such as headache, dizziness, fatigue, sleep disturbances and sensorimotor dysfunction. Sensorimotor function can be measured by tests such as the acoustic startle reflex (ASR), an evolutionarily conserved defensive response to a brief yet sharp acoustic stimulus. mTBI produces a long-lasting suppression of ASR in rodents and humans; however, the mechanism of this suppression is unknown. The present study examined whether inflammatory processes in the brainstem (particularly the caudal pontine reticular nucleus, PnC) could account for the suppression of ASR after mTBI, because the PnC is an essential nucleus of the ASR circuit. Furthermore, while inflammation after mTBI is commonly observed in brain regions proximal to the site of impact (cortex and hippocampus), the effects of mTBI in brainstem structures remains largely understudied. The present study demonstrated a suppression of ASR one day after injury and lasting at least three weeks after an mTBI, replicating previous findings. Within the PnC, transient elevations of IL-1 beta and TNF-alpha mRNA were observed at one day after injury, while IL-1 alpha mRNA exhibited a delayed increase at three weeks after injury. Reactive gliosis (via IBA-1-ir for microglia and GFAP-ir for astrocytes) were also observed in the PnC, at one day and seven days after injury, respectively. Finally, the number of giant neurons (the major functional cell population in the PnC) was decreased three weeks after injury. The results indicate that glial activation precedes neuronal loss in the PnC, and correlates with the behavioral suppression of the ASR. The results also raise implications for brainstem involvement in the development of post traumatic symptoms. (C) 2017 Elsevier Inc. All rights reserved.	[Cominski, Tara; Pang, Kevin C. H.] Dept Veteran Affairs Med Ctr New Jersey Hlth Care, Neurobehav Res Lab, E Orange, NJ USA; [Servatius, Richard J.; Pang, Kevin C. H.] Univ Med & Dent New Jersey, Dept Pharmacol Physiol & Neurosci, Rutgers Biomed & Hlth Sci, Newark, NJ USA; [Sinha, Swamini P.; Avcu, Pelin; Spiegler, Kevin M.; Servatius, Richard J.; Pang, Kevin C. H.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Rutgers Biomed & Hlth Sci, Newark, NJ USA; [Servatius, Richard J.] Syracuse Vet Affairs Med Ctr, Syracuse, NY USA; [Komaravolu, Sreeya; Kim, Kevin] Coll New Jersey, Program, Ewing, NJ USA		Pang, KCH (corresponding author), VA New Jersey Hlth Care Syst, 385 Tremont Ave Mailstop 15, E Orange, NJ 07018 USA.	kevin.pang@va.gov		Spiegler, Kevin/0000-0002-9271-5825; Servatius, Richard/0000-0002-7023-4895	Biomedical Laboratory Research & Development Service of the Department of Veterans Affairs Office of Research Development [101BX000132]; New Jersey Commission on Brain Injury Research [CBIR11 PJT003]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1-NS44373]; Stress and Motivated Behavior Institute; Veterans AffairsUS Department of Veterans Affairs [I01BX000132] Funding Source: NIH RePORTER	The research presented in the current study was funded by the Biomedical Laboratory Research & Development Service of the Department of Veterans Affairs Office of Research & Development (grant 101BX000132), New Jersey Commission on Brain Injury Research (grant CBIR11 PJT003), National Institutes of Health (grant RO1-NS44373), and the Stress and Motivated Behavior Institute.	Abdul-Wahab R., 2011, IEEE 37 ANN NE, V1, P22011; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BILLINGHAM MEJ, 1987, BRIT MED BULL, V43, P350, DOI 10.1093/oxfordjournals.bmb.a072187; Brough D, 2015, IUBMB LIFE, V67, P323, DOI 10.1002/iub.1377; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Correale J, 2014, MULT SCLER J, V20, P1288, DOI 10.1177/1352458514533230; DAVIS M, 1982, J NEUROSCI, V2, P791; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Dunn SL, 2002, GLIA, V37, P31, DOI 10.1002/glia.10010; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Grillon C, 1996, PSYCHIAT RES, V64, P169, DOI 10.1016/S0165-1781(96)02942-3; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Janke KL, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00106; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Luheshi NM, 2009, EUR J IMMUNOL, V39, P2973, DOI 10.1002/eji.200939712; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Miremami JD, 2014, SOMATOSENS MOT RES, V31, P127, DOI 10.3109/08990220.2014.897602; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Nurmi A, 2004, J NEUROCHEM, V91, P755, DOI 10.1111/j.1471-4159.2004.02756.x; Pang K, 1998, J COMP NEUROL, V394, P186, DOI 10.1002/(SICI)1096-9861(19980504)394:2<186::AID-CNE4>3.0.CO;2-Z; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pissiota A, 2002, EUR J NEUROSCI, V15, P395, DOI 10.1046/j.0953-816x.2001.01870.x; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Servatius RJ, 2005, BIOL PSYCHIAT, V57, P865, DOI 10.1016/j.biopsych.2005.01.015; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	57	12	13	3	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2017	61						353	364		10.1016/j.bbi.2017.01.006			12	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EM5PZ	WOS:000395365900037	28089558				2022-02-06	
J	Wang, Y; Li, JP; Song, YL; Zhao, QH				Wang, Yan; Li, Jin-ping; Song, Ying-lun; Zhao, Qi-huang			Intensive insulin therapy for preventing postoperative infection in patients with traumatic brain injury A randomized controlled trial	MEDICINE			English	Article						infection; intensive insulin therapy; randomized controlled trial; traumatic brain injury	MANAGEMENT; PRESSURE; GLUCOSE; SYSTEM	Objective: To assess the effect of intensive insulin therapy (IIT) for preventing postoperative infection in patients with traumatic brain injury (TBI). Methods: In total, 88 patients with TBI were randomly divided into 2 groups, 44 in each group. One group (group ITT) received IIT and the other group (group CIT) received conventional insulin therapy (CIT). This study was conducted between February 2013 and January 2016. Outcomes included infection rate, mortality, and neurological outcome (measured by the Glasgow Outcome Scale [GOS]). Results: A total of 81 patients completed the study. IIT showed greater efficacy than CIT, with a decreased infection rate in the IIT group compared to the CIT group (31.9% vs 52.3%, P=0.03), and also a reduced duration of stay in intensive care unit (ICU) (IIT group, 4.5+/-2.1 days vs CIT group, 5.7+/-2.8 days, P=0.02). In addition, a significant difference in scores on the GOS scale was observed between the 2 groups (P=0.04). The mortality rates in hospital and at the 26-week follow-up were similar between the 2 groups. Conclusion: IIT leads to a reduced infection rate, shorter stays in ICU, and improved neurological outcome.	[Wang, Yan] Capital Med Univ, Dept Neurosurg, Intens Care Unit, Beijing, Peoples R China; [Li, Jin-ping; Song, Ying-lun; Zhao, Qi-huang] Capital Med Univ, Dept Neurosurg, Beijing ChaoYang Hosp, Beijing, Peoples R China		Zhao, QH (corresponding author), Capital Med Univ, Dept Neurosurg, Beijing ChaoYang Hosp, 8 Gongti South Rd, Beijing 100020, Peoples R China.	qihuang2000@outlook.com					Abou-Abbass H, 2016, MEDICINE, V95; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Gandhi GY, 2007, ANN INTERN MED, V146, P233, DOI 10.7326/0003-4819-146-4-200702200-00002; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Horan TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005009; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Orsi GB, 2006, J HOSP INFECT, V64, P23, DOI 10.1016/j.jhin.2006.02.022; Park JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002204; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	20	12	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAR	2017	96	13							e6458	10.1097/MD.0000000000006458			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER2EK	WOS:000398606800025	28353579	gold, Green Published			2022-02-06	
J	Haefeli, J; Ferguson, AR; Bingham, D; Orr, A; Won, SJ; Lam, TI; Shi, J; Hawley, S; Liu, JL; Swanson, RA; Massa, SM				Haefeli, Jenny; Ferguson, Adam R.; Bingham, Deborah; Orr, Adrienne; Won, Seok Joon; Lam, Tina I.; Shi, Jian; Hawley, Sarah; Liu, Jialing; Swanson, Raymond A.; Massa, Stephen M.			A data-driven approach for evaluating multi-modal therapy in traumatic brain injury	SCIENTIFIC REPORTS			English	Article							PRINCIPAL-COMPONENTS-ANALYSIS; EXERCISE; MINOCYCLINE; PLASTICITY; NEUROGENESIS; IMPROVEMENT; MICROGLIA; STABILITY; LIGAND; CANCER	Combination therapies targeting multiple recovery mechanisms have the potential for additive or synergistic effects, but experimental design and analyses of multimodal therapeutic trials are challenging. To address this problem, we developed a data-driven approach to integrate and analyze raw source data from separate pre-clinical studies and evaluated interactions between four treatments following traumatic brain injury. Histologic and behavioral outcomes were measured in 202 rats treated with combinations of an anti-inflammatory agent (minocycline), a neurotrophic agent (LM11A-31), and physical therapy consisting of assisted exercise with or without botulinum toxin-induced limb constraint. Data was curated and analyzed in a linked workflow involving non-linear principal component analysis followed by hypothesis testing with a linear mixed model. Results revealed significant benefits of the neurotrophic agent LM11A-31 on learning and memory outcomes after traumatic brain injury. In addition, modulations of LM11A-31 effects by co-administration of minocycline and by the type of physical therapy applied reached statistical significance. These results suggest a combinatorial effect of drug and physical therapy interventions that was not evident by univariate analysis. The study designs and analytic techniques applied here form a structured, unbiased, internally validated workflow that may be applied to other combinatorial studies, both in animals and humans.	[Haefeli, Jenny; Ferguson, Adam R.; Liu, Jialing] Univ Calif San Francisco, Dept Neurol Surg, BASIC, San Francisco, CA USA; [Ferguson, Adam R.; Bingham, Deborah; Orr, Adrienne; Won, Seok Joon; Lam, Tina I.; Shi, Jian; Hawley, Sarah; Liu, Jialing; Swanson, Raymond A.; Massa, Stephen M.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Won, Seok Joon; Lam, Tina I.; Shi, Jian; Swanson, Raymond A.; Massa, Stephen M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA		Massa, SM (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.; Massa, SM (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	Stephen.Massa@ucsf.edu		Ferguson, Adam/0000-0001-7102-1608	Department of Veterans Affairs Research Enhancement Award Program GrantUS Department of Veterans Affairs; Craig H. Neilsen Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS067092, R01NS088475]; VA Merit ReviewsUS Department of Veterans Affairs [I01BX000267, I01RX000655]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067092, R01NS088475] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000655, I01BX000267] Funding Source: NIH RePORTER	The authors thank Dr. Frank Longo, Stanford University, for the generous provision of part of the LM11A-31 used in these studies. This work was funded by a Department of Veterans Affairs Research Enhancement Award Program Grant (RAS), the Craig H. Neilsen Foundation (http://chnfoundation.org/) (JH and ARF), NIH R01NS067092 (ARF), R01NS088475 (ARF) (https://grants.nih.gov/grants/oer.htm), and VA Merit Reviews (http://www.research.va.gov/) I01BX000267 (SMM) and I01RX000655 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CATTELL RB, 1969, EDUC PSYCHOL MEAS, V29, P781, DOI 10.1177/001316446902900405; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Duricki DA, 2016, NAT PROTOC, V11, P1112, DOI 10.1038/nprot.2016.048; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; GUADAGNOLI E, 1991, MULTIVAR BEHAV RES, V26, P323, DOI 10.1207/s15327906mbr2602_7; Holman C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002331; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Iqbal SA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002333; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Krzywinski M, 2014, NAT METHODS, V11, P355, DOI 10.1038/nmeth.2900; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2007, PSYCHOL METHODS, V12, P359, DOI 10.1037/1082-989X.12.3.359; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Meeker RB, 2012, J NEUROIMMUNE PHARM, V7, P388, DOI 10.1007/s11481-011-9325-0; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Paillard T, 2015, J CLIN NEUROL, V11, P212, DOI 10.3988/jcn.2015.11.3.212; Rubin MA, 2015, NATURE, V520, P290, DOI 10.1038/520290a; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Taylor J, 2015, P NATL ACAD SCI USA, V112, P7629, DOI 10.1073/pnas.1507583112; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604; Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007	54	12	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 16	2017	7								42474	10.1038/srep42474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK9CB	WOS:000394220400001	28205533	Green Published, gold			2022-02-06	
J	Meier, TB; Lancaster, MA; Mayer, AR; Teague, TK; Savitz, J				Meier, Timothy B.; Lancaster, Melissa A.; Mayer, Andrew R.; Teague, T. Kent; Savitz, Jonathan			Abnormalities in Functional Connectivity in Collegiate Football Athletes with and without a Concussion History: Implications and Role of Neuroactive Kynurenine Pathway Metabolites	JOURNAL OF NEUROTRAUMA			English	Article						kynurenine; mild traumatic brain injury; quinolinic acid; resting state; sport concussion	TRAUMATIC BRAIN-INJURY; RESTING-STATE-FMRI; QUINOLINIC ACID; RECURRENT CONCUSSION; CEREBROSPINAL-FLUID; CEREBRAL-CORTEX; NETWORK; HIPPOCAMPAL; ACTIVATION; DEPRESSION	There is a great need to identify potential long-term consequences of contact sport exposure and to identify molecular pathways that may be associated with these changes. We tested the hypothesis that football players with (Ath-mTBI) (n = 25) and without a concussion history (Ath) (n = 24) have altered resting state functional connectivity in regions with previously documented structural changes relative to healthy controls without football or concussion history (HC) (n = 27). As a secondary aim, we tested the hypothesis that group differences in functional connectivity are moderated by the relative ratio of neuroprotective to neurotoxic metabolites of the kynurenine pathway. Ath-mTBI had significantly increased connectivity of motor cortex to the supplementary motor area relative to Ath and HC. In contrast, both Ath-mTBI and Ath had increased connectivity between the left orbital frontal cortex and the right lateral frontal cortex, and between the left cornu ammonis areas 2 and 3/dentate gyrus (CA2-3/DG) of the hippocampus and the middle and posterior cingulate cortices, relative to HC. The relationship between the ratio of plasma concentrations of kynurenic acid to quinolinic acid (KYNA/QUIN) and left pregenual anterior cingulate cortex connectivity to multiple regions as well as KYNA/QUIN and right CA2-3/DG connectivity to multiple regions differed significantly according to football and concussion history. The results suggest that football exposure with and without concussion history can have a significant effect on intrinsic brain connectivity and implicate the kynurenine metabolic pathway as one potential moderator of functional connectivity dependent on football exposure and concussion history.	[Meier, Timothy B.; Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Meier, Timothy B.; Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA		Meier, TB (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Teague, T. Kent/A-2527-2008; Savitz, Jonathan/C-3088-2009	Teague, T. Kent/0000-0002-4680-5440; Savitz, Jonathan/0000-0001-8143-182X	Laureate Institute for Brain Research; William K. Warren Foundation; Research and Education Program of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K. Warren Foundation. Dr. Meier received support for this work through a project funded through the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin. The authors thank the psychiatric assessment team and MRI technicians at the Laureate Institute for Brain Research; Dr. Rashmi Singh and Dr. Patrick Bellgowan for their assistance with data collection; and Christopher Nerio, David Polanski, Dr. Thomas Allen, and Dr. Lamont Cavanagh for athlete referral and injury oversight.	Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Doucet GE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154660; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Goh JOS, 2011, AGING DIS, V2, P30; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guillemin GJ, 2012, FEBS J, V279, P1356, DOI 10.1111/j.1742-4658.2012.08485.x; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier T. B., 2016, BRAIN IMAGING BEHAV; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, BRAIN BEHAV IMMUN, V53, P39, DOI 10.1016/j.bbi.2015.11.003; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Ode JJ, 2007, MED SCI SPORT EXER, V39, P403, DOI 10.1249/01.mss.0000247008.19127.3e; Okuda S, 1998, J NEUROCHEM, V70, P299; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Quiroz YT, 2010, ANN NEUROL, V68, P865, DOI 10.1002/ana.22105; SAITO K, 1992, NEUROSCIENCE, V51, P25, DOI 10.1016/0306-4522(92)90467-G; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Savitz J, 2015, PSYCHONEUROENDOCRINO, V52, P200, DOI 10.1016/j.psyneuen.2014.11.015; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Seidenberg M, 2009, NEUROLOGY, V73, P612, DOI 10.1212/WNL.0b013e3181b389ad; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; St'astny F, 2000, BRAIN RES BULL, V53, P415, DOI 10.1016/S0361-9230(00)00368-3; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	86	12	12	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					824	837		10.1089/neu.2016.4599			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200009	27618518				2022-02-06	
J	Qin, XH; You, H; Cao, F; Wu, Y; Peng, JH; Pang, JW; Xu, H; Chen, Y; Chen, LG; Vitek, MP; Li, FQ; Sun, XC; Jiang, Y				Qin, Xinghu; You, Hong; Cao, Fang; Wu, Yue; Peng, Jianhua; Pang, Jinwei; Xu, Hong; Chen, Yue; Chen, Ligang; Vitek, Michael P.; Li, Fengqiao; Sun, Xiaochuan; Jiang, Yong			Apolipoprotein E Mimetic Peptide Increases Cerebral Glucose Uptake by Reducing Blood-Brain Barrier Disruption after Controlled Cortical Impact in Mice: An F-18-Fluorodeoxyglucose PET/CT Study	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; COG1410; metabolism; TBI; VEGF	ENDOTHELIAL GROWTH-FACTOR; MICROGLIAL ACTIVATION; RAT MODEL; INJURY; COG1410; INSULIN; CORTEX; INFLAMMATION; ANGIOGENESIS; METABOLISM	Traumatic brain injury (TBI) disrupts the blood-brain barrier (BBB) and reduces cerebral glucose uptake. Vascular endothelial growth factor (VEGF) is believed to play a key role in TBI, and COG1410 has demonstrated neuroprotective activity in several models of TBI. However, the effects of COG1410 on VEGF and glucose metabolism following TBI are unknown. The current study aimed to investigate the expression of VEGF and glucose metabolism effects in C57BL/6J male mice subjected to experimental TBI. The results showed that controlled cortical impact (CCI)-induced vestibulo-motor deficits were accompanied by increases in brain edema and the expression of VEGF, with a decrease in cerebral glucose uptake. COG1410 treatment significantly improved vestibulomotor deficits and glucose uptake and produced decreases in VEGF in the pericontusion and ipsilateral hemisphere of injury, as well as in brain edema and neuronal degeneration compared with the control group. These data support that COG1410 may have potential as an effective drug therapy for TBI.	[Qin, Xinghu; Peng, Jianhua; Pang, Jinwei; Chen, Yue; Chen, Ligang; Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, Luzhou 646000, Peoples R China; [Qin, Xinghu; Xu, Hong] Peoples Hosp Deyang City, Dept Neurosurg, Deyang, Peoples R China; [You, Hong] Peoples Hosp Deyang City, Dept Oncol, Deyang, Peoples R China; [Cao, Fang] Zunyi Med Coll, Affiliated Hosp, Dept Cerebrovasc Dis, Zunyi, Peoples R China; [Wu, Yue; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Surg, Chongqing, Peoples R China; [Vitek, Michael P.] Duke Univ, Med Ctr, Dept Med Neurol, Med, Durham, NC 27710 USA; [Li, Fengqiao] Cognosci Inc, Res Triangle Pk, NC USA		Jiang, Y (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, Luzhou 646000, Peoples R China.	jiangy0122@gmail.com		Peng, Jianhua/0000-0003-3348-9538; Vitek, Michael/0000-0001-8140-8048	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371319, 81000528]; Program for New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-12-1057]; Foundation for Outstanding Youth Academic Technology Leaders of Sichuan Province [2041JQ0022]; Cognosci Inc. [COG1410]	This work was supported by the National Natural Science Foundation of China (81371319, 81000528), the Program for New Century Excellent Talents in University (NCET-12-1057), and the Foundation for Outstanding Youth Academic Technology Leaders of Sichuan Province (2041JQ0022). We thank Cognosci Inc. for providing COG1410.	Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bosomtwi A, 2008, J CEREBR BLOOD F MET, V28, P1978, DOI 10.1038/jcbfm.2008.85; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Damianovich M, 2013, CLIN LUNG CANCER, V14, P688, DOI 10.1016/j.cllc.2013.06.007; Dimopoulos S, 2015, CLIN OPHTHALMOL, V9, P1537, DOI 10.2147/OPTH.S87919; Fernandez-Robredo P, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/213505; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Iliadis F, 2011, DIABETES RES CLIN PR, V93, pS86, DOI 10.1016/S0168-8227(11)70019-5; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kaufman NA, 2010, BEHAV BRAIN RES, V214, P395, DOI 10.1016/j.bbr.2010.06.017; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Keeney JTR, 2015, J ALZHEIMERS DIS, V48, P411, DOI 10.3233/JAD-150348; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Liew HK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-13; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shin JY, 2016, OPTOMETRY VISION SCI, V93, P173, DOI 10.1097/OPX.0000000000000777; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Ulbrich C, 2012, J STEROID BIOCHEM, V131, P10, DOI 10.1016/j.jsbmb.2012.01.007; van Berkel A, 2014, J NUCL MED, V55, P1253, DOI 10.2967/jnumed.114.137034; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295	50	12	13	2	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					943	951		10.1089/neu.2016.4485			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200022	27411737	Green Published			2022-02-06	
J	Wu, CL; Kor, CT; Chiu, PF; Tsai, CC; Lian, IB; Yang, TH; Tarng, DC; Chang, CC				Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Tsai, Chun-Chieh; Lian, Ie-Bin; Yang, Tao-Hsiang; Tarng, Der-Cherng; Chang, Chia-Chu			Long-term renal outcomes in patients with traumatic brain injury: A nationwide population-based cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; HEAD-INJURY; DEATH; TAIWAN; SYSTEM	Background Traumatic brain injury (TBI) is an important cause of death and disability worldwide. The relationship between TBI and kidney diseases is largely unknown. Methods We aimed to determine whether TBI is associated with long-term adverse renal outcomes. We performed a nationwide, population-based, propensity score-matched cohort study of 32,152 TBI patients and 128,608 propensity score-matched controls. Data were collected by the National Health Insurance Research Database of Taiwan from 2000 to 2012. Our clinical outcomes were chronic kidney disease (CKD), end-stage renal disease (ESRD) and the composite endpoint of ESRD or all-cause mortality. Results The incidence rate of CKD was higher in the TBI than in the control cohort (8.99 vs. 7.4 per 1000 person-years). The TBI patients also showed higher risks of CKD (adjusted hazard ratio [aHR] 1.14, 95% confidence interval [CI] 1.08-1.20; P < 0.001) and composite endpoints (aHR 1.08, 95% CI 1.01-1.15; P = 0.022) than the control groups, but the ESRD was not significantly different between the groups. In subgroup analyses, the risks of incident CKD and composite endpoints were significantly raised in TBI patients aged < 65 years and/ or without comorbidities. However, the risks of both CKD and composite outcome were little affected by the severity of TBI. Conclusions TBI has a modest but significant effect on incident CKD and composite endpoint, but not on ESRD alone. TBI patients under 65 are at greater risk of CKD and composite outcome than their older counterparts.	[Wu, Chia-Lin; Chiu, Ping-Fang; Tsai, Chun-Chieh; Chang, Chia-Chu] Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan; [Wu, Chia-Lin; Chiu, Ping-Fang; Tsai, Chun-Chieh; Chang, Chia-Chu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Chia-Lin; Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Wu, Chia-Lin; Kor, Chew-Teng; Chiu, Ping-Fang; Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan; [Wu, Chia-Lin; Yang, Tao-Hsiang; Chang, Chia-Chu] Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan; [Lian, Ie-Bin] Natl Changhua Univ Educ, Grad Inst Stat & Informat Sci, Changhua, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Physiol, Taipei, Taiwan		Chang, CC (corresponding author), Changhua Christian Hosp, Div Nephrol, Dept Internal Med, Changhua, Taiwan.; Chang, CC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Internal Med Res Ctr, Changhua, Taiwan.; Chang, CC (corresponding author), Changhua Christian Hosp, Environm & Precis Med Lab, Changhua, Taiwan.; Tarng, DC (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan.; Tarng, DC (corresponding author), Natl Yang Ming Univ, Inst Physiol, Taipei, Taiwan.	dctarng@vghtpe.gov.tw; 27509@cch.org.tw	Lian, Ie-Bin/AAE-3368-2021; Wu, Chia-Lin/V-8888-2017	Wu, Chia-Lin/0000-0001-6045-6956; Lian, Ie-bin/0000-0003-3992-6049	Changhua Christian Hospital Research Foundation [104-CCH-IRP-010]	This study was funded by grants 104-CCH-IRP-010 from the Changhua Christian Hospital Research Foundation.	[Anonymous], 2015, 2015 USRDS ANN DAT R; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Davenport A, 2008, BLOOD PURIFICAT, V26, P526, DOI 10.1159/000167800; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Herijgers P, 1996, TRANSPLANTATION, V62, P330, DOI 10.1097/00007890-199608150-00005; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Huang ST, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000429; Levin A, 2001, NEPHROL DIAL TRANSPL, V16, P57, DOI 10.1093/ndt/16.suppl_7.57; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lin JW, 2008, ACT NEUR S, V101, P113; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Morariu AM, 2008, AM J TRANSPLANT, V8, P933, DOI 10.1111/j.1600-6143.2008.02166.x; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Sanchez-Fructuoso AI, 2004, TRANSPLANTATION, V78, P142, DOI 10.1097/01.TP.0000134769.65550.70; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; SIPKINS JH, 1981, NEPHRON, V28, P36, DOI 10.1159/000182092; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wolbers M, 2014, EUR HEART J, V35, P2936, DOI 10.1093/eurheartj/ehu131; Wu CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158533; Yu TM, 2014, NEUROLOGY, V83, P686, DOI 10.1212/WNL.0000000000000711; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171999	10.1371/journal.pone.0171999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EL2BA	WOS:000394423900041	28196132	gold, Green Submitted, Green Published			2022-02-06	
J	Cole, WR; Arrieux, JP; Dennison, EM; Ivins, BJ				Cole, Wesley R.; Arrieux, Jacques P.; Dennison, Elizabeth M.; Ivins, Brian J.			The impact of administration order in studies of computerized neurocognitive assessment tools (NCATs)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Computerized neurocognitive tests; Computerized cognitive testing; Computerized neurocognitive assessment tools; Neuropsychological assessment; Order of test administration; Practice effects	TEST-RETEST RELIABILITY; NEUROPSYCHOLOGICAL ASSESSMENT; TEST-PERFORMANCE; ALTERNATE FORMS; TEST LENGTH; WAIS-III; WMS-III; CONCUSSION; BATTERY; TESTS	Computerized neurocognitive assessment tools (NCATs) have become a common way to assess postconcussion symptoms. As there is increasing research directly comparing multiple NCATs to each other, it is important to consider the impact that order of test administration may have on the integrity of the results. This study investigates the impact of administration order in a study of four different NCATs; Automated Neuropsychological Assessment Metrics (ANAM4), CNS Vital Signs (CNS-VS), CogState, and Immediate Post-Concussion Assessment and Cognitive Test (ImPACT). A total of 272 healthy active duty Service Members were enrolled into this study. All participants were randomly assigned to take two of the four NCATs with order of administration counterbalanced. Analyses attempted to investigate the effect of administration order alone (e.g., Time 1 versus Time 2), the effect of administration order combined with the impact of the specific NCAT received at Time 1, and only the impact of the Time 1 NCAT on Time 2 score variability. Specifically, independent samples ttests were used to compare Time 1 and Time 2 scores within each NCAT. Additional ttests compared Time 1 to Time 2 scores with Time 2 scores grouped by the NCAT received at Time 1. One-way analysis of variance (ANOVA) was used to compare only an NCAT's Time 2 scores grouped by the NCAT received at Time 1. Cohen's d effect sizes were calculated for all comparisons. The results from this study revealed statistically significant order effects for CogState and CNS-VS, though with effect sizes generally indicating minimum practical value, and marginal or absent order effects for ANAM4 and ImPACT with no clinically meaningful implications. Despite finding minimal order effects, clinicians should be mindful of the impact of administering multiple NCATs in a single session. Future studies should continue to be designed to minimize the potential effect of test administration order.	[Cole, Wesley R.; Arrieux, Jacques P.; Dennison, Elizabeth M.] Womack Army Med Ctr, Intrepid Spirit, Ft Bragg, NC 28310 USA; [Cole, Wesley R.; Arrieux, Jacques P.; Dennison, Elizabeth M.] DVBIC, Ft Bragg, NC USA; [Ivins, Brian J.] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Ivins, Brian J.] DVBIC, Div Res, Silver Spring, MD USA		Cole, WR (corresponding author), Womack Army Med Ctr, Intrepid Spirit, Ft Bragg, NC 28310 USA.	wesley.r.cole.ctr@mail.mil					Ackerman PL, 2009, J EXP PSYCHOL-APPL, V15, P163, DOI 10.1037/a0015719; Baird BJ, 2007, APPL NEUROPSYCHOL, V14, P88, DOI 10.1080/09084280701319912; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brophy LM, 2009, ARCH CLIN NEUROPSYCH, V24, P105, DOI 10.1093/arclin/acp013; Campbell DT., 1963, EXPT QUASI EXPT DESI; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Elias MF, 1996, J GERONTOL B-PSYCHOL, V51, pP331, DOI 10.1093/geronb/51B.6.P331; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Jensen JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070270; KAY G, 1991, J CLIN EXP NEUROPSYC, V13, P50; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Llorente AM, 2000, CLIN NEUROPSYCHOL, V14, P162, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT162; Lloyd KP, 2012, APPL NEUROPSYCH-ADUL, V19, P299, DOI 10.1080/09084282.2012.670153; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; McCaffrey RJ, 2001, ARCH CLIN NEUROPSYCH, V16, P9, DOI 10.1016/S0887-6177(99)00055-4; MCCAFFREY RJ, 1992, CLIN NEUROPSYCHOL, V0006, P00032, DOI [DOI 10.1080/138540492084041_15, DOI 10.1080/13854049208404115]; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; NEUGER GJ, 1981, J CONSULT CLIN PSYCH, V49, P722, DOI 10.1037/0022-006X.49.5.722; Rogers JM, 2012, ADV COGN PSYCHOL, V8, P281, DOI [10.2478/v10053-008-0123-z, 10.5709/acp-0123-z]; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P474, DOI 10.1076/clin.14.4.474.7205; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Zhu JJ, 2000, CLIN NEUROPSYCHOL, V14, P461, DOI 10.1076/clin.14.4.461.7197	32	12	12	0	67	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2017	39	1					35	45		10.1080/13803395.2016.1198470			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EE3OH	WOS:000389499700004	27690742				2022-02-06	
J	Gerrard, PB; Iverson, GL; Atkins, JE; Maxwell, BA; Zafonte, R; Schatz, P; Berkner, PD				Gerrard, Paul B.; Iverson, Grant L.; Atkins, Joseph E.; Maxwell, Bruce A.; Zafonte, Ross; Schatz, Philip; Berkner, Paul D.			Factor Structure of ImPACT (R) in Adolescent Student Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Cognitive; Concussion; Sports; Memory; Factor analysis; Concussion	TEST-RETEST RELIABILITY; COUNSELING PSYCHOMETRIC ISSUES; SPORT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL MEASURES; CONSTRUCT-VALIDITY; CLINICAL UTILITY; ONLINE VERSION; TEST BATTERY; HIGH-SCHOOL; SENSITIVITY	Objective: ImPACT (R) ( Immediate Post-Concussion Assessment and Cognitive Testing) is a computerized neuropsychological screening battery, which is widely used to measure the acute effects of sport-related concussion and to monitor recovery from injury. This study examined the factor structure of ImPACT (R) in several samples of high school student athletes. We hypothesized that a 2-factor structure would be present in all samples. Method: A sample of 4,809 adolescent student athletes was included, and subgroups with a history of treatment for headaches or a selfreported history of learning problems or attention-deficit hyperactivity disorder were analyzed separately. Exploratory principal axis factor analyses with Promax rotations were used. Results: As hypothesized, both the combination of Verbal Memory and Visual Memory Composite scores loaded on one (Memory) factor, while Visual Motor Speed and Reaction Time loaded on a different (Speed) factor, in the total sample and in all subgroups. Conclusion: These results provide reasonably compelling evidence, across multiple samples, which ImPACT r measures 2 distinct factors: memory and speed.	[Gerrard, Paul B.] New England Rehabil Hosp Portland, Portland, ME USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Home Base, Boston, MA USA; [Iverson, Grant L.; Schatz, Philip] Massachusetts Gen Hosp Program, Boston, MA USA; [Atkins, Joseph E.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Maxwell, Bruce A.] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Spaulding Rehabil Hosp Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA		Iverson, GL (corresponding author), Harvard Med Sch, Ctr Hlth & Rehabil, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.ed		Iverson, Grant/0000-0001-7348-9570			Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Lovell M, 2007, IMPACT 2007 6 0 CLIN; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; R CORE DEVELOPMENT TEAM, 2012, R LANG ENV STAT COMP; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, PM&R, V3, pS433, DOI 10.1016/j.pmrj.2011.08.002; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Revelle W., 2013, PSYCH PROCEDURES PSY; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	27	12	12	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2017	32	1					117	122		10.1093/arclin/acw097			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EO9KJ	WOS:000397007300015	28122770	Bronze			2022-02-06	
J	Kochanek, PM; Jackson, TC				Kochanek, Patrick M.; Jackson, Travis C.			The Brain and Hypothermia-From Aristotle to Targeted Temperature Management	CRITICAL CARE MEDICINE			English	Article						cardiac arrest; cold stress; hyperthermia; ribonucleic acid binding motif-3; traumatic brain injury	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; OPTIMAL HOUSING TEMPERATURES; HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; COLD STRESS; INJURY; HYPERTHERMIA; MODEL; NEUROPROTECTION; RESUSCITATION		[Kochanek, Patrick M.; Jackson, Travis C.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.; Jackson, Travis C.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Bioengn, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Clin & Translat Sci, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Kochanek, PM (corresponding author), UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA.; Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA.; Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA.; Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Bioengn, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Clin & Translat Sci, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu			National Institutes of Health/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 R21 NS088145]; National Institutes of Health (NIH), National Institutes of Neurological Disorders and Stroke (NINDS) [NS070003]; U.S. Army Grants [WH81XWH-10-0623, WH81XWH-14-2-0018]; American Heart Association National Scientist Development GrantAmerican Heart Association; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS088145]; National Neurotrauma Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088145, R21NS070003, R01NS087978] Funding Source: NIH RePORTER	Supported, in part, by National Institutes of Health/NINDS grant to Dr. Jackson (1 R21 NS088145).; Dr. Kochanek is a co-patent holder for U.S. patent 8,628,512 B2, Title: Method of inducing EPR following cardiopulmonary arrest, filing date; June 22, 2005, Investors P.M. Kochanek, S.A. Tisherman, X. Wu, S.W. Stezoski, L. J. Yaffe. Drs. Kochanek and Jackson are co-provisional patent holders for U.S. Invention Disclosure: Title: Method to improve neurologic outcomes in temperature managed patients, Application No: 62/164, 2005, Country: United States, Innovators: Travis C. Jackson (University of Pittsburgh) and Patrick M. Kochanek (University of Pittsburgh). Dr. Kochanek is supported by National Institutes of Health (NIH), National Institutes of Neurological Disorders and Stroke (NINDS) grant NS070003 and U.S. Army Grants WH81XWH-10-0623 and WH81XWH-14-2-0018. Dr. Jackson is supported by an American Heart Association National Scientist Development Grant and a grant from the NIH/NINDS (NS088145). Dr. Jackson received funding from the National Neurotrauma Society/Invited Speaker/$500 Travel Reimbursement for a presentation on this topic.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Ahmad FU, 2014, J NEUROSURG-SPINE, V21, P843, DOI 10.3171/2014.4.SPINE14330; Anderson KB, 2016, THER HYPOTHERMIA TEM, V6, P169, DOI 10.1089/ther.2016.0003; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BERNTMAN L, 1981, ANESTHESIOLOGY, V55, P495, DOI 10.1097/00000542-198111000-00003; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chen J, 2016, STROKE, V47, P1933, DOI 10.1161/STROKEAHA.116.012727; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; CONN AW, 1979, CAN MED ASSOC J, V120, P397; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Donnino MW, 2015, CIRCULATION, V132, P2448, DOI 10.1161/CIR.0000000000000313; Edwards AD, 1995, BIOCHEM BIOPH RES CO, V217, P1193, DOI 10.1006/bbrc.1995.2895; Fukuda H, 2001, BRAIN RES, V910, P187, DOI 10.1016/S0006-8993(01)02659-2; Gaskill BN, 2014, MOL METAB, V3, P335, DOI 10.1016/j.molmet.2013.05.003; GROSS CG, 1995, NEUROSCIENTIST, V1, P245, DOI DOI 10.1177/107385849500100408; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; HEY EN, 1969, J PHYSIOL-LONDON, V200, P589, DOI 10.1113/jphysiol.1969.sp008710; Hickey RW, 2000, PEDIATRICS, V106, P118, DOI 10.1542/peds.106.1.118; Holzinger U, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0856-2; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jackson TC, 2015, NEUROSCIENCE, V305, P268, DOI 10.1016/j.neuroscience.2015.08.012; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Remba SJ, 2010, RESUSCITATION, V81, P268, DOI 10.1016/j.resuscitation.2009.11.010; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Kiyatkin EA, 2011, J NEURAL TRANSM, V118, P47, DOI 10.1007/s00702-010-0477-5; KOBAYASHI S, 1986, BRAIN RES, V362, P132, DOI 10.1016/0006-8993(86)91406-X; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Kutcher ME, 2016, INT J SURG, V33, P209, DOI 10.1016/j.ijsu.2015.10.014; Laptook A, 2008, PEDIATRICS, V122, P491, DOI 10.1542/peds.2007-1673; Legriel S, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0159-z; LEONOV Y, 1990, J CEREBR BLOOD F MET, V10, P57, DOI 10.1038/jcbfm.1990.8; Lu XCM, 2016, THER HYPOTHERMIA TEM, V6, P30, DOI 10.1089/ther.2015.0017; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maher RL, 2015, AM J PHYSIOL-REG I, V308, pR1070, DOI 10.1152/ajpregu.00407.2014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; Phelps C, 1897, TRAUMATIC INJURIES B, P223; Reynolds JC, 2015, RESUSCITATION, V96, pA1, DOI 10.1016/j.resuscitation.2015.07.019; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; ROSOMOFF HL, 1959, ANN NY ACAD SCI, V80, P475, DOI 10.1111/j.1749-6632.1959.tb49225.x; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Speakman JR, 2014, MOL METAB, V3, P337, DOI 10.1016/j.molmet.2013.05.007; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; Takaoka S, 1996, NEUROSCI LETT, V218, P25, DOI 10.1016/S0304-3940(96)13112-8; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Vincent JL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1121-4; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013	56	12	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2017	45	2					305	310		10.1097/CCM.0000000000002182			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI4LF	WOS:000392464500019	28098626	Green Accepted			2022-02-06	
J	Abeare, CA; Freund, S; Kaploun, K; McAuley, T; Dumitrescu, C				Abeare, Christopher A.; Freund, Sabrina; Kaploun, Kristen; McAuley, Tara; Dumitrescu, Claudiu			The Emotion Word Fluency Test (EWFT): Initial psychometric, validation, and physiological evidence in young adults	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Affect; Emotion communication; Emotion word; Verbal fluency; Word generation	TRAUMATIC BRAIN-INJURY; VERBAL FLUENCY; NEURAL BASIS; ALZHEIMERS-DISEASE; COMPONENT ANALYSIS; CATEGORY FLUENCY; FRONTAL-CORTEX; NORMATIVE DATA; HEART-RATE; ANXIETY	Introduction: The clinical assessment of affective functioning has been slow to incorporate findings from affective neuroscience. Of particular interest in the current study is the assessment of affective word production. Method: In a series of four studies, we examined test-retest and interrater reliability for the Emotion Word Fluency Test (EWFT), basic construct validity with existing verbal fluency measures, physiological responses across verbal fluency tasks, and a novel scoring method to examine qualitative aspects of participant response sets. Results: Results demonstrated interrater and test-retest reliability values that were comparable to those of other commonly used verbal fluency tests. Construct validity was demonstrated by relations between the EWFT and other verbal fluency tests as well as through physiological evidence that performance on the EWFT is related to greater sympathetic activity than traditional verbal fluency tasks. Lastly, some of the novel scoring metrics related to two self-report measures of emotional functioning. Conclusions: Taken together, our findings provide initial support for the use of the EWFT as a measure of emotion word generation ability in young adults. This measure may prove to be useful in the assessment of affective language production in patient populations.	[Abeare, Christopher A.; Freund, Sabrina; Kaploun, Kristen; McAuley, Tara] Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Dumitrescu, Claudiu] Canandaigua Vet Affairs Med Ctr, Dept Psychol, Canandaigua, NY USA		Abeare, CA (corresponding author), Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	cabeare@uwindsor.ca		Abeare, Christopher/0000-0002-7163-7434	University of Windsor Humanities and Social Science Research Grant	This research was funded in part by a University of Windsor Humanities and Social Science Research Grant awarded to C. Abeare. There are no known conflicts of interest to report.	Abeare C. A., 2009, J INT NEUROPSYCH SOC, V15, P24; Abwender DA, 2001, ASSESSMENT, V8, P323, DOI 10.1177/107319110100800308; Airaksinen E, 2005, J PSYCHIAT RES, V39, P207, DOI 10.1016/j.jpsychires.2004.06.001; Beck AT, 1993, BECK ANXIETY INVENTO; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Borod J., 2000, NEUROPSYCHOLOGY EMOT; BRADLEY BP, 1995, BEHAV RES THER, V33, P755, DOI 10.1016/0005-7967(95)00029-W; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Carrillo E, 2001, INT J PSYCHOPHYSIOL, V42, P253, DOI 10.1016/S0167-8760(01)00147-7; Cato MA, 2004, J COGNITIVE NEUROSCI, V16, P167, DOI 10.1162/089892904322984481; Critchley HD, 2000, J NEUROSCI, V20, P3033; Crosson B, 2002, J INT NEUROPSYCH SOC, V8, P607, DOI 10.1017/S1355617702801394; Crosson B, 1999, NEUROREPORT, V10, P2449, DOI 10.1097/00001756-199908200-00003; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Danker JF, 2010, PSYCHOL BULL, V136, P87, DOI 10.1037/a0017937; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gawda B, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00010; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Herbert C, 2009, SOC COGN AFFECT NEUR, V4, P35, DOI 10.1093/scan/nsn027; Hoekert M, 2007, SCHIZOPHR RES, V96, P135, DOI 10.1016/j.schres.2007.07.023; Huth AG, 2016, NATURE, V532, P453, DOI 10.1038/nature17637; Izard C. E., 1971, FACE EMOTION; Jackson John Hughlings, 1866, LANCET, V87, P174; Jefferies E, 2013, CORTEX, V49, P611, DOI 10.1016/j.cortex.2012.10.008; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kennedy DO, 2000, PSYCHOPHARMACOLOGY, V149, P63, DOI 10.1007/s002139900335; Kissler J., 2013, CAMBRIDGE HDB HUMAN, P304; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Klumpp H, 2010, INT J PSYCHOPHYSIOL, V75, P77, DOI 10.1016/j.ijpsycho.2009.10.003; Koelkebeck K, 2010, SCHIZOPHR RES, V119, P115, DOI 10.1016/j.schres.2009.12.015; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Laeger I, 2012, BEHAV BRAIN RES, V233, P508, DOI 10.1016/j.bbr.2012.05.036; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Milner B., 1964, FRONTAL GRANULAR COR, P313; Morey L.C., 2007, PERSONALITY ASSESSME; NELSON LD, 1994, J CLIN EXP NEUROPSYC, V16, P796, DOI 10.1080/01688639408402693; Ree MJ, 2008, BEHAV COGN PSYCHOTH, V36, P313, DOI 10.1017/S1352465808004232; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; ROSSER A, 1994, J NEUROL NEUROSUR PS, V57, P1389, DOI 10.1136/jnnp.57.11.1389; Sanchez-Moreno J, 2009, PSYCHOTHER PSYCHOSOM, V78, P285, DOI 10.1159/000228249; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Sharpley CF, 2000, APPL PSYCHOPHYS BIOF, V25, P143, DOI 10.1023/A:1009598607998; Sheldon S, 2016, NEUROPSYCHOLOGIA, V90, P148, DOI 10.1016/j.neuropsychologia.2016.06.028; Sheldon S, 2012, HIPPOCAMPUS, V22, P1451, DOI 10.1002/hipo.20985; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Spalletta G, 2001, PSYCHOSOM MED, V63, P944, DOI 10.1097/00006842-200111000-00013; Spreen O., 1969, NEUROSENSORY CTR COM; Sturm VE, 2011, NEUROCASE, V17, P242, DOI 10.1080/13554794.2010.532503; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Suchy Y., 2011, CLIN NEUROPSYCHOLOGY; Tabert MH, 2001, CLIN NEUROPSYCHOL, V15, P531, DOI 10.1076/clin.15.4.531.1876; Testa JA, 2001, NEUROLOGY, V57, P1474, DOI 10.1212/WNL.57.8.1474; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Vallee-Tourangeau F, 1998, MEMORY, V6, P555; van Rijn S, 2011, PSYCHIAT RES, V187, P100, DOI 10.1016/j.psychres.2010.10.007; Vigliocco G, 2014, CEREB CORTEX, V24, P1767, DOI 10.1093/cercor/bht025; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Watson D., 1994, PANAS X MANUAL POSIT; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496	74	12	12	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2017	39	8					738	752		10.1080/13803395.2016.1259396			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FA7HI	WOS:000405616100002	27892775				2022-02-06	
J	Beaulieu-Bonneau, S; Ouellet, MC				Beaulieu-Bonneau, Simon; Ouellet, Marie-Christine			Fatigue in the first year after traumatic brain injury: course, relationship with injury severity, and correlates	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; fatigue; longitudinal study; rehabilitation	QUALITY-OF-LIFE; MULTIDIMENSIONAL FATIGUE; SELF-AWARENESS; HEAD-INJURY; ADAPTATION; PREDICTORS; TBI; REHABILITATION; DISTURBANCES; INDIVIDUALS	The objectives of this study were to document the evolution of fatigue in the first year after traumatic brain injury (TBI), and to explore correlates of fatigue. Participants were 210 adults who were hospitalised following a TBI. They completed questionnaires 4, 8, and 12 months post-injury, including the Multidimensional Fatigue Inventory (MFI). Participants with severe TBI presented greater mental and physical fatigue, and reduced activity compared to participants with moderate TBI. For all MFI subscales except reduced motivation, the general pattern was a reduction of fatigue levels over time after mild TBI, an increase of fatigue after severe TBI, and stable fatigue after moderate TBI. Fatigue was significantly associated with depression, insomnia, cognitive difficulties, and pain at 4 months; the same variables and work status at 8 months; and depression, insomnia, cognitive difficulties, and work status at 12 months. These findings suggest that injury severity could have an impact on the course of fatigue in the first year post-TBI. Depression, insomnia, and cognitive difficulties remain strong correlates of fatigue, while for pain and work status the association with fatigue evolves over time. This could influence the development of intervention strategies for fatigue, implemented at specific times for each severity subgroup.	[Beaulieu-Bonneau, Simon; Ouellet, Marie-Christine] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [Beaulieu-Bonneau, Simon; Ouellet, Marie-Christine] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada		Beaulieu-Bonneau, S (corresponding author), Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada.; Beaulieu-Bonneau, S (corresponding author), Univ Laval, Ecole Psychol, Quebec City, PQ, Canada.	simon.beaulieu-bonneau.1@ulaval.ca			Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec [16375]	This work was supported by the Fonds de Recherche du Quebec - Sante under Grant [16375].	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J. D., 2004, J REHABILITATION MED, V43; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Fillion L, 2003, CANCER NURS, V26, P143, DOI 10.1097/00002820-200304000-00008; Ghisletta P, 2004, J EDUC BEHAV STAT, V29, P421, DOI 10.3102/10769986029004421; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; IBM Corp, 2011, IBM SPSS STAT MAC VE; Johansson B, 2015, NEUROREHABILITATION, V36, P195, DOI 10.3233/NRE-151207; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Ministere de la sante et des services sociaux du Quebec & Societe d'assurance automobile du Quebec, 2005, OR MIN TRAUM CRAN LE; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet M.-C., 2012, OXFORD HDB SLEEP SLE, P820; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ouellet MC, 2015, INSOMNIE FATIGUE APR; Ponsford J., 2003, Z NEUROPSYCHOL, V14, P155, DOI [10.1024/1016-264X.14.3.155, DOI 10.1024/1016-264X.14.3.155]; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Schonberger M, 2014, NEUROPSYCHOL REHABIL, V24, P202, DOI 10.1080/09602011.2013.878252; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; TEASDALE G, 1974, LANCET, V2, P81; Vos-Vromans DCWM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-71; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Ware J., 2000, SF 36 HLTH SURVEY MA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	58	12	12	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	7					983	1001		10.1080/09602011.2016.1162176			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FB4WK	WOS:000406142500001		Green Accepted			2022-02-06	
J	Bethune, A; da Costa, L; van Niftrik, CHB; Feinstein, A				Bethune, A.; da Costa, L.; van Niftrik, C. H. B.; Feinstein, A.			Suicidal Ideation After Mild Traumatic Brain Injury: A Consecutive Canadian Sample	ARCHIVES OF SUICIDE RESEARCH			English	Article						concussion; mild traumatic brain injury; suicidal ideation; suicidality	CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; PREVALENCE; DEPRESSION; RISK; PREDICTORS; COMMUNITY; BEHAVIOR; STRESS; ADULTS	This study aims to elucidate psychosocial and injury features contributing to SI following concussion or mild traumatic brain injury (mTBI) and the time course for its development. Between 1998 and 2012, a sample of 871 patients referred to a follow-up clinic after concussion treatment in an urban tertiary care ED were consecutively offered enrollment at 3 months post injury. Data from psychiatric and social-demographic assessments were consecutively collected at 2 visits (3 and 6 months after injury) respectively. Chi-square and t-tests were performed to identify associations between variables related with SI. Logistic regression analysis was performed to identify factors independently associated. During the enrolment period, 2,296 patients with mTBI presented to the ED. 871 adults completed psychiatric and social demographic clinic assessments at 3 months, and 500 returned at 6 months. Suicidal ideation was expressed by 6.3% at 3 months and 8.2% at 6 months. Regression models showed SI independently associated with: speaking English as a second language (ESL) and injury mechanism (MVC passenger) at 3 and 6 months; and history of depression and marital status at 3 months only. SI is common 3 months after mTBI, and appears more at 6 month follow up. These findings suggest earlier screening for predisposing factors and closer monitoring of those at risk for suicidality.	[Bethune, A.; da Costa, L.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Neurosurg, Toronto, ON, Canada; [da Costa, L.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada; [van Niftrik, C. H. B.] Univ Zurich, Univ Zurich Hosp, Dept Neurosurg, Zurich, Switzerland; [Feinstein, A.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON, Canada		Bethune, A (corresponding author), Sunnybrook Hlth Sci Ctr, Div Neurosurg, 2075 Bayview Ave,Room B5-05, Toronto, ON M4N 3M5, Canada.	allison.bethune@sunnybrook.ca		van Niftrik, Christiaan/0000-0003-0930-8717			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson-Barnes Victoria C, 2010, Continuum (Minneap Minn), V16, P17, DOI 10.1212/01.CON.0000391450.48225.73; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jang JM, 2014, PSYCHIAT RES, V216, P74, DOI 10.1016/j.psychres.2013.12.054; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Kreutzer JS, 2001, J HEAD TRAUMA REHAB, V16, pV, DOI 10.1097/00001199-200108000-00001; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Riechers RG, 2014, JAMA PSYCHIAT, V71, P94, DOI 10.1001/jamapsychiatry.2013.2989; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Watson D, 2001, Crisis, V22, P12, DOI 10.1027//0227-5910.22.1.12; Weissman MM, 1999, PSYCHOL MED, V29, P9, DOI 10.1017/S0033291798007867; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	33	12	12	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1381-1118	1543-6136		ARCH SUICIDE RES	Arch. Suicide Res.		2017	21	3					392	402		10.1080/13811118.2016.1199990			11	Psychiatry; Psychology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	FG2YG	WOS:000409999700003	27310250				2022-02-06	
J	Bricker-Anthony, C; D'Surney, L; Lunn, B; Hines-Beard, J; Jo, M; Bernardo-Colon, A; Rex, TS				Bricker-Anthony, Courtney; D'Surney, Lauren; Lunn, Brendan; Hines-Beard, Jessica; Jo, Minhee; Bernardo-Colon, Alexandra; Rex, Tonia S.			Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing	OPTOMETRY AND VISION SCIENCE			English	Article						erythropoietin; eye trauma; blast; neuroprotection	BRAIN-INJURY; GANGLION-CELLS; MOUSE MODEL; VISUAL FUNCTION; OCULAR TRAUMA; GENE-TRANSFER; DEGENERATION; PROTECTS; GLAUCOMA; DERIVATIVES	Purpose. Erythropoietin (EPO) is a promising neuroprotective agent and is currently in Phase III clinical trials for the treatment of traumatic brain injury. The goal of this study was to determine if EPO is also protective in traumatic eye injury. Methods. The left eyes of anesthetized DBA/2J or Balb/c mice were exposed to a single 26 psi overpressure air-wave while the rest of the body was shielded. DBA/2J mice were given intraperitoneal injections of EPO or buffer and analyses were performed at 3 or 7 days post-blast. Balb/c mice were given intramuscular injections of rAAV.EpoR76E or rAAV.eGFP either pre- or post-blast and analyses were performed at 1 month post-blast. Results. EPO had a bimodal effect on cell death, glial reactivity, and oxidative stress. All measures were increased at 3 days post-blast and decreased at 7-days post-blast. Increased retinal ferritin and NADPH oxygenases were detected in retinas from EPO-treated mice. The gene therapy approach protected against axon degeneration, cell death, and oxidative stress when given after blast, but not before. Conclusions. Systemic, exogenous EPO and EPO-R76E protects the retina after trauma even when initiation of treatment is delayed by up to 3 weeks. Systemic treatment with EPO or EPO-R76E beginning before or soon after trauma may exacerbate protective effects of EPO within the retina as a result of increased iron levels from erythropoiesis and, thus, increased oxidative stress within the retina. This is likely overcome with time as a result of an increase in levels of antioxidant enzymes. Either intraocular delivery of EPO or treatment with non-erythropoietic forms of EPO may be more efficacious.	[Bricker-Anthony, Courtney; Hines-Beard, Jessica; Jo, Minhee; Bernardo-Colon, Alexandra; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN USA; [Bricker-Anthony, Courtney; Hines-Beard, Jessica; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN USA; [D'Surney, Lauren; Lunn, Brendan] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN USA		Rex, TS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, 11425 Langford MRB-4,2213 Garland Ave, Nashville, TN 37232 USA.	tonia.rex@vanderbilt.edu	Bricker-Anthony, Courtney/AAS-9583-2021	Bricker-Anthony, Courtney/0000-0001-5000-3523	Department of DefenseUnited States Department of Defense [W81XW-10-1-0528, W81XWH-13-1-0048, W81XWH-15-1-0096]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EY022349, P30 EY008126]; Fight for Sight Summer Undergraduate Fellowship; Research to Prevent Blindness Unrestricted Funds; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY022349, P30EY008126] Funding Source: NIH RePORTER	This research was funded by Department of Defense grants W81XW-10-1-0528 (TSR), W81XWH-13-1-0048 (TSR), W81XWH-15-1-0096 (TSR), NIH grants R01 EY022349 (TSR) and P30 EY008126 (David Calkins), Fight for Sight Summer Undergraduate Fellowship (LDS), and Research to Prevent Blindness Unrestricted Funds (Paul Sternberg, Jr.).	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bond WS, 2016, MOL THER, V24, P230, DOI 10.1038/mt.2015.198; Bond WS, 2012, FRONT IMMUNOL, V8, P24; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Dumont F, 2010, EXPERT OPIN THER PAT, V20, P715, DOI 10.1517/13543771003627464; Dvoriantchikova G, 2012, INVEST OPHTH VIS SCI, V53, P2823, DOI 10.1167/iovs.12-9526; Fisher JW, 2003, EXP BIOL MED, V228, P1; Gammella E, 2015, AM J PHYSIOL-REG I, V308, pR330, DOI 10.1152/ajpregu.00410.2014; Gawad AE, 2009, EYE, V23, P2245, DOI 10.1038/eye.2008.398; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Grimm C, 2004, J NEUROSCI, V24, P5651, DOI 10.1523/JNEUROSCI.1288-04.2004; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Hilber David J, 2011, MSMR, V18, P2; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kim A, 2015, CURR OPIN HEMATOL, V22, P199, DOI 10.1097/MOH.0000000000000132; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lee DE, 2006, BIOCHEM BIOPH RES CO, V339, P380, DOI 10.1016/j.bbrc.2005.11.034; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Louboutin JP, 2005, J GENE MED, V7, P442, DOI 10.1002/jgm.686; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Rex TS, 2009, EXP EYE RES, V89, P735, DOI 10.1016/j.exer.2009.06.017; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; Sullivan T, 2011, NEUROCHEM RES, V36, P613, DOI 10.1007/s11064-010-0272-6; Sullivan TA, 2012, EXP EYE RES, V96, P36, DOI 10.1016/j.exer.2012.01.006; Sullivan TA, 2011, HUM GENE THER, V22, P1191, DOI 10.1089/hum.2011.052; Tsai JC, 2005, CURR EYE RES, V30, P1025, DOI 10.1080/02713680500320729; U.S. Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62, P374; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; Weitlauf C, 2014, J NEUROSCI, V34, P15369, DOI 10.1523/JNEUROSCI.3424-14.2014; World Health Organization (WHO), WORLD HLTH ORG PRIOR; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844	44	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					20	32		10.1097/OPX.0000000000000898			13	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EM5ZZ	WOS:000395393900005	27281679	Green Accepted			2022-02-06	
J	Chen, W; Guo, YJ; Yang, WJ; Zheng, P; Zeng, JS; Tong, WS				Chen, Wei; Guo, Yijun; Yang, Wenjin; Zheng, Ping; Zeng, Jinsong; Tong, Wusong			Connexin40 correlates with oxidative stress in brains of traumatic brain injury rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); connexin40; oxidative stress	N-ACETYLCYSTEINE; COMMUNICATION; HEMICHANNELS; PREDICTORS; DISEASE; MODEL; TBI	Background: Oxidative stress is an important factor in the pathophysiologic changes after traumatic brain injury (TBI). Connexin43 (Cx43) was reported to contribute to cerebral damage. However, the impacts of Cx40 have not been investigated in detail. Objective: In the present study, we hypothesized that Cx40 was involved in oxidative stress-induced brain injury after TBI. Methods: The controlled cortical impact (CCI) model was introduced to Wistar rats as a TBI model. Neurological deficits, oxidative stress and Cx40 were evaluated in TBI rats and N-acetylcysteine (NAC)-treated TBI rats. Neurological severity score (NSS) was used to assess neurological deficits. Brain infarctionwas measured by histo-staining. Brain edemawas evaluated by measuring the brain water content. Cortex samples were collected to measure the tissue levels of malonyldialdehyde (MDA), nitric oxide (NO) and glutathione (GSH) and NADPH oxidase activity. Cx40 expression was determined by Western-blot. Results: TBI-induced brain injuries gradually increased from 6 h to 24 h post CCI, and the severity remained till 72 h. The level of oxidative stress was consistent with the extent of neurological deficits. Cx40 was upregulated after TBI in a linear correlated manner with increased oxidative stress. With NAC intervention, both neurological deficits and oxidative stress were significantly attenuated. Meanwhile, elevated Cx40 expression in cortex was also prevented by NAC treatment. Conclusion: These studies revealed the relationship between levels of Cx40 and oxidative stress after TBI. The cortex Cx40 expression was positively correlated with the cerebral oxidative stress, indicating the involvement of Cx40 in the progress of brain damage.	[Chen, Wei; Guo, Yijun; Yang, Wenjin; Zheng, Ping; Zeng, Jinsong; Tong, Wusong] Peoples Hosp Pu Dong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China		Tong, WS (corresponding author), Peoples Hosp Pu Dong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China.	wstong3@sina.com		Tong, Wusong/0000-0003-1072-7310; Chen, Wei/0000-0001-7438-3241	Outstanding Medical Talent Training Project of Health System of Shanghai Pudong New Area [PWRq2015-16]; Key Construction Specialty Project of Health and Family Planning Commission of Pudong New Area, Shanghai [PWZz2013-13]; Science and Technology Committee Project of Pudong New Area, Shanghai [PKJ2016-Y31]	This work was funded by the Outstanding Medical Talent Training Project of Health System of Shanghai Pudong New Area (PWRq2015-16), Key Construction Specialty Project of Health and Family Planning Commission of Pudong New Area, Shanghai (PWZz2013-13), The Science and Technology Committee Project of Pudong New Area, Shanghai (PKJ2016-Y31).	Avila MA, 2011, J NEUROTRAUM, V28, P1803, DOI 10.1089/neu.2011.1900; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Buhmann CB, 2014, DAN MED J, V61; Burra Sirisha, 2011, Int J Biochem Mol Biol, V2, P119; Chang Q, 2000, BRAIN RES REV, V32, P242, DOI 10.1016/S0165-0173(99)00085-5; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Davidson JO, 2013, CURR DRUG TARGETS, V14, P36; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Hu XM, 2005, ACTA PHARMACOL SIN, V26, P1454, DOI 10.1111/j.1745-7254.2005.00239.x; Kar R, 2013, J BONE MINER RES, V28, P1611, DOI 10.1002/jbmr.1917; Kim Y, 2016, ADV PROTEIN CHEM STR, V104, P1, DOI 10.1016/bs.apcsb.2015.12.001; Le HT, 2014, J BIOL CHEM, V289, P1345, DOI 10.1074/jbc.M113.508390; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; von Leden RE, 2017, J NEUROTRAUM, V34, P755, DOI 10.1089/neu.2016.4486; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055	27	12	15	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2017	35	2					217	224		10.3233/RNN-160705			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ5OG	WOS:000398131700006	28157110				2022-02-06	
J	Cheng, CJ; Yu, ZY; Zhao, S; Liao, ZB; Xing, CH; Jiang, YH; Yang, YG; Whalen, MJ; Lo, EH; Sun, XC; Wang, XY				Cheng, Chongjie; Yu, Zhanyang; Zhao, Song; Liao, Zhengbu; Xing, Changhong; Jiang, Yinghua; Yang, Yong-Guang; Whalen, Michael J.; Lo, Eng H.; Sun, Xiaochuan; Wang, Xiaoying			Thrombospondin-1 Gene Deficiency Worsens the Neurological Outcomes of Traumatic Brain Injury in Mice	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES			English	Article						traumatic brain injury; Thromspondin-1 (TSP-1); neurological severity score (NSS); blood-brain-barrier; morris water maze (MWM); angiogenesis; synaptogenesis	CONTROLLED CORTICAL IMPACT; NEUROTROPHIC FACTOR; DYNAMIC CHANGES; TISSUE-DAMAGE; CELL-DEATH; ANGIOGENESIS; SYNAPTOGENESIS; RECOVERY; MOTOR; DYSFUNCTION	Background: Thrombospondin-1 (TSP-1) is an extracellular matrix protein that plays multiple physiological and pathophysiological roles in the brain. Experimental reports suggest that TSP-1 may have an adverse role in neuronal function recovery under certain injury conditions. However, the roles of TSP-1 in traumatic brain injury (TBI) have not been elucidated. In this study we for the first time investigated the roles of TSP-1 in a controlled cortical impact (CCI) model of TBI in TSP-1 knockout (TSP-1 KO) and wild type (WT) mice. Methods: We examined blood brain-barrier (BBB) damage using at 1 day post-TBI by measuring Evans Blue leakage, and neurological functional recovery at 3 weeks post-TBI by measuring neurological severity score (NSS), wire gripping, corner test and Morris Water Maze (MWM). Mechanistically, we quantified pro-angiogenic biomarkers including cerebral vessel density, vascular endothelial growth factors (VEGF) and angiopoietin-1 (Ang-1) protein expression, synaptic biomarker synaptophysin, and synaptogenesis marker brain-derived neurotrophic factor (BDNF) protein expression in contralateral and ipsilateral (peri-lesion) cortex at 21 days after TBI using immunohistochemistry and Western Blot. Results: TSP-1 is upregulated at early phase of TBI in WT mice. Compared to WT mice, TSP-1 KO (1) significantly worsened TBI-induced BBB leakage at 1 day after TBI; (2) had similar lesion size as WT mice at 3 weeks after TBI; (3) exhibited a significantly worse neurological deficits in motor and cognitive functions; (4) had no significant difference in cerebral vessel density, but significant increase of VEGF and Ang-1 protein expressions in peri-lesion cortex; (5) significantly increased BDNF but not synaptophysin protein level in peri-lesion cortex compared to sham, but both synaptophysin and BDNF expressions were significantly decreased in contralateral cortex compared to WT. Conclusion: Our results suggest that TSP-1 may be beneficial for maintaining BBB integrity in the early phase and functional recovery in late phase after TBI. The molecular mechanisms of TSP-1 in early BBB pathophysiology, and long-term neurological function recovery after TBI need to be further investigated.	[Cheng, Chongjie; Liao, Zhengbu; Jiang, Yinghua; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Cheng, Chongjie; Yu, Zhanyang; Liao, Zhengbu; Xing, Changhong; Jiang, Yinghua; Lo, Eng H.; Wang, Xiaoying] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Cheng, Chongjie; Yu, Zhanyang; Liao, Zhengbu; Xing, Changhong; Jiang, Yinghua; Lo, Eng H.; Wang, Xiaoying] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; [Zhao, Song] Jilin Univ, Bethune Hosp 1, Dept Orthoped, Changchun, Jilin, Peoples R China; [Zhao, Song] Jilin Univ, Bethune Hosp 1, Dept Neurosurg, Changchun, Jilin, Peoples R China; [Yang, Yong-Guang] Columbia Univ Coll Phys & Surg, Dept Med, Columbia Ctr Translat Immunol, New York, NY USA; [Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Pediat Crit Care Med, Charlestown, MA USA		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.; Wang, XY (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.; Wang, XY (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA.	sunxch1445@qq.com; wangxi@helix.mgh.harvard.edu	liao, ZB/ABF-8804-2021	liao, ZB/0000-0003-4591-9689; sun, xiao chuan/0000-0001-6992-332X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI-064569]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301035, 81571159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI064569] Funding Source: NIH RePORTER	This work was supported in part by NIH grant R01AI-064569 (X.Wang) and the National Natural Science Foundation of China (81301035 to S.Zhao, 81571159 to X.Sun).	Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Cho SH, 2012, CURR PHARM DESIGN, V18, P3721, DOI 10.2174/138161212802002760; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Garg P, 2011, AM J PHYSIOL-LUNG C, V301, pL79, DOI 10.1152/ajplung.00287.2010; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Jerkic M, 2015, FASEB J, V29, P3678, DOI 10.1096/fj.14-269258; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Tran MD, 2012, NEUROREPORT, V23, P721, DOI 10.1097/WNR.0b013e32835688fe; Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Risher WC, 2012, MATRIX BIOL, V31, P170, DOI 10.1016/j.matbio.2012.01.004; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Song HS, 2002, BIOCHEM BIOPH RES CO, V290, P325, DOI 10.1006/bbrc.2001.6205; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang JL, 2015, ACTA NEUROLOGICA SCA; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xing CH, 2010, NEUROCHEM RES, V35, P1092, DOI 10.1007/s11064-010-0159-6; Xing CH, 2009, J NEUROSCI RES, V87, P2571, DOI 10.1002/jnr.22076; Xing CH, 2009, J NEUROCHEM, V108, P430, DOI 10.1111/j.1471-4159.2008.05777.x; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67	43	12	12	1	4	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-1907			INT J MED SCI	Int. J. Med. Sci.		2017	14	10					927	936		10.7150/ijms.18812			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3ZT	WOS:000408154900002	28924363	Green Published, gold, Green Submitted			2022-02-06	
J	Frias, FJL; McNamee, M				Frias, Francisco Javier Lopez; McNamee, Mike			Ethics, Brain Injuries, and Sports: Prohibition, Reform, and Prudence	SPORT ETHICS AND PHILOSOPHY			English	Article						Brain injuries; autonomy; paternalism; football; consensual domination	DANGEROUS SPORT; CONCUSSION; PATERNALISM; MEDICINE; MANAGEMENT; CONFLICTS; LIBERTY	In this paper, we explore the issue of the elimination of sports, or elements of sports, that present a high risk of brain injury. In particular, we critically examine two elements of Angelo Corlett's and Pam Sailors' arguments for the prohibition of football and Nicholas Dixon's claim for the reformation of boxing to eliminate blows to the head based on (a) the empirical assumption of an essential or causal connection between brain injuries incurred in football and the development of a degenerative brain disease known as chronic traumatic encephalopathy (CTE); and (b) John Stuart Mill's rejection of consensual domination (ie voluntary enslavement). We present four arguments to contest the validity of Corlett, Dixon's and Sailor's positions. Specifically, we argue that (i) certain autonomy-based arguments undermine paternalist arguments for reform; (ii) the nature of the goods people pursue in their lives might justify their foregoing (degrees of) future autonomy; (iii) Mill's argument against consensual domination draws on ambiguous and arbitrary distinctions; (iv) the lack of consensus and empirical evidence regarding CTE arising from brain injuries in sport underdetermines calls for reform. We conclude that these proposals for reforming or eliminating sports with high risks of brain injuries are not well founded.	[Frias, Francisco Javier Lopez] Penn State Univ, Kinesiol, University Pk, PA 16802 USA; [Frias, Francisco Javier Lopez] Penn State Univ, Rock Eth Inst, University Pk, PA 16802 USA; [McNamee, Mike] Swansea Univ, Coll Engn, Sch Sport & Exercise Sci, Swansea, W Glam, Wales		Frias, FJL (corresponding author), Penn State Univ, Kinesiol, University Pk, PA 16802 USA.; Frias, FJL (corresponding author), Penn State Univ, Rock Eth Inst, University Pk, PA 16802 USA.	fjl13@psu.edu	McNamee, Michael/AAI-8780-2020; Frias, Francisco Javier Lopez/AAQ-5337-2020	McNamee, Michael/0000-0002-5857-909X; Frias, Francisco Javier Lopez/0000-0001-7278-7656			Albrecht, 2000, HDB SOCIAL STUDIES H, P409, DOI DOI 10.4135/9781848608412.N26; Andre J., 1991, RETHINKING COLL ATHL; [Anonymous], 2014, BBC; ARCHARD D, 1990, PHILOS QUART, V40, P453, DOI 10.2307/2220110; Beauchamp TL, 2003, J MED ETHICS, V29, P269, DOI 10.1136/jme.29.5.269; Bloodworth A, 2014, SPORT ETHICS PHILOS, V8, P191, DOI 10.1080/17511321.2014.935741; BREIVIK G, 2007, PHILOS RISK ADVENTUR, V1024; Brink D., 2010, OXFORD HDB TIME, P353; Brink DO, 2003, PHILOS REV, V112, P215, DOI 10.1215/00318108-112-2-215; Corlett JA, 2014, SPORT ETHICS PHILOS, V8, P116, DOI 10.1080/17511321.2014.918167; Devlin P, 2009, ENFORCEMENT MORALS; Dixon N., 2001, SOCIAL THEORY PRACTI, V27, P323; Dixon N, 2007, J PHILOS SPORT, V34, P147, DOI 10.1080/00948705.2007.9714718; Duber D, 2015, LIBR ETHICS APPL PHI, V35, P31, DOI 10.1007/978-3-319-17960-5_3; DWORKIN G, 1972, MONIST, V56, P64, DOI 10.5840/monist197256119; Dworkin G., 2013, PATERNALISM THEORY P; Dworkin G., 1983, PATERNALISM, P105; Fainaru-Wada M., 2014, LEAGUE DENIAL NFL CO; Farrar D., 2012, SHUTDOWN CORNER 0710; Fateh-Moghadam B, 2014, ETHICAL THEORY MORAL, V17, P383, DOI 10.1007/s10677-013-9450-3; Feinberg J., 1984, HARM OTHERS; HUME D., 2014, ENQUIRY PRINCIPLES M; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P1, DOI 10.1007/s12152-015-9233-8; KANT I., 2006, OLD SAW MAY BE RIGHT; Loosemore Mike, 2008, Br J Sports Med, V42, P564; Lovett F, 2008, CAMB CRIT GUIDE, P123, DOI 10.1017/CBO9780511575181.007; LUNDBERG GD, 1986, JAMA-J AM MED ASSOC, V255, P2483, DOI 10.1001/jama.255.18.2483; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mcnamee M., 2007, PHILOS RISK ADVENTUR, P1; McNamee M., 2015, KINESIOL REV, V4, P190, DOI [10.1123/kr.2015-0011, DOI 10.1123/KR.2015-0011]; McNamee MJ, 2016, CLIN SPORT MED, V35, P257, DOI 10.1016/j.csm.2015.10.008; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Meeuwisse WH, 2017, BRIT J SPORT MED, V51, P873, DOI 10.1136/bjsports-2017-097569; Mill J.S., 1989, LIBERTY SUBJECTION W; PARFIT D, 2007, REASONS PERSONS; Parfit D., 2001, WHAT MATTERS; Parry S.J., 1998, ETHICS SPORT, P205; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Pettit Phillip, 2010, REPUBLICANISM THEORY; RADFORD C, 1988, PHILOSOPHY, V63, P63, DOI 10.1017/S0031819100043138; ROSENBERG D, 2014, BLOOMSBURY COMPANION, P262; Russell JS, 2007, J PHILOS SPORT, V34, P176, DOI 10.1080/00948705.2007.9714720; Russell JS, 2005, J PHILOS SPORT, V32, P1; Sailors PR, 2015, J PHILOS SPORT, V42, P269, DOI 10.1080/00948705.2014.1000338; SIDGWICK H., 2012, METHODS ETHICS; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Simon R.L., 2015, FAIR PLAY ETHICS SPO; Slobounov SM, 2013, NEUROSCI LETT, V547, P6, DOI 10.1016/j.neulet.2013.05.001; Slote M., 1983, GOODS AND VIRTUES; STRASSER M, 1984, PHILOS QUART, V34, P63, DOI 10.2307/2218890; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; VAN DER VEER D., 1986, PATERNALISTIC INTERV; VanDeVeer D., 2014, PATERNALISTIC INTERV; [No title captured]	58	12	12	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1751-1321	1751-133X		SPORT ETHICS PHILOS	Sport Ethics Philos.		2017	11	3			SI		264	280		10.1080/17511321.2017.1342688			17	Ethics	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	FQ6PF	WOS:000418485800002		Green Accepted			2022-02-06	
J	Gardner, AJ; Wojtowicz, M; Terry, DP; Levi, CR; Zafonte, R; Iverson, GL				Gardner, Andrew J.; Wojtowicz, Magdalena; Terry, Douglas P.; Levi, Christopher R.; Zafonte, Ross; Iverson, Grant L.			Video and clinical screening of national rugby league players suspected of sustaining concussion	BRAIN INJURY			English	Article						Concussion; sideline assessment; SCAT3; video analysis	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; ICE HOCKEY PLAYERS; ASSESSMENT-TOOL; BRAIN-INJURY; SCAT2; CHILDREN; SAC	Primary Objective: This study reviewed the available sideline Sport Concussion Assessment Tool-Third Edition (SCAT3) performance of players who were removed from play using the 'concussion interchange rule' (CIR), the available video footage of these incidences, and associated return to play and concussion diagnosis decisions. Research Design: Descriptive, observational case series. Methods and Procedures: Data were collected from all NRL players who used the CIR during the 2014 season. Main Outcomes and Results: Complete SCAT3 and video analysis data were available for 38 (23%) of 167 uses of the concussion interchange rule, of which 20 (52.6%) players were medically diagnosed with concussion. Those with video evidence of unresponsiveness performed more poorly on the modified Balance Error Scoring System (M-BESS; p = .04; Cohen's d = .69) and reported greater symptoms (p = .03; d = .51). Similarly, players with a vacant stare reported greater symptoms (p - .05; d = .78). Those who demonstrated three signs (unresponsiveness, vacant stare and gait ataxia) performed more poorly on the M-BESS (p = .03; d = 1.4) and reported greater symptoms than those with no observable signs (p = .03; d = 1.4). Conclusions: The SCAT3 is sensitive to the acute effects of concussion in professional athletes; however, a minority of injured athletes might go undetected by this test.	[Gardner, Andrew J.; Levi, Christopher R.] John Hunter Hosp, Hunter New England Sports Concuss Program, New Lambton Hts, NSW, Australia; [Gardner, Andrew J.; Levi, Christopher R.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Wojtowicz, Magdalena; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, MassGen Hosp Children,Sport Concuss Program, Boston, MA USA; [Wojtowicz, Magdalena; Zafonte, Ross; Iverson, Grant L.] Home Base, Boston, MA USA; [Terry, Douglas P.] MassGen Hosp Children, Sports Concuss Program, Spaulding Rehabil Network, Ctr Hlth & Rehabil Res, Boston, MA USA; [Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA USA		Gardner, AJ (corresponding author), Calvary Mater Hosp, Ctr Stroke & Brain Injury, Level 5,McCauley Bldg, Waratah, NSW, Australia.	andrew.gardner@neurogard.com.au		Iverson, Grant/0000-0001-7348-9570; Gardner, Andrew/0000-0001-5031-5586; Levi, Christopher/0000-0002-9474-796X	Hunter Medical Research Institute (HMRI); University of Newcastle's Priority Research Centre for Stroke and Brain Injury; Hunter New England Local Health District; Australian Football League (AFL); The Trust, a National Football League Players Association program; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; School of Medicine and Public Health, University of Newcastle	Andrew Gardner has a clinical practice in neuropsychology involving individuals who have sustained sports-related concussion (including current and former athletes). He has operated as a contracted concussion consultant to the Australian Rugby Union (ARU) from July 2016. He has received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013 and 2017. He acknowledges funding through the National Health and Medical Research Council (NHMRC), the School of Medicine and Public Health, University of Newcastle, the University of Newcastle's Priority Research Centre for Stroke and Brain Injury, the Hunter New England Local Health District and the Hunter Medical Research Institute (HMRI), support by Jennie Thomas and support by Anne Greaves.& para;& para;Ross Zafonte serves on the scientific advisory boards of Oxeia Biopharmaceuticals, Inc., ElMindA Ltd., and Myomo Inc. He provides health care services to former professional athletes through the Massachusetts General Hospital Brain and Body Program which is funded by The Trust, a National Football League Players Association program.	[Anonymous], 2013, Br J Sports Med, V47, P259; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Rugby League, 2014, MAN CONC RUGB LEAG; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zimmer A, 2014, APPL NEUROPSYCH-ADUL, P1	30	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1918	1924		10.1080/02699052.2017.1358399			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500026	28872354				2022-02-06	
J	Ghawami, H; Sadeghi, S; Raghibi, M; Rahimi-Movaghar, V				Ghawami, Heshmatollah; Sadeghi, Sadegh; Raghibi, Mahvash; Rahimi-Movaghar, Vafa			Executive functioning of complicated-mild to moderate traumatic brain injury patients with frontal contusions	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						D-KEFS; dysexecutive syndrome; executive functions; frontal lobe; traumatic brain injury	DESIGN FLUENCY; HEAD-INJURY; LOBE DAMAGE; STRATEGY APPLICATION; PREFRONTAL LESIONS; SORTING TEST; PERFORMANCE; DYSFUNCTION; REHABILITATION; SEQUELAE	Executive dysfunctions are among the most prevalent neurobehavioral sequelae of traumatic brain injuries (TBIs). Using culturally validated tests from the Delis-Kaplan Executive Function System (D-KEFS: Trail Making, Verbal Fluency, Design Fluency, Sorting, Twenty Questions, and Tower) and the Behavioural Assessment of the Dysexecutive Syndrome (BADS: Rule Shift Cards, Key Search, and Modified Six Elements), the current study was the first to examine executive functioning in a group of Iranian TBI patients with focal frontal contusions. Compared with a demographically matched normative sample, the frontal contusion patients showed substantial impairments, with very large effect sizes (p.003, 1.56<d<3.12), on all the executive measures. Controlling for respective lower-level/fundamental conditions, the differences on the highest-level executive (cognitive switching) conditions were still significant. The frontal patients also committed more errors. Patients with lateral prefrontal (LPFC) contusions were qualitatively worst. For example, only the LPFC patients committed perseverative repetition errors. Altogether, our results support the notion that the frontal lobes, specifically the lateral prefrontal regions, play a critical role in cognitive executive functioning, over and above the contributions of respective lower-level cognitive abilities. The results provide clinical evidence for validity of the cross-culturally adapted versions of the tests.	[Ghawami, Heshmatollah; Raghibi, Mahvash] Univ Sistan & Baluchestan, Dept Psychol, Zahedan, Iran; [Sadeghi, Sadegh] Zahedan Univ Med Sci, Dept Neurosurg, Zahedan, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Dept Neurosurg, Sina Trauma & Surg Res Ctr, Tehran, Iran		Rahimi-Movaghar, V (corresponding author), Univ Tehran Med Sci, Sina Hosp, Sina Trauma & Surg Res Ctr, Imam Khomeini St, Tehran 113653876, Iran.	v_rahimi@sina.tums.ac.ir	Ghawami, Heshmatollah/K-4816-2019; Rahimi-Movaghar, Vafa/L-6339-2019	Ghawami, Heshmatollah/0000-0002-9801-881X; 	Sina Trauma and Surgery Research Center, Tehran University of Medical SciencesTehran University of Medical Sciences; University of Sistan and Baluchestan	This work was supported in part by the Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences; and the University of Sistan and Baluchestan.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson V., 2008, EXECUTIVE FUNCTIONS; Baldo JV, 2004, ARCH CLIN NEUROPSYCH, V19, P407, DOI 10.1016/S0887-6177(03)00074-X; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Benson D.F., 1986, FRONTAL LOBES; Benton AL, 1991, FRONTAL LOBE FUNCTIO; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cohen J., 2013, STAT POWER ANAL BEHA; Conway MA, 2003, CORTEX, V39, P667, DOI 10.1016/S0010-9452(08)70859-1; Crawford J.R, 2005, EFFECTIVENESS REHABI, P233, DOI DOI 10.1093/ACPROF:OSO/9780198526544.003.0019; Cripe L., 1996, ECOLOGICAL VALIDITY, P171; Darby D, 2005, WALSHS NEUROPSYCHOLO; De Winter JCF, 2013, PRACTICAL ASSESSMENT, V18, P1; DELIS DC, 1992, NEUROPSYCHOLOGIA, V30, P683, DOI 10.1016/0028-3932(92)90039-O; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimitrov M, 1999, NEUROPSYCHOLOGY, V13, P135, DOI 10.1037/0894-4105.13.1.135; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Emmanouel A, 2014, NEUROPSYCHOL REHABIL, V24, P1, DOI 10.1080/09602011.2013.863731; Fagerland MW, 2009, STAT MED, V28, P1487, DOI 10.1002/sim.3561; Fuster J M, 1993, Curr Opin Neurobiol, V3, P160, DOI 10.1016/0959-4388(93)90204-C; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Ghawami H., 2015, 6 INT C COGN SCI ICC; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hartikainen K., 2003, DETECTION CHANGE EVE, P99, DOI DOI 10.1007/978-1-4615-0294-4; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hedges L.V., 1981, J EDUC BEHAV STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Kaplan E., 1988, CLIN NEUROPSYCHOLOGY; Keifer E, 2013, J CLIN EXP NEUROPSYC, V35, P1048, DOI 10.1080/13803395.2013.854319; Kramer JH, 2007, J INT NEUROPSYCH SOC, V13, P386, DOI 10.1017/S1355617707070567; Kulinskaya E, 2006, BRIT J MATH STAT PSY, V59, P97, DOI 10.1348/000711005X68174; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1973, WORKING BRAIN; McCullagh S., 2011, TRAUMATIC BRAIN INJU, P279; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald CR, 2005, NEUROPSYCHOLOGY, V19, P806, DOI 10.1037/0894-4105.19.6.806; Naglieri, 2014, HDB EXECUTIVE FUNCTI, DOI 10.1007/978-1-4614-8106-5; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; Gouveia PAR, 2007, BRAIN COGNITION, V63, P240, DOI 10.1016/j.bandc.2006.09.001; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Skovlund E, 2001, J CLIN EPIDEMIOL, V54, P86, DOI 10.1016/S0895-4356(00)00264-X; Stuss D. T., 2009, ENCY NEUROSCIENCE, P375; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Yochim B, 2007, J INT NEUROPSYCH SOC, V13, P704, DOI 10.1017/S1355617707070907; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669	66	12	12	1	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	4					299	307		10.1080/23279095.2016.1157078			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EW6FW	WOS:000402605300001	27101223				2022-02-06	
J	Green, J; Zuckerman, SL; Dalton, SL; Djoko, A; Folger, D; Kerr, ZY				Green, James; Zuckerman, Scott L.; Dalton, Sara L.; Djoko, Aristarque; Folger, Dustin; Kerr, Zachary Y.			A 6-year surveillance study of "Stingers" in NCAA American Football	RESEARCH IN SPORTS MEDICINE			English	Article						Epidemiology; injury surveillance; stingers; burners; neurologic injury	CERVICAL-SPINAL STENOSIS; STATES HIGH-SCHOOL; BURNER SYNDROME; NECK INJURIES; NERVE INJURY; PLAYERS; SPORTS; EPIDEMIOLOGY; ATHLETE; CONCUSSIONS	This study describes the epidemiology of stinger injuries in National Collegiate Athletic Association (NCAA) Men's Football. About 57 NCAA Men's Football programmes provided 153 team-seasons of injury data to the NCAA Injury Surveillance Programme (NCAA-ISP) during the 2009/2010-2014/2015 academic years. In the study period, 229 stingers were reported for an injury rate of 2.04/10,000 athlete-exposures (AE). Most stingers were reported during competitions (55.5%) and the preseason (80.3%) and resulted in time loss less than 24hours (63.8%). One in five (18.8%) were recurrent. Most stingers were due to player contact (93.0%), particularly while tackling (36.7%) and blocking (25.8%) and occurred to defensive ends/linebackers (25.8%) and offensive linemen (23.6%). Although previous research reports a large prevalence of stingers among football players, the NCAA-ISP reported a relatively low injury rate. The transient nature of pain associated with stingers may have contributed to under-reporting, highlighting the need to deduce manners to increase reporting.	[Green, James; Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Chapel Hill, NC 27514 USA; [Zuckerman, Scott L.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Dalton, Sara L.] Springfield Coll, Springfield, IL USA; [Djoko, Aristarque; Folger, Dustin; Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA		Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Chapel Hill, NC 27514 USA.; Kerr, ZY (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			NCAA	This work was supported by the NCAA.	ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; Charbonneau RME, 2012, CLIN J SPORT MED, V22, P472, DOI 10.1097/JSM.0b013e3182699ed5; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cunnane M, 2011, BRIT J SPORT MED, V45, pA19; Dick R, 2007, J ATHL TRAINING, V42, P221; Drakos MC, 2011, NEUROSURGERY, V68, pE1743, DOI 10.1227/NEU.0b013e31821815af; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenberg J, 2011, SPORTS HEALTH, V3, P264, DOI 10.1177/1941738111403866; Hibberd EE, 2013, CLIN J SPORT MED, V23, P450, DOI 10.1097/JSM.0b013e31829aa8ff; Kartal A, 2004, EUR SPINE J, V13, P76, DOI 10.1007/s00586-003-0623-y; Kawasaki T, 2015, AM J SPORT MED, V43, P2809, DOI 10.1177/0363546515597678; Kepler CK, 2012, CLIN SPORT MED, V31, P499, DOI 10.1016/j.csm.2012.03.005; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kuhlman GS, 1999, AM FAM PHYSICIAN, V60, P2035; Levitz CL, 1997, AM J SPORT MED, V25, P73, DOI 10.1177/036354659702500114; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MEYER SA, 1994, AM J SPORT MED, V22, P158, DOI 10.1177/036354659402200202; PAVLOV H, 1987, RADIOLOGY, V164, P771, DOI 10.1148/radiology.164.3.3615879; Presciutti SM, 2009, J NEUROSURG-SPINE, V11, P264, DOI 10.3171/2009.3.SPINE08642; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; ROBERTSON WC, 1979, JAMA-J AM MED ASSOC, V241, P1480, DOI 10.1001/jama.241.14.1480; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Safran MR, 2004, AM J SPORT MED, V32, P1063, DOI 10.1177/0363546504265193; SALLIS RE, 1992, PHYSICIAN SPORTSMED, V20, P47, DOI 10.1080/00913847.1992.11947521; Shannon B, 2002, CLIN SPORT MED, V21, P29, DOI 10.1016/S0278-5919(03)00055-3; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606; Standaert CJ, 2009, ARCH PHYS MED REHAB, V90, P402, DOI 10.1016/j.apmr.2008.09.569; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Vaccaro Alexander R, 2002, Spine J, V2, P351; WATKINS RG, 1986, CLIN SPORT MED, V5, P215; Weinstein SM, 1998, CLIN SPORT MED, V17, P127, DOI 10.1016/S0278-5919(05)70067-3; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	33	12	12	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2017	25	1					26	36		10.1080/15438627.2016.1258642			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG4ZX	WOS:000391053800003	27873542				2022-02-06	
J	How, TV; Hwang, AS; Green, REA; Mihailidis, A				How, Tuck-Voon; Hwang, Amy S.; Green, Robin E. A.; Mihailidis, Alex			Envisioning future cognitive telerehabilitation technologies: a co-design process with clinicians	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Co-design; cognitive rehabilitation; design methods; pervasive computing; pervasive health; telerehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERVASIVE HEALTH-CARE; REHABILITATION; SERVICES	Purpose Cognitive telerehabilitation is the concept of delivering cognitive assessment, feedback, or therapeutic intervention at a distance through technology. With the increase of mobile devices, wearable sensors, and novel human-computer interfaces, new possibilities are emerging to expand the cognitive telerehabilitation paradigm. This research aims to: (1) explore design opportunities and considerations when applying emergent pervasive computing technologies to cognitive telerehabilitation and (2) develop a generative co-design process for use with rehabilitation clinicians. Methods We conducted a custom co-design process that used design cards, probes, and design sessions with traumatic brain injury (TBI) clinicians. All field notes and transcripts were analyzed qualitatively. Results Potential opportunities for TBI cognitive telerehabilitation exist in the areas of communication competency, executive functioning, emotional regulation, energy management, assessment, and skill training. Designers of TBI cognitive telerehabilitation technologies should consider how technologies are adapted to a patient's physical/cognitive/emotional state, their changing rehabilitation trajectory, and their surrounding life context (e.g. social considerations). Clinicians were receptive to our co-design approach. Conclusion Pervasive computing offers new opportunities for life-situated cognitive telerehabilitation. Convivial design methods, such as this co-design process, are a helpful way to explore new design opportunities and an important space for further methodological development.	[How, Tuck-Voon; Hwang, Amy S.; Mihailidis, Alex] Univ Toronto, Intelligent Assist Technol & Syst Lab, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Green, Robin E. A.; Mihailidis, Alex] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Green, Robin E. A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada		How, TV (corresponding author), Univ Toronto, Intelligent Assist Technol & Syst Lab, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	tuckvoon.how@mail.utoronto.ca		Mihailidis, Alex/0000-0003-2233-0919; Green, Robin/0000-0001-9451-3963	CIHR-STIHR Fellowship in Health Care, Technology and PlaceCanadian Institutes of Health Research (CIHR) [TGF-53911]; CIHR Doctoral Research AwardCanadian Institutes of Health Research (CIHR)	The authors are grateful to all the clinicians who participated in this study. Funding is provided by the CIHR-STIHR Fellowship in Health Care, Technology and Place (TGF-53911), and the CIHR Doctoral Research Award.	Akama Y., 2010, P 11 BIENN PART DES P 11 BIENN PART DES, P11, DOI DOI 10.1145/1900441.1900444; Allen Meghan, 2008, Universal Access in the Information Society, V7, P145, DOI 10.1007/s10209-008-0112-5; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Arnrich B, 2010, METHOD INFORM MED, V49, P67, DOI 10.3414/ME09-02-0044; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Ayoade Mobolaji, 2014, P 32 ANN ACM C HUM F, P2521, DOI [10.1145/2556288.2557353, DOI 10.1145/2556288.2557353]; Ballegaard SA, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1807; Bardram JE, 2008, METHOD INFORM MED, V47, P178, DOI 10.3414/ME9107; Bate P, 2006, QUAL SAF HEALTH CARE, V15, P307, DOI 10.1136/qshc.2005.016527; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Boyd-Graber J., 2006, P SIGCHI C HUM FACT, DOI DOI 10.1145/1124772.1124797; Brennan DM, 2008, J TELEMED TELECARE, V14, P55, DOI 10.1258/jtt.2007.007040; Buxton B., 2014, WORKSSH SIGCHI C HUM; Buxton B., 2010, SKETCHING USER EXPER; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Cole E., 2013, PATIENT CTR DESIGN C, P128; Conti M, 2012, PERVASIVE MOB COMPUT, V8, P2, DOI 10.1016/j.pmcj.2011.10.001; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; Dawson DR, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-306; de Faria Borges L.C.L., 2012, P 11 BRAZ S HUM FACT P 11 BRAZ S HUM FACT, P57; Friedman Batya, 2012, P CHI 12, P1145; Gagnon A, 2015, DISABIL REHABIL, P1, DOI 10.3109/09638288.2015.1044035; Geurts L, 2011, TEI 2011: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON TANGIBLE EMBEDDED AND EMBODIED INTERACTION, P117; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Halskov K., 2006, P 6 C DES INT SYST N, P2, DOI 10.1145/1142405.1142409; Harper R., 2008, BEING HUMAN HUMAN CO; Hill AJ, 2010, REPORT POTENTIAL APP, P14; Holleis P., 2009, THESIS, P193; Illich, 1973, TOOLS CONVIVIALITY; Lathan CE, 1999, TELEMED J, V5, P169, DOI 10.1089/107830299312131; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Lucero A., 2010, P 3 INT C FUN GAM FU, DOI 10.1145/1823818.1823821; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Mancini C, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P153; Martin DM, 2013, P 1 INT ACM SIGACCES, P1; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattelmaki T., 2005, CoDesign, V1, P83, DOI 10.1080/15719880500135821; McCue Michael, 2010, Phys Med Rehabil Clin N Am, V21, P195, DOI 10.1016/j.pmr.2009.07.005; Moraiti Argyro, 2015, P 9 INT C TANG EMB E, P387; Norman Donald A., 2004, EMOTIONAL DESIGN WHY; Orwat C, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-26; Pullin G, 2009, DESIGN MEETS DISABILITY, P1; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rogers Yvonne, 2002, P 4 C DES INT SYST P, P373; Rooksby J., 2014, P SIGCHI C HUMAN FAC, P1163, DOI [DOI 10.1145/2556288.2557039, 10.1145/2556288.2557039, https://doi.org/10.1145/2556288.2557039]; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sanders E., 2008, CODESIGN, V4, P5, DOI DOI 10.1080/15710880701875068; Sanders E.B. N., 2011, NORDES, P1; Sanders EBN., 2012, CONVIVIAL TOOLBOX GE; Sanders Elizabeth., 2002, INFORM DESIGN, P1; Sanders L., 2014, INTERACTIONS, V21, P24, DOI DOI 10.1145/2670616; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Solana J, 2015, IEEE J BIOMED HEALTH, V19, P124, DOI 10.1109/JBHI.2014.2354537; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Tator C, 2007, BURDEN NEUROLOGICAL, P59; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tost D, 2009, 2009 VIRTUAL REHABILITATION INTERNATIONAL CONFERENCE, P87, DOI 10.1109/ICVR.2009.5174211; van der Linden J., 2011, 2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth 2011), P609, DOI 10.4108/icst.pervasivehealth.2011.246040; Vines J, 2013, P SIGCHI C HUM FACT, DOI DOI 10.1145/2470654.2470716; Vourvopoulos A, 2014, P 11 C ADV COMP ENT, P1; Wilson S., 2012, P 12 PART DES C RES, V1, P51, DOI [DOI 10.1145/2347635.2347643, 10.1145/2347635.2347643]	67	12	12	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2017	12	3					244	261		10.3109/17483107.2015.1129457			18	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EO2NW	WOS:000396534200005	26746683				2022-02-06	
S	Jackson, EK		Seifert, R		Jackson, Edwin K.			Discovery and Roles of 2 ',3 '-cAMP in Biological Systems	NON-CANONICAL CYCLIC NUCLEOTIDES	Handbook of Experimental Pharmacology		English	Article; Book Chapter						2 ',3 '-cAMP; 2 '-AMP; 3 '-AMP; Adenosine; CNPase; mPTP	CAMP-ADENOSINE PATHWAY; SMOOTH-MUSCLE-CELL; 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; CYCLIC-AMP; MESSENGER-RNA; EXTRACELLULAR CAMP; ALKALINE-PHOSPHATASE; MONOPHOSPHATE CGMP	In 2009, investigators using ultra-performance liquid chromatography-tandem mass spectrometry to measure, by selected reaction monitoring, 3',5'-cAMP in the renal venous perfusate from isolated, perfused kidneys detected a large signal at the same m/ z transition (330 -> 136) as 3',5'-cAMP but at a different retention time. Follow-up experiments demonstrated that this signal was due to a positional isomer of 3',5'-cAMP, namely, 2',3'-cAMP. Soon thereafter, investigative teams reported the detection of 2',3'-cAMP and other 2',3'-cNMPs (2',3'-cGMP, 2',3'-cCMP, and 2',3'-cUMP) in biological systems ranging from bacteria to plants to animals to humans. Injury appears to be the major stimulus for the release of these unique noncanonical cNMPs, which likely are formed by the breakdown of RNA. In mammalian cells in culture, in intact rat and mouse kidneys, and in mouse brains in vivo, 2',3'-cAMP is metabolized to 2'-AMP and 3'-AMP; and these AMPs are subsequently converted to adenosine. In rat and mouse kidneys and mouse brains, injury releases 2',3'-cAMP, 2'-AMP, and 3'-AMP into the extracellular compartment; and in humans, traumatic brain injury is associated with large increases in 2',3'-cAMP, 2'-AMP, 3'-AMP, and adenosine in the cerebrospinal fluid. These findings motivate the extracellular 2',3'-cAMP-adenosine pathway hypothesis: intracellular production of 2',3'-cAMP! export of 2',3'-cAMP! extracellular metabolism of 2',3'-cAMP to 2'-AMP and 3'-AMP! extracellular metabolism of 2'-AMP and 3'-AMP to adenosine. Since 2',3'-cAMP has been shown to activate mitochondrial permeability transition pores (mPTPs) leading to apoptosis and necrosis and since adenosine is generally tissue protective, the extracellular 2',3'-cAMP-adenosine pathway may be a protective mechanism [i.e., removes 2',3'-cAMP (an intracellular toxin) and forms adenosine (a tissue protectant)]. This appears to be the case in the brain where deficiency in CNPase (the enzyme that metabolizes 2',3'-cAMP to 2-AMP) leads to increased susceptibility to brain injury and neurological diseases. Surprisingly, CNPase deficiency in the kidney actually protects against acute kidney injury, perhaps by preventing the formation of 2'-AMP (which turns out to be a renal vasoconstrictor) and by augmenting the mitophagy of damaged mitochondria. With regard to 2',3'-cNMPs and their downstream metabolites, there is no doubt much more to be discovered.	[Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 100 Technol Dr,Room 514, Pittsburgh, PA 15219 USA		Jackson, EK (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, 100 Technol Dr,Room 514, Pittsburgh, PA 15219 USA.	edj@pitt.edu		Jackson, Edwin/0000-0002-8101-6009			Akahane M, 2001, J RECONSTR MICROSURG, V17, P203, DOI 10.1055/s-2001-14352; Akahane M, 2001, J ORTHOP RES, V19, P559, DOI 10.1016/S0736-0266(00)00062-0; Alberts B, 1989, MOL BIOL CELL, P481; Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428; Almeida A, 2004, ANAL BIOCHEM, V328, P101, DOI 10.1016/j.ab.2004.02.004; AMRHEIN N, 1973, P NATL ACAD SCI USA, V70, P1099, DOI 10.1073/pnas.70.4.1099; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Bahre H, 2014, J CHROMATOGR B, V964, P208, DOI 10.1016/j.jchromb.2014.02.046; Banholzer R, 1997, MOL CELL BIOL, V17, P3254, DOI 10.1128/MCB.17.6.3254; Boadu E, 2001, BIOCHEM PHARMACOL, V62, P425, DOI 10.1016/S0006-2952(01)00682-7; Boison D, 2007, DRUG NEWS PERSPECT, V20, P607, DOI 10.1358/dnp.2007.20.10.1181353; Bordeleau E, 2014, BIOORG MED CHEM LETT, V24, P4520, DOI 10.1016/j.bmcl.2014.07.080; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Burhenne H, 2013, BMC PHARMACOL TOXICO, V14, pP12, DOI [10.1186/2050-6511-14-S1-P12, DOI 10.1186/2050-6511-14-S1-P12]; BUSHFIELD M, 1990, MOL PHARMACOL, V38, P848; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Cheng DM, 2010, CLIN EXP PHARMACOL P, V37, P205, DOI 10.1111/j.1440-1681.2009.05272.x; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Chiavegatti T, 2008, BRIT J PHARMACOL, V153, P1331, DOI 10.1038/sj.bjp.0707648; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Day YJ, 2005, AM J PHYSIOL-RENAL, V288, pF722, DOI 10.1152/ajprenal.00378.2004; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; del Prete MJ, 2002, FASEB J, V16, P2003, DOI 10.1096/fj.02-0392fje; DENATALE G, 1963, Arch Ital Sci Farmacol, V13, P169; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Dobolyi A, 2011, CURR TOP MED CHEM, V11, P1058, DOI 10.2174/156802611795347618; Duarte T, 2012, J PHARMACOL EXP THER, V341, P820, DOI 10.1124/jpet.112.192997; Dubey RK, 2010, J PHARMACOL EXP THER, V333, P808, DOI 10.1124/jpet.110.166371; Dubey RK, 2001, HYPERTENSION, V37, P1095, DOI 10.1161/01.HYP.37.4.1095; Dubey RK, 2000, HYPERTENSION, V35, P267, DOI 10.1161/01.HYP.35.1.267; Dubey RK, 1998, HYPERTENSION, V31, P296, DOI 10.1161/01.HYP.31.1.296; Dubey RK, 1996, HYPERTENSION, V28, P765, DOI 10.1161/01.HYP.28.5.765; Dubey RK, 2000, HYPERTENSION, V36, P337, DOI 10.1161/01.HYP.36.3.337; Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893; Eltzschig HK, 2013, J MOL MED, V91, P141, DOI 10.1007/s00109-013-0999-z; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; FERN R, 1994, J NEUROPHYSIOL, V72, P2609, DOI 10.1152/jn.1994.72.6.2609; FISZMAN ML, 1984, N-S ARCH PHARMACOL, V328, P148, DOI 10.1007/BF00512064; FLEMING WA, 1976, J CELL PHYSIOL, V88, P323, DOI 10.1002/jcp.1040880308; Forman MB, 2014, DIGEST DIS SCI, V59, P1; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; FUHR JE, 1980, J CELL PHYSIOL, V103, P71, DOI 10.1002/jcp.1041030111; Fujimori H, 1998, BIOL PHARM BULL, V21, P624; Fujimori H, 1998, BIOL PHARM BULL, V21, P1348; GARRISON JC, 1975, J BIOL CHEM, V250, P2769; Giron MC, 2008, GASTROENTEROLOGY, V134, P1116, DOI 10.1053/j.gastro.2008.01.030; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Gu H, 2013, P NATL ACAD SCI USA, V110, P13002, DOI 10.1073/pnas.1215086110; Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230; HARTZELL HC, 1979, J PHYSIOL-LONDON, V293, P23, DOI 10.1113/jphysiol.1979.sp012877; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af; Hendrich KS, 2001, CRIT CARE MED, V29, pA22; Hinman JD, 2008, GLIA, V56, P118, DOI 10.1002/glia.20595; Hong KW, 1999, AM J PHYSIOL-HEART C, V276, pH376, DOI 10.1152/ajpheart.1999.276.2.H376; ICHIKAWA A, 1980, J PHARMACOBIO-DYNAM, V3, P123, DOI 10.1248/bpb1978.3.123; Jackson EK, 2008, J PHARMACOL EXP THER, V325, P210, DOI 10.1124/jpet.107.134445; Jackson EK, 2007, J PHARMACOL EXP THER, V321, P810, DOI 10.1124/jpet.106.119057; Jackson EK, 2007, J PHARMACOL EXP THER, V321, P799, DOI 10.1124/jpet.106.119164; Jackson EK, 2016, J AM SOC NEPHROL, V27, P2069, DOI 10.1681/ASN.2015040397; Jackson EK, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.24; Jackson EK, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12028; Jackson EK, 2014, J PHARMACOL EXP THER, V350, P719, DOI 10.1124/jpet.114.216978; Jackson EK, 2014, AM J PHYSIOL-RENAL, V307, pF14, DOI 10.1152/ajprenal.00134.2014; Jackson EK, 2013, J PHARMACOL EXP THER, V346, P190, DOI 10.1124/jpet.113.205757; Jackson EK, 2013, AM J PHYSIOL-CELL PH, V304, pC406, DOI 10.1152/ajpcell.00212.2012; Jackson EK, 2013, AM J PHYSIOL-RENAL, V304, pF49, DOI 10.1152/ajprenal.00571.2012; Jackson EK, 2012, AM J PHYSIOL-RENAL, V303, pF954, DOI 10.1152/ajprenal.00335.2012; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF565, DOI 10.1152/ajprenal.00094.2011; Jackson EK, 2011, AM J PHYSIOL-HEART C, V301, pH391, DOI 10.1152/ajpheart.00336.2011; Jackson EK, 2011, J PHARMACOL EXP THER, V337, P444, DOI 10.1124/jpet.110.178137; Jackson EK, 2010, HYPERTENSION, V56, P151, DOI 10.1161/HYPERTENSIONAHA.110.152454; Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876; Jackson EK, 2006, J PHARMACOL EXP THER, V317, P1219, DOI 10.1124/jpet.106.101360; JACKSON EK, 1991, ANNU REV PHARMACOL, V31, P1; Jackson EK, 2004, DIS COLON RECTUM, V47, P1390, DOI 10.1007/s10350-004-0578-z; Jackson EK, 1997, J PHARMACOL EXP THER, V283, P177; Jackson EK, 2000, J PHARMACOL EXP THER, V295, P23; Jackson EK, 2003, J PHARMACOL EXP THER, V307, P888, DOI 10.1124/jpet.103.057166; Jia X, 2014, BIOMOLECULES, V4, P1070, DOI 10.3390/biom4041070; JOHNSON RA, 1989, MOL PHARMACOL, V35, P681; Kim M, 2009, KIDNEY INT, V75, P809, DOI 10.1038/ki.2008.699; Kimura T, 2001, SLEEP, V24, P251, DOI 10.1093/sleep/24.3.251; Kochanek P.M., 2013, ADENOSINE, P307, DOI [10.1007/978-1-4614-3903-5_, DOI 10.1007/978-1-4614-3903-5]; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kochanek PM, 2001, MO CL BI CC, P37; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kruh GD, 2001, J BIOENERG BIOMEMBR, V33, P493, DOI 10.1023/A:1012827221844; Kuzhikandathil EV, 2011, J BIOL CHEM, V286, P32454, DOI 10.1074/jbc.M111.268136; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee HT, 2007, KIDNEY INT, V71, P1249, DOI 10.1038/sj.ki.5002227; Lee HT, 2000, AM J PHYSIOL-RENAL, V278, pF380, DOI 10.1152/ajprenal.2000.278.3.F380; Lee HT, 2002, AM J PHYSIOL-RENAL, V282, pF844, DOI 10.1152/ajprenal.00195.2001; LEE KS, 1981, NEUROSCI LETT, V23, P309, DOI 10.1016/0304-3940(81)90016-1; MARANGOS PJ, 1990, PROG CLIN BIOL RES, V361, P331; MI ZC, 1994, LIFE SCI, V54, pPL277, DOI 10.1016/0024-3205(94)00846-9; Mi ZC, 1998, J PHARMACOL EXP THER, V287, P926; MI ZC, 1995, J PHARMACOL EXP THER, V273, P728; Miyamoto A, 2008, J TOXICOL SCI, V33, P209, DOI 10.2131/jts.33.209; Muller G, 2008, BIOCHEMISTRY-US, V47, P1259, DOI 10.1021/bi701413t; Nakane T, 1993, J PHARMACOL EXP THER, V264, P1253; Newell EA, 2015, BRAIN RES, V1594, P27, DOI 10.1016/j.brainres.2014.10.059; Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404, DOI 10.1152/ajprenal.1999.277.3.F404; Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809, DOI 10.1152/ajprenal.2000.279.5.F809; Okusa MD, 2001, KIDNEY INT, V59, P2114, DOI 10.1046/j.1523-1755.2001.0590062114.x; Okusa MD, 2002, AM J PHYSIOL-RENAL, V282, pF10, DOI 10.1152/ajprenal.2002.282.1.F10; OSHIMA N, 1986, COMP BIOCHEM PHYS C, V85, P89; Osycka-Salut C, 2014, MOL HUM REPROD, V20, P89, DOI 10.1093/molehr/gat053; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; Peters E, 2013, J PHARMACOL EXP THER, V344, P2, DOI 10.1124/jpet.112.198226; Phillis JW, 2001, NEUROL RES, V23, P183, DOI 10.1179/016164101101198316; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Ren J, 2009, J PHARMACOL EXP THER, V328, P855, DOI 10.1124/jpet.108.146712; Richards H, 2002, PHYTOCHEMISTRY, V61, P531, DOI 10.1016/S0031-9422(02)00266-2; Robertson CL, 1999, CRIT CARE MED, V27, pA38, DOI 10.1097/00003246-199912001-00061; Schmidt S, 1999, MULT SCLER J, V5, P147, DOI 10.1177/135245859900500303; Sciaraffia E, 2014, J LEUKOCYTE BIOL, V96, P113, DOI 10.1189/jlb.3A0513-302RR; Sokurenko YV, 2015, RUSS J BIOORG CHEM+, V41, P31, DOI 10.1134/S1068162015010136; Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207; Sorrentino S, 1997, FEBS LETT, V404, P1, DOI 10.1016/S0014-5793(97)00086-0; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Thauerer B, 2012, J NEUROCHEM, V121, P329, DOI 10.1111/j.1471-4159.2012.07692.x; THOMPSON JE, 1994, BIOCHEMISTRY-US, V33, P7408, DOI 10.1021/bi00189a047; THOMPSON RJ, 1992, BIOCHEM SOC T, V20, P621, DOI 10.1042/bst0200621; Vallon V, 2006, PHYSIOL REV, V86, P901, DOI 10.1152/physrev.00031.2005; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Van Damme T, 2014, PHYTOCHEMISTRY, V103, P59, DOI 10.1016/j.phytochem.2014.03.013; Van Damme T, 2012, J CHROMATOGR B, V909, P14, DOI 10.1016/j.jchromb.2012.10.002; Verrier JD, 2015, J PHARMACOL EXP THER, V354, P175, DOI 10.1124/jpet.115.225219; Verrier JD, 2013, GLIA, V61, P1595, DOI 10.1002/glia.22523; Verrier JD, 2012, J NEUROCHEM, V122, P115, DOI 10.1111/j.1471-4159.2012.07705.x; Verrier JD, 2011, J NEUROCHEM, V118, P979, DOI 10.1111/j.1471-4159.2011.07392.x; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; WAHN HL, 1975, SCIENCE, V188, P366, DOI 10.1126/science.164060; WHITFELD PR, 1955, BIOCHEM J, V60, P15, DOI 10.1042/bj0600015; Wieser GL, 2013, GLIA, V61, P869, DOI 10.1002/glia.22480; WILLEMOT J, 1981, N-S ARCH PHARMACOL, V317, P110, DOI 10.1007/BF00500064; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	148	12	12	0	4	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	0171-2004		978-3-319-52673-7; 978-3-319-52671-3	HANDB EXP PHARMACOL	Handb. Exp. Pharmacol.		2017	238						229	252		10.1007/164_2015_40	10.1007/978-3-319-52673-7		24	Pharmacology & Pharmacy	Book Citation Index – Science (BKCI-S)	Pharmacology & Pharmacy	BL8HE	WOS:000456339400013	26721674				2022-02-06	
J	Jamal, A; Sankhyan, N; Jayashree, M; Singhi, S; Singhi, P				Jamal, Atahar; Sankhyan, Naveen; Jayashree, Murlidharan; Singhi, Sunit; Singhi, Pratibha			Full Outline of Unresponsiveness score and the Glasgow Coma Scale in prediction of pediatric coma	WORLD JOURNAL OF EMERGENCY MEDICINE			English	Article						Altered sensorium; Neuro-intensive care; Neuro-monitoring; Neuroinfection; Tropical neurology	INTERRATER RELIABILITY; HEAD TRAUMA; CHILDREN; VALIDATION; MORTALITY; VALIDITY	BACKGROUND: This study was done to compare the admission Ful l Out l ine of Unresponsiveness (FOUR) score and Glasgow Coma Scale (GCS) as predictors of outcome in children with impaired consciousness. METHODS: In this observational study, children (5-12 years) with impaired consciousness of <7 days were included. Children with traumatic brain injury, on sedatives or neuromuscular blockade; with pre-existing cerebral palsy, mental retardation, degenerative brain disease, vision/ hearing impairment; and seizure within last 1 hour were excluded. Primary outcomes: comparison of area under curve (AUC) of receiver operating characteristic (ROC) curve for in-hospital mortality. Secondary outcomes: comparison of AUC of ROC curve for mortality and poor outcome on Pediatric Overall Performance Category Scale at 3 months. RESULTS: Of the 63 children, 20 died during hospital stay. AUC for in-hospital mortality for GCS was 0.83 (CI 0.7 to 0.9) and FOUR score was 0.8 (CI 0.7 to 0.9) [difference between areas -0.0250 (95% CI 0.0192 to 0.0692), Z statistic 1.109, P = 0.2674]. AUC for mortality at 3 months for GCS was 0.78 (CI 0.67 to 0.90) and FOUR score was 0.74 (CI 0.62 to 0.87) (P = 0.1102) and AUC for poor functional outcome for GCS was 0.82 (CI 0.72 to 0.93) and FOUR score was 0.79 (CI 0.68 to 0.9) (P = 0.2377), which were also comparable. Inter-rater reliability for GCS was 0.96 and for FOUR score 0.98. CONCLUSION: FOUR score was as good as GCS in prediction of in-hospital and 3-month mortality and functional outcome at 3 months. FOUR score had a good inter-rater reliability.	[Jamal, Atahar; Sankhyan, Naveen; Jayashree, Murlidharan; Singhi, Sunit; Singhi, Pratibha] Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India		Sankhyan, N (corresponding author), Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India.	drnsankhyan@yahoo.co.in	SANKHYAN, NAVEEN/AAP-6531-2021				Buyukcam F, 2012, ULUS TRAVMA ACIL CER, V18, P469, DOI 10.5505/tjtes.2012.23169; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Czaikowski BL, 2014, J NEUROSCI NURS, V46, P79, DOI 10.1097/JNN.0000000000000041; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Idrovo L, 2010, EUR NEUROL, V63, P364, DOI 10.1159/000292498; Khajeh A, 2014, IRAN J PEDIATR, V24, P603; Kochar GS, 2014, J CHILD NEUROL, V29, P1299, DOI 10.1177/0883073813514293; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2011, NEUROLOGY, V77, P84, DOI 10.1212/WNL.0b013e318220ac06; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2014, THE COMATOSE PATIENT, P89	13	12	17	0	5	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	SECOND AFFILIATED HOSPITAL, 88 JIEFANG RD, HANGZHOU, 310009, PEOPLES R CHINA	1920-8642			WORLD J EMERG MED	World J. Emerg. Med.		2017	8	1					55	60		10.5847/wjem.j.1920-8642.2017.01.010			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ER7AQ	WOS:000398962600010	28123622	Green Published			2022-02-06	
J	Kim, HJ; Han, SJ				Kim, Ho Jeong; Han, Soo Jeong			Anodal Transcranial Direct Current Stimulation Provokes Neuroplasticity in Repetitive Mild Traumatic Brain Injury in Rats	NEURAL PLASTICITY			English	Article							NONINVASIVE CORTICAL STIMULATION; MOUSE MODEL; IMPAIRMENT; MEMORY; MICE	Repetitive mild traumatic brain injury (rmTBI) provokes behavioral and cognitive changes. But the study about electrophysiologic findings and managements of rmTBI is limited. In this study, we investigate the effects of anodal transcranial direct current stimulation (tDCS) on rmTBI. Thirty-one Sprague Dawley rats were divided into the following groups: sham, rmTBI, and rmTBI treated by tDCS. Animals received closed head mTBI three consecutive times a day. Anodal tDCS was applied to the left motor cortex. We evaluated the motor-evoked potential (MEP) and the somatosensory- evoked potential (SEP). T2-weighted magnetic resonance imaging was performed 12 days after rmTBI. After rmTBI, the latency of MEP was prolonged and the amplitude in the right hind limb was reduced in the rmTBI group. The latency of SEP was delayed and the amplitude was decreased after rmTBI in the rmTBI group. In the tDCS group, the amplitude in both hind limbs was increased after tDCS in comparison with the values before rmTBI. Anodal tDCS after rmTBI seems to be a useful tool for promoting transient motor recovery through increasing the synchronicity of cortical firing, and it induces early recovery of consciousness. It can contribute to management of concussion in humans if further study is performed.	[Kim, Ho Jeong] Ewha Womans Univ, Med Ctr, Seonam Hosp, Dept Rehabil Med, Seoul, South Korea; [Han, Soo Jeong] Ewha Womans Univ, Dept Rehabil Med, Sch Med, Seoul, South Korea		Han, SJ (corresponding author), Ewha Womans Univ, Dept Rehabil Med, Sch Med, Seoul, South Korea.	ocrystal@ewha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF 2013R1A1A2059711]; Research Grant of the Alumni Chapters of the Medical College of Ewha Womans University	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF 2013R1A1A2059711) and Research Grant of the Alumni Chapters of the Medical College of Ewha Womans University in 2015. The authors would like to acknowledge Professor Dr. Hae Soo Koo for her expert work on pathology. Also, the authors are grateful for her advices on pathology.	Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Han KH, 2012, J KOREAN NEUROSURG S, V52, P32, DOI 10.3340/jkns.2012.52.1.32; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kim HJ, 2017, PEERJ, V5, DOI 10.7717/peerj.2818; Kim SJ, 2010, J KOREAN MED SCI, V25, P1499, DOI 10.3346/jkms.2010.25.10.1499; Limoa E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0688-2; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Monai H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11100; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rotenberg A, 2010, CLIN NEUROPHYSIOL, V121, P104, DOI 10.1016/j.clinph.2009.09.008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Wang QM, 2014, NEUROSCI LETT, V569, P6, DOI 10.1016/j.neulet.2014.03.011; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Yoon KJ, 2016, J NEUROL SCI, V362, P314, DOI 10.1016/j.jns.2016.02.005	26	12	13	1	7	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2017	2017								1372946	10.1155/2017/1372946			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB5WW	WOS:000406214000001	28770112	Green Published, Green Submitted, gold			2022-02-06	
S	Korbakis, G; Vespa, PM		Wijdicks, EFM; Kramer, AH		Korbakis, G.; Vespa, P. M.			Multimodal neurologic monitoring	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; NEAR-INFRARED SPECTROSCOPY; VENOUS OXYGEN-SATURATION; LASER-DOPPLER FLOWMETRY; INTENSIVE-CARE-UNIT; INTRACRANIAL-PRESSURE	Neurocritical care has two main objectives. Initially, the emphasis is on treatment of patients with acute damage to the central nervous system whether through infection, trauma, or hemorrhagic or ischemic stroke. Thereafter, attention shifts to the identification of secondary processes that may lead to further brain injury, including fever, seizures, and ischemia, among others. Multimodal monitoring is the concept of using various tools and data integration to understand brain physiology and guide therapeutic interventions to prevent secondary brain injury. This chapter will review the use of electroencephalography, intracranial pressure monitoring, brain tissue oxygenation, cerebral microdialysis and neurochemistry, near-infrared spectroscopy, and transcranial Doppler sonography as they relate to neuromonitoring in the critically ill. The concepts and design of each monitor, in addition to the patient population that may most benefit from each modality, will be discussed, along with the various tools that can be used together to guide individualized patient treatment options. Major clinical trials, observational studies, and their effect on clinical outcomes will be reviewed. The future of multimodal monitoring in the field of bioinformatics, clinical research, and device development will conclude the chapter.	[Korbakis, G.; Vespa, P. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Vespa, P. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 757 Westwood Blvd,RR UCLA 6236A, Los Angeles, CA 90095 USA.	Pvespa@mednet.ucla.edu					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bhatia R, 2007, J NEUROSURG ANESTH, V19, P97, DOI 10.1097/ANA.0b013e318031376d; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; Carrera E, 2009, NEUROSURGERY, V65, P316, DOI 10.1227/01.NEU.0000349209.69973.88; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen Jan, 2002, Curr Neurol Neurosci Rep, V2, P534, DOI 10.1007/s11910-002-0042-1; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Coplin WM, 1997, NEUROSURGERY, V41, P101, DOI 10.1097/00006123-199707000-00022; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; De Turck F, 2007, COMPUT BIOL MED, V37, P97, DOI 10.1016/j.compbiomed.2005.10.004; Deans KJ, 2010, ANESTH ANALG, V111, P444, DOI 10.1213/ane.0b013e3181aa8903; Dhar Rajat, 2015, Acta Neurochir Suppl, V120, P161, DOI 10.1007/978-3-319-04981-6_27; Diaz-Arrastia R, 2014, 12 ANN NEUR CAR SOC; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; Ekelund A, 1996, BRIT J NEUROSURG, V10, P19, DOI 10.1080/bjn.10.1.19; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gaspard N, 2014, EPILEPSIA, V55, P1366, DOI 10.1111/epi.12653; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Gollwitzer S, 2015, CLIN NEUROPHYSIOL, V126, P1514, DOI 10.1016/j.clinph.2014.10.215; Gonzalez NR, 2007, J NEUROSURG, V107, P1101, DOI 10.3171/JNS-07/12/1101; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hametner C, 2015, J CEREBR BLOOD F MET, V35, P1722, DOI 10.1038/jcbfm.2015.181; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Heran NS, 2004, CAN J NEUROL SCI, V31, P80, DOI 10.1017/S0317167100002870; Highton D, 2010, CURR OPIN ANESTHESIO, V23, P576, DOI 10.1097/ACO.0b013e32833e1536; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kinoshita K, 2010, J SURG RES, V162, P221, DOI 10.1016/j.jss.2009.06.009; KIRKPATRICK PJ, 1994, J NEUROL NEUROSUR PS, V57, P1382, DOI 10.1136/jnnp.57.11.1382; Knight WA, 2013, EPILEPSY RES, V106, P396, DOI 10.1016/j.eplepsyres.2013.06.018; Kruyt ND, 2009, STROKE, V40, pE424, DOI 10.1161/STROKEAHA.108.529974; Kurtz P, 2014, CRIT CARE, V18, DOI 10.1186/cc13857; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Li CY, 2012, BIOMED MICRODEVICES, V14, P759, DOI 10.1007/s10544-012-9646-7; Lin C-M, 2015, BIOMED RES INT, V2015; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Loov C, 2015, J NEUROTRAUM, V32, P244, DOI 10.1089/neu.2014.3517; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mazzeo AT, 2015, J NEUROTRAUMA; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Naidech AM, 2008, NEUROCRIT CARE, V9, P326, DOI 10.1007/s12028-008-9077-8; Narotam PK, 2014, J NEUROTRAUM, V31, P630, DOI 10.1089/neu.2013.3104; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nikaina I, 2012, J CRIT CARE, V27, P83, DOI 10.1016/j.jcrc.2011.04.004; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Obrenovitch TP, 1999, ANN NY ACAD SCI, V890, P273, DOI 10.1111/j.1749-6632.1999.tb08004.x; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Paraforou Theoniki, 2011, BMC Res Notes, V4, P540, DOI 10.1186/1756-0500-4-540; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Ramakrishna R, 2008, J NEUROSURG, V109, P1075, DOI 10.3171/JNS.2008.109.12.1075; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rots ML, 2016, NEUROCRIT CARE, V24, P207, DOI 10.1007/s12028-015-0205-y; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Shannon RJ, 2013, J PHARMACOKINET PHAR, V40, P343, DOI 10.1007/s10928-013-9306-4; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Sorani MD, 2007, NEUROCRIT CARE, V7, P45, DOI 10.1007/s12028-007-0043-7; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Springborg JB, 2005, BRIT J ANAESTH, V94, P259, DOI 10.1093/bja/aei004; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; Woitzik J, 2014, STROKE, V45, P1183, DOI 10.1161/STROKEAHA.113.004475; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1996, ACT NEUR S, V67, P40; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	135	12	12	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						91	105		10.1016/B978-0-444-63600-3.00006-4			15	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500008	28187816				2022-02-06	
J	Kuhn, AW; Zuckerman, SL; Solomon, GS; Casson, IR; Viano, DC				Kuhn, Andrew W.; Zuckerman, Scott L.; Solomon, Gary S.; Casson, Ira R.; Viano, David C.			Interrelationships Among Neuroimaging Biomarkers, Neuropsychological Test Data, and Symptom Reporting in a Cohort of Retired National Football League Players	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						sport-related concussion; National Football League; chronic impairment; neuroimaging; neuroradiology; neuropsychological testing; cognitive function	CHRONIC TRAUMATIC ENCEPHALOPATHY; CAVUM SEPTI PELLUCIDI; HIGH-SCHOOL FOOTBALL; CEREBRAL MICROBLEEDS; BRAIN-INJURY; NFL PLAYERS; CONCUSSION HISTORY; AMATEUR BOXERS; LATER-LIFE; PREVALENCE	Background: Structural brain changes, potentially resulting from repetitive brain trauma (RBT), have been correlated with neurocognitive decline and increased symptom reporting in retired athletes. Hypothesis: In a cohort of retired National Football League (NFL) players, the relationships between 3 neuroimaging parameters, neuropsychological testing, and symptom scores will be significantly correlated. Study Design: Cross-sectional study. Level of Evidence: Level 3. Methods: Comprehensive magnetic resonance imaging was performed in 45 retired NFL players. Three neuroanatomical parameters were assessed by board-certified radiologists blinded to the purpose of the study: (1) the absence or presence of small or large cavum septum pellucidum, (2) a global mean score of fractional anisotropy (FA), and (3) the presence or absence of microhemorrhages. The subjects underwent a battery of 9 paper-and-pencil neuropsychological tests, a computerized neurocognitive test, and multiple symptom and depression scales. The associations among the neuroimaging results with these outcome measures were assessed utilizing Pearson, Spearman rank, and point-biserial correlations. Results: The 45 subjects (mean age, 46.7 +/- 9.1 years) reported a mean 6.9 (+/-6.2) concussions and 13.0 (+/-7.9) "dings" in the NFL. Ten (22%) did not have a cavum septum pellucidum, while 32 (71%) had a small and 3 (7%) had a large one. Four (9%) had microhemorrhages. Global FA mean was 0.459 (+/-0.035). The majority (50.8%) of correlations among the neuroimaging parameters and neurocognitive/symptom scores fell below the threshold of "small" effect size (r < 0.10). The remaining (49.2%) correlations were between "small" and "medium" effect sizes (0.1 < r < 0.3). However, all correlations were statistically nonsignificant. Conclusion: There were minimal and statistically nonsignificant correlations among the neuroimaging, neurocognitive, and symptom scores examined in this cohort of NFL retirees. Clinical Relevance: Associating the severity of structural brain changes to neurocognitive performance and symptom burden after RBT is complex may involve other moderating variables or biomarkers, and demands further study.	[Kuhn, Andrew W.; Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Casson, Ira R.] Hofstra North Shore LIJ Sch Med, Dept Neurol, Hempstead, NY USA; [Viano, David C.] ProBiomechanics LLC, Bloomfield Hills, MI USA; [Viano, David C.] Wayne State Univ, Dept Biomed Engn & Radiol, Detroit, MI USA		Solomon, GS (corresponding author), Neurosurg Clin, 1500 21st Ave South,Suite 1506, Nashville, TN 37232 USA.	gary.s.solomon@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Solomon, Gary/K-9011-2019	Kuhn, Andrew W/0000-0003-1836-7575; 	National Football League (NFL)	Examinations of the NFL retirees were funded by the National Football League (NFL) and coordinated with the NFL Players Association (NFLPA).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; [Anonymous], 2013, IBM SPSS STAT COMP P; Antonius D, 2014, J NEUROPSYCH CLIN N, V26, P313, DOI 10.1176/appi.neuropsych.13090201; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Cohen J., 2013, STAT POWER ANAL BEHA; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DeLamielleure J, 2014, J LAW MED ETHICS, V42, P133, DOI 10.1111/jlme.12127; Delis D.C., 2000, CALIFORNIA VERBAL LE; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Finke J, 1968, Dtsch Z Nervenheilkd, V193, P154; Folstein M.F., 2001, MINIMENTAL STATE EXA; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kim MJ, 2007, BIPOLAR DISORD, V9, P274, DOI 10.1111/j.1399-5618.2007.00442.x; Kirsch W, 2009, J ALZHEIMERS DIS, V17, P599, DOI 10.3233/JAD-2009-1073; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Korngold C, 2013, J AM ACAD PSYCHIATRY, V41, P430; LARROCHE JC, 1961, BIOL NEONATORUM, V3, P193; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Lezak M, 2004, CONTROLLED WORD ASS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2007, PACT 2007 6 0 CLIN I; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Maroon JC, 2015, NEUROLOGY, V85, P1007, DOI 10.1212/WNL.0000000000001942; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; NAKANO S, 1981, J COMPUT ASSIST TOMO, V5, P348, DOI 10.1097/00004728-198106000-00006; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Partington JE, 1949, PSYCHOL SERV CTR B, V1, P9; Pauling KJ, 1998, PEDIATR NEUROL, V19, P195, DOI 10.1016/S0887-8994(98)00040-X; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rajarethinam R, 2001, SCHIZOPHR RES, V48, P201, DOI 10.1016/S0920-9964(00)00110-9; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; SCHUNK H, 1963, RADIOLOGY, V81, P610, DOI 10.1148/81.4.610; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Solomon GS, 2014, PHYSICIAN SPORTSMED, V42, P26, DOI 10.3810/psm.2014.09.2072; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Terry DP, 2015, ARCH CLIN NEUROPSYCH, V30, P341, DOI 10.1093/arclin/acv020; THIEFFRY S, 1958, ACTA RADIOL, V50, P242, DOI 10.3109/00016925809171092; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tsushima Y, 2002, NEURORADIOLOGY, V44, P31, DOI 10.1007/s002340100649; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT	78	12	12	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2017	9	1					30	40		10.1177/1941738116674006			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8DW	WOS:000391287000004	30043690	Green Published			2022-02-06	
J	Li, D; Liu, N; Zhao, L; Tong, L; Kawano, H; Yan, HJ; Li, HP				Li, Dan; Liu, Nan; Zhao, Liang; Tong, Lei; Kawano, Hitoshi; Yan, Hong-Jing; Li, Hong-Peng			Protective effect of resveratrol against nigrostriatal pathway injury in striatum via JNK pathway	BRAIN RESEARCH			English	Article						Resveratrol; Nigrostriatal pathway injury; JNK pathway; Apoptosis; Inflammation	TRAUMATIC BRAIN-INJURY; CEREBELLAR GRANULE NEURONS; MAP KINASES; RED WINE; TRANS-RESVERATROL; IN-VITRO; APOPTOSIS; CELLS; P38; NEUROPROTECTION	Nigrostriatal pathway injury is one of the traumatic brain injury models that usually lead to neurological dysfunction or neuron necrosis. Resveratrol-induced benefits have recently been demonstrated in several models of neuronal degeneration diseases. However, the protective properties of resveratrol against neurodegeneration have not been explored definitely. Thus, we employ the nigrostriatal pathway injury model to mimic the insults on the brain. Resveratrol decreased the p-ERK expression and increased the p-JNK expression compared to the DMSO group, but not alter the p38 MAPK proteins around the lesion site by Western blot. Prior to the injury, mice were infused with resveratrol intracerebroventricularly with or without JNK-IN-8, a specific c-JNK pathway inhibitor for JNK1, JNK2 and JNK4. The study assessed modified improved neurological function score (mNSS) and beam/walking test, the level of inflammatory cytokines IL-1 beta, IL-6 and TNF-alpha, and striatal expression of Bax and Bcl-2 proteins associated with neuronal apoptosis. The results revealed that resveratrol exerted a neuroprotective effect as shown by the improved mNSS and beam latency, anti-inflammatory effects as indicated by the decreased level of IL-1 beta, TNF-alpha and IL-6. Furthermore, resveratrol up-regulated the protein expression of p-JNK and Bcl-2, down-regulated the expression of Bax and the number of Fluoro-Jade C (FJC) positive neurons. However, these advantages of resveratrol were abolished by JNK-IN-8 treatment. Overall, we demonstrated that resveratrol treatment attenuates the nigrostriatal pathway injury-induced neuronal apoptosis and inflammation via activation of c-JNK signaling.	[Li, Dan; Liu, Nan; Zhao, Liang; Tong, Lei; Yan, Hong-Jing; Li, Hong-Peng] China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Peoples R China; [Kawano, Hitoshi] Teikyo Helsei Univ, Fac Hlth & Med Sci, Dept Hlth & Dietet, Tokyo 1708445, Japan		Li, HP (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Peoples R China.	377317599@qq.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [NSFC-81171248]	This research was supported by National Natural Science Foundation of China (NSFC), Hong-Peng Li (Grants No: NSFC-81171248).	Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bastianetto S, 2015, BBA-MOL BASIS DIS, V1852, P1195, DOI 10.1016/j.bbadis.2014.09.011; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Bramanti V, 2010, NEUROCHEM RES, V35, P2070, DOI 10.1007/s11064-010-0256-6; Chang Y, 2009, NEUROCHEM INT, V54, P135, DOI 10.1016/j.neuint.2008.11.001; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115694; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen XH, 2009, BIOCHEM BIOPH RES CO, V379, P944, DOI 10.1016/j.bbrc.2008.12.177; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Gao DK, 2014, MOL MED REP, V9, P2197, DOI 10.3892/mmr.2014.2086; Giordano G, 2008, NEUROCHEM INT, V52, P1100, DOI 10.1016/j.neuint.2007.11.004; Gweon EJ, 2014, ONCOL REP, V32, P71, DOI 10.3892/or.2014.3192; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Inoue H, 2000, J BIOL CHEM, V275, P28028; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kawano H, 2005, J NEUROSCI RES, V80, P191, DOI 10.1002/jnr.20441; Kutuk O, 2006, TOXICOL SCI, V90, P120, DOI 10.1093/toxsci/kfj055; Lin HY, 2011, ANN NY ACAD SCI, V1215, P79, DOI 10.1111/j.1749-6632.2010.05846.x; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Lu KT, 2006, J AGR FOOD CHEM, V54, P3126, DOI [10.1021/jf053011q, 10.1021/JF053011Q]; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Morris-Blanco KC, 2014, J CEREBR BLOOD F MET, V34, P1024, DOI 10.1038/jcbfm.2014.51; Mundy WR, 2006, NEUROTOXICOLOGY, V27, P71, DOI 10.1016/j.neuro.2005.07.007; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Rigolio R, 2005, NEUROCHEM INT, V46, P205, DOI 10.1016/j.neuint.2004.11.001; Rubins HB, 2001, CIRCULATION, V103, P2828; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; Shigematsu S, 2003, FREE RADICAL BIO MED, V34, P810, DOI 10.1016/S0891-5849(02)01430-2; Shin JA, 2010, J NEUROIMMUNOL, V227, P93, DOI 10.1016/j.jneuroim.2010.06.017; Simao F, 2012, EUR J NEUROSCI, V36, P2899, DOI 10.1111/j.1460-9568.2012.08229.x; Singh N, 2013, ACS CHEM NEUROSCI, V4, P1151, DOI 10.1021/cn400094w; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Soleas GJ, 1997, J CLIN LAB ANAL, V11, P287, DOI 10.1002/(SICI)1098-2825(1997)11:5<287::AID-JCLA6>3.0.CO;2-4; Song J, 2014, INT J MOL SCI, V15, P15512, DOI 10.3390/ijms150915512; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Tang BL, 2010, BRAIN RES BULL, V81, P359, DOI 10.1016/j.brainresbull.2009.12.007; Torres G, 2011, NEUROSCIENCE, V179, P32, DOI 10.1016/j.neuroscience.2011.01.036; Virgili M, 2000, NEUROSCI LETT, V281, P123, DOI 10.1016/S0304-3940(00)00820-X; Wu XP, 2015, ACTA PHARMACOL SIN, V36, P353, DOI 10.1038/aps.2014.132; Yoshioka N, 2010, J COMP NEUROL, V518, P3867, DOI 10.1002/cne.22431; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhao Y, 2012, J NANOTECHNOL, V2012, P1, DOI DOI 10.1186/1741-7015-10-3]	47	12	16	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 1	2017	1654		A				1	8		10.1016/j.brainres.2016.10.013			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EG0SO	WOS:000390742700001	27769789				2022-02-06	
J	Li, XH; Chen, C; Yang, XP; Wang, JJ; Zhao, ML; Sun, HT; Zhang, S; Tu, Y				Li, Xiaohong; Chen, Chong; Yang, Xiping; Wang, Jingjing; Zhao, Ming-liang; Sun, Hongtao; Zhang, Sai; Tu, Yue			Acupuncture Improved Neurological Recovery after Traumatic Brain Injury by Activating BDNF/TrkB Pathway	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							NEUROTROPHIC FACTOR; STEM-CELLS; NEUROPROTECTION; NEUROGENESIS; STIMULATION; COMBINATION; EXPRESSION; RECEPTOR	How to promote neural repair following traumatic brain injury (TBI) has long been an intractable problem. Although acupuncture has been demonstrated to facilitate the neurological recovery, the underlying mechanism is elusive. Brain-derived neurotrophic factor (BDNF) exerts substantial protective effects for neurological disorders. In this study, we found that the level of BDNF and tropomyosin receptor kinase B (TrkB) was elevated spontaneously after TBI and reached up to the peak at 12 h. Nevertheless, this enhancement is quickly declined to the normal at 48 h. After combined stimulation at the acupoints of Baihui, Renzhong, Hegu, and Zusanli, we found that BDNF and TrkB were still significantly elevated at 168 h. We also observed that the downstream molecular p-Akt and p-Erk1/2 were significantly increased, suggesting that acupuncture could persistently activate the BDNF/TrkB pathway. To further verify that acupuncture improved recovery through activating BDNF/TrkB pathway, K252a (specific inhibitor of TrkB) was treated by injection stereotaxically into lateral ventricle. We observed that K252a could significantly prevent the acupuncture-induced amelioration of motor, sensation, cognition, and synaptic plasticity. These data indicated that acupuncture promoted the recovery of neurological impairment after TBI by activating BDNF/TrkB signaling pathway, providing new molecular mechanism for understanding traditional therapy of acupuncture.	[Li, Xiaohong; Chen, Chong; Yang, Xiping; Wang, Jingjing; Zhao, Ming-liang; Sun, Hongtao; Zhang, Sai; Tu, Yue] Logist Univ Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Pingjin Hosp, Tianjin 300162, Peoples R China; [Li, Xiaohong; Chen, Chong; Yang, Xiping; Wang, Jingjing; Zhao, Ming-liang; Sun, Hongtao; Zhang, Sai; Tu, Yue] Key Lab Neurotrauma Repair Tianjin, Tianjin 300162, Peoples R China		Zhang, S; Tu, Y (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Pingjin Hosp, Tianjin 300162, Peoples R China.; Zhang, S; Tu, Y (corresponding author), Key Lab Neurotrauma Repair Tianjin, Tianjin 300162, Peoples R China.	zhangsai718@vip.126.com; ytumail@vip.126.com			National Nature Scientific Fund of China [81301050, 81401067, 81271392, 81471275, 81541034]; National Nature Scientific Fund of Tianjin [14JCQNJC10200, 15JCQNJC11100, 16JCYBJC27600]	This work was supported by the National Nature Scientific Fund of China (81301050, 81401067, 81271392, 81471275, and 81541034) and the National Nature Scientific Fund of Tianjin (14JCQNJC10200, 15JCQNJC11100, and 16JCYBJC27600).	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Berthet C, 2012, CEREBROVASC DIS, V34, P329, DOI 10.1159/000343657; Chen C, 2014, NEUROSCIENCE, V257, P1, DOI 10.1016/j.neuroscience.2013.10.056; Chohan MO, 2015, NEUROSURGERY, V76, P201, DOI 10.1227/NEU.0000000000000577; Cook D. J., 2016, J CEREBRAL BLOOD FLO; De Santi L, 2009, J NEUROL SCI, V287, P17, DOI 10.1016/j.jns.2009.08.057; Feng R, 2014, AFR J TRADIT COMPLEM, V11, P25, DOI 10.4314/ajtcam.v11i3.5; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Jiang ST, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2047412; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kochanek PM, 2016, LANCET NEUROL, V15, P13, DOI 10.1016/S1474-4422(15)00339-7; Kramar EA, 2012, NEUROBIOL AGING, V33, P708, DOI 10.1016/j.neurobiolaging.2010.06.008; Lang SB, 2007, J NEUROSCI, V27, P1097, DOI 10.1523/JNEUROSCI.3590-06.2007; Li F, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0656-x; Li XH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.180; Li XH, 2013, MOL NEUROBIOL, V48, P490, DOI 10.1007/s12035-013-8437-3; Li XH, 2012, NEUROBIOL AGING, V33, P1400, DOI 10.1016/j.neurobiolaging.2011.02.003; Lin RH, 2016, MOL MED REP, V13, P1611, DOI 10.3892/mmr.2015.4751; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Nam MH, 2013, INT REV NEUROBIOL, V111, P67, DOI 10.1016/B978-0-12-411545-3.00004-3; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Park JW, 2014, BIOCHEM BIOPH RES CO, V447, P400, DOI 10.1016/j.bbrc.2014.03.145; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Shi GX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17981; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Tian T, 2016, SCI REP-UK, V6, DOI 10.1038/srep19714; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wattanathorn J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/937601; Watzlawick R, 2016, JAMA NEUROL, V73, P149, DOI 10.1001/jamaneurol.2015.3627; Xu Q, 2015, NEUROSCI LETT, V588, P88, DOI 10.1016/j.neulet.2014.12.057; Yamada K, 2004, DRUG NEWS PERSPECT, V17, P435, DOI 10.1358/dnp.2004.17.7.863702; Yu JS, 2013, INT REV NEUROBIOL, V111, P125, DOI 10.1016/B978-0-12-411545-3.00006-7; Zhao Zengqiang, 2015, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V35, P10, DOI 10.7606/j.issn.1000-4025.2015.01.0010	35	12	16	5	20	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2017	2017								8460145	10.1155/2017/8460145			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	EK8YY	WOS:000394211900001	28243312	Green Submitted, Green Published, gold			2022-02-06	
J	Lind, MJ; Brown, E; Farrell-Carnahan, L; Brown, RC; Hawn, S; Berenz, E; McDonald, S; Pickett, T; Danielson, CK; Thomas, S; Amstadter, AB				Lind, Mackenzie J.; Brown, Emily; Farrell-Carnahan, Leah; Brown, Ruth C.; Hawn, Sage; Berenz, Erin; McDonald, Scott; Pickett, Treven; Danielson, Carla Kmett; Thomas, Suzanne; Amstadter, Ananda B.			Sleep Disturbances in OEF/OIF/OND Veterans: Associations with PTSD, Personality, and Coping	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						combat; coping; personality; PTSD; sleep; trauma; veterans	POSTTRAUMATIC-STRESS-DISORDER; REM-SLEEP; MILITARY PERSONNEL; QUALITY INDEX; SYMPTOMS; INSOMNIA; RESILIENCE; VALIDATION; MOTIVES; MODEL	Study Objectives: Sleep disturbances are well documented in relation to trauma exposure and posttraumatic stress disorder (PTSD), but correlates of such disturbances remain understudied in veteran populations. We conducted a preliminary study of sleep disturbances in Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn veterans (n = 133; mean [standard deviation] age = 29.8 [4.7] y). Methods: Veterans were assigned to one of three groups based on responses to the Clinician Administered PTSD Scale: control (no trauma-exposure [TE] or PTSD), TE, and PTSD. Sleep disturbance was assessed using the Pittsburgh Sleep Quality Index (PSQI). Measures of resilience, trauma load, personality, coping, alcohol use, and mild traumatic brain injury were also assessed via self-report. Results: The PTSD group had significantly more disturbed sleep (PSQI global score mean = 8.94, standard deviation = 3.12) than control (mean = 5.27, standard deviation = 3.23) and TE (mean = 5.34, standard deviation = 3.17) groups, but there were no differences between TE and control. The same pattern emerged across most PSQI subscales. Results of linear regression analyses indicated that current smoking, Army (versus other military branches), neuroticism, and using substances to cope were all significant correlates of higher sleep disturbance, whereas post-deployment social support was associated with less sleep disturbance. However, when combined together into a model with PTSD status, only neuroticism and substance use coping remained significant as predictors of more disturbed sleep. Conclusions: These initial findings suggest that TE itself may not be an independent risk factor for disturbed sleep in veterans, and that neurotic personality and a tendency to cope by using substances may partially explain sleep disturbance, above and beyond a diagnosis of PTSD.	[Lind, Mackenzie J.; Brown, Emily; Brown, Ruth C.; Hawn, Sage; Amstadter, Ananda B.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, 800 E Leigh St,Biotech One,POB 980126, Richmond, VA 23298 USA; [Farrell-Carnahan, Leah; McDonald, Scott; Pickett, Treven] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Hawn, Sage; McDonald, Scott; Pickett, Treven; Amstadter, Ananda B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Berenz, Erin] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [McDonald, Scott; Pickett, Treven] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Danielson, Carla Kmett; Thomas, Suzanne] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA		Amstadter, AB (corresponding author), Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, 800 E Leigh St,Biotech One,POB 980126, Richmond, VA 23298 USA.	abamstadter@vcu.edu		Lind, Mackenzie/0000-0001-5105-2423	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AA020179, K02 AA023239, T32 MH020030]; VA RRD [1Ik2RX000703-01]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH020030] Funding Source: NIH RePORTER	The Virginia Commonwealth University IRB approved all study procedures. This work was supported in part by NIH grants R01 AA020179 and K02 AA023239 to Ananda B. Amstadter. Mackenzie J. Lind is supported by NIH grant T32 MH020030. Scott McDonald has received grant and/or research support from VA RR&D (1Ik2RX000703-01). The authors have indicated no financial conflicts of interest.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Babson KA, 2012, J TRAUMA STRESS, V25, P665, DOI 10.1002/jts.21757; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Blake D. D., 1998, CLIN ADMINISTERED PT; Boland EM, 2015, PSYCHIAT CLIN N AM, V38, P761, DOI 10.1016/j.psc.2015.07.005; Bonn-Miller MO, 2010, J DUAL DIAGN, V6, P111, DOI 10.1080/15504261003751887; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Costa P. T., 1989, NEO PI NEO FFI MAN S; Duggan KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090628; Edinger JD, 2016, SLEEP, V39, P237, DOI 10.5665/sleep.5356; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Hintsanen M, 2014, HEALTH PSYCHOL, V33, P1214, DOI 10.1037/hea0000105; Ho FYY, 2016, CLIN PSYCHOL REV, V43, P90, DOI 10.1016/j.cpr.2015.09.005; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King D. W., 2003, MANUAL DEPLOYMENT RI; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Malouff JM, 2005, J PSYCHOPATHOL BEHAV, V27, P101, DOI 10.1007/s10862-005-5384-y; McCrae Robert R., 2008, HDB PERSONALITY THEO, DOI DOI 10.3905/JPE.2000.319978; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Mellman TA, 2007, J TRAUMA STRESS, V20, P893, DOI 10.1002/jts.20246; Morin CM, 2013, SLEEP MED CLIN, V8, P281, DOI 10.1016/j.jsmc.2013.05.002; Nicassio PM, 2014, BEHAV SLEEP MED, V12, P1, DOI 10.1080/15402002.2012.720315; Nishith P, 2001, J TRAUMA STRESS, V14, P469, DOI 10.1023/A:1011152405048; Pace-Schott EF, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0018-9; Pietrzak RH, 2010, J PSYCHOSOM RES, V69, P441, DOI 10.1016/j.jpsychores.2010.07.002; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Roehrs TA, 2015, PSYCHIAT CLIN N AM, V38, P793, DOI 10.1016/j.psc.2015.07.008; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Vandrey R, 2014, INT REV PSYCHIATR, V26, P237, DOI 10.3109/09540261.2014.901300; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845; Wright KM, 2002, MIL MED, V167, P853, DOI 10.1093/milmed/167.10.853; Zillig LMP, 2002, PERS SOC PSYCHOL B, V28, P847, DOI 10.1177/0146167202289013	47	12	12	1	24	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.		2017	13	2					291	299		10.5664/jcsm.6466			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EP0AI	WOS:000397048800020	27998375	Green Published, Bronze			2022-02-06	
J	Mason, S; Kuczawski, M; Teare, MD; Stevenson, M; Goodacre, S; Ramlakhan, S; Morris, F; Rothwell, J				Mason, Suzanne; Kuczawski, Maxine; Teare, M. Dawn; Stevenson, Matt; Goodacre, Steve; Ramlakhan, Shammi; Morris, Francis; Rothwell, Joanne			AHEAD Study: an observational study of the management of anticoagulated patients who suffer head injury	BMJ OPEN			English	Article						Warfarin	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; CLOPIDOGREL USE; RISK; RULE; CT	Objectives Management of anticoagulated patients after head injury is unclear due to lack of robust evidence. This study aimed to determine the adverse outcome rate in these patients and identify risk factors associated with poor outcome. Design Multicentre, observational study using routine patient records. Setting 33 emergency departments in England and Scotland. Participants 3566 adults (aged 16years) who had suffered blunt head injury and were currently taking warfarin. Main outcome measures Primary outcome measure was rate of adverse outcome defined as death or neurosurgery following initial injury, clinically significant CT scan finding or reattendance with related complication within 10weeks of initial hospital attendance. Secondary objectives included identifying risk factors for adverse outcome using univariable and multivariable analyses. Results Clinical data available for 3534/3566 patients (99.1%), median age 79years; mean initial international normalised ratio (INR) 2.67 (SD 1.34); 81.2% Glasgow Coma Scale (GCS) 15: 59.8% received a CT scan with significant head injury-related finding in 5.4% (n=208); 0.5% underwent neurosurgery; 1.2% patients suffered a head injury-related death. Overall adverse outcome rate was 5.9% (95% CI 5.2% to 6.7%). Patients with GCS=15 and no associated symptoms had lowest risk of adverse outcome (risk 2.7%; 95% CI 2.1 to 3.6). Patients with GCS=15 multivariable analysis (using imputation) found risk of adverse outcome to increase when reporting at least one associated symptom: vomiting (relative risk (RR) 1.8; 95% CI 1.0 to 3.4), amnesia (RR 3.5; 95% CI 2.1 to 5.7), headache (RR 1.3; 95% CI 0.8 to 2.2), loss of consciousness (RR 1.75; 95% CI 1.0 to 3.0). INR measurement did not predict adverse outcome in patients with GCS=15 (RR 1.1; 95% CI 1.0 to 1.2). Conclusions In alert warfarinised patients following head injury, the presence of symptoms is associated with greater risk of adverse outcome. Those with GCS=15 and no symptoms are a substantial group and have a low risk of adverse outcome.	[Mason, Suzanne; Kuczawski, Maxine; Teare, M. Dawn; Stevenson, Matt; Goodacre, Steve; Rothwell, Joanne] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Ramlakhan, Shammi; Morris, Francis] Northern Gen Hosp, Emergency Dept, Sheffield, S Yorkshire, England		Mason, S (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	s.mason@sheffield.ac.uk	Ramlakhan, Shammi/ABD-5794-2020	Ramlakhan, Shammi/0000-0003-1792-0842; Teare, Marion Dawn/0000-0003-3994-0051; Mason, Suzanne/0000-0002-1701-0577; Kuczawski, Maxine/0000-0002-0774-8113	National Institute for Health Research (NIHR) under Research for Patient Benefit (RfPB) ProgrammeNational Institute for Health Research (NIHR) [PB-PG-0808-17148]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [MS-013-008-102] Funding Source: researchfish	This paper presents independent research commissioned by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme grant reference number PB-PG-0808-17148.	Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Batchelor JS, 2014, J TRAUMA, V16, P108, DOI [10.1177/1460408614525731, DOI 10.1177/1460408614525731]; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P1787, DOI 10.1136/jnnp.2004.041384; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Hanlon Dennis, 2011, Emerg Med Pract, V13, P1; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Leiblich A, 2011, EMERG MED J, V28, P115, DOI 10.1136/emj.2009.079442; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Morris F, 2014, MINOR INJURY ILLNESS, P25; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; National Institute for Health and Care Excellence, 2013, ANT THER COMM GUID C; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Rendell S, 2013, EMERG MED J, V30, P28, DOI 10.1136/emermed-2011-200176; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; The Information Centre for Health and Social Care, 2015, ACC EM ATT ENGL 2011; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	31	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JAN	2017	7	1							e014324	10.1136/bmjopen-2016-014324			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM8VX	WOS:000395590300172	28087556	Green Published, Green Accepted, gold			2022-02-06	
J	Nyholm, L; Howells, T; Lewen, A; Hillered, L; Enblad, P				Nyholm, Lena; Howells, Tim; Lewen, Anders; Hillered, Lars; Enblad, Per			The influence of hyperthermia on intracranial pressure, cerebral oximetry and cerebral metabolism in traumatic brain injury	UPSALA JOURNAL OF MEDICAL SCIENCES			English	Article						Cerebral oximetry; hyperthermia; ICP; microdialysis; traumatic brain injury	NEUROINTENSIVE CARE; INTRACEREBRAL MICRODIALYSIS; HEAD-INJURY; TEMPERATURE; OXYGENATION; REACTIVITY; FREQUENCY; IMPACT	Background: Hyperthermia is a common secondary insult in traumatic brain injury (TBI). The aim was to evaluate the relationship between hyperthermia and intracranial pressure (ICP), and if intracranial compliance and cerebral blood flow (CBF) pressure autoregulation affected that relationship. The relationships between hyperthermia and cerebral oximetry (B(ti)pO(2)) and cerebral metabolism were also studied. Methods: A computerized multimodality monitoring system was used for data collection at the neurointensive care unit. Demographic and monitoring data (temperature, ICP, blood pressure, microdialysis, B(ti)pO(2)) were analyzed from 87 consecutive TBI patients. ICP amplitude was used as measure of compliance, and CBF pressure autoregulation status was calculated using collected blood pressure and ICP values. Mixed models and comparison between groups were used. Results: The influence of hyperthermia on intracranial dynamics (ICP, brain energy metabolism, and B(ti)pO(2)) was small, but individual differences were seen. Linear mixed models showed that hyperthermia raises ICP slightly more when temperature increases in the groups with low compliance and impaired CBF pressure autoregulation. There was also a tendency (not statistically significant) for increased B(ti)pO(2), and for increased pyruvate and lactate, with higher temperature, while the lactate/pyruvate ratio and glucose were stable. Conclusions: The major finding was that the effects of hyperthermia on intracranial dynamics (ICP, brain energy metabolism, and B(ti)pO(2)) were not extensive in general, but there were exceptional cases. Hyperthermia treatment has many side effects, so it is desirable to identify cases in which hyperthermia is dangerous. Information from multimodality monitoring may be used to guide treatment in individual patients.	[Nyholm, Lena; Howells, Tim; Lewen, Anders; Hillered, Lars; Enblad, Per] Uppsala Univ Hosp, Dept Neurosci Neurosurg, SE-75185 Uppsala, Sweden		Nyholm, L (corresponding author), Uppsala Univ Hosp, Dept Neurosci Neurosurg, SE-75185 Uppsala, Sweden.	Lena.nyholm@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348	Uppsala County Council/Uppsala University Hospital (ALF); Swedish Research CouncilSwedish Research CouncilEuropean Commission; Selander Foundation	The study was financially supported by the Uppsala County Council/Uppsala University Hospital (ALF), the Swedish Research Council, and the Selander Foundation.	Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Boron WF., 2012, MED PHYSL; Citerio G, 2008, NEUROSURGERY, V63, P1152, DOI 10.1227/01.NEU.0000335148.87042.D7; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Edvinsson L., 1993, CEREBRAL BLOOD FLOW; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hillered L, 2008, CRIT CARE MED, V36, P2952, DOI 10.1097/CCM.0b013e3181872178; Hocker SE, 2013, JAMA NEUROL, V70, P1499, DOI 10.1001/jamaneurol.2013.4354; Howells T, 1995, J NEUROTRAUMA, V12; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Mcilvoy L, 2012, AACN ADV CRIT CARE, V23, P204, DOI 10.1097/NCI.0b013e31824db1c6; Mcllvoy L., 2007, J NEUROSCI NURS, V39, P324; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Nyholm L, 2012, ISRN NEUROL, V2012; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Oh HS, 2012, INT J NURS PRACT, V18, P295, DOI 10.1111/j.1440-172X.2012.02039.x; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Purins K, 2010, ACTA NEUROCHIR, V152, P681, DOI 10.1007/s00701-009-0532-x; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Siesj? BK., 1978, BRAIN ENERGY METABOL; Smielewski P, 2010, P 14 INT C INTR PRES; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Spiotta AM, 2008, NEUROSURGERY, V62, P864, DOI 10.1227/01.neu.0000316900.63124.ce; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Ziljstra WG., 1981, CEREBRAL BLOOD FLOW, V7	43	12	13	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-9734	2000-1967		UPSALA J MED SCI	Ups. J. Med. Sci.		2017	122	3					177	184		10.1080/03009734.2017.1319440			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FL3FH	WOS:000414107800004	28463046	Green Published, gold			2022-02-06	
J	Phelps, TI; Bondi, CO; Mattiola, VV; Kline, AE				Phelps, Thomas I.; Bondi, Corina O.; Mattiola, Vincent V.; Kline, Anthony E.			Relative to Typical Antipsychotic Drugs, Aripiprazole Is a Safer Alternative for Alleviating Behavioral Disturbances After Experimental Brain Trauma	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						agitation; cognition; environmental enrichment; neurological rehabilitation; spatial learning; receptor; serotonin; 5-HT1A; receptor; dopamine; D-2	ENVIRONMENTAL ENRICHMENT; PREFRONTAL CORTEX; TREATMENT REGIMEN; MOTOR RECOVERY; UNITED-STATES; DOPAMINE D2; INJURY; HALOPERIDOL; AGITATION; RISPERIDONE	Background. Antipsychotic drugs (APDs) are used to manage traumatic brain injury (TBI)-induced behavioral disturbances, such as agitation and aggression. However, APDs exhibiting D-2 receptor antagonism impede cognitive recovery after experimental TBI. Hence, empirical evaluation of APDs with different mechanistic actions is warranted. Aripiprazole (ARIP) is a D-2 and 5-hydroxytryptamine(1A) (5-HT1A) receptor agonist; pharmacotherapies with these properties enhance cognition after TBI. Objective. To test the hypothesis that ARIP would increase behavioral performance and decrease histopathology after TBI. Methods. Adult male rats were subjected to either a controlled cortical impact (CCI) or sham injury and then randomly assigned to ARIP (0.1 or 1.0 mg/kg) or VEH (1.0 mL/kg, saline vehicle) groups. Treatments began 24 hours after surgery and were administered once daily for 19 days. Motor (beam-balance/beam-walk) and cognitive (Morris water maze) performance was assessed on postoperative days 1 to 5 and 14 to 19, respectively, followed by quantification of hippocampal CA(1,3) neuron survival and cortical lesion volume. Results. Beam-balance was significantly improved in the CCI + ARIP (1.0 mg/kg) group versus CCI + ARIP (0.1 mg/kg) and CCI + VEH (P < .05). Spatial learning and memory retention were significantly improved in the CCI + ARIP (0.1 mg/kg) group versus the CCI + ARIP (1.0 mg/kg) and CCI + VEH groups (P < .05). Both doses of ARIP reduced lesion size and CA(3) cell loss versus VEH (P < .05). Importantly, neither dose of ARIP impeded functional recovery as previously reported with other APDs. Conclusion. These findings support the hypothesis and endorse ARIP as a safer APD for alleviating behavioral disturbances after TBI.	[Phelps, Thomas I.; Bondi, Corina O.; Mattiola, Vincent V.; Kline, Anthony E.] Univ Pittsburgh, Pittsburgh, PA USA; [Phelps, Thomas I.] Case Western MetroHlth Med Ctr, Cleveland, OH USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS084967, NS060005, HD069620, HD069620-S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005, R01NS084967] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported, in part, by National Institutes of Health grants NS084967, NS060005, HD069620, and HD069620-S1 (AEK).	Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Goozee R, 2016, SCHIZOPHR RES, V173, P174, DOI 10.1016/j.schres.2015.02.023; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Huang GB, 2012, NEUROSCI LETT, V528, P131, DOI 10.1016/j.neulet.2012.09.024; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Levy M, 2005, NEUROREHABILITATION, V20, P279; Li Z, 2004, EUR J PHARMACOL, V493, P75, DOI 10.1016/j.ejphar.2004.04.028; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Maat A, 2014, EUR NEUROPSYCHOPHARM, V24, P575, DOI 10.1016/j.euroneuro.2013.12.009; Matsuda Y, 2014, PSYCHIAT CLIN NEUROS, V68, P425, DOI 10.1111/pcn.12147; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Olsen AS, J NEUROTRAUMA; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tanahashi S, 2012, NEUROPHARMACOLOGY, V62, P765, DOI 10.1016/j.neuropharm.2011.08.031; Ukai W, 2004, J NEURAL TRANSM, V111, P667, DOI 10.1007/s00702-004-0109-z; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Wood M, EXPERT OPIN INVESTIG, P2; Yeh CB, 2014, NORD J PSYCHIAT, V68, P219, DOI 10.3109/08039488.2013.799228	56	12	12	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2017	31	1					25	33		10.1177/1545968316650281			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG2BG	WOS:000390846800002	27225976	Bronze, Green Accepted			2022-02-06	
J	Powell, JM; Wise, EK; Brockway, JA; Fraser, R; Temkin, N; Bell, KR				Powell, Janet M.; Wise, Elizabeth K.; Brockway, Jo Ann; Fraser, Robert; Temkin, Nancy; Bell, Kathleen R.			Characteristics and Concerns of Caregivers of Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; caregivers; problem solving; telehealth; telemedicine	FAMILY CAREGIVERS; HEAD-INJURY; LIFE SATISFACTION; SUPPORT NEEDS; RELATIVES; COMMUNITY; BURDEN	Objective: To describe the characteristics of caregivers of adults with traumatic brain injury (TBI) and their concerns in the first months after community discharge of the TBI survivor. Design: Secondary analysis of data collected during a parallel-group randomized controlled trial. Setting: Community. Participants: A total of 153 consecutively enrolled caregivers of adults with moderate to severe TBI discharged to the community following acute and/or rehabilitation care at a Level I trauma center with 71 caregivers in the treatment group identifying concerns as part of the intervention procedures. Main Measures: Caregiver demographics, caregiver-survivor relationship characteristics, caregiver activity changes, and concerns targeted by caregivers for education and problem-solving via biweekly phone calls. Results: Thirty-nine percent of caregivers were spouses and 35% parents. Sixty-five percent lived in the same house as the survivor preinjury with 86% in touch daily to several times per week. Concerns targeted by more than one-third of caregivers related to managing their emotional adjustment, strategies for getting things done, managing survivor emotions and behaviors, and engaging in healthful habits. Conclusions: Caregivers of TBI survivors targeted personal concerns relating to their own emotional adjustment and participation as well as concerns relating to symptoms and recovery of the TBI survivor to address through education and problem-solving.	[Powell, Janet M.] Univ Washington, Dept Rehabil Med, Div Occupat Therapy, Box 356490, Seattle, WA 98195 USA; [Brockway, Jo Ann; Fraser, Robert] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fraser, Robert] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Fraser, Robert; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wise, Elizabeth K.] Bonner Gen Hlth, Sandpoint, ID USA; [Bell, Kathleen R.] Univ Texas Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA		Powell, JM (corresponding author), Univ Washington, Dept Rehabil Med, Div Occupat Therapy, Box 356490, Seattle, WA 98195 USA.	jmpowell@uw.edu		Bell, Kathleen/0000-0002-0928-2046	Department of Education, National Institute on Disability and Rehabilitation Research, TBI Model Systems: University of Washington Traumatic Brain Injury Model System [H133A070032]	This study was funded by the Department of Education, National Institute on Disability and Rehabilitation Research, TBI Model Systems: University of Washington Traumatic Brain Injury Model System H133A070032.	BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cameron JI, 2008, PATIENT EDUC COUNS, V70, P305, DOI 10.1016/j.pec.2007.10.020; Campbell C H, 1988, Rehabil Nurs, V13, P320; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Engli M, 1993, J Neurosci Nurs, V25, P78; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Inzaghi M G, 2005, Eura Medicophys, V41, P265; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Manskow US, J HEAD TRAUMA REHABI; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Panting A, 1972, REHABILITATION, V38, P33; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	29	12	12	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					E33	E41		10.1097/HTR.0000000000000219			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400011	27022956				2022-02-06	
J	Reches, A; Kutcher, J; Elbin, RJ; Or-Ly, H; Sadeh, B; Greer, J; McAllister, DJ; Geva, A; Kontos, AP				Reches, A.; Kutcher, J.; Elbin, R. J.; Or-Ly, H.; Sadeh, B.; Greer, J.; McAllister, D. J.; Geva, A.; Kontos, A. P.			Preliminary investigation of Brain Network Activation (BNA) and its clinical utility in sport-related concussion	BRAIN INJURY			English	Article						Concussion management; sports-related concussion (SRC); mild traumatic brain injury (mTBI); event related potential (ERP); functional brain imaging; Brain Network Activation (BNA); electroencephalogram (EEG)	STATES HIGH-SCHOOL; INJURY; EPIDEMIOLOGY; CONNECTIVITY; ATTENTION; RECOVERY; ERPS	Background: The clinical diagnosis and management of patients with sport-related concussion is largely dependent on subjectively reported symptoms, clinical examinations, cognitive, balance, vestibular and oculomotor testing. Consequently, there is an unmet need for objective assessment tools that can identify the injury from a physiological perspective and add an important layer of information to the clinician's decision-making process.Objective: The goal of the study was to evaluate the clinical utility of the EEG-based tool named Brain Network Activation (BNA) as a longitudinal assessment method of brain function in the management of young athletes with concussion.Methods: Athletes with concussion (n = 86) and age-matched controls (n = 81) were evaluated at four time points with symptom questionnaires and BNA. BNA scores were calculated by comparing functional networks to a previously defined normative reference brain network model to the same cognitive task.Results: Subjects above 16 years of age exhibited a significant decrease in BNA scores immediately following injury, as well as notable changes in functional network activity, relative to the controls. Three representative case studies of the tested population are discussed in detail, to demonstrate the clinical utility of BNA.Conclusion: The data support the utility of BNA to augment clinical examinations, symptoms and additional tests by providing an effective method for evaluating objective electrophysiological changes associated with sport-related concussions.	[Reches, A.; Or-Ly, H.; Sadeh, B.; Geva, A.] ElMindA Ltd, 16 Haminhara St, Herzliyya, Israel; [Kutcher, J.; Greer, J.] Univ Michigan, Sports Neurol Clin, Ann Arbor, MI 48109 USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [McAllister, D. J.; Kontos, A. P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA		Reches, A (corresponding author), ElMindA Ltd, 16 Haminhara St, Herzliyya, Israel.	amit@elminda.com		Kontos, Anthony/0000-0002-3749-4310; Geva, Amir/0000-0003-3159-3673	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; ElMindA Ltd; University of MichiganUniversity of Michigan System; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by grants to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) and through a research contract between ElMindA Ltd on the one hand and both the University of Pittsburgh and the University of Michigan on the other. A. Reches, H. Ol-Ly, B. Sadeh and A. Geva are employees of ElmindA Ltd.	Rojas-Benjumea MA, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0067-7; Bonala BK, 2012, J INTEGR NEUROSCI, V11, P277, DOI 10.1142/S0219635212500215; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Hillyard S. A., 1994, COGNITIVE ELECTROPHY, P1, DOI DOI 10.1007/978-1-4612-0283-7_1; Hogan AM, 2005, DEVELOPMENTAL SCI, V8, P525, DOI 10.1111/j.1467-7687.2005.00444.x; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kiefer AW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00243; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lee TW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-121; Lovell MR, 2000, NEUROLOGICAL ATHLETI; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Mueller V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-18; Polich J., 1999, ELECTROEN CLIN NEURO, P1073; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Reches A, 2015, EUROPEAN J PAIN, V11, P22; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Wang HM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00064	40	12	12	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					237	246		10.1080/02699052.2016.1231343			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500012	28055228	Green Published, hybrid			2022-02-06	
J	Sashika, H; Takada, K; Kikuchi, N				Sashika, Hironobu; Takada, Kaoruko; Kikuchi, Naohisa			Rehabilitation needs and participation restriction in patients with cognitive disorder in the chronic phase of traumatic brain injury	MEDICINE			English	Article						psychosocial problems; qualitative research; quality of life; rehabilitation; social participation; traumatic brain injury	JAPANESE	The purpose of this study was to clarify psychosocial factors/problems, social participation, quality of life (QOL), and rehabilitation needs in chronic-phase traumatic brain injury (TBI) patients with cognitive disorder discharged from the level-1 trauma center (L1-TC), and to inspect the effects of rehabilitation intervention to these subjects. A mixed-method research (cross-sectional and qualitative study) was conducted at an outpatient rehabilitation department. Inclusion criteria of subjects were transfer to the L1-TC due to TBI; acute-stage rehabilitation treatment received in the L1-TC from November 2006 to October 2011; age of >= 18 and < 70 years at the time of injury; a score of 0-3 on the Modified Rankin Scale at discharge and that of 4-5 due to physical or severe aggressive behavioral comorbid disorders. Study details were sent, via mail, to 84 suitable candidates, of whom 36 replied. Thirty-one subjects (median age: 33.4 years; male: 17; and average time since injury: 48.1 months), who had consented to study participation, were participated. Cognitive function, social participation, QOL, psychosocial factors/problems, rehabilitation needs, and chronic-phase rehabilitation outcomes were evaluated using the Wechsler Adult Intelligence Scale, Third Edition, the Wechsler Memory Scale-Revised, the Zung Self-Rating Depression Scale, the Sydney Psychosocial Reintegration Scale, Version 2, and the Short Form 36, Version 2, qualitative analysis of semistructured interviews, etc. Participants were classified into achieved-social-participation (n= 11; employed: 8), difficult-social-participation (n= 12; unemployed: 8), and no-cognitive-dysfunction groups (n= 8; no social participation restriction). Relative to the achieved-socialparticipation group, the difficult-social-participation group showed greater injury and cognitive dysfunction and lower Sydney Psychosocial Reintegration Scale and Short Form 36 role/social component summary scores (64.9/49.1 vs 44.3/30.4, respectively, P< 0.05). Linear regression analysis showed that the social participation status was greatly affected by the later cognitive disorders and psychosocial factors/problems not by the severity of TBI. No changes were observed in these scores following chronic-phase rehabilitation intervention. Chronic-phase TBI with cognitive disorder led to rehabilitation needs, and improvement of subjects' psychosocial problems and QOL was difficult.	[Sashika, Hironobu] Yokohama City Univ, Assoc Med Sci, Grad Sch Med, Dept Rehabil Med,Kanazawa Ward, Yokohama, Kanagawa, Japan; [Takada, Kaoruko] Yokohama City Univ, Grad Sch Med, Kanazawa Ward, Yokohama, Kanagawa, Japan; [Kikuchi, Naohisa] Yokohama City Univ, Assoc Med Sci, Med Ctr, Dept Rehabil Med,Minami Ward, Yokohama, Kanagawa, Japan		Sashika, H (corresponding author), Yokohama City Univ, Assoc Med Sci, Grad Sch Med, Dept Rehabil Med, Yokohama, Kanagawa, Japan.	s3024@urahp.yokohama-cu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [24500599]	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology: "A qualitative study of rehabilitation needs and participation restriction of chronic-phase subjects with cognitive disorder due to traumatic brain injury" (2012-2014), Project Number: 24500599.	BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Bushnik T, 2000, LEVEL COGNITIVE FUNC; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Creswell JW, BEST PRACTICES MIXED; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Frieden TR, REPORTED C REPORT C; Frieden TR, 2010, TRAUMATIC BRAIN INJU; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Fukuhara S., 2004, MANUAL SF 36V2 JAPAN; Kinoshita, 2003, PRACTICE MODIFIED GR; Kubo Y, 2007, SOGO RIHABIRITESHON, V35, P921; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Ohira T, 2001, STROKE, V32, P903, DOI 10.1161/01.STR.32.4.903; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Shimura K., 2005, B SOCIAL WELFARE DEP, V5, P46; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Tate RL, MANUAL SYDNEY PSYCHO; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Watanabe Syu, 2009, JAPANESE J REHABILIT, V46, P118; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	25	12	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2017	96	4							e5968	10.1097/MD.0000000000005968			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EK1WT	WOS:000393717200037	28121947	Green Published, gold			2022-02-06	
J	Stone, S; Lee, B; Garrison, JC; Blueitt, D; Creed, K				Stone, Sarah; Lee, Bobby; Garrison, J. Craig; Blueitt, Damond; Creed, Kalyssa			Sex Differences in Time to Return-to-Play Progression After Sport-Related Concussion	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; sex; return-to-play progression	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; GENDER-DIFFERENCES; CLINICAL ARTICLE; SOCCER PLAYERS; SYMPTOMS; RECOVERY; EPIDEMIOLOGY	Background: Recently, female sports participation has increased, and there is a tendency for women to experience more symptoms and variable presentation after sport-related concussion (SRC). The purpose of this study was to determine whether sex differences exist in time to begin a return-to-play (RTP) progression after an initial SRC. Hypothesis: After initial SRC, female athletes (11-20 years old) would take longer to begin an RTP progression compared with age-matched male athletes. Study Design: Retrospective cohort study. Level of Evidence: Level 3. Methods: A total of 579 participants (365 males [mean age, 15.0 +/- 1.7 years], 214 females [mean age, 15.2 +/- 1.5 years]), including middle school, high school, and collegiate athletes who participated in various sports and experienced an initial SRC were included and underwent retrospective chart review. The following information was collected: sex, age at injury, sport, history of prior concussion, date of injury, and date of initiation of RTP progression. Participants with a history of more than 1 concussion or injury sustained from non-sport-related activity were excluded. Results: Despite American football having the greatest percentage (49.2%) of sport participation, female athletes took significantly longer to start an RTP progression after an initial SRC (29.1 +/- 26.3 days) compared with age-matched male athletes (22.7 +/- 18.3 days; P = 0.002). Conclusion: On average, female athletes took approximately 6 days longer to begin an RTP progression compared with age-matched male athletes. This suggests that sex differences exist between athletes, aged 11 to 20 years, with regard to initiation of an RTP progression after SRC. Clinical Relevance: Female athletes may take longer to recover after an SRC, and therefore, may take longer to return to sport. Sex should be considered as part of the clinical decision-making process when determining plan of care for this population.	[Stone, Sarah; Lee, Bobby; Garrison, J. Craig; Creed, Kalyssa] Texas Hlth Ben Hogan Sports Med, 800 5th Ave,Suite 150, Ft Worth, TX 76104 USA; [Blueitt, Damond] Texas Hlth Ben Hogan Concuss Ctr, Ft Worth, TX USA		Stone, S (corresponding author), Texas Hlth Ben Hogan Sports Med, 800 5th Ave,Suite 150, Ft Worth, TX 76104 USA.	sarahstone@texashealth.org					Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bloom GA, 2008, EUR J SPORT SCI, V8, P295, DOI 10.1080/17461390802251836; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	25	12	12	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2017	9	1					41	44		10.1177/1941738116672184			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8DW	WOS:000391287000005	27697890	Green Published			2022-02-06	
J	Tu, TW; Lescher, JD; Williams, RA; Jikaria, N; Turtzo, LC; Frank, JA				Tu, Tsang-Wei; Lescher, Jacob D.; Williams, Rashida A.; Jikaria, Neekita; Turtzo, L. Christine; Frank, Joseph A.			Abnormal Injury Response in Spontaneous Mild Ventriculomegaly Wistar Rat Brains: A Pathological Correlation Study of Diffusion Tensor and Magnetization Transfer Imaging in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; DTI; model of injury; rats; TBI	NEONATAL HYDROCEPHALUS; CORPUS-CALLOSUM; REACTIVE ASTROCYTOSIS; INFLAMMATION; EDEMA; MODEL; PATHOPHYSIOLOGY; AQUAPORIN-4; DYSGENESIS; AGENESIS	Spontaneous mild ventriculomegaly (MVM) was previously reported in similar to 43% of Wistar rats in association with vascular anomalies without phenotypic manifestation. This mild traumatic brain injury (TBI) weight drop model study investigates whether MVM rats (n = 15) have different injury responses that could inadvertently complicate the interpretation of imaging studies compared with normal rats (n = 15). Quantitative MRI, including diffusion tensor imaging (DTI) and magnetization transfer imaging (MTI), and immunohistochemistry (IHC) analysis were used to examine the injury pattern up to 8 days post-injury in MVM and normal rats. Prior to injury, the MVM brain showed significant higher mean diffusivity, axial diffusivity, and radial diffusivity, and lower fractional anisotropy (FA) and magnetization transfer ratio (MTR) in the corpus callosum than normal brain (p < 0.05). Following TBI, normal brains exhibited significant decreases of FA in the corpus callosum, whereas MVM brains demonstrated insignificant changes in FA, suggesting less axonal injury. At day 8 after mild TBI, MTR of the normal brains significantly decreased whereas the MTR of the MVM brains significantly increased. IHC staining substantiated the MRI findings, demonstrating limited axonal injury with significant increase of microgliosis and astrogliosis in MVM brain compared with normal animals. The radiological-pathological correlation data showed that both DTI and MTI were sensitive in detecting mild diffuse brain injury, although DTI metrics were more specific in correlating with histologically identified pathologies. Compared with the higher correlation levels reflecting axonal injury pathology in the normal rat mild TBI, the DTI and MTR metrics were more affected by the increased inflammation in the MVM rat mild TBI. Because MVM Wistar rats appear normal, there was a need to screen rats prior to TBI research to rule out the presence of ventriculomegaly, which may complicate the interpretation of imaging and IHC observations.	[Tu, Tsang-Wei; Lescher, Jacob D.; Williams, Rashida A.; Jikaria, Neekita; Frank, Joseph A.] NIH, Ctr Clin, Frank Lab Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Turtzo, L. Christine] NIH, Acute Studies Core, Natl Inst Neurol Disorders & Stroke, Bldg 10, Bethesda, MD 20892 USA; [Frank, Joseph A.] NIH, Natl Inst Biomed Imaging & Bioengn, Bldg 10, Bethesda, MD 20892 USA		Tu, TW (corresponding author), NIH, Radiol & Imaging Sci, Ctr Clin, USA Bldg 10,RM B1N256,10 Ctr Dr,MSC 1074, Bethesda, MD 20892 USA.	tut@cc.nih.gov	Frank, Joseph/W-2021-2019; frank, joseph/AAJ-6680-2020		Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation) [300604-8.01-60855, 305500-8.01-60855]; Intramural Research Programs of the Clinical Center at the National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); CLINICAL CENTER [ZIACL090020] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Defense through the Center for Neuroscience and Regenerative Medicine (Henry M. Jackson Foundation Awards #300604-8.01-60855 and #305500-8.01-60855) and from the Intramural Research Programs of the Clinical Center and of the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health.	Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Couzin-Frankel J, 2013, SCIENCE, V342, P922, DOI 10.1126/science.342.6161.922; Del Bigio MR, 2001, NEUROSURG CLIN N AM, V12, P639, DOI 10.1016/S1042-3680(18)30022-6; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Irfanoglu MO, 2008, LECT NOTES COMPUT SC, V5242, P1014, DOI 10.1007/978-3-540-85990-1_122; Jain-Ghai S, 2014, PEDIATRICS, V133, pE1092, DOI 10.1542/peds.2013-1230; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kacew S, 1996, J TOXICOL ENV HEALTH, V47, P1; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kuroiwa T, 2006, ACTA NEUROCHIR SUPPL, V96, P254; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Noguchi R, 2014, ARCH GYNECOL OBSTET, V290, P237, DOI 10.1007/s00404-014-3196-6; Oh KY, 2012, J ULTRAS MED, V31, P1811, DOI 10.7863/jum.2012.31.11.1811; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Schell-Apacik CC, 2008, AM J MED GENET A, V146A, P2501, DOI 10.1002/ajmg.a.32476; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070; Tu T., 2013, J NEUROSCI NEUROENG, V2, P415; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; YOSHIDA Y, 1990, Neurologia Medico-Chirurgica, V30, P445, DOI 10.2176/nmc.30.445	37	12	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					248	256		10.1089/neu.2015.4355			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100026	26905805	Green Published			2022-02-06	
J	Turner, RW; Lucas, JW; Margolis, LH; Corwell, BN				Turner, Robert W.; Lucas, Jeffery W.; Margolis, Lewis H.; Corwell, Brian N.			A preliminary study of youth sport concussions: Parents' health literacy and knowledge of return-to-play protocol criteria	BRAIN INJURY			English	Article						Youth sports; parents; education; concussion literacy; return-to-play	SCHOOL FOOTBALL PLAYERS; CHILDREN; BEHAVIOR; COACHES; INJURY	Primary objective: To preliminarily explore parents' health literacy and knowledge of youth sport league rules involving concussion education and training, and return-to-play protocols. Research design and methods: This study was guided by the Knowledge, Attitude and Prattice (KAP) model Of health knowledge to examine parents' concussion literacy, and understanding of concussion education and training, and return-to-play protocols in, youth sports. The mixed-method design involved 119 participants; that included in-person (n=8) and telephone (n=4) interviews, and web-based surveys administered through Mechanical Turk via Qualtrics (n=98). Main outcomes and results: Most respondents were not familiar with concussion protocols, but trusted coaches' knowledge in return-to-play rules. More than half of the respondents report that the return-to play concussion criteria have not been clearly explained to them. The majority of respondents were not familiar with the CDC's Heads Up' online concussion training programme, nor were they familiar with any other educational/training. tool. About one-fifth of the parents had conversations with a coach or medical staff about youth sport concussions. Conclusion: Parents have a general understanding of how to identify concussion symptoms, but lack knowledge of immediate steps to take following an incident other than seeking medical help.	[Turner, Robert W.] Duke Univ, Social Sci Res Inst, Ctr Biobehav Hlth Dispar Res, Box 90420, Durham, NC 27708 USA; [Lucas, Jeffery W.] Univ Maryland, Dept Sociol, College Pk, MD 20742 USA; [Margolis, Lewis H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA; [Corwell, Brian N.] Univ Maryland, Sch Med, Emergency Med, Baltimore, MD 21201 USA		Turner, RW (corresponding author), Duke Univ, Social Sci Res Inst, Ctr Biobehav Hlth Dispar Res, Box 90420, Durham, NC 27708 USA.	rwt13@duke.edu		Turner, Robert Winston/0000-0003-4229-7087	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG054762, P30AG015281] Funding Source: NIH RePORTER		Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; [Anonymous], 2015, NCSL NAT C STAT LEG; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Bernard H.R., 2011, RES METHODS ANTHR QU, V5th; CDC, 2015, HEADS UP YOUTH SPORT; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; DeNavas-Walt C, 2015, CURR POP REP INC POV; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Fricker R., 2008, SAGE HDB ONLINE RES, P195; Gorden R., 1998, BASIC INTERVIEWING S; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lin AC, 2015, ASSESSMENT PARENTAL; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Turocy Paula Sammarone, 2002, J Athl Train, V37, pS162; Verhagen EALM, 2010, SPORTS MED, V40, P899, DOI 10.2165/11536890-000000000-00000; Zemper ED, 2010, BRIT J SPORT MED, V44, P13, DOI 10.1136/bjsm.2009.069096; [No title captured]	31	12	12	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	8					1124	1130		10.1080/02699052.2017.1298003			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FC3JI	WOS:000406734500013	28506094	Green Accepted			2022-02-06	
J	Worthen-Chaudhari, L; McGonigal, J; Logan, K; Bockbrader, MA; Yeates, KO; Mysiw, WJ				Worthen-Chaudhari, Lise; McGonigal, Jane; Logan, Kelsey; Bockbrader, Marcia A.; Yeates, Keith O.; Mysiw, W. Jerry			Reducing concussion symptoms among teenage youth: Evaluation of a mobile health app	BRAIN INJURY			English	Article						Rehabilitation; intervention; children; concussion; mobile health; gaming	TRAUMATIC-BRAIN-INJURY; ECOLOGICAL MOMENTARY ASSESSMENT; SPORTS-RELATED CONCUSSION; STUDIES DEPRESSION SCALE; LIFE ORIENTATION TEST; HIGH-SCHOOL; RECOVERY; ADOLESCENTS; CHILDREN; ANXIETY	Objective: To evaluate whether a mobile health application that employs elements of social game design could compliment medical care for unresolved concussion symptoms.Design: Phase I and Phase II (open-label, non-randomized, ecological momentary assessment methodology).Setting: Outpatient concussion clinic.Participants: Youth, aged 13-18 years, with concussion symptoms 3+ weeks after injury; Phase I: n = 20; Phase II: n = 19.Interventions: Participants received standard of care for concussion. The experimental group also used a mobile health application as a gamified symptoms journal.Outcome measures: Phase I: feasibility and satisfaction with intervention (7-point Likert scale, 1 high). Phase II: change in SCAT-3 concussion symptoms (primary), depression and optimism.Results: Phase 1: A plurality of participants completed the intervention (14 of 20) with high use (110 +/- 18% play) and satisfaction (median +/- interquartile range (IQR) = 2.0+/- 0.0). Phase II: Groups were equivalent on baseline symptoms, intervention duration, gender distribution, days since injury and medication prescription. Symptoms and optimism improved more for the experimental than for the active control cohort (U = 18.5, p = 0.028, effect size r = 0.50 and U = 18.5, p = 0.028, effect size r = 0.51, respectively).Conclusions: Mobile apps incorporating social game mechanics and a heroic narrative may promote health management among teenagers with unresolved concussion symptoms.	[Worthen-Chaudhari, Lise; Bockbrader, Marcia A.; Mysiw, W. Jerry] Ohio State Univ, Dept Phys Med, Columbus, OH 43210 USA; [Worthen-Chaudhari, Lise; Bockbrader, Marcia A.; Mysiw, W. Jerry] Ohio State Univ, Rehabil & Neurol Inst, Columbus, OH 43210 USA; [McGonigal, Jane] Inst Future, Palo Alto, CA USA; [Logan, Kelsey] Univ Cincinnati, Coll Med, Div Sports Med, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Logan, Kelsey] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Worthen-Chaudhari, L (corresponding author), Dept Phys Med, Dodd Hall,Rm 1060,480 Med Ctr Dr, Columbus, OH 43220 USA.; Worthen-Chaudhari, L (corresponding author), Rehabil & Neurol Inst, Rm 1060,480 Med Ctr Dr, Columbus, OH 43220 USA.	lise.worthen-chaudhari@osumc.edu	Worthen-Chaudhari, Lise C./B-5618-2012; Bockbrader, Marcia/U-7844-2019; Bockbrader, Marcia/J-6203-2013; Yeates, Keith/AAJ-4223-2020	Worthen-Chaudhari, Lise C./0000-0003-1826-0380; Bockbrader, Marcia/0000-0001-6419-0630; Bockbrader, Marcia/0000-0001-6419-0630; Yeates, Keith/0000-0001-7680-2892	NIH-NICHD SBIR grant [1R43HD075638-01A1]; SuperBetter, LLC; Cherry Street Innovation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD075638] Funding Source: NIH RePORTER	Funding was provided by NIH-NICHD SBIR grant 1R43HD075638-01A1. (Clinicaltrials.gov Identifier: NCT01398566). SuperBetter was developed under the auspices of SuperBetter, LLC and is now owned by Cherry Street Innovation, both for-profit organizations. JM founded SuperBetter LLC and is Chief Scientific Officer of Cherry Street Innovation. LWC has served as a Science Advisor to SuperBetter Labs, LLC, on a pro bono basis. No other authors have any conflict to report.	Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Christakis N. A., 2009, CONNECTED SURPRISING; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; FAULSTICH ME, 1986, AM J PSYCHIAT, V143, P1024; FENDRICH M, 1990, AM J EPIDEMIOL, V131, P538, DOI 10.1093/oxfordjournals.aje.a115529; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glaesmer H, 2012, BRIT J HEALTH PSYCH, V17, P432, DOI 10.1111/j.2044-8287.2011.02046.x; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Lewandowski L, 2009, ARCH CLIN NEUROPSYCH, V24, P791, DOI 10.1093/arclin/acp087; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mayo Clinic Staff, 2011, CONC; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McGonigal J., 2011, REALITY IS BROKEN WH; McGonigal J., 2015, SUPERBETTER REVOLUTI; Pramana G, 2014, TELEMED E-HEALTH, V20, P419, DOI 10.1089/tmj.2013.0214; Roepke AM, 2015, GAMES HEALTH J, V4, P235, DOI 10.1089/g4h.2014.0046; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Seligman M.E., 2014, FLOW FDN POSITIVE PS, P279, DOI DOI 10.1007/978-94-017-9088-8_18; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stone A, 2007, SCI REAL TIME DATA C; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	33	12	12	1	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1279	1286		10.1080/02699052.2017.1332388			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800003	28665690	Green Accepted			2022-02-06	
J	Szmydynger-Chodobska, J; Shan, RZ; Thomasian, N; Chodobski, A				Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam			The Involvement of Pial Microvessels in Leukocyte Invasion after Mild Traumatic Brain Injury	PLOS ONE			English	Article							NEUTROPHIL INFILTRATION; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; HEAD-INJURY; P-SELECTIN; EXPRESSION; BARRIER; MODEL; INFLAMMATION; RECRUITMENT	The pathophysiological mechanisms underlying mild traumatic brain injury (mTBI) are not well understood, but likely involve neuroinflammation. Here the controlled cortical impact model of mTBI in rats was used to test this hypothesis. Mild TBI caused a rapid (within 6 h post-mTBI) upregulation of synthesis of TNF-alpha and IL-1 beta in the cerebral cortex and hippocampus, followed by an increase in production of neutrophil (CXCL1 - 3) and monocyte (CCL2) chemoattractants. While astrocytes were not a significant source of CXC chemokines, they highly expressed CCL2. An increase in production of CXC chemokines coincided with the influx of neutrophils into the injured brain. At 6 h post-mTBI, we observed a robust influx of CCL2-expressing neutrophils across pial microvessels into the subarachnoid space (SAS) near the injury site. Mild TBI was not accompanied by any significant influx of neutrophils into the brain parenchyma until 24 h after injury. This was associated with an early induction of expression of intercellular adhesion molecule 1 on the endothelium of the ipsilateral pial, but not intraparenchymal, microvessels. At 6 h post-mTBI, we also observed a robust influx of neutrophils into the ipsilateral cistern of velum interpositum (CVI), a slit-shaped cerebrospinal fluid space located above the 3rd ventricle with highly vascularized pia mater. From SAS and CVI, neutrophils appeared to move along the perivascular spaces to enter the brain parenchyma. The monocyte influx was not observed until 24 h post-mTBI, and these inflammatory cells predominantly entered the ipsilateral SAS and CVI, with a limited invasion of brain parenchyma. These observations indicate that the endothelium of pial microvessels responds to injury differently than that of intraparenchymal microvessels, which may be associated with the lack of astrocytic ensheathment of cerebrovascular endothelium in pial microvessels. These findings also suggest that neuroinflammation represents the potential therapeutic target in mTBI.	[Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam] Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA		Szmydynger-Chodobska, J (corresponding author), Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu		Thomasian, Nicole/0000-0001-9563-4580	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS94440, NS99605]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094440, R21NS099605] Funding Source: NIH RePORTER	This work was supported by grants NS94440 and NS99605 from NIH (to AC), and by funds from Diane N. Weiss and from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allt G, 1997, BRAIN RES REV, V24, P67, DOI 10.1016/S0165-0173(97)00011-8; Alvarez JI, 2006, J NEUROIMMUNOL, V173, P45, DOI 10.1016/j.jneuroim.2005.11.020; ANDERSSON PB, 1992, J EXP MED, V176, P255, DOI 10.1084/jem.176.1.255; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Faul M, 2010, TRAUMATIC BRAIN INJU; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Mishra PK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002099; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rot A, 2009, METHOD ENZYMOL, V461, P191, DOI 10.1016/S0076-6879(09)05409-3; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tran ND, 1999, STROKE, V30, P1671, DOI 10.1161/01.STR.30.8.1671; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Walker-Caulfield ME, 2015, J NEUROIMMUNOL, V278, P112, DOI 10.1016/j.jneuroim.2014.12.009; Walter UM, 1997, HYBRIDOMA, V16, P249, DOI 10.1089/hyb.1997.16.249; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; ZHANG ET, 1990, J ANAT, V170, P111	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167677	10.1371/journal.pone.0167677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	WOS:000391222000017	28030563	Green Published, Green Submitted, gold			2022-02-06	
J	Chen, JQ; Zhang, CC; Jiang, SN; Lu, H; Wang, W				Chen, Jian-Qiang; Zhang, Cheng-Cheng; Jiang, Sheng-Nan; Lu, Hong; Wang, Wei			Effects of Aquaporin 4 Knockdown on Brain Edema of the Uninjured Side After Traumatic Brain Injury in Rats	MEDICAL SCIENCE MONITOR			English	Article						Aquaporin 4; Brain Edema; Brain Injuries; RNA, Small Interfering	BARRIER	Background: Traumatic brain injury (TBI) induces edema on the uninjured side (i.e., contralateral brain tissue; CBT). We evaluated the role of AQP4 in CBT edema formation following TBI. Material/Methods: Mild or severe TBI was induced using a controlled cortical impact model in rats, immediately followed by intra-ventricular siRNA infusions. The effects of AQP4 siRNA on CBT edema were assessed at up to 168 h. Results: Mild or severe TBI induced different patterns of CBT edema. Furthermore, following mild TBI, brain water content (BWC) was increased at 72 h thereafter and AQP4 expression was increased after 168 h, relative to non-injured rats (i.e., sham). AQP4 interference reduced AQP4 expression 48 h thereafter and BWC 72 h thereafter, relative to control siRNA. In contrast, following severe TBI, BWC was increased 1 h thereafter and AQP4 expression was transiently enhanced after 1 h, relative to sham. However, AQP4 interference reduced AQP4 expression after 1 h and BWC 24 h thereafter, relative to control siRNA. Finally, apparent diffusion coefficient (ADC) value in CBT was positively correlated with AQP4 expression level following severe, but not mild, TBI. AQP4 interference disrupted this correlation. Conclusions: AQP4 interference reduces CBT edema formation, and ADC value may predict TBI severity.	[Chen, Jian-Qiang; Wang, Wei] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China; [Zhang, Cheng-Cheng] Cent S Univ, Dept Radiol, Affiliated Haikou Hosp, Xiangya Sch Med, Haikou, Hainan, Peoples R China; [Jiang, Sheng-Nan] Cent S Univ, Dept Nucl Med, Affiliated Haikou Hosp, Xiangya Sch Med, Haikou, Hainan, Peoples R China; [Lu, Hong] Chongqing Seventh Peoples Hosp, Dept Radiol, Chongqing, Peoples R China		Wang, W (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China.; Lu, H (corresponding author), Chongqing Seventh Peoples Hosp, Dept Radiol, Chongqing, Peoples R China.	cqluh@sohu.com; cjr.wangwei.vip@163.com			key scientific research projects funding of Haikou City, Hainan Province, P.R. China [2014-079]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC: 81160181]	This work was supported by key scientific research projects funding (2014-079) of Haikou City, Hainan Province, P.R. China and the National Natural Science Foundation of China (NSFC: 81160181)	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Hlatky R, 2003, NEUROSURG FOCUS, V14, pe; Iacovetta C, 2012, VET CLIN PATH, V41, P32, DOI 10.1111/j.1939-165X.2011.00390.x; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lu H, 2014, NEURAL REGEN RES, V9, P973, DOI 10.4103/1673-5374.133150; Lu H, 2013, CHINESE MED J-PEKING, V126, P4316, DOI 10.3760/cma.j.issn.0366-6999.20131139; Marmarou A, 2003, ACT NEUR S, V86, P7; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Yasui Masato, 2012, Nihon Yakurigaku Zasshi, V139, P230	21	12	16	2	5	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	DEC 8	2016	22									10.12659/MSM.898190			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EE2JN	WOS:000389410200002	27930615	Green Published			2022-02-06	
J	Demorest, RA; Koutures, C				Demorest, Rebecca A.; Koutures, Chris		Council Sports Med & Fitness	Youth Participation and Injury Risk in Martial Arts	PEDIATRICS			English	Article							VERTEBRAL-ARTERY DISSECTION; COMPETITION TAEKWONDO; SHOTOKAN KARATE; HEAD BLOWS; CONCUSSION; PREVENTION; RATES; SUGGESTIONS; TRAUMA; JUDO	The martial arts can provide children and adolescents with vigorous levels of physical exercise that can improve overall physical fitness. The various types of martial arts encompass noncontact basic forms and techniques that may have a lower relative risk of injury. Contact-based sparring with competitive training and bouts have a higher risk of injury. This clinical report describes important techniques and movement patterns in several types of martial arts and reviews frequently reported injuries encountered in each discipline, with focused discussions of higher risk activities. Some of these higher risk activities include blows to the head and choking or submission movements that may cause concussions or significant head injuries. The roles of rule changes, documented benefits of protective equipment, and changes in training recommendations in attempts to reduce injury are critically assessed. This information is intended to help pediatric health care providers counsel patients and families in encouraging safe participation in martial arts.						Moffatt, Kody/0000-0001-5539-9969; Peterson, Andrew/0000-0003-4555-7366			Alesi Marianha, 2014, Muscles Ligaments Tendons J, V4, P114; Birrer R B, 1983, Br J Sports Med, V17, P131; BIRRER RB, 1988, AM J SPORT MED, V16, P408, DOI 10.1177/036354658801600418; Birrer RB, 1996, AM J SPORT MED, V24, pS72, DOI 10.1177/036354659602406S21; Burke DT, 2003, BRIT J SPORT MED, V37, P401, DOI 10.1136/bjsm.37.5.401; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Clements John, 2006, MEIBUKAN MAGAZINE HO, V1, P2; Conant KD, 2008, EPILEPSY BEHAV, V12, P61, DOI 10.1016/j.yebeh.2007.08.011; Council On Communications and Media, 2016, PEDIATRICS, V138; Critchley GR, 1999, BRIT J SPORT MED, V33, P174, DOI 10.1136/bjsm.33.3.174; Deshmukh NV, BR J SPORTS MED; Doiz E, BR J SPORTS MED; Feehan M, 1995, BRIT J SPORT MED, V29, P258, DOI 10.1136/bjsm.29.4.258; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Gartland S, CLIN J SPORT MED; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Kochhar T, BR J SPORTS MED; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; LANNUZEL A, 1994, NEUROPEDIATRICS, V25, P106, DOI 10.1055/s-2008-1071595; Lee AD, SPORTS HLTH; Lystad RP, 2013, BRIT J SPORT MED, V47, P441, DOI 10.1136/bjsports-2012-091666; Lystad RP, ORTHOP J SPORTS MED; Macan J, 2006, BRIT J SPORT MED, V40, P330; Malek AM, 2000, J TRAUMA, V48, P143, DOI 10.1097/00005373-200001000-00027; Mars JS, 1995, BRIT J SPORT MED, V29, P273, DOI 10.1136/bjsm.29.4.273; Mbubaegbu CE, BR J SPORTS MED; McCarron MA, 1997, BRIT J SPORT MED, V31, P346, DOI 10.1136/bjsm.31.4.346; McClain R, 2014, CLIN J SPORT MED, V24, P497, DOI 10.1097/JSM.0000000000000078; National Collegiate Athletic Association, FOOTB INJ; Ngai KM, BR J SPORTS MED; Ortu M, 2006, BRIT J SPORT MED, V40, P730, DOI 10.1136/bjsm.2006.026500; Padulo J, 2014, J SPORT MED PHYS FIT, V54, P715; Pieter W, 2005, MED SPORT SCI, V48, P59, DOI 10.1159/000084283; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Reider B, 2014, AM J SPORT MED, V42, P1287, DOI 10.1177/0363546514535717; Slowey M, 2012, EMERG MED AUSTRALAS, V24, P203, DOI 10.1111/j.1742-6723.2011.01496.x; United States Fight League, 2016, PANKR GRAPPL MIX MAR; Vando S, 2013, J HUM KINET, V38, P45, DOI 10.2478/hukin-2013-0044; Wall Robert B, 2005, J Pediatr Health Care, V19, P230, DOI 10.1016/j.pedhc.2005.02.006; Wong V, PEDIAT SPORTS MED ES; Woodward Thomas W, 2009, WMJ, V108, P40; Yard EE, 2007, J SCI MED SPORT, V10, P219, DOI 10.1016/j.jsams.2006.06.016; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322; Zetaruk MN, 2000, CLIN J SPORT MED, V10, P117, DOI 10.1097/00042752-200004000-00006; Zigun JR, AM J SPORTS MED	51	12	12	0	25	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2016	138	6							e20163022	10.1542/peds.2016-3022			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	ED5WX	WOS:000388924800071		Bronze			2022-02-06	
J	Gu, YQ; Chen, J; Wang, TH; Zhou, CN; Liu, ZD; Ma, LH				Gu, Youquan; Chen, Jun; Wang, Tianhong; Zhou, Chaoning; Liu, Zhaodong; Ma, Lanhua			Hsp70 inducer, 17-allylamino-demethoxygeldanamycin, provides neuroprotection via anti-inflammatory effects in a rat model of traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						17-allylamino-demethoxygeldanamycin; neuroprotection; traumatic brain injury; inflammatory cytokines; neuronal death; rats	HEAT-SHOCK-PROTEIN; FOCAL CEREBRAL-ISCHEMIA; TRANSGENIC MOUSE MODEL; NF-KAPPA-B; OVEREXPRESSION; EXPRESSION; MICE; EXCITOTOXICITY; INFLAMMATION; MECHANISM	Traumatic brain injury (TBI) is the predominant cause of mortality in young adults and children living in China. TBI induces inflammatory responses; in addition, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and IL-6 are important pro-inflammatory cytokines. Considering the observation that Hsp-70 overexpression can exert neuroprotection, identifying a drug that is able to induce the upregulation of Hsp70 has the potential to be a promising therapy for the treatment of neurological diseases. Thus, the present study assessed the clinical effectiveness of an anticancer drug and Hsp70 activator, 17-allylamino-demethoxygeldanamycin (17-AAG), to evaluate its potential as a treatment for patients with TBI. The aim of present study was to determine the neuroprotective effects of 17-AAG following trauma and to investigate the underlying mechanisms of action. To establish rat models, rats were subjected to a controlled cortical impact injury and randomly divided into vehicle or 17-AAG groups. In the 17-AAG group, rats were administered with an intraperitoneal injection of 17-AAG (80 mg/kg) immediately following the establishment of TBI. The motor function was measured using Neurologic Severity Score, and neuronal death was evaluated using immunofluorescence. The expression levels of GLT-1, Bcl-2 and Hsp-70 were detected by western blot analysis and the expression levels of inflammatory cytokines were quantified using ELISA. The present study determined that 17-AAG significantly reduced brain edema and motor neurological deficits (P<0.05), in addition to increasing neuronal survival. The aforementioned findings are associated with a downregulation of the expression levels of pro-inflammatory cytokines TNF-alpha, IL-1 beta and IL-6. Conversely, no significant changes of glutamate transporter-1 expression were observed. The present results suggest that 17-AAG treatment may provide a neuroprotective effect by reducing inflammation following TBI.	[Gu, Youquan; Zhou, Chaoning; Liu, Zhaodong; Ma, Lanhua] Lanzhou Univ, Hosp 1, Donggang Branch, Dept Neurol, Lanzhou 730000, Gansu, Peoples R China; [Chen, Jun; Wang, Tianhong] Lanzhou Univ, Hosp 1, Dept Neurol, 1 Donggangxi Rd, Lanzhou 730000, Gansu, Peoples R China		Chen, J (corresponding author), Lanzhou Univ, Hosp 1, Dept Neurol, 1 Donggangxi Rd, Lanzhou 730000, Gansu, Peoples R China.	guyq@lzu.edu.cn					Adachi H, 2003, J NEUROSCI, V23, P2203; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Ding XZ, 2001, CYTOKINE, V16, P210, DOI 10.1006/cyto.2001.0959; Fumo G, 2004, BLOOD, V103, P1078, DOI 10.1182/blood-2003-07-2477; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Harrison EM, 2008, AM J PHYSIOL-RENAL, V295, pF397, DOI 10.1152/ajprenal.00361.2007; Heneka MT, 2000, J CEREBR BLOOD F MET, V20, P800, DOI 10.1097/00004647-200005000-00006; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Hutter JJ, 1996, CIRCULATION, V94, P1408, DOI 10.1161/01.CIR.94.6.1408; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kelly Stephen, 2002, Curr Med Res Opin, V18 Suppl 2, ps55, DOI 10.1185/030079902125000732; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; NOWAK TS, 1994, BRAIN PATHOL, V4, P67; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	31	12	13	0	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2016	12	6	A				3767	3772		10.3892/etm.2016.3821			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EG5IB	WOS:000391076400046	28101166	Green Published, gold			2022-02-06	
J	Roumeliotis, N; Dong, C; Pettersen, G; Crevier, L; Emeriaud, G				Roumeliotis, Nadia; Dong, Christian; Pettersen, Graldine; Crevier, Louis; Emeriaud, Guillaume			Hyperosmolar therapy in pediatric traumatic brain injury: a retrospective study	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Pediatric; Hyperosmolar therapy; Mannitol; 3% hypertonic saline; Intracranial hypertension	INCREASED INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; 20-PERCENT MANNITOL; CHILDREN; HYPERTENSION; 7.2-PERCENT; TRIAL	The objectives of the study are to describe the use of hyperosmolar therapy in pediatric traumatic brain injury (TBI) and examine its effect on intracranial pressure (ICP) and cerebral perfusion pressure (CPP). A retrospective review of patients with severe TBI admitted to the pediatric intensive care unit (PICU) was conducted. Inclusion criteria were ICP monitoring and administration of a hyperosmolar agent (20 % mannitol or 3 % hypertonic saline) within 48 h of PICU admission; for which dose and timing were recorded. For the first two boluses received for increased ICP (> 20 mmHg), the impact on ICP and CPP was assessed during the following 4 h, using repeated measures ANOVA. Co-interventions to control ICP (additional hyperosmolar agent, propofol, or barbiturate bolus) and serum sodium were also documented. A tertiary care pediatric hospital center. Children aged 1 month to 18 years, with severe traumatic brain injury (Glasgow Coma Score 8) and intracranial pressure (ICP) monitor. Sixty-four patients were eligible, of which 16 met inclusion criteria. Average age was 11 years (SD +/- 4) and median Glasgow Coma Score was 6 (range 4-7). Seventy percent of boluses were 3 % hypertonic saline, with no identified baseline difference associated with this initial choice. Both mannitol and hypertonic saline were followed by a non-significant decrease in ICP (mannitol, p = 0.055 and hypertonic saline, p = 0.096). There was no significant change in CPP post bolus. A co-intervention occurred in 69 % of patients within the 4 h post hyperosmolar agent, and eight patients received continuous 3 % saline. In pediatric TBI with intracranial hypertension, mannitol and 3 % hypertonic saline are commonly used, but dose and therapeutic threshold for use vary without clear indications for one versus another. Controlled trials are warranted, but several barriers were identified, including high exclusion rate, multiple co-interventions, and care variability.	[Roumeliotis, Nadia; Pettersen, Graldine; Emeriaud, Guillaume] Univ Montreal, CHU St Justine, Dept Critial Care, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada; [Dong, Christian] Univ Montreal, CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Crevier, Louis] Univ Montreal, CHU St Justine, Dept Neurosurg, Montreal, PQ, Canada		Roumeliotis, N (corresponding author), Univ Montreal, CHU St Justine, Dept Critial Care, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nadia.roumeliotis@gmail.com	Roumeliotis, Nadia/AAU-2218-2021	Roumeliotis, Nadia/0000-0001-7463-1233	Centre D'excellence en Traumatologie du CHU Sainte-Justine; Fonds de Recherche Quebec Sant (FRQS)	Centre D'excellence en Traumatologie du CHU Sainte-Justine 2) GE's research program is supported by the Fonds de Recherche Quebec Sant (FRQS).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Favre JB, 1996, SCHWEIZ MED WSCHR, V126, P1635; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Heron Melonie, 2015, Natl Vital Stat Rep, V64, P1; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Li M, 2015, MEDICINE, V94; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Shein SL, 2015, PEDIAT CRIT CARE MED; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF	23	12	15	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2016	32	12					2363	2368		10.1007/s00381-016-3231-y			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EE5GL	WOS:000389633500017	27568371				2022-02-06	
J	Vaiman, M; Sigal, T; Kimiagar, I; Bekerman, I				Vaiman, Michael; Sigal, Tal; Kimiagar, Itzhak; Bekerman, Inessa			Noninvasive assessment of the intracranial pressure in non-traumatic intracranial hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Adults; Computed tomography (CT) scan; Hemorrhagic stroke; Intracranial pressure; Non-traumatic intracerebral hemorrhage (ICH); Optic nerve sheath diameter	OPTIC-NERVE SHEATH; SUBARACHNOID HEMORRHAGE; BRAIN-INJURY; DIAMETER; ULTRASONOGRAPHY; TOMOGRAPHY; ADULTS	The article describes the modified technique of measuring the diameters of the optic nerve sheath (ONSD) for assessment of the intracranial pressure (ICP) in patients with intracerebral or subarachnoid hemorrhage (SAH). The CT scans of 443 patients were analyzed retrospectively. The ONSDs were measured at 3 mm behind the globe and at the point where the ophthalmic artery crosses the optic nerve. The ONSD/eyeball transverse diameter (ETD) ratio was calculated. The correlation analysis was performed with the Glasgow Coma Scale score, Hemispheric Stroke Scale-score, Glasgow Outcome Score, and invasive ICP readings. ONSD was enlarged in 95% of patients with intracerebral hemorrhage or SAH. Pathological ONSDs were 6.6 +/- 0.8 mm (cut-off value >5.5 mm; p < 0.05). ONSD/ETD ratio was 0.29 +/- 0.05 against normative 0.19 +/- 0.02 (p < 0.01) with no correlation with initial Glasgow Coma Scale score or Hemispheric Stroke Scale score. There was an inverse correlation between ONSD/ETD ratio and Glasgow Outcome Score (r = -0.7) and direct correlation with invasive ICP readings. This study provides further evidence that in patients with intracranial hemorrhage and SAH, the presence of ONSD greater than a threshold of 5.5 mm is significantly predictive of invasively measured elevated ICP. The prediction of raised ICP can be further refined by measuring ONSD at the point where the optic nerve and the ophthalmic artery cross, and by determining the ratio between the ONSD and ETD. (C) 2016 Elsevier Ltd. All rights reserved.	[Vaiman, Michael] Tel Aviv Univ, Sackler Fac Med, Dept Otolaryngol Head & Neck Surg, Assaf Harofe Med Ctr, IL-6997801 Tel Aviv, Israel; [Sigal, Tal; Bekerman, Inessa] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Radiol, Tel Aviv, Israel; [Kimiagar, Itzhak] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Neurol, Tel Aviv, Israel		Vaiman, M (corresponding author), 33 Shapiro St, IL-59561 Bat Yam, Israel.	vaimed@yahoo.com					ADAMS RJ, 1987, STROKE, V18, P665, DOI 10.1161/01.STR.18.3.665; Bekerman I, 2016, J CLIN NEUROSCI, V30, P106, DOI 10.1016/j.jocn.2016.01.018; Bekerman I, 2016, J NEUROIMAGING, V26, P309, DOI 10.1111/jon.12322; Bekerman I, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/503645; Frumin E, 2014, WEST J EMERG MED, V15, P217, DOI 10.5811/westjem.2013.9.16191; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Giger-Tobler C, 2015, KLIN MONATSBL AUGENH, V232, P467, DOI 10.1055/s-0035-1545711; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-177; Moradiya Y, 2015, CRIT CARE MED, V43, P253, DOI 10.1097/CCM.0000000000000698; OSBORN AG, 2004, DIAGNOSTIC IMAGING; Passi N, 2013, AM J NEURORADIOL, V34, P919, DOI 10.3174/ajnr.A3022; Qiu WS, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-112; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Ridha MA, 2013, NEURO-OPHTHALMOLOGY, V37, P1, DOI 10.3109/01658107.2012.738759; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; UNSOLD R, 1980, AM J ROENTGENOL, V135, P767, DOI 10.2214/ajr.135.4.767; Vaiman M, 2016, J NEUROTRAUMA; Vaiman M, 2015, INT J OPHTHALMOL-CHI, V8, P1240, DOI 10.3980/j.issn.2222-3959.2015.06.30; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	26	12	14	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2016	34						177	181		10.1016/j.jocn.2016.06.008			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED8AE	WOS:000389093300035	27612672				2022-02-06	
J	Wang, Y; Li, CS; Gao, CJ; Li, Z; Yang, J; Liu, XH; Liang, F				Wang, Yong; Li, Chunsheng; Gao, Chunjin; Li, Zhuo; Yang, Jing; Liu, Xuehua; Liang, Fang			Effects of hyperbaric oxygen therapy on RAGE and MCP-1 expression in rats with spinal cord injury	MOLECULAR MEDICINE REPORTS			English	Article						hyperbaric oxygen treatment; spinal cord injury; receptor for advanced glycation end products; monocyte chemoattractant protein-1	GLYCATION END-PRODUCTS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TRAUMATIC BRAIN-INJURY; INFLAMMATORY CYTOKINES; RECEPTOR RAGE; ISCHEMIA; SEVERITY; STRESS; DAMAGE; MODEL	The inflammatory response is an important source of secondary damage to neuronal tissue in the spinal cord following spinal cord injury (SCI). Hyperbaric oxygen (HBO) therapy reduces inflammation and promotes the restoration of locomotor function following SCI, however, the mechanisms underlying this effect remain to be determined. The aim of the current study was to investigate the mechanisms by which HBO therapy promotes recovery in a rat model of SCI by measuring expression levels of receptor for advanced glycation end products (RAGE) and monocyte chemoattractant protein-1 (MCP-1) in spinal cord tissue. Experimental animals (n=90) were divided into three groups: Sham-operated (SH), SCI (T-10 laminectomy) and SCI + HBO. Each group was further divided into five subgroups (n=6) that were examined at 12 h, and at 1, 3, 7 and 14 days post-injury. Recovery of locomotor function was evaluated using the Basso, Beattie and Bresnahan (BBB) scoring system. Neutrophil infiltration was analyzed using myeloperoxidase (MPO) activity assays. The expression of RAGE and MCP-1 was measured by immunohistochemistry, reverse transcription-quantitative polymerase chain reaction and western blotting. RAGE and MCP-1 expression and MPO activity were higher in the SCI groups than in the SH groups at each time point. HBO therapy reduced RAGE and MCP-1 expression and MPO activity compared with untreated, injured animals at early post-injury stages. In addition, HBO therapy improved BBB scores at post-operative day 7 and 14. HBO therapy was, therefore, demonstrated to relieve secondary inflammatory responses, potentially by inhibiting the expression of RAGE and MCP-1, resulting in significant recovery of loco motor function. The results of the present study may, therefore, be useful in improving the clinical application of HBO therapy for patients with SCI.	[Wang, Yong; Li, Chunsheng] Capital Med Univ, Beijing Chaoyang Hosp, Dept Emergency, 8 Gongti South Rd, Beijing 100020, Peoples R China; [Wang, Yong] Capital Med Univ, Fuxing Hosp, Dept Hyperbar Oxygen, Beijing 100038, Peoples R China; [Gao, Chunjin; Li, Zhuo; Yang, Jing; Liu, Xuehua; Liang, Fang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hyperbar Oxygen, Beijing 100020, Peoples R China		Li, CS (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Emergency, 8 Gongti South Rd, Beijing 100020, Peoples R China.	chunshengl1912@163.com					Allen EA, 2012, NEURON, V74, P603, DOI 10.1016/j.neuron.2012.05.001; Anik I, 2011, J SPINAL CORD MED, V34, P257, DOI 10.1179/107902611X12972448729648; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Chen KB, 2011, SPINE, V36, P2122, DOI 10.1097/BRS.0b013e318203941c; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Dayan K, 2012, LIFE SCI, V90, P360, DOI 10.1016/j.lfs.2011.12.005; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Galasso JM, 2000, NEUROSCIENCE, V101, P737, DOI 10.1016/S0306-4522(00)00399-7; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Guo JD, 2014, MOL CELL BIOCHEM, V390, P215, DOI 10.1007/s11010-014-1972-z; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Leskovar A, 2000, J EXP BIOL, V203, P1783; Li H, 2014, BRAIN RES, V1543, P315, DOI 10.1016/j.brainres.2013.11.023; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Liu Shi-qing, 2005, Chin J Traumatol, V8, P216; Liu XY, 2014, 2014 Fifth International Conference on Intelligent Systems Design and Engineering Applications (ISDEA), P14, DOI 10.1109/ISDEA.2014.12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PG, 2013, J NEUROSURG SCI, V57, P253; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Nie H, 2006, J CEREBR BLOOD F MET, V26, P666, DOI 10.1038/sj.jcbfm.9600221; Sandhir R, 2011, NEUROCHEM RES, V36, P856, DOI 10.1007/s11064-011-0414-5; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Sinescu Crina, 2010, J Med Life, V3, P254; Stammers AT, 2012, J NEUROSCI RES, V90, P782, DOI 10.1002/jnr.22820; Stern D, 2002, ADV DRUG DELIVER REV, V54, P1615, DOI 10.1016/S0169-409X(02)00160-6; Tan JW, 2014, INT J CLIN EXP PATHO, V7, P1911; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tjoa T, 2003, J NEUROSCI METH, V129, P49, DOI 10.1016/S0165-0270(03)00205-X; Topuz K, 2010, ARCH MED RES, V41, P506, DOI 10.1016/j.arcmed.2010.10.004; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Xue H, 2013, BRAIN RES, V1516, P83, DOI 10.1016/j.brainres.2013.04.016; Yang J, 2013, SPINE, V38, pE1641, DOI 10.1097/BRS.0000000000000005; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Zhang XS, 2015, MOL MED REP, V11, P4262, DOI 10.3892/mmr.2015.3330	42	12	17	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	DEC	2016	14	6	B				5619	5625		10.3892/mmr.2016.5935			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	EG5HZ	WOS:000391076200026	27840972	Bronze			2022-02-06	
J	Kobeissy, FH; Guingab-Cagmat, JD; Zhang, ZQ; Moghieb, A; Glushakova, OY; Mondello, S; Boutte, AM; Anagli, J; Rubenstein, R; Bahmad, H; Wagner, AK; Hayes, RL; Wang, KKW				Kobeissy, Firas H.; Guingab-Cagmat, Joy D.; Zhang, Zhiqun; Moghieb, Ahmed; Glushakova, Olena Y.; Mondello, Stefania; Boutte, Angela M.; Anagli, John; Rubenstein, Richard; Bahmad, Hisham; Wagner, Amy K.; Hayes, Ronald L.; Wang, Kevin K. W.			Neurprotemics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats	FRONTIERS IN NEUROLOGY			English	Article						proteomics; traumatic brain injury; controlled cortical impact; biomarker; prognosis and therapeutics; inflammation; oxidative stress	NEURON-SPECIFIC ENOLASE; PROLYL ISOMERASE PIN1; SPINAL-CORD-INJURY; ALPHA-II-SPECTRIN; LECITHINIZED SUPEROXIDE-DISMUTASE; TANDEM MASS-SPECTROMETRY; C-TERMINAL HYDROLASE-L1; PROTEOMIC ANALYSIS; ALZHEIMERS-DISEASE; PROGNOSTIC BIOMARKER	Traumatic brain injury (TBI) represents a critical health problem of which diagnosis, management, and treatment remain challenging. TBI is a contributing factor in approximately one-third of all injury-related deaths in the United States. The Centers for Disease Control and Prevention estimate that 1.7 million people suffer a TBI in the United States annually. Efforts continue to focus on elucidating the complex molecular mechanisms underlying TBI pathophysiology and defining sensitive and specific biomarkers that can aid in improving patient management and care. Recently, the area of neuroproteomics-systems biology is proving to be a prominent tool in biomarker discovery for central nervous system injury and other neurological diseases. In this work, we employed the controlled cortical impact (CCI) model of experimental TBI in rat model to assess the temporal-global proteome changes after acute (1 day) and for the first time, subacute (7 days), post-injury time frame using the established cation-anion exchange chromatography-1D SDS gel electrophoresis LC-MS/MS platform for protein separation combined with discrete systems biology analyses to identify temporal biomarker changes related to this rat TBI model. Rather than focusing on any one individual molecular entity, we used in silico systems biology approach to understand the global dynamics that govern proteins that are differentially altered post-injury. In addition, gene ontology analysis of the proteomic data was conducted in order to categorize the proteins by molecular function, biological process, and cellular localization. Results show alterations in several proteins related to inflammatory responses and oxidative stress in both acute (1 day) and subacute (7 days) periods post-TBI. Moreover, results suggest a differential upregulation of neuroprotective proteins at 7 days post-CCI involved in cellular functions such as neurite growth, regeneration, and axonal guidance. Our study is among the first to assess temporal neuroproteome changes in the CCI model. Data presented here unveil potential neural biomarkers and therapeutic targets that could be used for diagnosis, for treatment and, most importantly, for temporal prognostic assessment following brain injury. Of interest, this work relies on in silico bioinformatics approach to draw its conclusion; further work is conducted for functional studies to validate and confirm the omics data obtained.	[Kobeissy, Firas H.; Zhang, Zhiqun; Moghieb, Ahmed; Hayes, Ronald L.; Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA; [Kobeissy, Firas H.; Zhang, Zhiqun; Moghieb, Ahmed; Hayes, Ronald L.; Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Neurosci, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA; [Guingab-Cagmat, Joy D.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL USA; [Glushakova, Olena Y.; Hayes, Ronald L.] Virginia Commonwealth Univ, Sch Med, Dept Neurosurg, Richmond, VA USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Boutte, Angela M.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD USA; [Anagli, John] NeuroTheranost Inc, Detroit, MI USA; [Anagli, John] Henry Ford Hlth Syst, Detroit, MI USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Bahmad, Hisham] Beirut Arab Univ, Fac Med, Beirut, Lebanon; [Bahmad, Hisham] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Wang, KKW (corresponding author), Univ Florida, McKnight Brain Inst, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA.; Wang, KKW (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosci, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA.	kawangwang17@gmail.com	Glushakova, Olena/AAY-1130-2021; Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017; Bahmad, Hisham/A-5369-2019	Glushakova, Olena/0000-0002-2109-3651; Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Bahmad, Hisham/0000-0003-3799-2595; Wang, Kevin/0000-0002-9343-6473	Office of the Assistant Secretary of Defense for Health Affairs through the US Army Medical Research and Materiel Command [W81XWH-07-1-070]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the US Army Medical Research and Materiel Command under award #W81XWH-07-1-070 (AW). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DoD. In conducting research using animals, the investigators adhere to the laws of the USA and regulations of the Department of Agriculture. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Abbass H, 2016, ELECTROPHORESIS, V37, P1562, DOI 10.1002/elps.201500583; Abou-Abbass H, 2016, ELECTROPHORESIS, V37, P1549, DOI 10.1002/elps.201500585; Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Arguelles S, 2013, FREE RADICAL BIO MED, V61, P61, DOI 10.1016/j.freeradbiomed.2013.03.016; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; Arosio B, 2007, AGING CLIN EXP RES, V19, P406; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Bai XY, 2013, PROTEIN CELL, V4, P695, DOI 10.1007/s13238-013-3041-x; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bernal J, 1999, BIOFACTORS, V10, P271, DOI 10.1002/biof.5520100227; Billcliff PG, 2016, MOL BIOL CELL, V27, P90, DOI 10.1091/mbc.E15-06-0329; Bonnet Agnes, 2009, BMC Proc, V3 Suppl 4, pS11, DOI 10.1186/1753-6561-3-S4-S11; Bouter A, 2015, PLACENTA, V36, pS43, DOI 10.1016/j.placenta.2015.01.193; BRACIAK TA, 1988, J BIOL CHEM, V263, P3999; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Chen AS, 2009, METHODS MOL BIOL, V566, P57, DOI 10.1007/978-1-59745-562-6_4; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Cid C, 2007, PROTEOMICS, V7, P3207, DOI 10.1002/pmic.200700214; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Delange F, 2000, P NUTR SOC, V59, P75, DOI 10.1017/S0029665100000094; Devaux S, 2016, MOL CELL PROTEOMICS, V15, P2641, DOI 10.1074/mcp.M115.057794; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Ekegren T, 2008, J MASS SPECTROM, V43, P559, DOI 10.1002/jms.1409; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Grimm-Gunter EMS, 2008, EXP CELL RES, V314, P1991, DOI 10.1016/j.yexcr.2008.03.015; Guingab-Cagmat JD, 2010, ESSENTIALS SPINAL CO, P605; Hallen A, 2013, AMINO ACIDS, V45, P1249, DOI 10.1007/s00726-013-1590-1; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; HATTORI T, 1995, NEUROSCI RES, V21, P191, DOI 10.1016/0168-0102(94)00849-B; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Junker H, 2007, GLIA, V55, P1630, DOI 10.1002/glia.20581; Kalman M, 2001, EXP BRAIN RES, V139, P426, DOI 10.1007/s002210100789; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Katano T, 2006, PROTEOMICS, V6, P6085, DOI 10.1002/pmic.200600300; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Kobeissy FH, 2011, PM&R, V3, pS139, DOI 10.1016/j.pmrj.2011.02.012; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liu B, 2009, BBA-PROTEINS PROTEOM, V1794, P476, DOI 10.1016/j.bbapap.2008.12.008; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Livingston BM, 2000, CRIT CARE MED, V28, P389, DOI 10.1097/00003246-200002000-00017; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Lu PJ, 1999, NATURE, V399, P784; Mackensen GB, 2001, J NEUROSCI, V21, P4582, DOI 10.1523/JNEUROSCI.21-13-04582.2001; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Moghieb A, 2016, MOL CELL PROTEOMICS, V15, P2379, DOI 10.1074/mcp.M116.058115; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Ottens AK, 2005, ANAL CHEM, V77, P4836, DOI 10.1021/ac050478r; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Ottens AK, 2009, METHODS MOL BIOL, V566, P1, DOI 10.1007/978-1-59745-562-6_1; Ottens AK, 2010, J NEUROTRAUM, V27, P1837, DOI 10.1089/neu.2010.1374; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Popp J, 2009, J PSYCHIATR RES, V43, P749, DOI 10.1016/j.jpsychires.2008.10.006; Prieto DA, 2008, EXPERT REV PROTEOMIC, V5, P283, DOI 10.1586/14789450.5.2.283; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Rostami E, 2013, J NEUROTRAUM, V30, P1954, DOI 10.1089/neu.2012.2583; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Schael S, 2013, J BIOL CHEM, V288, P9303, DOI 10.1074/jbc.M113.461293; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Singh OV, 2009, PROTEOMICS, V9, P1241, DOI 10.1002/pmic.200800636; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Takahashi K, 2014, CURR DRUG TARGETS, V15, P973, DOI 10.2174/1389450115666140903110724; Takano M, 2013, NEUROSCI LETT, V534, P85, DOI 10.1016/j.neulet.2012.11.010; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thompson JS, 2010, FREE RADICAL RES, V44, P529, DOI 10.3109/10715761003649578; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yao G, 2014, HUM MOL GENET, V23, P2769, DOI 10.1093/hmg/ddt672; Yunoki M, 1997, J NEUROTRAUM, V14, P739, DOI 10.1089/neu.1997.14.739; Yunoki M, 2003, SURG NEUROL, V59, P156, DOI 10.1016/S0090-3019(02)01040-6; Yuryev A, 2009, EXPERT OPIN DRUG DIS, V4, P1307, DOI 10.1517/17460440903413488; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang Gang, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P992, DOI 10.3969/j.issn.1672-7347.2011.10.010; Zhang ZQ, 2009, METHODS MOL BIOL, V566, P181, DOI 10.1007/978-1-59745-562-6_12; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	104	12	12	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 22	2016	7								198	10.3389/fneur.2016.00198			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC6EL	WOS:000388229200001	27920753	Green Published, gold			2022-02-06	
J	Tang, WC; Hsu, YC; Wang, CC; Hu, CY; Chio, CC; Kuo, JR				Tang, Wei-Chen; Hsu, Yao-Chin; Wang, Che-Chuan; Hu, Chiao-Ya; Chio, Chung-Ching; Kuo, Jinn-Rung			Early electroacupuncture treatment ameliorates neuroinflammation in rats with traumatic brain injury	BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article						Astrocyte; Electroacupuncture; Microglia; Neuronal apoptosis; Traumatic brain injury; Tumor Necrosis factor-alpha a	TUMOR-NECROSIS-FACTOR; LATERAL FLUID-PERCUSSION; ACUPUNCTURE; ETANERCEPT; ACTIVATION; EXPRESSION; APOPTOSIS; ALPHA; ST36	Background: Neuroinflammation is the leading cause of neurological sequelae after traumatic brain injury (TBI). The aim of the present study was to investigate whether the neuroprotective effects of electroacupuncture (EA) are mediated by anti-neuroinflammatory effects in a rat model of TBI. Methods: Male Sprague-Dawley rats were randomly divided into three groups: sham-operated, TBI control, and EA-treated. The animals in the sham-operated group underwent a sham operation, those in the TBI control group were subjected to TBI, but not EA, and those in the EA group were treated with EA for 60 min immediately after TBI, daily for 3 consecutive days. EA was applied at the acupuncture points GV20, GV26, LI4, and KI1, using a densedispersed wave, at frequencies of 0.2 and 1 Hz, and an amplitude of 1 mA. Cell infarction volume (TTC stain), neuronal apoptosis (markers: TUNEL and Caspase-3), activation of microglia (marker: Iba1) and astrocytes (marker: GFAP), and tumor necrosis factor (TNF)-alpha expression in the microglia and astrocytes were evaluated by immunofluorescence. Functional outcomes were assessed using the inclined plane test. All tests were performed 72 h after TBI. Results: We found that TBI-induced loss of grasp strength, infarction volume, neuronal apoptosis, microglial and astrocyte activation, and TNF-alpha expression in activated microglia and astrocytes were significantly attenuated by EA treatment. Conclusions: Treatment of TBI in the acute stage with EA for 60 min daily for 3 days could ameliorate neuroinflammation. This may thus represent a mechanism by which functional recovery can occur after TBI.	[Tang, Wei-Chen] Tainan Municipal An Nan Hosp, Dept Chinese Med, Tainan, Taiwan; [Hsu, Yao-Chin] Chi Mei Med Ctr, Dept Chinese Med, Tainan, Taiwan; [Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Wang, Che-Chuan; Hu, Chiao-Ya; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Kuo, Jinn-Rung] Chi Mei Hosp, Traumat Brain Injury Ctr, 901 Zhonghua Rd, Tainan 710, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com			Chi-Mei Medical Center [CMFHR10315]	This work was supported by Chi-Mei Medical Center, grant number CMFHR10315.	Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chan HHL, 2005, J ALTERN COMPLEM MED, V11, P315, DOI 10.1089/acm.2005.11.315; Cheng CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091426; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chuang CH, 2013, ACUPUNCT MED, V31, P395, DOI 10.1136/acupmed-2013-010406; Du MH, 2015, J SURG RES, V195, P89, DOI 10.1016/j.jss.2014.12.043; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eshkevari L, 2013, J ENDOCRINOL, V217, P95, DOI 10.1530/JOE-12-0404; Gu Chen-Yi, 2011, Zhongguo Zhen Jiu, V31, P236; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Jiang SH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/431580; Kim MW, 2012, ACUPUNCT MED, V30, P222, DOI 10.1136/acupmed-2011-010126; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kuai Le, 2005, Zhongguo Zhen Jiu, V25, P68; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu Xuan, 2009, Zhongguo Zhen Jiu, V29, P1026; Mayer DJ, 2000, ANNU REV MED, V51, P49, DOI 10.1146/annurev.med.51.1.49; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Wang Q, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-24; Wang Y, 1997, J NEUROSCI, V17, P4341; Xu H, 2014, CHIN J INTEGR MED, V20, P369, DOI 10.1007/s11655-014-1800-z; Yu JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104924; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang Jinhong, 2014, ScientificWorldJournal, V2014, P910421, DOI 10.1155/2014/910421; Zhang L., 2014, EVID-BASED COMPL ALT, V2014	34	12	14	1	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6882		BMC COMPLEM ALTERN M	BMC Complement. Altern. Med.	NOV 16	2016	16								470	10.1186/s12906-016-1457-6			12	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	EC7RZ	WOS:000388339300001	27852302	gold, Green Published			2022-02-06	
J	Failla, MD; Juengst, SB; Graham, KM; Arenth, PM; Wagner, AK				Failla, Michelle D.; Juengst, Shannon B.; Graham, Kristin M.; Arenth, Patricia M.; Wagner, Amy K.			Effects of Depression and Antidepressant Use on Cognitive Deficits and Functional Cognition Following Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						antidepressants; cognition; depression; international classification of functioning; Rehabilomics; traumatic brain injury	MULTIPLE ERRANDS TEST; MAJOR DEPRESSION; SIMPLIFIED VERSION; OLDER-ADULTS; SEVERE TBI; MILD; MEMORY; MODERATE; REHABILITATION; RECOVERY	Objective: To use a Rehabilomics framework to evaluate relations hips between post-traumatic brain injury (TBI) depression (PTD) and potential associated factors, including antidepressant use, on cognitive recovery following severe TBI. Participants: Severe TBI survivors (n = 154), recruited from a level 1 trauma center. Design: Prospective cohort study with assessments at 6 and 12 months postinjury. Main Measures: Patient Health Questionnaire-9 (PTD symptoms); cognitive composite score from a neuropsychological assessment battery (cognitive impairment); and Functional Independence Measure-Cognition (FIM-Cog, self-reported functional cognition). Results: Individuals with and without PTD did not differ with respect to cognitive impairment. However, antidepressant use, regardless of PTD status, was associated with cognitive impairment. Individuals with PTD reported lower FIM-Cog scores at both time points compared with those without PTD. In a post hoc longitudinal analysis, individuals with late-onset PTD had worse cognitive impairment. Conclusion: These results suggest that antidepressant use impairs cognition among individuals without PTD. Also, PTD did not directly affect cognitive impairment but may affect functional cognitive limitations through self-evaluation and apathy/motivation factors.	[Failla, Michelle D.; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, 4200 Fifth Ave, Pittsburgh, PA 15260 USA; [Failla, Michelle D.; Juengst, Shannon B.; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Sch Med, Pittsburgh, PA USA; [Graham, Kristin M.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Coll Arts & Sci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, 3471 Fifth Ave Ste 202, Pittsburgh, PA 15213 USA.; Arenth, PM (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 4200 Fifth Ave, Pittsburgh, PA 15260 USA.	arenthpm@upmc.edu; wagnerak@upmc.edu	Juengst, Shannon B/AAC-5891-2019; Failla, Michelle/AAI-3788-2021	Juengst, Shannon B/0000-0003-4709-545X; Failla, Michelle/0000-0001-9734-3373	Department of DefenseUnited States Department of Defense [DoD W81XWH-07-1-0701]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) GrantUnited States Department of Health & Human Services [90DP0041]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048162]; UPMC Rehabilitation Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER	This research was supported by Department of Defense (DoD W81XWH-07-1-0701), National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) Grant 90DP0041, National Institute of Health (R01HD048162), and the UPMC Rehabilitation Institute. NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of the DoD, NIDILRR, ACL, NIH, or HHS, and endorsement of this content by the Federal Government should not be assumed.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Banos JH, 2010, J HEAD TRAUMA REHAB, V25, P357, DOI 10.1097/HTR.0b013e3181d6c715; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castiel M, 2012, NEUROPSYCHOL REHABIL, V22, P734, DOI 10.1080/09602011.2012.686884; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P177, DOI 10.1097/00001199-200303000-00008; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Fleming J, 1999, BRAIN INJURY, V13, P417; Gavett BE, 2013, NEUROREHABILITATION, V32, P253, DOI 10.3233/NRE-130842; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Heaton R.K., 1981, WISCONSIN CARD SORTI; HERTEL PT, 1991, J EXP PSYCHOL GEN, V120, P301, DOI 10.1037/0096-3445.120.3.301; Hertel PT, 1998, J ABNORM PSYCHOL, V107, P166, DOI 10.1037/0021-843X.107.1.166; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juengst SB, 2012, THESIS; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Levin RL, 2007, COGNITIVE THER RES, V31, P211, DOI 10.1007/s10608-007-9128-z; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Murphy E, 2013, NEUROPSYCHOPHARMACOL, V38, P2598, DOI 10.1038/npp.2013.166; NINDS Common Data Elements, TRAUMATIC BRAIN INJU; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Peckham AD, 2010, DEPRESS ANXIETY, V27, P1135, DOI 10.1002/da.20755; Pedroli E, 2013, STUD HEALTH TECHNOL, V191, P38, DOI 10.3233/978-1-61499-282-0-38; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reitan R, 1985, HALSTEAD REITAN NEUR; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2011, PM&R, V3, pS28, DOI 10.1016/j.pmrj.2011.04.013; Wang YG, 2011, J NEUROTRAUM, V28, P259, DOI 10.1089/neu.2010.1648; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson MS, 2002, AM J PHYS MED REHAB, V81, P364, DOI 10.1097/00002060-200205000-00009; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	77	12	12	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E62	E73		10.1097/HTR.0000000000000214			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800007	26828711	Green Accepted			2022-02-06	
J	Kristman, VL; Brison, RJ; Bedard, M; Reguly, P; Chisholm, S				Kristman, Vicki L.; Brison, Robert J.; Bedard, Michel; Reguly, Paula; Chisholm, Shelley			Prognostic Markers for Poor Recovery After Mild Traumatic Brain Injury in Older Adults: A Pilot Cohort Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; aged; brain injuries; depression; emergency service; fatigue; follow-up studies; hospital; prognosis; prospective studies	SYMPTOMS FOLLOWING MILD; GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; GENERAL-PRACTITIONER; COPING STRATEGIES; PHYSICAL-THERAPY; EARLY PREDICTION; CONTINUED CARE; MANUAL THERAPY; HEALTH SURVEY	Objective: To identify prognostic markers associated with poor recovery from mild traumatic brain injury (MTBI) in older adults. Setting: Three Ontario emergency departments. Participants: Forty-nine participants aged 65 years and older that visited an emergency department for MTBI. Design: Pilot prospective cohort study. Main Measures: Recovery from MTBI determined using the Rivermead Postconcussion symptom Questionnaire, the Glasgow Outcomes Scale-Extended, physical and mental health functioning (SF-12), and a single question on selfrated recovery assessed by telephone shortly after emergency department visit (baseline) and again 6 months later. Predictors were measured at baseline. Results: Markers potentially associated with poor recovery included reporting worse health 1 year before the injury, poor expectations for recovery, depression, and fatigue. Conclusion: Recovery after MTBI in older adults may be associated more with psychosocial than with biomedical or injury-related factors.	[Kristman, Vicki L.; Bedard, Michel; Reguly, Paula] Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada; [Kristman, Vicki L.; Bedard, Michel] Lakehead Univ, Div Human Sci, Northern Ontario Sch Med, Thunder Bay, ON, Canada; [Kristman, Vicki L.; Bedard, Michel] Lakehead Univ, Ctr Educ & Res Aging & Hlth, Thunder Bay, ON, Canada; [Kristman, Vicki L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Brison, Robert J.] Queens Univ, Kingston Gen Hosp, Dept Emergency Med, Kingston, ON, Canada; [Bedard, Michel] St Josephs Care Grp, Thunder Bay, ON, Canada; [Chisholm, Shelley] Thunder Bay Reg Hlth Sci Ctr, Thunder Bay, ON, Canada		Kristman, VL (corresponding author), Lakehead Univ, Dept Hlth Sci, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	vkristman@lakeheadu.ca			Ontario Neurotrauma Foundation [2012-ABI-MTBI-EP-950]; CIHR New Investigator Award in Community-Based Primary Health CareCanadian Institutes of Health Research (CIHR)	This project was funded by the Ontario Neurotrauma Foundation, grant reference number 2012-ABI-MTBI-EP-950. Dr Kristman is supported by a CIHR New Investigator Award in Community-Based Primary Health Care.	AMACHER AL, 1987, NEUROSURGERY, V20, P954; ANDERSON AJ, 2002, INT J PSYCHOSOC REHA, V6, P69; Beaton DE, 2001, ARTHRIT RHEUM-ARTHR, V45, P270, DOI 10.1002/1529-0131(200106)45:3<270::AID-ART260>3.3.CO;2-K; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BROWN GK, 1989, J CONSULT CLIN PSYCH, V57, P652, DOI 10.1037/0022-006X.57.5.652; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS101, DOI 10.1016/j.apmr.2013.12.001; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2007, SPINE, V32, P126, DOI 10.1097/01.brs.0000249526.76788.e8; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; Devins G., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Fischer D, 1999, JAMA-J AM MED ASSOC, V282, P1157, DOI 10.1001/jama.282.12.1157; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Hartford Institute for Geriatric Nursing New York university College of Nursing, 2008, BEST PRACT INF CAR O; Hoving JL, 2006, CLIN J PAIN, V22, P370, DOI 10.1097/01.ajp.0000180185.79382.3f; Hoving JL, 2002, ANN INTERN MED, V136, P713, DOI 10.7326/0003-4819-136-10-200205210-00006; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Jacelon CS, 2007, NURSE RES, V14, P65; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Karasik D, 2005, J GERONTOL A-BIOL, V60, P574, DOI 10.1093/gerona/60.5.574; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MacDonald SWS, 2011, J GERONTOL B-PSYCHOL, V66, P59, DOI 10.1093/geronb/gbr039; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; ORME JG, 1986, J CLIN PSYCHOL, V42, P28, DOI 10.1002/1097-4679(198601)42:1<28::AID-JCLP2270420104>3.0.CO;2-T; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riedel-Heller SG, 2006, ACTA PSYCHIAT SCAND, V113, P388, DOI 10.1111/j.1600-0447.2005.00632.x; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Salmi L Rachid, 2014, Arch Phys Med Rehabil, V95, pS95, DOI 10.1016/j.apmr.2013.10.026; SMITH CA, 1995, HEALTH PSYCHOL, V14, P64, DOI 10.1037/0278-6133.14.1.64; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Taylor RR, 2000, PSYCHOL MED, V30, P849, DOI 10.1017/S0033291799002500; Thompson HJ, 2008, J AM GERIATR SOC, V54, P1590; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weiss D.S., 2007, CROSS CULTURAL ASSES, P219, DOI 10.1007/978-0-387-70990-1_10; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	65	12	12	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2016	31	6					E33	E43		10.1097/HTR.0000000000000226			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EC0IW	WOS:000387784800004	27022959				2022-02-06	
J	Miller, K; Eljamel, S				Miller, Kate; Eljamel, Sam			Does Size and Site Matter in Therapeutic Decompressive Craniectomy? A Laboratory-Based Experimental Study	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Intracranial hypertension; Middle cerebral artery ischemia; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; INTRACRANIAL-PRESSURE; MALIGNANT INFARCTION; PERFUSION-PRESSURE; HEMICRANIECTOMY; MANAGEMENT; DETERIORATION; METAANALYSIS; MULTICENTER	BACKGROUND: Therapeutic decompressive craniectomy (TDC) controls increased intracranial pressure (ICP). Its role was controversial until its successful introduction to treat malignant middle cerebral artery ischemia. However, standardization of size and site of TDC remains controversial. This study was designed to evaluate whether size and site matter in TDC. METHODS: A replica skull of a patient with refractory increased ICP and successful TDC was used. ICP was increased using an intracranial balloon modified to monitor ICP and permit progressive incremental increases in ICP. When a desired increased ICP was reached, segments of TDC were removed sequentially to increase its size until the ICP normalized. We also measured the volume of air required to raise the ICP back to the increased ICP value. RESULTS: The most effective TDC size to lower increased ICP was 8.3 cm in diameter (P < 0.001). However, a 7.5-cm TDC was sufficient to control increased ICP of 25-30 mm Hg (P < 0.01). There was strong correlation between TDC size and potential volume created to accommodate brain swelling postoperatively (Pearson correlation coefficient = 0.95928). The location of TDC did not matter when size was <= 3.5 cm or >= 7.5 cm; location mattered when size was 4.5 cm or 5.5 cm, where anteriorly located flaps were more effective in lowering increased ICP and increasing cranial volume (P < 0.05). CONCLUSIONS: The size of a TDC is very important in reducing increased ICP. The size should be tailored to the level of increased ICP and the likelihood of further brain swelling postoperatively. A smaller TDC should be located more anteriorly to control increased ICP. Although location is not as important when increased ICP is > 30 mm Hg and TDC size >= 8.3 cm is required.	[Miller, Kate; Eljamel, Sam] Univ Dundee, Ctr Neurosci, Dundee, Scotland; [Eljamel, Sam] HTNMS, Edinburgh, Midlothian, Scotland		Eljamel, S (corresponding author), Univ Dundee, Ctr Neurosci, Dundee, Scotland.; Eljamel, S (corresponding author), HTNMS, Edinburgh, Midlothian, Scotland.	professor.ms.eljamel@gmail.com		Millar, Kate/0000-0001-7349-875X; Eljamel, Muftah Salem (Sam)/0000-0002-1491-0094			Back L, 2015, INTERN MED J, V45, P711, DOI 10.1111/imj.12724; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Frank JI, 2014, STROKE, V45, P781, DOI 10.1161/STROKEAHA.113.003200; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; WIRTZ CR, 1997, NEUROSURG FOCUS, V2, P1; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	21	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2016	95						441	446		10.1016/j.wneu.2016.08.061			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5EZ	WOS:000390354800060	27567573				2022-02-06	
J	Treble-Barna, A; Zang, HY; Zhang, NH; Taylor, HG; Stancin, T; Yeates, KO; Wade, SL				Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Taylor, H. Gerry; Stancin, Terry; Yeates, Keith Owen; Wade, Shari L.			Observed Parent Behaviors as Time-Varying Moderators of Problem Behaviors Following Traumatic Brain Injury in Young Children	DEVELOPMENTAL PSYCHOLOGY			English	Article						pediatric traumatic brain injury; child behavior problems; parenting; recovery; parent-child interactions	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD-INJURY; AT-RISK MOTHERS; EARLY-CHILDHOOD; EXTERNALIZING BEHAVIOR; WARM RESPONSIVENESS; FUNCTIONAL RECOVERY; MATERNAL BEHAVIORS; ADULT SURVIVORS; SHORT-TERM	Parent behaviors moderate the adverse consequences of pediatric traumatic brain injury (TBI); however, it is unknown how these moderating effects change over time. This study examined the moderating effect of observed parent behaviors over time since injury on the relation between TBI and behavioral outcomes. Participants included children, ages 3-7 years, hospitalized for moderate (n = 52) or severe (n = 20) TBI or orthopedic injury (OI; n = 95). Parent-child dyads were videotaped during structured task and free play conditions, and parents completed child behavior ratings. Linear mixed models using a lagged, time-varying moderator analysis examined the relationship of observed parent behaviors at the baseline, 6-month, and 12-month assessments to child behavior problems at 6 months, 12 months, and 18 months postinjury, after controlling for preinjury levels of child behavior problems. The effect of TBI on behavior was exacerbated by less favorable parent behaviors, and buffered by more favorable parent behaviors, in children with severe TBI over the first 12 months postinjury. By 18 months postinjury, however, the moderating effect of parent behaviors diminished, such that children with severe TBI showed more behavior problems relative to children with moderate TBI or OI regardless of parent behaviors or in response to parent behaviors that were initially protective. The results suggest that the moderating effects of the family environment are complex and likely vary in relation to both recovery and developmental factors, with potentially important implications for targets and timing of intervention.	[Treble-Barna, Amery; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Div Dev & Behav Pediat & Psychol, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada		Treble-Barna, A (corresponding author), Univ Pittsburgh, Sch Med, Div Phys Med & Rehabil, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	amery.treble-barna@pitt.edu	Yeates, Keith/AAJ-4223-2020; Zang, Huaiyu/AAY-6603-2021; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD042729] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER		Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Akai CE, 2008, J PRIM PREV, V29, P223, DOI 10.1007/s10935-008-0134-z; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; BAKEMAN R, 1980, CHILD DEV, V51, P437, DOI 10.2307/1129277; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Bates JE., 2015, HDB SOCIALIZATION, P372; Baumrind D., 1989, CHILD DEV TODAY TOMO, P349; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bradley RH, 2001, CHILD DEV, V72, P1868, DOI 10.1111/1467-8624.t01-1-00383; Bradley RH, 2007, DEV PSYCHOL, V43, P1390, DOI 10.1037/0012-1649.43.6.1390; Brock RL, 2015, J ABNORM CHILD PSYCH, V43, P1295, DOI 10.1007/s10802-015-0008-9; Brody GH, 2002, CHILD DEV, V73, P274, DOI 10.1111/1467-8624.00405; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; BURGE D, 1991, J ABNORM PSYCHOL, V100, P174, DOI 10.1037/0021-843X.100.2.174; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chang H, 2011, J ABNORM CHILD PSYCH, V39, P71, DOI 10.1007/s10802-010-9437-7; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cohen J., 2013, STAT POWER ANAL BEHA; Cook DR, 1982, RESIDUALS INFLUENCE; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Davidov M, 2006, CHILD DEV, V77, P44, DOI 10.1111/j.1467-8624.2006.00855.x; Denham SA., 2015, HDB SOCIALIZATION TH, P590; Derogatis LR, 1982, BRIEF SYMPTOM INVENT; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; Eisenberg N, 1999, CHILD DEV, V70, P513, DOI 10.1111/1467-8624.00037; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ge XJ, 1996, DEV PSYCHOL, V32, P717, DOI 10.1037/0012-1649.32.4.717; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grusec J., 2015, HDB SOCIALIZATION TH, V2nd, P566; Grusec JE, 2011, ANNU REV PSYCHOL, V62, P243, DOI 10.1146/annurev.psych.121208.131650; Guttentag CL, 2014, DEV PSYCHOL, V50, P1482, DOI 10.1037/a0035682; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; HENDERSON B, 1980, CHILD DEV, V51, P457; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; LANDRY SH, 1990, CHILD DEV, V61, P1605, DOI 10.2307/1130768; Landry SH, 1997, DEV PSYCHOL, V33, P1040, DOI 10.1037/0012-1649.33.6.1040; Landry SH, 2006, DEV PSYCHOL, V42, P627, DOI 10.1037/0012-1649.42.4.627; Landry SH, 1996, MERRILL PALMER QUART, V42, P177; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; Landry SH, 2001, DEV PSYCHOL, V37, P387, DOI 10.1037//0012-1649.37.3.387; Landry SH, 2008, DEV PSYCHOL, V44, P1335, DOI 10.1037/a0013030; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Luyckx K, 2011, J CLIN CHILD ADOLESC, V40, P468, DOI 10.1080/15374416.2011.563470; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; ROBINSON EA, 1981, J CONSULT CLIN PSYCH, V49, P245, DOI 10.1037/0022-006X.49.2.245; ROTHBAUM F, 1994, PSYCHOL BULL, V116, P55, DOI 10.1037/0033-2909.116.1.55; Rubin KH, 2003, DEV PSYCHOL, V39, P164, DOI 10.1037//0012-1649.39.1.164; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; TRONICK EZ, 1989, AM PSYCHOL, V44, P112, DOI 10.1037/0003-066X.44.2.112; Verger K, 2000, BRAIN INJURY, V14, P495; Vygotsky L.S., 1978, MIND SOC; Wade M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00354; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Weeks M, 2014, DEPRESS ANXIETY, V31, P608, DOI 10.1002/da.22235; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	96	12	12	0	16	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0012-1649	1939-0599		DEV PSYCHOL	Dev. Psychol.	NOV	2016	52	11					1777	1792		10.1037/dev0000208			16	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	EB1WK	WOS:000387146800008	27786528	Green Accepted			2022-02-06	
J	Feng, K; Zhang, LY; Jin, X; Chen, CY; Kallakuri, S; Saif, T; Cavanaugh, J; King, A				Feng, Ke; Zhang, Liying; Jin, Xin; Chen, Chaoyang; Kallakuri, Srinivasu; Saif, Tal; Cavanaugh, John; King, Albert			Biomechanical responses of the Brain in swine subject to Free-Field Blasts	FRONTIERS IN NEUROLOGY			English	Article						free-field blast; head kinematics; traumatic brain injury; swine; intracranial pressure	MILITARY PERSONNEL; MACH REFLECTION; SHOCK-WAVES; INJURY; PRESSURE; EXPOSURE; MODELS; HEAD; CARE	Blast-induced traumatic brain injury (bTBI) is a signature wound of modern warfare. The current incomplete understanding of its injury mechanism impedes the development of strategies for effective protection of bTBI. Despite a considerable amount of experimental animal studies focused on the evaluation of brain neurotrauma caused by blast exposure, there is very limited knowledge on the biomechanical responses of the gyrenecephalic brain subjected to primary free-field blast waves imposed in vivo. This study aims to evaluate the external and internal mechanical responses of the brain against different levels of blast loading with Yucatan swine in free field. The incident overpressure (IOP) was generated using 3.6 kg of C4 charge placed at three standoff distances from the swine. Five swine were exposed to a total of 19 blasts. The three average peak IOP pressure levels in this study were 148.8, 278.9, and 409.2 kPa as measured by a pencil probe. The duration of the first positive wave was in the range of 2.1-3 ms. Pressure changes in the brain and head kinematics were recorded with intracranial pressure (ICP) sensors, linear accelerometers, and angular rate sensors. The corresponding average peak ICPs were in the range of 79-143, 210-281, and 311-414 kPa designated as low, medium, and high blast level, respectively. Peak head linear accelerations were in the range of 120-412 g. A positive correlation between IOP and its corresponding biomechanical responses of the brain was also observed. These experimental data can be used to validate computer models of bTBI.	[Feng, Ke; Zhang, Liying; Jin, Xin; Chen, Chaoyang; Kallakuri, Srinivasu; Saif, Tal; Cavanaugh, John; King, Albert] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA		Feng, K (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	ea3853@wayne.edu	Chen, Chaoyang/H-3605-2012	Chen, Chaoyang/0000-0003-0838-2245	MRMC, US Army [W81XWH-12-2-0038]	This research was supported by MRMC Contract No. W81XWH-12-2-0038, US Army. The views, opinions, and/or findings contained in this paper are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. This study was conducted with assistance from WSU Veterinary Surgical Services, Team Wendy LLC and ARES, Inc. We thank Alok Desai, Haonan Fan, and Chengpeng Zhou for their technical support.	Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Ben-Dor G, 2007, SHOCK WAVE HIGH PRES, P1; Bir C., 2011, DTIC DOCUMENT; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00128; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; DE ROSA M, 1992, PHYS REV A, V45, P6130, DOI 10.1103/PhysRevA.45.6130; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ivanov MS, 2001, SHOCK WAVES, V11, P199, DOI 10.1007/PL00004075; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Meyers MA., 1994, DYNAMIC BEHAV MAT, V2nd ed.; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Przekwas A., 2011, P HFM 207 NATO S SUR; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Richmond D. R., 1967, 1854 DASA FISS PROD, P1; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; White C S, 1965, CEX Rep Civ Eff Exerc, P1; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	42	12	12	0	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 24	2016	7								179	10.3389/fneur.2016.00179			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ6LC	WOS:000385972900001	27822197	Green Published, gold			2022-02-06	
J	Davidson, TW; Tremblay, F				Davidson, Travis W.; Tremblay, Francois			Evidence of alterations in transcallosal motor inhibition as a possible long-term consequence of concussions in sports: A transcranial magnetic stimulation study	CLINICAL NEUROPHYSIOLOGY			English	Article						Motor cortex; Concussion; Mild traumatic brain injury; Transcallosal inhibition; Corticomotor excitability; Inter-hemispheric interactions	TRAUMATIC BRAIN-INJURY; INTERHEMISPHERIC INHIBITION; CORPUS-CALLOSUM; AFFERENT INHIBITION; SILENT PERIOD; YOUTH SPORTS; CORTEX; ABNORMALITIES; EXCITABILITY; DIAGNOSIS	Objective: Growing evidence suggests that long-term structural and physiological alterations are present in the brain of previously concussed athletes. In this study, we sought to further explore the long-term consequences of concussions with transcranial magnetic stimulation (TMS) by examining excitability changes both within and between hemispheres. Methods: Participants (32 young adults with and without a history of concussions (HxC)) first underwent testing to assess cognitive and motor performance using standardized tests. Then, the following TMS measures were derived bilaterally: (1) resting motor threshold and motor evoked potentials (MEP), (2) afferent-induced modulation, (3) contralateral silent period (cSP) and MEP facilitation, and, (4) ipsilateral silent period (iSP). Results: Multivariate analyses of performance data revealed no major group differences. For TMS data, no "hemisphere" effects were detected for all measures. Group differences were detected only for iSP derived measures owing to alterations in the onset latency and duration of transcallosal inhibition in the HxC group. Conclusions: While no major asymmetries were found between hemispheres, participants in the HxC group showed evidence of impaired transcallosal inhibition. Significance: Results provide one of the first piece of evidence pointing to alterations in transcallosal inhibition as a potential neurophysiological marker of long-term consequences of concussions in sports. (C) 2016 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Davidson, Travis W.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Tremblay, Francois] Univ Ottawa, Sch Rehabil Sci, Ottawa, ON, Canada; [Davidson, Travis W.; Tremblay, Francois] Bruyere Res Inst, Ottawa, ON, Canada		Tremblay, F (corresponding author), Univ Ottawa, Sch Rehabil Sci, Ottawa, ON, Canada.; Tremblay, F (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada.	tdav012@uottawa.ca; ftrembla@uottawa.ca	Tremblay, Francois/D-4378-2009	Tremblay, Francois/0000-0001-5450-8035	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	TWD received a graduate scholarship from Natural Sciences and Engineering Research Council of Canada towards the completion of this project. The authors wish to thank all participants for their time and patience during testing. Special thanks to Anthony Remaud for helping with implementing the automated analysis of silent period data. Part of this work served for the partial fulfillment of a Ph.D. thesis in Human Kinetics by TWD.	Bernard JA, 2011, J NEUROPHYSIOL, V105, P88, DOI 10.1152/jn.00512.2010; Borckardt JJ, 2006, J ECT, V22, P169, DOI 10.1097/01.yct.0000235923.52741.72; Bryden PJ, 2000, BRAIN COGNITION, V44, P402, DOI 10.1006/brcg.1999.1201; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2014, PROG NEUROL SURG, V28, P75, DOI 10.1159/000358766; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Davidson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070286; Davidson T, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-62; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Devanne H, 2009, EUR J NEUROSCI, V30, P439, DOI 10.1111/j.1460-9568.2009.06815.x; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V569, P315, DOI 10.1113/jphysiol.2005.092155; Di Lazzaro V, 2002, NEUROLOGY, V59, P392, DOI 10.1212/WNL.59.3.392; Doeltgen SH, 2010, CLIN NEUROPHYSIOL, V121, P448, DOI 10.1016/j.clinph.2009.11.085; Finch H., 2005, METHODOLOGY-EUR, V1, P27, DOI DOI 10.1027/1614-1881.1.1.27; Fischer M, 2011, BRAIN STIMUL, V4, P202, DOI 10.1016/j.brs.2010.10.005; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Lapitskaya N, 2013, BRAIN STIMUL, V6, P130, DOI 10.1016/j.brs.2012.03.010; Lefebvre G, 2015, BRAIN INJURY, V29, P1032, DOI 10.3109/02699052.2015.1028447; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li JY, 2013, J NEUROPHYSIOL, V109, P659, DOI 10.1152/jn.01044.2011; Livingston SC, 2010, J CLIN MONIT COMPUT, V24, P427, DOI 10.1007/s10877-010-9267-8; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lovell M.R.C.M., 2003, IMMEDIATE POSTCONCUS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Meyer BU, 1998, ANN NEUROL, V43, P360, DOI 10.1002/ana.410430314; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Perez MA, 2009, J PHYSIOL-LONDON, V587, P725, DOI 10.1113/jphysiol.2008.166926; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Phillips KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1535; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schmierer K, 2002, NEUROLOGY, V59, P1218, DOI 10.1212/WNL.59.8.1218; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Wah Chia Chin, 2010, THESIS; Young-Bernier M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.012; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028	57	12	12	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2016	127	10					3364	3375		10.1016/j.clinph.2016.07.012			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX0BU	WOS:000384027300025	27531393				2022-02-06	
J	Derakhshanrad, N; Yekaninejad, MS; Vosoughi, F; Fazel, FS; Saberi, H				Derakhshanrad, N.; Yekaninejad, M. S.; Vosoughi, F.; Fazel, F. Sadeghi; Saberi, H.			Epidemiological study of traumatic spinal cord injuries: experience from a specialized spine center in Iran	SPINAL CORD			English	Article							CLINICAL-OUTCOMES; UNITED-STATES; PREVALENCE; WORLDWIDE; ETIOLOGY; PROFILE; TRENDS	Study design: A cross-sectional study. Objectives: This study was performed for epidemiological assessment of Iranian Traumatic Spinal Cord Injuries (TSCI), referred to a specialized spine center. Setting: Patient recruitment and evaluations were conducted at the Brain and Spinal Injury Research Center, Tehran, Iran. Methods: This study was performed from September 2011 to March 2015 on 1137 consecutive TSCIs. History, clinicoradiological findings as well as chronic complications and social integration were recorded. The capture-recapture method was used to calculate a rough estimation of TSCI prevalence in Tehran Province. Results: Our report includes 1137 cases with a mean age of 29.1 years (s.d.=11.2 year)-79.2% of them being male (M/F=3.8/1). Rough estimation of TSCI prevalence in Tehran province was 2.36 per 10 000 population. Regarding etiology, 61.8% were due to motor vehicle accident (MVA), followed by falling 24.5%, heavy drop 5.2%, violence 3.8%, sport 2.8% and others causes 1.9%. Regarding injury level, 31.5% were cervical, 57.9% thoracic and 10.6% lumbar. Complete lesions were 53.5% of patients and 46.5% were incomplete. Most common neurological type was T1-S5 (American Spinal Injury Association Impairment Scale: A, B, C, 61.7%). Most common complications included urinary tract infection followed by pressure sore (grade III and IV, 37.5%), autonomic dysreflexia (37%) and neuropathic pain (31.2%). Substance abuse was observed in 8.8% of cases. Overall, similar to 25% in our cases were employed after TSCI. Secondary divorce was also much more frequent than normal matched controls. Conclusion: MVA was the most common cause for TSCI. The elderly subjects were less frequent among our patients than more developed countries. The high rate of unemployment and divorce in our cases deserves special consideration.	[Derakhshanrad, N.; Vosoughi, F.; Fazel, F. Sadeghi; Saberi, H.] Univ Tehran Med Sci, Neurosci Inst, Brain & Spinal Cord Injuries Res Ctr BASIR, Imam Khomeini Hosp Complex, Tehran, Iran; [Yekaninejad, M. S.] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Saberi, H.] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Neurosurg, Tehran, Iran		Saberi, H (corresponding author), Univ Tehran Med Sci, Brain & Spinal Cord Injuries Res Ctr, Imam Khomeini Hosp Complex,Keshavarz Blvd, Tehran 1449614535, Iran.	hgsaberi@yahoo.com	Yekaninejad, Mir Saeed/L-6752-2016; Vosoughi, fardis/AAG-9424-2019	Yekaninejad, Mir Saeed/0000-0003-3648-5276; Vosoughi, Fardis/0000-0002-9136-0479			Aito S, 2014, SPINAL CORD, V52, P268, DOI 10.1038/sc.2014.2; Alshahri SS, 2012, SPINAL CORD, V50, P882, DOI 10.1038/sc.2012.65; Bakhtiyari M, 2014, INT J INJ CONTROL SA, V21, P103, DOI 10.1080/17457300.2012.762027; Botterell E H, 1975, Can J Neurol Sci, V2, P361; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Chen Y, 2015, J SPINAL CORD MED; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; CHIU WT, 1993, J TRAUMA, V35, P206, DOI 10.1097/00005373-199308000-00006; Committee Membership:, 2012, Top Spinal Cord Inj Rehabil, V18, P85, DOI 10.1310/sci1801-85; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Hagen EM, 2010, SPINAL CORD, V48, P313, DOI 10.1038/sc.2009.133; Hoque MF, 1999, SPINAL CORD, V37, P858, DOI 10.1038/sj.sc.3100938; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Jetha Arif, 2014, Top Spinal Cord Inj Rehabil, V20, P310, DOI 10.1310/sci2004-310; Johnson RL, 1996, SPINAL CORD, V34, P470, DOI 10.1038/sc.1996.81; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Knutsdottir S, 2012, SPINAL CORD, V50, P123, DOI 10.1038/sc.2011.105; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P1708, DOI 10.1016/j.apmr.2009.04.020; Lofvenmark I, 2015, SPINAL CORD, V53, P150, DOI 10.1038/sc.2014.203; Mann R, 2013, SPINAL CORD, V51, P564, DOI 10.1038/sc.2013.34; Mathur N, 2015, SPINAL CORD, V53, P349, DOI 10.1038/sc.2014.153; McCammon JR, 2011, J SPINAL CORD MED, V34, P6, DOI 10.1179/107902610X12923394765733; Mena Quinones PO NM, 2002, MIDDLE E J EMERGENCY, V2, P1; Murphy G, 2009, J REHABIL MED, V41, P1074, DOI 10.2340/16501977-0465; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Nijendijk JHB, 2014, SPINAL CORD, V52, P258, DOI 10.1038/sc.2013.180; Noonan VK, 2012, SPINAL CORD, V50, P22, DOI 10.1038/sc.2011.109; Obalum DC, 2009, SPINAL CORD, V47, P134, DOI 10.1038/sc.2008.93; Patel AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E8; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; Post MWM, 2016, SPINAL CORD, V54, P314, DOI 10.1038/sc.2015.99; Powell-Cope G, 2015, REHABIL NURS, V40, P100, DOI 10.1002/rnj.134; Rahimi-Movaghar V, 2009, J SPINAL CORD MED, V32, P428, DOI 10.1080/10790268.2009.11754572; Raibulet T, 2001, KUWAIT MED J, V33, P211; Rekand Tiina, 2012, Tidsskr Nor Laegeforen, V132, P970, DOI 10.4045/tidsskr.10.0872; Bellucci CHS, 2015, NEUROEPIDEMIOLOGY, V44, P85, DOI 10.1159/000371519; Vaccaro AR, 2005, J SPINAL DISORD TECH, V18, P209; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Wilson JR, 2013, SPINE, V38, P97, DOI 10.1097/BRS.0b013e31826e2b91; Wyndaele JJ, 2012, SPINAL CORD, V50, P483, DOI 10.1038/sc.2012.73; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yousefzadeh Chabok Shahrokh, 2010, Acta Med Iran, V48, P308	46	12	13	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	OCT	2016	54	10					901	907		10.1038/sc.2016.10			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EA1QF	WOS:000386366200023	26882485	Bronze			2022-02-06	
J	Kimura-Ohba, S; Yang, Y; Thompson, J; Kimura, T; Salayandia, VM; Cosse, M; Yang, YR; Sillerud, LO; Rosenberg, GA				Kimura-Ohba, Shihoko; Yang, Yi; Thompson, Jeffrey; Kimura, Tomonori; Salayandia, Victor M.; Cosse, Melissa; Yang, Yirong; Sillerud, Laurel O.; Rosenberg, Gary A.			Transient increase of fractional anisotropy in reversible vasogenic edema	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Blood-brain barrier; brain vasogenic edema; diffusion tensor imaging; fractional anisotropy; posterior reversible encephalopathy syndrome	TRAUMATIC BRAIN-INJURY; DIFFUSION-TENSOR; ENCEPHALOPATHY SYNDROME; WHITE-MATTER; ACUTE STROKE; MULTIPLE-SCLEROSIS; HYPERTENSIVE-RATS; CYCLOSPORINE; ISCHEMIA; BARRIER	Brain vasogenic edema, involving disruption of the blood-brain barrier, is a common pathological condition in several neurological diseases, with a heterogeneous prognosis. It is sometimes reversible, as in posterior reversible encephalopathy syndrome, but often irreversible and our current clinical tools are insufficient to reveal its reversibility. Here, we show that increased fractional anisotropy in magnetic resonance imaging is associated with the reversibility of vasogenic edema. Spontaneously, hypertensive rats-stroke prone demonstrated posterior reversible encephalopathy syndrome-like acute encephalopathy in response to high-dose cyclosporine A treatment; the deteriorating neurological symptoms and worsening scores in behavioral tests, which were seen in acute phase, dissappered after recovery by cessation of cyclosporine A. In the acute phase of encephalopathy, the fractional anisotropy and apparent diffusion coefficient increased in areas with IgG leakage. This increase of fractional anisotropy occurred in the absence of demyelination: fluid leakage into the myelinated space increased the axial, but not the radial, diffusivity, resulting in the increased fractional anisotropy. This increased fractional anisotropy returned to pre-encephalopathy values in the recovery phase. Our results highlight the importance of the fractional anisotropy increase as a marker for the reversibility of brain edema, which can delineate the brain areas for which recovery is possible.	[Kimura-Ohba, Shihoko; Yang, Yi; Thompson, Jeffrey; Salayandia, Victor M.; Cosse, Melissa; Sillerud, Laurel O.; Rosenberg, Gary A.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Kimura, Tomonori] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Yang, Yirong; Sillerud, Laurel O.] Univ New Mexico, BRaIN Imaging Ctr, Albuquerque, NM 87131 USA; [Yang, Yirong; Sillerud, Laurel O.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; [Rosenberg, Gary A.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Rosenberg, Gary A.] Univ New Mexico, Dept Cell Biol & Physiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA		Kimura-Ohba, S (corresponding author), Univ New Mexico, Dept Neurol, Hlth Sci Ctr, MSC11 6035,Domenici Hall NRF,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	ShKimura@salud.unm.edu		Kimura, Tomonori/0000-0001-8186-094X	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS045847]; Manpei Suzuki Diabetes Foundation; Uehara Memorial FoundationUehara Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045847] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: GAR was supported by the NINDS (RO1 NS045847). TK was supported by Manpei Suzuki Diabetes Foundation and Uehara Memorial Foundation.	Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aoki Shigeki, 2005, Radiat Med, V23, P195; Arroyo MVA, 2002, TRANSPLANTATION, V74, P1618, DOI 10.1097/01.TP.0000041449.31360.16; Bailey EL, 2011, NEUROPATH APPL NEURO, V37, P711, DOI 10.1111/j.1365-2990.2011.01170.x; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chen YJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-62; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Endo A, 2012, PEDIATR EMERG CARE, V28, P153, DOI 10.1097/PEC.0b013e3182442fe8; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.2307/2334381; Guo AC, 2002, RADIOLOGY, V222, P729, DOI 10.1148/radiol.2223010311; Hugonnet E, 2013, Diagn Interv Imaging, V94, P45, DOI 10.1016/j.diii.2012.02.005; Jalal FY, 2015, J CEREBR BLOOD F MET, V35, P1145, DOI 10.1038/jcbfm.2015.21; Jalal FY, 2012, STROKE, V43, P1115, DOI 10.1161/STROKEAHA.111.643080; Lawrence AJ, 2014, NEUROLOGY, V83, P304, DOI 10.1212/WNL.0000000000000612; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lin JT, 2003, AM J NEURORADIOL, V24, P102; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu X, 2013, J MAGN RESON IMAGING, V37, P15, DOI 10.1002/jmri.23647; Liu Y, 2013, BEHAV BRAIN RES, V257, P166, DOI 10.1016/j.bbr.2013.10.007; LUKE DR, 1990, DRUG METAB DISPOS, V18, P158; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Osuka S, 2012, J NEUROSURG, V117, P363, DOI 10.3171/2012.4.JNS112305; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Puig J, 2013, STROKE, V44, P1162, DOI 10.1161/STROKEAHA.111.678110; Rosenberg GA, 2005, LANCET, V365, P1291, DOI 10.1016/S0140-6736(05)61008-2; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shbarou RM, 2000, BONE MARROW TRANSPL, V26, P801, DOI 10.1038/sj.bmt.1702603; Singh N, 2000, TRANSPLANTATION, V69, P467, DOI 10.1097/00007890-200002270-00001; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Wood JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006597; Yamagata K, 2012, NEUROCHEM INT, V60, P91, DOI 10.1016/j.neuint.2011.11.002; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yasuhara T, 2011, J CLIN NEUROSCI, V18, P406, DOI 10.1016/j.jocn.2010.06.011	45	12	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2016	36	10					1731	1743		10.1177/0271678X16630556			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	DY8AC	WOS:000385349400007	26865662	Bronze, Green Published			2022-02-06	
J	Li, D; Tong, L; Kawano, H; Liu, N; Yan, HJ; Zhao, L; Li, HP				Li, Dan; Tong, Lei; Kawano, Hitoshi; Liu, Nan; Yan, Hong-Jing; Zhao, Liang; Li, Hong-Peng			Regulation and role of ERK phosphorylation in glial cells following a nigrostriatal pathway injury	BRAIN RESEARCH			English	Article						Nigrostriatal pathway injury; ERK signal pathway; U0126; Astrocyte; Microglia/macrophage	TRAUMATIC BRAIN-INJURY; RAT CORTICAL-NEURONS; DOPAMINERGIC AXONS; INDUCED APOPTOSIS; MEK/ERK PATHWAY; SPINAL-CORD; CNS INJURY; ADULT-RAT; ACTIVATION; ASTROCYTES	This study was undertaken to examine the function of extracellular signal-regulated kinase (ERIC) signaling pathway on the proliferation and activation of microglia/macrophage and astrocytes after brain injury in mice. The result of Western blot showed that p-ERK was immediately activated after injury ( <4 h), but the duration was short ( <4 days). According to immunofluorescence double staining, it was found that at 4 and 8 h after injury, p-ERK was expressed in microglia/macrophages, and that more cells were co-expressed by p-ERK and IBA-1 (microglia/macrophage marker) at 8 h; at days 1 and 4, p-ERK was expressed in astrocytes, and more cells were co-expressed by p-ERK and GFAP (astrocyte marker) at day 4. After injury, the mice were injected with U0126 (MAPK/ERK signaling pathway inhibitor) via the femoral vein. Compared with those injected with DMSO, the cell number co-expressed by p-ERK and IBA-1 or GFAP significantly decreased (P < 0.05). The increase of microglia/macrophage and astrocyte caused by injury was remitted, and the positive cell number significantly decreased (P < 0.05). Western blot showed that the expression quantity of IBA-1 and GFAP significantly decreased (P < 0.05). Furthermore, the ERIC signaling pathway was involved in the proliferation and activation of the two glial cells types and improved long-term neurobehavioral function after brain injury. Therefore, the exploration of the formation mechanism of glial scar after injury and further research on the therapeutic method of neural regeneration are essential. (C) 2016 Elsevier B.V. All rights reserved.	[Li, Dan; Tong, Lei; Liu, Nan; Yan, Hong-Jing; Zhao, Liang; Li, Hong-Peng] China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Peoples R China; [Kawano, Hitoshi] Teikyo Heisei Univ, Fac Hlth & Med Sci, Dept Hlth & Dietet, Tokyo 1708445, Japan		Li, HP (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Peoples R China.	377317599@qq.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [NSFC-81171248]	The authors would like to thank Professor Hong Lai for the integrity of the data and the accuracy of the data analysis. This research was supported by National Natural Science Foundation of China (NSFC), Grants no: NSFC-81171248.	Armstead WM, 2012, NEUROL RES, V34, P530, DOI 10.1179/1743132812Y.0000000039; Aschner M, 2002, BRAIN PATHOL, V12, P475; Ashabi G, 2012, BEHAV BRAIN RES, V232, P165, DOI 10.1016/j.bbr.2012.04.006; Chen C., 2012, EURASIP J WIREL COMM, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0052975; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Cheng PP, 2013, INT J DEV NEUROSCI, V31, P783, DOI 10.1016/j.ijdevneu.2013.09.008; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hayakawa K, 2010, GLIA, V58, P1007, DOI 10.1002/glia.20982; Inoue T, 2009, MOL IMMUNOL, V47, P222, DOI 10.1016/j.molimm.2009.09.033; Ji Haiwang, 2002, J Tradit Chin Med, V22, P252; Jiang PF, 2015, EUR ARCH PSY CLIN N, V265, P497, DOI 10.1007/s00406-015-0588-y; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Katayama T, 2010, EUR J NEUROSCI, V31, P1359, DOI 10.1111/j.1460-9568.2010.07160.x; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kawano H, 2005, J NEUROSCI RES, V80, P191, DOI 10.1002/jnr.20441; KEMPSKI OS, 1994, ACTA NEUROCHIR, P7; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khuwaja G, 2011, BRAIN RES, V1368, P254, DOI 10.1016/j.brainres.2010.10.023; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Lacroix S, 2000, NEUROREHAB NEURAL RE, V14, P265, DOI 10.1177/154596830001400403; Li B, 2014, TUMOR BIOL, V35, P10057, DOI 10.1007/s13277-014-2312-3; Li HP, 2007, J NEUROSCI RES, V85, P536, DOI 10.1002/jnr.21141; Liu L, 2000, EXP BRAIN RES, V131, P64, DOI 10.1007/s002219900273; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Mabuchi N, 2000, J CARDIOVASC PHARM, V36, pS87, DOI 10.1097/00005344-200000006-00019; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; Moore AJ, 2002, AM NAT, V160, pS186, DOI 10.1086/342899; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Szydlowska K, 2010, J NEUROCHEM, V113, P904, DOI 10.1111/j.1471-4159.2010.06656.x; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Tian YD, 2014, CANCER BIOTHER RADIO, V29, P339, DOI 10.1089/cbr.2014.1666; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; TOWER DB, 1973, J NEUROCHEM, V20, P269, DOI 10.1111/j.1471-4159.1973.tb12126.x; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; VICK RS, 1992, J NEUROTRAUM, V9, pS93; Wang LF, 2015, MOL NEUROBIOL, V52, P478, DOI 10.1007/s12035-014-8848-9; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yang GA, 2011, BRAIN PATHOL, V21, P279, DOI 10.1111/j.1750-3639.2010.00445.x; Yenari MA, 2010, NEUROTHERAPEUTICS, V7, P378, DOI 10.1016/j.nurt.2010.07.005; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051	48	12	15	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 1	2016	1648		A				90	100		10.1016/j.brainres.2016.07.008			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DY7OI	WOS:000385318400010	27402431				2022-02-06	
J	Li, DP; Ma, SS; Guo, DW; Cheng, T; Li, HW; Tian, Y; Li, JB; Guan, FX; Yang, B; Wang, J				Li, Dongpeng; Ma, Shanshan; Guo, Dewei; Cheng, Tian; Li, Hongwei; Tian, Yi; Li, Jianbin; Guan, Fangxia; Yang, Bo; Wang, Jian			Environmental Circadian Disruption Worsens Neurologic Impairment and Inhibits Hippocampal Neurogenesis in Adult Rats After Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Circadian rhythms; Traumatic brain injury; Constant light; Hippocampus; Neurogenesis	SLEEP-DEPRIVATION; LIGHT EXPOSURE; DIM LIGHT; CLOCK; DISTURBANCES; MECHANISMS; MELATONIN; RESPONSES; RECOVERY; MEMORY	Circadian rhythms modulate many physiologic processes and behaviors. Therefore, their disruption causes a variety of potential adverse effects in humans and animals. Circadian disruption induced by constant light exposure has been discovered to produce pathophysiologic consequences after brain injury. However, the underlying mechanisms that lead to more severe impairment and disruption of neurophysiologic processes are not well understood. Here, we evaluated the effect of constant light exposure on the neurobehavioral impairment and survival of neurons in rats after traumatic brain injury (TBI). Sixty adult male Sprague-Dawley rats were subjected to a weight-drop model of TBI and then exposed to either a standard 12-/12-h light/dark cycle or a constant 24-h light/light cycle for 14 days. Our results showed that 14 days of constant light exposure after TBI significantly worsened the sensorimotor and cognitive deficits, which were associated with decreased body weight, impaired water and food intake, increased cortical lesion volume, and decreased neuronal survival. Furthermore, environmental circadian disruption inhibited cell proliferation and newborn cell survival and decreased immature cell production in rats subjected to the TBI model. We conclude that circadian disruption induced by constant light exposure worsens histologic and neurobehavioral impairment and inhibits neurogenesis in adult TBI rats. Our novel findings suggest that light exposure should be decreased and circadian rhythm reestablished in hospitalized TBI patients and that drugs and strategies that maintain circadian rhythm would offer a novel therapeutic option.	[Li, Dongpeng; Guo, Dewei; Cheng, Tian; Li, Hongwei; Tian, Yi; Yang, Bo] Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Li, Dongpeng; Li, Jianbin] Henan Prov Red Cross Blood Ctr, Zhengzhou 450014, Henan, Peoples R China; [Ma, Shanshan; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Peoples R China; [Cheng, Tian; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA		Yang, B (corresponding author), Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China.; Guan, FX (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Peoples R China.	guanfangxia@126.com; yangbo96@126.com	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171177, 81471306, U1404313]; Innovative Research Team (in Science and Technology) of the University of Henan Province [15IRTSTHN022]; Plan For Scientific Innovation Talent of Henan Province [154200510008]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS078026, R01AT007317]; China Scholarship CouncilChina Scholarship Council; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078026] Funding Source: NIH RePORTER	This study was supported by the National Natural Science Foundation of China (81171177,81471306, U1404313), the Innovative Research Team (in Science and Technology) of the University of Henan Province (15IRTSTHN022), the Plan For Scientific Innovation Talent of Henan Province (154200510008) and NIH (R01NS078026, R01AT007317). T.C. is a recipient of the China Scholarship Council Joint PhD Training award. We thank Claire Levine, MS, ELS, for assistance with this manuscript.	Alibhai FJ, 2015, CAN J CARDIOL, V31, P860, DOI 10.1016/j.cjca.2015.01.015; Antle MC, 2009, REV ENDOCR METAB DIS, V10, P279, DOI 10.1007/s11154-009-9116-6; Aubrecht TG, 2015, CHRONOBIOL INT, V32, P557, DOI 10.3109/07420528.2014.986682; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Bales JW, 2012, ANIMAL MODELS ACUTE, VII, P385, DOI DOI 10.1007/978-1-61779-782-8_33; Bedrosian TA, 2011, PSYCHONEUROENDOCRINO, V36, P1062, DOI 10.1016/j.psyneuen.2011.01.004; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Castro JPMV, 2005, PHYSIOL BEHAV, V86, P218, DOI 10.1016/j.physbeh.2005.07.009; Chakir I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00190; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Costa SSF, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00043; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Fonken LK, 2013, BRAIN BEHAV IMMUN, V34, P159, DOI 10.1016/j.bbi.2013.08.011; Fonken LK, 2013, J BIOL RHYTHM, V28, P262, DOI 10.1177/0748730413493862; Giebultowicz JM, 2015, CURR OPIN INSECT SCI, V7, P82, DOI 10.1016/j.cois.2015.03.001; Hardin KA, 2009, CHEST, V136, P284, DOI 10.1378/chest.08-1546; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Kott J, 2012, NEUROSCI LETT, V515, P177, DOI 10.1016/j.neulet.2012.03.048; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; Martinez-Vargas M, 2012, NEUROSCI LETT, V529, P118, DOI 10.1016/j.neulet.2012.09.037; Matulka K, 2013, CELL STEM CELL, V13, P706, DOI 10.1016/j.stem.2013.09.016; Miyamoto H, 2012, J NEUROSCI, V32, P14794, DOI 10.1523/JNEUROSCI.0793-12.2012; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mueller AD, 2011, NEUROSCIENCE, V193, P170, DOI 10.1016/j.neuroscience.2011.07.019; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Park SY, 2013, MOL CELL ENDOCRINOL, V371, P114, DOI 10.1016/j.mce.2012.11.010; Roenneberg Till, 2013, Handb Exp Pharmacol, P311, DOI 10.1007/978-3-642-25950-0_13; Stevens RG, 2007, ENVIRON HEALTH PERSP, V115, P1357, DOI 10.1289/ehp.10200; Stevens RG, 2013, AM J PREV MED, V45, P343, DOI 10.1016/j.amepre.2013.04.011; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Tataroglu O, 2004, BRAIN RES, V1001, P118, DOI 10.1016/j.brainres.2003.11.063; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang HQ, 2014, NEUROPHARMACOLOGY, V86, P9, DOI 10.1016/j.neuropharm.2014.06.018; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Zelinski EL, 2014, NEUROSCI BIOBEHAV R, V40, P80, DOI 10.1016/j.neubiorev.2014.01.007; Zuurbier LA, 2015, EUR J NEUROL, V22, P1482, DOI 10.1111/ene.12775	42	12	13	1	48	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2016	36	7					1045	1055		10.1007/s10571-015-0295-2			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DS3KA	WOS:000380680500003	26886755	Green Accepted			2022-02-06	
J	Magruder, JT; Hibino, N; Collica, S; Zhang, HT; Harness, HL; Heitmiller, ES; Jacobs, ML; Cameron, DE; Vricella, LA; Everett, AD				Magruder, J. Trent; Hibino, Narutoshi; Collica, Sarah; Zhang, Huaitao; Harness, H. Lynn; Heitmiller, Eugenie S.; Jacobs, Marshall L.; Cameron, Duke E.; Vricella, Luca A.; Everett, Allen D.			Association of nadir oxygen delivery on cardiopulmonary bypass with serum glial fibrillary acid protein levels in paediatric heart surgery patients	INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY			English	Article						Congenital heart disease; Paediatric; Brain injury; Cardiopulmonary bypass	TRAUMATIC BRAIN-INJURY; BIOMARKER; HYPOTENSION; CHILDREN; RISK	OBJECTIVES: Protecting the brain during cardiac surgery is a major challenge. We evaluated associations between nadir oxygen delivery (DO2) during paediatric cardiac surgery and a biomarker of brain injury, glial fibrillary acidic protein (GFAP). METHODS: Blood samples were obtained during a prospective, single-centre observational study of children undergoing congenital heart surgery with cardiopulmonary bypass (CPB) (2010-2011). Remnant blood samples, collected serially prior to cannulation for bypass and until incision closure, were analysed for GFAP levels. Perfusion records were reviewed to calculate nadir DO2. Linear regression analysis was used to assess the association between nadir DO2 and GFAP levels. RESULTS: A total of 116 consecutive children were included, with the median age of 0.75 years (interquartile range: 0.42-8.00) and the median weight of 8.3 kg (5.8-20.0). Single-ventricle anatomy was present in 19 patients (16.4%). Deep hypothermic circulatory arrest (DHCA) was used in 14 patients (12.1%). On univariable analysis, nadir DO2 was significantly associated with GFAP values measured during rewarming on CPB (P = 0.005) and after CPB decannulation (P = 0.02). On multivariable analysis controlling for CPB time, DHCA and procedure risk category, a significant negative relationship remained between nadir DO2 and post-CPB GFAP (P = 0.03). CONCLUSIONS: Lower nadir DO2 is associated with increased GFAP levels, suggesting that diminished DO2 during paediatric heart surgery may be contributing to neurological injury. The DO2-GFAP relationship may provide a useful measure for the implementation of neuroprotective strategies in paediatric heart surgery, including goal-directed perfusion.	[Magruder, J. Trent; Hibino, Narutoshi; Collica, Sarah; Zhang, Huaitao; Harness, H. Lynn; Jacobs, Marshall L.; Cameron, Duke E.; Vricella, Luca A.] Johns Hopkins Univ, Sch Med, Div Cardiac Surg, Baltimore, MD USA; [Heitmiller, Eugenie S.] Johns Hopkins Univ, Sch Med, Div Anesthesiol, Baltimore, MD USA; [Everett, Allen D.] Johns Hopkins Univ, Sch Med, Div Pediat Cardiol, Baltimore, MD USA		Everett, AD (corresponding author), 1800 Orleans St, Baltimore, MD 21231 USA.	aeveret3@jhmi.edu			Veracis	Under a licensing agreement between ImmunArray Ltd and the Johns Hopkins University, Allen D. Everett is entitled to royalties on an invention described in this article. Allen D. Everett also is a paid consultant to Veracis, a subsidiary of ImmunArray Ltd. Otherwise, the authors have no competing interests or conflicts of interest to disclose.	Andropoulos DB, 2010, J THORAC CARDIOV SUR, V139, P543, DOI 10.1016/j.jtcvs.2009.08.022; Beca J, 2013, CIRCULATION, V127, P971, DOI 10.1161/CIRCULATIONAHA.112.001089; Bembea MM, 2011, PEDIATR CRIT CARE ME, V12, P572, DOI 10.1097/PCC.0b013e3181fe3ec7; Brunetti MA, 2014, CARDIOL YOUNG, V24, P623, DOI 10.1017/S1047951113000851; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; de Somer F, 2011, CRIT CARE, V15, DOI 10.1186/cc10349; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hori D, 2015, ANN THORAC SURG, V100, P1353, DOI 10.1016/j.athoracsur.2015.04.006; Hori D, 2015, ANN THORAC SURG, V100, P487, DOI 10.1016/j.athoracsur.2015.03.036; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Magruder JT, 2015, ANN THORAC SURG, V100, P1697, DOI 10.1016/j.athoracsur.2015.05.059; Mahle WT, 2002, CIRCULATION, V106, pI109, DOI 10.1161/01.cir.0000032908.33237.b1; McKenney SL, 2016, CARDIOL YOUNG, P1; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Ranucci M, 2005, ANN THORAC SURG, V80, P2213, DOI 10.1016/j.athoracsur.2005.05.069; Rappold T, 2016, BRIT J ANAESTH, V116, P83, DOI 10.1093/bja/aev415; Sarajuuri A, 2012, PEDIATRICS, V130, pE1636, DOI 10.1542/peds.2012-0486; Savage WJ, 2011, AM J HEMATOL, V86, P427, DOI 10.1002/ajh.21995; Seghaye MC, 1996, J THORAC CARDIOV SUR, V112, P687, DOI 10.1016/S0022-5223(96)70053-3; Stewart A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.02.049	25	12	12	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1569-9293	1569-9285		INTERACT CARDIOV TH	Interact Cardiovasc. Thorac. Surg.	OCT	2016	23	4					531	537		10.1093/icvts/ivw194			7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	DZ8NS	WOS:000386127700005	27316657	Bronze			2022-02-06	
J	Mazaherpur, S; Khatony, A; Abdi, A; Pasdar, Y; Najafi, F				Mazaherpur, Sakine; Khatony, Alireza; Abdi, Alireza; Pasdar, Yahia; Najafi, Farid			The Effect of Continuous Enteral Nutrition on Nutrition Indices, Compared to the Intermittent and Combination Enteral Nutrition in Traumatic Brain Injury Patients	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Intensive care units; Mortality; Nutritional support	CRITICALLY-ILL PATIENTS; RANDOMIZED CONTROLLED-TRIAL; PARENTERAL-NUTRITION; CARE MANAGEMENT; EPIDEMIOLOGY; SUPPORT; ICU	Introduction: Nutrition support is one of the most common care, which is undertaken for patients who suffered from Traumatic Brain Injury (TBI) and are admitted in intensive care units. Literature indicates some controversies regarding the appropriate method of nutrition support in these patients. Aim: This study was conducted for determining the effect of continuous enteral nutrition on nutrition indices, compared to the intermittent enteral and combination nutrition in TBI patients. Materials and Methods: In a randomized clinical trial, 60 TBI patients who were admitted to critical care units of Taleghani Hospital of Kermanshah-Iran in 2010 recruited to the study. The samples were allocated to three groups of continuous enteral nutrition, intermittent enteral nutrition and combination nutrition supports by random sampling. The tool was a researchermade checklist. The three methods of nutrition support were performed to the participants, then nutrition indices of patients were measured before and during three weeks. Data were analysed using SPSS software, descriptive, and inferential statistics. Results: The mean of received energy in the combination group (53.1 +/- 18.3%) was higher than continuous (38.5 +/- 19.7%) and intermittent (32.2 +/- 14.7%) groups, significantly (p<0.001). The received protein was also greater in combination method (67.7 +/- 16.9%) than continuous (31.8 +/- 15.1%) and intermittent groups (17.2 +/- 10.1%), (p=0.001). The mean of nitrogen balance was improved in continuous method from -4.7 +/--1.6 to 7.2 +/- 5.2, (p<0.001) significantly. Conclusion: In this study, received energy of patients was not enough by three methods. However, the continuous method, having a positive effect on nitrogen balance, reducing hypercatabolism and maintaining the total body protein, was preferred to brain injury patients compared with intermittent enteral and parenteral methods that demand more studies.	[Mazaherpur, Sakine; Khatony, Alireza; Abdi, Alireza] Kermanshah Univ Med Sci, Fac Nursing & Midwifery, Dept Nursing, Kermanshah, Iran; [Pasdar, Yahia] Kermanshah Univ Med Sci, Coll Publ Hlth, Dept Nutr, Kermanshah, Iran; [Najafi, Farid] Kermanshah Univ Med Sci, Res & Technol Ctr, Stat & Epidemiol Dept, Kermanshah, Iran		Khatony, A (corresponding author), Kermanshah Univ Med Sci, Fac Nursing & Midwifery, Kerrnanshah, Iran.	AKhatony@gmail.com	khatony, alireza/M-8348-2017; Pasdar, Yahya/J-9064-2017				Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; Awad S, 2010, CLIN NUTR, V29, P243, DOI 10.1016/j.clnu.2009.08.016; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chakravarty C, 2013, INDIAN J CRIT CARE M, V17, P170, DOI 10.4103/0972-5229.117058; De Jonghe B, 2001, CRIT CARE MED, V29, P8, DOI 10.1097/00003246-200101000-00002; De Waele E, 2014, CRITICAL CARE S1, V18, pP427; Dhandapani S, 2012, SURG NEUROLOGY INT, V3; Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124; Dudek S. G., 2001, Nutrition essentials for nursing practice, pi; Elke G, 2014, JPEN J PARENTER ENTE; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hegazi RA, 2011, CRIT CARE, V15, DOI 10.1186/cc10430; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Heyland DK, 1998, JAMA-J AM MED ASSOC, V280, P2013, DOI 10.1001/jama.280.23.2013; Huang YC, 2000, CLIN NUTR, V19, P101, DOI 10.1054/clnu.1999.0077; Jivnani Sabita, 2010, J Emerg Trauma Shock, V3, P109, DOI 10.4103/0974-2700.62101; Meirelles CMJ, 2011, NUTR HOSP, V26, P1120, DOI [10.1590/S0212-16112011000500030, 10.3305/nh.2011.26.5.5133]; Kadamani I, 2014, AUST CRIT CARE, V27, P188, DOI 10.1016/j.aucc.2013.12.001; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lederman Vania Guertzenstein, 2009, Complement Ther Clin Pract, V15, P38, DOI 10.1016/j.ctcp.2008.10.006; Lee JSW, 2010, CLIN NUTR, V29, P453, DOI 10.1016/j.clnu.2009.10.003; MacLeod JBA, 2007, J TRAUMA, V63, P57, DOI 10.1097/01.ta.0000249294.58703.11; Mahan L., 2012, KRAUSE DIETOTERAPIA; Maurya I, 2011, SAUDI J ANAESTH, V5, P195, DOI 10.4103/1658-354X.82800; Meier R, 2006, CLIN NUTR, V25, P275, DOI 10.1016/j.clnu.2006.01.019; Mowe M, 2008, CLIN NUTR, V27, P196, DOI 10.1016/j.clnu.2007.10.014; Nagata S, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-24; Park JS, 2012, J KOREAN MED SCI, V27, P261, DOI 10.3346/jkms.2012.27.3.261; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Shahriari Mohsen, 2015, J Educ Health Promot, V4, P95, DOI 10.4103/2277-9531.171809; Sheean PM, 2013, CLIN NUTR, V32, P752, DOI 10.1016/j.clnu.2012.12.012; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Vizzini A, 2011, NUTRITION, V27, P129, DOI 10.1016/j.nut.2010.05.004; Wang S, 2013, CRIT CARE, V17, DOI 10.1186/cc12850; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838	41	12	16	0	6	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	OCT	2016	10	10					JC1	JC5		10.7860/JCDR/2016/19271.8625			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ3OF	WOS:000397981700020	27891355	Green Published, gold			2022-02-06	
J	Padgett, CR; Summers, MJ; Skilbeck, CE				Padgett, Christine R.; Summers, Mathew J.; Skilbeck, Clive E.			Is APOE epsilon 4 Associated With Poorer Cognitive Outcome Following Traumatic Brain Injury? A Meta-Analysis	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; apolipoprotein E; cognitive function; executive function; memory	APOLIPOPROTEIN-E POLYMORPHISM; ENVIRONMENT INTERACTION RESEARCH; GLASGOW COMA SCALE; ALZHEIMERS-DISEASE; OLDER-ADULTS; HEAD-INJURY; ANTAGONISTIC PLEIOTROPY; POSTTRAUMATIC AMNESIA; GENETIC POLYMORPHISMS; NEURONAL DAMAGE	Objective: Cognitive impairment is a common sequelae of traumatic brain injury (TBI); however, predicting who will experience poorer outcomes remains challenging. A potential risk factor that has gained attention is the APOE gene, with the epsilon 4 allele hypothesized to have a detrimental effect on post-TBI cognitive outcome. The aim of this meta-analysis was to evaluate the effect of APOE epsilon 4 both in terms of general cognitive function and within specific domains known to be prone to impairment following TBI (executive function, working memory, verbal memory and visual memory). Method: A literature search was undertaken in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA), resulting in the inclusion of 10 studies (epsilon 4-carriers n = 143, noncarriers n = 510). Neuropsychological tasks were identified, and Cohen's d was calculated and pooled. Meta-analyses were conducted on general cognitive functioning and for the specific cognitive domains of interest. Results: No significant differences were found between APOE epsilon 4-carriers or noncarriers, either in general cognitive function or in the cognitive domains of executive function, working memory, verbal memory, or visual memory. Conclusions: This meta-analysis indicates that APOE epsilon 4 does not have a detrimental effect on cognitive performance following TBI. We propose that the relationship between APOE and cognitive function following TBI is complex, and a more-nuanced exploration of APOE genotypes is needed.	[Padgett, Christine R.] Univ Tasmania, Fac Hlth Sci, Sch Med Psychol, Launceston, Tas, Australia; [Summers, Mathew J.] Univ Sunshine Coast, Fac Arts & Business, Sch Social Sci, Sunshine Coast, Qld, Australia; [Summers, Mathew J.] Univ Tasmania, Sch Med, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia; [Skilbeck, Clive E.] Univ Tasmania, Bag 1342, Launceston, Tas 7250, Australia		Padgett, CR (corresponding author), Univ Tasmania, Bag 1342, Launceston, Tas 7250, Australia.	christine.padgett@utas.edu.au	Summers, Mathew J/G-3168-2011; Padgett, Christine/J-2774-2013	Summers, Mathew J/0000-0002-3869-4920; Padgett, Christine/0000-0003-4398-4268	Eli Lily (Australia) Pty Ltd; Novotech Pty Ltd	Mathew J. Summers reports personal fees from Eli Lily (Australia) Pty Ltd and grants from Novotech Pty Ltd, outside the submitted work. The remaining authors declare that they have no conflicts of interest.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; American Psychological Association, 2012, PUBL MAN AM PSYCH AS; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Becker JT, 2015, J NEUROVIROL, V21, P24, DOI 10.1007/s13365-014-0290-2; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Bour AMJJ, 2010, DEMENT GERIATR COGN, V29, P534, DOI 10.1159/000314678; Bunce D, 2014, J GERONTOL A-BIOL, V69, P379, DOI 10.1093/gerona/glt103; Bunce D, 2011, NEUROPSYCHOLOGIA, V49, P1693, DOI 10.1016/j.neuropsychologia.2011.02.042; Carter AJR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-160; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chang L, 2011, NEUROIMAGE, V58, P1017, DOI 10.1016/j.neuroimage.2011.07.010; Chang L, 2014, NEUROLOGY, V82, P2213, DOI 10.1212/WNL.0000000000000526; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cudaback E, 2015, GLIA, V63, P51, DOI 10.1002/glia.22732; Cumming G, 2012, UNDERSTANDING NEW ST, P2012; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Engelborghs S, 2006, NEUROBIOL AGING, V27, P285, DOI 10.1016/j.neurobiolaging.2005.02.005; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Federoff M, 2012, NEUROBIOL DIS, V46, P389, DOI 10.1016/j.nbd.2012.02.002; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Hodgkinson A, 2009, BRAIN IMPAIR, V10, P162, DOI 10.1375/brim.10.2.162; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Horsburgh K, 2003, INT CONGR SER, V1252, P171, DOI 10.1016/S0531-5131(03)00024-4; Hostage CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054483; Howell D. C, 2013, STAT METHODS PSYCHOL; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; Jorm AF, 2007, NEUROPSYCHOLOGY, V21, P1, DOI 10.1037/0894-4105.21.1.1; Kemp S, 2010, J NEUROPSYCHOL, V4, P231, DOI 10.1348/174866409X482614; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koutseff A, 2014, BRAIN RES, V1542, P32, DOI 10.1016/j.brainres.2013.10.003; Kulminski AM, 2013, AGING CELL, V12, P237, DOI 10.1111/acel.12046; Kulminski AM, 2011, AGING CELL, V10, P533, DOI 10.1111/j.1474-9726.2011.00689.x; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Leoni V, 2010, BIOCHEM SOC T, V38, P1021, DOI 10.1042/BST0381021; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lipsey M.W., 2001, PRACTICAL META ANAL; Louko AM, 2006, ACTA NEUROL SCAND, V114, P315, DOI 10.1111/j.1600-0404.2006.00676.x; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mata IF, 2014, JAMA NEUROL, V71, P1405, DOI 10.1001/jamaneurol.2014.1455; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Maxwell SS, 2011, NEUROLOGY, V77, P158, DOI 10.1212/WNL.0b013e318224afa3; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morris PG, 2004, ACTA NEUROL SCAND, V109, P205, DOI 10.1034/j.1600-0404.2003.00206.x; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Noe E, 2010, BRAIN INJURY, V24, P886, DOI 10.3109/02699051003724952; Orihara Y, 2002, INT J LEGAL MED, V116, P92, DOI 10.1007/s00414-001-0265-8; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; SCOTT J, 1985, HUM GENET, V71, P144; Shadli RM, 2011, BRAIN INJURY, V25, P596, DOI 10.3109/02699052.2011.572947; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2015, ARCH PHYS MED REHAB, V96, P652, DOI 10.1016/j.apmr.2014.10.024; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; SNIPS GJ, 1986, P NATL ACAD SCI USA, V83, P1130, DOI 10.1073/pnas.83.4.1130; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Struble RG, 2007, EXP GERONTOL, V42, P54, DOI 10.1016/j.exger.2006.05.013; Stubbs B., 2017, BMJ, V7, P1, DOI [10.1038/s41467-019-10003-8, 10.1038/s41598-017-07579-w, DOI 10.1136/BMJ.B2535]; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Suri S, 2013, NEUROSCI BIOBEHAV R, V37, P2878, DOI 10.1016/j.neubiorev.2013.10.010; Tai LM, 2015, J NEUROCHEM, V133, P465, DOI 10.1111/jnc.13072; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Teasdale TW, 2000, NEUROPSYCHOL REHABIL, V10, P151, DOI 10.1080/096020100389228; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tuminello Elizabeth R, 2011, Int J Alzheimers Dis, V2011, P726197, DOI 10.4061/2011/726197; UTERMANN G, 1980, AM J HUM GENET, V32, P339; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wagle J, 2010, INT J GERIATR PSYCH, V25, P833, DOI 10.1002/gps.2425; Wagner AK, 2012, BRAIN INJURY, V26, P1658, DOI 10.3109/02699052.2012.700089; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; White F, 2001, EXP NEUROL, V169, P307, DOI 10.1006/exnr.2001.7655; Wierenga CE, 2013, J ALZHEIMERS DIS, V34, P921, DOI 10.3233/JAD-121897; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	127	12	12	1	24	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2016	30	7					775	790		10.1037/neu0000270			16	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DY9FX	WOS:000385440400001	26986748				2022-02-06	
J	Ragsdale, KA; Horrell, SCV				Ragsdale, Katie A.; Horrell, Sarah C. Voss			Effectiveness of Prolonged Exposure and Cognitive Processing Therapy for US Veterans With a History of Traumatic Brain Injury	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DIAGNOSIS; PTSD	This retrospective analysis of previously existing nonrandomized clinical data examined the effectiveness of completing prolonged exposure (PE) or cognitive processing therapy (CPT) in a sample of 41 U.S. veterans at a Veterans Affairs medical center. The sample included 19 veterans with diagnoses of posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) and 22 veterans with PTSD only. Diagnostic groups did not significantly differ on PTSD and depression symptom reduction, F(2, 36) = 0.05, p = .951; Pillai's trace = 0.00, partial (2)= .00. Veterans who completed PE showed greater symptom reduction than those who completed CPT, F(2, 36) = 12.10, p < .001; Pillai's trace = 0.40, partial (2) = .40, regardless of TBI status. Overall, our results suggested that TBI status should not preclude individuals from being offered trauma-focused PTSD treatment.	[Ragsdale, Katie A.; Horrell, Sarah C. Voss] Salem Vet Affairs Med Ctr, Salem, VA 24153 USA		Ragsdale, KA (corresponding author), Salem Vet Affairs Med Ctr, Salem, VA 24153 USA.	KatieRagsdale@knights.ucf.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chard KM, 2012, J REHABIL RES DEV, V49, P667, DOI 10.1682/JRRD.2011.10.0198; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Foa E.B., 2007, PROLONGED EXPOSURE T; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Resick PA, 2014, COGNITIVE PROCESSING; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Steenkamp MM, 2013, CLIN PSYCHOL REV, V33, P45, DOI 10.1016/j.cpr.2012.10.002; U.S. Department of Veteran Affairs, 2015, AN VA HLTH CAR UT OP; U. S. Department of Veterans Affairs & U. S. Department of Defense, 2010, VA DOD CLIN PRACT GU; Weathers F.W., 1993, 9 ANN C ISTSS; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	22	12	12	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	OCT	2016	29	5					474	477		10.1002/jts.22130			4	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	DZ9HO	WOS:000386185600010	27681034				2022-02-06	
J	Raji, CA; Merrill, DA; Barrio, JR; Omalu, B; Small, GW				Raji, Cyrus A.; Merrill, David A.; Barrio, Jorge R.; Omalu, Bennet; Small, Gary W.			Progressive Focal Gray Matter Volume Loss in a Former High School Football Player: A Possible Magnetic Resonance Imaging Volumetric Signature for Chronic Traumatic Encephalopathy	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						CTE; volumetric MRI; Neuroreader; FDDNP; brain PET	BRAIN-INJURY; LEAGUE PLAYER; MRI; PATTERN; ATROPHY	Here a case is presented of a 51-year-old former high school football player with multiple concussions, including one episode with loss of consciousness. The patient experienced 6 years of cognitive and mood decline, and his wife corroborated increasing memory loss, attentional difficulties, and depressed mood without suicidal ideation. He had been unable to maintain full-time employment because of progressive decline. Based on his presentation, he had been previously diagnosed with attention deficit hyperactivity disorder and bipolar disorder, type II. Neuropsychological tests indicated domain-specific cognitive impairment, and longitudinal volumetric magnetic resonance imaging (MRI) of the brain showed progressive brainstem, diencephalic, and frontal lobe atrophy. This regional volume loss correlated with the increased signal seen on tau and amyloid imaging (FDDNP-PET scan) of a separate case of suspected chronic traumatic encephalopathy (CTE). Visual assessment of the MRI also showed evidence of old petechial hemorrhages in the frontal and temporal-parietal lobe white matter. This case raises the possibility of distinct quantitative and visual brain MRI findings in suspected CTE.	[Raji, Cyrus A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, CLA, Los Angeles, CA 90095 USA; [Merrill, David A.; Small, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, CLA, Los Angeles, CA 90095 USA; [Barrio, Jorge R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, CLA, Los Angeles, CA 90095 USA; [Omalu, Bennet] Univ Calif Davis, Med Ctr, Dept Pathol, Davis, CA 95616 USA		Raji, CA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, 10751 Wilshire Blvd,Unit 608, Los Angeles, CA 90024 USA.	cyrusraji@gmail.com	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146			Ahdidan J, 2016, J ALZHEIMERS DIS, V49, P723, DOI 10.3233/JAD-150559; Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Boccardi M, 2003, NEUROBIOL AGING, V24, P95, DOI 10.1016/S0197-4580(02)00045-3; Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.1155/2009/616581, 10.3233/BEN-2009-0226]; Brueggen K, 2015, J ALZHEIMERS DIS, V48, P197, DOI 10.3233/JAD-150063; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Iverson GL, 2014, APPL NEUROPSYCH-ADUL, V21, P36, DOI 10.1080/09084282.2012.721149; Klein C, 2012, TEDDY ROOSEVELT SAVE; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037; Redlich R, 2014, JAMA PSYCHIAT, V71, P1222, DOI 10.1001/jamapsychiatry.2014.1100; Ross DE, 2012, J NEUROPSYCH CLIN N, V24, pE33, DOI 10.1176/appi.neuropsych.11020044; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; YARNELL PR, 1970, NEUROLOGY, V20, P416	23	12	12	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	OCT	2016	24	10					784	790		10.1016/j.jagp.2016.07.018			7	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	EA6WX	WOS:000386770900002	27567184	Green Published			2022-02-06	
J	Sveen, U; Roe, C; Sigurdardottir, S; Skandsen, T; Andelic, N; Manskow, U; Berntsen, SA; Soberg, HL; Anke, A				Sveen, Unni; Roe, Cecilie; Sigurdardottir, Solrun; Skandsen, Toril; Andelic, Nada; Manskow, Unn; Berntsen, Svein A.; Soberg, Helene L.; Anke, Audny			Rehabilitation pathways and functional independence one year after severe traumatic brain injury	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Critical pathway; Multicenter study; Rehabilitation; Treatment outcome; Brain injuries	PROSPECTIVE MULTICENTER; CONTINUOUS CHAIN; NATIONAL COHORT; PRACTICAL SCALE; HEAD-INJURY; 1ST YEAR; CARE; OUTCOMES; ADULTS; EPIDEMIOLOGY	BACKGROUND: After severe traumatic brain injury (TBI) it is recommended that patients in need of rehabilitation be transferred directly from acute care to specialized rehabilitation. However, recent European cohort studies found a variety of care pathways and delays in admission to rehabilitation after severe TBI. AIM: To study the pathways within rehabilitation services in a Norwegian national cohort with severe TBI and the association to functional independence 12 months post-injury. DESIGN: Observational prospective multicenter study. SETTING: Regional trauma centers. POPULATION: A total of 163 adults, age 16-85 years, with severe TBI. METHODS: The main variables were transfer between acute care and rehabilitation, type of rehabilitation services and functional independence. Results: 75% of the patients had specialized TBI rehabilitation, 11% non-specialized and 14% no in-patient rehabilitation. In total, 48% were transferred directly to specialized rehabilitation from acute units in regional trauma centers. There were no differences in injury severity between patients transferred directly and non-directly, but the direct-transfer patients were younger. At 12 months post-injury, 71% were functionally independent and 90% lived in their home. Younger age, fewer days of ventilation and shorter post-traumatic amnesia were associated with independence. Among patients treated with specialized rehabilitation, direct transfer to rehabilitation was associated with functional independence (OR=4.3, P<0.01). CONCLUSIONS: A direct clinical pathway including specialized rehabilitation in dedicated units was associated with functional independence.	[Sveen, Unni; Roe, Cecilie; Andelic, Nada; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Sveen, Unni; Soberg, Helene L.] Oslo & Akershus Univ, Fac Hlth Sci, Coll Appl Sci, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Sigurdardottir, Solrun] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Oslo, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neurosci, Fac Med, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Manskow, Unn; Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Berntsen, Svein A.] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway; [Anke, Audny] Univ Tromso, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Manskow, Unn] Univ Tromso, Dept Hlth & Care Sci, Fac Hlth Sci, Tromso, Norway		Sveen, U (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	unni.sveen@hioa.no		Andelic, Nada/0000-0002-3719-4406; Anke, Audny/0000-0002-2491-2560	Norwegian Research CouncilResearch Council of NorwayEuropean Commission [185267]	This study was conducted with grants from the Norwegian Research Council, grant no. 185267.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL AIS 20; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Cullen N, 2013, BRAIN INJURY, V27, P799, DOI 10.3109/02699052.2013.775488; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Mcilvoy L, 2001, J NEUROSCI NURS, V32, P72, DOI DOI 10.1097/01376517-200104000-00002; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587	30	12	12	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	OCT	2016	52	5					650	661					12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	ET0PI	WOS:000399965500006	27050083				2022-02-06	
J	Wu, QL; Liu, GD; Xu, LX; Wen, XC; Cai, Y; Fan, WJ; Yao, XH; Huang, HL; Li, QG				Wu, Qiaoli; Liu, Guodong; Xu, Lixia; Wen, Xiaochang; Cai, Ying; Fan, Weijia; Yao, Xiuhua; Huang, Huiling; Li, Qingguo			Repair of Neurological Function in Response to FK506 Through CaN/NFATc1 Pathway Following Traumatic Brain Injury in Rats	NEUROCHEMICAL RESEARCH			English	Article						FK506; Traumatic brain injury; NFATc1 pathway; Neurological protection	MARROW STROMAL CELLS; INDUCED APOPTOSIS; CALCINEURIN; ASTROCYTES; EXPRESSION; THERAPY; CALCIUM; NFAT	Tacrolimus (FK506), an immunophilin ligand, has been widely shown to be neuroprotective in a posttraumatic period. The nuclear factor of activated T cells (NFATc1) pathway plays an important role in regenerating neurological function following traumatic brain injury (TBI), but the precise mechanism underlying FK506-induced repair of neurological functions remains unclear. In the present study, a total of 210 SD rats were enrolled and randomly divided into sham group, TBI group and FK506 group. The rats in the TBI and FK506 groups were inflicted with moderate TBI left lateral fluid percussion impact. A modified neurological severity score (mNSS) system was used to evaluate the severity of effects on nerve function. mNSS levels were significantly lower in the FK506 group than in the TBI group. The zaccumulation of cerebral water content was lower, cerebral Aquaporin 4 (AQP4) mRNA level was lower, the number of growth-associated protein-43 (GAP-43)-positive cells was higher, and the distribution of vesicles containing excitatory neurotransmitters was altered in the injured cortex in the FK506 group. Moreover, the cortical mRNA and serum protein expression levels of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) were decreased in FK506 group, especially at 6 h and at 1 day after TBI. At days 1-28 after TBI, the expression of cleaved-caspase 3, which indicates apoptosis, was lower in the FK506 group than in the TBI group. Mechanistically, FK506 significantly down-regulated the mRNA and protein levels of calcium-regulated phosphatase (calcineurin, CaN) and inhibited the activation of NFATc1. These results demonstrate that FK506 relieved inflammatory responses by regulating the NFATc1 signaling pathway and promoting the synaptic reconstruction of neurons and glial cells by regulating cell apoptosis, thereby facilitated improvements in neurological function.	[Wu, Qiaoli; Xu, Lixia; Cai, Ying; Fan, Weijia; Yao, Xiuhua; Huang, Huiling] Tianjin Neurosurg Inst, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin 300060, Peoples R China; [Liu, Guodong] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept 8, Chongqing 400042, Peoples R China; [Li, Qingguo] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300060, Peoples R China; [Wen, Xiaochang] Logist Univ, PAP, Tianjin 300162, Peoples R China		Huang, HL (corresponding author), Tianjin Neurosurg Inst, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin 300060, Peoples R China.; Li, QG (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300060, Peoples R China.	huanghuiling@126.com; lqg369@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571216]; Science and Technology Fund of Tianjin Public Health Bureau [2012KR09, 14KG115]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015T81090]	This study was supported by the grants from National Natural Science Foundation of China (81571216) and Science and Technology Fund of Tianjin Public Health Bureau (2012KR09, 14KG115). China Postdoctoral Science Foundation (2015T81090).	Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Gold BG, 1999, DRUG METAB REV, V31, P649, DOI 10.1081/DMR-100101940; Gomez-Lechon MJ, 2004, BIOCHEM PHARMACOL, V68, P2427, DOI 10.1016/j.bcp.2004.08.028; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kelly Stephen, 2002, Curr Med Res Opin, V18 Suppl 2, ps55, DOI 10.1185/030079902125000732; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Kobeissy FH, 2015, BRAIN NEUROTRAUMA MO; Laskowitz D., 2016, TRANSLATIONAL RES TR; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Miekisiak G, 2016, BRAIN INJURY, V30, P79, DOI 10.3109/02699052.2015.1104550; Nottingham S, 2002, EXP NEUROL, V177, P242, DOI 10.1006/exnr.2002.7975; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Palacin M, 2013, CELL BIOL TOXICOL, V29, P407, DOI 10.1007/s10565-013-9263-0; Poulter MO, 2004, NEUROSCIENCE, V128, P1, DOI 10.1016/j.neuroscience.2004.06.016; Que J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.56; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Suda S, 2011, LIFE SCI, V89, P50, DOI 10.1016/j.lfs.2011.05.001; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Taylor DO, 2003, ANN THORAC SURG, V75, pS72, DOI 10.1016/S0003-4975(03)00482-X; Viola JPB, 2005, BRAZ J MED BIOL RES, V38, P335, DOI 10.1590/S0100-879X2005000300003; Ward JL, 2011, J TRAUMA, V70, P1471, DOI 10.1097/TA.0b013e31821c38bd; Zawadzka M, 2003, MOL CELL NEUROSCI, V22, P202, DOI 10.1016/S1044-7431(03)00036-8	29	12	12	1	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2016	41	10					2810	2818		10.1007/s11064-016-1997-7			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA1TY	WOS:000386376000030	27386875				2022-02-06	
J	Li, ZQ; Oganesyan, D; Mooney, R; Rong, XF; Christensen, MJ; Shahmanyan, D; Perrigue, PM; Benetatos, J; Tsaturyan, L; Aramburo, S; Annala, AJ; Lu, Y; Najbauer, J; Wu, XW; Barish, ME; Brody, DL; Aboody, KS; Gutova, M				Li, Zhongqi; Oganesyan, Diana; Mooney, Rachael; Rong, Xianfang; Christensen, Matthew J.; Shahmanyan, David; Perrigue, Patrick M.; Benetatos, Joseph; Tsaturyan, Lusine; Aramburo, Soraya; Annala, Alexander J.; Lu, Yang; Najbauer, Joseph; Wu, Xiwei; Barish, Michael E.; Brody, David L.; Aboody, Karen S.; Gutova, Margarita			L-MYC Expression Maintains Self- Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells	STEM CELL REPORTS			English	Article							ENZYME/PRODRUG THERAPY; GENERATION; NEURONS; CARBOXYLESTERASE; MOUSE; MODEL; LINE	Pre-clinical studies indicate that neural stem cells (NSCs) can limit or reverse CNS damage through direct cell replacement, promotion of regeneration, or delivery of therapeutic agents. Immortalized NSC lines are in growing demand due to the inherent limitations of adult patient-derived NSCs, including availability, expandability, potential for genetic modifications, and costs. Here, we describe the generation and characterization of a new human fetal NSC line, immortalized by transduction with L-MYC (LM-NSC008) that in vitro displays both self-renewal and multipotent differentiation into neurons, oligodendrocytes, and astrocytes. These LM-NSC008 cells were non-tumorigenic in vivo, and migrated to orthotopic glioma xenografts in immunodeficient mice. When administered intranasally, LM-NSC008 distributed specifically to sites of traumatic brain injury (TBI). These data support the therapeutic development of immortalized LM-NSC008 cells for allogeneic use in TBI and other CNS diseases.	[Li, Zhongqi; Oganesyan, Diana; Mooney, Rachael; Christensen, Matthew J.; Shahmanyan, David; Tsaturyan, Lusine; Aramburo, Soraya; Annala, Alexander J.; Barish, Michael E.; Aboody, Karen S.; Gutova, Margarita] City Hope Natl Med Ctr, Dept Dev & Stem Cell Biol, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Li, Zhongqi; Oganesyan, Diana; Mooney, Rachael; Christensen, Matthew J.; Shahmanyan, David; Tsaturyan, Lusine; Aramburo, Soraya; Annala, Alexander J.; Lu, Yang; Wu, Xiwei; Barish, Michael E.; Aboody, Karen S.; Gutova, Margarita] City Hope Natl Med Ctr, Beckman Res Inst, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Lu, Yang; Wu, Xiwei] City Hope Natl Med Ctr, Integrat Genom Core, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Perrigue, Patrick M.] Polish Acad Sci, Inst Bioorgan Chem, Dept Epigenet, PL-61704 Poznan, Poland; [Najbauer, Joseph] Univ Pecs, Sch Med, Dept Immunol & Biotechnol, H-7624 Pecs, Hungary; [Rong, Xianfang; Benetatos, Joseph; Brody, David L.] Washington Univ, Hope Ctr Neurol Disorders, Dept Neurol, St Louis, MO 63110 USA		Gutova, M (corresponding author), City Hope Natl Med Ctr, Dept Dev & Stem Cell Biol, 1500 East Duarte Rd, Duarte, CA 91010 USA.; Gutova, M (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, 1500 East Duarte Rd, Duarte, CA 91010 USA.	mgutova@coh.org		Annala, Alex/0000-0002-5967-6596; Mooney, Rachael/0000-0002-9069-0206	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS065069-07]; Accelerate Brain Cancer Cure (ABC2); Alex's Lemonade Stand Foundation; Altschul foundation; Pediatric Cancer Research Foundation; Bioinformatics, Cytogenetics and Pathology Cores - National Cancer Institute of the NIH [P30CA033572]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065069] Funding Source: NIH RePORTER	The authors acknowledge the technical expertise and advice of Sofia Loera of the City of Hope Pathology Core, and the editorial assistance of Dr. Keely L. Walker and Andrea Lynch (City of Hope). We also thank Dr. Shinya Yamanaka for providing the L-MYC plasmids. This work was supported by funding from NIH (R01 NS065069-07), Accelerate Brain Cancer Cure (ABC2), Alex's Lemonade Stand Foundation, Altschul foundation, and Pediatric Cancer Research Foundation. Research was also supported by work performed in the Bioinformatics, Cytogenetics and Pathology Cores supported by the National Cancer Institute of the NIH under grant number P30CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. K.S.A. and A.J.A. are uncompensated Board Members, Chief Scientific and Chief Financial Officers, and shareholders of TheraBiologics.	Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365; Addicott B, 2011, CONTRAST MEDIA MOL I, V6, P7, DOI 10.1002/cmmi.396; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Begum AN, 2015, STEM CELL RES, V15, P731, DOI 10.1016/j.scr.2015.10.014; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Conacci-Sorrell Maralice, 2014, Cold Spring Harb Perspect Med, V4, pa014357, DOI 10.1101/cshperspect.a014357; Daniela Ferrari, 2007, V399, P199, DOI 10.1007/978-1-59745-504-6_14; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gutova M, 2013, GENE THER, V20, P143, DOI 10.1038/gt.2012.12; Gutova M., 2015, J STEM CELLS REGEN M, V1; Gutova M, 2010, CURR STEM CELL RES T, V5, P273, DOI 10.2174/157488810791824421; Hicks C, 2013, CELL TRANSPLANT, V22, P1541, DOI 10.3727/096368912X657936; Kallos MS, 1999, BIOTECHNOL BIOENG, V63, P473, DOI 10.1002/(SICI)1097-0290(19990520)63:4<473::AID-BIT11>3.3.CO;2-3; Kanojia D, 2015, STEM CELLS, V33, P2985, DOI 10.1002/stem.2109; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023; Meng J, 2014, METHODS, V69, P274, DOI 10.1016/j.ymeth.2014.06.008; Metz MZ, 2013, STEM CELL TRANSL MED, V2, P983, DOI 10.5966/sctm.2012-0177; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, ADV EXP MED BIOL, V695, P215, DOI 10.1007/978-1-4419-7037-4_14; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Pathan Shadab A, 2009, Recent Pat Drug Deliv Formul, V3, P71; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Tang HL, 2013, CELL REPROGRAM, V15, P435, DOI 10.1089/cell.2012.0081; Tu WB, 2015, BBA-GENE REGUL MECH, V1849, P469, DOI 10.1016/j.bbagrm.2014.06.002; Umeda K, 2016, ONCOL LETT, V11, P856, DOI 10.3892/ol.2015.3928; Watanabe A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0292; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wierdl M, 2008, CANCER GENE THER, V15, P183, DOI 10.1038/sj.cgt.7701112	38	12	13	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	SEP 13	2016	7	3					483	495		10.1016/j.stemcr.2016.07.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EE3QD	WOS:000389508300014	27546534	gold, Green Published			2022-02-06	
J	Markus, TE; Zeharia, A; Cohen, YH; Konen, O				Markus, Tal Eidlitz; Zeharia, Avraham; Cohen, Yishai Haimi; Konen, Osnat			Persistent Headache and Cephalic Allodynia Attributed to Head Trauma in Children and Adolescents	JOURNAL OF CHILD NEUROLOGY			English	Article						mild traumatic brain injury; moderate to severe traumatic brain injury; allodynia; tension headache; migraine headache	CHRONIC POSTTRAUMATIC HEADACHE; BRAIN-INJURY; MIGRAINE; SENSITIZATION	The aim of the study was to investigate clinical features of headache associated with minor versus moderate to severe traumatic brain injury and of posttraumatic versus primary headache in children and adolescents. Study group included 74 patients after mild (n = 60) or moderate to severe (n = 14) traumatic brain injury identified by retrospective review of the computerized files of a tertiary pediatric headache clinic. Forty patients (54%) had migraine-like headache, 23 (31.1%) tension-like headache, and 11 (14.9%) nonspecified headache. Fourteen patients (53.8%) had allodynia. In comparison with 174 control patients, the study group had a significantly lower proportion of patients with migraine-like headache and a higher proportion of male patients and patients with allodynia. There was no statistically significant correlation of any of the clinical parameters with the type or severity of the posttraumatic headache or rate of allodynia. The high rate of allodynia in the study group may indicate a central sensitization in posttraumatic headache.	[Markus, Tal Eidlitz; Zeharia, Avraham; Cohen, Yishai Haimi] Schneider Childrens Med Ctr Israel, Day Hospitalizat Dept, Pediat Headache Clin, IL-49202 Petah Tiqwa, Israel; [Markus, Tal Eidlitz; Zeharia, Avraham; Cohen, Yishai Haimi; Konen, Osnat] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Konen, Osnat] Schneider Childrens Med Ctr Israel, Dept Pediat Radiol, Petah Tiqwa, Israel		Markus, TE (corresponding author), Schneider Childrens Med Ctr Israel, Day Hospitalizat Dept, Pediat Headache Clin, IL-49202 Petah Tiqwa, Israel.	eidlitz@post.tau.ac.il					Abu-Arafeh I, 2014, PAIN MANAG, V4, P303, DOI [10.2217/pmt.14.16, 10.2217/PMT.14.16]; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Callaghan M, 2001, DEV MED CHILD NEUROL, V43, P819, DOI 10.1017/S0012162201001487; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; De Felice M, 2011, CURR OPIN NEUROL, V24, P193, DOI 10.1097/WCO.0b013e328346af25; De Felice M, 2010, BRAIN, V133, P2475, DOI 10.1093/brain/awq159; De Felice M, 2010, ANN NEUROL, V67, P325, DOI 10.1002/ana.21897; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dixon WJ, 1993, BMPD STAT SOFTWARE M; Eidlitz-Markus T, 2007, HEADACHE, V47, P1219, DOI 10.1111/j.1526-4610.2007.00892.x; Ekizoglu E, 2012, CEPHALALGIA, V32, P1049, DOI 10.1177/0333102412457091; Fanciullacci Marcello, 2005, J Headache Pain, V6, P331, DOI 10.1007/s10194-005-0224-8; Goryunova A V, 2007, Neurosci Behav Physiol, V37, P761, DOI 10.1007/s11055-007-0079-3; Jankowski MP, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-34; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lewis DW, 2002, NEUROLOGY, V59, P490, DOI 10.1212/WNL.59.4.490; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Moscato Davide, 2005, J Headache Pain, V6, P284, DOI 10.1007/s10194-005-0208-8; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P100; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x	30	12	12	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	SEP	2016	31	10					1213	1219		10.1177/0883073816650036			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	DU9OA	WOS:000382546000001	27221373				2022-02-06	
J	Martini, DN; Goulet, GC; Gates, DH; Broglio, SP				Martini, Douglas N.; Goulet, Grant C.; Gates, Deanna H.; Broglio, Steven P.			Long-term effects of adolescent concussion history on gait, across age	GAIT & POSTURE			English	Article						Chronic; Sport concussion; High school; Dual task	TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; OLDER-ADULTS; BIOMECHANICS; STABILITY; OBSTACLES; EPIDEMIOLOGY; SYMPTOMS; PATTERNS; EXERCISE	The aim of this study was to examine the possible long-term effects of high school concussion history on gait performance across the lifespan. Individuals with and without a concussion history were grouped into 20-year-old (yo) (n=40), 40yo (n=19), and 60yo (n= 18) age groups. Participants completed five trials of four walking conditions: a normal walk, a dual task walk, an obstructed walk, and an obstructed, dual task walk. Spatiotemporal gait parameters for gait analyses during single and dual task conditions. Gait velocity, step width, stride length, percent of time in double support, and obstacle toe clearance were the gait variables assessed along with number correct from dual task. Gait was analyzed via optical motion capture. Data were analyzed by two-factor, multivariate ANOVAs and significant interactions were explored using post hoc contrasts. A significant (F= 2.62, p = 0.03) interaction was observed for the obstructed walk condition. Further analyses yielded no significant concussion history and control group differences, within age. The data indicate that an adolescent concussion history has a non-observable effect on gait across the lifespan. (C) 2016 Elsevier B.V. All rights reserved.	[Martini, Douglas N.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Goulet, Grant C.] Univ Michigan, Sch Kinesiol, Michigan Performance Res Lab, Ann Arbor, MI 48109 USA; [Gates, Deanna H.] Univ Michigan, Sch Kinesiol, Rehabil Biomech Lab, Ann Arbor, MI 48109 USA		Martini, DN (corresponding author), 3181 SW Sam Jackson Pk Rd OP32, Portland, OR 97239 USA.	martidou@ohsu.edu		Gates, Deanna/0000-0002-6086-0913	National Athletic Trainers' Association - Research and Education Foundation (NATA-REF.); Rackham Graduate School - University of MichiganUniversity of Michigan System; University of Michigan Injury Center	This project was funded by the National Athletic Trainers' Association - Research and Education Foundation (NATA-REF.) The Rackham Graduate School - University of Michigan, and The University of Michigan Injury Center.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; BROOKS LR, 1967, Q J EXP PSYCHOL, V19, P289, DOI 10.1080/14640746708400105; Buckley T. A., 2015, J SPORT HLTH SCI; CHEN HC, 1991, J GERONTOL, V46, pM196, DOI 10.1093/geronj/46.6.M196; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cohen J., 2013, STAT POWER ANAL BEHA; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gibson T. B., 2014, NEUROLOGY; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Judge JO, 1996, CLIN GERIATR MED, V12, P659; JUDGE JO, 1993, ARCH PHYS MED REHAB, V74, P400; Kahneman D., 1973, ATTENTION EFFORT; Kerrigan DC, 1998, ARCH PHYS MED REHAB, V79, P317, DOI 10.1016/S0003-9993(98)90013-2; Krebs DE, 1998, ARCH PHYS MED REHAB, V79, P1489, DOI 10.1016/S0003-9993(98)90408-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lu TW, 2006, GAIT POSTURE, V23, P471, DOI 10.1016/j.gaitpost.2005.06.005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McAuley E, 2004, BRAIN BEHAV IMMUN, V18, P214, DOI 10.1016/j.bbi.2003.12.007; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLean SG, 2004, MED SCI SPORT EXER, V36, P1008, DOI 10.1249/01.MSS.0000128180.51443.83; Nandy S, 2004, J PUBLIC HEALTH-UK, V26, P138, DOI 10.1093/pubmed/fdh132; Palmieri-Smith RM, 2015, AM J SPORT MED, V43, P1662, DOI 10.1177/0363546515578252; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sparrow WA, 1996, HUM MOVEMENT SCI, V15, P605, DOI 10.1016/0167-9457(96)00022-X; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239	41	12	12	2	18	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	SEP	2016	49						264	270		10.1016/j.gaitpost.2016.06.028			7	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	DY1MF	WOS:000384858400046	27472823				2022-02-06	
J	Mayer, SW; Abdo, JCM; Hill, MK; Kestel, LA; Pan, ZX; Novais, EN				Mayer, Stephanie W.; Munhoz Abdo, Joao Caetano; Hill, Mary K.; Kestel, Lauryn A.; Pan, Zhaoxing; Novais, Eduardo N.			Femoroacetabular Impingement Is Associated With Sports-Related Posterior Hip Instability in Adolescents: A Matched-Cohort Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						femoroacetabular impingement; adolescent; hip dislocation	DISLOCATION; CHILDREN; ACETABULUM; ANATOMY	Background: Femoroacetabular impingement (FAI) deformity has been associated with posterior hip instability in adult athletes. Purpose: To determine if FAI deformity is associated with posterior hip instability in adolescents, the femoral head-neck junction or acetabular structure in a cohort of adolescent patients who sustained a low-energy, sports-related posterior hip dislocation was compared with that in a group of healthy age- and sex-matched controls with no history of hip injury or pain. Study Design: Cross-sectional study; Level of evidence, 3. Methods: We identified 12 male patients (mean age, 13.9 years; range, 12-16 years) who sustained a sports-related posterior hip dislocation and underwent a computed tomography (CT) scan after closed reduction. For each patient, 3 age- and sex-matched healthy controls were identified. Femoral head-neck type was assessed by measurement of the alpha angle on the radially oriented CT images at the 12-, 1-, 2-, and 3-o'clock positions. Age, body mass index (BMI), alpha angle at each position, acetabular version, Tonnis angle, and lateral center-edge angle (LCEA) on the involved hip in the dislocation group were compared with those of the matched controls using a mixed-effects model. A logistic regression analysis using a generalized estimating equation was used to compare the percentage of subjects with cam-type FAI deformity (alpha angle >55 degrees) in each group. Results: The dislocation and control groups were similar in age distribution and BMI (P > .05). The mean alpha angles were statistically significantly higher in the dislocation group compared with the control group at the superior (46.3 degrees 1.1 degrees vs 42.7 degrees +/- 0.6 degrees; P = .0213), superior-anterior (55.5 degrees +/- 1.9 degrees vs 46.0 degrees +/- 1.3 degrees; P = .0005), and anterior-superior (54.9 degrees +/- 1.5 degrees vs 48.9 degrees +/- 1.0 degrees; P = .0045) regions. Cam deformity was present in a larger proportion of patients in the dislocation group than in the control group (P < .0035). An alpha angle greater than 55 degrees was present in 16.7% of the dislocation group and 0% of the control group at the 12-o'clock position (P = .1213), 41.7% versus 0% at the 1-o'clock position (P = .0034), 58% versus 6% at the 2-o'clock position (P = .0004), and 25% versus 2.8% at the 3-o'clock position (P = .0929). Acetabular anteversion was lower in the dislocation group (9.6 degrees +/- 1.4 degrees) compared with the control group (15.1 degrees +/- 0.8 degrees) (P = .0068). Mean acetabular LCEA was within a normal range in both groups. Conclusion: A significantly higher mean alpha angle from the superior to the anterior-superior regions of the femoral head-neck junction and lower acetabular version were found in adolescents who sustained low-energy, sports-related posterior hip dislocations.	[Mayer, Stephanie W.; Munhoz Abdo, Joao Caetano; Hill, Mary K.; Kestel, Lauryn A.; Pan, Zhaoxing; Novais, Eduardo N.] Childrens Hosp Colorado, Aurora, CO USA; [Mayer, Stephanie W.] Childrens Hosp Colorado, Ctr Sports Med, Aurora, CO USA; [Mayer, Stephanie W.; Hill, Mary K.; Kestel, Lauryn A.] Childrens Hosp Colorado, Dept Orthopaed Surg, Aurora, CO USA; [Munhoz Abdo, Joao Caetano] Hosp Pequeno Principe Curitiba, Dept Orthopaed Surg, Curitiba, Parana, Brazil; [Hill, Mary K.; Kestel, Lauryn A.] Childrens Hosp Colorado, Musculoskeletal Res Ctr, Aurora, CO USA; [Pan, Zhaoxing] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [Novais, Eduardo N.] Boston Childrens Hosp, Dept Orthopaed Surg, 300 Longwood Ave,Hun newell Bldg, Boston, MA 02115 USA		Novais, EN (corresponding author), Boston Childrens Hosp, Dept Orthopaed Surg, 300 Longwood Ave,Hun newell Bldg, Boston, MA 02115 USA.	Eduardo.Novais@childrens.harvard.edu			Arthrex Inc.	S.W.M. is a paid consultant for Arthrex Inc.	ANDA S, 1991, SKELETAL RADIOL, V20, P267, DOI 10.1007/BF02341662; Berkes Marschall B, 2012, Am J Orthop (Belle Mead NJ), V41, P166; Bixby SD, 2013, AM J SPORT MED, V41, P2074, DOI 10.1177/0363546513495346; Chan Y H, 2003, Singapore Med J, V44, P614; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P47, DOI 10.2106/JBJS.H.00756; Fabricant PD, 2013, J BONE JOINT SURG AM, V95A, P230, DOI [10.2106/JBJS.L.00592, 10.2106/JBJS.L.00772]; Figueras Coll G, 2010, HIP INT, V20, P524; Herrera-Soto JA, 2009, J AM ACAD ORTHOP SUR, V17, P15, DOI 10.5435/00124635-200901000-00003; Jamali AA, 2013, CLIN ORTHOP RELAT R, V471, P3581, DOI 10.1007/s11999-013-3166-5; Krych AJ, 2012, CLIN ORTHOP RELAT R, V470, P3390, DOI 10.1007/s11999-012-2468-3; Lax-Perez R, 2012, HIP INT, V22, P339, DOI 10.5301/HIP.2012.9249; Manner HM, 2012, J PEDIATR ORTHOP B, V21, P574, DOI 10.1097/BPB.0b013e328357bf04; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; Moorman CT, 2003, J BONE JOINT SURG AM, V85A, P1190, DOI 10.2106/00004623-200307000-00002; Hung NN, 2012, J PEDIATR ORTHOP B, V21, P542, DOI 10.1097/BPB.0b013e328356371b; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Philippon MJ, 2009, ARTHROSCOPY, V25, P169, DOI 10.1016/j.arthro.2008.09.013; Quick TJ, 2005, CLIN ORTHOP RELAT R, P87, DOI 10.1097/01.blo.0000155372.65446.40; Steppacher SD, 2013, CLIN ORTHOP RELAT R, V471, P1937, DOI 10.1007/s11999-013-2863-4; Sulaiman AR, 2013, J PEDIATR ORTHOP B, V22, P557, DOI 10.1097/BPB.0b013e328363b5cd; Tonnis D., 1987, CONGENITAL DYSPLASIA; UPADHYAY SS, 1985, J BONE JOINT SURG BR, V67, P232, DOI 10.1302/0301-620X.67B2.3884614; Vialle R, 2005, J PEDIATR ORTHOPED, V25, P138, DOI 10.1097/01.bpo.0000151059.85227.ea; Wiberg G., 1939, ACTA CHIR SCAND S58, V83, P5	24	12	12	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2016	44	9					2299	2303		10.1177/0363546516651119			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DV6CU	WOS:000383019300019	27311413				2022-02-06	
J	Mrozek, S; Srairi, M; Marhar, F; Delmas, C; Gaussiat, F; Abaziou, T; Larcher, C; Atthar, V; Menut, R; Fourcade, O; Geeraerts, T				Mrozek, Segolene; Srairi, Mohamed; Marhar, Fouad; Delmas, Clement; Gaussiat, Francois; Abaziou, Timothee; Larcher, Claire; Atthar, Vincent; Menut, Remi; Fourcade, Olivier; Geeraerts, Thomas			Successful treatment of inverted Takotsubo cardiomyopathy after severe traumatic brain injury with milrinone after dobutamine failure	HEART & LUNG			English	Article						Takotsubo cardiomyopathy; Milrinone; Dobutamine; Traumatic brain injury; Catecholamines	ANEURYSMAL SUBARACHNOID HEMORRHAGE; STRESS-INDUCED CARDIOMYOPATHY; LEFT-VENTRICULAR DYSFUNCTION; TAKO-TSUBO CARDIOMYOPATHY; HEART-FAILURE; MODEL REVEALS; PATTERNS	Background: Takotsubo cardiomyopathy can occur at the early phase of severe acute brain injuries. In the case of cardiac output decrease or shock, the optimal treatment is still a matter of debate. Due to massive stress hormone release, the infusion of catecholamines may have limited effects and may even aggravate cardiac failure. Other inotropic agents may be an option. Levosimendan has been shown to have potential beneficial effects in this setting, although milrinone has not been studied. Methods: We report a case of a young female presenting with inverted Takotsubo cardiomyopathy syndrome after severe traumatic brain injury. Results: Due to hemodynamic instability and increasing levels of infused norepinephrine, dobutamine infusion was begun but rapidly stopped due to tachyarrhythmia. Milrinone infusion stabilized the patient's hemodynamic status and improved cardiac output without deleterious effects. Conclusion: Milrinone could be a good alternative when inotropes are required in Takotsubo cardiomyopathy and when dobutamine infusion is associated with tachyarrhythmia. (C) 2016 Elsevier Inc. All rights reserved.	[Mrozek, Segolene; Srairi, Mohamed; Marhar, Fouad; Gaussiat, Francois; Abaziou, Timothee; Larcher, Claire; Atthar, Vincent; Menut, Remi; Fourcade, Olivier; Geeraerts, Thomas] Univ Toulouse 3, Univ Hosp Toulouse, Dept Anesthesia & Intens Care, F-31000 Toulouse, France; [Delmas, Clement] Univ Toulouse 3, Univ Hosp Toulouse, Dept Cardiol, F-31000 Toulouse, France		Mrozek, S (corresponding author), Hop Pierre Paul Riquet, Pole Anesthesie Reanimat, F-31059 Toulouse 9, France.	mrozek.s@chu-toulouse.fr		FOUAD, MARHAR/0000-0001-6429-3234; Srairi, Mohamed/0000-0001-7219-501X; Delmas, Clement/0000-0001-9180-9128			Ako J, 2006, AM J MED, V119, P10, DOI 10.1016/j.amjmed.2005.08.022; Ako J, 2003, CIRCULATION, V108, pE158, DOI 10.1161/01.CIR.0000102942.24174.AE; Banki NM, 2005, CIRCULATION, V112, P3314, DOI 10.1161/CIRCULATIONAHA.105.558239; Blanc C, 2015, EUR NEUROL, V74, P163, DOI 10.1159/000440717; Boland TA, 2015, CRIT CARE MED, V43, P686, DOI 10.1097/CCM.0000000000000851; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Dande Amit S, 2011, J Invasive Cardiol, V23, pE76; Doyen D, 2014, HEART LUNG, V43, P331, DOI 10.1016/j.hrtlng.2014.03.007; Ennezat PV, 2005, ECHOCARDIOGR-J CARD, V22, P599, DOI 10.1111/j.1540-8175.2005.40046.x; Gelow J, 2009, AM J MED, V122, P583, DOI 10.1016/j.amjmed.2008.12.016; Guglin Maya, 2011, Congest Heart Fail, V17, P127, DOI 10.1111/j.1751-7133.2011.00210.x; Khush K, 2005, J AM SOC ECHOCARDIOG, V18, P168, DOI 10.1016/j.echo.2004.08.045; KLINE RC, 1981, J NUCL MED, V22, P129; Lee VH, 2006, NEUROCRIT CARE, V5, P243, DOI 10.1385/NCC:5:3:243; Lee VH, 2006, J NEUROSURG, V105, P264, DOI 10.3171/jns.2006.105.2.264; Lyon AR, 2015, EUR J HEART FAIL; MAGER G, 1991, AM HEART J, V121, P1974, DOI 10.1016/0002-8703(91)90834-5; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; Mebazaa A, 2010, CRIT CARE, V14, DOI 10.1186/cc8153; Padayachee Laven, 2007, Heart Lung Circ, V16 Suppl 3, pS65, DOI 10.1016/j.hlc.2007.03.018; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Porto I, 2013, INT J CARDIOL, V167, P2441, DOI 10.1016/j.ijcard.2013.01.031; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Redmond M, 2013, BRIT J ANAESTH, V110, P487, DOI 10.1093/bja/aes586; Riera Maria, 2010, J Trauma, V68, pE13, DOI 10.1097/TA.0b013e3181469d5b; Shao YZ, 2013, INT J CARDIOL, V168, P1943, DOI 10.1016/j.ijcard.2012.12.092; Shao YZ, 2013, EUR J HEART FAIL, V15, P9, DOI 10.1093/eurjhf/hfs161; Tariq S, 2015, INT J MOL SCI, V16, P29060, DOI 10.3390/ijms161226147; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; van der Bilt I, 2014, NEUROLOGY, V82, P351, DOI 10.1212/WNL.0000000000000057; Yoshimura S, 2008, ANN NEUROL, V64, P547, DOI 10.1002/ana.21459; Zaroff JG, 2000, J AM SOC ECHOCARDIOG, V13, P774, DOI 10.1067/mje.2000.105763	32	12	13	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0147-9563	1527-3288		HEART LUNG	Heart Lung	SEP-OCT	2016	45	5					406	408		10.1016/j.hrtlng.2016.06.007			3	Cardiac & Cardiovascular Systems; Nursing; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Nursing; Respiratory System	DX9ID	WOS:000384705900005	27402629				2022-02-06	
J	Reeves, TM; Trimmer, PA; Colley, BS; Phillips, LL				Reeves, Thomas M.; Trimmer, Patricia A.; Colley, Beverly S.; Phillips, Linda L.			Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Microglia; Inflammation; White matter injury; Recovery of function; Compound action potentials; Glial cell culture	MITOCHONDRIAL PERMEABILITY TRANSITION; CALCINEURIN-INDEPENDENT INHIBITION; SOLID-ORGAN TRANSPLANTATION; GATED POTASSIUM CHANNEL; RAT CORPUS-CALLOSUM; CYCLOSPORINE-A; UNMYELINATED AXONS; THERAPEUTIC TARGET; K+ CHANNELS; ACTIVATED MICROGLIA	Axonal injury is present in essentially all clinically significant cases of traumatic brain injury (TBI). While no effective treatment has been identified to date, experimental TBI models have shown promising axonal protection using immunosuppressants FK506 and Cyclosporine-A, with treatment benefits attributed to calcineurin inhibition or protection of mitochondrial function. However, growing evidence suggests neuroprotective efficacy of these compounds may also involve direct modulation of ion channels, and in particular Kv1.3. The present study tested whether blockade of Kv1.3 channels, using Clofazimine (CFZ), would alleviate TEI-induced white matter pathology in rodents. Postinjury CFZ administration prevented suppression of compound action potential (CAP) amplitude in the corpus callosum of adult rats following midline fluid percussion TBI, with injury and treatment effects primarily expressed in unmyelinated CAPs. Kv1.3 protein levels in callosal tissue extracts were significantly reduced postinjury, but this loss was prevented by CFZ treatment. In parallel, CFZ also attenuated the injury-induced elevation in pro-inflammatory cytokine IL1-beta. The effects of CFZ on glial function were further studied using mixed microglia/astrocyte cell cultures derived from P3-5 mouse corpus callosum. Cultures of callosal glia challenged with lipopolysaccharide exhibited a dramatic increase in IL1-beta levels, accompanied by reactive morphological changes in microglia, both of which were attenuated by CFZ treatment. These results support a cell specific role for Kv1.3 signaling in white matter pathology after TBI, and suggest a treatment approach based on the blockade of these channels. This therapeutic strategy may be especially efficacious for normalizing neuro-glial interactions affecting unmyelinated axons after TBI. (C) 2016 Elsevier Inc All rights reserved.	[Reeves, Thomas M.; Trimmer, Patricia A.; Colley, Beverly S.; Phillips, Linda L.] Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Reeves, TM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, 1217 E Marshall St,Room 740,MCV Campus Box 980709, Richmond, VA 23298 USA.				NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-057758, NS-056247]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057758, R01NS056247] Funding Source: NIH RePORTER	The authors gratefully acknowledge the expert technical assistance of Nancy Lee, Terry Smith, Raiford Black and Lesley Harris. This study was supported by NIH research grants NS-057758 (TMR) and NS-056247 (LLP).	Ahn HS, 2007, AM J PHYSIOL-CELL PH, V292, pC1714, DOI 10.1152/ajpcell.00258.2006; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; ARBISER JL, 1995, J AM ACAD DERMATOL, V32, P241, DOI 10.1016/0190-9622(95)90134-5; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Baik J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047494; Baik J, 2011, MOL PHARMACEUT, V8, P1742, DOI 10.1021/mp200101b; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BLACK RA, 1989, FEBS LETT, V247, P386, DOI 10.1016/0014-5793(89)81376-6; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Charolidi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128463; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; Cohen J., 2013, STAT POWER ANAL BEHA; Colley B, 2004, RECEPTOR CHANNEL, V10, P25, DOI 10.1080/10606820490270870; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Crompton M, 1999, BIOCHEM SOC SYMP, V66, P167, DOI 10.1042/bss0660167; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Duque A, 2013, DEV NEUROBIOL, V73, P841, DOI 10.1002/dneu.22105; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Fukutomi Y, 2011, ANTIMICROB AGENTS CH, V55, P4000, DOI 10.1128/AAC.00434-11; FUNG JJ, 1995, THER DRUG MONIT, V17, P592, DOI 10.1097/00007691-199512000-00008; Gertig U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00101; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Koeberle PD, 2010, CELL DEATH DIFFER, V17, P134, DOI 10.1038/cdd.2009.113; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kozlova EN, 2005, BRAIN RES PROTOC, V15, P59, DOI 10.1016/j.brainresprot.2005.03.005; Lam J, 2011, DRUG DEVELOP RES, V72, P573, DOI 10.1002/ddr.20467; Leanza L, 2014, CURR PHARM DESIGN, V20, P189, DOI 10.2174/13816128113199990032; Leanza L, 2012, EMBO MOL MED, V4, P577, DOI 10.1002/emmm.201200235; Liu WL, 2007, J NEUROSCI RES, V85, P829, DOI 10.1002/jnr.21179; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mourre C, 1999, J PHARMACOL EXP THER, V291, P943; Moussaud S, 2009, CELL PHYSIOL BIOCHEM, V24, P141, DOI 10.1159/000233240; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; OConnor R, 1995, DRUG METAB REV, V27, P591, DOI 10.3109/03602539508994208; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Pannasch U, 2006, MOL CELL NEUROSCI, V33, P401, DOI 10.1016/j.mcn.2006.08.009; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Rangaraju S, 2015, J ALZHEIMERS DIS, V44, P797, DOI 10.3233/JAD-141704; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Rasband MN, 2004, J NEUROSCI RES, V76, P749, DOI 10.1002/jnr.20073; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Rohl C, 2007, BRAIN RES, V1129, P43, DOI 10.1016/j.brainres.2006.10.057; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Steel HC, 1999, J ANTIMICROB CHEMOTH, V44, P209, DOI 10.1093/jac/44.2.209; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Szabo I, 2008, P NATL ACAD SCI USA, V105, P14861, DOI [10.1073/pnas.0804236105, 10.1073/pnas.0804236T05]; Szmydynger-Chodobska J., 2011, J CEREB BLOOD FLOW M, V32, P93; Terashima A, 1998, BRAIN RES, V786, P255, DOI 10.1016/S0006-8993(97)01435-2; THOMSON AW, 1995, THER DRUG MONIT, V17, P584, DOI 10.1097/00007691-199512000-00007; TRIMMER PA, 1991, J HISTOCHEM CYTOCHEM, V39, P891, DOI 10.1177/39.7.1865105; Utsunomiya I, 2008, EXP NEUROL, V210, P51, DOI 10.1016/j.expneurol.2007.09.032; Villalonga N, 2010, BIOCHEM PHARMACOL, V80, P858, DOI 10.1016/j.bcp.2010.05.012; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Wang TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043950; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Yoon GS, 2015, MOL PHARMACEUT, V12, P2517, DOI 10.1021/acs.molpharmaceut.5b00035; Yu Y, 2007, BRAIN RES, V1148, P62, DOI 10.1016/j.brainres.2007.02.022; Zawadzka M, 2012, J MOL MED, V90, P1459, DOI 10.1007/s00109-012-0925-9; Zhang JW, 1997, J NEUROSCI METH, V76, P15, DOI 10.1016/S0165-0270(97)00065-4; Zhu J, 2014, FEBS J, V281, P3433, DOI 10.1111/febs.12871	101	12	12	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2016	283		A				188	203		10.1016/j.expneurol.2016.06.011			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW0EU	WOS:000383314500018	27302680	Green Accepted			2022-02-06	
J	Sawyer, Q; Vesci, B; McLeod, TCV				Sawyer, Quinton; Vesci, Brian; McLeod, Tamara C. Valovich			Physical Activity and Intermittent Postconcussion Symptoms After a Period of Symptom-Limited Physical and Cognitive Rest	JOURNAL OF ATHLETIC TRAINING			English	Article							SPORT-RELATED CONCUSSION; MANAGEMENT	Reference: Schneider KJ, Iverson GL, Emery CA, McCrory P, Herring SA, Meeuwisse WH. The effects of rest and treatment following sport-related concussion: a systematic review of the literature. Br J Sports Med. 2013; 47(5):304-307. Clinical Question: After concussion and a period of symptom-limited physical and cognitive rest, do athletes who experience intermittent symptoms return to asymptomatic condition more quickly with physical activity than with prolonged physical rest? Data Sources: One investigator performed an individual search for each research question using the following databases: CINAHL, Cochrane Controlled Trials Registers, EMBASE, HealthSTAR, ProQuest, PsychInfo, PubMed, SPORTDiscus, and Web of Science. Search terms for rest were brain concussion, cognitive rest, mild traumatic brain injury, physical exertion, postconcussive syndrome, rehabilitation, sport-related concussion, therapy, treatment, and treatment outcome. Search terms for treatment were the same terms as for rest, as well as brain training, cervical spine, cognitive therapy, dizziness, exercise, headache, neck, pharmacotherapy, postural balance, and vertigo. The authors included peer-reviewed, published articles and abstracts and performed a citation search. Study Selection: Studies were included based on the following criteria as determined before searching: classified as original research, symptoms resulted after sport-related concussion, and investigation of the effects of either rest or treatment on symptoms. Abstracts that were excluded failed to evaluate rest, omitted sport-related concussion as the cause of symptoms, failed to evaluate a treatment's effect on sport-related concussion, or did not present original research. Data Extraction: The following data were extracted from each study that fit the selection criteria: study design; sample size; participants' demographic information (age and sex); type, duration, and intensity of treatment; key findings including effect sizes and means with 95% confidence intervals (calculated when possible using the data provided in the original study, even if not presented in the original study); and relevant comments. Main Results: The search revealed 749 articles evaluating the effects of rest and 1175 articles evaluating the effects of treatment. Of the 749 articles evaluating the effects of rest, only 2 met all the inclusion criteria. Of the 1175 articles evaluating the effects of treatment, only 10 met all the inclusion criteria. Ultimately, the authors were able to identify additional treatment articles that met the inclusion criteria, for a total of 12. The nature of the treatments and the participants differed enough that meta-analysis was not possible. One of the 2 articles that evaluated rest was a retrospective analysis of athletes that showed those who were prescribed a period of cognitive rest had a longer duration of symptoms. The other study followed athletes postconcussion who were retrospectively assigned to groups based on self-reported activity level after injury. Those who reported moderate levels of cognitive and physical exertion over the first month post-injury appeared to demonstrate improved outcomes compared with those who pursued small or large amounts of activity. Twelve studies evaluated the effects of treatment on symptoms after sport-related concussion. Various interventions were reviewed, including pharmacotherapy, light aerobic activity, graded exercise treadmill test, hyperbaric oxygen therapy, vestibular physiotherapy, and cervical spine manual therapy. Unfortunately, the authors did not report effect sizes for specific interventions, and due to the varied nature of each study and its respective treatment approach, no pooled data could be analyzed. However, a group of adolescents treated with submaximal aerobic and coordination exercises, visualization, and imagery returned to full normal physical activity at a mean duration of 4.4 weeks (95% confidence interval = 3.1, 5.7 weeks). Furthermore, a randomized controlled trial of patients experiencing persistent neck pain, dizziness, and headaches who underwent manual and physical therapy showed they were more likely to return to sport after 8 weeks of treatment. Despite the inability to pool data, the authors concluded that each treatment appeared to positively influence specific aspects of certain patients' symptoms. Conclusions: Little high-quality evidence has addressed the effects of rest and treatment after sport-related concussion. Current evidence suggests that an initial period of rest appears to be beneficial. Further research is needed to evaluate the long-term outcomes of rest (including the quality and quantity of the rest). Low levels of exercise may benefit the athlete post-injury, but additional study is required to determine the optimal timing for initiation of treatment postinjury. Patients with cervical spine or vestibular dysfunction may benefit from rehabilitation techniques targeted at their individual symptom profile to facilitate recovery. Overall, we need high-quality studies evaluating resting period, pharmacologic interventions, rehabilitative techniques, and exercise and their effects on patients slow to recover from concussion symptoms.	[Sawyer, Quinton] Phoenix Suns, 201 East Jefferson St, Phoenix, AZ 85004 USA; [Vesci, Brian] Northwestern Univ, Evanston, IL USA; [Sawyer, Quinton; Vesci, Brian; McLeod, Tamara C. Valovich] AT Still Univ, Arizona Sch Hlth Sci, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA		Sawyer, Q (corresponding author), Phoenix Suns, 201 East Jefferson St, Phoenix, AZ 85004 USA.	qsawyer@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Diaz DS, 2014, SEMIN SPEECH LANG, V35, P204, DOI 10.1055/s-0034-1384682; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	11	12	12	0	25	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2016	51	9					739	742		10.4085/1062-6050-51.12.01			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EI9WI	WOS:000392859700010	27813685	Bronze, Green Published			2022-02-06	
J	Song, SY; Lee, SK; Eom, KS				Song, Seung Yoon; Lee, Sang Koo; Eom, Ki Seong		KNTDB Investigators	Analysis of Mortality and Epidemiology in 2617 Cases of Traumatic Brain Injury : Korean Neuro-Trauma Data Bank System 2010-2014	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Korean Neuro-Trauma Data Bank System; Mortality; Traumatic brain injury	HEAD-INJURY; TRENDS	Objective : The aims of the Korean Neuro-Trauma Data Bank System (KNTDBS) are to evaluate and improve treatment outcomes for brain trauma, prevent trauma, and provide data for research. Our purpose was to examine the mortality rates following traumatic brain injury (TBI) in a retrospective study and to investigate the sociodemographic variables, characteristics, and causes of TBI-related death based on data from the KNTDBS. Methods : From 2010 to 2014, we analyzed the data of 2617 patients registered in the KNTDBS. The demographic characteristics of patients with TBI were investigated. We divided patients into 2 groups, survivors and nonsurvivors, and compared variables between the groups to investigate variables that are related to death after TBI. We also analyzed variables related to the interval between TBI and death, mortality by region, and cause of death in the nonsurvivor group. Results : The frequency of TBI in men was higher than that in women. With increasing age of the patients, the incidence of TBI also increased. Among 2617 patients, 688 patients (26.2%) underwent surgical treatment and 125 patients (4.7%) died. The age distributions of survivors vs. nonsurvivor groups and mortality rates according the severity of the brain injury, surgical treatment, and initial Glasgow Coma Scale (GCS) scores were statistically significantly different. Among 125 hospitalized nonsurvivors, 70 patients (56%) died within 7 days and direct brain damage was the most common cause of death (80.8%). The time interval from TBI to death differed depending on the diagnosis, surgical or nonsurgical treatment, severity of brain injury, initial GCS score, and cause of death, and this difference was statistically significant. Conclusion : Using the KNTDBS, we identified epidemiology, mortality, and various factors related to nonsurvival. Building on our study, we should make a conscious effort to increase the survival duration and provide rapid and adequate treatment for TBI patients.	[Song, Seung Yoon; Eom, Ki Seong] Wonkwang Univ Hosp, Dept Neurosurg, 895 Muwang Ro, Iksan 54538, South Korea; [Lee, Sang Koo] Dankook Univ Hosp, Dept Neurosurg, Cheonan, South Korea; [Lee, Sang Koo; Eom, Ki Seong; KNTDB Investigators] Korean Neurotraumatol Soc, Korea Neurotrauma Data Bank Comm, Seoul, South Korea		Eom, KS (corresponding author), Wonkwang Univ Hosp, Dept Neurosurg, 895 Muwang Ro, Iksan 54538, South Korea.	kseom@wonkwang.ac.kr			Wonkwang University	This work was supported by Wonkwang University in 2015. Authors are thankful to Professor Cheol Lee of Wonkwang University Hospital for statistical advice and members of the KNTDB investigators include Bo-Ra Seo (CNNUH<SUP>2</SUP>), Byeong-Cheol Rim (CBNUH), Byung-Moon Cho (HUKH), Hyun-Ho Jung (WSCH), Jae-Hoon Kim (EJUH), Jeong-Ho Lee (DFH), Jong-Hyun Kim (KUKH), Min-Su Kim (YNUH), Seung-Won Choi (CNNUH<SUP>1</SUP>), Taek-Kyun Nam (CAUH), and Young-Jin Song (DAUH).	Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Faul M, 2010, TRAUMATIC BRAIN INJU; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lagbas C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143092; Lee KS, 2001, J KOREAN MED SCI, V16, P342, DOI 10.3346/jkms.2001.16.3.342; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5	15	12	12	0	6	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	SEP	2016	59	5					485	491		10.3340/jkns.2016.59.5.485			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY2OY	WOS:000384933100010	27651867	Green Published, gold, Green Submitted			2022-02-06	
J	Wang, X; Wang, Y; Zhang, C; Liu, C; Zhao, BT; Wei, NL; Zhang, JG; Zhang, K				Wang, Xiu; Wang, Yao; Zhang, Chao; Liu, Chang; Zhao, Baotian; Wei, Naili; Zhang, Jian-guo; Zhang, Kai			CB1 receptor antagonism prevents long-term hyperexcitability after head injury by regulation of dynorphin-KOR system and mGluR5 in rat hippocampus	BRAIN RESEARCH			English	Article						Post-traumatic epilepsy; Prevention; Endocannabinoid; Dynorphin; Metabotropic glutamate receptor	METABOTROPIC GLUTAMATE RECEPTORS; TRAUMATIC BRAIN-INJURY; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; EPILEPTIFORM ACTIVITY; OPIOID-PEPTIDES; DENTATE GYRUS; EPILEPSY; INDUCTION; MODULATION	Both endocannabinoids and dynorphin are feedback messengers in nervous system that act at the presynaptic nerve terminal to inhibit transmitter release. Many studies showed the cannabinoid-opioid cross-modulation in antinociception, hypothermia, sedation and reward. The aim of this study was to assess the influence of early application of cannabinoid type 1 (CB1) receptor antagonism SR141716A after brain injury on dynorphin-x opioid receptor (KOR) system and the expression of metabotropic glutamate receptors (mGluRs) in a rat model of fluid percussion injury (FPI). Firstly, seizure latency induced by pentylenetetrazole was significantly prolonged 6 weeks after brain injury in group of SR141716A treatment. Then, PCR and western blot showed that SR141716A inhibited the long-term up regulation of CB1 receptors in hippocampus. However, SR141716A resulted in long-term potentiation of dynorphin release and did not influence the up-regulation of KOR in hippocampus after brain injury. Furthermore, SR141716A reverse the overexpression of mGluR5 in the late stage of brain injury. We propose that during the induction of epileptogenesis after brain injury, early application of CB1 receptor antagonism could prevent long-term hyperexcitability by up-regulation of dynorphin-KOR system and prevention of mGluR5 induced epileptogenesis in hippocampus. (C) 2016 Elsevier B.V. All rights reserved.	[Wang, Xiu; Zhang, Chao; Liu, Chang; Zhao, Baotian; Zhang, Jian-guo; Zhang, Kai] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Tiantan Xili 6, Beijing 100050, Peoples R China; [Wang, Yao] Beijing Jingmei Grp, Gen Hosp, Heishan St 18, Beijing 102300, Peoples R China; [Zhang, Jian-guo; Zhang, Kai] Beijing Neurosurg Inst, Tiantan Xili 6, Beijing 100050, Peoples R China; [Zhang, Chao; Liu, Chang; Zhao, Baotian; Zhang, Jian-guo; Zhang, Kai] Beijing Key Lab Neurostimulat, Tiantan Xili 6, Beijing 100050, Peoples R China; [Wei, Naili] Lanzhou Univ, Hosp 2, Dept Neurosurg, Lanzhou 730030, Gansu, Peoples R China		Zhang, K (corresponding author), Beijing Tiantan Hosp, Dept Neurosurg, Tiantan Xili 6, Beijing 100050, Peoples R China.	zhangkai62035@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171218]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding [XM201304, ZY201305]	This work was supported by Research Grant no. 81171218 from the National Natural Science Foundation of China and Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding (Nos. XM201304 and ZY201305).	Befort K, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00006; Castane A, 2003, EUR J NEUROSCI, V17, P155, DOI 10.1046/j.1460-9568.2003.02409.x; Chapman AG, 2000, J NUTR, V130, p1043S, DOI 10.1093/jn/130.4.1043S; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Cichewicz DL, 2004, LIFE SCI, V74, P1317, DOI 10.1016/j.lfs.2003.09.038; Clynen E, 2014, MOL NEUROBIOL, V50, P626, DOI 10.1007/s12035-014-8669-x; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Echegoyen J, 2009, EPILEPSY RES, V85, P123, DOI 10.1016/j.eplepsyres.2009.02.019; Gambardella A, 2003, EPILEPSIA, V44, P1255, DOI 10.1046/j.1528-1157.2003.18003.x; Gerald TM, 2006, BRAIN RES, V1093, P20, DOI 10.1016/j.brainres.2006.03.088; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HENRIKSEN SJ, 1982, ANN NY ACAD SCI, V398, P207, DOI 10.1111/j.1749-6632.1982.tb39495.x; Iremonger KJ, 2011, J NEUROSCI, V31, P12011, DOI 10.1523/JNEUROSCI.2925-11.2011; Isokawa M, 2005, J PHYSIOL-LONDON, V567, P1001, DOI 10.1113/jphysiol.2005.094219; Karr L, 2008, EPILEPSY RES, V81, P14, DOI 10.1016/j.eplepsyres.2008.04.005; Karr L, 2010, EPILEPSIA, V51, P121, DOI 10.1111/j.1528-1167.2010.02625.x; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Li BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093158; Loacker S, 2007, BRAIN, V130, P1017, DOI 10.1093/brain/awl384; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Lutz B, 2008, NAT MED, V14, P721, DOI 10.1038/nm0708-721; Manzanares J, 1999, BRAIN RES, V839, P173, DOI 10.1016/S0006-8993(99)01756-4; MCGINTY JF, 1983, P NATL ACAD SCI-BIOL, V80, P589, DOI 10.1073/pnas.80.2.589; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Robledo P, 2008, ADDICT BIOL, V13, P213, DOI 10.1111/j.1369-1600.2008.00107.x; Saez-Cassanelli JL, 2007, J NEUROCHEM, V103, P2629, DOI 10.1111/j.1471-4159.2007.05000.x; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Sayin U, 2003, EPILEPSY RES, V53, P186, DOI 10.1016/S0920-1211(03)00020-2; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Schunk E, 2011, HIPPOCAMPUS, V21, P1010, DOI 10.1002/hipo.20813; Setkowicz Z., 2016, BRAIN RES; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Simao F., 2016, DEV NEUROBIOL; Solbrig MV, 2006, BRAIN, V129, P642, DOI 10.1093/brain/awl008; Solbrig MV, 2004, TRENDS PHARMACOL SCI, V25, P98, DOI 10.1016/j.tips.2003.12.010; Terman GW, 2000, J NEUROSCI, V20, P4379, DOI 10.1523/JNEUROSCI.20-12-04379.2000; TORTELLA FC, 1988, TRENDS PHARMACOL SCI, V9, P366, DOI 10.1016/0165-6147(88)90256-8; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Watanabe Y, 2011, EPILEPSIA, V52, P140, DOI 10.1111/j.1528-1167.2010.02764.x; WEISSKOPF MG, 1993, NATURE, V365, P188, DOI 10.1038/365188a0; Wettschureck N, 2006, MOL CELL BIOL, V26, P5888, DOI 10.1128/MCB.00397-06; Wong R K, 1999, Adv Neurol, V79, P685; Wong Robert K. S., 2002, Epilepsy Curr, V2, P81, DOI 10.1046/j.1535-7597.2002.00031.x	49	12	12	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2016	1646						174	181		10.1016/j.brainres.2016.05.055			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT9TH	WOS:000381844700019	27262683				2022-02-06	
J	Zhang, H; Ma, L; Yin, YL; Dong, LQ; Cheng, GG; Ma, YQ; Li, YF; Xu, BN				Zhang, Hui; Ma, Li; Yin, Yan-ling; Dong, Lian-qiang; Cheng, Gang-ge; Ma, Ya-qun; Li, Yun-feng; Xu, Bai-nan			Over-expression of TSPO in the hippocampal CA1 area alleviates cognitive dysfunction caused by lipopolysaccharide in mice	BRAIN RESEARCH			English	Article						Tspo; Lps; Neuroinflammation; Cognition; Allopregnanolone; Finasteride	POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; TRANSLOCATOR PROTEIN; MOUSE MODEL; IN-VIVO; ALLOPREGNANOLONE CONCENTRATIONS; BENZODIAZEPINE RECEPTORS; PROGESTERONE-RECEPTORS	The translocator protein 18 kDa (TSPO) is closely related to regulation of immune/inflammatory response. However, the putative role and signaling mechanisms of TSPO in regulation of neuroinflammation remain unclear. GV287 lentiviral vectors mediating TSPO over-expression were injected into bilateral hippocampal CA1 areas to test whether TSPO over-expression was neuroprotective in lipopolysaccharide (LPS)-induced mice model. Finasteride, a blocker of allopregnanolone production, was used to test whether the protective effects were related to steroideogenesis. The results demonstrated that TSPO over-expression increased progesterone and allopregnanolone synthesis. TSPO over-expression in CA1 area improved LPS-induced cognitive deficiency in mice and this cognitive improvement was reversed by finasteride administration. These data suggest that up-regulation of TSPO level during neuroinflammation may be an adaptive response mechanism, a way to provide more neurosteroids. We confer that TSPO could be an attractive drug target for controlling neuroinflammation in the future. (C) 2016 Elsevier B.V. All rights reserved.	[Zhang, Hui; Dong, Lian-qiang; Cheng, Gang-ge] Air Force Gen Hosp Chinese PLA, Dept Neurosurg, Beijing 100142, Peoples R China; [Zhang, Hui; Li, Yun-feng] Acad Mil Med Sci, Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Ma, Li; Yin, Yan-ling; Ma, Ya-qun] Chinese PLA Army Gen Hosp, Dept Anesthesiol, Beijing 100700, Peoples R China; [Xu, Bai-nan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China		Li, YF (corresponding author), Acad Mil Med Sci, Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China.; Ma, YQ (corresponding author), Chinese PLA Army Gen Hosp, Dept Anesthesiol, Beijing 100700, Peoples R China.; Xu, BN (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China.	ma_yq126@126.com; lyf619@aliyun.com; bn_xu@yahoo.com			WU JIEPING Medical foundation [320.6750.14149]	This project was conducted with the support of WU JIEPING Medical foundation (320.6750.14149).	Agrawal V, 2011, FERTIL STERIL, V95, P1471, DOI 10.1016/j.fertnstert.2010.08.046; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Bassani TB, 2015, ARQ NEURO-PSIQUIAT, V73, P616, DOI 10.1590/0004-282X20150057; Billiards SS, 2006, BIOL NEONATE, V90, P258, DOI 10.1159/000094146; Billiards SS, 2002, PEDIATR RES, V52, P892, DOI 10.1203/01.PDR.0000036604.14242.94; Borowicz Kinga K, 2011, Front Endocrinol (Lausanne), V2, P50, DOI 10.3389/fendo.2011.00050; BOUVET JF, 1988, NEUROSCI RES, V5, P214, DOI 10.1016/0168-0102(88)90050-8; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Cagnin A, 2004, ANN NEUROL, V56, P894, DOI 10.1002/ana.20332; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Chen SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024293; De Felice FG, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00094; Dickens AM, 2014, J NUCL MED, V55, P466, DOI 10.2967/jnumed.113.125625; Dong H.W., 2008, ALLEN REFERENCE ATLA; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Espinosa-Oliva AM, 2011, NEUROBIOL AGING, V32, P85, DOI 10.1016/j.neurobiolaging.2009.01.012; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ghezzi P, 2000, EUR CYTOKINE NETW, V11, P464; Goddard LM, 2013, VASC PHARMACOL, V59, P36, DOI 10.1016/j.vph.2013.06.001; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Irwin Ronald W, 2011, Front Endocrinol (Lausanne), V2, P117, DOI 10.3389/fendo.2011.00117; Jaremko M, 2015, BIOCHEM SOC T, V43, P566, DOI 10.1042/BST20150029; Ji B, 2015, J NEUROCHEM, V135, P859, DOI 10.1111/jnc.13293; Kahn MS, 2012, BEHAV BRAIN RES, V229, P176, DOI 10.1016/j.bbr.2012.01.010; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Li SY, 2013, BRAIN RES, V1496, P84, DOI 10.1016/j.brainres.2012.12.025; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Calejman CM, 2011, MOL CELL ENDOCRINOL, V337, P1, DOI 10.1016/j.mce.2010.12.036; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Mellon SH, 2007, PHARMACOL THERAPEUT, V116, P107, DOI 10.1016/j.pharmthera.2007.04.011; Midzak A, 2015, BIOCHEM SOC T, V43, P572, DOI 10.1042/BST20150061; Miller AA, 2014, BRAIN BEHAV IMMUN, V42, P10, DOI 10.1016/j.bbi.2014.04.001; Ory D, 2016, EUR J NUCL MED MOL I, V43, P163, DOI 10.1007/s00259-015-3172-9; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Price JC, 2013, ENDOCRINOLOGY, V154, P3377, DOI 10.1210/en.2013-1102; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; RIDLEY RM, 1995, NEUROSCIENCE, V67, P263, DOI 10.1016/0306-4522(95)00063-O; Robertson CL, 2015, PEDIATR CRIT CARE ME, V16, P236, DOI 10.1097/PCC.0000000000000323; Rolstad S, 2015, EUR NEUROPSYCHOPHARM, V25, P1091, DOI 10.1016/j.euroneuro.2015.04.023; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Shadfar S, 2015, ARCH PHARM RES, V38, P2106, DOI 10.1007/s12272-015-0648-x; Stein A, 2015, MOL THER, V23, P1160, DOI 10.1038/mt.2015.69; Steinman L, 2010, P NATL ACAD SCI USA, V107, P20595, DOI 10.1073/pnas.1015282107; Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501; Thiel A, 2014, STROKE, V45, P2825, DOI 10.1161/STROKEAHA.114.004285; Tiwari AK, 2015, THERANOSTICS, V5, P961, DOI 10.7150/thno.12027; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Versijpt J, 2005, MULT SCLER J, V11, P127, DOI 10.1191/1352458505ms1140oa; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Ward Roberta J, 2015, Front Biosci (Schol Ed), V7, P189; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Zhao Yan-Yin, 2011, Neuron Glia Biol, V7, P187, DOI 10.1017/S1740925X12000129	61	12	13	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2016	1646						402	409		10.1016/j.brainres.2016.06.001			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT9TH	WOS:000381844700044	27265418				2022-02-06	
J	Hu, JZ; Cao, Y; Wu, TD; Li, DZ; Lu, HB				Hu, Jianzhong; Cao, Yong; Wu, Tianding; Li, Dongzhe; Lu, Hongbin			Micro-CT as a Tool to Investigate the Efficacy of Tetramethylpyrazine in a Rat Spinal Cord Injury Model	SPINE			English	Article						angiogenesis; 3D; micro-CT; spinal cord injury; tetramethylpyrazine	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; METHYLPREDNISOLONE; ANGIOGENESIS; INFLAMMATION; EXPRESSION; PROTECTS; RECOVERY; GROWTH	Study Design. The micro-computed tomography (micro-CT) was applied to assess the effect of tetramethylpyrazine (TMP) on experimental spinal cord injury (SCI). Objective. The aim of the study was to explore the therapeutic effect of TMP on a rat SCI model using micro-CT. Summary of Background Data. SCI is a devastating event and always accompanied by severe vascular injury. Promoting angiogenesis after SCI has recently been recognized as a potential way to enhance the neurological function recovery. How the TMP promotes angiogenesis and improved locomotor function recovery after SCI has, however, not been fully clarified. In this study, we used micro-CT to evaluate the effect on the microvasculature changes after TMP treatment. Methods. The contusion SCI model was induced in rats by a modified Allen's impact method. In the TMP treatment group, rats were injected intraperitoneally with TMP. The control group was treated with saline. Hindlimb motor function was evaluated using the Basso, Beattie, Bresnahan score. Histology was employed to examine the pathological changes and quantified at 28 days after injury. Spinal cord vessel network and angiogenesis were assessed using micro-CT. Results. Angiogenesis was increased in groups treated with TMP compared with rat in the control groups (P < 0.05). Micro-CT vividly depicted the three-dimensional morphology changes of the spinal cord microvasculature after injury and demonstrated more vessels number, vessel volume fraction, and vessel connectivity value in the groups treated with TMP than in the control groups (P < 0.05). In addition, the injury-induced lesion area in TMP group was attenuated in comparison with control groups. Similarly, neurological functions were greatly improved in groups treated with TMP compared with rats in the control groups. Conclusion. Micro-CT is useful for detecting angiogenesis after SCI. TMP therapy reduced the neuronal loss, promoted angiogenesis, and exerted a positive effect on neurological function recovery after SCI.	[Hu, Jianzhong; Cao, Yong; Wu, Tianding; Li, Dongzhe] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China; [Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China		Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698, 81301542, 81371956]; Hunan Provincial Innovation Foundation for Postgraduate [CX2015B060]	The National Natural Science Foundation of China (Nos. 81171698, 81301542, and 81371956) and Hunan Provincial Innovation Foundation for Postgraduate (No. CX2015B060) funds were received in support of this work.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bearden SE, 2004, MICROCIRCULATION, V11, P633, DOI 10.1080/10739680490517659; Breslin K, 2012, PEDIATR EMERG CARE, V28, P1238, DOI 10.1097/PEC.0b013e3182724434; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Chen L, 2014, NEUROCHEM INT, V66, P27, DOI 10.1016/j.neuint.2014.01.006; Debbaut C, 2014, J ANAT, V224, P509, DOI 10.1111/joa.12156; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Fan LH, 2011, J VASC SURG, V54, P192, DOI 10.1016/j.jvs.2010.12.030; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Ghanavati S, 2014, J NEUROSCI METH, V221, P70, DOI 10.1016/j.jneumeth.2013.09.002; Gruner JA, 1996, BRAIN RES, V729, P90, DOI 10.1016/S0006-8993(96)00366-6; Harrop James S, 2014, Neurosurgery, V61 Suppl 1, P30, DOI 10.1227/NEU.0000000000000391; Hsiao G, 2006, PLANTA MED, V72, P411, DOI 10.1055/s-2005-917242; Hu JZ, 2013, J NEUROL SCI, V324, P94, DOI 10.1016/j.jns.2012.10.009; Hu JZ, 2012, J NEUROSCI METH, V204, P150, DOI 10.1016/j.jneumeth.2011.10.018; Jiao F, 2004, J PRACT TRADIT CHIN, V20, P174; Kao TK, 2006, NEUROCHEM INT, V48, P166, DOI 10.1016/j.neuint.2005.10.008; Kao TK, 2013, EXP NEUROL, V247, P188, DOI 10.1016/j.expneurol.2013.04.010; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Losey P, 2014, BRAIN RES, V1569, P9, DOI 10.1016/j.brainres.2014.04.033; Lui C., 1978, CLIN MED RES, V4, P24; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Nori S, 2015, STEM CELL REP, V4, P360, DOI 10.1016/j.stemcr.2015.01.006; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Raab S, 2007, ACTA NEUROPATHOL, V113, P607, DOI 10.1007/s00401-007-0228-3; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Wang YF, 2015, SPINE, V40, P95, DOI 10.1097/BRS.0000000000000694; Xu Hao, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P376; Zhang YL, 2014, SPINE, V39, pE493, DOI 10.1097/BRS.0000000000000218	31	12	13	3	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	AUG 15	2016	41	16					1272	1278		10.1097/BRS.0000000000001546			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	DU5KK	WOS:000382250400010	26953664				2022-02-06	
J	Bailey, ZS; Grinter, MB; VandeVord, PJ				Bailey, Zachary S.; Grinter, Michael B.; VandeVord, Pamela J.			Astrocyte Reactivity Following Blast Exposure Involves Aberrant Histone Acetylation	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						blast neurotrauma; neuroinflammation; histone acetylation; brain injury; epigenetics	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; OXIDATIVE STRESS; MEMORY FORMATION; WORKING-MEMORY; RAT-BRAIN; BARRIER PERMEABILITY; ACTIVATED MICROGLIA	Blast induced neurotrauma (BINT) is a prevalent injury within military and civilian populations. The injury is characterized by persistent inflammation at the cellular level which manifests as a multitude of cognitive and functional impairments. Epigenetic regulation of transcription offers an important control mechanism for gene expression and cellular function which may underlie chronic inflammation and result in neurodegeneration. We hypothesize that altered histone acetylation patterns may be involved in blast induced inflammation and the chronic activation of glial cells. This study aimed to elucidate changes to histone acetylation occurring following injury and the roles these changes may have within the pathology. Sprague Dawley rats were subjected to either a 10 or 17 psi blast overpressure within an Advanced Blast Simulator (ABS). Sham animals underwent the same procedures without blast exposure. Memory impairments were measured using the Novel Object Recognition (NOR) test at 2 and 7 days post-injury. Tissues were collected at 7 days for Western blot and immunohistochemistry (IHC) analysis. Sham animals showed intact memory at each time point. The novel object discrimination decreased significantly between two and 7 days for each injury group (p < 0.05). This is indicative of the onset of memory impairment. Western blot analysis showed glial fibrillary acidic protein (GFAP), a known marker of activated astrocytes, was elevated in the prefrontal cortex (PFC) following blast exposure for both injury groups. Analysis of histone protein extract showed no changes in the level of any total histone proteins within the PFC. However, acetylation levels of histone H2b, H3, and H4 were decreased in both groups (p < 0.05). Co-localization immunofluorescence was used to further investigate any potential correlation between decreased histone acetylation and astrocyte activation. These experiments showed a similar decrease in H3 acetylation in astrocytes exposed to a 17 psi blast but not a 10 psi blast. Further investigation of gene expression by polymerase chain reaction (PCR) array, showed dysregulation of several cytokine and cytokine receptors that are involved	[Bailey, Zachary S.; Grinter, Michael B.; VandeVord, Pamela J.] Virginia Tech, Dept Biomed Engn Mech, Blacksburg, VA 24061 USA; [VandeVord, Pamela J.] Salem Vet Affairs Med Ctr, Salem, VA 24153 USA		VandeVord, PJ (corresponding author), Virginia Tech, Dept Biomed Engn Mech, Blacksburg, VA 24061 USA.; VandeVord, PJ (corresponding author), Salem Vet Affairs Med Ctr, Salem, VA 24153 USA.	pvord@vt.edu			Department of Veterans Affairs RRD award [RX001104-01]; Veterans AffairsUS Department of Veterans Affairs [I01RX001499] Funding Source: NIH RePORTER	The project was supported by the Department of Veterans Affairs RRD award #RX001104-01.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Baird AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014593; Bilmes L., 2006, NAT BUR EC RES, DOI [10.3386/w12054, DOI 10.3386/W12054]; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Correa F, 2011, NEUROBIOL DIS, V44, P142, DOI 10.1016/j.nbd.2011.06.016; Courtney SM, 1998, PHILOS T R SOC B, V353, P1819, DOI 10.1098/rstb.1998.0334; Czerniawski J, 2014, J NEUROSCI, V34, P12470, DOI 10.1523/JNEUROSCI.0542-14.2014; Sousa LFD, 2013, CLINICS, V68, P391, DOI 10.6061/clinics/2013(03)OA17; Danik M, 2003, J NEUROSCI RES, V74, P286, DOI 10.1002/jnr.10744; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Dunn SL, 2002, GLIA, V37, P31, DOI 10.1002/glia.10010; Easton AS, 2013, ADV EXP MED BIOL, V763, P1; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Einarsson EO, 2012, LEARN MEMORY, V19, P449, DOI 10.1101/lm.027227.112; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Federman N, 2013, J NEUROSCI, V33, P7603, DOI 10.1523/JNEUROSCI.4181-12.2013; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fontan-Lozano A, 2008, MOL CELL NEUROSCI, V39, P193, DOI 10.1016/j.mcn.2008.06.009; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Grant PA, 2001, GENOME BIOL, V2; Hasegawa I, 1999, ANN MED, V31, P380, DOI 10.3109/07853899908998795; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kanski R, 2014, J CELL SCI, V127, P4368, DOI 10.1242/jcs.145912; Khorooshi R, 2008, J IMMUNOL, V181, P7284, DOI 10.4049/jimmunol.181.10.7284; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Lenartowicz A, 2005, J COGNITIVE NEUROSCI, V17, P1026, DOI 10.1162/0898929054475127; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Atalaya JP, 2014, TRENDS GENET, V30, P529, DOI 10.1016/j.tig.2014.09.003; Lubin FD, 2011, NEUROBIOL LEARN MEM, V96, P68, DOI 10.1016/j.nlm.2011.03.001; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Morales V, 2000, MOL CELL BIOL, V20, P7230, DOI 10.1128/MCB.20.19.7230-7237.2000; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rumbaugh G, 2011, METHODS MOL BIOL, V670, P263, DOI 10.1007/978-1-60761-744-0_18; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; SCHMITT M, 1979, ACTA BIOL MED GER, V38, P683; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Siva Sai Sujith Sajja Benkata, 2014, Biomed Sci Instrum, V50, P375; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soliman ML, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-51; Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	74	12	12	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	AUG 8	2016	9								64	10.3389/fnmol.2016.00064			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS7QN	WOS:000380978100001	27551260	gold, Green Published			2022-02-06	
J	Franke, LM; Walker, WC; Hoke, KW; Wares, JR				Franke, Laura M.; Walker, William C.; Hoke, Kathy W.; Wares, Joanna R.			Distinction in EEG slow oscillations between chronic mild traumatic brain injury and PTSD	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Mild traumatic brain injury; PTSD; Electroencephalography; Resting state	RESTING STATE NETWORKS; FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; BARRIER DISRUPTION; ATTENTION; CORRELATE; PREDICTION; DISORDERS; DYNAMICS; AROUSAL	Spectral information from resting state EEG is altered in acute mild traumatic brain injury (mTBI) and in disorders of consciousness, but there is disagreement about whether mTBI can elicit long term changes in the spectral profile. Even when identified, any long-term changes attributed to TBI can be confounded by psychiatric comorbidities such as PTSD, particularly for combat -related mTBI where postdeployment distress is commonplace. To address this question, we measured spectral power during the resting state in a large sample of service members and Veterans varying in mTBI history and active PTSD diagnosis but matched for having had combat blast exposure. We found that PTSD was associated with decreases in low frequency power, especially in the right temporoparietal region, while conversely, blast -related mTBI was associated with increases in low frequency power, especially in prefrontal and right temporal areas. Results support the idea that long-term neurophysiological effects of mTBI share some features with states of reduced arousal and cognitive dysfunction, suggesting a role for EEG in tracking the trajectory of recovery and persisting vulnerabilities to injury. Additionally, results suggest that EEG power reflects distinct pathophysiologies for current PTSD and chronic mTBI. (C) 2016 Elsevier B.V. All rights reserved.	[Franke, Laura M.; Walker, William C.] Def & Vet Brain Injury Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA; [Franke, Laura M.; Walker, William C.] Hunter Holmes McGuire VA Med Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA; [Franke, Laura M.; Walker, William C.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, 1223 E Marshall St, Richmond, VA 23298 USA; [Hoke, Kathy W.; Wares, Joanna R.] Univ Richmond, Dept Math, 28 Westhampton Way, Richmond, VA 23173 USA		Franke, LM (corresponding author), Res Serv 151, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	Laura.Franke@va.gov; William.Walker@vcuhealth.org; khoke@richmond.edu; jwares@richmond.edu	Franke, Lude/P-7036-2016	Franke, Lude/0000-0002-5159-8802	Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC); Hunter Holmes McGuire Veterans Affairs Medical Center in Richmond, VA	We would like to thank Paul Kvam, Ph.D. and three anonymous reviewers for their helpful comments, and Tiffany Amos, Tiffany Lewis, Angela Satariano, and Emily Lynn for their efforts in data collection and processing. This material is based upon work supported with resources and the use of facilities at the Hunter Holmes McGuire Veterans Affairs Medical Center in Richmond, VA, and is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC).	Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1113, DOI 10.1016/j.clinph.2006.01.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blume WT, 2006, J CLIN NEUROPHYSIOL, V23, P306, DOI 10.1097/01.wnp.0000229137.94384.fa; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chen Y.-H., 2015, BR J PSYCHIAT BJP BP; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; da Silva FL, 2013, NEURON, V80, P1112, DOI 10.1016/j.neuron.2013.10.017; Department of Veterans Affairs Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Dressler O, 2004, BRIT J ANAESTH, V93, P806, DOI 10.1093/bja/aeh270; Eggermont J. J., 2015, FRONT NEUROL, V6; FORD MR, 1986, BIOL PSYCHIAT, V21, P1175, DOI 10.1016/0006-3223(86)90224-6; Fu Y., 2008, DELTA EEG ACTIVITY L; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; HARTIKAINEN P, 1992, ACTA NEUROL SCAND, V86, P148, DOI 10.1111/j.1600-0404.1992.tb05057.x; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Knott V, 2002, J AFFECT DISORDERS, V69, P241, DOI 10.1016/S0165-0327(01)00308-1; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McDonald S.D., 2015, BRAIN INJURY, P1; Meerwijk EL, 2014, PSYCHOPHYSIOLOGY, V51, P247, DOI 10.1111/psyp.12175; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2006, NEUROBIOL AGING, V27, P471, DOI 10.1016/j.neurobiolaging.2005.07.021; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Schiff ND, 2014, CURR OPIN NEUROBIOL, V25, P7, DOI 10.1016/j.conb.2013.10.007; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shvil E, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0358-3; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Tabachnick B. G., 2006, USING MULTIVARIATE S, V5th; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Vlahou E.L., 2014, SCI REP, V4; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Weathers F.W., 1993, ANN CONV INT SOC TRA; Yufik T, 2010, J ABNORM PSYCHOL, V119, P764, DOI 10.1037/a0020981; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	54	12	12	3	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	AUG	2016	106						21	29		10.1016/j.ijpsycho.2016.05.010			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	DT7EG	WOS:000381649300003	27238074				2022-02-06	
J	Park, S; Davis, AE				Park, Soohyun; Davis, Alice E.			Effectiveness of direct and non-direct auditory stimulation on coma arousal after traumatic brain injury	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						auditory stimulation; brain injuries; coma; direct; non-direct	CONSCIOUSNESS; SCALE	The aim of this study was to evaluate the effect of direct and non-direct auditory stimulation on arousal in coma patients with severe traumatic brain injury and to compare the effects of direct vs. non-direct auditory stimulation. A crossover intervention study design was used. Nine participants who were comatose after a severe traumatic brain injury underwent direct and non-direct auditory stimulation. Direct auditory stimulation requires a higher level of interpersonal interaction between the patient and stimuli such as voices of family members, orientation by a nurse or family member and familiar music. In contrast, non-direct auditory stimuli were characterized as more general, less familiar, less interactive, indirect and not lively such as general music and TV sounds. Participants received both direct and non-direct auditory stimulation in randomized order for 15 minutes. Recovery of consciousness was measured with the Glasgow Coma Scale (GCS) and Sensory Stimulation Assessment Measure (SSAM). The Friedman test with post hoc analysis by Wilcoxon's signed-rank test comparisons was used for data analysis. Patients who received both direct and non-direct auditory stimulation exhibited significantly increased GCS (p=0.008) and SSAM scores (p=0.008) over baseline. The improvement in SSAM scores after direct auditory stimulation was significantly greater than that after non-direct auditory stimulation (p=0.021), but there was no statistically significant difference in GCS scores (p=0.139). Auditory stimulation, in particular direct auditory stimulation, might be useful for improving the recovery of consciousness and increasing the arousal of comatose patients. The SSAM is more useful for detecting subtle changes from stimulation intervention than the GCS.	[Park, Soohyun] Eulji Univ, Dept Nursing, 553 Sanseong Daero, Songnam 13135, Gyeonggi Do, South Korea; [Davis, Alice E.] Univ Hawaii, Sch Nursing, Hilo, HI 96720 USA		Park, S (corresponding author), Eulji Univ, Dept Nursing, 553 Sanseong Daero, Songnam 13135, Gyeonggi Do, South Korea.	soohyunp@eulji.ac.kr					Abbasi M, 2009, JPN J NURS SCI, V6, P21, DOI 10.1111/j.1742-7924.2009.00117.x; Abbate Carlo, 2014, Front Hum Neurosci, V8, P616, DOI 10.3389/fnhum.2014.00616; Cheng L, 2013, BMC NEUROLOGY, V18, P13; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Faul M, 2010, TRAUMATIC BRAIN INJU; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P69, DOI 10.4103/1658-354X.125940; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Hotz GA, 2006, BRAIN INJURY, V20, P879, DOI 10.1080/02699050600832635; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; Lnu M., 2012, INT J HEAD NECK SURG, V3, P137; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Megha M, 2013, BRAIN INJURY, V27, P570, DOI 10.3109/02699052.2013.767937; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; Rader MA, 1994, SENSORY STIMULATION; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sanchez-Sanchez MM, 2014, ENFERM INTENSIV, V25, P15, DOI 10.1016/j.enfi.2013.09.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Urbenjaphol P, 2009, J NEUROSCI NURSING, V41, pE10, DOI DOI 10.1097/JNN.0B013E3181A23E94; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	26	12	13	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	AUG	2016	22	4					391	396		10.1111/ijn.12448			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DV9NE	WOS:000383266700011	27241789				2022-02-06	
J	Cartagena, CM; Mountney, A; Hwang, H; Swiercz, A; Rammelkamp, Z; Boutte, AM; Shear, DA; Tortella, FC; Schmid, KE				Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.			Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; BETA ACCUMULATION; CASPASE CLEAVAGE; PROGENITOR CELLS; HEAD-INJURY; PROLIFERATION; MITOCHONDRIA; AGGREGATION; FRAGMENT	Traumatic brain injury (TBI) is an established risk factor for the development of Alzheimer's disease (AD). Here the effects of severe penetrating TBI on APP and tau cleavage processing were investigated in a rodent model of penetrating ballistic-like brain injury (PBBI). PBBI was induced by stereotactically inserting a perforated steel probe through the right frontal cortex of the anesthetized rat and rapidly inflating/deflating the probe's elastic tubing into an elliptical shaped balloon to 10% of total rat brain volume causing temporary cavitation injury. Separate animals underwent probe injury (PrI) alone without balloon inflation. Shams underwent craniectomy. Brain tissue was collected acutely (4h, 24h, 3d) and subacutely (7d) post-injury and analyzed by immunoblot for full length APP (APP-FL) and APP beta c-terminal fragments (beta CTFs), full length tau (tau-FL) and tau truncation fragments and at 7d for cytotoxic Beta amyloid (A beta) peptides A beta 40 and A beta 42 analysis. APP-FL was significantly decreased at 3d and 7d following PBBI whereas APP beta CTFs were significantly elevated by 4h post-injury and remained elevated through 7d post-injury. Effects on beta CTFs were mirrored with PrI, albeit to a lesser extent. A beta 40 and A beta 42 were significantly elevated at 7d following PBBI and PrI. Tau-FL decreased substantially 3d and 7d post-PBBI and PrI. Importantly, a 22 kDa tau fragment (tau22), similar to that found in AD, was significantly elevated by 4h and remained elevated through 7d post-injury. Thus both APP and tau cleavage was dramatically altered in the acute and subacute periods post-injury. As cleavage of these proteins has also been implicated in AD, TBI pathology shown here may set the stage for the later development of AD or other tauopathies.	[Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA		Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA.	casandra.m.cartagena@gmail.com			U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program	This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Rebecca Pedersen and Weihong Yang for their excellent technical assistance. This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or reflecting true views of the Department of the Army or the Department of Defense.	Amadoro G, 2014, NEUROBIOL DIS, V62, P489, DOI 10.1016/j.nbd.2013.10.018; Amadoro G, 2014, J ALZHEIMERS DIS, V42, P211, DOI 10.3233/JAD-140267; Amadoro G, 2010, J ALZHEIMERS DIS, V21, P445, DOI 10.3233/JAD-2010-100120; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Baratchi S, 2012, HIPPOCAMPUS, V22, P1517, DOI 10.1002/hipo.20988; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Demars MP, 2013, NEUROBIOL AGING, V34, P2431, DOI 10.1016/j.neurobiolaging.2013.04.016; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hill T., 2006, STAT METHODS APPL CO; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Koike MA, 2011, NEUROSCI LETT, V495, P55, DOI 10.1016/j.neulet.2011.03.034; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Muller K.E., 2002, REGRESSION ANOVA INT; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015	44	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158576	10.1371/journal.pone.0158576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	WOS:000380169300013	27428544	Green Submitted, Green Published, gold			2022-02-06	
J	Shariatgorji, M; Nilsson, A; Bonta, M; Gan, JR; Marklund, N; Clausen, F; Kallback, P; Loden, H; Limbeck, A; Andren, PE				Shariatgorji, Mohammadreza; Nilsson, Anna; Bonta, Maximilian; Gan, Jinrui; Marklund, Niklas; Clausen, Fredrik; Kallback, Patrik; Loden, Henrik; Limbeck, Andreas; Andren, Per E.			Direct imaging of elemental distributions in tissue sections by laser ablation mass spectrometry	METHODS			English	Article						Brain; Kidney; Elemental imaging; Mass spectrometry; Laser ablation; Inductively coupled plasma	LA-ICP-MS; CALCIUM-ACCUMULATION; BIOLOGICAL TISSUES; CEREBRAL-ISCHEMIA; HIGH-RESOLUTION; TRACE-ELEMENTS; THIN-SECTION; ION; SAMPLES; SODIUM	We present a strategy for imaging of elements in biological tissues using laser ablation (LA) mass spectrometry (MS), which was compared to laser ablation inductively coupled plasma (LA-ICP) MS. Both methods were adopted for quantitative imaging of elements in mouse kidney, as well as traumatic brain injury model tissue sections. MS imaging (MSI) employing LA provides quantitative data by comparing signal abundances of sodium from tissues to those obtained by imaging quantitation calibration standards of the target element applied to adjacent control tissue sections. LA-ICP MSI provided quantitative data for several essential elements in both brain and kidney tissue sections using a dried-droplet approach. Both methods were used to image a rat model of traumatic brain injury, revealing accumulations of sodium and calcium in the impact area and its peripheral regions. LA MSI is shown to be a viable option for quantitative imaging of specific elements in biological tissue sections. (C) 2016 Elsevier Inc. All rights reserved.	[Shariatgorji, Mohammadreza; Nilsson, Anna; Gan, Jinrui; Kallback, Patrik; Loden, Henrik; Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Biomol Imaging & Prote, Box 591 BMC, SE-75124 Uppsala, Sweden; [Bonta, Maximilian; Limbeck, Andreas] TU Wien, Inst Chem Technol & Analyt, Vienna, Austria; [Gan, Jinrui] Fudan Univ, Dept Chem, Inst Biomed Sci, Shanghai, Peoples R China; [Gan, Jinrui] Fudan Univ, State Key Lab Mol Engn Polymers, Shanghai, Peoples R China; [Marklund, Niklas; Clausen, Fredrik] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, Neurosurg, Uppsala, Sweden		Andren, PE (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Biomol Imaging & Prote, Box 591 BMC, SE-75124 Uppsala, Sweden.	per.andren@farmbio.uu.se		Shariatgorji, Reza/0000-0001-9484-0921; Clausen, Fredrik/0000-0003-3592-4417; Limbeck, Andreas/0000-0001-5042-2445; Andren, Per/0000-0002-4062-7743; Marklund, Niklas/0000-0002-9797-5626; Kallback, Patrik/0000-0003-2621-136X	Swedish Research Council (Medicine and Health)Swedish Research Council [2013-3105]; Swedish Research Council (Natural and Engineering Science)Swedish Research Council [2014-6215]; Swedish Brain Foundation; Swedish Foundation for Strategic ResearchSwedish Foundation for Strategic Research [RIF14-0078]; China Scholarship CouncilChina Scholarship Council	This work was supported by the Swedish Research Council (Medicine and Health #2013-3105, Natural and Engineering Science #2014-6215), the Swedish Brain Foundation, the Swedish Foundation for Strategic Research (#RIF14-0078) (to P.E.A.) and the China Scholarship Council (to J.G.).	Becker JS, 2013, J MASS SPECTROM, V48, P255, DOI 10.1002/jms.3168; Becker JS, 2007, ANAL CHEM, V79, P6074, DOI 10.1021/ac0700528; Becker JS, 2008, SPECTROCHIM ACTA B, V63, P1248, DOI 10.1016/j.sab.2008.08.001; Becker JS, 2007, J ANAL ATOM SPECTROM, V22, P736, DOI 10.1039/b701558e; Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q; Becker JS, 2005, J ANAL ATOM SPECTROM, V20, P912, DOI 10.1039/b504978b; BETZ AL, 1994, J CEREBR BLOOD F MET, V14, P29, DOI 10.1038/jcbfm.1994.5; BICKLER PE, 1994, BRAIN RES, V665, P269, DOI 10.1016/0006-8993(94)91347-1; Boada FE, 2012, TRANSL STROKE RES, V3, P236, DOI 10.1007/s12975-012-0168-7; Bonta M, 2016, ANAL CHIM ACTA, V908, P54, DOI 10.1016/j.aca.2015.12.048; Bonta M, 2014, J ANAL ATOM SPECTROM, V29, P2159, DOI 10.1039/c4ja00245h; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chandra S, 2003, APPL SURF SCI, V203, P679, DOI 10.1016/S0169-4332(02)00790-0; CHANDRA S, 1995, INT J MASS SPECTROM, V143, P161, DOI 10.1016/0168-1176(94)04134-S; Chumbley CW, 2016, ANAL CHEM, V88, P2392, DOI 10.1021/acs.analchem.5b04409; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Edelson-Averbukh M, 2006, ANAL CHEM, V78, P1249, DOI 10.1021/ac051649v; Haraguchi H, 2004, J ANAL ATOM SPECTROM, V19, P5, DOI 10.1039/b308213j; Isaure MP, 2006, SPECTROCHIM ACTA B, V61, P1242, DOI 10.1016/j.sab.2006.10.009; ITO U, 1979, STROKE, V10, P542, DOI 10.1161/01.STR.10.5.542; Jones SC, 2006, STROKE, V37, P883, DOI 10.1161/01.STR.0000198845.79254.0f; Kallback P, 2012, J PROTEOMICS, V75, P4941, DOI 10.1016/j.jprot.2012.07.034; Kindness A, 2003, CLIN CHEM, V49, P1916, DOI 10.1373/clinchem.2003.022046; Leung S, 2011, ADV BIOM ENG, P45; Lobinski R, 2006, BIOCHIMIE, V88, P1591, DOI 10.1016/j.biochi.2006.10.003; Mai FD, 2006, APPL SURF SCI, V252, P6809, DOI 10.1016/j.apsusc.2006.02.227; Margui E, 2009, TRAC-TREND ANAL CHEM, V28, P362, DOI 10.1016/j.trac.2008.11.011; McDonnell LA, 2006, J AM SOC MASS SPECTR, V17, P1195, DOI 10.1016/j.jasms.2006.05.003; Moore KL, 2013, SURF INTERFACE ANAL, V45, P309, DOI 10.1002/sia.4903; NIEHUIS E, 1989, SURF INTERFACE ANAL, V14, P135, DOI 10.1002/sia.740140307; Nilsson A, 2015, ANAL CHEM, V87, P1437, DOI 10.1021/ac504734s; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Norris JL, 2013, CHEM REV, V113, P2309, DOI 10.1021/cr3004295; Shariatgorji M, 2014, NEUROPSYCHOPHARMACOL, V39, P34, DOI 10.1038/npp.2013.215; Spengler B, 2002, J AM SOC MASS SPECTR, V13, P735, DOI 10.1016/S1044-0305(02)00376-8; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Werner M, 1995, CLIN CHIM ACTA, V243, P101; Wu B, 2009, TALANTA, V78, P132, DOI 10.1016/j.talanta.2008.10.061; Yushmanov VE, 2013, BRAIN RES, V1527, P199, DOI 10.1016/j.brainres.2013.06.012	39	12	12	2	56	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	JUL 15	2016	104						86	92		10.1016/j.ymeth.2016.05.021			7	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS0PN	WOS:000380299300012	27263025				2022-02-06	
J	Epstein, DS; Mitra, B; Cameron, PA; Fitzgerald, M; Rosenfeld, JV				Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.; Fitzgerald, Mark; Rosenfeld, Jeffrey V.			Normalization of coagulopathy is associated with improved outcome after isolated traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Blood coagulation; Coagulopathy; Craniocerebral trauma; Injuries; Isolated head trauma; Traumatic brain injury	INTRACRANIAL HEMORRHAGE; COAGULATION DISORDERS; MASSIVE TRANSFUSION; PROGRESSION; DEFINITION; MORTALITY; COMPLEX; PATIENT; MILD	Acute traumatic coagulopathy (ATC) has been reported in the setting of isolated traumatic brain injury (iTBI) and is associated with poor outcomes. We aimed to evaluate the effectiveness of procoagulant agents administered to patients with ATC and iTBI during resuscitation, hypothesizing that timely normalization of coagulopathy may be associated with a decrease in mortality. A retrospective review of the Alfred Hospital trauma registry, Australia, was conducted and patients with iTBI (head Abbreviated Injury Score [AIS] >= 3 and all other body AIS <3) and coagulopathy (international normalized ratio >= 1.3) were selected for analysis. Data on procoagulant agents used (fresh frozen plasma, platelets, cryoprecipitate, prothrombin complex concentrates, tranexamic acid, vitamin K) were extracted. Among patients who had achieved normalization of INR or survived beyond 24 hours and were not taking oral anticoagulants, the association of normalization of INR and death at hospital discharge was analyzed using multivariable logistic regression analysis. There were 157 patients with ATC of whom 68 (43.3%) received procoagulant products within 24 hours of presentation. The median time to delivery of first products was 182.5 (interquartile range [IQR] 115-375) minutes, and following administration of coagulants, time to normalization of INR was 605 (IQR 274-1146) minutes. Normalization of INR was independently associated with significantly lower mortality (adjusted odds ratio 0.10; 95% confidence interval 0.03-0.38). Normalization of INR was associated with improved mortality in patients with ATC in the setting of iTBI. As there was a substantial time lag between delivery of products and eventual normalization of coagulation, specific management of coagulopathy should be implemented as early as possible. (c) 2016 Elsevier Ltd. All rights reserved.	[Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia; [Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Mitra, Biswadev; Fitzgerald, Mark] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Cameron, Peter A.] Hamad Med Corp, Emergency Med, Doha, Qatar; [Fitzgerald, Mark] Alfred Hosp, Trauma Serv, Melbourne, Vic 3004, Australia; [Fitzgerald, Mark; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA		Mitra, B (corresponding author), Alfred Hosp, Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia.; Mitra, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.; Mitra, B (corresponding author), Natl Trauma Res Inst, Melbourne, Vic, Australia.	biswadev.mitra@monash.edu	Epstein, Daniel/AAQ-4181-2020; Mitra, Biswadev/AAC-3724-2019	Epstein, Daniel/0000-0003-2215-7749; Mitra, Biswadev/0000-0002-0508-2450; Fitzgerald, Mark/0000-0003-0183-7761; Cameron, Peter/0000-0002-1443-557X			Brophy GM, 2013, ANN PHARMACOTHER, V47, P447, DOI 10.1345/aph.1R729; Cameron PA, 2014, BRIT J ANAESTH, V113, P226, DOI 10.1093/bja/aeu231; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Fitzgerald M, 2011, ARCH SURG-CHICAGO, V146, P218, DOI 10.1001/archsurg.2010.333; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Huynh TK, 2014, PHARMACOTHERAPY, V34, P260, DOI 10.1002/phar.1384; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kalina M, 2008, AM SURGEON, V74, P858; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mitra B, 2014, SHOCK, V42, P307, DOI 10.1097/SHK.0000000000000219; Mitra B, 2012, EMERG MED AUSTRALAS, V24, P363, DOI 10.1111/j.1742-6723.2012.01556.x; Nascimento B, 2014, BRIT J ANAESTH, V113, P922, DOI 10.1093/bja/aeu158; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tran HA, 2013, MED J AUSTRALIA, V198, P198, DOI 10.5694/mja12.10614; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	36	12	13	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2016	29						64	69		10.1016/j.jocn.2015.11.024			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP4EU	WOS:000378449800013	26947341				2022-02-06	
J	Gill, J; Merchant-Borna, K; Lee, H; Livingston, WS; Olivera, A; Cashion, A; Wang, D; Bazarian, JJ				Gill, Jessica; Merchant-Borna, Kian; Lee, Hyunhwa; Livingston, Whitney S.; Olivera, Anlys; Cashion, Ann; Wang, Dan; Bazarian, Jeffrey J.			Sports-Related Concussion Results in Differential Expression of Nuclear Factor-kappa B Pathway Genes in Peripheral Blood During the Acute and Subacute Periods	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute-phase reaction; brain concussion; gene expression; inflammation; sports-related concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MICROGLIA ACTIVATION; CCL2; INTERLEUKIN-6; BIOMARKERS; CHEMOKINES; APOPTOSIS; RELEASE; PLASMA	Objective: To determine changes in global gene expression in peripheral leukocytes in the acute and subacute periods following a sports-related concussion in athletes. Setting: Samples were collected at 2 universities in Rochester, New York. Participants: Fifteen contact sport athletes who experienced a sports-related concussion, and 16 nonconcussed teammates served as controls. Design: Blood samples were collected at the start of the season (baseline), within 6 hours of injury (acute), and at 7 days (subacute) postinjury. Differential gene expression was measured using the GeneChip 3' in vitro transcription Expression kit and Affymetrix microarrays, and genes with fold difference of 2 or more were identified using Partek. Main Measures: Whole genome differential gene expression, and cognitive and balance measures to asses for clinical symptoms pre- and postinjury. Results: In the concussed athletes, we observed 67 downregulated and 4 upregulated genes in the acute period and 63 downregulated and 2 upregulated genes in the subacute period compared with baseline. Of these, there were 28 genes from both time points involved in the inflammatory response. No significant differences in gene expression were detected in the control group. Conclusions: Our findings suggest that recovery from sports-related concussion relates to modulation of inflammation through cytokine and chemokine gene pathways, which can contribute to future development of personalized therapeutic agents.	[Gill, Jessica; Livingston, Whitney S.; Olivera, Anlys; Cashion, Ann; Wang, Dan] NINR, NIH, 1 Cloister Ct,Rm 259, Bethesda, MD 20814 USA; [Lee, Hyunhwa] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA; [Merchant-Borna, Kian; Bazarian, Jeffrey J.] Univ Rochester, Rochester, NY USA		Livingston, WS (corresponding author), NINR, NIH, 1 Cloister Ct,Rm 259, Bethesda, MD 20814 USA.	whitney.livingston@nih.gov	Gill, Gill M/Q-2020-2017	Lee, Hyunhwa/0000-0002-5625-3141	NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD064754]; NIH Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD064754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000030] Funding Source: NIH RePORTER	This work was supported by funds from the NIH/NICHD (award no. K24HD064754) and the NIH Intramural Research Program. Dr Sijung Yun provided additional review of data analyses methods and results from this study.	Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Matsuoka Y, 1999, NEUROCHEM INT, V34, P91, DOI 10.1016/S0197-0186(98)00053-9; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Owen JL, 2011, CELL IMMUNOL, V270, P172, DOI 10.1016/j.cellimm.2011.05.004; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026	34	12	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					269	276		10.1097/HTR.0000000000000191			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000012	26479397				2022-02-06	
J	Li, W; Long, JA; Watts, L; Shen, Q; Liu, YC; Jiang, Z; Duong, TQ				Li, Wei; Long, Justin Alexander; Watts, Lora; Shen, Qiang; Liu, Yichu; Jiang, Zhao; Duong, Timothy Q.			Spatiotemporal changes in diffusion, T-2 and susceptibility of white matter following mild traumatic brain injury	NMR IN BIOMEDICINE			English	Article						traumatic brain injury; white matter; quantitative susceptibility mapping; diffusion tensor imaging; T-2 mapping	MAGNETIC-FIELD; MRI; PHASE; VIVO; RECOVERY; COSMOS; MYELIN; ORDER	Impaired white matter integrity in traumatic brain injury (TBI) can lead to deficits in various neurological functions. The differentiation of the underlying pathological processes, e.g. edema, demyelination, axonal damage, to name a few, is of key clinical interest for the assessment of white matter injury. In this study, a combination of T-2, diffusion and susceptibility MRI was used to study the spatiotemporal changes in white matter at 1h, 3h, and 1, 2, 7 and 14days following TBI, using a rat controlled cortical impact (CCI) model. Based on radial diffusivity (RD), the rats were divided into two groups: group 1 showed widespread increases in RD along the corpus callosum of the ipsilesional hemisphere at day 2, and group 2 showed normal RD. Based on this group separation, group 1 also showed similar widespread changes in fractional anisotropy (FA) and T-2 at day 2, and group 2 showed normal FA and T-2. The widespread changes in RD and T-2 in group 1 on day 2 were apparently dominated by edema, which obscured possible myelin and axonal damage. In contrast, the susceptibility of group 1 showed more localized increases near the impact site on day 2, and otherwise similar contrast to the contralesional hemisphere. The localized susceptibility increase is probably a result of demyelination and axonal injury. The extent of brain damage between the two groups revealed by MRI was consistent with behavioral results, with the first group showing significantly increased forelimb asymmetry and increased forelimb foot fault deficits. Our results suggest that the combination of T-2, diffusion and susceptibility MRI may provide an opportunity for the differential assessment of edema and axonal damage in TBI. Copyright (c) 2016 John Wiley & Sons, Ltd.	[Li, Wei; Long, Justin Alexander; Watts, Lora; Shen, Qiang; Liu, Yichu; Jiang, Zhao; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Li, Wei; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Watts, Lora] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA		Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, Dept Ophthalmol, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Duong, Tim/AAL-8357-2021; Shen, Qiang/B-8784-2008	Duong, Tim/0000-0001-6403-2827; Shen, Qiang/0000-0002-4287-3403; jiang, zhao/0000-0002-8192-9908	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS 45879]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2T001118]; Clinical Translational Science Awards (CTSA) [UL1TR001119]; William & Ella Owens Medical Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001118, UL1TR001120, TL1TR001119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) R01NS 45879 (T.Q.D.). The project described was also supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2T001118 (L.W.). W.L. was also supported in part by UL1TR001119 via the Clinical Translational Science Awards (CTSA), and a research grant from William & Ella Owens Medical Research Foundation.	Argyridis L, 2014, NEUROIMAGE, V88, P134, DOI 10.1016/j.neuroimage.2013.11.026; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; GO KG, 1975, ARCH NEUROL-CHICAGO, V32, P462, DOI 10.1001/archneur.1975.00490490066006; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kressler B, 2010, IEEE T MED IMAGING, V29, P273, DOI 10.1109/TMI.2009.2023787; Lee J, 2012, NEUROIMAGE, V59, P3967, DOI 10.1016/j.neuroimage.2011.10.076; Li W, 2013, P 1 ACM WORKSH COGN, P21; Li Wei, 2013, J Neurosci Neuroeng, V2, P431; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Li W, 2014, NMR BIOMED, V27, P219, DOI 10.1002/nbm.3056; Li W, 2012, NEUROIMAGE, V59, P2088, DOI 10.1016/j.neuroimage.2011.10.038; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Liu CL, 2012, NEUROIMAGE, V59, P1290, DOI 10.1016/j.neuroimage.2011.07.096; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Liu CL, 2010, MAGN RESON MED, V63, P1471, DOI 10.1002/mrm.22482; Liu CL, 2010, MAGN RESON MED, V63, P243, DOI 10.1002/mrm.22192; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Lodygensky GA, 2012, NEUROIMAGE, V59, P1979, DOI 10.1016/j.neuroimage.2011.09.057; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; LOUNILA J, 1994, PHYS REV LETT, V72, P4049, DOI 10.1103/PhysRevLett.72.4049; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Sati P, 2013, NEUROIMAGE, V77, P268, DOI 10.1016/j.neuroimage.2013.03.005; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Wharton S, 2015, MAGN RESON MED, V73, P1258, DOI 10.1002/mrm.25189; Wharton S, 2012, P NATL ACAD SCI USA, V109, P18559, DOI 10.1073/pnas.1211075109; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000	48	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	JUL	2016	29	7					896	903		10.1002/nbm.3536			8	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	DQ2JM	WOS:000379028600005	27149577	Green Accepted			2022-02-06	
J	Watanabe, J; Maruya, J; Kanemaru, Y; Miyauchi, T; Nishimaki, K				Watanabe, Jun; Maruya, Jun; Kanemaru, Yu; Miyauchi, Takaharu; Nishimaki, Keiichi			Transient disappearance of microbleeds in the subacute period based on T2*-weighted gradient echo imaging in traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Diffuse axonal injury; T2*-weighted gradient echo imaging; Magnetic resonance imaging; Microbleeds; Traumatic brain injury	DIFFUSE AXONAL INJURY; HEMORRHAGE; LESIONS; HYPERACUTE; CHILDREN; PHASE; MRI	We report three cases of traumatic microbleeds evaluated by sequential observation. Hypo-intensities on T2* gradient echo imaging (T2*GEI) appeared just 2-3 h after the injury (the hyper-acute period). However, these hypo-intensities on T2*GEI disappeared or became obscure 2-6 days after the injury (the subacute period). A follow-up MRI again revealed clear hypo-intensities on T2*GEI 1-3 months after the injury (the chronic period). Our cases indicate that hypo-intensities on T2*GEI might change dynamically from the hyper-acute to the chronic period. The differences of susceptibility effects by hematoma age might be the cause of this dynamic change.	[Watanabe, Jun; Maruya, Jun; Nishimaki, Keiichi] Akita Red Cross Hosp, Dept Neurosurg, 222-1 Nawashirosawa, Akita 0101495, Japan; [Kanemaru, Yu] Nagano Red Cross Hosp, Dept Neurosurg, Nagano, Japan; [Miyauchi, Takaharu] Akita Red Cross Hosp, Dept Radiol, Akita 0101495, Japan		Watanabe, J (corresponding author), Akita Red Cross Hosp, Dept Neurosurg, 222-1 Nawashirosawa, Akita 0101495, Japan.	watanabejun1003@yahoo.co.jp					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Ezaki Y, 2006, ACTA NEUROCHIR, V148, P547, DOI 10.1007/s00701-005-0692-2; Hermier M, 2004, STROKE, V35, P1989, DOI 10.1161/01.STR.0000133341.74387.96; Linfante I, 1999, STROKE, V30, P2263, DOI 10.1161/01.STR.30.11.2263; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ripoll MA, 2002, ACTA RADIOL, V43, P2, DOI 10.1080/028418502127347538; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176	12	12	12	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2016	158	7					1247	1250		10.1007/s00701-016-2805-5			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DO3YX	WOS:000377719800003	27106841				2022-02-06	
J	Xiong, KL; Zhang, JN; Zhang, YL; Zhang, Y; Chen, H; Qiu, MG				Xiong, K. L.; Zhang, J. N.; Zhang, Y. L.; Zhang, Y.; Chen, H.; Qiu, M. G.			Brain functional connectivity and cognition in mild traumatic brain injury	NEURORADIOLOGY			English	Article						Mild traumatic brain injury; Resting-state fMRI; Low-frequency fluctuation; Functional connectivity	RESTING-STATE FMRI; HEAD-INJURY; SMALL-WORLD; FOLLOW-UP; NETWORKS; MEMORY; MRI; SCHIZOPHRENIA; ADULTS	The aim of this study was to analyze brain functional connectivity and its relationship to cognition in patients with mild traumatic brain injury (mTBI). Twenty-five patients with mTBI and 25 healthy control subjects were studied using resting-state functional MRI (rs-fMRI). Amplitudes of low-frequency fluctuations (ALFFs) and functional connectivity (FC) were calculated and correlated with cognition. Compared with the normal control group, the mTBI patients showed a significant decrease in working memory index (WMI) and processing speed index (PSI), as well as significantly decreased ALFFs in the cingulate gyrus, the middle frontal gyrus and superior frontal gyrus. In contrast, the mTBI patients' ALFFs in the left middle occipital gyrus, the left precuneus, and lingual gyrus increased. Additionally, FC significantly decreased in the thalamus, caudate nucleus, and right hippocampus in the mTBI patients. Statistical analysis further showed a significant positive correlation between the ALFF in the cingulate gyrus and the WMI (R (2) = 0.423, P < 0.05) and a significant positive correlation between the FC in the left thalamus and left middle frontal gyrus and the WMI (R (2) = 0.381, P < 0.05). rs-fMRI can reveal the functional state of the brain in patients with mTBI. This finding differed from observations of the normal control group and was significantly associated with clinical cognitive dysfunction. Therefore, rs-fMRI offers an objective imaging modality for treatment planning and prognosis assessment in patients with mTBI.	[Xiong, K. L.; Zhang, Y. L.; Chen, H.] Third Mil Med Univ, Daping Hosp, Dept Radiol, Chongqing, Peoples R China; [Zhang, J. N.; Zhang, Y.; Qiu, M. G.] Third Mil Med Univ, Dept Med Imaging, Coll Biomed Engn, 30 Gaotanyan Rd, Chongqing 400038, Peoples R China		Qiu, MG (corresponding author), Third Mil Med Univ, Dept Med Imaging, Coll Biomed Engn, 30 Gaotanyan Rd, Chongqing 400038, Peoples R China.	jellyhuangsci@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171866, 81571889]; Starting Fund of Overseas Returnees of Ministry of Education; National Basic Key Research Program (973)National Basic Research Program of China [2014CB541602]	This study was funded by the General Program of National Natural Science Foundation of China (81171866,81571889), the Starting Fund of Overseas Returnees of Ministry of Education (2012) and the National Basic Key Research Program (973) (2014CB541602).	Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yin Y, 2011, NEUROSCI LETT, V498, P185, DOI 10.1016/j.neulet.2011.02.069; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	31	12	14	2	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	JUL	2016	58	7					733	739		10.1007/s00234-016-1675-0			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DS9EF	WOS:000381084900012	27000797				2022-02-06	
J	Yang, GM; Peng, XY; Hu, Y; Lan, D; Wu, Y; Li, T; Liu, LM				Yang, Guangming; Peng, Xiaoyong; Hu, Yi; Lan, Dan; Wu, Yue; Li, Tao; Liu, Liangming			4-Phenylbutyrate Benefits Traumatic Hemorrhagic Shock in Rats by Attenuating Oxidative Stress, Not by Attenuating Endoplasmic Reticulum Stress	CRITICAL CARE MEDICINE			English	Article						4-phenylbutyrate; endoplasmic reticulum stress; mitochondria; oxidative stress; traumatic hemorrhagic shock; vascular hyporeactivity	REGULATE VASCULAR REACTIVITY; UREA CYCLE DISORDERS; EARLY BRAIN-INJURY; ARGININE-VASOPRESSIN; SHORT-TERM; ER STRESS; ISCHEMIA; PROTECTS; PLAYS; MITOCHONDRIA	Objective: Vascular dysfunction such as vascular hyporeactivity following severe trauma and shock is a major cause of death in injured patients. Oxidative stress and endoplasmic reticulum stress play an important role in vascular dysfunction. The objective of the present study was to determine whether or not 4-phenylbutyrate can improve vascular dysfunction and elicit antishock effects by inhibiting oxidative and endoplasmic reticulum stress. Design: Prospective, randomized, controlled laboratory experiment. Setting: State key laboratory of trauma, burns, and combined injury. Subjects: Five hundred and fifty-two Sprague-Dawley rats. Interventions: Rats were anesthetized, and a model of traumatic hemorrhagic shock was established by left femur fracture and hemorrhage. The effects of 4-phenylbutyrate (5, 20, 50, 100, 200, and 300 mg/kg) on vascular reactivity, animal survival, hemodynamics, and vital organ function in traumatic hemorrhagic shock rats and cultured vascular smooth muscle cells, and the relationship to oxidative stress and endoplasmic reticulum stress was observed. Measurements and Main Results: Lower doses of 4-phenylbutyrate significantly improved the vascular function, stabilized the hemodynamics, and increased the tissue blood flow and vital organ function in traumatic hemorrhagic shock rats, and markedly improved the survival outcomes. Among all dosages observed in the present study, 20 mg/kg of 4-phenylbutyrate had the best effect. Further results indicated that 4-phenylbutyrate significantly inhibited the oxidative stress, decreased shock-induced oxidative stress index such as the production of reactive oxygen species, increased the antioxidant enzyme levels such as superoxide dismutase, catalase, and glutathione, and improved the mitochondrial function by inhibiting the opening of the mitochondrial permeability transition pore in rat artery and vascular smooth muscle cells. In contrast, 4-phenylbutyrate did not affect the changes of endoplasmic reticulum stress markers following traumatic hemorrhagic shock. Furthermore, 4-phenylbutyrate increased the nuclear levels of nuclear factor-E2-related factor 2, and decreased the nuclear levels of nuclear factor kappa B in hypoxic vascular smooth muscle cells. Conclusions: 4-phenylbutyrate has beneficial effects for traumatic hemorrhagic shock including improving animal survival and protecting organ function. These beneficial effects of 4-phenylbutyrate in traumatic hemorrhagic shock result from its vascular function protection via attenuation of the oxidative stress and mitochondrial permeability transition pore opening. Nuclear factor-E2-related factor 2 and nuclear factor-kappa B may be involved in 4-phenylbutyrate-mediated inhibition of oxidative stress.	[Yang, Guangming; Peng, Xiaoyong; Hu, Yi; Lan, Dan; Wu, Yue; Li, Tao; Liu, Liangming] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury,Dept, Chongqing, Peoples R China		Li, T; Liu, LM (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury,Dept, Chongqing, Peoples R China.	lt200132@163.com; liangmingliu@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270400, 81571886]; Natural Science Foundation of Chongqing CityNatural Science Foundation of Chongqing [stc2013j-cyjA10012]; State Key Laboratory of Trauma, Burns and Combined Injury [SKLZZ200912, SKLZZ201020]	All authors received support for article research from the National Natural Science Foundation of China (grant no. 81270400 and 81571886), the Natural Science Foundation of Chongqing City (grant no. stc2013j-cyjA10012), and the Foundation of State Key Laboratory of Trauma, Burns and Combined Injury (grant no. SKLZZ200912 and SKLZZ201020).	Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Chen G, 2013, CRIT CARE, V17, DOI 10.1186/cc12820; Chung YL, 2009, CARCINOGENESIS, V30, P1387, DOI 10.1093/carcin/bgp079; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Dodson M, 2015, BIOCHEM J, V469, P347, DOI 10.1042/BJ20150568; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fessler EB, 2013, CURR PHARM DESIGN, V19, P5105, DOI 10.2174/1381612811319280009; Hasan A, 1997, SHOCK, V8, P305, DOI 10.1097/00024382-199710000-00011; Kaste M, 2013, CEREBROVASC DIS, V36, P196, DOI 10.1159/000353680; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kusaczuk M, 2015, CURR PHARM DESIGN, V21, P2147, DOI 10.2174/1381612821666150105160059; Li T, 2012, ANESTHESIOLOGY, V116, P1288, DOI 10.1097/ALN.0b013e318256f09d; Li T, 2011, ANN SURG, V253, P185, DOI 10.1097/SLA.0b013e3181f9b88b; Liu LM, 2013, ANESTHESIOLOGY, V119, P379, DOI 10.1097/ALN.0b013e31829b3804; Lupachyk S, 2013, DIABETES, V62, P944, DOI 10.2337/db12-0716; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Mimori S, 2013, BIOORG MED CHEM LETT, V23, P6015, DOI 10.1016/j.bmcl.2013.08.001; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Mizukami T, 2010, J VASC SURG, V52, P1580, DOI 10.1016/j.jvs.2010.06.172; Mokhtarani M, 2013, MOL GENET METAB, V110, P446, DOI 10.1016/j.ymgme.2013.09.017; Mujumdar N, 2014, AM J PHYSIOL-GASTR L, V306, pG1011, DOI 10.1152/ajpgi.00466.2013; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Pagano G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/541230; Persson T, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/427318; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Sennoun N, 2009, CRIT CARE MED, V37, P246, DOI 10.1097/CCM.0b013e318192fe4f; Siomek A, 2012, ACTA BIOCHIM POL, V59, P323; Smith W, 2013, J PEDIATR-US, V162, P1228, DOI 10.1016/j.jpeds.2012.11.084; Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8; van der Meer AJ, 2015, CRIT CARE MED, V43, pE199, DOI 10.1097/CCM.0000000000000949; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; WEBSTER KA, 1993, J BIOL CHEM, V268, P16852; Wu MY, 2012, INVEST OPHTH VIS SCI, V53, P4595, DOI 10.1167/iovs.12-9910; Wu Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/752387; Xu J, 2012, CARDIOVASC RES, V96, P308, DOI 10.1093/cvr/cvs254; Yang GM, 2006, J TRAUMA, V61, P1336, DOI 10.1097/01.ta.0000197928.99745.22; Yang GM, 2013, J TRAUMA ACUTE CARE, V74, P1033, DOI 10.1097/TA.0b013e31828586a2; Yang GM, 2010, EUR J PHARMACOL, V628, P148, DOI 10.1016/j.ejphar.2009.11.040; Zhan Y, 2012, CRIT CARE MED, V40, P1291, DOI 10.1097/CCM.0b013e31823da96d; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730	46	12	15	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2016	44	7					E477	E491		10.1097/CCM.0000000000001469			15	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO9BX	WOS:000378080400004	26646458				2022-02-06	
J	Mazzeo, AT; Filippini, C; Rosato, R; Fanelli, V; Assenzio, B; Piper, I; Howells, T; Mastromauro, I; Berardino, M; Ducati, A; Mascia, L				Mazzeo, Anna Teresa; Filippini, Claudia; Rosato, Rosalba; Fanelli, Vito; Assenzio, Barbara; Piper, Ian; Howells, Timothy; Mastromauro, Ilaria; Berardino, Maurizio; Ducati, Alessandro; Mascia, Luciana			Multivariate projection method to investigate inflammation associated with secondary insults and outcome after human traumatic brain injury: a pilot study	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Intracranial hypertension; Secondary insults; Neuroinflammation; Cytokines; Principal component analysis	INTRACRANIAL HYPERTENSION; CEREBROSPINAL-FLUID; PROGNOSTIC VALUE; INTENSIVE-CARE; HEAD-INJURY; PRESSURE; SERUM; CYTOKINE; INTERLEUKIN-8; BIOMARKERS	Background: Neuroinflammation has been proposed as a possible mechanism of brain damage after traumatic brain injury (TBI), but no consensus has been reached on the most relevant molecules. Furthermore, secondary insults occurring after TBI contribute to worsen neurological outcome in addition to the primary injury. We hypothesized that after TBI, a specific pattern of cytokines is related to secondary insults and outcome. Methods: A prospective observational clinical study was performed. Secondary insults by computerized multimodality monitoring system and systemic value of different cytokines were collected and analysed in the first week after intensive care unit admission. Neurological outcome was assessed at 6 months (GOSe). Multivariate projection technique was applied to analyse major sources of variation and collinearity within the cytokines dataset without a priori selecting potential relevant molecules. Results: Twenty-nine severe traumatic brain injury patients undergoing intracranial pressure monitoring were studied. In this pilot study, we demonstrated that after TBI, patients who suffered of prolonged and severe secondary brain damage are characterised by a specific pattern of cytokines. Patients evolving to brain death exhibited higher levels of inflammatory mediators compared to both patients with favorable and unfavorable neurological outcome at 6 months. Raised ICP and low cerebral perfusion pressure occurred in 21 % of good monitoring time. Furthermore, the principal components selected by multivariate projection technique were powerful predictors of neurological outcome. Conclusions: The multivariate projection method represents a valuable methodology to study neuroinflammation pattern occurring after secondary brain damage in severe TBI patients, overcoming multiple putative interactions between mediators and avoiding any subjective selection of relevant molecules.	[Mascia, Luciana] Univ Roma La Sapienza, Dipartimento Sci & Biotecnol Med Chirurg, Rome, Italy; [Mazzeo, Anna Teresa; Fanelli, Vito; Assenzio, Barbara; Mastromauro, Ilaria] Univ Turin, Dept Surg Sci, Anesthesia & Intens Care Unit, Turin, Italy; [Filippini, Claudia] Univ Turin, Dept Surg Sci, Turin, Italy; [Rosato, Rosalba] Univ Turin, Dept Psychol, Turin, Italy; [Piper, Ian] So Gen Hosp, Dept Clin Phys, Glasgow, Lanark, Scotland; [Howells, Timothy] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Berardino, Maurizio] AOU Citta Salute & Sci Torino, Presidio CTO, Anesthesia & Intens Care Unit, Turin, Italy; [Ducati, Alessandro] Univ Turin, Dept Neurosci, Neurosurg Unit, Turin, Italy		Mascia, L (corresponding author), Univ Roma La Sapienza, Dipartimento Sci & Biotecnol Med Chirurg, Rome, Italy.	luciana.mascia@uniroma1.it	mascia, Luciana/L-3039-2018; Fanelli, Vito/K-4028-2018	Filippini, Claudia/0000-0003-0194-142X; ROSATO, Rosalba/0000-0002-4921-374X; Mazzeo, Anna Teresa/0000-0002-8454-7243; Fanelli, Vito/0000-0002-1647-2411	University of Torino [MASL1RIL12]	This work was supported by the University of Torino (grant no.: MASL1RIL12) for data collection, mining and analysis.	ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Helmy A, 2015, J CEREBRAL BLOOD FLO; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Perez-Barcena J, 2011, CRIT CARE MED, V39, P533, DOI 10.1097/CCM.0b013e318205c7a4; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stein DM, 2012, SHOCK, V37, P563, DOI 10.1097/SHK.0b013e3182534f93; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	44	12	14	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUN 21	2016	13								157	10.1186/s12974-016-0624-5			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DQ0BS	WOS:000378863300001	27324502	Green Published, gold			2022-02-06	
J	Yi, MN; Dou, FF; Lu, Q; Yu, ZH; Chen, HZ				Yi, Mengni; Dou, Fangfang; Lu, Qin; Yu, Zhihua; Chen, Hongzhuan			Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway	NEUROSCIENCE LETTERS			English	Article						Astrocytes; Migration; Calcium; KCa3.1; Reactivity	SPINAL-CORD-INJURY; K+ CHANNELS; IN-VIVO; MIGRATION; ASTROCYTES; INHIBITION; EXPRESSION; CELLS; MODEL; PROTECTION	Reactive astrogliosis is widely considered to contribute to pathogenic responses to stress and brain injury and to diseases as diverse as ischemia and neurodegeneration. We previously found that expression of the intermediate-conductance calcium-activated potassium channel (KCa3.1) involved in TGF-beta-activated astrogliosis. In the present study, we investigated whether migration of cortical astrocytes following mechanical scratch injury involves the KCa3.1 channel, which contributes to Ca2+ -mediated migration in other cells. We found that scratch injury increased the expression of KCa3.1 protein in reactive astrocytes. Application of the KCa3.1 blocker TRAM-34 decreased glial fibrillary acidic protein (GFAP) expression and slowed migration in a concentration-dependent manner. Application of the Ca2+ chelators, EGTA and BAPTA-AM, also slowed the migration of astrocytes. Blockade or genetic deletion of KCa3.1 both slowed and dramatically reduced the scratch injuries induced the sharp rise in astrocytes Ca2+ concentrations. The scratch injury-induced phosphorylation of JNK and c-Jun proteins was also attenuated both by blockade of KCa3.1 with TRAM-34 and in KCa3.1(-/-) astrocytes. Using KCa3.1 knockout mice, we further confirmed that deletion of KCa3.1 reduced expression of GFAP in an in vivo stab wound model. Taken together, our findings highlight a novel role for KCa3.1 in phenotypic modulation of reactive astrocytes and in astrocyte mobilization in response to mechanical stress, providing a potential target for therapeutic intervention in brain injuries. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Yi, Mengni; Lu, Qin; Yu, Zhihua; Chen, Hongzhuan] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Dou, Fangfang] Shanghai Univ Tradit Chinese Med, Shanghai Geriatr Inst Chinese Med, Longhua Hosp, Cent Lab, Shanghai 200031, Peoples R China		Yu, ZH; Chen, HZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.	yuzhihua@shsmu.edu.cn; hongzhuan_chen@hotmail.com			Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [16ZR1418700]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102491]	This work was supported by Science and Technology Commission of Shanghai Municipality grant 16ZR1418700 and National Natural Science Foundation of China grant 81102491. The authors declare no competing financial interests.	Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Chimote AA, 2013, J IMMUNOL, V191, P6273, DOI 10.4049/jimmunol.1300702; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Ferreira R, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fncel.2014.0018, 10.3389/fncel.2014.00183]; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Lanosa XA, 2007, IN VITRO CELL DEV-AN, V43, P186, DOI 10.1007/s11626-007-9038-0; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWAB A, 1994, J CLIN INVEST, V93, P1631, DOI 10.1172/JCI117144; Schwab A, 2007, PFLUG ARCH EUR J PHY, V453, P421, DOI 10.1007/s00424-006-0138-6; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Takarada-Iemata M, 2014, J NEUROCHEM, V130, P374, DOI 10.1111/jnc.12729; Turner KL, 2014, CEREB CORTEX, V24, P2388, DOI 10.1093/cercor/bht090; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; Yu ZH, 2014, J NEUROCHEM, V130, P41, DOI 10.1111/jnc.12710; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	23	12	14	1	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 15	2016	624						62	71		10.1016/j.neulet.2016.05.004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP3YV	WOS:000378433200010	27163196				2022-02-06	
J	Collins, CL; McKenzie, LB; Ferketich, AK; Andridge, R; Xiang, HY; Comstock, RD				Collins, Christy L.; McKenzie, Lara B.; Ferketich, Amy K.; Andridge, Rebecca; Xiang, Huiyun; Comstock, R. Dawn			Concussion Characteristics in High School Football by Helmet Age/Recondition Status, Manufacturer, and Model: 2008-2009 Through 2012-2013 Academic Years in the United States	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; football; helmet; adolescent	SPORT-RELATED CONCUSSION; IMPACT; PERFORMANCE; PLAYERS	Background: Football helmets used by high school athletes in the United States should meet the National Operating Committee on Standards for Athletic Equipment performance standards. Despite differences in interior padding and exterior shells, all football helmets should provide comparable protection against concussions. Yet, debate continues on whether differences in the rates or severity of concussions exist based on helmet age/recondition status, manufacturer, or model. Purpose: To investigate whether high school football concussion characteristics varied by helmet age/recondition status, manufacturer, and model. Study Design: Descriptive epidemiological study. Methods: High school football concussion and helmet data were collected from academic years 2008-2009 through 2012-2013 as part of the National High School Sports-Related Injury Surveillance Study. The certified athletic trainers of participating schools submitted athlete-exposure (AE) and injury information weekly. Results: Participating schools reported 2900 football concussions during 3,528,790 AEs for an overall rate of 8.2 concussions per 10,000 AEs. Concussion rates significantly increased from 2008-2009 through 2012-2013 overall (P = .006) as well as in competition (P = .027) and practice (P = .023). Characteristics of concussed football players (ie, mean number of symptoms, specific concussion symptoms, symptom resolution time, and time until return to play) were similar among players wearing new helmets when compared with reconditioned helmets. Fewer players wearing an old/not reconditioned helmet had concussion symptoms resolve within 1 day compared with players wearing a new helmet. Despite differences in the manufacturers and models of helmets worn by all high school football players compared with players who sustained a concussion, the mean number of concussion symptoms, specific concussion symptoms, symptom resolution time, and time until return to play were similar for concussions sustained by football players wearing the most common helmet manufacturers and models. Conclusion: Overall, for new and reconditioned football helmets, the most common helmet manufacturers and models on the market today appear to provide high school football players with similar protection against concussions. Clinical Relevance: Concussions can have serious acute and long-term effects. An understanding of concussion patterns in high school athletes can drive targeted preventive measures, including improvements to and/or better use of protective equipment, to reduce the incidence and/or severity of sports-related concussions.	[Collins, Christy L.; McKenzie, Lara B.; Ferketich, Amy K.; Andridge, Rebecca; Xiang, Huiyun; Comstock, R. Dawn] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Collins, Christy L.] OhioHlth Res & Innovat Inst, 3545 Olentangy River Rd,NMB Suite 310, Columbus, OH 43214 USA; [McKenzie, Lara B.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [McKenzie, Lara B.; Ferketich, Amy K.; Xiang, Huiyun] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Andridge, Rebecca] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Comstock, R. Dawn] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Comstock, R. Dawn] Univ Colorado Anschutz, Sch Med, Pediat Emergency Med, Aurora, CO USA		Collins, CL (corresponding author), OhioHlth Res & Innovat Inst, 3545 Olentangy River Rd,NMB Suite 310, Columbus, OH 43214 USA.	christy.collins@ohiohealth.com		McKenzie, Lara/0000-0003-2889-0001	National Operating Committee on Standards for Athletic Equipment; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was funded by the National Operating Committee on Standards for Athletic Equipment. The content of this report was also funded in part by the Centers for Disease Control and Prevention (grants R49/CE000674-01 and R49/CE001172-01). The authors also acknowledge the generous research funding contributions of the National Federation of State High School Associations.	[Anonymous], 2013 14 HIGH SCH ATH; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Centers for Disease Control and Prevention, 2010, ASS SCH BAS PHYS ACT; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Conidi FX, 2015, PRACT NEUROL, V15, P32; Faul M, 2010, TRAUMATIC BRAIN INJU; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; National Operating Committee on Standards for Athletic Equipment, STAND PERF SPEC NEW; Patel Dilip R, 2002, Adolesc Med, V13, P569; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; The National Federation of State High School Associations, 2013, 2013 NFHS FOOTB RUL; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; United States Census Bureau, CENS REG DIV US; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Virginia Tech Institute for Critical Technology and Applied Science, FREQ ASK QUEST	22	12	12	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2016	44	6					1382	1390		10.1177/0363546516629626			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DO5KJ	WOS:000377821700010	26905506				2022-02-06	
J	Donat, CK; Gaber, K; Meixensberger, J; Brust, P; Pinborg, LH; Hansen, HH; Mikkelsen, JD				Donat, Cornelius K.; Gaber, Khaled; Meixensberger, Juergen; Brust, Peter; Pinborg, Lars H.; Hansen, Henrik H.; Mikkelsen, Jens D.			Changes in Binding of [I-123]CLINDE, a High-Affinity Translocator Protein 18 kDa (TSPO) Selective Radioligand in a Rat Model of Traumatic Brain Injury	NEUROMOLECULAR MEDICINE			English	Article						Traumatic brain injury; Translocator protein 18 kDa; TSPO; Microglia; Neuroinflammation	PERIPHERAL BENZODIAZEPINE-RECEPTORS; POSITRON-EMISSION-TOMOGRAPHY; MICROGLIAL ACTIVATION; NERVOUS-SYSTEM; IN-VIVO; FOCAL ISCHEMIA; INFLAMMATION; PET; NEUROINFLAMMATION; SITES	After traumatic brain injury (TBI), secondary injuries develop, including neuroinflammatory processes that contribute to long-lasting impairments. These secondary injuries represent potential targets for treatment and diagnostics. The translocator protein 18 kDa (TSPO) is expressed in activated microglia cells and upregulated in response to brain injury and therefore a potential biomarker of the neuroinflammatory processes. Second-generation radioligands of TSPO, such as [I-123]CLINDE, have a higher signal-to-noise ratio as the prototype ligand PK11195. [I-123]CLINDE has been employed in human studies using single-photon emission computed tomography to image the neuroinflammatory response after stroke. In this study, we used the same tracer in a rat model of TBI to determine changes in TSPO expression. Adult Sprague-Dawley rats were subjected to moderate controlled cortical impact injury and sacrificed at 6, 24, 72 h and 28 days post surgery. TSPO expression was assessed in brain sections employing [I-123]CLINDE in vitro autoradiography. From 24 h to 28 days post surgery, injured animals exhibited a marked and time-dependent increase in [I-123]CLINDE binding in the ipsilateral motor, somatosensory and parietal cortex, as well as in the hippocampus and thalamus. Interestingly, binding was also significantly elevated in the contralateral M1 motor cortex following TBI. Craniotomy without TBI caused a less marked increase in [I-123]CLINDE binding, restricted to the ipsilateral hemisphere. Radioligand binding was consistent with an increase in TSPO mRNA expression and CD11b immunoreactivity at the contusion site. This study demonstrates the applicability of [I-123]CLINDE for detailed regional and quantitative assessment of glial activity in experimental models of TBI.	[Donat, Cornelius K.; Pinborg, Lars H.; Hansen, Henrik H.; Mikkelsen, Jens D.] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Gaber, Khaled; Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany; [Brust, Peter] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, Res Site Leipzig,Permoserstr 15, D-04318 Leipzig, Germany; [Pinborg, Lars H.] Copenhagen Univ Hosp, Rigshosp, Epilepsy Clin, Blegdamsvej 9, DK-2100 Copenhagen, Denmark		Mikkelsen, JD (corresponding author), Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	jens.mikkelsen@nru.dk		, Peter/0000-0001-5555-7058; Pinborg, Lars Hageman/0000-0001-9024-7936	Desiree and Niels Ydes Foundation; Lundbeck FoundationLundbeckfonden; Danish Strategic Research Council (project COGNITO); European UnionEuropean Commission [HEALTH-F2-2011-278850]	We thank Tina Spalholz and the staff of MEZ Leipzig for excellent technical support and assistance in animal experiments and Felix Fischer for assistance in tissue sectioning. CLINDE was kindly supplied by Dr. Nicolas Arlicot, Universite Francois Rabelais de Tours, France. This work was supported by Desiree and Niels Ydes Foundation, the Lundbeck Foundation and the Danish Strategic Research Council (project COGNITO). The research leading to these results was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement HEALTH-F2-2011-278850 (INMiND).	Arlicot N, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2013.00075; Arlicot N, 2010, EUR J NUCL MED MOL I, V37, P2371, DOI 10.1007/s00259-010-1598-7; Arlicot N, 2008, EUR J NUCL MED MOL I, V35, P2203, DOI 10.1007/s00259-008-0834-x; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Collste K., 2015, EUROPEAN J NUCL MED, V43, P173; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Feng L, 2014, J NUCL MED, V55, P1966, DOI 10.2967/jnumed.114.143727; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hartig W, 2013, BRAIN RES, V1498, P69, DOI 10.1016/j.brainres.2012.12.022; Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Jensen P, 2015, J NUCL MED, V56, P1386, DOI 10.2967/jnumed.115.158998; Jensen P, 2015, NEUROLOGY, V84, P859, DOI 10.1212/WNL.0000000000001278; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kuhlmann AC, 2000, J NEUROCHEM, V74, P1694, DOI 10.1046/j.1471-4159.2000.0741694.x; Kumar A., 2015, J NEUROTRAUMA; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lavisse S, 2015, EUR J NUCL MED MOL I, V42, P478, DOI 10.1007/s00259-014-2962-9; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu ZW, 2011, STROKE, V42, P740, DOI 10.1161/STROKEAHA.110.607226; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattner F, 2005, EUR J NUCL MED MOL I, V32, P557, DOI 10.1007/s00259-004-1690-y; Mattner F, 2008, EUR J NUCL MED MOL I, V35, P779, DOI 10.1007/s00259-007-0645-5; Mattner F, 2011, EUR J NUCL MED MOL I, V38, P1516, DOI 10.1007/s00259-011-1784-2; Miyazawa N, 1995, ACTA NEUROCHIR, V137, P207, DOI 10.1007/BF02187195; MYERS R, 1991, NEUROSCI LETT, V133, P20, DOI 10.1016/0304-3940(91)90047-W; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Owen DR, 2010, J CEREBR BLOOD F MET, V30, P1608, DOI 10.1038/jcbfm.2010.63; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Toth M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125917; Trapani A, 2013, BIOCONJUGATE CHEM, V24, P1415, DOI 10.1021/bc300666f; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	68	12	13	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	JUN	2016	18	2					158	169		10.1007/s12017-016-8385-y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN9XZ	WOS:000377435300003	26969181	Green Submitted			2022-02-06	
J	Lee, WK; Yeom, J; Lee, WH; Seo, HG; Oh, BM; Han, TR				Lee, Won Kyung; Yeom, Jiwoon; Lee, Woo Hyung; Seo, Han Gil; Oh, Byung-Mo; Han, Tai Ryoon			Characteristics of Dysphagia in Severe Traumatic Brain Injury Patients: A Comparison With Stroke Patients	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Deglutition disorders; Fluoroscopy; Deglutition; Brain injuries	FUNCTIONAL ORAL INTAKE; REHABILITATION	Objective To compare the swallowing characteristics of dysphagic patients with traumatic brain injury (TBI) with those of dysphagic stroke patients. Methods Forty-one patients with TBI were selected from medical records (between December 2004 to March 2013) and matched to patients with stroke (n=41) based on age, sex, and disease duration. Patients' swallowing characteristics were analyzed retrospectively using a videofluoroscopic swallowing study (VFSS) and compared between both groups. Following thorough review of medical records, patients who had a history of diseases that could affect swallowing function at the time of the study were excluded. Dysphagia characteristics and severity were evaluated using the American Speech-Language-Hearing Association National Outcome Measurement System swallowing scale, clinical dysphagia scale, and the videofluoroscopic dysphagia scale. Results There was a significant difference in radiological lesion location (p=0.024) between the two groups. The most common VFSS finding was aspiration or penetration, followed by decreased laryngeal elevation and reduced epiglottis inversion. Swallowing function, VFSS findings, or quantified dysphagia severity showed no significant differences between the groups. In a subgroup analysis of TBI patients, the incidence of tube feeding was higher in patients with surgical intervention than in those without (p=0.011). Conclusion The swallowing characteristics of dysphagic patients after TBI were comparable to those of dysphagic stroke patients. Common VFSS findings comprised aspiration or penetration, decreased laryngeal elevation, and reduced epiglottis inversion. Patients who underwent surgical intervention after TBI were at high risk of tube feeding requirement.	[Lee, Won Kyung; Yeom, Jiwoon; Lee, Woo Hyung; Seo, Han Gil; Oh, Byung-Mo] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea; [Han, Tai Ryoon] Gangwon Do Rehabil Hosp, Dept Rehabil Med, 24-16,Chungyeol Ro 142Beon Gil, Chunchon 24227, South Korea		Han, TR (corresponding author), Gangwon Do Rehabil Hosp, Dept Rehabil Med, 24-16,Chungyeol Ro 142Beon Gil, Chunchon 24227, South Korea.	tairyoon@snu.ac.kr		Seo, Han Gil/0000-0001-6904-7542			Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Chang YC, 2003, DYSPHAGIA, V18, P135, DOI 10.1007/s00455-002-0096-x; DOTY RW, 1967, EXP NEUROL, V17, P91, DOI 10.1016/0014-4886(67)90125-2; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Geeganage C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000323.pub2; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; Jung SH, 2005, ANN REHABIL MED-ARM, V29, P343; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Paik NJ, 2005, ANN REHABIL MED-ARM, V29, P43; Rogus-Pulia N, 2013, SEMIN SPEECH LANG, V34, P154, DOI 10.1055/s-0033-1358368; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; TANDON PN, 1964, ACTA NEUROL SCAND, V40, P375; Terre R, 2007, REV ESP ENFERM DIG, V99, P7; Terrte R, 2007, BRAIN INJURY, V21, P1411, DOI 10.1080/02699050701785096; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	23	12	13	0	12	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	JUN	2016	40	3					432	439		10.5535/arm.2016.40.3.432			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FG9WR	WOS:000410791100007	27446779	gold, Green Published, Green Submitted			2022-02-06	
J	Rosa, M; da Rocha, AJ; Maia, ACM; Saade, N; Veiga, JCE; Romero, JM				Rosa, Marcos, Jr.; da Rocha, Antonio Jose; Martins Maia, Antonio Carlos, Jr.; Saade, Nelson; Esteves Veiga, Jose Carlos; Romero, Javier M.			Contusion Contrast Extravasation Depicted on Multidetector Computed Tomography Angiography Predicts Growth and Mortality in Traumatic Brain Contusion	JOURNAL OF NEUROTRAUMA			English	Article						contrast extravasation; multidetector CT angiography; spot sign; traumatic brain contusion; traumatic brain injury	LONG-TERM DISABILITY; ACUTE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; HEMATOMA EXPANSION; SPOT SIGN; INTRACRANIAL HEMORRHAGE; CT ANGIOGRAPHY; UNITED-STATES; ACTIVE EXTRAVASATION; RISK-FACTORS	Traumatic brain injury (TBI) is the main cause of death in trauma victims and causes high rates of disability and neurological sequelae. Approximately 38-65% of traumatic brain contusions (TBC) demonstrate hemorrhagic expansion on serial computed tomography (CT) scans. Thus far, however, no single variable can accurately predict the hemorrhage expansion of a TBC. Our purpose was to evaluate contrast extravasation (CE) as a predictor of expansion, mortality, and poor outcome in TBC in a Brazilian cohort. After Institutional Review Board approval, we used multidetector CT angiography (MDCTA) to study 121 consecutive patients (106 men, 87.6%) with ages varying from 10 to 85 years. Informed consent was obtained from all subjects. The clinical and imaging findings were correlated with the findings on the initial MDCTA using either the Fisher exact test or Student t test and a multivariate logistic regression model. Of the persons who presented CE in TBC, 21.8% died (in-hospital mortality), whereas in the absence of this sign, the mortality rate was 7.6% (p=0.014). In addition, expansion of the hemorrhagic component of the TBC was detected in 61.1% of the CE-positive patients, whereas expansion was only observed in 10% of the CE-negative patients (p<0.001). Poor outcome was observed in 24.2% of the patients in the CE-negative group, but in the presence of CE, 72.7% evolved with poor outcome (p<0.001). The CE was a strong independent predictor of expansion, poor outcome, and increased risk of in-hospital mortality in our series of patients with TBC.	[Rosa, Marcos, Jr.; da Rocha, Antonio Jose; Martins Maia, Antonio Carlos, Jr.] Santa Casa Misericordia Sao Paulo, Neuroradiol Sect, Sao Paulo, SP, Brazil; [Rosa, Marcos, Jr.] Univ Fed Espirito Santo, Sect Radiol, Vitoria, ES, Brazil; [Saade, Nelson; Esteves Veiga, Jose Carlos] Santa Casa Misericordia Sao Paulo, Div Neurosurg, Sao Paulo, SP, Brazil; [Romero, Javier M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Neuroradiol, Boston, MA USA		Rosa, M (corresponding author), Santa Casa Misericordia Sao Paulo, Serv Diagnost Imagem, Rua Dr Cesario Motta Jr 112, BR-01221020 Sao Paulo, SP, Brazil.	marcosrosajr@hotmail.com	Veiga, Jose/AAV-1687-2020; Rosa-Junior, Marcos/S-6617-2017	Rosa-Junior, Marcos/0000-0001-8668-2804; Romero, Javier/0000-0001-5749-3000			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Almandoz JED, 2012, J NEUROINTERV SURG, V4, P442, DOI 10.1136/neurintsurg-2011-010061; Almandoz JED, 2011, NEUROIMAG CLIN N AM, V21, P197, DOI 10.1016/j.nic.2011.01.001; Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Divani AA, 2011, STROKE, V42, P1569, DOI 10.1161/STROKEAHA.110.607861; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Letourneau-Guillon L, 2013, AM J NEURORADIOL, V34, P773, DOI 10.3174/ajnr.A3309; Li N, 2011, STROKE, V42, P3441, DOI 10.1161/STROKEAHA.111.623405; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Marion DW, 2006, NEUROSURGERY, V58, P655; MAUSER HW, 1984, NEURORADIOLOGY, V26, P31, DOI 10.1007/BF00328200; Murai Y, 1998, J NEUROSURG, V88, P650, DOI 10.3171/jns.1998.88.4.0650; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park SY, 2010, J KOREAN NEUROSURG S, V48, P399, DOI 10.3340/jkns.2010.48.5.399; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Rosa M, 2015, J COMPUT ASSIST TOMO, V39, P217, DOI 10.1097/RCT.0000000000000182; Rosa M, 2013, ARQ NEURO-PSIQUIAT, V71, P791, DOI 10.1590/0004-282X20130124; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Takanashi Y, 2001, J CLIN NEUROSCI, V8, P240, DOI 10.1054/jocn.2000.0804; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomida M, 1998, NEUROSURGERY, V43, P66, DOI 10.1097/00006123-199807000-00040; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	43	12	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1015	1022		10.1089/neu.2015.4062			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600005	26214242				2022-02-06	
J	Xu, XP; Cao, SW; Chao, HL; Liu, YL; Ji, J				Xu, Xiupeng; Cao, Shengwu; Chao, Honglu; Liu, Yinlong; Ji, Jing			Sex-related differences in striatal dopaminergic system after traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Sex-related differences; DA; Methamphetamine; Potassium; TBI	VESICULAR MONOAMINE-TRANSPORTER; RAT STRIATUM; CD-1 MICE; METHAMPHETAMINE; GENDER; IMPACT; NEUROTOXICITY; ESTROGEN; FEMALE; EXPRESSION	Several studies have demonstrated alterations in the dopamine (DA) system after traumatic brain injury (TBI). Additionally, the existence of significant sex-related differences in the dopaminergic system has long been recognized. Accordingly, the purpose of the present study was to investigate whether TBI would differentially alter, in female and male mice, the expression and the function of the striatal vesicular monoamine transporter-2 (VMAT-2), an important DA transporter. After controlled cortical impact (CCI) injury, female mice showed significantly lower striatal DA concentrations and K+-evoked DA output. By contrast, no significant sex-related differences were observed in the mRNA and protein levels of striatal dopamine transporter (DAT) and VMAT-2 and the methamphetamine (MA)-evoked DA output. These results demonstrated clear sex-related differences in striatal VMAT-2 function in response to TBI and suggested that female mice may be more sensitive to the TBI-induced inhibition of the VMAT-2 function, as indicated by the greater degree of deficits observed when the VMAT-2 DA-storage function was inhibited by TBI. Moreover, the TBI-induced suppression of locomotion was more pronounced than female mice. Such findings highlight the need for sex-specific considerations when examining differences among brain injury conditions. (C) 2016 Elsevier Inc. All rights reserved.	[Xu, Xiupeng; Cao, Shengwu; Chao, Honglu; Liu, Yinlong; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Ji, Jing] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Ji, Jing] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA		Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300998]; National Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20131022]; Specially-Appointed Professor Foundation of Jiangsu Province [ky216r201307]	This study was funded by the National Natural Science Foundation of China (81300998), National Natural Science Foundation of Jiangsu Province (BK20131022) and the Specially-Appointed Professor Foundation of Jiangsu Province (ky216r201307).	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bhatt SD, 2005, BRAIN RES, V1035, P188, DOI 10.1016/j.brainres.2004.12.013; Brown JM, 2006, J NEUROCHEM, V98, P495, DOI 10.1111/j.1471-4159.2006.03902.x; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Carlson S. W., 2015, J NEUROTRAUMA; Chen L, 2013, BRAIN RES, V1521, P59, DOI 10.1016/j.brainres.2013.05.016; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dluzen DE, 2008, ANN NY ACAD SCI, V1139, P140, DOI 10.1196/annals.1432.010; Dluzen DE, 2003, ENDOCRINE, V21, P67, DOI 10.1385/ENDO:21:1:67; Dluzen DE, 2005, NEUROENDOCRINOLOGY, V82, P78, DOI 10.1159/000090983; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ji J, 2007, J NEUROENDOCRINOL, V19, P725, DOI 10.1111/j.1365-2826.2007.01581.x; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2009, BIOCHEM PHARMACOL, V78, P1401, DOI 10.1016/j.bcp.2009.07.004; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kunnathur V, 2006, NEUROTOXICOL TERATOL, V28, P557, DOI 10.1016/j.ntt.2006.07.001; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; Le Saux M, 2006, J NEUROENDOCRINOL, V18, P25, DOI 10.1111/j.1365-2826.2005.01380.x; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Miller DB, 1998, ANN NY ACAD SCI, V844, P153, DOI 10.1111/j.1749-6632.1998.tb08230.x; Murray HE, 2003, NEUROSCIENCE, V116, P213, DOI 10.1016/S0306-4522(02)00578-X; Podurgiel SJ, 2013, NEUROSCIENCE, V250, P507, DOI 10.1016/j.neuroscience.2013.07.008; Rehavi M, 1998, MOL BRAIN RES, V57, P31, DOI 10.1016/S0169-328X(98)00058-8; RIVEST R, 1995, BRAIN RES, V692, P269, DOI 10.1016/0006-8993(95)00611-S; Sandoval V, 2001, J NEUROSCI, V21, P1413; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Walker QD, 2000, NEUROSCIENCE, V95, P1061; Xie T, 2000, J NEUROSCI, V20, P7838; Yu L., 2000, J NEURAL T, V107, P419; Zlotnik A, 2012, INTENS CARE MED, V38, P137, DOI 10.1007/s00134-011-2401-3	38	12	13	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2016	124						214	221		10.1016/j.brainresbull.2016.05.010			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS2JM	WOS:000380595800025	27210290				2022-02-06	
J	Lund, SB; Gjeilo, KH; Moen, KG; Schirmer-Mikalsen, K; Skandsen, T; Vik, A				Lund, Stine B.; Gjeilo, Kari H.; Moen, Kent G.; Schirmer-Mikalsen, Kari; Skandsen, Toril; Vik, Anne			Moderate traumatic brain injury, acute phase course and deviations in physiological variables: an observational study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Moderate traumatic brain injury; TBI; Physiological variables; Guidelines; Acute phase; Deviations	SEVERE HEAD-INJURY; INTENSIVE-CARE; PROGNOSTIC VALUE; PROSPECTIVE MULTICENTER; SECONDARY INSULTS; SEVERITY; CLASSIFICATION; IMPACT; SCALE; TRANSFUSION	Background: Patients with moderate traumatic brain injury (TBI) are a heterogeneous group with great variability in clinical course. Guidelines for monitoring and level of care in the acute phase are lacking. The main aim of this observational study was to describe injury severity and the acute phase course during the first three days post-injury in a cohort of patients with moderate TBI. Deviations from defined parameters in selected physiological variables were also studied, based on guidelines for severe TBI during the same period. Methods: During a 5-year period (2004-2009), 119 patients = 16 years (median age 47 years, range 16-92) with moderate TBI according to the Head Injury Severity Scale were admitted to a Norwegian level 1 trauma centre. Injury-related and acute phase data were collected prospectively. Deviations in six physiological variables were collected retrospectively. Results: Eighty-six percent of the patients had intracranial pathology on CT scan and 61 % had extracranial injuries. Eighty-four percent of all patients were admitted to intensive care units (ICUs) the first day, and 51 % stayed in ICUs >= 3 days. Patients staying in ICUs >= 3 days had lower median Glasgow Coma Scale score; 12 (range 9-15) versus 13 (range 9-15, P = 0.003) and more often extracranial injuries (77 % versus 42 %, P = 0.001) than patients staying in ICU 0-2 days. Most patients staying in ICUs >= 3 days had at least one episode of hypotension (53 %), hypoxia (57 %), hyperthermia (59 %), anaemia (56 %) and hyperglycaemia (65 %), and the proportion of anaemia related to number of measurements was high (33 %). Conclusion: Most of the moderate TBI patients stayed in an ICU the first day, and half of them stayed in ICUs = 3 days due to not only intracranial, but also extracranial injuries. Deviations in physiological variables were often seen in this latter group of patients. Lack of guidelines for patients with moderate TBI may leave these deviations uncorrected. We propose that in future research of moderate TBI, patients might be differentiated with regard to their need for monitoring and level of care the first few days post-injury. This could contribute to improvement of acute phase management.	[Lund, Stine B.; Vik, Anne] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Gjeilo, Kari H.] Univ Trondheim Hosp, St Olavs Hosp, Dept Cardiothorac Surg, Trondheim, Norway; [Moen, Kent G.] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Imaging, Trondheim, Norway; [Schirmer-Mikalsen, Kari] Univ Trondheim Hosp, St Olavs Hosp, Dept Anaesthesia & Intens Care Med, Trondheim, Norway; [Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Gjeilo, Kari H.; Schirmer-Mikalsen, Kari] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Fac Med, NTNU, Trondheim, Norway; [Lund, Stine B.; Moen, Kent G.; Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol, Dept Neurosci, Fac Med, NTNU, 3250 Sluppen, N-7006 Trondheim, Norway; [Lund, Stine B.] Norwegian Univ Sci & Technol, Fac Hlth & Social Sci, Dept Nursing Sci, NTNU, Trondheim, Norway		Lund, SB (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway.; Lund, SB (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Fac Med, NTNU, 3250 Sluppen, N-7006 Trondheim, Norway.; Lund, SB (corresponding author), Norwegian Univ Sci & Technol, Fac Hlth & Social Sci, Dept Nursing Sci, NTNU, Trondheim, Norway.	stine.b.lund@ntnu.no			Norwegian Nurse Organization of Critical Care Nurses; St. Olavs Hospital, Trondheim University Hospital	Funding by the Norwegian Nurse Organization of Critical Care Nurses and St. Olavs Hospital, Trondheim University Hospital. The authors would like to thank Beate M. Voll for the management of the patient database, Ingrid H. Strand (IHS) for describing CT-scans and Sozaburo Hara (SH) for performing some of the ISS calculation.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bergman Karen, 2010, J Trauma Nurs, V17, P102, DOI 10.1097/JTN.0b013e3181ecc452; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Enblad P, 2003, EUR J TRAUMA, V29, P74; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sund-Levander Martha, 2013, Br J Nurs, V22, P882; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	37	12	13	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAY 23	2016	24								77	10.1186/s13049-016-0269-5			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DR9BV	WOS:000380193000001	27216804	Green Published, gold			2022-02-06	
J	DeCuypere, M; Muhlbauer, MS; Boop, FA; Klimo, P				DeCuypere, Michael; Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.			Pediatric intracranial gunshot wounds: the Memphis experience	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric intracranial gunshot wound; survival; traumatic brain injury; pediatric management; trauma	PENETRATING HEAD-INJURY; TRAUMATIC BRAIN INJURY; PROGNOSTIC-FACTORS; CHILDREN; PREDICTORS; CIVILIANS; MORTALITY; OUTCOMES; UPDATE	OBJECTIVE Penetrating brain injury in civilians is much less common than blunt brain injury but is more severe overall. Gunshot wounds (GSWs) cause high morbidity and mortality related to penetrating brain injury; however, there are few reports on the management and outcome of intracranial GSWs in children. The goals of this study were to identify clinical and radiological factors predictive for death in children and to externally validate a recently proposed pediatric prognostic scale. METHODS The authors conducted a retrospective review of penetrating, isolated GSWs sustained in children whose ages ranged from birth to 18 years and who were treated at 2 major metropolitan Level 1 trauma centers from 1996 through 2013. Several standard clinical, laboratory, and radiological factors were analyzed for their ability to predict death in these patients. The authors then applied the St. Louis Scale for Pediatric Gunshot Wounds to the Head, a scoring algorithm that was designed to provide rapid prognostic information for emergency management decisions. The scale's sensitivity, specificity, and positive and negative predictability were determined, with death as the primary outcome. RESULTS Seventy-one children (57 male, 14 female) had a mean age of 14 years (range 19 months to 18 years). Overall mortality among these children was 47.9%, with 81% of survivors attaining a favorable clinical outcome (Glasgow Outcome Scale score >= 4). A number of predictors of mortality were identified (all p < 0.05): 1) bilateral fixed pupils; 2) deep nuclear injury; 3) transventricular projectile trajectory; 4) bihemispheric injury; 5) injury to >= 3 lobes; 6) systolic blood pressure < 100 mm Hg; 7) anemia (hematocrit < 30%); 8) Glasgow Coma Scale score <= 5; and 9) a blood base deficit < -5 mEq/L. Patient age, when converted to a categorical variable (0-9 or 10-18 years), was not predictive. Based on data from the 71 patients in this study, the positive predictive value of the St. Louis scale in predicting death (score >= 5) was 78%. CONCLUSIONS This series of pediatric cranial GSWs underscores the importance of the initial clinical exam and CT studies along with adequate resuscitation to make the appropriate management decision(s). Based on our population, the St. Louis Scale seems to be more useful as a predictor of who will survive than who will succumb to their injury. http://thejns.org/doi/abs/10.3171/2015.7.PEDS15285	[DeCuypere, Michael; Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.] Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA; [Muhlbauer, Michael S.; Boop, Frederick A.; Klimo, Paul, Jr.] Le Bonheur Childrens Hosp, Le Bonheur Neurosci Inst, Memphis, TN USA		Klimo, P (corresponding author), Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklimo@semmes-murphey.com		DeCuypere, Michael/0000-0002-4598-8644			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; [Anonymous], 2001, J TRAUMA, V51, pS16; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; BEAVER BL, 1990, J PEDIATR SURG, V25, P97, DOI 10.1016/S0022-3468(05)80171-X; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; KRIEGER MD, 1995, NEUROSURG CLIN N AM, V6, P605; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; Murano T, 2005, AM SURGEON, V71, P1009; Nakagawa TA, 2011, PEDIATRICS, V128, pE720, DOI 10.1542/peds.2011-1511; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; Petridis AK, 2011, CENT EUR NEUROSURG, V72, P5, DOI 10.1055/s-0029-1241850; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Sustic A, 2001, MIL MED, V166, P331, DOI 10.1093/milmed/166.4.331; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370	31	12	12	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAY	2016	17	5					595	601		10.3171/2015.7.PEDS15285			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DK2CS	WOS:000374722800013	26728100	Bronze			2022-02-06	
J	Kuenemund, A; Zwick, S; Rief, W; Exner, C				Kuenemund, Anna; Zwick, Sarah; Rief, Winfried; Exner, Cornelia			(Re-)defining the self - Enhanced posttraumatic growth and event centrality in stroke survivors: A mixed-method approach and control comparison study	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						control comparison; event centrality; mixed-method; posttraumatic growth; stroke	TRAUMATIC BRAIN-INJURY; BREAST-CANCER; PERCEIVED GROWTH; IDENTITY; OUTCOMES; SUPPORT; REHABILITATION; FOUNDATIONS; RECOVERY; DECLINE	Growing evidences highlight the co-existence of negative and positive (e.g. posttraumatic growth) identity changes following stroke. Identity changes were assessed by comparing 42 survivors 21 months after stroke and healthy controls. A total of 26 stroke survivors participated in a semi-structured interview. Stroke survivors showed significantly higher posttraumatic growth (F(1, 75) = 9.79, p = .003) and integrated the critical life event to a higher extent into their identity (event centrality) (F(1, 74) = 37.54, p < .001). Qualitative analysis revealed increased appreciation of life and more intense/selective relationships as the most common positive changes. Considering positive changes might provide additional perspectives for rehabilitation.	[Kuenemund, Anna; Zwick, Sarah; Rief, Winfried] Univ Marburg, Gutenbergstr 18, D-35037 Marburg, Germany; [Exner, Cornelia] Univ Leipzig, Leipzig, Germany		Kuenemund, A (corresponding author), Univ Marburg, Dept Clin Psychol & Psychotherapy, Gutenbergstr 18, D-35037 Marburg, Germany.	anna.kuenemund@yahoo.de	Rief, Winfried/ABD-4994-2021	Rief, Winfried/0000-0002-7019-2250; Exner, Cornelia/0000-0001-5904-6511			AFFLECK G, 1987, J CONSULT CLIN PSYCH, V55, P29, DOI 10.1037/0022-006X.55.1.29; Andrykowski M.A., 1993, PSYCHO-ONCOLOGY, V2, P261, DOI [10.1002/pon.2960020406, DOI 10.1002/PON.2960020406]; Barger SD, 2012, J HEALTH PSYCHOL, V17, P169, DOI 10.1177/1359105311412837; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Boals A, 2011, APPL COGNITIVE PSYCH, V25, P817, DOI 10.1002/acp.1753; Bocker M., 2009, 18 REH K INN REH KOM; Calhoun LG, 2004, PSYCHOL INQ, V15, P93, DOI 10.1207/s15327965pli1501_03; Ch'ng AM, 2008, J HEALTH PSYCHOL, V13, P1136, DOI 10.1177/1359105308095967; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Doering B, 2011, CURR OPIN PSYCHIATR, V24, P156, DOI 10.1097/YCO.0b013e328343804e; Efron B., 1993, INTRO BOOTSTRAP; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Essue BM, 2012, STROKE, V43, P3110, DOI 10.1161/STROKEAHA.112.666453; Field EL, 2008, BEHAV RES THER, V46, P62, DOI 10.1016/j.brat.2007.10.006; Fleiss J.L., 1981, STAT METHODS RATES P; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gillen G, 2005, AM J OCCUP THER, V59, P346, DOI 10.5014/ajot.59.3.346; Glaser B., 1967, DISCOVERY GROUNDED T; Groleau JM, 2013, PSYCHOL TRAUMA-US, V5, P477, DOI 10.1037/a0028809; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Knaevelsrud C, 2010, J HEALTH PSYCHOL, V15, P1030, DOI 10.1177/1359105309360073; Kuenemund A, 2013, NEUROPSYCHOL REHABIL, V23, P678, DOI 10.1080/09602011.2013.801779; Lelorain S, 2012, J HEALTH PSYCHOL, V17, P627, DOI 10.1177/1359105311427475; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Maercker A, 2004, PSYCHOL INQ, V15, P41; Maercker A, 2001, DIAGNOSTICA, V47, P153, DOI 10.1026//0012-1924.47.3.153; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Proulx T, 2006, PSYCHOL INQ, V17, P309, DOI 10.1080/10478400701366985; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Smith C.P., 2000, HDB RES METHODS SOCI, P313, DOI DOI 10.1017/CBO9780511996481; Stewart TL, 2016, J HEALTH PSYCHOL, V21, P40, DOI 10.1177/1359105314521477; Sumalla EC, 2009, CLIN PSYCHOL REV, V29, P24, DOI 10.1016/j.cpr.2008.09.006; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tomich PL, 2005, PSYCHO-ONCOL, V14, P1018, DOI 10.1002/pon.914	45	12	12	2	24	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	MAY	2016	21	5					679	689		10.1177/1359105314535457			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DM3NC	WOS:000376252100011	24913010				2022-02-06	
J	Kurowski, BG; Backeljauw, B; Zang, HY; Zhang, NH; Martin, LJ; Pilipenko, V; Yeates, K; Taylor, HG; Wade, S				Kurowski, Brad G.; Backeljauw, Barynia; Zang, Huaiyu; Zhang, Nanhua; Martin, Lisa J.; Pilipenko, Valentina; Yeates, Keith; Taylor, H. Gerry; Wade, Shari			Influence of Catechol-O-methyltransferase on Executive Functioning Longitudinally After Early Childhood Traumatic Brain Injury: Preliminary Findings	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; child; executive function; genetics; pediatrics; recovery	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GENE-ENVIRONMENT INTERACTION; D2 RECEPTOR GENE; SELF-REGULATION; DOPAMINE; OUTCOMES; PREDICTORS; DYSFUNCTION; SYMPTOMS; CHILDREN	Objective: To elucidate the association of a functional catechol-O-methyltransferase (COMT) genotype (rs4680) with recovery of executive functions up to 18 months after early childhood traumatic brain injury (TBI) compared with an orthopedic injury (OI) group. Setting: Outpatient. Participants: A total of 134 children with a moderate to severe TBI (n = 63) or OI (n = 71) between the ages of 3 and 6 years who were followed 18 months postinjury. Design: Case-comparison, longitudinal cohort Main Measures: The Behavior Rating Inventory of Executive Function, developmental NEuroPSYchological Assessment (NEPSY) of Verbal Fluency, and a modified Stroop Test for young children (Shape School). Results: The low-activity COMT enzyme genotype (AA) was associated with better scores on the developmental NEPSY of Verbal Fluency (F = 3.80; P = .02) and the Shape School (F = 2.89; P = .06) in all participants when controlling for injury type (TBI vs OI) over the first 18 months after injury. Injury type (TBI vs OI) did not significantly moderate the effect of the COMT genotypes on executive function recovery. Conclusion: This study provides preliminary evidence for a role of COMT genotypes in long-term recovery of executive function after pediatric TBI and OI. Larger studies are needed to determine the exact link between genetic variation in the COMT gene and TBI recovery in children.	[Kurowski, Brad G.; Backeljauw, Barynia; Wade, Shari] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.; Pilipenko, Valentina] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Yeates, Keith] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, 2101 Adelbert Rd, Cleveland, OH 44106 USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.; Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Yeates, Keith/AAJ-4223-2020; Martin, Lisa/E-2425-2016; Zang, Huaiyu/AAY-6603-2021	Martin, Lisa/0000-0001-8702-9946; Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	Rehabilitation Medicine Scientist Training Program [K-12 HD001097-16]; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1, R01 HD42729]; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, R01HD042729, K23HD074683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER	Funding for this study was supported in part by the Rehabilitation Medicine Scientist Training Program (K-12 HD001097-16), National Institute for Child Health and Human Development (K23HD074683-01A1 and R01 HD42729), and grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beaver KM, 2012, PSYCHIAT QUART, V83, P29, DOI 10.1007/s11126-011-9180-4; Berry D, 2014, DEV PSYCHOBIOL, V56, P373, DOI 10.1002/dev.21105; Berry D, 2013, DEV PSYCHOPATHOL, V25, P291, DOI 10.1017/S095457941200106X; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Bussing R, 2010, J AM ACAD CHILD PSY, V49, P595, DOI 10.1016/j.jaac.2010.03.006; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Cicchetti D, 2012, DEV PSYCHOPATHOL, V24, P411, DOI 10.1017/S0954579412000077; Das D, 2011, AM J MED GENET B, V156B, P346, DOI 10.1002/ajmg.b.31169; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Espy KA, 2006, PSYCHOL ASSESSMENT, V18, P373, DOI 10.1037/1040-3590.18.4.373; Faul M, 2010, TRAUMATIC BRAIN INJU; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Halleland H, 2009, AM J MED GENET B, V150B, P403, DOI 10.1002/ajmg.b.30831; Hayden EP, 2010, PSYCHIAT GENET, V20, P304, DOI 10.1097/YPG.0b013e32833adccb; Kemp, 1998, NEPSY DEV NEUROPSYCH; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lavigne JV, 2013, DEV PSYCHOPATHOL, V25, P555, DOI 10.1017/S0954579412001241; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Martel MM, 2011, J ABNORM CHILD PSYCH, V39, P1, DOI 10.1007/s10802-010-9439-5; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nussbaum R. L., 2007, THOMPSON THOMPSON GE, P151; Schellekens AFA, 2013, ADDICT BIOL, V18, P344, DOI 10.1111/j.1369-1600.2012.00438.x; Sweitzer MM, 2013, SOC COGN AFFECT NEUR, V8, P499, DOI 10.1093/scan/nss020; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; van Roekel E, 2011, J CHILD PSYCHOL PSYC, V52, P1044, DOI 10.1111/j.1469-7610.2011.02424.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wasserman T, 2013, APPL NEUROPSYCH-CHIL, V2, P88, DOI 10.1080/21622965.2013.748394; Williams Leanne M., 2008, Journal of Integrative Neuroscience, V7, P367, DOI 10.1142/S0219635208001939; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	61	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E1	E9		10.1097/HTR.0000000000000162			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800001	26394291	Green Accepted			2022-02-06	
J	Williamson, MLC; Elliott, TR; Bogner, J; Dreer, LE; Arango-Lasprilla, JC; Kolakowsky-Hayner, SA; Pretz, CR; Lequerica, A; Perrin, PB				Williamson, Meredith L. C.; Elliott, Timothy R.; Bogner, Jennifer; Dreer, Laura E.; Arango-Lasprilla, Juan Carlos; Kolakowsky-Hayner, Stephanie A.; Pretz, Christopher R.; Lequerica, Anthony; Perrin, Paul B.			Trajectories of Life Satisfaction Over the First 10 Years After Traumatic Brain Injury: Race, Gender, and Functional Ability	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adjustment; disparities; functional ability; gender; hierarchical linear modeling; life satisfaction; quality of life; race; traumatic brain injury	QUALITY-OF-LIFE; MODEL SYSTEMS; NATIONAL INSTITUTE; RACIAL-DIFFERENCES; HEALTH-CARE; REHABILITATION; DISABILITY; OUTCOMES; DISCRIMINATION; RELIABILITY	Objective: This study investigated the influence of race, gender, functional ability, and an array of preinjury, injury-related, and sociodemographic variables on life satisfaction trajectories over 10 years following moderate to severe traumatic brain injury (TBI). Setting/Participants: A sample of 3157 individuals with TBI from the TBI Model Systems database was included in this study. Design: Hierarchical linear modeling (HLM) analyses were conducted to examine the trajectories of life satisfaction. Main Measures: The Functional Independence Measure, Glasgow Coma Scale, and the Satisfaction With Life Scale were utilized. Results: Initial models suggested that life satisfaction trajectories increased over the 10-year period and Asian/Pacific Islander participants experienced an increase in life satisfaction over time. In a comprehensive model, time was no longer a significant predictor of increased life satisfaction. Black race, however, was associated with lower life satisfaction, and significant interactions revealed that black participants' life satisfaction trajectory decreased over time while white participants' trajectory increased over the same time period. Life satisfaction trajectories did not significantly differ by gender, and greater motor and cognitive functioning were associated with increasingly positive life satisfaction trajectories over the 10 years. Conclusion: Individuals with more functional impairments are at risk for decreases in life satisfaction over time. Further research is needed to identify the mechanisms and factors that contribute to the lower levels of life satisfaction observed among black individuals post-TBI. This work is needed to determine strategic ways to promote optimal adjustment for these individuals.	[Williamson, Meredith L. C.] Vet Affairs North Texas Hlth Care Syst, 4500 S Lancaster Rd 116A, Dallas, TX 75216 USA; [Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Arango-Lasprilla, Juan Carlos] Univ Deusto, Ikerbasque, Basque Fdn Sci, Dept Psychol, Bilbao, Spain; [Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA USA; [Pretz, Christopher R.] Craig Hosp, Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Lequerica, Anthony] Kessler Fdn, Traumat Brain Injury Res, W Orange, NJ USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA		Williamson, MLC (corresponding author), Vet Affairs North Texas Hlth Care Syst, 4500 S Lancaster Rd 116A, Dallas, TX 75216 USA.	mcmeredithcampbell@gmail.com	Kolakowsky-Hayner, Stephanie A./I-9858-2019; Elliott, Timothy R./I-5301-2012; Perrin, Paul/L-5373-2015	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Elliott, Timothy R./0000-0002-6608-7714; Perrin, Paul/0000-0003-2070-215X	National Institute of Disability and Rehabilitation Research (NIDRR), United States Department of Education [H133A120086, H133A070038, H133A110006]	This work was supported by the National Institute of Disability and Rehabilitation Research (NIDRR), United States Department of Education (Grants: H133A120086, H133A070038, H133A110006). The authors express appreciation to Dr Oi-Man Kwok for his assistance in calculating the effect sizes.	Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Argyle M., 1999, WELL BEING FDN HEDON, P353, DOI DOI 10.7758/9781610443258.22; Baird BM, 2010, SOC INDIC RES, V99, P183, DOI 10.1007/s11205-010-9584-9; Benjamins MR, 2014, J BEHAV MED, V37, P402, DOI 10.1007/s10865-013-9496-7; Bond T, 2001, APPL RASCH MODEL FUN; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2012, AM PSYCHOL, V67, P590, DOI 10.1037/a0029541; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dreer LE, 2013, OPTOMETRY VISION SCI, V90, P883, DOI 10.1097/OPX.0000000000000009; Dunn D.S., 2009, OXFORD HDB POSITIVE, P650, DOI [DOI 10.1093/OXFORDHB/9780195187243.013.0062, 10.1093/oxfordhb/9780195187243.013.0062]; Dunn DS, 2013, OXFORD HDB POSITIVE, P427, DOI DOI 10.1093/OXFORDHB/9780195398786.013.013.0026; ELLIOTT TR, 2007, PSYCHOL MANAGEMENT P, P16; ELLIOTT TR, 2002, HDB POSITIVE PSYCHOL, P00687; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Fisher G. H., 1976, ADV PSYCHOL ED MEASU, P97; Fuhrer MJ, 2000, DISABIL REHABIL, V22, P481, DOI 10.1080/096382800413961; Garson G, 2013, HIERARCHICAL LINEAR, DOI [10.4135/9781483384450, DOI 10.4135/9781483384450]; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; JONES C, 1979, AM J NURS, V79, P1551; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Juarez V J, 1995, J Neurosci Nurs, V27, P283; Kalpinski RJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/102570; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kok B.E., 2008, POSITIVE PSYCHOL EXP, P1; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Linacre JM, 2012, USERS GUIDE WINSTEPS; Lucas RE, 2007, J PERS SOC PSYCHOL, V92, P717, DOI 10.1037/0022-3514.92.4.717; Mase S, 2013, MMWR RECOMM REP, V62, P1; Mroczek DK, 2005, J PERS SOC PSYCHOL, V88, P189, DOI 10.1037/0022-3514.88.1.189; National Center for Health Statistics, 2011, HLTH US 2011 SPEC FE; Niemeier JP, 2008, DISABIL REHABIL, V30, P166, DOI 10.1080/09638280701532169; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Penner L. A., 2010, SAGE HDB PREJUDICE S, P472, DOI [DOI 10.4135/9781446200919.N29, 10.4135/9781446200919.N29]; Penner LA, 2009, J BLACK PSYCHOL, V35, P180, DOI 10.1177/0095798409333585; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Schwei RJ, 2014, PATIENT EDUC COUNS, V96, P333, DOI 10.1016/j.pec.2014.06.003; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; SUE S, 1991, J CONSULT CLIN PSYCH, V59, P533, DOI 10.1037/0022-006X.59.4.533; TEASDALE G, 1974, LANCET, V2, P81; Traumatic Brain Injury Model Systems National Data and Statistical Center, ID SUBJ TBI MOD SYST; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Warren L, 1996, J REHABIL RES DEV, V33, P404; Wright B. D., 2003, RASCH MEASUREMENT T, V17, P905	79	12	12	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					167	179		10.1097/HTR.0000000000000111			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800009	25699619				2022-02-06	
J	Zeiler, FA; AlSubaie, F; Zeiler, K; Bernard, F; Skrobik, Y				Zeiler, Frederick A.; AlSubaie, Fand; Zeiler, Kaitlin; Bernard, Francis; Skrobik, Yoanna			Analgesia in Neurocritical Care: An International Survey and Practice Audit	CRITICAL CARE MEDICINE			English	Article						analgesia; intensive care; neurologic critical care; practice audit; pharmacology; survey	CRITICALLY-ILL PATIENTS; POSTOPERATIVE PAIN; DOUBLE-BLIND; SEDATION; DELIRIUM; ACETAMINOPHEN; EFFICACY; ICU; MULTICENTER; GUIDELINES	Objective: To characterize analgesic administration in neurocritical care. Design: ICU pharmacy database analgesic delivery audits from five countries. A 31-question analgesic agent survey was constructed, validated, and e-distributed in four countries. Setting: International multicenter neuro-ICU database audit and electronic survey. Patients: Six ICUs provided individual, anonymized analgesic delivery data in primary neurological diagnosis patients. Prescriber surveys were disseminated by neurocritical care societies. Interventions: None. Measurements and Main Results: Analgesic delivery data from 173 patients in French, Canadian, American, and Australian and New Zealand ICUs suggest that acetaminophen/paracetamol is the most common first-line analgesic (49.1% of patients); opiates are the "second line" in 31.5% of patients; however, 33% patients received no second agent. In the 2.3% with demyelinating disease, gabapentin was the most likely second analgesic (50.0%). Third-line analgesics were scarce across sites and neuropathologies. Few national or regional differences were found. The analgesic preference rankings noted by the 95 international physicians who completed the survey matched the audits. However, self-reported analgesic prescription rates were much higher than pharmacy records indicate, with self reported prescribing of both acetaminophen/paracetamol and opiates in 97% of patients and gabapentin in 45% of patients. Third-line analgesic variability appeared to be driven by neuropathology; ibuprofen was preferred for traumatic brain injury, postcraniotomy, and thromboembolic stroke patients, whereas gabapentin/pregabalin were favored in subarachnoid hemorrhage, intracranial hemorrhage, spine, demyelinating disease, and epileptic patients. Conclusions: Opiates and acetaminophen are preferred analgesic agents, and gabapentin is a contextual third choice, in neurocritically ill patients. Other agents are rarely prescribed. The discordance in physician self-reports and objective audits suggest that pain management optimization studies are warranted.	[Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Neurosurg Sect, Winnipeg, MB R3T 2N2, Canada; [AlSubaie, Fand] Natl Inst Neurosci, Dept Neurosci, Riyadh, Saudi Arabia; [Zeiler, Kaitlin] Misericordia Hosp, Dept Nursing, Winnipeg, MB, Canada; [Zeiler, Kaitlin] McGill Univ, Montreal Neurol Inst, Sect Neurocrit Care, Montreal, PQ, Canada; [Bernard, Francis] McGill & Queens Univ, Dept Med, Montreal, PQ, Canada; [Skrobik, Yoanna] McGill Univ, Dept Med, Montreal, PQ, Canada		Skrobik, Y (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Desk D05-5133,1001 Boul Decarie,Suite D05-2013, Montreal, PQ H4A 3J1, Canada.	skrobik@sympatico.ca	Skrobik, Yoanna/K-8165-2014; Skrobik, Yoanna/J-6393-2013	Skrobik, Yoanna/0000-0002-5315-6020; Zeiler, Frederick/0000-0003-1737-0510; Teitelbaum, Jeanne/0000-0002-9834-3882			Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; AlSubaie F, 2014, CAN J NEUROL SCI S3, V41; Azzam PN, 2013, J INTENSIVE CARE MED, V28, P140, DOI 10.1177/0885066611432417; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Burry LD, 2014, CAN J ANESTH, V61, P619, DOI 10.1007/s12630-014-0174-1; Chanques G, 2011, BRIT J ANAESTH, V106, P336, DOI 10.1093/bja/aeq375; Chanques G, 2007, ANESTHESIOLOGY, V107, P858, DOI 10.1097/01.anes.0000287211.98642.51; Crews KR, 2014, CLIN PHARMACOL THER, V95, P376, DOI 10.1038/clpt.2013.254; Czaja R, 2005, DESIGNING SURVEYS, P103; Derry CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010210.pub2; Flexman AM, 2010, CURR OPIN ANESTHESIO, V23, P551, DOI 10.1097/ACO.0b013e32833e15b9; Gelinas C, 2013, SEMIN RESP CRIT CARE, V34, P236, DOI 10.1055/s-0033-1342986; Hall JB, 2010, CRIT CARE MED, V38, pS668, DOI 10.1097/CCM.0b013e3181f203aa; Hynninen MS, 2000, CAN J ANAESTH, V47, P1182, DOI 10.1007/BF03019866; Ilan R, 2007, CRIT CARE MED, V35, P1696, DOI 10.1097/01.CCM.0000269041.05527.80; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Martin J, 2010, GER MED SCI, V8, pDoc02; McMillian Wesley D, 2011, J Pharm Pract, V24, P27, DOI 10.1177/0897190010388139; Memis D, 2010, J CRIT CARE, V25, P458, DOI 10.1016/j.jcrc.2009.12.012; Mordhorst C, 2010, J NEUROSURG ANESTH, V22, P202, DOI 10.1097/ANA.0b013e3181df0600; Mullins ME, 2011, NEUROCRIT CARE, V15, P375, DOI 10.1007/s12028-011-9533-8; Nair S, 2011, BRIT J NEUROSURG, V25, P100, DOI 10.3109/02688697.2010.534199; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Payen JF, 2009, ANESTHESIOLOGY, V111, P1308, DOI 10.1097/ALN.0b013e3181c0d4f0; Pierce CA, 2010, ANN PHARMACOTHER, V44, P489, DOI 10.1345/aph.1M332; Preslaski CR, 2013, CHEST, V144, P1687, DOI 10.1378/chest.12-1615; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Qi DS, 2012, CLIN THER, V34, P2247, DOI 10.1016/j.clinthera.2012.11.003; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Singla NK, 2012, PAIN PRACT, V12, P523, DOI 10.1111/j.1533-2500.2012.00556.x; Skrobik Y, 2013, BRAIN DISORDERS IN CRITICAL ILLNESS: MECHANISMS, DIAGNOSIS, AND TREATMENT, P305; Skrobik Y, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-9; Skrobik Y, 2010, ANESTH ANALG, V111, P451, DOI 10.1213/ANE.0b013e3181d7e1b8; Teitelbaum JS, 2011, CAN J NEUROL SCI, V38, P815, DOI 10.1017/S0317167100012385; Yu A, 2013, CRIT CARE MED, V41, P2002, DOI 10.1097/CCM.0b013e31828e96c0; Yue Y, 2013, CLIN THER, V35, P1306, DOI 10.1016/j.clinthera.2013.07.422	37	12	12	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2016	44	5					973	980		10.1097/CCM.0000000000001602			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ7BF	WOS:000374366200015	26983164				2022-02-06	
J	Ekmark-Lewen, S; Flygt, J; Fridgeirsdottir, GA; Kiwanuka, O; Hanell, A; Meyerson, BJ; Mir, AK; Gram, H; Lewen, A; Clausen, F; Hillered, L; Marklund, N				Ekmark-Lewen, Sara; Flygt, Johanna; Fridgeirsdottir, Gudrun A.; Kiwanuka, Olivia; Hanell, Anders; Meyerson, Bengt J.; Mir, Anis K.; Gram, Hermann; Lewen, Anders; Clausen, Fredrik; Hillered, Lars; Marklund, Niklas			Diffuse traumatic axonal injury in mice induces complex behavioural alterations that are normalized by neutralization of interleukin-1	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						axonal injury; behavioural outcome; central fluid percussion injury; interleukin-1; traumatic brain injury	EXPERIMENTAL BRAIN-INJURY; CONCENTRIC SQUARE FIELD; FLUID PERCUSSION INJURY; ROAD TRAFFIC ACCIDENT; CLOSED-HEAD INJURY; RECEPTOR ANTAGONIST; INFLAMMATORY RESPONSE; UP-REGULATION; PERIPHERAL LIPOPOLYSACCHARIDE; NEUROINFLAMMATORY RESPONSES	Widespread traumatic axonal injury (TAI) results in brain network dysfunction, which commonly leads to persisting cognitive and behavioural impairments following traumatic brain injury (TBI). TBI induces a complex neuroinflammatory response, frequently located at sites of axonal pathology. The role of the pro-inflammatory cytokine interleukin (IL)-1 has not been established in TAI. An IL-1-neutralizing or a control antibody was administered intraperitoneally at 30min following central fluid percussion injury (cFPI), a mouse model of widespread TAI. Mice subjected to moderate cFPI (n=41) were compared with sham-injured controls (n=20) and untreated, naive mice (n=9). The anti-IL-1 antibody reached the target brain regions in adequate therapeutic concentrations (up to similar to 30g/brain tissue) at 24h post-injury in both cFPI (n=5) and sham-injured (n=3) mice, with lower concentrations at 72h post-injury (up to similar to 18g/g brain tissue in three cFPI mice). Functional outcome was analysed with the multivariate concentric square field (MCSF) test at 2 and 9days post-injury, and the Morris water maze (MWM) at 14-21days post-injury. Following TAI, the IL-1-neutralizing antibody resulted in an improved behavioural outcome, including normalized behavioural profiles in the MCSF test. The performance in the MWM probe (memory) trial was improved, although not in the learning trials. The IL-1-neutralizing treatment did not influence cerebral ventricle size or the number of microglia/macrophages. These findings support the hypothesis that IL-1 is an important contributor to the processes causing complex cognitive and behavioural disturbances following TAI.	[Ekmark-Lewen, Sara; Flygt, Johanna; Fridgeirsdottir, Gudrun A.; Kiwanuka, Olivia; Hanell, Anders; Lewen, Anders; Clausen, Fredrik; Hillered, Lars; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Meyerson, Bengt J.] Uppsala Univ, Biomed Ctr, Dept Neurosci, Pharmacol, Uppsala, Sweden; [Mir, Anis K.; Gram, Hermann] Novartis Inst Biomed Res, Basel, Switzerland; [Marklund, Niklas] Univ Uppsala Hosp, Dept Neurosurg, Ing 85,2 Tr, SE-75655 Uppsala, Sweden		Marklund, N (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.; Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, Ing 85,2 Tr, SE-75655 Uppsala, Sweden.	niklas.marklund@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Marklund, Niklas/0000-0002-9797-5626; Clausen, Fredrik/0000-0003-3592-4417; Kiwanuka, Olivia/0000-0003-3562-5513	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Uppsala University Hospital; Selander Foundation; Ahlen Foundation	This work was funded by grants from Swedish Research Council, Uppsala University Hospital, The Selander Foundation and The Ahlen Foundation.	AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campbell SJ, 2007, NEUROBIOL DIS, V27, P151, DOI 10.1016/j.nbd.2007.04.013; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Depino AM, 2004, HIPPOCAMPUS, V14, P526, DOI 10.1002/hipo.10164; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Ekmark-Lewen S, 2010, J NEUROTRAUM, V27, P1643, DOI 10.1089/neu.2009.0953; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Johansson E., 2006, MULTI MEGAVARIATE 1; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; Meyerson BJ, 2006, BEHAV BRAIN RES, V168, P100, DOI 10.1016/j.bbr.2005.10.020; Moore AH, 2009, NEUROSCIENCE, V164, P1484, DOI 10.1016/j.neuroscience.2009.08.073; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Pittella JEH, 2004, ARQ NEURO-PSIQUIAT, V62, P406, DOI 10.1590/S0004-282X2004000300007; Rooker S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/90123; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schmitter-Edgecombe M, 2012, J CLIN EXP NEUROPSYC, V34, P256, DOI 10.1080/13803395.2011.633497; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Sparkman NL, 2005, BEHAV BRAIN RES, V159, P145, DOI 10.1016/j.bbr.2004.10.011; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thomale UW, 2007, IMMUNOBIOLOGY, V212, P567, DOI 10.1016/j.imbio.2007.01.007; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Wu CW, 2007, J NEUROCHEM, V103, P2471, DOI 10.1111/j.1471-4159.2007.04987.x; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	90	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2016	43	8					1016	1033		10.1111/ejn.13190			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK1BA	WOS:000374645700004	27091435				2022-02-06	
J	Garzon, D; Cabezas, R; Vega, N; Avila-Rodriguez, M; Gonzalez, J; Gomez, RM; Echeverria, V; Aliev, G; Barreto, GE				Garzon, Daniel; Cabezas, Ricardo; Vega, Nelson; Avila-Rodriguez, Marcos; Gonzalez, Janneth; Margarita Gomez, Rosa; Echeverria, Valentina; Aliev, Gjumrakch; Barreto, George E.			Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Astrocytes; Neurosteroids; Growth factors; Mesenchymal stemfactors; Nicotine; Computational biology	MESENCHYMAL STEM-CELLS; NICOTINIC ACETYLCHOLINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; GROWTH-FACTORS; NEUROTROPHIC FACTOR; PARKINSONS-DISEASE; OXIDATIVE STRESS; SYSTEMS BIOLOGY; BREAST-CANCER; RAT MODEL	Astrocytes are important for normal brain functioning. Astrocytes are metabolic regulators of the brain that exert many functions such as the preservation of blood-brain barrier (BBB) function, clearance of toxic substances, and generation of antioxidant molecules and growth factors. These functions are fundamental to sustain the function and survival of neurons and other brain cells. For these reasons, the protection of astrocytes has become relevant for the prevention of neuronal death during brain pathologies such as Parkinson's disease, Alzheimer's disease, stroke, and other neurodegenerative conditions. Currently, different strategies are being used to protect the main astrocytic functions during neurological diseases, including the use of growth factors, steroid derivatives, mesenchymal stem cell paracrine factors, nicotine derivatives, and computational biology tools. Moreover, the combined use of experimental approaches with bioinformatics tools such as the ones obtained through system biology has allowed a broader knowledge in astrocytic protection both in normal and pathological conditions. In the present review, we highlight some of these recent paradigms in assessing astrocyte protection using experimental and computational approaches and discuss how they could be used for the study of restorative therapies for the brain in pathological conditions.	[Garzon, Daniel; Cabezas, Ricardo; Vega, Nelson; Avila-Rodriguez, Marcos; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Margarita Gomez, Rosa] Univ La Sabana, Grp Neurociencias, Chia, Cundinamarca, Colombia; [Echeverria, Valentina] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33647 USA; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Concepcion 1457, Chile; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci, E Johns Crossing 175, Johns Creek, GA 30097 USA; [Aliev, Gjumrakch] Univ Atlanta, Healthcare Adm, E Johns Crossing 175, Johns Creek, GA USA; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gesbarreto@gmail.com	Barreto, George E./B-5747-2014; Valentina Echeverria Moran, BCh/E-7765-2013; Aliev, Gjumrakch/K-7302-2017; Aliev, Gjumrakch/AAE-7734-2020; GONZALEZ, JANNETH/AAB-9948-2020; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971; Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Aliev, Gjumrakch/0000-0001-7373-3182; GONZALEZ, JANNETH/0000-0003-2009-3374; Barreto, George E./0000-0002-6644-1971; Avila-Rodriguez, Marco/0000-0003-4612-3236; Gonzalez, Janneth/0000-0003-4482-256X; Vega, Nelson/0000-0003-2404-6858	grants PUJ [4509, 5024, 5608]; Colciencias projectDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [528, 511]; GALLY International Biomedical Research Consulting LLC, San Antonio, TX, USA	This work was supported in part by grants PUJ IDs 4509, 5024, and 5608 to GEB, Colciencias project (convocatoria 528) to RC and Colciencias project (convocatoria 511). G. Aliev work was supported by the GALLY International Biomedical Research Consulting LLC, San Antonio, TX, USA.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Andriamaharavo NR, 2005, J NAT PROD, V68, P1743, DOI 10.1021/np058089f; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Barragan-Osorio L., 2015, CENT NERV SYST AGENT; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2015, CURR PHARM DESIGN, V21, P3589, DOI 10.2174/1381612821666150710145250; Barreto GE, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00340; Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Cabezas R., 2015, MED CHEM IN PRESS; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Castellani G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00253; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; CHENG B, 1995, J NEUROSCI, V15, P7095; COLDITZ GA, 1993, AM J OBSTET GYNECOL, V168, P1473, DOI 10.1016/S0002-9378(11)90784-4; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Coulter DA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022434; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; De Schutter E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000078; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fujita KA, 2014, MOL NEUROBIOL, V49, P88, DOI 10.1007/s12035-013-8489-4; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gibson W., 2008, MATH MODELING BIOL S, P193; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gompel A, 1999, CONTRACEPT FERTIL S, V27, P368; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Han D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-95, 10.1186/1471-2164-15-477]; He T, 2012, MICROVASC RES, V83, P366, DOI 10.1016/j.mvr.2012.01.001; Henriques A, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00032; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Krupinski J, 1997, STROKE, V28, P564, DOI 10.1161/01.STR.28.3.564; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lanussa O.H., 2015, CNS NEUROLO IN PRESS; Likic Vladimir A., 2010, Advances in Bioinformatics, V2010, P268925, DOI 10.1155/2010/268925; Lin CH, 2006, EXP NEUROL, V201, P225, DOI 10.1016/j.expneurol.2006.04.014; Liu Y, 2015, NEUROPHARMACOLOGY, V91, P87, DOI 10.1016/j.neuropharm.2014.11.028; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Lunn JS, 2011, ANN NEUROL, V70, P353, DOI 10.1002/ana.22487; Malik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096139; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; McMurray R, 2003, BRAIN RES, V980, P140, DOI 10.1016/S0006-8993(03)02984-6; Miller RH, 2010, DISCOV MED, V9, P236; MORENS DM, 1995, NEUROLOGY, V45, P1041, DOI 10.1212/WNL.45.6.1041; Nimmerjahn A, 2015, CURR OPIN NEUROBIOL, V32, P95, DOI 10.1016/j.conb.2015.01.015; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161; Onose G., 2011, ROMANIAN NEUROSURGER, V18, P11; Parpura V, 2011, BBA-MOL CELL RES, V1813, P984, DOI 10.1016/j.bbamcr.2010.11.006; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; Pogocki D, 2007, EUR J PHARMACOL, V563, P18, DOI 10.1016/j.ejphar.2007.02.038; Proschel C, 2014, EMBO MOL MED, V6, P504, DOI 10.1002/emmm.201302878; Ramaswamy S, 2009, PARKINSONISM RELAT D, V15, pS176, DOI 10.1016/S1353-8020(09)70809-0; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Rossignol J, 2014, STEM CELLS, V32, P500, DOI 10.1002/stem.1508; Safi R, 2012, J MOL NEUROSCI, V46, P654, DOI 10.1007/s12031-011-9654-8; Salazar DA, 2016, MOL GENET METAB, V117, P129, DOI 10.1016/j.ymgme.2015.08.001; Sejnowski TJ, 2015, INT ENCY SOCIAL BEHA, P480; Sertbas M, 2014, FEBS OPEN BIO, V4, P542, DOI 10.1016/j.fob.2014.05.006; Tegner JN, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-56; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; [田文艳 TIAN Wen-yan], 2009, [第二军医大学学报, Academic Journal of Second Military Medical University], V30, P790; Tonder JE, 2001, CURR MED CHEM, V8, P651, DOI 10.2174/0929867013373165; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Torrente Daniel, 2015, Front Biosci (Elite Ed), V7, P434; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vos RME, 2002, DRUG METAB DISPOS, V30, P106, DOI 10.1124/dmd.30.2.106; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yasuda T, 2010, EXPERT REV NEUROTHER, V10, P915, DOI [10.1586/ern.10.55, 10.1586/ERN.10.55]; Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017; Yu JH, 2003, J BIOCHEM MOL BIOL, V36, P49; Zheng LS, 2010, J NEUROSCI RES, V88, P1273, DOI 10.1002/jnr.22302	97	12	12	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	APR	2016	58	4					483	492		10.1007/s12031-016-0719-6			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DJ5YI	WOS:000374286300011	26803310				2022-02-06	
J	McNamee, MJ; Partridge, B; Anderson, L				McNamee, Michael J.; Partridge, Bradley; Anderson, Lynley			Concussion Ethics and Sports Medicine	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Mild traumatic brain injury; Conflicts of interest; Rugby union; Australian football; Rugby league	CONFLICTS-OF-INTEREST; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; BRAIN; CONFIDENTIALITY; MANAGEMENT; CLINICIAN; PRESSURE; ZURICH	Despite considerable scientific dispute regarding the science of concussion, there has been a proliferation of position statements and professional guidelines published on sports concussion management over the last 15 years. A number of ethical and clinical problems associated with concussion management protocols remain concerning, (i) diagnosis and management; (ii) conflicts of interest and coercion; (iii) same day return to play; and (iv) reporting, auditing and confidentiality. These issues are critically discussed in the light of recent Consensus Statements. It is argued that the use of independent match day doctors may ameliorate some of these concerns.	[McNamee, Michael J.] Swansea Univ, Coll Engn, Singleton Pk, Swansea SA1 8QQ, W Glam, Wales; [Partridge, Bradley] Univ Queensland, Fac Hlth & Behav Sci, St Lucia, Qld 4072, Australia; [Anderson, Lynley] Univ Otago, Div Hlth Sci, Dunedin 9016, New Zealand		McNamee, MJ (corresponding author), Swansea Univ, Coll Engn, Singleton Pk, Swansea SA1 8QQ, W Glam, Wales.	m.j.mcnamee@swansea.ac.uk	McNamee, Michael/AAI-8780-2020	McNamee, Michael/0000-0002-5857-909X			Anderson L, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024794; Anderson LC, 2005, J MED ETHICS, V31, P88, DOI 10.1136/jme.2002.000836; [Anonymous], 2013, SPORTS RELATED CONCU; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Chammas M, 2015, PARRAMATTA EELS CONC; Crawley P, 2014, WESTS TIGERS HIT 20K; Davis M., 2001, CONFLICT INTEREST PR; Dunn WR, 2007, AM J SPORT MED, V35, P840, DOI 10.1177/0363546506295177; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Holm S, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3898; Khan K, 2013, BJSM BLOG; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McNamee M., 2015, KINESIOL REV, V4, P190, DOI [10.1123/kr.2015-0011, DOI 10.1123/KR.2015-0011]; McNamee M, 2013, AM J BIOETHICS, V13, P15, DOI 10.1080/15265161.2013.828123; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Olson DE, 2013, BRIT J SPORT MED, V47, P5, DOI 10.1136/bjsports-2012-091936; Orchard J., 2012, BJSM BLOG; Partridge B, 2011, AJOB NEUROSCI, V2, P62, DOI DOI 10.1080/21507740.2011.620066; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Partridge B, 2014, NEUROETHICS-NETH, V7, P63, DOI 10.1007/s12152-013-9182-z; Ribbans B, 2013, BRIT J SPORT MED, V47, P40, DOI 10.1136/bjsports-2011-090439; Thompson C, 2015, KINESIOL REV, V4, P203; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Waddington I, 2002, BRIT J SPORT MED, V36, P118, DOI 10.1136/bjsm.36.2.118; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	36	12	12	0	29	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	APR	2016	35	2					257	+		10.1016/j.csm.2015.10.008			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	DG9AR	WOS:000372375700008	26832975				2022-02-06	
J	Park, S; Williams, RA; Lee, D				Park, Soohyun; Williams, Reg Arthur; Lee, Donghyun			Effect of Preferred Music on Agitation After Traumatic Brain Injury	WESTERN JOURNAL OF NURSING RESEARCH			English	Article						agitation; music intervention; traumatic brain injury; familiarity	HEAD-INJURY; THERAPY; BEHAVIOR; AGGRESSION; THROMBOSIS; ATTITUDES; ANXIETY; PEOPLE; STAGE	Agitation is a common behavioral problem after traumatic brain injury (TBI), which threatens the safety of patients and caregivers and disrupts the rehabilitation process. This study aimed to evaluate the effects of a preferred music intervention on the reduction of agitation in TBI patients and to compare the effects of preferred music with those of classical relaxation music. A single group, within-subjects, randomized crossover trial design was formed, consisting of 14 agitated patients with cognitive impairment after severe TBI. Patients listened to preferred music and classical relaxation music, with a wash-out period in between. Patients listening to the preferred music reported a significantly greater reduction in agitation compared with the effect seen during the classical relaxation music intervention (p = .046). These findings provide preliminary evidence that the preferred music intervention may be effective as an environmental therapeutic approach for reducing agitation after TBI.	[Park, Soohyun] Eulji Univ, Dept Nursing, Songnam, South Korea; [Williams, Reg Arthur] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Lee, Donghyun] Chung Ang Univ, Dept Biomed Engn, Seoul 156756, South Korea		Park, S (corresponding author), Eulji Univ, Dept Nursing, 553 Sanseong Daero, Songnam, Gyeonggi Do, South Korea.	soohyunp@eulji.ac.kr					ALDRIDGE D, 1990, J ROY SOC MED, V83, P345, DOI 10.1177/014107689008300602; Baker F, 2001, J MUSIC THER, V38, P170, DOI 10.1093/jmt/38.3.170; Baker FA, 2006, MUSIC THERAPY METHOD; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bower J, 2014, DEV NEUROREHABIL, V17, P339, DOI 10.3109/17518423.2013.778910; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Citrome L, 2002, POSTGRAD MED, V112, P85, DOI 10.3810/pgm.2002.12.1369; Cole R, 2014, NURS CLIN N AM, V49, P371, DOI 10.1016/j.cnur.2014.05.010; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Dunn KS, 2013, J HOLIST NURS, V31, P62, DOI 10.1177/0898010112461977; Durham C, 1994, P INT C MUS THER PAL, P185; Evans L K, 1990, Image J Nurs Sch, V22, P124; Figueiro MG, 2014, CLIN INTERV AGING, V9, P1527, DOI 10.2147/CIA.S68557; Formisano R, 2001, Ann Ist Super Sanita, V37, P627; Garland K, 2007, AM J GERIAT PSYCHIAT, V15, P514, DOI 10.1097/01.JGP.0000249388.37080.b4; Gerdner L., 1997, J AM PSYCHIAT NURSES, V3, P177, DOI DOI 10.1016/S1078-3903(97)90043-4; Gerdner LA, 2000, INT PSYCHOGERIATR, V12, P49, DOI 10.1017/S1041610200006190; GLASSMAN LR, 1991, ART PSYCHOTHER, V18, P149, DOI 10.1016/0197-4556(91)90022-3; Gold C, 2011, PSYCHOTHER PSYCHOSOM, V80, P304, DOI 10.1159/000323166; HANSEN CH, 1991, J BROADCAST ELECTRON, V35, P335, DOI 10.1080/08838159109364129; Hem E, 2001, ACTA PSYCHIAT SCAND, V103, P73, DOI 10.1034/j.1600-0447.2001.00082.x; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; Janelli L M, 1997, Rehabil Nurs, V22, P14; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Laursen SB, 2005, ACTA PSYCHIAT SCAND, V111, P324, DOI 10.1111/j.1600-0447.2004.00456.x; Ledger AJ, 2007, AGING MENT HEALTH, V11, P330, DOI 10.1080/13607860600963406; Mitchell LA, 2006, EUR J PAIN, V10, P343, DOI 10.1016/j.ejpain.2005.03.005; Myskja A., 2014, OXFORD HDB NEUROLOGI, P221; North AC, 2005, PERS INDIV DIFFER, V38, P1903, DOI 10.1016/j.paid.2004.11.016; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Plylar P A, 1989, J Neurosci Nurs, V21, P353; Ragneskog H, 2001, Int J Nurs Pract, V7, P146, DOI 10.1046/j.1440-172X.2001.00254.x; Rubin AM, 2001, MEDIA PSYCHOL, V3, P25, DOI 10.1207/S1532785XMEP0301_02; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Seibert PS, 2000, BRAIN INJURY, V14, P295; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Sung HC, 2012, INT J GERIATR PSYCH, V27, P621, DOI 10.1002/gps.2761; Van de Winckel A, 2004, CLIN REHABIL, V18, P253, DOI 10.1191/0269215504cr750oa; Walworth DD, 2003, J MUSIC THER, V40, P2, DOI 10.1093/jmt/40.1.2; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Willis TJ, 2003, J HEAD TRAUMA REHAB, V18, P75, DOI 10.1097/00001199-200301000-00008; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yuen HK, 1996, BRAIN INJURY, V10, P229, DOI 10.1080/026990596124548; Zafonte RD, 1997, J HEAD TRAUMA REHAB, V12, P78, DOI 10.1097/00001199-199704000-00008	51	12	13	2	35	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-9459	1552-8456		WESTERN J NURS RES	West. J. Nurs. Res.	APR	2016	38	4					394	410		10.1177/0193945915593180			17	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DH6MW	WOS:000372905800002	26129873	Green Submitted			2022-02-06	
J	Roscigno, CI				Roscigno, Cecelia I.			Parent Perceptions of How Nurse Encounters Can Provide Caring Support for the Family in Early Acute Care After Children's Severe Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						parenting; caring; palliative care; family centered; phenomenology; traumatic brain injury; content analysis	SECONDARY ANALYSIS; QUALITATIVE DATA; DECISION-MAKING; UNITED-STATES; NEEDS; ICU; CONSCIOUSNESS; COMMUNICATION; PROFESSIONALS; PERSPECTIVES	Objective: A child's severe traumatic brain injury (TBI) creates a family crisis requiring extensive cultural, informational, psychological, and environmental support. Nurses need to understand parents' expectations of caring in early acute care so they can tailor their attitudes, beliefs, and behaviors appropriately to accommodate the family's needs. Methods: In a previous qualitative study of 42 parents or caregivers from 37 families of children with moderate-to-severe TBI, parents of children with severe TBI (n = 25) described their appraisals of nurse caring and uncaring behaviors in early acute care. Swanson's theory of caring was used to categorize parents' descriptions to inform nursing early acute care practices and family-centered care. Results: Caring nurse encounters included (a) involving parents in the care of their child and reflecting on all sociocultural factors shaping family resources and responses (knowing); (b) respecting that family grief can be co-mingled with resilience and that parents are typically competent to be involved in decision making (maintaining belief); (d) actively listening and engaging parents to fully understand family values and needs (being with); (e) decreasing parents' workload to get information and emotional support and provide a safe cultural, psychological, and physical environment for the family (doing for); and (f) providing anticipatory guidance to navigate the early acute care system and giving assistance to learn and adjust to their situation (enabling). Conclusion: Application of Swanson's caring theory is prescriptive in helping individual nurses and early acute care systems to meet important family needs after children's severe TBI.	[Roscigno, Cecelia I.] Univ N Carolina, Sch Nursing, Family Hlth Div, Chapel Hill, NC USA		Roscigno, CI (corresponding author), Univ N Carolina, Sch Nursing, Family Hlth Div, Chapel Hill, NC USA.	croscign@email.unc.edu			National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness [5T32NR007091-17]; NINR Ruth L. Kirschstein Predoctoral Research Fellowship [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation Martha E. Brill Scholars Award; University of Washington School of Nursing Hester McLaws Scholarship Fund; University of Washington LEND Training Grant (TG) [6 T73 MC 00041-11-03]; University of Washington Gatzert Child Welfare Fellowship; Integra Lifesciences Grant; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007091, F31NR009599] Funding Source: NIH RePORTER	The author disclosed receipt of the following financial support: Training during the analysis was funded by a National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness (5T32NR007091-17; PI: M. Mishel, PhD). The original research study and predoctoral training was funded by an NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02), a Psi Chapter of Sigma Theta Tau Grant, a 2006 American Nurses Foundation Martha E. Brill Scholars Award, a University of Washington School of Nursing Hester McLaws Scholarship Fund, a University of Washington LEND Training Grant (TG #6 T73 MC 00041-11-03), a University of Washington Gatzert Child Welfare Fellowship, and an Integra Lifesciences Grant. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of any of the funders.	Adams JA, 2014, HEART LUNG, V43, P406, DOI 10.1016/j.hrtlng.2014.02.001; Adler R. B., 2013, INTERPLAY PROCESS IN; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Albrecht TL, 1987, COMMUNICATING SOCIAL; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Auerbach SM, 2005, AM J CRIT CARE, V14, P202, DOI 10.4037/ajcc2005.14.3.202; Bach JR, 2003, ARCH PHYS MED REHAB, V84, pS23, DOI 10.1053/apmr.2003.50243; Beard D, 2009, INT J LISTENING, V23, P7, DOI DOI 10.1080/10904010802591771; Bernat JL, 2009, ANN NY ACAD SCI, V1157, P117, DOI 10.1111/j.1749-6632.2008.04124.x; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; BOURHIS RY, 1989, SOC SCI MED, V28, P339, DOI 10.1016/0277-9536(89)90035-X; Cegala DJ, 2013, PATIENT EDUC COUNS, V93, P34, DOI 10.1016/j.pec.2013.03.015; Coronado V. G., 2010, TRAUMATIC BRAIN INJU; Cronenwett L, 2007, NURS OUTLOOK, V55, P122, DOI 10.1016/j.outlook.2007.02.006; Duff Diane, 2006, Axone, V27, P9; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.2307/3527759; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Gan C, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P621; Gee J. P., 2014, INTRO DISCOURSE ANAL, V4; Grant A M, 1995, Rehabil Nurs, V20, P306; Heyland DK, 2003, INTENS CARE MED, V29, P75, DOI 10.1007/s00134-002-1569-y; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Iverson E, 2014, INTENS CRIT CARE NUR, V30, P77, DOI 10.1016/j.iccn.2013.08.008; Jee RA, 2012, PEDIATR CRIT CARE ME, V13, pE166, DOI 10.1097/PCC.0b013e31823893ad; Larson E, 1998, SOC SCI MED, V47, P865, DOI 10.1016/S0277-9536(98)00113-0; LATHER P, 1986, INTERCHANGE, V17, P63, DOI 10.1007/BF01807017; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Marris Peter, 1986, LOSS AND CHANGE; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Meert KL, 2013, PEDIATR CLIN N AM, V60, P761, DOI 10.1016/j.pcl.2013.02.011; Michelson KN, 2013, PEDIATR CRIT CARE ME, V14, pE34, DOI 10.1097/PCC.0b013e31826e7408; Miller KS, 2012, PEDIATR BLOOD CANCER, V59, P914, DOI 10.1002/pbc.24146; Morse JM, 1995, QUALITATIVE RES METH; Nichols R. G., 2006, INT J LISTENING, V20, P4, DOI [10. 1080/10904018. 2006. 10499081, DOI 10.1080/10904018.2006.10499081]; October TW, 2014, PEDIATR CRIT CARE ME, V15, P291, DOI 10.1097/PCC.0000000000000076; Patterson JM, 2002, J CLIN PSYCHOL, V58, P233, DOI 10.1002/jclp.10019; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pelchat D, 2009, J CHILD HEALTH CARE, V13, P239, DOI 10.1177/1367493509336684; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Purkis M E, 1997, Can J Nurs Res, V29, P47; Rehling D., 2008, INT J LISTENING, V22, P83, DOI [10.1080/10904010701808516, DOI 10.1080/10904010701808516]; Rolfe G, 2006, J ADV NURS, V53, P304, DOI 10.1111/j.1365-2648.2006.03727.x; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; Roscigno CI, 2012, QUAL HEALTH RES, V22, P1232, DOI 10.1177/1049732312449210; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Ryan-Nicholls Kimberley D, 2009, Nurse Res, V16, P70; Sandelowski M, 2011, RES NURS HEALTH, V34, P342, DOI 10.1002/nur.20437; Schenker Y, 2013, J PALLIAT MED, V16, P243, DOI 10.1089/jpm.2012.0331; Shapiro J. P., 1993, NO PITY PEOPLE DISAB; Shaver J.L.F., 1999, HDB CLIN NURSING RES, P31; Shotter J., 2009, INT J LISTENING, V23, P21, DOI 10.1080/10904010802591904; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Solomon A., 2012, FAR TREE PARENTS CHI; Stark M, 2013, HASTINGS CENT REP, V43, P13, DOI 10.1002/hast.188; Swanson K M, 1993, Image J Nurs Sch, V25, P352; Szabo V, 1997, ADV NURS SCI, V20, P66, DOI 10.1097/00012272-199712000-00008; Thorne S., 1994, CRITICAL ISSUES QUAL; Van Hook M. P., 2008, SOCIAL WORK PRACTICE	62	12	12	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2016	48	2					E2	E15		10.1097/JNN.0000000000000192			14	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	DG5WI	WOS:000372149600002	26871242	Green Submitted, Green Accepted			2022-02-06	
J	Tsermoulas, G; Shah, O; Wijesinghe, HE; Silva, AHD; Ramalingam, SK; Belli, A				Tsermoulas, Georgios; Shah, Omid; Wijesinghe, Haren Eranga; Silva, Adikarige Haritha Dulanka; Ramalingam, Satheesh K.; Belli, Antonio			Surgery for Acute Subdural Hematoma: Replace or Remove the Bone Flap?	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Brain edema; Craniotomy; Decompressive craniectomy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; RETROSPECTIVE ANALYSIS; SURGICAL-MANAGEMENT; CRANIOTOMY; CRANIOPLASTY; IMPACT; EPIDEMIOLOGY; MULTICENTER	OBJECTIVE: In surgery for acute subdural hematoma (ASDH), the bone flap can be fixed onto the skull, left riding to provide partial skull decompression, or removed. This study assessed whether removing the bone flap improved outcome. METHODS: We conducted an observational study on consecutive patients who were operated for ASDH in our hospital from July 2011 to June 2014. We retrospectively collected data on demographics, injury severity, and predicted and observed outcomes at 6 months. The cohort was divided into 2 groups based on whether the bone flap was replaced (fixed and riding flap craniotomy) or removed (decompressive craniectomy). The differences in functional status, postoperative control of intracranial hypertension, and number of cranial reoperations were analyzed. A subgroup analysis compared decompressive craniectomy with riding flap craniotomy alone. RESULTS: Data were obtained for 99 patients; 69 had decompressive craniectomy, 17 had riding flap craniotomy, and 13 had fixed flap craniotomy. The decompressive craniectomy group had statistically worse injuries, more predicted poor outcomes (69% vs. 57%, P = 0.013), more observed poor outcomes (59% vs. 37%, P = 0.037), equivalent control of intracranial hypertension, and a similar number of reoperations compared with the craniotomy groups. Subgroup analysis between decompressive craniectomy and riding flap craniotomy showed no significant difference in baseline characteristics and outcomes. CONCLUSIONS: Our study concluded that removing the bone flap after ASDH evacuation was not associated with a better outcome. We recommend replacing the bone flap if brain conditions allow. Further research is required to evaluate the role of skull decompression in surgery for ASDH.	[Tsermoulas, Georgios; Shah, Omid; Wijesinghe, Haren Eranga; Silva, Adikarige Haritha Dulanka; Belli, Antonio] Queen Elizabeth Hosp, Dept Neurosurg, Birmingham B15 2TH, W Midlands, England; [Ramalingam, Satheesh K.] Queen Elizabeth Hosp, Dept Neuroradiol, Birmingham B15 2TH, W Midlands, England		Tsermoulas, G (corresponding author), Queen Elizabeth Hosp, Dept Neurosurg, Birmingham B15 2TH, W Midlands, England.	georgios.tsermoulas@nhs.net	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Cruz-Flores S, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Edlow BL, 2010, POCKET NEUROLOGY, P34; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kano T, 2012, NEUROL MED-CHIR, V52, P816, DOI 10.2176/nmc.52.816; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Lee L, 2013, BRIT J NEUROSURG, V27, P629, DOI 10.3109/02688697.2013.815313; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lu XC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07070; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Meyer SH, 1996, PRACTICE NEUROSURGER, V2, P1443; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Perel P, 2012, BMJ-BRIT MED J, V336, P425; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; TJUVAJEV J, 1990, ACT NEUR S, V51, P305; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019	34	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						569	575		10.1016/j.wneu.2015.10.045			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700074	26523763				2022-02-06	
J	Arya, V; Chigurupati, R				Arya, Varun; Chigurupati, Radhika			Treatment Algorithm for Intracranial Intrusion Injuries of the Mandibular Condyle	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							MIDDLE CRANIAL FOSSA; TRAUMATIC DISLOCATION; GLENOID FOSSA; FRACTURES; EXPERIENCE; MANAGEMENT; DIAGNOSIS; CHILDREN	Purpose: Traumatic injuries of the mandible resulting in intrusion of the condyle into the middle cranial fossa are rare and treatment is often based on anecdotal experience. The objective of this study was to develop an algorithm for the management of condylar intrusion injuries by identifying factors that influenced the treatment decision of closed versus open reduction of the condyle. Materials and Methods: This study was a systematic review of the literature on intracranial intrusion injuries of the mandibular condyle. A thorough search of the PubMed and Cochrane databases and individual maxillofacial and craniofacial journal databases was conducted using the Medical Subject Heading terms condylar impaction, condylar dislocation, condylar intrusion, and middle cranial fossa and condyle without date and language restriction. Quantitative data on the patient's age, gender, etiology of injury, and time from injury to diagnosis were analyzed using descriptive statistics. The authors studied how the predictor variables of age, etiology, time from injury to diagnosis, and associated neurologic injuries influenced the outcome variable of closed versus open reduction of the condyle. Results: Forty-eight of the 62 retrieved case reports, case series, and review articles were published in the English-language literature from 1963 to 2015. Data on 51 patients with these injuries showed that 38 (75%) were female and younger than 30 years. The most common etiology of injury was motor vehicular accidents, occurring in 25 of 51 patients (49%). The mean time from injury to diagnosis was 31.2 days (0 to 106.4 days). Forty of the 51 patients (78%) were diagnosed within the first 2 weeks of injury. A good proportion of patients underwent open reduction (63%) and 18 of the 51 of patients (35%) underwent closed reduction. Conclusions: Predictor variables that influenced the treatment decision of open versus closed reduction were age of the patient, etiology of injury, and time from injury to diagnosis. Based on the present results, younger patients (0 to 15 yr old), patients who sustain condylar intrusion injuries from bicycle accidents, and those diagnosed within the first 2 weeks of injury are more likely to benefit from closed reduction. The treatment algorithm emphasizes the importance of assessment of associated neurologic injuries and an interdisciplinary approach for the management of these injuries. (C) 2016 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 74: 569-581, 2016	Boston Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA 02215 USA; Boston Med Ctr, Boston, MA USA		Arya, V (corresponding author), 100 E Newton St,Suite G-407, Boston, MA 02118 USA.	arya@bu.edu		Arya, Varun/0000-0002-8665-1300			BALDWIN AJ, 1990, J ORAL MAXIL SURG, V48, P623, DOI 10.1016/S0278-2391(10)80479-3; Barron RP, 2002, ORAL SURG ORAL MED O, V93, P640, DOI 10.1067/moe.2002.122824; Cascone P, 2003, J CRANIOFAC SURG, V14, P184, DOI 10.1097/00001665-200303000-00009; Chacon GE, 2003, J ORAL MAXIL SURG, V61, P668, DOI 10.1053/joms.2003.50134; Clauser L, 2006, J CRANIOFAC SURG, V17, P590, DOI 10.1097/00001665-200605000-00036; DAFONSECA GD, 1974, INT J ORAL MAXILLOF, V3, P89, DOI 10.1016/S0300-9785(74)80040-2; DAHLBERG G, 1995, J ORAL MAXIL SURG, V53, P461, DOI 10.1016/0278-2391(95)90725-4; Dijkstra PU, 2005, J TRAUMA, V59, P422, DOI 10.1097/01.ta.0000174942.80363.06; DINGMAN R O, 1963, Plast Reconstr Surg, V31, P563, DOI 10.1097/00006534-196306000-00008; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; ENGEVALL S, 1992, J ORAL MAXIL SURG, V50, P524, DOI 10.1016/S0278-2391(10)80330-1; Erol BE, 2004, J CRANIO MAXILL SURG, V32, P308, DOI 10.1016/j.jcms.2004.04.006; Harstall R, 2005, J TRAUMA, V59, P1495, DOI 10.1097/01.ta.0000199241.49446.80; KALLAL RH, 1977, ORAL SURG ORAL MED O, V43, P2, DOI 10.1016/0030-4220(77)90342-5; Lloyd TE, 2010, BRIT J ORAL MAX SURG, V48, P176, DOI 10.1016/j.bjoms.2009.08.031; Magge SN, 2007, J NEUROSURG, V107, P75, DOI 10.3171/PED-07/07/075; Man C, 2011, INT J ORAL MAX SURG, V40, P118, DOI 10.1016/j.ijom.2010.02.028; Marker P, 2000, BRIT J ORAL MAX SURG, V38, P417, DOI 10.1054/bjom.2000.0317; Marston AP, 2012, LARYNGOSCOPE, V122, P1401, DOI 10.1002/lary.23260; Matsumoto K, 2006, DENTOMAXILLOFAC RAD, V35, P357, DOI 10.1259/dmfr/30011413; Melugin MB, 1997, J ORAL MAXIL SURG, V55, P1342, DOI 10.1016/S0278-2391(97)90199-3; Meyers JA, 2014, OTOLARYNG HEAD NECK, V150, P133, DOI 10.1177/0194599813512772; Oberman B, 2014, AM J OTOLARYNG, V35, P251, DOI 10.1016/j.amjoto.2013.11.004; Ohura N, 2006, J ORAL MAXIL SURG, V64, P1165, DOI 10.1016/j.joms.2006.03.043; Oikarinen K, 2005, MED PRIN PRACT, V14, P10, DOI 10.1159/000081917; PIROK DJ, 1970, ORAL SURG ORAL MED O, V29, P13, DOI 10.1016/0030-4220(70)90405-6; Rosa Vera L M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe4, DOI 10.1016/j.tripleo.2006.02.004; Sandler NA, 1996, J ORAL MAXIL SURG, V54, P506, DOI 10.1016/S0278-2391(96)90129-9; Scafati CT, 2008, CHILD NERV SYST, V24, P1067, DOI 10.1007/s00381-008-0659-8; SEYMOUR RL, 1976, J ORAL SURG, V34, P180; Smith RR, 1980, ESSENTIALS NEUROSURG, p[6, 108, 118]; Struewer J, 2012, J CRANIO MAXILL SURG, V40, P396, DOI 10.1016/j.jcms.2011.07.006; Tutela JP, 2013, J CRANIOFAC SURG, V24, P1703, DOI 10.1097/SCS.0b013e31828a76b1; Vaezi T, 2014, ORAL MAXILLOFAC SURG, V18, P69, DOI 10.1007/s10006-013-0395-4; WISH-BARATZ S, 1992, Journal of Craniomandibular Disorders, V6, P171; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854; Zhang SL, 2014, CRANIO, V32, P63, DOI 10.1179/0886963413Z.0000000007	37	12	12	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAR	2016	74	3					569	581		10.1016/j.joms.2015.09.033			13	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	DE1FX	WOS:000370373300025	26514632				2022-02-06	
J	Bahado-Singh, RO; Graham, SF; Turkoglu, O; Beauchamp, K; Bjorndahl, TC; Han, B; Mandal, R; Pantane, J; Kowalenko, T; Wishart, DS; Stahel, PF				Bahado-Singh, Ray O.; Graham, Stewart F.; Turkoglu, Onur; Beauchamp, Kathryn; Bjorndahl, Trent C.; Han, BeomSoo; Mandal, Rupasri; Pantane, Jenee; Kowalenko, Terry; Wishart, David S.; Stahel, Philip F.			Identification of candidate biomarkers of brain damage in a mouse model of closed head injury: a metabolomic pilot study	METABOLOMICS			English	Article						Metabolomics; Traumatic brain injury; NMR; Biomarkers	MAGNETIC-RESONANCE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; RAT MODEL; METABOANALYST; MICRODIALYSIS; GLUTAMATE; MICE; HMDB	We aim to identify candidate brain biomarkers for, and to elucidate the pathophysiology of closed traumatic brain injury (TBI). Nuclear magnetic resonance (NMR) based metabolomic analysis was performed on the whole brain of mice undergoing TBI using a validated technique. There were 10 TBI mice compared to 8 sham operated controls. A total of 45 metabolites were evaluated. There was a statistically significant alteration in concentrations of 29 metabolites in TBI brains as compared to controls (FDR <0.05). Profound disturbances of severalmetabolic pathways (FDR <1E-07), including pathways associated with purine, alanine, aspartate and glutamine and glutathione metabolism were observed. Also, a significant elevation in glutamate (the main excitatory neurotransmitter) and depression of GABA (the main inhibitory neurotransmitter) was observed. Four metabolites, ADP, AMP, NAD+, and IMP were the most important indicators of TBI, relative to normal controls. All were elevated in the TBI mice. A combination of these 4 biomarkers produced a perfect predictor of TBI status, AUC (95 % CI) = 1.0 (1.0, 1.0). We also detected significant disturbances in mitochondrial function, energy metabolism, neurotransmitter metabolism and other important biochemical pathways in TBI mouse brains. Further studies to assess the utility of metabolomics to detect and classify the severity of and assess the prognosis of TBI is warranted.	[Bahado-Singh, Ray O.; Graham, Stewart F.; Turkoglu, Onur] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Beauchamp, Kathryn; Stahel, Philip F.] Univ Colorado, Sch Med, Dept Neurosurg, Denver Hlth Med Ctr, Denver, CO USA; [Bjorndahl, Trent C.; Han, BeomSoo; Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Biol & Comp Sci, Edmonton, AB, Canada; [Kowalenko, Terry] Oakland Univ, Dept Emergency Med, William Beaumont Sch Med, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Pantane, Jenee; Stahel, Philip F.] Univ Colorado, Sch Med, Dept Orthoped, Denver Hlth Med Ctr, Denver, CO USA		Graham, SF (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA.	stewart.graham@beaumont.org	Graham, Stewart/AAE-9772-2020; Wishart, David Scott/ABI-3181-2020	Graham, Stewart/0000-0003-1001-0002; Wishart, David S/0000-0002-3207-2434	Alberta Innovates [201201143] Funding Source: researchfish		Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; FAWCETT T, 2003, ROC GRAPHS NOTES PRA; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Graham SF, 2014, METABOLOMICS, V10, P744, DOI 10.1007/s11306-013-0610-1; Graham SF, 2013, METABOLOMICS, V9, P974, DOI 10.1007/s11306-013-0516-y; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Lemaire L, 2011, J BIOMED SCI ENG, V4, P110; Lionetto L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-55; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Ravanbakhsh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124219; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Wang Y, 2014, INT J CLIN EXP PATHO, V7, P4067; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2010, METHODS MOL BIOL, V593, P283, DOI 10.1007/978-1-60327-194-3_14; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008	54	12	12	1	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	MAR	2016	12	3							42	10.1007/s11306-016-0957-1			13	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DG5XY	WOS:000372156000003					2022-02-06	
J	Cai, SS; Bonds, BW; Hu, PF; Stein, DM				Cai, Stephen S.; Bonds, Brandon W.; Hu, Peter F.; Stein, Deborah M.			The role of cardiac troponin I in prognostication of patients with isolated severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; cardiac dysfunction; cardiac troponin I; in-hospital mortality	ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEUROGENIC STUNNED MYOCARDIUM; ACUTE CORONARY SYNDROMES; BETA-BLOCKER EXPOSURE; GLASGOW COMA SCALE; INTRACRANIAL HYPERTENSION; CEREBRAL HYPOPERFUSION; UNITED-STATES; INTRACEREBRAL HEMORRHAGE; IMPROVED SURVIVAL	BACKGROUND Cardiac dysfunction is frequently observed after severe traumatic brain injury (sTBI); however, its significance is poorly understood. Our study sought to elucidate the association of cardiac troponin I (cTnI) elevation with all-cause in-hospital mortality following isolated sTBI (brain Abbreviated Injury Scale score 3 and admission Glasgow Coma Scale score 8, no Abbreviated Injury Scale score 3 to any other bodily regions). METHODS We retrospectively reviewed all adult patients (aged 18 years) with isolated sTBI admitted to a Level I trauma center between June 2007 and January 2014. Patients must have cTnI values within 24 hours of admission. Mortality risks were examined by Cox proportional hazard model. RESULTS Of 580 patients identified, 30.9% had detectable cTnI in 24 hours of admission. The median survival time was 4.19 days (interquartile range, 1.27-11.69). When adjusted for potential confounders, patients in the highest cTnI category (0.21 ng/mL) had a significantly higher risk of in-hospital mortality (hazard ratio, 1.39; 95% confidence interval, 1.04-1.88) compared with patients with undetectable cTnI. Mortality risk increased with higher troponin levels (p < 0.0001). This association was more pronounced in patients aged 65 years or younger (hazard ratio, 2.28; 95% confidence interval, 1.53-3.40; p < 0.0001) while, interestingly, insignificant in those older than 65 years (p = 0.0826). CONCLUSION Among patients with sTBI, cTnI elevation is associated with all-cause in-hospital mortality via a nonlinear positive trend. Age modified the effect of cTnI on mortality. LEVEL OF EVIDENCE Prognostic and epidemiologic study, level III.	[Bonds, Brandon W.; Hu, Peter F.; Stein, Deborah M.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Cai, Stephen S.; Hu, Peter F.; Stein, Deborah M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Stein, DM (corresponding author), Univ Maryland, Sch Med, Surg, R Adams Cowley Shock Trauma Ctr, 22 S Greene St,T1R52, Baltimore, MD 21201 USA.	dstein@umm.edu		Stein, Deborah/0000-0003-3683-3963	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T35AG036679, T35 AG036679] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T35AG036679] Funding Source: NIH RePORTER		Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Bernstein R, 2000, NEUROLOGY, V54, P759, DOI 10.1212/WNL.54.3.759; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Chang PC, 1998, INT J CARDIOL, V63, P189; Christensen H, 2004, CEREBROVASC DIS, V18, P194, DOI 10.1159/000079941; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; De'Ath HD, 2012, BRIT J SURG, V99, P789, DOI 10.1002/bjs.8728; DeWitt DS, 1999, CRIT CARE MED, V27, P2592, DOI 10.1097/00003246-199911000-00056; Enderson BL, 2007, J TRAUMA, V62, P33; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HELMERS C, 1983, STROKE, V14, P828, DOI 10.1161/01.STR.14.5.828; Hravnak M, 2009, STROKE, V40, P3478, DOI 10.1161/STROKEAHA.109.556753; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Inamasu J, 2013, INT J CARDIOL, V168, P1667, DOI 10.1016/j.ijcard.2013.03.096; Jeon IC, 2009, J KOREAN NEUROSURG S, V46, P99, DOI 10.3340/jkns.2009.46.2.99; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Lee VH, 2006, NEUROCRIT CARE, V5, P243, DOI 10.1385/NCC:5:3:243; Martorano P P, 1998, Minerva Anestesiol, V64, P231; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Millham FH, 2004, J TRAUMA, V56, P1090, DOI 10.1097/01.TA.0000119689.81910.06; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Myint PK, 2014, HEART, V100, P1583, DOI 10.1136/heartjnl-2014-305533; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Noeller TP, 2003, AM J EMERG MED, V21, P293, DOI 10.1016/S0735-6757(03)00081-0; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Provencio J Javier, 2007, Cleve Clin J Med, V74 Suppl 1, pS86; Putaala J, 2014, INT J STROKE, V9, P741, DOI 10.1111/ijs.12180; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Sieweke N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-58; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Webb IG, 2015, HEART LUNG CIRC, V24, P142, DOI 10.1016/j.hlc.2014.07.071; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zaroff JG, 2000, STROKE, V31, P1136, DOI 10.1161/01.STR.31.5.1136; Zhang X, 2007, COMPUT METH PROG BIO, V88, P95, DOI 10.1016/j.cmpb.2007.07.010; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	50	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2016	80	3					477	483		10.1097/TA.0000000000000916			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DF7XT	WOS:000371571900026	26910044	Green Accepted			2022-02-06	
J	Davis, KC; Slomine, BS; Salorio, CF; Suskauer, SJ				Davis, Kimberly C.; Slomine, Beth S.; Salorio, Cynthia F.; Suskauer, Stacy J.			Time to Follow Commands and Duration of Posttraumatic Amnesia Predict GOS-E Peds Scores 1 to 2 Years After TBI in Children Requiring Inpatient Rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; outcome assessment; posttraumatic amnesia; consciousness disorders; traumatic brain injury; Glasgow Outcome Scale; child	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; PRACTICAL SCALE; PEDIATRIC TBI; OUTCOMES; TERM; ORIENTATION; SEVERITY; RECOVERY	Objective: To evaluate the utility of time to follow commands (TFC) in predicting functional outcome after pediatric traumatic brain injury (TBI), as assessed by an outcome measure sensitive to the range of outcomes observed after pediatric TBI, the Glasgow Outcome Scale-Extended, Pediatric Revision (GOS-E Peds). Setting: Pediatric inpatient rehabilitation hospital and associated multidisciplinary brain injury follow-up clinic. Participants: Sixty-seven children with moderate-to-severe TBI (mean age at injury = 10.9 years; range, 3-18 years). Design: Outcomes were scored retrospectively on the basis of documentation from an outpatient follow-up evaluation 1 to 2 years postinjury (days from injury to follow-up: mean = 518, SD = 137). Correlations between measures of severity and functional outcome were examined. Hierarchical logistic and linear regression analyses were performed to examine predictors of outcome. Main Measures: Earliest documented Glasgow Coma Scale (GCS), TFC, posttraumatic amnesia (PTA), total duration of impaired consciousness (TFC + PTA), and GOS-E Peds. Results: For the logistic regression, TFC and TFC + PTA were significant predictors of outcome above and beyond GCS. For the linear analysis, PTA was also a significant predictor of functional outcome above and beyond GCS and TFC. The overall models were very comparable, with R-2 values ranging from 0.31 to 0.36 for prediction of GOS-E Peds scores. Conclusion: Above and beyond the influence of GCS, TFC, PTA, and TFC + PTA are important predictors of later outcome after TBI.	[Davis, Kimberly C.; Slomine, Beth S.; Salorio, Cynthia F.; Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Slomine, Beth S.; Salorio, Cynthia F.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Slomine, Beth S.; Salorio, Cynthia F.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Davis, Kimberly C.] Hlth Bridge Childrens Hosp, Houston, TX USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, Pediat Rehabil, 707 North Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org		Davis, Kimberly/0000-0002-3695-4784	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611] Funding Source: NIH RePORTER	Dr Suskauer received a grant (K23HD061611) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Ewing-Cobbs L, 1990, NEUROSURGERY, V27, P691; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Howard M, 1986, INTERDISCIPLINARY NE; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; TEASDALE G, 1974, LANCET, V2, P81; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	22	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E39	E47		10.1097/HTR.0000000000000159			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300004	26098263	Green Accepted			2022-02-06	
J	Galgano, MA; Cantu, R; Chin, LS				Galgano, Michael A.; Cantu, Robert; Chin, Lawrence S.			Chronic Traumatic Encephalopathy: The Impact on Athletes	CUREUS			English	Article						chronic traumatic encephalopathy; mild traumatic brain injury; repetitive traumatic brain injury; athletics; sports; high impact sports	BRAIN-INJURY; HIGH-SCHOOL; MOUSE MODEL; CONCUSSION; SPORTS; TAUOPATHY; DISEASE; TDP-43; TAU	Chronic traumatic encephalopathy (CTE) is a devastating neuropsychological condition afflicting a small percentage of athletes partaking in high-impact sports. The onset of symptoms lags years behind the inciting events. Repetitive minor head injuries are felt to be the main etiology behind CTE. Routine radiographic imaging generally is unremarkable in cases of CTE. Functional magnetic resonance imaging (fMRI), magnetic resonance spectroscopy (MRS), and diffusion tensor imaging (DTI) are advanced MRI-based sequences that have shown promise in detecting early radiographic findings that may be reflective of CTE. Progressive neuronal loss is the histopathological hallmark of this neurodegenerative disease. Strategizing earlier detection techniques is paramount in delivering optimal care to athletes afflicted with CTE.	[Galgano, Michael A.; Chin, Lawrence S.] SUNY Upstate Med Univ, Neurosurg, Syracuse, NY 13210 USA; [Cantu, Robert] Emerson Hosp, Neurosurg, Concord, MA USA		Galgano, MA (corresponding author), SUNY Upstate Med Univ, Neurosurg, Syracuse, NY 13210 USA.	mgalgano13@gmail.com					Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Centers for Disease Control and prevention, 2015, NON TRADITIONAL REF; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Flannagan P.P., 1998, CONT NEUROSURG, V20, P1; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	37	12	12	2	12	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAR	2016	8	3							e532	10.7759/cureus.532			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VH6DZ	WOS:000453611000018	27088064	Green Published, gold			2022-02-06	
J	Orr, R; Cheng, HL				Orr, Rhonda; Cheng, Hoi Lun			Incidence and characteristics of injuries in elite Australian junior rugby league players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Adolescent; Rugby; Athletic injuries; Accident; Ankle; Brain concussion	DATA-COLLECTION PROCEDURES; CONSENSUS STATEMENT; TRAINING INJURIES; DEFINITIONS; SPORTS; PREVENTION; SEASONS; UNION; MATCH	Objectives: Rugby league (RL) is a physically demanding collision sport, yet few studies describe injuries at the junior level despite their potential impact on career pathways and long-term health. With the absence of an injury surveillance paradigm in junior competition, this study aimed to investigate injury incidence in an Australian setting. Design: Prospective cohort study. Methods: A set of injury surveillance forms were developed and used to record injury characteristics, mechanism, severity and follow-up throughout one season. Results: Junior RL players (n =368, ages 15.8 +/- 1.0 years) from 15 clubs provided baseline information. Of these, approximately six clubs (n = 122) provided longitudinal injury data. A total of 109 injuries (90% matchrelated) were recorded, with the tackle accounting for 61%. Injury incidence (37.1 injuries per 1000 match hours) was consistent with previous literature. Most injuries did not result in missed matches. The ankle and head/face were most frequently injured (both 13%), with ankle injuries leading to the highest losses of matchplay. Contusions were common (38%), although ligament injuries caused the greatest matchplay losses. Injury site significantly differed between forwards and backs (p = 0.003), with forwards sustaining more head/face and sternum injuries, and backs more ankle injuries. Injury type (p = 0.25) and severity (p = 0.09) were similar between positions. Conclusions: Given the ongoing biological maturation in adolescent players and the injury risks related to RL, playing intensity, training regimes and injury incidence warrant rigorous documentation and monitoring. This study argues for functional but low-burden injury surveillance systems (e.g. electronic platforms) to be developed and implemented in junior RL. (C) 2015 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Orr, Rhonda; Cheng, Hoi Lun] Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia; [Cheng, Hoi Lun] Childrens Hosp Westmead, Acad Dept Adolescent Med, Sydney, NSW, Australia		Orr, R (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW 2006, Australia.	rhonda.orr@sydney.edu.au	Orr, Rhonda/C-1817-2008; Cheng, Hoi Lun/AAK-8937-2021	Cheng, Hoi Lun/0000-0002-2144-9195	NSW Sporting Injuries Committee	This study is supported by the NSW Sporting Injuries Committee. The authors thank the players and clubs for their participation and students who assisted with data entry. The authors acknowledge Martin Meredith (NSW Rugby League) and Brian Canavan (Chairman, National Rugby League Research Committee) for their support and assistance.	Breivik SL, 2007, SPORT EXERCISE PHYSL, VI; Cheng HL, 2014, J SCI MED SPORT, V17, P546, DOI 10.1016/j.jsams.2013.07.020; Donaldson A, 2013, BRIT J SPORT MED, V47, P473, DOI 10.1136/bjsports-2013-092323; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Estell J, 1995, Aust J Sci Med Sport, V27, P95; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gabbe BJ, 2010, BRIT J SPORT MED, V44, P799, DOI 10.1136/bjsm.2009.062554; Gabbett T, 2008, SPORTS MED, V38, P119, DOI 10.2165/00007256-200838020-00003; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gabbett TJ, 2000, BRIT J SPORT MED, V34, P98, DOI 10.1136/bjsm.34.2.98; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gabbett TJ, 2002, BRIT J SPORT MED, V36, P334, DOI 10.1136/bjsm.36.5.334; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hodgson L, 2007, CLIN J SPORT MED, V17, P188, DOI 10.1097/JSM.0b013e3180547513; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; King D, 2006, NZ J SPORTS MED, V34, P21; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; King D, 2014, INT J SPORTS SCI COA, V9, P417, DOI 10.1260/1747-9541.9.2.417; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Rugby League, 2014, NRL COACH MAN; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P207, DOI 10.2147/OAJSM.S7715; Pringle RG, 1998, BRIT J SPORT MED, V32, P49, DOI 10.1136/bjsm.32.1.49; Raftery M., 1999, INCIDENCE INJURY JUN; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Williams Jay H, 2013, J Sports Med (Hindawi Publ Corp), V2013, P380523, DOI 10.1155/2013/380523; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	30	12	13	1	20	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2016	19	3					212	217		10.1016/j.jsams.2015.03.007			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DF6DH	WOS:000371445600005	25882397				2022-02-06	
J	Ubukata, S; Ueda, K; Sugihara, G; Yassin, W; Aso, T; Fukuyama, H; Murai, T				Ubukata, Shiho; Ueda, Keita; Sugihara, Genichi; Yassin, Walid; Aso, Toshihiko; Fukuyama, Hidenao; Murai, Toshiya			Corpus Callosum Pathology as a Potential Surrogate Marker of Cognitive Impairment in Diffuse Axonal Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER; TENSOR; ATTENTION; SEQUELAE; MODERATE; DAMAGE; SPEED; MR	Diffuse axonal injury is a major form of traumatic brain injury. Neuropsychological assessments and high-resolution structural MRI were conducted using T1-weighted and diffusion tensor imaging. This study included 10 patients with diffuse axonal injury (all men, mean age 30.8 +/- 10.5 years) and 12 age-and sex-matched normal control participants. Patients with diffuse axonal injury had widespread volume reductions and lower fractional anisotropy in the corpus callosum (CC) compared with controls. Furthermore, cognitive processing speed was associated with reductions in white matter volume and fractional anisotropy in the CC. These findings suggest that CC pathology may be a potential surrogate marker of the cognitive deficits in these patients.	[Ubukata, Shiho; Ueda, Keita; Sugihara, Genichi; Yassin, Walid; Murai, Toshiya] Kyoto Univ, Dept Psychiat, Grad Sch Med, Kyoto, Japan; [Aso, Toshihiko; Fukuyama, Hidenao] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Kyoto, Japan		Ubukata, S (corresponding author), Kyoto Univ, Dept Psychiat, Grad Sch Med, Kyoto, Japan.	ubukata@kuhp.kyoto-u.ac.jp	Aso, Toshihiko/C-2798-2018; Yassin, Walid/ABD-4751-2020; Fukuyama, Hidenao/AAI-7118-2020	Aso, Toshihiko/0000-0003-4814-089X; Yassin, Walid/0000-0001-9612-0485	Industrial Disease Clinical Research Grant [150502-02]; Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [23118004]; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K19722, 26461766]; General Insurance Association of Japan; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26461766] Funding Source: KAKEN	This work was supported by an Industrial Disease Clinical Research Grant (150502-02); a Grant-in-Aid for Scientific Research in Innovative Areas (23118004) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Young Scientists B (15K19722) and C (26461766) from the Japan Society for the Promotion of Science; and a research grant from the General Insurance Association of Japan.	Arlinghaus KA, 2011, TXB TRAUMATIC BRAIN, P5; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Forn C, 2013, BRAIN COGNITION, V82, P152, DOI 10.1016/j.bandc.2013.04.003; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; Kurki T, 2014, NEURORADIOLOGY, V56, P833, DOI 10.1007/s00234-014-1410-7; Kuznetsova K.A., 2015, BRAIN STRUCT FUNCT; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuoka K, 2007, JAPANESE ADULT READI; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rypma B, 2009, INTELLIGENCE, V37, P207, DOI 10.1016/j.intell.2008.12.004; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sbardella E, 2015, MULT SCLER; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Sweet LH., 2011, ENCY CLIN NEUROPSYCH, P1317, DOI [10.1007/978-0-387-79948-3_1321, DOI 10.1007/978-0-387-79948-3_1321]; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Winardi W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129796; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	40	12	13	0	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2016	28	2					97	103		10.1176/appi.neuropsych.15070159			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DM0PE	WOS:000376047100011	26569151	Bronze			2022-02-06	
J	Wang, JW; Li, J; Han, L; Guo, SB; Wang, L; Xiong, ZJ; Chen, Z; Chen, W; Liang, J				Wang, Junwen; Li, Jun; Han, Lin; Guo, Songbo; Wang, Lei; Xiong, Zuojun; Chen, Zhi; Chen, Wen; Liang, Jian			Serum tau protein as a potential biomarker in the assessment of traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						tau protein; traumatic brain injury; biomarker; outcome	CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; CSF; PHOSPHORYLATION; HEMORRHAGE; DISORDERS; PROGNOSIS; SEVERITY; ISOFORMS; SCALE	Traumatic brain injury (TBI) is the leading cause of mortality and disabilities among all trauma cases. Following TBI, damage to axons results in tau protein hyperphosphorylation leading to microtubule instability and tau-mediated neurodegeneration. In addition, tau protein is proteolytically cleaved and is able to access the cerebrospinal fluid (CSF) and serum; thus, this protein may serve as a potential biomarker in the diagnosis of injury severity and outcome prediction. Although a limited number of studies have investigated the CSF tau protein levels after TBI, the data are divergent and conflicting, and investigations into the serum tau protein levels have yet to be conducted. Therefore, the present study aimed to examine the serum tau protein levels in the full spectrum of TBI patients on days 0-14 after TBI, using an enzyme-linked immunosorbent assay. The protein levels were compared to the initial Glasgow Coma Score (GCS) and the Extended Glasgow Outcome Scale (GOS-E), which are used to represent the injury severity and patient outcome, respectively. In total, 56 patients, including 20 patients with mild TBI (GCS, 13-15), 19 patients with moderate TBI (GCS, 9-12) and 17 patients with severe TBI (GCS, 3-8), were included in the current study. The outcome was assessed 1 year after the injury and patients were classified into the good outcome (40 cases; GOS-E, 5-8) and poor outcome groups (16 cases; GOS-E, 1-4). The results indicated that serum tau protein levels increased soon after TBI and reached a peak value at similar to 2 days after the injury. The serum t protein levels were significantly higher in the severe TBI group compared with those in the mild and moderate TBI groups (P<0.0001). Univariate analysis indicated that poor outcome was significantly associated with higher serum tau protein levels on day 2 (P<0.0001). A receiver operating characteristic curve demonstrated that a tau protein level of >116.04 pg/ml on day 2 resulted in a 93.75% sensitivity and 92.50% specificity for predicting a poor outcome. Furthermore, a tau protein level of >372.1 pg/ml on day 2 yielded 100% sensitivity and 83.33% specificity for 1 year mortality in the severe TBI group. In conclusion, the present study suggests that serum tau protein may serve as a potential biomarker for evaluating the injury severity and predicting the outcome of TBI patients.	[Wang, Junwen; Li, Jun; Wang, Lei; Xiong, Zuojun; Chen, Zhi; Chen, Wen; Liang, Jian] Huazhong Univ Sci & Technol, Wuhan Cent Hosp, Tongji Med Coll, Dept Neurosurg, 26 Shengli St, Wuhan 430014, Hubei, Peoples R China; [Han, Lin; Guo, Songbo] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430014, Hubei, Peoples R China		Li, J (corresponding author), Huazhong Univ Sci & Technol, Wuhan Cent Hosp, Tongji Med Coll, Dept Neurosurg, 26 Shengli St, Wuhan 430014, Hubei, Peoples R China.	wangcelia2013@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81101620]; Wuhan Health Bureau [WX14B08]	The present study was partially supported by grants from the National Natural Science Foundation of China (grant no. 81101620) and Clinical Project of Wuhan Health Bureau (grant no. WX14B08). Mr. Junwen Wang would like to thank Miss. Shunying Liu (Wuhan Central Hospital) for her great support in this study.	Amadoro G, 2014, J ALZHEIMERS DIS, V42, P211, DOI 10.3233/JAD-140267; BLENNOW K, 1995, ACTA NEUROCHIR, V136, P135, DOI 10.1007/BF01410615; Brain Trauma Foundation, 2000, AM ASS NEUR SURG JOI, P449; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Clarke NA, 2011, INT J GERIATR PSYCH, V26, P1283, DOI 10.1002/gps.2678; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Pedersen AR, 2015, NEUROREHAB NEURAL RE, V29, P299, DOI 10.1177/1545968314545171; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shiihara T, 2014, BRAIN DEV-JPN, V36, P489, DOI 10.1016/j.braindev.2013.06.011; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Takahashi K, 2014, BRAIN DEV-JPN, V36, P670, DOI 10.1016/j.braindev.2013.10.007; TEASDALE G, 1974, LANCET, V2, P81; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016	31	12	15	1	13	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAR	2016	11	3					1147	1151		10.3892/etm.2016.3017			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DC9PV	WOS:000369554400071	26998051	gold, Green Published			2022-02-06	
J	Yang, DS; Kwon, HG; Jang, SH				Yang, Dong Seok; Kwon, Hyeok Gyu; Jang, Sung Ho			Injury of the Thalamocingulate Tract in the Papez Circuit in Patients with Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Thalamocortical Tract; Mild Traumatic Brain Injury; Papez Circuit; Diffusion Tensor Imaging; Memory	DIFFUSION TENSOR TRACTOGRAPHY; THALAMOCORTICAL TRACT; ABNORMALITIES; HEMORRHAGE; FORNIX; MEMORY	The thalamocingulate tract between the anterior thalamic nuclei and the cingulate gyrus is a part of the Papez circuit. Using diffusion tensor tractography, injury of the thalamocingulate tract was investigated in patients with mild traumatic brain injury. Two patients (patient 1: a 58-yr-old woman and patient 2: a 49-yr-old man) with head trauma resulting from a car accident were enrolled. They were classified as mild traumatic brain injury and no specific lesion was observed on brain magnetic resonance imaging. These patients complained of memory impairment after head trauma. The entire Papez circuits, including thalamocingulate tract, fornix, mammillothalamic tract, and cingulum, were reconstructed in both hemispheres except for the left thalamocingulate tract: patient 1, it was thinner and discontinued compared with the right thalamocingulate tract; and patient 2, it was not reconstructed. The injury of the left thalamocingulate tract appeared to be related to the memory impairment in these patients.	[Yang, Dong Seok] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Phys Med & Rehabil, Ulsan 680749, South Korea; [Kwon, Hyeok Gyu; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea.				Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2013R1A1A4A01013178]	Supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (grant no. 2013R1A1A4A01013178).	Concha L, 2005, AM J NEURORADIOL, V26, P2267; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jang SH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005613; Jang SH, 2014, NEUROLOGY, V82, pE178, DOI 10.1212/WNL.0000000000000444; Jang SH, 2013, BRAIN IMAGING BEHAV, V7, P236, DOI 10.1007/s11682-013-9222-7; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kwon HG, 2015, NEURAL REGEN RES, V10, P321, DOI 10.4103/1673-5374.152390; Kwon HG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00366; Kwon HG, 2010, NEUROSCI LETT, V481, P51, DOI 10.1016/j.neulet.2010.06.052; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D, 1981, WECHSLER ADULT INTEL; Williams JM., 1991, MAS MEMORY ASSESSMEN; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145	26	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2016	95	3					E34	E38		10.1097/PHM.0000000000000413			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DE9LJ	WOS:000370958700002	26544855				2022-02-06	
J	Shannon, RJ; van der Heide, S; Carter, EL; Jalloh, I; Menon, DK; Hutchinson, PJ; Carpenter, KLH				Shannon, Richard J.; van der Heide, Susan; Carter, Eleanor L.; Jalloh, Ibrahim; Menon, David K.; Hutchinson, Peter J.; Carpenter, Keri L. H.			Extracellular N-Acetylaspartate in Human Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; microdialysis; N-acetylaspartate; traumatic brain injury (human)	MYELIN LIPID-SYNTHESIS; ACETYL-L-ASPARTATE; CEREBRAL MICRODIALYSIS; VERTEBRATE BRAIN; CANAVAN-DISEASE; NEURONAL DAMAGE; AXONAL INJURY; RAT-BRAIN; SEVERITY; SPECTROSCOPY	N-acetylaspartate (NAA) is an amino acid derivative primarily located in the neurons of the adult brain. The function of NAA is incompletely understood. Decrease in brain tissue NAA is presently considered symptomatic and a potential biomarker of acute and chronic neuropathological conditions. The aim of this study was to use microdialysis to investigate the behavior of extracellular NAA (eNAA) levels after traumatic brain injury (TBI). Sampling for this study was performed using cerebral microdialysis catheters (M Dialysis 71) perfused at 0.3L/min. Extracellular NAA was measured in microdialysates by high-performance liquid chromatography in 30 patients with severe TBI and for comparison, in radiographically normal areas of brain in six non-TBI neurosurgical patients. We established a detailed temporal eNAA profile in eight of the severe TBI patients. Microdialysate concentrations of glucose, lactate, pyruvate, glutamate, and glycerol were measured on an ISCUS clinical microdialysis analyzer. Here, we show that the temporal profile of microdialysate eNAA was characterized by highest levels in the earliest time-points post-injury, followed by a steady decline; beyond 70h post-injury, average levels were 40% lower than those measured in non-TBI patients. There was a significant inverse correlation between concentrations of eNAA and pyruvate; eNAA showed significant positive correlations with glycerol and the lactate/pyruvate (L/P) ratio measured in microdialysates. The results of this on-going study suggest that changes in eNAA after TBI relate to the release of intracellular components, possibly due to neuronal death or injury, as well as to adverse brain energy metabolism.	[Shannon, Richard J.; van der Heide, Susan; Jalloh, Ibrahim; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Menon, David K.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Carter, Eleanor L.; Menon, David K.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England		van der Heide, S (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	sv377@cam.ac.uk		Carpenter, Keri/0000-0001-8236-7727; Hutchinson, Peter/0000-0002-2796-1835	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G1002277, G0600986] Funding Source: UKRI; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, NIHR-RP-R3-12-013] Funding Source: researchfish; Department of HealthEuropean Commission [NIHR-RP-R3-12-013] Funding Source: Medline; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986, G1002277] Funding Source: Medline		Al-Samsam RH, 2000, J NEUROTRAUM, V17, P31, DOI 10.1089/neu.2000.17.31; Alessandri B, 2000, NEUROL RES, V22, P705; Amaral A. I., 2013, FRONT ENDOCRINOL, V4, P1, DOI DOI 10.3389/FEND0.2013.00054; ANDERSON RGW, 1978, CELL, V15, P919, DOI 10.1016/0092-8674(78)90276-3; Ariyannur PS, 2008, BRAIN RES, V1227, P34, DOI 10.1016/j.brainres.2008.06.040; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Bonneville F, 2002, AM J NEURORADIOL, V23, P371; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Davies SEC, 1998, NEUROCHEM RES, V23, P1021, DOI 10.1023/A:1020778832745; Demougeot C, 2003, J CEREBR BLOOD F MET, V23, P482, DOI 10.1097/01.WCB.0000050066.57184.60; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Gotoh M, 1997, J NEUROCHEM, V69, P655; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1994, AM J HUM GENET, V55, P34; Kumar S, 2006, MENT RETARD DEV D R, V12, P157, DOI 10.1002/mrdd.20108; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Miller SL, 1996, NEUROCHEM RES, V21, P615, DOI 10.1007/BF02527761; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Sager TN, 1999, J CEREBR BLOOD F MET, V19, P164, DOI 10.1097/00004647-199902000-00008; Sager TN, 1997, J NEUROCHEM, V68, P675; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; TALLAN HH, 1956, J BIOL CHEM, V219, P257; Tavazzi B, 2000, ANAL BIOCHEM, V277, P104, DOI 10.1006/abio.1999.4386; TAYLOR DL, 1994, J NEUROCHEM, V62, P2349; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; Tyson RL, 1998, NEUROSCI LETT, V251, P181, DOI 10.1016/S0304-3940(98)00527-8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wu WE, 2012, NEUROBIOL AGING, V33, P2440, DOI 10.1016/j.neurobiolaging.2011.12.008	48	12	13	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					319	329		10.1089/neu.2015.3950			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800001	26159566	Green Published, hybrid, Green Submitted			2022-02-06	
J	Caccamo, D; Pisani, LR; Mazzocchetti, P; Ientile, R; Calabresi, P; Pisani, F; Costa, C				Caccamo, D.; Pisani, L. R.; Mazzocchetti, P.; Ientile, R.; Calabresi, P.; Pisani, F.; Costa, C.			Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs	NEUROCHEMICAL RESEARCH			English	Article						AEDs; Neuroprotection; Experimental animal models	HISTONE DEACETYLASE INHIBITION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; IN-VITRO ISCHEMIA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PROTECTS DOPAMINERGIC-NEURONS; CELLULAR STRESS RESPONSES; NEURITIC PLAQUE-FORMATION; TEMPORAL-LOBE EPILEPSY; VALPROIC ACID	Neuroprotection is conceived as one of the potential tool to prevent or slow neuronal death and hence a therapeutic hope to treat neurodegenerative diseases, like Parkinson's and Alzheimer's diseases. Increase of oxidative stress, mitochondrial dysfunction, excitotoxicity, inflammatory changes, iron accumulation, and protein aggregation have been identified as main causes of neuronal death and adopted as targets to test experimentally the putative neuroprotective effects of various classes of drugs. Among these agents, antiepileptic drugs (AEDs), both the old and the newer generations, have shown to exert protective effects in different experimental models. Their mechanism of action is mediated mainly by modulating the activity of sodium, calcium and potassium channels as well as the glutamatergic and GABAergic (gamma-aminobutyric acid) synapses. Neurological pathologies in which a neuroprotective action of AEDs has been demonstrated in specific experimental models include: cerebral ischemia, Parkinson's disease, and Alzheimer's disease. Although the whole of experimental data indicating that neuroprotection can be achieved is remarkable and encouraging, no firm data have been produced in humans so far and, at the present time, neuroprotection still remains a challenge for the future.	[Caccamo, D.; Ientile, R.] Univ Messina, Dept Biomed Sci Dent Sci & Morphofunct Imaging, AOU Policlin G Martino, Messina, Italy; [Pisani, L. R.] IRCCS, Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Mazzocchetti, P.; Calabresi, P.; Costa, C.] Univ Perugia, Dept Med, Neurol Clin, S Maria Misericordia Hosp, I-06156 Perugia, Italy; [Calabresi, P.] IRCCS, Fdn Santa Lucia, Rome, Italy; [Pisani, F.] Univ Messina, Dept Clin & Expt Med, Messina, Italy		Costa, C (corresponding author), Univ Perugia, Dept Med, Neurol Clin, S Maria Misericordia Hosp, I-06156 Perugia, Italy.	cinzia.costa@unipg.it	Costa, Cinzia/K-8485-2016; Ientile, Riccardo/AAL-6349-2020	Costa, Cinzia/0000-0002-4862-4221; mazzocchetti, petra/0000-0003-2445-6443; Calabresi, Paolo/0000-0003-0326-5509			Al-Izki S, 2014, BRAIN, V137, P92, DOI 10.1093/brain/awt324; Alberio T, 2012, FEBS J, V279, P1146, DOI 10.1111/j.1742-4658.2012.08516.x; Amin B, 2012, FITOTERAPIA, V83, P888, DOI 10.1016/j.fitote.2012.03.022; Andaluz N, 2002, NEUROSURG CLIN N AM, V13, P385, DOI 10.1016/S1042-3680(02)00006-2; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Arawaka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089076; Asanuma M, 2008, NEUROSCI RES, V60, P106, DOI 10.1016/j.neures.2007.10.002; Barks JD, 2010, PEDIATR RES, V67, P532, DOI 10.1203/PDR.0b013e3181d4ff4d; Belcastro V, 2011, BRAIN DEV-JPN, V33, P289, DOI 10.1016/j.braindev.2010.06.008; Bialer M, 2002, EPILEPSY RES, V51, P31, DOI 10.1016/S0920-1211(02)00106-7; Biton V, 2007, CLIN NEUROPHARMACOL, V30, P230, DOI 10.1097/01.WNF.0B013E3180413D7D; Black JA, 2008, J NEUROL SCI, V274, P57, DOI 10.1016/j.jns.2008.04.001; Black JA, 2007, ANN NEUROL, V62, P21, DOI 10.1002/ana.21172; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Boku S, 2011, PROG NEURO-PSYCHOPH, V35, P111, DOI 10.1016/j.pnpbp.2010.09.019; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Brown-Croyts LM, 2000, LIFE SCI, V67, P643, DOI 10.1016/S0024-3205(00)00658-5; Calabrese EJ, 2015, BIOGERONTOLOGY, V16, P693, DOI 10.1007/s10522-015-9601-0; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Calabresi P, 2003, EXP NEUROL, V182, P461, DOI 10.1016/S0014-4886(03)00117-1; Calabresi P, 2003, NEUROBIOL DIS, V12, P82, DOI 10.1016/S0969-9961(02)00016-5; Chang RB, 2015, DRUG DES DEV THER, V9, P2179, DOI 10.2147/DDDT.S58470; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; Choudhury ME, 2012, EUR J PHARMACOL, V689, P72, DOI 10.1016/j.ejphar.2012.05.012; Choudhury ME, 2010, J PHARMACOL SCI, V114, P298, DOI 10.1254/jphs.10120FP; Condello S, 2013, NEUROCHEM RES, V38, P2631, DOI 10.1007/s11064-013-1181-2; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Costa C, 2006, STROKE, V37, P1319, DOI 10.1161/01.STR.0000217303.22856.38; Costa C, 2004, STROKE, V35, P596, DOI 10.1161/01.STR.0000113691.32026.06; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; Costa C, 2012, BRAIN, V135, P1884, DOI 10.1093/brain/aws101; Costa C, 2011, NEUROBIOL DIS, V44, P185, DOI [10.1016/j.nbd.2011.06.011, 10.1016/j.nbd.2011.06.015]; Costa C, 2010, EXP NEUROL, V221, P217, DOI 10.1016/j.expneurol.2009.11.002; Cuomo O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080852; Czapinski P, 2005, CURR TOP MED CHEM, V5, P3, DOI 10.2174/1568026053386962; Czuczwar SJ, 2002, EPILEPSY RES, V52, P15, DOI 10.1016/S0920-1211(02)00181-X; Das A, 2010, NEUROCHEM RES, V35, P2175, DOI 10.1007/s11064-010-0321-1; Descalzi G, 2015, TRENDS NEUROSCI, V38, P237, DOI 10.1016/j.tins.2015.02.001; Diaz-Ruiz A, 2013, NEUROCHEM RES, V38, P1819, DOI 10.1007/s11064-013-1087-z; Eikermann-Haerter K, 2015, STROKE, V46, P229, DOI 10.1161/STROKEAHA.114.006982; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; Follett PL, 2004, J NEUROSCI, V24, P4412, DOI 10.1523/JNEUROSCI.0477-04.2004; Fraser CM, 1999, EPILEPTIC DISORD, V1, P153; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gomez CD, 2014, J NEUROCHEM, V130, P770, DOI 10.1111/jnc.12784; Graham SM, 2004, COMPARATIVE MED, V54, P486; Grover ND, 2013, INDIAN J PHARMACOL, V45, P547, DOI 10.4103/0253-7613.121266; Gubellini P, 2015, REV NEUROL-FRANCE, V171, P750, DOI 10.1016/j.neurol.2015.07.011; Hahm TS, 2009, J KOREAN MED SCI, V24, P146, DOI 10.3346/jkms.2009.24.1.146; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Halonen T, 1996, EUR J PHARMACOL, V299, P69, DOI 10.1016/0014-2999(95)00835-7; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; HAYAKAWA T, 1994, EUR J PHARMACOL, V257, P131; Hayden MR, 2005, DRUG DISCOV TODAY, V4, P291; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hu JP, 2011, BRAIN RES BULL, V85, P194, DOI 10.1016/j.brainresbull.2011.03.006; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; Katsuno M, 2012, J NEUROL NEUROSUR PS, V83, P329, DOI 10.1136/jnnp-2011-301307; Kawajiri S, 2010, NEUROSCI LETT, V481, P88, DOI 10.1016/j.neulet.2010.06.058; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Komur M, 2014, CHILD NERV SYST, V30, P1001, DOI 10.1007/s00381-014-2375-x; Kondziella D, 2011, NEUROREPORT, V22, P97, DOI 10.1097/WNR.0b013e328342d2fa; Kovacs G, 2014, EUR MED J NEUROL, V1, P78; Kumar P, 2012, EUR J PHARMACOL, V674, P265, DOI 10.1016/j.ejphar.2011.11.030; Kwon KJ, 2013, NEUROCHEM INT, V62, P240, DOI 10.1016/j.neuint.2012.12.019; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Leng Y, 2013, INT J NEUROPSYCHOPH, V16, P607, DOI 10.1017/S1461145712000429; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Li YL, 2013, INT J NEUROSCI, V123, P823, DOI 10.3109/00207454.2013.804821; Lo AC, 2002, NEUROREPORT, V13, P1909, DOI 10.1097/00001756-200210280-00015; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Long ZM, 2013, CURR ALZHEIMER RES, V10, P261, DOI 10.2174/1567205011310030005; Maragakis NJ, 2003, NEUROSCI LETT, V338, P107, DOI 10.1016/S0304-3940(02)01386-1; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Markowitz GJ, 2011, EPILEPSY RES, V94, P138, DOI 10.1016/j.eplepsyres.2011.01.002; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Minato H, 1997, EPILEPSIA, V38, P975, DOI 10.1111/j.1528-1157.1997.tb01479.x; Murata M, 2007, NEUROLOGY, V68, P45, DOI 10.1212/01.wnl.0000250236.75053.16; NEY GC, 1994, ARCH NEUROL-CHICAGO, V51, P767, DOI 10.1001/archneur.1994.00540200043014; Noda Y, 1999, RES COMMUN MOL PATH, V105, P23; Noe FM, 2013, NEUROBIOL DIS, V59, P183, DOI 10.1016/j.nbd.2013.07.015; Noh H, 2014, NEUROSCIENCE, V266, P255, DOI 10.1016/j.neuroscience.2014.02.012; Northington FJ, 2006, ILAR J, V47, P32, DOI 10.1093/ilar.47.1.32; Owen AJ, 1997, BRAIN RES, V770, P115, DOI 10.1016/S0006-8993(97)00789-0; Papazisis G, 2008, INT J NEUROPSYCHOPH, V11, P321, DOI 10.1017/S1461145707008012; Pappalardo A, 2004, Clin Ter, V155, P75; Park HJ, 2013, J MOL NEUROSCI, V49, P172, DOI 10.1007/s12031-012-9854-x; Park SW, 2015, BIPOLAR DISORD, V17, P278, DOI 10.1111/bdi.12262; Peng GS, 2005, MOL BRAIN RES, V134, P162, DOI 10.1016/j.molbrainres.2004.10.021; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Pisani A, 2004, EPILEPSIA, V45, P719, DOI 10.1111/j.0013-9580.2004.02204.x; PISANI A, 1995, BRIT J PHARMACOL, V116, P2053, DOI 10.1111/j.1476-5381.1995.tb16411.x; Pisani F, 2001, EXP NEUROL, V170, P162, DOI 10.1006/exnr.2001.7681; Pisani F, 2006, EXP BRAIN RES, V171, P511, DOI 10.1007/s00221-005-0298-1; Pitkanen A, 2002, NEUROLOGY, V59, pS27, DOI 10.1212/WNL.59.9_suppl_5.S27; Pitkanen A, 2002, EPILEPSY RES, V50, P141, DOI 10.1016/S0920-1211(02)00076-1; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Qian YR, 2010, KOREAN J PHYSIOL PHA, V14, P435, DOI 10.4196/kjpp.2010.14.6.435; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Reijs R, 2004, EPILEPSY BEHAV, V5, pS66, DOI 10.1016/j.yebeh.2003.11.009; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Rigoulot MA, 2004, J PHARMACOL EXP THER, V308, P787, DOI 10.1124/jpet.103.057091; Sano H, 2015, J NEUROCHEM, V134, P371, DOI 10.1111/jnc.13116; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Seckin H, 2008, SURG NEUROL, V70, P344, DOI 10.1016/j.surneu.2007.07.052; Sendrowski K, 2015, PHARMACOL REP, V67, P326, DOI 10.1016/j.pharep.2014.09.013; Shao L, 2005, BIOL PSYCHIAT, V58, P879, DOI 10.1016/j.biopsych.2005.04.052; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Sonsalla PK, 2010, EXP NEUROL, V221, P329, DOI 10.1016/j.expneurol.2009.11.018; Stepien K, 2005, PHARMACOL REP, V57, P719; Tasca CI, 2015, METHODS MOL BIOL, V1254, P197, DOI 10.1007/978-1-4939-2152-2_15; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Topcu Y, 2014, NEUROL SCI, V35, P1769, DOI 10.1007/s10072-014-1834-1; Tortiglione A, 2007, STROKE, V38, P1614, DOI 10.1161/STROKEAHA.106.478644; Trojnar MK, 2002, POL J PHARMACOL, V54, P557; Tsai LK, 2011, STROKE, V42, P2932, DOI 10.1161/STROKEAHA.110.612788; Tsujii S, 2015, EUR J PHARMACOL, V746, P301, DOI 10.1016/j.ejphar.2014.09.023; Vizuete ML, 1997, J NEUROSCI RES, V49, P301, DOI 10.1002/(SICI)1097-4547(19970801)49:3<301::AID-JNR5>3.0.CO;2-G; Wakita M, 2014, J PHARMACOL EXP THER, V348, P246, DOI 10.1124/jpet.113.208751; Wallis RA, 1995, EUR J PHARMACOL, V294, P475, DOI 10.1016/0014-2999(95)00568-4; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wang Z, 2014, CNS NEUROSCI THER, V20, P209, DOI 10.1111/cns.12186; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; WIARD RP, 1995, STROKE, V26, P466, DOI 10.1161/01.STR.26.3.466; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xuan AG, 2015, MOL NEUROBIOL, V51, P300, DOI 10.1007/s12035-014-8751-4; Yao ZG, 2014, CELL MOL NEUROBIOL, V34, P805, DOI 10.1007/s10571-013-0012-y; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Yokoyama H, 2010, METAB BRAIN DIS, V25, P135, DOI 10.1007/s11011-010-9191-0; Yurekli VA, 2013, CELL MOL NEUROBIOL, V33, P205, DOI 10.1007/s10571-012-9886-3; Zadori D, 2012, J NEUROL SCI, V322, P187, DOI 10.1016/j.jns.2012.06.004; Zadori D, 2009, PHARMACOL BIOCHEM BE, V94, P148, DOI 10.1016/j.pbb.2009.08.001; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	145	12	12	0	10	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	FEB	2016	41	1-2			SI		340	352		10.1007/s11064-015-1809-5			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DF5SO	WOS:000371412800033	26721507				2022-02-06	
J	Honeybul, S; Janzen, C; Kruger, K; Ho, KM				Honeybul, Stephen; Janzen, Courtney; Kruger, Kate; Ho, Kwok M.			The Incidence of Neurologic Susceptibility to a Skull Defect	WORLD NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Syndrome of trephined	TRAUMATIC BRAIN-INJURY; COGNITIVE STATUS EXAMINATION; DECOMPRESSIVE CRANIECTOMY; CRANIOPLASTY; REHABILITATION; COMPLICATIONS; IMPROVEMENT; SERIES; BONE	OBJECTIVE: To determine whether there is a measureable change in neurologic function after cranioplasty. METHODS: This is a prospective single-surgeon, single-center study. Fifty patients who required a cranioplasty procedure were assessed neurologically within 72 hours before and 7 days after surgery. The assessment tools were the Functional Independence Measure (FIM) and the Cognitive assessment report (Cognistat). The scores for both assessments were calculated and then compared before and after surgery. RESULTS: FIM assessment was performed on all fifty patients, and a Cognistat assessment was performed on 47 patients. Most improvements were seen in the Cognistat scores; however, there appeared to be no specific areas in which there was consistent improvement. There were substantial improvements in the Cognistat assessment in 9 patients. One patient had a much-improved FIM assessment (improved from 18 to 34), but a Cognistat assessment was not possible because of poor neurologic function. These results suggested that improvements after cranioplasty were more likely to occur in the domain of cognitive function than motor function, although overall these results did not reach statistically significance. Bifrontal (vs. unilateral) cranioplasty, timing between decompression and cranioplasty, and age of the patients did not appear to affect the postoperative FIM scores, after we adjusted for preoperative FIM scores and surgical complications. CONCLUSIONS: A small but significant number of patients appear to improve clinically after cranioplasty. Neurologic susceptibility to a skull defect may be more common than had been appreciated previously.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; [Janzen, Courtney; Kruger, Kate] Sir Charles Gairdner Hosp, Dept Occupat Therapy, Nedlands, WA 6009, Australia; [Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA 6001, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Chalouhi N, 2012, NEUROLOGIST, V18, P423, DOI 10.1097/NRL.0b013e318272f7be; Corallo F, 2014, FUNCT NEUROL, V29, P273, DOI 10.11138/FNeur/2014.29.4.273; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Dickson HG, 1995, SCAND J REHABIL MED, V27, P253; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; Doninger NA, 2006, REHABIL PSYCHOL, V51, P281, DOI 10.1037/0090-5550.51.4.281; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Granthan E, 1947, J NEUROSURG, V5, P19; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul Stephen, 2014, Surg Neurol Int, V5, P83, DOI 10.4103/2152-7806.133886; Honeybul S, 2013, BRAIN INJURY, V27, P1732, DOI 10.3109/02699052.2013.830194; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Krishnan P, 2015, J NEUROSCI RURAL PRA, V6, P225, DOI 10.4103/0976-3147.150281; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	30	12	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2016	86						147	152		10.1016/j.wneu.2015.09.081			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD0QU	WOS:000369625300044	26433098	Green Published			2022-02-06	
J	Mehos, CJ; Nelson, LH; Saldanha, CJ				Mehos, C. J.; Nelson, L. H.; Saldanha, C. J.			A Quantification of the Injury-Induced Changes in Central Aromatase, Oestrogenic Milieu and Steroid Receptor Expression in the Zebra Finch	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						traumatic brain injury; aromatisation; steroid receptor; neuroprotection	TRAUMATIC BRAIN-INJURY; TAENIOPYGIA-GUTTATA; SONGBIRD BRAIN; GLIAL AROMATIZATION; GROWTH-FACTOR; SEXUAL-DIFFERENTIATION; MESSENGER-RNA; NEURAL INJURY; UP-REGULATION; ADULT-RATS	In songbirds and mammals, brain injury results in the up-regulation of aromatase (oestrogen synthase) expression in astroglia. The resulting presumed synthesis of neural oestradiol (E-2) has neuroprotective effects including a decrease in neurodegeneration, neuroinflammation and apoptosis. The development of therapeutic tools that exploit oestrogenic neuroprotection in the treatment of neurotrauma requires a precise quantification of the endogenous changes in neural aromatase and E-2 following brain injury. Surprisingly, the expected increase in neural oestrogens following brain injury has not been demonstrated. Furthermore, we are just beginning to unravel the mechanisms behind the protective effects of centrally synthesised E-2. In the present study, levels of aromatase immunoprotein, neural E-2 and steroid receptor mRNA were quantified in adult male and female zebra finches 48h following a unilateral penetrating brain injury. Both aromatase and E-2 were up-regulated in the injured hemisphere of the brain compared to the uninjured hemisphere, demonstrating for the first time a robust increase in neural E-2 levels following injury. We did not detect an effect of injury on mRNA expression of the oestrogen receptors (ER)-, ER- or GPER-1, but observed a significant decrease in androgen receptor transcription in the injured lobe relative to the contralateral uninjured hemisphere. We conclude that mechanical damage causes a dramatic increase in local aromatisation, and the resultant high levels of central E-2 are available to modulate steroid sensitive targets. Studies using alternate methods of receptor detection and/or time points may be necessary to understand the complete suite of mechanisms underlying the neuroprotective effects of induced oestrogen synthesis in this animal model.	[Saldanha, C. J.] Amer Univ, Dept Biol, 4400 Massachusetts Ave NW, Washington, DC 20016 USA; Amer Univ, Ctr Behav Neurosci, 4400 Massachusetts Ave NW, Washington, DC 20016 USA		Saldanha, CJ (corresponding author), Amer Univ, Dept Biol, 4400 Massachusetts Ave NW, Washington, DC 20016 USA.	saldanha@american.edu		Saldanha, Colin/0000-0003-4034-6877; Nelson, Lars/0000-0003-1143-8596	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [042767, 080585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042767, R21NS080585] Funding Source: NIH RePORTER	We thank Benjamin Kussin-Shoptaw for excellent technical assistance. This work was supported by NIH 042767 and 080585 to CJS. No competing financial interests exist.	Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Balthazart J, 1996, J NEUROBIOL, V31, P129, DOI 10.1002/(SICI)1097-4695(199610)31:2<129::AID-NEU1>3.3.CO;2-2; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Buchanan CD, 2000, BIOL REPROD, V62, P1710, DOI 10.1095/biolreprod62.6.1710; Chao A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00057; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; DUENAS M, 1994, NEUROENDOCRINOLOGY, V59, P528, DOI 10.1159/000126702; Duncan KA, 2013, J NEUROTRAUM, V30, P1919, DOI 10.1089/neu.2013.2951; Duncan KA, 2013, HORM BEHAV, V63, P208, DOI 10.1016/j.yhbeh.2012.02.026; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Flores C, 1999, J NEUROSCI, V19, P8665; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 2003, PROG NEUROBIOL, V71, P31, DOI 10.1016/j.pneurobio.2003.09.005; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Lee DW, 2007, DEV NEUROBIOL, V67, P1107, DOI 10.1002/dneu.20399; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; Newman AEM, 2008, GEN COMP ENDOCR, V155, P503, DOI 10.1016/j.ygcen.2007.08.007; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Pradhan DS, 2008, J NEUROCHEM, V104, P244, DOI 10.1111/j.1471-4159.2007.04953.x; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Remage-Healey L, 2009, J NEUROENDOCRINOL, V21, P191, DOI 10.1111/j.1365-2826.2009.01820.x; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Remage-Healey L, 2011, J NEUROSCI, V31, P10034, DOI 10.1523/JNEUROSCI.0566-11.2011; Rohmann KN, 2007, DEV NEUROBIOL, V67, P1, DOI 10.1002/dneu.20303; Saldanha CJ, 2013, J NEUROENDOCRINOL, V25, P1032, DOI 10.1111/jne.12067; Saldanha CJ, 1997, GEN COMP ENDOCR, V105, P390, DOI 10.1006/gcen.1996.6841; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saldanha CJ, 2005, J NEUROBIOL, V64, P192, DOI 10.1002/neu.20147; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Schlinger BA, 1997, BRAIN RES BULL, V44, P359, DOI 10.1016/S0361-9230(97)00215-3; SCHLINGER BA, 1994, J NEUROSCI, V14, P7541; Schlinger BA, 2008, NEUROCHEM INT, V52, P611, DOI 10.1016/j.neuint.2007.05.003; SCHUMACHER M, 1984, HORM BEHAV, V18, P298, DOI 10.1016/0018-506X(84)90018-7; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; SHEN P, 1994, MOL BRAIN RES, V24, P227, DOI 10.1016/0169-328X(94)90136-8; Soma KK, 2004, ENDOCRINOLOGY, V145, P1668, DOI 10.1210/en.2003-0883; Walters BJ, 2008, J NEUROCHEM, V106, P216, DOI 10.1111/j.1471-4159.2008.05352.x; Walters BJ, 2011, DEV NEUROBIOL, V71, P170, DOI 10.1002/dneu.20839; Wynne RD, 2004, J NEUROENDOCRINOL, V16, P676, DOI 10.1111/j.1365-2826.2004.01217.x; Wynne RD, 2008, GLIA, V56, P97, DOI 10.1002/glia.20594; Zheng JB, 1999, J STEROID BIOCHEM, V68, P65, DOI 10.1016/S0960-0760(98)00161-7	49	12	13	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	FEB	2016	28	2								10.1111/jne.12348			8	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	DF5ZS	WOS:000371434100005	26661058				2022-02-06	
J	Peng, SP; Li, YN; Liu, J; Wang, ZY; Zhang, ZS; Zhou, SK; Tao, FX; Zhang, ZX				Peng, Shu-ping; Li, Yi-ning; Liu, Jun; Wang, Zhi-yuan; Zhang, Zi-shu; Zhou, Shun-ke; Tao, Fang-xu; Zhang, Zhi-xue			Pulsed arterial spin labeling effectively and dynamically observes changes in cerebral blood flow after mild traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; MRI; pulsed arterial spin labeling technique; cerebral blood flow; mild traumatic brain injury; Glasgow Coma Scale; white matter; gray matter; CT; neural regeneration	MRI; CONNECTIVITY	Cerebral blood flow is strongly associated with brain function, and is the main symptom and diagnostic basis for a variety of encephalopathies. However, changes in cerebral blood flow after mild traumatic brain injury remain poorly understood. This study sought to observe changes in cerebral blood flow in different regions after mild traumatic brain injury using pulsed arterial spin labeling. Our results demonstrate maximal cerebral blood flow in gray matter and minimal in the white matter of patients with mild traumatic brain injury. At the acute and subacute stages, cerebral blood flow was reduced in the occipital lobe, parietal lobe, central region, subcutaneous region, and frontal lobe. Cerebral blood flow was restored at the chronic stage. At the acute, subacute, and chronic stages, changes in cerebral blood flow were not apparent in the insula. Cerebral blood flow in the temporal lobe and limbic lobe diminished at the acute and subacute stages, but was restored at the chronic stage. These findings suggest that pulsed arterial spin labeling can precisely measure cerebral blood flow in various brain regions, and may play a reference role in evaluating a patients condition and judging prognosis after traumatic brain injury.	[Peng, Shu-ping; Li, Yi-ning; Liu, Jun; Zhang, Zi-shu; Zhou, Shun-ke; Tao, Fang-xu; Zhang, Zhi-xue] Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China; [Wang, Zhi-yuan] Hunan Canc Hosp, Changsha, Hunan, Peoples R China		Liu, J (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Radiol, Changsha, Hunan, Peoples R China.	2322349829@qq.com	liu, jun/AAW-9645-2020	liu, jun/0000-0002-0344-4745; Liu, Jun/0000-0002-2900-0915			Aquino C, 2015, EMERG RADIOL, V22, P65, DOI 10.1007/s10140-014-1226-0; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Grade M, 2015, NEURORADIOLOGY, V57, P1181, DOI 10.1007/s00234-015-1571-z; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Liu J, 2016, J NEUROTRAUM, V33, P10, DOI 10.1089/neu.2014.3856; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ott R, 1994, FUNCT IM IEE C; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith Katherine, 2012, Nat Rev Neurol, V8, P474, DOI 10.1038/nrneurol.2012.164; Toth A., 2015, BRAIN NEUROTRAUMA MO; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403	21	12	12	1	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2016	11	2					257	261		10.4103/1673-5374.177733			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DI0XZ	WOS:000373221900026	27073378	gold, Green Published			2022-02-06	
J	Ramsamy, Y; Muckart, DJJ; Bruce, JL; Hardcastle, TC; Han, KSS; Mlisana, KP				Ramsamy, Y.; Muckart, D. J. J.; Bruce, J. L.; Hardcastle, T. C.; Han, K. S. S.; Mlisana, K. P.			Empirical antimicrobial therapy for probable v. directed therapy for possible ventilator-associated pneumonia in critically injured patients	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							INTENSIVE-CARE-UNIT; SURVEILLANCE; INFECTION; OUTCOMES; SEPSIS	Background. Ventilator-associated pneumonia (VAP) has recently been classified as possible or probable. Although direct attributable mortality has been difficult to prove, delay in instituting appropriate therapy has been reported to increase morbidity and mortality. Recent literature suggests that in possible VAP, instituting directed therapy while awaiting microbiological culture does not prejudice outcome compared with best-guess empirical therapy. Objectives. To ascertain outcomes of directed v. empirical therapy in possible and probable VAP, respectively. Methods. Endotracheal aspirates were obtained from patients with suspected VAR Those considered to have possible VAP were given directed therapy following culture results, whereas patients with more convincing evidence of VAP were classed as having probable VAP and commenced on empirical antimicrobials based on microbiological surveillance. Results. Pneumonia was suspected in 106 (36.8%) of 288 patients admitted during January - December 2014. Of these, 13 did not, fulfil the criteria for VAR Of the remaining 93 (32.2%), 31 (33.3%) were considered to have probable and 62 (66.7%) possible VAP. The former were commenced on empirical antimicrobials, with 28 (90.3%) receiving appropriate therapy. Of those with possible VAR 34 (54.8%) were given directed therapy and in 28 (45.2%) no antimicrobials were prescribed. Of the latter, 24 recovered without antimicrobials and 4 died, 3 from severe traumatic brain injury and due to overwhelming intra-abdominal sepsis. No death was directly attributable to failure to treat VAR. No significant difference in mortality was found between the 34 patients with possible VAP who were commenced on directed therapy and the 31 with probable VAP who were commenced on empirical antimicrobials (p=0.75). Conclusions. Delaying antimicrobial therapy for VAP where clinical doubt exists does not adversely affect outcome. Furthermore, this policy limits the use of antimicrobials in patients with possible VAP following improvement in their clinical condition despite no-therapy.	[Ramsamy, Y.; Bruce, J. L.] Prince Mshiyeni Mem Hosp, Dept Med Microbiol, Durban, South Africa; [Ramsamy, Y.; Han, K. S. S.; Mlisana, K. P.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Sch Lab Med & Med Sci,Dept Med Microbiol, Durban, South Africa; [Muckart, D. J. J.; Bruce, J. L.; Hardcastle, T. C.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Dept Surg, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Durban, South Africa; Pietermaritzburg Trauma Serv, Kwa Zulu, South Africa; [Ramsamy, Y.; Han, K. S. S.; Mlisana, K. P.] Natl Hlth Lab Serv, KZN Acad Complex, Durban, South Africa		Ramsamy, Y (corresponding author), Prince Mshiyeni Mem Hosp, Dept Med Microbiol, Durban, South Africa.; Ramsamy, Y (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Coll Hlth Sci, Sch Lab Med & Med Sci,Dept Med Microbiol, Durban, South Africa.; Ramsamy, Y (corresponding author), Natl Hlth Lab Serv, KZN Acad Complex, Durban, South Africa.	yogandree@gmail.com	; Mlisana, Koleka/N-6204-2013	SWE SWE HAN, KHINE/0000-0002-4574-6258; Hardcastle, Timothy/0000-0002-3967-0234; Mlisana, Koleka/0000-0002-8436-3268			[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; [Anonymous], BBC NEWS HLTH; Bhagwanjee S, 1997, BRIT MED J, V314, P1077, DOI 10.1136/bmj.314.7087.1077a; Borgatta B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-211; Cook A, 2010, J TRAUMA, V69, P1083, DOI 10.1097/TA.0b013e3181f9fb51; Cusini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014011; de Groot B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0936-3; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Gastmeier P, 2009, ANTIMICROB AGENTS CH, V53, P2714, DOI 10.1128/AAC.01070-08; Hranjec Tjasa, 2013, Curr Opin Crit Care, V19, P461, DOI 10.1097/MCC.0b013e328364d525; Kale R, 1997, BRIT MED J, V314, P1081, DOI 10.1136/bmj.314.7087.1081; Kollef MH, 2013, CRIT CARE CLIN, V29, P33, DOI 10.1016/j.ccc.2012.10.004; Kollef MH, 2015, CHEST, V147, P1448, DOI 10.1378/chest.14-2745; Kumar A, 2014, VIRULENCE, V5, P80, DOI 10.4161/viru.26913; Magill SS, 2013, CRIT CARE MED, V41, P2467, DOI 10.1097/CCM.0b013e3182a262db; May AK, 2015, CHEST, V147, P1494, DOI 10.1378/chest.14-1687; McMillian WD, 2010, J TRAUMA, V69, P861, DOI 10.1097/TA.0b013e3181e83f8b; Munro N, 2014, AACN ADV CRIT CARE, V25, P163, DOI 10.1097/NCI.0000000000000019; National Health Laboratory Service, 2010, Q PULS STAND OP PROC; PCAST, 2014, REP PRES COMB ANT RE; Ramsamy Y, 2013, SAMJ S AFR MED J, V103, P371, DOI [10.7196/SAMJ.6459, 10.7196/samj.6459]; Simonetti A, 2012, CLIN MICROBIOL INFEC, V18, P1149, DOI 10.1111/j.1469-0691.2011.03709.x; Swanson JM, 2013, ANTIBIOTICS-BASEL, V2, P339, DOI 10.3390/antibiotics2030339; WHO, 2014, ANT RES GLOB REP SUR	24	12	13	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	FEB	2016	106	2					196	200		10.7196/SAMJ.2016.v106i2.9870			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3IJ	WOS:000374810000026	26821903	gold			2022-02-06	
J	Sebastiani, A; Granold, M; Ditter, A; Sebastiani, P; Golz, C; Pottker, B; Luh, C; Schaible, EV; Radyushkin, K; Timaru-Kast, R; Werner, C; Schafer, MK; Engelhard, K; Moosmann, B; Thal, SC				Sebastiani, Anne; Granold, Matthias; Ditter, Anja; Sebastiani, Philipp; Goelz, Christina; Poettker, Bruno; Luh, Clara; Schaible, Eva-Verena; Radyushkin, Konstantin; Timaru-Kast, Ralph; Werner, Christian; Schaefer, Michael K.; Engelhard, Kristin; Moosmann, Bernd; Thal, Serge C.			Posttraumatic Propofol Neurotoxicity Is Mediated via the Pro-Brain-Derived Neurotrophic Factor-p75 Neurotrophin Receptor Pathway in Adult Mice	CRITICAL CARE MEDICINE			English	Article						anesthesia; BDNF; brain-derived neurotrophic factor; gamma-aminobutyric acid; GABA(A); nerve growth factor receptor; neurotoxicity; neurotrophin; p75NTR; p75 neurotrophin receptor; proBDNF; proneurotrophin; propofol; TAT-Pep5; traumatic brain injury	NEURONAL CELL-DEATH; SPECTRIN BREAKDOWN PRODUCTS; DEVELOPING RAT-BRAIN; GENERAL-ANESTHESIA; CEREBRAL-ISCHEMIA; INJURED NEURONS; NERVOUS-SYSTEM; P75(NTR); INHIBITION; NEUROPROTECTION	Objectives: The gamma-aminobutyric acid modulator propofol induces neuronal cell death in healthy immature brains by unbalancing neurotrophin homeostasis via p75 neurotrophin receptor signaling. In adulthood, p75 neurotrophin receptor becomes down-regulated and propofol loses its neurotoxic effect. However, acute brain lesions, such as traumatic brain injury, reactivate developmental-like programs and increase p75 neurotrophin receptor expression, probably to foster reparative processes, which in turn could render the brain sensitive to propofol-mediated neurotoxicity. This study investigates the influence of delayed single-bolus propofol applications at the peak of p75 neurotrophin receptor expression after experimental traumatic brain injury in adult mice. Design: Randomized laboratory animal study. Setting: University research laboratory. Subjects: Adult C57BL/6N and nerve growth factor receptor-deficient mice. Interventions: Sedation by IV propofol bolus application delayed after controlled cortical impact injury. Measurements and Main Results: Propofol sedation at 24 hours after traumatic brain injury increased lesion volume, enhanced calpain-induced II-spectrin cleavage, and increased cell death in perilesional tissue. Thirty-day postinjury motor function determined by CatWalk (Noldus Information Technology, Wageningen, The Netherlands) gait analysis was significantly impaired in propofol-sedated animals. Propofol enhanced pro-brain-derived neurotrophic factor/brain-derived neurotrophic factor ratio, which aggravates p75 neurotrophin receptor-mediated cell death. Propofol toxicity was abolished both by pharmacologic inhibition of the cell death domain of the p75 neurotrophin receptor (TAT-Pep5) and in mice lacking the extracellular neurotrophin binding site of p75 neurotrophin receptor. Conclusions: This study provides first evidence that propofol sedation after acute brain lesions can have a deleterious impact and implicates a role for the pro-brain-derived neurotrophic factor-p75 neurotrophin receptor pathway. This observation is important as sedation with propofol and other compounds with GABA receptor activity are frequently used in patients with acute brain pathologies to facilitate sedation or surgical and interventional procedures.	[Sebastiani, Anne; Ditter, Anja; Sebastiani, Philipp; Goelz, Christina; Poettker, Bruno; Luh, Clara; Schaible, Eva-Verena; Timaru-Kast, Ralph; Werner, Christian; Schaefer, Michael K.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55122 Mainz, Germany; [Granold, Matthias; Moosmann, Bernd] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55122 Mainz, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mouse Behav Outcome Unit, Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany; [Schaefer, Michael K.; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, D-55122 Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55122 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	Collaborative Research Center - German Research Foundation (DFG)German Research Foundation (DFG) [1080]; Johannes Gutenberg-University; DFGGerman Research Foundation (DFG)European Commission [TH1430/3-1]; Federal Ministry of Education and Research (BMBF)Federal Ministry of Education & Research (BMBF) [01EO1003]; DFGGerman Research Foundation (DFG)European Commission	Drs. Sebastiani, Schafer, Engelhard, and Thal were supported by the Collaborative Research Center 1080 funded by the German Research Foundation (DFG). Drs. Sebastiani and Thal were supported by Stage 1 funding of the Johannes Gutenberg-University. Dr. Engelhard lectured for AbbVie and Fresenius Kabi and she received support for research from the DFG. Dr. Thal was supported by the Federal Ministry of Education and Research (BMBF 01EO1003) and by the DFG (TH1430/3-1). Dr. Thal's institution received grant support from the DFG. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Brambrink AM, 2012, ANESTHESIOLOGY, V116, P372, DOI 10.1097/ALN.0b013e318242b2cd; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008; Cui DR, 2013, NEUROSCIENCE, V246, P117, DOI 10.1016/j.neuroscience.2013.04.054; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; FLOWER O, 2012, EMERG MED INT, V2012, DOI DOI 10.1155/2012/637171; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Hung PL, 2013, STROKE, V44, P2275, DOI 10.1161/STROKEAHA.113.001552; Jevtovic-Todorovic V, 2013, MOL NEUROBIOL, V48, P288, DOI 10.1007/s12035-013-8488-5; Karmarkar SW, 2010, COMPARATIVE MED, V60, P256; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Milanovic D, 2010, DEV NEUROSCI-BASEL, V32, P288, DOI 10.1159/000316970; Mintz CD, 2013, ANESTHESIOLOGY, V118, P825, DOI 10.1097/ALN.0b013e318287b850; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pariat M, 2000, BIOCHEM J, V345, P129, DOI 10.1042/0264-6021:3450129; Park JA, 2000, J NEUROSCI, V20, P9096; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Pesic V, 2009, INT J DEV NEUROSCI, V27, P279, DOI 10.1016/j.ijdevneu.2008.12.005; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Popic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034396; RONAN KP, 1995, CRIT CARE MED, V23, P286, DOI 10.1097/00003246-199502000-00014; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Shulga A, 2013, NEUROSCIENCE, V239, P241, DOI 10.1016/j.neuroscience.2012.12.007; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; Wang HY, 2011, J NEUROCHEM, V119, P210, DOI 10.1111/j.1471-4159.2011.07400.x; Wei HF, 2011, ANESTH ANALG, V113, P972, DOI 10.1213/ANE.0b013e3182323261; Wise-Faberowski L, 2005, ANESTH ANALG, V101, P651, DOI 10.1213/01.ane.0000167382.79889.7c; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zheng H, 2013, ANESTHESIOLOGY, V118, P516, DOI 10.1097/ALN.0b013e3182834d5d; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	60	12	14	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2016	44	2					E70	E82		10.1097/CCM.0000000000001284			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB4SR	WOS:000368504000002	26317567				2022-02-06	
J	Toor, GK; Harris, JE; Escobar, M; Yoshida, K; Velikonja, D; Rizoli, S; Cusimano, M; Cullen, N; Sokoloff, S; Colantonio, A				Toor, Gurjit K.; Harris, Jocelyn E.; Escobar, Michael; Yoshida, Karen; Velikonja, Diana; Rizoli, Sandro; Cusimano, Michael; Cullen, Nora; Sokoloff, Sandra; Colantonio, Angela			Long-Term Health Service Outcomes Among Women With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Community health services; Rehabilitation Women	GENDER-DIFFERENCES; CARE ACCESS; PRECARIOUS EMPLOYMENT; PATIENT SATISFACTION; POPULATION; MODERATE; SEX; HOSPITALIZATION; EPIDEMIOLOGY; DISABILITIES	Objectives: To (1) assess long-term health care service utilization and satisfaction with health care services among women with traumatic brain injury (W-TBI); (2) examine bathers that prevent W-TBI from receiving care when needed; and (3) understand the perceived supports available for W-TBI. Design: Retrospective cohort study. Setting: Community. Participants: W-TBI (n = 105) 5 to 12 years postinjury and women without TBI (n = 105) matched on age, education, and geographic location. Interventions: Not applicable. Main Outcome Measures: Pre- and postinjury data were collected using a questionnaire administered via a semistructured interview. Questions on health services utilization, satisfaction with and quality of services, barriers to receiving care, and perceived social support were from the Canadian Community Health Survey; additional questions on perceived social support were from another large-scale study of people with moderate to severe brain injury. Results: Compared with women without TBI, W-TBI reported using more family physician and community health services. W-TBI reported that they did not receive care when needed (40%), particularly for emotional/mental health problems. Significantly more W-TBI reported financial and structural barriers. There were no significant differences in reported satisfaction with services between women with and without TBI. Conclusions: Health service providers and policymakers should recognize the long-term health and social needs of W-TBI and address societal factors that result in financial and structural barriers, to ensure access to needed services. (C) 2016 by the American Congress of Rehabilitation Medicine	[Toor, Gurjit K.; Escobar, Michael; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada; [Harris, Jocelyn E.; Cullen, Nora; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Harris, Jocelyn E.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Yoshida, Karen] Univ Toronto, Dept Phys Therapy, Toronto, ON M5G 1V7, Canada; [Velikonja, Diana] Hamilton Hlth Sci, Acquired Brain Injury Program, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Rizoli, Sandro; Cusimano, Michael] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Rizoli, Sandro; Cusimano, Michael] Univ Toronto, Dept Surg, Toronto, ON M5G 1V7, Canada; [Cullen, Nora] West Pk Healthcare Ctr, Toronto, ON, Canada; [Cullen, Nora] Univ Toronto, Dept Med, Div Physiatry, Toronto, ON M5G 1V7, Canada; [Sokoloff, Sandra; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Cusimano, Michael/X-4059-2019; Harris, Jocelyn Ellen/ABE-7420-2021	Harris, Jocelyn Ellen/0000-0002-3293-1833; Cullen, Nora/0000-0001-6359-9418; Colantonio, Angela/0000-0003-2094-4765; Escobar, Michael/0000-0001-9055-4709	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [200903MOP]; Toronto Rehabilitation Institute University Health Network (UHN); Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; CIHR Fellowship AwardCanadian Institutes of Health Research (CIHR); CIHR Strategic Training Fellowship in Health Care, Technology and Place [FRN: STP 53911]; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Saunderson Family Chair at the Toronto Rehabilitation Institute-UHN; Canadian Institutes of Health Research Research Chair in Gender, Work and Health from the Institute of Gender and Health [CGW-126580]	Supported by the Canadian Institutes of Health Research (CIHR) (grant no. 200903MOP); the Toronto Rehabilitation Institute University Health Network (UHN); a grant from the Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute-UHN; a CIHR Fellowship Award and CIHR Strategic Training Fellowship in Health Care, Technology and Place (award no. FRN: STP 53911); a Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (grant no. TIR-103946); the Ontario Neurotrauma Foundation; the Saunderson Family Chair at the Toronto Rehabilitation Institute-UHN; and a Canadian Institutes of Health Research Research Chair in Gender, Work and Health (grant no. CGW-126580) from the Institute of Gender and Health.	Acker J, 2009, SOCIOL TRAV, V51, P199, DOI 10.1016/j.soctra.2009.03.004; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Anderson Roger, 2007, J Med Pract Manage, V22, P255; Batchelor C, 1994, Int J Health Care Qual Assur, V7, P22; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Benoit C, 2009, SOCIOL RES ONLINE, V14, DOI 10.5153/sro.2024; Bierman AS, 2007, CAN MED ASSOC J, V177, P1520, DOI 10.1503/cmaj.071541; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Campbell C, 2013, SOC SCI RES, V42, P1693, DOI 10.1016/j.ssresearch.2013.07.014; Canadian Institutes of Health Research. Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2014, TRI COUN; Carlin CS, 2012, HEALTH SERV RES, V47, P2250, DOI 10.1111/j.1475-6773.2012.01412.x; Carrillo JE, 2011, J HEALTH CARE POOR U, V22, P562, DOI 10.1353/hpu.2011.0037; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carter KN, 2012, AUST NZ J PUBL HEAL, V36, P218, DOI 10.1111/j.1753-6405.2012.00867.x; CFHI, 2013, J HEALTH SERV RES PO, V18, P255, DOI 10.1177/1355819613501426; Clement W, 2009, ROUTL IAFFE ADV FEM, P240; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio Angela, 2010, Healthc Policy, V5, pe120; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cranford CJ, 2003, RELAT IND-IND RELAT, V58, P454, DOI 10.7202/007495ar; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox J. B., 2010, Morbidity and Mortality Weekly Report, V59, P1448; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Fuller S, 2008, SOC INDIC RES, V88, P31, DOI 10.1007/s11205-007-9201-8; Gibson BE, 2012, WOMEN HEALTH ISS, V22, pE111, DOI 10.1016/j.whi.2011.07.011; Gibson J., 2010, SOCIAL CARE NEURODIS, V1, P21, DOI [DOI 10.5042/SCN.2010.0599, DOI 10.1080/09687599627598]; Gill L, 2009, LEADERSH HEALTH SERV, V22, P8, DOI 10.1108/17511870910927994; Haldeman S, 2012, SPINE J, V12, P1138, DOI 10.1016/j.spinee.2012.09.002; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hudak PL, 2003, J CLIN EPIDEMIOL, V56, P103, DOI 10.1016/S0895-4356(02)00602-9; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iezzoni LI, 2001, AM J MED QUAL, V16, P135; Ioannidis JPA, 2013, AM J BIOETHICS, V13, P40, DOI 10.1080/15265161.2013.768864; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Keith RA, 1998, ARCH PHYS MED REHAB, V79, P1122, DOI 10.1016/S0003-9993(98)90182-4; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Liu SY, 2008, J WOMENS HEALTH, V17, P1321, DOI 10.1089/jwh.2007.0591; Lupu I., 2012, CRIT PERSPECT, V23, P351, DOI DOI 10.1016/J.CPA.2012.01.003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; Odette Fran, 2003, Health Care Women Int, V24, P125, DOI 10.1080/07399330390170105; Parekh S, 2011, HYPATIA, V26, P672, DOI 10.1111/j.1527-2001.2010.01159.x; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rothstein MA, 2013, AM J BIOETHICS, V13, P27, DOI 10.1080/15265161.2013.767955; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schoen C, 2009, HEALTH AFFAIR, V28, pW1, DOI 10.1377/hlthaff.28.1.w1; Schopp LH, 2002, J MIDWIFERY WOM HEAL, V47, P74, DOI 10.1016/S1526-9523(02)00216-7; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Shuey KM, 2013, WORK OCCUPATION, V40, P174, DOI 10.1177/0730888413481030; Spenceley SM, 2005, WESTERN J NURS RES, V27, P465, DOI 10.1177/0193945904272384; Statistics Canada, 2004, JOINT CAN US SURV; Statistics Canada. Canadian Community Health Survey (CCHS), QUEST CYCL; Talbot Y, 2001, CAN FAM PHYSICIAN, V47, P58; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; World Economic Forum, 2014, GLOB GEND; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; Young MC, 2010, RELAT IND-IND RELAT, V65, P74	73	12	12	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2		1			S54	S63		10.1016/j.apmr.2015.02.010			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DC4RI	WOS:000369207600008	25707697	Bronze			2022-02-06	
J	Tsushima, WT; Siu, AM; Pearce, AM; Zhang, GX; Oshiro, RS				Tsushima, William T.; Siu, Andrea M.; Pearce, Annina M.; Zhang, Guangxiang; Oshiro, Ross S.			Two-year Test-Retest Reliability of ImPACT in High School Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						ImPACT; Test-retest reliability	AGE-RELATED DIFFERENCES; BASE-LINE; CLINICAL UTILITY; NORMATIVE DATA; CONCUSSION; SPORT; STATEMENT	This research evaluated the 2-year test-retest reliability of the Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) neuropsychological battery, and clarified the need for biennial updated baseline testing of high school athletes. This study compared the baseline test scores of 212 non-concussed athletes that were obtained in Grade 9 and again 2 years later when they were in Grade 11. Regression-based methods indicated that 4 of the 5 ImPACT scores were stable over 2 years, as they fell within the 80% and 95% confidence intervals (CIs). The results suggested that updating baseline testing for high school athletes after 2 years is not necessary. Further research into the consistency of computerized neuropsychological tests over 2 years with high school athletes is recommended.	[Tsushima, William T.] Straub Clin & Hosp, 888 South King St, Honolulu, HI 96813 USA; [Siu, Andrea M.] Hawaii Pacific Hlth, Honolulu, HI USA; [Pearce, Annina M.] Scripps Coll, Claremont, CA 91711 USA; [Zhang, Guangxiang] Univ Hawaii, Honolulu, HI 96822 USA; [Oshiro, Ross S.] Queens Med Ctr, Honolulu, HI USA		Tsushima, WT (corresponding author), Straub Clin & Hosp, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			Hawaii Concussion Awareness and Management Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103466] Funding Source: NIH RePORTER	The authors wish to acknowledge the support of the Hawaii Concussion Awareness and Management Program. The third author, A.M.P., participated in the Hawaii Pacific Health Summer Student Research Program while she assisted in this research project.	Barr William B, 2002, CNS Spectr, V7, P300; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A., 2006, SPORTS NEUROPSYCHOLO, P176; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Slick DJ, 2006, COMPENDIUM NEUROPSYC, P3; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Urbina S, 1997, PSYCHOL TESTING	30	12	12	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2016	31	1					105	111		10.1093/arclin/acv066			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DD8QQ	WOS:000370192400014	26572159	Green Published, Bronze			2022-02-06	
J	Bailie, JM; Kennedy, JE; French, LM; Marshall, K; Prokhorenko, O; Asmussen, S; Reid, MW; Qashu, F; Brickell, TA; Lange, RT				Bailie, Jason M.; Kennedy, Jan E.; French, Louis M.; Marshall, Kathryn; Prokhorenko, Olga; Asmussen, Sarah; Reid, Matthew W.; Qashu, Felicia; Brickell, Tracey A.; Lange, Rael T.			Profile Analysis of the Neurobehavioral and Psychiatric Symptoms Following Combat-Related Mild Traumatic Brain Injury: Identification of Subtypes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cluster analysis; mild traumatic brain injury; military; postconcussive symptoms	POSTTRAUMATIC-STRESS-DISORDER; MILITARY SERVICE MEMBERS; COMPLAINTS	Objective: To explore the taxonomy of combat-related mild traumatic brain injury (mTBI) based on symptom patterns. Participants: Up to 1341 military personnel who experienced a combat-related mTBI within 2 years of evaluation. Measures: Neurobehavioral Symptom Inventory and PTSD Checklist-Civilian Version (PCL-C). Results: Cluster analysis revealed the following 4 subtypes: primarily psychiatric (posttraumatic stress disorder) group, a cognitive group, a mixed symptom group, and a good recovery group. The posttraumatic stress disorder cluster (21.9% of the sample) reported symptoms related to hyperarousal and dissociation/depression with few complaints related to cognition or headaches. The cognitive group (21.5% of the sample) had primarily cognitive and headache complaints with few mood symptoms. The mixed profile cluster included 18.6% of the sample and was characterized by a combination of mood complaints (hyperarousal and dissociation/depression), cognitive complaints, and headaches. The largest cluster (37.8% of the sample) had an overall low symptom profile and was labeled the "good recovery" group. Conclusions: The results support a unique taxonomy for combat-related mTBI. The clinical differences among these subtypes indicate a need for unique treatment resources and programs.	[Bailie, Jason M.; Kennedy, Jan E.; French, Louis M.; Marshall, Kathryn; Prokhorenko, Olga; Asmussen, Sarah; Reid, Matthew W.; Qashu, Felicia; Brickell, Tracey A.; Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [French, Louis M.; Brickell, Tracey A.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Kennedy, Jan E.; Reid, Matthew W.] San Antonio Mil Med Ctr, Dept Neurol, San Antonio, TX USA; [Bailie, Jason M.] Naval Med Ctr San Diego, Dept Phys Med & Rehabil, San Diego, CA 92134 USA; [Asmussen, Sarah] Marine Corps Base Camp Pendleton, Oceanside, CA USA; [Kennedy, Jan E.; Marshall, Kathryn; Prokhorenko, Olga; Asmussen, Sarah; Reid, Matthew W.; Brickell, Tracey A.; Lange, Rael T.] Gen Dynam Informat Technol, Frederick, MD USA; [Bailie, Jason M.] Amer Hosp Serv Grp LLC, Exton, PA USA		Bailie, JM (corresponding author), Navy Med Ctr San Diego, Def & Vet Brain Injury Ctr, San Diego, CA 92134 USA.	jason.m.bailie.ctr@mail.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			Aldenderfer FA, 1984, CLUSTER ANAL; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Costello A. B., 2005, PRACTICAL ASSESSMENT, V10, P173, DOI DOI 10.1234/12345678; Everitt B. S., 1993, CLUSTER ANAL; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Force T.B.I.T., 2008, REPORT SURG GEN TRAU; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Headquarters D.o.t.A., 2012, ARM 2020 GEN HLTH DI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL., 2012, PTSD MILD TRAUMATIC; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange R. T., 2002, J COGNITIVE REHABILI, V20, P16; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2011, 12 MONTH OUTCOME MIL; Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46, pCP1; Medicine A.f.t.A.o.A., 2007, ABBREVIATED INJURY S; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Schinka J A, 1997, J Int Neuropsychol Soc, V3, P120; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Weathers FW, 1991, PCL C FOR DSM 4	36	12	12	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					2	12		10.1097/HTR.0000000000000142			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000008	26716696				2022-02-06	
J	Chiavaroli, F; Derraik, JGB; Zani, G; Lavezzi, S; Chiavaroli, V; Sherwin, E; Basaglia, N				Chiavaroli, Francesca; Derraik, Jose G. B.; Zani, Giulia; Lavezzi, Susanna; Chiavaroli, Valentina; Sherwin, Elisabeth; Basaglia, Nino			Epidemiology and clinical outcomes in a multicentre regional cohort of patients with severe acquired brain injury	DISABILITY AND REHABILITATION			English	Article						Age; assessment; brain injury; outcomes; sex	HEAD-INJURY; REHABILITATION; TRAUMA; MODERATE; CHILDREN; SCALE; COMA	Purpose: To evaluate epidemiological and clinical data on patients with severe acquired brain injury (sABI) admitted to rehabilitation units in the first 6 years since the inception of a regional register (2005-2010) in the Emilia-Romagna region (Italy). Method: Retrospective multicentre study of a regional cohort using data from an online regional register (Gravi Cerebrolesioni Emilia-Romagna - GRACER). The study included 318 patients who suffered sABI (defined by Glasgow Coma Scale score <= 8 recorded in the initial 24 h following injury), who were admitted to and subsequently discharged from rehabilitation units. Physical and cognitive functions were evaluated at admission and discharge. Other data recorded included aetiology, presence of secondary conditions and need for specific medical support. Results: Three-quarters of patients displayed improvements in physical and/or cognitive function at discharge from rehabilitation units, with 71.4% of patients returning home. Better outcomes at discharge were associated in particular with younger age, traumatic brain injury (versus non-traumatic), or absence of tracheostomy at admission. Conclusion: The GRACER register is a useful tool for the assessment of epidemiological and clinical information on sABI patients. In light of the positive impact on patient outcomes, rehabilitation in specialised units is highly encouraged and should occur as soon as possible.	[Chiavaroli, Francesca; Zani, Giulia; Lavezzi, Susanna; Basaglia, Nino] Univ Ferrara, S Giorgio Hosp, Dept Neurosci & Rehabil, Via Fiera, I-44124 Ferrara, Italy; [Derraik, Jose G. B.; Chiavaroli, Valentina] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Sherwin, Elisabeth] Univ Arkansas, Dept Psychol, Little Rock, AR 72204 USA		Basaglia, N (corresponding author), Univ Ferrara, S Giorgio Hosp, Dept Neurosci & Rehabil, Via Fiera, I-44124 Ferrara, Italy.	n.basaglia@ospfe.it	Derraik, Jose Guilherme Behrensdorf/A-1925-2008; Chiavaroli, Valentina/ABB-1911-2020	Derraik, Jose Guilherme Behrensdorf/0000-0003-1226-1956; Chiavaroli, Valentina/0000-0003-0555-2173			Abdennour L, 2012, Ann Fr Anesth Reanim, V31, pe101, DOI 10.1016/j.annfar.2012.04.013; Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P1; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Crandon IW, 2007, W INDIAN MED J, V56, P223; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Foxx-Orenstein A, 2003, ARCH PHYS MED REHAB, V84, P231, DOI 10.1053/apmr.2003.50095; Goldstein Larry B, 2002, J Stroke Cerebrovasc Dis, V11, P80, DOI 10.1053/jscd.2002.126691; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hagen C, 1979, LEVELS COGNITIVE FUN, P87; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kraus J F, 2000, Neurosurg Focus, V8, pe5; MAHONEY F I, 1965, Md State Med J, V14, P61; Marshall, 2013, EVIDENCE BASED REV M; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; TEASDALE G, 1974, LANCET, V2, P81; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; The Australian Council on Healthcare Standards, 2008, REH MED VERS 4 ACHS; Wade D T, 1988, Int Disabil Stud, V10, P64; Zampolini M, 2013, EUR J PHYS REHAB MED, V49, P365; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358	35	12	12	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2016	38	20-21					2038	2046		10.3109/09638288.2015.1111439			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DT5RF	WOS:000381539600007	26729309				2022-02-06	
J	Cuthbert, JP; Whiteneck, GG; Corrigan, JD; Bogner, J				Cuthbert, Jeffrey P.; Whiteneck, Gale G.; Corrigan, John D.; Bogner, Jennifer			The Reliability of a Computer-Assisted Telephone Interview Version of the Ohio State University Traumatic Brain Injury Identification Method	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computer-assisted telephone interview; Ohio State University Traumatic Brain Injury Identification Method; test-retest reliability; traumatic brain injury	VALIDITY	Objectives: Provide test-retest reliability (>5 months) of the Ohio State University Traumatic Brain Injury Identification Method modified for use as a computer-assisted telephone interview (CATI) to capture traumatic brain injury (TBI) and other substantial bodily injuries among a representative sample of noninstitutionalized adults living in Colorado. Design: Four subsamples of 50 individuals, including people with no major lifetime injury, a major lifetime injury but no TBI, TBI with no loss of consciousness, and TBI with loss of consciousness, were interviewed using the CATI Ohio State University Traumatic Brain Injury Identification Method between 6 and 18 months after an initial interview. Participants: Stratified random sample of Coloradans (n = 200) selected from a larger study of TBI. Primary Measures: Cumulative, Severity and Age-related indices were assessed for long-term reliability. Cumulative indices were those that summed the total number of specific TBI severities across the lifetime; Severity indices included measures of the most severe type of injury incurred throughout the lifetime; and Age-related indices assessed the timing of specific injury types across the lifespan. Results: Test-retest reliabilities ranged from poor to excellent. The indices demonstrating the greatest reliability were Severity measures, with intraclass correlations for ordinal indices ranging from 0.62 to 0.78 and Cohen kappa ranging from 0.50 to 0.62. One Cumulative outcome demonstrated high reliability (0.70 for number of TBIs with loss of consciousness >= 30 minutes), while the remaining Cumulative outcomes demonstrated low reliability, ranging from 0.06 to 0.21. Age-related test-retest reliabilities were fair to poor, with intraclass correlations of 0.38 to 0.49 and Cohen kappa of 0.32 and 0.34. Conclusion: The CATI modified Ohio State University Traumatic Brain Injury Identification Method used in this study is an effective measure for evaluating the maximum TBI severity incurred throughout the lifetime within a general population survey. The CATI measure is not recommended for use in determining cumulative counts of lifetime incidence of TBI.	[Cuthbert, Jeffrey P.; Whiteneck, Gale G.] Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Cuthbert, JP (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	JCuthbert@Craighospital.org			Colorado Injury Control Research Center from the Centers for Disease Control and Prevention [R49 CE001168]; National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, TBI Model System Centers grants [H133A070029]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001168] Funding Source: NIH RePORTER	This publication was supported by the Colorado Injury Control Research Center through grant number R49 CE001168 from the Centers for Disease Control and Prevention and the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, U.S. Department of Education, TBI Model System Centers grants to Ohio State University (H133A070029).	Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sosin DM, 1996, BRAIN INJURY, V10, P47	5	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E36	E42		10.1097/HTR.0000000000000075			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000012	24922042				2022-02-06	
J	D'Cruz, K; Unsworth, C; Roberts, K; Morarty, J; Turner-Stokes, L; Wellington-Boyd, A; Matchado, J; Lannin, NA				D'Cruz, Kate; Unsworth, Carolyn; Roberts, Karen; Morarty, Jacqui; Turner-Stokes, Lynne; Wellington-Boyd, Anna; Matchado, Joanne; Lannin, Natasha A.			Engaging patients with moderate to severe acquired brain injury in goal setting	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						Brain injuries; Rehabilitation; Acute care; Goals; Occupational therapy; Social work	NEUROLOGICAL REHABILITATION; ENGAGEMENT; COMMUNITY; ADULTS; EXPERIENCES; OUTCOMES; PEOPLE; CARE	Background/Aims: An exploratory study of a novel approach to using the Goal Engagement Scale to examine patients', families' and health professionals' perceptions of patient engagement in goal setting. Methods: This mixed methods study was conducted from September 2013 to April 2014 in both inpatient trauma and rehabilitation units at an Australian health care service. Participants were 22 triads (patients with moderate to severe traumatic brain injury or stroke, their family member(s) and a treating health professional) participating in routine goal setting interviews. Goal setting interviews were audio recorded, transcribed and thematically analysed, drawing upon an iterative process of qualitative data analysis, while the Goal Engagement Scale scores were analysed descriptively, drawing comparison between triad participant findings. Findings: Perception of patient's level of engagement in goal setting differed between health professionals, patients and families. Health professionals' views dominated the goal setting process. Goal setting interview data revealed four main themes, highlighting the importance of reflective listening skills to build a trusting relationship with patients and families to support engagement in goal setting. Conclusions: The findings of this exploratory study both affirm the suitability of future research into goal setting engagement and provide clinically useful strategies to support engagement of patients and families in goal setting.	[D'Cruz, Kate; Unsworth, Carolyn] La Trobe Univ, Dept Community & Clin Allied Hlth, Melbourne, Vic, Australia; [Roberts, Karen] Alfred Hlth, Melbourne, Vic, Australia; [Morarty, Jacqui] Alfred Hlth, ABI Community & Transit Living Serv, Melbourne, Vic, Australia; [Turner-Stokes, Lynne] Kings Coll London, Rehabil, Dept Palliat Care Policy & Rehabil, Cicely Saunders Inst, London WC2R 2LS, England; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Harrow HA1 3UJ, Middx, England; [Wellington-Boyd, Anna] Alfred Hlth, Acute Social Work, Melbourne, Vic, Australia; [Matchado, Joanne] Alfred Hlth, Acute Neurosurg, Melbourne, Vic, Australia; [Lannin, Natasha A.] La Trobe Univ, Occupat Therapy, Melbourne, Vic, Australia		D'Cruz, K (corresponding author), La Trobe Univ, Dept Community & Clin Allied Hlth, Melbourne, Vic, Australia.	k.dcruz@latrobe.edu.au	D'Cruz, Kate/ABC-7970-2021; Lannin, Natasha A/A-4195-2013; Turner-Stokes, Lynne/F-4418-2012	D'Cruz, Kate/0000-0002-5155-1350; Lannin, Natasha A/0000-0002-2066-8345; Turner-Stokes, Lynne/0000-0002-3302-9462	National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185] Funding Source: researchfish		Acquired Brain Injury Knowledge Uptake Strategy, 2007, ABIKUS EV BAS REC RE; [Anonymous], 2010, MAN PAT STROK REH PR; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Conneeley A. L., 2004, BR J OCCUP THER, V67, P248, DOI DOI 10.1177/030802260406700603; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Curtin M, 2007, AUST OCCUP THER J, V54, P88, DOI 10.1111/j.1440-1630.2007.00661.x; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Doig E, 2015, SCAND J OCCUP THER, V22, P302, DOI 10.3109/11038128.2015.1017530; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Hunt AW, 2015, BRIT J OCCUP THER, V78, P488, DOI 10.1177/0308022614562784; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Law M, 1999, CAN J OCCUP THER, V57, P82; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Liamputtong P., 2010, RES METHODS HLTH FDN; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Turner BJ, 2008, AUST OCCUP THER J, V55, P96, DOI 10.1111/j.1440-1630.2007.00660.x; Turner-Stokes L, 2015, INT J THER REHABIL, V22, P210, DOI 10.12968/ijtr.2015.22.5.210; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; Wade DT, 1998, CLIN REHABIL, V12, P273, DOI 10.1191/026921598678166365; Yan HST, 2014, DISABIL REHABIL, V36, P1943, DOI 10.3109/09638288.2014.884173; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; Young CA, 2008, J REHABIL MED, V40, P190, DOI 10.2340/16501977-0147	36	12	12	0	16	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	JAN	2016	23	1					20	31		10.12968/ijtr.2016.23.1.20			12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	DI7UC	WOS:000373706500004					2022-02-06	
S	Deng-Bryant, Y; Leung, LY; Caudle, K; Tortella, F; Shear, D		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Deng-Bryant, Ying; Leung, Lai Yee; Caudle, Krista; Tortella, Frank; Shear, Deborah			Cognitive Evaluation Using Morris Water Maze in Neurotrauma	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Neurotrauma; Traumatic brain injury; Morris water maze; Cognitive function; Spatial learning; Memory; Cognitive deficit	TRAUMATIC BRAIN-INJURY; RAT; MEMORY; PLACE; DEGENERATION; NAVIGATION; LESIONS; IMPACT; MODEL; MOTOR	The Morris water maze (MWM) task is one of the most widely used and versatile tools in behavioral neuroscience for evaluating spatial learning and memory. With regard to detecting cognitive deficits following central nervous system (CNS) injuries, MWM has been commonly utilized in various animal models of neurotrauma, such as fluid percussion injury (FPI), cortical controlled impact (CCI) injury, weight-drop impact injury, and penetrating ballistic-like brain injury (PBBI). More importantly, it serves as a therapeutic index for assessing the efficacy of treatment interventions on cognitive performance following neurotrauma. Thus, it is critical to design an MWM testing paradigm that is sensitive yet discriminating for the purpose of evaluating potential therapeutic interventions. In this chapter, we discuss how multiple test manipulations, including the size of platform, numbers of trials per day, the frequency of retesting intervals, and the texture of platform surface, impact MWM's ability to detect cognitive deficits using a rat model of PBBI.	[Deng-Bryant, Ying; Leung, Lai Yee; Caudle, Krista; Tortella, Frank; Shear, Deborah] Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Deng-Bryant, Y (corresponding author), Walter Reed Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.						Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828	22	12	15	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						539	551		10.1007/978-1-4939-3816-2_29	10.1007/978-1-4939-3816-2		13	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500031	27604737				2022-02-06	
J	Durand, E; Watier, L; Fix, M; Weiss, JJ; Chevignard, M; Pradat-Diehl, P				Durand, E.; Watier, L.; Fix, M.; Weiss, J. J.; Chevignard, M.; Pradat-Diehl, P.			Prevalence of traumatic brain injury and epilepsy among prisoners in France: Results of the Fleury TBI study	BRAIN INJURY			English	Article						Prisoners; traumatic brain injury; inmates; head injury; neuropsychology	HEAD-INJURY; UNITED-STATES; SUBSTANCE-ABUSE; PUBLIC-HEALTH; POPULATION; EPIDEMIOLOGY; RISK; CHILDREN; OUTCOMES; DEATH	Objective: The first aim of this study was to estimate the prevalence of TBI and epilepsy in a French prison population and to study variables known to be associated with TBI. The second aim was to compare prisoners with and without a history of TBI. Participants: All offenders (females, males and juveniles) admitted consecutively to Fleury-Merogis prison over a period of 3 months were included in the study. Design: During the admission procedure, offenders were interviewed by healthcare staff using a self-reported questionnaire. Results: In all, 1221 prisoners were included. The rates of TBI and epilepsy were high, with a prevalence of 30.6% and 5.9%, respectively. Psychiatric care, anxiolytic and antidepressant treatment, use of alcohol and cannabis were all significantly higher among offenders with a history of TBI. Moreover, the number of times in custody and the total time spent in jail over the preceding 5 years were significantly higher among offenders with a history of TBI. Conclusions: These results provide further evidence that specific measures need to be developed such as, first of all, screening for TBI upon arrival in prison.	[Durand, E.; Chevignard, M.; Pradat-Diehl, P.] UPMC, Univ Paris 04, Lab Imagerie Biomed, Paris, France; [Durand, E.] Fdn Hosp St Marie, Serv MPR, 167 Rue Raymond Losserand, F-75014 Paris, France; [Watier, L.] INSERM, Paris, France; [Watier, L.] Inst Pasteur, PhEMI, Paris, France; [Watier, L.] Univ Versailles St Quentin, Fac Med Paris & Ile de France Ouest, Versailles, France; [Fix, M.] UCSA Maisons Arret Fleury Merogis, St Genevieve Des Bois, France; [Weiss, J. J.] Ctr Ressources Francilien Traumatisme Cranien, Paris, France; [Chevignard, M.] Hop St Maurice, Serv Reeducat Pathol Neurol Acquises Enfant, St Maurice, France; [Pradat-Diehl, P.] Hop La Pitie Salpetriere, Serv Med Phys &Readaptat, Paris, France		Durand, E (corresponding author), Fdn Hosp St Marie, Serv MPR, 167 Rue Raymond Losserand, F-75014 Paris, France.	edurand@fhsm.fr	, Watier/K-8213-2013		'Fondation des Gueules Cassees'; 'Centre Ressources du Traumatisme Cranien Ile de France'; Sorbonne Univ 540 Paris 06 [UMR 7371, UMR S 1146]; Laboratoire d'Imagerie Biomedicale, Paris, France	This study was funded by 'Fondation des Gueules Cassees' and has been supported by the 'Centre Ressources du Traumatisme Cranien Ile de France' and Sorbonne Univ 540 Paris 06, UMR 7371, UMR S 1146, Laboratoire d'Imagerie Biomedicale, F-75005, Paris, France. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	[Anonymous], TRAUM BRAIN INJ US F; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; Cattelani R, 2008, EUR J PHYS REHAB MED, V44, P245; Chodorge G, 1993, RAPPORT AMELIORATION; Diaz F G, 1995, Med Law, V14, P131; Durand E, 2001, REV NEUROL-FRANCE, V157, P87; Falk Ann-Charlotte, 2007, Dev Neurorehabil, V10, P49, DOI 10.1080/13638490600864066; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; GODIN-BLANDEAU E., 2013, B EPIDEMIOLOGIQUE HE, V35-36, P434; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Gunter TD, 2009, BEHAV SCI LAW, V27, P695, DOI 10.1002/bsl.887; Harmon K., 2012, BRAIN INJURY RATE 7; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Li HF, 2011, NEUROSCI LETT, V497, P172, DOI 10.1016/j.neulet.2011.02.042; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; Mouquet MC, 1999, HLTH INCOMERS PRISON; Mouquet MC, 2005, STUDIES AND FINDINGS; Nixon SJ, 1999, PSYCHOL SCI, V10, P181, DOI 10.1111/1467-9280.00130; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Perkes I, 2011, BRAIN INJURY, V25, P1028; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Schofield P, 2011, BRAIN INJURY, V25, P1028, DOI 10.3109/02699052.2011.605098; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Watson R, 2004, INT J NURS STUD, V41, P119, DOI 10.1016/S0020-7489(03)00128-7; WHO, 2001, EP AET EP PROGN; WHO, 2001, WHO EP EP AET PROGR; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	64	12	12	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					363	372		10.3109/02699052.2015.1131848			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200001	26963289				2022-02-06	
J	Jurick, SM; Bangen, KJ; Evangelista, ND; Sanderson-Cimino, M; Delano-Wood, L; Jak, AJ				Jurick, S. M.; Bangen, K. J.; Evangelista, N. D.; Sanderson-Cimino, M.; Delano-Wood, L.; Jak, A. J.			Advanced neuroimaging to quantify myelin in vivo: Application to mild TBI	BRAIN INJURY			English	Article						Concussion; DTI; mcDESPOT	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; TENSOR IMAGING DETECTS; WHITE-MATTER INTEGRITY; MULTIPLE-SCLEROSIS; MULTICOMPONENT T-2; ENDURING FREEDOM; CORPUS-CALLOSUM; OPTIC-NERVE; TRACK-TBI	Background: Difficulty providing accurate diagnosis and prognosis, especially after mild forms of traumatic brain injury (TBI), has increased efforts to detect changes in white matter microstructure using advanced neuroimaging techniques. Although methods such as diffusion tensor imaging (DTI) have greatly increased knowledge of white matter changes resulting from TBI, several shortcomings limit the utility of these techniques particularly when applied to populations with mild TBI (mTBI) history. In vivo imaging of myelin may be particularly well suited to detect changes in white matter microstructure resulting from mTBI.Review: This manuscript will briefly review the animal and histological data supporting the important role of myelin following TBI, contributions and shortcomings of the use of diffusion tensor imaging (DTI) in mild TBI and the utility of multi-component relaxometry (MCR) techniques as a method for improved visualizing of white matter microstructural integrity in myelin.Conclusion: The use of MCR-based techniques has potential as a clinical and research tool to assess and track changes in myelin as well as the common behavioural changes such as slowed processing speed following TBI.	[Jurick, S. M.] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Jurick, S. M.; Evangelista, N. D.; Delano-Wood, L.; Jak, A. J.] Vet Med Res Fdn, San Diego, CA USA; [Bangen, K. J.; Delano-Wood, L.; Jak, A. J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Bangen, K. J.; Evangelista, N. D.; Sanderson-Cimino, M.; Delano-Wood, L.; Jak, A. J.] Res Serv, San Diego, CA USA; [Delano-Wood, L.; Jak, A. J.] VA San Diego Hlthcare Syst, Psychol Serv, San Diego, CA USA		Jurick, SM (corresponding author), VA San Diego Hlthcare Syst, 3350 La Jolla Village Dr MC 151B, San Diego, CA 92161 USA.	ajak@ucsd.edu		Sanderson-Cimino, Mark/0000-0002-5872-3186	US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium]US Department of Veterans Affairs [W81XWH-13-2-0095, I01 RX002076]; US Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD [21702-5014]; Veterans AffairsUS Department of Veterans Affairs [I01RX002076] Funding Source: NIH RePORTER	This work was supported by the US Army Medical Research and Material Command and the US Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium] under Award No. W81XWH-13-2-0095 and I01 RX002076. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the US Government, or the US Department of Veterans Affairs, and no official endorsement should be inferred. The funding agencies had no role in data collection, analysis or manuscript development.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Armstrong R. C., 2015, NEUROPHARMACOLOGY; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bombardier CH, 2016, J NEUROTRAUMA; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bruce CC, 2010, HORM BEHAV, V57, P56, DOI 10.1016/j.yhbeh.2009.06.004; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chevalier N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139897; Choi KS, 2014, NEUROPSYCHOPHARMACOL, V39, P1332, DOI 10.1038/npp.2013.345; Conti AC, 1998, J NEUROSCI, V18, P5663; Crawford MA, 2007, J INT NEUROPSYCH SOC, V13, P178, DOI 10.1017/S135561770707021X; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Deoni SCL, 2015, MAGN RESON MED, V73, P161, DOI 10.1002/mrm.25108; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Department of Veterans Affairs/ Department of Defense ( VA/ DoD), 2009, VA DOD CLIN PRACT GU; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Johansen-Berg H, 2013, DIFFUSION MRI QUANTI; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Kolind S, 2015, NEUROIMAGE-CLIN, V9, P574, DOI 10.1016/j.nicl.2015.10.002; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lamar M, 2014, AM J GERIAT PSYCHIAT, V22, P111, DOI 10.1016/j.jagp.2013.08.001; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; LUDWIN SK, 1979, ACTA NEUROPATHOL, V47, P49, DOI 10.1007/BF00698272; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Norton WT, 1984, MYELIN, V2nd, P147; O'Muircheartaigh J, 2014, HUM BRAIN MAPP, V35, P4475, DOI 10.1002/hbm.22488; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raine C., 1984, MYELIN, P1, DOI 10.1007/978-1-4757-1830-0_1; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sanchez I, 1996, J NEUROSCI, V16, P5095; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shaw K, 2001, CLIN NEUROPATHOL, V20, P106; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spader HS, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.1.FOCUS12426; Stanisz GJ, 2004, MAGNET RESON MED, V51, P473, DOI 10.1002/mrm.20008; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; TEASDALE G, 1974, LANCET, V2, P81; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Uschkureit T, 2000, J NEUROSCI, V20, P5225, DOI 10.1523/JNEUROSCI.20-14-05225.2000; Webb S, 2003, MAGNET RESON MED, V49, P638, DOI 10.1002/mrm.10411; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	87	12	12	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1452	1457		10.1080/02699052.2016.1219064			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100007	27834545				2022-02-06	
J	Kim, BR; Kim, HY; Chun, YI; Yun, YM; Kim, H; Choi, DH; Lee, J				Kim, Bo-Ram; Kim, Hahn Young; Chun, Young Il; Yun, Yeo-Min; Kim, Hyuntae; Choi, Dong-Hee; Lee, Jongmin			Association between genetic variation in the dopamine system and motor recovery after stroke	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Stroke; single-nucleotide polymorphism; dopamine; rehabilitation	CATECHOL-O-METHYLTRANSFERASE; VAL(108/158) MET GENOTYPE; TRAUMATIC BRAIN-INJURY; RECEPTOR GENE; SER9GLY POLYMORPHISM; TARDIVE-DYSKINESIA; SCHIZOPHRENIA; MEMORY; RISK; D2	Background: The dopamine system plays a key role in motor learning and neuroplasticity. Several studies have studied the efficacy of dopaminergic drugs in enhancing motor recovery after stroke, but the effects are controversial. Although genetic variations in plasticity-related genes influence each individual's capacity for recovery after stroke, limited studies have investigated the effects of polymorphism of dopamine-related genes. Objective: We aimed to investigate the association between motor recovery in stroke patients and polymorphisms in the dopamine-related genes catechol-O-methyltransferase (COMT), dopamine receptor D1 (DRD1), DRD2, and DRD3. Methods: We enrolled 74 patients with first-ever stroke (42 males, 32 females, mean age: 61.4 +/- 14.1 y). During admission, blood samples were collected, and the genotypes of COMT, DRD1, DRD2, and DRD3 were analyzed. The primary outcome was assessed with Fugl-Meyer Assessment (FMA) at 1 week, 3 months, and 6 months after stroke; secondary outcomes were assessed with Functional Independence Measure (FIM) and mini-mental state examination at 3 and 6 months after stroke. The association between polymorphisms and functional outcome was analyzed. Results: There were no significant associations between COMT polymorphisms and FMA or FIM scores at 1 week after stroke or between DRD1, DRD2, or DRD3 genotypes and FMA or FIM scores at any point. COMT genotypes were significantly associated with FMA and FIM at 3 months (p < 0.01 and p < 0.05, respectively) and at 6 months (p < 0.01 and p < 0.05, respectively). Conclusion: These data suggest that genetic variation of dopamine-related genes may affect motor recovery after stroke and that COMT polymorphism could be useful for predicting motor recovery.	[Kim, Bo-Ram; Kim, Hyuntae; Lee, Jongmin] Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul, South Korea; [Kim, Bo-Ram; Kim, Hahn Young; Chun, Young Il; Yun, Yeo-Min; Kim, Hyuntae; Lee, Jongmin] Med Ctr, Seoul, South Korea; [Kim, Hahn Young] Konkuk Univ, Sch Med, Dept Neurol, Seoul, South Korea; [Chun, Young Il] Konkuk Univ, Sch Med, Dept Neurosurg, Seoul, South Korea; [Yun, Yeo-Min] Konkuk Univ, Sch Med, Dept Lab Med, Seoul, South Korea; [Choi, Dong-Hee] Konkuk Univ, Sch Med, Dept Med Sci, Seoul, South Korea; [Choi, Dong-Hee; Lee, Jongmin] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Neurosci Res, Seoul, South Korea		Lee, J (corresponding author), Konkuk Univ, Med Ctr, Dept Rehabil Med, 120-1 Neungdong Ro, Seoul 05030, South Korea.	leej@kuh.ac.kr	Lee, Jongmin/Q-4909-2019	Yun, Yeo-Min/0000-0002-5485-8331; Lee, Jongmin/0000-0001-8718-0099	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2014R1A2A1A11050248]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2339]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2014R1A2A1A11050248) and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2339).	Aberg ND, 2013, EUR J ENDOCRINOL, V169, P759, DOI 10.1530/EJE-13-0486; Bakker PR, 2006, SCHIZOPHR RES, V83, P185, DOI 10.1016/j.schres.2006.01.010; Berthele A, 2005, NEUROIMAGE, V28, P185, DOI 10.1016/j.neuroimage.2005.05.030; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; CICHON S, 1994, HUM MOL GENET, V3, P209, DOI 10.1093/hmg/3.1.209; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Comings DE, 1997, MOL PSYCHIATR, V2, P44, DOI 10.1038/sj.mp.4000207; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Cramer SC, 2009, STROKE, V40, P3034, DOI 10.1161/STROKEAHA.109.552075; Djamshidian A, 2011, MOVEMENT DISORD, V26, P1976, DOI 10.1002/mds.23821; Dmitrzak-Weglarz M, 2006, NEUROPSYCHOBIOLOGY, V53, P46, DOI 10.1159/000090703; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Duan ZX, 2015, J AFFECT DISORDERS, V188, P210, DOI 10.1016/j.jad.2015.08.066; DUNCAN PW, 1994, STROKE, V25, P1181, DOI 10.1161/01.STR.25.6.1181; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Floel A, 2005, NEUROLOGY, V65, P472, DOI 10.1212/01.wnl.0000172340.56307.5e; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; Forero DA, 2015, DRUG ALCOHOL DEPEN, V149, P259, DOI 10.1016/j.drugalcdep.2015.01.017; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Grzywacz A, 2012, PHARMACOL REP, V64, P1126, DOI 10.1016/S1734-1140(12)70909-X; Heinz A, 2006, REV NEUROSCIENCE, V17, P359; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Kim B.J., 2007, KOREAN J BIOL PSYCHI, V14, P106; Kim BR, 2016, J STROKE, V18, P220, DOI 10.5853/jos.2015.01767; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; Lee S.I., 2006, KOREAN J BIOL PSYCHI, V13, P299; Liepert J, 2013, NEUROREHAB NEURAL RE, V27, P491, DOI 10.1177/1545968313481282; Lim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033767; Lim S, 2012, J GAMBL STUD, V28, P481, DOI 10.1007/s10899-011-9261-1; Limosin F, 2003, ALCOHOL CLIN EXP RES, V27, P1226, DOI 10.1097/01.ALC.0000081624.57507.87; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Maguire J, 2011, J STROKE CEREBROVASC, V20, P134, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.011; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; NOBLE EP, 1994, MED HYPOTHESES, V42, P257, DOI 10.1016/0306-9877(94)90127-9; OLSEN TS, 1990, STROKE, V21, P247, DOI 10.1161/01.STR.21.2.247; Politis M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-1; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Schweizer S, 2013, J CEREBR BLOOD F MET, V33, P1335, DOI 10.1038/jcbfm.2013.93; Shin D.W., 2002, J KOREAN NEUROPSYCHI, V41, P612; Stochino ME, 2003, PHARMACOL RES, V48, P531, DOI 10.1016/S1043-6618(03)00213-5; Suzuki A, 2000, PHARMACOGENETICS, V10, P335, DOI 10.1097/00008571-200006000-00007; Thirugnanasambandam N, 2011, J NEUROSCI, V31, P5294, DOI 10.1523/JNEUROSCI.6258-10.2011; Woo SI, 2002, PSYCHIAT CLIN NEUROS, V56, P469, DOI 10.1046/j.1440-1819.2002.01038.x; Zaleska MM, 2009, NEUROPHARMACOLOGY, V56, P329, DOI 10.1016/j.neuropharm.2008.10.006	52	12	13	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	6					925	934		10.3233/RNN-160667			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE0DG	WOS:000389243100005	27689550				2022-02-06	
J	Lejbman, N; Olivera, A; Heinzelmann, M; Feng, R; Yun, S; Kim, HS; Gill, J				Lejbman, Natasha; Olivera, Anlys; Heinzelmann, Morgan; Feng, Rebekah; Yun, Sijung; Kim, Hyung-Suk; Gill, Jessica			Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of A40 and lower ratios of A42/40	BRAIN INJURY			English	Article						Traumatic brain injury; military; amyloid; tauopathies	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; HEAD-INJURY; NEUROLOGICAL STATUS; MILITARY PERSONNEL; BETA DYNAMICS; ENCEPHALOPATHY; ASSOCIATION; POPULATION; DEPOSITION	Primary objective: Excessive accumulation of amyloid beta (A) and tau have been observed in older individuals with chronic neurological symptoms related to a traumatic brain injury (TBI), yet little is known about the possible role of A in younger active duty service members following a TBI. The purpose of the study was to determine if A 40 or 42 related to sustaining a TBI or to chronic neurological symptoms in a young cohort of military personnel.Research design: This was a cross-sectional study of active duty service members who reported sustaining a TBI and provided self-report of neurological and psychological symptoms and provided blood.Methods and procedures: An ultrasensitive single-molecule enzyme-linked immunosorbent assay was used to compare concentrations of A in active duty service members with (TBI+; n = 53) and without (TBI-; n = 18) a history of TBI. Self-report and medical history were used to measure TBI occurrence and approximate the number of total TBIs and the severity of TBIs sustained during deployment.Main outcomes and results: This study reports that TBI is associated with higher concentrations of A40 (F-1,F-68 = 6.948, p = 0.009) and a lower ratio of A42/A40 (F-1,F-62 = 5.671, p = 0.020). These differences remained significant after controlling for co-morbid symptoms of post-traumatic stress disorder and depression.Conclusions: These findings suggest that alterations in A relate to TBIs and may contribute to chronic neurological symptoms.	[Lejbman, Natasha; Olivera, Anlys; Heinzelmann, Morgan; Feng, Rebekah; Yun, Sijung; Kim, Hyung-Suk; Gill, Jessica] NIH, NINR, Bldg 10, Bethesda, MD 20892 USA; [Yun, Sijung] LLC, Yotta Biomed, Bethesda, MD USA		Gill, J (corresponding author), 1 Cloister Court,Rm 256, Bethesda, MD 20814 USA.	gillj@mail.nih.gov	Feng, Li Rebekah/Y-9204-2019; Gill, Gill M/Q-2020-2017	Feng, Li Rebekah/0000-0003-0445-4088; Heinzelmann, Morgan/0000-0002-4399-6229	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; National Institutes of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000015] Funding Source: NIH RePORTER	This study was funded, in part, by the Center for Neuroscience and Regenerative Medicine (Grant 60855). This study was funded by the intramural research program of the National Institutes of Nursing Research. The authors report no conflicts of interest. The opinions and assertions in this manuscript are those of the authors and do not necessarily represent those of the Department of the Army, Department of Defense, US Government, or the Center for Neuroscience and Regenerative Medicine.	Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Claeysen S, 2012, CELL SIGNAL, V24, P1831, DOI 10.1016/j.cellsig.2012.05.008; Dumurgier J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0114-5; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Seppala TT, 2010, J NEUROL NEUROSUR PS, V81, P1123, DOI 10.1136/jnnp.2010.205757; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Sun XJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00221; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	37	12	13	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1436	1441		10.1080/02699052.2016.1219054			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100005	27834544	Green Published, hybrid			2022-02-06	
J	Ma, GYK; Mak, WWS				Ma, Gloria Y. K.; Mak, Winnie W. S.			Caregiving-Specific Worry, Affiliate Stigma, and Perceived Social Support on Psychological Distress of Caregivers of Children With Physical Disability in Hong Kong	AMERICAN JOURNAL OF ORTHOPSYCHIATRY			English	Article						caregivers; physical disability; caregiving-specific worry; affiliate stigma; barrier-free environment	DUCHENNE MUSCULAR-DYSTROPHY; TRAUMATIC BRAIN-INJURY; MENTAL-ILLNESS; INTELLECTUAL DISABILITIES; FAMILY CAREGIVERS; CEREBRAL-PALSY; HEALTH; MOTHERS; IMPACT; STRESS	The present study tested a model on the relationship between functional status of children with physical disability, caregiving-specific worry, affiliate stigma, and psychological distress among their caregivers. One hundred thirty-one caregivers of children with physical disability in Hong Kong completed a self-report questionnaire. Structural equation modeling showed that the final model had good fit to the data: chi(2) = 102.05, (df = 83, p = .08), comparative fit index = .98, nonnormed fit index = .98, standardized root mean square residual = .08, root mean square error of approximation = .04. Caregivers whose children had a lower functional status reported more caregiving-specific worry. Affiliate stigma had significant and positive indirect effect on psychological distress through increasing worry. Results also supported the direct and indirect effects of perceived social support in ameliorating worry, affiliate stigma, and psychological distress. Findings suggested that health care and social service providers should consider the functional impairment of each child when designing stress reduction interventions for their caregivers. Findings implicate the importance of establishing barrier-free environment and public facilities in the society. Caregivers are encouraged to distinguish those worries that are actionable and convert them into problem solving plans and to actively engage in peer support and social activities to reduce their affiliate stigma. To truly promote inclusion and well-being of individuals with disability and their caregivers, the scope and targets of social services and stigma reduction programs by the government should include not only the persons with disabilities, but also their caregivers and family members who play essential roles in the rehabilitation journey.	[Ma, Gloria Y. K.; Mak, Winnie W. S.] Chinese Univ Hong Kong, Dept Psychol, Divers & Well Being Lab, Shatin, Hong Kong, Peoples R China		Mak, WWS (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Divers & Well Being Lab, Shatin, Hong Kong, Peoples R China.	wwsmak@psy.cuhk.edu.hk		Mak, Winnie/0000-0002-9714-7847	I.CARE Programme Research and Studies; Chinese University of Hong KongChinese University of Hong Kong [R21-11]	We would like to express our heartfelt thanks to (in alphabetical order) Families of Spinal Muscular Atrophy Charitable Trust, Hong Kong Association for Parents of Persons With Physical Disabilities, Hong Kong Neuromuscular Disease Association, Hong Kong PHAB (Physically Handicapped and Able-Bodied) Association, Hong Kong Red Cross John F. Kennedy Center, Hong Kong Red Cross Margaret Trench School, and SAHK (The Spastics Association of Hong Kong) Ko Fook Iu Memorial School for their assistance in recruitment and data collection. We also sincerely thank all the caregivers who participated in the present study. Special thanks to Rita Law for her comments on the manuscript. The present study was funded by the I.CARE Programme Research and Studies, 2011-2012, the Chinese University of Hong Kong (Reference No. R21-11).	Begum R., 2010, INDIAN OCCUP THER, V42, P3; Benson PR, 2012, J AUTISM DEV DISORD, V42, P2597, DOI 10.1007/s10803-012-1517-9; Bierman A., 2013, HDB SOCIOLOGY MENTAL, P357, DOI DOI 10.1007/978-94-007-4276-5_18; Brannan AM, 2006, J BEHAV HEALTH SER R, V33, P408, DOI 10.1007/s11414-006-9035-1; Brosschot JF, 2005, PSYCHONEUROENDOCRINO, V30, P1043, DOI 10.1016/j.psyneuen.2005.04.008; Chen JY, 2007, FAM COMMUNITY HEALTH, V30, P296, DOI 10.1097/01.FCH.0000290542.10458.f8; Chiu MYL, 2013, J INTELL DISABIL RES, V57, P1117, DOI 10.1111/j.1365-2788.2012.01624.x; Chou YC, 2009, J INTELL DISABIL RES, V53, P654, DOI 10.1111/j.1365-2788.2009.01173.x; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; DeCoster J., 1998, OVERVIEW OF FACTOR A; Galfin JM, 2010, J PALLIAT MED, V13, P1345, DOI 10.1089/jpm.2010.0139; Green S, 2005, SOCIOL INQ, V75, P197, DOI 10.1111/j.1475-682X.2005.00119.x; Green SE, 2004, SOC SCI MED, V59, P799, DOI 10.1016/j.socscimed.2003.11.023; Green SE, 2003, SOC SCI MED, V57, P1361, DOI 10.1016/S0277-9536(02)00511-7; Hastings RP, 2002, J APPL RES INTELLECT, V15, P269, DOI 10.1046/j.1468-3148.2002.00104.x; Heaney CA., 2008, HLTH BEHAV HLTH ED T, V4, P189, DOI DOI 10.1177/109019818501200106; HELGESON VS, 1993, J APPL SOC PSYCHOL, V23, P825, DOI 10.1111/j.1559-1816.1993.tb01008.x; Horton TV, 2001, REHABIL PSYCHOL, V46, P382, DOI 10.1037/0090-5550.46.4.382; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; KAZAK AE, 1984, FAM RELAT, V33, P67, DOI 10.2307/584591; Knussen C., 1992, J MENTAL HLTH, V1, P241, DOI DOI 10.3109/09638239209005457; LAAKE K, 1995, AGE AGEING, V24, P393, DOI 10.1093/ageing/24.5.393; Lee Youjung, 2013, J Appl Gerontol, V32, P422, DOI 10.1177/0733464811431163; Leung SOC, 2007, CLIN REHABIL, V21, P912, DOI 10.1177/0269215507077286; Gras RML, 2009, J DEV PHYS DISABIL, V21, P169, DOI 10.1007/s10882-009-9133-0; Mak W. W. S., 2010, SOC SCI MED, V70, P2054; Mak WWS, 2008, J APPL RES INTELLECT, V21, P532, DOI 10.1111/j.1468-3148.2008.00426.x; Mak WWS, 2012, COMMUNITY MENT HLT J, V48, P270, DOI 10.1007/s10597-011-9422-9; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; MCDANIEL SH, 1995, PROF PSYCHOL-RES PR, V26, P117, DOI 10.1037/0735-7028.26.2.117; Mcdowell TL, 2007, AIDS CARE, V19, P1223, DOI 10.1080/09540120701402830; McLean LA, 2004, REHABIL PSYCHOL, V49, P233, DOI 10.1037/0090-5550.49.3.233; Mitchell MM, 2009, AIDS PATIENT CARE ST, V23, P611, DOI 10.1089/apc.2008.0279; Murphy NA, 2007, CHILD CARE HLTH DEV, V33, P180, DOI 10.1111/j.1365-2214.2006.00644.x; Nair KPS, 2001, J REHABIL MED, V33, P147, DOI 10.1080/165019701750300591; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Noojin AB, 1996, J PEDIATR PSYCHOL, V21, P483, DOI 10.1093/jpepsy/21.4.483; Ostman M, 2002, BRIT J PSYCHIAT, V181, P494, DOI 10.1192/bjp.181.6.494; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Perrin PB, 2008, REHABIL PSYCHOL, V53, P54, DOI 10.1037/0090-5550.53.1.54; Quinn DM, 2013, SOC PERSONAL PSYCHOL, V7, P40, DOI 10.1111/spc3.12005; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Raina Parminder, 2004, BMC Pediatr, V4, P1, DOI 10.1186/1471-2431-4-1; Resch JA, 2010, REHABIL PSYCHOL, V55, P139, DOI 10.1037/a0019473; Ritvo PG., 1997, MULTIPLE SCLEROSIS Q; Roick C, 2006, ACTA PSYCHIAT SCAND, V114, P363, DOI 10.1111/j.1600-0447.2006.00797.x; Rozario PA, 2004, RES AGING, V26, P413, DOI 10.1177/0164027504264437; Sawin Kathleen J, 2003, Rehabil Nurs, V28, P173; Segerstrom S., 2011, STRUCTURE CONSEQUENC; Shewchuk RM, 2004, J CLIN PSYCHOL MED S, V11, P141, DOI 10.1023/B:JOCS.0000037608.55768.df; Skok A, 2006, J INTELLECT DEV DIS, V31, P53, DOI 10.1080/13668250600561929; Smith JM, 2009, CLIN PSYCHOL REV, V29, P116, DOI 10.1016/j.cpr.2008.10.003; Stjernsward S, 2008, INT J SOC PSYCHIATR, V54, P358, DOI 10.1177/0020764008090794; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337; Wade D T, 1988, Int Disabil Stud, V10, P64; Watkins E, 2005, BEHAV RES THER, V43, P1577, DOI 10.1016/j.brat.2004.11.008; Werner S, 2013, RES DEV DISABIL, V34, P4103, DOI 10.1016/j.ridd.2013.08.029; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	60	12	13	1	39	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0002-9432	1939-0025		AM J ORTHOPSYCHIAT	Am. J. Orthopsychiatr.		2016	86	4					436	446		10.1037/ort0000171			11	Psychiatry; Social Work	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Social Work	DS6ZP	WOS:000380932400010	26950080				2022-02-06	
J	McLafferty, FS; Barmparas, G; Ortega, A; Roberts, P; Ko, A; Harada, M; Nuno, M; Black, KL; Ley, EJ				McLafferty, Fred S.; Barmparas, Galinos; Ortega, Alicia; Roberts, Pamela; Ko, Ara; Harada, Megan; Nuno, Miriam; Black, Keith L.; Ley, Eric J.			Predictors of improved functional outcome following inpatient rehabilitation for patients with traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury (TBI); inpatient rehabilitation; hypotension; Glasgow Coma Scale (GCS); rehabilitation responder	UNITED-STATES; HEAD-INJURIES; IMPACT; MORTALITY; CONSCIOUSNESS; DISORDERS; SEVERITY; RECOVERY; SURVIVAL; AGE	OBJECTIVE: To determine factors associated with response to inpatient rehabilitation treatment among TBI patients. SETTING: Inpatient rehabilitation service at a Level I trauma center. PARTICIPANTS: Moderate-severe TBI patients ages >= 18 years old admitted between January 1, 2002 and December 31, 2012. MAIN MEASURES: Response to inpatient rehabilitation, measured by the Functional Independence Measure (FIM) score. DESIGN: Retrospective cohort study. RESULTS: Of 1,984 patients treated for TBI, 184 (10.8%) underwent inpatient rehabilitation. The largest proportion of patients improved in mobility (98.9%), followed by self-care (93.7%), communication/social cognition (84.0%), and sphincter control (65.7%). Of these, 99 (53.8%) improved by 2 or more levels of functional independence and were considered rehabilitation responders. Responders were younger (53.1 years vs. 63.8, p < 0.01), had longer average rehabilitation stays (15.4 days vs. 12.2, p < 0.01), and were less likely to have an admission SBP < 100 mm Hg (7.1% vs. 17.1%, p = 0.01). On multivariate analysis, normotension at admission (AOR 0.06, p = 0.01) and longer rehabilitation LOS (AOR 1.11, p < 0.01) were associated with a response to inpatient rehabilitation. CONCLUSION: Of the TBI patients who qualified for same-center inpatient rehabilitation, approximately half responded to treatment. Longer rehabilitation time and normotension at admission predicted response to rehabilitation. Further efforts are necessary to identify and optimize TBI patients for inpatient rehabilitation.	[McLafferty, Fred S.; Ortega, Alicia; Nuno, Miriam; Black, Keith L.] Cedars Sinai Med Ctr, Ctr Neurosurg Outcomes Res, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA; [Barmparas, Galinos; Ko, Ara; Harada, Megan; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Acute Care Surg, Los Angeles, CA 90048 USA; [Roberts, Pamela] Cedars Sinai Med Ctr, Dept Phys Med & Rehabil, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org	Roberts, Pamela S/G-4059-2015; Barmparas, Galinos/L-6530-2019	Black, Keith/0000-0002-0546-4934			Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Faul M., 2014, TRAUMATIC BRAIN INJU; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Roberts PS, 2014, PM&R, V6, P514, DOI 10.1016/j.pmrj.2013.12.007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	29	12	12	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	3					423	430		10.3233/NRE-161373			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DW7XA	WOS:000383865200009	27589512				2022-02-06	
J	Meng, XE; Zhang, Y; Li, N; Fan, DF; Yang, C; Li, H; Guo, DZ; Pan, SY				Meng, X. E.; Zhang, Y.; Li, N.; Fan, D. F.; Yang, C.; Li, H.; Guo, D. Z.; Pan, S. Y.			Effects of hyperbaric oxygen on the Nrf2 signaling pathway in secondary injury following traumatic brain injury	GENETICS AND MOLECULAR RESEARCH			English	Article						Traumatic brain injury; Hyperbaric oxygen; Nrf2	OXIDATIVE STRESS; ENZYMES; MICE	We investigated the effects of hyperbaric oxygen treatment on the Nrf2 signaling pathway in secondary injury following traumatic brain injury, using a rat model. An improved Feeney freefall method was used to establish the rat traumatic brain injury model. Sixty rats were randomly divided into three groups: a sham surgery group, a traumatic brain injury group, and a group receiving hyperbaric oxygen treatment after traumatic brain injury. Neurological function scores were assessed at 12 and 24 h after injury. The expression levels of Nrf2, heme oxygenase 1 (HO-1), and quinine oxidoreductase 1 (NQO-1) in the cortex surrounding the brain lesion were detected by western blotting 24 h after the injury. Additionally, the TUNEL method was used to detect apoptosis of nerve cells 24 h after traumatic injury and Nissl staining was used to detect the number of whole neurons. Hyperbaric oxygen treatment significantly increased the expression of nuclear Nrf2 protein (P < 0.05), HO-1, and NQO-1 in the brain tissues surrounding the lesion after a traumatic brain injury (P < 0.05) and also significantly reduced the number of apoptotic and injured nerve cells. The neurological function scores also improved with hyperbaric oxygen treatment (P < 0.05). Therefore, hyperbaric oxygen has a neuroprotective role in traumatic brain injury, which is mediated by up-regulation of the Nrf2 signaling pathway.	[Meng, X. E.; Zhang, Y.; Li, N.; Fan, D. F.; Yang, C.; Li, H.; Guo, D. Z.; Pan, S. Y.] Navy Gen Hosp, Dept Hyperbar Oxygen, Beijing, Peoples R China		Pan, SY (corresponding author), Navy Gen Hosp, Dept Hyperbar Oxygen, Beijing, Peoples R China.	shuyipan_oooo@126.com					Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Lannin NA, 2014, NEUROREHABILITATION, V35, P635, DOI 10.3233/NRE-141161; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Xie Y, 2014, PHARMACOL BIOCHEM BE, V126, P181, DOI 10.1016/j.pbb.2014.08.005; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	12	12	13	0	2	FUNPEC-EDITORA	RIBEIRAO PRETO	RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL	1676-5680			GENET MOL RES	Genet. Mol. Res.		2016	15	1							15016933	10.4238/gmr.15016933			7	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	DJ0GM	WOS:000373879900011	26909929	Bronze			2022-02-06	
J	Meulenbroek, O; O'Dwyer, S; de Jong, D; van Spijker, G; Kennelly, S; Cregg, F; Rikkert, MO; Abdullah, L; Wallin, A; Walsh, C; Coen, R; Kenny, RA; Daly, L; Segurado, R; Borjesson-Hanson, A; Crawford, F; Mullan, M; Lucca, U; Banzi, R; Pasquier, F; Breuilh, L; Riepe, M; Kalman, J; Molloy, W; Tsolaki, M; Howard, R; Adams, J; Gaynor, S; Lawlor, B				Meulenbroek, Olga; O'Dwyer, Sarah; de Jong, Daan; van Spijker, Gerrita; Kennelly, Sean; Cregg, Fiona; Rikkert, Marcel Olde; Abdullah, Laila; Wallin, Anders; Walsh, Cathal; Coen, Robert; Kenny, Rose Anne; Daly, Leslie; Segurado, Ricardo; Borjesson-Hanson, Anne; Crawford, Fiona; Mullan, Michael; Lucca, Ugo; Banzi, Rita; Pasquier, Florence; Breuilh, Laetitia; Riepe, Matthias; Kalman, Janos; Molloy, William; Tsolaki, Magda; Howard, Robert; Adams, Jessica; Gaynor, Siobhan; Lawlor, Brian			European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; SERUM A-BETA; COGNITIVE IMPAIRMENT; OLDER-ADULTS; DEMENTIA; CSF; PROTEIN; RISK; AUTOREGULATION; HYPERTENSION	Introduction: In conjunction with the NILVAD trial, a European Multicentre Double-Blind Placebo Controlled trial of Nilvadipine in Mild-to-Moderate Alzheimer's disease (AD), there are four NILVAD substudies in which eligible NILVAD patients are also invited to participate. The main NILVAD protocol was previously published in BMJ Open (2014). The objectives of the NILVAD substudies are to determine whether frailty, cerebrospinal fluid (CSF), blood biomarker profile and Apolipoprotein E (APOE) status predict response to Nilvadipine, and to investigate the effect of Nilvadipine on cerebral blood flow and blood biomarkers. Methods and analysis: All participants who fulfil criteria for the main NILVAD study are eligible for participation in the NILVAD substudies. Participation is subject to informed consent and whether the substudy is available at a particular NILVAD study site. Each substudy entails extra measurements during the course of the main NILVAD study. For example, in the blood and genetic biomarkers substudy, extra blood (30 mL) will be collected at week 0, week 13, week 52 and week 78, while in the cerebral blood flow substudy, participants will receive an MRI and transcranial Doppler measurements at week 0, week 26 and week 78. In the CSF substudy, 10 mL CSF is collected at week 0 and week 78. Ethics and dissemination: All NILVAD substudies and all subsequent amendments have received ethical approval within each participating country, according to national regulations. Each participant provides written consent to participate. All participants remain anonymised throughout and the results of each substudy will be published in an international peer reviewed journal.	[Meulenbroek, Olga; de Jong, Daan; van Spijker, Gerrita; Rikkert, Marcel Olde] Radboud Univ Nijmegen, Med Ctr, Radboud Alzheimer Ctr, Nijmegen, Netherlands; [O'Dwyer, Sarah; Coen, Robert; Kenny, Rose Anne; Lawlor, Brian] St James Hosp, Mercers Inst Res Ageing, Dublin, Ireland; [Kennelly, Sean; Cregg, Fiona] TCD, Dublin, Ireland; [Abdullah, Laila] Roskamp Inst, Sarasota, FL USA; [Wallin, Anders; Borjesson-Hanson, Anne] Goeteborgs Univ UGOT, Gothenburg, Sweden; [Walsh, Cathal; Daly, Leslie; Segurado, Ricardo] UCD, Dublin, Ireland; [Crawford, Fiona; Mullan, Michael] Archer Pharmaceut Inc, Sarasota, FL USA; [Lucca, Ugo; Banzi, Rita] IRFMN, IRCCS, Dept Lab Geriatr Neuropsychiat, Milan, Italy; [Pasquier, Florence; Breuilh, Laetitia] Ctr Hosp Reg & Univ Lille CHRU LILLE, Lille, France; [Riepe, Matthias] Univ Ulm, UULM, Ulm, Germany; [Kalman, Janos] Szegedi Tudomanyegyetem SZEGED, Szeged, Hungary; [Molloy, William] Univ Coll Cork, Ctr Gerontol & Rehabil, Cork, Ireland; [Tsolaki, Magda] Aristotle Univ Thessaloniki AUTH, Thessaloniki, Greece; [Howard, Robert; Adams, Jessica] KCL, London, England; [Gaynor, Siobhan] MMI, Dublin, Ireland		Lawlor, B (corresponding author), St James Hosp, Mercers Inst Res Ageing, Dublin, Ireland.	blawlor@stjames.ie	van Spijker, Gerrita/AAW-9189-2021; Pasquier, Florence/F-1527-2017; Rikkert, Marcel Olde/D-9773-2012; Banzi, Rita/AAA-6381-2020; van Spijker, Gerrita/A-1264-2016; Lucca, Ugo/ABC-1460-2020; Rikkert, M.G.M. Olde/H-8078-2014; de Jong, Daan LK/P-8260-2015; Segurado, Ricardo/K-6116-2014	Pasquier, Florence/0000-0001-9880-9788; Banzi, Rita/0000-0002-2211-3300; Lucca, Ugo/0000-0003-0452-3215; Rikkert, M.G.M. Olde/0000-0003-1397-1677; de Jong, Daan LK/0000-0002-4263-4402; Tsolaki, Magda/0000-0002-2072-8010; Segurado, Ricardo/0000-0002-3547-6733; Kennelly, Sean/0000-0002-3721-0197; Howard, Robert/0000-0002-3071-2338; Kenny, Rose Anne/0000-0002-9336-8124	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [279093]; Alzheimer's Drug Discovery Foundation (ADDF) [20121210]; Dutch Alzheimer Society [WE.03-2015-01]	The main NILVAD trial and associated substudies are funded by the European Commission Framework 7 Programme health theme collaborative project. Grant Agreement Number: 279093. The CBF substudy is funded by the Alzheimer's Drug Discovery Foundation (ADDF), Grant number: 20121210 and by the Dutch Alzheimer Society, grant number WE.03-2015-01.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2009, MOL MED, V15, P432, DOI 10.2119/molmed.2009.00083; Abdullah L, 2009, MOL MED, V15, P95, DOI 10.2119/molmed.2008.00118; Bjerke M, 2011, J ALZHEIMERS DIS, V27, P665, DOI 10.3233/JAD-2011-110566; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Blennow K, 1995, MOL CHEM NEUROPATHOL, V26, P231, DOI 10.1007/BF02815140; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Claassen JAHR, 2011, J CEREBR BLOOD F MET, V31, P1572, DOI 10.1038/jcbfm.2011.69; Crean S, 2011, DEMENT GERIATR COGN, V31, P20, DOI 10.1159/000321984; de Vries NM, 2011, AGEING RES REV, V10, P104, DOI 10.1016/j.arr.2010.09.001; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Fleisher AS, 2009, NEUROBIOL AGING, V30, P1737, DOI 10.1016/j.neurobiolaging.2008.01.012; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Gray SL, 2013, J GERONTOL A-BIOL, V68, P1083, DOI 10.1093/gerona/glt013; Hanyu H, 2007, NUCL MED COMMUN, V28, P281, DOI 10.1097/MNM.0b013e32804c58aa; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Kagawa H, 1999, CLIN EXP HYPERTENS, V21, P1177, DOI 10.3109/10641969909052196; Katz M, 2011, MULTIVARIABLE ANAL P; Kennelly S, 2012, INT J GERIATR PSYCH, V27, P415, DOI 10.1002/gps.2735; Kulmala J, 2014, GERONTOLOGY, V60, P16, DOI 10.1159/000353859; Lawlor B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006364; Lee KS, 2009, DEMENT GERIATR COGN, V28, P281, DOI 10.1159/000245156; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MOHS RC, 1983, PSYCHOPHARMACOL BULL, V19, P448; Mozolic JL, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.016.2010; Murphy K, 2011, MAGN RESON IMAGING, V29, P1382, DOI 10.1016/j.mri.2011.02.030; Nagga K, 2004, DEMENT GERIATR COGN, V18, P59, DOI 10.1159/000077737; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Paris D, 2004, BRAIN RES, V999, P53, DOI 10.1016/j.brainres.2003.11.061; Paris D, 2011, MOL MED, V17, P149, DOI 10.2119/molmed.2010.00180; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rosengren LE, 1999, NEUROLOGY, V52, P1090, DOI 10.1212/WNL.52.5.1090; Salloway S, 2011, NEUROLOGY, V77, P1253, DOI 10.1212/WNL.0b013e3182309fa5; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x; Thambisetty M, 2010, BIOMARK MED, V4, P65, DOI 10.2217/BMM.09.84; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	48	12	12	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	7							e011584	10.1136/bmjopen-2016-011584			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU5LB	WOS:000382252100088	27436668	Green Published, Green Submitted, gold			2022-02-06	
S	Rincon, S; Gupta, R; Ptak, T		Masdeu, JC; Gonzalez, RG		Rincon, Sandra; Gupta, Rajiv; Ptak, Thomas			Imaging of head trauma	NEUROIMAGING, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							BRAIN-INJURY; INTRACRANIAL-PRESSURE; CT; MANAGEMENT; FRACTURES; HEMORRHAGE; DIAGNOSIS; ANTIBIOTICS; GUIDELINES; SIGNAL	Imaging is an indispensable part of the initial assessment and subsequent management of patients with head trauma. Initially, it is important for diagnosing the extent of injury and the prompt recognition of treatable injuries to reduce mortality. Subsequently, imaging is useful in following the sequelae of trauma. In this chapter, we review indications for neuroimaging and typical computed tomography (CT) and magnetic resonance imaging (MRI) protocols used in the evaluation of a patient with head trauma. We review the role of CT), the imaging modality of choice in the acute setting, and the role of MRI in the evaluation of patients with head trauma. We describe an organized and consistent approach to the interpretation of imaging of these patients. Important topics in head trauma, including fundamental concepts related to skull fractures, intracranial hemorrhage, parenchymal injury, penetrating trauma, cerebrovascular injuries, and secondary effects of trauma, are reviewed. The chapter concludes with advanced neuroimaging techniques for the evaluation of traumatic brain injury, including use of diffusion tensor imaging (DTI), functional MRI (fMRI), and MR spectroscopy (MRS), techniques which are still under development.	[Rincon, Sandra; Gupta, Rajiv; Ptak, Thomas] Massachusetts Gen Hosp, Div Neuroradiol, Boston, MA 02114 USA; [Gupta, Rajiv] Massachusetts Gen Hosp, Div Neuroradiol & Cardiac Radiol, Boston, MA 02114 USA; [Ptak, Thomas] Massachusetts Gen Hosp, Div Emergency Radiol, Boston, MA 02114 USA		Rincon, S (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,Gray 2-B285, Boston, MA 02114 USA.	srincon@mgh.harvard.edu					Adalarasan S, 2010, J CRANIOFAC SURG, V21, P1009, DOI 10.1097/SCS.0b013e3181e47d43; Ali B, 2002, EMERG MED J, V19, P552, DOI 10.1136/emj.19.6.552; Anon J, 2008, J MAGN RESON IMAGING, V28, P823, DOI 10.1002/jmri.21495; Arthurs OJ, 2002, TRENDS NEUROSCI, V25, P27, DOI 10.1016/S0166-2236(00)01995-0; BRANT WE, 2007, FUNDAMENTALS DIAGNOS; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P539; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P330, DOI 10.1097/TA.0b013e31823de8a0; CANTU RC, 1995, CLIN SPORT MED, V14, P517; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chalela JA, 2013, NEUROCRIT CARE, V18, P398, DOI 10.1007/s12028-013-9836-z; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Collins JM, 2012, SEMIN ULTRASOUND CT, V33, P418, DOI 10.1053/j.sult.2012.06.006; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Davis P C, 2000, Radiology, V215 Suppl, P507; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; ELJAMEL MS, 1994, BRIT J NEUROSURG, V8, P289, DOI 10.3109/02688699409029616; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Larsen DW, 2002, NEUROIMAG CLIN N AM, V12, P249, DOI 10.1016/S1052-5149(02)00006-0; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Leclerc X, 1996, STROKE, V27, P461, DOI 10.1161/01.STR.27.3.461; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liu XS, 2012, J NEUROSURG-PEDIATR, V9, P670, DOI 10.3171/2012.2.PEDS11538; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; MILLER JD, 1982, CLIN NEUR, V29, P103; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Collaborating Centre for Acute Care, 2007, HEAD INJ TRIAG ASS I; Osborn A., 2005, DIAGNOSTIC IMAGING B; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; TEASDALE G, 1974, LANCET, V2, P81; THUOMAS KA, 1993, ACTA RADIOL, V34, P289; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wellwood J, 2002, NEUROL RES, V24, pS13; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Young RJ, 2002, NEUROIMAG CLIN N AM, V12, P189, DOI 10.1016/S1052-5149(02)00003-5; Yousem D. M., 2003, NEURORADIOLOGY REQUI; Zwienenberg M, 2003, CLIN PATHOPHYSIOLOGY, P5039	52	12	13	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-7020-4537-0; 978-0-444-53485-9	HAND CLINIC			2016	135						447	477					31	Clinical Neurology; Neuroimaging	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BH8WG	WOS:000403702900024	27432678				2022-02-06	
J	Rossi-Mossuti, F; Fisch, U; Schoettker, P; Gugliotta, M; Morard, M; Schucht, P; Schatlo, B; Levivier, M; Walder, B; Fandino, J				Rossi-Mossuti, Frederic; Fisch, Urs; Schoettker, Patrick; Gugliotta, Marinella; Morard, Marc; Schucht, Philippe; Schatlo, Bawarjan; Levivier, Marc; Walder, Bernhard; Fandino, Javier			Surgical Treatment of Severe Traumatic Brain Injury in Switzerland: Results from a Multicenter Study	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						severe traumatic brain injury; surgical management and monitoring strategies; standardized documentation; standardized operative procedures; neurosurgery	DECOMPRESSIVE CRANIECTOMY; COMATOSE PATIENTS; EPIDEMIOLOGY; MANAGEMENT; HEMATOMA; CLASSIFICATION; OUTCOMES; LESIONS; TRIAL; SCALE	Objective Since the introduction of modern surgical techniques and monitoring tools for the treatment of severe traumatic brain injury (TBI) in Switzerland, standardized nationwide operative procedures are still lacking. This study aimed to assess surgical management and monitoring strategies in patients admitted throughout Switzerland with severe TBI. Methods Demographic, clinical, and radiologic data from a prospective national cohort study on severe brain-injured patients (Patient-relevant Endpoints after Brain Injury from Traumatic Accidents [PEBITA]) were collected during a 3-year period. This study evaluated patients admitted to 7 of the 11 trauma centers included in PEBITA. We retrospectively analyzed surgery-related computed tomography (CT) findings prior to and after treatment, intracranial pressure (ICP) monitoring, size and technical features of craniotomy, as well as surgical complications. Results This study included 353 of the 921 patients enrolled in PEBITA who underwent surgical treatment for severe TBI. At admission, acute subdural hematoma was the most frequent focal lesion diagnosed (n = 154 [44%]), followed by epidural hematoma (n = 96 [27%]) and intracerebral hematoma (n = 84 [24%]). A total of 198 patients (61%) presented with midline shift. Clinical deterioration in terms of Glasgow Coma Scale scores or intractable ICP values as an indication for surgical evacuation or decompression were documented in 20% and 6%, respectively. A total of 97 (27.5%) only received a catheter/probe for ICP monitoring. Surgical procedures to treat a focal lesion or decompress the cerebrum were performed in 256 patients (72.5%). Of the 290 surgical procedures (excluding ICP probe implantation), craniotomy (137 [47.2%]) or decompressive craniectomy (133 [45.9%]) were performed most frequently. The mean size of craniectomy in terms of maximal linear width on the CT axial slice was 8.4 +/- 2.9 cm. Intraoperative ICP monitoring was reported in 61% of the interventions. Significant intraoperative brain swelling was documented in 50.6% of the procedures. Surgery-related complications occurred in 89 cases (32%). Conclusion This study highlights the lack of standardized and systematic documentation of technical aspects of surgical treatment of patients presenting with severe TBI in Switzerland. Technical strategies such as size of craniectomy and the use of perioperative ICP measurement were not documented in a standardized manner. A prospective systematic surgical documentation system might contribute to future formulation of recommendations for the surgical treatment of patients presenting with severe TBI in Switzerland.	[Rossi-Mossuti, Frederic; Gugliotta, Marinella; Schatlo, Bawarjan; Fandino, Javier] Kantonsspital, Dept Neurosurg, Aarau, Switzerland; [Fisch, Urs] Univ Basel Hosp, Dept Neurosurg, CH-4031 Basel, Switzerland; [Schoettker, Patrick] Univ Hosp Ctr Lausanne, Dept Anaesthesiol, Lausanne, Switzerland; [Morard, Marc] Hop Valais, Dept Neurosurg, Sion, Switzerland; [Schucht, Philippe] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [Levivier, Marc] Univ Hosp Ctr Lausanne, Dept Neurosurg, Lausanne, Switzerland; [Walder, Bernhard] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Schatlo, Bawarjan] Univ Hosp Gottingen, Dept Neurosurg, Gottingen, Germany		Rossi-Mossuti, F (corresponding author), Kantonsspital, Dept Neurosurg, Editorial Off, Tellstr, CH-5000 Aarau, Switzerland.	neurosurgery@ksa.ch	Schoettker, Patrick/AAE-4462-2020; SCHATLO, Bawarjan/F-4285-2010	Schoettker, Patrick/0000-0001-5370-048X; Levivier, Marc/0000-0002-6273-2595			Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; Forsyth RJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub2; Gregson BA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-193; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; KAYE AH, 1999, OPERATIVE NEUROSURGE; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Marion DW, 2006, NEUROSURGERY, V58, P655; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Michel P, 2009, INT J STROKE, V4, P218, DOI 10.1111/j.1747-4949.2009.00283.x; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; PASQUALIN A, 1991, NEUROSURGERY, V28, P370, DOI 10.1227/00006123-199103000-00006; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Taussky P, 2008, BRIT J NEUROSURG, V22, P279, DOI 10.1080/02688690701818885; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Winn R, 2011, YOUMANS NEUROLOGICAL; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	48	12	12	0	5	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	JAN	2016	77	1					36	45		10.1055/s-0035-1563556			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DB4ZT	WOS:000368522900007	26351872				2022-02-06	
J	Sabre, L; Tomberg, T; Korv, J; Kepler, J; Kepler, K; Linnamagi, U; Asser, T				Sabre, L.; Tomberg, T.; Korv, J.; Kepler, J.; Kepler, K.; Linnamaegi, Ue; Asser, T.			Brain activation in the chronic phase of traumatic spinal cord injury	SPINAL CORD			English	Article							SYSTEM; PLASTICITY; REPAIR	Study design: Cross-sectional clinical study. Objectives: Plastic changes within cortical areas occur after traumatic spinal cord injury (TSCI). The aim of the study was to assess cortical activation in the chronic phase of TSCI using functional magnetic resonance imaging (fMRI). Setting: Tartu University Hospital, Tartu, Estonia. Methods: Ten right-handed patients with paraplegia and 18 healthy controls were studied by fMRI. Individuals performed simple flexion/extension of the right hand fingers and the right ankle during fMRI. The activation volumes, maximum t values (T max) and centres of gravity (COG) were calculated. Results: The mean time since trauma was 1848 +/- 1046 days (range 388-4459). During hand movements, the volume of activation (VOA) in the contralateral primary motor cortex was significantly larger among the TSCI patients who did not recover compared with the controls (4112 vs 2777, P=0.02). The VOA did not enlarge during the ankle movements (2420 vs 1114, P=0.08). There was a significant relationship between the VOA in Brodmann area 4 (BA4) and American Spinal Injury Association motor score during hand movements (r=-0.67, P=0.03). A positive correlation was found during hand movements in the VOA of BA4 and time since injury (r=0.62, P=0.05). Conclusions: We found increased cortical activation in the chronic phase of thoraco-lumbar TSCI that may be caused by increased use of upper limbs.	[Sabre, L.; Tomberg, T.; Korv, J.; Linnamaegi, Ue; Asser, T.] Univ Tartu, Dept Neurol & Neurosurg, 8L Puusepa St, EE-51014 Tartu, Estonia; [Tomberg, T.] Tartu Univ Hosp, Radiol Clin, Tartu, Estonia; [Kepler, J.] Parnu Hosp, Med Technol Serv, Parnu, Estonia; [Kepler, K.] Univ Tartu, Inst Phys, EE-51014 Tartu, Estonia		Sabre, L (corresponding author), Univ Tartu, Dept Neurol & Neurosurg, 8L Puusepa St, EE-51014 Tartu, Estonia.	liis.sabre@kliinikum.ee	Sabre, Liis/D-7931-2014; Korv, Janika/I-4395-2015	Sabre, Liis/0000-0002-5727-8404; Korv, Janika/0000-0002-6074-0727	Estonian Science Foundation [7868]; Estonian Institutional Research grant [IUT2-4]	The study was supported by the Estonian Science Foundation research grant No. 7868 and by the Estonian Institutional Research grant IUT2-4.	Brett M., 2002, NEUROIMAGE, P497; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Cadotte DW, 2013, NAT REV NEUROL, V9, P546, DOI 10.1038/nrneurol.2013.190; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Halder P, 2006, NEUROIMAGE, V31, P692, DOI 10.1016/j.neuroimage.2005.12.018; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Sabre L, 2013, SPINAL CORD, V51, P623, DOI 10.1038/sc.2013.41; Sabre L, 2012, SPINAL CORD, V50, P755, DOI 10.1038/sc.2012.54	20	12	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2016	54	1					65	68		10.1038/sc.2015.158			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DD1VJ	WOS:000369710400012	26391190	Bronze			2022-02-06	
J	Tzekov, R; Phifer, J; Myers, A; Mouzon, B; Crawford, F				Tzekov, Radouil; Phifer, Josie; Myers, April; Mouzon, Benoit; Crawford, Fiona			Inflammatory changes in optic nerve after closed-head repeated traumatic brain injury: Preliminary study	BRAIN INJURY			English	Article						Traumatic brain injury; vision; animal models; closed head injury	HUMAN TAU-ISOFORMS; TRANSGENIC MICE; MOUSE MODEL; AXONAL INJURY; PATHOLOGY; AGE; TAUOPATHY; GLAUCOMA; DAMAGE; HYPERPHOSPHORYLATION	Background: Closed-head, repeated, mild traumatic brain injury (r-mTBI) leads to inflammatory and degenerative changes in the optic nerve of young wild type mice. This work has investigated whether similar changes may be present when the same model is applied to htau mice, a transgenic mouse in which the non-mutated human tau gene is expressed on a null murine tau background.Methods: This study investigated neuropathological changes in the optic nerve in both young (15 weeks) and old (65-70 weeks) htau mice at 24 hours after r-mTBI or anaesthesia only (r-sham). Change in the level of cellularity, myelin content and astroglial reactivity were evaluated in optic nerve samples.Results: Increased cellularity and areas of demyelination were clearly detectable in the intracranial portion of the optic nerve in both young (10-15 weeks) and old (65-75) htau r-mTBI mice at 24 hours post-injury, in contrast to r-sham. Increased astroglial reactivity was also observed, together with increased tau phosphorylation.Conclusions: Localized inflammatory and degenerative response of the intracranial part of the optic nerve was detected in htau mice after r-mTBI. Further studies to clarify the cause and consequences of this phenomenon are warranted.	[Tzekov, Radouil; Phifer, Josie; Myers, April; Mouzon, Benoit; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Tzekov, Radouil] Univ S Florida, Dept Ophthalmol, Tampa, FL USA; [Tzekov, Radouil; Mouzon, Benoit; Crawford, Fiona] James Hayley Vet Adm Hosp, Tampa, FL USA		Tzekov, R (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	rtzekov@roskampinstitute.net		Tzekov, Radouil/0000-0002-3662-9818	Roskamp Foundation; Chronic Effects of Neurotrauma Consortium [CENC - VA I01 RX001774, DoD W81XWH-13-2-0095]	This work was funded by the Roskamp Foundation and supported by the Chronic Effects of Neurotrauma Consortium (CENC - VA I01 RX001774 and DoD W81XWH-13-2-0095). Dr. Crawford is a VA Research Career Scientist. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Adams SJ, 2009, AM J PATHOL, V175, P1598, DOI 10.2353/ajpath.2009.090462; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Belkadi A, 2008, J NEUROCHEM, V107, P351, DOI 10.1111/j.1471-4159.2008.05600.x; Bennett RE, 2016, GENETIC INFLUENCES T, P179; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Bull ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034724; Cavallotti C, 2002, CAN J OPHTHALMOL, V37, P389, DOI 10.1016/S0008-4182(02)80040-0; Cavallotti D, 2001, OPHTHALMOLOGICA, V215, P366, DOI 10.1159/000050887; Chiasseu M, 2016, J NEUROSCI, V36, P5785, DOI 10.1523/JNEUROSCI.3986-15.2016; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Higuchi M, 2005, J NEUROSCI, V25, P9434, DOI 10.1523/JNEUROSCI.2691-05.2005; Ho WL, 2012, MOL VIS, V18, P2700; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; MIGHELI A, 1988, J NEUROSCI, V8, P1846; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sandell JH, 2002, J COMP NEUROL, V445, P13, DOI 10.1002/cne.10162; SHELDON WG, 1995, LAB ANIM SCI, V45, P508; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Turner JWA, 1943, BRAIN, V66, P140; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, SURV OPHTHALMOL, V59, P414, DOI 10.1016/j.survophthal.2013.10.002; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Wang CH, 2013, EXP THER MED, V5, P621, DOI 10.3892/etm.2012.844; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Yoneda S, 2005, JPN J OPHTHALMOL, V49, P106, DOI 10.1007/s10384-004-0156-x; Zhang YQ, 2012, ACTA OPHTHALMOL, V90, pE295, DOI 10.1111/j.1755-3768.2011.02346.x; ZIMMERMAN LORENZ E., 1967, INVEST OPHTHALMOL, V6, P109	44	12	12	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1428	1435		10.1080/02699052.2016.1219062			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100004	27834542				2022-02-06	
J	van Velzen, JM; van Bennekom, CAM; van Dormolen, M; Sluiter, JK; Frings-Dresen, MHW				van Velzen, Judith M.; van Bennekom, Coen A. M.; van Dormolen, Max; Sluiter, Judith K.; Frings-Dresen, Monique H. W.			Evaluation of the implementation of the protocol of an early vocational rehabilitation intervention for people with acquired brain injury	DISABILITY AND REHABILITATION			English	Article						Acquired brain injury; intervention; stroke; traumatic brain injury; vocational	RETURN; WORK; GUIDELINES	Purpose: The purpose of this study was to evaluate (1) the feasibility of an early vocational rehabilitation (EVR) protocol in the standard rehabilitation process, (2) promoting factors and barriers encountered with the EVR protocol, and (3) perceived effectiveness of the protocol in facilitating return to work (RTW) following acquired brain injury (ABI). Method: A pre- and post-process evaluation was performed in a Dutch rehabilitation center. Dependent variables were feasibility (defined by the usability on process level and fulfillment of usability expectations), promoting factors and barriers, and perceived effectiveness of the protocol. Usability (defined by 13 performance and timing goals) was evaluated with existing forms and registrations. Fulfillment of usability expectations, perceived promoting factors and barriers, and perceived effectiveness were investigated with questionnaires. Data of 23 patients were available for process evaluation. Nine rehabilitation professionals, 10 patients with ABI, nine employers, and six occupational physicians completed the questionnaires. Results: Two-thirds of the performance goals and one-fourth of the timing goals were reached. All respondents cited the structured protocol as a promoting factor. Thirty-two of the thirty-four participants perceived the protocol as being suitable facilitating RTW after ABI. Conclusions: The EVR protocol provides a structured strategy to focus on RTW during standard rehabilitation. It is now possible to implement and test the protocol in other rehabilitation settings.	[van Velzen, Judith M.; van Bennekom, Coen A. M.; Sluiter, Judith K.; Frings-Dresen, Monique H. W.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, POB 22700, NL-1100 DE Amsterdam, Netherlands; [van Velzen, Judith M.; van Bennekom, Coen A. M.; van Dormolen, Max] Heliomare Rehabil Ctr, Inst Vocat Assessment & Educ, Dept Res & Dev, Wijk Aan Zee, Netherlands		van Velzen, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, POB 22700, NL-1100 DE Amsterdam, Netherlands.	j.vanvelzen@amc.uva.nl					Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Grol R, 2000, FAM PRACT, V17, pS32, DOI 10.1093/fampra/17.suppl_1.S32; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; HULSHOF CTJ, 2010, OCCUP HLTH WORK, V6, P19; Littlejohns P, 2000, FAM PRACT, V17, pS3, DOI 10.1093/fampra/17.suppl_1.S3; Rebergen DS, 2010, SCAND J WORK ENV HEA, V36, P488, DOI 10.5271/sjweh.3084; Tamminga SJ, 2012, J OCCUP REHABIL, V22, P565, DOI 10.1007/s10926-012-9372-2; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; van der Molen HF, 2005, SCAND J WORK ENV HEA, V31, P96; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; World Health Organization, 2002, INT CLASS FUNCT DISA	18	12	12	0	15	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2016	38	1					62	70		10.3109/09638288.2015.1017057			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DL7TA	WOS:000375841800008	25738905				2022-02-06	
J	Walker, JM; James, NT; Campbell, H; Wilson, SH; Churchill, S; Weaver, LK				Walker, James M.; James, Nathan T.; Campbell, Harlan; Wilson, Steffanie H.; Churchill, Susan; Weaver, Lindell K.			Sleep assessments for a mild traumatic brain injury trial in a military population	UNDERSEA AND HYPERBARIC MEDICINE			English	Article						actigraphy; sleep; brain concussion; post-concussive syndrome	RESTLESS LEGS SYNDROME; COMORBID INSOMNIA; STRESS-DISORDER; APNEA SYNDROME; EPIDEMIOLOGY; ACTIGRAPHY; PREVALENCE; HEALTH; QUESTIONNAIRE; DISTURBANCES	Baseline sleep characteristics were explored for 71 U.S. military service members with mild traumatic brain injury (mTBI) enrolled in a post-concussive syndrome clinical trial. The Pittsburgh Sleep Quality Index (PSQI), sleep diary, several disorder-specific questionnaires, actigraphy and polysomnographic nap were collected. Almost all (97%) reported ongoing sleep problems. The mean global PSQI score was 13.5 (SD=3.8) and 87% met insomnia criteria. Sleep maintenance efficiency was 79.1% for PSQI, 82.7% for sleep diary and 90.5% for actigraphy; total sleep time was 288, 302 and 400 minutes, respectively. There was no correlation between actigraphy and subjective questionnaires. Overall, 70% met hypersomnia conditions, 70% were at high risk for obstructive sleep apnea (OSA), 32% were symptomatic for restless legs syndrome, and 6% reported cataplexy. Nearly half (44%) reported coexisting insomnia, hypersomnia and high OSA risk. Participants with post-traumatic stress disorder (PTSD) had higher PSQI scores and increased OSA risk. Older participants and those with higher aggression, anxiety or depression also had increased OSA risk. The results confirm poor sleep quality in mTBI with insomnia, hypersomnia, and OSA risk higher than previously reported, and imply sleep disorders in mTBI may be under diagnosed or exacerbated by comorbid PTSD.	[Walker, James M.] PSG Profess Serv Inc, Farmington, UT USA; [Walker, James M.] Lovelace Biomed Res, Albuquerque, NM USA; [James, Nathan T.; Campbell, Harlan; Wilson, Steffanie H.] Emmes Corp, Rockville, MD USA; [Churchill, Susan; Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Churchill, Susan; Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA		Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA.	lindell.weaver@imail.org			U.S. Army Medical Materiel Development Activity	This work was supported by the U.S. Army Medical Materiel Development Activity. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army or its subordinate activities. Because the BIMA study is still ongoing, clinical trial data summarized in this publication has not yet been locked and is therefore subject to change.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Anic-Labat S, 1999, SLEEP, V22, P77; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Farney RJ, 2004, CHEST, V125, P1279, DOI 10.1378/chest.125.4.1279; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Khawaja IS, 2014, PAK J MED SCI, V30, P438; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lim MM, 2015, UPTODATE; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mitterling T, 2015, SLEEP, V38, P867, DOI 10.5665/sleep.4730; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Parthasarathy S, 2015, AM J MED, V128, P268, DOI 10.1016/j.amjmed.2014.10.015; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pillai V, 2012, SLEEP, V35, P897, DOI 10.5665/sleep.1940; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, P1; Vaughn BV, 2015, AASM MANUAL SCORING; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Walker JM, 2007, J CLIN SLEEP MED, V3, P455; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Watson NF, 2015, J CLIN SLEEP MED, V11, P931, DOI 10.5664/jcsm.4950; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	47	12	12	0	8	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.		2016	43	5			SI		549	566					18	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Marine & Freshwater Biology; Research & Experimental Medicine	EA8EE	WOS:000386867300006	28768073				2022-02-06	
J	Elliott, M				Elliott, Marta			Predicting Problems on Campus: An Analysis of College Student Veterans	ANALYSES OF SOCIAL ISSUES AND PUBLIC POLICY			English	Article							MENTAL-HEALTH PROBLEMS; TRAUMATIC BRAIN-INJURY; PEER SUPPORT; POSTTRAUMATIC-STRESS; COMBAT; IRAQ; DEPRESSION; SYMPTOMS; ALCOHOL; SCREEN		[Elliott, Marta] Univ Nevada, Sociol, Reno, NV 89557 USA		Elliott, M (corresponding author), Univ Nevada, 1664 N Virginia St, Reno, NV 89557 USA.	melliott@unr.edu		Elliott, Marta/0000-0003-1738-9887			Ackerman R., 2009, NEW DIRECTIONS STUDE, V126, P5, DOI [https://doi.org/10.1002/ss.311, DOI 10.1002/SS.311]; American Council on Education, 2013, TOOLK VET FRIENDL I; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 2012, MILITARY TIMES; [Anonymous], 2013, NY TIMES, pA17; Astin, 1993, WHAT MATTERS COLL 4; Barber JA, 2008, COMMUNITY MENT HLT J, V44, P433, DOI 10.1007/s10597-008-9146-7; Barnhart D., 2011, RELATIONSHIP ACAD SO; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; Basham K, 2008, CLIN SOC WORK J, V36, P83, DOI 10.1007/s10615-007-0138-9; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; BRAY RM, 1991, AM J PUBLIC HEALTH, V81, P865, DOI 10.2105/AJPH.81.7.865; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cate C. A., 2013, STUDENT VET AM RES B, V1; Church TE., 2009, J POSTSECOND ED DISA, V22, P224; DeAngelis T, 2008, APA MONITOR PSYCHOL, V39, P40; Defense Casualty Analysis System, 2013, CONFL CAS CONFL; Dennis JM, 2005, J COLL STUDENT DEV, V46, P223, DOI 10.1353/csd.2005.0023; Dennis ML, 2012, DRUG ALCOHOL DEPEN, V121, P10, DOI 10.1016/j.drugalcdep.2011.07.026; DiRamio D., 2011, ASHE HIGHER ED REPOR, V37; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Dobbins L., 2012, VITAL PROGRAM HELPS; Durdella NR., 2012, J STUD ED, V2, P109; Elliott M, 2000, HEALTH PLACE, V6, P287, DOI 10.1016/S1353-8292(00)00010-1; Elliott M., 2012, STATE STUDENT VET NE; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Festinger L., 1962, THEORY COGNITIVE DIS, V2; Gibbs DA, 2012, MIL MED, V177, P1178, DOI 10.7205/MILMED-D-12-00008; GLASSER I, 2009, ANTHR NEWS, V50, P33; Gonzalez C. A., 2013, EXAMINATION STUDENT; Greden JF, 2010, ANN NY ACAD SCI, V1208, P90, DOI 10.1111/j.1749-6632.2010.05719.x; HAMILTON RF, 1993, SOC FORCES, V71, P603, DOI 10.2307/2579887; HARPER SR, 2007, J MENS STUDIES, V0014, P00337, DOI DOI 10.3149/JMS.1403.337; Hassan A. M., 2010, CAMPUS, DOI DOI 10.1002/ABC.20020; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; Laffaye C, 2008, J TRAUMA STRESS, V21, P394, DOI 10.1002/jts.20348; Lipka S, 2011, CHRONICLE HIGHER ED; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Mead S, 2001, PSYCHIATR REHABIL J, V25, P134, DOI 10.1037/h0095032; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; MOSS MICHAEL, 2006, NEW YORK TIMES, pA1; Muthen L. K., 1998, MPLUS USERS GUIDE, V7th; PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956; PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676; Pew Research Center, 2011, MIL CIV GAP WAR SACR; Redden E., 2009, INSIDE HIGHER ED; Robinson R., 2004, INTRO POST DEPLOYMEN; Rounsaville BJ, 2000, HDB PSYCHIAT MEASURE, P460; Rudd MD, 2011, PROF PSYCHOL-RES PR, V42, P354, DOI 10.1037/a0025164; Sander L., 2012, CHRONICLE HIGHER ED; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Shackelford AL, 2009, J POSTSECOND EDUC DI, V22, P36; Steele JL., 2010, SERVICE MEMBERS SCH; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wheaton B., 1994, STRESS MENTAL HLTH C, P77, DOI [DOI 10.1007/978-1-4899-1106-3, 10.1007/978-1-4899-1106-3_4]; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001	60	12	12	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1529-7489	1530-2415		ANAL SOC ISS PUB POL	Anal. Soc. Issues Public Policy	DEC	2015	15	1					105	126		10.1111/asap.12066			22	Social Issues; Psychology, Social	Social Science Citation Index (SSCI)	Social Issues; Psychology	CZ3AC	WOS:000366975400007					2022-02-06	
J	Lazaridis, C; Yang, M; DeSantis, SM; Luo, ST; Robertson, CS				Lazaridis, Christos; Yang, Ming; DeSantis, Stacia M.; Luo, Sheng T.; Robertson, Claudia S.			Predictors of intensive care unit length of stay and intracranial pressure in severe traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Intensive care unit; Length of stay; Intracranial pressure; Computed tomography; Mass lesions	SEVERE HEAD-INJURY; CLASSIFICATION; MANAGEMENT; MODERATE; SCAN	Objective: The aim of this study was to explore the relationship of intracranial pressure (ICP) with intensive care unit (ICU) length of stay in a large cohort of severe traumatic brain injury patients and identify factors associating with prolonged ICU course. Methods: This was a single-center database review of de-identified research data that had been prospectively collected; setting: neurosurgical ICU, Ben Taub General Hospital, Houston, TX. Results: In a cohort of 438 severe traumatic brain injury (TBI) patients, 149 (34%) had a motor Glasgow Coma Scale score of 1 to 3 on admission and 284 (65%) had 4 to 5. Intracranial pressure during the ICU course was 19.8 +/- 11.2 mm Hg. Favorable outcome was obtained in 148 (34%), and unfavorable, in 211 (48%) patients with a mortality of 28%. ICU length of stay (LOS) was 19.4 +/- 13.9 days. Joint modeling of ICP and ICU LOS was undertaken, adjusted for the International Mission for Prognosis and Analysis of Clinical Trials in TBI admission prognostic indicators. A higher ICP was not significantly associated with longer ICU LOS (P = .4). However, presence of a mass lesion on admission head computed tomography was strongly correlated with a prolonged ICU LOS (P = .0007). Diffuse injuries with basal cistern compression or midline shift were marginally associated with a longer ICU LOS (P = .053). Conclusions: ICP, as monitored and managed according to BTF guidelines, is not associated with ICU length of stay. Patients with severe TBI and a mass lesion on admission head computed tomography were found to have prolonged ICU LOS independently of other indicators of injury severity and intracranial pressure course. (C) 2015 Elsevier Inc. All rights reserved.	[Lazaridis, Christos] Baylor Coll Med, Dept Neurol, Div Neurocrit Care, Houston, TX 77030 USA; [Yang, Ming; DeSantis, Stacia M.; Luo, Sheng T.] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Lazaridis, C (corresponding author), Dept Neurol, Div Neurocrit Care, 6501 Fannin St,MS NB 320, Houston, TX 77030 USA.	lazaridi@bcm.edu		Luo, Sheng/0000-0003-4214-5809; Yang, Ming/0000-0002-6211-9985	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS038660] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER		Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Bratton S, 2007, J NEUROTRAUM, V24, P7; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Coronado V, 2012, EPIDEMIOLOG IN PRESS; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Finkelstein E., 2006, INCIDENCE EC BURDEN; Henderson R, 2000, Biostatistics, V1, P465, DOI 10.1093/biostatistics/1.4.465; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; *WHO OMS, 2009, GLOB STAT REP ROAD S	24	12	13	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2015	30	6					1258	1262		10.1016/j.jcrc.2015.08.003			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0MX	WOS:000363945900020	26324412	Green Published, Green Accepted			2022-02-06	
J	Probst, MA; Dayan, PS; Raja, AS; Slovis, BH; Yadav, K; Lam, SH; Shapiro, JS; Farris, C; Babcock, CI; Griffey, RT; Robey, TE; Fortin, EM; Johnson, JO; Chong, ST; Davenport, M; Grigat, DW; Lang, EL				Probst, Marc A.; Dayan, Peter S.; Raja, Ali S.; Slovis, Benjamin H.; Yadav, Kabir; Lam, Samuel H.; Shapiro, Jason S.; Farris, Coreen; Babcock, Charlene I.; Griffey, Richard T.; Robey, Thomas E.; Fortin, Emily M.; Johnson, Jamlik O.; Chong, Suzanne T.; Davenport, Moira; Grigat, Daniel W.; Lang, Eddy L.			Knowledge Translation and Barriers to Imaging Optimization in the Emergency Department: A Research Agenda	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Academic-Emergency-Medicine (AEM) Consensus Conference	MAY 12, 2015	San Diego, CA	Acad Emergency Med			CLINICAL DECISION-SUPPORT; HEALTH INFORMATION EXCHANGE; COMPUTED-TOMOGRAPHY USE; TRAUMATIC BRAIN-INJURY; PHYSICIAN ORDER ENTRY; CT HEAD RULE; PRACTICE GUIDELINES; DEFENSIVE MEDICINE; AMERICAN-COLLEGE; CRITICAL-ISSUES	Researchers have attempted to optimize imaging utilization by describing which clinical variables are more predictive of acute disease and, conversely, what combination of variables can obviate the need for imaging. These results are then used to develop evidence-based clinical pathways, clinical decision instruments, and clinical practice guidelines. Despite the validation of these results in subsequent studies, with some demonstrating improved outcomes, their actual use is often limited. This article outlines a research agenda to promote the dissemination and implementation (also known as knowledge translation) of evidence-based interventions for emergency department (ED) imaging, i.e., clinical pathways, clinical decision instruments, and clinical practice guidelines. We convened a multidisciplinary group of stakeholders and held online and telephone discussions over a 6-month period culminating in an in-person meeting at the 2015 Academic Emergency Medicine consensus conference. We identified the following four overarching research questions: 1) what determinants (barriers and facilitators) influence emergency physicians' use of evidence-based interventions when ordering imaging in the ED; 2) what implementation strategies at the institutional level can improve the use of evidence-based interventions for ED imaging; 3) what interventions at the health care policy level can facilitate the adoption of evidence-based interventions for ED imaging; and 4) how can health information technology, including electronic health records, clinical decision support, and health information exchanges, be used to increase awareness, use, and adherence to evidence-based interventions for ED imaging? Advancing research that addresses these questions will provide valuable information as to how we can use evidence-based interventions to optimize imaging utilization and ultimately improve patient care. (C) 2015 by the Society for Academic Emergency Medicine	[Probst, Marc A.; Slovis, Benjamin H.; Shapiro, Jason S.] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA; [Raja, Ali S.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Yadav, Kabir] Univ Calif Los Angeles, Los Angeles Sch Med, Dept Emergency Med, Los Angeles, CA USA; [Lam, Samuel H.] Advocate Christ Med Ctr, Dept Emergency Med, Oak Lawn, IL USA; [Babcock, Charlene I.] St John Hosp & Med Ctr, Dept Emergency Med, Detroit, MI USA; [Griffey, Richard T.] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Robey, Thomas E.] Yale Univ, Waterbury Hosp, Dept Emergency Med, New Haven, CT USA; [Davenport, Moira] Allegheny Gen Hosp, Dept Emergency Med, Pittsburgh, PA 15212 USA; [Lang, Eddy L.] Univ Calgary, Dept Emergency Med, Calgary, AB, Canada; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Dept Pediat, Div Emergency Med, New York, NY 10032 USA; [Farris, Coreen] RAND Corp, Santa Monica, CA USA; [Farris, Coreen; Fortin, Emily M.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Johnson, Jamlik O.] Emory Healthcare, Dept Radiol, Atlanta, GA USA; [Chong, Suzanne T.] Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI USA; [Grigat, Daniel W.] Emergency Strateg Clin Network, Alberta Hlth Serv, Calgary, AB, Canada		Probst, MA (corresponding author), Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA.	mprobst@gmail.com	Raja, Ali S./AAE-5103-2019; Lang, Eddy/AAS-2080-2020	Griffey, Richard/0000-0002-6279-7380; Yadav, Kabir/0000-0002-1092-9935	Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1R13HS023498-01]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [1 R13 EB 019813-01]; Alberta Innovates [201300468] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R13HS023498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R13EB019813] Funding Source: NIH RePORTER	Funding for this conference was made possible (in part) by grant number 1R13HS023498-01 from the Agency for Healthcare Research and Quality (AHRQ) and grant number 1 R13 EB 019813-01 from the National Institute of Biomedical Imaging and Bioengineering. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.	Agrawal P, 2009, EMERG MED CLIN N AM, V27, P555, DOI 10.1016/j.emc.2009.07.001; American Board of Internal Medicine Foundation. Choosing Wisely, AM COLL EM PHYS 5 TH; American Board of Internal Medicine Foundation. Choosing Wisely, 2015, AM COLL RAD 5 THINGS; Anderson NR, 2007, INT J MED INFORM, V76, P821, DOI 10.1016/j.ijmedinf.2006.09.022; Andruchow JE, 2012, ARCH INTERN MED, V172, P660, DOI 10.1001/archinternmed.2011.2243; Arasu VA, 2015, J AM COLL RADIOL, V12, P467, DOI 10.1016/j.jacr.2014.11.018; Ash JS, 2007, J AM MED INFORM ASSN, V14, P415, DOI 10.1197/jamia.M2373; Ash JS, 2012, J AM MED INFORM ASSN, V19, P980, DOI 10.1136/amiajnl-2011-000705; Bailey JE, 2013, J GEN INTERN MED, V28, P176, DOI 10.1007/s11606-012-2092-7; Barac R, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/s12911-014-0121-7; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Beitia Anton Oscar, 2013, AMIA Annu Symp Proc, V2013, P94; Blackmore CC, 2011, J AM COLL RADIOL, V8, P19, DOI 10.1016/j.jacr.2010.07.009; Bourgeois FC, 2010, ARCH INTERN MED, V170, P1989, DOI 10.1001/archinternmed.2010.439; Bowen S, 2011, J AM COLL RADIOL, V8, P251, DOI 10.1016/j.jacr.2010.11.020; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Carr CM, 2014, J EMERG MED, V46, P250, DOI 10.1016/j.jemermed.2013.05.068; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Curran JA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-25; Curry L, 2011, J AM MED INFORM ASSN, V18, P267, DOI 10.1136/amiajnl-2011-000049; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Edlow JA, 2008, ANN EMERG MED, V52, P407, DOI 10.1016/j.annemergmed.2008.07.001; Erstad Tricia L, 2003, J Healthc Inf Manag, V17, P51; Finnell John T, 2011, AMIA Annu Symp Proc, V2011, P409; Frisse ME, 2007, J BIOMED INFORM, V40, pS27, DOI 10.1016/j.jbi.2007.08.004; Frisse ME, 2012, J AM MED INFORM ASSN, V19, P328, DOI [10.1136/amiajnl-2011-000394, 10.1136/amiajnl-2011000394]; Gaddis GM, 2007, ACAD EMERG MED, V14, P1015, DOI 10.1197/j.aem.2007.07.010; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Glanz K, 2008, AM J PREV MED, V35, pS3, DOI 10.1016/j.amepre.2008.04.011; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Green RA, 2015, ANN EMERG MED, V65, P679, DOI 10.1016/j.annemergmed.2014.11.017; Griffey RT, 2014, ACAD EMERG MED, V21, P768, DOI 10.1111/acem.12410; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; Hawasli AH, 2015, NEUROSURGERY, V76, P1, DOI 10.1227/NEU.0000000000000560; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Huff JS, 2007, ANN EMERG MED, V49, P431, DOI 10.1016/j.annemergmed.2007.02.001; Huff JS, 2014, ANN EMERG MED, V63, P437, DOI 10.1016/j.annemergmed.2014.01.018; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Ip IK, 2012, J AM COLL RADIOL, V9, P129, DOI 10.1016/j.jacr.2011.10.010; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Johnson KB, 2011, J AM MED INFORM ASSN, V18, P690, DOI 10.1136/amiajnl-2011-000308; Judkins A, 2013, ARCH DIS CHILD, V98, P521, DOI 10.1136/archdischild-2012-303032; Kanzaria HK, 2015, ACAD EMERG MED, V22, P390, DOI 10.1111/acem.12625; Kanzaria HK, 2015, ACAD EMERG MED, V22, P399, DOI 10.1111/acem.12627; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Khorasani R, 2001, RADIOGRAPHICS, V21, P1015, DOI 10.1148/radiographics.21.4.g01jl371015; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LaBorde DV, 2011, J AM MED INFORM ASSN, V18, P698, DOI 10.1136/amiajnl-2011-000140; Lammers EJ, 2014, MED CARE, V52, P227, DOI 10.1097/MLR.0000000000000067; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Levy G, 2006, AM J ROENTGENOL, V187, P855, DOI 10.2214/AJR.05.1055; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Melnick ER, 2010, ANN EMERG MED, V56, P317, DOI 10.1016/j.annemergmed.2010.03.006; Melnick ER, 2010, INT J EMERG MED, V3, P97, DOI 10.1007/s12245-010-0168-x; Menachemi N, 2006, J MED SYST, V30, P159, DOI 10.1007/s10916-005-7988-x; Menachemi N, 2011, RISK MANAG HEALTHC P, V4, P47, DOI 10.2147/RMHP.S12985; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Neta G, 2015, AM J PUBLIC HEALTH, V105, P49, DOI 10.2105/AJPH.2014.302206; Overhage JM, 2005, J AM MED INFORM ASSN, V12, P107, DOI 10.1197/jamia.M1680; Overhage JM, 2002, ANN EMERG MED, V39, P14, DOI 10.1067/mem.2002.120794; Perry JJ, 2006, INJURY, V37, P1157, DOI 10.1016/j.injury.2006.07.028; Perry JJ, 2013, JAMA-J AM MED ASSOC, V310, P1248, DOI 10.1001/jama.2013.278018; Pines JM, 2009, AM J EMERG MED, V27, P552, DOI 10.1016/j.ajem.2008.04.031; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Raja AS, 2014, AM J ROENTGENOL, V203, P355, DOI 10.2214/AJR.13.11892; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Raja AS, 2010, ANN EMERG MED, V56, P597, DOI 10.1016/j.annemergmed.2010.09.013; Rosenthal Daniel I, 2006, J Am Coll Radiol, V3, P799, DOI 10.1016/j.jacr.2006.05.006; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Sathiyakumar V, 2013, J ORTHOP TRAUMA, V27, P592, DOI 10.1097/BOT.0b013e31828b7ab4; Schuur JD, 2014, JAMA INTERN MED, V174, P509, DOI 10.1001/jamainternmed.2013.12688; Schuur JD, 2011, ANN EMERG MED, V57, P704, DOI 10.1016/j.annemergmed.2011.02.011; Shah LM, 2014, J AM COLL RADIOL, V11, P1002, DOI 10.1016/j.jacr.2013.12.015; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Straus SE, 2011, J CLIN EPIDEMIOL, V64, P6, DOI 10.1016/j.jclinepi.2009.08.016; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Walker Jan, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Wang SJ, 2003, AM J MED, V114, P397, DOI 10.1016/S0002-9343(03)00057-3; Waxman DA, 2014, NEW ENGL J MED, V371, P1518, DOI 10.1056/NEJMsa1313308; Winters BD, 2009, CRIT CARE, V13, DOI 10.1186/cc7792; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7; Yamada J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006808; Zuccotti G, 2014, APPL CLIN INFORM, V5, P746, DOI 10.4338/ACI-2014-02-RA-0018	96	12	12	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2015	22	12			SI		1455	1464		10.1111/acem.12830			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	DA5FP	WOS:000367828900012	26568148	Bronze			2022-02-06	
J	Toklu, HZ; Muller-Delp, J; Yang, ZH; Oktay, S; Sakarya, Y; Strang, K; Ghosh, P; Delp, MD; Scarpace, PJ; Wang, KKW; Tumer, N				Toklu, Hale Z.; Muller-Delp, Judy; Yang, Zhihui; Oktay, Sehkar; Sakarya, Yasemin; Strang, Kevin; Ghosh, Payal; Delp, Michael D.; Scarpace, Philip J.; Wang, Kevin K. W.; Tuemer, Nihal			The functional and structural changes in the basilar artery due to overpressure blast injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						basilar artery; endothelium; endothelin; NO; overpressure blast injury; trauma	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL NO SYNTHASE; SUBARACHNOID HEMORRHAGE; BARRIER PERMEABILITY; OXIDATIVE STRESS; CEREBRAL VASOSPASM; NITRIC-OXIDE; TETRAHYDROBIOPTERIN; INFLAMMATION; PRESSURE	Overpressure blast-wave induced brain injury (OBI) leads to progressive pathophysiologic changes resulting in a reduction in brain blood flow, blood brain barrier breakdown, edema, and cerebral ischemia. The aim of this study was to evaluate cerebral vascular function after single and repeated OBI. Male Sprague-Dawley rats were divided into three groups: Control (Naive), single OBI (30 psi peak pressure, 1 to 2 msec duration), and repeated (days 1, 4, and 7) OBI (r-OBI). Rats were killed 24 hours after injury and the basilar artery was isolated, cannulated, and pressurized (90 cm H2O). Vascular responses to potassium chloride (KCl) (30 to 100 mmol/L), endothelin-1 (10(-12) to 10(-7) mol/L), acetylcholine (ACh) (10(-10) to 10(-4) mol/L) and diethylamine-NONO-ate (DEA-NONO-ate) (10(-10) to 10(-4) mol/L) were evaluated. The OBI resulted in an increase in the contractile responses to endothelin and a decrease in the relaxant responses to ACh in both single and r-OBI groups. However, impaired DEA-NONO-ate-induced vasodilation and increased wall thickness to lumen ratio were observed only in the r-OBI group. The endothelin-1 type A (ETA) receptor and endothelial nitric oxide synthase (eNOS) immunoreactivity were significantly enhanced by OBI. These findings indicate that both single and r-OBI impairs cerebral vascular endothelium-dependent dilation, potentially a consequence of endothelial dysfunction and/or vascular remodelling in basilar arteries after OBI.	[Toklu, Hale Z.; Sakarya, Yasemin; Tuemer, Nihal] Malcolm Randall Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Gainesville, FL 32608 USA; [Toklu, Hale Z.; Oktay, Sehkar; Sakarya, Yasemin; Scarpace, Philip J.; Tuemer, Nihal] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Muller-Delp, Judy] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Yang, Zhihui; Strang, Kevin; Wang, Kevin K. W.] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarker Res, Gainesville, FL USA; [Oktay, Sehkar] Marmara Univ, Sch Dent, Istanbul, Turkey; [Ghosh, Payal; Delp, Michael D.] Florida State Univ, Coll Human Sci, Dept Nutr Food & Exercise Sci, Tallahassee, FL 32306 USA		Toklu, HZ (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, 1200 Newell Dr PO 100267, Gainesville, FL 32610 USA.	haletoklu@yahoo.com; ntumer@ufl.edu	Toklu, Hale/AAR-2330-2020	Toklu, Hale/0000-0002-9797-3591; Delp, Michael/0000-0002-2916-0783; Wang, Kevin/0000-0002-9343-6473; Muller-Delp, Judy/0000-0001-5322-0611	North Florida/South Georgia Veterans Health System, Research/GRECC, Gainesville, FL; McKnight Brain Institute, University of Florida, Gainesville, FL; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028740] Funding Source: NIH RePORTER	This study was supported by the North Florida/South Georgia Veterans Health System, Research/GRECC, Gainesville, FL and McKnight Brain Institute, University of Florida, Gainesville, FL.	Bachschmid MM, 2013, ANN MED, V45, P17, DOI 10.3109/07853890.2011.645498; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bevers LM, 2006, HYPERTENSION, V47, P87, DOI 10.1161/01.HYP.0000196735.85398.0e; Biber N, 2009, BRAIN INJURY, V23, P577, DOI 10.1080/02699050902926317; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Covey Dana C, 2010, J Surg Orthop Adv, V19, P8; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Ersahin M, 2010, J NEUROTRAUM, V27, P1143, DOI 10.1089/neu.2009.1210; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Gardner A.J., 2014, BR J SPORTS MED; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hutter BO, 2001, J NEUROSURG, V94, P241, DOI 10.3171/jns.2001.94.2.0241; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lauer N, 2005, CARDIOVASC RES, V65, P254, DOI 10.1016/j.cardiores.2004.09.010; Lekic T, 2012, J BIOMED BIOTECHNOL, V2012, P587; Mattle HP, 2011, LANCET NEUROL, V10, P1002, DOI 10.1016/S1474-4422(11)70229-0; Muller-Delp JM, 2012, MICROCIRCULATION, V19, P19, DOI 10.1111/j.1549-8719.2011.00139.x; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Ohicita M, 2012, J PHARMACOL SCI, V119, P302, DOI 10.1254/jphs.12R01CR; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sams R, 2012, MIL MED, V177, P48, DOI 10.7205/MILMED-D-11-00214; SCOTTBURDEN T, 1994, TEX HEART I J, V21, P91; Sindler AL, 2009, J PHYSIOL-LONDON, V587, P3885, DOI 10.1113/jphysiol.2009.172221; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Toklu HZ, 2014, J NEUROTRAUM, V31, pA116; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Tumer N, 2014, PHYSL REP, V2, P1; Vuceljic Marina, 2006, Vojnosanit Pregl, V63, P545, DOI 10.2298/VSP0606545V; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; ZELLERS TM, 1991, CIRC RES, V68, P1437, DOI 10.1161/01.RES.68.5.1437; Zubkov AY, 2009, NEUROL RES, V31, P626, DOI 10.1179/174313209X382331	37	12	12	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2015	35	12					1950	1956		10.1038/jcbfm.2015.151			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CX7OI	WOS:000365891300006	26104291	Green Published, Bronze			2022-02-06	
J	Warren, AM; Boals, A; Elliott, TR; Reynolds, M; Weddle, RJ; Holtz, P; Trost, Z; Foreman, ML				Warren, Ann Marie; Boals, Adriel; Elliott, Timothy R.; Reynolds, Megan; Weddle, Rebecca Jo; Holtz, Pamela; Trost, Zina; Foreman, Michael L.			Mild traumatic brain injury increases risk for the development of posttraumatic stress disorder	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	45th Annual Meeting of the Western-Trauma-Association	MAR 01-06, 2015	Telluride, CO	Western Trauma Assoc		Posttraumatic stress disorder; mild traumatic brain injury; Level 1 trauma center	SYMPTOMS; PTSD	BACKGROUND Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) occur in individuals who sustain physical injury and share a significant overlap in symptoms. PTSD rates in the civilian injury population range from 20% to 40%. The current study examined the presence of PTSD symptoms at multiple time points (3 months and 6 months after injury) among individuals with and without TBI after admission to a Level I trauma center. METHODS This prospective cohort study included patients 18 years and older admitted to a Level I trauma center for 24 hours or greater. Demographic and injury-related data were gathered in addition to assessments of PTSD during initial hospitalization after injury, as well as 3 months and 6 months later. The Primary Care PTSD Screen and PTSD Checklist-Civilian version were used to determine probable PTSD. International Classification of Diseases, 9th Rev. codes were used to determine mild TBI (MTBI). RESULTS A total of 494 patients were enrolled at baseline, 311 (63%) completed 3-month follow-up, and 231 (47%) completed 6-month follow-up at the time of analysis. Preinjury PTSD was reported by 7% of the participants. At 3 months, patients with MTBI evidenced a probable PTSD rate of 18%, compared with a rate of 9% for patients with no MTBI (p = 0.04), although this relationship became a nonsignificant trend (p = 0.06) when demographics were included. At 6 months, patients with MTBI evidenced a probable PTSD rate of 26%, compared with a rate of 15% for patients with no MTBI (p = 0.04), and this relationship remained significant when demographics were included. Preinjury history of TBI did not predict PTSD, but incidence of TBI for the injury in which they were hospitalized did predict PTSD. CONCLUSION TBI at time of injury demonstrated a nonsignificant trend toward higher rates of PTSD at 3 months and significantly predicted PTSD at 6 months after injury. This important finding may help clinicians identify patients at high risk for PTSD after injury and target these patients for screening, intervention, and referral for treatment. LEVEL OF EVIDENCE Prognostic study, level III.	[Warren, Ann Marie; Reynolds, Megan; Weddle, Rebecca Jo; Foreman, Michael L.] Baylor Univ, Med Ctr, Div Trauma Acute Care & Crit Care Surg, Dept Surg, Dallas, TX 75246 USA; [Boals, Adriel; Holtz, Pamela; Trost, Zina] Univ N Texas, Dept Psychol, Denton, TX 76203 USA; [Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA		Warren, AM (corresponding author), Baylor Univ, Med Ctr, Wadley 1155, Dallas, TX 75246 USA.	AnnMariW@baylorhealth.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714; Warren, Ann Marie/0000-0002-3753-5573	Stanley Seeger Surgical Fund of the Baylor Healthcare System Foundation	Support for this study was graciously provided by the Stanley Seeger Surgical Fund of the Baylor Healthcare System Foundation. No other conflicts of interest exist.	American College of Surgeons, 2006, RESOURCES OPTIMAL CA; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Butler DL, 2011, CARING VETERANS DEPL, P87; Center for Disease Control and Prevention (CDC), 2014, INJ PREV CONTR DAT S; Centers for Disease Control and Prevention National Center for Health Statistics, 2015, CLASS DIS FUNCT DIS; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Hanley J, 2013, J TRAUMA ACUTE CARE, V75, P722, DOI 10.1097/TA.0b013e3182a53a5f; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Osenbach JE, 2014, PSYCHIATRY, V77, P386, DOI 10.1521/psyc.2014.77.4.386; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Reese C, 2012, J TRAUMA ACUTE CARE, V73, P462, DOI 10.1097/TA.0b013e31825ff713; Rubin DC, 2013, CLIN PSYCHOL SCI, V1, P375, DOI 10.1177/2167702613483112; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 2011, TREATING PTSD MILITA, P239; Weathers FW, 1996, MEASUREMENT STRESS T, P250; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; World Health Organization, 2014, INT STAT CLASS DIS R	28	12	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2015	79	6					1062	1066		10.1097/TA.0000000000000875			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	CX4TD	WOS:000365692300042	26488326				2022-02-06	
J	Kim, SG; Lee, EH; Hwang, ST; Park, K; Chey, J; Hong, SH; Kim, JH				Kim, Sung-Geon; Lee, Eun-Ho; Hwang, Soon-Taeg; Park, Kwangbai; Chey, Jeanyung; Hong, Sang-Hwang; Kim, Ji-Hae			Estimation of K-WAIS-IV Premorbid Intelligence in South Korea: Development of the KPIE-IV	CLINICAL NEUROPSYCHOLOGIST			English	Article						Estimated intelligence; OPIE; KPIE.; Premorbid intelligence; WAIS-IV	TRAUMATIC BRAIN-INJURY; CLINICAL UTILITY; NEUROCOGNITIVE DEFICITS; DEMOGRAPHIC-VARIABLES; COMBINED PERFORMANCE; SCALE-4TH EDITION; OPIE-3; INDEX; IQ	Objective: The accurate estimation of premorbid intellectual functioning in patients with known or suspected cognitive impairment is crucial for clinicians. However, there is no reliable method for estimating premorbid intelligence in South Korea. The purpose of this study was to develop the Korea Premorbid Intelligence Estimate (KPIE) as an estimate of the premorbid intellectual functioning. Method: Data from the Korean WAIS-IV standardization sample were used to generate several Full Scale Intelligence Quotient (FSIQ) estimation formulas using demographic variables and current WAIS-IV subtest performance. The standardization sample (N=1216) was randomly divided into two groups: the first group was used to develop the formulas and the second group was used to validate the prediction equations. Age, education, gender, region of the country, and select subtest raw scores (Vocabulary, Information, Matrix Reasoning, and Visual Puzzle) were used as predictor variables. Results: Five KPIE-4 equations were generated. Estimated FSIQ derived from the KPIE-4 equation is highly correlated with K-WAIS-IV FSIQ. Conclusions: The resulting formulas for estimating premorbid FSIQ were highly significant and precise in predicting FSIQ scores of participants in the K-WAIS-IV normative sample. These equations provide a means for clinicians to estimate intellectual functioning in adults, and can be utilized as a method of estimating individuals premorbid functioning.	[Kim, Sung-Geon; Kim, Ji-Hae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 50 Irwon Dong, Seoul 137710, South Korea; [Lee, Eun-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat,Depress Ctr, Seoul 137710, South Korea; [Hwang, Soon-Taeg; Park, Kwangbai] Chungbuk Natl Univ, Dept Psychol, Chungju, South Korea; [Chey, Jeanyung] Seoul Natl Univ, Dept Psychol, Seoul, South Korea; [Hong, Sang-Hwang] Chinju Natl Univ Educ, Dept Educ, Chinju, South Korea		Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 50 Irwon Dong, Seoul 137710, South Korea.	jihae0931.kim@samsung.com		Lee, Eun-ho/0000-0003-2550-8225			Baxendale S, 2014, J CLIN EXP NEUROPSYC, V36, P137, DOI 10.1080/13803395.2013.870535; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; EPPINGER MG, 1987, J CONSULT CLIN PSYCH, V55, P86, DOI 10.1037/0022-006X.55.1.86; Fallows RR, 2012, CLIN NEUROPSYCHOL, V26, P942, DOI 10.1080/13854046.2012.697193; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Groth-Marnat, 2009, HDB PSYCHOL ASSESSME; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Jaeger J, 2006, PSYCHIAT RES, V145, P39, DOI 10.1016/j.psychres.2005.11.011; Kim HK, 2001, KOREAN J CLIN PSYCHO, V20, P155; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Kurtz MM, 2009, NEUROPSYCHOLOGY, V23, P551, DOI 10.1037/a0016277; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2012, KOREAN WECHSLER ADUL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1955, MANUAL WECHSLER ADUL; Weiss LG, 2010, PRACT RESOUR MENT, P1; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242	21	12	12	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 10	2015	29			1			19	29		10.1080/13854046.2015.1072248			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DG5HK	WOS:000372107700002	26247852				2022-02-06	
J	Bueso-Izquierdo, N; Hart, SD; Hidalgo-Ruzzante, N; Kropp, PR; Perez-Garcia, M				Bueso-Izquierdo, Natalia; Hart, Stephen D.; Hidalgo-Ruzzante, Natalia; Kropp, P. Randall; Perez-Garcia, Miguel			The mind of the male batterer: A neuroscience perspective	AGGRESSION AND VIOLENT BEHAVIOR			English	Article						Intimate partner violence; Batterers; Neuropsychology; Neuroimaging and psychophysiology	INTIMATE PARTNER VIOLENCE; EXECUTIVE FUNCTION DEFICITS; TRAUMATIC BRAIN-INJURY; HEART-RATE REACTIVITY; DOMESTIC VIOLENCE; COGNITIVE NEUROSCIENCE; AGGRESSIVE-BEHAVIOR; MEN; ALCOHOL; PERPETRATION	This review analyzes neuropsychology, psychophysiology, and neuroimaging studies that examine the neuropsychological functioning and the nervous system (central and peripheral) of male batterers. Previous research has attempted to establish a neuropsychological profile for batterers. Yet factors such as brain injury, drug abuse antecedents, and other methodological concerns (e.g., sample size, control group selection, education level, socio-economic status, ethnicity, variability of the specific neuropsychological measures, and constructs assessed) may have led to inconsistent results. Neuropsychological studies reveal that poor performance on tests of executive functioning, verbal skills, and vocabulary is the most frequently reported characteristic for these men. With regard to research on the central and peripheral nervous system, these results should be considered with caution due to the small number of studies conducted on this topic. Therefore, the neuroscientific approach may be utilized in future studies to provide a better account of batterer typologies, the individualization of therapeutic approaches, and the prediction of recidivism. In summary, advancing our understanding of the mind and brain functioning of male batterers may aid in the prediction and reduction of violence against women in the future. (C) 2015 Elsevier Ltd. All rights reserved.	[Bueso-Izquierdo, Natalia; Perez-Garcia, Miguel] Univ Granada, Sch Psychol, E-18071 Granada, Spain; [Bueso-Izquierdo, Natalia; Hidalgo-Ruzzante, Natalia; Perez-Garcia, Miguel] Univ Granada CIMCYC UGR, Brain Mind & Behav Res Ctr, Granada 18071, Spain; [Hart, Stephen D.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Hidalgo-Ruzzante, Natalia] Univ Granada, Dept Evolutionary & Educ Psychol, E-18071 Granada, Spain; [Kropp, P. Randall] Forens Psychiat Serv Commiss British Columbia, Vancouver, BC V5A 1P8, Canada; [Perez-Garcia, Miguel] CIBERSAM, Cibersam Ctr Invest Biomed Red Salud Mental, Granada C1BERSAM, Spain		Bueso-Izquierdo, N (corresponding author), Univ Granada CIMCYC UGR, Brain Mind & Behav Res Ctr, Spain Campus Cartuja S-N, Granada 18071, Spain.	nbueso@ugr.es; hart@sfu.ca; nhidalgo@ugr.es; rkropp@sfu.ca; mperezg@ugr.es	Hidalgo-Ruzzante, Natalia/F-1108-2016; Hart, Stephen D./D-3908-2013; Garcia, Miguel Perez/F-9630-2010	Hidalgo-Ruzzante, Natalia/0000-0002-9952-9478; Hart, Stephen D./0000-0002-1027-6081; Garcia, Miguel Perez/0000-0003-4775-7556; Bueso Izquierdo, Natalia/0000-0002-2469-8867	Ministry of Science and Innovation, Spain (MICINN)Spanish Government [PSI 2009-13585]; Ministry of Economy and Competitiveness [PSI2013-42792-R]; Regional Ministry of Economy, Innovation and Science from Andalusian Government [P2012-SEJ1723]	This work has been funded by grants grant by the Ministry of Science and Innovation, Spain (MICINN) (Project: PSI 2009-13585), Ministry of Economy and Competitiveness (Project: PSI2013-42792-R), and Regional Ministry of Economy, Innovation and Science from Andalusian Government (Project: P2012-SEJ1723). The authors declare no conflicts of interest.	Babcock JC, 2005, J ABNORM PSYCHOL, V114, P444, DOI 10.1037/0021-843X.114.3.444; Babcock JC, 2004, J FAM PSYCHOL, V18, P396, DOI 10.1037/0893-3200.18.2.396; Bell KM, 2008, CLIN PSYCHOL REV, V28, P1096, DOI 10.1016/j.cpr.2008.03.003; Blair RJR, 2013, SOC NEUROSCI-UK, V8, P108, DOI 10.1080/17470919.2012.757869; Cacioppo JT, 2000, PSYCHOL BULL, V126, P829, DOI 10.1037//0033-2909.126.6.829; Chan SC, 2010, PSYCHIAT RES, V176, P246, DOI 10.1016/j.psychres.2008.12.013; Chiao JY, 2009, PROG BRAIN RES, V178, P287, DOI 10.1016/S0079-6123(09)17821-4; Choi MH, 2011, PSYCHIAT RES, V186, P441, DOI 10.1016/j.psychres.2010.08.035; Claramunt C., 1999, CASITAS QUEBRADAS PR; Cohen R A, 1999, Violence Vict, V14, P397; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Corvo K., 2006, J AGGRESS MALTREAT T, V13, P49; Corvo K, 2014, PARTN ABUSE, V5, P342, DOI 10.1891/1946-6560.5.3.342; Corvo K, 2015, PARTN ABUSE, V6, P351, DOI 10.1891/1946-6560.6.3.351; Corvo K, 2013, AGGRESS VIOLENT BEH, V18, P175, DOI 10.1016/j.avb.2012.11.017; Easton CJ, 2008, AM J DRUG ALCOHOL AB, V34, P29, DOI 10.1080/00952990701764326; Echeverri-Vera JA., 2010, PENSANDO PSICOLOGIA, V6, P157; Fabian JM, 2010, AGGRESS VIOLENT BEH, V15, P209, DOI 10.1016/j.avb.2009.12.004; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Fernandez-Serrano MJ, 2011, NEUROSCI BIOBEHAV R, V35, P377, DOI 10.1016/j.neubiorev.2010.04.008; FitzGeraid M. J. T., 2011, CLIN NEUROANATOMY NE; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; George DT, 2004, PSYCHIAT RES-NEUROIM, V130, P11, DOI 10.1016/S0925-4927(03)00105-7; Gondolf E W, 1997, Violence Vict, V12, P373; Gondolf E W, 1988, Violence Vict, V3, P187; GOTTMAN JM, 1995, J FAM PSYCHOL, V9, P227, DOI 10.1037/0893-3200.9.3.227; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Holtzworth-Munroe A, 2000, J CONSULT CLIN PSYCH, V68, P1000, DOI 10.1037/0022-006X.68.6.1000; HOLTZWORTHMUNROE A, 1994, PSYCHOL BULL, V116, P476, DOI 10.1037/0033-2909.116.3.476; JACOBSON NS, 1994, J CONSULT CLIN PSYCH, V62, P982, DOI 10.1037/0022-006X.62.5.982; Kingsnorth R, 2006, VIOLENCE AGAINST WOM, V12, P917, DOI 10.1177/1077801206293081; Lee TMC, 2008, MOL PSYCHIATR, V13, P655, DOI 10.1038/mp.2008.46; Lee TMC, 2009, J CLIN PSYCHIAT, V70, P36, DOI 10.4088/JCP.08m04143; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loinaz I, 2010, PSICOTHEMA, V22, P106; MARGOLIN G, 1988, J CONSULT CLIN PSYCH, V56, P24, DOI 10.1037/0022-006X.56.1.24; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; McMurran M, 2008, PSYCHOL CRIME LAW, V14, P107, DOI 10.1080/10683160701483435; Meehan JC, 2001, J FAM PSYCHOL, V15, P394, DOI 10.1037//0893-3200.15.3.394; Merino B., 2009, C IN DENTR CURS HUM, V21, P1; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Murphy CM, 2010, AGGRESS VIOLENT BEH, V15, P325, DOI 10.1016/j.avb.2010.01.006; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Patrick CJ, 2008, PHILOS T R SOC B, V363, P2543, DOI 10.1098/rstb.2008.0028; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Puente A. E., 2013, HDB MULTICULTURAL ME, VSecond, P225; Romero-Martinez A, 2013, INT J PSYCHOPHYSIOL, V90, P329, DOI 10.1016/j.ijpsycho.2013.10.003; Romero-Martinez A, 2014, STRESS, V17, P321, DOI 10.3109/10253890.2014.919448; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Schafer J, 1997, ADDICT BEHAV, V22, P127, DOI 10.1016/S0306-4603(96)00012-3; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Siegel JP, 2013, TRAUMA VIOLENCE ABUS, V14, P295, DOI 10.1177/1524838013495982; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Stanford MS, 2007, PERS INDIV DIFFER, V43, P365, DOI 10.1016/j.paid.2006.12.011; Teichner G, 2001, INT J NEUROSCI, V111, P241, DOI 10.3109/00207450108994235; Thomas MD, 2013, J FAM VIOLENCE, V28, P121, DOI 10.1007/s10896-012-9479-4; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Villemarette-Pittman N. R., 2002, PERSONALITY INDIVIDU, V34, P1533, DOI DOI 10.1016/S0191-8869(02)00136-8; Walling SM, 2012, J MARITAL FAM THER, V38, P471, DOI 10.1111/j.1752-0606.2011.00226.x; Westby MD, 1999, GENET SOC GEN PSYCH, V125, P71; World Health Organisation, 2013, GLOB REG EST VIOL WO; Zhang LS, 2013, ADDICT BIOL, V18, P537, DOI 10.1111/j.1369-1600.2011.00381.x	66	12	12	1	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-1789	1873-6335		AGGRESS VIOLENT BEH	Aggress. Violent Behav.	NOV-DEC	2015	25		B				243	251		10.1016/j.avb.2015.09.009			9	Criminology & Penology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	CY9ZW	WOS:000366765900007					2022-02-06	
J	Krych, AJ; Sousa, PL; King, AH; Morgan, JA; May, JH; Dahm, DL				Krych, Aaron J.; Sousa, Paul L.; King, Alexander H.; Morgan, Joseph A.; May, Jedediah H.; Dahm, Diane L.			The Effect of Cartilage Injury After Arthroscopic Stabilization for Shoulder Instability	ORTHOPEDICS			English	Article							HUMERAL HEAD; OSTEOCHONDRITIS-DISSECANS; INTRAARTICULAR PATHOLOGY; ANTERIOR DISLOCATION; AMERICAN SHOULDER; LESIONS; RESPONSIVENESS; OSTEOARTHRITIS; ARTHROPLASTY; RELIABILITY	This study was undertaken to (1) determine the incidence of articular cartilage injuries in patients with instability of the glenohumeral joint, (2) determine whether recurrent dislocations increased the risk of articular damage, and (3) correlate these injuries with postoperative clinical outcomes. A cohort was identified of consecutive patients who underwent diagnostic magnetic resonance imaging and shoulder arthroscopy for glenohumeral instability with documented dislocation or subluxation between 1997 and 2006 at a single institution. Patients with moderate or severe osteoarthritis were excluded. Arthroscopic findings were recorded, including lesion location and Outerbridge grade. The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES) was used to assess outcome in 61 patients who were available for follow-up. Outcomes were compared between shoulders with and without articular lesions. A total of 87 shoulders (83 patients) met the inclusion criteria, with 69 (83%) men and 14 (17%) women. Mean age was 26.1 years (range, 18-64 years), and mean follow-up was 36 months (range, 33-39 months). Cartilage injuries were found in 56 shoulders (64%). Previously documented shoulder dislocation requiring closed reduction (P=.046) and the number of discrete dislocations (P=.032) were significant for glenoid injury. A greater number of dislocations was associated with higher-grade lesions of the glenohumeral joint (P<.001). Overall, mean ASES score was 89.6 (range, 37-100). In patients with an articular cartilage lesion, mean ASES score was 90.4 (range, 58-100) compared with 88.1 (range, 37-100) in those without this injury (P=.75). Although clinical outcomes were not significantly affected, further investigation is warranted to establish a relationship between these injuries and longer-term outcomes.	[Krych, Aaron J.; Morgan, Joseph A.; May, Jedediah H.; Dahm, Diane L.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Sousa, Paul L.; King, Alexander H.] Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA		Krych, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	Krych.Aaron@Mayo.edu		King, Alexander/0000-0003-3102-4657	Arthrex, Inc.	Mr Sousa, Mr King, Dr Morgan, Dr May, and Dr Dahm have no relevant financial relationships to disclose. Dr Krych's institution receives consulting fees from Arthrex, Inc.	ANDERSON WJ, 1983, CLIN ORTHOP RELAT R, P166; Buscayret F, 2004, AM J SPORT MED, V32, P1165, DOI 10.1177/0363546503262686; CALANDRA J J, 1989, Arthroscopy, V5, P254, DOI 10.1016/0749-8063(89)90138-2; Cameron ML, 2003, AM J SPORT MED, V31, P53, DOI 10.1177/03635465030310012001; Carroll KW, 2001, AM J ROENTGENOL, V176, P393, DOI 10.2214/ajr.176.2.1760393; Crall TS, 2012, ARTHROSCOPY, V28, P1755, DOI 10.1016/j.arthro.2012.05.885; Guntern DV, 2003, RADIOLOGY, V226, P165, DOI 10.1148/radiol.2261012090; HINTERMANN B, 1995, AM J SPORT MED, V23, P545, DOI 10.1177/036354659502300505; Hovelius L, 1996, J BONE JOINT SURG AM, V78A, P1677, DOI 10.2106/00004623-199611000-00006; Hsu HC, 2003, ACTA ORTHOP SCAND, V74, P89, DOI 10.1080/00016470310013725; Jeon IH, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.007708; Johnson DL, 1997, J SHOULDER ELB SURG, V6, P160, DOI 10.1016/S1058-2746(97)90038-0; Kocher MS, 2005, J BONE JOINT SURG AM, V87A, P2006, DOI 10.2106/JBJS.C.01624; McCarty LP, 2005, ARTHROSCOPY, V21, P1131, DOI 10.1016/j.arthro.2005.06.023; Messner K, 1996, ACTA ORTHOP SCAND, V67, P523, DOI 10.3109/17453679608996682; Michener LA, 2002, J SHOULDER ELB SURG, V11, P587, DOI 10.1067/mse.2002.127096; NEER CS, 1974, J BONE JOINT SURG AM, VA 56, P1; NORLIN R, 1993, ARTHROSCOPY, V9, P546, DOI 10.1016/S0749-8063(05)80402-5; Ogawa K, 2006, J SHOULDER ELB SURG, V15, P23, DOI 10.1016/j.jse.2005.05.011; Robinson CM, 2008, J BONE JOINT SURG AM, V90A, P708, DOI 10.2106/JBJS.G.00679; Ruckstuhl H, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-107; SAMILSON RL, 1983, J BONE JOINT SURG AM, V65, P456, DOI 10.2106/00004623-198365040-00005; Sperling JW, 2002, J BONE JOINT SURG AM, V84A, P1775, DOI 10.2106/00004623-200210000-00006; Werner A, 2003, UNFALLCHIRURG, V106, P110, DOI 10.1007/s00113-002-0480-x	24	12	12	0	3	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0147-7447	1938-2367		ORTHOPEDICS	Orthopedics	NOV	2015	38	11					E965	E969		10.3928/01477447-20151020-03			5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	DA5JT	WOS:000367840100003	26558675				2022-02-06	
J	Cheng, CY; Ho, CH; Wang, CC; Liang, FW; Wang, JJ; Chio, CC; Chang, CH; Kuo, JR				Cheng, Chieh-Yang; Ho, Chung-Han; Wang, Che-Chuan; Liang, Fu-Wen; Wang, Jhi-Joung; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung			One-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients-A Ten-Year Population-Based Study	MEDICINE			English	Article							HEPATITIS-C VIRUS; ALCOHOL-CONSUMPTION; B-VIRUS; ESSENTIAL-HYPERTENSION; CLINICAL-RELEVANCE; NONHEPATIC SURGERY; MEDICAL PROGRESS; RENAL-FAILURE; FOLLOW-UP; DISEASE	This study investigated the 1-year mortality of patients who underwent brain surgery following traumatic brain injury (TBI) who also had alcoholic and/or nonalcoholic liver cirrhosis (LC) using a nationwide database in Taiwan. A longitudinal cohort study matched by propensity score with age, gender, length of ICU stay, HTN, DM, MI, stroke, HF, renal diseases, and year of TBI diagnosis in TBI patients with alcoholic and/or nonalcoholic LC and TBI patients without LC was conducted using the National Health Insurance Research Database in Taiwan between January 1997 and December 2007. The main outcome studied was 1-year mortality. In total, 7296 subjects (2432 TBI patients with LC and 4864 TBI patients without LC) were enrolled in this study. The main findings were (1) TBI patients with LC had a higher 1-year mortality (52.18% vs 30.61%) and a 1.75-fold increased risk of mortality (95% CI 1.61-1.90) compared with non-LC TBI patients, (2) renal diseases and HF are risk factors, but hypertension could be a protective factor in cirrhotic TBI patients, and (3) TBI patients with non-alcoholic LC and the coexistence of alcoholic and nonalcoholic LC had higher 1-year mortality compared with TBI patients with alcoholic cirrhosis. This study showed that patients with LC who have undergone brain surgery might have higher risk of 1-year mortality than those without LC. In addition, nonalcoholic and the coexistence of alcoholic and nonalcoholic LC show higher 1-year mortality risk than alcoholic in TBI patients with LC, especially in those with comorbidities of hypertension, diabetes mellitus, and stroke.	[Cheng, Chieh-Yang; Wang, Che-Chuan; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, ChildCare, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Dept Publ Hlth, Tainan 701, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Hlth Care Adm, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Traumat Brain Ctr, Dept Neurosurg, 901 Zhonghua Rd, Tainan 710, Taiwan.	kuojinnrung@gmail.com		Liang, Fu-Wen/0000-0002-3396-037X; Ho, Chung-Han/0000-0001-5925-8477	Chi-Mei Medical Center [CMFHR10337]	This study is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health, and Welfare and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, the Ministry of Health and Welfare or the National Health Research Institutes. In addition, this work was supported by Chi-Mei Medical Center grant number CMFHR10337.	Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Andersen UO, 2002, BLOOD PRESSURE, V11, P357, DOI 10.1080/080370502321095320; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338; CHEN DS, 1977, NEW ENGL J MED, V297, P668; CHEN DS, 1990, J INFECT DIS, V162, P817, DOI 10.1093/infdis/162.4.817; Chen YW, 2010, J AM GERIATR SOC, V58, P2230, DOI 10.1111/j.1532-5415.2010.03102.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien CC, 2012, AM J HYPERTENS, V25, P900, DOI 10.1038/ajh.2012.60; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chou YC, 2013, J HEAD TRAUMA REHAB; Christmas AB, 2005, AM SURGEON, V71, P996; Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000; Corrao G, 1998, HEPATOLOGY, V27, P914, DOI 10.1002/hep.510270404; de Goede B, 2012, BEST PRACT RES CL GA, V26, P47, DOI 10.1016/j.bpg.2012.01.010; Fede G, 2012, J HEPATOL, V56, P810, DOI 10.1016/j.jhep.2011.10.016; Georgiou C, 2009, WORLD J SURG, V33, P1087, DOI 10.1007/s00268-009-9923-7; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Hayashi PH, 2005, MED CLIN N AM, V89, P371, DOI 10.1016/j.mcna.2004.08.014; Henriksen JH, 2006, WORLD J GASTROENTERO, V12, P678, DOI 10.3748/wjg.v12.i5.678; Jepsen P, 2008, HEPATOLOGY, V48, P214, DOI 10.1002/hep.22341; Kerr WC, 2000, ADDICTION, V95, P339, DOI 10.1046/j.1360-0443.2000.9533394.x; Krousel-Wood MA, 2004, MED CLIN N AM, V88, P223, DOI 10.1016/S0025-7125(03)00126-3; Lai CH, 2011, STROKE, V42, P2615, DOI 10.1161/STROKEAHA.111.617076; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093956; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Lin Tung-Yi, 2014, Biomed J, V37, P18, DOI 10.4103/2319-4170.113376; LOYKE HF, 1962, ARCH INTERN MED, V110, P45, DOI 10.1001/archinte.1962.03620190047006; Lustenberger T, 2011, AM SURGEON, V77, P311; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MENDENHALL CL, 1991, HEPATOLOGY, V14, P581; Moller S, 2002, HEART, V87, P9, DOI 10.1136/heart.87.1.9; Mueller S, 2009, WORLD J GASTROENTERO, V15, P3462, DOI 10.3748/wjg.15.3462; Neeff HP, 2014, SURGERY, V155, P623, DOI 10.1016/j.surg.2013.11.009; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Riggio Oliviero, 2010, World J Gastrointest Pharmacol Ther, V1, P54, DOI 10.4292/wjgpt.v1.i2.54; Roman E., 2010, AM J GASTROENTEROL; SCHWARTZ DT, 1967, ANN INTERN MED, V66, P862, DOI 10.7326/0003-4819-66-5-862; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tarantino G, 2013, WORLD J GASTROENTERO, V19, P3375, DOI 10.3748/wjg.v19.i22.3375; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; TINKOFF G, 1990, ANN SURG, V211, P172, DOI 10.1097/00000658-199002000-00009; VEGLIO F, 1992, CLIN EXP HYPERTENS A, V14, P889, DOI 10.3109/10641969209036225; Wahlstrom K, 2000, AM SURGEON, V66, P1071; Wiese S, 2014, NAT REV GASTRO HEPAT, V11, P177, DOI 10.1038/nrgastro.2013.210; Younossi ZM, 2013, ALIMENT PHARM THER, V37, P703, DOI 10.1111/apt.12265; [No title captured]	51	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	OCT	2015	94	40							e1468	10.1097/MD.0000000000001468			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC7NC	WOS:000369406100001	26448001	Green Published, gold			2022-02-06	
J	Harrison, DA; Griggs, KA; Prabhu, G; Gomes, M; Lecky, FE; Hutchinson, PJA; Menon, DK; Rowan, KM				Harrison, David A.; Griggs, Kathryn A.; Prabhu, Gita; Gomes, Manuel; Lecky, Fiona E.; Hutchinson, Peter J. A.; Menon, David K.; Rowan, Kathryn M.		Risk Adjustment Neurocritical Care	External Validation and Recalibration of Risk Prediction Models for Acute Traumatic Brain Injury among Critically Ill Adult Patients in the United Kingdom	JOURNAL OF NEUROTRAUMA			English	Article						outcome measures; prospective study; traumatic brain injury	LONG-TERM OUTCOMES; HEAD-INJURY; PROGNOSTIC-FACTORS; CARE; MORTALITY; MODERATE; IMPACT; RECOVERY; CLASSIFICATION; EPIDEMIOLOGY	This study validates risk prediction models for acute traumatic brain injury (TBI) in critical care units in the United Kingdom and recalibrates the models to this population. The Risk Adjustment In Neurocritical care (RAIN) Study was a prospective, observational cohort study in 67 adult critical care units. Adult patients admitted to critical care following acute TBI with a last pre-sedation Glasgow Coma Scale score of less than 15 were recruited. The primary outcomes were mortality and unfavorable outcome (death or severe disability, assessed using the Extended Glasgow Outcome Scale) at six months following TBI. Of 3626 critical care unit admissions, 2975 were analyzed. Following imputation of missing outcomes, mortality at six months was 25.7% and unfavorable outcome 57.4%. Ten risk prediction models were validated from Hukkelhoven and colleagues, the Medical Research Council (MRC) Corticosteroid Randomisation After Significant Head Injury (CRASH) Trial Collaborators, and the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) group. The model with the best discrimination was the IMPACT Lab model (C index, 0.779 for mortality and 0.713 for unfavorable outcome). This model was well calibrated for mortality at six months but substantially under-predicted the risk of unfavorable outcome. Recalibration of the models resulted in small improvements in discrimination and excellent calibration for all models. The risk prediction models demonstrated sufficient statistical performance to support their use in research and audit but fell below the level required to guide individual patient decision-making. The published models for unfavorable outcome at six months had poor calibration in the UK critical care setting and the models recalibrated to this setting should be used in future research.	[Harrison, David A.; Griggs, Kathryn A.; Prabhu, Gita; Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr, Clin Trials Unit, London WC1V 6AZ, England; [Gomes, Manuel] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Lecky, Fiona E.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Hutchinson, Peter J. A.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge, England		Harrison, DA (corresponding author), Intens Care Natl Audit & Res Ctr, Clin Trials Unit, Napier House,24 High Holborn, London WC1V 6AZ, England.	david.harrison@icnarc.org	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Grieve, Richard/0000-0001-8899-1301; Hutchinson, Peter/0000-0002-2796-1835; Rowan, Kathryn/0000-0001-8217-5602; Gomes, Manuel/0000-0002-1428-1232	National Institute for Health Research Health Technology Assessment (NIHR HTA) ProgrammeNational Institute for Health Research (NIHR) [07/37/29]; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Neurocritical Care Network; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, 07/37/29, NF-SI-0512-10090] Funding Source: researchfish	This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 07/37/29) and has been published in full in Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PJAH was supported by the NIHR Cambridge Biomedical Research Centre.; The authors wish to thank all the participants for taking part in the study, GPs and health care professionals for their assistance in patient follow-up, the Scottish Intensive Care Society Audit Group for providing access to their database, the Trauma Audit and Research Network for providing data for verification of recruitment, and the Neurocritical Care Network for adopting and supporting the study.	Brier GW, 1950, MON WEATHER REV, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P418, DOI 10.1016/j.apmr.2007.01.010; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Efron B., 1993, INTRO BOOTSTRAP; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hayes J A, 2000, Health Technol Assess, V4, P1; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Johnson P, 2006, BRAIN COGNITION, V60, P205; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; LI KH, 1991, STAT SINICA, V1, P65; Liao CC, 2007, J TRAUMA, V63, P827, DOI 10.1097/TA.0b013e31814b9466; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Oh Hyun Soo, 2006, Taehan Kanho Hakhoe Chi, V36, P621; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pape TLB, 2006, BRAIN INJURY, V20, P743, DOI 10.1080/02699050600676933; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Rocker GM, 2006, CAN J ANAESTH, V53, P814, DOI 10.1007/BF03022799; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rubin D.B., 1987, MULTIPLE IMPUTATION; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Skrobik Y, 2006, CAN J ANAESTH, V53, P432, DOI 10.1007/BF03022613; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; The CRASH trial management group, 2001, BMC Emerg Med, V1, P1; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; van Buuren S, 2011, J STAT SOFTW, V45, P1; Xu XY, 2007, BRAIN INJURY, V21, P575, DOI 10.1080/02699050701426881; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	56	12	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1522	1537		10.1089/neu.2014.3628			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500010	25898072	Green Published			2022-02-06	
J	Lee, M; Chen, ZZ; Tomlinson, BN; Gooyit, M; Hesek, D; Juarez, MR; Nizam, R; Boggess, B; Lastochkin, E; Schroeder, VA; Wolter, WR; Suckow, MA; Cui, JC; Mobashery, S; Gu, ZZ; Chang, M				Lee, Mijoon; Chen, Zhenzhou; Tomlinson, Brittany N.; Gooyit, Major; Hesek, Dusan; Juarez, Maria Raquel; Nizam, Rasheeq; Boggess, Bill; Lastochkin, Elena; Schroeder, Valerie A.; Wolter, William R.; Suckow, Mark A.; Cui, Jiancun; Mobashery, Shahriar; Gu, Zezong; Chang, Mayland			Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						MMP-9; prodrug; brain distribution; traumatic brain injury	GELATINASE INHIBITOR; MATRIX METALLOPROTEINASES; POTENT; BLOOD; MATRIX-METALLOPROTEINASE-9; BARRIER; BINDING	SB-3CT is a potent and selective inhibitor of matrix metalloproteinase (MMP)-2 and -9, which has shown efficacy in an animal model of severe traumatic brain injury (TBI). However, SB-3CT is poorly water-soluble and is metabolized primarily to p-hydroxy SB-3CT (2), a more potent inhibitor than SB-3CT. We synthesized the O-phosphate prodrug (3) of compound 2 to enhance its water solubility by more than 2000-fold. The prodrug 3 was a poor MMP inhibitor, but readily hydrolyzed to the active 2 in human blood. Pharmacokinetics and brain distribution studies in mice showed that 2 crossed the blood-brain barrier (BBB) and achieved therapeutic concentrations in the brain. The prodrug 3/compound 2 was evaluated in a mouse model of severe TBI and found to significantly decrease the brain lesion volume and improve neurological outcomes. MMP-9 inhibition by a water-soluble thiirane inhibitor is a promising therapy for treatment of TBI.	[Lee, Mijoon; Gooyit, Major; Hesek, Dusan; Boggess, Bill; Lastochkin, Elena; Mobashery, Shahriar; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Wolter, William R.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Wolter, William R.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chen, Zhenzhou; Tomlinson, Brittany N.; Juarez, Maria Raquel; Nizam, Rasheeq; Cui, Jiancun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Chen, Zhenzhou; Tomlinson, Brittany N.; Juarez, Maria Raquel; Nizam, Rasheeq; Cui, Jiancun; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO 65212 USA		Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA.	guze@health.missouri.edu; mchang@nd.edu		Lee, Mijoon/0000-0001-7432-0427; Suckow, Mark/0000-0001-7317-697X	Indiana Department of Health Spinal Cord and Brain Injury Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM075762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075762] Funding Source: NIH RePORTER	This work was supported by a grant from the Indiana Department of Health Spinal Cord and Brain Injury Fund. M.G. is a Fellow of the Chemistry-Biochemistry-Biology Interface Program, supported by a training grant GM075762 from the National Institutes of Health.	Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Faul M, 2010, TRAUMATIC BRAIN INJU; Forbes C, 2009, CHEM BIOL DRUG DES, V74, P527, DOI 10.1111/j.1747-0285.2009.00881.x; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gooyit M, 2011, J MED CHEM, V54, P6676, DOI 10.1021/jm200566e; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Lee M, 2009, CHEM BIOL DRUG DES, V73, P189, DOI 10.1111/j.1747-0285.2008.00750.x; O'Daniel PI, 2014, J AM CHEM SOC, V136, P3664, DOI 10.1021/ja500053x; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Pardridge William M, 2005, NeuroRx, V2, P3; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Testero SA, 2011, ACS MED CHEM LETT, V2, P177, DOI 10.1021/ml100254e; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000	20	12	12	0	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	OCT	2015	6	10					1658	1664		10.1021/acschemneuro.5b00140			7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	CU3OS	WOS:000363435300001	26241578	Green Accepted			2022-02-06	
J	Plackett, TP; Asturias, S; Tadlock, M; Wright, F; Ton-That, H; Demetriades, D; Esposito, T; Inaba, K				Plackett, Timothy P.; Asturias, Sabrina; Tadlock, Matthew; Wright, Franklin; Ton-That, Hieu; Demetriades, Demetrios; Esposito, Thomas; Inaba, Kenji			Re-evaluating the need for hospital admission and observation of pediatric traumatic brain injury after a normal head CT	JOURNAL OF PEDIATRIC SURGERY			English	Article						Traumatic brain injury; Concussion; Closed head injury; Pediatrics; Blunt head trauma; Resource utilization	CHILDREN; MANAGEMENT	There is no consensus on the optimal management of pediatric patients with suspected trauma brain injury and a normal head CT. This study characterizes the clinical outcomes of patients with a normal initial CT scan of the head. A retrospective chart review of pediatric blunt trauma patients who underwent head CT for closed head injury at two trauma centers was performed. Charts were reviewed for demographics, neurologic function, CT findings, and complications. 631 blunt pediatric trauma patients underwent a head CT. 63% had a negative CT, 7% had a non-displaced skull fracture, and 31% had an intracranial hemorrhage and/or displaced skull fracture. For patients without intracranial injury, the mean age was 8 years, mean ISS was 5, and 92% had a GCS of 13-15 on arrival. All patients with an initial GCS of 13-15 and no intracranial injury were eventually discharged to home with a normal neurologic exam and no patient required craniotomy. Not admitting those children with an initial GCS of 13-15, normal CT scan, and no other injuries would have saved 1.8 +/- 1.5 hospital days per patient. Pediatric patients who have sustained head trauma, have a negative CT scan, and present with a GCS 13-15 can safely be discharged home without admission. Published by Elsevier Inc.	[Plackett, Timothy P.; Wright, Franklin; Ton-That, Hieu; Esposito, Thomas] Loyola Univ, Med Ctr, Dept Surg, Div Trauma Surg Crit Care & Burns, Maywood, IL 60153 USA; [Asturias, Sabrina; Tadlock, Matthew; Demetriades, Demetrios; Inaba, Kenji] Los Angeles Cty Univ Southern Calif Med Ctr, Div Acute Care Surg & Surg Crit Care, Dept Surg, Los Angeles, CA USA		Plackett, TP (corresponding author), Loyola Univ, Med Ctr, Dept Surg, 2160 S First Ave, Maywood, IL 60153 USA.	tplacke@lumc.edu; sasturias@hotmail.com; matthewtadlockmd@gmail.com; fwright@gmail.com; hton@lumc.edu; demetria@usc.edu; tesposi@gmail.com; kenji.inaba@med.usc.edu	INABA, KENJI/AAC-8532-2020	Wright, Franklin/0000-0002-4433-5385			Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bergman DA, 1999, PEDIATRICS, V104, P1407; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Martin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014	11	12	12	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	OCT	2015	50	10					1758	1761		10.1016/j.jpedsurg.2015.03.067			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	CU1HI	WOS:000363271000027	25957025				2022-02-06	
J	Findler, P				Findler, Patrick			SHOULD KIDS PLAY (AMERICAN) FOOTBALL?	JOURNAL OF THE PHILOSOPHY OF SPORT			English	Article						children; football; dangerous sport; chronic traumatic encephalopathy	HEAD IMPACT EXPOSURE; DANGEROUS SPORT; YOUTH FOOTBALL; CONCUSSION	In recent years, Pop Warner, the world's largest youth football organization, has seen its numbers decline. This decline is due to concerns about new research establishing a link between football and chronic traumatic encephalopathy, a debilitating neurodegenerative disease. Hundreds of thousands of parents are now struggling with a difficult ethical issue: should kids play football? Since parents have an obligation to help children develop the capacities required for autonomous choice, the risks posed by football establish a strong presumption against allowing kids to play the game. I consider whether this presumption can be defeated by the arguments for allowing kids to play dangerous sports offered by John Russell in his papers 'The Value of Dangerous Sport' and Children and Dangerous Sport and Recreation'. While Russell does not argue that kids should be permitted to play football, and agrees that some sports may be too risky for children, he argues that kids should often be allowed to participate in extraordinarily risky sports. I contend that the reasons given in support of this position fail to defeat the presumption against allowing kids to play football. Thus, in the absence of further argument, or radical changes to the game, children should not play football.	Kwantlen Polytech Univ, Dept Philosophy, Surrey, BC, Canada		Findler, P (corresponding author), Kwantlen Polytech Univ, Dept Philosophy, Surrey, BC, Canada.	Patrick.Findler@kpu.ca			k polytechnic university	This work was supported by the k polytechnic university.	BELLER JM, 1995, PEDIATR EXERC SCI, V7, P352, DOI 10.1123/pes.7.4.352; Belson K., 2014, NY TIMES; Boston University CTE Center, 2015, 18 YEAR OLD HIGH SCH; Boston University CTE Center, 2015, WHAT IS CTE; Breslow J. M., 2014, 76 79 DECASED NFL PL; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Brussoni M, 2012, INT J ENV RES PUB HE, V9, P3134, DOI 10.3390/ijerph9093134; Butler J., 2013, US TODAY; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Coleman DL, 2013, PEDIATRICS, V131, P786, DOI 10.1542/peds.2012-2470; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; DeLessio J., 2014, NEW YORK MAGAZINE; Dixon N., 2001, SOCIAL THEORY PRACTI, V27, P323; Fainaru S., 2013, ESPN; Gbajabiamila A., 2013, NFL; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Howe LA, 2008, J PHILOS SPORT, V35, P1; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kirk M., 2013, FRONTLINE INTERVIEW; Kucera KL, 2014, ANN SURVEY FOOTBALL; Mandell Nina, 2013, US TODAY; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moser R.S., 2012, AHEAD GAME PARENTS G; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Russell JS, 2007, J PHILOS SPORT, V34, P176, DOI 10.1080/00948705.2007.9714720; Russell JS, 2005, J PHILOS SPORT, V32, P1; Sailors PR, 2015, J PHILOS SPORT, V42, P269, DOI 10.1080/00948705.2014.1000338; Sandseter EBH, 2009, CONTEMP ISS EARLY CH, V10, P92, DOI 10.2304/ciec.2009.10.2.92; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; SIMON RL, 2003, SPORT ETHICS ANTHOLO, P15; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Swartz A., 2010, NY TIMES; Thompson Derek, 2014, ATLANTIC; Walsh N., 2011, MEDPAGE TODAY; WCVB. com, 2011, BRAIN EXP KIDS SHOUL	38	12	12	0	25	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0094-8705	1543-2939		J PHILOS SPORT	J. Philos. Sport	SEP 2	2015	42	3					443	462		10.1080/00948705.2015.1079132			20	Ethics; Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	CS3EV	WOS:000361955500001					2022-02-06	
J	Blow, AJ; Curtis, AF; Wittenborn, AK; Gorman, L				Blow, Adrian J.; Curtis, Ansley Fraser; Wittenborn, Andrea K.; Gorman, Lisa			Relationship Problems and Military Related PTSD: The Case for Using Emotionally Focused Therapy for Couples	CONTEMPORARY FAMILY THERAPY			English	Article						Couple therapy; Marital therapy; Military couples; PTSD; Emotionally focused therapy	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; RESOLVING ATTACHMENT INJURIES; VIETNAM COMBAT VETERANS; PSYCHOLOGICAL DISTRESS; SOCIAL SUPPORT; MENTAL-HEALTH; RISK-FACTORS; SYMPTOMS; SOLDIERS	In this paper, the authors argue that effective couple interventions are important for the military given the impact deployment-related posttraumatic stress disorder (PTSD) has on couple relationships. The authors review the literature on military relationships and how PTSD, in particular, is problematic for these relationships. The authors then review evidence based couple therapy interventions targeting military couples and argue that Emotionally Focused Therapy is an ideally suited means of working with these couples as they face PTSD.	[Blow, Adrian J.] Michigan State Univ, Couple & Family Therapy Program, Dept Human Dev & Family Studies, Human Ecol 3B, 552 W Circle Dr, E Lansing, MI 48824 USA; [Curtis, Ansley Fraser] Providence Serv Corp, Catalyst Program, San Diego, CA 92111 USA; [Wittenborn, Andrea K.] Michigan State Univ, Couple & Family Therapy Program, Dept Human Dev & Family Studies, Human Ecol 13E, E Lansing, MI 48824 USA; [Gorman, Lisa] Michigan Publ Hlth Inst, Okemos, MI 48864 USA		Blow, AJ (corresponding author), Michigan State Univ, Couple & Family Therapy Program, Dept Human Dev & Family Studies, Human Ecol 3B, 552 W Circle Dr, E Lansing, MI 48824 USA.	blowa@msu.edu; aefraser@vt.edu; andreaw@msu.edu; lgorman@mphi.org	Blow, Adrian/U-1647-2019	Wittenborn, Andrea/0000-0003-4608-0635			Adler L.B., 2001, J ARMY MED DEP, V2, P15; Allen ES, 2010, J FAM PSYCHOL, V24, P280, DOI 10.1037/a0019405; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; BARRETT TW, 1988, BEHAV MODIF, V12, P100, DOI 10.1177/01454455880121005; Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; Bay EH, 2012, J MARITAL FAM THER, V38, P556, DOI 10.1111/j.1752-0606.2011.00231.x; Blow AJ, 2013, J FAM PSYCHOL, V27, P303, DOI 10.1037/a0031881; Bradley B, 2004, J MARITAL FAM THER, V30, P233, DOI 10.1111/j.1752-0606.2004.tb01236.x; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; CARROLL EM, 1985, J ABNORM PSYCHOL, V94, P329, DOI 10.1037/0021-843X.94.3.329; Cloutier PR, 2002, J MARITAL FAM THER, V28, P391, DOI 10.1111/j.1752-0606.2002.tb00364.x; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Cook JM, 2004, J FAM PSYCHOL, V18, P36, DOI 10.1037/0893-3200.18.1.36; Dalton EJ, 2013, COUPLE FAM PSYCHOL, V2, P209, DOI 10.1037/a0032772; Dekel R, 2005, FAM RELAT, V54, P24, DOI 10.1111/j.0197-6664.2005.00003.x; Dekel R, 2006, J FAM PSYCHOL, V20, P709, DOI 10.1037/0893-3200.20.4.709; Denton WH, 2012, J MARITAL FAM THER, V38, P23, DOI 10.1111/j.1752-0606.2012.00291.x; Denton WH, 2000, J MARITAL FAM THER, V26, P65, DOI 10.1111/j.1752-0606.2000.tb00277.x; Department of Defense, 2013, 2013 DEM PROF MIL CO; Dessaulles A, 2003, AM J FAM THER, V31, P345, DOI 10.1080/01926180390232266; Erbes CR, 2008, J CLIN PSYCHOL, V64, P972, DOI 10.1002/jclp.20521; Erbes CR, 2012, J TRAUMA STRESS, V25, P187, DOI 10.1002/jts.21689; Fincham FD, 2010, J MARRIAGE FAM, V72, P630, DOI 10.1111/j.1741-3737.2010.00722.x; Foa E.B., 2000, EFFECTIVE TREATMENTS; Ford JD, 1998, J MARITAL FAM THER, V24, P243, DOI 10.1111/j.1752-0606.1998.tb01080.x; Furrow JL, 2012, J MARITAL FAM THER, V38, P39, DOI 10.1111/j.1752-0606.2012.00293.x; Furrow JL, 2011, EMOTIONALLY FOCUSED CASEBOOK: NEW DIRECTIONS IN TREATING COUPLES, P1; Gerlock AA, 2014, J MARITAL FAM THER, V40, P344, DOI 10.1111/jmft.12017; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Glynn S. M., 1990, J CONSULT CLIN PSYCH, V67, P243; Goff BSN, 2007, J FAM PSYCHOL, V21, P344, DOI 10.1037/0893-3200.21.3.344; Goff BSN, 2005, J MARITAL FAM THER, V31, P145, DOI 10.1111/j.1752-0606.2005.tb01552.x; Gorman LA, 2011, PSYCHIAT SERV, V62, P28, DOI 10.1176/ps.62.1.pss6201_0028; Greenman PS, 2012, J CLIN PSYCHOL, V68, P561, DOI 10.1002/jclp.21853; Guay S, 2006, J TRAUMA STRESS, V19, P327, DOI 10.1002/jts.20124; Halchuk RE, 2010, J COUPLE RELATSH THE, V9, P31, DOI 10.1080/15332690903473069; Herman J.L., 1992, TRAUMA RECOVERY; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jankowski MK, 2004, J TRAUMA STRESS, V17, P303, DOI 10.1023/B:JOTS.0000038478.63664.5f; Johnson S., 2012, COUPLE FAMILY RELATI; Johnson S. M., 2004, PRACTICE EMOTIONALLY, V2nd; Johnson SM, 2002, GUIL FAM TH, P3; Johnson SM, 1999, CLIN PSYCHOL-SCI PR, V6, P67, DOI 10.1093/clipsy/6.1.67; Johnson SM, 1998, J MARITAL FAM THER, V24, P25, DOI 10.1111/j.1752-0606.1998.tb01061.x; Johnson SM, 2001, J MARITAL FAM THER, V27, P145, DOI 10.1111/j.1752-0606.2001.tb01152.x; Johnson SM, 2002, EFFECTIVENESS RES MA, P163; JOHNSON SM, 2004, HDB STRESS TRAUMA FA, P493; Keane TM, 2006, ANNU REV CLIN PSYCHO, V2, P161, DOI 10.1146/annurev.clinpsy.2.022305.095305; Lambert JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082599; Lambert JE, 2012, J FAM PSYCHOL, V26, P729, DOI 10.1037/a0029341; Lepore SJ, 2002, PSYCHOL HEALTH, V17, P547, DOI 10.1080/08870440290025768; Litz B. T., 2009, PTSD RES Q, V20, P1; MacIntosh HB, 2008, J MARITAL FAM THER, V34, P298, DOI 10.1111/j.1752-0606.2008.00074.x; Makinen JA, 2006, J CONSULT CLIN PSYCH, V74, P1055, DOI 10.1037/0022-006X.74.6.1055; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; Monson CM, 2012, JAMA-J AM MED ASSOC, V308, P700, DOI 10.1001/jama.2012.9307; Monson CM, 2011, J TRAUMA STRESS, V24, P97, DOI 10.1002/jts.20604; Monson CM, 2004, J TRAUMA STRESS, V17, P341, DOI 10.1023/B:JOTS.0000038483.69570.5b; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Renshaw KD, 2011, J FAM PSYCHOL, V25, P953, DOI 10.1037/a0025871; Rheem K., 2012, HDB COUNSELING MILIT; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; ROBERTS WR, 1982, J ABNORM PSYCHOL, V91, P444, DOI 10.1037/0021-843X.91.6.444; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2004, J TRAUMA STRESS, V17, P85, DOI 10.1023/B:JOTS.0000022614.21794.f4; Shadish W., 2002, EFFECTIVENESS RES MA; Sherman MD, 2005, PROF PSYCHOL-RES PR, V36, P626, DOI 10.1037/0735-7028.36.6.626; Sherman MD, 2006, J MARITAL FAM THER, V32, P479, DOI 10.1111/j.1752-0606.2006.tb01622.x; Sneath L, 2011, PSYCHOSOC STRES, P127; SOLOMON Z, 1990, J SOC CLIN PSYCHOL, V9, P456, DOI 10.1521/jscp.1990.9.4.456; Solomon Z, 2008, J FAM PSYCHOL, V22, P659, DOI 10.1037/a0013596; Taft CT, 2007, J FAM PSYCHOL, V21, P270, DOI 10.1037/0893-3200.21.2.270; Tanielian T., 2008, RAND MONOGRAPHS; Tarrier N, 1999, PSYCHOL MED, V29, P801, DOI 10.1017/S0033291799008569; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; U.S. Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Wadsworth SMM, 2010, J MARRIAGE FAM, V72, P537, DOI 10.1111/j.1741-3737.2010.00717.x; Walker JG, 1996, J CONSULT CLIN PSYCH, V64, P1029, DOI 10.1037/0022-006X.64.5.1029; Waysman M., 1993, J FAMILY PSYCHOL, V7, P104, DOI [10.1037/0893-3200.7.1.104, DOI 10.1037/0893-3200.7.1.104]; Wittenborn A. K., 2015, EMOTIONALLY FOCUSED; WORTMAN C, 1985, SOCIAL SUPPORT THEOR	82	12	12	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-2764	1573-3335		CONTEMP FAM THER	Contemp. Fam. Ther.	SEP	2015	37	3			SI		261	270		10.1007/s10591-015-9345-7			10	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB0TB	WOS:000412565300007					2022-02-06	
J	Helmich, I; Saluja, RS; Lausberg, H; Kempe, M; Furley, P; Berger, A; Chen, JK; Ptito, A				Helmich, Ingo; Saluja, Rajeet S.; Lausberg, Hedda; Kempe, Mathias; Furley, Philip; Berger, Alisa; Chen, Jen-Kai; Ptito, Alain			Persistent Postconcussive Symptoms Are Accompanied by Decreased Functional Brain Oxygenation	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							NEAR-INFRARED SPECTROSCOPY; MILD HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; SPORTS-RELATED CONCUSSION; VISUAL WORKING-MEMORY; BASE-LINE VALUES; LONG-TERM; NEUROPSYCHOLOGICAL DEFICITS; FOOTBALL PLAYERS; NEUROMETABOLIC CHANGES	Diagnostic methods are considered a major concern in the determination of mild traumatic brain injury. The authors examined brain oxygenation patterns in subjects with severe and minor persistent postconcussive difficulties and a healthy control group during working memory tasks in prefrontal brain regions using functional near-infrared spectroscopy. The results demonstrated decreased working memory performances among concussed subjects with severe postconcussive symptoms that were accompanied by decreased brain oxygenation patterns. An association appears to exist between decreased brain oxygenation, poor performance of working memory tasks, and increased symptom severity scores in subjects suffering from persistent postconcussive symptoms.	[Helmich, Ingo; Lausberg, Hedda; Berger, Alisa] German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Cologne, Germany; [Saluja, Rajeet S.; Chen, Jen-Kai; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Kempe, Mathias] German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany; [Kempe, Mathias; Furley, Philip] German Sport Univ Cologne, Inst Cognit & Team Racket Sport Res, Cologne, Germany; [Ptito, Alain] McGill Univ, Dept Psychol, Ctr Hlth, Montreal, PQ, Canada		Helmich, I (corresponding author), German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Cologne, Germany.	in.helmich@gmail.com	Furley, Philip/V-2921-2019; Kempe, Matthias/M-3953-2019	Kempe, Matthias/0000-0002-4709-6172	German Sports University, Cologne; Heinrich Hertz Foundation, Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia [6/13]	The study was funded by the University research funding of the German Sports University, Cologne and by the Heinrich Hertz Foundation, Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia (B 41 Nr. 6/13).	ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Adelson PD, 1998, ACT NEUR S, V71, P250; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barr W.B., 2010, HDB SPORT NEUROPSYCH; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bodmer T, 1997, J CLIN MICROBIOL, V35, P1604, DOI 10.1128/JCM.35.6.1604-1605.1997; BOGEN JE, 1965, J NEUROSURG, V23, P394, DOI 10.3171/jns.1965.23.4.0394; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen JK, 2004, CLIN J SPORT MED, V14, P379; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chiaravalloti ND, 2005, J CLIN EXP NEUROPSYC, V27, P33, DOI 10.1080/138033990513609; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cope M, 1988, Adv Exp Med Biol, V222, P183; Covasin T, 2011, HIST EPIDEMIOLOGY CO; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; CROVITZ HF, 1962, AM J PSYCHOL, V75, P271, DOI 10.2307/1419611; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Denker P., 1944, NY STATE J MED, V44, P379; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GAZZANIG.MS, 1965, BRAIN, V88, P221, DOI 10.1093/brain/88.2.221; GAZZANIGA MS, 1962, P NATL ACAD SCI USA, V48, P1765, DOI 10.1073/pnas.48.10.1765; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Helmich I, INT J PSYCH IN PRESS; Helmich I, 2013, ADV EXP MED BIOL, V789, P59, DOI 10.1007/978-1-4614-7411-1_9; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Jang KE, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127204; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LONG CJ, 1986, SOUTHERN MED J, V79, P728, DOI 10.1097/00007611-198606000-00020; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Petrides M, 2000, HDB NEUROPSYCHOLOGY, V2, P67; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stern CE, 2000, NEUROIMAGE, V11, P392, DOI 10.1006/nimg.2000.0569; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE G, 1974, LANCET, V2, P81; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Webbe F., 2011, HDB SPORT NEUROPSYCH	123	12	12	1	12	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2015	27	4					287	298		10.1176/appi.neuropsych.14100276			12	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DM0ON	WOS:000376045400006	25803447				2022-02-06	
J	Lee, HD; Jang, SH				Lee, Han Do; Jang, Sung Ho			Injury of the corticoreticular pathway in patients with mild traumatic brain injury: A diffusion tensor tractography study	BRAIN INJURY			English	Article						Corticoreticulospinal tract; corticoreticular pathway; diffusion tensor imaging; mild traumatic brain injury; motor weakness	IMPAIRMENT; RECOVERY; MODERATE	Background: Little is known about injury of the corticoreticular pathway (CRP) in patients with mild traumatic brain injury (TBI). The current study attempted to investigate injury of the CRP in patients with mild TBI, using diffusion tensor tractography (DTT) Methods: This study recruited 29 consecutive patients with proximal weakness following mild TBI and 25 control subjects. The CRP was reconstructed and the fractional anisotropy (FA) value, apparent diffusion coefficient (ADC) value and fibre volume of the CRP were measured. The patients were classified according to the configurational classification of the CRP injury: type A the CRP showed narrowing, type B-the CRP showed partial tearing at subcortical white matter or brainstem and type C-the CRP showed discontinuation at the subcortical white matter or brainstem. Result: No significant differences in FA and ADC of the CRP were observed between the patient and control groups (p>0.05). In contrast, the tract volume of the CRP was significantly lower in the patient group than in the control group (p<0.05). According to the configurational classification of the CRP injury on DTT, the patients were classified as follows: among 58 hemispheres of 29 patients: type A-9 hemispheres (15.5%) of eight patients, type B-30 hemispheres (51.7%) of 22 patients and type C-13 hemispheres (22.4%) of 11 patients. Conclusion: This study demonstrated injury of the CRP in patients who showed proximal weakness following mild TBI, using DTT.	[Lee, Han Do; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Daegu 705717, South Korea.	strokerehab@hanmail.net			DGIST R&D Program of the Ministry of Science, ICT and Future Planning [15-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (15-BD-0401).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Do KH, 2013, NEUROSCI LETT, V546, P21, DOI 10.1016/j.neulet.2013.04.040; FREUND HJ, 1990, REV NEUROL, V146, P543; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Jang SH, 2010, INT J REHABIL RES, V33, P285, DOI 10.1097/MRR.0b013e32833f0500; Kably B, 1998, J NEUROPHYSIOL, V80, P389, DOI 10.1152/jn.1998.80.1.389; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Mendoza J., 2007, CLIN NEUROANATOMY NE; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	28	12	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1219	1222		10.3109/02699052.2015.1045028			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400011	26204321				2022-02-06	
J	Poersch, AB; Trombetta, F; Souto, NS; Lima, CD; Braga, ACM; Dobrachinski, F; Ribeiro, LR; Soares, FAA; Fighera, MR; Royes, LFF; Oliveira, MS; Furian, AF				Poersch, Alice Bertotto; Trombetta, Francielle; Souto, Naieli Schiefelbein; Lima, Camilla de Oliveira; Monteiro Braga, Ana Claudia; Dobrachinski, Fernando; Ribeiro, Leandro Rodrigo; Antunes Soares, Felix Alexandre; Fighera, Michele Rechia; Freire Royes, Luiz Fernando; Oliveira, Mauro Schneider; Furian, Ana Flavia			Fumonisin B1 facilitates seizures induced by pentylenetetrazol in mice	NEUROTOXICOLOGY AND TERATOLOGY			English	Article						Fumonisin 61; Seizure; Mitochondrial membrane potential; Neurotoxicity	OXYGEN SPECIES GENERATION; TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL DYSFUNCTION; NA+,K+-ATPASE ACTIVITY; OXIDATIVE STRESS; RATS; SUSCEPTIBILITY; TOXICITY; B-1; MYCOTOXIN	Fumonisin B1 (FB1) is a Fusarium spp. mycotoxin which constitutes a major public health issue because of its worldwide distribution and diversity of toxic effects. While the liver and kidney are considered the major target organs of FB1 toxicity in several species, evidence indicates that FB1 may be toxic to the brain. To further investigate the effects of FB1 on the central nervous system the present study aimed to test the hypothesis that acute FB1 exposure causes brain hyperexcitability and the potential underlying mechanisms. For these purposes, adult male C57BL/6 mice were injected with FB1 (8 mg/kg, i.p.) or its vehicle and 30 min thereafter received with a low dose of the classical convulsant pentylenetetrazol (PTZ, 30 mg/kg, i.p.) or its vehicle. After behavioral evaluation the cerebral cortex and the hippocampus were collected for analysis of Na+,K+-ATPase activity, mitochondrial membrane potential (Delta psi m) and mitochondrial complex I and II activities. We found that FB1 reduced the latency for PTZ-induced myoclonic jerks and increased the number of these events. After exposure to FB1 total and alpha 1 Na+,K+-ATPase activities increased in cerebral cortex, whereas the same enzyme activities decreased in the hippocampus. Although no changes in mitochondrial complex I and II activities were found, acute exposure to FB1 increased Delta psi m in the cerebral cortex. Altogether, present results indicate that FB1 causes brain hyperexcitability in vivo, and that mitochondrial dysfunction may represent a potential underlying mechanism. (C) 2015 Elsevier Inc. All rights reserved.	[Poersch, Alice Bertotto; Trombetta, Francielle; Lima, Camilla de Oliveira; Monteiro Braga, Ana Claudia; Ribeiro, Leandro Rodrigo; Fighera, Michele Rechia; Freire Royes, Luiz Fernando; Oliveira, Mauro Schneider; Furian, Ana Flavia] Univ Fed Santa Maria, Programa Posgrad Farmacol, BR-97105900 Santa Maria, RS, Brazil; [Souto, Naieli Schiefelbein; Furian, Ana Flavia] Univ Fed Santa Maria, Programa Posgrad Ciencia & Tecnol Alimentos, BR-97105900 Santa Maria, RS, Brazil; [Dobrachinski, Fernando; Antunes Soares, Felix Alexandre; Freire Royes, Luiz Fernando; Oliveira, Mauro Schneider] Univ Fed Santa Maria, Programa Posgrad Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil		Furian, AF (corresponding author), Univ Fed Santa Maria, Dept Tecnol & Ciencia Alimentos, Predio 43,Sala 4217, BR-97105900 Santa Maria, RS, Brazil.	furian.anaflavia@gmail.com	Soares, Felix AA/K-7611-2012; Fighera, Michele R/J-9576-2014; Dobrachinski, Fernando/C-4316-2014; Soares, Felix/AAE-6251-2020; Oliveira, Mauro Schneider/G-3437-2012	Soares, Felix AA/0000-0002-6453-7902; Dobrachinski, Fernando/0000-0002-3948-1273; Soares, Felix/0000-0002-6453-7902; Oliveira, Mauro Schneider/0000-0002-5381-1208; Fighera, Michele/0000-0002-3111-7530; Ribeiro, Leandro/0000-0002-8442-4075; Bertotto Poersch, Alice/0000-0003-2353-0314			AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Banczerowski-Pelyhe I, 2002, MYCOPATHOLOGIA, V153, P149, DOI 10.1023/A:1014584303427; Bhat RV, 1997, J TOXICOL-CLIN TOXIC, V35, P249, DOI 10.3109/15563659709001208; BONDY G, 1995, FOOD CHEM TOXICOL, V33, P653, DOI 10.1016/0278-6915(95)00031-V; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulder A.S., 2012, 74 M JOINT FAO WHO E; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Domijan AM, 2012, NEUROSCIENCE, V202, P10, DOI 10.1016/j.neuroscience.2011.12.005; Domijan AM, 2012, ARH HIG RADA TOKSIKO, V63, P531, DOI 10.2478/10004-1254-63-2012-2239; Domijan AM, 2011, INT J BIOCHEM CELL B, V43, P897, DOI 10.1016/j.biocel.2011.03.003; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; Fiske CH, 1925, J BIOL CHEM, V66, P375; Folbergrova J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004; Funck VR, 2015, NEUROSCIENCE, V298, P171, DOI 10.1016/j.neuroscience.2015.04.031; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; Kwon OS, 1997, NEUROTOXICOL TERATOL, V19, P151, DOI 10.1016/S0892-0362(96)00217-6; Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029; Malfatti CRM, 2003, EPILEPSIA, V44, P761, DOI 10.1046/j.1528-1157.2003.42902.x; Mary VS, 2012, TOXICOLOGY, V302, P299, DOI 10.1016/j.tox.2012.08.012; Monnet-Tschudi F, 1999, NEUROTOXICOLOGY, V20, P41; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021; Rambo LM, 2013, AMINO ACIDS, V44, P857, DOI 10.1007/s00726-012-1408-6; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; SHEPHARD GS, 1992, TOXICON, V30, P768, DOI 10.1016/0041-0101(92)90011-S; SHEPHARD GS, 1992, FOOD CHEM TOXICOL, V30, P277, DOI 10.1016/0278-6915(92)90004-5; Tsunoda M, 1998, COMP BIOCHEM PHYS C, V120, P457, DOI 10.1016/S0742-8413(98)10061-0; Veliskova J., 2006, BEHAV CHARACTERIZAIT; Vilagi I, 2002, BRAIN RES BULL, V59, P35, DOI 10.1016/S0361-9230(02)00835-3; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Willis S, 2010, NEUROBIOL DIS, V40, P565, DOI 10.1016/j.nbd.2010.07.017; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yazar S, 2008, INT J MOL SCI, V9, P2062, DOI 10.3390/ijms9112062	40	12	13	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-0362	1872-9738		NEUROTOXICOL TERATOL	Neurotoxicol. Teratol.	SEP-OCT	2015	51						61	67		10.1016/j.ntt.2015.08.007			7	Neurosciences; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Toxicology	CT6LQ	WOS:000362924900008	26342287				2022-02-06	
J	Saban, KL; Hogan, NS; Hogan, TP; Pape, TLB				Saban, Karen L.; Hogan, Nancy S.; Hogan, Timothy P.; Pape, Theresa Louise-Bender			He Looks Normal But ... Challenges of Family Caregivers of Veterans Diagnosed with a Traumatic Brain Injury	REHABILITATION NURSING			English	Article						Caregivers; brain injury; research; qualitative	QUALITATIVE CONTENT-ANALYSIS; PSYCHIATRIC DIAGNOSES; FEMALE CAREGIVERS; WAR VETERANS; HEALTH; IMPACT; TBI; AGGRESSION; RELATIVES; SURVIVORS	Purpose: To describe the experience of family caregivers providing care to veterans with traumatic brain injury (TBI). Design/Methods: Using a qualitative design, interviews were conducted with a purposeful sample of women caregivers. Data were analyzed using content analysis procedures. Findings: Findings resulted in the key concept phrased by participants as "He looks normal but." This phrase conceptualizes the participants' description of their experience caring for a brain injured veteran who could appear normal to others but the caregiver's description revealed substantial cognitive, social, and emotional deficits. Concepts include (a) Becoming aware of his disabilities, (b) Observing his troubling symptoms, (c) Dealing with his memory loss, (d) Being fearful of his anger, (e) Sensing his loneliness, (f) Acknowledging the effects on the children, and (g) Managing the best I can. Conclusions/Clinical Relevance: A better understanding of the needs of caregivers of veterans with TBI may allow clinicians to better support caregivers.	[Saban, Karen L.; Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Hines, IL USA; [Saban, Karen L.; Hogan, Nancy S.] Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Maywood, IL 60153 USA; [Hogan, Timothy P.] Edith Nourse Rogers Mem Vet Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Hogan, Timothy P.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Saban, KL (corresponding author), Loyola Univ Chicago, Marcella Niehoff Sch Nursing, 2160 S First Ave, Maywood, IL 60153 USA.	ksaban@luc.edu		Saban, Karen/0000-0001-5767-5453	Center for Complex Chronic Care Management, Edward Hines VA Hospital (LIP) [42-104]; 3-year Veterans Affairs (VA) Health Service Research and Development (HSR&D) Postdoctoral Fellowship [TPN-42-001]	The authors would like to kindly acknowledge the financial support from the Center for Complex Chronic Care Management, Edward Hines VA Hospital (LIP #42-104). In addition, KLS was supported by a 3-year Veterans Affairs (VA) Health Service Research and Development (HSR&D) Postdoctoral Fellowship (TPN-42-001).	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Aveyard P, 2009, SOC SCI MED, V68, P397, DOI 10.1016/j.socscimed.2008.10.036; Bakas Tamilyn, 2004, J Neurosci Nurs, V36, P95; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Ben A. N., 2000, BRAIN INJURY, V14, P725; Brain Injury Association of America, 2012, FAM CAR; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Calvete E, 2012, BRAIN INJURY, V26, P834, DOI 10.3109/02699052.2012.655363; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Crewe-Brown SJ, 2011, S AFR J COMMUN DISOR, V58, P48; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Engstrom A, 2011, J NEUROSCI NURS, V43, P253, DOI 10.1097/JNN.0b013e318227ef9b; Fumiyo I, 2009, J NEUROSCI NURS, V41, P277, DOI 10.1097/JNN.0b013e3181b2c73c; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kalb R, 2007, J NEUROL SCI, V256, pS29, DOI 10.1016/j.jns.2007.01.061; King PR, 2012, J CLIN PSYCHOL MED S, V19, P376, DOI 10.1007/s10880-012-9345-9; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Morgan DG, 2002, SOC SCI MED, V55, P1129, DOI 10.1016/S0277-9536(01)00255-6; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Saban KL, 2012, BIOL RES NURS, V14, P396, DOI 10.1177/1099800412439458; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d	33	12	12	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	SEP-OCT	2015	40	5					277	285		10.1002/rnj.182			9	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	CV9FI	WOS:000364592400002	25424609	Bronze			2022-02-06	
J	Zhuo, JC; Keledjian, K; Xu, S; Pampori, A; Gerzanich, V; Simard, JM; Gullapalli, RP				Zhuo, Jiachen; Keledjian, Kaspar; Xu, Su; Pampori, Adam; Gerzanich, Volodymyr; Simard, J. Marc; Gullapalli, Rao P.			Changes in Diffusion Kurtosis Imaging and Magnetic Resonance Spectroscopy in a Direct Cranial Blast Traumatic Brain Injury (dc-bTBI) Model	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; PATTERN SEPARATION; HIGH-RESOLUTION; DENTATE GYRUS; PROTON MRS; MODERATE; RATS; CA3; NEUROPATHOLOGY; SENSORIMOTOR	Explosive blast-related injuries are one of the hallmark injuries of veterans returning from recent wars, but the effects of a blast overpressure on the brain are poorly understood. In this study, we used in vivo diffusion kurtosis imaging (DKI) and proton magnetic resonance spectroscopy (MRS) to investigate tissue microstructure and metabolic changes in a novel, direct cranial blast traumatic brain injury (dc-bTBI) rat model. Imaging was performed on rats before injury and 1, 7, 14 and 28 days after blast exposure (similar to 517 kPa peak overpressure to the dorsum of the head). No brain parenchyma abnormalities were visible on conventional T2-weighted MRI, but microstructural and metabolic changes were observed with DKI and proton MRS, respectively. Increased mean kurtosis, which peaked at 21 days post injury, was observed in the hippocampus and the internal capsule. Concomitant increases in myo-Inositol (Ins) and Taurine (Tau) were also observed in the hippocampus, while early changes at 1 day in the Glutamine (Gln) were observed in the internal capsule, all indicating glial abnormality in these regions. Neurofunctional testing on a separate but similarly treated group of rats showed early disturbances in vestibulomotor functions (days 1-14), which were associated with imaging changes in the internal capsule. Delayed impairments in spatial memory and in rapid learning, as assessed by Morris Water Maze paradigms (days 14-19), were associated with delayed changes in the hippocampus. Significant microglial activation and neurodegeneration were observed at 28 days in the hippocampus. Overall, our findings indicate delayed neurofunctional and pathological abnormalities following dc-bTBI that are silent on conventional T2-weighted imaging, but are detectable using DKI and proton MRS.	[Zhuo, Jiachen; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol, Baltimore, MD 21201 USA; [Zhuo, Jiachen; Xu, Su; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Nucl Med, Baltimore, MD 21201 USA; [Keledjian, Kaspar; Pampori, Adam; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA		Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu; rgullapalli@umm.edu			Department of the Army [W81XWH-12-1-0098, W81XWH-08-1-0725, W81XWH 10-1-0898]; Baltimore Veterans Affairs Medical Center [1I01BX001629]; Veterans AffairsUS Department of Veterans Affairs [I01BX001629] Funding Source: NIH RePORTER	This work was supported by the Department of the Army (W81XWH-12-1-0098 and W81XWH-08-1-0725 to RPG, W81XWH 10-1-0898 to JMS, http://cdmrp.army.mil/funding/), and the Baltimore Veterans Affairs Medical Center (1I01BX001629 to JMS, http://www.maryland.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Gerzanich V, 2003, CIRC RES, V93, P805, DOI 10.1161/01.RES.0000097872.69043.A0; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mellor S G, 1988, Br J Hosp Med, V39, P536; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Petullo D, 1999, LIFE SCI, V64, P1099, DOI 10.1016/S0024-3205(99)00038-7; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Salzman SK, 1994, NEUROBIOLOGY CENTRAL; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiemanck SK, 2008, J REHABIL MED, V40, P96, DOI 10.2340/16501977-0130; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Tosun C, 2013, BRAIN SCI, V3, P215, DOI 10.3390/brainsci3010215; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Xu S, 2006, J MAGN RESON, V182, P221, DOI 10.1016/j.jmr.2006.07.003; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Zwingmann C, 2000, DEV NEUROSCI-BASEL, V22, P463, DOI 10.1159/000017476	61	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2015	10	8							e0136151	10.1371/journal.pone.0136151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5VA	WOS:000359951900044	26301778	Green Published, Green Submitted, gold			2022-02-06	
J	Cristofori, I; Viola, V; Chau, A; Zhong, WT; Krueger, F; Zamboni, G; Grafman, J				Cristofori, Irene; Viola, Vanda; Chau, Aileen; Zhong, Wanting; Krueger, Frank; Zamboni, Giovanna; Grafman, Jordan			The neural bases for devaluing radical political statements revealed by penetrating traumatic brain injury	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						political beliefs; radicalism; traumatic brain injury; ventromedial prefrontal cortex; voxel-based lesion-symptom mapping	VENTROMEDIAL PREFRONTAL CORTEX; MORAL JUDGMENT; VIETNAM VETERANS; SOCIAL KNOWLEDGE; COMBAT VETERANS; FRONTAL DAMAGE; BEHAVIOR; LESIONS; COGNITION; DEFICITS	Given the determinant role of ventromedial prefrontal cortex (vmPFC) in valuation, we examined whether vmPFC lesions also modulate how people scale political beliefs. Patients with penetrating traumatic brain injury (pTBI; N = 102) and healthy controls (HCs; N = 31) were tested on the political belief task, where they rated 75 statements expressing political opinions concerned with welfare, economy, political involvement, civil rights, war and security. Each statement was rated for level of agreement and scaled along three dimensions: radicalism, individualism and conservatism. Voxel-based lesion-symptom mapping (VLSM) analysis showed that diminished scores for the radicalism dimension (i.e. statements were rated as less radical than the norms) were associated with lesions in bilateral vmPFC. After dividing the pTBI patients into three groups, according to lesion location (i.e. vmPFC, dorsolateral prefrontal cortex [dlPFC] and parietal cortex), we found that the vmPFC, but not the dlPFC, group had reduced radicalism scores compared with parietal and HC groups. These findings highlight the crucial role of the vmPFC in appropriately valuing political behaviors and may explain certain inappropriate social judgments observed in patients with vmPFC lesions.	[Cristofori, Irene; Chau, Aileen; Zhong, Wanting; Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Cristofori, Irene; Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Viola, Vanda] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Viola, Vanda] Fdn Santa Lucia, IRCCS, I-00179 Rome, Italy; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Zamboni, Giovanna] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England		Cristofori, I (corresponding author), Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, 345 E Super St, Chicago, IL 60611 USA.	irene.cristofori@northwestern.edu	Zamboni, Giovanna/AAA-7612-2022; Zamboni, Giovanna/F-3583-2017	Zamboni, Giovanna/0000-0002-6133-3373; Zamboni, Giovanna/0000-0002-6133-3373; Zhong, Wanting/0000-0002-6025-1739; Cristofori, Irene/0000-0003-2339-1457	Department of EducationUS Department of Education [H133F130009]	We thank our dedicated Vietnam veterans for their invaluable participation in the study. We also thank G.J. Solomon for his assistance with ABLe, as well as V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding and G. Tasick for testing and evaluating participants. Finally, we thank the National Naval Medical Center and the National Institute of Neurological Disorders and Stroke for their support and provision of their facilities. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, or the US Government. IC is supported by the Department of Education (# H133F130009).	AFQT-7A, 1960, AFQT7A US DEP DEF; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Burgess P. W., 1990, NEUROPSYCHOLOGY BEHA; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Ciaramelli E, 2013, SOC COGN AFFECT NEUR, V8, P171, DOI 10.1093/scan/nss087; Coronel JC, 2012, AM J POLIT SCI, V56, P837, DOI 10.1111/j.1540-5907.2012.00608.x; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Delazer M, 2011, EPILEPSY BEHAV, V20, P34, DOI 10.1016/j.yebeh.2010.11.006; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimitrov M, 1999, NEUROPSYCHOLOGY, V13, P135, DOI 10.1037/0894-4105.13.1.135; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FeldmanHall O, 2014, SOC COGN AFFECT NEUR, V9, P297, DOI 10.1093/scan/nss139; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Gozzi M, 2010, HUM BRAIN MAPP, V31, P1763, DOI 10.1002/hbm.20976; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; HARLOW JM, 1868, RECOVERY SEVERE INJU; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; HYER L, 1991, J CLIN PSYCHOL, V47, P510, DOI 10.1002/1097-4679(199107)47:4<510::AID-JCLP2270470407>3.0.CO;2-F; Knutson KM, 2013, NEUROPSYCHOLOGIA, V51, P686, DOI 10.1016/j.neuropsychologia.2013.01.003; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; McNeil M., 1994, REVISED TOKEN TEST; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Moretti L, 2009, J COGNITIVE NEUROSCI, V21, P128, DOI 10.1162/jocn.2009.21011; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Rangel A, 2012, CURR OPIN NEUROBIOL, V22, P970, DOI 10.1016/j.conb.2012.07.011; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Robinson John P., 1999, MEASURES POLITICAL A; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schintu S, 2014, CORTEX, V57, P244, DOI 10.1016/j.cortex.2014.04.009; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler D., 2011, WECHSLER ABBREVIATED; Willis ML, 2010, NEUROPSYCHOLOGIA, V48, P2182, DOI 10.1016/j.neuropsychologia.2010.04.010; Winecoff A, 2013, J NEUROSCI, V33, P11032, DOI 10.1523/JNEUROSCI.4317-12.2013; Young L, 2010, NEURON, V65, P845, DOI 10.1016/j.neuron.2010.03.003; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zamboni G, 2009, SOC NEUROSCI-UK, V4, P367, DOI 10.1080/17470910902860308	55	12	12	0	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	AUG	2015	10	8					1038	1044		10.1093/scan/nsu155			7	Neurosciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CX2PW	WOS:000365540100003	25656509	Green Submitted, hybrid, Green Published			2022-02-06	
J	Dockree, PM; Tarleton, YM; Carton, S; FitzGerald, MCC				Dockree, Paul M.; Tarleton, Yvonne M.; Carton, Simone; FitzGerald, Mary C. C.			Connecting Self-Awareness and Error-Awareness in Patients with Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Volition; Intention; Goals; Executive function; Neuropsychology; Caregivers	EXECUTIVE FUNCTION; SUSTAINED ATTENTION; ANTERIOR CINGULATE; IMPAIRED AWARENESS; GOAL MANAGEMENT; NEURAL BASIS; DEFICITS; REHABILITATION; FAILURES; INSIGHT	Impaired self-awareness after in traumatic brain injury (TBI) is often seen in stark contrast to the observations of significant-others, who are acutely aware of the difficulties experienced by patients. Our objective was to investigate the relationship between metacognitive knowledge in daily life and emergent awareness of errors during laboratory tasks, since the breakdown of error detection mechanisms may impose limitations on the recovery of metacognitive knowledge after TBI. We also examined the extent to which these measures of awareness can predict dysexecutive behaviors. A sample of TBI patients (n=62) and their significant-others, provided reports of daily functioning post injury. In addition, patients underwent a neuropsychological assessment and were instructed to signal their errors during go/no-go tests. Interrelationships between metacognitive and emergent levels of awareness were examined, after controlling for the influence of secondary cognitive variables. Significant-other ratings correlated with errors made by the patients on neuropsychological tests but not with their premorbid function. Patients who under-reported daily life difficulties or over-reported their competency, compared to significant-other reports, were less likely to show awareness of laboratory errors. Emergent awareness was also identified as the sole predictor of performance on the modified six-element test, an ecologically valid test of multitasking. The online breakdown of error awareness after brain injury is related to difficulties with metacognitive awareness as reported in daily life, and is also predictive of dysexecutive behaviors. These findings are discussed in the context of multidimensional and neural models of awareness and error monitoring.	[Dockree, Paul M.; Tarleton, Yvonne M.; FitzGerald, Mary C. C.] Univ Dublin Trinity Coll, Sch Psychol, Dublin 2, Ireland; [Dockree, Paul M.; Tarleton, Yvonne M.; FitzGerald, Mary C. C.] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland; [Carton, Simone; FitzGerald, Mary C. C.] Dun Laoghaire Co, Natl Rehabil Hosp, Dublin, Ireland		Dockree, PM (corresponding author), Univ Dublin Trinity Coll, Coll Green, Sch Psychol, Aras Phiarsaigh, Dublin 2, Ireland.	dockreep@tcd.ie			Health Research Board of Ireland [PA-06-17]; National Rehabilitation Hospital Trust, University College Dublin; National Disability Authority; Trinity College Dublin, Ireland	The authors are extremely grateful to the patients from the National Rehabilitation Hospital and their families for taking part in this research. The data analyzed for this study was collected as part of Mary FitzGerald's PhD, awarded by Trinity College Dublin, Ireland. This work was supported by grants from the Health Research Board (PA-06-17) of Ireland, the National Rehabilitation Hospital Trust, University College Dublin Seed funding, and the National Disability Authority awarded to Dr. Simone Carton and provided to Dr. Mary FitzGerald to conduct the research. There are no actual or potential conflicts of interest.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Clare L, 2010, AGING NEUROPSYCHOL C, V17, P462, DOI 10.1080/13825580903581558; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; FitzGerald M. C., 2012, IRISH J PSYCHOL, V33, P78, DOI [10.1080/03033910.2012.708898, DOI 10.1080/03033910.2012.708898]; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Harty S, 2013, PSYCHOL AGING, V28, P1032, DOI 10.1037/a0033567; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Hoerold D, 2013, NEUROPSYCHOLOGIA, V51, P385, DOI 10.1016/j.neuropsychologia.2012.11.019; Kolakowsky-Hayner S., 2010, PATIENT COMPENTENCY; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Nelson H.E., 1982, NATL ADULT READING T; Nelson TO, 1990, PSYCHOL LEARNING MOT; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Orr C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00177; Philippi CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038413; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Shimamura AP, 2008, HDB MEMORY METACOGNI; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	12	12	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2015	21	7					473	482		10.1017/S1355617715000594			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	CQ9UW	WOS:000360961700001	26235053				2022-02-06	
J	Heyanka, DJ; Thaler, NS; Linck, JF; Pastorek, NJ; Miller, B; Romesser, J; Sim, AH				Heyanka, Daniel J.; Thaler, Nicholas S.; Linck, John F.; Pastorek, Nicholas J.; Miller, Brian; Romesser, Jennifer; Sim, Anita H.			A Factor Analytic Approach to the Validation of the Word Memory Test and Test of Memory Malingering as Measures of Effort and Not Memory	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Forensic neuropsychology; Head injury; traumatic brain injury; Malingering/symptom validity testing; Learning and Memory	TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; SYMPTOM VALIDITY TEST; DISABILITY INCENTIVES; COGNITIVE IMPAIRMENT; EXTERNAL INCENTIVES; HEAD-INJURY; TEST-SCORES; FAILURE; TOMM	Research has demonstrated the utility of performance validity tests (PVTs) as a method of determining adequate effort during a neuropsychological evaluation. Although some studies affirm that forced-choice PVTs measure effort rather than memory, doubts remain in the literature. The purpose of the current study was to evaluate the relationship between effort and memory variables in a mild traumatic brain injury (TBI) sample (n = 160) by separating memory and effort as distinct factors while statistically controlling for the shared covariance between the variables. A two-factor solution was extracted such that the five PVT variables loaded on Factor 1 and the four memory variables loaded on Factor 2. The pattern matrix, which controls for the covariance between variables, provided clear support of two highly distinct factors with minimal cross-loadings. Our findings support assertions that PVTs measure effort independent of memory in veterans with mild TBI.	[Heyanka, Daniel J.] Bay Pines Dept Vet Affairs Med Ctr, Bay Pines, FL USA; [Thaler, Nicholas S.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Linck, John F.] Oklahoma City Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Pastorek, Nicholas J.; Miller, Brian] Michael E DeBakey Dept Vet Affairs Med Ctr, Houston, TX USA; [Romesser, Jennifer] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Sim, Anita H.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA		Heyanka, DJ (corresponding author), Bay Pines Dept Vet Affairs Med Ctr, Dept Mental Hlth & Behav Sci, Bay Pines, FL 33744 USA.	dhneuropsych@gmail.com		Pastorek, Nicholas/0000-0002-9290-380X			Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Courville T, 2001, EDUC PSYCHOL MEAS, V61, P229, DOI 10.1177/0013164401612006; Delis D.C., 2000, CALIFORNIA VERBAL LE; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gervais R, 2000, ARCH CLIN NEUROPSYCH, V15, P841, DOI 10.1016/S0887-6177(00)80347-9; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, MANUAL WORD MEMORY T; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Thompson B., 2004, EXPLORATORY CONFIRMA; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Williamson David J., 2003, Epilepsia, V44, P13; Williamson DJ, 2004, EPILEPSIA, V45, P179; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168	32	12	12	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2015	30	5					369	376		10.1093/arclin/acv025			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CO3PS	WOS:000359071300002	25964105	Bronze			2022-02-06	
J	Peng, FY; Muzik, O; Gatson, J; Kernie, SG; Diaz-Arrastia, R				Peng, Fangyu; Muzik, Otto; Gatson, Joshua; Kernie, Steven G.; Diaz-Arrastia, Ramon			Assessment of Traumatic Brain Injury by Increased Cu-64 Uptake on (CuCl2)-Cu-64 PET/CT	JOURNAL OF NUCLEAR MEDICINE			English	Article						traumatic brain injury; copper metabolism; neuroimaging; positron emission tomography; Cu-64-chloride	POSITRON-EMISSION-TOMOGRAPHY; RADIOACTIVE COPPER; WILSONS-DISEASE; MOUSE MODEL; METABOLISM; ACTIVATION; ZINC; RATS; MICE; EXPRESSION	Copper is a nutritional trace element required for cell proliferation and wound repair. Methods: To explore increased copper uptake as a biomarker for noninvasive assessment of traumatic brain injury (TBI), experimental TBI in C57BL/6 mice was induced by controlled cortical impact, and Cu-64 uptake in the injured cortex was assessed with (CuCl2)-Cu-64 PET/CT. Results: At 24 h after intravenous injection of the tracer, uptake was significantly higher in the injured cortex of TBI mice (1.15 +/- 0.53 percentage injected dose per gram of tissue [%ID/g]) than in the uninjured cortex of mice without TBI (0.53 +/- 0.07 %ID/g, P = 0.027) or the cortex of mice that received an intracortical injection of zymosan A (0.62 +/- 0.22 %ID/g, P = 0.025). Furthermore, uptake in the traumatized cortex of untreated TBI mice (1.15 +/- 0.53 %ID/g) did not significantly differ from that in minocycline-treated TBI mice (0.93 +/- 0.30 %ID/g, P = 0.33). Conclusion: Overall, the data suggest that increased Cu-64 uptake in traumatized brain tissues holds potential as a new biomarker for noninvasive assessment of TBI with (CuCl2)-Cu-64 PET/CT.	[Peng, Fangyu] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Peng, Fangyu] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Muzik, Otto] Wayne State Univ, Sch Med, Carman & Ann Adams Dept Pediat, Detroit, MI USA; [Muzik, Otto] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Gatson, Joshua] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Kernie, Steven G.] Columbia Univ, Dept Pediat, Coll Physicians & Surg, New York, NY 10027 USA; [Kernie, Steven G.] Columbia Univ, Dept Pathol & Cell Biol, Coll Physicians & Surg, New York, NY USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Peng, FY (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	fangyu.peng@utsouthwestern.edu	Peng, Fangyu/D-1079-2015; Kernie, Steven/AAT-9912-2020	Peng, Fangyu/0000-0002-3142-3845; Kernie, Steven/0000-0003-1371-0549	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24 CA086307, R24 CA86307] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21 AG047953] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [7R21EB005331-03, R21 EB005331] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21NS074394-01A, R21 NS074394] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24CA086307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB005331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS074394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG047953] Funding Source: NIH RePORTER		BUSH JA, 1955, J CLIN INVEST, V34, P1766, DOI 10.1172/JCI103232; Cai HW, 2014, J NUCL MED, V55, P622, DOI 10.2967/jnumed.113.126979; Choi BS, 2009, BRAIN RES, V1248, P14, DOI 10.1016/j.brainres.2008.10.056; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Converse AK, 2011, J NUCL MED, V52, P257, DOI 10.2967/jnumed.110.082743; Cowell RM, 2003, J NEUROSCI, V23, P9459; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Hattori N, 2004, J NUCL MED, V45, P775; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jones PW, 2000, J INORG BIOCHEM, V81, P1, DOI 10.1016/S0162-0134(00)00119-7; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Lech T, 2007, BIOL TRACE ELEM RES, V118, P10, DOI 10.1007/s12011-007-0014-z; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Linder MC, 1991, BIOCH COPPER; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lutsenko S, 2010, METALLOMICS, V2, P596, DOI 10.1039/c0mt00006j; Matusch A, 2010, J AM SOC MASS SPECTR, V21, P161, DOI 10.1016/j.jasms.2009.09.022; Mirastschijski U, 2013, BIOL TRACE ELEM RES, V153, P76, DOI 10.1007/s12011-013-9658-z; Noshita N, 2002, J NEUROSCI, V22, P7923; OSBORN SB, 1969, Q J MED, V38, P467; Peng FY, 2012, MOL IMAGING BIOL, V14, P70, DOI 10.1007/s11307-011-0476-4; Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Turnlund JR, 1998, AM J CLIN NUTR, V67, p960S, DOI 10.1093/ajcn/67.5.960S; WALSHE JM, 1977, Q J MED, V46, P445; Wang LM, 2010, METALLOMICS, V2, P348, DOI 10.1039/c003875j; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525; Zhang HY, 2011, ACAD RADIOL, V18, P1561, DOI 10.1016/j.acra.2011.08.006; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x	39	12	13	1	17	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	AUG	2015	56	8					1252	1257		10.2967/jnumed.115.154575			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CO5CX	WOS:000359178300037	26112025	Bronze, Green Accepted			2022-02-06	
J	Powell, MA; Corbo, V; Fonda, JR; Otis, JD; Milberg, WP; McGlinchey, RE				Powell, Margaret A.; Corbo, Vincent; Fonda, Jennifer R.; Otis, John D.; Milberg, William P.; McGlinchey, Regina E.			Sleep Quality and Reexperiencing Symptoms of PTSD Are Associated With Current Pain in US OEF/OIF/OND Veterans With and Without mTBIs	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; OPERATIONS ENDURING FREEDOM; IRAQI FREEDOM; CLINICAL INTERVIEW; GENDER-DIFFERENCES; BOSTON ASSESSMENT; SAMPLE; RISK; QUESTIONNAIRE	Pain, a debilitating condition, is frequently reported by U.S. veterans returning from Afghanistan and Iraq. This study investigated how commonly reported clinical factors were associated with pain and whether these associations differed for individuals with a history of chronic pain. From the Boston metropolitan area, 171 veterans enrolled in the Veterans Affairs Center of Excellence were assessed for current posttraumatic stress disorder (PTSD) symptom severity, current mood and anxiety diagnoses, lifetime traumatic brain injury, combat experiences, sleep quality, and alcohol use. Hierarchical regression models were used to determine the association of these conditions with current pain. Average pain for the previous 30 days, assessed with the McGill Pain Questionnaire, was 30.07 out of 100 (SD = 25.43). Sleep quality, PTSD symptom severity, and alcohol use were significantly associated with pain (R-2 = .24), as were reexperiencing symptoms of PTSD (R-2 = .25). For participants with a history of chronic pain (n = 65), only PTSD symptoms were associated with pain (R-2 = .19). Current pain severity was associated with increased PTSD severity (notably, reexperiencing symptoms), poor sleep quality, and increased alcohol use. These data support the hypothesis that PTSD symptoms influence pain, but suggest that problems with sleep and alcohol use may exacerbate the relationship. Resumen SUENO, TEPT Y DOLOR EN VETERANOS El dolor, una condicion debilitante, es frecuentemente reportado por veteranos norteamericanos que vuelven de Afganistan e Iraq. Este estudio investigo como los factores clinicos comunmente reportados se asociaron con dolor y si estas asociaciones difieren en los individuos con historia de dolor cronico. Desde el area metropolitana de Boston, 171 veteranos enrolados en el Centro de Excelencia de Asuntos Veteranos fueron evaluados en la severidad de los sintomas de TEPT, diagnosticos de estado de animo y ansiedad actuales, LCT (lesion cerebral traumatica) a lo largo de la vida, experiencias de combate, calidad del sueno y consumo de alcohol. Modelos de regresion jerarquica fueron usados para determinar la asociacion de estas condiciones con el dolor actual. El dolor promedio para los 30 dias previos, evaluados con el cuestionario de dolor McGill, fue 30.07 de 100 (DE = 25.43). La calidad del sueno, severidad de los sintomas de TEPT, y uso de alcohol se asociaron significativamente con dolor (R2 = .24), asi como tambien los sintomas de re-experimentacion de TEPT (R2 = .25). Para los participantes con historia de dolor cronico (n = 67), solo los sintomas de TEPT se asociaron con dolor (R2 = .19). La severidad del dolor actual se asocio con mayor severidad de TEPT (mayormente, sintomas de re-experimentacion), mala calidad de sueno, y aumento del consumo de alcohol. Estos datos apoyan la idea que los sintomas de TEPT influyen sobre el dolor, pero sugieren que los problemas del sueno y consumo de alcohol pueden exacerbar esta asociacion. Traditional and Simplified Chinese Abstracts by AsianSTSS ?? : ????????????OEF/OIF/OND????,?????PTSD????????????? ??: ??????,????????????????????????????????????????????,??????????????????????????,171??????????????????????????(PTSD)??????????????????????????(TBIs)???????????????????????????????????????????????????????,??????,??30???????30.07 (SD = 25.43)??????PTSD??????????????????(R2 = .24),PTSD???????????????(R2 = .25)???????????(n = 67)?,??PTSD???????(R2 = .19)?????????PTSD?????(????????)????????????????????????PTSD?????????,?????????????????????? ?? : ????????????OEF/OIF/OND????,?????PTSD????????????? ??: ??????,????????????????????????????????????????????,??????????????????????????,171??????????????????????????(PTSD)??????????????????????????(TBIs)??????????????????????????????????????????????????????,??????,??30???????30.07 (SD = 25.43)??????PTSD??????????????????(R2 = .24),PTSD???????????????(R2 = .25)???????????(n = 67)?,??PTSD???????(R2 = .19)?????????PTSD?????(????????)????????????????????????PTSD?????????,??????????????????????	[Powell, Margaret A.; Corbo, Vincent; Fonda, Jennifer R.; Otis, John D.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA 02130 USA; [Powell, Margaret A.; Corbo, Vincent; Fonda, Jennifer R.; Otis, John D.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA; [Corbo, Vincent] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Fonda, Jennifer R.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Otis, John D.] Boston Univ, Dept Psychiat, Boston, MA 02215 USA; [Otis, John D.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Milberg, William P.; McGlinchey, Regina E.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA		McGlinchey, RE (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	Regina_McGlinchey@hms.harvard.edu	Fonda, Jennifer R./ABG-2890-2021; McGlinchey, Regina E/R-1971-2016	Fonda, Jennifer R./0000-0001-9482-2918; Otis, John/0000-0002-5441-7421	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B9254-C]; VA CSR&D Merit Review Award from the United States Department of Veterans Affairs [CX000181]	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B9254-C), and in part by a VA CSR&D Merit Review Award (CX000181) to Regina McGlinchey from the United States Department of Veterans Affairs. The authors would like to thank Wally Musto, CMSgt (Ret) for his recruitment efforts, and Drs. Alexandra Kenna, Catherine Fortier, Brad Brummett, Melissa Amick, and Sara Lippa for the clinical interviews.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Galloway SK, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/851276; Geisser ME, 1996, PAIN, V66, P207, DOI 10.1016/0304-3959(96)03038-2; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goebel JR, 2011, J PAIN SYMPTOM MANAG, V41, P848, DOI 10.1016/j.jpainsymman.2010.07.009; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Manchikanti Laxmaiah, 2007, J Opioid Manag, V3, P89; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Merskey H., 1994, CLASSIFICATION CHRON; Mogil JS, 2010, PROG BRAIN RES, V186, P141, DOI 10.1016/B978-0-444-53630-3.00009-9; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Norman SB, 2014, J STUD ALCOHOL DRUGS, V75, P557, DOI 10.15288/jsad.2014.75.557; Otis J. D., 2012, PSTD MILD TRAUMATIC; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; U. S. Department of Defense, 2012, DEM PROF MIL COMM; U. S. Department of Veterans Affairs Office of Public Health Epidemiology Program, 2012, HLTH CAR UT OP END F; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630	42	12	12	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	AUG	2015	28	4					322	329		10.1002/jts.22027			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	CP5HR	WOS:000359912400008	26194844				2022-02-06	
J	von der Brelie, C; Schneegans, I; van den Boom, L; Meier, U; Hedderich, J; Lemcke, J				von der Brelie, Christian; Schneegans, Insa; van den Boom, Leander; Meier, Ullrich; Hedderich, Juergen; Lemcke, Johannes			Impaired coagulation is a risk factor for clinical and radiologic deterioration in patients with traumatic brain injury and isolated traumatic subarachnoid hemorrhage	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Mild traumatic brain injury; traumatic subarachnoid hemorrhage; clinical management; coagulation	REPEAT HEAD CT; SUBDURAL-HEMATOMA; MANAGEMENT; OLDER	BACKGROUND Isolated traumatic subarachnoid hemorrhage (itSAH) is found in approximately 25% of all patients with mild traumatic brain injury (TBI). The aim of this study was to analyze the clinical course and identify risk factors for potential clinical and radiologic deterioration in consideration of impaired coagulation in patients with itSAH. METHODS A retrospective analysis of 735 patients with TBI resulting in a pathologic computer-assisted tomography (CAT) was performed. Only those patients with itSAH and Glasgow Coma Scale (GCS) of greater than 8 points and follow-up CAT scan were included. Patients with hemorrhage in any other brain compartment (subdural, epidural, and intracerebral) were excluded. Impaired coagulation was operationally defined. RESULTS Of the 735 patients, 89 met the inclusion criteria. The majority of these patients experienced mild TBI. The rate of radiologic expansion or conversion of the SAH was 28.1%. The rate of clinical deterioration was 6.7%. Neither the initial pattern of itSAH on different intracranial localizations nor the number of sulci involved in the itSAH was associated with clinical worsening. The rate of patients with impaired coagulation was 38%; 17.9% of all patients showed elevated international normalized ratio (INR). Radiologic and clinical deterioration was significantly associated with elevated INR. INR was shown to be independent of age in a logistic regression analysis. CONCLUSION TBI patients with itSAH and impaired coagulation especially those who showed elevated INR are at risk of clinical and radiologic deterioration. Despite coagulation status, routine repetition of cranial CAT scan is advised in patients with itSAH to detect potential radiologic worsening, which if occurring should result in close clinical monitoring. LEVEL OF EVIDENCE Therapeutic study, level IV; prognostic study, level III.	[von der Brelie, Christian; Schneegans, Insa; van den Boom, Leander; Meier, Ullrich; Lemcke, Johannes] Unfallkrankenhaus Berlin, Dept Neurosurgery, Berlin, Germany; [von der Brelie, Christian] Univ Kiel, Med Ctr, Dept Neurosurg, Kiel, Germany; [Hedderich, Juergen] Univ Kiel, Med Ctr, Dept Med Informat & Stat, Kiel, Germany		von der Brelie, C (corresponding author), Unfallkrankenhaus Berlin, Dept Neurosurg, Warener Str 7, D-12683 Berlin, Germany.	cvdb@gmx.net		Lemcke, Johannes/0000-0002-8073-1625			Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042; Leung GKK, 2012, INJURY, V43, P1419, DOI 10.1016/j.injury.2011.03.017; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Nishijima DK, 2013, AM J EMERG MED, V31, P1244, DOI 10.1016/j.ajem.2013.04.035; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Zakaria Z, 2013, CLIN NEUROL NEUROSUR, V115, P1201, DOI 10.1016/j.clineuro.2013.05.012	17	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2015	79	2					295	300		10.1097/TA.0000000000000722			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CS2II	WOS:000361892800020	26218700				2022-02-06	
J	Yue, L; Humayun, MS				Yue, Lan; Humayun, Mark S.			Monte Carlo analysis of the enhanced transcranial penetration using distributed near-infrared emitter array	JOURNAL OF BIOMEDICAL OPTICS			English	Article						Monte Carlo; near infrared; emitter array; transcranial propagation; scatter; tissues	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; LASER THERAPY; LIGHT THERAPY; NEUROTHERA EFFECTIVENESS; PHOTON MIGRATION; ADULT HEAD; MODEL; PROPAGATION; SAFETY	Transcranial near-infrared (NIR) treatment of neurological diseases has gained recent momentum. However, the low NIR dose available to the brain, which shows severe scattering and absorption of the photons by human tissues, largely limits its effectiveness in clinical use. Hereby, we propose to take advantage of the strong scattering effect of the cranial tissues by applying an evenly distributed multiunit emitter array on the scalp to enhance the cerebral photon density while maintaining each single emitter operating under the safe thermal limit. By employing the Monte Carlo method, we simulated the transcranial propagation of the array emitted light and demonstrated markedly enhanced intracranial photon flux as well as improved uniformity of the photon distribution. These enhancements are correlated with the source location, density, and wavelength of light. To the best of our knowledge, we present the first systematic analysis of the intracranial light field established by the scalp-applied multisource array and reveal a strategy for the optimization of the therapeutic effects of the NIR radiation. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Yue, Lan; Humayun, Mark S.] Univ So Calif, Inst Biomed Therapeut, USC Eye Inst, Los Angeles, CA 90033 USA		Yue, L (corresponding author), Univ So Calif, Inst Biomed Therapeut, USC Eye Inst, 1441 Eastlake Ave,NTT Room 4463, Los Angeles, CA 90033 USA.	lyue@usc.edu; humayun@med.usc.edu			W. M. Keck FoundationW.M. Keck Foundation; National Science Foundation (NSF) grantNational Science Foundation (NSF) [CBET-1404089]; Guangdong Innovative and Entrepreneurial Research Team Program [2013S046]; Shenzhen Peacock Plan, China	This work is supported by the W. M. Keck Foundation, the National Science Foundation (NSF) grant (Award No.: CBET-1404089), the Guangdong Innovative and Entrepreneurial Research Team Program (No. 2013S046), and Shenzhen Peacock Plan, China.	Barker JW, 2014, BIOMED OPT EXPRESS, V5, P4300, DOI 10.1364/BOE.5.004300; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Bozkurt A, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-9; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Dehghani H, 2003, PHYS MED BIOL, V48, P2713, DOI 10.1088/0031-9155/48/16/310; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Fang QQ, 2009, OPT EXPRESS, V17, P20178, DOI 10.1364/OE.17.020178; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Ito Y, 2000, J BIOMED OPT, V5, P383, DOI 10.1117/1.1287730; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Moges H, 2009, LASER SURG MED, V41, P52, DOI 10.1002/lsm.20732; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; SCHWEIGER M, 1995, MED PHYS, V22, P1779, DOI 10.1118/1.597634; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Yue L, 2015, PROC SPIE, V9321, DOI 10.1117/12.2077019; Zhang L, 2008, CELL PHYSIOL BIOCHEM, V22, P215, DOI 10.1159/000149799; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	32	12	12	1	8	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	AUG	2015	20	8							088001	10.1117/1.JBO.20.8.088001			9	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CT0VV	WOS:000362516700026	26252627				2022-02-06	
J	Burns, TC; Verfaillie, CM				Burns, Terry C.; Verfaillie, Catherine M.			From mice to mind: Strategies and progress in translating neuroregeneration	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article							STEM-CELL TRANSPLANTATION; AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD-INJURY; MESENCHYMAL STROMAL CELLS; ADULT PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; ANIMAL-MODELS; DOPAMINE NEURONS; GROWTH-FACTOR	Decisions about what experimental therapies are advanced to clinical trials are based almost exclusively on findings in preclinical animal studies. Over the past 30 years, animal models have forecast the success of hundreds of neuroprotective pharmacological therapies for stroke, Alzheimer's disease, spinal cord injury, traumatic brain injury and amyotrophic lateral sclerosis. Yet almost without exception, all have failed. Rapid advances in stem cell technologies have raised new hopes that these neurological diseases may one day be treatable. Still, how can neuroregenerative therapies be translated into clinical realities if available animal models are such poor surrogates of human disease? To address this question we discuss human and rodent neurogenesis, evaluate mechanisms of action for cellular therapies and describe progress in translating neuroregeneration to date. We conclude that not only are appropriate animal models critical to the development of safe and effective therapies, but that the multiple mechanisms of stem cell-mediated therapies may be particularly well suited to the mechanistically diverse nature of central nervous system diseases in mice and man. (C) 2015 Elsevier B.V. All rights reserved.	[Burns, Terry C.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Burns, Terry C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Verfaillie, Catherine M.] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium		Burns, TC (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	tcburns@stanford.edu	Verfaillie, Catherine/H-5148-2013	Verfaillie, Catherine/0000-0001-7564-4079; Terry, Burns/0000-0001-7633-3045	California Institute of Regenerative MedicineCalifornia Institute for Regenerative Medicine	We thank Cindy Samos for Editorial Assistance. Funding support was provided by the California Institute of Regenerative Medicine (TCB).	Abbott A, 2014, NATURE, V510, P195, DOI 10.1038/510195a; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Alonso M, 2012, NAT NEUROSCI, V15, P897, DOI 10.1038/nn.3108; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Aranguren XL, 2008, J CLIN INVEST, V118, P505, DOI [10.1172/JC131153, 10.1172/JCI31153]; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Bath PMW, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub4; Benraiss A, 2013, CELL STEM CELL, V12, P787, DOI 10.1016/j.stem.2013.04.014; Bherer Louis, 2013, J Aging Res, V2013, P657508, DOI [10.1155/2013/197326, 10.1155/2013/657508]; Bjorklund A, 1992, Curr Opin Neurobiol, V2, P683, DOI 10.1016/0959-4388(92)90039-N; BJORKLUND A, 1976, NATURE, V262, P787, DOI 10.1038/262787a0; Bovenberg MSS, 2013, TRENDS MOL MED, V19, P281, DOI 10.1016/j.molmed.2013.03.001; Burns T. C., 2015, EUR J PHARM; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Cavanaugh SE, 2014, ALTEX-ALTERN ANIM EX, V31, P279, DOI 10.14573/altex.1310071; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Choi Sung S, 2014, Exp Neurobiol, V23, P45, DOI 10.5607/en.2014.23.1.45; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; Dlouhy BJ, 2014, J NEUROSURG-SPINE, V21, P618, DOI 10.3171/2014.5.SPINE13992; Doeppner TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00357; Donnelly EM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt115; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Faravelli I, 2014, CELL MOL LIFE SCI, V71, P3257, DOI 10.1007/s00018-014-1613-4; Federici T, 2012, JOVE-J VIS EXP, DOI 10.3791/4371; Feldman EL, 2014, ANN NEUROL, V75, P363, DOI 10.1002/ana.24113; Ferreira D, 2015, J ALZHEIMERS DIS, V43, P1059, DOI 10.3233/JAD-141068; Fjord-Larsen L, 2010, MOL THER, V18, P2164, DOI 10.1038/mt.2010.154; Franco R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00146; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Ganat YM, 2012, J CLIN INVEST, V122, P2928, DOI 10.1172/JCI58767; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hartley MD, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0485-1; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Huttner HB, 2014, NAT NEUROSCI, V17, P801, DOI 10.1038/nn.3706; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Janowski M, 2010, STEM CELLS DEV, V19, P5, DOI 10.1089/scd.2009.0271; Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848; Jessberger S, 2014, TRENDS CELL BIOL, V24, P558, DOI 10.1016/j.tcb.2014.07.003; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kim HY, 2014, STEM CELLS, V32, P2724, DOI 10.1002/stem.1770; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Krstic D, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-62; Kwon BK, 2011, J NEUROTRAUM, V28, P1525, DOI 10.1089/neu.2010.1296; Kwon BK, 2012, J NEUROTRAUM, V29, P2727, DOI 10.1089/neu.2012.2550; Lacy CR, 2001, STROKE, V32, P63, DOI 10.1161/01.STR.32.1.63; Lane EL, 2010, PROG BRAIN RES, V184, P295, DOI 10.1016/S0079-6123(10)84015-4; Lee HK, 2013, ONCOTARGET, V4, P346, DOI 10.18632/oncotarget.868; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Leon-Jimenez C, 2014, NEUROLOGIA, V29, P200, DOI 10.1016/j.nrl.2013.05.003; Leten C, 2014, STEM CELLS, V32, P2833, DOI 10.1002/stem.1819; Li MD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0093-y; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Li ZJ, 2008, STEM CELLS, V26, P864, DOI 10.1634/stemcells.2007-0843; Nigro A, 2012, J MOL CELL BIOL, V4, P423, DOI 10.1093/jmcb/mjs046; Lukovic D, 2014, STEM CELLS DEV, V23, P1, DOI 10.1089/scd.2013.0266; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Martinez Ana Maria Blanco, 2014, World J Stem Cells, V6, P179, DOI 10.4252/wjsc.v6.i2.179; Martinez HR, 2009, CYTOTHERAPY, V11, P26, DOI 10.1080/14653240802644651; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Neha, 2014, LIFE SCI, V109, P73, DOI 10.1016/j.lfs.2014.05.017; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014; Olson SD, 2012, MOL NEUROBIOL, V45, P87, DOI 10.1007/s12035-011-8219-8; Panza F, 2014, CURR OPIN PSYCHIATR, V27, P128, DOI 10.1097/YCO.0000000000000041; Patzke N., 2013, BRAIN STRUCT FUNCT; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Polanco JC, 2013, STEM CELLS, V31, P1498, DOI 10.1002/stem.1425; Polgar S, 2003, BRAIN RES BULL, V60, P1, DOI 10.1016/S0361-9230(03)00017-0; Prasad K., 2014, STROKE J CEREB CIRC; Ramon y Cajal, 1928, DEGENERATION REGENER; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Robinson R, 2003, NEUROL TODAY, V3, P9, DOI [10.1097/00132985- 200301000-00001, DOI 10.1097/00132985-200301000-00001]; Roper SN, 2013, EXP NEUROL, V244, P59, DOI 10.1016/j.expneurol.2012.01.004; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Savitz SI, 2014, STROKE, V45, P634, DOI 10.1161/STROKEAHA.113.003379; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Selden NR, 2013, J NEUROSURG-PEDIATR, V11, P643, DOI 10.3171/2013.3.PEDS12397; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stinear CM, 2014, CURR OPIN NEUROL, V27, P624, DOI 10.1097/WCO.0000000000000153; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Teasell R, 2012, TOP STROKE REHABIL, V19, P457, DOI 10.1310/tsr1906-457; Teng YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004579; Thomsen GM, 2014, EXP NEUROL, V262, P127, DOI 10.1016/j.expneurol.2014.02.021; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Vu Q, 2014, NEUROLOGY, V82, P1277, DOI 10.1212/WNL.0000000000000278; Wahlberg LU, 2012, J NEUROSURG, V117, P340, DOI 10.3171/2012.2.JNS11714; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Wurmser AE, 2002, NATURE, V416, P485, DOI 10.1038/416485a; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	132	12	12	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JUL 15	2015	759				SI		90	100		10.1016/j.ejphar.2015.03.041			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CJ3DB	WOS:000355362500011	25814255				2022-02-06	
J	Bekelis, K; Missios, S; Mackenzie, TA				Bekelis, Kimon; Missios, Symeon; Mackenzie, Todd A.			The Association of Insurance Status and Race With Transfers of Patients With Traumatic Brain Injury Initially Evaluated at Level III and IV Trauma Centers	ANNALS OF SURGERY			English	Article						insurance coverage; interfacility transfer; NTDB; race; traumatic brain injury	DATA-BANK; DISPARITIES; HELICOPTER; SURVIVAL; SERVICES; CARE	Objective: To investigate the association of lack of insurance and African American race with the probability of transfer to level I/II trauma centers after evaluation in the emergency department of level III/IV trauma centers for traumatic brain injury (TBI). Background: The influence of nonmedical factors on the disposition of TBI patients initially seen in less specialized institutions is debated. Methods: We conducted a retrospective cohort study involving TBI patients who were registered in the National Trauma Data Bank between 2009 and 2011. Regression methods were used to investigate the association of insurance status and race with the disposition of TBI patients evaluated in less specialized trauma centers. Results: During the study period, there were 26,031 TBI patients who were registered in the National Trauma Data Bank and met inclusion criteria. Of these, 10,572 (35.9%) were transferred to a higher level of care institution. Multivariable logistic regression after coarsened exact matching demonstrated an association of uninsured patients with an increased possibility of transfer (odds ratio [OR] = 1.22; 95% confidence interval [CI], 1.05-1.42). On the contrary, there was no association of African Americans with transfers (OR = 1.27; 95% CI, 0.99-1.62). Those with Glasgow Coma Scale score above 8 (OR = 1.22; 95% CI, 1.08-1.39) or Injury Severity Score below 16 (OR = 1.33; 95% CI, 1.13-1.56) had a higher possibility of transfer. Conclusions: In TBI patients, lack of insurance was associated with an increased possibility of transfer to higher level of care institutions after evaluation in a level III or IV trauma center emergency department. Regardless of insurance status, this transfer pattern was also observed for African Americans, but only for those with milder injuries.	[Bekelis, Kimon] Dartmouth Hitchcock Med Ctr, Neurosurg Sect, 1 Med Ctr Dr, Lebanon, NH 03766 USA; [Missios, Symeon] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA 71105 USA; [Mackenzie, Todd A.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; [Mackenzie, Todd A.] Dartmouth Hitchcock Med Ctr, Dept Community & Family Med, Lebanon, NH 03766 USA; [Mackenzie, Todd A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA		Bekelis, K (corresponding author), Dartmouth Hitchcock Med Ctr, Neurosurg Sect, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	kbekelis@gmail.com	Bekelis, Kimon/Y-3402-2019		National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [PO1-AG19783]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG019783] Funding Source: NIH RePORTER	Supported by grant from the National Institute on Aging (PO1-AG19783). The authors declare no conflicts of interest.	American College of Surgeons, 2011, ANN REPORT; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Archdeacon MT, 2007, J BONE JOINT SURG AM, V89A, P2625, DOI 10.2106/JBJS.F.01499; Delgado MK, 2014, JAMA SURG, V149, P422, DOI 10.1001/jamasurg.2013.4398; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Haupt MT, 2003, CRIT CARE MED, V31, P2677, DOI 10.1097/01.CCM.0000094227.89800.93; Ho D, MATCHIT NONPARAMETRI; Honaker J, AMELIA 2 PROGRAM MIS; Imai K, ZELIG EVERYONES STAT; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; Newgard CD, 2007, J TRAUMA, V63, P965, DOI 10.1097/TA.0b013e31803c5665; Oyetunji TA, 2011, J SURG RES, V165, pE37, DOI 10.1016/j.jss.2010.09.025; Parks Jennifer, 2009, Am J Surg, V198, pe35, DOI 10.1016/j.amjsurg.2009.01.012; R Core Team, 2014, R LANG ENV STAT COMP; Roudsari B, 2008, INJURY PREV, V14, P96, DOI 10.1136/ip.2007.017129; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; RUTLEDGE R, 1993, ANN SURG, V218, P512, DOI 10.1097/00000658-199310000-00011; Shafi S, 2008, ARCH SURG-CHICAGO, V143, P1057, DOI 10.1001/archsurg.143.11.1057; Taylor CB, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2009.09.030; Taylor P., 1985, WASH POST, pA1; Traumatic brain injury in the United States, 2010, TRAUMATIC BRAIN INJU	29	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JUL	2015	262	1					9	15		10.1097/SLA.0000000000001239			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DD0LV	WOS:000369612400030	26020113	Green Accepted			2022-02-06	
J	Kankipati, P; Boninger, ML; Gagnon, D; Cooper, RA; Koontz, AM				Kankipati, Padmaja; Boninger, Michael L.; Gagnon, Dany; Cooper, Rory A.; Koontz, Alicia M.			Upper limb joint kinetics of three sitting pivot wheelchair transfer techniques in individuals with spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Activities of daily living; Secondary impairments; Biomechanics; Rehabilitation; Shoulder pain	CARPAL-TUNNEL SYNDROME; PARAPLEGIC PATIENTS; MEASUREMENT SYSTEM; KINEMATICS; SHOULDER; INDEPENDENCE; PATHOLOGY; MOTION; TRUNK; USERS	Study design: Repeated measures design. Objective: This study compared the upper extremity (UE) joint kinetics between three transfer techniques. Setting: Research laboratory. Methods: Twenty individuals with spinal cord injury performed three transfer techniques from their wheelchair to a level tub bench. Two of the techniques involved a head-hips method with leading hand position close (HH-I) and far (HH-A) from the body, and the third technique with the trunk upright (TU) and hand far from body. Motion analysis equipment recorded upper body movements and force sensors recorded their hand and feet reaction forces during the transfers. Results: Several significant differences were found between HH-A and HH-I and TU and HH-I transfers indicating that hand placement was a key factor influencing the UE joint kinetics. Peak resultant hand, elbow, and shoulder joint forces were significantly higher for the HH-A and TU techniques at the trailing arm (P < 0.036) and lower at the leading arm (P < 0.021), compared to the HH-I technique. Conclusion: Always trailing with the same arm if using HH-A or TU could predispose that arm to overuse related pain and injuries. Technique training should focus on initial hand placement close to the body followed by the amount of trunk flexion needed to facilitate movement.	[Kankipati, Padmaja; Boninger, Michael L.; Cooper, Rory A.; Koontz, Alicia M.] Dept Vet Affairs, Human Engn Res Labs, Pittsburgh, PA 15240 USA; [Kankipati, Padmaja; Cooper, Rory A.; Koontz, Alicia M.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Boninger, Michael L.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Gagnon, Dany] Ctr Interdisciplinary Res Rehabil Greater Montrea, Pathokinesiol Lab, Inst Readaptat Gingras Lindsay de Montreal, Montreal, PQ, Canada; [Gagnon, Dany] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada		Koontz, AM (corresponding author), Dept Vet Affairs, Human Engn Res Labs, 6425 Penn Ave, Pittsburgh, PA 15240 USA.	akoontz@pitt.edu		Boninger, Michael/0000-0001-6966-919X	VA Rehabilitation Research RD Services; National Institute on Disability and Rehabilitation Research; National Institute of Health (VA-RRD) [E3589V, B3079R]; National Institute of Health (NIDRR) [H133A011107]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024827] Funding Source: NIH RePORTER	The funding for this study was provided by the VA Rehabilitation Research R&D Services and the National Institute on Disability and Rehabilitation Research and the National Institute of Health (VA-RR&D E3589V and B3079R NIDRR H133A011107).	ALJURE J, 1985, PARAPLEGIA, V23, P182, DOI 10.1038/sc.1985.31; Allison GT, 1996, DISABIL REHABIL, V18, P35, DOI 10.3109/09638289609167087; Allison GT, 1997, SPINAL CORD, V35, P217, DOI 10.1038/sj.sc.3100393; BURNHAM RS, 1994, ARCH PHYS MED REHAB, V75, P519; Cooper RA, 1999, AM J PHYS MED REHAB, V78, P435, DOI 10.1097/00002060-199909000-00006; Desroches G, 2013, CLIN BIOMECH, V28, P1, DOI 10.1016/j.clinbiomech.2012.11.001; FARLEY TE, 1994, SKELETAL RADIOL, V23, P641, DOI 10.1007/BF02580386; Gagnon D, 2003, CLIN BIOMECH, V18, P319, DOI 10.1016/S0268-0033(03)00016-0; Gagnon D., 2009, TOP SPINAL CORD INJ, V15, P33, DOI DOI 10.1310/SCI1502-33; Gagnon D, 2008, J REHABIL RES DEV, V45, P863, DOI 10.1682/JRRD.2007.11.0189; Gagnon D, 2008, J REHABIL MED, V40, P468, DOI 10.2340/16501977-0192; Gagnon D, 2008, CLIN BIOMECH, V23, P279, DOI 10.1016/j.clinbiomech.2007.09.017; Gagnon D, 2009, J REHABIL RES DEV, V46, P1099, DOI 10.1682/JRRD.2009.02.0012; GELLMAN H, 1988, J BONE JOINT SURG AM, V70A, P517, DOI 10.2106/00004623-198870040-00006; HANAVAN E P Jr, 1964, AMRL TR, P1; Kankipati P, 2011, 35 ANN M AM SOC BIOM; Koontz AM, 2011, J REHABIL RES DEV, V48, P1015, DOI 10.1682/JRRD.2010.09.0169; Koontz AM, 2011, CLIN BIOMECH, V26, P923, DOI 10.1016/j.clinbiomech.2011.05.005; Mercer JL, 2006, CLIN BIOMECH, V21, P781, DOI 10.1016/j.clinbiomech.2006.04.010; Minkel JL, 2010, P 4 INT INT C POST W; Nyland J, 2000, SPINAL CORD, V38, P649, DOI 10.1038/sj.sc.3101070; Papuga M, 2004, THESIS CASE W RESERV; Paralyzed Veterans of America Consortium for Spinal Cord Medicine, 2005, J Spinal Cord Med, V28, P434; PENTLAND WE, 1994, PARAPLEGIA, V32, P211, DOI 10.1038/sc.1994.40; Requejo P, 2008, TOP SPINAL CORD INJ, V13, P86, DOI DOI 10.1310/SCI1304-86; SIE IH, 1992, ARCH PHYS MED REHAB, V73, P44; Somers M., 2001, SPINAL CORD INJURY F; Tanimoto Y, 2008, IEEE T INSTRUM MEAS, V57, P213, DOI 10.1109/TIM.2007.909501; TUN CG, 1988, J HAND SURG-AM, V13A, P716, DOI 10.1016/S0363-5023(88)80132-1; Winter D.A., 1990, BIOMECHANICS MOTOR C, VVol. 1; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yarnall M, 2005, P 28 ANN RESNA C 200	32	12	13	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2015	38	4					485	497		10.1179/2045772314Y.0000000258			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL4RS	WOS:000356941800011	25130053	Green Published			2022-02-06	
J	Kuimi, BLB; Moore, L; Cisse, B; Gagne, M; Lavoie, A; Bourgeois, G; Lapointe, J				Kuimi, Brice L. Batomen; Moore, Lynne; Cisse, Brahim; Gagne, Mathieu; Lavoie, Andre; Bourgeois, Gilles; Lapointe, Jean			Influence of access to an integrated trauma system on in-hospital mortality and length of stay	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury; Access to care; Trauma system; Mortality Length of stay	SEVERELY INJURED PATIENTS; CENTER CARE; SEVERITY; OUTCOMES; ADMISSION; ABILITIES; SURVIVAL; IMPACT	Background: Few data are available on population-based access to specialised trauma care and its influence on patient outcomes in an integrated trauma system. We aimed to evaluate the influence of access to an integrate trauma system on in-hospital mortality and length of stay (LOS). Methods: All adults admitted to acute care hospitals for major trauma [International Classification of Diseases Injury Severity Score (ICISS < 0.85)] in a Canadian province with an integrated trauma system between 2006 and 2011 were included using an administrative hospital discharge database. The influence of access to an integrated trauma system on in-hospital mortality and LOS was assessed globally and for critically injured patients (ICISS < 0.75), according to the type of injury [traumatic brain injury (TBI), abdominal/thoracic, spine, orthopaedic] using logistic and linear multivariable regression models. Results: We identified 22,749 injury admissions. In-hospital mortality was 7% and median LOS was 9 days for all injuries. Overall, 92% of patients were treated within the trauma system. Globally, patients who did not have access had similar mortality and LOS compared to patients who had access. However, we observed a 62% reduction in mortality for critical abdominal/thoracic injuries (odds ratio = 0.38; 95% CI, 0.16-0.92) and an 8% increase in LOS for TBI patients (geometric mean ratio = 1.08; 95% CI, 1.02-1.14) treated within the trauma system. Conclusions: Results provides evidence that in a health system with an integrated mature trauma system, access to specialised trauma care is high and the small proportion of patients treated outside the system, have similar mortality and LOS compared to patients treated within the system. This study suggests that the Quebec trauma system performs well in its mandate to offer appropriate treatment to victims of injury that require specialised care. (C) 2015 Elsevier Ltd. All rights reserved.	[Kuimi, Brice L. Batomen; Moore, Lynne; Cisse, Brahim; Gagne, Mathieu; Lavoie, Andre] Univ Laval, Dept Social & Preventat Med, Quebec City, PQ, Canada; [Kuimi, Brice L. Batomen; Moore, Lynne; Cisse, Brahim; Gagne, Mathieu; Lavoie, Andre] Univ Laval, Axe Sante Populat & Prat Optimales Sante Traumato, Ctr Rech CHU Quebec Hop Enfant Jesus, Quebec City, PQ, Canada; [Kuimi, Brice L. Batomen; Gagne, Mathieu] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Bourgeois, Gilles; Lapointe, Jean] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada		Moore, L (corresponding author), Univ Laval, Axe Sante Populat & Prat Optimales Sante Traumato, Ctr Rech CHU Quebec Hop Enfant Jesus, Quebec City, PQ, Canada.	brice-lionel.batomen-kuimi.1@ulaval.ca	Kuimi, Brice Lionel Batomen/AAF-3970-2020	Kuimi, Brice Lionel Batomen/0000-0002-5772-120X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [110996]; Fonds de la recherche du Quebec SanteFonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research: young investigator award [LM] and research grant [LM; #110996]; Fonds de la recherche du Quebec Sante: young investigator award [LM].	[Anonymous], 2013, HIST TRAUM SAAQ; Arthur M, 2009, J RURAL HEALTH, V25, P182, DOI 10.1111/j.1748-0361.2009.00215.x; Bellner J, 2003, J NEUROL NEUROSUR PS, V74, P351, DOI 10.1136/jnnp.74.3.351; Bergeron E, 2005, CAN J SURG, V48, P361; Bugaev N, 2013, J TRAUMA ACUTE CARE, V74, P1151, DOI 10.1097/TA.0b013e3182827191; Ciesla DJ, 2013, J AM COLL SURGEONS, V216, P687, DOI 10.1016/j.jamcollsurg.2012.12.033; Ciesla DJ, 2012, J TRAUMA ACUTE CARE, V73, P618, DOI 10.1097/TA.0b013e3182509132; Daly L, 2000, INTERPRETATION USES; Durham R, 2006, ANN SURG, V243, P775, DOI 10.1097/01.sla.0000219644.52926.f1; Eastman AB, 2006, J TRAUMA, V60, P535; Expert Group on Injury Severity Measurement, 2004, DISC DOC INJ SEV MEA; Hannan EL, 2005, J TRAUMA, V58, P244, DOI 10.1097/01.TA.0000141995.44721.44; Hwabejire JO, 2013, JAMA SURG, V148, P956, DOI 10.1001/jamasurg.2013.2148; Institut de la statistique Quebec, 2012, POP QUEB CAN 1851 20; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; Kim Y, 2000, J TRAUMA, V48, P280, DOI 10.1097/00005373-200002000-00014; Kuimi BL, 2015, INJURY; Lansink KWW, 2007, CURR OPIN CRIT CARE, V13, P686, DOI 10.1097/MCC.0b013e3282f1e7a4; Lansink KWW, 2013, WORLD J SURG, V37, P2353, DOI 10.1007/s00268-013-2103-9; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Mann NC, 2001, J TRAUMA, V50, P1111, DOI 10.1097/00005373-200106000-00022; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Ministere de la Santeet des Services Sociaux, 2013, ET SOMM PROV REG SEL; Ministere de la Santeet des Services Sociaux, 2013, CADR NORM SYST MED E; Moore L, 2014, ANN SURG, V260, P179, DOI 10.1097/SLA.0000000000000624; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Moore L, 2011, CRIT CARE MED, V39, P2246, DOI 10.1097/CCM.0b013e3182227a59; Moore L, 2012, INJURY, V43, P1580, DOI 10.1016/j.injury.2011.02.010; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Mullins RJ, 1996, J TRAUMA, V40, P45; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Ruffieux C, 2000, CASEMIX Q, V2, P1; Stammers J, 2013, ANN ROY COLL SURG, V95, P184, DOI 10.1308/003588413X13511609957416; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Trauma Association of Canada, 2011, TRAUM SYST ACCR GUID; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e	40	12	12	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2015	46	7					1257	1261		10.1016/j.injury.2015.02.024			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CP8EK	WOS:000360124800012	25801066				2022-02-06	
J	Shahim, P; Mattsson, N; Macy, EM; Crimmins, DL; Ladenson, JH; Zetterberg, H; Blennow, K; Tegner, Y				Shahim, Pashtun; Mattsson, Niklas; Macy, Elizabeth M.; Crimmins, Dan L.; Ladenson, Jack H.; Zetterberg, Henrik; Blennow, Kaj; Tegner, Yelverton			Serum visinin-like protein-1 in concussed professional ice hockey players	BRAIN INJURY			English	Article						Biomarker; brain injury; concussion; ice hockey; VILIP-1	BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CEREBROSPINAL-FLUID; OVEREXPRESSION; BIOMARKERS; STATEMENT; SPORT	Primary objective: Visinin-like protein-1 (VILIP-1) has shown potential utility as a biomarker for neuronal injury in cerebrospinal fluid. This study investigated serum VILIP-1 as a diagnostic and prognostic marker in sports-related concussion. Methods: This multi-centre prospective cohort study involved the 12 teams of the professional ice hockey league in Sweden. A total of 288 players consented to participate in the study. Thirty-five players sustained concussions, of whom 28 underwent repeated blood samplings at 1, 12, 36 and 144 hours after the trauma or when the player returned to play (7-90+ days). Main outcomes and results: The highest levels of VILIP-1 were measured 1 hour after concussion and the levels decreased during rehabilitation, reaching a minimum level at the 36-hour sampling. However, the levels of serum VILIP-1 at 1 hour after concussion were not significantly higher than pre-season baseline values. Serum levels of VILIP-1 1 hour post-concussion did not correlate with-the number of days for the concussion symptoms to resolve. Further, serum levels of VILIP-1 increased after a friendly game in players who were not concussed. Conclusions: These results provide evidence that serum VILIP-1 may not be a useful biomarker for diagnosis and prognosis of sports-related concussion.	[Shahim, Pashtun; Mattsson, Niklas; Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Sahlgrenska Univ Hosp, SE-43180 Molndal, Sweden; [Mattsson, Niklas] Univ Calif San Francisco, Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Macy, Elizabeth M.; Crimmins, Dan L.; Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO USA; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UCL Inst Neurol, Reta Lila Weston Labs, London, England; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, Div Med Sci, S-95187 Lulea, Sweden		Shahim, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Sahlgrenska Univ Hosp, SE-43180 Molndal, Sweden.	pashtun.shahim@neuro.gu.se	Mattsson-Carlgren, Niklas/H-7597-2019	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Tegner, Yelverton/0000-0003-3628-0705	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Centrum for Idrottsforskning; Emil and Maria Palm Foundation	The authors report no conflicts of interest. The study was supported by grants from the Swedish Research Council, the Knut and Alice Wallenberg Foundation, Centrum for Idrottsforskning and the Emil and Maria Palm Foundation.	Akagi T, 2012, INT J CANCER, V131, P1307, DOI 10.1002/ijc.27341; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Buttgereit J, 2010, REGUL PEPTIDES, V161, P51, DOI 10.1016/j.regpep.2009.12.019; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Lee JM, 2008, CLIN CHEM, V54, P1617, DOI 10.1373/clinchem.2008.104497; Mahloogi H, 2003, CANCER RES, V63, P4997; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Stejskal D, 2011, BIOMED PAP, V155, P263, DOI 10.5507/bp.2011.049; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tarawneh R, 2011, ANN NEUROL, V70, P274, DOI 10.1002/ana.22448; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	18	12	12	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					872	876		10.3109/02699052.2015.1018324			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800012	25955117				2022-02-06	
J	Yousuf, A; Khursheed, N; Rasool, I; Kundal, V; Jeelani, H; Afroze, D				Yousuf, Adfar; Khursheed, Nayil; Rasool, Ishrat; Kundal, Vijay; Jeelani, Humira; Afroze, Dil			Genetic Variation of ApoE Gene in Ethnic Kashmiri Population and Its Association with Outcome After Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Genotyping; Apolipoprotein E; PCR-RFLP	APOLIPOPROTEIN-E POLYMORPHISM; E GENOTYPE; MODERATE; E4; DISEASE; LIPIDS; E3	The outcome from traumatic brain injury (TBI) is variable and only partly explained by known prognostic factors. Genetic factors may influence the brain's susceptibility to injury or capacity for repair and regeneration. ApoE has been implicated in modifying neurological outcome after TBI, although the mechanisms by which this occurs remain poorly defined. Apolipoprotein E is an apparently multifunctional protein involved in the response of the brain to injury and in subsequent repair processes. Several studies have shown that patients with APOE e4 have a poorer outcome after TBI. This study was aimed to analyse the genotypes of ApoE in Kashmiri population and to examine the association of APOE genotype with outcome after TBI. A total of 450 subjects (300 healthy controls and 150 TBI patients) were recruited for the study. Genotyping was done by PCR-restriction fragment length polymorphism (RFLP).Our study indicated Apoe3/e3 to be the most common genotype in this study group. The allele frequency of the Apo E gene in these study subjects was observed to be 0.07 for the e2 allele, 0.82 for the e3 allele and 0.11 for the e4 allele. However, no association between the presence of APOe4 allele and outcome after head injury was observed in this study [p = 0.92]. Thus, genotype containing the e4 allele (e4/e3 and e4/e4) was not associated with unfavourable outcome after TBI in Kashmiri population.	[Yousuf, Adfar; Afroze, Dil] Sherikashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, Jammu & Kashmir, India; [Khursheed, Nayil; Kundal, Vijay] Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, Jammu & Kashmir, India; [Rasool, Ishrat] Amity Univ, Dept Virol & Immunol, Noida, UP, India; [Jeelani, Humira] Univ Kashmir, Dept Biochem, Srinagar 190006, Jammu & Kashmir, India		Afroze, D (corresponding author), Sherikashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, Jammu & Kashmir, India.	afrozedil@gmail.com	Afroze, Dil/ABG-9180-2021	KUNDAL, VIJAY KUMAR/0000-0003-0348-5173			Adamson MM, 2011, NEUROPSYCHOLOGIA, V49, P2448, DOI 10.1016/j.neuropsychologia.2011.04.022; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; DAS HK, 1985, J BIOL CHEM, V260, P6240; Djan I, 2011, ARCH BIOL SCI, V63, P89, DOI 10.2298/ABS1101089D; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; EVANS AE, 1993, HUM GENET, V92, P191; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GAJRA B, 1994, GENET EPIDEMIOL, V11, P19, DOI 10.1002/gepi.1370110103; GAJRA B, 1994, HUM HERED, V44, P209, DOI 10.1159/000154219; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Gururaj G, 2008, NATL MED J INDIA, V21, P14; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Ilveskoski E, 1999, CIRCULATION, V100, P608, DOI 10.1161/01.CIR.100.6.608; Jainh Y, 2006, NEUROSCI LETT, V408, P155; Kamboh MI, 1996, HUM BIOL, V68, P231; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445; Pathak A, 2008, J INDIAN ACAD FORENS, V30; Peden M., 2004, WORLD REPORT ROAD TR; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Romer CJ, 1995, PREVENTION CRITICAL; SMIT M, 1988, HUM GENET, V78, P90, DOI 10.1007/BF00291243; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; UTERMANN G, 1980, AM J HUM GENET, V32, P339; W.H. Organization, 2006, NEUR DIS PUBL HLTH C	41	12	12	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JUL	2015	56	3					597	601		10.1007/s12031-015-0554-1			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CL0BN	WOS:000356603600011	25859935				2022-02-06	
J	Yuan, Q; Wu, X; Yu, J; Sun, YR; Li, ZQ; Du, ZY; Wu, XH; Zhou, LF; Hu, J				Yuan, Qiang; Wu, Xing; Yu, Jian; Sun, Yirui; Li, Zhiqi; Du, Zhuoying; Wu, Xuehai; Zhou, Liangfu; Hu, Jin			Subdural hygroma following decompressive craniectomy or non-decompressive craniectomy in patients with traumatic brain injury: Clinical features and risk factors	BRAIN INJURY			English	Article						Decompressive craniectomy; post-traumatic hydrocephalus; risk factor; subdural hygroma; traumatic brain injury	POSTTRAUMATIC HYDROCEPHALUS; INTRACRANIAL HYPERTENSION; INTERHEMISPHERIC HYGROMA; SURGICAL COMPLICATIONS; UNITED-STATES; HEAD-INJURY; EFFUSION; SECONDARY; HEMATOMA; SURGERY	Objective: Subdural hygroma (SDG) is a common complication that can occur after head trauma or secondary to decompressive craniectomy (DC). SDGs can be located not only ipsilateral or contralateral to the side of the DC, but also bilateral or unilateral in patients without DC. This study investigated the incidence and risk factors for different types of SDG in a large cohort of patients with traumatic brain injury (TB:). Methods: A retrospective study was conducted involving 379 adult patients with TBI who were admitted to Huashan Hospital, Fudan University between January 2009 and December 2013. As the outcome was dichotomous (SDG vs no SDG or hydrocephalus vs no hydrocephalus), multivariate logistic regression analyses were used to identify independent risk factors for the development of SDGs in patients without DC, ipsilateral SDG after unilateral DC, contralateral SDG after unilateral DC or SDG after bilateral DC. Risk factors for the development of hydrocephalus were also evaluated in patients with and without DC. Results: Among the 207 (54.6%) patients without DC, 30 (14.5%) had unilateral SDGs and 34 (16.4%) had bilateral SDGs. Of the 172 patients (45.4%) with DC, 134 (77.9%) underwent unilateral DC and 38 (22.1%) underwent bilateral DC. Of the 134 patients who underwent unilateral DC, 49 developed SDG, including 22 (16.4%) ipsilateral SDG, 19 (14.2%) contralateral SDG and eight (6.0%) both ipsilateral and contralateral SDGs. For patients undergoing bilateral DC, 13 (34.2%) developed a SDG. No significant difference in the incidence of SDG was observed between the patients with and without DC (36.0% vs 30.9%, p = 0.291), but the characteristics of SDGs were different between the two groups. Logistic regression analysis showed that factors independently associated with the development of SDG were male sex (odds ratio [OR] = 3.861; 95% CI = 1.642-9.091; p = 0.002), older age (OR = 1.046; 95% CI = 1.021-1.070; p < 0.001), basal cistern haemorrhage (OR = 4.608; 95% CI = 1.510-14.064; p = 0.007), diffuse injury and swelling (OR = 3.158; 95% CI = 1.341-7.435; p = 0.008) or diffuse injury and shift (OR = 3.826; 95% CI = 1.141-12.830; p = 0.030) in patients without DC. Temporal haematoma or contusion in the non-DC side (OR = 2.623; 95% CI = 1.070-6.428; p = 0.035) and traumatic SAH (OR = 3.751; 95% CI = 1.047-13.438; p = 0.042) were independently associated with the development of ipsilateral SDG in patients who underwent unilateral DC. However, factors independently associated with the development of contralateral SDG were frontal haematoma or contusion on the non-DC side (OR = 3.145; 95% CI = 1.272-7.774; p = 0.013) and SDH on the non-DC side (OR = 7.024; 95% CI = 1.477-33.390; p = 0.014). Only craniectomy area (OR = 1.030; 95% CI = 1.008-1.052; p = 0.008) was independently associated with the development of SDG in patients with bilateral DC. In the multivariate analysis, SDG in patients without DC was not associated with the development of hydrocephalus. However, SDG was significantly associated with the development of hydrocephalus for patients who underwent DC (OR = 2.173; 95% CI = 1.362-3.467; p = 0.001). Conclusions: This study suggested that the incidence of SDG in patients who have and have not undergone DC was identical; however, the patients' characteristics and risk factors differed. Therefore, the management and prediction of SDG should be performed according to SDG type.	[Yuan, Qiang; Wu, Xing; Yu, Jian; Sun, Yirui; Li, Zhiqi; Du, Zhuoying; Wu, Xuehai; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Road, Shanghai 200040, Peoples R China.	277089712@qq.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30371454, 81271375, 81171133]; Science and Technology Commission of Shanghai Municipality ProjectScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This work was supported by the National Natural Science Foundation of China (NSFC Grants 30371454, 81271375 and 81171133), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300) and Shanghai Nature Science Foundation (08411952000).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; BORN JD, 1984, ACTA NEUROL BELG, V84, P174; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Huang Qiang, 2003, Chin J Traumatol, V6, P305; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; KAUFMAN HH, 1984, ACTA NEUROCHIR, V72, P197, DOI 10.1007/BF01406870; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; OHNO K, 1987, J NEUROL NEUROSUR PS, V50, P1694, DOI 10.1136/jnnp.50.12.1694; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; Su FW, 2008, J CLIN NEUROSCI, V15, P305, DOI 10.1016/j.jocn.2006.08.019; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Wang HK, 2012, INJURY, V43, P594, DOI 10.1016/j.injury.2010.06.004; WETTERLING T, 1986, ACTA NEUROCHIR, V83, P99, DOI 10.1007/BF01402385; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	32	12	17	3	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					971	980		10.3109/02699052.2015.1004760			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800025	25915113				2022-02-06	
J	Zhou, R; Liu, B; Lin, K; Wang, R; Qin, Z; Liao, R; Qiu, Y				Zhou, R.; Liu, B.; Lin, K.; Wang, R.; Qin, Z.; Liao, R.; Qiu, Y.			ECMO support for right main bronchial disruption in multiple trauma patient with brain injurya case report and literature review	PERFUSION-UK			English	Article						ECMO; bronchial disruption; respiratory failure; multiple trauma; brain injury	EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; LIFE-SUPPORT; SHOCK; LUNG	Extracorporeal membrane oxygenation (ECMO) may offer life-saving treatment in severe pulmonary contusion or acute respiratory distress syndrome when conventional treatments have failed. However, because of the bleeding risk of systemic anticoagulation, ECMO should be performed only as a last resort in multiple trauma victims. Here, we report ECMO as a bridge for right main bronchus reconstruction and recovery of traumatic wet lung in a 31-year-old male multi-trauma patient with right main bronchial disruption, bilateral pulmonary contusion, cerebral contusion and long bone fracture. The patient was discharged without any obvious complication. ECMO support in a traumatic brain injured patient with severe hypoxemia caused by lung contusion and/or tracheal bronchus disruption is not an absolute contraindication.	[Zhou, R.; Liu, B.; Wang, R.; Qin, Z.; Liao, R.; Qiu, Y.] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610041, Sichuan, Peoples R China; [Lin, K.] Sichuan Univ, West China Hosp, Dept Cardiac Surg, Chengdu 610041, Sichuan, Peoples R China		Liu, B (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China.	liubinhx@foxmail.com			Science&Technology Agency of Sichuan Province, China	This research received grant from Science&Technology Agency of Sichuan Province, China. The Approval Number is 2012FZ0123.	Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Ballouhey Q, 2013, EUR J CARDIO-THORAC, V43, P864, DOI 10.1093/ejcts/ezs607; Bonacchi M, 2013, J THORAC CARDIOV SUR, V145, P1617, DOI 10.1016/j.jtcvs.2012.08.046; Campione A, 2007, J THORAC CARDIOV SUR, V133, P1673, DOI 10.1016/j.jtcvs.2007.02.011; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204; Korvenoja P, 2008, ANN THORAC SURG, V86, P1348, DOI 10.1016/j.athoracsur.2008.04.018; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Muellenbach RM, 2011, ANAESTHESIST, V60, P647, DOI 10.1007/s00101-011-1872-5; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Tiruvoipati R, 2012, J CRIT CARE, V27, P192, DOI 10.1016/j.jcrc.2011.04.003	12	12	13	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0267-6591	1477-111X		PERFUSION-UK	Perfusion-UK	JUL	2015	30	5					403	406		10.1177/0267659114554326			4	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	CK2AJ	WOS:000356011400008	25300436				2022-02-06	
J	Mantua, J; Mahan, KM; Henry, OS; Spencer, RMC				Mantua, Janna; Mahan, Keenan M.; Henry, Owen S.; Spencer, Rebecca M. C.			Altered sleep composition after traumatic brain injury does not affect declarative sleep-dependent memory consolidation	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						sleep; memory consolidation; TBI; traumatic brain injury; NREM	MINOR HEAD-INJURY; SLOW-WAVE SLEEP; PROCEDURAL MEMORY; DISTURBANCES; ADOLESCENTS; SPINDLES; QUALITY; CYCLES; RECALL; NEED	Individuals with a history of traumatic brain injury (TBI) often report sleep disturbances, which may be caused by changes in sleep architecture or reduced sleep quality (greater time awake after sleep onset, poorer sleep efficiency, and sleep stage proportion alterations). Sleep is beneficial for memory formation, and herein we examine whether altered sleep physiology following TBI has deleterious effects on sleep-dependent declarative memory consolidation. Participants learned a list of word pairs in the morning or evening, and recall was assessed 12-h later, following an interval awake or with overnight sleep. Young adult participants (18-22 years) were assigned to one of four experimental groups: TBI Sleep (n = 14), TBI Wake (n = 12), non-TBI Sleep (n = 15), non-TBI Wake (n = 15). Each TBI participant was >1 year post injury. Sleep physiology was measured with polysomnography. Memory consolidation was assessed by comparing change in word-pair recall over 12-h intersession intervals. The TBI group spent a significantly greater proportion of the night in SWS than the non-TBI group at the expense of NREM1. The TBI group also had marginally lower EEG delta power during SVVS in the central region. Intersession changes in recall were greater for intervals with sleep than without sleep in both groups. However, despite abnormal sleep stage proportions for individuals with a TBI history, there was no difference in the intersession change in recall following sleep for the TBI and non-TBI groups. In both Sleep groups combined, there was a positive correlation between Intersession Change and the proportion of the night in NREM2 + SWS. Overall, sleep composition is altered following TBI but such deficits do not yield insufficiencies in sleep-dependent memory consolidation.	[Mantua, Janna; Spencer, Rebecca M. C.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA; [Mahan, Keenan M.; Henry, Owen S.] Univ Massachusetts, Commonwealth Honors Coll, Amherst, MA 01003 USA; [Spencer, Rebecca M. C.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA		Spencer, RMC (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, 135 Hicks Way,Tobin 419, Amherst, MA 01003 USA.	rspencer@psych.umass.edu		Henry, Owen/0000-0002-2266-7768			Ackermann S., 2014, SLEEP; Ackermann S, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0430-8; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Feld GB, 2013, SLEEP, V36, P1317, DOI 10.5665/sleep.2954; Ficca G, 2000, BEHAV BRAIN RES, V112, P159, DOI 10.1016/S0166-4328(00)00177-7; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Genzel L, 2009, SLEEP, V32, P302, DOI 10.1093/sleep/32.3.302; Goder R, 2007, SLEEP MED, V8, P503, DOI 10.1016/j.sleep.2006.11.014; Hershner SD, 2014, NAT SCI SLEEP, V6, P73, DOI 10.2147/NSS.S62907; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Holz J, 2012, J SLEEP RES, V21, P612, DOI 10.1111/j.1365-2869.2012.01017.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Martin SE, 1997, AM J RESP CRIT CARE, V155, P1596, DOI 10.1164/ajrccm.155.5.9154863; Mazzoni G, 1999, J SLEEP RES, V8, P185, DOI 10.1046/j.1365-2869.1999.00154.x; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Ruch S, 2012, NEUROPSYCHOLOGIA, V50, P2389, DOI 10.1016/j.neuropsychologia.2012.06.008; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Toki S, 2014, J AFFECT DISORDERS, V152, P462, DOI 10.1016/j.jad.2013.07.021; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wechsler D., 2008, WECHSLER ADULT INTEL; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029	51	12	12	0	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUN 5	2015	9								328	10.3389/fnhum.2015.00328			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CK3EZ	WOS:000356100700001	26097451	Green Published, gold			2022-02-06	
J	Hsu, CY; Schneller, B; Ghaffari, M; Alaraj, A; Linninger, A				Hsu, Chih-Yang; Schneller, Ben; Ghaffari, Mahsa; Alaraj, Ali; Linninger, Andreas			Medical Image Processing for Fully Integrated Subject Specific Whole Brain Mesh Generation	TECHNOLOGIES			English	Article						image processing; computational meshes; simulation		Currently, anatomically consistent segmentation of vascular trees acquired with magnetic resonance imaging requires the use of multiple image processing steps, which, in turn, depend on manual intervention. In effect, segmentation of vascular trees from medical images is time consuming and error prone due to the tortuous geometry and weak signal in small blood vessels. To overcome errors and accelerate the image processing time, we introduce an automatic image processing pipeline for constructing subject specific computational meshes for entire cerebral vasculature, including segmentation of ancillary structures; the grey and white matter, cerebrospinal fluid space, skull, and scalp. To demonstrate the validity of the new pipeline, we segmented the entire intracranial compartment with special attention of the angioarchitecture from magnetic resonance imaging acquired for two healthy volunteers. The raw images were processed through our pipeline for automatic segmentation and mesh generation. Due to partial volume effect and finite resolution, the computational meshes intersect with each other at respective interfaces. To eliminate anatomically inconsistent overlap, we utilized morphological operations to separate the structures with a physiologically sound gap spaces. The resulting meshes exhibit anatomically correct spatial extent and relative positions without intersections. For validation, we computed critical biometrics of the angioarchitecture, the cortical surfaces, ventricular system, and cerebrospinal fluid (CSF) spaces and compared against literature values. Volumina and surface areas of the computational mesh were found to be in physiological ranges. In conclusion, we present an automatic image processing pipeline to automate the segmentation of the main intracranial compartments including a subject-specific vascular trees. These computational meshes can be used in 3D immersive visualization for diagnosis, surgery planning with haptics control in virtual reality. Subject-specific computational meshes are also a prerequisite for computer simulations of cerebral hemodynamics and the effects of traumatic brain injury.	[Hsu, Chih-Yang; Schneller, Ben; Ghaffari, Mahsa; Linninger, Andreas] Univ Illinois, Dept Bioengn, 851 S Morgan St, Chicago, IL 60607 USA; [Alaraj, Ali; Linninger, Andreas] Univ Illinois, Dept Neurosurg, Chicago, IL 60607 USA		Linninger, A (corresponding author), Univ Illinois, Dept Bioengn, 851 S Morgan St, Chicago, IL 60607 USA.	chsu33@uic.edu; bschne3@uic.edu; mghaff2@uic.edu; alaraj@uic.edu; linninge@uic.edu			NSFNational Science Foundation (NSF) [CBET-0756154, CBET-1301198]	The authors would like to gratefully partial support of this project by NSF grants CBET-0756154 and CBET-1301198.	Adams CM, 2011, ANAT SCI EDUC, V4, P340, DOI 10.1002/ase.256; Alaraj A, 2013, COMPREHENSIVE TXB HE, P415, DOI [10.1007/978-1-4614-5993-4_28, DOI 10.1007/978-1-4614-5993-4_28]; Alaraj A, 2015, OPER NEUROSURG, V11, P52, DOI 10.1227/NEU.0000000000000583; Alaraj A, 2013, NEUROSURGERY, V72, pA115, DOI 10.1227/NEU.0b013e3182753093; Alaraj Ali, 2011, Surg Neurol Int, V2, P52, DOI 10.4103/2152-7806.80117; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Borouchaki H, 2000, INT J NUMER METH ENG, V49, P233; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dogdas B, 2005, HUM BRAIN MAPP, V26, P273, DOI 10.1002/hbm.20159; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Duncan JS, 2000, IEEE T PATTERN ANAL, V22, P85, DOI 10.1109/34.824822; Erdt M, 2008, LECT NOTES COMPUT SC, V5128, P403, DOI 10.1007/978-3-540-79982-5_44; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/bfb0056195; Ghaffari M., 2015, COMPUT AIDE IN PRESS; Ghaffari M., 2014, J MODERN ENG, V14, P54; GRANT R, 1987, MAGN RESON IMAGING, V5, P465, DOI 10.1016/0730-725X(87)90380-8; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Ito H, 2001, ANN NUCL MED, V15, P111, DOI 10.1007/BF02988600; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Liao PS, 2001, J INF SCI ENG, V17, P713; Lim SP, 2014, ARTIF INTELL REV, V42, P59, DOI 10.1007/s10462-012-9329-z; Linninger AA, 2005, IEEE T BIO-MED ENG, V52, P557, DOI 10.1109/TBME.2005.844021; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Linninger AA, 2009, ANN BIOMED ENG, V37, P1434, DOI 10.1007/s10439-009-9691-4; Lorensen W.E., 1987, COMPUT GRAPHICS-US, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Luders E, 2002, NEUROREPORT, V13, P2371, DOI 10.1097/01.wnr.0000049603.85580.da; Meegama RGN, 2003, INT J PATTERN RECOGN, V17, P995, DOI 10.1142/S0218001403002745; Milner JS, 1998, J VASC SURG, V28, P143, DOI 10.1016/S0741-5214(98)70210-1; Nielson G. M., 1991, Proceedings Visualization '91 (Cat. No.91CH3046-0), P83, DOI 10.1109/VISUAL.1991.175782; Nowinski WL, 2015, J NEUROSCI METH, V246, P65, DOI 10.1016/j.jneumeth.2015.02.012; Nowinski WL, 2005, NEUROINFORMATICS, V3, P293, DOI 10.1385/NI:3:4:293; Nowinski WL, 2003, INT CONGR SER, V1256, P75, DOI 10.1016/S0531-5131(03)00269-3; Nowinski WL, 2003, NEUROIMAGE, V20, P50, DOI 10.1016/S1053-8119(03)00252-0; Oshima M, 2001, COMPUT METHOD APPL M, V191, P661, DOI 10.1016/S0045-7825(01)00307-3; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Penn RD, 2009, COLLECTIONS, V116, P1069; Pons JP, 2007, LECT NOTES COMPUT SC, V4584, P198; Reichold J, 2009, J CEREBR BLOOD F MET, V29, P1429, DOI 10.1038/jcbfm.2009.58; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Shikata H, 2004, PRO BIOMED OPT IMAG, V5, P107, DOI 10.1117/12.537032; Spiegel M, 2011, COMPUT METHOD BIOMEC, V14, P9, DOI 10.1080/10255842.2010.518565; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Sweetman B, 2011, ANN BIOMED ENG, V39, P484, DOI 10.1007/s10439-010-0141-0; Takahashi T, 2007, P ANN INT IEEE EMBS, P3613, DOI 10.1109/IEMBS.2007.4353113; Wardlaw JM, 2005, RADIOLOGY, V235, P444, DOI 10.1148/radiol.2352040262; Yudkowsky R, 2013, SIMUL HEALTHC, V8, P25, DOI 10.1097/SIH.0b013e3182662c69; Zhang JY, 2013, INT J NUMER METH BIO, V29, P293, DOI 10.1002/cnm.2507; Zhu Dajiang, 2009, Conf Rec Asilomar Conf Signals Syst Comput, V2009, P1094, DOI 10.1109/ACSSC.2009.5470064; Zhu DC, 2006, J MAGN RESON IMAGING, V24, P756, DOI 10.1002/jmri.20679	56	12	12	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2227-7080			TECHNOLOGIES	Technologies	JUN	2015	3	2					126	141		10.3390/technologies3020126			16	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	V3T7Z	WOS:000218580200006		Green Submitted, gold			2022-02-06	
J	Lemogne, C; Smadja, J; Zerdazi, EH; Soudry, Y; Robin, M; Berthoz, S; Limosin, F; Consoli, SM; Bonfils, P				Lemogne, Cedric; Smadja, Julien; Zerdazi, El-Hadi; Soudry, Yael; Robin, Marion; Berthoz, Sylvie; Limosin, Frederic; Consoli, Silla M.; Bonfils, Pierre			Congenital anosmia and emotion recognition: A case-control study	NEUROPSYCHOLOGIA			English	Article						Acquired anosmia; Congenial anosmia; Emotion; Facial expressions; Olfaction	ODOR IDENTIFICATION; FACIAL EXPRESSIONS; DISGUST; SENSITIVITY; ASSOCIATION	Patients with anosmia are not able to detect volatile chemicals signaling the presence of infectious and non-infectious environmental hazards, which typically elicit disgust and fear, respectively. Social animals may compensate a loss of olfaction by taking advantage of signals of threat that are produced by their conspecifics. Among humans and other primates, body postures and facial expressions are powerful cues conveying emotional information, including fear and disgust. The aim of the present study was to examine whether humans with agenesis of the olfactory bulb, a rare disorder characterized by congenital anosmia, would be more accurate in recognizing facial expressions of fear and disgust. A total of 90 participants with no history of mental disorder or traumatic brain injury were recruited, including 17 patients with congenital anosmia (10 men, mean age + standard deviation: 36.5 + 14.8 years), 34 patients with acquired anosmia (18 men, mean age + standard deviation: 57.2 + 11.8 years) and 39 healthy subjects (22 men, mean age + standard deviation: 36.7 + 13.2 years). For each patient with congenital anosmia, the agenesis of the olfactory bulb was ascertained through magnetic resonance imaging. Emotion recognition abilities were examined with a dynamic paradigm in which a morphing technique allowed displaying emotional facial expressions increasing in intensity over time. Adjusting for age, education, depression and anxiety, patients with congenital anosmia required similar levels of intensity to correctly recognize fear and disgust than healthy subjects while they displayed decreased error rates for both fear (mean difference [95% confidence interval]=-28.3% [-46.3%, -10.2%], P=0.003) and disgust (mean difference [95% confidence interval] = -15.8% [-31.5%, -0.2%], P=0.048). Furthermore, among patients with acquired anosmia, there was a negative correlation between duration of anosmia and the rate of errors for fearful (Spearman's rho=-0.531, P=0.001) or disgust (Spearman's rho=0.719, P<0.001) faces recognition. No significant difference was observed for the other primary emotions. Overall, these results suggest that patients with congenital anosmia and long-lasting acquired anosmia may compensate their inability to detect environmental hazards through olfaction by an increased ability to detect fear or disgust as facially expressed by others. (C) 2015 Elsevier Ltd. All rights reserved.	[Lemogne, Cedric; Smadja, Julien; Limosin, Frederic; Consoli, Silla M.; Bonfils, Pierre] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75015 Paris, France; [Lemogne, Cedric; Smadja, Julien; Zerdazi, El-Hadi; Soudry, Yael; Limosin, Frederic; Consoli, Silla M.] Hop Univ Paris Ouest, AP HP, Serv Psychiat Adulte & Sujet Age, F-75015 Paris, France; [Lemogne, Cedric; Limosin, Frederic] INSERM, Ctr Psychiat & Neurosci, U894, F-75014 Paris, France; [Robin, Marion; Berthoz, Sylvie] INSERM, U1178, F-75014 Paris, France; [Robin, Marion; Berthoz, Sylvie] Univ Paris 11, Inst Mutualiste Montsouris, F-75014 Paris, France; [Robin, Marion; Berthoz, Sylvie] Univ Paris 05, Inst Mutualiste Montsouris, F-75014 Paris, France; [Bonfils, Pierre] Hop Univ Paris Ouest, AP HP, Serv ORL & Chirurg Cervicofaciale, F-75015 Paris, France; [Bonfils, Pierre] CNRS, Ctr Univ St Peres, Cognit & Act Grp, UMR MD 8257, F-75006 Paris, France		Lemogne, C (corresponding author), Hop Europeen Georges Pompidou, Unite Psychol & Psychiat Liaison & Urgence, 20 Rue Leblanc, F-75908 Paris 15, France.	cedric.lemogne@egp.aphp.fr	Berthoz Landron, Sylvie/M-4517-2018; Lemogne, Cedric/Q-6091-2019	Lemogne, Cedric/0000-0002-3487-4721; Berthoz, Sylvie/0000-0002-6862-2362			Atanasova B, 2008, NEUROSCI BIOBEHAV R, V32, P1315, DOI 10.1016/j.neubiorev.2008.05.003; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Biszak AM, 2014, BRAIN INJURY, V28, P97, DOI 10.3109/02699052.2013.856475; Bonfils P., 2009, HOME ACCIDENTS ASS A, V37, P742; Bulsing PJ, 2009, CHEM SENSES, V34, P111, DOI 10.1093/chemse/bjn062; Chapman HA, 2013, PSYCHOL BULL, V139, P300, DOI 10.1037/a0030964; Cosmides L, 2013, ANNU REV PSYCHOL, V64, P201, DOI 10.1146/annurev.psych.121208.131628; Curtis V, 2011, PHILOS T R SOC B, V366, P3478, DOI 10.1098/rstb.2011.0165; Darwin C., 1965, EXPRESSION EMOTIONS; Davey GCL, 2011, PHILOS T R SOC B, V366, P3453, DOI 10.1098/rstb.2011.0039; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Domes G, 2008, J PERS DISORD, V22, P135, DOI 10.1521/pedi.2008.22.2.135; Eisenberger NI, 2012, PSYCHOSOM MED, V74, P126, DOI 10.1097/PSY.0b013e3182464dd1; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gagnon M, 2014, J GENET PSYCHOL, V175, P416, DOI 10.1080/00221325.2014.941322; Harmer Catherine J, 2013, Curr Top Behav Neurosci, V14, P209, DOI 10.1007/7854_2012_210; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kohler CG, 2007, J NEUROPSYCH CLIN N, V19, P128, DOI 10.1176/appi.neuropsych.19.2.128; Lecanu J B, 2002, Ann Otolaryngol Chir Cervicofac, V119, P164; Lynch TR, 2006, EMOTION, V6, P647, DOI 10.1037/1528-3542.6.4.647; Matsumoto D, 2009, J PERS SOC PSYCHOL, V96, P1, DOI 10.1037/a0014037; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Naudin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046938; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Robin M, 2012, PSYCHIAT RES, V200, P417, DOI 10.1016/j.psychres.2012.03.032; Rotge JY, 2015, SOC COGN AFFECT NEUR, V10, P19, DOI 10.1093/scan/nsu110; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Spielberger CD, 1993, INVENTAIRE ANXIETE E; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Stevenson RJ, 2010, DEV PSYCHOL, V46, P165, DOI 10.1037/a0016692; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Widen SC, 2013, PSYCHOL BULL, V139, P271, DOI 10.1037/a0031640	38	12	12	0	29	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUN	2015	72						52	58		10.1016/j.neuropsychologia.2015.04.028			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CK0FY	WOS:000355882300006	25921869				2022-02-06	
J	Yamazaki, J; Gilgien, M; Kleiven, S; Mcintosh, AS; Nachbauer, W; Muller, E; Bere, T; Bahr, R; Krosshaug, T				Yamazaki, Junya; Gilgien, Matthias; Kleiven, Svein; Mcintosh, Andrew S.; Nachbauer, Werner; Mueller, Erich; Bere, Tone; Bahr, Roald; Krosshaug, Tron			Analysis of a Severe Head Injury in World Cup Alpine Skiing	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						TRAUMATIC BRAIN INJURY; SKIING INJURY; ALPINE SKIING; HELMET; BIOMECHANICS; MODEL-BASED IMAGE MATCHING TECHNIQUE	VIDEO SEQUENCES; HELMET USE; SKIERS; SNOWBOARDERS; RISK; RECONSTRUCTION; MECHANISMS; MOTION; COHORT	Traumatic brain injury (TBI) is the leading cause of death in alpine skiing. It has been found that helmet use can reduce the incidence of head injuries between 15% and 60%. However, knowledge on optimal helmet performance criteria in World Cup alpine skiing is currently limited owing to the lack of biomechanical data from real crash situations. Purpose: This study aimed to estimate impact velocities in a severe TBI case in World Cup alpine skiing. Methods: Video sequences from a TBI case in World Cup alpine skiing were analyzed using a model-based image matching technique. Video sequences from four camera views were obtained in full high-definition (1080p) format. A three-dimensional model of the course was built based on accurate measurements of piste landmarks and matched to the background video footage using the animation software Poser 4. A trunk-neck-head model was used for tracking the skier's trajectory. Results: Immediately before head impact, the downward velocity component was estimated to be 8 m.s(-1). After impact, the upward velocity was 3 m.s(-1), whereas the velocity parallel to the slope surface was reduced from 33 m.s(-1) to 22 m.s(-1). The frontal plane angular velocity of the head changed from 80 radIsj1 left tilt immediately before impact to 20 rad.s(-1) right tilt immediately after impact. Conclusions: A unique combination of high-definition video footage and accurate measurements of landmarks in the slope made possible a high-quality analysis of head impact velocity in a severe TBI case. The estimates can provide crucial information on how to prevent TBI through helmet performance criteria and design.	[Yamazaki, Junya; Bahr, Roald; Krosshaug, Tron] Oslo Sports Trauma Res Ctr, Oslo, Norway; [Yamazaki, Junya] Tokyo Med & Dent Univ Hosp, Sch Med, Sect Orthoped Surg, Tokyo, Japan; [Gilgien, Matthias] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Kleiven, Svein] Royal Inst Technol, Stockholm, Sweden; [Mcintosh, Andrew S.] Federat Univ Australia, ACRISP, Ballarat, Vic, Australia; [Nachbauer, Werner] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria; [Mueller, Erich] Salzburg Univ, Dept Sport & Exercise Sci, A-5020 Salzburg, Austria; [Bere, Tone] Aspetar Orthopaed & Sports Med Hosp, Doha, Qatar		Yamazaki, J (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan.	kuma-kuma@yd5.so-net.ne.jp	Krosshaug, Tron/AAT-2390-2021		Royal Norwegian Ministry of Culture; South-Eastern Norway Regional Health Authority; International Olympic Committee; Norwegian Olympic Committee & Confederation of Sport; Norsk Tipping AS	The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sport Sciences through generous grants from the Royal Norwegian Ministry of Culture, the South-Eastern Norway Regional Health Authority, the International Olympic Committee, the Norwegian Olympic Committee & Confederation of Sport, and Norsk Tipping AS.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Bere T, 2014, BRIT J SPORT MED, V48, P36, DOI 10.1136/bjsports-2013-092206; Chinn B., 2001, COST 327 MOTORCYCLE; Ekeland A, 2006, SKI TRAU SAF, V16, P1; Fauve M, 2002, PREPARATION MAINTENA, P134; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Gilgien M., 2014, THESIS NORWEGIAN SCH; Gilgien M, 2014, J SPORTS SC IN PRESS; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Gilgien M, 2013, SENSORS-BASEL, V13, P9821, DOI 10.3390/s130809821; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; International Ski Federation, 2013, SPEC COMP EQ COMM MA; Koehle MS, 2002, SPORTS MED, V32, P785, DOI 10.2165/00007256-200232120-00003; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, SCAND J MED SCI SPOR, V17, P508, DOI 10.1111/j.1600-0838.2006.00558.x; Krosshaug T, 2005, J BIOMECH, V38, P919, DOI 10.1016/j.jbiomech.2004.04.033; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Steenstrup SE, 2014, BRIT J SPORT MED, V48, P41, DOI 10.1136/bjsports-2013-093145; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Westin M, 2012, KNEE SURG SPORT TR A, V20, P1175, DOI 10.1007/s00167-012-1921-x; Wolfsperger F, 2013, 6 INT C SCI SKIING	26	12	12	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2015	47	6					1113	1118		10.1249/MSS.0000000000000511			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CI4TC	WOS:000354745500002	25207934	Green Accepted, Green Published			2022-02-06	
J	Woods, DL; Yund, EW; Wyma, JM; Ruff, R; Herron, TJ				Woods, David L.; Yund, E. William; Wyma, John M.; Ruff, Ron; Herron, Timothy J.			Measuring executive function in control subjects and TBI patients with question completion time (QCT)	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						aging; gender; reaction time; executive function; head injury; reading	COGNITIVE FAILURES QUESTIONNAIRE; CHECKLIST-CIVILIAN VERSION; TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; PROCESSING SPEED; WORKING-MEMORY; NORMATIVE DATA; PTSD; SCALE; AGE	Questionnaire completion is a complex task that places demands on cognitive functions subserving reading, introspective memory, decision-making, and motor control. Although computerized questionnaires and surveys are used with increasing frequency in clinical practice, few studies have examined question completion time (QCT), the time required to complete each question. Here, we analyzed QCTs in 172 control subjects and 31 patients with traumatic brain injury (TBI) who completed two computerized questionnaires, the 17-question Post-Traumatic Stress Disorder (PTSD) Checklist (PCL) and the 25-question Cognitive Failures Questionnaire (CFQ). In control subjects, robust correlations were found between self paced QCTs on the PCL and CFQ (r = 0.82). QCTs on individual questions correlated strongly with the number of words in the question, indicating the critical role of reading speed. QCTs increased significantly with age, and were reduced in females and in subjects with increased education and computer experience. QCT z-scores, corrected for age, education, computer use, and sex, correlated more strongly with each other than with the results of other cognitive tests. Patients with a history of severe TBI showed significantly delayed QCTs, but QCTs fell within the normal range in patients with a history of mild TBI. When questionnaires are used to gather relevant patient information, simultaneous QCT measures provide reliable and clinically sensitive measures of processing speed and executive function.	[Woods, David L.; Yund, E. William; Wyma, John M.; Herron, Timothy J.] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA USA; [Ruff, Ron] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA		Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Neurol Serv 127E, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587	CSRD VA [I01 CX001000] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER		Allenby A, 2002, EUR J CANCER CARE, V11, P245, DOI 10.1046/j.1365-2354.2002.00310.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borella E, 2011, J GERONTOL B-PSYCHOL, V66, P311, DOI 10.1093/geronb/gbr002; Brand M, 2010, GERONTOLOGY, V56, P319, DOI 10.1159/000248829; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Caplan D, 2011, PSYCHOL AGING, V26, P439, DOI 10.1037/a0021837; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Commodari E, 2008, AGING CLIN EXP RES, V20, P578; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1111/j.1360-0443.1995.tb03552.x; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Karstoft KI, 2014, PSYCHOL ASSESSMENT, V26, P321, DOI 10.1037/a0034889; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lynn R, 2009, TRAMES-J HUMANIT SOC, V13, P3, DOI 10.3176/tr.2009.1.01; Malhotra N, 2008, PUBLIC OPIN QUART, V72, P914, DOI 10.1093/poq/nfn050; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Novakovic-Agopian T, 2014, J HEAD TRAUMA REHAB, V29, P136, DOI 10.1097/HTR.0b013e3182691b15; POLLINA LK, 1992, BRIT J PSYCHOL, V83, P305, DOI 10.1111/j.2044-8295.1992.tb02443.x; REASON J, 1984, BRIT J CLIN PSYCHOL, V23, P121, DOI 10.1111/j.2044-8260.1984.tb00635.x; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P443, DOI 10.1016/S0887-6177(99)00043-8; Reitan RM, 2005, ARCH CLIN NEUROPSYCH, V20, P957, DOI 10.1016/j.acn.2005.07.010; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Schneider ALC, 2015, ALZ DIS ASSOC DIS, V29, P32, DOI 10.1097/WAD.0000000000000042; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tiu RD, 2003, J LEARN DISABIL-US, V36, P424, DOI 10.1177/00222194030360050401; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Verma A, 2007, J CLIN SLEEP MED, V3, P357; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Woods D. L., 2015, PLOS ONE IN PRESS; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Yarnold PR, 1996, PERCEPT MOTOR SKILL, V82, P689, DOI 10.2466/pms.1996.82.2.689	41	12	12	0	10	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 19	2015	9								288	10.3389/fnhum.2015.00288			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CK2SW	WOS:000356063600002	26042021	Green Published, gold			2022-02-06	
J	Kulkarni, P; Kenkel, W; Finklestein, SP; Barchet, TM; Ren, JM; Davenport, M; Shenton, ME; Kikinis, Z; Nedelman, M; Ferris, CF				Kulkarni, Praveen; Kenkel, William; Finklestein, Seth P.; Barchet, Thomas M.; Ren, JingMei; Davenport, Mathew; Shenton, Martha E.; Kikinis, Zora; Nedelman, Mark; Ferris, Craig F.			Use of Anisotropy, 3D Segmented Atlas, and Computational Analysis to Identify Gray Matter Subcortical Lesions Common to Concussive Injury from Different Sites on the Cortex	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; IMAGING FINDINGS; C-FOS; RAT; AGGRESSION; BEHAVIOR; AMYGDALA; ATROPHY; MODEL; HIPPOCAMPUS	Traumatic brain injury (TBI) can occur anywhere along the cortical mantel. While the cortical contusions may be random and disparate in their locations, the clinical outcomes are often similar and difficult to explain. Thus a question that arises is, do concussions at different sites on the cortex affect similar subcortical brain regions? To address this question we used a fluid percussion model to concuss the right caudal or rostral cortices in rats. Five days later, diffusion tensor MRI data were acquired for indices of anisotropy (IA) for use in a novel method of analysis to detect changes in gray matter microarchitecture. IA values from over 20,000 voxels were registered into a 3D segmented, annotated rat atlas covering 150 brain areas. Comparisons between left and right hemispheres revealed a small population of subcortical sites with altered IA values. Rostral and caudal concussions were of striking similarity in the impacted subcortical locations, particularly the central nucleus of the amygdala, laterodorsal thalamus, and hippocampal complex. Subsequent immunohistochemical analysis of these sites showed significant neuroinflammation. This study presents three significant findings that advance our understanding and evaluation of TBI: 1) the introduction of a new method to identify highly localized disturbances in discrete gray matter, subcortical brain nuclei without postmortem histology, 2) the use of this method to demonstrate that separate injuries to the rostral and caudal cortex produce the same subcortical, disturbances, and 3) the central nucleus of the amygdala, critical in the regulation of emotion, is vulnerable to concussion.	[Kulkarni, Praveen; Kenkel, William; Barchet, Thomas M.; Ferris, Craig F.] Northeastern Univ, Boston, MA 02115 USA; [Finklestein, Seth P.; Ren, JingMei; Davenport, Mathew] Biotrofix, Waltham, MA USA; [Shenton, Martha E.; Kikinis, Zora] Brigham & Womens Hosp, Boston, MA 02115 USA; [Nedelman, Mark] Ekam Imaging, Boston, MA USA		Ferris, CF (corresponding author), Northeastern Univ, Boston, MA 02115 USA.	c.ferris@neu.edu	Kenkel, William/T-5695-2019; Shenton, Martha/V-8780-2019	Kenkel, William/0000-0002-0271-1071; Kulkarni, Praveen/0000-0002-8876-4544	Ekam Imaging; Biotrofix	The work was supported by funding from Ekam Imaging and Biotrofix. The funders provided support in the form of salaries for authors MN, MD, SF & MR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Coccaro EF, 1997, NEUROPSYCHOPHARMACOL, V16, P211, DOI 10.1016/S0893-133X(96)00194-7; Coccaro EF, 1997, BIOL PSYCHIAT, V41, P273, DOI 10.1016/S0006-3223(96)00257-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gussin HA, 2010, BIOCONJUGATE CHEM, V21, P1455, DOI 10.1021/bc100050s; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Johnsen EL, 2009, INT J PSYCHOPHYSIOL, V72, P24, DOI 10.1016/j.ijpsycho.2008.03.011; Kao C, 2012, J NEUROSURG, V117, P316, DOI 10.3171/2012.4.JNS111170; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McCloskey MS, 2008, PSYCHIAT RES, V158, P248, DOI 10.1016/j.psychres.2007.09.011; McCloskey MS, 2008, AGGRESSIVE BEHAV, V34, P51, DOI 10.1002/ab.20216; McCloskey M, 2009, PSYCHOPHARMACOLOGY, V203, P53, DOI 10.1007/s00213-008-1374-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MOSELEY ME, 1991, MAGNET RESON MED, V19, P321, DOI 10.1002/mrm.1910190222; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Pasternak O, 2015, SCHIZOPHR RES, V161, P113, DOI 10.1016/j.schres.2014.07.031; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rathi Y, 2014, HUM BRAIN MAPP, V35, P3841, DOI 10.1002/hbm.22441; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Silverstein SM, 2010, NEUROPSYCHOLOGIA, V48, P2886, DOI 10.1016/j.neuropsychologia.2010.05.030; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang L, 2008, BIOL PSYCHIAT, V64, P1060, DOI 10.1016/j.biopsych.2008.08.007; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196	64	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125748	10.1371/journal.pone.0125748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	WOS:000356768100070	25955025	Green Submitted, Green Published, gold			2022-02-06	
J	Svoboda, E; Richards, B; Yao, C; Leach, L				Svoboda, Eva; Richards, Brian; Yao, Christie; Leach, Larry			Long-term maintenance of smartphone and PDA use in individuals with moderate to severe memory impairment	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; FOLLOW-UP; COGNITIVE REHABILITATION; PLANNING PROBLEMS; SELF-AWARENESS; N-OF-1 TRIALS; PAGING SYSTEM; THERAPY GOALS; HEAD-INJURY	In an earlier paper we described a structured, theory-driven training programme which was administered to 10 individuals with moderate-to-severe memory impairment. All individuals received an errorless-fading-of-cues protocol in the use of personal digital assistants (PDAs) or smartphones (Svoboda, Richards, Leach, & Mertens, 2012) and demonstrated generalisation of acquired skills to day-to-day memory challenges. Maintenance of intervention gains over the long-term is another indicator of successful generalisation. Here we present the maintenance of device use in the same group of individuals 12 to 19 months after programme completion. A within-subject, ABABB multi-case experimental design was used to evaluate the impact of PDA or smartphone use on day-to-day memory functioning at baseline, immediately post-intervention, at return to baseline, and at short-term and long-term follow-up. Results presented here focus predominantly on long-term follow-up. All 10 individuals showed maintenance of gains in day-to-day functioning as quantified across several ecologically valid questionnaire and task-based measures. This was corroborated by family members with whom six of the participants resided. This study further demonstrates the programme's clinical effectiveness in enabling individuals with moderate-to-severe memory impairment to function more independently and with greater confidence up to 19 months following programme completion.	[Svoboda, Eva; Richards, Brian; Yao, Christie; Leach, Larry] Baycrest Hlth Sci, Neuropsychol & Cognit Hlth Program, Toronto, ON M6A 2E1, Canada		Svoboda, E (corresponding author), Baycrest Hlth Sci, Neuropsychol & Cognit Hlth Program, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	esvoboda@baycrest.org		Yao, Christie/0000-0002-0507-4717			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cicerone K. D., 2005, EFFECTIVENESS REHABI; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cullen C. N., 1976, NURS TIMES, V72, P45; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Donaghy S, 1998, BRAIN INJURY, V12, P1061, DOI 10.1080/026990598121963; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gentry T, 2008, AM J OCCUP THER, V62, P18, DOI 10.5014/ajot.62.1.18; GILES GM, 1989, AM J OCCUP THER, V43, P409, DOI 10.5014/ajot.43.6.409; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Martin-Saez M, 2011, NEUROPSYCHOL REHABIL, V21, P769, DOI 10.1080/09602011.2011.614378; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Moscovitch M., 1982, AGING COGNITIVE PROC, P55; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Savage KR, 2013, CLIN REHABIL, V27, P521, DOI 10.1177/0269215512464230; Schacter D.L, 1994, MEMORY SYSTEMS 1994, P1; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; SIDMAN M, 1967, J EXP ANAL BEHAV, V10, P3, DOI 10.1901/jeab.1967.10-3; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; SOHLBERG MM, 2001, COGNITIVE REHABILITA, P194; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Teasdale TW, 2009, J NEUROL NEUROSUR PS, V80, P781, DOI 10.1136/jnnp.2008.162966; Troyer A. K., 2002, J GERONTOLOGY SERIES, V57B, P19, DOI [10.1093/geronb/57.1.P19, DOI 10.1093/GERONB/57.1.P19, DOI 10.1093/geronb/57.1.P19]; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1997, NEUROPSYCHOL REHABIL, V7, P43, DOI 10.1080/713755518; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239	52	12	12	0	23	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 4	2015	25	3					353	373		10.1080/09602011.2014.927368			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CF1QL	WOS:000352322600002	24945553				2022-02-06	
J	Blaha, RZ; Arnett, AB; Kirkwood, MW; Taylor, HG; Stancin, T; Brown, TM; Wade, SL				Blaha, Robert Z.; Arnett, Anne B.; Kirkwood, Michael W.; Taylor, H. Gerry; Stancin, Terry; Brown, Tanya M.; Wade, Shari L.			Factors Influencing Attrition in a Multisite, Randomized, Clinical Trial Following Traumatic Brain Injury in Adolescence	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescence; attrition; closed head injury; pediatrics; randomized clinical trial; retention; traumatic brain injury	HEAD-INJURY; PREDICTORS; RETENTION; CHILDREN; PROGRAM; ISSUES	Background: Attrition in longitudinal research negatively affects statistical power, disrupts statistical stability, and can produce unwanted bias. Objective: To investigate factors associated with shorter length of study participation and lower rates of study completion (ie, attrition) in a large, multisite, longitudinal, randomized, clinical trial examining the efficacy of a Web-based family problem-solving treatment following traumatic brain injury (TBI) in adolescence. Setting: Five major trauma centers in the central and western regions of the United States. Participants: Children (N = 132) aged 12 to 17 years hospitalized for complicated mild to severe TBI within the previous 6 months. Results: Completers had a higher primary caregiver education and higher family income than noncompleters, whereas ethnicity, latency to baseline assessment, and intervention group were not significantly associated with study completion. Conclusion: This is the first study that has specifically examined factors of attrition in a pediatric TBI population. The results suggest that research on pediatric TBI populations may be biased toward higher-income families and highlights the importance of designing studies with increased awareness of the impact of participant demographic factors.	[Blaha, Robert Z.; Arnett, Anne B.; Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Kirkwood, Michael W.] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Brown, Tanya M.] Mayo Clin, Rochester, MN USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Blaha, RZ (corresponding author), Childrens Hosp Colorado, Dept Rehabil Med, 13123 E 16th Ave,B285, Aurora, CO 80045 USA.	robert.blaha@childrenscolorado.org	Stancin, Terry/L-7993-2019	Arnett, Anne/0000-0003-1342-0488	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073764, R01 MH073764] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER		Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Bender BG, 2003, ANN ALLERG ASTHMA IM, V91, P168; Bender BG, 1997, J ALLERGY CLIN IMMUN, V99, P197, DOI 10.1016/S0091-6749(97)70096-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; CICCHETTI DV, 1994, J CLIN EXP NEUROPSYC, V16, P339, DOI 10.1080/01688639408402644; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Davis MJ, 1999, ANN BEHAV MED, V21, P339, DOI 10.1007/BF02895967; Driscoll KA, 2009, CONTEMP CLIN TRIALS, V30, P212, DOI 10.1016/j.cct.2009.01.008; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Harris PM, 1998, AM J EVAL, V19, P293, DOI 10.1016/S1098-2140(99)80213-6; Karlson CW, 2009, J PEDIATR PSYCHOL, V34, P782, DOI 10.1093/jpepsy/jsn122; Kazdin AE, 1999, J CONSULT CLIN PSYCH, V67, P332, DOI 10.1037/0022-006X.67.3.332; Kennard BD, 2008, J AM ACAD CHILD PSY, V47, P1395, DOI 10.1097/CHI.0b013e31818914a1; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Marcellus Lenora, 2004, Can J Nurs Res, V36, P82; O'Connor TM, 2013, CHILD CARE HLTH DEV, V39, P141, DOI 10.1111/j.1365-2214.2011.01344.x; Reed-Knight B, 2012, J CLIN PSYCHOL MED S, V19, P188, DOI 10.1007/s10880-011-9269-9; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Skelton JA, 2014, J HEALTHC QUAL, V36, P5, DOI 10.1111/jhq.12003; Stinson JN, 2010, J RHEUMATOL, V37, P1944, DOI 10.3899/jrheum.091327; TEASDALE G, 1974, LANCET, V2, P81; ter Huurne ED, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2211; Toerien M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-52; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zebracki K, 2003, J PEDIATR PSYCHOL, V28, P519, DOI 10.1093/jpepsy/jsg042; Zook PM, 2010, CLIN TRIALS, V7, P400, DOI 10.1177/1740774510373798	32	12	12	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E33	E40		10.1097/HTR.0000000000000059			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100004	24842589	Green Accepted			2022-02-06	
J	Ganti, L; Conroy, LM; Bodhit, A; Daneshvar, Y; Patel, PS; Ayala, S; Kuchibhotla, S; Hatchitt, K; Pulvinott, C; Peters, KR; Lottenberg, LL				Ganti, Latha; Conroy, Lauren M.; Bodhit, Aakash; Daneshvar, Yasamin; Patel, Pratik Shashikant; Ayala, Sarah; Kuchibhotla, Sudeep; Hatchitt, Kelsey; Pulvinott, Christa; Peters, Keith R.; Lottenberg, Lawrence L.			Understanding Why Patients Return to the Emergency Department after Mild Traumatic Brain Injury within 72 Hours	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							DETERIORATION; RECIDIVISM; UNIT; CARE	Introduction: Although there are approximately 1,1 million case presentations of mild traumatic brain injury (mTBI) in the emergency department (ED) each year, little data is available to clinicians to identify patients who are at risk for poor outcomes, including 72-hour ED return after discharge. An understanding of patients at risk for ED return visits during the hyperacute phase following head injury would allow ED providers to develop clinical interventions that reduce its occurrence and improve outcomes. Methods: This institutional review board-approved consecutive cohort study collected injury and outcome variables on adults with the purpose of identifying positive predictors for 72-hour ED return visits in mTBI patients. Results: Of 2,787 mTBI patients, 145 (5%) returned unexpectedly to the ED within 72 hours of hospital discharge. Positive predictors for ED return visits included being male (p=0,0298), being black (p=0.0456), having a lower prehospital Glasgow Coma Score (p=0.0335), suffering the injury due to a motor vehicle collision (p=0.0065), or having a bleed on head computed tomography (CT) (p=0.0334). ED return visits were not significantly associated with age, fracture on head CT, or synnptonnology following head trauma, Patients with retum visits most commonly reported post-concussion syndrome (43.1%), pain (18.7%), and recall for further clinical evaluation (14,6%) as the reason for retum. Of the 124 patients who returned to the ED within 72 hours, one out of five were admitted to the hospital for further care, with five requiring intensive care unit stays and four undergoing neurosurgery. Conclusion: Approximately 5% of adult patients who present to the ED for mTBI will return within 72 hours of discharge for further care. Clinicians should identify at-risk individuals during their initial visits and attempt to provide anticipatory guidance when possible.	[Ganti, Latha] North Florida South Georgia Vet Affairs Med Ctr, 619 S Marion Ave, Lake City, FL 32025 USA; [Conroy, Lauren M.] Univ Florida, Coll Med, Gainesville, FL USA; [Bodhit, Aakash] St Louis Univ, Dept Neurol, St Louis, MO 63103 USA; [Daneshvar, Yasamin] NYU, Coll Arts & Sci, New York, NY USA; [Patel, Pratik Shashikant] Univ Florida, Dept Emergency Med, Gainesville, FL USA; [Ayala, Sarah] Univ Calif San Diego, Coll Arts & Sci, San Diego, CA 92103 USA; [Kuchibhotla, Sudeep] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; [Hatchitt, Kelsey] George Washington Univ, Washington, DC USA; [Pulvinott, Christa] Tulane Univ, New Orleans, LA 70118 USA; [Peters, Keith R.] Univ Florida, Dept Radiol, Gainesville, FL 32610 USA; [Lottenberg, Lawrence L.] Univ Florida, Dept Surg, Gainesville, FL USA		Ganti, L (corresponding author), North Florida South Georgia Vet Affairs Med Ctr, 619 S Marion Ave, Lake City, FL 32025 USA.	lathagantimd@gmail.com	Ganti, Latha/AAF-6268-2020; Bodhit, Aakash/AAM-5786-2021	Ganti, Latha/0000-0001-7717-3864; Bodhit, Aakash/0000-0003-2722-025X			Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Caufeild J, 2004, J TRAUMA, V57, P872, DOI 10.1097/01.TA.0000135350.06670.60; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Choudhry OJ, 2013, NEUROSURGERY, V73, P753, DOI 10.1227/NEU.0000000000000105; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Goh S. H., 1996, Annals Academy of Medicine Singapore, V25, P541; Madden C, 1997, ACAD EMERG MED, V4, P772, DOI 10.1111/j.1553-2712.1997.tb03782.x; McCoy AM, 2013, J TRAUMA ACUTE CARE, V75, P116, DOI 10.1097/TA.0b013e31829231b7; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miro O, 1999, MED CLIN-BARCELONA, V112, P610; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; REDELMEIER DA, 1995, LANCET, V345, P1131, DOI 10.1016/S0140-6736(95)90975-3; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Sayfan J, 1997, J TRAUMA, V43, P123, DOI 10.1097/00005373-199707000-00028; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; STERN RS, 1991, JAMA-J AM MED ASSOC, V266, P2238, DOI 10.1001/jama.266.16.2238; Williams JM, 1997, ANN EMERG MED, V30, P176, DOI 10.1016/S0196-0644(97)70139-2	18	12	12	0	3	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	MAY	2015	16	3					481	485		10.5811/westjem.2015.2.23546			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	DH9KV	WOS:000373115900027	25987933	gold, Green Published			2022-02-06	
J	Moriarty, H; Winter, L; Robinson, K; True, G; Piersol, C; Vause-Earland, T; Iacovone, DB; Holbert, L; Newhart, B; Fishman, D; Short, TH				Moriarty, Helene; Winter, Laraine; Robinson, Keith; True, Gala; Piersol, Catherine; Vause-Earland, Tracey; Iacovone, Dolores Blazer; Holbert, Laura; Newhart, Brian; Fishman, Deborah; Short, Thomas H.			Exploration of Individual and Family Factors Related to Community Reintegration in Veterans With Traumatic Brain Injury	JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION			English	Article						traumatic brain injury; veterans; community reintegration; depression; posttraumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MAJOR DEPRESSION; NEUROPSYCHIATRIC SEQUELAE; TEMPORAL RELATIONSHIP; LIFE SATISFACTION; COMBAT VETERANS; INTEGRATION; MILITARY; REHABILITATION	BACKGROUND: Community reintegration (CR) poses a major problem for military veterans who have experienced a traumatic brain injury (TBI). Factors contributing to CR after TBI are poorly understood. OBJECTIVE: To address the gap in knowledge, an ecological framework was used to explore individual and family factors related to CR. DESIGN: Baseline data from an intervention study with 83 veterans with primarily mild to moderate TBI were analyzed. Instruments measured CR, depressive symptoms, physical health, quality of the relationship with the family member, and sociodemographics. Posttraumatic stress disorder and TBI characteristics were determined through record review. RESULTS: Five variables that exhibited significant bivariate relationships with CR (veteran rating of quality of relationship, physical functioning, bodily pain, posttraumatic stress disorder diagnosis, and depressive symptoms) were entered into hierarchical regression analysis. In the final analysis, the five variables together accounted for 35% of the variance, but only depression was a significant predictor of CR, with more depressed veterans exhibiting lower CR. CONCLUSIONS: Efforts to support CR of Veterans with TBI should carefully assess and target depression, a modifiable factor.	[Moriarty, Helene] Philadelphia Vet Affairs VA Med Ctr, Nursing Serv, Philadelphia, PA USA; [Moriarty, Helene] Villanova Univ, Coll Nursing, Villanova, PA 19085 USA; [Winter, Laraine; Fishman, Deborah] Philadelphia VA Med Ctr, Nursing Serv, Philadelphia, PA USA; [Winter, Laraine; Holbert, Laura] Philadelphia VA Med Ctr, Philadelphia Res & Educ Fdn, Philadelphia, PA USA; [Robinson, Keith; Iacovone, Dolores Blazer; Newhart, Brian] Philadelphia VA Med Ctr, Polytrauma Serv, Philadelphia, PA USA; [Robinson, Keith; True, Gala] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [True, Gala] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Piersol, Catherine; Vause-Earland, Tracey] Thomas Jefferson Univ, Sch Hlth Profess, Philadelphia, PA 19107 USA; [Short, Thomas H.] John Carroll Univ, Dept Math & Comp Sci, University Hts, OH USA		Moriarty, H (corresponding author), Villanova Univ, Coll Nursing, Driscoll Hall,800 Lancaster Ave, Villanova, PA 19085 USA.	helene.moriarty@villanova.edu		Piersol, Catherine/0000-0003-4992-8988	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD068857-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD068857] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The project described was supported by Award No. R21 HD068857-01 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. This material is the result of work also supported with resources and the use of facilities at the Philadelphia VA Medical Center.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Brown JL, 2012, JAMA-J AM MED ASSOC, V308, P1869, DOI 10.1001/jama.2012.14254; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 1983, APPL MULTIPLE REGRES; Crocker T, 2014, J REHABIL RES DEV, V51, pXI, DOI [10.1682/JRRD.2014.01.00111, 10.1682/JRRD.2014.01.0011]; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fleming J, 1999, BRAIN INJURY, V13, P417; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Jaycox, 2008, INVISIBLE WOUNDS WAR, P3; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kazis LE., 2000, MED OUTCOMES TRUST M, V5, P1; Kelly PJ, 2014, NURS RES, V63, P346, DOI 10.1097/NNR.0000000000000051; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kupersmith J, 2009, J REHABIL RES DEV, V46, pvii; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Murphy RA, 2013, CLIN CHILD FAM PSYCH, V16, P348, DOI 10.1007/s10567-013-0149-8; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pomerantz AS, 2010, FAM SYST HEALTH, V28, P78, DOI 10.1037/a0020341; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Resnik L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-145; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Ross AM, 2014, HEALTH SOC WORK, V39, P47, DOI 10.1093/hsw/hlu001; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Ruff Robert L, 2010, F1000 Med Rep, V2, P64, DOI 10.3410/M2-64; Salter K, 2011, BRAIN INJURY, V25, P1147, DOI 10.3109/02699052.2011.613088; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2015, ADM POLICY MENT HLTH, V42, P493, DOI 10.1007/s10488-014-0564-2; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Skodol A, 2000, HDB PSYCHIAT MEASURE, P45; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; WILLIAMSON GM, 1990, PSYCHOL AGING, V5, P502, DOI 10.1037/0882-7974.5.4.502; Williamson GM, 2001, PSYCHOL AGING, V16, P217, DOI 10.1037//0882-7974.16.2.217; WILLIAMSON GM, 1995, J APPL SOC PSYCHOL, V25, P93, DOI 10.1111/j.1559-1816.1995.tb01586.x; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	93	12	12	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3903	1532-5725		J AM PSYCHIAT NURSES	J. Am. Psych. Nurses Assoc.	MAY-JUN	2015	21	3					195	211		10.1177/1078390315591879			17	Nursing; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Psychiatry	CM5SN	WOS:000357749000005	26156059				2022-02-06	
J	Stelmashook, EV; Genrikhs, EE; Novikova, SV; Barskov, IV; Gudasheva, TA; Seredenin, SB; Khaspekov, LG; Isaev, NK				Stelmashook, Elena V.; Genrikhs, Elisaveta E.; Novikova, Svetlana V.; Barskov, Igor V.; Gudasheva, Tatyana A.; Seredenin, Sergey B.; Khaspekov, Leonid G.; Isaev, Nickolay K.			Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						traumatic brain injury; neuroprotection; dipeptide mimetic of nerve growth factor; GK-2; cerebellar granule cultures	NERVE GROWTH-FACTOR; DEFICITS; MITOCHONDRIA; ISCHEMIA; DESIGN; LIGAND; EDEMA	A protective behavioral effect of a nerve growth factor dipeptide mimetic GK-2 in the model of open focal trauma of rat brain sensorimotor cortex and its antioxidative and regenerative properties in cultures of rat cerebellar granule cells and mouse embryonal spinal ganglion, respectively, were studied. Intraperitoneal injections of GK-2 (1 mg/kg) for 5 days daily after traumatic brain injury improved significantly motor function of limbs. Moreover, supplementation the incubation medium with GK-2 (0.5-1.5 mg/l) decreased neuronal death induced by H2O2] in cerebellar granule cell cultures and stimulated neurite outgrowth from cultured mouse embryonal spinal ganglia. Our results suggest that GK-2 exhibits pronounced positive behavioral effect in vivo as well as neuroprotective and regenerative effects in vitro, and that these neuroprotective properties probably associated with cell survival but not with cell differentiation pathway.	[Stelmashook, Elena V.; Genrikhs, Elisaveta E.; Novikova, Svetlana V.; Barskov, Igor V.; Khaspekov, Leonid G.; Isaev, Nickolay K.] Russian Acad Med Sci, Res Ctr Neurol, Moscow 125367, Russia; [Gudasheva, Tatyana A.; Seredenin, Sergey B.] Russian Acad Med Sci, VV Zakusov Inst Pharmacol, Moscow 125367, Russia; [Isaev, Nickolay K.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia		Stelmashook, EV (corresponding author), Russian Acad Med Sci, Res Ctr Neurol, Volokolamskoe Shosse 80, Moscow 125367, Russia.	estelmash@mail.ru	Khaspekov, Leonid/B-9327-2012; Gudasheva, Tatiana/A-5242-2017; Genrikhs, Elizaveta E/C-3854-2012; Stelmashook, Elena V/B-4442-2012; Frumkina, Lidia E/B-9971-2012; Isaev, Nikolay K/B-4194-2012; Seredenin, Sergey B/S-6574-2016	Khaspekov, Leonid/0000-0002-6652-9412; Seredenin, Sergey B/0000-0003-4482-9331; Genrikhs, Elizaveta/0000-0002-3203-0250	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [12-04-00025-a]	This work was supported by the Russian Foundation for Basic Research (project 12-04-00025-a).	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Antipova, 2014, NEUROSCI MED, V5, P101, DOI DOI 10.4236/NM.2014.52013; Antipova TA, 2011, B EXP BIOL MED+, V150, P607, DOI 10.1007/s10517-011-1202-6; Beglova N, 2000, J MED CHEM, V43, P3530, DOI 10.1021/jm990441x; Bruno MA, 2004, J NEUROSCI, V24, P8009, DOI 10.1523/JNEUROSCI.1508-04.2004; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Colangelo AM, 2008, J NEUROSCI, V28, P2698, DOI 10.1523/JNEUROSCI.5201-07.2008; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; EstenneBouhtou G, 1996, INT J PEPT PROT RES, V48, P337; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FSBI Zakusov Institute of Pharmacology, 2011, RU Patent, Patent No. [No 2410392C2, 2410392]; Gudasheva TA, 2010, DOKL BIOCHEM BIOPHYS, V434, P262, DOI 10.1134/S160767291005011X; HICKS SP, 1977, EXP NEUROL, V56, P410, DOI 10.1016/0014-4886(77)90357-0; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; LEVIMONTALCINI R, 1985, P NATL ACAD SCI USA, V82, P7111, DOI 10.1073/pnas.82.20.7111; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; Markova E. G., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P318; Massa SM, 2002, J MOL NEUROSCI, V19, P107, DOI 10.1007/s12031-002-0019-1; Neet KE, 2011, ALZHEIMER'S DISEASE PATHOGENESIS - CORE CONCEPTS, SHIFTING PARADIGMS AND THERAPEUTIC TARGETS, P243; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Peleshok J, 2006, BIOCHEM SOC T, V34, P612, DOI 10.1042/BST0340612; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Povarnina PY, 2013, ACTA NATURAE, V5, P84, DOI 10.32607/20758251-2013-5-3-84-91; Scarpi D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.129; Seredenin SB, 2011, B EXP BIOL MED+, V151, P584; Seredenin SB, 2011, B EXP BIOL MED+, V150, P432, DOI 10.1007/s10517-011-1161-y; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stelmashook EV, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1039, DOI 10.1134/S0006297910080134; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059	32	12	14	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	MAY	2015	125	5					375	379		10.3109/00207454.2014.935376			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL8SW	WOS:000357245400009	24950445				2022-02-06	
J	Zhang, XQ; Lu, JT; Jiang, WX; Lu, YB; Wu, M; Wei, EQ; Zhang, WP; Tang, C				Zhang, X. -Q.; Lu, J. -T.; Jiang, W. -X.; Lu, Y. -B.; Wu, M.; Wei, E. -Q.; Zhang, W. -P.; Tang, C.			NAMPT INHIBITOR AND METABOLITE PROTECT MOUSE BRAIN FROM CRYOINJURY THROUGH DISTINCT MECHANISMS	NEUROSCIENCE			English	Article						NAMPT; FK866; NMN; NAD; cryoinjury; brain injury	COLONY-ENHANCING FACTOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CEREBRAL-ISCHEMIA; NAD BIOSYNTHESIS; ENZYMATIC-ACTIVITY; IN-VITRO; INJURY; NEUROPROTECTION; INFLAMMATION; PATHWAY	Nicotinamide phosphoribosyltransferase (NAMPT) is the key enzyme in the biosynthesis of nicotinamide adenine dinucleotide (NAD). In the brain, NAMPT is primarily expressed in neurons and can prevent neuronal degeneration. NAMPT is also highly expressed in inflammatory cells, and is responsible for their activation. Since inflammation following traumatic brain injury enhances neuronal damage, we assessed the effects of nicotinamide mononucleotide (NMN), the direct NAMPT metabolite, and FK866, a potent NAMPT inhibitor, on brain injury in a cryoinjury mouse model. Twenty-four hours after brain cryoinjury, the density of neuron and the level of NAD decreased. Both NMN and FK866 alleviated the neuronal loss and decreased the lesion volume. NMN prevented the cryoinjury-induced decrease of NAD level, and FK866 decreased it further. On day 14 after cryoinjury, further neuronal loss occurred, astrocytes and Iba1-positive macrophage/microglia activated, and the NAD level increased. At this time-point, NAMPT expression was strongly induced in Iba1-positive macrophages/microglia in the lesion core. NMN and FK866 also alleviated the neuronal loss and decreased the lesion volume. In addition, FK866 significantly attenuated the activation of astrocytes and Iba1-positive macrophages/microglia, and decreased the NAD, while NMN had no such effects. Taken together, both FK866 and NMN attenuate traumatic brain injury. However, FK866 acts via the inhibition of the NAMPT activity in inflammatory cells resulting in the inhibition of inflammation, whereas NMN is effective via replenishing NAD. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Zhang, X. -Q.; Lu, J. -T.; Lu, Y. -B.; Wei, E. -Q.; Zhang, W. -P.] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Jiang, W. -X.; Tang, C.] Chinese Acad Sci, Natl Ctr Magnet Resonance Wuhan, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom Mol Phys, Wuhan 430071, Hubei Province, Peoples R China; [Jiang, W. -X.; Tang, C.] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Hubei Province, Peoples R China; [Wu, M.] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Cardiothorac Surg, Hangzhou 310058, Zhejiang, Peoples R China		Zhang, WP (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	weiping601@zju.edu.cn	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2013CB910200]; National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373392, 81173041, 81273491, 81272594, 81072619]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [Z2110059]; Howard Hughes Medical InstituteHoward Hughes Medical Institute	This work was supported by funds from the Ministry of Science and Technology of China (2013CB910200), the National Natural Sciences Foundation of China (81373392, 81173041, 81273491, 81272594 and 81072619) and the Zhejiang Provincial Natural Science Foundation of China (Z2110059). We are grateful to the Core Facilities of Zhejiang University Institute of Neuroscience for technical assistance. We thank Dr. IC Bruce for critically reading and revising this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C. T. is supported in part by the International Early Career Scientist grant from the Howard Hughes Medical Institute.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; Czlonkowska A, 2011, J NEUROIMMUNOL, V231, P78, DOI 10.1016/j.jneuroim.2010.09.020; Drevs J, 2003, ANTICANCER RES, V23, P4853; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Hasmann M, 2003, CANCER RES, V63, P7436; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Kim H, 2013, BRAIN RES, V1502, P11, DOI 10.1016/j.brainres.2013.01.043; Koczan D, 2005, EUR J DERMATOL, V15, P251; Liu LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044933; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Mayi TH, 2011, BIOCHEM BIOPH RES CO, V404, P458, DOI 10.1016/j.bbrc.2010.12.002; Montecucco F, 2013, CURR TOP MED CHEM, V13, P2930, DOI 10.2174/15680266113136660208; Montecucco F, 2013, CURR DRUG TARGETS, V14, P637; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Nencioni A, 2014, THROMB HAEMOSTASIS, V111, P308, DOI 10.1160/TH13-07-0531; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Schilling E, 2012, INNATE IMMUN-LONDON, V18, P518, DOI 10.1177/1753425911423853; Soares HD, 1995, J NEUROSCI, V15, P8223; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sun ZJ, 2013, CYTOKINE GROWTH F R, V24, P433, DOI 10.1016/j.cytogfr.2013.05.006; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097378; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; WILSON DF, 1994, MED SCI SPORT EXER, V26, P37; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098972; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71	43	12	12	3	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 16	2015	291						230	240		10.1016/j.neuroscience.2015.02.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD7VN	WOS:000351303100020	25684751				2022-02-06	
J	Konda, S; Reichard, A; Tiesman, HM; Hendricks, S				Konda, Srinivas; Reichard, Audrey; Tiesman, Hope M.; Hendricks, Scott			Non-fatal work-related traumatic brain injuries treated in US hospital emergency departments, 1998-2007	INJURY PREVENTION			English	Article							UNITED-STATES; OLDER-ADULTS; COMMUNITY; NEISS; FALLS	Purpose Little is known about work-related traumatic brain injuries (WRTBI). This study describes non-fatal WRTBIs treated in US emergency departments (ED) from 1998 through 2007. Methods Non-fatal WRTBIs were identified from the National Electronic Injury Surveillance System occupational supplement (NEISS-Work) using the diagnoses of concussion, internal organ injury to the head and skull fracture. WRTBI rates and rate ratios were calculated, and the trend in rates was assessed. Results An estimated 586 600 (95% CI=+/- 150 000) WRTBIs were reported during the 10-year period at a rate of 4.3 (CI=+/- 1.1) per 10 000 full-time equivalent (FTE) workers (1 FTE=2000 h per year). From 1998 through 2007, the rate of WRTBIs increased at an average of 0.21 per 10 000 FTE per year (p<0.0001) and the rate of fall-related WRTBIs increased at an average of 0.10 per 10 000 FTE (p<0.0001). During the same period, the annual rate of WRTBIs resulting in hospitalisation increased 0.04 per 10 000 FTE (p<0.0001). Ten percent of WRTBIs were hospitalised, compared with hospitalisation of 2% all NEISS-Work injuries. Also, workers with highest fall-related TBI rates per 10 000 FTE were the youngest (2.4; CI=+/- 1.4) and oldest (55 and older) workers (1.9; CI=+/- 0.8). Conclusions Non-fatal WRTBIs are one of the most serious workplace injuries among ED-treated work-related injuries. Non-fatal WRTBIs are much more likely to result in hospitalisation compared with other types of injuries. The upward trend of WRTBI rates from 1998 through 2007 underscore the need for more directed effective prevention methods to reduce WRTBI injuries.	[Konda, Srinivas; Tiesman, Hope M.; Hendricks, Scott] NIOSH, Div Safety Res, Anal & Field Evaluat Branch, Morgantown, WV 26505 USA; [Reichard, Audrey] NIOSH, Div Safety Res, Surveillance & Field Invest Branch, Morgantown, WV 26505 USA		Konda, S (corresponding author), NIOSH, Div Safety Res, 1095 Willowdale Rd,M-S 1811, Morgantown, WV 26505 USA.	skonda@cdc.gov	Konda, Srinivas/G-2747-2015	Konda, Srinivas/0000-0002-8934-4111	Intramural CDC HHS [CC999999] Funding Source: Medline		Bell J, 2010, DHHS NIOSH PUBLICATI, V2011-123; Bobick TG, 2010, J SAFETY RES, V41, P203, DOI 10.1016/j.jsr.2010.02.008; Centers for Disease Control and Prevention, 2014, SEV TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ; Chang VH, 2011, PHY MED REHAB, V3, P387; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Graves JM, 2013, J SAFETY RES, V45, P133, DOI 10.1016/j.jsr.2012.11.001; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kim H, 2006, NEUROREHABILITATION, V21, P269; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; National Institute for Occupational Safety and Health (NIOSH), 2010, TEACH YOUNG WORK JOB; National Institute of Neurological Disorders and Stroke, TRAUMATIC BRAIN INJU; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Slavova S, 2012, J KY MED ASS, V110, P191; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thompson MC, 2014, BRAIN INJURY, V28, P431, DOI 10.3109/02699052.2014.887146; Tiesman HM, 2007, AM J PREV MED, V33, P464, DOI 10.1016/j.amepre.2007.07.034; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; U.S Army, 2012, NFL ARM BOTH WORK CO; U.S. Census Bureau, 2002, ALPH IND IND OCC CEN; US Department of Labor Bureau of Labor Statistics, 2008, SPOTL STAT OLD WORK; US Department of Labor. Bureau of Labor Statistics, CURR POP SURV MICR F; Wei Chia, 2012, Minn Med, V95, P55; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	31	12	12	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2015	21	2					115	120		10.1136/injuryprev-2014-041323			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CE2YU	WOS:000351689900008	25216672	Green Accepted			2022-02-06	
J	Kuo, CY; Chiou, HY; Lin, JW; Tsai, SH; Chiang, YH; Lin, CM; Chiu, WT				Kuo, Chia-Ying; Chiou, Hung-Yi; Lin, Jia-Wei; Tsai, Shin-Han; Chiang, Yung-Hsiao; Lin, Chien-Min; Chiu, Wen-Ta			Seatbelt Use and Traumatic Brain Injury in Taiwan: A 16-Year Study	IRANIAN JOURNAL OF PUBLIC HEALTH			English	Article						Glasgow coma scale; Motor vehicle accident; Seat belt; Traumatic brain injury	MOTOR-VEHICLE CRASH; PREVALENCE; ACCIDENTS; KNOWLEDGE; PATTERNS	Background: A motor vehicle seat belt use law for the driver and front-seat passenger was implemented in Taiwan on June 1, 2001. The purpose of this study was to determine the effect of motor vehicle seat belt use on the severity of traumatic brain injuries because of motor vehicle accidents. Methods: Data were collected from 27 major teaching hospitals four years before June 1, 2001 and until May 31, 2013. A total of 822 brain-injured patients with a mean age of 37.4 (+/- 13.4) years were included; 251 were injured prior to implementation of the law and 571 after. The Glasgow coma scale was adapted to rate the severity of traumatic brain injury on admission. The Glasgow outcome scale was used to categorize the outcome on discharge. Results: After the seat belt law was implemented, traumatic brain injuries were less severe (P<0.001) and the rates of loss of consciousness, neurologic deficit, intracranial hematoma, craniotomy, and poor physical condition at discharge were all significantly lower (all P<0.05). Male gender, longer hospital stays, not wearing a seat belt, and injury before the law was enacted were all associated with poorer physical condition at the time of discharge (all P<0.01). Conclusion: Among occupants who survived a motor vehicle accident but had traumatic brain injuries, those who had worn seat belts had a better prognosis. Seat belts remain one of the best methods to reduce both the severity of injuries and the number of fatalities.	[Kuo, Chia-Ying; Chiou, Hung-Yi; Tsai, Shin-Han; Chiu, Wen-Ta] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Kuo, Chia-Ying] Taipei Med Univ, Off Med Affairs, Shuang Ho Hosp, Taipei, Taiwan; [Lin, Jia-Wei; Lin, Chien-Min] Taipei Med Univ, Div Neurosurg, Shuang Ho Hosp, Taipei, Taiwan; [Lin, Jia-Wei; Tsai, Shin-Han] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Dept Emergency Med, Shuang Ho Hosp, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Div Neurosurg, Taipei, Taiwan		Chiu, WT (corresponding author), Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan.	kuo@s.tmu.edu.tw		Chiou, Hung Yi/0000-0002-4545-9697	National Health Research Institute, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX99-9707PI]	This study was supported by a grant (NHRI-EX99-9707PI) from the National Health Research Institute, Taiwan. The authors thank the directors and staff of the collaborating hospitals for their full support and for providing complete and invaluable data. The authors declare that there is no conflict of interests.	[Anonymous], 2011, HLTH STAT INFORM SYS; [Anonymous], 2010, VITAL STAT TAIWAN; ATTICO NB, 1986, J REPROD MED, V31, P187; Bastida JL, 2004, J TRAUMA, V56, P883, DOI 10.1097/01.TA.0000069207.43004.A5; Campello C, 1996, Epidemiol Prev, V20, P313; LESTINA DC, 1991, JAMA-J AM MED ASSOC, V265, P1409, DOI 10.1001/jama.265.11.1409; Lin JW, 2008, ACT NEUR S, V101, P113; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Mayrose J, 2005, ACAD EMERG MED, V12, P130, DOI 10.1197/j.aem.2004.09.017; McGwin G, 2004, J TRAUMA, V56, P670, DOI 10.1097/01.TA.0000117014.57431.1D; Metzger J, 2004, J TRAUMA, V56, P1009, DOI 10.1097/01.TA.0000124303.68187.C1; Mirzaei R, 2014, ACCIDENT ANAL PREV, V66, P36, DOI 10.1016/j.aap.2014.01.013; Moradi A, 2013, INT J INJ CONTROL SA, V20, P307, DOI 10.1080/17457300.2012.692693; Ndiaye A, 2009, FORENSIC SCI INT, V184, P21, DOI 10.1016/j.forsciint.2008.11.007; Peden M., 2004, WORLD REPORT ROAD TR; Porter RS, 1998, ANN EMERG MED, V32, P418, DOI 10.1016/S0196-0644(98)70169-6; Rahimi-Movaghar V, 2009, INT J INJ CONTROL SA, V16, P179, DOI 10.1080/17457300903024277; Rahimi-Movaghar V, 2010, ARCH IRAN MED, V13, P172; Rasouli MR, 2008, CHIN J TRAUMATOL, V11, P131, DOI 10.1016/S1008-1275(08)60028-0; REDELMEIER DA, 1993, J GEN INTERN MED, V8, P199, DOI 10.1007/BF02599267; Sangowawa AO, 2010, INJURY PREV, V16, P85, DOI 10.1136/ip.2009.023242; SCHIFF M, 1992, WESTERN J MED, V156, P655; Schrader W, 2000, KLIN MONATSBL AUGENH, V217, P23, DOI 10.1055/s-2000-10379; Shults RA, 2012, J SAFETY RES, V43, P417, DOI 10.1016/j.jsr.2012.10.010; Zarzaur BL, 2008, J TRAUMA, V64, P412, DOI 10.1097/TA.0b013e3180f61c33	25	12	12	0	4	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	2251-6085	2251-6093		IRAN J PUBLIC HEALTH	Iran J. Public Health	APR	2015	44	4					470	478					9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CH0LL	WOS:000353711200004	26056665				2022-02-06	
J	Tatla, SK; Jarus, T; Virji-Babul, N; Holsti, L				Tatla, Sandy K.; Jarus, Tal; Virji-Babul, Naznin; Holsti, Liisa			The development of the Pediatric Motivation Scale for rehabilitation	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Acquired brain injury; Child health services; Developmental disabilities; Pediatrics; Psychometric properties	SELF-DETERMINATION THEORY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; INTRINSIC MOTIVATION; CEREBRAL-PALSY; CHILDREN; INTERVENTIONS; PERCEPTIONS; OUTCOMES; ENVIRONMENT	Background. Clinicians recognize that client motivation is key to optimizing rehabilitation; however, they are limited in its assessment by a paucity of motivation measures. Purpose. This paper presents the preliminary psychometrics of the Pediatric Motivation Scale (PMOT) designed to measure motivation from a child's perspective. Method. Content validity of the PMOT was measured through expert feedback (n = 12), and field testing ocurred with 41 children, 21 in rehabilitation and 20 healthy. Pearson product-moment correlations were used to analyze subscale correlations, test-retest reliability, and convergent validity with the Pediatric Volitional Questionnaire (PVQ). Internal consistency was measured using Cronbach's alpha. Findings. Preliminary psychometric evaluation indicates strong internal consistency for PMOT total ( = .96) and subscales ( = .79-.91). The PMOT and PVQ moderately correlated in the rehabilitation subsample (r = .71, p < .01); no correlation was found in the healthy subsample (p > .05). Test-retest reliability was excellent (r = .97). Implications. This study provides preliminary psychometric evidence of the PMOT for children undergoing rehabilitation. These pilot findings warrant ongoing scale development. Description. Les cliniciens reconnaissent que la motivation des clients est un facteur-cle pour optimiser la readaptation. Toutefois, leur habilete a evaluer la motivation est limitee par l'absence d'outils de mesure. But. Cet article presente les mesures psychometriques preliminaires de la << Pediatric Motivation Scale >> (PMOT) concue pour mesurer la motivation selon le point de vue de l'enfant. Methodologie. La validite du contenu de la PMOT a ete mesuree selon la retroaction d'experts (n = 12) et des essais sur le terrain realises aupres de 41 enfants, dont 21 d'entre eux etaient en readaptation et 20 en sante. Des coefficients de correlation de Pearson ont servi a analyser les correlations entre les sous-echelles, la fiabilite test-retest, et de la validite convergente avec le << Pediatric Volitional Questionnaire >> (PVQ). La coherence interne a ete mesuree a l'aide de l'alpha de Cronbach. Resultats. L'evaluation psychometrique preliminaire indique une forte coherence interne pour le total de la PMOT ( = .96) et les sous-echelles ( = .79-.91). La PMOT et le PVQ etaient moderement correles pour l'echantillon d'enfants en readaptation (r = .71, p < .01); aucune correlation n'a ete trouvee pour l'echantillon d'enfants en sante (p > .05). La fiabilite du test-retest etait excellente (r = .97). Consequences. Cette etude fournit l'evidence psychometrique preliminaire de la PMOT pour les enfants qui sont actuellement en readaptation. Ces resultats pilotes justifient la poursuite de l'elaboration de l'echelle de mesure.	[Tatla, Sandy K.] Univ British Columbia, Sunny Hill Hlth Ctr Children, Acute Rehabil Team, Vancouver, BC V5Z 1M9, Canada; [Tatla, Sandy K.; Jarus, Tal; Holsti, Liisa] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC V5Z 1M9, Canada; [Virji-Babul, Naznin] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada		Tatla, SK (corresponding author), Sunny Hill Hlth Ctr Children, Therapy Dept, 3644 Slocan Ave, Vancouver, BC V5M 3E8, Canada.	statla2@cw.bc.ca	Tatla, Sandy/V-6805-2019	Tatla, Sandy/0000-0001-5708-2666; Virji-Babul, Naznin/0000-0002-8984-5848; Holsti, Liisa/0000-0003-0315-0330; Jarus, Tal/0000-0003-4124-7782	Child and Family Research Institute; University of British Columbia, Vancouver, BC, Canada	Sandy Tatla was supported by the Child and Family Research Institute, an agency working in close partnerships with the British Columbia Provincial Health Services Authority and the University of British Columbia, Vancouver, BC, Canada.	Andersen Susan, 2005, Phys Occup Ther Pediatr, V25, P39, DOI 10.1300/J006v25n01_04; Bacharach V., 2008, PSYCHOMETRICS INTRO; BARRY J R, 1965, Cleft Palate J, V45, P62; Bartlett DJ, 2002, PHYS THER, V82, P237, DOI 10.1093/ptj/82.3.237; Basu S., 2008, USERS MANUAL PEDIAT, V2; Boosman H, 2013, BRAIN INJURY, V27, P685, DOI 10.3109/02699052.2013.775504; Choi J, 2010, SCHIZOPHRENIA BULL, V36, P966, DOI 10.1093/schbul/sbp030; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Deci E.L., 1985, INTRINSIC MOTIVATION; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Deci EL, 2008, CAN PSYCHOL, V49, P14, DOI 10.1037/0708-5591.49.1.14; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dunn W, 2013, ART SCI MOTIVATION T, P225; Fonteyn M.E., 1993, QUAL HEALTH RES, V3, DOI [DOI 10.1177/104973239300300403, https://doi.org/10.1177/104973239300300403]; Gilmore L, 2009, RES DEV DISABIL, V30, P1023, DOI 10.1016/j.ridd.2009.02.005; Gilmore R, 2010, DEV NEUROREHABIL, V13, P88, DOI 10.3109/17518420903386161; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Greber C., 2013, ART SCI MOTIVATION T, P123; Hagen C, 1998, RANCHOS LEVELS COGNI; Haley S, 1992, PEDIAT EVALUATION DI; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Katartzi ES, 2011, RES DEV DISABIL, V32, P2674, DOI 10.1016/j.ridd.2011.06.005; Kim SI, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00098; King G, 2014, CHILD ADOL MENT H-UK, V19, P2, DOI 10.1111/camh.12015; Koka A, 2003, PSYCHOL SPORT EXERC, V4, P333, DOI 10.1016/S1469-0292(02)00012-2; Leng EY., 2010, EURASIA J MATH SCI T, V6, P215, DOI [10.12973/ejmste/75241, DOI 10.12973/EJMSTE/75241]; Lundgren-Laine H, 2010, QUAL HEALTH RES, V20, P565, DOI 10.1177/1049732309354278; Maclean N, 2000, SOC SCI MED, V50, P495; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Majnemer A, 2011, PHYS OCCUP THER PEDI, V31, P1, DOI 10.3109/01942638.2011.541747; Markland D, 1997, RES Q EXERCISE SPORT, V68, P20, DOI 10.1080/02701367.1997.10608863; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; MCAULEY E, 1991, J APPL SOC PSYCHOL, V21, P139, DOI 10.1111/j.1559-1816.1991.tb00493.x; Miller L, 2014, PHYS OCCUP THER PEDI, V34, P90, DOI 10.3109/01942638.2013.771720; Morgan GA, 2009, DIMENSIONS MASTERY Q; Nichols DS., 1996, PEDIATR PHYS THER, V8, P15, DOI DOI 10.1097/00001577-199600810-00004; Oddy M, 2008, J CLIN EXP NEUROPSYC, V30, P568, DOI 10.1080/13803390701555598; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Reid D, 2005, EARLY CHILD DEV CARE, V175, P153, DOI 10.1080/0300443042000230366; Ronen GM, 2011, DEV MED CHILD NEUROL, V53, P305, DOI 10.1111/j.1469-8749.2011.03919.x; Ryan RM, 2006, MOTIV EMOTION, V30, P347, DOI 10.1007/s11031-006-9051-8; Self-Determination Theory Research Group, INTR MOT INV; Tatla S. K., 2014, THESIS U BRIT COLUMB; Tatla SK, 2014, BRAIN INJURY, V28, P1022, DOI 10.3109/02699052.2014.890747; Tatla SK, 2013, DEV MED CHILD NEUROL, V55, P593, DOI 10.1111/dmcn.12147; Tokcan Gul, 2003, Pediatr Phys Ther, V15, P16, DOI 10.1097/01.PEP.0000050765.71924.6C; Wright FV, 2014, J CHILD NEUROL, V29, P1055, DOI 10.1177/0883073814533423; Ziviani J, 2013, DEV MED CHILD NEUROL, V55, P965, DOI 10.1111/dmcn.12179; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91	50	12	12	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	APR	2015	82	2					93	105		10.1177/0008417414556884			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CE0ZS	WOS:000351541400004	26281433				2022-02-06	
J	Yu, ZY; Liu, N; Zhao, JH; Li, YD; McCarthy, TJ; Tedford, CE; Lo, EH; Wang, XY				Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; McCarthy, Thomas J.; Tedford, Clark E.; Lo, Eng H.; Wang, Xiaoying			Near infrared radiation rescues mitochondrial dysfunction in cortical neurons after oxygen-glucose deprivation	METABOLIC BRAIN DISEASE			English	Article						Near infrared radiation; Oxygen-glucose deprivation; Primary cortical neurons; MTT reduction; Mitochondrial membrane potential; ATP	LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; PROMOTES REGENERATION; FUNCTIONAL RECOVERY; OXIDATIVE STRESS; LIGHT; PHOTOBIOMODULATION; ACTIVATION; EXPRESSION; INDUCTION	Near infrared radiation (NIR) is known to penetrate and affect biological systems in multiple ways. Recently, a series of experimental studies suggested that low intensity NIR may protect neuronal cells against a wide range of insults that mimic diseases such as stroke, brain trauma and neurodegeneration. However, the potential molecular mechanisms of neuroprotection with NIR remain poorly defined. In this study, we tested the hypothesis that low intensity NIR may attenuate hypoxia/ischemia-induced mitochondrial dysfunction in neurons. Primary cortical mouse neuronal cultures were subjected to 4 h oxygen-glucose deprivation followed by reoxygenation for 2 h, neurons were then treated with a 2 min exposure to 810-nm NIR. Mitochondrial function markers including MTT reduction and mitochondria membrane potential were measured at 2 h after treatment. Neurotoxicity was quantified 20 h later. Our results showed that 4 h oxygen-glucose deprivation plus 20 h reoxygenation caused 33.8 +/- 3.4 % of neuron death, while NIR exposure significantly reduced neuronal death to 23.6 +/- 2.9 %. MTT reduction rate was reduced to 75.9 +/- 2.7 % by oxygen-glucose deprivation compared to normoxic controls, but NIR exposure significantly rescued MTT reduction to 87.6 +/- 4.5 %. Furthermore, after oxygen-glucose deprivation, mitochondria membrane potential was reduced to 48.9 +/- 4.39 % of normoxic control, while NIR exposure significantly ameliorated this reduction to 89.6 +/- 13.9 % of normoxic control. Finally, NIR significantly rescued OGD-induced ATP production decline at 20 min after NIR. These findings suggest that low intensity NIR can protect neurons against oxygen-glucose deprivation by rescuing mitochondrial function and restoring neuronal energetics.	[Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; Lo, Eng H.; Wang, Xiaoying] Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Neurol, Charlestown, MA 02129 USA; [Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; Lo, Eng H.; Wang, Xiaoying] Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Radiol, Charlestown, MA 02129 USA; [Yu, Zhanyang; Liu, Ning; Zhao, Jianhua; Li, Yadan; Lo, Eng H.; Wang, Xiaoying] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [McCarthy, Thomas J.] Sequent Med Inc, Aliso Viejo, CA 92656 USA; [Tedford, Clark E.] Solentix Biosci Inc, Poulsbo, WA 98370 USA		Yu, ZY (corresponding author), Massachusetts Gen Hosp, Neuroprotect Res Lab, Dept Neurol, Charlestown, MA 02129 USA.	Yu.Zhanyang@mgh.harvard.edu; wangxi@helix.mgh.harvard.edu		Liu, Ning/0000-0002-5632-0359	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS037074, R01NS076694, R01NS065998, P01NS055104] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37 NS037074, R01 NS065998, P01 NS055104, R01 NS076694] Funding Source: Medline		Anders JJ, 2004, NEUROL RES, V26, P233, DOI 10.1179/016164104225013914; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Brosseau L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002049.pub2; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Duan R, 2001, LASER SURG MED, V29, P174, DOI 10.1002/lsm.1106; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; FRIEDMANN H, 1991, J PHOTOCH PHOTOBIO B, V11, P87, DOI 10.1016/1011-1344(91)80271-I; Huang Y. Y., 2013, J BIOPHOTONICS; Huang YY, 2013, J BIOPHOTONICS, V6, P829, DOI 10.1002/jbio.201200157; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Liu JX, 2009, J NEUROSCI RES, V87, P164, DOI 10.1002/jnr.21826; Majem M, 2006, LARYNGOSCOPE, V116, P1651, DOI 10.1097/01.mlg.0000231736.08477.47; Morimoto Yusuke, 2013, Laser Ther, V22, P17; Moriyama Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P1351, DOI 10.1562/2005-02-28-RA-450; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Peplow PV, 2010, PHOTOMED LASER SURG, V28, P291, DOI 10.1089/pho.2008.2446; Plaetzer K, 2002, PHOTOCH PHOTOBIO SCI, V1, P172, DOI 10.1039/b108816e; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; Wang X. Y., 2013, LASERS MED SCI; Wang XY, 2002, STROKE, V33, P1882, DOI 10.1161/01.STR.0000020121.41527.5D; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xavier M, 2010, LASER SURG MED, V42, P553, DOI 10.1002/lsm.20896; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055	31	12	12	0	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	APR	2015	30	2					491	496		10.1007/s11011-014-9515-6			6	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	CD2HA	WOS:000350894800015	24599760	Green Accepted			2022-02-06	
J	Zhang, Z; Gao, F; Kang, XK; Li, J; Zhang, LT; Dong, WT; Jin, ZN; Li, F; Gao, NN; Cai, XW; Yang, SY; Zhang, JN; Ren, XL; Yang, XY				Zhang, Zhen; Gao, Feng; Kang, Xiaokui; Li, Jia; Zhang, Litong; Dong, Wentao; Jin, Zhangning; Li, Fan; Gao, Nannan; Cai, Xinwang; Yang, Shuyuan; Zhang, Jianning; Ren, Xinliang; Yang, Xinyu			Exploring the potential relationship between Notch pathway genes expression and their promoter methylation in mice hippocampal neurogenesis	BRAIN RESEARCH BULLETIN			English	Article						Notch1; Hes1; Neurogenin2; DNA methylation; Hippocampal neurogenesis	NEURAL STEM-CELLS; EPIGENETIC REGULATION; DNA METHYLATION; DENTATE GYRUS; BRAIN-INJURY; ADULT; DIFFERENTIATION; HES1; MAINTENANCE; MECHANISMS	The Notch pathway is a highly conserved pathway that regulates hippocampal neurogenesis during embryonic development and adulthood. It has become apparent that intracellular epigenetic modification including DNA methylation is deeply involved in fate specification of neural stem cells (NSCs). However, it is still unclear whether the Notch pathway regulates hippocampal neurogenesis by changing the Notch genes' DNA methylation status. Here, we present the evidence from DNA methylation profiling of Notch1, Hes1 and Ngn2 promoters during neurogenesis in the dentate gyrus (DG) of postnatal, adult and traumatic brains. We observed the expression of Notch1, Hes1 and Ngn2 in hippocampal DG with qPCR. Western blot and immunofluorescence staining. In addition, we investigated the methylation status of Notch pathway genes using the bisulfite sequencing PCR (BSP) method. The number of Notchl or Hesl (+) and BrdU (+) cells decreased in the subgranular zone (SGZ) of the DG in the hippocampus following TBI. Nevertheless, the number of Ngn2-positive cells in the DG of injured mice was markedly higher than in the DG of non-TBI mice. Accordingly, the DNA methylation level of the three gene promoters changed with their expression in the DG. These findings suggest that the strict spatio-temporal expression of Notch effector genes plays an important role during hippocampal neurogenesis and suggests the possibility that Notchl, Hesl and Ngn2 were regulated by changing some specific CpG sites of their promoters to further orchestrate neurogenesis in vivo. (C) 2015 Elsevier Inc. All rights reserved.	[Zhang, Zhen; Gao, Feng; Zhang, Litong; Dong, Wentao; Jin, Zhangning; Gao, Nannan; Cai, Xinwang; Yang, Shuyuan; Zhang, Jianning; Yang, Xinyu] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Zhang, Zhen; Gao, Feng; Zhang, Litong; Dong, Wentao; Jin, Zhangning; Gao, Nannan; Cai, Xinwang; Yang, Shuyuan; Zhang, Jianning; Yang, Xinyu] Tianjin Neurol Inst, Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Li, Fan; Ren, Xinliang] Changzhi Med Coll, Heji Hosp, Dept Neurosurg, Changzhi 046000, Peoples R China; [Kang, Xiaokui] Liaocheng Peoples Hosp, Dept Neurosurg, Liaocheng 252000, Peoples R China; [Li, Jia] Baoding 1 Hosp, Dept Neurosurg, Baoding 071000, Peoples R China		Yang, XY (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	yangxinyu@tijmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973090]; Natural Science Foundation of TianjinNatural Science Foundation of Tianjin [10JCYBJC25700]; Natural Science Foundation of ShanxiNatural Science Foundation of Shanxi Province [2014011041-8]	We thank Haining Wang, Lin Zhang and Rong Yan for their helpful comments on the manuscript. This work was supported by the National Natural Science Foundation of China, No. 30973090, Natural Science Foundation of Tianjin No. 10JCYBJC25700 and Natural Science Foundation of Shanxi No. 2014011041-8.	Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Covic M, 2010, HEREDITY, V105, P122, DOI 10.1038/hdy.2010.27; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kim M, 2014, HUM MOL GENET, V23, P657, DOI 10.1093/hmg/ddt453; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Kobayashi T, 2010, GENES CELLS, V15, P689, DOI 10.1111/j.1365-2443.2010.01413.x; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Salama-Cohen P, 2005, MOL BIOL CELL, V16, P339, DOI 10.1091/mbc.e04-05-0438; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Stigloher C, 2008, BRAIN RES BULL, V75, P266, DOI 10.1016/j.brainresbull.2007.10.032; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun JQ, 2011, EUR J NEUROSCI, V33, P1087, DOI 10.1111/j.1460-9568.2011.07607.x; Szyf M, 2009, BBA-GEN SUBJECTS, V1790, P878, DOI 10.1016/j.bbagen.2009.01.009; Tatsumi K, 2010, J CHEM NEUROANAT, V39, P15, DOI 10.1016/j.jchemneu.2009.09.003; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Zhang L, 2011, EUR J NEUROSCI, V33, P1, DOI 10.1111/j.1460-9568.2010.7483.x; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037	49	12	15	1	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	APR	2015	113						8	16		10.1016/j.brainresbull.2015.02.003			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG2CQ	WOS:000353082900002	25701255				2022-02-06	
J	Vaagenes, IC; Tsai, SY; Ton, ST; Husak, VA; McGuire, SO; O'Brien, TE; Kartje, GL				Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; O'Brien, Timothy E.; Kartje, Gwendolyn L.			Binge Ethanol Prior to Traumatic Brain Injury Worsens Sensorimotor Functional Recovery in Rats	PLOS ONE			English	Article							COGNITIVE RECOVERY; ADULT-RATS; STROKE; NEUROGENESIS; PREVALENCE; PLASTICITY; DRINKING; THERAPY; TRENDS; DAMAGE	A significant number of patients suffering from traumatic brain injury (TBI) have a high blood alcohol level at the time of injury. Furthermore, drinking alcohol in a binge-like pattern is now recognized as a national problem, leading to a greater likelihood of being injured. Our objective was to determine the consequences of a binge paradigm of alcohol intoxication at the time of TBI on long-term functional outcome using a sensitive test of sensorimotor function. We trained adult, male, Sprague Dawley rats on the skilled forelimb reaching task and then administered a single binge dose of ethanol (2g/kg, i.p.) or saline for three consecutive days (for a total of 3 doses). One hour after the final ethanol dose, rats underwent a TBI to the sensorimotor cortex corresponding to the preferred reaching forelimb. Animals were then tested for seven weeks on the skilled forelimb reaching task to assess the profile of recovery. We found that the group given ethanol prior to TBI displayed a slower recovery curve with a lower recovery plateau as compared to the control group. Therefore, even a relatively short (3 day) episode of binge alcohol exposure can negatively impact long-term recovery from a TBI, underscoring this significant public health problem.	[Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; Kartje, Gwendolyn L.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Ton, Son T.; Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Neurosci Res Inst, Maywood, IL 60153 USA; [O'Brien, Timothy E.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [McGuire, Susan O.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA		Vaagenes, IC (corresponding author), Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.	Ian.Vaagenes@va.gov	McGuire, Susan O/AAD-8582-2020		National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AA020951]; National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32 AA013526]; Department of Veterans AffairsUS Department of Veterans Affairs; Office of Academic AffiliationsUS Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA013526, T32AA013527, R21AA020951] Funding Source: NIH RePORTER	Funding: This research was supported by a grant from the National Institute of Health R21 AA020951, an National Institute on Alcohol Abuse and Alcoholism training grant T32 AA013526, the Department of Veterans Affairs and the Office of Academic Affiliations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; ODONOGHUE DL, 1986, BRAIN RES, V385, P311, DOI 10.1016/0006-8993(86)91078-4; Olthuis JV, 2011, J AM COLL HEALTH, V59, P239, DOI 10.1080/07448481.2010.497523; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ostrovskaya O, 2011, J PHARMACOL EXP THER, V337, P171, DOI 10.1124/jpet.110.176990; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Prasad RM, 2001, J NEUROTRAUM, V18, P1019, DOI 10.1089/08977150152693719; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thurman V DJC, 2007, BRAIN INJURY MED; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; Wolf WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108031; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; Young ME, 2009, LEARN MOTIV, V40, P160, DOI 10.1016/j.lmot.2008.10.004; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120356	10.1371/journal.pone.0120356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	WOS:000351277500121	25768795	Green Published, gold, Green Submitted			2022-02-06	
J	Andelic, N; Perrin, PB; Forslund, MV; Soberg, HL; Sigurdardottir, S; Sveen, U; Jerstad, T; Roe, C				Andelic, Nada; Perrin, Paul B.; Forslund, Marit V.; Soberg, Helene L.; Sigurdardottir, Solrun; Sveen, Unni; Jerstad, Tone; Roe, Cecilie			Trajectories of physical health in the first 5 years after traumatic brain injury	JOURNAL OF NEUROLOGY			English	Article						TBI; Longitudinal study; SF-36; Physical functioning; General health	QUALITY-OF-LIFE; MULTIPLE INJURIES; HEAD-INJURY; POPULATION; MODERATE; SF-36; INDIVIDUALS; SATISFACTION; RELIABILITY; PREDICTORS	The aims of the study were to examine whether self-reported physical health changes over the first 5 years after traumatic brain injury (TBI), and whether the trajectories of physical health over that time period could be predicted by demographic and injury-related variables. A longitudinal cohort study was conducted with 97 individuals with moderate-to-severe TBI who had been admitted to a Trauma Referral Centre in 2005/2007. Patients were followed up at 1, 2 and 5 years post-injury. Physical health-related quality of life (HRQL) (i.e., physical health) was measured by four subscales of the Medical Outcomes 36-Item Short Form Health Survey (SF-36): Physical Functioning, Role-Physical, Bodily Pain and General Health. Only the Physical Functioning domain showed statistically significant improvements across time. Women had lower scores on Role-Physical, Bodily Pain (more pain) and General Health. Unemployment prior to injury and having been in a "blue collar" physical job was associated with lower Physical Functioning and General Health, while greater TBI severity was associated with lower Physical Functioning, but better Role-Physical. Bodily Pain, Role-Physical and General Health remained fairly stable over time, despite the improvement in Physical Functioning. There were a number of significant injury-related and demographic predictors across the four trajectories of physical health. A better understanding of factors influencing these domains over the first 5 years after TBI and effective pain reducing rehabilitation strategies are needed.	[Andelic, Nada; Forslund, Marit V.; Soberg, Helene L.; Sveen, Unni; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada; Sigurdardottir, Solrun] Univ Oslo, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Fac Med, Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Forslund, Marit V.; Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp Trust, Akershus, Norway; [Sveen, Unni] Oslo & Akershus Univ Coll, Fac Hlth Sci, Oslo, Norway; [Jerstad, Tone] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway		Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	nandelic@online.no	; Perrin, Paul/L-5373-2015	Andelic, Nada/0000-0002-3719-4406; Perrin, Paul/0000-0003-2070-215X	Research Council of NorwayResearch Council of Norway; Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	The authors would like to thank all the patients for their participation. Special thanks to Nini Hammergren for assistance with patient registrations during the first 2 years post-injury. This study was funded by grants from The Research Council of Norway and Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2013, J REHABIL MED, V45, P708, DOI [10.2340/16501977-1224, 10.2340/16501977-1216]; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Harris IA, 2008, J TRAUMA, V64, P969, DOI 10.1097/01.ta.0000245972.83948.1a; Hopman WM, 2006, QUAL LIFE RES, V15, P527, DOI 10.1007/s11136-005-2096-4; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Kjeldsberg M, 2013, SCAND J PRIM HEALTH, V31, P36, DOI 10.3109/02813432.2012.751697; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Loge JH, 1998, SCAND J SOC MED, V26, P250; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; TEASDALE G, 1974, LANCET, V2, P81; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vaananen A, 2004, WOMEN HEALTH, V40, P1, DOI [10.1300/J013v403_01, 10.1300/J013v40n03_01]; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	37	12	12	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	MAR	2015	262	3					523	531		10.1007/s00415-014-7595-1			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE0BX	WOS:000351469200003	25476694				2022-02-06	
J	Imam, A; Jin, G; Sillesen, M; Dekker, SE; Bambakidis, T; Hwabejire, JO; Jepsen, CH; Halaweish, I; Alam, HB				Imam, Ayesha; Jin, Guang; Sillesen, Martin; Dekker, Simone E.; Bambakidis, Ted; Hwabejire, John O.; Jepsen, Cecilie H.; Halaweish, Ihab; Alam, Hasan B.			Fresh Frozen Plasma Resuscitation Provides Neuroprotection Compared to Normal Saline in a Large Animal Model of Traumatic Brain Injury and Polytrauma	JOURNAL OF NEUROTRAUMA			English	Article						hemorrhage; brain; trauma; resuscitation; plasma	NITRIC-OXIDE; FLUID RESUSCITATION; CEREBROSPINAL-FLUID; LYOPHILIZED PLASMA; MORTALITY; ENDOTHELIN-1; MANAGEMENT; OUTCOMES	We have previously shown that early treatment with fresh frozen plasma (FFP) is neuroprotective in a swine model of hemorrhagic shock (HS) and traumatic brain injury (TBI). However, it remains unknown whether this strategy would be beneficial in a more clinical polytrauma model. Yorkshire swine (42-50 kg) were instrumented to measure hemodynamic parameters, brain oxygenation, and intracranial pressure (ICP) and subjected to computer-controlled TBI and multi-system trauma (rib fracture, soft-tissue damage, and liver injury) as well as combined free and controlled hemorrhage (40% blood volume). After 2 h of shock (mean arterial pressure, 30-35 mm Hg), animals were resuscitated with normal saline (NS; 3xvolume) or FFP (1xvolume; n=6/group). Six hours postresuscitation, brains were harvested and lesion size and swelling were evaluated. Levels of endothelial-derived vasodilator endothelial nitric oxide synthase (eNOS) and vasoconstrictor endothelin-1 (ET-1) were also measured. FFP resuscitation was associated with reduced brain lesion size (1005.8 vs. 2081.9 mm(3); p=0.01) as well as swelling (11.5% vs. 19.4%; p=0.02). Further, FFP-resuscitated animals had higher brain oxygenation as well as cerebral perfusion pressures. Levels of cerebral eNOS were higher in the FFP-treated group (852.9 vs. 816.4 ng/mL; p=0.03), but no differences in brain levels of ET-1 were observed. Early administration of FFP is neuroprotective in a complex, large animal model of polytrauma, hemorrhage, and TBI. This is associated with a favorable brain oxygenation and cerebral perfusion pressure profile as well as higher levels of endothelial-derived vasodilator eNOS, compared to normal saline resuscitation.	[Imam, Ayesha; Sillesen, Martin; Hwabejire, John O.; Jepsen, Cecilie H.] Harvard Univ, Sch Med, Dept Surg,Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02115 USA; [Jin, Guang; Dekker, Simone E.; Bambakidis, Ted; Halaweish, Ihab; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Sillesen, Martin] Copenhagen Univ Hosp, Dept Surg, Hillerod, Denmark; [Dekker, Simone E.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, Amsterdam, Netherlands		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]	The study was funded by a grant from the U.S. Army Medical Research and Materiel Command (GRANTT00521959; to H.B.A.).	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P358, DOI 10.1097/TA.0b013e31825889ba; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Faul M, 2010, TRAUMATIC BRAIN INJU; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kasotakis G, 2013, J TRAUMA ACUTE CARE, V74, P1215, DOI 10.1097/TA.0b013e3182826e13; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kramer DR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415813; Lee TH, 2013, TRANSFUSION, V53, p72S, DOI 10.1111/trf.12039; Leijdesdorff HA, 2014, J NEUROTRAUM, V31, P459, DOI [10.1089/NEU.2013.3111, 10.1089/neu.2013.3111]; Liu P, 2013, BRAIN RES, V1522, P67, DOI 10.1016/j.brainres.2013.05.032; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Tisdall MM, 2013, NEUROCRIT CARE, V19, P65, DOI 10.1007/s12028-011-9633-5	27	12	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2015	32	5					307	313		10.1089/neu.2014.3535			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CC0SD	WOS:000350045700003	25153180	Green Published, Green Submitted			2022-02-06	
J	Garcia-Grajales, JA; Rucabado, G; Garcia-Dopico, A; Pena, JM; Jerusalem, A				Garcia-Grajales, Julian A.; Rucabado, Gabriel; Garcia-Dopico, Antonio; Pena, Jose-Maria; Jerusalem, Antoine			Neurite, a Finite Difference Large Scale Parallel Program for the Simulation of Electrical Signal Propagation in Neurites under Mechanical Loading	PLOS ONE			English	Article							MESSAGE-PASSING INTERFACE; NERVE-FIBERS; QUANTITATIVE-ANALYSIS; COMPUTER-SIMULATION; IMPULSE CONDUCTION; MYELINATED FIBERS; ACTION-POTENTIALS; THEORETICAL BASIS; HIGH-PERFORMANCE; MODEL	With the growing body of research on traumatic brain injury and spinal cord injury, computational neuroscience has recently focused its modeling efforts on neuronal functional deficits following mechanical loading. However, in most of these efforts, cell damage is generally only characterized by purely mechanistic criteria, functions of quantities such as stress, strain or their corresponding rates. The modeling of functional deficits in neurites as a consequence of macroscopic mechanical insults has been rarely explored. In particular, a quantitative mechanically based model of electrophysiological impairment in neuronal cells, Neurite, has only very recently been proposed. In this paper, we present the implementation details of this model: a finite difference parallel program for simulating electrical signal propagation along neurites under mechanical loading. Following the application of a macroscopic strain at a given strain rate produced by a mechanical insult, Neurite is able to simulate the resulting neuronal electrical signal propagation, and thus the corresponding functional deficits. The simulation of the coupled mechanical and electrophysiological behaviors requires computational expensive calculations that increase in complexity as the network of the simulated cells grows. The solvers implemented in Neurite-explicit and implicit-were therefore parallelized using graphics processing units in order to reduce the burden of the simulation costs of large scale scenarios. Cable Theory and Hodgkin-Huxley models were implemented to account for the electrophysiological passive and active regions of a neurite, respectively, whereas a coupled mechanical model accounting for the neurite mechanical behavior within its surrounding medium was adopted as a link between electrophysiology and mechanics. This paper provides the details of the parallel implementation of Neurite, along with three different application examples: a long myelinated axon, a segmented dendritic tree, and a damaged axon. The capabilities of the program to deal with large scale scenarios, segmented neuronal structures, and functional deficits under mechanical loading are specifically highlighted.	[Garcia-Grajales, Julian A.] IMDEA Mat Inst, Madrid, Spain; [Garcia-Grajales, Julian A.; Garcia-Dopico, Antonio; Pena, Jose-Maria] Univ Politecn Madrid, DATSI Comp Sci, Madrid, Spain; [Rucabado, Gabriel] Univ Oxford, Madrid Supercomp & Visualizat Ctr, Oxford, England; [Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Garcia-Grajales, Julian A.; Jerusalem, Antoine] Univ Oxford, Math Inst, Oxford, England		Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	antoine.jerusalem@eng.ox.ac.uk	Dopico, Antonio Garcia/ABH-3119-2020	Dopico, Antonio Garcia/0000-0001-7373-7853; Jerusalem, Antoine/0000-0001-5026-8038	European Union's Seventh Framework Programme (FP7) ERC Grant Agreement [306587]; Spanish Ministry of ScienceSpanish Government [TIN2010-21289-C02-02]; Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project	Support was provided by the European Union's Seventh Framework Programme (FP7 2007-2013) ERC Grant Agreement no. 306587 [http://cordis.europa.eu/fp7/home_en.html], the Spanish Ministry of Science, (TIN2010-21289-C02-02) [http://www.idi.mineco.gob.es/portal/site/MICINN/], and the Cajal Blue Brain project, Spain, the Spanish partner of the Blue Brain Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; Belu R, 2007, ANNUAL ASEE CONFEREN; Ben-Shalom R, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00004; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; BLIGHT AR, 1985, NEUROSCIENCE, V15, P1, DOI 10.1016/0306-4522(85)90118-6; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Bower James M, 1998, BOOK GENESIS EXPLORI; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Dalton S, 2013, CUSP C TEMPLATED SPA; de Camargo R, 2011, HIPC INT C, P1; de Camargo RY, 2011, CONCURR COMP-PRACT E, V23, P556, DOI 10.1002/cpe.1665; Fidjeland AK, 2013, NEUROINFORMATICS, V11, P267, DOI 10.1007/s12021-012-9174-x; FITZHUGH R, 1962, BIOPHYS J, V2, P11, DOI 10.1016/S0006-3495(62)86837-4; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; GOLDMAN L, 1968, BIOPHYS J, V8, P596, DOI 10.1016/S0006-3495(68)86510-5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gonzalez C, 2014, SEMIN CELL DEV BIOL, V27, P23, DOI 10.1016/j.semcdb.2013.12.004; Gropp W, 1996, PARALLEL COMPUT, V22, P789, DOI 10.1016/0167-8191(96)00024-5; HAMORI J, 1981, J NEUROCYTOL, V10, P879, DOI 10.1007/BF01262659; Heinecke A, 2012, COMPUT SCI ENG, V14, P78, DOI 10.1109/MCSE.2012.23; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hines ML, 2008, J NEUROSCI METH, V169, P425, DOI 10.1016/j.jneumeth.2007.09.010; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; HUTCHINSON NA, 1970, J PHYSIOL-LONDON, V208, P279, DOI 10.1113/jphysiol.1970.sp009119; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Koch Christof, 1999, P1; KOLES ZJ, 1972, J PHYSIOL-LONDON, V227, P351, DOI 10.1113/jphysiol.1972.sp010036; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; LAX PD, 1956, COMMUN PUR APPL MATH, V9, P267, DOI 10.1002/cpa.3160090206; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; MCNEAL DR, 1976, IEEE T BIO-MED ENG, V23, P329, DOI 10.1109/TBME.1976.324593; Meek J, 2001, J COMP NEUROL, V431, P255, DOI 10.1002/1096-9861(20010312)431:3<255::AID-CNE1069>3.0.CO;2-9; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; Minkovich K, 2014, IEEE T NEUR NET LEAR, V25, P316, DOI 10.1109/TNNLS.2013.2276056; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; nVidia, 2012, CUBLAS LIB US GUID; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Richardson AG, 2000, MED BIOL ENG COMPUT, V38, P438, DOI 10.1007/BF02345014; SCHAUF CL, 1974, J NEUROL NEUROSUR PS, V37, P152, DOI 10.1136/jnnp.37.2.152; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; WALKER DW, 1994, PARALLEL COMPUT, V20, P657, DOI 10.1016/0167-8191(94)90033-7; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WAXMAN SG, 1978, J NEUROL NEUROSUR PS, V41, P408, DOI 10.1136/jnnp.41.5.408; Wojcik GM, 2007, NEUROCOMPUTING, V70, P2593, DOI 10.1016/j.neucom.2006.12.015	59	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2015	10	2							e0116532	10.1371/journal.pone.0116532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IO	WOS:000350682600026	25680098	Green Published, gold, Green Accepted			2022-02-06	
J	Vas, AK; Spence, J; Chapman, SB				Vas, Asha Kuppachi; Spence, Jeffrey; Chapman, Sandra Bond			Abstracting meaning from complex information (gist reasoning) in adult traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Gist; Reasoning; Cognition; Abstraction; Adults; Functional outcomes; Executive function; Traumatic brain injury; Cognitive processes; Healthy	GLASGOW OUTCOME SCALE; EXECUTIVE FUNCTION; WORKING-MEMORY; DISCOURSE; COMPREHENSION; PATTERNS; BEHAVIOR; DEFICITS	Gist reasoning (abstracting meaning from complex information) was compared between adults with moderate-to-severe traumatic brain injury (TBI, n = 30) at least one year post injury and healthy adults (n = 40). The study also examined the contribution of executive functions (working memory, inhibition, and switching) and memory (immediate recall and memory for facts) to gist reasoning. The correspondence between gist reasoning and daily function was also examined in the TBI group. Results indicated that the TBI group performed significantly lower than the control group on gist reasoning, even after adjusting for executive functions and memory. Executive function composite was positively associated with gist reasoning (p < .001). Additionally, performance on gist reasoning significantly predicted daily function in the TBI group beyond the predictive ability of executive function alone (p = .011). Synthesizing and abstracting meaning(s) from information (i.e., gist reasoning) could provide an informative index into higher order cognition and daily functionality.	[Vas, Asha Kuppachi; Spence, Jeffrey; Chapman, Sandra Bond] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75235 USA		Vas, AK (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 W Mockingbird Lane, Dallas, TX 75235 USA.	asha.vas@utdallas.edu					Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Barratt W, 2005, BARRATT SIMPLIFIED M; Burgess P.W., 1997, HAYLING SENTENCE COM; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; Chapman S. B., 1995, AM J SPEECH-LANG PAT, V4, P124, DOI DOI 10.1044/1058-0360.0404.124; Chapman S. B., TEST STRATE IN PRESS; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2002, ALZ DIS ASSOC DIS, V16, P177, DOI 10.1097/00002093-200207000-00008; Chapman SB, 1998, APHASIOLOGY, V12, P1081, DOI 10.1080/02687039808249473; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cook LG, 2007, CHILDRENS COMPREHENS, P218; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Ferstl EC, 2005, J CLIN EXP NEUROPSYC, V27, P367, DOI 10.1080/13803390490515784; Gabrieli John D E, 2004, Cerebrum, V6, P39; Gamino J. F., 2009, CURRENT MED LIT PEDI, V22, P65; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Holliday R, 2005, BRAIN LANG, V95, P74, DOI 10.1016/j.bandl.2005.07.041; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [DOI 10.1044/1058-0360.0403.69, 10.1044/1058-0360.0403.69]; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stern L, 2009, VISUAL APPROACH SPSS; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TEASDALE G, 1983, LANCET, V2, P678; Ulatowska H. K., 1994, DISCOURSE ANAL APPL, P29; Ulatowska Hanna K., 1990, DISCOURSE ABILITY BR, P180, DOI 10.1007/978-1-4612-3262-9_8; Ulatowska HK, 1998, APHASIOLOGY, V12, P619, DOI 10.1080/02687039808249562; Vas A. K., 2012, INT NEUROTRAUMA LETT, V28, P1; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2002, WAIS 3 WMS 3 TECHNIC; WechslerD, 2001, WECHSLER TEST ADULT; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	53	12	12	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB 7	2015	37	2					152	161		10.1080/13803395.2014.994478			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CC9IP	WOS:000350682700004	25633568				2022-02-06	
J	Tse, KH; Novikov, LN; Wiberg, M; Kingham, PJ				Tse, Kai-Hei; Novikov, Lev N.; Wiberg, Mikael; Kingham, Paul J.			Intrinsic mechanisms underlying the neurotrophic activity of adipose derived stem cells	EXPERIMENTAL CELL RESEARCH			English	Article						Brain derived neurotrophic factor; Differentiation; Neurite; Regeneration; Stem cells	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; DORSAL-ROOT GANGLIA; NERVE REGENERATION; BDNF TRANSCRIPTION; NEURONAL-ACTIVITY; IN-VITRO; GENE-TRANSCRIPTION; CALCIUM REGULATION; NEURITE OUTGROWTH	Adipose derived stem cells (ADSC) can be differentiated into Schwann cell-like cells which enhance nerve function and regeneration. However, the signalling mechanisms underlying the neurotrophic potential of ADSC remain largely unknown. In this study, we hypothesised that ADSC, upon stimulation with a combination of growth factors, could rapidly produce brain derived neurotrophic factor (BDNF) with a similar molecular mechanism to that functioning in the nervous system. Within 48 h of stimulation, ADSC demonstrated potent neurotrophic effects on dorsal root ganglion neurons, at a magnitude equivalent to that of the longer term differentiated Schwann cell-like cells. Stimulated ADSC showed rapid up-regulation of the neuronal activity dependent promoter BDNF exon IV along with an augmented expression of full length protein encoding BDNF exon IX. BDNF protein was secreted at a concentration similar to that produced by differentiated Schwann cell-like cells. Stimulation also activated the BDNF expression gating transcription factor, cAMP responsive element binding (CREB) protein. However, blocking phosphorylation of CREB with the protein kinase A small molecule inhibitor H89 did not suppress secretion of BDNF protein. These results suggest rapid BDNF production in ADSC is mediated through multiple compensatory pathways independent of, or in addition to, the CREB neuronal activation cascade. (C) 2014 Elsevier Inc. All rights reserved.	[Tse, Kai-Hei; Novikov, Lev N.; Wiberg, Mikael; Kingham, Paul J.] Umea Univ, Dept Integrat Med Biol, Sect Anat, SE-90187 Umea, Sweden; [Wiberg, Mikael] Umea Univ, Dept Surg & Perioperat Sci, Sect Hand & Plast Surg, Umea, Sweden		Kingham, PJ (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, SE-90187 Umea, Sweden.	paul.kingham@umu.se	Tse, Kai-Hei/ABA-7834-2021	Tse, Kai-Hei/0000-0001-7287-3984; Novikov, Lev/0000-0001-5520-3890; Kingham, Paul/0000-0003-2596-5936	Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2009-61X-20112-04-03]; European UnionEuropean Commission [154693]; Umea University, County of Vasterbotten, Ake Wibergs Stiftelse; Clas Groschinskys Minnesfond	We would like to thank Gunnel Folkesson and Gunvor Hallstrom for their excellent technical assistance. This study was supported by the Swedish Research Council (Grant no. K2009-61X-20112-04-03), European Union (Grant no. 154693), Umea University, County of Vasterbotten, Ake Wibergs Stiftelse, and the Clas Groschinskys Minnesfond. We would also like to thank Acorda Therapeutics (USA) for their generous gift of GGF-2.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Arthur-Farraj P, 2011, GLIA, V59, P720, DOI 10.1002/glia.21144; Bagayogo IP, 2009, ASN NEURO, V1, DOI 10.1042/AN20090006; Brohlin M, 2009, NEUROSCI RES, V64, P41, DOI 10.1016/j.neures.2009.01.010; Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Dai XD, 2001, GLIA, V34, P234, DOI 10.1002/glia.1057; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Gomez-Casati ME, 2010, P NATL ACAD SCI USA, V107, P17005, DOI 10.1073/pnas.1008938107; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; HERMANSON M, 1995, EXP BRAIN RES, V102, P415; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Jean YY, 2008, NEURON GLIA BIOL, V4, P35, DOI 10.1017/S1740925X09000052; Ji RR, 1995, EUR J NEUROSCI, V7, P2458, DOI 10.1111/j.1460-9568.1995.tb01044.x; Kaewkhaw R, 2011, GLIA, V59, P734, DOI 10.1002/glia.21145; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kingham PJ, 2009, NEUROSCI LETT, V467, P164, DOI 10.1016/j.neulet.2009.10.030; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; Mahay D, 2008, EXP CELL RES, V314, P2692, DOI 10.1016/j.yexcr.2008.05.013; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Monje PV, 2010, J BIOL CHEM, V285, P31024, DOI 10.1074/jbc.M110.116970; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Shimizu S, 2007, BIOCHEM BIOPH RES CO, V359, P915, DOI 10.1016/j.bbrc.2007.05.212; Tabernero A, 1998, MOL CELL NEUROSCI, V10, P309, DOI 10.1006/mcne.1998.0662; Takasaki I, 2008, GLIA, V56, P1369, DOI 10.1002/glia.20704; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Terenghi G, 2009, INT REV NEUROBIOL, V87, P393, DOI 10.1016/S0074-7742(09)87021-9; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Verderio C, 2006, BRAIN CELL BIOL, V35, P187, DOI 10.1007/s11068-007-9011-6; Walsh S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E2; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wrage PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001453; Wu H, 2004, J NEUROSCI RES, V76, P76, DOI 10.1002/jnr.20060; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	12	14	0	7	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	FEB 1	2015	331	1					142	151		10.1016/j.yexcr.2014.08.034			10	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	CA0UK	WOS:000348631600013	25193075				2022-02-06	
J	Walsh, DV; Capo-Aponte, JE; Jorgensen-Wagers, K; Temme, LA; Goodrich, G; Sosa, J; Riggs, DW				Walsh, David V.; Capo-Aponte, Jose E.; Jorgensen-Wagers, Kendra; Temme, Leonard A.; Goodrich, Gregory; Sosa, Josue; Riggs, Daniel W.			Visual Field Dysfunctions in Warfighters During Different Stages Following Blast and Nonblast mTBI	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROOPHTHALMOLOGICAL FINDINGS; FREQUENCY; REHABILITATION; IMPAIRMENT; PERIMETRY; EYE	Objectives: Traumatic brain injury (TBI) is the leading injury coming out of the past decades' two major military conflicts, with mild TBI (mTBI) being the most commonly diagnosed form. The aim of this study was to assess the frequency and types of visual field (VF) defects seen at different testing stages following nonblast and blast-induced mTBI. Methods: A comprehensive retrospective review was performed on 500 electronic health records for military personnel sustaining an mTBI during deployment, of which 166 patients were tested with both confrontation VF and 30-2 Humphrey Matrix Frequency Doubling Technology (FDT) perimetry. Results: Scatter defects (48%) were the most predominantly found deficits in both blast and nonblast mTBI injury mechanisms and over postinjury test time frames. Confrontation VF was shown to be a poor qualitative predictor of VF defect. A profound decrease in VF sensitivity was noted in comparison to previously reported FDT normative data. Finally, a significant trend of decreasing VF defects was seen over time, indicating the potential usage of FDT as a visual biomarker for monitoring mTBI recovery. Conclusions: The findings of this study highlight the importance of performing threshold perimeter testing in those who have suffered an mTBI or concussion-like event.	[Walsh, David V.; Capo-Aponte, Jose E.; Temme, Leonard A.; Sosa, Josue; Riggs, Daniel W.] US Army Aeromed Res Lab, Sensory Res Div, Visual Sci Branch, Ft Rucker, AL 36362 USA; [Capo-Aponte, Jose E.] Womack Army Med Ctr, Dept Optometry, Ft Bragg, NC 28310 USA; [Jorgensen-Wagers, Kendra] Landstuhl Reg Med Ctr, Traumat Brain Injury Clin, D-09180 Landstuhl, Germany; [Goodrich, Gregory] Vet Affairs Palo Alto Hlth Care Syst, Psychol Serv & Western Blind Rehabil Ctr, Menlo Pk, CA 94025 USA		Walsh, DV (corresponding author), US Army Aeromed Res Lab, Sensory Res Div, Visual Sci Branch, 6901 Farrel Rd, Ft Rucker, AL 36362 USA.		Goodrich, Gregory L./AAF-7184-2019	Riggs, Daniel/0000-0002-3503-0600	Military Operational Medicine Research Program of the U.S. Army Medical Research and Materiel Command	This research was funded by the Military Operational Medicine Research Program of the U.S. Army Medical Research and Materiel Command.	Adams CW, 1999, OPTOMETRY VISION SCI, V76, P582, DOI 10.1097/00006324-199908000-00027; Anderson AJ, 2005, INVEST OPHTH VIS SCI, V46, P1540, DOI 10.1167/iovs.04-0968; Anderson Andrew J, 2003, Ophthalmol Clin North Am, V16, P213, DOI 10.1016/S0896-1549(03)00011-7; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Cap?-Aponte JE., 2013, SPINE, V4, P1; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carlson NB, 2004, CLIN PROCEDURES OCUL, P28; Chauhan BC, 1999, INVEST OPHTH VIS SCI, V40, P648; Ciuffreda K. J., 1994, EYE MOVEMENTS READIN, P163; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda KJ, 2007, JBO, V18, P72; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; Cockerham GC, 2013, OCUL SURF, V11, P25, DOI 10.1016/j.jtos.2012.09.004; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Department of Defense, DOD NUMB TRAUM BRAIN; DoD, DOD NUM TRAUM BRAIN; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Gracitelli CPB, 2013, CLIN OPHTHALMOL, V7, P1015, DOI 10.2147/OPTH.S43897; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KEANE JR, 1989, ARCH NEUROL-CHICAGO, V46, P761, DOI 10.1001/archneur.1989.00520430055017; Kerr NM, 2010, NEUROLOGY, V74, P1184, DOI 10.1212/WNL.0b013e3181d90017; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Moster ML, 1999, NEUROLOGY, V52, pA23; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Patel N, 2004, J BEHAV OPTOM, V15, P31; Pierre PD, 2010, EUR J OPHTHALMOL, V20, P538, DOI 10.1177/112067211002000328; SABATES NR, 1991, J CLIN NEURO-OPHTHAL, V11, P273; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Spry PGD, 2005, BRIT J OPHTHALMOL, V89, P1031, DOI 10.1136/bjo.2004.057778; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Sutter P., 1995, TRAUMATIC BRAIN INJU, P187; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Yoonessi Ali, 2011, J Ophthalmic Vis Res, V6, P119; ZIHL J, 1989, NEUROPSYCHOLOGY VISU, P35	43	12	12	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2015	180	2					178	185		10.7205/MILMED-D-14-00230			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7MR	WOS:000349101900010	25643385	Bronze			2022-02-06	
J	Bates, KA; Rodger, J				Bates, Kristyn Alissa; Rodger, Jennifer			Repetitive transcranial magnetic stimulation for stroke rehabilitation-potential therapy or misplaced hope?	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Repetitive transcranial magnetic stimulation; brain plasticity; stroke; neuroprotection	THETA-BURST-STIMULATION; MOTOR FUNCTION RECOVERY; LOW-FREQUENCY RTMS; PULSED ELECTROMAGNETIC-FIELDS; LONG-TERM POTENTIATION; CORTEX EXCITABILITY; PREFRONTAL CORTEX; CONTROLLED TRIAL; POSTSTROKE REORGANIZATION; CORTICOMOTOR EXCITABILITY	Repeated sessions of transcranial magnetic stimulation (rTMS) are capable of changing and modulating neural activity beyond the period of stimulation. Because many neurological disorders are thought to involve abnormal or dysfunctional neuronal activity, it is hypothesised that the therapeutic action of rTMS may occur through modulating and reversing abnormal activity and facilitating neuroplasticity. Numerous clinical studies have investigated the safety and efficacy of rTMS treatment for a wide variety of conditions including depression, anxiety disorders including obsessive compulsive disorder, Parkinson's disease, stroke, tinnitus, affective disorders, schizophrenia and chronic pain. Despite some promising results, rTMS is not currently widely used to assist in recovery from neurotrama. In this review, we argue that the therapeutic promise of rTMS is limited because the mechanisms of action of rTMS are not completely understood and therefore it is difficult to determine which treatment protocols are appropriate for specific neurological conditions. We use the application of rTMS in motor functional recovery from cerebral ischemic stroke to illustrate the difficulties in interpreting and assessing the therapeutic potential of rTMS for neurotrauma in terms of the presumed mechanisms of action of rTMS. Future directions for research will also be discussed.	[Bates, Kristyn Alissa; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia		Bates, KA (corresponding author), Univ Western Australia, M317,35 Stirling Highway, Crawley, WA 6009, Australia.	kristyn.bates@uwa.edu.au	Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; Raine Medical Research Foundation; Neurotrauma Research Program of Western Australia (NRP)	The authors acknowledge funding from the National Health and Medical Research Council (NHMRC, JR), the Raine Medical Research Foundation (KAB) and the Neurotrauma Research Program of Western Australia (NRP, KAB and JR).	Ackerley SJ, 2014, CLIN NEUROPHYSIOL, V125, P1451, DOI 10.1016/j.clinph.2013.11.020; Ahmed Z, 2006, BIOELECTROMAGNETICS, V27, P288, DOI 10.1002/bem.20211; Aldinucci C, 2000, BBA-MOL CELL RES, V1499, P101, DOI 10.1016/S0167-4889(00)00111-7; Arias-Carrion Oscar, 2008, Int Arch Med, V1, P2, DOI 10.1186/1755-7682-1-2; Avenanti A, 2012, NEUROLOGY, V78, P256, DOI 10.1212/WNL.0b013e3182436558; Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Barwood CHS, 2011, EUR J NEUROL, V18, P935, DOI 10.1111/j.1468-1331.2010.03284.x; Bates KA, 2012, BRAIN RES, V1458, P76, DOI 10.1016/j.brainres.2012.04.006; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bocchio-Chiavetto L, 2008, NEUROSCI LETT, V437, P130, DOI 10.1016/j.neulet.2008.04.005; Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Carson RG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00823; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cicinelli P, 2003, STROKE, V34, P2653, DOI 10.1161/01.STR.0000092122.96722.72; Cicinelli P, 1997, ELECTROMYOGR MOTOR C, V105, P438, DOI 10.1016/S0924-980X(97)00052-0; Delvaux V, 2003, CLIN NEUROPHYSIOL, V114, P1217, DOI 10.1016/S1388-2457(03)00070-1; Di Lazzaro V, 2009, EXP BRAIN RES, V194, P661, DOI 10.1007/s00221-009-1774-9; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Escudero JV, 1998, STROKE, V29, P1854, DOI 10.1161/01.STR.29.9.1854; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fox P, 1997, NEUROREPORT, V8, P2787, DOI 10.1097/00001756-199708180-00027; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Fregni F, 2006, STROKE, V37, P2115, DOI 10.1161/01.STR.0000231390.58967.6b; Fujiki M, 2003, J NEUROSURG, V99, P1063, DOI 10.3171/jns.2003.99.6.1063; Fujiwara T, 2004, CLIN NEUROPHYSIOL, V115, P1514, DOI 10.1016/j.clinph.2004.01.021; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Goldstein LB, 1998, ARCH NEUROL-CHICAGO, V55, P454, DOI 10.1001/archneur.55.4.454; Grefkes C, 2010, NEUROIMAGE, V50, P233, DOI 10.1016/j.neuroimage.2009.12.029; Hao ZL, 2013, SAO PAULO MED J, V131, P440, DOI [10.1590/1516-3180.20131316T2, 10.1002/14651858.CD008862.pub2]; Hausmann A, 2000, MOL BRAIN RES, V76, P355, DOI 10.1016/S0169-328X(00)00024-3; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hsu WY, 2012, STROKE, V43, P1849, DOI 10.1161/STROKEAHA.111.649756; Hsu YF, 2013, BRAIN STIMUL, V6, P166, DOI 10.1016/j.brs.2012.04.007; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Ikeda T, 2005, BIOCHEM BIOPH RES CO, V327, P218, DOI 10.1016/j.bbrc.2004.12.009; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jorge RE, 2004, BIOL PSYCHIAT, V55, P398, DOI 10.1016/j.biopsych.2003.08.017; Kanno M, 2004, J NEUROL SCI, V217, P73, DOI 10.1016/j.jns.2003.08.013; Khaleel SH, 2010, EUR NEUROL, V63, P337, DOI 10.1159/000302708; Khedr EM, 2010, ACTA NEUROL SCAND, V121, P30, DOI 10.1111/j.1600-0404.2009.01195.x; Khedr EM, 2009, EUR J NEUROL, V16, P1323, DOI 10.1111/j.1468-1331.2009.02746.x; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Khedr EM, 2010, RESTOR NEUROL NEUROS, V28, P545, DOI 10.3233/RNN-2010-0558; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; Kimbrell TA, 2002, PSYCHIAT RES-NEUROIM, V115, P101, DOI 10.1016/S0925-4927(02)00041-0; Kirton A, 2008, LANCET NEUROL, V7, P507, DOI 10.1016/S1474-4422(08)70096-6; Koch G, 2012, NEUROLOGY, V78, P24, DOI 10.1212/WNL.0b013e31823ed08f; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P105, DOI 10.1016/j.neucli.2006.08.011; Levkovitz Y, 1999, J NEUROSCI, V19, P3198; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liepert J, 2007, RESTOR NEUROL NEUROS, V25, P461; Lisanby SH, 2000, INT J NEUROPSYCHOPH, V3, P259, DOI 10.1017/S1461145700002005; Luborzewski A, 2007, J PSYCHIATR RES, V41, P606, DOI 10.1016/j.jpsychires.2006.02.003; Malcolm MP, 2007, AM J PHYS MED REHAB, V86, P707, DOI 10.1097/PHM.0b013e31813e0de0; Manganotti P, 2002, CLIN NEUROPHYSIOL, V113, P936, DOI 10.1016/S1388-2457(02)00062-7; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Massie CL, 2013, CLIN NEUROPHYSIOL, V124, P371, DOI 10.1016/j.clinph.2012.07.026; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Michael N, 2003, EUR J NEUROSCI, V17, P2462, DOI 10.1046/j.1460-9568.2003.02683.x; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Ogiue-Ikeda M, 2003, BRAIN RES, V993, P222, DOI 10.1016/j.brainres.2003.09.009; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Pessina GP, 2001, BIOELECTROMAGNETICS, V22, P503, DOI 10.1002/bem.79; Plow EB, 2009, STROKE, V40, P1926, DOI 10.1161/STROKEAHA.108.540823; Pomeroy VM, 2007, NEUROREHAB NEURAL RE, V21, P509, DOI 10.1177/1545968307300418; Rodger J, 2012, FASEB J, V26, P1593, DOI 10.1096/fj.11-194878; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Ruohonen J, 2012, CLIN NEUROPHYSIOL, V123, P2006, DOI 10.1016/j.clinph.2012.02.082; Seniow J, 2012, NEUROREHAB NEURAL RE, V26, P1072, DOI 10.1177/1545968312445635; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Szaflarski JP, 2011, MED SCI MONITOR, V17, pCR132, DOI 10.12659/MSM.881446; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Takeuchi N, 2008, J REHABIL MED, V40, P298, DOI 10.2340/16501977-0181; Takeuchi N, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/584727; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P333, DOI 10.1016/j.clinph.2006.10.014; Talelli P, 2012, NEUROREHAB NEURAL RE, V26, P976, DOI 10.1177/1545968312437940; Tan T, 2013, BRAIN RES, V1520, P23, DOI 10.1016/j.brainres.2013.04.053; Tokay T, 2009, NEUROSCI LETT, V461, P150, DOI 10.1016/j.neulet.2009.06.032; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Wang RY, 2012, NEUROREHAB NEURAL RE, V26, P222, DOI 10.1177/1545968311423265; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Weiduschat N, 2011, STROKE, V42, P409, DOI 10.1161/STROKEAHA.110.597864; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009; Zanardini R, 2006, J AFFECT DISORDERS, V91, P83, DOI 10.1016/j.jad.2005.12.029; Zangen A, 2002, NEUROREPORT, V13, P2401, DOI 10.1097/00001756-200212200-00005	98	12	13	1	18	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2015	33	4					557	569		10.3233/RNN-130359			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ1IP	WOS:000360350900013	24595227				2022-02-06	
J	Bell, KR; Brockway, JA; Fann, JR; Cole, WR; De Lore, JS; Bush, N; Lang, AJ; Hart, T; Warren, M; Dikmen, S; Temkin, N; Jain, S; Raman, R; Stein, MB				Bell, Kathleen R.; Brockway, Jo Ann; Fann, Jesse R.; Cole, Wesley R.; De Lore, Jef St.; Bush, Nigel; Lang, Ariel J.; Hart, Tessa; Warren, Michael; Dikmen, Sureyya; Temkin, Nancy; Jain, Sonia; Raman, Rema; Stein, Murray B.			Concussion treatment after combat trauma: Development of a telephone based, problem solving intervention for service members	CONTEMPORARY CLINICAL TRIALS			English	Article						Concussion; Brain Injury; Military; Problem solving training; Telephone intervention; Telehealth	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; IDENTIFICATION TEST AUDIT; BRAIN-INJURY; MENTAL-HEALTH; PRIMARY-CARE; PSYCHOLOGICAL TREATMENT; 1ST YEAR; DEPRESSION; VETERANS	Military service members (SMs) and veterans who sustain mild traumatic brain injuries (mTBI) during combat deployments often have co-morbid conditions but are reluctant to seek out therapy in medical or mental health settings. Efficacious methods of intervention that are patient-centered and adaptable to a mobile and often difficult-to-reach population would be useful in improving quality of life. This article describes a new protocol developed as part of a randomized clinical trial of a telephone-mediated program for SMs with mTBI. The 12-session program combines problem solving training (PST) with embedded modules targeting depression, anxiety, insomnia, and headache. The rationale and development of this behavioral intervention for implementation with persons with multiple co-morbidities is described along with the proposed analysis of results. In particular, we provide details regarding the creation of a treatment that is manualized yet flexible enough to address a wide variety of problems and symptoms within a standard framework. The methods involved in enrolling and retaining an often hard-to-study population are also highlighted. (C) 2014 Elsevier Inc. All rights reserved.	[Bell, Kathleen R.; Brockway, Jo Ann; Dikmen, Sureyya; Temkin, Nancy] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cole, Wesley R.] WAMC, Dept Brain Injury Med, Def & Vet Brain Injury Ctr, Ft Bragg, NC 28310 USA; [De Lore, Jef St.; Dikmen, Sureyya; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Bush, Nigel] Natl Ctr Telehlth & Technol, Tacoma, WA 98431 USA; [Lang, Ariel J.; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Warren, Michael] Fielding Behav Hlth, Clin Psychol Doctoral Intern, Kirkland, WA 98034 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Jain, Sonia; Raman, Rema; Stein, Murray B.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA		Bell, KR (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490,1959 NE Pacific St, Seattle, WA 98195 USA.	Icrbell@uw.edu; brockja@uw.edu; fann@uw.edu; wesley.r.cole.ctr@mail.mil; saint@uw.edu; nigel.e.bush.civ@mail.mil; ajlang@ucsd.edu; thart@einstein.edu; mwarren@email.fielding.edu; dilcmen@uw.edu; temIdn@uw.edu; sojain@ucsd.edu; reraman@ucsd.edu; mstein@ucsd.edu		Bell, Kathleen/0000-0002-0928-2046; Bush, Nigel/0000-0002-8137-7998	U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0159]; National Institute on Disability and Rehabilitation Research [H133G070143]	The research reported in this article was supported by the U.S. Army Medical Research and Materiel Command (USAMRMC), USAMRMC Funding Mechanism: Contract# W81XWH-08-2-0159. Supplemental funding for development of the treatment manual and fidelity assessment system was provided by the National Institute on Disability and Rehabilitation Research, grant # H133G070143.	[Anonymous], 2009, VA DOD CLIN PRACTICE; Attkisson CC, 1999, UCSF CLIENT SATISFAC; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Britt TW, 2008, J SOC CLIN PSYCHOL, V27, P317, DOI 10.1521/jscp.2008.27.4.317; Britt TW, 2000, J APPL SOC PSYCHOL, V30, P1599, DOI 10.1111/j.1559-1816.2000.tb02457.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CATALAN J, 1991, PSYCHOL MED, V21, P1013, DOI 10.1017/S0033291700030002; CDC, 2003, REP C MILD TRAUM BRA; Choi NG, 2014, DEPRESS ANXIETY, V31, P653, DOI 10.1002/da.22242; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Duggan M., 2014, SOCIAL MEDIA UPDATE; Fann JR, 2014, J NEUROTRAUMA; French L., 2008, J SPECIAL OPERATIONS, V8, P68; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Group E, 2009, HLTH POLICY, V37, P53; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hughes KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-46; Johnson DR, 1997, J TRAUMA STRESS, V10, P391, DOI 10.1023/A:1024885103409; Kasckow J, 2014, INT J GERIATR PSYCHI; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lynch DJ, 1997, J FAM PRACTICE, V44, P293; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marx B. P., 2009, 25 ANN M INT SOC TRA; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Mikami K, 2014, J NEUROPSYCHIATRY CL; Mohr DC, 2012, JAMA-J AM MED ASSOC, V307, P2278, DOI 10.1001/jama.2012.5588; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Pfeiffer PN, 2012, MIL MED, V177, P1471, DOI 10.7205/MILMED-D-12-00115; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rosen CS, 2006, COMMUNITY MENT HLT J, V42, P501, DOI 10.1007/s10597-006-9047-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sirey JA, 2005, PSYCHIAT SERV, V56, P1564, DOI 10.1176/appi.ps.56.12.1564; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Stewart CD, 2009, SUICIDE LIFE-THREAT, V39, P538, DOI 10.1521/suli.2009.39.5.538; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wilson JAB, 2008, CYBERPSYCHOL BEHAV, V11, P767, DOI 10.1089/cpb.2008.0071; Wright KM, 2009, PSYCHOL SERV, V6, P108, DOI 10.1037/a0012620; Zinzow HM, 2012, CLIN PSYCHOL REV, V32, P741, DOI 10.1016/j.cpr.2012.09.002	67	12	12	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	JAN	2015	40						54	62		10.1016/j.cct.2014.11.001			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	CB6IZ	WOS:000349732000007	25460344				2022-02-06	
J	Brewer-Smyth, K; Cornelius, ME; Pickelsimer, EE				Brewer-Smyth, Kathleen; Cornelius, Monica E.; Pickelsimer, E. Elisabeth			Childhood Adversity, Mental Health, and Violent Crime	JOURNAL OF FORENSIC NURSING			English	Article						Behavior; brain; brain injuries; child abuse; child adversity; neighborhood; sexual abuse; TBI; trauma; violence	TRAUMATIC BRAIN-INJURY; AGGRESSION QUESTIONNAIRE BPAQ; PSYCHOMETRIC PROPERTIES; SALIVARY CORTISOL; CRIMINAL BEHAVIOR; MEASURING RISK; SUBSTANCE USE; SEXUAL-ABUSE; HEAD-INJURY; SHORT-FORM	Background: Little is understood about childhood traumatic brain injury (TBI) and lifetime violent crime perpetration. Objectives: The purpose was to evaluate TBI before the age of 15 years and other childhood environmental factors, mental health, and lifetime history of committing a violent crime. Methods: A cross-sectional study of 636 male and female offenders from a southeastern state prison population was conducted using Chi-squared tests, t tests, and logistic regression to determine factors associated with ever committing a violent crime. Results: Committing a violent crime was associated with male gender, younger age, greater childhood sexual abuse (CSA), greater childhood emotional abuse, no TBI by the age of 15 years, and greater neighborhood adversity during childhood. Discussion: Although TBI has been related to violent and nonviolent crime, this study showed that absence of TBI by the age of 15 years was associated with lifetime violent crime when adjusting for CSA, childhood emotional abuse, and neighborhood adversity during childhood. This builds upon neurobehavioral development literature suggesting that CSA and the stress of violence exposure without direct physical victimization may play a more critical role in lifetime violent criminal behavior than childhood TBI. Violence risk reduction must occur during childhood focusing on decreasing adversity, especially violence exposure as a witness as well as a direct victim.	[Brewer-Smyth, Kathleen] Univ Delaware, McDowell Hall, Newark, DE 19716 USA; [Cornelius, Monica E.] Med Univ S Carolina, Charleston, SC USA; [Pickelsimer, E. Elisabeth] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC USA		Brewer-Smyth, K (corresponding author), Univ Delaware, McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu		Brewer-Smyth, PhD, RN, CRRN, FAAN, Kathleen/0000-0001-8468-6991	NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U49CE001318] Funding Source: NIH RePORTER; NCIPC CDC HHS [U49CE001318] Funding Source: Medline		Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; [Anonymous], 2011, SAS 9 3; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Arthur MW, 2007, EVAL PROGRAM PLANN, V30, P197, DOI 10.1016/j.evalprogplan.2007.01.009; Arthur MW, 2002, EVALUATION REV, V26, P575, DOI 10.1177/019384102237850; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K, 2008, ADV NURS SCI, V31, P119, DOI 10.1097/01.ANS.0000319562.84007.22; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Bryant FB, 2001, J RES PERS, V35, P138, DOI 10.1006/jrpe.2000.2302; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; De Bellis MD, 2011, J CHILD SEX ABUS, V20, P548, DOI 10.1080/10538712.2011.607753; Diamond PM, 2006, ASSESSMENT, V13, P227, DOI 10.1177/1073191106287666; Diamond PM, 2005, CRIM JUSTICE BEHAV, V32, P546, DOI 10.1177/0093854805278416; DuMont KA, 2007, CHILD ABUSE NEGLECT, V31, P255, DOI 10.1016/j.chiabu.2005.11.015; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; FISHBEIN D, 2006, NEUROPSYCHOLOGICAL E; Hesse M, 2012, BRIT J CLIN PSYCHOL, V51, P172, DOI 10.1111/j.2044-8260.2011.02019.x; Howard AL, 2012, J ABNORM CHILD PSYCH, V40, P1237, DOI 10.1007/s10802-012-9647-2; Hyman SM, 2005, ADDICT BEHAV, V30, P847, DOI 10.1016/j.addbeh.2004.08.009; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Kronenberger WG, 2005, J CLIN PSYCHOL, V61, P725, DOI 10.1002/jclp.20022; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Mezzich AC, 1997, DRUG ALCOHOL DEPEN, V44, P157, DOI 10.1016/S0376-8716(96)01333-6; Millon T., 2006, MILLON CLIN MULTIAXI, VThird; Monuteaux MC, 2012, ACAD EMERG MED, V19, P535, DOI 10.1111/j.1553-2712.2012.01341.x; Pardini DA, 2003, J AM ACAD CHILD PSY, V42, P364, DOI 10.1097/00004583-200303000-00018; Patel D., 2012, SOCIAL EC COSTS VIOL; Raine A, 2011, SCHIZOPHRENIA BULL, V37, P937, DOI 10.1093/schbul/sbr082; Retzlaff P, 2002, INT J OFFENDER THER, V46, P319, DOI 10.1177/0306624X02046003006; Roberti JW, 2003, J PERS ASSESS, V81, P291, DOI 10.1207/S15327752JPA8103_12; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Sellbom M, 2011, LAW HUMAN BEHAV, V35, P440, DOI 10.1007/s10979-010-9249-x; Sheffield JM, 2013, SCHIZOPHR RES, V143, P185, DOI 10.1016/j.schres.2012.10.032; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Snelbaker AJ, 2001, PERSP INDIV, P259; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Tyrka AR, 2009, PSYCHIAT RES, V165, P281, DOI 10.1016/j.psychres.2007.10.017; WEILER BL, 1996, CRIMINAL BEHAV MENTA, V0006; Widom Cathy Spatz, 2006, Violence Vict, V21, P675, DOI 10.1891/vv-v21i6a001; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC; ZUCKERMAN M, 1993, J PERS SOC PSYCHOL, V65, P757, DOI 10.1037/0022-3514.65.4.757	57	12	13	0	39	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-3693	1939-3938		J FORENSIC NURS	J. Forensic Nurs.	JAN-MAR	2015	11	1					4	14		10.1097/JFN.0000000000000062			11	Criminology & Penology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Criminology & Penology; Nursing	DD7WV	WOS:000370136500002	25695207				2022-02-06	
J	Cao, L; Tian, Y; Jiang, Y; Zhang, GJ; Lei, H; Di, ZL				Cao, Lei; Tian, Ye; Jiang, Yi; Zhang, Ge-Juan; Lei, Hui; Di, Zheng-Li			Down-Regulation of Homer1b/c Protects Against Chemically Induced Seizures Through Inhibition of mTOR Signaling	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Epilepsy; Homer; mGluRs; mTOR	TRAUMATIC BRAIN-INJURY; ANTIEPILEPTIC DRUGS; IN-VITRO; EPILEPSY; ACTIVATION; MECHANISMS; PATHWAY; MODEL	Background: Homer is a family of post synaptic density proteins functionally and physically attached to target proteins at proline-rich sequences. Reducing Homer1b/c expression has been shown in previous studies to be protective against excitotoxic insults, implicating Homer1b/c in the physiological regulation of aberrant neuronal excitability. Methods: To test the efficacy of a Homer1b/c reducing therapy for disorders with a detrimental hyperexcitability profile in mice, we used small interfere RNA (siRNA) to decrease endogenous Homer1b/c expression in mouse hippocampus. The baseline motor and cognitive behavior was measured by sensorimotor tests, Morris water maze and elevated plus maze tasks. The anti-epileptic effects of Homer1b/c knockdown were determined in two chemically induced seizure models induced by Picrotoxin (PTX) or pentylenetetrazole (PTZ) administration. Results: The results of sensorimotor tests, Morris water maze and elevated plus maze tasks showed that Homer1b/c reduction had no effect on baseline motor or cognitive behavior. In two chemically induced seizure models, mice with reduced Homerb/c protein had less severe seizures than control mice. Total Homer1b/c protein levels and seizure severity were highly correlated, such that those mice with the most severe seizures also had the highest levels of Homer1b/c. In addition, the phosphorylation of mammalian target of rapamycin (mTOR) and its target protein 56 was significantly inhibited in Homer1b/c down-regulated mice. Homer1b/c knockdown-induced inhibition of mTOR pathway was partially ablated by the metabotropic glutamate receptor 5 (mGluR5) agonist CHPG. Conclusion: Our results demonstrate that endogenous Homer1b/c is integral for regulating neuronal hyperexcitability in adult animals and suggest that reduction of Homer1b/c could protect against chemically induced seizures through inhibition mTOR pathway. Copyright (C) 2015 S Karger AG, Basel	[Cao, Lei; Tian, Ye; Jiang, Yi; Zhang, Ge-Juan; Lei, Hui; Di, Zheng-Li] Xi An Jiao Tong Univ, Xian Cent Hosp, Dept Neurol Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Cao, Lei] Capital Med Univ, Xuanwu Hosp, Dept Rehabil, Beijing, Peoples R China		Tian, Y (corresponding author), Xi An Jiao Tong Univ, Xian Cent Hosp, Dept Neurol Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	tianye_xjtu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201004]	This work was supported by the National Natural Science Foundation of China (No. 81201004).	Avedissian M, 2007, HIPPOCAMPUS, V17, P130, DOI 10.1002/hipo.20248; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Dhir A., 2012, CURR PROTOC NEUROSCI, V9, P37, DOI [10.1002/0471142301.ns0937s58, DOI 10.1002/0471142301.NS0937S58]; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Ghazizadeh V, 2014, METAB BRAIN DIS, V29, P787, DOI 10.1007/s11011-014-9549-9; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; LaSarge CL, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00018, 10.3389/fnmol.2014.00018]; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2012, NEUROCHEM INT, V61, P731, DOI 10.1016/j.neuint.2012.06.014; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Pitkanen A, 2011, BIOMARK MED, V5, P629, DOI [10.2217/BMM.11.67, 10.2217/bmm.11.67]; Rogawski MA, 2006, EPILEPSY RES, V69, P273, DOI 10.1016/j.eplepsyres.2006.02.004; Russo E, 2012, MOL NEUROBIOL, V46, P662, DOI 10.1007/s12035-012-8314-5; Shandra AA, 1996, EPILEPSIA, V37, P269, DOI 10.1111/j.1528-1157.1996.tb00024.x; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331	27	12	12	1	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2015	35	4					1633	1642		10.1159/000373977			10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	CF3OC	WOS:000352457400030	25824461	gold			2022-02-06	
J	de Guise, E; LeBlanc, J; Dagher, J; Tinawi, S; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; LeBlanc, Joanne; Dagher, Jehane; Tinawi, Simon; Lamoureux, Julie; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Traumatic brain injury in the elderly: A level 1 trauma centre study	BRAIN INJURY			English	Article						Ageing; level 1 trauma centre; older age; outcome; traumatic brain injury	OLDER-ADULTS; GENDER-DIFFERENCES; HEAD-INJURIES; AGE; MORTALITY; HEALTH; CONSEQUENCES; SPEED	Objective: To explore the characteristics and outcome of patients with TBI over 65 years old admitted to an acute care Level 1 Trauma centre in Montreal, Canada. Methods: Data were retrospectively collected on patients (n = 1812) who were admitted post-TBI to the McGill University Health Centre-Montreal General Hospital from 2000-2011. The cohort was composed of four groups over 65 years old (65-75; 76-85; 86-95; and 96 and more). Outcome measures used were the extended Glasgow Outcome Scale (GOSE) as well as discharge destination. Results: As the patients got older, the odds of having a poor outcome increased (OR = 2.344 for those 75-85 years old, 4.313 for those 86-95 years of age and 3.465 for those aged 96 years of age or older). Also, the proportion of patients going home or going home with out-patient rehabilitation decreased as age increased (p = 0.001 and p<0.001, respectively). In contrast, the proportion of patients being discharged to long-term care facilities increased significantly as age increased (p<0.001). Conclusion: This descriptive study provides a better understanding of characteristics and outcome of different age groups of patients with TBI all over 65 years old in Montreal, Canada.	[de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Neurol & Neurosurg Dept, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [de Guise, Elaine; LeBlanc, Joanne; Dagher, Jehane; Tinawi, Simon; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [Dagher, Jehane; Tinawi, Simon] McGill Univ, Ctr Hlth, Phys Med & Rehabil Serv, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada		de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124, Montreal, PQ H3G 1A4, Canada.	elaine.de.guise@umontreal.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	Arber S, 1999, SOC SCI MED, V48, P61, DOI 10.1016/S0277-9536(98)00289-5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; McDonough P, 2001, SOC SCI MED, V52, P547, DOI 10.1016/S0277-9536(00)00159-3; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; MILLER J D, 1989, Neurosurgical Review, V12, P441; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Ritchie PD, 2011, J CLIN NEUROSCI, V7, P301; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Salthouse T, 2012, ANNU REV PSYCHOL, V63, P201, DOI 10.1146/annurev-psych-120710-100328; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Statistique Canada, 2011, RAPP LEST POP SEL GR; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z	30	12	12	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					558	564		10.3109/02699052.2014.976593			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000003	25625679				2022-02-06	
J	De La Pena, I; Sanberg, PR; Acosta, S; Lin, SZ; Borlongan, CV				De La Pena, Ike; Sanberg, Paul R.; Acosta, Sandra; Lin, Shinn-Zong; Borlongan, Cesar V.			G-CSF as an Adjunctive Therapy With Umbilical Cord Blood Cell Transplantation for Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article; Proceedings Paper	7th Pan Pacific Sympsosium on Stem Cells and Cancer Research	APR 12-14, 2014	Taichung, TAIWAN			Traumatic brain injury (TBI); Stem cells; Granulocyte-colony-stimulating factor (G-CSF); Neuroinflammation	COLONY-STIMULATING FACTOR; MESENCHYMAL STEM-CELLS; BONE-MARROW-TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; FUNCTIONAL RECOVERY; PERIPHERAL-BLOOD; PROGENITOR CELLS; ISCHEMIC-STROKE; HEMATOPOIETIC CYTOKINES; MYOCARDIAL-INFARCTION	Traumatic brain injury (TBI), a major contributor to deaths and permanent disability worldwide, has been recently described as a progressive cell death process rather than an acute event. TBI pathophysiology is complicated and can be distinguished by the initial primary injury and the subsequent secondary injury that ensues days after the trauma. Therapeutic opportunities for TBI remain very limited with patients subjected to surgery or rehabilitation therapy. The efficacy of stem cell-based interventions, as well as neuroprotective agents in other neurological disorders of which pathologies overlap with TBI, indicates their potential as alternative TBI treatments. Furthermore, their therapeutic limitations may be augmented when combination therapy is pursued instead of using a single agent. Indeed, we demonstrated remarkable combined efficacy of human umbilical cord blood (hUCB) cell therapy and granulocyte-colony-stimulating factor (G-CSF) treatment in TBI models, providing essential evidence for the translation of this approach to treat TBI. Further studies are warranted to determine the mechanisms underlying therapeutic benefits exerted by hUCB + G-CSF in order to enhance its safety and efficacy in the clinic.	[De La Pena, Ike; Sanberg, Paul R.; Acosta, Sandra; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA; [Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigan Hosp, Dept Neurosurg, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, An Nan Hosp, Dept Neurosurg, Tainan, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan		Borlongan, CV (corresponding author), 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Lin, Shinn-Zong/AAX-2379-2020	dela Pena, Ike/0000-0003-2046-522X	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]; University of South Florida Signature Interdisciplinary Program in Neuroscience Funds; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS071956-01A1]; James and Esther King Biomedical Research Foundation [1KG01-33966]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956] Funding Source: NIH RePORTER	This study was funded by the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience Funds, the University of South Florida and Veterans Administration Reintegration Funds, and the University of South Florida Neuroscience Collaborative Program. P. R. Sanberg and C. V. Borlongan serve as consultant and founder, respectively, of Saneron CCEL Therapeutics, Inc. C. V. Borlongan is funded by the National Institutes of Health 1R01NS071956-01A1 and James and Esther King Biomedical Research Foundation 1KG01-33966. The funders had no role in the decision to publish or prepare this manuscript.	Acosta S. A., 2013, J STEM CELL RES T S4, V1, pS004; Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; BENSINGER W, 1993, BLOOD, V81, P3158; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BODINE DM, 1994, BLOOD, V84, P1482; Boltze J, 2012, CELL TRANSPLANT, V21, P723, DOI 10.3727/096368911X586783; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care AANS/CNS Carney, 2007, METHODS J NEUROTR S1, V24, pS3; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; BRONCHUD MH, 1987, BRIT J CANCER, V56, P809, DOI 10.1038/bjc.1987.295; Buga AM, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00044, 10.3389/fnagi.2014.00130]; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Copeland N, 2009, CLIN MED, V9, P342, DOI 10.7861/clinmedicine.9-4-342; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CRAWFORD J, 1991, NEW ENGL J MED, V325, P164, DOI 10.1056/NEJM199107183250305; DALE DC, 1993, BLOOD, V81, P2496; Dawn B., 2012, 20 YEARS G CSF MILES, P435; Dela Pena I, 2014, J NEUROSURG SCI, V58, P145; DELUCA E, 1992, BRIT J CANCER, V66, P893, DOI 10.1038/bjc.1992.381; DEMETRI GD, 1991, BLOOD, V78, P2791; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Dong F, 2000, BLOOD, V95, P1656, DOI 10.1182/blood.V95.5.1656.005k29_1656_1662; DUHRSEN U, 1988, BLOOD, V72, P2074; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Faul M, 2010, TRAUMATIC BRAIN INJU; Fesli A, 2014, J PLAST RECONSTR AES, V67, P837, DOI 10.1016/j.bjps.2014.02.011; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gorin NC, 2013, EUR J HAEMATOL, V91, P315, DOI 10.1111/ejh.12154; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Guo XH, 2012, TURK NEUROSURG, V22, P732, DOI 10.5137/1019-5149.JTN.6177-12.1; Han JL, 2008, NEUROSCI LETT, V432, P167, DOI 10.1016/j.neulet.2007.07.056; HANAZONO Y, 1990, EXP HEMATOL, V18, P1097; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Henning RJ, 2008, STEM CELLS DEV, V17, P1207, DOI 10.1089/scd.2008.0023; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Huang HY, 2012, CELL TRANSPLANT, V21, pS3, DOI 10.3727/096368912X633725; Hunter MG, 1998, J IMMUNOL, V160, P4979; Ilic D, 2012, BRIT MED BULL, V102, P43, DOI 10.1093/bmb/lds008; Iskander A, 2013, STEM CELL TRANSL MED, V2, P703, DOI 10.5966/sctm.2013-0066; Kadota R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050391; Kaneko Y, 2012, CELL MED, V4, P55, DOI 10.3727/215517912X639306; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee EJ, 2012, MOL THER, V20, P155, DOI 10.1038/mt.2011.202; Lemoli RM, 1996, J CLIN ONCOL, V14, P3018, DOI 10.1200/JCO.1996.14.11.3018; Li T, 2014, MOL CELL BIOCHEM, V387, P91, DOI 10.1007/s11010-013-1874-5; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Meuer K, 2006, J NEUROCHEM, V97, P675, DOI 10.1111/j.1471-4159.2006.03727.x; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Morikawa K, 2002, BRIT J HAEMATOL, V118, P296, DOI 10.1046/j.1365-2141.2002.03574.x; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Newman MB, 2003, NEUROTOX RES, V5, P355, DOI 10.1007/BF03033155; Newman MB, 2005, STEM CELLS DEV, V14, P29, DOI 10.1089/scd.2005.14.29; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Piao CS, 2012, DIFFERENTIATION, V83, P17, DOI 10.1016/j.diff.2011.08.006; Pimentel-Coelho PM, 2012, PEDIATR RES, V71, P464, DOI 10.1038/pr.2011.59; PLATZER E, 1985, J EXP MED, V162, P1788, DOI 10.1084/jem.162.6.1788; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Prakash A, 2013, PHARMACOL BIOCHEM BE, V110, P46, DOI 10.1016/j.pbb.2013.05.015; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Sanchez-Ramos J, 2012, J ALZHEIMERS DIS, V31, P843, DOI 10.3233/JAD-2012-120196; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; Sanganalmath SK, 2011, BASIC RES CARDIOL, V106, P709, DOI 10.1007/s00395-011-0183-y; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shahaduzzaman M, 2013, AGE, V35, P2071, DOI 10.1007/s11357-012-9496-5; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5; SHERIDAN WP, 1989, LANCET, V2, P891; Shim W, 2011, CARDIOVASC RES, V89, P20, DOI 10.1093/cvr/cvq301; SHIMODA K, 1993, J CLIN INVEST, V91, P1310, DOI 10.1172/JCI116330; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Takahashi H, 2012, EUR SPINE J, V21, P2580, DOI 10.1007/s00586-012-2213-3; TAYLOR KM, 1989, J CLIN ONCOL, V7, P1791, DOI 10.1200/JCO.1989.7.12.1791; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TIAN SS, 1994, BLOOD, V84, P1760; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Tsuji T, 1999, GROWTH FACTORS, V16, P225, DOI 10.3109/08977199909002132; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Urdzikova L, 2011, CYTOTHERAPY, V13, P1090, DOI 10.3109/14653249.2011.575355; Verina T, 2013, PEDIATR NEUROL, V48, P346, DOI 10.1016/j.pediatrneurol.2012.10.010; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808; Welte K., 2012, 20 YEARS G CSF MILES, P15; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiao BG, 2007, J CELL MOL MED, V11, P1272, DOI 10.1111/j.1582-4934.2007.00101.x; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Yu GL, 2008, MED SCI MONITOR, V14, pRA163; Zhang XM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-61; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao Li R, 2013, Recent Pat CNS Drug Discov, V8, P2	134	12	12	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2015	24	3			SI		447	457		10.3727/096368915X686913			11	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cell Biology; Research & Experimental Medicine; Transplantation	CF7RQ	WOS:000352754400012	25646620				2022-02-06	
J	Kalpakis, K; Yang, SM; Hu, PF; Mackenzie, CF; Stansbury, LG; Stein, DM; Scalea, TM				Kalpakis, Konstantinos; Yang, Shiming; Hu, Peter F.; Mackenzie, Colin F.; Stansbury, Lynn G.; Stein, Deborah M.; Scalea, Thomas M.			Permutation entropy analysis of vital signs data for outcome prediction of patients with severe traumatic brain injury	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Permutation entropy; Ordinal pattern; Traumatic brain injury; Vital signs; Prediction	INTRACRANIAL HYPERTENSION; EEG; MORTALITY	Permutation entropy is computationally efficient, robust to outliers, and effective to measure complexity of time series. We used this technique to quantify the complexity of continuous vital signs recorded from patients with traumatic brain injury (TBI). Using permutation entropy calculated from early vital signs (initial 10-20% of patient hospital stay time), we built classifiers to predict in-hospital mortality and mobility, measured by 3-month Extended Glasgow Outcome Score (GOSE). Sixty patients with severe TBI produced a skewed dataset that we evaluated for accuracy, sensitivity and specificity. The overall prediction accuracy achieved 91.67% for mortality, and 76.67% for 3-month GOSE in testing datasets, using the leave-one-out cross validation. We also applied Receiver Operating Characteristic analysis to compare classifiers built from different learning methods. Those results support the applicability of permutation entropy in analyzing the dynamic behavior of TBI vital signs for early prediction of mortality and long-term patient outcomes. (C) 2014 Elsevier Ltd. All rights reserved.	[Kalpakis, Konstantinos] Univ Maryland, Dept Comp Sci & Elect Engn, Baltimore, MD 21250 USA; [Yang, Shiming; Hu, Peter F.; Mackenzie, Colin F.; Stansbury, Lynn G.; Stein, Deborah M.; Scalea, Thomas M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Kalpakis, K (corresponding author), Univ Maryland, Dept Comp Sci & Elect Engn, Baltimore, MD 21250 USA.	kalpakis@umbc.edu	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963	 [W81XWH-07-2-0118];  [FA8650-11-2-6D01]	This research was funded in part by the grants W81XWH-07-2-0118 (Early Support of Intracranial Perfusion) and FA8650-11-2-6D01 (Continuing Non-Invasive Monitoring and the Development of Predictive Triage Indices for Outcomes Following Trauma). The authors thank Karen Murdoch, RPT; Melissa Binder, BS; Betsy Kramer RN, MS; and the ONPOINT investigators group for their support.	Bandt C, 2005, ECOL MODEL, V182, P229, DOI 10.1016/j.ecolmodel.2004.04.003; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Berg S., 2010, P BIOS BERL GERM; Bezerianos A, 2003, ANN BIOMED ENG, V31, P221, DOI 10.1114/1.1541013; Bian C., 2012, PHYS REV E, V85, P7; Bruzzo AA, 2008, NEUROL SCI, V29, P3, DOI 10.1007/s10072-008-0851-3; Cai YY, 2006, MED ENG PHYS, V28, P297, DOI 10.1016/j.medengphy.2005.05.002; Cao YH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046217; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Fawcelt T., HPL20034 INT ENT TEC; Fulcher BD, 2014, IEEE T KNOWL DATA EN, V26, P3026, DOI 10.1109/TKDE.2014.2316504; Guo DS, 2010, INT J GEOGR INF SCI, V24, P1367, DOI 10.1080/13658811003619143; Japkowicz N, 2011, EVALUATING LEARNING; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kahraman S., CLIN INVEST, V22; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kantz H., 2003, NONLINEAR TIME SERIE; Li XL, 2008, ANESTHESIOLOGY, V109, P448, DOI 10.1097/ALN.0b013e318182a91b; Li XL, 2007, EPILEPSY RES, V77, P70, DOI 10.1016/j.eplepsyres.2007.08.002; Lopes FM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-61; MacKay DJC, 2003, INFORM THEORY INFERE; Nicolaou N, 2011, CLIN EEG NEUROSCI, V42, P24, DOI 10.1177/155005941104200107; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Ouyang GX, 2010, CLIN NEUROPHYSIOL, V121, P694, DOI 10.1016/j.clinph.2009.12.030; Platt JC, 2000, ADV NEUR IN, P61; Provost F, 2000, WELL TRAINED PETS IM; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Simon N., 2011, SCIENCE         1216; Sinai Y.G., 2007, METRIC ENTROPY DYNAM; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Sun XL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-607; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Veisi I, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P200; Zanin M, 2008, CHAOS, V18; Zanin M, 2012, ENTROPY-SWITZ, V14, P1553, DOI 10.3390/e14081553	38	12	13	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	JAN 1	2015	56						167	174		10.1016/j.compbiomed.2014.11.007			8	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	AZ5MQ	WOS:000348265400016	25464358				2022-02-06	
J	Kiyatkin, EA; Sharma, HS				Kiyatkin, Eugene A.; Sharma, Hari S.			Not Just the Brain: Methamphetamine Disrupts Blood-Spinal Cord Barrier and Induces Acute Glial Activation and Structural Damage of Spinal Cord Cells	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Albumin leakage; blood-spinal cord barrier; brain; cellular damage; glial fibrillary acidic protein; hyperthermia; metabolic brain activation; spinal cord	NORMOTENSIVE YOUNG-RATS; CENTRAL-NERVOUS-SYSTEM; NEURODEGENERATIVE DISORDERS; ENVIRONMENTAL-TEMPERATURE; PARA-CHLOROPHENYLALANINE; TRAUMATIC INJURY; I-131 SODIUM; HYPERTHERMIA; EDEMA; PATHOPHYSIOLOGY	Acute methamphetamine (METH) intoxication induces metabolic brain activation as well as multiple physiological and behavioral responses that could result in life-threatening health complications. Previously, we showed that METH (9 mg/kg) used in freely moving rats induces robust leakage of blood-brain barrier, acute glial activation, vasogenic edema, and structural abnormalities of brain cells. These changes were tightly correlated with drug-induced brain hyperthermia and were greatly potentiated when METH was used at warm ambient temperatures (29 degrees C), inducing more robust and prolonged hyperthermia. Extending this line of research, here we show that METH also strongly increases the permeability of the blood-spinal cord barrier as evidenced by entry of Evans blue and albumin immunoreactivity in T9-12 segments of the spinal cord. Similar to the blood-brain barrier, leakage of bloodspinal cord barrier was associated with acute glial activation, alterations of ionic homeostasis, water tissue accumulation (edema), and structural abnormalities of spinal cord cells. Similar to that in the brain, all neurochemical alterations correlated tightly with drug-induced elevations in brain temperature and they were enhanced when the drug was used at 29 degrees C and brain hyperthermia reached pathological levels (>40 degrees C). We discuss common features and differences in neural responses between the brain and spinal cord, two inseparable parts of the central nervous system affected by METH exposure.	[Kiyatkin, Eugene A.] NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, Baltimore, MD USA; [Sharma, Hari S.] Uppsala Univ, Dept Surg Sci, Univ Hosp, SE-75421 Uppsala, Sweden		Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Anesthesiol & Intens Care Med, Dept Surg Sci, Frodingsgatan 12 28, SE-75421 Uppsala, Sweden.	Sharma@surgsci.uu.se		Kiyatkin, Eugene A./0000-0002-3744-0873	Intramural Research Program of NIDA-NIH; Leaderal Foundation for Acute Medicine, Stavanger, Norway; NIDA Distinguished International Scientist Collaboration Award (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000445] Funding Source: NIH RePORTER	This study was supported by the Intramural Research Program of NIDA-NIH, the Leaderal Foundation for Acute Medicine, Stavanger, Norway, and NIDA Distinguished International Scientist Collaboration Award (NIH) to Hari S. Sharma. The authors greatly appreciate editorial assistance and valuable suggestions of Dr. Ken T. Wakabayashi, technical assistance in conducting experiments and data analyses of Mari-Anne Carlsson, Inga Horte (Uppsala University) and Leon Brown (NIDA-IRP), and valuable help in constructing color figures of Suraj Sharma (Uppsala).	Albers DS, 1995, J PHARMACOL EXP THER, V275, P1104; Arenander AT, 1984, CLIN NEUROSCI, VV, P53; BALENTINE JD, 1978, LAB INVEST, V39, P236; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; BOWYER JF, 1992, J PHARMACOL EXP THER, V260, P817; Brown PL, 2003, J NEUROSCI, V23, P3924; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Gordh T, 2006, PAIN, V124, P211, DOI 10.1016/j.pain.2006.05.020; Graham BA, 2008, J NEUROPHYSIOL, V99, P2048, DOI 10.1152/jn.01176.2007; Joo F, 1976, J PHARM PHARMACOL, V328, P162; Kalat JW, 1998, BIOL PSYCHIAT; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Kiyatkin EA, 2007, EUR J NEUROSCI, V26, P1242, DOI 10.1111/j.1460-9568.2007.05741.x; Kiyatkin EA, 2012, INT REV NEUROBIOL, V102, P147, DOI 10.1016/B978-0-12-386986-9.00006-5; Kiyatkin EA, 2010, FRONT BIOSCI-LANDMRK, V15, P73, DOI 10.2741/3608; Miller DB, 2003, ENVIRON RES, V92, P48, DOI 10.1016/S0013-9351(02)00051-8; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; NOBLE LJ, 1988, EXP NEUROL, V99, P567, DOI 10.1016/0014-4886(88)90173-2; OLSSON Y, 1990, ACTA NEUROPATHOL, V79, P595, DOI 10.1007/BF00294236; Paxinos J, 1998, RAT BRAIN STEREOTAXI; Pehl U, 1997, J PHYSIOL-LONDON, V498, P483, DOI 10.1113/jphysiol.1997.sp021874; Rapoport S. I., 1976, BLOOD BRAIN BARRIER; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Sharma H. S., 2004, BLOOD SPINAL CORD BR, P437; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Sharma HS, 2006, ANN NY ACAD SCI, V1074, P198, DOI 10.1196/annals.1369.020; Sharma HS, 2007, CURR PHARM DESIGN, V13, P1841; Sharma HS, 2006, INDIAN J MED RES, V123, P629; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Sharma HS, 2003, INT J HYPERTHER, V19, P325, DOI 10.1080/0265673021000054621; SHARMA HS, 1993, ACTA NEUROPATHOL, V86, P422; SHARMA HS, 1995, RESTOR NEUROL NEUROS, V7, P207, DOI 10.3233/RNN-1994-7403; SHARMA HS, 1990, NEUROSCIENCE, V36, P725, DOI 10.1016/0306-4522(90)90014-U; SHARMA HS, 1990, ACT NEUR S, V51, P383; SHARMA HS, 1986, J NEUROL SCI, V72, P61, DOI 10.1016/0022-510X(86)90036-5; SHARMA HS, 1992, NEUROSCIENCE, V48, P889, DOI 10.1016/0306-4522(92)90277-9; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; Sharma HS, 2004, BLOOD SPINAL CORD BR; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	12	12	0	6	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	2					282	294		10.2174/1871527314666150217121354			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CF0FZ	WOS:000352219800014	25687701	Green Accepted			2022-02-06	
J	Man, DWK; Chan, MKL; Yip, CCK				Man, David W. K.; Chan, M. K. L.; Yip, C. C. K.			Validation of the Cambridge Prospective Memory Test (Hong Kong Chinese version) for people with stroke	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Stroke; Prospective memory; Cambridge Prospective Memory Test (CAMPROMPT); Reliability; Validity; Sensitivity; Specificity	TRAUMATIC BRAIN-INJURY; RETROSPECTIVE MEMORY; EVENT; TASKS; REHABILITATION; IMPAIRMENT; INTENTIONS; DEMENTIA; PROGRAM; ADULTS	This study aimed to develop and evaluate a Hong Kong Chinese version of the Cambridge Prospective Memory Test (CAMPROMPT-HKCV). Thirty-three subjects at least one year post-stroke participated in the study. They were simultaneously rated on version A of the CAMPROMPT-HKCV by two testers to establish its internal consistency and inter-rater reliability. Raters used the parallel versions of the test (A and B), in rating 10 patients within 2 weeks to establish the parallel form reliability. Another 10 were also assessed on the same day using both version A of the CAMPROMPT-HKCV and the Rivermead Behavioural Memory Test-Chinese version (RBMT-CV) to establish concurrent validity. A new group of 40 stroke patients and 44 healthy controls was recruited to establish its sensitivity and specificity. Results indicated that test-re-test reliability on time-based, event-based and total scores, and inter-rater reliability for versions A and B of the test were high. Cronbach's alpha of the event-based score was higher than that of the time-based score. The reliability and concurrent validity of the parallel forms were established. There was a significant difference in performance on CAMPROMPT-HKCV (version A) between the stroke group and the healthy control group. ROC analysis showed that the ability of the cut-off CAMPROMPT-HKCV (total score) to differentiate PM problems was 20.5 (out of 36) with sensitivity at 95.5% and specificity at 55.9%. Further study in developing stratified norms across different age groups in Chinese-speaking stroke patients is recommended.	[Man, David W. K.; Yip, C. C. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, M. K. L.] Kowloon Hosp, Occupat Therapy Dept, Hong Kong, Hong Kong, Peoples R China		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Yuk Choi Rd, Kowloon, Hong Kong, Peoples R China.	David.Man@polyu.edu.hk		YIP, Chi Kong/0000-0002-5393-6609			Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Brown L., 1997, TEST NONVERBAL INTEL, V3rd; Chiu FK, 1994, HONG KONG J PSYCH S2, V4, P25, DOI DOI 10.1017/S1041610209008588; Chiu HFK, 1998, NEUROLOGY, V50, P1002, DOI 10.1212/WNL.50.4.1002; Dodhia RM, 2009, APPL COGNITIVE PSYCH, V23, P73, DOI 10.1002/acp.1441; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 2003, J EXP PSYCHOL-APPL, V9, P147, DOI 10.1037/1076-898X.9.3.147; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Gregory R. J., 1999, PSYCHOL TESTING HIST; Hachinski V, 2007, STROKE, V38, P1396, DOI 10.1161/01.STR.0000260101.08944.e9; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Kim HJ, 2009, NEUROCASE, V15, P145, DOI 10.1080/13554790802709039; Kime SK, 1996, BRAIN INJURY, V10, P17; Li R., 2001, CLIN GERONTOLOGY, V24, P27; Lou Z., 2009, THESIS; Marsh RL, 1998, J EXP PSYCHOL LEARN, V24, P336, DOI 10.1037/0278-7393.24.2.336; MAYLOR EA, 1993, PSYCHOL AGING, V8, P420, DOI 10.1037/0882-7974.8.3.420; Maylor EA, 1996, PSYCHOL AGING, V11, P74, DOI 10.1037/0882-7974.11.1.74; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; Radford KA, 2011, CLIN NEUROPSYCHOL, V25, P127, DOI 10.1080/13854046.2010.529463; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO	33	12	12	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2015	25	6					895	912		10.1080/09602011.2014.997253			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DP1TC	WOS:000378271300006	25561019				2022-02-06	
J	Martinez-Valverde, T; Vidal-Jorge, M; Montoya, N; Sanchez-Guerrero, A; Manrique, S; Munar, F; Pellegri, MD; Poca, MA; Sahuquillo, J				Martinez-Valverde, Tamara; Vidal-Jorge, Marian; Montoya, Noelia; Sanchez-Guerrero, Angela; Manrique, Susana; Munar, Francisca; Pellegri, Maria-Dolors; Poca, Maria-Antonia; Sahuquillo, Juan			Brain Microdialysis as a Tool To Explore the Ionic Profile of the Brain Extracellular Space in Neurocritical Patients: A Methodological Approach and Feasibility Study	JOURNAL OF NEUROTRAUMA			English	Article						ionic profile; relative recovery; brain microdialysis; brain edema; potassium	CEREBRAL MICRODIALYSIS; IN-VIVO; POTASSIUM; TISSUE; ISCHEMIA; CONSENSUS; INJURY; ROBUST; EDEMA; VITRO	Our aim is to determine whether the ionic concentration in brain microdialysate enables calculations of the actual Na+, K+, and Cl- concentrations in vitro and whether this method can be applied to determine the ionic concentrations in the brain extracellular fluid. We designed an experiment using CMA-71 probes (M Dialysis, Stockholm, Sweden) and the standard conditions used in a clinical setting. Nine CMA-71 probes were inserted in different matrices and perfused with mock cerebrospinal fluid containing 3% albumin at the standard infusion rate used in the clinical setting (0.3 mu L/min). Microvials were replaced every 12 h, and the ionic concentrations, both in the dialysate and the matrix, were analyzed. For each ion, scatter plots were built, with [Na+], [K+], and [Cl-] in the dialysate as the predictor variables and the matrix concentrations as the outcome variables. A linear regression model allowed us to calculate the true ionic concentrations in the matrix. To demonstrate the feasibility of the method, we present the calculated ionic profile of one patient with a malignant infarction and a second with a severe traumatic brain injury. Our results confirm that the ionic concentration in microdialysate can be used to calculate the true concentrations of ions in a matrix and the actual concentrations in the extracellular fluid. Microdialysis offers the unique possibility of monitoring the dynamic changes of ions in the brain over time and opens a new avenue to explore the brain's ionic profile, its changes in brain edema, and how this profile can be modified with different therapies.	[Martinez-Valverde, Tamara; Vidal-Jorge, Marian; Montoya, Noelia; Sanchez-Guerrero, Angela; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona 08035, Spain; [Manrique, Susana; Munar, Francisca] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Anesthesiol, Barcelona 08035, Spain; [Pellegri, Maria-Dolors] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Biochem, Barcelona 08035, Spain; [Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona 08035, Spain		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg & Neurotraumatol, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Montoya, Noelia/AAB-7839-2019; Bauza, Francisca Munar/AAB-6682-2019; Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Vidal-Jorge, Marian/D-4402-2017	Montoya, Noelia/0000-0002-8634-5303; Bauza, Francisca Munar/0000-0003-4579-3027; Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Vidal-Jorge, Marian/0000-0002-3459-9336	Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)Instituto de Salud Carlos III [PI10/00302, FIS PI11/00700]; European Regional DevelopmentEuropean Commission; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [FI11/00195, FI12/00074]	This work has been supported, in part, by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) with grants PI10/00302 and FIS PI11/00700, which were cofinanced by the European Regional Development and awarded to M.A. Poca and J. Sahuquillo, respectively. T. Martinez-Valverde and A. Sanchez-Guerrero are the recipients of personal predoctoral grants from the Instituto de Salud Carlos III (grant nos. FI11/00195 and FI12/00074, respectively).	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; Bungay PM, 2011, J PHARMACEUT BIOMED, V55, P54, DOI 10.1016/j.jpba.2011.01.005; BUNGAY PM, 1990, LIFE SCI, V46, P105, DOI 10.1016/0024-3205(90)90043-Q; De Los Rios JA, 2009, NEUROCIRUGIA, V20, P433; Dipylon Medical, 2011, CMA 71 HIGH CUT OFF; Doppenberg EMR, 1999, ACT NEUR S, V75, P31; Elmquist WF, 1997, PHARMACEUT RES, V14, P267, DOI 10.1023/A:1012081501464; Fox J., 2019, R COMPANION APPL REG, V3 rd; Galea JP, 2014, PHYSIOL MEAS, V35, pN21, DOI 10.1088/0967-3334/35/3/N21; Goodman JC, 1999, ACT NEUR S, V75, P35; Grubb BR, 2002, AM J PHYSIOL-CELL PH, V282, pC1423, DOI 10.1152/ajpcell.00612.2001; Helmy A, 2007, CURR MED CHEM, V14, P1525, DOI 10.2174/092986707780831113; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Horn PS, 1999, CLIN CHEM, V45, P2284; Horn PS, 1998, CLIN CHEM, V44, P622; HSIAO JK, 1990, J NEUROCHEM, V54, P1449, DOI 10.1111/j.1471-4159.1990.tb01982.x; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katayama Y., 1994, INTRACRANIAL PRESSUR, P324; Kitagawa R, 2013, NEUROSURG CLIN N AM, V24, P417, DOI 10.1016/j.nec.2013.02.002; Landolt H, 1996, EUR J ANAESTH, V13, P269, DOI 10.1046/j.1365-2346.1996.00975.x; Li ZH, 2008, PROG NAT SCI-MATER, V18, P503, DOI 10.1016/j.pnsc.2008.02.001; Lieutaud T., 2007, HDB MICRODIALYSIS ME, pxiv; Mori K, 2002, J NEUROTRAUM, V19, P1261, DOI 10.1089/08977150260338047; NORDENVALL M, 1989, GYNECOL OBSTET INVES, V28, P73, DOI 10.1159/000293518; Perez-Barcena J, 2011, CRIT CARE MED, V39, P533, DOI 10.1097/CCM.0b013e318205c7a4; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; R Development Core Team, 2012, R LANG ENV STAT COMP; Reiber H, 2003, CLIN CHEM LAB MED, V41, P331, DOI 10.1515/CCLM.2003.053; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; RStudio, 2013, RSTUD INT DEV ENV R; Seehusen DA, 2003, AM FAM PHYSICIAN, V68, P1103; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Somjen GG, 2004, IONS BRAIN NORMAL FU; STAHLE L, 1991, J PHARMACOL METHOD, V25, P41, DOI 10.1016/0160-5402(91)90021-V; Thomas R, 2008, PRACT SPECTROSC, P1; Torto N, 2009, CHROMATOGRAPHIA, V70, P1305, DOI 10.1365/s10337-009-1335-1; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Waelchli R O, 2000, J Reprod Fertil Suppl, P327	44	12	13	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2015	32	1					7	16		10.1089/neu.2014.3473			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AX4JX	WOS:000346900100002	25019674	Green Published			2022-02-06	
J	Molina, PE; Katz, PS; Souza-Smith, F; Ford, SM; Teng, SX; Dodd, TY; Maxi, JK; Mayeux, JP				Molina, Patricia E.; Katz, Paige S.; Souza-Smith, Flavia; Ford, Stephen M.; Teng, Sophie X.; Dodd, Tracy Y.; Maxi, John K.; Mayeux, Jacques P.			Alcohol's Burden on Immunity Following Burn, Hemorrhagic Shock, or Traumatic Brain Injury	ALCOHOL RESEARCH-CURRENT REVIEWS			English	Article						Alcohol consumption; alcohol use; abuse; and dependence; chronic alcohol use; acute alcohol use; injury; traumatic injury; morbidity; mortality; immune response; impaired immune response; bacterial pathogens; viral pathogens; tissue; organs; disease	ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; ACUTE ETHANOL EXPOSURE; TUMOR-NECROSIS-FACTOR; BROWN ADIPOSE-TISSUE; CARE-UNIT STAY; BACTERIAL TRANSLOCATION; INSULIN-RESISTANCE; HOST-DEFENSE; HYPERMETABOLIC RESPONSE	Alcohol consumption contributes to increased incidence and severity of traumatic injury. Compared with patients who do not consume alcohol, alcohol-consuming patients have higher rates of long-term morbidity and mortality during recovery from injury. This can be attributed in part to an impaired immune response in individuals who consume alcohol. Acute and chronic alcohol use can affect both the innate and adaptive immune defense responses within multiple organ systems; the combination of alcohol use and injury results in increased susceptibility to bacterial and viral pathogens. This review examines the major deleterious effects of alcohol on immunity following tissue damage or traumatic injury, with a focus on alcohol's influence on the ability of the immune and major organ systems to fight disease and to repair damaged tissues following injury.	[Molina, Patricia E.; Katz, Paige S.; Souza-Smith, Flavia; Ford, Stephen M.; Teng, Sophie X.; Dodd, Tracy Y.; Maxi, John K.; Mayeux, Jacques P.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, Comprehens Alcohol Res Ctr, New Orleans, LA 70148 USA; [Molina, Patricia E.; Katz, Paige S.; Souza-Smith, Flavia; Ford, Stephen M.; Teng, Sophie X.; Dodd, Tracy Y.; Maxi, John K.; Mayeux, Jacques P.] Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, New Orleans, LA USA		Molina, PE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, Comprehens Alcohol Res Ctr, New Orleans, LA 70148 USA.		Molina, Patricia E./AAK-9814-2021	Molina, Patricia E./0000-0002-3598-384X	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32 AA007577] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007577] Funding Source: NIH RePORTER		Abraham E, 1993, New Horiz, V1, P28; Adams ZW, 2012, ADDICT BEHAV, V37, P848, DOI 10.1016/j.addbeh.2012.03.016; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Angele MK, 1999, ANN SURG, V229, P651, DOI 10.1097/00000658-199905000-00007; Arbabi S, 1999, J IMMUNOL, V162, P7441; AYALA A, 1991, AM J PHYSIOL, V260, pR167, DOI 10.1152/ajpregu.1991.260.1.R167; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Baker R C, 1993, Recent Dev Alcohol, V11, P249; Beech DJ, 1998, J NATL MED ASSOC, V90, P761; Behan LA, 2007, HORM RES, V68, P18, DOI 10.1159/000110466; Bessey PQ, 2014, J BURN CARE RES, V35, pS218, DOI 10.1097/BCR.0000000000000080; Bird MD, 2008, J LEUKOCYTE BIOL, V84, P607, DOI 10.1189/jlb.1107766; Bird MD, 2010, J BURN CARE RES, V31, P652, DOI 10.1097/BCR.0b013e3181e4c58c; Blanco AM, 2007, FRONT BIOSCI-LANDMRK, V12, P2616, DOI 10.2741/2259; Boe DM, 2009, J LEUKOCYTE BIOL, V86, P1097, DOI 10.1189/jlb.0209087; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; Brown LAS, 2006, ALCOHOL CLIN EXP RES, V30, P1624, DOI 10.1111/j.1530-0277.2006.00195.x; CARTER EA, 1990, SURGERY, V107, P335; Carter EA, 2004, INT J MOL MED, V14, P653; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Centers for Disease Control and Prevention, 2012, CDC CHRON DIS EXC AL; Centers for Disease Control and Prevention, 2009, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention, 2012, CDC STAT INJ PREV CO; Chen MM, 2013, ALCOHOL, V47, P223, DOI 10.1016/j.alcohol.2013.01.004; Choudhry MA, 2000, ALCOHOL, V21, P239, DOI 10.1016/S0741-8329(00)00093-8; Choudhry MA, 2002, AM J PHYSIOL-GASTR L, V282, pG937, DOI 10.1152/ajpgi.00235.2001; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cree MG, 2007, ANN SURG, V245, P214, DOI 10.1097/01.sla.0000250409.51289.ca; Crews FT, 2004, ALCOHOL CLIN EXP RES, V28, P350, DOI 10.1097/01.ALC.0000113416.65546.01; Cuthbertson D P, 2001, Nutr Hosp, V16, P176; Cuthbertson DP, 1942, NUTR HOSP, V16, P175; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; de la Monte S, 2012, J GASTROEN HEPATOL, V27, P33, DOI 10.1111/j.1440-1746.2011.07023.x; Deitch E A, 1987, J Burn Care Rehabil, V8, P475, DOI 10.1097/00004630-198708060-00005; DEITCH EA, 1990, CRIT CARE MED, V18, P529, DOI 10.1097/00003246-199005000-00014; DEITCH EA, 1990, ARCH SURG-CHICAGO, V125, P403; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; DSOUZA NB, 1989, ALCOHOL CLIN EXP RES, V13, P295, DOI 10.1111/j.1530-0277.1989.tb00329.x; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Elliott MK, 2007, AM J RESP CELL MOL, V36, P452, DOI 10.1165/rcmb.2005-0440OC; ERTEL W, 1993, AM J PHYSIOL, V264, pR655, DOI 10.1152/ajpregu.1993.264.4.R655; FAN L, 1995, MOL BRAIN RES, V30, P125; Faunce DE, 1998, SHOCK, V10, P135, DOI 10.1097/00024382-199808000-00009; Faunce DE, 2003, ALCOHOL CLIN EXP RES, V27, P1199, DOI 10.1097/01.ALC.0000075833.92139.35; Faunce DE, 1997, J LEUKOCYTE BIOL, V62, P733, DOI 10.1002/jlb.62.6.733; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; FINK MP, 1991, CRIT CARE MED, V19, P627, DOI 10.1097/00003246-199105000-00009; Foul M., 2010, TRAUMATIC BRAIN INJU; Gauglitz GG, 2009, J CLIN ENDOCR METAB, V94, P1656, DOI 10.1210/jc.2008-1947; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Goo L., 2010, ACTA PHARMACOL SIN, V31, P1576; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Greiffenstein P, 2007, ALCOHOL CLIN EXP RES, V31, P704, DOI 10.1111/j.1530-0277.2007.00355.x; Guidot DM, 2005, J INVEST MED, V53, P235, DOI 10.2310/6650.2005.53506; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Happel Kyle I, 2005, Proc Am Thorac Soc, V2, P428, DOI 10.1513/pats.200507-065JS; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; HAUM A, 1995, BURNS, V21, P194, DOI 10.1016/0305-4179(95)80008-C; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Helms CM, 2014, PSYCHOPHARMACOLOGY, V231, P3425, DOI 10.1007/s00213-014-3590-6; Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5; Hierholzer C, 1998, AM J PHYSIOL-LUNG C, V275, pL611, DOI 10.1152/ajplung.1998.275.3.L611; HILLERS VN, 1985, AM J CLIN NUTR, V41, P356, DOI 10.1093/ajcn/41.2.356; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; HORTON JW, 1994, SHOCK, V1, P286, DOI 10.1097/00024382-199404000-00007; HURST PM, 1994, ACCIDENT ANAL PREV, V26, P647, DOI 10.1016/0001-4575(94)90026-4; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2004, ARCH SURG-CHICAGO, V139, P641, DOI 10.1001/archsurg.139.6.641; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kavanaugh MJ, 2005, BURNS, V31, P290, DOI 10.1016/j.burns.2004.09.021; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; KEOGH C, 1990, ARCH SURG-CHICAGO, V125, P79; Keogh C., 1990, ARCH SURG-CHICAGO, V125, P85; KESHAVARZIAN A, 1994, AM J GASTROENTEROL, V89, P2205; Koren S, 2007, BEST PRACT RES CL EN, V21, P621, DOI 10.1016/j.beem.2007.08.004; Korzick DH, 2013, AM J PHYSIOL-REG I, V304, pR887, DOI 10.1152/ajpregu.00083.2013; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kramer G.C., 2007, TOTAL BURN CARE, P93, DOI 10.1016/B978-1-4160-3274-8.50011-8; Lang CH, 2005, INT J BIOCHEM CELL B, V37, P2180, DOI 10.1016/j.biocel.2005.04.013; Lang CH, 2014, ALCOHOL CLIN EXP RES, V38, P897, DOI 10.1111/acer.12343; Li XL, 2008, SHOCK, V29, P377, DOI 10.1097/shk.0b013e31815abe80; Li XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1193, DOI 10.1152/ajplung.00408.2006; LIVINGSTON DH, 1988, J SURG RES, V45, P37, DOI 10.1016/0022-4804(88)90018-2; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pa.35.040195.002221; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Mathis KW, 2006, SHOCK, V26, P55, DOI 10.1097/01.shk.0000215320.06866.30; McDonough KH, 2002, J TRAUMA, V53, P541, DOI 10.1097/00005373-200209000-00024; MCGILL V, 1995, J TRAUMA, V38, P931, DOI 10.1097/00005373-199506000-00019; McGwin G, 2000, J BURN CARE REHABIL, V21, P75, DOI 10.1097/00004630-200021010-00016; Mehta AJ, 2012, AM J MED SCI, V343, P244, DOI 10.1097/MAJ.0b013e31823ede77; Messingham KAN, 2002, ALCOHOL, V28, P137, DOI 10.1016/S0741-8329(02)00278-1; Messingham KAN, 2000, ALCOHOL, V22, P35, DOI 10.1016/S0741-8329(00)00100-2; Molina PE, 2013, SHOCK, V39, P240, DOI 10.1097/SHK.0b013e318285b86d; Molina PE, 2010, ALCOHOL RES HEALTH, V33, P97; Molina PE, 2005, SHOCK, V24, P3, DOI 10.1097/01.shk.0000167112.18871.5c; Molina PE, 2001, SHOCK, V16, P459, DOI 10.1097/00024382-200116060-00010; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; NAPOLITANO LM, 1995, J TRAUMA, V38, P198, DOI 10.1097/00005373-199502000-00008; NELSON S, 1991, ADV EXP MED BIOL, V288, P245; NICOLAS JM, 1993, ALCOHOL ALCOHOLISM, V28, P551; Nicolas JM, 2001, ALCOHOL CLIN EXP RES, V25, P83; NILSSON E, 1988, BIOCHEM PHARMACOL, V37, P3237, DOI 10.1016/0006-2952(88)90633-8; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Patel M, 1996, ALCOHOL CLIN EXP RES, V20, P275, DOI 10.1111/j.1530-0277.1996.tb01640.x; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Pereira Clifford T, 2005, Adv Surg, V39, P245, DOI 10.1016/j.yasu.2005.05.005; Phelan H, 2002, J TRAUMA, V52, P675, DOI 10.1097/00005373-200204000-00010; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Pravdova Eliska, 2006, Endocr Regul, V40, P91; Qin YY, 2014, ALCOHOL CLIN EXP RES, V38, P204, DOI 10.1111/acer.12210; Ransohoff RM, 2002, J INFECT DIS, V186, pS152, DOI 10.1086/344266; RASHBASTEP J, 1993, ARCH BIOCHEM BIOPHYS, V300, P401, DOI 10.1006/abbi.1993.1054; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Sato H, 2013, ALCOHOL, V47, P47, DOI 10.1016/j.alcohol.2012.10.002; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Shellito JE, 1998, ALCOHOL CLIN EXP RES, V22, P658, DOI 10.1111/j.1530-0277.1998.tb04308.x; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Skotzko CE, 2009, HEART FAIL REV, V14, P51, DOI 10.1007/s10741-007-9048-8; Souza-Smith FM, 2010, MICROCIRCULATION, V17, P514, DOI 10.1111/j.1549-8719.2010.00050.x; Spies CD, 1998, ALCOHOL ALCOHOLISM, V33, P661, DOI 10.1093/alcalc/33.6.661; Spies CD, 1996, INTENS CARE MED, V22, P286, DOI 10.1007/s001340050082; Spies CD, 1996, ACTA ANAESTH SCAND, V40, P649, DOI 10.1111/j.1399-6576.1996.tb04505.x; Standiford TJ, 1997, ALCOHOL CLIN EXP RES, V21, P1212, DOI 10.1111/j.1530-0277.1997.tb04440.x; Sulzer JK, 2013, J TRAUMA ACUTE CARE, V74, P196, DOI 10.1097/TA.0b013e31826fc747; Szabo G, 1998, ALCOHOL CLIN EXP RES, V22, p216S, DOI 10.1111/j.1530-0277.1998.tb04005.x; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Tabata T, 2002, J GASTROENTEROL, V37, P726, DOI 10.1007/s005350200118; TAIVAINEN H, 1995, ALCOHOL CLIN EXP RES, V19, P759, DOI 10.1111/j.1530-0277.1995.tb01579.x; Tang YM, 2009, ALCOHOL CLIN EXP RES, V33, P1220, DOI 10.1111/j.1530-0277.2009.00946.x; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Turnage RH, 2002, WORLD J SURG, V26, P848, DOI 10.1007/s00268-002-4063-3; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; Venkatesh B, 2009, CRIT CARE, V13, DOI 10.1186/cc7941; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Wade CE, 2013, CRIT CARE, V17, DOI 10.1186/cc13048; WANG P, 1993, AM J PHYSIOL, V264, pH1166, DOI 10.1152/ajpheart.1993.264.4.H1166; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitaker AM, 2010, NEUROIMMUNOMODULAT, V17, P349, DOI 10.1159/000292039; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Wichmann MW, 1998, CRIT CARE MED, V26, P1372, DOI 10.1097/00003246-199808000-00024; Williams FN, 2011, J BURN CARE RES, V32, P269, DOI 10.1097/BCR.0b013e31820aafcf; Williams FN, 2009, CLIN PLAST SURG, V36, P583, DOI 10.1016/j.cps.2009.05.001; Willoughby RPN, 1996, SURGERY, V120, P547, DOI 10.1016/S0039-6060(96)80076-6; WILMORE DW, 1978, SURG CLIN N AM, V58, P1173; Wittebole X, 2005, J ELECTROCARDIOL, V38, P77, DOI 10.1016/j.jelectrocard.2004.09.004; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; WORLD MJ, 1985, ALCOHOL ALCOHOLISM, V20, P89; Xu DZ, 2002, SHOCK, V17, P139, DOI 10.1097/00024382-200202000-00010; Xu YX, 1998, J TRAUMA, V44, P335, DOI 10.1097/00005373-199802000-00018; Xu YX, 1997, J SURG RES, V70, P55, DOI 10.1006/jsre.1997.5111; Yo K, 2013, AM J PHYSIOL-ENDOC M, V304, pE331, DOI 10.1152/ajpendo.00098.2012; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Zambell KL, 2004, ALCOHOL CLIN EXP RES, V28, P635, DOI 10.1097/01.ALC.0000122104.85971.55; Zhang P, 1999, J INFECT DIS, V179, P1441, DOI 10.1086/314763; Zhang Q, 2008, J BURN CARE RES, V29, P358, DOI 10.1097/BCR.0b013e318166739c; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x; Zink BJ, 2006, J NEUROSURG, V105, P884, DOI 10.3171/jns.2006.105.6.884	181	12	12	0	4	NATL INST ALCOHOL ABUSE  ALCOHOLISM	ROCKVILLE	6000 EXECUTIVE BLVD, ROCKVILLE, MD 20892-7003 USA	1535-7414	1930-0573		ALCOHOL RES-CURR REV	Alcohol Res.-Curr. Rev.		2015	37	2					263	278					16	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	CU0RH	WOS:000363225900011	26695749				2022-02-06	
J	Nardone, A; Sampson, E; Stauffer, C; Leopold, A; Jacobs, K; Hendricks, DJ; Elias, E; Chen, H; Rumrill, P				Nardone, Amanda; Sampson, Elaine; Stauffer, Callista; Leopold, Anne; Jacobs, Karen; Hendricks, Deborah J.; Elias, Eileen; Chen, Hui; Rumrill, Phillip			Project Career: A qualitative examination of five college students with traumatic brain injuries	NEUROREHABILITATION			English	Article						Traumatic brain injury; secondary education; employment; cognitive support technology		BACKGROUND: Project Career is an interprofessional five-year development project designed to improve the employment success of undergraduate college and university students with traumatic brain injury (TBI). The case study information was collected and synthesized by the project's Technology and Employment Coordinators (TECs) at each of the project's three university sites. The project's evaluation is occurring independently through JBS International, Inc. OBJECTIVE: Five case studies are presented to provide an understanding of student participants' experiences within Project Career. Each case study includes background on the student, engagement with technology, vocational supports, and interactions with his/her respective TEC. METHODS: A qualitative analysis from the student's case notes is provided within each case study, along with a discussion of the overall qualitative analysis. RESULTS: Across all five students, the theme Positive Outcomes was mentioned most often in the case notes. Of all the different type of challenges, Cognitive Challenges were most often mentioned during meetings with the TECs, followed by Psychological Challenges, Physical Challenges, Other Challenges, and Academic Challenges, respectively. CONCLUSION: Project Career is providing academic enrichment and career enhancement that may substantially improve the unsatisfactory employment outcomes that presently await students with TBI following graduation.	[Nardone, Amanda; Jacobs, Karen] Boston Univ, Boston, MA 02215 USA; [Sampson, Elaine; Hendricks, Deborah J.] W Virginia Univ, Morgantown, WV 26506 USA; [Stauffer, Callista; Rumrill, Phillip] Kent State Univ, Kent, OH 44242 USA; [Leopold, Anne; Elias, Eileen; Chen, Hui] JBS Int Inc, North Bethesda, MD USA		Jacobs, K (corresponding author), Boston Univ, 635 Commonwealth Ave, Boston, MA 02215 USA.	kjacobs@bu.edu		Jacobs, Karen/0000-0002-4718-990X	United States Department of Education, NIDRRUS Department of Education [H133A130066]	The contents of this article were developed under a grant from the United States Department of Education, NIDRR grant #H133A130066. However, those contents do not necessarily represent the policy of the Department of Education, and readers should not assume endorsement by the Federal Government.	Basso A., 2006, WHO NEUROLOGICAL DIS, P164; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Centers for Disease Control and Prevention, 2015, TRAUM BRAIN INJ US F; Faul M, 2010, TRAUMATIC BRAIN INJU; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Scherer MJ., 1998, MATCHING PERSON TECH; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc	9	12	12	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	37	3					459	469		10.3233/NRE-151274			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY3QH	WOS:000366324100011	26518535				2022-02-06	
J	Paldor, I; Rosenthal, G; Cohen, JE; Leker, R; Harnof, S; Shoshan, Y; Itshayek, E				Paldor, Iddo; Rosenthal, Guy; Cohen, Jose E.; Leker, Ronen; Harnof, Sagi; Shoshan, Yigal; Itshayek, Eyal			Intracranial pressure monitoring following decompressive hemicraniectomy for malignant cerebral infarction	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cerebral infarction; Decompressive surgery; Intracranial pressure; Middle cerebral artery; Stroke	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; INTRA-CRANICAL PRESSURE; ACUTE ISCHEMIC-STROKE; ARTERY INFARCTION; CRANIECTOMY; DETERIORATION; HYPERTENSION; OXYGENATION; EXPERIENCE	Randomized controlled trials have demonstrated the efficacy of decompressive craniectomy in substantially decreasing mortality and improving functional outcome in middle cerebral artery infarction. The role of intracranial pressure (ICP) monitoring following decompressive craniectomy for stroke has not been well studied. We present a retrospective review of our experience with postoperative ICP monitoring in 12 stroke patients who underwent decompressive craniectomy. All elevations of ICP above a 20 mmHg threshold were noted. ICP was recorded for 1417 hours during which 68 ICP elevations were seen. Nine out of 12 patients had events of raised ICP, including eight with more than three elevations. A total of 81 interventions were employed to treat elevated ICP; 71 were effective in reducing ICP below the 20 mmHg threshold. The most frequent intervention was cerebrospinal fluid drainage via an external ventricular drain, which was effective in 85.4% of cases. Eleven out of 12 patients survived (92%) and attained a median modified Rankin Scale score of 4 (interquartile range 4-5) at a mean 15 month follow-up. In our experience, elevated ICP may commonly occur following decompressive craniectomy for stroke. Monitoring ICP influenced postoperative management and standard measures for reducing ICP were usually effective in the current series. (C) 2014 Published by Elsevier Ltd.	[Paldor, Iddo; Rosenthal, Guy; Cohen, Jose E.; Shoshan, Yigal; Itshayek, Eyal] Hebrew Univ Jerusalem, Med Ctr, Dept Neurosurg, IL-91120 Jerusalem, Israel; [Leker, Ronen] Hebrew Univ Jerusalem, Med Ctr, Dept Neurol, IL-91120 Jerusalem, Israel; [Rosenthal, Guy] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Harnof, Sagi] Sheba Med Ctr, Dept Neurosurg, Tel Aviv, Israel		Itshayek, E (corresponding author), Hebrew Univ Jerusalem, Med Ctr, Dept Neurosurg, POB 12000, IL-91120 Jerusalem, Israel.	eyal.itshayek@gmail.com	Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334			Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Curry WT, 2005, NEUROSURGERY, V56, P681, DOI 10.1227/01.NEU.0000156604.41886.62; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Fandino Y, 2004, SWISS MED WKLY, V134, P423; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Maramattom BV, 2004, NEUROLOGY, V63, P2142, DOI 10.1212/01.WNL.0000145626.30318.8A; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; TONI D, 1995, ARCH NEUROL-CHICAGO, V52, P670, DOI 10.1001/archneur.1995.00540310040014; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	23	12	13	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	2015	22	1					79	82		10.1016/j.jocn.2014.07.006			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AZ6NX	WOS:000348337300014	25224584				2022-02-06	
J	Rogers, JM; Fox, AM; Donnelly, J				Rogers, Jeffrey M.; Fox, Allison M.; Donnelly, James			Impaired practice effects following mild traumatic brain injury: An event-related potential investigation	BRAIN INJURY			English	Article						Attention; event-related potentials; mild TBI; PASAT; practice effects	CLOSED-HEAD INJURY; ATTENTION; RECOVERY; SYMPTOMS; VALIDITY; DEFICITS; TBI; IDENTIFICATION; PARADIGM; STRESS	Background: The negative effects of mild traumatic brain injury (mTBI) on attention are well established. Effects of practice on neuropsychological test performance have also been long recognized and more recently linked to electrophysiological indices of information processing. Objective: The current study examined the behavioural and electrophysiological impact of mTBI on consistent practice of a neuropsychological test of attention. Research design: Prospective cohort study. Methods: Adult participants with a history of mild TBI (n = 10; time since injury > 2 months, mean = 15.2 months) and healthy matched controls (n = 10) completed the Paced Auditory Serial Addition Task (PASAT) at four separate sessions. Event-related potentials (ERPs) were simultaneously recorded. Results: Accuracy of PASAT performance in both groups improved significantly with practice. In healthy controls behavioural improvements were associated with significant attenuation of a frontally distributed ERP component marker of executive attention. These executive attention demands did not appear to ease with consistent practice in the mTBI group, who also endorsed more concussion-related symptoms. Conclusions: These preliminary results suggest sustained mental effort is required to achieve 'normal' performance levels following mTBI and support the use of practice-related, ERP indices of recovery from mTBI as a sensitive correlate of persistent post-concussion symptoms.	[Rogers, Jeffrey M.] Australian Catholic Univ, Sch Psychol, Strathfield, NSW 2135, Australia; [Fox, Allison M.] Univ Western Australia, Sch Psychol, Crawley, WA, Australia; [Donnelly, James] So Cross Univ, Sch Hlth & Human Sci Psychol, Coffs Harbour, NSW, Australia		Rogers, JM (corresponding author), Australian Catholic Univ, Sch Psychol, Locked Bag 2002, Strathfield, NSW 2135, Australia.	jeffrey.rogers@acu.edu.au	Fox, Allison M/H-9218-2014; Donnelly, James F/P-5932-2015	Fox, Allison M/0000-0001-5189-6271; Donnelly, James F/0000-0002-2052-7948; Rogers, Jeffrey M/0000-0002-0320-969X	University of Western Australia	The authors report no conflicts of interest. This work was supported by a University of Western Australia International Postgraduate Research Scholarship awarded to the first author.	Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Andreassi J., 1995, PSYCHOPHYSIOLOGY HUM; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Jennett B, 1989, MILD HEAD INJURY, P23; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS., 1982, NEUROBEHAVIORAL CONS; LOGAN GD, 1991, J EXP PSYCHOL LEARN, V17, P179, DOI 10.1037/0278-7393.17.2.179; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Naatanen R., 1985, ATTENTION PERFORM, P355; Norman D., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Patton J.H., 1991, CLIN NEUROPSYCHOL, V5, P33, DOI [10.1080/13854049108401840, DOI 10.1080/13854049108401840]; Potter DD, 2002, J INT NEUROPSYCH SOC, V8, P828, DOI 10.1017/S1355617702860118; Potter DD, 1999, J PSYCHOPHYSIOL, V13, P173, DOI 10.1027//0269-8803.13.3.173; Prigatano, 2010, STUDY ANOSOGNOSIA, P229; *PSYCH CORP, 2001, WECHSL IND ACH TEST; *PSYCH CORP, 2001, WECHSL TEST AD READ; Rey A., 1964, EXAMEN CLIN PSYCHOL; Richardson J, 2000, CLIN NEUROPSYHOLOGIC; Rogers JM, 2012, ADV COGN PSYCHOL, V8, P281, DOI [10.2478/v10053-008-0123-z, 10.5709/acp-0123-z]; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Ryan L M, 1996, Appl Neuropsychol, V3, P49, DOI 10.1207/s15324826an0302_1; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; SCHNEIDER W, 1987, BEHAV RES METH INSTR, V19, P73, DOI 10.3758/BF03203762; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; SHALLICE T, 1993, ATTENTION SELECTION, P00171; SHELLEY AM, 1991, PSYCHOPHYSIOLOGY, V28, P496, DOI 10.1111/j.1469-8986.1991.tb01987.x; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; The Psychological Corporation, 1998, PAC AUD SER ADD TEST; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Woods DL., 1990, EVENT RELATED BRAIN, P178; Zasler N, 2000, NEUROPSYCHOLOGICAL M, P23	74	12	12	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					343	351		10.3109/02699052.2014.976273			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000009	25436891				2022-02-06	
J	Ustinova, KI; Chernikova, LA; Dull, A; Perkins, J				Ustinova, Ksenia I.; Chernikova, Ludmila A.; Dull, Ann; Perkins, Jan			Physical therapy for correcting postural and coordination deficits in patients with mild-to-moderate traumatic brain injury	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Ataxia; gait; motor recovery; neurorehabilitation; postural instability; therapeutic exercises; traumatic brain injury	CEREBELLAR GAIT ATAXIA; INDIVIDUALS; BALANCE; STROKE; STABILITY; PROGRAM; PEOPLE; RELIABILITY; EXERCISES; SERIES	The purpose of this study was to test the effects of a conventional exercise program designed for correcting postural and coordination abnormalities in patients with mild-to-moderate traumatic brain injury (TBI). Using principles of motor learning applied to functional exercise training, exercises were performed while lying, sitting, standing and walking, with the goal of improving intra-and inter-limb coordination in the upper and lower extremities, postural stability and gait pattern. Twenty-two participants with TBI-related deficits received therapy in a supervised outpatient clinic. Therapy included 20 sessions, each approximately 55 to 60 min in duration, scheduled four to five times a week over four consecutive weeks. Each participant was evaluated with a battery of clinical tests at baseline and immediately after therapy. Upon completion of the therapy, participants improved static and dynamic postural stability and gait, evaluated with the Berg Balance Scale (from 45.2 +/- 5.9 to 49.2 +/- 4.2 points) and the Functional Gait Assessment (from 22.8 +/- 4.1 to 26.9 +/- 3.4 points). They also reduced truncal, upper and lower extremity ataxia, evaluated with the Ataxia Scale (from 7.3 +/- 4.5 to 5.9 +/- 4.2 points). Results will be used to refine the current version of the exercise therapy, which focused on whole body coordination and balance, and to design a large-scale clinical trial establishing effectiveness of this intervention and for comparison with other forms of therapy.	[Ustinova, Ksenia I.; Perkins, Jan] Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48859 USA; [Chernikova, Ludmila A.] Russian Acad Med Sci, Res Ctr Neurol, Moscow, Russia; [Dull, Ann] MidMichigan Hlth, Midland, MI USA		Ustinova, KI (corresponding author), Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48859 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016; Chernikova, Ludmila/D-3182-2013	Ustinova, Ksenia I/0000-0002-1531-7591; Chernikova, Ludmila/0000-0001-5728-0179			Arce FI, 2004, HUM MOVEMENT SCI, V22, P749, DOI 10.1016/j.humov.2003.12.002; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; BERG K, 1989, Physiotherapy Canada, V41, P304; Bernstein NA., 1967, COORDINATION REGULAT; Bovonsunthonchai S, 2012, KAOHSIUNG J MED SCI, V28, P667, DOI 10.1016/j.kjms.2012.04.036; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Bruijn SM, 2010, J EXP BIOL, V213, P3945, DOI 10.1242/jeb.045112; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carr J. H., 1998, NEUROLOGICAL REHABIL; Corna S, 2003, ARCH PHYS MED REHAB, V84, P1173, DOI 10.1016/S0003-9993(03)00130-8; Danek A, 2004, NERVENARZT, V75, P411, DOI 10.1007/s00115-004-1717-4; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; Dix M R, 1979, Acta Otorhinolaryngol Belg, V33, P370; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Edwards S, 1996, NEUROLOGICAL PHYSIOT, P89; Esquenazi A, 2013, PM&R, V5, P280, DOI 10.1016/j.pmrj.2012.10.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fulk GD, 2007, PHYS REHABILITATION, P895; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hu F, 2012, IEEE ENG MED BIO, P4831, DOI 10.1109/EMBC.2012.6347075; Jauregui-Renaud K, 2007, J VESTIBUL RES-EQUIL, V17, P63; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Lin JH, 2010, STROKE, V41, P2021, DOI 10.1161/STROKEAHA.110.589739; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Paavola JM, 2013, J NOV PHYSIOTHER, V3, P129, DOI 10.4172/2165-7025.1000129; Page S, 2003, BRAIN INJURY, V17, P675, DOI 10.1080/0269905031000107160; Perry SB, 2014, J HEAD TRAUMA REHAB, V29, P117, DOI 10.1097/HTR.0b013e3182864f2f; Sartor-Glittenberg C, 2014, PHYSIOTHER THEOR PR, V30, P138, DOI 10.3109/09593985.2013.819952; Schenkman M, 2006, PHYS THER, V86, P1681, DOI 10.2522/ptj.20050260; Schmidt R. A., 2011, MOTOR CONTROL LEARNI; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stephenson JL, 2009, GAIT POSTURE, V29, P11, DOI 10.1016/j.gaitpost.2008.05.013; Sullivan KJ, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1149; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Ustinova KI, 2013, C P INT C VIRT REH P; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Yan CC, 2008, PHYSIOTHERAPY SINGAP, V11, P6	44	12	12	0	42	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.	JAN	2015	31	1					1	7		10.3109/09593985.2014.945674			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AW3RA	WOS:000346202800001	25083579				2022-02-06	
J	Winkler-Schwartz, A; Correa, JA; Marcoux, J				Winkler-Schwartz, Alexander; Correa, Jose A.; Marcoux, Judith			Clival fractures in a Level I trauma center	JOURNAL OF NEUROSURGERY			English	Article						clivus; skull base; trauma	BASILAR ARTERY; OCCIPITAL CONDYLES; AVULSION FRACTURE; EPIDURAL HEMATOMA; HEAD-INJURY; SKULL BASE; OCCLUSION; INCARCERATION; CT	OBJECT Clival fracture (CF) is rare among head traumas. The aim of this study was to explore how radiological features observed in CF reflect the clinical picture and mechanism of injury in such cases. METHODS Radiological data for patients with skull base fracture admitted to the Montreal General Hospital between February 2002 and October 2012 were obtained from the Quebec Trauma Registry and reviewed for CF. Identified CF was categorized by orientation and quality. Injury mechanism, clinical presentation, and follow-up outcome were obtained through retrospective chart review. RESULTS Of the 1738 patients with skull base fractures, 65 exhibited CF, representing 1.2% of the 5416 patients with traumatic brain injuries admitted during the period studied. Thirty-nine (60%) of the 65 CFs were obliquely oriented, 17 (26.2%) were longitudinal, and 9 (14%) were transverse. Twenty-nine (45%) of the 65 patients demonstrated linear fracture, 17 (26%) hairline, 10(15%) diastatic, and 9 (14%) displaced. Cranial nerve deficits and vascular injury occurred in 18.8% and 7.7% of cases, respectively. Twenty-five patients (38.5%) died in hospital. The long-term Extended Glasgow Outcome Scale score was significantly lower in transverse compared with longitudinal and oblique fractures (p = 0.03 and 0.03, respectively) and lower in diastatic compared with displaced fractures (p = 0.05). CONCLUSIONS This study provides information on the largest CF population studied to date, expands the current CF classification to include fracture quality as well as orientatidn, and underscores the existence of significant differences in pathogenesis and clinical presentation of CF subtypes.	[Winkler-Schwartz, Alexander; Marcoux, Judith] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; [Correa, Jose A.] McGill Univ, Dept Math & Stat, Montreal, PQ H3G 1A4, Canada; [Marcoux, Judith] McGill Univ, Ctr Hlth, Dept Neurosurg, Montreal, PQ H3G 1A4, Canada		Marcoux, J (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Neurol & Neurosurg, Rm L7-516,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca					ANTHONY DC, 1987, J NEUROSURG, V66, P929, DOI 10.3171/jns.1987.66.6.0929; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bala A, 2004, J CLIN NEUROSCI, V11, P660, DOI 10.1016/j.jocn.2003.11.008; Bonilha L, 2002, ARQ NEURO-PSIQUIAT, V60, P636, DOI 10.1590/S0004-282X2002000400023; Buyukkaya R, 2014, AM J EMERG MED, V32; CARTER LP, 1971, J NEUROSURG, V34, P423, DOI 10.3171/jns.1971.34.3.0423; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; Dashti R, 2007, EUR SPINE J, V16, pS261, DOI 10.1007/s00586-006-0270-1; de Melo PMP, 2003, ARQ NEURO-PSIQUIAT, V61, P499, DOI 10.1590/S0004-282X2003000300034; DOLAN KD, 1979, CRC CR REV DIAGN IM, V12, P101; Evers Julia J E, 2013, BMC Res Notes, V6, P554, DOI 10.1186/1756-0500-6-554; Garcia-Garcia J, 2012, ARCH NEUROL-CHICAGO, V69, P662, DOI 10.1001/archneurol.2011.1155; Geisler FH, 2012, PRINCIPLES NEUROLOGI, P365; Grossbach AJ, 2013, J NEUROSURG, V118, P775, DOI 10.3171/2013.1.JNS121451; GUHA A, 1989, CAN J NEUROL SCI, V16, P81, DOI 10.1017/S0317167100028560; Heggeness MH, 2010, SCHWARTZS PRINCIPLES; Imamura T, 2000, Leg Med (Tokyo), V2, P49, DOI 10.1016/S1344-6223(00)80010-3; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JONES DN, 1990, AM J NEURORADIOL, V11, P1181; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; KAPILA A, 1985, J COMPUT ASSIST TOMO, V9, P1142, DOI 10.1097/00004728-198511000-00033; Katsuno M, 2007, NEUROL MED-CHIR, V47, P307, DOI 10.2176/nmc.47.307; Khan N, 2000, SURG NEUROL, V54, P171, DOI 10.1016/S0090-3019(00)00284-6; Kim SH, 2012, J KOREAN NEUROSURG S, V51, P305, DOI 10.3340/jkns.2012.51.5.305; LOOP JW, 1964, RADIOLOGY, V83, P36, DOI 10.1148/83.1.36; Masopust V, 1998, Rozhl Chir, V77, P385; MCELHANEY JH, 1995, J NEUROTRAUM, V12, P669, DOI 10.1089/neu.1995.12.669; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; Moore Lynne, 2013, J Emerg Trauma Shock, V6, P95, DOI 10.4103/0974-2700.110754; Morris Andrew, 2003, Annu Proc Assoc Adv Automot Med, V47, P165; Ochalski PG, 2011, J NEUROSURG-PEDIATR, V7, P261, DOI 10.3171/2010.12.PEDS10190; Ochalski PG, 2009, NEUROSURGERY, V65, P1063, DOI 10.1227/01.NEU.0000360154.18604.28; Ogungbo B, 2001, BRIT J NEUROSURG, V15, P159; Ono H, 2011, NEUROL MED-CHIR, V51, P707, DOI 10.2176/nmc.51.707; Paterakis KN, 2005, CLIN NEUROL NEUROSUR, V108, P67, DOI 10.1016/j.clineuro.2004.11.010; Portier F, 2002, AURIS NASUS LARYNX, V29, P195, DOI 10.1016/S0385-8146(01)00139-0; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; SANDERS BB, 1973, J NEUROSURG, V39, P610, DOI 10.3171/jns.1973.39.5.0610; Sante et Services sociaux Quebec, 2012, PROJ POP QUEB SEL TE; SATO H, 1990, Neurological Surgery, V18, P1147; Sato S, 2001, NEUROL MED-CHIR, V41, P541, DOI 10.2176/nmc.41.541; SIGHTS WP, 1968, J NEUROSURG, V28, P588, DOI 10.3171/jns.1968.28.6.0588; Taguchi Y, 2000, J TRAUMA, V48, P1148, DOI 10.1097/00005373-200006000-00023; Tanabe M, 1999, NEUROL MED-CHIR, V39, P358, DOI 10.2176/nmc.39.358; Tay BKB, 2014, CURRENT DIAGNOSIS TR, P156; Wang E, 2012, CURR PROBL DIAGN RAD, V41, P114, DOI 10.1067/j.cpradiol.2011.07.021; Yavuz Cevdet, 2006, Ulus Travma Acil Cerrahi Derg, V12, P321	48	12	12	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2015	122	1					227	235		10.3171/2014.9.JNS14245			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX5DQ	WOS:000346947600032	25343182	Bronze			2022-02-06	
J	Yadav, NK; Ciuffreda, KJ				Yadav, Naveen K.; Ciuffreda, Kenneth J.			Objective assessment of visual attention in mild traumatic brain injury (mTBI) using visual-evoked potentials (VEP)	BRAIN INJURY			English	Article						Alpha band power; attenuation ratio (AR); attention deficit; mild traumatic brain injury (mTBI); primary visual cortex (V1); visual attention; visual-evoked potential (VEP)	REPORT SCALE ASRS; ADULT ADHD; EEG ALPHA; DEFICITS; PERFORMANCE; CONCUSSION; VALIDITY	Purpose: To quantify visual attention objectively using the visual-evoked potential (VEP) in those having mild traumatic brain injury (mTBI) with and without a self-reported attentional deficit. Research design and methods: Subjects were comprised of 16 adults with mTBI: 11 with an attentional deficit and five without. Three test conditions were used to assess the visual attentional state to quantify objectively the VEP alpha band attenuation ratio (AR) related to attention: (1) pattern VEP; (2) eyes-closed; and (3) eyes-closed number counting. The AR was calculated for both the individual and combined alpha frequencies (8-13 Hz). The objective results were compared to two subjective tests of visual and general attention (i.e. the VSAT and ASRS, respectively). Results: The AR for both the individual and combined alpha frequencies was found to be abnormal in those with mTBI having an attentional deficit. In contrast, the AR was normal in those with mTBI but without an attentional deficit. The AR correlated with the ASRS, but not with the VSAT, test scores. Conclusions: The objective and subjective tests were able to differentiate between those having mTBI with and without an attentional deficit. The proposed VEP protocol can be used in the clinic to detect and assess objectively and reliably a visual attentional deficit in the mTBI population.	[Yadav, Naveen K.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Yadav, NK (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	nyadav@sunyopt.edu			College of Optometrists in Vision Development (COVD)	We thank DIOPSYS Inc., Pine Brook, NJ for providing the VEP system for the study. We also thank Dr Kevin Willeford for his helpful comments on the manuscript. This work was supported by the College of Optometrists in Vision Development (COVD).	Abdi Herve., 2010, ENCY RES DESIGN, V1, P169; American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; Babiloni C, 2004, COGNITIVE BRAIN RES, V19, P259, DOI 10.1016/j.cogbrainres.2003.12.010; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BERNAL J, 1992, INT J NEUROSCI, V66, P45, DOI 10.3109/00207459208999788; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DUMERMUTH G, 1987, NEUROPSYCHOBIOLOGY, V17, P85, DOI 10.1159/000118345; Faul M, 2010, TRAUMATIC BRAIN INJU; FULLER PW, 1978, J LEARN DISABIL-US, V11, P303, DOI 10.1177/002221947801100507; Garson GD, 2013, CORRELATION STAT ASS; Gomarus HK, 2009, CLIN NEUROPHYSIOL, V120, P73, DOI 10.1016/j.clinph.2008.10.017; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hale TS, 2009, NEUROPSYCHOLOGIA, V47, P2082, DOI 10.1016/j.neuropsychologia.2009.03.021; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hansen C., 2001, UNDERSTANDING ACTIVE; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kim JH, 2013, PSYCHIAT INVEST, V10, P41, DOI 10.4306/pi.2013.10.1.41; Kirschfeld K, 2008, NEUROREPORT, V19, P907, DOI 10.1097/WNR.0b013e328302c545; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LEGEWIE H, 1969, ELECTROEN CLIN NEURO, V27, P470, DOI 10.1016/0013-4694(69)90187-4; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; LUDLAM WM, 1979, J AM OPTOM ASSOC, V50, P111; Luria A.R., 1966, HIGHER CORTICAL FUNC; MACKIE RT, 1995, BRIT J OPHTHALMOL, V79, P290, DOI 10.1136/bjo.79.3.290; Marr A., 2004, CENTRAL NERVOUS SYST; MCCULLOCH DL, 1991, INVEST OPHTH VIS SCI, V32, P2372; Nazhvani AD, 2013, CLIN NEUROL NEUROSUR, V115, P2329, DOI 10.1016/j.clineuro.2013.08.009; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Schnabel R, 2012, CLIN NEUROPSYCHOL, V26, P769, DOI 10.1080/13854046.2012.693541; SMITH A, 1967, ARCH NEUROL-CHICAGO, V17, P78, DOI 10.1001/archneur.1967.00470250082008; Solan HA, 2003, J LEARN DISABIL-US, V36, P556, DOI 10.1177/00222194030360060601; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Thiabault LE, 1990, 34 ANN P ASS ADV AUT, V34, P337; Trenerry MR, 1989, PROFESSIONAL MANUAL; van de Glind G, 2013, DRUG ALCOHOL DEPEN, V132, P587, DOI 10.1016/j.drugalcdep.2013.04.010; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wick B., 2008, CLIN MANAGEMENT BINO; Willeford KT, 2013, DOC OPHTHALMOL, V126, P105, DOI 10.1007/s10633-012-9363-9; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Yadav NK, 2013, BRAIN INJURY, V27, P1631, DOI 10.3109/02699052.2013.844856; Yadav NK, 2012, DOC OPHTHALMOL, V124, P177, DOI 10.1007/s10633-012-9319-0; Yadav NK, 2014, BRAIN INJURY, V28, P1; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Zasler N., 2007, BRAIN INJURY MED PRI	65	12	13	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					352	365		10.3109/02699052.2014.979229			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000010	25415539				2022-02-06	
J	Zhang, W; Li, B; Guo, Y; Bal, YN; Wang, TX; Fu, K; Sun, GL				Zhang, Wei; Li, Ben; Guo, Yan; Bal, Yunan; Wang, Tongxin; Fu, Kun; Sun, Gaoling			Rhamnetin attenuates cognitive deficit and inhibits hippocampal inflammatory response and oxidative stress in rats with traumatic brain injury	Central European Journal of Immunology			English	Article						rhamnetin; cognitive deficit; TBI; inflammation; oxidative stress	KAPPA-B; NEUROINFLAMMATION; CELLS; MODEL; NEURODEGENERATION; DYSFUNCTION; MICROGLIA; APOPTOSIS; PATHWAYS; MAPK	Activation of the immune system in the central nervous system and oxidative stress play,important roles in traumatic brain injury (TBI)-induced cognitive impairment. Rhamnetin possesses anti-inflammatory and anti-oxidative properties. This study aimed to detect the possible effects of rhamnetin on cognitive deficit, hippocampal inflammatory factors, and oxidative stress in rats with TBI. In this study, we established the traumatic brain injury model in rats. Rats respectively received vehicle saline or rhamnetin for 21 days. Cognitive functions were evaluated by assessing the acquisition of spatial learning and memory retention in Morris Water Maze test from day 15 to 19 post TBI. Levels of interleukin (IL)-1 beta, IL-6, IL-8, tumor necrosis factor alpha (TNF-alpha), IL-I0, and nuclear factor kappa B (NF-kappa B) in hippocampal homogenate were measured using ELISA. Oxidative stress was analysed by investigating the activities of MDA, H2O2, SOD, and GSH-Px. We found that rhamnetin significantly improved cognitive impairment in rats with TBI, and inhibited the inflammatory response and oxidative stress in the hippocampus. The results suggested that rhamnetin could enhance the recovery of cognitive deficits induced by TBI, and that its mechanism might be associated with the inhibition of inflammation and oxidative stress in the hippocampus.	[Zhang, Wei; Li, Ben; Guo, Yan; Bal, Yunan; Wang, Tongxin; Fu, Kun; Sun, Gaoling] Shandong Univ, Yidu Cent Hosp, Dept Neurosurg, Qingzhou 262500, Peoples R China		Zhang, W (corresponding author), Shandong Univ, Yidu Cent Hosp, Dept Neurosurg, Linglongshan Rd,Qingzhoushi 2, Qingzhou 262500, Peoples R China.	zhangweiyidu@163.com					Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cordaro M., 2014, J NEUROTRAUMA; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Jnawali HN, 2014, J NAT PROD, V77, P258, DOI 10.1021/np400803n; Kim YJ, 2013, BIOL PHARM BULL, V36, P1341, DOI 10.1248/bpb.b13-00276; Li JC, 2014, DRUG DES DEV THER, V8, P315, DOI 10.2147/DDDT.S52354; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lutz JA, 2014, FITOTERAPIA, V98, P11, DOI 10.1016/j.fitote.2014.06.012; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Marks W, 2013, CENT EUR J IMMUNOL, V38, P494, DOI 10.5114/ceji.2013.39767; Mondal A, 2013, J ETHNOPHARMACOL, V147, P525, DOI 10.1016/j.jep.2013.01.021; Park ES, 2014, J ETHNOPHARMACOL, V153, P552, DOI 10.1016/j.jep.2014.02.019; Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Schwalm MT, 2014, MOL NEUROBIOL, V49, P380, DOI 10.1007/s12035-013-8526-3; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tiwari V, 2012, PSYCHOPHARMACOLOGY, V224, P519, DOI 10.1007/s00213-012-2779-9; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang H, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/851692; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093837; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0	33	12	17	0	5	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	WENEDOW ST 9-1, POZNAN, 61-614, POLAND	1426-3912	1644-4124		CENT EUR J IMMUNOL	Central Eur. J. Immunol.		2015	40	1					35	41		10.5114/ceji.2015.50831			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG6RT	WOS:000353430800007	26155182	Green Published, gold, Green Submitted			2022-02-06	
J	Zimmermann, N; Pereira, N; Hermes-Pereira, A; Holz, M; Joanette, Y; Fonseca, RP				Zimmermann, Nicolle; Pereira, Natalie; Hermes-Pereira, Andressa; Holz, Maila; Joanette, Yves; Fonseca, Rochele Paz			Executive functions profiles in traumatic brain injury adults: Implications for rehabilitation studies	BRAIN INJURY			English	Article						Cluster analysis; executive functions; methods; neuropsychological assessment; traumatic brain injury	INDIVIDUAL-DIFFERENCES; PERFORMANCE; DYSFUNCTION; EDUCATION; MODERATE; AGE; VALIDATION; MODELS; IMPACT; TESTS	Primary objective: This study aimed to identify and characterize profiles of executive functions (EF) following traumatic brain injury (TBI). Research design: The sample was comprised of 84 adult outpatients with mild and moderate/severe TBI who were assessed by means of a battery of EF tasks. A Hierarchical Cluster analysis was performed with tasks Z-scores. Clusters were compared by means of ANOVA and Chi-square analyses. Main outcomes and results: Three clusters were characterized by deficits in: (1) inhibition, flexibility and focused attention; (2) inhibition, flexibility, working memory and focused attention; and (3) no expressive executive deficits. Clusters did not differ in clinical or demographical variables. Conclusions: The first cluster replicated findings of previous studies on TBI EF profiles. IT is suggested that TBI rehabilitation studies of EF must select participants by their EF profile rather than for clinical or demographical variables.	[Zimmermann, Nicolle; Pereira, Natalie; Hermes-Pereira, Andressa; Holz, Maila; Fonseca, Rochele Paz] Pontifical Catolica Univ Rio Grande do Sul, Fac Psychol, BR-90619900 Porto Alegre, RS, Brazil; [Zimmermann, Nicolle] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil; [Joanette, Yves] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada		Zimmermann, N (corresponding author), Pontifical Catolica Univ Rio Grande do Sul, 6681 Ipiranga Ave,Bldg 11, BR-90619900 Porto Alegre, RS, Brazil.	nicolle.zimmermann@gmail.com		ZIMMERMANN, NICOLLE/0000-0003-4771-4070; Joanette, Yves/0000-0001-9212-1827; Rossato Holz, Maila/0000-0001-8648-4234	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	Data collection and organization was supported by team work of the students Camila Borges Parana, Simone Begni and Renata Pereira. Also, we thank Ricardo Gurgel Reboucas, MD, for institutional contacts to data collection and Tulio Becker Hainzenreder, MD, for training support on the analysis of traumatic brain injury lesions. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the first author studentship.	AIT AITB, 1944, ARM IND TEST BATT; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Ardila A, 2013, J NEUROLOGICAL DISOR, V1, P1, DOI DOI 10.4172/2329-6895.1000114; Associacao Brasileira de Empresas de Pesquisa (ABEP) BA of RC, 2008, SOC STAT QUEST; Beausoleil N, 2003, APHASIOLOGY, V17, P143, DOI 10.1080/729255219; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Burgess P.W., 1997, HAYLING BRIXTON TEST; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cicerone KA, 2009, ARCH PHYS MED REHAB, V90, pS52, DOI 10.1016/j.apmr.2009.05.019; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; FINKE RA, 1988, MEM COGNITION, V16, P252, DOI 10.3758/BF03197758; Fonseca RP, 2008, BATERIA MONTREAL AVA; Fonseca RP, 2009, INSTRUMENTO AVALIACA; Fonseca RPOC, 2010, AVALIACAO PSICOLOGIC, P337; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friedman NP, 2011, DEV PSYCHOL, V47, P1410, DOI 10.1037/a0023750; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Institute of Medicine, 2011, COGN REH THER TRAUM; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Joanette Y, 2004, COMMUNICATION; Kave G, 2007, J INT NEUROPSYCH SOC, V13, P424, DOI 10.1017/S1355617707070622; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kim JS, 2009, J KOREAN NEUROSURG S, V46, P459, DOI 10.3340/jkns.2009.46.5.459; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak M, 2011, NEUROPSYCHOLOGICAL A; Lin HL, 2010, J TRAUMA, V69, P1310, DOI 10.1097/TA.0b013e3181ede90f; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Mainland BJ, 2010, CLUSTER PROFILES MIL; Mateer CA, 2008, TXB CLIN NEUROPSYCHO, P996; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Montani V, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00409; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Pawlowski J, 2012, READ WRIT, V25, P2275, DOI 10.1007/s11145-012-9357-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; Russell J, 1998, J AUTISM DEV DISORD, V28, P177, DOI 10.1023/A:1026009203333; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Sohlberg M., 2001, COGNITIVE REHABILITA; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; TEASDALE G, 1974, LANCET, V2, P81; Tirapu-Ustarroz J, 2008, REV NEUROLOGIA, V46, P684, DOI 10.33588/rn.4611.2008119; Tirapu-Ustarroz J, 2008, REV NEUROLOGIA, V46, P742, DOI 10.33588/rn.4612.2008252; Wright Andy, 2014, Front Psychol, V5, P213, DOI 10.3389/fpsyg.2014.00213	67	12	12	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1071	1081		10.3109/02699052.2015.1015613			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000008	25950264				2022-02-06	
J	Mallick, S; D'Mello, SR				Mallick, Sathi; D'Mello, Santosh R.			JAZ (Znf346), a SIRT1-interacting Protein, Protects Neurons by Stimulating p21 (WAF/CIP1) Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Huntington Disease; Neurodegeneration; Neuroprotection; Sirtuin 1 (SIRT1)	TRAUMATIC BRAIN-INJURY; ZINC-FINGER PROTEIN; CELL-CYCLE ARREST; PROVIDES NEUROPROTECTION; DEACETYLASE ACTIVITY; OXIDATIVE STRESS; CORTICAL-NEURONS; SIRT1; P21(WAF1/CIP1); APOPTOSIS	SIRT1, a class III histone deacetylase, protects neurons in various models of neurodegenerative diseases. We previously described that neuroprotection by SIRT1 is independent of its catalytic activity. To elucidate how SIRT1 protects neurons, we performed a mass spectrometric screen to find SIRT1-interacting proteins. One of the proteins identified was JAZ (Znf346), a member of a new class of Cys-2-His-2 zinc finger proteins. To investigate the significance of JAZ in the regulation of neuronal survival, we overexpressed it in neurons. We found that JAZ protects cerebellar granule neurons against potassium deprivation-induced death and cortical neurons from death resulting from oxidative stress. JAZ also protects neurons against toxicity induced by mutant huntingtin and mutant ataxin-1 expression. Although expression of endogenous JAZ does not change in neurons primed to die, knockdown of its expression promotes death of otherwise healthy neurons. In contrast to its protective effect in neurons, overexpression of JAZ in different cell lines promotes death. We find that JAZ suppresses cell cycle progression, thereby explaining its contrasting effect in postmitotic neurons versus proliferating cell lines. Although not affecting the expression of several cyclins, overexpression of JAZ stimulates expression of p21 (WAF1/CIP1), a cell cycle inhibitor known to have neuroprotective effects. Results of chromatin immunoprecipitation and transcriptional assays indicate that the stimulatory effect of JAZ on p21 expression is mediated at the transcriptional level. Furthermore, knockdown of p21 expression inhibits the neuroprotective effect of JAZ. Together, our results suggest that JAZ protects neurons by inhibiting cell cycle re-entry through the transcriptional stimulation of p21 expression.	[Mallick, Sathi] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Mallick, Sathi; D'Mello, Santosh R.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA		D'Mello, SR (corresponding author), So Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA.	sdmello@smu.edu	D'Mello, Santosh/AAO-7192-2020; D'Mello, Santosh/AAM-3644-2020	D'Mello, Santosh/0000-0002-7652-1334; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS040408, NS066404]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040408, R21NS066404] Funding Source: NIH RePORTER	This work was supported, in whole or in part, by National Institutes of Health Grants NS040408 and NS066404.	Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Burge RG, 2014, BIOCHEMISTRY-US, V53, P1495, DOI 10.1021/bi401675h; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Duan WZ, 2013, CNS DRUGS, V27, P345, DOI 10.1007/s40263-013-0055-0; Finerty PJ, 1997, J MOL BIOL, V271, P195, DOI 10.1006/jmbi.1997.1177; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Haskew-Layton RE, 2010, P NATL ACAD SCI USA, V107, P17385, DOI 10.1073/pnas.1003996107; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Ma TC, 2013, NEUROBIOL DIS, V49, P13, DOI 10.1016/j.nbd.2012.08.016; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Mergenthaler P, 2013, J CEREBR BLOOD F MET, V33, P351, DOI 10.1038/jcbfm.2012.213; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Poluha W, 1996, MOL CELL BIOL, V16, P1335; RATAN RR, 1994, J NEUROSCI, V14, P4385; Schaefer JS, 2010, J BIOL CHEM, V285, P11258, DOI 10.1074/jbc.M109.073932; Tang BL, 2008, MOL ASPECTS MED, V29, P187, DOI 10.1016/j.mam.2007.02.001; Tomita K, 2006, BRAIN RES, V1081, P44, DOI 10.1016/j.brainres.2006.01.120; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Yang ML, 2006, BLOOD, V108, P4136, DOI 10.1182/blood-2006-06-029645; Yang ML, 2011, CELL CYCLE, V10, P2390, DOI 10.4161/cc.10.14.16587; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399	35	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2014	289	51					35409	35420		10.1074/jbc.M114.597575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX0RT	WOS:000346660200031	25331946	Green Published, hybrid			2022-02-06	
J	Jacqmain, J; Nudi, ET; Fluharty, S; Smith, JS				Jacqmain, Justin; Nudi, Evan T.; Fluharty, Sarah; Smith, Jeffrey S.			Pre and post-injury environmental enrichment effects functional recovery following medial frontal cortical contusion injury in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						TBI; Behavior; Neuroplasticity; Rat	TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; PREFRONTAL CORTEX; COGNITIVE DEFICITS; CELL-PROLIFERATION; NERVOUS-SYSTEM; ANIMAL-MODELS; ADULT-RATS; OPEN-FIELD; INCREASES	The rodent has been the preferred research model for evaluating the mechanisms related to, and potential treatments for, traumatic brain injury (TB!). Many therapies previously determined to be effective in preclinical investigations have failed to show the same effectiveness in clinical trials. The environment a rodent is housed in plays an important role in brain and behavioral development. Housing rodents in non-enriched environments significantly alters the development of the rodent brain and its behavioral profile, negatively impacting the ecological validity of the rodent model. This investigation employed 113 male Long-Evans rats assigned to either an enriched environment (EE) or standard environment (SE) from post-natal day 25. At four months of age, rats received either a controlled cortical impact (CCI) to the medial frontal cortex (mFC) or sham injury. Rats assigned to EE or SE pre-injury were re-assigned to remain in, or switch to, EE or SE post-injury. The open-field test (OFT), vermicelli handling test (VHT) Morris water maze (MWM), and rotor-rod (RR), were used to evaluate the animals response to TBI. The data from the current investigation indicates that the performance of TBI rats assigned to pre-injury EE was improved on the MWM compared to the TBI rats assigned to pre-injury SE. However, those that were reared in the EE performed better on the MWM if placed into a SE post-injury as compared to those placed into the EE after insult. The TBI and sham groups that were raised, and remained, in the SE performed worse than any of the EE groups on the RR. TBI rats that were placed in the EE had larger cortices and more cells in the hippocampus than the TBI rats housed in the SE. These data strongly suggest that the pre-injury housing environment should be considered as investigators refine pre-clinical models of TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Jacqmain, Justin; Nudi, Evan T.; Fluharty, Sarah; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Malcolm & Lois Field Endowed Chair Hlth Sci, Dept Hlth Sci, Crystal M Lange Coll Hlth & Human Serv, 7400 Bay Rd, University Ctr, MI 48710 USA.	jmjacqma@svsu.edu; etnudi@svsu.edu; snfluhar@svsu.edu; jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475	Saginaw Valley State University Student Research and Creativity Institute	Both JJ and EN contributed equally to the development of this manuscript. This work was supported by funding from the Saginaw Valley State University Student Research and Creativity Institute. The authors would like to thank Jacob Dunkerson, Kasey Moritz, David Mudd, Garrick Salois, Madeleine Searles, Robert Underly, and Jennica Young for their help with animal care and assistance throughout the course of the study.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; KATZ HB, 1984, EXP NEUROL, V83, P274, DOI 10.1016/0014-4886(84)90098-0; Kleim JA, 1996, J NEUROSCI, V16, P4529; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; KOLB B, 1982, BEHAV BRAIN RES, V6, P365, DOI 10.1016/0166-4328(82)90018-3; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; Kolb B., 2013, CORTEX; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Kozlowski DA, 2004, J NEUROTRAUM, V21, P513, DOI 10.1089/089771504774129856; KRECH D, 1966, PHYSIOL BEHAV, V1, P99, DOI 10.1016/0031-9384(66)90051-5; Landers MS, 2011, NEUROSCIENCE, V199, P143, DOI 10.1016/j.neuroscience.2011.10.040; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; MISSLIN R, 1986, BEHAV PROCESS, V12, P45, DOI 10.1016/0376-6357(86)90069-0; MOHAMMED AK, 1986, BRAIN RES, V398, P6, DOI 10.1016/0006-8993(86)91243-6; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; OWENS DGC, 1982, ARCH GEN PSYCHIAT, V39, P452; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PAYLOR R, 1992, BEHAV BRAIN RES, V52, P49, DOI 10.1016/S0166-4328(05)80324-9; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pinaud R, 2004, INT J NEUROSCI, V114, P321, DOI 10.1080/00207450490264142; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Rosenzweig M.R., 1987, ENRICHED IMPOVERISHE; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Shaw CL, 2013, BEHAV BRAIN RES, V236, P94, DOI 10.1016/j.bbr.2012.08.024; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Spolidoro M, 2009, EXP BRAIN RES, V192, P335, DOI 10.1007/s00221-008-1509-3; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tennant KA, 2010, J VIS EXP, P41; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; WALSH RN, 1969, J COMP NEUROL, V137, P361, DOI 10.1002/cne.901370309; Wang RY, 2001, BRAIN RES, V922, P140, DOI 10.1016/S0006-8993(01)03154-7; Wiedenmayer C, 1997, ANIM BEHAV, V53, P461, DOI 10.1006/anbe.1996.0296; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	73	12	13	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	DEC 15	2014	275						201	211		10.1016/j.bbr.2014.08.056			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AS7IX	WOS:000344431100027	25196632				2022-02-06	
J	Beijer, LJ; Rietveld, ACM; Ruiter, MB; Geurts, ACH				Beijer, L. J.; Rietveld, A. C. M.; Ruiter, M. B.; Geurts, A. C. H.			Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers	CLINICAL LINGUISTICS & PHONETICS			English	Article						Clinical outcome research; dysarthria; outcome measures; speech intelligibility; web-based training	PARKINSONS-DISEASE; WEB APPLICATION; DISCRIMINATION; INTENSITY; DEFICITS; STROKE; IMPACT; MODEL; SUS	We explored the suitability of perceptual and acoustic outcome measures to prepare E-learning based Speech Therapy (EST) efficacy tests regarding speech intelligibility in dysarthric speakers. Eight speakers with stroke (n = 3), Parkinson's disease (n = 4) and traumatic brain injury (n = 1) participated in a 4 weeks EST trial. A repeated measures design was employed. Perceptual measures were (a) scale ratings for "ease of intelligibility'' and "pleasantness'' in continuous speech and (b) orthographic transcription scores of semantically unpredictable sentences. Acoustic measures were (c) "intensity during closure'' (Delta IDC) in the occlusion phase of voiceless plosives, (d) changes in the vowel space of /a/, /e/ and /o/ and (e) the F0 variability in semantically unpredictable sentences. The only consistent finding concerned an increased (instead of the expected decreased) Delta IDC after EST, possibly caused by increased speech intensity without articulatory adjustments. The importance of suitable perceptual and acoustic measures for efficacy research is discussed.	[Beijer, L. J.; Rietveld, A. C. M.; Ruiter, M. B.; Geurts, A. C. H.] Sint Maartensklin Res, Nijmegen, Netherlands; [Rietveld, A. C. M.; Ruiter, M. B.] Radboud Univ Nijmegen, Fac Arts, Dept Linguist, NL-6525 ED Nijmegen, Netherlands; [Geurts, A. C. H.] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands		Beijer, LJ (corresponding author), Sint Maartensklin, POB 9011, NL-6500 GM Nijmegen, Netherlands.	L.Beijer@maartenskliniek.nl	Geurts, Alexander/H-8032-2014; Ruiter, Marina B./J-3128-2016	Geurts, Alexander/0000-0001-7478-1119; Ruiter, Marina B./0000-0001-6147-5235			Abdi H., 2007, KENDALL RANK CORRELA; ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Basso A, 2005, APHASIOLOGY, V19, P975, DOI 10.1080/02687030544000182; Beijer LJ, 2012, J MED SPEECH-LANG PA, V20, P17; Beijer LJ, 2011, J COMMUN DISORD, V44, P701, DOI 10.1016/j.jcomdis.2011.05.002; Beijer LJ, 2010, TELEMED J E-HEALTH, V16, P732, DOI 10.1089/tmj.2009.0183; Beijer LJ, 2010, TELEMED J E-HEALTH, V16, P178, DOI 10.1089/tmj.2009.0104; Benoit C, 1996, SPEECH COMMUN, V18, P381, DOI 10.1016/0167-6393(96)00026-X; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Blaney B, 2000, CLIN LINGUIST PHONET, V14, P307; BOERSMA P, 1998, THESIS U AMSTERDAM N; Boersma Paul, 2009, PRAAT DOING PHONETIC; Boves L., 1984, PHONETIC BASIS PERCE; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; De Bodt MS, 2002, J COMMUN DISORD, V35, P283, DOI 10.1016/S0021-9924(02)00065-5; de Rue N. P. W. D., 2012, THESIS RADBOUD U NIJ; de Swart BJM, 2003, NEUROLOGY, V60, P498, DOI 10.1212/01.WNL.0000044480.95458.56; Enderby, 2007, INT J SPEECH LANGUAG, V9, P140, DOI [DOI 10.1080/14417040600970606, 10.1080/14417040600970606]; Hill A., 2008, THESIS U QUEENSLAND; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kent RD, 1999, J MED SPEECH-LANG PA, V7, P83; Kent RD, 2003, CLIN LINGUIST PHONET, V17, P427, DOI 10.1080/0269920031000086248; Kim Y, 2011, J SPEECH LANG HEAR R, V54, P417, DOI 10.1044/1092-4388(2010/10-0020); Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Laures J. S., 2012, J COMMUN DISORD, V36, P449; Laures JS, 1999, J SPEECH LANG HEAR R, V42, P1148, DOI 10.1044/jslhr.4205.1148; Maas E, 2008, AM J SPEECH-LANG PAT, V17, P277, DOI 10.1044/1058-0360(2008/025); Martens H., 2010, LOGOPEDIE, V23, P31; Neger T., 2010, THESIS RADBOUD U NIJ; Palmer R, 2004, J MED SPEECH-LANG PA, V12, P183; Ramig LO, 2001, J NEUROL NEUROSUR PS, V71, P493, DOI 10.1136/jnnp.71.4.493; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Rvachew S., 2004, J SPEECH HEAR RES, V37, P347; SCHEFFE H, 1952, J AM STAT ASSOC, V47, P381, DOI 10.2307/2281310; Schneider W., 2007, E PRIME VERSION 2 0; Troche J, 2012, AM J SPEECH-LANG PAT, V21, P258, DOI 10.1044/1058-0360(2012/11-0007); Van de Weijer J, 1991, LOGOPEDIE FONIATRIE, V63, P97; van Doremalen J., 2009, P INTERSPEECH, P592; Van Heuven, 2009, ALGEMENE FONETIEK; VANBERGEM DR, 1993, SPEECH COMMUN, V12, P1, DOI 10.1016/0167-6393(93)90015-D; Wang YT, 2005, J COMMUN DISORD, V38, P231, DOI 10.1016/j.jcomdis.2004.12.001; Winters JM, 2004, TELEMED J E-HEALTH, V10, P200, DOI 10.1089/1530562041641255	42	12	12	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	DEC	2014	28	12					927	950		10.3109/02699206.2014.936627			24	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AT2YI	WOS:000344800100004	25025268				2022-02-06	
J	Edut, S; Rubovitch, V; Rehavi, M; Schreiber, S; Pick, CG				Edut, S.; Rubovitch, V.; Rehavi, M.; Schreiber, S.; Pick, C. G.			A Study on the Mechanism by Which MDMA Protects Against Dopaminergic Dysfunction After Minimal Traumatic Brain Injury (mTBI) in Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; MDMA; Mice; Tyrosine hydroxylase; BDNF	SPATIAL WORKING-MEMORY; NECROSIS-FACTOR-ALPHA; TYROSINE-HYDROXYLASE; PREFRONTAL CORTEX; BEHAVIORAL RECOVERY; COGNITIVE DEFICITS; ATTENTION DEFICITS; FRONTAL-CORTEX; D2 RECEPTORS; BDNF	Driving under methylenedioxymethamphetamine (MDMA) influence increases the risk of being involved in a car accident, which in turn can lead to traumatic brain injury. The behavioral deficits after traumatic brain injury (TBI) are closely connected to dopamine pathway dysregulation. We have previously demonstrated in mice that low MDMA doses prior to mTBI can lead to better performances in cognitive tests. The purpose of this study was to assess in mice the changes in the dopamine system that occurs after both MDMA and minimal traumatic brain injury (mTBI). Experimental mTBI was induced using a concussive head trauma device. One hour before injury, animals were subjected to MDMA. Administration of MDMA before injury normalized the alterations in tyrosine hydroxylase (TH) levels that were observed in mTBI mice. This normalization was also able to lower the elevated dopamine receptor type 2 (D-2) levels observed after mTBI. Brain-derived neurotrophic factor (BDNF) levels did not change following injury alone, but in mice subjected to MDMA and mTBI, significant elevations were observed. In the behavioral tests, haloperidol reversed the neuroprotection seen when MDMA was administered prior to injury. Altered catecholamine synthesis and high D-2 receptor levels contribute to cognitive dysfunction, and strategies to normalize TH signaling and D-2 levels may provide relief for the deficits observed after injury. Pretreatment with MDMA kept TH and D-2 receptor at normal levels, allowing regular dopamine system activity. While the beneficial effect we observe was due to a dangerous recreational drug, understanding the alterations in dopamine and the mechanism of dysfunction at a cellular level can lead to legal therapies and potential candidates for clinical use.	[Edut, S.; Rubovitch, V.; Pick, C. G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Rehavi, M.] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Schreiber, S.] Tel Aviv Univ, Dept Psychiat, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Edut, S (corresponding author), Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	eshaha12@campus.haifa.ac.il; rubovitc@post.tau.ac.il; mrehavi@post.tau.ac.il; shaulsch@tlvmc.gov.il; pickc@post.tau.ac.il	Pick, Chaim/D-4789-2009; Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693	Dr. Herman Schauder Endowment Fund for Research; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel	This study was supported (in part) by a grant from the Dr. Herman Schauder Endowment Fund for Research and by a grant from The Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel. We would like to thank Netta Roz for her expert technical assistance in the dopamine type 2 receptor binding assay and analyses.	Ahmed R. H., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Assaf F, 2011, BEHAV BRAIN RES, V220, P194, DOI 10.1016/j.bbr.2011.02.005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beaulieu JM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00038; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Camarero J, 2002, J NEUROCHEM, V81, P961, DOI 10.1046/j.1471-4159.2002.00879.x; Cassol OJ, 2011, J NEUROIMMUNOL, V230, P48, DOI 10.1016/j.jneuroim.2010.08.026; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Connor TJ, 2000, LIFE SCI, V67, P1601, DOI 10.1016/S0024-3205(00)00743-8; Connor TJ, 2005, J PHARMACOL EXP THER, V312, P134, DOI 10.1124/jpet.104.073023; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Di Cara B, 2011, J NEUROSCI, V31, P16928, DOI 10.1523/JNEUROSCI.2502-11.2011; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Gerstenbrand F, 2001, BRAIN INJURY, V15, P95; Granado N, 2008, J NEUROCHEM, V107, P1102, DOI 10.1111/j.1471-4159.2008.05705.x; Granado N, 2011, NEUROBIOL DIS, V42, P391, DOI 10.1016/j.nbd.2011.01.033; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Haavik J, 1998, MOL NEUROBIOL, V16, P285, DOI 10.1007/BF02741387; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; HEWITT KE, 1994, NEUROPHARMACOLOGY, V33, P1589, DOI 10.1016/0028-3908(94)90134-1; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Li YC, 2011, P NATL ACAD SCI USA, V108, P12107, DOI 10.1073/pnas.1109718108; Li YC, 2011, NEUROSCI BIOBEHAV R, V35, P645, DOI 10.1016/j.neubiorev.2010.08.001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma X., 2000, Journal of Neurotrauma, V17, P951; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Mehta MA, 2005, PSYCHOPHARMACOLOGY, V180, P654, DOI 10.1007/s00213-004-2128-8; Meisner F, 2008, NEUROPSYCHOPHARMACOL, V33, P2228, DOI 10.1038/sj.npp.1301615; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; SCHMIDT CJ, 1990, EUR J PHARMACOL, V181, P59, DOI 10.1016/0014-2999(90)90245-2; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; Shin S. S., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Sil'kis I G, 2002, Neurosci Behav Physiol, V32, P205, DOI 10.1023/A:1015093619476; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Sumi-Ichinose C, 2010, J PHARMACOL SCI, V114, P17, DOI 10.1254/jphs.09R28FM; Takahashi H, 2006, BIOL PSYCHIAT, V59, P919, DOI 10.1016/j.biopsych.2006.01.022; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Tio DL, 2011, J NEUROTRAUM, V28, pA80; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; Whyte J, 2006, BRAIN COGNITION, V60, P191; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; WOTHERSPOON G, 1994, MOL BRAIN RES, V25, P34, DOI 10.1016/0169-328X(94)90275-5; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yan HO, 2004, J NEUROTRAUM, V21, P1338; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yan HQ, 2007, J NEUROTRAUMA, V24, pP182; Zhan LX, 2010, J NEUROCHEM, V114, P897, DOI 10.1111/j.1471-4159.2010.06816.x; Zhang HX, 2003, NEUROL RES, V25, P471; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	88	12	13	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	DEC	2014	54	4					684	697		10.1007/s12031-014-0399-z			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW0PP	WOS:000345995700010	25124230				2022-02-06	
J	Karnatovskaia, LV; Lee, AS; Festic, E; Kramer, CL; Freeman, WD				Karnatovskaia, Lioudmila V.; Lee, Augustine S.; Festic, Emir; Kramer, Christopher L.; Freeman, William D.			Effect of Prolonged Therapeutic Hypothermia on Intracranial Pressure, Organ Function, and Hospital Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Subarachnoid hemorrhage; Targeted temperature management; Therapeutic hypothermia; Global cerebral edema; Intracranial pressure; Decompressive hemicraniectomy	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL EDEMA; SEVERE HEAD-INJURY; ACUTE LUNG INJURY; DECOMPRESSIVE HEMICRANIECTOMY; INTRACEREBRAL HEMORRHAGE; MILD HYPOTHERMIA; COMPLICATIONS; HYPERTENSION	Global cerebral edema (GCE) with subsequent refractory intracranial hypertension complicates some cases of aneurysmal subarachnoid hemorrhage (aSAH), and typically is associated with poorer outcome. Treatment options for refractory intracranial pressure (ICP) cases are limited to decompressive hemicraniectomy (DHC) and targeted temperature management (TTM) with induced hypothermia (32-34 A degrees C). No outcomes comparison between patients treated with either or both forms of refractory ICP therapy exists, and data on the effect of prolonged hypothermia on ICP and organ function among patients with aSAH are limited. This is a retrospective study of aSAH patients who underwent DHC and/or prolonged hypothermia (greater than 48 h) for refractory ICP (i.e., ICP > 20 mmHg after osmotherapy) in the intensive care unit of a single, tertiary-care academic center. Nineteen individuals with aSAH underwent TTM with or without DHC; sixteen patients underwent DHC alone. The patients in TTM group were younger (median age 44 years) than the DHC without TTM population (median age 60 years). TTM was started on median day 2 with a median duration of 7 days. There were no significant group differences in survival to discharge (59 % vs. 69 %) or in the mean modified Rankin score on follow-up (3.6 vs. 3.7), despite the TTM group having longer hospital length of stay (24 vs. 19 days, p = 0.03), longer duration of mechanical ventilation (20 vs. 9 days, p = 0.04), a higher cumulative fluid balance (12.8 vs. 5.1 L, p = 0.01), and higher APACHEII scores. The median maximal ICP decreased from 23.5 to 21 mmHg within 24 h of hypothermia initiation. There were no significant differences in other markers of end-organ function (respiratory, hematologic, renal, liver, and cardiac), infection rate, or adverse events between groups. Use of prolonged TTM among aSAH patients with GCE and refractory ICP elevations is associated with a longer duration of mechanical ventilation but is not different in terms of neurological outcomes measured by modified Rankin score or organ function outcomes compared to patients who received DHC alone.	[Karnatovskaia, Lioudmila V.; Lee, Augustine S.; Festic, Emir] Mayo Clin, Dept Pulm & Crit Care Med, Jacksonville, FL 32224 USA; [Kramer, Christopher L.] Mayo Clin, Dept Neurol, Rochester, MA USA; [Freeman, William D.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA		Karnatovskaia, LV (corresponding author), Mayo Clin, Dept Pulm & Crit Care Med, 4500 San Pablo Rd,Davis Bldg E-7A, Jacksonville, FL 32224 USA.	karnatovskaia.lioudmila@mayo.edu		Freeman, M.D., William D./0000-0003-2326-0633			Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Anei R, 2010, NEUROL MED-CHIR, V50, P879, DOI 10.2176/nmc.50.879; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Burger CD, 2006, MAYO CLIN PROC, V81, P849, DOI 10.4065/81.6.849; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Dorfer C, 2010, WORLD NEUROSURG, V74, P465, DOI 10.1016/j.wneu.2010.08.001; Duan M, 2011, RESP CARE, V56, P1956, DOI 10.4187/respcare.01211; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hoesch RE, 2012, CRIT CARE MED, V40, P587, DOI 10.1097/CCM.0b013e3182329617; Kamps M, 2011, CRIT CARE, V15, DOI 10.1186/cc10012; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Kreiter KT, 2002, STROKE, V33, P200, DOI 10.1161/hs0102.101080; le Roux AA, 2010, NEUROSURG CLIN N AM, V21, P235, DOI 10.1016/j.nec.2009.10.014; Mourand I, 2012, J NEUROL SCI, V316, P104, DOI 10.1016/j.jns.2012.01.014; Murakami M, 2007, NEUROL MED-CHIR, V47, P116, DOI 10.2176/nmc.47.116; Nagao S, 2000, ACT NEUR S, V76, P547; Ng H Kee, 2009, J Vasc Interv Neurol, V2, P142; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Petridis AK, 2010, ACTA NEUROCHIR, V152, P2143, DOI 10.1007/s00701-010-0761-z; Pillai S, 2004, NEUROL INDIA, V52, P67; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Ramsey D, 2011, 9 ANN NEUR CAR SOC M; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rodling-Wahlstrom M, 2012, SCAND J CLIN LAB INV, V72, P484, DOI 10.3109/00365513.2012.699098; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Scaravilli V, 2011, NEUROCRIT CARE, V15, P287, DOI 10.1007/s12028-011-9588-6; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Staykov D, 2013, NEUROCRIT CARE, V18, P178, DOI 10.1007/s12028-012-9762-5; VILLAR J, 1993, RESUSCITATION, V26, P183, DOI 10.1016/0300-9572(93)90178-S; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; Zetterling M, 2010, ACTA NEUROCHIR, V152, P1527, DOI 10.1007/s00701-010-0684-8; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	41	12	14	1	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2014	21	3					451	461		10.1007/s12028-014-9989-4			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AT2TY	WOS:000344790100011	24865270				2022-02-06	
J	Kumasaka, K; Marks, JA; Eisenstadt, R; Murcy, MA; Samadi, D; Li, SJ; Johnson, V; Browne, KD; Smith, DH; Schwab, CW; Pascual, JL				Kumasaka, Kenichiro; Marks, Joshua A.; Eisenstadt, Rachel; Murcy, Mohammad A.; Samadi, Davoud; Li, Shengjie; Johnson, Victoria; Browne, Kevin D.; Smith, Douglas H.; Schwab, C. William; Pascual, Jose L.			In vivo leukocyte-mediated brain microcirculatory inflammation: a comparison of osmotherapies and progesterone in severe traumatic brain injury	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	66th Annual Meeting of the Southwestern-Surgical-Congress	APR 13-16, 2014	Scottsdale, AZ	SW Surg Congress		Intravital microscopy; Neuroinflammation; Traumatic brain injury; Osmotherapy; Progesterone; Polymorphonuclear neutrophil	HYPERTONIC SALINE; HEMORRHAGIC-SHOCK; CEREBRAL MICROCIRCULATION; NEUTROPHIL ACTIVATION; MANNITOL; RESUSCITATION; NEUROPROTECTION; THERAPY; BARRIER; IMPACT	BACKGROUND: Mannitol, hypertonic saline, and progesterone may blunt leukocyte recruitment after traumatic brain injury (TBI). We hypothesized that progesterone reduces pericontusional recruitment of leukocytes to a greater extent than either osmotherapy a day after TBI. METHODS: CD1 mice underwent controlled cortical impact and were treated with osmotherapy (mannitol and hypertonic saline) or progesterone. Thirty-two hours after TBI, live pial microscopy was used to evaluate leukocyte-endothelial interactions and immunohistochemistry was used for the detection of pericontusional tissue polymorphonuclear neutrophils. Neurologic recovery was assessed before sacrifice. RESULTS: Mannitol resulted in the lowest in vivo leukocyte recruitment compared with progesterone (795 +/- 282 vs 1,636 +/- 434 LEU/100 mm/minutes, P < .05). Mannitol also displayed lower tissue accumulation of leukocytes as compared with progesterone (5.7 +/- 1.7 vs 15.2 +/- .1 LEU/mm(2), P -.03). However, progesterone resulted in better neurologic recovery than either osmotherapy. CONCLUSIONS: Leukocyte recruitment to injured brain is lowest with mannitol administration. How different agents alter progression of secondary brain injury will require further evaluation in humans. (C) 2014 Elsevier Inc. All rights reserved.	[Kumasaka, Kenichiro; Marks, Joshua A.; Eisenstadt, Rachel; Murcy, Mohammad A.; Samadi, Davoud; Li, Shengjie; Schwab, C. William; Pascual, Jose L.] Univ Penn, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Johnson, Victoria; Browne, Kevin D.; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA		Pascual, JL (corresponding author), Univ Penn, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092398] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398] Funding Source: Medline		Alvarez B, 1998, FREE RADICAL BIO MED, V24, P1331, DOI 10.1016/S0891-5849(98)00005-7; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Antonenko D, 2013, AM J SURG, V206, P845; Barone M, 1997, ACT NEUR S, V70, P267; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; David Wasserman OM, GLUCOSE CLAMPING CON; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943, DOI 10.1055/s-0037-1613338; Hinson HE, 2013, J INTENSIVE CARE MED, V28, P3, DOI 10.1177/0885066611400688; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; NOLTE D, 1992, AM J PHYSIOL, V263, pH1411, DOI 10.1152/ajpheart.1992.263.5.H1411; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Vachharajani V, 2007, MICROCIRCULATION, V14, P223, DOI 10.1080/10739680601139153; Wong CH, 2006, FOOD CHEM TOXICOL, V44, P1399, DOI 10.1016/j.fct.2006.03.004; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yada-Langui MM, 2004, EXP BIOL MED, V229, P684, DOI 10.1177/153537020422900713	30	12	13	0	6	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2014	208	6					961	967		10.1016/j.amjsurg.2014.08.004			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	AW2LU	WOS:000346120300025	25305798	Green Accepted			2022-02-06	
J	LeBlanc, J; de Guise, E; Champoux, MC; Couturier, C; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M				LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Acute evaluation of conversational discourse skills in traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Traumatic brain injury; conversational discourse; acute care; Protocole Montreal d'evaluation de la communication; Montreal Communication Evaluation Battery	CLOSED-HEAD-INJURY; NARRATIVE DISCOURSE; SOCIAL INTEGRATION; COMMUNICATION; MILD; ABILITIES; ADULTS; DISABILITY; MODERATE; OUTCOMES	This study looked at performance on the conversational discourse checklist of the Protocole Montreal d'evaluation de la communication (D-MEC) in 195 adults with TBI of all severity hospitalized in a Level 1 Trauma Centre. To explore validity, results were compared to findings on tests of memory, mental flexibility, confrontation naming, semantic and letter category naming, verbal reasoning, and to scores on the Montreal Cognitive Assessment. The relationship to outcome as measured with the Disability Rating Scale (DRS), the Extended Glasgow Outcome Scale (GOS-E), length of stay, and discharge destinations was also determined. Patients with severe TBI performed significantly worse than mild and moderate groups (chi(2)(KW2df) = 24.435, p = .0001). The total D-MEC score correlated significantly with all cognitive and language measures (p < .05). It also had a significant moderate correlation with the DRS total score (r - -.6090, p < .0001) and the GOS-E score (r = .539, p < .0001), indicating that better performance on conversational discourse was associated with a lower disability rating and better global outcome. Finally, the total D-MEC score was significantly different between the discharge destination groups (F-(3,F-90) = 20.19, p < .0001). Thus, early identification of conversational discourse impairment in acute care post-TBI was possible with the D-MEC and could allow for early intervention in speech-language pathology.	[LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Montreal, PQ, Canada		LeBlanc, J (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca					Baker H. J., 1965, DETROIT TEST LEARNIN; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Benton A., 1976, MULTILINGUAL APHASIA; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cote H., 2004, REEDUCATION ORTHOPHO, V219, P107; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fonseca RP, 2008, SPAN J PSYCHOL, V11, P678, DOI 10.1017/S1138741600004686; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hoofien D, 2001, BRAIN INJURY, V15, P189; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joanette Y, 2004, PROTOCOLE MONTREAL E; Kaplan E, 1983, BOSTON NAMING TEST; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Le K., 2011, DISCOURSE ANAL CHARA; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; MCDONALD S, 1999, COMMUNICATION DISORD; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tompkins CA, 2012, ARCH PHYS MED REHAB, V93, pS61, DOI 10.1016/j.apmr.2011.10.015; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wechsler D., 1997, WMS 3 MANUAL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Ylvisaker M., 2008, LANGUAGE INTERVENTIO, P879; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	57	12	13	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	DEC	2014	16	6					582	593		10.3109/17549507.2013.871335			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AT4QK	WOS:000344925300005	24447162				2022-02-06	
J	Liu, MD; Luo, P; Wang, ZJ; Fei, Z				Liu Mengdong; Luo Peng; Wang Zhanjiang; Fei Zhou			Changes of serum Tau, GFAP, TNF-alpha and malonaldehyde after blast-related traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Blast-related traumatic brain injury; Tau proteins; Glial fibrillary acidic protein; Tumor necrosis factor-alpha; Malondialdehyde	PROTEIN; BIOMARKERS; DAMAGE	Objective: To determine the changes of serum Tau protein, glial fibrillary acidic protein (GFAP), tumor necrosis factor alpha (TNF-alpha), and malonaldehyde (MDA) in rats after blast-related traumatic brain injury (BTBI) and to provide relative information for further studies on BTBI mechanism and seek specific biomarkers for BTBI. Methods: Ninety male Sprague-Dawley rats were randomly assigned into three groups: control group, moderate blast injury group, and severe blast injury group (n=30 for each). Rats in the moderate and severe blast injury groups were respectively exposed to corresponding levels of BTBI. After explosion, serum levels of Tau, GFAP, TNF-alpha, and MDA in each group were determined by Elisa assay at different time points after injury (8 h, 24 h, 3 d, and 6 d). The extent of brain damage was detected by Nissl staining and TUNEL assay. Results: Serum levels of Tau and GFAP rapidly increased and reached the peak at 24 h after either moderate or severe blast injury. All the values were significantly higher than control group at all time points (P<0.05). Serum TNF-alpha level of both injury groups peaked at 8 h after BTBI and stayed significantly higher than control group at all time points (P<0.05). Serum MDA of two injury groups began to significantly increase at 3 d and the level stayed significantly higher than control group until 6 d (P<0.05). Moreover, unlike the other biomarkers, serum MDA of severe blast injury group was significantly higher than moderate blast injury group at 6 d (P<0.05). Conclusion: The changes of serum Tau, GFAP, and TNF-alpha showed a good sensitivity at the acute phase after BTBI (within 24 h). However, their specificity and correlation with the extent of injury were limited in this experiment. Moreover, although the change of serum MDA showed a poor sensitivity and specificity to the diagnosis of BTBI during the first few days, it can reflect the injury degree at 6 d after injury. Therefore, further studies are needed to improve the methods of detecting more serum markers and investigate the significance of multiple markers in diagnosing BTBI.	[Liu Mengdong; Luo Peng; Fei Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Wang Zhanjiang] Northwest Inst Nucl Technol, Xian 710024, Shaanxi, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.	zhoufei@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30930093]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science & Technology Pillar Program of China [2012BAI11B02]; Program for Changjiang Scholars and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT1053]; Research Foundation of PLA [2010gxjs078, AWS11J008]	The work was supported by National Natural Science Foundation of China (No. 30930093), National Science and Technology Major Project of China (2013ZX 09J13109-02C), National Science & Technology Pillar Program of China (No. 2012BAI11B02), Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1053), and Research Foundation of PLA (No. 2010gxjs078 and No. AWS11J008).	Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Zhang C, 2013, CHIN J NEUROSURG DIS, V12, P130	17	12	14	5	6	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	DEC	2014	17	6					317	322		10.3760/cma.j.issn.1008-1275.2014.06.003			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1LW	WOS:000442081900003	25471424				2022-02-06	
J	Majdan, M; Mauritz, W; Wilbacher, I; Brazinova, A; Rusnak, M; Leitgeb, J				Majdan, M.; Mauritz, W.; Wilbacher, I.; Brazinova, A.; Rusnak, M.; Leitgeb, J.			Timing and duration of intracranial hypertension versus outcomes after severe traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries; Intracranial hypertension; Intensive care units	DECOMPRESSIVE CRANIECTOMY; PRESSURE; PATTERNS; IMPACT	Background. The goal of this paper was to investigate the association between patterns of intracranial hypertension (IH) and outcomes, to describe the treatment of patients with different patterns of IH, and to examine whether IH is an independent predictor of mortality and unfavourable outcome, respectively. Methods. A retrospective analysis of data collected prospectively in 9 central European centers is presented. 204 patients with severe TBI who had intracranial pressure (ICP) monitoring were coded as having either early (within first 2 days), late (after first 2 days), or no IH. IH was defined as >60 min of ICP >20 mmHg/day. The total number of hours/day of IH was recorded. Treatment was followed closely for the first 10 days using the therapy intensity level (TIL) score. Associations between types of IH and demographic factors, trauma severity, or treatment factors as well as outcomes were analysed. Results. Patients in the early IH group were the most severely injured. They had the highest TIL levels, had the highest mortality (48%) and the highest rate of unfavourable outcome (65%) followed by the late IH group (20% and 57%) and the no IH group (23% and 36%). Duration of IH correlated significantly with hospital mortality. IH was an independent predictor of mortality and unfavourable outcome after adjusting for age, Glasgow Coma Scale score, and Abbreviated Injury Score "head". Conclusion. Intracranial hypertension with early onset is independently associated with significantly worse outcome in patients with severe TBI. The total duration of IH shows a significant correlation to mortality.	[Majdan, M.; Brazinova, A.; Rusnak, M.] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Trnava 91843, Slovakia; [Majdan, M.; Mauritz, W.; Wilbacher, I.; Brazinova, A.; Rusnak, M.] INRO, Vienna, Austria; [Leitgeb, J.] Med Univ Vienna, Dept Traumatol, Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012; Rusnak, Martin/K-9349-2016	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Rusnak, Martin/0000-0003-3321-1042	EUEuropean Commission [ICA2-CT-2002-100]	The data used for this study were collected for a project funded by an EU grant (Project "Research Treat TBI"; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; Contract number: ICA2-CT-2002-100), and for another project funded by the Austrian Worker's Compensation Board (AUVA; Contract number FK 33/2003) and by the "Jubilee Fund" of the Austrian National Bank (Project number 8987). The International Neurotrauma Research Organisation (INRO) is supported by an annual grant from Mrs. Ala Auersperg-Isham and Mr. Ralph Isham, and by donations from various sources. The funding agencies and persons approved the original research plans. They were not otherwise involved in this analysis of the collected data.	Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bremmer R, 2010, NEUROCRIT CARE, V12, P362, DOI 10.1007/s12028-009-9329-2; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Leitgeb J, 2012, J TRAUMA ACUTE CARE, V72, P1263, DOI 10.1097/TA.0b013e318248ed83; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; RCoreTeam, 2013, R LANG ENV STAT COMP; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Young Jeffrey S, 2003, Neurosurg Focus, V15, pE2	27	12	13	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	DEC	2014	80	12					1261	1272					12	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	AX5CU	WOS:000346945500005	24622160				2022-02-06	
J	Radhakrishna, M; Makriyianni, I; Marcoux, J; Zhang, X				Radhakrishna, Mohan; Makriyianni, Ioli; Marcoux, Judith; Zhang, Xun			Effects of injury level and severity on direct costs of care for acute spinal cord injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						cost; epidemiology; traumatic spinal cord injury		New treatments are being investigated for spinal cord injury (SCI), and any improvement may result in incremental cost savings. The objective of this study was to determine the direct costs of care 2 years after an SCI, stratifying for completeness and level of injury. A retrospective database analysis was carried out using data from the Quebec Trauma Registry, the Quebec Medical Insurance Board, and the Quebec Automobile Insurance Corporation between 1997 and 2007. Excluding individuals sustaining moderate or severe traumatic brain injuries, 481 individuals who sustained an SCI from motor vehicle accidents were identified. Individuals were classified as complete and incomplete in the following categories: C1-C7, C8-T6, T7-L1, L2-S5. Using data from governmental public healthcare organizations makes this study comprehensive. For C1-C7 complete and incomplete spinal cord injuries, the first-year cost was $157 718 and $56 505, respectively (2009 Canadian dollars calculated per patient). Similar differences between complete and incomplete spinal cord injuries were seen for the other groups. Furthermore, for complete injuries, costs were higher for higher levels of injury during both the first and the second year after injury. For incomplete lesions, costs did not differ significantly between groups during the first or the second year. Incomplete spinal cord injuries result in lower healthcare costs compared with complete injuries across all groups during the first 2 years after injury. As less severe levels of injury result in measurably lower costs, the funds spent to reduce the severity or level of SCI could at least partially be recouped through healthcare savings. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Radhakrishna, Mohan; Makriyianni, Ioli; Marcoux, Judith; Zhang, Xun] McGill Univ, Ctr Hlth, Montreal, PQ H3G 1A4, Canada		Radhakrishna, M (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Campus,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mohan.radhakrishna@muhc.mcgill.ca					Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Berkowitz M, 1992, EC CONSEQUENCES TRAU; Canadian Institute for Health Information, 2008, INP REH CAN 2006 200, P59; Canadian Institute for Health Information, 2009, HIGHL 2008 2009 INP, P6; Cifu DX, 1999, J NEUROTRAUM, V16, P805, DOI 10.1089/neu.1999.16.805; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; Dryden DM, 2005, J TRAUMA, V59, P441, DOI 10.1097/01.ta.0000174732.90517.df; Fiedler IG, 1999, ARCH PHYS MED REHAB, V80, P1441, DOI 10.1016/S0003-9993(99)90256-3; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; HARVEY C, 1992, PARAPLEGIA, V30, P834, DOI 10.1038/sc.1992.160; Johnson RL, 1996, SPINAL CORD, V34, P470, DOI 10.1038/sc.1996.81; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; New PW, 2010, SPINE, V35, P796, DOI 10.1097/BRS.0b013e3181be76f5; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Priebe MM, 2007, ARCH PHYS MED REHAB, V88, pS84, DOI 10.1016/j.apmr.2006.12.005; TATOR CH, 1993, PARAPLEGIA, V31, P700, DOI 10.1038/sc.1993.112; WALSH J, 1988, PARAPLEGIA, V26, P380, DOI 10.1038/sc.1988.58; Wehman P, 1994, Int J Rehabil Res, V17, P268, DOI 10.1097/00004356-199409000-00008	21	12	12	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2014	37	4					349	353		10.1097/MRR.0000000000000081			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AT4NM	WOS:000344916100010	25192008				2022-02-06	
J	Sethuraman, KN; Marcolini, EG; McCunn, M; Hansoti, B; Vaca, FE; Napolitano, LM				Sethuraman, Kinjal N.; Marcolini, Evie G.; McCunn, Maureen; Hansoti, Bhakti; Vaca, Federico E.; Napolitano, Lena M.			Gender-specific Issues in Traumatic Injury and Resuscitation: Consensus-based Recommendations for Future Research	ACADEMIC EMERGENCY MEDICINE			English	Article							CRITICALLY-ILL TRAUMA; MAJOR TRAUMA; INTENSIVE-CARE; BRAIN-INJURY; SEXUAL-DIMORPHISM; ADVERSE OUTCOMES; MORTALITY; WOMEN; MEDICINE; SURVIVAL	Traumatic injury remains an unacceptably high contributor to morbidity and mortality rates across the United States. Gender-specific research in trauma and emergency resuscitation has become a rising priority. In concert with the 2014 Academic Emergency Medicine consensus conference Gender-specific Research in Emergency Care: Investigate, Understand, and Translate How Gender Affects Patient Outcomes, a consensus-building group consisting of experts in emergency medicine, critical care, traumatology, anesthesiology, and public health convened to generate research recommendations and priority questions to be answered and thus move the field forward. Nominal group technique was used for the consensus-building process and a combination of face-to-face meetings, monthly conference calls, e-mail discussions, and preconference surveys were used to refine the research questions. The resulting research agenda focuses on opportunities to improve patient outcomes by expanding research in sex-and gender-specific emergency care in the field of traumatic injury and resuscitation.	[Sethuraman, Kinjal N.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Sethuraman, Kinjal N.] Univ Maryland, Div Hyperbar Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Marcolini, Evie G.; Vaca, Federico E.] Yale Univ, Dept Emergency Med, New Haven, CT USA; [McCunn, Maureen] Dept Anesthesiol, Div Trauma Anesthesiol, Baltimore, MD USA; [McCunn, Maureen] Dept Anesthesiol, Div Surg Crit Care, Baltimore, MD USA; [Hansoti, Bhakti] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD USA; [Napolitano, Lena M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA		Sethuraman, KN (corresponding author), Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA.	ksethuraman@umm.edu	Napolitano, Lena/AAZ-8651-2021	Hansoti, Bhakti/0000-0003-0188-9764	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R13NS087861-01]; Office of Research on Women's Health at the National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R13NS087861] Funding Source: NIH RePORTER	The consensus conference was supported by grant 1R13NS087861-01 from the National Institute of Neurological Disorders and Stroke and the Office of Research on Women's Health at the National Institutes of Health. Additional funding was provided by several organizational, institutional, and individual donors. Non-CME events were supported by Janssen Pharmaceuticals and Besins Critical Care/BH Pharma. See the executive summary elsewhere in this issue for full funding information.	ALSPACH JG, 2012, CRIT CARE NURSE, V32, P8; ANGELE MK, 2000, EUR J TRAUMA Q, V26, P267; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Axinn WG, 2013, J HEALTH SOC BEHAV, V54, P444, DOI 10.1177/0022146513501518; Bartels C, 2008, J WOMENS HEALTH, V17, P1615, DOI 10.1089/jwh.2008.0798; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bowles BJ, 2003, INJURY, V34, P27; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Fowler RA, 2009, CURR OPIN CRIT CARE, V15, P442, DOI 10.1097/MCC.0b013e3283307a12; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Gale SC, 2007, AM SURGEON, V73, P454; Gannon CJ, 2004, SHOCK, V21, P410, DOI 10.1097/00024382-200405000-00003; Gannon CJ, 2002, J AM COLL SURGEONS, V195, P11, DOI 10.1016/S1072-7515(02)01187-0; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Gee AC, 2008, SHOCK, V29, P334, DOI 10.1097/shk.0b013e3181506ee5; George RL, 2005, J BURN CARE REHABIL, V26, P416, DOI 10.1097/01.bcr.0000176888.44949.87; George RL, 2003, J TRAUMA, V54, P464, DOI 10.1097/01.TA.0000051939.95039.E6; Gilliver SC, 2010, J STEROID BIOCHEM, V120, P105, DOI 10.1016/j.jsbmb.2009.12.015; Gomez D, 2012, SURGERY, V152, P179, DOI 10.1016/j.surg.2012.04.006; Guidry CA, 2014, CRIT CARE MED, V42, P1110, DOI 10.1097/CCM.0000000000000139; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Hagemo JS, 2014, CRIT CARE, V18, DOI 10.1186/cc13798; Haider AH, 2010, J TRAUMA, V69, P537, DOI 10.1097/TA.0b013e3181efc67b; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Heffernan DS, 2011, J TRAUMA, V71, P878, DOI 10.1097/TA.0b013e31822c0d31; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; HoustonBolze MS, 1996, CRIT CARE MED, V24, P1988; HoustonBolze MS, 1996, CRIT CARE MED, V24, P1982, DOI 10.1097/00003246-199612000-00009; Kerby JD, 2006, J BURN CARE RES, V27, P452, DOI 10.1097/01.BCR.0000225957.01854.EE; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; McCunn M, 2014, MID REG M SOC AC EM; McCunn M, 2014, ANN SCI M E ASS SURG; McGregor AJ, 2013, ACAD EMERG MED, V20, P313, DOI 10.1111/acem.12085; Mohr AM, 2010, AM SURGEON, V76, P896; Napolitano LM, 2012, CRIT CARE MED, V40, P990, DOI 10.1097/CCM.0b013e3182411154; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Rowell SE, 2011, J TRAUMA, V71, pS375, DOI 10.1097/TA.0b013e318227f1aa; Schoeneberg C, 2013, CRIT CARE, V17, DOI 10.1186/cc13132; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Sperry J, 2014, 134 ANN M AM SURG AS; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Spoerke N, 2010, J TRAUMA, V68, P1106, DOI 10.1097/TA.0b013e3181d86860; Summers JI, 2014, J BURN CARE RES; Toubiana J, 2010, CRIT CARE MED, V38, P2287, DOI 10.1097/CCM.0b013e3181f9f9c7; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang KC, 2014, SHOCK, V42, P11, DOI 10.1097/SHK.0000000000000168	67	12	12	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2014	21	12					1386	1394		10.1111/acem.12536			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AW9KS	WOS:000346576700013	25420732	Green Published, Green Accepted			2022-02-06	
J	Bailes, JE; Patel, V				Bailes, Julian E.; Patel, Vimal			The Potential for DHA to Mitigate Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							OMEGA-3-FATTY-ACID DOCOSAHEXAENOIC ACID; PHOSPHOLIPID DEGRADATION; DIETARY SUPPLEMENTATION; RECURRENT CONCUSSION; ALZHEIMER-DISEASE; AXONAL INJURY; ENCEPHALOPATHY; MECHANISMS; DEPRESSION; RISK	Scientific knowledge of omega-3 fatty acids (FAs) has grown in the last decade to a greater understanding of their mechanisms of action and their potential therapeutic effects. Omega-3 FAs have shown therapeutic potential with respect to hyperlipidemia, depression, attention-deficit hyperactivity disorder, and mild cognitive impairment. Laboratory evidence and clinical interest have grown such that omega-3 FAs have now assumed a role in concussion management. This has coincided with recent research that has also helped to increase the scientific understanding of cerebral concussion; although concussion or mild traumatic brain injury was assumed to be a malfunctioning brain without anatomical damage, we now know that there is the potential for damage and dysfunction at the cellular and microstructural levels. Specifically, with concussion abnormal metabolism of glucose may occur and intracellular mitochondrial dysfunction can persist for several days. In this article, we discuss the role of omega-3 FAs, particularly docosahexaenoic acid, in concussion management.	[Bailes, Julian E.; Patel, Vimal] Univ Chicago, NorthShore Neurol Inst, NorthShore Univ Hlth Syst, Pritzker Sch Med, Evanston, IL 60201 USA		Bailes, JE (corresponding author), Univ Chicago, NorthShore Neurol Inst, NorthShore Univ Hlth Syst, Pritzker Sch Med, 2650 Ridge Ave,Kellogg 3rd Floor, Evanston, IL 60201 USA.				Martek Biosciences, Inc.	The authors appreciate the contributions of Rebecca Kessler for her assistance in the manuscript preparation. Some of the laboratory and clinical experiments described herein have been funded by Martek Biosciences, Inc., for which the author was a consultant.	Aberg MA, 2009, ACTA PAEDIATR, V98, P555, DOI 10.1111/j.1651-2227.2008.01103.x; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Cao DH, 2004, PHARMACOL BIOCHEM BE, V79, P651, DOI 10.1016/j.pbb.2004.09.016; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; Colangelo LA, 2009, NUTRITION, V25, P1011, DOI 10.1016/j.nut.2008.12.008; Devore EE, 2009, AM J CLIN NUTR, V90, P170, DOI 10.3945/ajcn.2008.27037; Freund-Levi Y, 2008, INT J GERIATR PSYCH, V23, P161, DOI 10.1002/gps.1857; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Heller AR, 2006, CRIT CARE MED, V34, P972, DOI 10.1097/01.CCM.0000206309.83570.45; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Heude B, 2003, AM J CLIN NUTR, V77, P803, DOI 10.1093/ajcn/77.4.803; Homayoun P, 1997, J NEUROCHEM, V69, P199; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Keller D.D., 2007, J CLIN LIPIDOL, V1, P151; Kelley DS, 2007, AM J CLIN NUTR, V86, P324, DOI 10.1093/ajcn/86.2.324; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lewis MD, 2011, MIL MED, V176, P1120, DOI 10.7205/MILMED-D-10-00466; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lorente-Cebrian S, 2013, J PHYSL BIOCH, V69, P633; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Maes M, 1996, J AFFECT DISORDERS, V38, P35, DOI 10.1016/0165-0327(95)00092-5; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Mischoulon D, 2013, PSYCHIAT CLIN N AM, V36, P15, DOI 10.1016/j.psc.2012.12.002; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Muldoon MF, 2010, J NUTR, V140, P848, DOI 10.3945/jn.109.119578; NEEDLEMAN P, 1979, P NATL ACAD SCI USA, V76, P944, DOI 10.1073/pnas.76.2.944; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pauwels EKJ, 2009, DRUG NEWS PERSPECT, V22, P205, DOI 10.1358/dnp.2009.22.4.1367709; Roberts L, 2008, J AM COLL SURGEONS, V207, P276, DOI 10.1016/j.jamcollsurg.2008.02.015; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Sears Barry, 2013, PharmaNutrition, V1, P86, DOI 10.1016/j.phanu.2013.04.002; Stilwell W, 2006, FOOD NUTR RES, V50; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Wang X, 2003, NEUROREPORT, V14, P2457, DOI 10.1097/00001756-200312190-00033; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wurtman RJ, 2009, J NUTR HEALTH AGING, V13, P189, DOI 10.1007/s12603-009-0056-3; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	56	12	12	0	24	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11		S			112	116		10.7205/MILMED-D-14-00139			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7LS	WOS:000349099400009	25373094	Bronze			2022-02-06	
J	Damkliang, J; Considine, J; Kent, B; Street, M				Damkliang, Jintana; Considine, Julie; Kent, Bridie; Street, Maryann			Initial emergency nursing management of patients with severe traumatic brain injury: Development of an evidence-based care bundle for the Thai emergency department context	AUSTRALASIAN EMERGENCY NURSING JOURNAL			English	Article						Brain injury; Trauma; Neurotrauma; Emergency nursing; Evidence-based practice; Care bundle; Thailand		Background: Thai emergency nurses play a vital role in caring for patients with severe TBI, and are an important part of the healthcare team throughout the resuscitation phase. They are also responsible for continuous physiological monitoring, and detecting deterioration associated with increased intracranial pressure and preventing secondary brain injury. However, there is known variation in Thai nurses' knowledge and care practices for patients with severe TBI. In addition, there are no specific evidence-based practice guidelines available for emergency nursing management of patients with severe TBI. Aim: The aim of this paper is to describe the development of an evidence-based care bundle for initial emergency nursing management of patients with severe TBI for use in a Thai ED context. Results: An evidence-based care bundle focused on seven major elements: (1) establish a secure airway along with c-spine protection, (2) maintain adequacy of oxygenation and ventilation, (3) maintain circulation and fluid balance, (4) assessment of GCS, and pupil size and reactivity, ( 5) maintain cerebral venous outflow, ( 6) management of pain, agitation, and irritability, and ( 7) administer for urgent CT scan. Conclusions: A care bundle is one method of promoting consistent, evidence-based emergency nursing care of patients with severe TBI, decreasing unnecessary variations in nursing care and reducing the risk of secondary brain injury from suboptimal care. Implementation of this evidence-based care bundle developed specifically for the Thai emergency nursing context has the potential to improve the care of the patients with severe TBI. (C) 2014 College of Emergency Nursing Australasia Ltd. Published by Elsevier Ltd. All rights reserved.	[Damkliang, Jintana] Deakin Univ, Sch Nursing & Midwifery, 221 Burwood Hwy, Burwood, Vic 3125, Australia; [Damkliang, Jintana] Prince Songkla Univ, Fac Nursing, Hat Yai, Thailand; [Considine, Julie; Street, Maryann] Deakin Univ, Eastern Hlth Nursing & Midwifery Res Centre, Ctr Qual & Patient Safety Res, Sch Nursing & Midwifery, Burwood, Vic 3125, Australia; [Kent, Bridie] Univ Plymouth, Sch Nursing & Midwifery, Plymouth PL4 8AA, Devon, England		Damkliang, J (corresponding author), Deakin Univ, Sch Nursing & Midwifery, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	jdamklia@deakin.edu.au; julie.considine@deakin.edu.au; brigid.kent@plymouth.ac.uk; maryann.street@deakin.edu.au	Street, Maryann/A-2709-2010	Street, Maryann/0000-0002-5615-141X; Considine, Julie/0000-0003-3801-2456	Faculty of Nursing, Prince of Songkla University, Thailand	This study is an unfunded PhD study. Ms Damkliang is supported by a scholarship from Faculty of Nursing, Prince of Songkla University, Thailand.	American Association of Neuroscience Nurses, 2009, NURS MAN ADULTS SEV; American College of Surgeons Committee on Trauma, 2008, ADV TRAUMA LIFE SUPP, V8th, P25; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Book D. S., 2009, PATHOPHYSIOLOGY CONC, P1299; Brain Trauma Foundation, 2007, GUID PREH MAN TRAUM; Brain Trauma Foundation, 2007, GUID MAN OFS TRAUM B; Bureau of Epidemiology Ministry of Public Health, 2007, SEV INJ DUE TRANSP A; Bureau of Nursing Ministry of Public Health, STAND PRACT ACC EM C; Bureau of Policy and Strategy Ministry of Public Health, HLTH STAT INF; Damkliang J, 2013, AUSTRALAS EMERG NURS, V16, P127, DOI 10.1016/j.aenj.2013.09.001; Douglas B, 2011, EMERGENCY TRAUMA CAR, P1169; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Fulbrook Paul, 2003, Nurs Crit Care, V8, P249; Institute for healthcare improvement, EV BAS CAR; McQuillan K, 2009, TRAUMA NURSING RESUS, P448; Mittal R, 2009, EMERG MED J, V26, P513, DOI 10.1136/emj.2009.072041; National Institute for Emergency Medicine, 2011, STAT EM MED SERV; National Institute for Health Care Excellence [NICE], 2007, HEAD TRIAG ASS INV E; NZGG, 2006, TRAUM BRAIN INJ DIAG; O'Phelan K, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P3; Ollerton JE, 2007, ADULT TRAUMA CLIN PR; Price Ann M, 2003, Nurs Crit Care, V8, P126, DOI 10.1046/j.1478-5153.2003.00019.x; Ratanalert S, 2007, EMERG MED J, V24, P25, DOI 10.1136/emj.2006.039974; Reed D, 2011, ADULT TRAUMA CLIN PR; Rycroft-Malone J, 2004, J NURS CARE QUAL, V19, P297, DOI 10.1097/00001786-200410000-00002; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SIGN, 2009, EARL MAN PAT HEAD IN; Somporn P., 2011, NEUROL SURG, V2, P36; Winter CD, 2005, SURG-J R COLL SURG E, V3, P329, DOI 10.1016/S1479-666X(05)80112-X; Wong F W, 2000, Crit Care Nurse, V20, P18; Wright D, 2011, TINTINALLIS EMERGENC, P1692	31	12	12	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1574-6267			AUSTRALAS EMERG NURS	Australas. Emerg. Nurs. J.	NOV	2014	17	4					152	160		10.1016/j.aenj.2014.05.005			9	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V16SW	WOS:000214636900003	25443429				2022-02-06	
J	Fuller, G; Lawrence, T; Woodford, M; Lecky, F				Fuller, Gordon; Lawrence, Thomas; Woodford, Maralyn; Lecky, Fiona			The accuracy of alternative triage rules for identification of significant traumatic brain injury: a diagnostic cohort study	EMERGENCY MEDICINE JOURNAL			English	Article							HEAD-INJURY; CARE	Introduction Traumatic brain injury (TBI) is a leading cause of death and disability in young adults. Reorganisation of trauma services with direct triage of suspected head injury patients to trauma centres may improve outcomes following TBI. This study aimed to determine the sensitivity of principal English triage tools for identifying significant TBI. Methods We performed a diagnostic cohort study using data prospectively collated from the Trauma Audit and Research Network database between 2005 and 2011. Adult head injury patients were retrospectively classified according to London Ambulance Service (LAS) and Head Injury Transportation Straight to Neurosurgery study (HITS-NS) triage criteria. Sensitivity and specificity were then calculated against a reference standard of significant TBI, comprising head region abbreviated injury score (AIS) >= 3 or neurosurgical operation. Results 6559 patients were included in complete case analyses. The LAS and HITS-NS triage tools demonstrated sensitivities of 44.5% (95% CI 43.2 to 45.9) and 32.6% (95% CI 31.4 to 33.9), respectively, for identifying significant TBI patients. False negative significant TBI cases were relatively older, more likely to be female, more frequently secondary to low-level falls, and were less likely to have very severe AIS five or six head injuries, p<0.01. Conclusions A considerable proportion of significant head injury patients may not be triaged directly to trauma centres. Investment is therefore necessary to improve the accuracy of existing triage rules and maintain expertise in TBI diagnosis and management in non-specialist emergency departments.	[Fuller, Gordon; Lawrence, Thomas; Woodford, Maralyn] Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Hlth Sci Res Grp, Trauma Audit & Res Network, Salford M6 8HD, Lancs, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England		Fuller, G (corresponding author), Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Hlth Sci Res Grp, Trauma Audit & Res Network, Mayo Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	gordonwfuller@doctors.org.uk		Fuller, Gordon Ward/0000-0001-8532-3500; Lawrence, Thomas/0000-0003-3648-7634			Allison PD, 2001, MISSING DATA; *AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; Campbell FM, 1996, THESIS U MANCHESTER; Committee on Injury Scaling, 2005, ABBR INJ SCAL 2005 R; Cox S, 2012, INJURY, V43, P573, DOI 10.1016/j.injury.2010.10.003; Department of Health, HOSP EP STAT; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; Fuller G, 2011, J NEUROSURG ANESTH, V23, P198, DOI 10.1097/ANA.0b013e3182161816; Gage AM, 2012, J AM COLL SURGEONS, V215, P148, DOI 10.1016/j.jamcollsurg.2012.02.025; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hedges JR, 2009, J EMERG MED, V37, P115, DOI 10.1016/j.jemermed.2008.07.001; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kann SH, 2007, ACTA ANAESTH SCAND, V51, P1172, DOI 10.1111/j.1399-6576.2007.01354.x; Lossius Hans Morten, 2012, J Trauma Manag Outcomes, V6, P9, DOI 10.1186/1752-2897-6-9; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; National Institute for Clinical Excellence, 2007, CLIN GUID 56 HEAD IN; O'Reilly GM, 2012, INJURY, V43, P1917, DOI 10.1016/j.injury.2012.07.185; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sleat G, 2011, INJURY, V42, P838, DOI 10.1016/j.injury.2011.05.014; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014	22	12	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	NOV	2014	31	11					914	919		10.1136/emermed-2013-202575			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AQ8YO	WOS:000343126800015	23939945				2022-02-06	
J	Kessel, B; Dagan, J; Swaid, F; Ashkenazi, I; Olsha, O; Peleg, K; Givon, A; Alfici, R				Kessel, Boris; Dagan, Jasmin; Swaid, Forat; Ashkenazi, Itamar; Olsha, Oded; Peleg, Kobi; Givon, Adi; Alfici, Ricardo		Israel Trauma Grp	Rib fractures: comparison of associated injuries between pediatric and adult population	AMERICAN JOURNAL OF SURGERY			English	Article						Blunt trauma; Rib fractures; Associated injuries; Pattern of injury	THORACIC TRAUMA; CHILDREN; MORTALITY; MORBIDITY	BACKGROUND: Rib fractures are considered a marker of exposure to significant traumatic energy. In children, because of high elasticity of the chest wall, higher energy levels are necessary for ribs to fracture. The purpose of this study was to analyze patterns of associated injuries in children as compared with adults, all of whom presented with rib fractures. METHODS: A retrospective cohort study involving blunt trauma patients with rib fractures registered in the National Trauma Registry was conducted. RESULTS: Of 6,995 trauma victims who were found to suffer from rib fractures, 328 were children and 6,627 were adults. Isolated rib fractures without associated injuries occurred in 19 children (5.8%) and 731 adults (11%). More adults had 4 or more fractured ribs compared with children (P < .001). Children suffered from higher rates of associated brain injuries (P = .003), hemothorax/pneumothorax (P = .006), spleen, and liver injury (P < .001). Mortality rate was 5% in both groups. CONCLUSIONS: The incidence of associated head, thoracic, and abdominal solid organ injuries in children was significantly higher than in adults suffering from rib fractures. In spite of a higher Injury Severity Score and incidence of associated injuries, mortality rate was similar. Mortality of rib fracture patients was mostly affected by the presence of extrathoracic injuries. (C) 2014 Elsevier Inc. All rights reserved.	[Kessel, Boris] Hillel Yaffe Med Ctr, Trauma Unit, Hadera, Israel; [Dagan, Jasmin; Ashkenazi, Itamar; Alfici, Ricardo] Hillel Yaffe Med Ctr, Div Surg, Hadera, Israel; [Swaid, Forat] Bnai Zion Med Ctr, Dept Gen Surg, Haifa, Israel; [Olsha, Oded] Shaare Zedek Med Ctr, Dept Surg, Jerusalem, Israel; [Peleg, Kobi; Givon, Adi] Gertner Inst Epidemiol & Hlth Policy Res, Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel		Swaid, F (corresponding author), Bnai Zion Med Ctr, Dept Gen Surg, Haifa, Israel.	foratola@gmail.com	, ita/AAG-5879-2020	, ita/0000-0002-6305-4159			Al-Hassani A, 2010, AM SURGEON, V76, P888; Balci AE, 2004, EUR J CARDIO-THORAC, V26, P387, DOI 10.1016/j.ejcts.2004.04.024; Bergeron E, 2003, J TRAUMA, V54, P478, DOI 10.1097/01.TA.0000037095.83469.4C; Black TL, 1996, SOUTHERN MED J, V89, P494, DOI 10.1097/00007611-199605000-00009; Bulger EM, 2000, J TRAUMA, V48, P1040, DOI 10.1097/00005373-200006000-00007; Ceran S, 2002, EUR J CARDIO-THORAC, V21, P57, DOI 10.1016/S1010-7940(01)01056-9; Flagel BT, 2005, SURGERY, V138, P717, DOI 10.1016/j.surg.2005.07.022; GARCIA VF, 1990, J TRAUMA, V30, P695, DOI 10.1097/00005373-199006000-00007; Jones KM, 2011, AM J SURG, V202, P598, DOI 10.1016/j.amjsurg.2010.09.029; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; NAKAYAMA DK, 1989, ANN SURG, V210, P770, DOI 10.1097/00000658-198912000-00013; PECLET MH, 1990, J PEDIATR SURG, V25, P961, DOI 10.1016/0022-3468(90)90238-5; Sirmali M, 2003, EUR J CARDIO-THORAC, V24, P133, DOI 10.1016/S1010-7940(03)00256-2; ZIEGLER DW, 1994, J TRAUMA, V37, P975, DOI 10.1097/00005373-199412000-00018	14	12	12	0	5	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	NOV	2014	208	5					831	834		10.1016/j.amjsurg.2013.10.033			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AT4TO	WOS:000344935500023	24832239				2022-02-06	
J	Walsh, KP; Kuhn, TB; Bamburg, JR				Walsh, Keifer P.; Kuhn, Thomas B.; Bamburg, James R.			Cellular prion protein: A co-receptor mediating neuronal cofilin-actin rod formation induced by beta-amyloid and proinflammatory cytokines	PRION			English	Article						actin; Alzheimer disease; cofilin; caveolin-1; cellular prion protein; lipid rafts; oxidative stress; NADPH oxidase; proinflammatory cytokines	NADPH-OXIDASE; ALZHEIMERS-DISEASE; SYNAPTIC LOSS; LIPID RAFTS; NEURODEGENERATION; ACTIVATION; CELLS; TRAFFICKING; MECHANISM; BINDING	Increasing evidence suggests that proteins exhibiting prion-like behavior cause distinct neurodegenerative diseases, including inherited, sporadic and acquired types. The conversion of cellular prion protein (PrPC) to its infectious protease resistant counterpart (PrPRes) is the essential feature of prion diseases. However, PrPC also performs important functions in transmembrane signaling, especially in neurodegenerative processes. Beta-amyloid (A) synaptotoxicity and cognitive dysfunction in mouse models of Alzheimer disease are mediated by a PrPC-dependent pathway. Here we review how this pathway converges with proinflammatory cytokine signaling to activate membrane NADPH oxidase (NOX) and generate reactive oxygen species (ROS) leading to dynamic remodeling of the actin cytoskeleton. The NOX signaling pathway may also be integrated with those of other transmembrane receptors clustered in PrPC-enriched membrane domains. Such a signal convergence along the PrPC-NOX axis could explain the relevance of PrPC in a broad spectrum of neurodegenerative disorders, including neuroinflammatory-mediated alterations in synaptic function following traumatic brain injury. PrPC overexpression alone activates NOX and generates a local increase in ROS that initiates cofilin activation and formation of cofilin-saturated actin bundles (rods). Rods sequester cofilin from synaptic regions where it is required for plasticity associated with learning and memory. Rods can also interrupt vesicular transport by occluding the neurite within which they form. Through either or both mechanisms, rods may directly mediate the synaptic dysfunction that accompanies various neurodegenerative disorders.	[Walsh, Keifer P.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Kuhn, Thomas B.] Univ Alaska, Dept Chem & Biochem, Fairbanks, AK 99701 USA		Bamburg, JR (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	James.Bamburg@ColoState.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG044812]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG044812] Funding Source: NIH RePORTER	Supported in part by a grant from National Institutes of Health (AG044812 to JRB).	Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Barth BM, 2012, CELL SIGNAL, V24, P1126, DOI 10.1016/j.cellsig.2011.12.020; Bate C, 2012, PRION, V6, P350, DOI 10.4161/pri.21751; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; Fantini J, 2009, BBA-BIOMEMBRANES, V1788, P2345, DOI 10.1016/j.bbamem.2009.08.016; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hernandez-Rapp J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00025; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; McDonald JM, 2012, BRAIN RES, V1450, P138, DOI 10.1016/j.brainres.2012.02.041; Mi JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083609; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Pradines E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.195; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Renner M, 2014, PATHOL BIOL, VS0369-8114, P33; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Scheff SW, 2014, BIOCHEM PHARMACOL, V88, P517, DOI 10.1016/j.bcp.2013.12.028; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Schonhofen P, 2014, MINI-REV MED CHEM, V14, P393, DOI 10.2174/1389557514666140506161458; Shi Q, 2013, MED MICROBIOL IMMUN, V202, P215, DOI 10.1007/s00430-012-0284-8; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Walsh KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095995; Wolf M., 2014, CEREB CORTEX, V1991; Yang BH, 2007, AM J PHYSIOL-HEART C, V292, pH954, DOI 10.1152/ajpheart.00758.2006	40	12	13	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1933-6896	1933-690X		PRION	Prion	NOV-DEC	2014	8	6					375	380		10.4161/pri.35504			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ7DD	WOS:000348377600001	25426519	Green Published, Bronze			2022-02-06	
J	Skardelly, M; Gaber, K; Burdack, S; Scheidt, F; Schuhmann, MU; Hilbig, H; Meixensberger, J; Boltze, J				Skardelly, Marco; Gaber, Khaled; Burdack, Swen; Scheidt, Franziska; Schuhmann, Martin U.; Hilbig, Heidegard; Meixensberger, Juergen; Boltze, Johannes			Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						neural progenitor cells; cell therapy; TBI; long-term functional outcome; translational research	NEURAL STEM-CELLS; IMMUNE-RESPONSES; NITRIC-OXIDE; TRANSPLANTATION; NEUROGENESIS; STROKE; RECOVERY; CNS; ANGIOGENESIS; REGENERATION	Background: Numerous studies have reported a beneficial impact of neural progenitor cell transplantation on functional outcome after traumatic brain injury (TBI) during short and medium follow-up periods. However, our knowledge regarding long-term functional effects is fragmentary while a direct comparison between local and systemic transplantation is missing so far. Objectives: This study investigated the long-term (12 week) impact of human fetal neuronal progenitor cell (hNPC) transplantation 24 h after severe TB I in rats. Methods: Cells were either transplanted stereotactically (1 x 105) into the putamen or systemically (5 x 105) via the tail vein. Control animals received intravenous transplantation of vehicle solution. Results: An overall functional benefit was observed after systemic, but not local hNPC transplantation by area under the curve analysis (p < 0.01). Surprisingly, this effect vanished during later stages after TBI with all groups exhibiting comparable functional outcomes 84 days after TBI. Investigation of cell-mediated inflammatory processes revealed increasing microglial activation and macrophage presence during these stages, which was statistically significant after systemic cell administration (p < 0.05). Intracerebral hNPC transplantation slightly diminished astrogliosis in perilesional areas (p < 0.01), but did not translate into a permanent functional benefit. No significant effects on angiogenesis were observed among the groups. Conclusion: Our results suggest the careful long-term assessment of cell therapies for TBI, as well as to identify potential long-term detrimental effects of such therapies before moving on to clinical trials. Moreover, immunosuppressive protocols, though widely used, should be rigorously assessed for their applicability in the respective setup.	[Skardelly, Marco; Gaber, Khaled; Burdack, Swen; Scheidt, Franziska; Schuhmann, Martin U.; Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany; [Hilbig, Heidegard] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Boltze, Johannes] Univ Leipzig, Fraunhofer Inst Cell Therapy & Immunol, D-04109 Leipzig, Germany; [Boltze, Johannes] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Boltze, Johannes] Massachusetts Gen Hosp, Stroke & Neurovasc Regulat Lab, Charlestown, MA USA; [Boltze, Johannes] Harvard Univ, Sch Med, Charlestown, MA USA		Skardelly, M (corresponding author), Univ Tubingen, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	marco.skardelly@med.uni-tuebingen.de	Skardelly, Marco/AAF-8680-2021	Boltze, Johannes/0000-0003-3956-4164	funds of the Free State of Saxony distributed by the University of Leipzig [1-56]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); Open Access Publishing Fund of Tuebingen University	The authors would like to thank Ingo Roeder for statistical support and Jochen Neuhaus for technical support. This work was supported by funds of the Free State of Saxony distributed by the University of Leipzig (Formel-1-program, 1-56). The authors acknowledge support from Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Boltze J, 2012, CELL TRANSPLANT, V21, P1199, DOI 10.3727/096368911X589609; Buga AM, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/fnagi.2014.00044, 10.3389/fnagi.2014.00130]; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Halloran PF, 1999, TRANSPLANTATION, V68, P1356, DOI 10.1097/00007890-199911150-00023; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Ji S, 2009, EXP NEUROL, V216, P321, DOI 10.1016/j.expneurol.2008.12.007; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; McIntosh TK, 1996, LAB INVEST, V74, P315; Mosher KI, 2012, NAT NEUROSCI, V15, P1485, DOI 10.1038/nn.3233; Mrass P, 2006, IMMUNOL REV, V213, P195, DOI 10.1111/j.1600-065X.2006.00433.x; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Schwarz SC, 2006, PARKINSONISM RELAT D, V12, P302, DOI 10.1016/j.parkreldis.2006.01.003; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Smith Quentin R, 2003, Methods Mol Med, V89, P193; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Wang L, 2009, EXP NEUROL, V216, P177, DOI 10.1016/j.expneurol.2008.11.017; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang Y, 2009, J GENE MED, V11, P899, DOI 10.1002/jgm.1377	44	12	13	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	OCT 14	2014	8								318	10.3389/fncel.2014.00318			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS8WF	WOS:000344525200003	25352780	Green Published, gold			2022-02-06	
J	Fletcher, TL; Kolias, AG; Hutchinson, PJ; Sutcliffe, MPF				Fletcher, Tim L.; Kolias, Angelos G.; Hutchinson, Peter J.; Sutcliffe, Michael P. F.			A New Improved Method for Assessing Brain Deformation after Decompressive Craniectomy	PLOS ONE			English	Article							INJURY; PLATFORM	Background: Decompressive craniectomy (DC) is a surgical intervention used following traumatic brain injury to prevent or alleviate raised intracranial pressure. However the clinical effectiveness of the intervention remains in doubt. The location of the craniectomy (unilateral or bifrontal) might be expected to change the brain deformation associated with the operation and hence the clinical outcome. As existing methods for assessing brain deformation have several limitations, we sought to develop and validate a new improved method. Methods: Computed tomography (CT) scans were taken from 27 patients who underwent DC (17 bifrontal patients and 10 unilateral patients). Pre-operative and post-operative images were processed and registered to determine the change in brain position associated with the operation. The maximum deformation in the herniated brain, the change in volume and estimates of the craniectomy area were determined from the images. Statistical comparison was made using the Pearson's correlation coefficient r and a Welch's two-tailed T-test, with statistical significance reported at the 5% level. Results: There was a reasonable correlation between the volume increase and the maximum brain displacement (r = 0.64), a low correlation between the volume increase and the craniectomy area (r = 0.30) and no correlation between the maximum displacement and the craniectomy area (r = -0.01). The maximum deformation was significantly lower (P = 0.023) in the bifrontal patients (mean = 22.5 mm) compared with the unilateral patients (mean = 29.8 mm). Herniation volume was significantly lower (P = 0.023) in bifrontal (mean = 50.0 ml) than unilateral patients (mean = 107.3 ml). Craniectomy area was not significantly different for the two craniectomy locations (P = 0.29). Conclusions: A method has been developed to quantify changes in brain deformation due to decompressive craniectomy from CT images and allow comparison between different craniectomy locations. Measured displacement is a reasonable way to characterise volume changes.	[Fletcher, Tim L.; Sutcliffe, Michael P. F.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J.] Univ Cambridge, Cambridge, England		Sutcliffe, MPF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mpfs@eng.cam.ac.uk		Kolias, Angelos/0000-0003-3992-0587; Hutchinson, Peter/0000-0002-2796-1835	Engineering and Physical Sciences Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Royal College of Surgeons of England Research Fellowship - Freemasons and the Rosetrees Trust; National Institute of Health Research (NIHR) Academic Clinical FellowshipNational Institute for Health Research (NIHR); Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, 12/35/57] Funding Source: researchfish	TLF acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC). AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), a National Institute of Health Research (NIHR) Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Frise E, 2008, LEVEL SETS FAST MARC; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Johnson HJ, 2007, INSIGHT J; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nock R, 2004, IEEE T PATTERN ANAL, V26, P1452, DOI 10.1109/TPAMI.2004.110; Pieper S, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P632; Pieper S, 2006, I S BIOMED IMAGING, P698; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Quintus K, 2010, MODULES LABELSTATIST; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Vashu R, 2011, ACTA NEUROCHIR, V153, P2065, DOI 10.1007/s00701-011-1101-7; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Wirtz CR, 1997, NEUROSURG FOCUS, V2	22	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2014	9	10							e110408	10.1371/journal.pone.0110408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR6ZS	WOS:000343730400129	25303305	Green Published, gold, Green Submitted			2022-02-06	
J	Mollica, RF; Chernoff, MC; Berthold, SM; Lavelle, J; Lyoo, IK; Renshaw, P				Mollica, Richard F.; Chernoff, Miriam C.; Berthold, S. Megan; Lavelle, James; Lyoo, In Kyoon; Renshaw, Perry			The mental health sequelae of traumatic head injury in South Vietnamese ex-political detainees who survived torture	COMPREHENSIVE PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HOPKINS SYMPTOM CHECKLIST-25; CONCENTRATION-CAMP SURVIVORS; DOSE-EFFECT RELATIONSHIPS; BRAIN-INJURY; PSYCHOLOGICAL SEQUELAE; PSYCHIATRIC-DISORDERS; CAMBODIAN SURVIVORS; POW SURVIVORS; FOLLOW-UP	Little is known about the relationship between traumatic head injury (THI) and psychiatric morbidity in torture survivors. We examine the relationship between THI and depression, PTSD, post-concussive syndrome (PCS), disability and poor health status in Vietnamese ex-political detainees who survived incarceration in Vietnamese re-education camps. A community sample of ex-political detainees (n = 337) and a non-THI, non-ex-detainee comparison group (n = 82) were surveyed. Seventy-eight percent of the ex-political detainees had experienced THI; 90.6% of the ex-political detainees and 3.6% of the comparison group had experienced 7 or more trauma events. Depression and PTSD were greater in ex-detainees than in the comparison group (40.9% vs 23.2% and 13.4% vs 0%). Dose-effect relationships for THI and trauma/torture in the ex-political detainee group were significant. Logistic regression in the pooled sample of ex-detainees and the comparison group confirmed the independent impact of THI from trauma/torture on psychiatric morbidity (OR for PTSD = 22.4; 95% CI: 3.0-165.8). These results demonstrate important effects of THI on depression and PTSD in Vietnamese ex-detainees who have survived torture. (C) 2014 Elsevier Inc. All rights reserved.	[Mollica, Richard F.; Lavelle, James] Massachusetts Gen Hosp, Dept Psychiat, Harvard Program Refugee Trauma, Boston, MA 02114 USA; [Chernoff, Miriam C.] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Berthold, S. Megan] Univ Connecticut, Sch Social Work, West Harford, CT USA; [Lyoo, In Kyoon] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Renshaw, Perry] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT USA		Mollica, RF (corresponding author), Harvard Program Refugee Trauma, 22 Putnam Ave, Cambridge, MA 02139 USA.	rmollica@partners.org; miriam.chernoff@juno.com; megan.berthold@uconn.edu; jlavelle@partners.org; inkylyoo@ewha.ac.kr; Perry.Renshaw@hsc.utah.edu			National Institute of Health, Bethesda, MarylandUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH R01-059559-04]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH059559] Funding Source: NIH RePORTER	Research for this manuscript was made possible by Grant No. MH R01-059559-04 from the National Institute of Health, Bethesda, Maryland. There are no conflicts of interest. The authors would like to acknowledge the following for their contributions to this study: (1) Vietnamese American Civic Association (VACA) and (2) Daniel H. Hovelson, BA, Harvard Program in Refugee Trauma.	ACS Strom, 1968, NORW CONC CAMP SURV; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; ARMSTRONG C, 1991, J REHABIL, V57, P15; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Burnett A, 2001, BRIT MED J, V322, P606, DOI 10.1136/bmj.322.7286.606; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Centers for Disease Control Prevention, 2004, HEADS FACTS PHYS MIL; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097; EITINGER L, 1965, ISRAEL J MED SCI, V1, P883; Eitinger L., 1973, MORTALITY MOBIDITY E; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fawzi MCS, 1997, J TRAUMA STRESS, V10, P101, DOI 10.1023/A:1024812514796; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Flannelly KJ, 2007, J NERV MENT DIS, V195, P996, DOI 10.1097/NMD.0b013e31815c19b1; FREEDLAND KE, 2004, DIABETES SPECTR, V17, P150; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hatch SL, 2007, AM J COMMUN PSYCHOL, V40, P313, DOI 10.1007/s10464-007-9134-z; Hendrickson P., 1996, LIVING DEAD R MCNAMA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollander AC, 2007, J NERV MENT DIS, V195, P955, DOI 10.1097/NMD.0b013e318159604b; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; IDLER EL, 1991, J GERONTOL, V46, pS55, DOI 10.1093/geronj/46.2.S55; International Amnesty, 1990, VIETN REN DOI MOI LA; Jacobs U, 2001, PROF PSYCHOL-RES PR, V32, P458, DOI 10.1037/0735-7028.32.5.458; JENSEN TS, 1982, NEW ENGL J MED, V307, P1341; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Keatley E, 2013, J HEAD TRAUMA REHAB, V28, pE8, DOI 10.1097/HTR.0b013e3182776a70; King BS, 2000, SURG CLIN N AM, V80, P855, DOI 10.1016/S0039-6109(05)70100-6; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Kleijn WC, 2001, PSYCHOL REP, V88, P527, DOI 10.2466/PR0.88.2.527-532; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; Michael M, 1984, BIOMEDICAL BESTIARY; Mollica R, 1988, CLIN GUIDELINES CROS, P262; Mollica R.F., 2004, MEASURING TRAUMA MEA; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 1998, J NERV MENT DIS, V186, P543, DOI 10.1097/00005053-199809000-00005; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mollica RF, 2007, J NERV MENT DIS, V195, P572, DOI 10.1097/NMD.0b013e318093ed2c; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moreno A, 2002, SPINAL CORD, V40, P213, DOI 10.1038/sj.sc.3101284; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; PETERSEN HD, 1985, FORENSIC SCI INT, V29, P179, DOI 10.1016/0379-0738(85)90111-2; QUIROGA J, 2006, TORTURE, V15, P1; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; Roemer L, 1998, J TRAUMA STRESS, V11, P597, DOI 10.1023/A:1024469116047; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruff RM, 1999, BRAIN INJURY, V13, P943; *SAS I, 1999, SAS STAT US GUID VER; SAS Institute, 2001, SAS STAT SOFTW CHANG; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Sinnerbrink I, 1997, J PSYCHOL, V131, P463, DOI 10.1080/00223989709603533; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Steel Z, 2002, LANCET, V360, P1056, DOI 10.1016/S0140-6736(02)11142-1; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; STROM A, 1962, J NEUROPSYCHIATRY, V4, P43; Strom A, 1984, NORWEGIAN CONCENTRAT; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; SUTKER PB, 1990, J PERS ASSESS, V54, P170, DOI 10.1207/s15327752jpa5401&2_17; THYGESEN P, 1970, DAN MED BULL, V17, P65; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; Ware J., 2001, SCORE INTERPRET SING; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; Weiss L, 1994, ATL MON, V273, P32; WESTERMEYER J, 1985, AM J PSYCHIAT, V142, P798; World Health Organization, 1980, INT CLASS IMP DIS HA	95	12	12	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	OCT	2014	55	7					1626	1638		10.1016/j.comppsych.2014.04.014			13	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AP5LX	WOS:000342121800023	24962448	Green Accepted			2022-02-06	
J	Rubino, S; Zaman, RA; Sturge, CR; Fried, JG; Desai, A; Simmons, NE; Lollis, SS				Rubino, Sebastian; Zaman, Rifat A.; Sturge, Caleb R.; Fried, Jessica G.; Desai, Atman; Simmons, Nathan E.; Lollis, S. Scott			Outpatient follow-up of nonoperative cerebral contusion and traumatic subarachnoid hemorrhage: does repeat head CT alter clinical decision-making?	JOURNAL OF NEUROSURGERY			English	Article						cerebral contusion; traumatic subarachnoid hemorrhage; subdural hematoma; computed tomography; traumatic brain injury	COMPUTED-TOMOGRAPHY; BRAIN-INJURY; MANAGEMENT	Object. Many neurosurgeons obtain repeat head CT at the first clinic follow-up visit for nonoperative cerebral contusion and traumatic subarachnoid hemorrhage (tSAH). The authors undertook a single-center, retrospective study to determine whether outpatient CT altered clinical decision-making. Methods. The authors evaluated 173 consecutive adult patients admitted to their institution from April 2006 to August 2012 with an admission diagnosis of cerebral contusion or tSAH and at least 1 clinic follow-up visit with CT. Patients with epidural, subdural, aneurysmal subarachnoid, or intraventricular hemorrhage, and those Who underwent craniotomy, were excluded. Patient charts were reviewed for new CT findings, new patient symptoms, and changes in treatment plan. Patients were stratified by neurological symptoms into 3 groups: 1) asymptomatic; 2) mild, nonspecific symptoms; and 3) significant symptoms. Mild, nonspecific symptoms included minor headaches, vertigo, fatigue, and mild difficulties with concentration, short-term memory, or sleep; significant symptoms included moderate to severe headaches, nausea, vomiting, focal neurological complaints, impaired consciousness, or new cognitive impairment evident on routine clinical examination. Results. One hundred seventy-three patients met inclusion criteria, with initial clinic follow-up obtained within approximately 6 weeks. Of the 173 patients, 104 (60.1%) were asymptomatic, 68 patients (39.3%) had mild, nonspecific neurological symptoms, and 1 patient (1.0%) had significant neurological symptoms. Of the asymptomatic patients, 3 patients (2.9%) had new CT findings and 1 of these patients (1.0%) underwent a change in treatment plan because of these findings. This change involved an additional clinic appointment and CT to monitor a 12-mm chronic subdural hematoma that ultimately resolved without treatment. Of the patients with mild, nonspecific neurological symptoms, 6 patients (8.8%) had new CT findings and 3 of these patients (4.4%) underwent a change in treatment plan because of these findings; none of these patients required surgical intervention. The single patient with significant neurological symptoms did not have any new CT findings. Conclusions. Repeat outpatient CT of asymptomatic patients after nonoperative cerebral contusion and tSAH is very unlikely to demonstrate significant new pathology. Given the cost and radiation exposure associated with CT, imaging should be reserved for patients with significant symptoms or focal findings on neurological examination.	[Rubino, Sebastian; Zaman, Rifat A.; Sturge, Caleb R.; Fried, Jessica G.; Simmons, Nathan E.; Lollis, S. Scott] Geisel Sch Med Dartmouth, Hanover, NH USA; [Desai, Atman; Simmons, Nathan E.; Lollis, S. Scott] Dartmouth Hitchcock Med Ctr, Neurosurg Sect, Lebanon, NH 03756 USA		Rubino, S (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	sebastian.rubino.med@dartmouth.edu					AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2005, BEIR 7 HLTH RISKS EX; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; ROBERSON FC, 1979, SURG NEUROL, V12, P161; Semelka RC, 2007, J MAGN RESON IMAGING, V25, P900, DOI 10.1002/jmri.20895; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	14	12	12	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2014	121	4					944	949		10.3171/2014.6.JNS132204			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AQ7DR	WOS:000342973300028	25061865				2022-02-06	
J	Selvarajah, S; Schneider, EB; Becker, D; Sadowsky, CL; Haider, AH; Hammond, ER				Selvarajah, Shalini; Schneider, Eric B.; Becker, Daniel; Sadowsky, Cristina L.; Haider, Adil H.; Hammond, Edward R.			The Epidemiology of Childhood and Adolescent Traumatic Spinal Cord Injury in the United States: 2007-2010	JOURNAL OF NEUROTRAUMA			English	Article						adolescents; burden; children; epidemiology; Nationwide Emergency Department Sample; traumatic spinal cord injury	PEDIATRIC POPULATION; NEUROLOGICAL CLASSIFICATION; INTERNATIONAL STANDARDS; SEVERITY SCORE; MANAGEMENT; FEATURES; BURDEN; TRENDS; MOTOR; AGE	The burden of acute traumatic spinal cord injury (TSCI) among U. S. children and adolescents was last described over a decade ago using inpatient data. We describe cumulative incidence, mortality, discharge disposition, and inflation-adjusted charges of childhood and adolescent TSCI in the U. S. using emergency department (ED) data from the Nationwide Emergency Department Sample (2007-2010). Patients ages 17 years and younger with a diagnosis of acute TSCI were identified using the International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes 806.* and 952.* (N = 6132). The cumulative incidence of childhood and adolescent TSCI averaged 17.5 per million population per year. The median age at presentation was 15 years (interquartile range [IQR] = 12-16) and the majority of patients were male (72.5%). The overall median new injury severity score (NISS) was 16 (IQR = 9-27), remaining unchanged during the study duration (p = 0.703). Children 5 years and younger were more likely to be injured from a road traffic accident (RTA; 50.9%), sustain C1-C4 injuries (47.4%), have more severe injury (median NISS = 22; IQR = 13-29), and concurrent brain injury (24%) compared to older children and adolescents, p < 0.001. Firearms were implicated in 8.3% of injuries, of which 94.7% were among adolescents ages 13-17 years. Of the 35 TSCI-related ED deaths, 40% occurred among children ages 5 years and younger. 62.4% of patients required inpatient admission. Despite stable cumulative incidence and overall injury severity, ED treatment charge per visit increased on average $1394 from $3495 in 2007 to $4889 in 2010 (p = 0.008). RTA-related TSCI disproportionately affects young children, while firearm-related TSCI is most common among adolescents. These findings inform TSCI prevention strategies. Prevention may be key in mitigating rising healthcare cost.	[Selvarajah, Shalini; Schneider, Eric B.; Haider, Adil H.] Johns Hopkins Univ, Sch Med, Ctr Surg Trials & Outcomes Res, Baltimore, MD USA; [Haider, Adil H.] Johns Hopkins Univ, Sch Med, Div Acute Care Surg, Baltimore, MD USA; [Becker, Daniel] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Becker, Daniel] Int Neurorehabil Inst, Lutherville Timonium, MD USA; [Sadowsky, Cristina L.; Hammond, Edward R.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Int Ctr Spinal Cord Injury, Baltimore, MD USA; [Hammond, Edward R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA		Selvarajah, S (corresponding author), Johns Hopkins Sch Med, Dept Surg, Ctr Surg Trials & Outcomes Res, 600 N Wolfe St,Blalock 611, Baltimore, MD 21287 USA.	sselvar2@jhmi.edu					Augutis M, 2003, SPINAL CORD, V41, P328, DOI 10.1038/sj.sc.3101478; BRACKEN MB, 1981, AM J EPIDEMIOL, V113, P615, DOI 10.1093/oxfordjournals.aje.a113140; Burke D C, 1971, Paraplegia, V9, P1; BURNEY RE, 1993, ARCH SURG-CHICAGO, V128, P596; Centers for Disease Control and Prevention, 2013, WEB BAS INJ STAT QUE; Chafetz RS, 2009, J SPINAL CORD MED, V32, P157, DOI 10.1080/10790268.2009.11760767; Charyk Stewart T., J TRAUMA ACUTE CARE, V74, P628; Clark D. E., 2012, ICDPIC STATA MODULE; Clarke EC, 2012, SPINAL CORD INJURIES, P251; Consortium for Spinal Cord Medicine Clinical Practice Guidelines, 2008, EARL AC MAN AD SPIN; Costacurta MLG, 2010, SPINAL CORD, V48, P118, DOI 10.1038/sc.2009.130; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DeVivo MJ, 2011, ARCH PHYS MED REHAB, V92, P332, DOI 10.1016/j.apmr.2010.08.031; Fehlings MG, 1996, AM FAM PHYSICIAN, V54, P155; FENSTERMAKER RA, 1993, UROL CLIN N AM, V20, P413; Fine P.R., 1976, J MED SCI, V13, P173; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2011, INTR HCUP NAT EM DEP; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality. The Nationwide Emergency Department Sample (NEDS), 2013, OV NAT EM DEP SAMPL; KEWALRAMANI LS, 1980, PARAPLEGIA, V18, P206, DOI 10.1038/sc.1980.36; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Martins F, 1998, SPINAL CORD, V36, P574, DOI 10.1038/sj.sc.3100657; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Mulcahey M.J., 2010, J NURSE LIFE CARE PL, V10, P204; National Spinal Cord Injury Statistical Center, 2011, ANN REP SPIN CORD IN; National Spinal Cord Injury Statistical Center, 2013, SPIN CORD INJ FACTS; ORENSTEIN JB, 1994, PEDIATR EMERG CARE, V10, P132, DOI 10.1097/00006565-199406000-00003; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Parent S, 2011, J NEUROTRAUM, V28, P1515, DOI 10.1089/neu.2009.1153; Parent S, 2010, SPINE, V35, pS202, DOI 10.1097/BRS.0b013e3181f35acb; Retting RA, 2003, J SAFETY RES, V34, P485, DOI 10.1016/j.jsr.2003.05.001; Sahr RC, 2013, CONSUMER PRICE INDEX; Schottler J, 2012, DEV MED CHILD NEUROL, V54, P1138, DOI 10.1111/j.1469-8749.2012.04411.x; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Shavelle RM, 2007, J SPINAL CORD MED, V30, pS48, DOI 10.1080/10790268.2007.11753969; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; U. S Census Bureau, 2010, PROJ TOT RES POP 5 Y; Vitale MG, 2006, J PEDIATR ORTHOPED, V26, P745, DOI 10.1097/01.bpo.0000235400.49536.83; Vogel Lawrence C, 2012, Handb Clin Neurol, V109, P131, DOI 10.1016/B978-0-444-52137-8.00008-5	41	12	14	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2014	31	18					1548	1560		10.1089/neu.2014.3332			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AP5UH	WOS:000342143700003	24811704				2022-02-06	
J	Doig, E; Kuipers, P; Prescott, S; Cornwell, P; Fleming, J				Doig, Emmah; Kuipers, Pim; Prescott, Sarah; Cornwell, Petrea; Fleming, Jennifer			Development of Self-Awareness After Severe Traumatic Brain Injury Through Participation in Occupation-Based Rehabilitation: Mixed-Methods Analysis of a Case Series	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; awareness; brain injuries; goals; patient-centered care; patient-centered outcome	PERFORMANCE-MEASURE; ADULTS; DEFICITS; INTERVENTIONS; ASSOCIATION; FEEDBACK; PROGRAM; UTILITY; TOOL	OBJECTIVE. We examined participation in goal planning and development of self-awareness for people. with impaired self-awareness after traumatic brain injury. METHOD. We performed a mixed-methods study of 8 participants recently discharged from inpatient rehabilitation. Self,awareness via measured using discrepancy between self and significant other ratings on the Mayo Portland Adaptability Index (MPAI-4) at four time points. We calculated effect size to evaluate the change in MPAI-4 discrepancy over time. RESULTS. Seven participants identified their own goals. We found a large reduction in mean MPAI-4 discrepancy (M = 8.57, SD = 6.59, N = 7, d = 1.08) in the,first 6 wk and a further small reduction (M = 5.33, SD = 9,09, N = 6, d = 0.45) in the second 6 wk of intervention. Case data indicated that 7 participants demonstrated some growth in self-awareness. CONCLUSION. Engagement in occupation-based, goal-directed rehabilitation appeared to foster awareness of injury-related changes to varying extents.	[Doig, Emmah; Prescott, Sarah; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4067, Australia; [Kuipers, Pim; Fleming, Jennifer] Queensland Hlth, Metro South Hlth Dist, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Kuipers, Pim] Griffith Univ, Griffith Hlth Inst, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4067, Australia; [Cornwell, Petrea] Queensland Hlth, Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia; [Cornwell, Petrea] Griffith Univ, Griffith Hlth Inst, Sch Appl Psychol & Behav Basis Hlth, Brisbane, Qld 4111, Australia		Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia Campus, Brisbane, Qld 4067, Australia.	e.doig@uq.edu.au	Cornwell, Petrea/AAE-5547-2019; Doig, Emmah/AAG-6674-2021	Doig, Emmah/0000-0002-7020-053X; Kuipers, Pim/0000-0003-0340-2286			Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Landa-Gonzalez BELKIS, 2001, Occup Ther Int, V8, P49, DOI 10.1002/oti.131; Law M., 1994, CANADIAN OCCUPATIONA, V2; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec J.F., 2008, MANUAL MAYOPORTLAND; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; McColl M A, 2000, Can J Occup Ther, V67, P22; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Pendleton HM, 2013, PEDRETTIS OCCUPATION; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Tate RL, 2013, J HEAD TRAUMA REHAB, V28, P77, DOI 10.1097/HTR.0b013e31824e103e; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640; Wressle E, 2003, DISABIL REHABIL, V25, P497, DOI 10.1080/0963828031000090560; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	45	12	12	0	9	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2014	68	5			SI		578	588		10.5014/ajot.2014.010785			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AO9MB	WOS:000341678700012	25184471	Green Published			2022-02-06	
J	Enicker, B; Madiba, TE				Enicker, Basil; Madiba, Thandinkosi E.			Cranial injuries secondary to assault with a machete	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Machete; Compound depressed skull fracture; Intra-cranial haematoma	DEPRESSED SKULL FRACTURES; MANAGEMENT; EXPERIENCE; INFECTION	Background: Assaults with a machete cause compound skull fractures which present as a neurosurgical emergency. We aimed to profile cranial injuries caused by a machete over a 10 year period in a single neurosurgical unit. Materials and methods: Retrospective data analysis of cranial injuries following assault with a machete, admitted to the neurosurgery ward, from January 2003 to December 2012 was performed. Medical records were analyzed for demographics, clinical presentation, CT scan findings, surgical treatment and Glasgow Outcome Scale (GOS) at discharge. Management involved wound debridement with antibiotic cover. Results: Of 185 patients treated 172 (93%) were male. Mean age was 31 +/- 11.4 years. Mean GCS on admission was 13 +/- 2. Presenting features were focal neurological deficit (48%), brain matter oozing from wounds (20%), and post traumatic seizures (12%). Depressed skull fractures were found in 162 (88%) patients. Findings on CT brain scan were intra-cranial haematoma (88%), pneumocephalus (39%) and features of raised intra-cranial pressure (37%). Thirty-one patients (17%) presented with septic head wounds. One hundred and fifty seven patients (85%) were treated surgically. The median hospital stay was 8 days (range 1-145). The median GOS at discharge was 5 (range 1-5). Twelve patients died within the same admission (6.5%). Conclusion: Machetes cause complex cranial injuries with associated neurological deficit and should be treated as neurosurgical emergency. Timeous intervention and good surgical principles are advocated to prevent secondary infection and further neurological deterioration. (C) 2014 Elsevier Ltd. All rights reserved.	[Enicker, Basil] Univ KwaZulu Natal, Dept Neurosurg, Durban, South Africa; [Enicker, Basil; Madiba, Thandinkosi E.] Inkosi Albert Luthuli Cent Hosp, Durban, South Africa; [Madiba, Thandinkosi E.] Univ KwaZulu Natal, Durban, South Africa		Enicker, B (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Inkosi Albert Luthuli Cent Hosp, Dept Neurosurg, Private Bag X03, ZA-4058 Mayville, South Africa.	basilenicker@yahoo.com	Madiba, T E/ABI-8313-2020; Madiba, T E/N-6069-2013	Madiba, T E/0000-0002-0155-9143; Madiba, T E/0000-0002-0155-9143			[Anonymous], 2012, CENS 2011 STAT REL P; Borkar SA, 2009, TURK NEUROSURG, V19, P103; BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V35, P395, DOI 10.1136/jnnp.35.3.395; Crandon IW, 2011, INT J INJ CONTROL SA, V18, P293, DOI 10.1080/17457300.2011.569890; Irmay F, 2000, LANCET, V356, P1072, DOI 10.1016/S0140-6736(00)02731-8; JENNETT B, 1972, J NEUROSURG, V36, P333, DOI 10.3171/jns.1972.36.3.0333; LeFeuvre D, 2004, SURG NEUROL, V62, P121, DOI 10.1016/j.surneu.2003.10.048; Marion DW, 2006, NEUROSURGERY, V58, P655; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; Omoke NI, 2010, INJURY, V41, P120, DOI 10.1016/j.injury.2009.08.023; Omoke NI, 2012, INT ORTHOP, V36, P613, DOI 10.1007/s00264-011-1322-7; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; Wiedeman JE, 2001, MIL MED, V166, P1023, DOI 10.1093/milmed/166.11.1023; Wylen EL, 1999, SURG NEUROL, V51, P452, DOI 10.1016/S0090-3019(98)00040-8	14	12	12	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2014	45	9					1355	1358		10.1016/j.injury.2014.04.036			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AN0NI	WOS:000340280900013	24933443				2022-02-06	
J	Hillary, FG; Medaglia, JD; Gates, KM; Molenaar, PC; Good, DC				Hillary, F. G.; Medaglia, J. D.; Gates, K. M.; Molenaar, P. C.; Good, D. C.			Examining network dynamics after traumatic brain injury using the extended unified SEM approach	BRAIN IMAGING AND BEHAVIOR			English	Article						fMRI; TBI; Brain injury; Rehabilitation; Working memory; Cognitive control	WORKING-MEMORY; EFFECTIVE CONNECTIVITY; PREFRONTAL CORTEX; FMRI; PERFORMANCE; ACTIVATION; SPEED; TASK; 2-DEOXYGLUCOSE; ATTENTION	The current study uses effective connectivity modeling to examine how individuals with traumatic brain injury (TBI) learn a new task. We make use of recent advancements in connectivity modeling (extended unified structural equation modeling, euSEM) and a novel iterative grouping procedure (Group Iterative Multiple Model Estimation, GIMME) in order to examine network flexibility after injury. The study enrolled 12 individuals sustaining moderate and severe TBI to examine the influence of task practice on connections between 8 network nodes (bilateral prefrontal cortex, anterior cingulate, inferior parietal lobule, and Crus I in the cerebellum). The data demonstrate alterations in networks from pre to post practice and differences in the models based upon distinct learning trajectories observed within the TBI sample. For example, better learning in the TBI sample was associated with diminished connectivity within frontal systems and increased frontal to parietal connectivity. These findings reveal the potential for using connectivity modeling and the euSEM to examine dynamic networks during task engagement and may ultimately be informative regarding when networks are moving in and out of periods of neural efficiency.	[Hillary, F. G.; Medaglia, J. D.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Hillary, F. G.; Good, D. C.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 347 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021		New Jersey Comission for Brain Injury Research [09.001.BIR1]	We wish to thank Julia Slocomb and Jeffrey Vesek for their efforts in subject recruitment and MRI data acquisition. This work was funded in part by the New Jersey Comission for Brain Injury Research (09.001.BIR1).	Albantakis L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002086; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; Bergerbest D, 2004, J COGNITIVE NEUROSCI, V16, P966, DOI 10.1162/0898929041502760; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Collette F, 1999, NEUROPSYCHOLOGIA, V37, P905, DOI 10.1016/S0028-3932(98)00148-1; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Gates KM, 2011, NEUROIMAGE, V54, P1151, DOI 10.1016/j.neuroimage.2010.08.051; Gates KM, 2010, NEUROIMAGE, V50, P1118, DOI 10.1016/j.neuroimage.2009.12.117; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Hillary F., 2011, BRAIN 5, V134; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Joreskog K. G., 1992, LISREL; Katori Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002266; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Leavitt VM, 2012, MULT SCLER J, V18, P409, DOI 10.1177/1352458511423651; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCINTOSH AR, 1991, BRAIN RES, V547, P295, DOI 10.1016/0006-8993(91)90974-Z; MCINTOSH AR, 1992, BRAIN RES, V578, P75, DOI 10.1016/0006-8993(92)90232-X; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Sporns O., 2011, NETWORKS BRAIN, P207; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; [No title captured], DOI DOI 10.1098/RSTB.1996.0123	51	12	12	0	21	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		435	445		10.1007/s11682-012-9205-0			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP9ZR	WOS:000342441400012	23138853				2022-02-06	
J	Lovstad, M; Andelic, N; Knoph, R; Jerstad, T; Anke, A; Skandsen, T; Hauger, SL; Giacino, JT; Roe, C; Schanke, AK				Lovstad, Marianne; Andelic, Nada; Knoph, Rein; Jerstad, Tone; Anke, Audny; Skandsen, Toril; Hauger, Solveig L.; Giacino, Joseph T.; Roe, Cecilie; Schanke, Anne-Kristine			Rate of Disorders of Consciousness in a Prospective Population-Based Study of Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						incidence; minimally conscious state; outcome assessment; traumatic brain injury; vegetative state	HEAD-INJURY; VEGETATIVE STATE; RECOVERY; COMA; EPIDEMIOLOGY; SCALE; REHABILITATION; NEUROPATHOLOGY; MANAGEMENT; DIAGNOSIS	Objective: Establish rate of disorders of consciousness (DOC) and course of recovery in adults who have sustained severe traumatic brain injury (sTBI). Setting: Four Norwegian neurosurgical departments. Participants: Vegetative or minimally conscious patients. Design: Prospective, longitudinal population-based study of adults with sTBI with follow-ups at 3, 12, and 24-36 months postinjury. Main Measures: Coma Recovery Scale-Revised, Glasgow Coma Scale, Extended Glasgow Outcome Scale, and Disability Rating Scale. Results: Three months postinjury, 2% of the sTBI population remained in a vegetative or minimally conscious state, reduced by the half after 1 year, corresponding to average annual age-adjusted incidence rates of DOC of 0.09 per 100 000 3 months post-sTBI. At 3 and 12 months, the incidence was 0.06 and 0.01 per 100 000 for the vegetative state and 0.03 and 0.04 per 100 000 for the minimally conscious state. Diagnostic categorization was stable between 12 and 24-36 months, although clinically relevant improvements were observed in minimally conscious patients. Conclusion: The data suggest that prolonged DOC is rare following sTBI in Norway, contrary to the commonly held belief that improvements in intensive care treatment have resulted in an increased incidence of DOC. Prolonged DOC was associated with severity of injury, subcortical lesions, and diffuse axonal injury.	[Lovstad, Marianne; Hauger, Solveig L.; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Res Dept, Nesodden, Norway; [Lovstad, Marianne; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway; [Andelic, Nada; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Jerstad, Tone] Oslo Univ Hosp, Dept Radiol, Oslo, Norway; [Knoph, Rein] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway; [Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Anke, Audny] Univ Tromso, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Skandsen, Toril] Univ Trondheim Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway		Lovstad, M (corresponding author), Sunnaas Rehabil Hosp, Res Dept, N-1450 Nesoddtangen, Nesoddtangen, Norway.	mar.lovstad@gmail.com	Giacino, Joseph/AAF-1952-2021; Skandsen, Toril/P-6767-2014	Giacino, Joseph/0000-0002-7916-9698; Skandsen, Toril/0000-0001-5495-9338; Anke, Audny/0000-0002-2491-2560; Andelic, Nada/0000-0002-3719-4406	Norwegian Research CouncilResearch Council of NorwayEuropean Commission [185267]	This study was conducted with grants from the Norwegian Research Council (grant no. 185267).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annoni J M, 1992, Disabil Rehabil, V14, P23; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Gennarelli TA., 2008, ABBREVIATED INJURY S; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kelly DF, 2001, WORLD J SURG, V25, P1179; Kotchoubey B, 2005, PROG BRAIN RES, V150, P427, DOI 10.1016/S0079-6123(05)50030-X; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2007, CURR OPIN NEUROL, V20, P609, DOI 10.1097/WCO.0b013e3282f1d6dd; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; Pryor JP, 2003, J TRAUMA, V55, P442; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; Sazbon L, 2002, POST-TRAUMATIC VEGETATIVE STATE, P3; SAZBON L, 1992, Brain Injury, V6, P359, DOI 10.3109/02699059209034950; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Sollid S, 2009, EMERG MED J, V26, P769, DOI 10.1136/emj.2008.061630; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; TEASDALE G, 1974, LANCET, V2, P81; Walder B, 2013, J NEUROTRAUMA; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	62	12	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					E31	E43		10.1097/HTR.0000000000000017			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700003	24413075				2022-02-06	
J	Medina-Torres, CE; Pollitt, CC; Underwood, C; Castro-Olivera, EM; Collins, SN; Allavena, RE; Richardson, DW; van Eps, AW				Medina-Torres, C. E.; Pollitt, C. C.; Underwood, C.; Castro-Olivera, E. M.; Collins, S. N.; Allavena, R. E.; Richardson, D. W.; van Eps, A. W.			Equine lamellar energy metabolism studied using tissue microdialysis	VETERINARY JOURNAL			English	Article						Horse; Laminitis; Lamellae; Bioenergetics; Urea clearance	HUMAN SKELETAL-MUSCLE; TRAUMATIC BRAIN-INJURY; LACTATE METABOLISM; ADIPOSE-TISSUE; GLUCOSE; BLOOD; HORSE; ANESTHESIA; ISCHEMIA; CAFFEINE	Failure of lamellar energy metabolism may contribute to the pathophysiology of equine laminitis. Tissue microdialysis has the potential to dynamically monitor lamellar energy balance over time. The objectives of this study were to develop a minimally invasive lamellar microdialysis technique and use it to measure normal lamellar energy metabolite concentrations over 24 h. Microdialysis probes were placed (through the white line) into either the lamellar dermis (LAM) (n = 6) or the sublamellar dermis (SUBLAM) (n = 6) and perfused continuously over a 24 h study period. Probes were placed in the skin dermis (SKIN) for simultaneous comparison to LAM (n = 6). Samples were collected every 2 h and analysed for glucose, lactate, pyruvate, urea and glycerol concentrations. LAM was further compared with SUBLAM by simultaneous placement and sampling in four feet from two horses over 4 h. Horses were monitored for lameness, and either clinically evaluated for 1 month after probe removal (n = 4) or subjected to histological evaluation of the probe site (n = 10). There were no deleterious clinical effects of probe placement and the histological response was mild. Sample fluid recovery and metabolite concentrations were stable for 24 h. Glucose was lower (and lactate:glucose ratio higher) in LAM compared with SUBLAM and SKIN (P < 0.05). Pyruvate was lower in SUBLAM than SKIN and urea was lower in LAM than SKIN (P < 0.05). These differences suggest lower perfusion and increased glucose consumption in LAM compared with SUBLAM and SKIN. In conclusion, lamellar tissue microdialysis was well tolerated and may be useful for determining the contribution of energy failure in laminitis pathogenesis. (C) 2014 Elsevier Ltd. All rights reserved.	[Medina-Torres, C. E.; Pollitt, C. C.; Underwood, C.; Castro-Olivera, E. M.; Collins, S. N.; Allavena, R. E.; van Eps, A. W.] Univ Queensland, Fac Sci, Sch Vet Sci, Australian Equine Laminitis Res Unit, Gatton, Qld 4343, Australia; [Richardson, D. W.] Univ Penn, Sch Vet Med, New Bolton Ctr, Kennett Sq, PA 19348 USA		van Eps, AW (corresponding author), Univ Queensland, Fac Sci, Sch Vet Sci, Australian Equine Laminitis Res Unit, Gatton Campus, Gatton, Qld 4343, Australia.	a.vaneps@uq.edu.au	Pollitt, Christopher/L-3964-2019; van Eps, Andrew William/B-3633-2013; Allavena, Rachel/F-5720-2012; Medina-Torres, Carlos E./V-7880-2019	van Eps, Andrew William/0000-0001-6108-2503; Allavena, Rachel/0000-0001-5126-7125; Medina-Torres, Carlos E./0000-0003-2048-8165	Grayson Jockey Club Research Foundation Grant	Supported by a Grayson Jockey Club Research Foundation Grant. This material has been presented in part as an abstract at the American College of Veterinary Internal Medicine Forum, Seattle, 12-15 June, 2013.	Belknap JK, 2009, VET IMMUNOL IMMUNOP, V129, P155, DOI 10.1016/j.vetimm.2008.11.013; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; Chou CC, 2001, J VET PHARMACOL THER, V24, P405, DOI 10.1046/j.1365-2885.2001.00364.x; de Lange E.C.M., 2013, MICRODIALYSIS DRUG D, P13, DOI DOI 10.1007/978-1-4614-4815-0; Diczfalusy E, 2011, MED BIOL ENG COMPUT, V49, P1459, DOI 10.1007/s11517-011-0841-0; Edner A, 2005, J VET MED A, V52, P99, DOI 10.1111/j.1439-0442.2004.00685.x; Edner AH, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-10; Farnebo S, 2010, CLIN PHYSIOL FUNCT I, V30, P57, DOI 10.1111/j.1475-097X.2009.00904.x; French KR, 2004, EQUINE VET J, V36, P261, DOI 10.2746/0425164044877170; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; GLICK JH, 1969, AM J CLIN PATHOL, V52, P320; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hall JE, 2011, GUYTON HALL TXB MED; Hamrin K, 2002, J APPL PHYSIOL, V92, P385, DOI 10.1152/jappl.2002.92.1.385; Heller A., 2013, APPL ELECTROCHEMISTR, V108, P2482; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; INGVASTLARSSON C, 1992, J VET PHARMACOL THER, V15, P386, DOI 10.1111/j.1365-2885.1992.tb01030.x; Klaus S, 2004, CRIT CARE, V8, P363, DOI 10.1186/cc2882; Langemann H, 2001, NEUROL RES, V23, P531, DOI 10.1179/016164101101198785; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Murchie TA, 2006, EQUINE VET J, V38, P520, DOI 10.2746/042516406X156136; Nichols SP, 2011, ANAL CHEM, V83, P1180, DOI 10.1021/ac103070t; Nourian AR, 2010, VET J, V183, P273, DOI 10.1016/j.tvjl.2009.05.008; Nourian AR, 2010, VET J, V183, P22, DOI 10.1016/j.tvjl.2009.01.003; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Pass M A, 1998, Equine Vet J Suppl, P133; Pawlak EA, 2014, EQUINE VET J, V46, P203, DOI 10.1111/evj.12092; Pollitt CC, 1996, EQUINE VET J, V28, P38, DOI 10.1111/j.2042-3306.1996.tb01588.x; Redden R.F., 2003, AAEP P, V49, P57; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronquist G, 2003, EXP DERMATOL, V12, P572, DOI 10.1034/j.1600-0625.2003.00018.x; Rosdahl H, 1997, ACTA PHYSIOL SCAND, V159, P261, DOI 10.1046/j.1365-201X.1997.123358000.x; Rosdahl H, 1998, AM J PHYSIOL-ENDOC M, V274, pE936, DOI 10.1152/ajpendo.1998.274.5.E936; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Setala LP, 2004, MICROSURG, V24, P223, DOI 10.1002/micr.20045; Sorg Brian S., 2005, Journal of Pharmacological and Toxicological Methods, V52, P341, DOI 10.1016/j.vascn.2005.05.004; van Eps A, 2010, VET CLIN N AM-EQUINE, V26, P287, DOI 10.1016/j.cveq.2010.06.007; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vickroy TW, 2008, J VET PHARMACOL THER, V31, P156, DOI 10.1111/j.1365-2885.2008.00942.x; Waelgaard L, 2012, ACTA ANAESTH SCAND, V56, P200, DOI 10.1111/j.1399-6576.2011.02572.x; Wattle O., 2004, Clinical Techniques in Equine Practice, V3, P22, DOI 10.1053/j.ctep.2004.07.002; Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008	45	12	12	0	14	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	SEP	2014	201	3					275	282		10.1016/j.tvjl.2014.05.030			8	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	AQ3RQ	WOS:000342711600009	24947715	Green Accepted			2022-02-06	
J	Orman, G; Tekes, A; Poretti, A; Robertson, C; Huisman, TAGM				Orman, Gunes; Tekes, Aylin; Poretti, Andrea; Robertson, Courtney; Huisman, Thierry A. G. M.			Posttraumatic Carotid Artery Dissection in Children: Not to be missed!	JOURNAL OF NEUROIMAGING			English	Article						Children; head trauma; neck trauma; carotid artery; dissection; neuroimaging	TRAUMATIC BRAIN-INJURY; UNIQUE FEATURES; PEDIATRIC SKULL; ISCHEMIC-STROKE; COMPLICATIONS; ANGIOGRAPHY; MECHANISMS; CHILDHOOD; DIAGNOSIS; PATTERNS	BACKGROUND Post-traumatic carotid artery dissection (PTCAD) may result in acute arterial ischemic stroke (AIS). Pediatric PTCAD is rarely diagnosed prior to onset of neurological symptoms. We report on neuroimaging findings in a series of children with PTCAD. METHODS Five children with head or neck trauma were included in this study. Clinical histories were reviewed for mechanism of trauma, symptoms, complications, therapy, and outcome. Computed tomography (CT), magnetic resonance imaging (MRI), and CT/MR angiography (CTA, MRA) studies were retrospectively evaluated for signs and complications of PTCAD and presence and extent of skull base fractures. RESULTS PTCAD was located at the level of the skull base in all children and was associated with a skull base fracture in two. The diagnosis was made in five children by combined MRI/MRA and in two by CTA. Air in the carotid canal suggested skull base injury with PTCAD in two children. PTCAD was complicated by AIS in three children. CONCLUSION PTCAD may result from neck and head trauma. To avoid secondary AIS, radiologists should be familiar with neuroimaging findings in children, especially as acute PTCAD may initially be clinically silent. Consequently, pediatric neuroradiologists should actively exclude PTCAD in children with head and neck trauma.	[Orman, Gunes; Tekes, Aylin; Poretti, Andrea; Huisman, Thierry A. G. M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol, Sect Pediat Neuroradiol,Div Pediat Radiol, Baltimore, MD USA; [Robertson, Courtney] Johns Hopkins Univ, Sch Med, Dept Pediat, Pediat Intens Care Unit, Baltimore, MD 21205 USA		Huisman, TAGM (corresponding author), Charlotte R Bloomberg Childrens Ctr, Russell H Morgan Dept Radiol & Radiol Sci, Sheikh Zayed Tower,Room 4174,1800 Orleans St, Baltimore, MD 21287 USA.	thuisma1@jhmi.edu	Poretti, Andrea/H-6269-2019	Poretti, Andrea/0000-0002-9594-3858			Agner C, 2005, CHILD NERV SYST, V21, P416, DOI 10.1007/s00381-004-1056-6; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Camacho A, 2001, PEDIATR NEUROL, V25, P250, DOI 10.1016/S0887-8994(01)00294-6; Chabrier S, 2003, EUR J PAEDIATR NEURO, V7, P39, DOI 10.1016/S1090-3798(02)00138-1; Chamoun RB, 2008, J NEUROS-PEDIATR, V2, P101, DOI 10.3171/PED/2008/2/8/101; de Borst GJ, 2006, PEDIATR NEUROL, V34, P408, DOI 10.1016/j.pediatrneurol.2005.09.005; Fullerton HJ, 2001, NEUROLOGY, V57, P1155, DOI 10.1212/WNL.57.7.1155; Ganesan V, 2011, NEUROLOGY, V76, P166, DOI 10.1212/WNL.0b013e318205d4d5; Giroud M, 1997, ACTA NEUROL SCAND, V96, P401, DOI 10.1111/j.1600-0404.1997.tb00306.x; Jones TS, 2012, AM J SURG, V204, P7, DOI 10.1016/j.amjsurg.2011.07.015; Kopelman TR, 2011, J TRAUMA, V71, P559, DOI 10.1097/TA.0b013e318226eadd; Lequin MH, 2004, EUR J PAEDIATR NEURO, V8, P155, DOI 10.1016/j.ejpn.2004.02.001; Levack MM, 2009, J PEDIATR SURG, V44, pE29, DOI 10.1016/j.jpedsurg.2009.05.026; LEVY C, 1994, RADIOLOGY, V190, P97, DOI 10.1148/radiology.190.1.8259436; Lew SM, 1999, PEDIATR NEUROSURG, V30, P239, DOI 10.1159/000028804; Moriarty JM, 2009, IRISH J MED SCI, V178, P535, DOI 10.1007/s11845-009-0374-9; Mortazavi MM, 2011, CHILD NERV SYST, V27, P2045, DOI 10.1007/s00381-011-1409-x; Oelerich M, 1999, EUR RADIOL, V9, P1385, DOI 10.1007/s003300050853; PATEL H, 1995, PEDIATR NEUROL, V13, P55, DOI 10.1016/0887-8994(95)00056-L; Pierrot S, 2006, ANN OTO RHINOL LARYN, V115, P323, DOI 10.1177/000348940611500501; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Rafay MF, 2006, J CHILD NEUROL, V21, P8, DOI 10.1177/08830738060210010101; Robertson WC, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-16; Rommel O, 1999, CEREBROVASC DIS, V9, P202, DOI 10.1159/000015956; Silverboard G, 2000, Semin Pediatr Neurol, V7, P289, DOI 10.1053/spen.2000.2077; Tabarki B, 1997, ARCH PEDIATRIE, V4, P763, DOI 10.1016/S0929-693X(97)83418-5; York G, 2005, AM J ROENTGENOL, V184, P1672, DOI 10.2214/ajr.184.5.01841672	28	12	14	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	SEP-OCT	2014	24	5					467	472		10.1111/jon.12071			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AP3PW	WOS:000341990200005	24251954				2022-02-06	
J	Wang, WH; Hu, LS; Lin, H; Li, J; Luo, F; Huang, W; Lin, JM; Cai, GP; Liu, CC				Wang, Wen-hao; Hu, Lian-shui; Lin, Hong; Li, Jun; Luo, Fei; Huang, Wei; Lin, Jun-ming; Cai, Gen-ping; Liu, Chang-chun			Risk Factors for Post-Traumatic Massive Cerebral Infarction Secondary to Space-Occupying Epidural Hematoma	JOURNAL OF NEUROTRAUMA			English	Article						brain herniation; cerebral infarction; craniotomy; decompressive craniectomy; epidural hematoma	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; OUTCOMES; CT	Post-traumatic massive cerebral infarction (MCI) is a fatal complication of concurrent epidural hematoma (EDH) and brain herniation that commonly requires an aggressive decompressive craniectomy. The risk factors and surgical indications of MCI have not been fully elucidated. In this retrospective study, post-traumatic MCI was diagnosed in 32 of 176 patients. The performance of a decompressive craniectomy simultaneously with the initial hematoma-evacuation surgery improved their functional outcomes, compared with delayed surgery (on the 6-month Extended Glasgow Outcome Scale, 5.6 +/- 1.5 vs. 3.4 +/- 0.6; p < 0.001). Significantly increased risks for MCI were observed in patients with an EDH at a transtemporal location (adjusted odds ratio [OR], 16.48; p = 0.003), an EDH larger than 100 mL in volume (OR, 7.04; p = 0.001), preoperative shock for longer than 30 min (OR, 13.78; p = 0.002), bilateral mydriasis (OR, 7.08; p = 0.004), preoperative brain herniation for longer than 90 min (OR, 6.41; p < 0.001), and a Glasgow Coma Score of 3-5 points (OR, 2.86; p < 0.053). Multi-variate logistic regression analysis revealed no significant association between post-traumatic MCI and age, gender, mid-line shift, Rotterdam computed tomography score, intraoperative hypotension, or serum concentrations of sodium or glucose. Incidence of post-traumatic MCI increased from 16.4% in those having any two of the six risk factors to 47.7% in those having any three or more of the six risk factors (p < 0.001). Patients with concurrent EDH and brain herniation exhibited an increased risk for post-traumatic MCI with the accumulation of several critical clinical factors. Early decompressive craniectomy based on accurate risk estimation is recommended in efforts to improve patient functional outcomes.	[Wang, Wen-hao; Hu, Lian-shui; Lin, Hong; Li, Jun; Luo, Fei; Huang, Wei; Lin, Jun-ming; Cai, Gen-ping; Liu, Chang-chun] Xiamen Univ, Southeast Hosp, Hosp PLA 175, Dept Neurosurg, Zhangzhou 363000, Peoples R China		Wang, WH (corresponding author), Xiamen Univ, Southeast Hosp, Hosp PLA 175, Dept Neurosurg, 269th Zhanghua Rd, Zhangzhou 363000, Peoples R China.	wenhao_wang0712@126.com		Wang, Wen-Hao/0000-0001-9568-3876			Araujo João Luiz Vitorino, 2012, Rev. Col. Bras. Cir., V39, P268; BULLOCK MR, 2006, NEUROSURGERY, V3, pS7; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Kruetzelmann A, 2014, INT J STROKE, V9, P210, DOI 10.1111/ijs.12060; Lau D, 2012, J NEUROSURG, V116, P234, DOI 10.3171/2011.7.JNS11396; Liu WG, 2008, BRAIN INJURY, V22, P199, DOI 10.1080/02699050801895407; Manawadu D, 2008, CAN J NEUROL SCI, V35, P544, DOI 10.1017/S031716710000932X; Mangla R, 2014, EMERG RADIOL, V21, P49, DOI 10.1007/s10140-013-1125-9; Marion DW, 2006, NEUROSURGERY, V58, P655; Mattos JP, 2010, ARQ NEURO-PSIQUIAT, V68, P339, DOI 10.1590/S0004-282X2010000300002; Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017; Nelson JA, 2011, ACAD EMERG MED, V18, P78, DOI 10.1111/j.1553-2712.2010.00949.x; Otani N, 2010, ACTA NEUROCHIR SUPPL, V106, P261, DOI 10.1007/978-3-211-98811-4_49; Smith SW, 2010, J EMERG MED, V39, P377, DOI 10.1016/j.jemermed.2009.04.062; Subramaniam S, 2005, NEUROLOGIST, V11, P150, DOI 10.1097/01.nrl.0000159987.70461.d7; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e	19	12	16	2	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2014	31	16					1444	1450		10.1089/neu.2013.3142			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4DB	WOS:000340536700008	24773559				2022-02-06	
J	Sillesen, M; Jin, G; Johansson, PI; Alam, HB				Sillesen, Martin; Jin, Guang; Johansson, Par I.; Alam, Hasan B.			Resuscitation speed affects brain injury in a large animal model of traumatic brain injury and shock	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Hemorrhagic shock resuscitation; Fresh frozen plasma; Swine	RAPID INFUSION SYSTEM; HEMORRHAGIC-SHOCK; FLUID RESUSCITATION; ENDOTHELIAL GLYCOCALYX; 0.9-PERCENT SALINE; RINGERS SOLUTION; VOLUME KINETICS; BLOOD-VOLUME; ANESTHESIA; PLASMA	Background: Optimal fluid resuscitation strategy following combined traumatic brain injury (TBI) and hemorrhagic shock (HS) remain controversial and the effect of resuscitation infusion speed on outcome is not well known. We have previously reported that bolus infusion of fresh frozen plasma (FFP) protects the brain compared with bolus infusion of 0.9% normal saline (NS). We now hypothesize reducing resuscitation infusion speed through a stepwise infusion speed increment protocol using either FFP or NS would provide neuroprotection compared with a high speed resuscitation protocol. Methods: 23 Yorkshire swine underwent a protocol of computer controlled TBI and 40% hemorrhage. Animals were left in shock (mean arterial pressure of 35 mmHg) for two hours prior to resuscitation with bolus FFP (n = 5, 50 ml/min) or stepwise infusion speed increment FFP (n = 6), bolus NS (n = 5, 165 ml/min) or stepwise infusion speed increment NS (n = 7). Hemodynamic variables over a 6-hour observation phase were recorded. Following euthanasia, brains were harvested and lesion size as well as brain swelling was measured. Results: Bolus FFP resuscitation resulted in greater brain swelling (22.36 +/- 1.03% vs. 15.58 +/- 2.52%, p = 0.04), but similar lesion size compared with stepwise resuscitation. This was associated with a lower cardiac output (CO: 4.81 +/- 1.50 l/min vs. 5.45 +/- 1.14 l/min, p = 0.03). In the NS groups, bolus infusion resulted in both increased brain swelling (37.24 +/- 1.63% vs. 26.74 +/- 1.33%, p = 0.05) as well as lesion size (3285.44 +/- 130.81 mm(3) vs. 2509.41 +/- 297.44 mm(3), p = 0.04). This was also associated with decreased cardiac output (NS: 4.37 +/- 0.12 l/min vs. 6.35 +/- 0.10 l/min, p < 0.01). Conclusions: In this clinically relevant model of combined TBI and HS, stepwise resuscitation protected the brain compared with bolus resuscitation.	[Sillesen, Martin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Div Trauma Emergency Surg & Surg Crit C, Boston, MA 02114 USA; [Sillesen, Martin] Copenhagen Univ Hosp, Dept Surg, DK-3400 Hillerod, Denmark; [Jin, Guang; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA; [Johansson, Par I.] Rigshosp, Copenhagen Univ Hosp, Capital Reg Blood Bank, DK-2100 Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Houston, Sch Med, Dept Surg, Houston, TX 77030 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Johansson, Par I/P-9283-2015	Johansson, Par I/0000-0001-9778-5964; Sillesen, Martin/0000-0001-9494-5475	U.S ArmyUnited States Department of Defense [T00521959]; Lundbeck foundationLundbeckfonden; Laerdal foundation	The study was funded by a grant (GRANTT00521959) from the U.S Army to Hasan B. Alam and grants from the Laerdal and Lundbeck foundations to MS.	[Anonymous], 2012, ADV TRAUM LIF SUPP M; Barcelona SL, 2003, ANESTH ANALG, V97, P358, DOI 10.1213/01.ANE.0000070235.67887.5C; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bruegger D, 2005, AM J PHYSIOL-HEART C, V289, pH1993, DOI 10.1152/ajpheart.00218.2005; Bruegger D, 2011, BASIC RES CARDIOL, V106, P1111, DOI 10.1007/s00395-011-0203-y; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; Dyer RA, 2004, ANAESTH INTENS CARE, V32, P351, DOI 10.1177/0310057X0403200308; Ewaldsson CA, 2005, ANESTHESIOLOGY, V103, P460, DOI 10.1097/00000542-200509000-00006; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Hahn RG, 2010, ANESTHESIOLOGY, V113, P470, DOI 10.1097/ALN.0b013e3181dcd88f; Hambly PR, 1996, RESUSCITATION, V31, P127, DOI 10.1016/0300-9572(95)00910-8; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Krausz MM, 2003, J TRAUMA, V55, P62, DOI 10.1097/01.TA.0000074110.77122.46; Lee EH, 2010, KOREAN J ANESTHESIOL, V58, P514, DOI 10.4097/kjae.2010.58.6.514; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Li Y, 2007, ACTA ANAESTH SCAND, V51, P880, DOI 10.1111/j.1399-6576.2007.01351.x; Lobo DN, 2010, CRIT CARE MED, V38, P464, DOI 10.1097/CCM.0b013e3181bc80f1; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Norberg A, 2007, ANESTHESIOLOGY, V107, P24; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Rehm M, 2001, ANESTHESIOLOGY, V95, P849, DOI 10.1097/00000542-200110000-00011; Schmidt BM, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-S1-S9; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Starling E H, 1896, J Physiol, V19, P312; Stern SA, 2000, SHOCK, V14, P616, DOI 10.1097/00024382-200014060-00008; White S J, 1991, Prehosp Disaster Med, V6, P429; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515	32	12	12	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	AUG 14	2014	22								46	10.1186/s13049-014-0046-2			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AO2MC	WOS:000341155900001	25116886	Green Published, gold			2022-02-06	
J	Desgranges, FP; Javouhey, E; Mottolese, C; Migeon, A; Szathmari, A; Baudin, F; de Queiroz, M; Cogniat, B; Chassard, D				Desgranges, Francois-Pierrick; Javouhey, Etienne; Mottolese, Carmine; Migeon, Anne; Szathmari, Alexandru; Baudin, Florent; de Queiroz, Mathilde; Cogniat, Berengere; Chassard, Dominique			Intraoperative blood loss during decompressive craniectomy for intractable intracranial hypertension after severe traumatic brain injury in children	CHILDS NERVOUS SYSTEM			English	Article						Decompressive craniectomy; Traumatic brain injury; Child; Blood loss; Coagulopathy; Hemodynamics	SINGLE-CENTER EXPERIENCE; SEVERE HEAD-INJURY; SURGERY; COAGULOPATHY; COAGULATION; MANAGEMENT	There are no data available on the risk of intraoperative bleeding during decompressive craniectomy (DC) after traumatic brain injury (TBI) in children. The objectives of this study were to assess the risk of intraoperative bleeding during DC for intractable intracranial hypertension after TBI, to identify potential factors associated with the risk of bleeding during DC, and to assess the impact of DC on systemic and cerebral hemodynamics and on coagulation. Twelve children were identified as having undergone DC after TBI from April 2009 to June 2013 in our center. Subjects were allocated into two groups according to the percentage of blood loss (IBL) during the intraoperative period (< or a parts per thousand yen50 % of the estimated blood volume (EBV)). The median IBL during DC was 49 [17-349] % of the EBV. Children with an IBL a parts per thousand yenaEuro parts per thousand 50 % of EBV had higher preoperative intracranial pressure (ICP) (p = 0.03) and international normalized ratio (INR) (p = 0.02) than those with an IBL < 50 % of EBV. DC induced significant decreases in ICP (p = 0.0005), mean arterial pressure (p = 0.01), and a significant increase in norepinephrine flow rate (p = 0.04) between the immediate pre- and postoperative periods. DC allows a significant decrease in ICP after severe pediatric TBI but is a surgical procedure at a high risk of bleeding. High ICP and INR during the immediate preoperative period are the main factors associated with increased IBL during DC. Further studies are needed to confirm our results and to assess the impact of the amount of IBL on the postoperative survival and functional outcome.	[Desgranges, Francois-Pierrick; Migeon, Anne; de Queiroz, Mathilde; Cogniat, Berengere; Chassard, Dominique] Univ Lyon 1, Hosp Civils Lyon, Dept Pediat Anesthesia, Hop Femme Mere Enfant, F-69365 Lyon, France; [Javouhey, Etienne; Baudin, Florent] Univ Lyon 1, Hosp Civils Lyon, Dept Pediat Intens Care Unit, Hop Femme Mere Enfant, F-69365 Lyon, France; [Mottolese, Carmine; Szathmari, Alexandru] Univ Lyon 1, Hop Neurol Pierre Weirtheimer, Dept Pediat Neurosurg, F-69365 Lyon, France; [Mottolese, Carmine; Szathmari, Alexandru] Univ Lyon 1, Hosp Civils Lyon, Hop Femme Mere Enfant, F-69365 Lyon, France; [Desgranges, Francois-Pierrick] Hosp Civils Lyon, Dept Anesthesie Reanimat, Hop Femme Mere Enfant, F-69677 Bron, France		Desgranges, FP (corresponding author), Hosp Civils Lyon, Dept Anesthesie Reanimat, Hop Femme Mere Enfant, 59 Blvd Pinel, F-69677 Bron, France.	fp_desgranges@yahoo.fr	Javouhey, Etienne/G-3651-2013				Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Glick RP, 2011, PEDIATR NEUROSURG, V47, P152, DOI 10.1159/000330709; Goobie SM, 2011, ANESTHESIOLOGY, V114, P862, DOI 10.1097/ALN.0b013e318210fd8f; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Haas T, 2012, BRIT J ANAESTH, V108, P36, DOI 10.1093/bja/aer342; Jacob AT, 2011, PEDIATR NEUROSURG, V47, P81, DOI 10.1159/000329624; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Manohar C, 2011, J CLIN NEUROSCI, V18, P1180, DOI 10.1016/j.jocn.2011.02.018; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Piastra M, 2008, J NEURO-ONCOL, V90, P191, DOI 10.1007/s11060-008-9643-0; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	21	12	12	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2014	30	8					1393	1398		10.1007/s00381-014-2417-4			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AM3CY	WOS:000339730800008	24748064				2022-02-06	
J	Fietzek, UM; Kossmehl, P; Schelosky, L; Ebersbach, G; Wissel, J				Fietzek, U. M.; Kossmehl, P.; Schelosky, L.; Ebersbach, G.; Wissel, J.			Early botulinum toxin treatment for spastic pes equinovarus - a randomized double-blind placebo-controlled study	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						Ashworth scale; botulinum toxin; pes equinovarus; randomized controlled trial; spasticity	LOWER-LIMB SPASTICITY; POSTSTROKE SPASTICITY; CONTROLLED-TRIAL; STROKE PATIENTS; BRAIN-INJURY; FOOT; MUSCLE; ADULTS; MANAGEMENT; INJECTION	Background and purpose: Spastic pes equinovarus is a frequent pathological posture of the lower extremity. Botulinum toxin (BoNT/A) has been successfully applied to treat lower limb spasticity. However, the best time to initiate treatment remains unclear. A beneficial effect of an early treatment has been suggested in previous studies. Methods: A single-centre double-blind randomized placebo-controlled trial was performed to investigate the efficacy of BoNT/A to reduce muscle hypertonicity at the ankle. Fifty-two patients with unilateral or bilateral spastic pes equinovarus with a modified Ashworth score (mAS) of at least 1+ after stroke, traumatic brain injury or hypoxic encephalopathy were allocated to receive either BoNT/A or placebo treatment. A second, open injection was optional at week 12. Patients received unilateral or bilateral injections with 230 or 460 U onabotulinumtoxinA, respectively. The course of the mAS was explored during the open study phase. Results: Patients who had received BoNT/A treatment had lower mAS compared with placebo at week 12 (P < 0.01). During the open label phase, patients from the placebo group showed further deterioration of muscle tone despite starting from a similar baseline and receiving BoNT treatment. Spastic feet that had received BoNT/A in the first cycle had comparatively lower mAS scores over all follow-up data and at week 24 (P < 0.01). Conclusions: The study demonstrates a reduction of muscular hypertonicity in spastic pes equines with BoNT/A treatment given during the first 3 months after the lesion. Exploratory analyses of the course of muscular hypertonicity during the open phase favour earlier to later treatment.	[Fietzek, U. M.] Schon Klin Munchen Schwabing, Dept Neurol & Clin Neurophysiol, Munich, Germany; [Kossmehl, P.] Kliniken Beelitz, Neurol Rehabil Med Ctr, Beelitz, Germany; [Schelosky, L.] Kantonsspital Munsterlingen, Dept Neurol, Munsterlingen, Switzerland; [Ebersbach, G.] Kliniken Beelitz, Beelitz, Germany; [Wissel, J.] Vivantes Klinikum Spandau, Dept Neurol Rehabil & Phys Med, D-13585 Berlin, Germany		Wissel, J (corresponding author), Vivantes Klinikum Spandau, Neurol Klin, Neue Bergstr 6, D-13585 Berlin, Germany.	joerg.wissel@vivantes.de		Fietzek, Urban/0000-0002-4323-9930; Ebersbach, Georg/0000-0003-3403-6987	PharmAllergan GmbH, Ettlingen, Germany	The study was funded with a restricted grant from PharmAllergan GmbH, Ettlingen, Germany, that paid for the physiotherapist's recording of study data. No influence was made on the design of the protocol and the drafting of the manuscript.	Burbaud P, 1996, J NEUROL NEUROSUR PS, V61, P265, DOI 10.1136/jnnp.61.3.265; COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P379; de Haart M, 2004, ARCH PHYS MED REHAB, V85, P886, DOI 10.1016/j.apmr.2003.05.012; DENGLER R, 1992, J NEUROL, V239, P375; DUNNE JW, 1995, J NEUROL NEUROSUR PS, V58, P232, DOI 10.1136/jnnp.58.2.232; Farina S, 2008, FUNCT NEUROL, V23, P87; Fock J, 2004, BRAIN INJURY, V18, P57, DOI 10.1080/0269905031000149498; Foley N, 2010, EUR J NEUROL, V17, P1419, DOI 10.1111/j.1468-1331.2010.03084.x; Hesse S, 2012, CLIN REHABIL, V26, P237, DOI 10.1177/0269215511421355; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Mayer NH, 1997, MUSCLE NERVE, pS21; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Olver J, 2010, EUR J NEUROL, V17, P57, DOI 10.1111/j.1468-1331.2010.03128.x; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Reiter F, 1998, ARCH PHYS MED REHAB, V79, P532, DOI 10.1016/S0003-9993(98)90068-5; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Rosales RL, 2008, J NEURAL TRANSM, V115, P617, DOI 10.1007/s00702-007-0869-3; Rousseaux M, 2008, EUR J NEUROL, V15, P506, DOI 10.1111/j.1468-1331.2008.02112.x; Sheean G, 2006, DRUG SAFETY, V29, P31, DOI 10.2165/00002018-200629010-00003; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Ward AB, 2012, EUR J NEUROL, V19, P21, DOI 10.1111/j.1468-1331.2011.03448.x; Wissel J, 2000, J PAIN SYMPTOM MANAG, V20, P44, DOI 10.1016/S0885-3924(00)00146-9; Wissel J, 2013, NEUROLOGY, V80, pS13, DOI 10.1212/WNL.0b013e3182762448; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1	28	12	16	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	AUG	2014	21	8					1089	1095		10.1111/ene.12381			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM9ZA	WOS:000340238800010	24754350				2022-02-06	
J	Hyatt, K; Davis, LL; Barroso, J				Hyatt, Kyong; Davis, Linda L.; Barroso, Julie			Chasing the Care: Soldiers Experience Following Combat-Related Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							HEAD-INJURY; VETERANS; BARRIERS; IRAQ	Objective: One of the most common, yet most difficult to detect injuries sustained by U.S. soldiers in Iraq and Afghanistan is mild traumatic brain injury (mTBI). Left untreated, mTBI can negatively impact soldiers' postdeployment adjustment. This research describes the rehabilitation experiences of soldiers with a history of mTBI and their spouses. Method: Nine soldiers with mTBI and their spouses participated in the study. A total of 27 interviews were conducted exploring couples' post-mTBI rehabilitation experiences. Participants consisted of active duty soldiers with mTBI who had returned from deployment within 2 years, and their civilian spouses. Strauss and Corbin's grounded theory methodology was used to collect and analyze the data. Findings: The majority of the soldiers and spouses who participated (16/18) indicated that uncertain prognosis and symptom management were the greatest challenges of post-mTBI. Other challenges, such as delayed diagnosis, limited access to mental health care, and difficulty navigating an unfamiliar military health care system was also reported. Conclusions: Because of mTBI's lack of visible manifestation, soldiers may confuse their mTBI symptoms with those of other deployment-related injuries and this leads to a delay in treatment. Future research should explore the standardization of post-mTBI rehabilitation programs and the effectiveness of soldier education to promote early detection and treatment.	[Hyatt, Kyong] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Davis, Linda L.; Barroso, Julie] Duke Univ, Durham, NC 27710 USA		Hyatt, K (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave Bldg 17B,Suite 3E, Bethesda, MD 20889 USA.		Davis, Linda Lindsey/T-7351-2019		TriService Nursing Research Program [HU0001-11-1-TS14 (N11-C17)]	The authors thank Dr Charles Vacchiano, Dr. Susan Silva, Dr. Paul Lewis, and LCDR Billy Collins for their support. This study was funded by grant HU0001-11-1-TS14 (N11-C17) from the TriService Nursing Research Program.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bradshaw D., 2008, TRAUMATIC BRAIN INJU; Carlson K, 2009, ASSESSMENT TREATMENT; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC), 2010, TRAUMATIC BRAIN INJU; Charmaz K., 2014, BROKERAGE CLOSURE IN; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Department of Defense Personnel & Procurement Statistics, 2008, DEF MANP DAT 2008; *DVBIC, 2006, DEF VET BRAIN INJ CT; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Pandit N.R., 1996, QUALITATIVE REPORT, V2, P1; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Rutherford WH, 1989, BRAIN INJURY, V10, P225; Sosin DM, 1996, BRAIN INJURY, V10, P47; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; ZOROYA G, 2006, CTR WAR RELATED BRAI	28	12	12	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2014	179	8					849	855		10.7205/MILMED-D-13-00526			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7UO	WOS:000340806700006	25102527	Bronze			2022-02-06	
J	Lee, JY; Kim, DK; Seo, KM; Kang, SH				Lee, Ji Young; Kim, Don-Kyu; Seo, Kyung Mook; Kang, Si Hyun			Usefulness of the Simplified Cough Test in Evaluating Cough Reflex Sensitivity as a Screening Test for Silent Aspiration	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Deglutition disorders; Cough; Respiratory aspiration of gastric contents; Diagnosis; Citric acid		Objective To assess cough reflex sensitivity using the simplified cough test (SCT) and to evaluate the usefulness of SCT to screen for silent aspiration. Methods The healthy control group was divided into two subgroups: the young (n=29, 33.44 +/- 9.99 years) and the elderly (n=30, 63.66 +/- 4.37 years). The dysphagic elderly group (n=101, 72.95 +/- 9.19 years) consisted of patients with dysphagia, who suffered from a disease involving central nervous system (ischemic stroke 47, intracerebral hemorrhage 27, traumatic brain injury 11, encephalitis 5, hypoxic brain damage 3, and Parkinson disease 8). The SCT was performed using the mist of a 1% citric acid from a portable nebulizer. The time from the start of the inhalation to the first cough was measured as the cough latency. All the dysphagic patients underwent the videofluoroscopic swallowing study. Results The cough latency was more significantly prolonged in the healthy elderly group than in the healthy young group (p<0.001), and in the dysphagic elderly group than in the healthy elderly group (p<0.001). The sensitivity and specificity of SCT were 73.8% and 72.5% for detecting aspiration in the dysphagic patients, and 87.1% and 66.7% for detecting silent aspiration in the aspirated patients. Conclusion Cough latency measured with the SCT reflects the impairment of cough reflex in healthy elderly and dysphasic subjects. The results of this study show that the SCT test can be a valuable method of screening aspiration with or without cough in dysphasic patients.	[Lee, Ji Young; Kim, Don-Kyu; Seo, Kyung Mook; Kang, Si Hyun] Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, Seoul, South Korea		Kim, DK (corresponding author), Chung Ang Univ, Dept Phys Med & Rehabil, Coll Med Hosp, 102 Heukseok Ro, Seoul 156755, South Korea.	donkim21@cau.ac.kr			Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A100054]	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (No. A100054).	Bours GJ, 2009, J ADV NURS, V65, P477, DOI 10.1111/j.1365-2648.2008.04915.x; Dicpinigaitis PV, 2003, CHEST, V123, P685, DOI 10.1378/chest.123.3.685; Ebihara S, 2012, LUNG, V190, P29, DOI 10.1007/s00408-011-9334-z; Ebihara Satoru, 2011, Cough, V7, P3, DOI 10.1186/1745-9974-7-3; Ebihara S, 2011, PULM PHARMACOL THER, V24, P318, DOI 10.1016/j.pupt.2010.10.003; Fujimura M, 1996, EUR RESPIR J, V9, P1624, DOI 10.1183/09031936.96.09081624; Gilbert R, 2001, WESTERN J MED, V174, P405, DOI 10.1136/ewjm.174.6.405; Harsoliya MS, 2011, INT J PHARM BIOL ARC, V2, P840; Kelly AM, 2007, LARYNGOSCOPE, V117, P1723, DOI 10.1097/MLG.0b013e318123ee6a; Langmore Susan E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P485, DOI 10.1097/00020840-200312000-00014; Mazzone SB, 2004, PULM PHARMACOL THER, V17, P361, DOI 10.1016/j.pupt.2004.09.021; Mazzone SB, 2003, COUGH: CAUSES, MECHANISMS AND THERAPY, P161; Nakajoh K, 2000, J INTERN MED, V247, P39, DOI 10.1046/j.1365-2796.2000.00565.x; Newnham DM, 1997, AGE AGEING, V26, P185, DOI 10.1093/ageing/26.3.185; Palmer J. B., 2011, PHYS MED REHABILITAT, P581, DOI 10.1016/B978-1-4377-0884-4.10027-8; Perry L, 2001, DYSPHAGIA, V16, P7, DOI 10.1007/s004550000047; Sato M, 2012, ARCH PHYS MED REHAB, V93, P1982, DOI 10.1016/j.apmr.2012.05.016; SEKIZAWA K, 1990, LANCET, V335, P1228, DOI 10.1016/0140-6736(90)92758-A; Smith J, 2006, CHEST, V130, P379, DOI 10.1016/S0012-3692(15)51851-5; Wakasugi Y, 2008, DYSPHAGIA, V23, P364, DOI 10.1007/s00455-008-9150-7; Widdicombe J, 2006, EUR RESPIR J, V28, P10, DOI 10.1183/09031936.06.00096905; Widdicombe J, 2006, RESP PHYSIOL NEUROBI, V150, P105, DOI 10.1016/j.resp.2005.04.013	22	12	13	0	4	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	AUG	2014	38	4					476	484		10.5535/arm.2014.38.4.476			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC6DF	WOS:000433885900006	25229026	Green Submitted, Green Published, gold			2022-02-06	
J	Reed-Jones, RJ; Murray, NG; Powell, DW				Reed-Jones, Rebecca J.; Murray, Nicholas G.; Powell, Douglas W.			Clinical Assessment of Balance in Adults with Concussion	SEMINARS IN SPEECH AND LANGUAGE			English	Article						Balance assessment; standing balance; vestibular; sensory integration; concussion	MILD HEAD-INJURY; POSTURAL STABILITY; CEREBRAL CONCUSSION; RECOVERY; ADAPTATION; MANAGEMENT; DIZZINESS; DEFICITS	Balance is a key component to the assessment of concussion injury; however, the efficacies of clinical tests used are currently under debate. It is questionable whether currently accepted methods of standing balance assessment quantify balance disturbances sufficiently to support decisions on recovery and return to play. Recent evidence of balance abnormalities postconcussion that linger beyond the typical 3-to 5-day recovery period support arguments that currently available standing balance tests are not sensitive enough to determine recovery of function. This article discusses the current clinical tests used in the assessment of concussion in adults and their limitations and the evidence supporting continued balance dysfunction. Implications for the future of balance assessment in concussed adults and recommendations to clinicians for best practices are presented.	[Reed-Jones, Rebecca J.] Univ Prince Edward Isl, Fac Sci, Dept Appl Human Sci, Charlottetown, PE C1A 4P3, Canada; [Murray, Nicholas G.] Univ Texas El Paso, Interdisciplinary Hlth Sci PhD Program, El Paso, TX 79968 USA; [Powell, Douglas W.] Campbell Univ, Dept Phys Therapy, Buies Creek, NC 27506 USA		Reed-Jones, RJ (corresponding author), Univ Prince Edward Isl, Fac Sci, Dept Appl Human Sci, 550 Univ Ave, Charlottetown, PE C1A 4P3, Canada.	rreedjones@upei.ca	Reed-Jones, Rebecca/L-2021-2019	Reed-Jones, Rebecca/0000-0002-2128-2671			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 1995, GAIT POSTURE; Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Horak FB, 1997, GAIT POSTURE, V6, P76, DOI 10.1016/S0966-6362(97)00018-0; Khasnis A, 2003, J Postgrad Med, V49, P169; Lanska DJ, 2000, NEUROLOGY, V55, P1201, DOI 10.1212/WNL.55.8.1201; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2012, J SCI MED SPORT; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Metcalfe JS, 2000, INFANT BEHAV DEV, V23, P391, DOI 10.1016/S0163-6383(01)00054-6; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Murray NO, 2014, THESIS U TEXAS EL PA; NASHNER LM, 1982, J NEUROSCI, V2, P536; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Powell D, GREATER CTR PRESSURE; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Reed-Jones RJ, 2008, NEUROSCI LETT, V435, P204, DOI 10.1016/j.neulet.2008.02.047; Reed-Jones RJ, 2012, GAIT POSTURE, V36, P430, DOI 10.1016/j.gaitpost.2012.03.027; Riemann BL, 2000, J ATHL TRAINING, V35, P19; ROGERS JH, 1980, J LARYNGOL OTOL, V94, P1401, DOI 10.1017/S002221510009023X; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Wikstrom EA, 2012, J ATHL TRAINING, V47, P306, DOI 10.4085/1062-6050-47.3.16	39	12	12	1	14	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	AUG	2014	35	3					186	195		10.1055/s-0034-1384680			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AM6PA	WOS:000339985900006	25116212				2022-02-06	
J	Fletcher, TL; Kolias, AG; Hutchinson, PJA; Sutcliffe, MPF				Fletcher, Tim L.; Kolias, Angelos G.; Hutchinson, Peter J. A.; Sutcliffe, Michael P. F.			Development of a Finite Element Model of Decompressive Craniectomy	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; MICROSCOPY	Decompressive craniectomy (DC), an operation whereby part of the skull is removed, is used in the management of patients with brain swelling. While the aim of DC is to reduce intracranial pressure, there is the risk that brain deformation and mechanical strain associated with the operation could damage the brain tissue. The nature and extent of the resulting strain regime is poorly understood at present. Finite element (FE) models of DC can provide insight into this applied strain and hence assist in deciding on the best surgical procedures. However there is uncertainty about how well these models match experimental data, which are difficult to obtain clinically. Hence there is a need to validate any modelling approach outside the clinical setting. This paper develops an axisymmetric FE model of an idealised DC to assess the key features of such an FE model which are needed for an accurate simulation of DC. The FE models are compared with an experimental model using gelatin hydrogel, which has similar poro-viscoelastic material property characteristics to brain tissue. Strain on a central plane of the FE model and the front face of the experimental model, deformation and load relaxation curves are compared between experiment and FE. Results show good agreement between the FE and experimental models, providing confidence in applying the proposed FE modelling approach to DC. Such a model should use material properties appropriate for brain tissue and include a more realistic whole head geometry.	[Fletcher, Tim L.; Sutcliffe, Michael P. F.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Kolias, Angelos G.; Hutchinson, Peter J. A.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kolias, Angelos G.; Hutchinson, Peter J. A.] Univ Cambridge, Cambridge, England		Sutcliffe, MPF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mpfs@eng.cam.ac.uk		Hutchinson, Peter/0000-0002-2796-1835; Kolias, Angelos/0000-0003-3992-0587	Engineering and Physical Sciences Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC); Royal College of Surgeons of England Research Fellowship; Freemasons; Rosetrees TrustRosetrees Trust; NIHR Academic Clinical Fellowship; Raymond and Beverly Sackler Studentship; NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, 12/35/57] Funding Source: researchfish	TLF acknowledges funding from the Engineering and Physical Sciences Research Council (EPSRC). AGK is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), an NIHR Academic Clinical Fellowship and a Raymond and Beverly Sackler Studentship. PJH is supported by a NIHR Research Professorship and the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Cruz-Flores S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003435.pub2; Dassault Systemes Simulia, 2011, AB US MAN 6 11 1 SEC; Detournay E, 1993, COMPREHENSIVE ROCK E, P113, DOI DOI 10.1016/B978-0-08-040615-2.50011-3; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Franceschini G, 2006, THESIS U TRENTO; Galli M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2957993; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Hert S, 2010, CGAL USER REFERENCE; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Kalyanam S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127250; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0; Lakes R, 2009, VISCOELASTIC MAT, DOI [10.1017/CBO9780511626722, DOI 10.1017/CB09780511626722]; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2010, INT J NUMER METH BIO, V26, P117, DOI 10.1002/cnm.1260; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Screen HRC, 2009, J STRAIN ANAL ENG, V44, P327, DOI 10.1243/03093247JSA491; Strange DGT, 2012, J MECH BEHAV BIOMED, V11, P16, DOI 10.1016/j.jmbbm.2011.10.003; Suh JK, 1999, J APPL MECH-T ASME, V66, P528, DOI 10.1115/1.2791079; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; von Holst H, 2012, ACTA NEUROCHIR, P1; Wright RM, 2011, BIOMECH MODEL MECHAN, V11, P245; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021	32	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e102131	10.1371/journal.pone.0102131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	WOS:000339992400044	25025666	Green Published, Green Submitted, gold			2022-02-06	
J	Austin, BS; Lee, CL				Austin, Bryan S.; Lee, Chun-Lung			A Structural Equation Model of Vocational Rehabilitation Services: Predictors of Employment Outcomes for Clients with Intellectual and Co-occurring Psychiatric Disabilities	JOURNAL OF REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; MENTAL-RETARDATION; DEVELOPMENTAL-DISABILITIES; COMPETITIVE EMPLOYMENT; SUPPORTED EMPLOYMENT; INDIVIDUALS; PEOPLE; ADULTS; OPPORTUNITIES; ILLNESS	Despite low employment rates and significant barriers to competitive employment, individuals with intellectual disabilities (ID) and co-occurring psychiatric disabilities want to work and are capable of working. From the context of the state-federal vocational rehabilitation (VR) program, this study analyzed variables from the Rehabilitation Services Administration 911 national data set through structural equation modeling. New knowledge about the state-federal VR program was generated. In particular, job-related VR services (Job Placement, Job Search Assistance, Job Readiness Training, and On-the-Job Support) were found to significantly predict employment outcomes for VR clients with ID and co-occurring psychiatric disabilities. Implications for VR practice and future research are discussed.	[Austin, Bryan S.] Univ Idaho, Boise, ID 83702 USA; [Lee, Chun-Lung] Michigan State Univ, E Lansing, MI 48824 USA		Austin, BS (corresponding author), Univ Idaho, Dept Leadership & Counseling, Rehabil Counseling & Human Serv Program, 322 E Front St,Suite 440, Boise, ID 83702 USA.	baustin@uidaho.edu					Baron R. C., 2002, BEHAV SCI LAW, V20, P585; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Bond GR, 2008, J REHABIL, V74, P33; Butterworth J, 2012, J REHABIL, V78, P20; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P61; Chan F, 2007, REHABIL COUNS BULL, V51, P44; Chan Fong, 2008, J Cancer Surviv, V2, P169, DOI 10.1007/s11764-008-0057-y; Chiu CY, 2013, MULT SCLER J, V19, P1655, DOI 10.1177/1352458513482372; Cimera R. E., 2001, J DISABILITY POLICY, V11, P194, DOI DOI 10.1177/104420730101100401; Cooper, 2003, EFFECT SIZE SUBSTANT; Degeneffe C.E., 2000, J APPL REHABIL COUS, V31, P41; Dutta A, 2008, J OCCUP REHABIL, V18, P326, DOI 10.1007/s10926-008-9154-z; Equal Employment Opportunity Commission [EEOC], 2011, QUEST ANSW IND INT D; Erickson W, 2010, DISABILITY STAT 2008; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang I. C., 2013, DEV MED CHILD NEUROL, DOI [10.1111/dmcn.1224, DOI 10.1111/DMCN.1224]; Huang WH, 1997, J REHABIL, V63, P27; Institute for Community Inclusion, 2011, REAL PEOPL REAL JOBS; Jacobson JW, 1996, J REHABIL, V62, P11; Jahoda A, 2008, J APPL RES INTELLECT, V21, P1, DOI 10.1111/j.1468-3148.2007.00365.x; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Joreskog K., 2001, LISREL 8 USERS REFER; Kaplan D, 2009, STRUCTURAL EQUATION, V2nd; Kiernan W., 2000, FOCUS AUTISM OTHER D, V15, P90, DOI DOI 10.1177/108835760001500204; Kline R.B., 2011, PRINCIPLES PRACTICE, V3rd; Kosciulek JF, 2001, REHABIL COUNS BULL, V44, P209, DOI 10.1177/003435520104400403; Luecking D. M., 2006, J APPL REHABILITATIO, V37, P22; Mank D, 1998, MENT RETARD, V36, P205, DOI 10.1352/0047-6765(1998)036<0205:EOFPWS>2.0.CO;2; Mank D, 1997, MENT RETARD, V35, P185, DOI 10.1352/0047-6765(1997)035<0185:AOTTOS>2.0.CO;2; Marcoulides G., 2001, NEW DEV TECHNIQUES S; Martin Luecking D., 2006, J APPL REHABILITATIO, V37, P14; Migliore A, 2008, REHABIL COUNS BULL, V52, P35, DOI 10.1177/0034355208320075; Moore CL, 2004, MENT RETARD, V42, P253, DOI 10.1352/0047-6765(2004)42<253:EAOCEO>2.0.CO;2; Moore CL, 2002, J REHABIL, V68, P14; Moore CL, 2002, REHABIL COUNS BULL, V45, P162, DOI 10.1177/003435520204500305; National Association of State Mental Health Program Directors [NASMHPD], 2004, SERV IND COOCC DEV D; National Association of the Dually Diagnosed [NADD], 2011, INF DUAL DIAGN; Olney MF, 2001, MENT RETARD, V39, P32, DOI 10.1352/0047-6765(2001)039<0032:NEOVSU>2.0.CO;2; Raykov T., 2006, 1 COURSE STRUCTURAL, V2nd; Rehabilitation Services Administration, 2008, 911 RSA; Rosenthal DA, 2007, INT J SOC PSYCHIATR, V53, P357, DOI 10.1177/0020764006074555; Rubin S. E., 1995, FDN VOCATIONAL REHAB, P175; Saunders J. L., 2006, J APPL REHABILITATIO, V37, P3; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Strauser D, 2010, J CANCER SURVIV, V4, P179, DOI 10.1007/s11764-010-0119-9; Strauser DR, 2004, REHABIL COUNS BULL, V47, P215, DOI 10.1177/00343552040470040301; Timmons JC, 2002, J VOCATIONAL REHABIL, V17, P183; VanderSchie-Bezyak JL, 2003, J REHABIL, V69, P53; Yamaki K, 2002, MENT RETARD, V40, P132, DOI 10.1352/0047-6765(2002)040<0132:EAISOA>2.0.CO;2; [No title captured]; [No title captured]	52	12	13	0	17	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	JUL-SEP	2014	80	3					11	20					10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AU8ZK	WOS:000345881600003					2022-02-06	
J	Brewer-Smyth, K				Brewer-Smyth, Kathleen			Obesity, Traumatic Brain Injury, Childhood Abuse, and Suicide Attempts in Females at Risk	REHABILITATION NURSING			English	Article						Brain injury; child; child abuse sexual; traumatic brain injury; trauma; suicide; obesity; female	ALL-CAUSE MORTALITY; SEXUAL-ABUSE; SALIVARY CORTISOL; PHYSICAL ABUSE; BEHAVIOR; HEALTH; CONSEQUENCES; ASSOCIATION; OVERWEIGHT; NEGLECT	Purpose: This study tested the hypothesis that obesity is related to history of traumatic brain injury (TBI), severity and frequency of childhood physical (CPA) and sexual abuse (CSA), and suicide attempts, adjusting for related variables in a high risk female population. Design: This cross-sectional study of 81 females compared obese to non-obese. Methods: All variables were verified by private interviews, physical examination, and documented evidence, then statistically analyzed with logistic regression. Findings: Obesity at the time of interview was related to history of a decreased number of TBIs per person, greater CSA, suicide attempts, and decreased CPA, adjusting for current smoking, depression, currently using selective serotonin reuptake inhibitors, and age. Conclusions: Number of TBIs per person and CPA were inversely related to obesity, adjusting for related variables. Greater CSA frequency and severity, and having attempted suicide were significantly related to greater risk of obesity, adjusting for related variables. Though causes of obesity cannot be determined by this design, and findings should be viewed with caution, this study provides new insight into the obesity epidemic that requires further investigation. Clinical Relevance: Rehabilitation nurses are in ideal settings when patient's conditions are less acute, providing opportunities to address complex serious underlying etiologies of obesity. Obesity has not been alleviated by teaching about diet and exercise because obesity may be the result of dietary self-medication of pain from previous experiences. CSA is a very serious problem that could precipitate suicide attempts, obesity, and multifaceted poor health outcomes throughout the life span; subsequently placing individuals at greater risk of requiring rehabilitation services.	Univ Delaware, Coll Hlth Sci, Newark, DE 19716 USA		Brewer-Smyth, K (corresponding author), Univ Delaware, Coll Hlth Sci, McDowell Hall, Newark, DE 19716 USA.	kbsmyth@udel.edu		Brewer-Smyth, PhD, RN, CRRN, FAAN, Kathleen/0000-0001-8468-6991	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [20RR016472-04, T32 NR07036]; Sigma Theta Tau International Honor Society; Rehabilitation Nursing Foundation; Baxter Foundation; University of Delaware General University Research Fund; University of Delaware Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007036] Funding Source: NIH RePORTER	Data collection for this study was funded in part by the National Institutes of Health 20RR016472-04, T32 NR07036, Sigma Theta Tau International Honor Society, Rehabilitation Nursing Foundation, The Baxter Foundation, University of Delaware General University Research Fund, and University of Delaware Research Foundation. Barry Milcarek is also acknowledged posthumously for his statistical assistance.	Amitai M, 2012, INT J ENV RES PUB HE, V9, P985, DOI 10.3390/ijerph9030985; Anderson WL, 2013, OBESITY, V21, pE798, DOI 10.1002/oby.20531; Ashrafian H, 2012, ENDOCRINE, V42, P218, DOI 10.1007/s12020-011-9581-z; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; Bandura A., 1977, SOCIAL LEARNING THEO; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Berthoud HR, 2012, P NUTR SOC, V71, P478, DOI 10.1017/S0029665112000602; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K., 2001, NEUROLOGIC NEUROENDO; Brewer-Smyth K, 2008, ADV NURS SCI, V31, P119, DOI 10.1097/01.ANS.0000319562.84007.22; Brewer-Smyth Kathleen, 2007, J Neurosci Nurs, V39, P361; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; Brewer-Smyth Kathleen, 2004, Rehabil Nurs, V29, P75; Capodaglio P, 2013, EUR J PHYS REHAB MED, V49, P399; CDC, 2011, HLTH WEIGHT; CDC, 2013, OV OB; Cooper Gregory D, 2011, Issues Ment Health Nurs, V32, P696, DOI 10.3109/01612840.2011.597911; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; De Bellis MD, 2011, J CHILD SEX ABUS, V20, P548, DOI 10.1080/10538712.2011.607753; Dumont DM, 2012, ANNU REV PUBL HEALTH, V33, P325, DOI 10.1146/annurev-publhealth-031811-124614; Felitti VJ, 2009, ACAD PEDIATR, V9, P131, DOI 10.1016/j.acap.2009.03.001; FELITTI VJ, 1993, SOUTHERN MED J, V86, P732, DOI 10.1097/00007611-199307000-00002; FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008; Fergusson DM, 2008, CHILD ABUSE NEGLECT, V32, P607, DOI 10.1016/j.chiabu.2006.12.018; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P1681, DOI 10.1001/jama.2013.3101; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fuller-Thomson E, 2013, PUBLIC HEALTH, V127, P449, DOI 10.1016/j.puhe.2013.01.006; Hollingsworth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051868; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Klinitzke G, 2013, J AFFECT DISORDERS, V145, P277, DOI 10.1016/j.jad.2012.07.010; Meyer IH, 1996, CHILD ABUSE NEGLECT, V20, P213, DOI 10.1016/S0145-2134(95)00137-9; MUENZENMAIER K, 1993, HOSP COMMUNITY PSYCH, V44, P666; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; da Silva SSP, 2013, J INTERPERS VIOLENCE, V28, P1989, DOI 10.1177/0886260512471077; Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Shin SH, 2012, CHILD ABUSE NEGLECT, V36, P84, DOI 10.1016/j.chiabu.2011.08.007; Smeets PAM, 2012, P NUTR SOC, V71, P511, DOI 10.1017/S0029665112000808; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; VanHoy S. N., 2009, CRITICAL CARE NURSIN, V21, pvi; VanHoy Sherry N, 2009, Crit Care Nurs Clin North Am, V21, P377, DOI 10.1016/j.ccell.2009.07.004; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Williamson DF, 2002, INT J OBESITY, V26, P1075, DOI 10.1038/sj.ijo.0802038	45	12	14	1	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	JUL-AUG	2014	39	4					183	191		10.1002/rnj.150			9	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	AM0OR	WOS:000339545400004	24668743	Green Accepted			2022-02-06	
J	Dinnen, S; Kane, V; Cook, JM				Dinnen, Stephanie; Kane, Vince; Cook, Joan M.			Trauma-Informed Care: A Paradigm Shift Needed for Services With Homeless Veterans	PROFESSIONAL CASE MANAGEMENT			English	Article						homeless; PTSD; trauma-informed care; veterans	POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT DESENSITIZATION; MENTAL-HEALTH; LIFETIME PREVALENCE; GENDER-DIFFERENCES; REPROCESSING EMDR; BRAIN-INJURY; EXPOSURE; COMORBIDITY; WOMEN	Purpose of Study: Exposure to traumatic events is a highly prevalent, although often overlooked, aspect in the lives of homeless veterans. In this study, the prevalence and correlates of potentially traumatic events, including posttraumatic stress disorder, in the homeless veteran population are presented. Findings/Conclusions: Presently, there exists a lack of trauma-informed case management services for homeless veterans. Failing to recognize the association between trauma and homelessness may lead to further victimization, exacerbate mental health symptomology, and hinder a provider's ability to effectively intervene on behalf of homeless veterans. Implications for Case Management: Subgroups of homeless veterans such as those who served in the Vietnam and post-Vietnam era, more recent returnees from Iraq and Afghanistan, women, rural-residing veterans, and those who are justice involved, are discussed for unique trauma histories and service needs. Barriers to receiving trauma-informed care among homeless veterans are reviewed. Information to assist providers in assessing trauma histories and current best practices in the treatment of posttraumatic stress disorder are noted. Suggestions for how this document can be used in varied organizational settings are made.	[Dinnen, Stephanie] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Kane, Vince] Natl Ctr Homelessness Vet, Philadelphia, PA USA; [Kane, Vince] HUD VASH, Washington, DC USA; [Cook, Joan M.] Yale Sch Med, Psychiat, New Haven, CT USA; [Cook, Joan M.] Natl Ctr PTSD, Washington, DC USA		Cook, JM (corresponding author), Yale Sch Med, NEPEC 182,950 Campbell Ave, West Haven, CT 06516 USA.	Joan.Cook@yale.edu					Bassuk EL, 1996, JAMA-J AM MED ASSOC, V276, P640; Beck A., 1985, ANXIETY DISORDERS PH; Benda BB, 2006, AM J ORTHOPSYCHIAT, V76, P70, DOI 10.1037/0002-9432.76.1.70; Boscarino JA, 1997, PSYCHOSOM MED, V59, P605, DOI 10.1097/00006842-199711000-00008; Buhrich N, 2000, AUST NZ J PSYCHIAT, V34, P963, DOI 10.1080/000486700270; Burt M., 2000, AM HOMELESS 2 POPULA; BURT MR, 1989, AM HOMELESS NUMBERS; Cahill S. P., 2009, EFFECTIVE TREATMENTS, P139; Center for Health Care Evaluation, 2013, STR EV REV ID TREATM; Cloitre M, 2009, CNS SPECTRUMS, V14, P32; Connell MJO, 2008, PSYCHIAT SERV, V59, P268, DOI 10.1176/appi.ps.59.3.268; Davidson PR, 2001, J CONSULT CLIN PSYCH, V69, P305, DOI 10.1037/0022-006X.69.2.305; Department of Labor Women's Bureau, 2010, TRAUM CAR WOM VET EX; Department of Veterans Affairs Office of the Inspector General., 2012, HOM INC RISK FACT BE HOM INC RISK FACT BE; Elliott DE, 2005, J COMMUNITY PSYCHOL, V33, P461, DOI 10.1002/jcop.20063; Foa E.B., 2007, PROLONGED EXPOSURE T; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Gamache G, 2003, AM J PUBLIC HEALTH, V93, P1132, DOI 10.2105/AJPH.93.7.1132; GOODMAN L, 1991, AM PSYCHOL, V46, P1219, DOI 10.1037/0003-066X.46.11.1219; Greenberg GA, 2007, ARMED FORCES SOC, V33, P337, DOI 10.1177/0095327X06296585; Hamilton AB, 2012, J SOC WORK PRACT ADD, V12, P52, DOI 10.1080/1533256X.2012.647584; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hopper E., 2010, OPEN HLTH SERVICES P, V3, DOI [DOI 10.2174/1874924001003020080, 10.2174/1874924001003020080, DOI 10.2174/1874924001003010080]; Housing and Urban Development Annual Homeless Assessment Report, 2013, 2013 ANN HOM ASS REP; Jennings A, 2004, MODELS DEV TRAUMA IN; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kim MM, 2010, HEALTH SOC WORK, V35, P39, DOI 10.1093/hsw/35.1.39; Ko SJ, 2008, PROF PSYCHOL-RES PR, V39, P396, DOI 10.1037/0735-7028.39.4.396; Meichenbaum D., 1996, CLIN PSYCHOL, V49, P4, DOI DOI 10.1037/E555362011-002; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Mumola CJ., 2000, VETERANS PRISON JAIL; National Alliance to End Homelessness, 2010, ANN REPORT; National Association of State Head Injury Administrators, 2006, NEUR ISS TRAUM BRAIN; National Coalition for the Homeless, 2006, MENT ILLN HOM; NORTH CS, 1992, HOSP COMMUNITY PSYCH, V43, P1010; Perron BE, 2008, SOC SCI MED, V67, P1475, DOI 10.1016/j.socscimed.2008.07.012; Pietrzak RH, 2011, PSYCHOSOM MED, V73, P697, DOI 10.1097/PSY.0b013e3182303775; Prescott L., 2007, LONG JOURNEY HOME GU; Rayburn NR, 2005, J CONSULT CLIN PSYCH, V73, P667, DOI 10.1037/0022-006X.73.4.667; Resick P. A., 1996, COGNITIVE PROCESSING; ROSENHECK R, 1993, HOSP COMMUNITY PSYCH, V44, P858; ROSENHECK R, 1994, AM J PUBLIC HEALTH, V84, P466, DOI 10.2105/AJPH.84.3.466; ROSENHECK R, 1994, J NERV MENT DIS, V182, P685, DOI 10.1097/00005053-199412000-00002; Rothbaum BO, 2005, J TRAUMA STRESS, V18, P607, DOI 10.1002/jts.20069; Saxon AJ, 2001, PSYCHIATR SERV, V52, P959, DOI 10.1176/appi.ps.52.7.959; Schnurr P. P., 2004, TRAUMA HLTH PHYS HLT; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Segal Z. V., 2002, MINDFULNESS BASED CO; Shapiro F., 2001, EYE MOVEMENT DESENSI; Steenkamp MM, 2013, CLIN PSYCHOL REV, V33, P45, DOI 10.1016/j.cpr.2012.10.002; Taylor KM, 2008, AUST NZ J PSYCHIAT, V42, P206, DOI 10.1080/00048670701827218; Tessler R, 2001, J SOC DISTRESS HOMEL, V10, P243, DOI 10.1023/A:1016688707698; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsai J, 2014, ADM POLICY MENT HLTH, V41, P360, DOI 10.1007/s10488-013-0483-7; Tsai J, 2013, ADM POLICY MENT HLTH, V40, P400, DOI 10.1007/s10488-012-0431-y; U. S. Bureau of Labor Statistics Division of Labor Statistics, 2013, EMPL SIT VET SUMM 20; U. S. Census Bureau, 2012, NAT SEC VET AFF MIL; U.S. Government Accountability Office, 2011, HOM WOM VET ACT NEED; U. S. Interagency Council on Homelessness, 2012, US INT COUNC HOM REP; U. S. Interagency Council on Homelessness, 2010, OP DOOR FED STRAT PL; Veterans Healthcare Administration Office of Rural Health, 2013, FACT SHEET INF OFF R; Walser R. D., 2007, ACCEPTANCE COMMITMEN; Washington D. I., 2011, J HEALTH CARE POOR U, V21, P82; Williams JK, 2009, SOC WORK RES, V33, P199, DOI 10.1093/swr/33.4.199	67	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1932-8087	1932-8095		PROF CASE MANAG	Prof. Case Manag.	JUL-AUG	2014	19	4					161	170		10.1097/NCM.0000000000000038			10	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	V1K9U	WOS:000216998900002	24871433				2022-02-06	
J	Kant, N; van den Berg, E; van Zandvoort, MJE; Frijns, CJM; Kappelle, LJ; Postma, A				Kant, Neeltje; van den Berg, Esther; van Zandvoort, Martine J. E.; Frijns, Catharina J. M.; Kappelle, L. Jaap; Postma, Albert			Functional correlates of prospective memory in stroke	NEUROPSYCHOLOGIA			English	Article						Prospective memory; Stroke; Cognitive functioning; Monitoring; Focality; Superior temporal gyrus	TRAUMATIC BRAIN-INJURY; TEST SCORE; INDIVIDUALS; IMPAIRMENT; RETRIEVAL; EVENT; TIME; NEUROPSYCHOLOGY; PEOPLE; AGE	Introduction: Prospective memory is the ability to remember actions to be performed later in time or when a certain event occurs. Multiple cognitive processes are involved in prospective memory, and the degree to which automatic or effortful processes are involved may differ for different types of prospective memory tasks. This study aimed to investigate prospective memory (dys)functioning in stroke patients, and to get more insight in which cognitive processes are involved in time- versus event-based prospective memory. Methods: We investigated 39 community-dwelling stroke survivors and 53 matched control participants. Assessment included naturalistic and experimental event- and time-based prospective memory tasks, as well as standard neuropsychological measures of (retrospective) memory, processing speed and attention/executive functioning. Results: 41% of the stroke patients performed significantly worse than control participants on prospective memory tasks. Deficits in prospective memory occurred as frequently as impairments in retrospective memory (33%, chi(2)(1, N=39)=3.4, p=.066), and more often than impairments in attention/executive functioning (15%, chi(2)(1, N=39)=5.2, p=.022) and speed of processing (23%, chi(2)(1, N=39)=6.5, p=.011). Regression analyses showed that event-based ('focal') prospective memory is supported by retrospective memory, indicating that it is a relatively simple and automatic process. Time-based (non-'focal') prospective memory proved to be a more complex process, requiring active monitoring of the environment. Performance was predicted by speed of processing, attention/executive functioning and retrospective memory. Thirteen percent of the patients suffered from selective prospective memory impairment, which was associated with damage to the superior temporal gyrus. Conclusions: Impairment of prospective memory occurs frequently after stroke. Different cognitive operations are involved in distinct types of prospective memory. Results fit within the multi-process framework of prospective memory and help further specify its contents. (C) 2014 Elsevier Ltd. All rights reserved.	[Kant, Neeltje; van den Berg, Esther; van Zandvoort, Martine J. E.; Postma, Albert] Univ Utrecht, Helmholtz Inst, NL-3584 CS Utrecht, Netherlands; [Kant, Neeltje; van den Berg, Esther] Nieuw Unicum, NL-2042 XK Zandvoort, Netherlands; [van Zandvoort, Martine J. E.; Frijns, Catharina J. M.; Kappelle, L. Jaap; Postma, Albert] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands		Kant, N (corresponding author), Univ Utrecht, Helmholtz Inst, Langeveld Bldg,Heidelberglaan 1, NL-3584 CS Utrecht, Netherlands.	n.kant@uu.nl	van den Berg, Esther/ABD-8026-2020	van den Berg, Esther/0000-0002-8120-7366			Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Baddeley, 1990, HUMAN MEMORY THEORY; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Carlesimo GA, 2011, NEUROPSYCHOLOGIA, V49, P2143, DOI 10.1016/j.neuropsychologia.2011.05.010; Cheng HD, 2010, BEHAV NEUROSCI, V124, P152, DOI 10.1037/a0018306; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Crawford JR, 2006, NEUROPSYCHOLOGIA, V44, P666, DOI 10.1016/j.neuropsychologia.2005.06.001; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; de Haan EH, 2006, CURR OPIN NEUROL, V19, P559, DOI 10.1097/01.wco.0000247612.21235.d9; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ghio M, 2010, BRAIN LANG, V112, P223, DOI 10.1016/j.bandl.2008.11.002; Gonneaud J., 2013, HUMAN BRAIN MAPPING; Gonneaud J, 2011, MEMORY, V19, P360, DOI 10.1080/09658211.2011.570765; Gordon BA, 2011, NEUROPSYCHOLOGIA, V49, P3795, DOI 10.1016/j.neuropsychologia.2011.09.035; Grilli MD, 2011, NEUROPSYCHOL REHABIL, V21, P847, DOI 10.1080/09602011.2011.627263; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hicks JL, 2005, J EXP PSYCHOL LEARN, V31, P1160, DOI 10.1037/0278-7393.31.5.1160; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kim HJ, 2009, NEUROCASE, V15, P145, DOI 10.1080/13554790802709039; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Marsh RL, 1998, J EXP PSYCHOL LEARN, V24, P336, DOI 10.1037/0278-7393.24.2.336; Martin T, 2007, INT J PSYCHOPHYSIOL, V64, P247, DOI 10.1016/j.ijpsycho.2006.09.010; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McFarland C, 2012, MEM COGNITION, V40, P62, DOI 10.3758/s13421-011-0126-8; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Otani H, 1997, MEMORY, V5, P343, DOI 10.1080/741941393; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Rose NS, 2010, PSYCHOL AGING, V25, P595, DOI 10.1037/a0019771; SAAN RJ, 1986, NIEUWE 15 WOORDENTES; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Schmand B., 1992, NLV NEDERLANDSE LEES; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Snaphaan L, 2007, STROKE, V38, P198, DOI 10.1161/01.STR.0000251842.34322.8f; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; van den Berg E, 2012, J INT NEUROPSYCH SOC, V18, P706, DOI 10.1017/S1355617712000331; Verhage F., 1983, REV SCORING METHOD; Wechsler D., 1997, MANUAL WECHSLER ADUL; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson ME, 2013, PFLUG ARCH EUR J PHY, V465, P595, DOI 10.1007/s00424-013-1260-x	50	12	12	0	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUL	2014	60						77	83		10.1016/j.neuropsychologia.2014.05.015			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	AN0WR	WOS:000340305200009	24892223				2022-02-06	
J	Nordeman, P; Estrada, S; Odell, LR; Larhed, M; Antoni, G				Nordeman, Patrik; Estrada, Sergio; Odell, Luke R.; Larhed, Mats; Antoni, Gunnar			C-11-Labeling of a potent hydroxyethylamine BACE-1 inhibitor and evaluation in vitro and in vivo	NUCLEAR MEDICINE AND BIOLOGY			English	Article						beta-secretase; BACE-1; Position emission tomography; PET; Alzheimer's disease	CATALYZED CARBONYLATION REACTIONS; TRAUMATIC BRAIN-INJURY; STRUCTURE-BASED DESIGN; BETA-SECRETASE; ALZHEIMERS-DISEASE; AMYLOID-BETA; ARYL BROMIDES; AXONS; C-11; PET	Introduction: The enzyme beta-secretase 1 (BACE-1) is associated with the catalytic cleavage of amyloid precursor protein (APP) which leads to the production of amyloid-p, an amyloidogenic peptide that forms insoluble fibrils and is linked to neurodegeneration and Alzheimer's disease (AD). A PET-radioligand for the quantification of BACE-1 would be useful for the understanding of AD. In this report, we describe the synthesis and carbon-11 radiolabeling of a potent hydroxyethylamine BACE-1 enzyme inhibitor (BSI-IV) and its evaluation in vitro and in vivo. Methods: (11)[C]-N-1-((2S,3R)-4-(cyclopropylamino)-3-hydroxy-1-phenylbutan-2-y1)-5-(N-methylmethylsulfonamido)-N-3-((R)-1-phenylethyl)isophthalamide, a p-secretase inhibitor, denoted here as [C-11]BSIIV was synthesized through a palladium-mediated aminocarbonylation with an aryl halide precursor (I or Br) and [C-11]CO. The effect of different palladium/ligand-complexes on radiochemical yield in the carbonylative reaction was investigated. The binding of the labeled compound to BACE-1 enzyme was studied in vitro by frozen section autoradiography from brains of healthy rats. Dynamic small animal PET-CT studies and ex vivo biodistribution were performed in male rats. Results: The halide precursors were synthesized in six steps starting from methyl-3-nitrobenzoate with an overall yield of 21-26%. [C-11]BSI-IV was obtained in 29 +/- 12% decay corrected radiochemical yield (n = 12) with a specific activity of 790 +/- 155 GBq/umol at the end of synthesis with a radiochemical purity of >99%. The predinical studies showed that [C-11]BSI-IV has a rapid metabolism in rat with excretion to the small intestines. Conclusion: [C-11]BSI-IV was obtained in sufficient amount and purity to enable predinical investigation. The predinical studies showed low specific binding in vitro and fast clearance in vivo and a low uptake in the brain. These findings suggests that [C-11]BSI-IV has limited use as a PET-ligand for the study of BACE-1 or AD. (c) 2014 Elsevier Inc. All rights reserved.	[Nordeman, Patrik; Estrada, Sergio; Antoni, Gunnar] Uppsala Univ, Dept Med Chem, Preclin PET Platform, SE-75123 Uppsala, Sweden; [Odell, Luke R.; Larhed, Mats] Uppsala Univ, Dept Med Chem, SE-75123 Uppsala, Sweden		Antoni, G (corresponding author), Uppsala Univ, Dept Med Chem, Preclin PET Platform, SE-75123 Uppsala, Sweden.	gunnar.antoni@pet.medchem.uu.se		Nordeman, Patrik/0000-0002-4334-7368	Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation	We thank Knut and Alice Wallenberg Foundation for financial support, Veronica Asplund for technical support and Ashkan Fardost for help with LC-MS-MS.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brennfuhrer A, 2009, ANGEW CHEM INT EDIT, V48, P4114, DOI 10.1002/anie.200900013; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Dahl K, 2013, EUR J ORG CHEM, V2013, P1228, DOI 10.1002/ejoc.201201708; Decourt B, 2011, J ALZHEIMERS DIS, V24, P53, DOI 10.3233/JAD-2011-110017; DISCHINO DD, 1983, J NUCL MED, V24, P1030; FARDE L, 1995, SYNAPSE, V20, P200, DOI 10.1002/syn.890200303; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Ghosh AK, 2001, J MED CHEM, V44, P2865, DOI 10.1021/jm0101803; Grigg R, 2010, TETRAHEDRON, V66, P5515, DOI 10.1016/j.tet.2010.03.090; Guo T, 2006, CURR MED CHEM, V13, P1811, DOI 10.2174/092986706777452489; Honer M, 2013, 11 INT C QUANT BRAIN; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Karimi F, 2003, ORG BIOMOL CHEM, V1, P541, DOI 10.1039/b209553j; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kawai T, 2013, NUCL MED BIOL, V40, P705, DOI 10.1016/j.nucmedbio.2013.03.008; Kihlberg T, 2002, PCT INT APPL, Patent No. WO:2002102711 A1; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mane RS, 2013, TETRAHEDRON LETT, V54, P6912, DOI 10.1016/j.tetlet.2013.10.040; Martinelli JR, 2008, J ORG CHEM, V73, P7102, DOI 10.1021/jo801279r; Martinelli JR, 2006, ORG LETT, V8, P4843, DOI 10.1021/ol061902t; Meredith JE, 2008, J PHARMACOL EXP THER, V326, P502, DOI 10.1124/jpet.108.138974; Miller PW, 2008, ANGEW CHEM INT EDIT, V47, P8998, DOI 10.1002/anie.200800222; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Mulder SD, 2010, J ALZHEIMERS DIS, V20, P253, DOI 10.3233/JAD-2010-1367; Nordeman P, 2012, J ORG CHEM, V77, P11393, DOI 10.1021/jo302322w; Odell LR, 2012, SYNLETT, P685, DOI 10.1055/s-0031-1290350; Patel S, 2008, NUCL MED BIOL, V35, P805, DOI 10.1016/j.nucmedbio.2008.10.002; Pennington LD, 2013, BIOORG MED CHEM LETT, V23, P4459, DOI 10.1016/j.bmcl.2013.05.028; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Schmidt B, 2006, CURR TOP MED CHEM, V6, P377, DOI 10.2174/156802606776287027; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Stachel SJ, 2006, J MED CHEM, V49, P6147, DOI 10.1021/jm060884i; Stachel SJ, 2006, BIOORG MED CHEM LETT, V16, P641, DOI 10.1016/j.bmcl.2005.10.032; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Thompson LA, 2005, CURR PHARM DESIGN, V11, P3383, DOI 10.2174/138161205774370825; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	42	12	12	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	JUL	2014	41	6					536	543		10.1016/j.nucmedbio.2014.03.024			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AI5YH	WOS:000336946400014	24857866				2022-02-06	
J	Radomski, MV; Finkelstein, M; Llanos, I; Scheiman, M; Wagener, SG				Radomski, Mary Vining; Finkelstein, Marsha; Llanos, Imelda; Scheiman, Mitchell; Wagener, Sharon Gowdy			Composition of a Vision Screen for Servicemembers With Traumatic Brain Injury: Consensus Using a Modified Nominal Group Technique	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; military personnel; vision disorders; vision screening	INSUFFICIENCY SYMPTOM SURVEY; OCCUPATIONAL-THERAPY; VISUAL IMPAIRMENTS; CONVERGENCE; VALIDITY; MILITARY; VETERANS	Vision impairment is common in the first year after traumatic brain injury (TBI), including among service members whose brain injuries occurred during deployment in Iraq and Afghanistan. Occupational therapy practitioners provide routine vision screening to inform treatment planning and referral to vision specialists, but existing methods are lacking because many tests were developed for children and do not screen for vision dysfunction typical of TBI. An expert panel was charged with specifying the composition of a vision screening protocol for servicemembers with TBI. A modified nominal group technique fostered discussion and objective determinations of consensus. After considering 29 vision tests, the panel recommended a nine-test vision screening that examines functional performance, self-reported problems, far near acuity, reading, accommodation, convergence, eye alignment and binocular vision, saccades, pursuits, and visual fields. Research is needed to develop reliable, valid, and clinically feasible vision screening protocols to identify TBI-related vision disorders in adults.	[Radomski, Mary Vining; Finkelstein, Marsha] Courage Kenny Res Ctr, Minneapolis, MN 55407 USA; [Llanos, Imelda] James A Haley Vet Hosp, Tampa, FL USA; [Scheiman, Mitchell] Penn Coll Optometry, Philadelphia, PA 19141 USA; [Wagener, Sharon Gowdy] Courage Kenny Rehabil Inst, Minneapolis, MN USA		Radomski, MV (corresponding author), Courage Kenny Res Ctr, 800 East 28th St & Chicago 12212, Minneapolis, MN 55407 USA.	mary.radomski@allina.com		Scheiman, Mitchell/0000-0002-9274-5696			Anderson AJ, 2009, CLIN EXP OPTOM, V92, P45, DOI 10.1111/j.1444-0938.2008.00280.x; Berger S, 2013, AM J OCCUP THER, V67, P263, DOI 10.5014/ajot.2013.007203; Bulson R, 2012, J REHABIL RES DEV, V49, P1075, DOI 10.1682/JRRD.2011.02.0017; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cate Y, 2000, AM J OCCUP THER, V54, P326, DOI 10.5014/ajot.54.3.326; Ciuffreda K, 2001, VISUAL VESTIBULAR CO, P1; Ciuffreda K. J., 2001, DOWNEY DARLINGS PHYS, P241; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Daugherty K. M., 2007, OPTOMETRY VISION DEV, V38, P75; Davies S, 2011, HEALTH SERV RES, V46, P2005, DOI 10.1111/j.1475-6773.2011.01297.x; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN; DELBECQ AL, 1971, J APPL BEHAV SCI, V7, P466, DOI 10.1177/002188637100700404; Fricke T. R., 1997, CLIN EXP OPTOMETRY, V80, P165, DOI DOI 10.1111/J.1444-0938.1997.TB04876.X; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gallaway M, 2010, OPTOMETRY, V81, P571, DOI 10.1016/j.optm.2010.07.024; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Gene-Sampedro A., 2003, J BEHAV OPTOM, V14, P101; Gillen G., 2009, COGNITIVE PERCEPTUAL; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Janet M. P., 2005, J BEHAV OPTOMETRY, V16, P38; Kaiser Peter K, 2009, Trans Am Ophthalmol Soc, V107, P311; Kent C., 2013, USING LOW TECH ASSES; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Maples W C, 1988, J Am Optom Assoc, V59, P549; Maples W. C., 1992, J BEHAV OPTOM, V3, P143; Powell JM., 2006, J BEHAV OPTOM, V17, P59; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Sample J. A., 1984, J EXTENSION, V22; Scheiman M, 2011, UNDERSTANDING AND MANAGING VISION DEFICITS: A GUIDE FOR OCCUPATIONAL THERAPISTS, THIRD EDITION, P1; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Sue Stevens, 2007, Community Eye Health, V20, P52; WAINAPEL SF, 1995, AM J PHYS MED REHAB, V74, P313, DOI 10.1097/00002060-199507000-00010; Weisser-Pike O., 2014, OCCUPATIONAL THERAPY, P105; Yothers Tracey, 2002, Optometry, V73, P91	42	12	12	0	11	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2014	68	4					422	429		10.5014/ajot.2014.011445			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	AL4FR	WOS:000339088800007	25005505	Green Published			2022-02-06	
J	Thomsen, GM; Le Belle, JE; Harnisch, JA; Mc Donald, WS; Hovda, DA; Sofroniew, MV; Kornblum, HI; Harris, NG				Thomsen, Gretchen M.; Le Belle, Janel E.; Harnisch, Jessica A.; Mc Donald, Whitney S.; Hovda, David A.; Sofroniew, Michael V.; Kornblum, Harley I.; Harris, Neil G.			Traumatic brain injury reveals novel cell lineage relationships within the subventricular zone	STEM CELL RESEARCH			English	Article							NEURAL STEM-CELLS; ADULT BRAIN; FOREBRAIN NEUROGENESIS; NEURONAL PROGENITORS; PROLIFERATION; ISCHEMIA; PRECURSORS; REGENERATION; REPLACEMENT; ASTROCYTES	The acute response of the rodent subventricular zone (SVZ) to traumatic brain injury (TBI) involves a physical expansion through increased cell proliferation. However, the cellular underpinnings of these changes are not well understood. Our analyses have revealed that there are two distinct transit-amplifying cell populations that respond in opposite ways to injury. Mash1+ transit-amplifying cells are the primary SVZ cell type that is stimulated to divide following TBI. In contrast, the EGFR+ population, which has been considered to be a functionally equivalent progenitor population to Mash1+ cells in the uninjured brain, becomes significantly less proliferative after injury. Although normally quiescent GFAP+ stem cells are stimulated to divide in SVZ ablation models, we found that the GFAP+ stem cells do not divide more after TBI. We found, instead, that TBI results in increased numbers of GFAP+/EGFR+ stem cells via non-proliferative means-potentially through the dedifferentiation of progenitor cells. EGFR+ progenitors from injured brains only were competent to revert to a stem cell state following brief exposure to growth factors. Thus, our results demonstrate previously unknown changes in lineage relationships that differ from conventional models and likely reflect an adaptive response of the SVZ to maintain endogenous brain repair after TBI. (C) 2014 The Authors. Published by Elsevier B.V.	[Thomsen, Gretchen M.; Harnisch, Jessica A.; Mc Donald, Whitney S.; Hovda, David A.; Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, UCLA Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Le Belle, Janel E.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA		Kornblum, HI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Neurosci Res Bldg,Suite 379, Los Angeles, CA 90095 USA.	hkornblum@mednet.ucla.edu; ngharris@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020	Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS055910, NRSA 5F31NS064697-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS064697, R01NS055910] Funding Source: NIH RePORTER	We wish to thank Dr. David McArthur for helpful discussion about the statistics. This work was supported by the UCLA Brain Injury Research Center, and Award Number R01 NS055910 and NRSA 5F31NS064697-02 from the National Institute of Neurological Disorders and Stroke (NINDS).	Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cesetti T, 2009, STEM CELLS, V27, P1443, DOI 10.1002/stem.74; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Craig G, 1996, J NEUROSCI, V16, P2649; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Imura T, 2003, J NEUROSCI, V23, P2824; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008122; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; R Development Core Team, 2008, R LANG ENV STAT COMP; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rasband W. S, 2008, IMAGEJ; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Tsai YW, 2013, J CEREBR BLOOD F MET, V33, P764, DOI 10.1038/jcbfm.2013.15; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798	42	12	12	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	JUL	2014	13	1					48	60		10.1016/j.scr.2014.04.013			13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology	AP7VY	WOS:000342287000005	24835668	gold, Green Accepted			2022-02-06	
J	Turkstra, LS; Abbeduto, L; Meulenbroek, P				Turkstra, Lyn S.; Abbeduto, Leonard; Meulenbroek, Peter			Social Cognition in Adolescent Girls With Fragile X Syndrome	AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES			English	Article						social cognition; fragile X syndrome; executive function; social outcome; adolescent	TRAUMATIC BRAIN-INJURY; HIGH-FUNCTIONING AUTISM; THEORY-OF-MIND; EXECUTIVE FUNCTION; ASPERGER-SYNDROME; FRONTOTEMPORAL DEMENTIA; LANGUAGE IMPAIRMENT; TURNER-SYNDROME; SELF-CONCEPT; EYES TEST	This study aimed to characterize social cognition, executive functions (EFs), and everyday social functioning in adolescent girls with fragile X syndrome, and identify relationships among these variables. Participants were 20 girls with FXS and 20 age-matched typically developing peers. Results showed significant between-groups differences in social cognition, accounted for by differences in IQ and language. Within the FXS group, IQ and language were related to social cognition; parent-reported social functioning was related to language and EFs; and self-reported social functioning was generally good and not related to cognitive or social cognition variables. Results suggest that intervention might focus on managing language and cognitive contributions to social functioning, rather than social cognition, and underscore the importance of considering parent and adolescent perspectives.	[Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Abbeduto, Leonard] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Abbeduto, Leonard] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Meulenbroek, Peter] Univ Wisconsin, Madison, WI 53706 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Meulenbroek, Peter/0000-0003-4233-9910; Turkstra, Lyn/0000-0002-6948-6921	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD024356, P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD054586] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30 HD03352, R01HD024356, R03 HD054586, R01 HD024356, P30 HD003352, R03HD054586] Funding Source: Medline		Achenbach T, 1980, CHILD BEHAV CHECKLIS; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adrian JE, 2005, J CHILD LANG, V32, P673, DOI 10.1017/S0305000905006963; Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; American Educational Research Association American Psychological Association National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Ames DR, 2004, J NONVERBAL BEHAV, V28, P187, DOI 10.1023/B:JONB.0000039649.20015.0e; Anderson PJ., 2000, CLIN NEUROPSYCHOL AS, V1, P247; Armor DA, 1998, ADV EXP SOC PSYCHOL, V30, P309, DOI 10.1016/S0065-2601(08)60386-X; Banerjee R, 2001, SOC DEV, V10, P558, DOI 10.1111/1467-9507.00180; Banerjee R, 2011, CHILD DEV, V82, P1887, DOI 10.1111/j.1467-8624.2011.01669.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S., 2001, J DEV LEARN DISORD, V5, P47, DOI [10.1177/1362361303007002005, DOI 10.1177/1362361303007002005]; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bora E, 2006, PSYCHIAT RES, V145, P95, DOI 10.1016/j.psychres.2005.11.003; Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess S, 2010, LANG SPEECH HEAR SER, V41, P474, DOI 10.1044/0161-1461(2010/09-0007); Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; CAVELL TA, 1990, J CLIN CHILD PSYCHOL, V19, P111, DOI 10.1207/s15374424jccp1902_2; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Ciccia AH, 2009, TOP LANG DISORD, V29, P249, DOI 10.1097/TLD.0b013e3181b53211; Cornish K, 2005, J INTELL DISABIL RES, V49, P372, DOI 10.1111/j.1365-2788.2005.00678.x; Cornish K, 2005, BRAIN COGNITION, V57, P53, DOI 10.1016/j.bandc.2004.08.020; Cornish KM, 2001, J COGNITIVE NEUROSCI, V13, P144, DOI 10.1162/089892901564126; Cornish KM, 1998, NEUROPSYCHOLOGIA, V36, P1239, DOI 10.1016/S0028-3932(97)00162-0; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Daley TC, 2003, MED ANTHROPOL Q, V17, P25, DOI 10.1525/maq.2003.17.1.25; Eddy CM, 2012, ACTA NEUROL SCAND, V126, P376, DOI 10.1111/j.1600-0404.2012.01659.x; Flesch R., 1994, WRITE SPEAK THINK MO; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; FREUND LS, 1993, PEDIATRICS, V91, P321; Gioia G. A, 2006, TESTS EXECUTIVE CONT; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hagerman R.J., 1999, NEURODEVELOPMENTAL D; HAGERMAN RJ, 1992, PEDIATRICS, V89, P395; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Harter S., 1988, MANUAL SELF PERCEPTI; Harter S., 1985, MANUAL SELF PERCEPTI; Hartley SL, 2011, AJIDD-AM J INTELLECT, V116, P16, DOI 10.1352/1944-7558-116.1.16; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hendry LB, 2000, J ADOLESCENCE, V23, P705, DOI 10.1006/jado.2000.0354; Hessl D, 2004, MENT RETARD DEV D R, V10, P17, DOI 10.1002/mrdd.20004; Hessl D, 2002, PSYCHONEUROENDOCRINO, V27, P855, DOI 10.1016/S0306-4530(01)00087-7; Hoffman KB, 2000, J ABNORM PSYCHOL, V109, P651, DOI 10.1037//0021-843X.109.4.651; Hughes DM, 2009, INT J LANG COMM DIS, V44, P901, DOI [10.3109/13682820802425693, 10.1080/13682820802425693]; Isquith P. K., 2010, TASKS EXECUTIVE CONT; John K., 2001, CHILD PSYCHOL PSYCHI, V6, P181, DOI DOI 10.1111/1475-3588.00343; Jones JL, 2012, INTELLECT DEV DISAB, V50, P31, DOI 10.1352/1934-9556-50.1.31; Keysor CS, 2002, MICROSC RES TECHNIQ, V57, P179, DOI 10.1002/jemt.10070; Keysor CS, 2002, DEV PSYCHOBIOL, V41, P133, DOI 10.1002/dev.10060; Kirk JW, 2005, DEV NEUROPSYCHOL, V28, P755, DOI 10.1207/s15326942dn2803_2; KURDEK LA, 1994, CHILD DEV, V65, P1137; Larson R., 1984, BEING ADOLESCENT CON; LARSON RW, 1983, J MARRIAGE FAM, V45, P739, DOI 10.2307/351787; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; Mailloux S L, 1995, Comput Nurs, V13, P221; Marschark M, 2000, J CHILD PSYCHOL PSYC, V41, P1067, DOI 10.1017/S0021963099006496; MAZZOCCO MMM, 1993, J DEV BEHAV PEDIATR, V14, P328; MAZZOCCO MMM, 1994, J AUTISM DEV DISORD, V24, P473, DOI 10.1007/BF02172129; McDonald S., 2002, AWARENESS SOCIAL INF; Mesulam MM, 2002, PRINCIPLES FRONTAL L, P8, DOI [10.1093/acprof:oso/9780195134971.003.0002, DOI 10.1093/ACPROF:OSO/9780195134971.003.0002]; Miller CA, 2004, INT J LANG COMM DIS, V39, P191, DOI 10.1080/13682820310001616994; Moss J, 2009, J INTELL DISABIL RES, V53, P852, DOI 10.1111/j.1365-2788.2009.01197.x; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; PAKASLAHTI L, 2000, EDUC PSYCHOL-UK, V0020, P00177, DOI DOI 10.1080/713663710; Perner J, 1999, DEVELOPING THEORIES OF INTENTION, P133; Peterson E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00220; Pyers J., 1997, P 21 ANN BOST U C LA, V1, P136; RAFFAELLI M, 1989, J YOUTH ADOLESCENCE, V18, P567, DOI 10.1007/BF02139074; Roid G. H., 1997, LEITER INT PERFORMAN; Russell PA, 1998, J CHILD PSYCHOL PSYC, V39, P903, DOI 10.1017/S0021963098002844; Sabbagh MA, 2004, BRAIN COGNITION, V55, P209, DOI 10.1016/j.bandc.2003.04.002; Shapka JD, 2005, CAN J BEHAV SCI, V37, P83, DOI 10.1037/h0087247; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Simon JA, 2001, COGNITIVE NEUROPSYCH, V18, P1, DOI 10.1080/02643290126042; Sobesky WE, 1996, AM J MED GENET, V64, P340, DOI 10.1002/(SICI)1096-8628(19960809)64:2<340::AID-AJMG21>3.3.CO;2-K; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Sumter SR, 2009, J ADOLESCENCE, V32, P1009, DOI 10.1016/j.adolescence.2008.08.010; Sutterby SR, 2012, PSYCHIAT RES, V197, P242, DOI 10.1016/j.psychres.2012.02.014; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Todd SY, 2003, ADOLESCENCE, V38, P659; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Wang YG, 2008, PSYCHIAT RES, V161, P153, DOI 10.1016/j.psychres.2007.07.018; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WICHSTROM L, 1995, J PERS ASSESS, V65, P100, DOI 10.1207/s15327752jpa6501_8; Wilding J, 2002, NEUROPSYCHOLOGIA, V40, P1343, DOI 10.1016/S0028-3932(01)00212-3; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; World Health Organization, 2007, INT CLASS FUNCT DIS; Zelazo PD, 1996, J CHILD PSYCHOL PSYC, V37, P479, DOI 10.1111/j.1469-7610.1996.tb01429.x	99	12	12	0	25	AMER ASSOC INTELLECTUAL DEVELOPMENTAL DISABILITIES	WASHINGTON	444 N CAPITOL ST, NW STE 846, WASHINGTON, DC 20001-1512 USA	1944-7515	1944-7558		AJIDD-AM J INTELLECT	AJIDD-Am. J. Intellect. Dev. Disabil.	JUL	2014	119	4					319	339		10.1352/1944-7558-119.4.319			21	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	AO3XP	WOS:000341270900003	25007297	Green Accepted			2022-02-06	
J	Wang, HC; Lin, YJ; Tsai, NW; Su, BYJ; Kung, CT; Chen, WF; Kwan, AL; Lu, CH				Wang, Hung-Chen; Lin, Yu-Jun; Tsai, Nai-Wen; Su, Ben Yu-Jih; Kung, Chia-Te; Chen, Wu-Fu; Kwan, Aij-Lie; Lu, Cheng-Hsien			Serial Plasma Deoxyribonucleic Acid Levels as Predictors of Outcome in Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mitochondrial DNA; nuclear DNA; outcome; traumatic brain injury	MITOCHONDRIAL-DNA LEVELS; CELL-FREE DNA; QUANTITATIVE-ANALYSIS; PROGNOSTIC MARKER; ACUTE STROKE; NUCLEAR; HEMORRHAGE; SEPSIS	Increased plasma deoxyribonucleic acid (DNA) levels may be associated with disease severity after acute traumatic brain injury (TBI). This study posits that increased plasma DNA levels in acute TBI are predictive of outcome. Both serial plasma nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) levels were examined in 88 consecutive patients with acute TBI and 66 control subjects. Additional samples were obtained on day 4 and day 7. Results showed that plasma nDNA and mtDNA on admission were significantly increased in patients with TBI compared with controls. Plasma nDNA, but not plasma mtDNA, levels in patients with acute TBI significantly correlated with Glasgow Coma Scale (GCS) score and Injury Severity Score (ISS) on presentation. Plasma nDNA increased significantly from day 1 to day 7 in patients with poor outcome. Its levels on presentation were independently associated with outcome and higher levels (cutoff value >72.95 ng/mL) were associated with poorer outcomes. These findings suggest plasma nDNA levels reflect the severity of cerebral damage and can be considered a neuropathologic marker of patients with acute TBI. Further studies with bigger patient populations are warranted for better unbiased comparison.	[Wang, Hung-Chen; Lin, Yu-Jun; Chen, Wu-Fu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Tsai, Nai-Wen; Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Su, Ben Yu-Jih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Kaohsiung, Taiwan; [Kung, Chia-Te] Kaohsiung Chang Gung Mem Hosp, Dept Emergency Med, Kaohsiung, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wang, Hung-Chen; Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Yu-Jun; Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan		Lu, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurol, 123 Ta Pei Rd, Kaohsiung, Taiwan.	chlu99@ms44.url.com.tw		Su, Yu-Jih/0000-0002-7274-3458; WANG, HUNG-CHEN/0000-0003-3962-1958			Arnalich F, 2013, CRIT CARE, V17, DOI 10.1186/cc12735; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; FOURNIE GJ, 1993, GERONTOLOGY, V39, P215; Kung CT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-130; Lam NYL, 2006, RESUSCITATION, V68, P71, DOI 10.1016/j.resuscitation.2005.05.021; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Lo YMD, 2000, CLIN CHEM, V46, P319; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lu CH, 2010, QJM-INT J MED, V103, P169, DOI 10.1093/qjmed/hcp201; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rainer TH, 2007, CLIN CHIM ACTA, V376, P190, DOI 10.1016/j.cca.2006.08.025; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Schmidt OI, 2007, ORTHOPADE, V36, P248, DOI 10.1007/s00132-007-1061-z; Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036; TSUMITA T, 1963, NATURE, V198, P1088, DOI 10.1038/1981088a0; Wang HC, 2012, EUR J NEUROL, V19, P1532, DOI 10.1111/j.1468-1331.2012.03761.x; Wang HC, 2013, J NEUROSURG, V118, P13, DOI 10.3171/2012.8.JNS112093; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160	24	12	13	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2014	31	11					1039	1045		10.1089/neu.2013.3070			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AJ7RS	WOS:000337895300006	24467366				2022-02-06	
J	Wang, Q; Wei, X; Gao, H; Li, J; Liao, J; Liu, X; Qin, B; Yu, Y; Deng, C; Tang, B; Huang, XF				Wang, Q.; Wei, X.; Gao, H.; Li, J.; Liao, J.; Liu, X.; Qin, B.; Yu, Y.; Deng, C.; Tang, B.; Huang, X. -F.			SIMVASTATIN REVERSES THE DOWNREGULATION OF M1/4 RECEPTOR BINDING IN 6-HYDROXYDOPAMINE-INDUCED PARKINSONIAN RATS: THE ASSOCIATION WITH IMPROVEMENTS IN LONG-TERM MEMORY	NEUROSCIENCE			English	Article						Parkinson's disease; simvastatin; M1/4 receptors; memory	TRAUMATIC BRAIN-INJURY; MEDIAL FOREBRAIN-BUNDLE; ALZHEIMERS-DISEASE; STRIATAL DOPAMINE; DIFFERENTIAL RESPONSE; COGNITIVE DYSFUNCTION; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; UP-REGULATION; RISK-FACTORS	Background: It is believed that muscarinic M1/4 receptors are closely correlated to the dopaminergic system and are strongly involved in the pathogenesis of Parkinson's disease (PD). In addition to regulating lipid metabolism and protection from stroke, statins have been used to regulate the declined cognition. We aimed to explore the regional changes in M1/4 receptors in the 6-hydroxydopamine (6-OHDA)-lesioned rat brain. Methods: PD rat model was set up by injecting 6-OHDA into the unilateral medial forebrain bundle; while simvastatin (10 mg/kg/day) or saline was orally administrated for 3 weeks, respectively. Long-term memory was measured using the Morris water maze. [H-3] pirenzepine binding autoradiography was applied to investigate the alterations of M1/4 receptors in the PD rat brains. Results: 6-OHDA induced long-term memory deficits along with downregulation of M1/4 receptors in the hippocampus, the medial amygdala, the posteromedial cortical and the piriform cortex; simvastatin administration significantly ameliorated the impaired memory and reversed the downregulation of M1/4 receptors in the examined brain regions. Profound positive correlations were verified between the decline in long-term memory activity and the restoration of M1/4 receptors in different brain regions after simvastatin treatment. Conclusions/significance: Our results provide strong evidence that M1/4 receptor modulation after simvastatin administration did, at least partially, contribute to the improvement in the long-term memory in 6-OHDA-induced PD rats. These results provide a possible mechanism for simvastatin treatment in psycho-neurological diseases such as PD via M1/4 receptors. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wang, Q.; Wei, X.; Gao, H.; Li, J.; Liao, J.; Liu, X.; Qin, B.] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Q.; Yu, Y.; Deng, C.; Huang, X. -F.] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW 2522, Australia; [Tang, B.] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China		Wang, Q (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Neurol Res Lab, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.	denniswq@yahoo.com	Huang, Xu-Feng/H-7408-2015; Deng, Chao/F-4417-2016	Huang, Xu-Feng/0000-0002-5895-2253; Deng, Chao/0000-0003-1147-5741; Wang, Qing/0000-0002-3882-6540; Yu, Yinghua/0000-0003-2508-7512	973 ProjectNational Basic Research Program of China [2011CB510000]; National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81071031, 81271427]; 985 project grant [820003281901]; Australia National Health and Medical Research Council Grant (NHMRC)National Health and Medical Research Council of Australia [514640]	This work was supported by the 973 Project (2011CB510000), National Natural Science Foundations of China (Grant No. 81071031, 81271427), 985 project grant (820003281901), and Australia National Health and Medical Research Council Grant (NHMRC, ID: 514640) from Q. W. The authors thank Mr. Nikolce Mackovski for preparation on the 6-OHDA-induced PD rat model. The study utilized the Schizophrenia Research Institute funded beta imager.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Andersson DR, 2010, EXP NEUROL, V221, P251, DOI 10.1016/j.expneurol.2009.11.011; Andringa G, 2000, EUR J NEUROSCI, V12, P3033, DOI 10.1046/j.1460-9568.2000.00181.x; Araki T, 2000, J NEURAL TRANSM, V107, P873, DOI 10.1007/s007020070039; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Ayer RE, 2013, ACTA NEUROCHIR SUPPL, V115, P259, DOI 10.1007/978-3-7091-1192-5_46; Becker C, 2008, DRUG SAFETY, V31, P399, DOI 10.2165/00002018-200831050-00004; Bymaster FP, 2003, PROG NEURO-PSYCHOPH, V27, P1125, DOI 10.1016/j.pnpbp.2003.09.008; Caviness JN, 2011, CNS NEUROSCI THER, V17, P32, DOI 10.1111/j.1755-5949.2010.00216.x; Da Cunha C, 2002, CELL MOL NEUROBIOL, V22, P227, DOI 10.1023/A:1020736131907; Dean B, 1999, NEUROCHEM INT, V34, P109, DOI 10.1016/S0197-0186(98)00074-6; Digby GJ, 2012, J NEUROSCI, V32, P8532, DOI 10.1523/JNEUROSCI.0337-12.2012; Dolga AM, 2011, EXP NEUROL, V228, P1, DOI 10.1016/j.expneurol.2010.11.013; Doralp S, 2008, NEUROBIOL LEARN MEM, V90, P382, DOI 10.1016/j.nlm.2008.05.013; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FLYNN DD, 1993, SYNAPSE, V14, P283, DOI 10.1002/syn.890140406; Gao X, 2012, ARCH NEUROL-CHICAGO, V69, P380, DOI 10.1001/archneurol.2011.1060; Gubellini P, 2004, PROG NEUROBIOL, V74, P271, DOI 10.1016/j.pneurobio.2004.09.005; HOWARDJONES N, 1985, WHO CHRON, V39, P51; Hu Y, 2005, BRAIN RES, V1060, P26, DOI 10.1016/j.brainres.2005.08.019; Hu Y, 2010, NEUROBIOL AGING, V31, P1010, DOI 10.1016/j.neurobiolaging.2008.06.008; JOYCE JN, 1991, EXP NEUROL, V113, P277, DOI 10.1016/0014-4886(91)90017-7; JOYCE JN, 1991, EXP NEUROL, V113, P261, DOI 10.1016/0014-4886(91)90016-6; Keener A, 2008, CNS NEUROSCI THER, V14, P287, DOI 10.1111/j.1755-5949.2008.00055.x; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Li Y, 2010, SYNAPSE, V64, P224, DOI 10.1002/syn.20722; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Muma NA, 2001, EXP NEUROL, V168, P135, DOI 10.1006/exnr.2000.7582; Mutez E, 2009, PHARMACOL RES, V60, P41, DOI 10.1016/j.phrs.2009.03.010; Newell KA, 2007, PROG NEURO-PSYCHOPH, V31, P225, DOI 10.1016/j.pnpbp.2006.07.004; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Pakrasi S, 2007, J NEUROL, V254, P907, DOI 10.1007/s00415-006-0473-8; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Reiss AB, 2007, DRUGS, V67, P2111, DOI 10.2165/00003495-200767150-00001; Rezvani AH, 2008, NEUROSCIENCE, V154, P885, DOI 10.1016/j.neuroscience.2008.04.020; RodriguezPuertas R, 1997, SYNAPSE, V26, P341, DOI 10.1002/(SICI)1098-2396(199708)26:4<341::AID-SYN2>3.0.CO;2-6; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Solomon A, 2009, NEUROBIOL AGING, V30, P1006, DOI 10.1016/j.neurobiolaging.2007.09.012; SUGAWARA T, 2011, ACTA NEUROCHIR SUPPL, V2, P9, DOI DOI 10.1007/978-3-7091-0356-2_2; Tayebati SK, 2006, MECH AGEING DEV, V127, P115, DOI 10.1016/j.mad.2005.09.024; Uc EY, 2009, NEUROLOGY, V73, P1469, DOI 10.1212/WNL.0b013e3181bf992f; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wang G, 2009, CLIN NEUROL NEUROSUR, V111, P523, DOI 10.1016/j.clineuro.2009.02.005; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2008, NEUROSCIENCE, V154, P1100, DOI 10.1016/j.neuroscience.2008.04.026; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; Wang Q, 2011, EXP NEUROL, V230, P27, DOI 10.1016/j.expneurol.2010.04.006; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Wisman LAB, 2008, J NEUROSCI, V28, P7797, DOI 10.1523/JNEUROSCI.1885-08.2008; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu YQ, 2013, CNS NEUROSCI THER, V19, P170, DOI 10.1111/cns.12053; Xu YQ, 2012, PROG NEUROBIOL, V97, P1, DOI 10.1016/j.pneurobio.2012.02.002; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020945; Yang J, 2004, PHARMACOL BIOCHEM BE, V78, P179, DOI 10.1016/j.pbb.2004.03.007; Young Anne B., 1994, P293; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004; Zhang QJ, 2008, BRAIN RES, V1243, P152, DOI 10.1016/j.brainres.2008.09.028	60	12	12	1	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAY 16	2014	267						57	66		10.1016/j.neuroscience.2014.02.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF0KM	WOS:000334402700006	24613723	Green Submitted			2022-02-06	
J	Evans, RW				Evans, Randolph W.			Posttraumatic Headaches in Civilians, Soldiers, and Athletes	NEUROLOGIC CLINICS			English	Article						Headaches; Posttraumatic; Migraine; Tension-type; Occipital neuralgia; Soldiers; Athletes	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; POST-CONCUSSION SYNDROME; OCCIPITAL NERVE; US SOLDIERS; POSTCONCUSSIONAL DISORDER; MIGRAINE CHARACTERISTICS; ONABOTULINUM TOXIN; NATURAL-HISTORY; UNITED-STATES	Posttraumatic headaches are one of the most common and controversial secondary headache types. After mild head injury, more than 50% of people develop a postconcussion syndrome which has been controversial for more than 150 years. Headache is estimated as present in 30% to 90% of patients after mild head injury. Most headaches are of the tension type, although migraines can increase in frequency or occur acutely or chronically de novo. A review is provided of headaches in civilians, soldiers after blast trauma, athletes, and post-craniotomy including pathogenesis. The treatments are the same as for the primary phenotypes.	Baylor Coll Med, Houston, TX 77004 USA		Evans, RW (corresponding author), Baylor Coll Med, 1200 Binz 1370, Houston, TX 77004 USA.	revansmd@gmail.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andrikopoulos J, 2003, HEADACHE, V43, P553; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bekkelund SI, 2003, HEADACHE, V43, P59, DOI 10.1046/j.1526-4610.2003.03010.x; BENOIT BG, 1982, CAN J NEUROL SCI, V9, P321, DOI 10.1017/S0317167100044140; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bettucci D, 1998, ITAL J NEUROL SCI, V19, P20, DOI 10.1007/BF03028807; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blume HK, 2013, CEPHALALGIA, V33, P244; Blumenfeld A, 2013, HEADACHE, V53, P437, DOI 10.1111/head.12053; Bogduk N, 2013, NEURAL CLIN, V32; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Couch JR, 2009, EUR J NEUROL, V16, DOI 10.1111/j.1468-1331.2008.02362.x; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Denker P., 1944, NY STATE J MED, V44, P379; DiTommaso C, HEADACHE IN PRESS; Domowitch P, 1998, INQUIRER; Ducic I, 2012, HEADACHE, V52, P1136, DOI 10.1111/j.1526-4610.2011.02068.x; Edna T H, 1987, J Oslo City Hosp, V37, P41; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Erichsen J.E., 1867, RAILWAY OTHER INJURI; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans R W, 2009, Cephalalgia, V29, P801, DOI 10.1111/j.1468-2982.2008.01795_1.x; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Evans RW, 2000, HEADACHE, V40, P761, DOI 10.1046/j.1526-4610.2000.00135.x; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Evans RW, 2014, MEDLINK NEUROLOGY; Evans RW, 2014, UPTODATE; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fischer HUS, 2013, RS22452 C RES SERV; Fukutake T, 2000, NEUROLOGY, V54, P264, DOI 10.1212/WNL.54.1.264; Gabrhelik T, 2011, Prague Med Rep, V112, P279; GAWEL MJ, 1993, HEADACHE, V33, P96, DOI 10.1111/j.1526-4610.1993.hed3302096.x; Gee JR, 2003, HEADACHE, V43, P276, DOI 10.1046/j.1526-4610.2003.03053.x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Graff-Radford SB, 2013, NEUROL CLIN, V32; Graham DI, 2006, NEUROLOGY TRAUMA, P45; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang JHY, 2012, PAIN MED, V13, P489, DOI 10.1111/j.1526-4637.2012.01348.x; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jacob S, 2008, CEPHALALGIA, V28, P991, DOI 10.1111/j.1468-2982.2008.01622.x; Jennett B, 1990, HDB CLIN NEUROLOGY, V13, P1; Jensen TS, 2000, HEADACHES, P781; Kalidas K, 2013, CEPHALALGIA, V33, P205; Kaplan JB, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-10; Kaur A, 2000, NEUROSURGERY, V47, P633; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Li FY, 2012, TURK NEUROSURG, V22, P427, DOI 10.5137/1019-5149.JTN.5234-11.1; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Limmroth V, 1991, AM J EPIDEMIOL, V134, P1111; Linde M, 2011, CEPHALALGIA, V31, P797, DOI 10.1177/0333102411398402; Lucas S, 2013, CEPHALALGIA; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Magalhaes JE, 2013, HEADACHE, V53, P1613, DOI 10.1111/head.12165; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; MATTHEWS WB, 1972, BRIT MED J, V2, P326, DOI 10.1136/bmj.2.5809.326; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILO R, 1987, ACTA NEUROCHIR, V84, P13, DOI 10.1007/BF01456345; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Natsis K, 2006, CLIN ANAT, V19, P332, DOI 10.1002/ca.20190; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; Palmisani Stefano, 2013, J Headache Pain, V14, P67, DOI 10.1186/1129-2377-14-67; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Pennington B, 1998, NY TIMES; Putzki N, 2005, CEPHALALGIA, V25, P395, DOI 10.1111/j.1468-2982.2004.00860.x; Radanov BP, 2001, EUR SPINE J, V10, P403, DOI 10.1007/s005860000227; Rigler I, 1879, UEBER VERLETZUNGEN E; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rocha PAS, 2008, CEPHALALGIA, V28, P41, DOI 10.1111/j.1468-2982.2007.01465.x; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; Russell MB, 1996, EUR J NEUROL, V3, P424, DOI 10.1111/j.1468-1331.1996.tb00243.x; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; Schaller B, 2003, OTOLARYNG HEAD NECK, V128, P387, DOI 10.1067/mhn.2003.104; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Soloman S, 1998, HEADACHE, V38, P772, DOI 10.1046/j.1526-4610.1998.3810772.x; Soriani S, 2000, ARCH PEDIAT ADOL MED, V154, P90; Stewart M, 2012, BMJ-BRIT MED J, V21, P2012; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; SYMONDS C, 1962, LANCET, V1, P1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tatrow K, 2003, HEADACHE, V43, P755, DOI 10.1046/j.1526-4610.2003.03133.x; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trimble M.R., 1981, POSTTRAUMATIC NEUROS; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Vilming ST, 2000, HEADACHES, P831; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; WEINSTOCK A, 1995, NEUROLOGY, V45, pA347; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yerry JA, 2013, CEPHALALGIA, V33, P984	132	12	13	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	MAY	2014	32	2					283	+		10.1016/j.ncl.2013.11.010			22	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AG0RA	WOS:000335122100001	24703532				2022-02-06	
J	Liu, CL; Chen, CC; Lee, HC; Cho, DY				Liu, Chun-Lin; Chen, Chun-Chang; Lee, Han-Chung; Cho, Der-Yang			Matrix Metalloproteinase-9 in the Ventricular Cerebrospinal Fluid Correlated with the Prognosis of Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Cerebrospinal fluid; Biomarker; Matrix metalloproteinase-9; Traumatic brain injury; Glasgow Coma Scale	MATRIX-METALLOPROTEINASE EXPRESSION; SPECTRIN BREAKDOWN PRODUCTS; SEVERE HEAD-INJURY; CEREBRAL-ISCHEMIA; HUMAN STROKE; BLOOD; BARRIER; SERUM; INHIBITION; DISRUPTION	AIM: Matrix metalloproteinase 9 (MMP-9) has been shown to be a potential biomarker for outcome prediction after neuron damage. This study investigated whether MMP-9 could be used for outcome prediction after traumatic brain injury (TBI). MATERIAL and METHODS: For the TBI group, cerebrospinal fluid (CSF) was collected at different days after surgery from 6 head injury patients who had received surgical intervention with external ventricular drainage insertion. CSF collected from non-TBI patients (N=85) diagnosed with isolated hydrocephalus by a ventricular puncture during a ventriculo-peritoneal shunt surgery was used as control. RESULTS: The mean concentration of MMP-9 in the CSF of 85 non-TBI patients was determined to be 1.172 +/- 0.859 ng/mL. We found that the CSF MMP-9 concentration from TBI patients was elevated immediately after head injury with a median of 1.926 ng/mL (range, 0.673 to 24.990). Despite an early increase in the concentration of MMP-9, levels decreased within 72 hrs and nearly reached the normal range. Nevertheless, the concentration of MMP-9 was negatively correlated with the Glasgow Coma Scale (gamma = - 0.337, p = 0.013). CONCLUSION: MMP-9 concentration in the CSF of TBI patients correlated with neurological outcome and may represent an early indicator for the prognosis of this condition.	[Liu, Chun-Lin; Chen, Chun-Chang; Lee, Han-Chung; Cho, Der-Yang] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan; [Chen, Chun-Chang; Lee, Han-Chung; Cho, Der-Yang] China Med Univ Hosp, Dept Neurosurg, Taichung 40402, Taiwan		Liu, CL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan.	chunlin_lliu@yeah.net					Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Barr TL, 2010, STROKE, V41, pE123, DOI 10.1161/STROKEAHA.109.570515; Batra A, 2010, J CEREBR BLOOD F MET, V30, P1188, DOI 10.1038/jcbfm.2010.1; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Ghajar J, 2009, MT SINAI J MED, V76, P190, DOI 10.1002/msj.20095; Gottschall PE, 1996, NEUROIMMUNOMODULAT, V3, P69, DOI 10.1159/000097229; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P247, DOI 10.1007/978-3-211-98811-4_46; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kolar M, 2008, ACTA NEUROCHIR SUPPL, V102, P373, DOI 10.1007/978-3-211-85578-2_71; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Pfefferkorn T, 2003, STROKE, V34, P2025, DOI 10.1161/01.STR.0000083051.93319.28; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Ramos-Fernandez M, 2011, J STROKE CEREBROVASC, V20, P47, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.008; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stangl AP, 1998, SURG NEUROL, V50, P77, DOI 10.1016/S0090-3019(97)00301-7; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31	32	12	14	0	5	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAY	2014	24	3					363	368		10.5137/1019-5149.JTN.8551-13.0			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AI5ZO	WOS:000336949700015	24848175	Bronze			2022-02-06	
J	Si, DW; Yang, P; Jiang, RC; Zhou, HX; Wang, HT; Zhang, YX				Si, Daowen; Yang, Peng; Jiang, Rongcai; Zhou, Hongxia; Wang, Haitao; Zhang, Yuxin			Improved cognitive outcome after progesterone administration is associated with protecting hippocampal neurons from secondary damage studied in vitro and in vivo	BEHAVIOURAL BRAIN RESEARCH			English	Article						Progesterone; Traumatic brain injury; Cognitive function; Hippocampal neuron		Previous studies reported that progesterone could improve cognitive outcome following TBI. Moreover, some evidence implied that the hippocampus is associated with cognitive function. The aim of this study was to investigate the neuroprotective effects of progesterone on hippocampal neurons in vitro and in vivo, and its influence on the cognitive outcome. In vitro, the model of primary cultured hippocampal neurons against glutamate-induced excitotoxic damage was used. After 10-day culture, neurons were pretreated with progesterone in a concentration 10 ng/ml, 48 h before a 5-min exposure to 200 mu mol/l glutamate. Then 24 h after glutamate exposure, the nerve cells were observed and LDH was detected. The results showed progesterone protected the cultured hippocampal neurons morphology and significantly reduced the amount of LDH. In vivo, the model of TBI was established by modified Feeney's weight-dropping method. The progesterone was given in a dose of 16 mg/kg by intraperitoneal injection 1 h post injury and subsequent injections subcutaneously at 6 h and 12 h after TBI. Brain samples were extracted at 24 h after injury. Histology and the iNOS expression were examined by Nissl stain, immunohistochemistry and Western blot. The cognitive outcome was assessed by Morris water maze test (MWM). The results revealed that the neuronal cell damage and the expression of iNOS in the hippocampus CA1 were significantly decreased after progesterone administration. Progesterone significantly improved cognitive outcome after TBI. The results suggest that the positive effects of progesterone on cognitive outcome may be linked to protecting hippocampal neurons from secondary damage. (C) 2014 Elsevier B.V. All rights reserved.	[Si, Daowen; Zhou, Hongxia; Wang, Haitao; Zhang, Yuxin] Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China; [Yang, Peng] Hebei United Univ, Affiliated Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China; [Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300000, Peoples R China		Wang, HT (corresponding author), Hebei United Univ, Sch Basic Med Sci, Tangshan 063000, Hebei, Peoples R China.	sidaowen@126.com; wht92725@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201048]; Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401009]; Tangshan Science and Technology Research and Development Program [12140209a-55]	This work was supported by National Natural Science Foundation of China (81201048); Natural Science Foundation of Hebei Province (H2012401009); Tangshan Science and Technology Research and Development Program (12140209a-55).	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Bottino MC, 2011, BREAST CANCER RES TR, V126, P621, DOI 10.1007/s10549-010-0971-3; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Coughlan T, 2005, J NEUROCHEM, V93, P932, DOI 10.1111/j.1471-4159.2005.03068.x; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Mani SK, 2006, NEUROSCIENCE, V138, P773, DOI 10.1016/j.neuroscience.2005.07.034; Mohler H, 2008, PHARMACOL BIOCHEM BE, V90, P58, DOI 10.1016/j.pbb.2008.03.003; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; OGATA T, 1993, NEUROSCIENCE, V55, P445, DOI 10.1016/0306-4522(93)90513-F; Pierson RC, 2005, MOL BRAIN RES, V138, P105, DOI 10.1016/j.molbrainres.2004.10.047; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Schmidt BMW, 2000, FRONT NEUROENDOCRIN, V21, P57, DOI 10.1006/frne.1999.0189; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Silva MAD, 2008, NEUROSCIENCE, V157, P196, DOI 10.1016/j.neuroscience.2008.09.003; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; SyNAPSe, 2011, RAND DOUBL BLIND PLA; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wang YS, 2009, J NEUROL SCI, V285, P172, DOI 10.1016/j.jns.2009.06.034; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P409, DOI 10.1113/jphysiol.1992.sp019424	49	12	12	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2014	264						135	142		10.1016/j.bbr.2014.01.049			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	AE3CA	WOS:000333853300015	24518203				2022-02-06	
J	Pajoohesh-Ganji, A; Burns, MP; Pal-Ghosh, S; Tadvalkar, G; Hokenbury, NG; Stepp, MA; Faden, AI				Pajoohesh-Ganji, Ahdeah; Burns, Mark P.; Pal-Ghosh, Sonali; Tadvalkar, Gauri; Hokenbury, Nicole G.; Stepp, Mary Ann; Faden, Alan I.			Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury	BRAIN RESEARCH			English	Article						Spinal cord injury; Amyloid precursor protein; gamma-Secretase; Bace1; Amyloid-beta	TRANSGENIC MOUSE MODEL; LONG-TERM ACCUMULATION; ALZHEIMERS-DISEASE; BETA-SECRETASE; BRAIN TRAUMA; A-BETA; INFLAMMATORY RESPONSES; BACE1; AXONS; EXPRESSION	Amyloid-beta (A beta) is produced through the enzymatic cleavage of amyloid precursor protein (APP) by beta (Bace1) and gamma-secretases. The accumulation and aggregation of A beta as amyloid plaques is the hallmark pathology of Alzheimer's disease and has been found in other neurological disorders, such as traumatic brain injury and multiple sclerosis. Although the role of A beta after injury is not well understood, several studies have reported a negative correlation between A beta formation and functional outcome. In this study we show that levels of APP, the enzymes cleaving APP (Bace1 and gamma-secretase), and A beta are significantly increased from 1 to 3 days after impact spinal cord injury (SCI) in mice. To determine the role of All after SCI, we reduced or inhibited A beta in vivo through pharmacological (using DAFT) or genetic (Bace1 knockout mice) approaches. We found that these interventions significantly impaired functional recovery as evaluated by white matter sparing and behavioral testing. These data are consistent with a beneficial role for A beta after SCI. (C) 2014 Elsevier B.V. All rights reserved.	[Pajoohesh-Ganji, Ahdeah; Pal-Ghosh, Sonali; Tadvalkar, Gauri; Hokenbury, Nicole G.; Stepp, Mary Ann] George Washington Univ, Washington, DC 20037 USA; [Burns, Mark P.; Hokenbury, Nicole G.] Georgetown Univ, Washington, DC USA; [Hokenbury, Nicole G.; Faden, Alan I.] Univ Maryland, Baltimore, MD 21201 USA		Pajoohesh-Ganji, A (corresponding author), George Washington Univ, Dept Anat & Regenerat Biol, Ross Hall,Room 226C,2300 1 St NW, Washington, DC 20037 USA.	andeah@gwu.edu	Stepp, Mary Ann/ABF-2702-2020	Stepp, Mary Ann/0000-0001-5623-2538; Faden, Alan I./0000-0003-0128-2348; Burns, Mark P/0000-0003-4750-2000	Paralyzed Veterans of America [PVA2685]; NIH SIG [F10 RR025565]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR025565] Funding Source: NIH RePORTER	We would like to thank the valuable technical assistance of Qing Shu and Dr. Anastas Popratiloff, Director of GWU Center for Microscopy and Image Analysis. Also, we would like to thank Dr. Samuel Simmens and Gill Brooks from the Department of Epidemiology and Biostatistics for their valuable advice with statistical analysis. This work was supported by Paralyzed Veterans of America (PVA2685) and NIH SIG Grants (F10 RR025565).	Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brosnan CF, 2009, J CLIN INVEST, V119, P10, DOI 10.1172/JCI37786; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Cornish R, 2000, SPINE, V25, P1227, DOI 10.1097/00007632-200005150-00005; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; De Strooper B, 1999, NATURE, V402, P471, DOI 10.1038/44973; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Farah MH, 2011, J NEUROSCI, V31, P5744, DOI 10.1523/JNEUROSCI.6810-10.2011; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; GEHRMANN J, 1995, GLIA, V15, P141, DOI 10.1002/glia.440150206; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2013, FASEB J, V27, P1868, DOI 10.1096/fj.12-224212; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kobayashi S, 2010, NEUROCHEM INT, V56, P387, DOI 10.1016/j.neuint.2009.11.005; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Pajoohesh-Ganji A, 2012, BRAIN RES, V1475, P96, DOI 10.1016/j.brainres.2012.07.058; Pajoohesh-Ganji A, 2011, NEUROTHERAPEUTICS, V8, P195, DOI 10.1007/s13311-011-0036-2; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saeidi H., 2013, Journal of Isfahan Medical School, V30, P1942; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Velanac V, 2012, GLIA, V60, P203, DOI 10.1002/glia.21255; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8	52	12	12	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 29	2014	1560						73	82		10.1016/j.brainres.2014.02.049			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH1IV	WOS:000335874700008	24630972	Green Accepted			2022-02-06	
J	Pugh, MJ; Leykum, LK; Lanham, HJ; Finley, EP; Noel, PH; McMillan, KK; Pugh, JA				Pugh, Mary Jo; Leykum, Luci K.; Lanham, Holly J.; Finley, Erin P.; Noel, Polly H.; McMillan, Katharine K.; Pugh, Jacqueline A.			Implementation of the epilepsy center of excellence to improve access to and quality of care - protocol for a mixed methods study	IMPLEMENTATION SCIENCE			English	Article						Epilepsy; Relational Coordination; Veterans Health Administration (VA)	RELATIONAL COORDINATION; ANTIEPILEPTIC DRUG; HEALTH-STATUS; IMPACT; OUTCOMES; MECHANISMS; VETERANS; SERVICES; DISEASE; PATIENT	Background: To address the growing problem of epilepsy among aging Veterans and younger Veterans who have experienced a traumatic brain injury (TBI), the Veterans Health Administration (VA) has implemented 16 Epilepsy Centers of Excellence (ECOE) to assure increased access to high quality of care for Veterans with epilepsy. Each ECOE consists of a network of regional hubs to which spoke facilities refer Veterans for subspecialty treatment. The ECOEs are expected to improve access to and quality of epilepsy care through patient care, consultation and education. This study aims to: evaluate the effectiveness of the ECOE structure by describing changes in the quality of and access to care for epilepsy before and after the ECOE initiative using QUality Indicators in Epilepsy Treatment (QUIET Indicators); describe associations between changes in the structure and processes of care and Relational Coordination (RC), a model of task-oriented communication that has been shown to play a role in implementation science; and determine if variations in care are related to levels of RC. Methods: This four-year comparative case study uses a mixed-methods approach. We will use VA inpatient, outpatient, pharmacy, and chart abstraction data to identify changes in the quality of and access to epilepsy care in the VA between Fiscal Year 2008 and Fiscal Year 2014. Qualitative and survey methods will be used to identify changes in the structure and processes of epilepsy care and RC over the course of the study. We will then link data from the first two objectives to determine the extent to which quality of and access to epilepsy care is associated with RC using multivariable models. Discussion: This innovative study has the potential to improve understanding of hub-and-spoke model effectiveness, VA epilepsy care, and models of epilepsy specialty care more globally. Moreover, it contributes to implementation science by advancing understanding of the role of RC in the context of a major transformation in the structure of care delivery in a national integrated healthcare system.	[Pugh, Mary Jo; Leykum, Luci K.; Lanham, Holly J.; Finley, Erin P.; Noel, Polly H.; McMillan, Katharine K.; Pugh, Jacqueline A.] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Pugh, Mary Jo] VA Epilepsy Ctr Excellence, San Antonio, TX 78229 USA		Pugh, MJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, 7400 Merton Minter BLVD, San Antonio, TX 78229 USA.	Maryjo.Pugh2@va.gov	Pugh, Mary Jo/K-5336-2019; Pugh, Jacqueline/I-6199-2013	Pugh, Mary Jo/0000-0003-4196-7763; Pugh, Jacqueline/0000-0003-4933-141X; Noel, Polly/0000-0002-1519-7489; Finley, Erin/0000-0003-4497-7721	Department of Veterans Affairs, VA Health Services Research and Development ServiceUS Department of Veterans Affairs [IIR-062]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25 MH080916-01A2]; Department of Veterans Affairs, Health Services Research & Development Service, Quality Enhancement Research Initiative (QUERI); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH080916] Funding Source: NIH RePORTER	This project was funded by the Department of Veterans Affairs, VA Health Services Research and Development Service (IIR-062; MJ Pugh PI). Dr. Finley is an investigator with the Implementation Research Institute (IRI), at the George Warren Brown School of Social Work, Washington University in St. Louis; through an award from the National Institute of Mental Health (R25 MH080916-01A2) and the Department of Veterans Affairs, Health Services Research & Development Service, Quality Enhancement Research Initiative (QUERI).	Aldenkamp AP, 2006, SEIZURE-EUR J EPILEP, V15, P219, DOI 10.1016/j.seizure.2006.02.010; [Anonymous], 2012, EP SPECTR; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; Barbour R S, 1999, J Health Serv Res Policy, V4, P39; Begley CE, 2000, EPILEPSIA, V41, P342, DOI 10.1111/j.1528-1157.2000.tb00166.x; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; Ficker DM, 2000, EPILEPSIA, V41, pS7, DOI 10.1111/j.1528-1157.2000.tb01519.x; Finley EP, 2013, ANN FAM MED, V11, P543, DOI 10.1370/afm.1554; Fisher RS, 2000, EPILEPSY RES, V41, P39, DOI 10.1016/S0920-1211(00)00126-1; Fountain NB, 2011, NEUROLOGY, V76, P94, DOI 10.1212/WNL.0b013e318203e9d1; Gittell JH, 2000, MED CARE, V38, P807, DOI 10.1097/00005650-200008000-00005; Gittell JH, 2004, J MANAGE STUD, V41, P127, DOI 10.1111/j.1467-6486.2004.00424.x; Gittell JH, 2002, MANAGE SCI, V48, P1408; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Holland JH., 2000, EMERGENCE CHAOS ORDE; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Jordan ME, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-15; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Labiner DM, 2010, EPILEPSIA, V51, P2322, DOI 10.1111/j.1528-1167.2010.02648.x; Lanham HJ, 2009, JT COMM J QUAL PATIE, V35, P457, DOI 10.1016/S1553-7250(09)35064-3; Leykum Luci K, 2010, J Hosp Med, V5, pE2, DOI 10.1002/jhm.642; Leykum LK, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-66; Leykum LK, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-28; McDaniel RR, 2009, HEALTH CARE MANAGE R, V34, P191, DOI 10.1097/HMR.0b013e31819c8b38; Pugh MJV, 2008, NEUROLOGY, V70, P2171, DOI 10.1212/01.wnl.0000313157.15089.e6; Pugh MJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-1; Pugh MJV, 2008, PSYCHIAT SERV, V59, P925, DOI 10.1176/ps.2008.59.8.925; Pugh MJV, 2010, J AM GERIATR SOC, V58, P465, DOI 10.1111/j.1532-5415.2010.02732.x; Pugh MJV, 2004, J AM GERIATR SOC, V52, P417, DOI 10.1111/j.1532-5415.2004.52115.x; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Sperling MR, 2004, CNS SPECTRUMS, V9, P98, DOI 10.1017/S1092852900008464; Tague NR, 2005, QUALITY TOOLBOX, P35; Taylor J, 2010, EPILEPSY BEHAV, V18, P397, DOI 10.1016/j.yebeh.2010.05.007; Vogus TJ, 2010, ACAD MANAGE PERSPECT, V24, P60; Weinberg DB, 2007, HEALTH SERV RES, V42, P7, DOI 10.1111/j.1475-6773.2006.00653.x; Zeber JE, 2007, EPILEPSY BEHAV, V10, P539, DOI 10.1016/j.yebeh.2007.02.008	38	12	12	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	APR 9	2014	9								44	10.1186/1748-5908-9-44			10	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	AF7KI	WOS:000334893300001	24712733	Green Published, gold			2022-02-06	
J	An, Y; Belevych, N; Wang, YF; Zhang, H; Herschman, H; Chen, Q; Quan, N				An, Ying; Belevych, Natalya; Wang, Yufen; Zhang, Hao; Herschman, Harvey; Chen, Qun; Quan, Ning			Neuronal and Nonneuronal COX-2 Expression Confers Neurotoxic and Neuroprotective Phenotypes in Response to Excitotoxin Challenge	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						injury; inflammation; knockout mouse	MESSENGER-RNA EXPRESSION; TRAUMATIC BRAIN-INJURY; CYCLOOXYGENASE 2; SPINAL-CORD; SPREADING DEPRESSION; INHIBITORS; ISCHEMIA; RECEPTORS; INDUCTION; MODEL	Treating acute brain injuries with COX-2 inhibitors can produce both neuroprotective and neurotoxic effects. This study investigated the role of COX-2 in modulating acute brain injury induced by excitotoxic neural damage. Intrastriatal injection of excitotoxin (RS)-(tetrazole-5yl) glycine elicited COX-2 expression in two distinct groups of cells. cortical neurons surrounding the lesion and vascular cells in the lesion core. The vascular COX-2 was expressed in two cell types, endothelial cells and monocytes. Selective deletion of COX-2 in vascular cells in Tie2Cre Cox-2(flox/flox) mice did not affect the induction of COX-2 in neurons after the excitotoxin injection but resulted in increased lesion volume, indicating a neuroprotective role for the COX-2 expressed in the vascular cells. Selective deletion of monocyte COX-2 in LysMCre Cox-2(flox/flox) mice did not reduce COX-2-dependent neuroprotection, suggesting that endothelial COX-2 is sufficient to confer neuroprotection. Pharmacological inhibition of COX-2 activity in Tie2Cre Cox-2(flox/flox) mice reduced lesion volume, indicating a neurotoxic role for the COX-2 expressed in neurons. Furthermore, COX-2-dependent neurotoxicity was mediated, at least in part, via the activation of the EP1 receptor. These results show that Cox-2 expression induced in different cell types can confer opposite effects. (c) 2013 Wiley Periodicals, Inc.	[An, Ying; Belevych, Natalya; Wang, Yufen; Zhang, Hao; Chen, Qun; Quan, Ning] Ohio State Univ, Inst Behav Med Res, Columbus, OH 43210 USA; [An, Ying; Belevych, Natalya; Wang, Yufen; Chen, Qun; Quan, Ning] Ohio State Univ, Coll Dent, Dept Oral Biol, Columbus, OH 43210 USA; [Herschman, Harvey] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA		Quan, N (corresponding author), Ohio State Univ, Inst Behav Med Res, 460 Med Ctr Dr,Room 232, Columbus, OH 43210 USA.	quan.14@osu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 AI076926]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI076926] Funding Source: NIH RePORTER	Contract grant sponsor: NIH, contract grant number: RO1 AI076926 (to N.Q.)	Adams J, 1996, J NEUROCHEM, V66, P6; Ahmad M, 2009, BRAIN RES, V1279, P168, DOI 10.1016/j.brainres.2009.05.020; Anrather J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025916; ARIKUNI T, 1986, J COMP NEUROL, V244, P492, DOI 10.1002/cne.902440407; Ashok V, 2011, BREAST, V20, P66, DOI 10.1016/j.breast.2010.07.004; Azari MF, 2005, EUR J NEUROL, V12, P357, DOI 10.1111/j.1468-1331.2004.00987.x; Busija David W., 1996, Microcirculation (Philadelphia), V3, P379, DOI 10.3109/10739689609148310; Candelario-Jalil E, 2008, PHARMACOL RES, V57, P266, DOI 10.1016/j.phrs.2008.03.003; Chan FKL, 2010, LANCET, V376, P173, DOI 10.1016/S0140-6736(10)60673-3; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Dore S, 2003, ANN NEUROL, V54, P155, DOI 10.1002/ana.10612; Friess SH, 2012, LAB ANIM-UK, V46, P164, DOI 10.1258/la.2011.011084; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hara K, 1998, NEUROSCI LETT, V256, P53, DOI 10.1016/S0304-3940(98)00755-1; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hoozemans JJM, 2001, ACTA NEUROPATHOL, V101, P2, DOI 10.1007/s004010000251; Iadecola C, 1999, ACTA NEUROPATHOL, V98, P9, DOI 10.1007/s004010051045; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kim HJ, 2008, BRAIN RES, V1193, P153, DOI 10.1016/j.brainres.2007.12.017; Koistinaho J, 1999, STROKE, V30, P1900, DOI 10.1161/01.STR.30.9.1900; Koistinaho J, 2000, NEUROCHEM RES, V25, P645, DOI 10.1023/A:1007559003261; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Lopez-Vales R, 2006, SPINE, V31, P1100; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Mangoni AA, 2010, PHARMACOEPIDEM DR S, V19, P490, DOI 10.1002/pds.1945; Miettinen S, 1997, P NATL ACAD SCI USA, V94, P6500, DOI 10.1073/pnas.94.12.6500; Narasimha AJ, 2010, ARTERIOSCL THROM VAS, V30, P260, DOI 10.1161/ATVBAHA.109.198762; Oka A, 1997, NEUROREPORT, V8, P1161, DOI 10.1097/00001756-199703240-00020; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Peura DA, 2002, CLEV CLIN J MED, V69, P31, DOI 10.3949/ccjm.69.Suppl_1.SI31; Proescholdt MG, 2002, NEUROSCIENCE, V112, P731, DOI 10.1016/S0306-4522(02)00048-9; Quan N, 1998, BRAIN RES, V802, P189, DOI 10.1016/S0006-8993(98)00402-8; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; SAINATI SM, 2000, 6 INT STOCKH SPRINGF; Schiltz JC, 2002, J NEUROSCI, V22, P5606; Straccia M, 2013, GLIA, V61, P1607, DOI 10.1002/glia.22542; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Strauss KI, 2010, CRIT CARE MED, V38, P723, DOI 10.1097/CCM.0b013e3181bc80b9; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22; Yasojima K, 2001, NEUROLOGY, V57, P952, DOI 10.1212/WNL.57.6.952	46	12	12	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2014	92	4					486	495		10.1002/jnr.23317			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301UY	WOS:000330558800008	24375716	Green Accepted			2022-02-06	
J	Jain, A; Mittal, RS; Sharma, A; Sharma, A; Gupta, ID				Jain, Akhilesh; Mittal, R. S.; Sharma, Achal; Sharma, Anand; Gupta, I. D.			Study of insomnia and associated factors in traumatic brain injury	ASIAN JOURNAL OF PSYCHIATRY			English	Article						Insomnia; Traumatic brain injury; Depression		Objectives: This study is designed to investigate prevalence and risk factors of insomnia in TBI. This study has also tried to explore the connection between insomnia with neuroanatomical localization of TBI as well as depression. Design: Prospective study. Materials and methods: All eligible participants were evaluated initially after two week interval for first 4 weeks and monthly interval subsequently till one year. Demographic and injury characteristics of the participants were assessed on a self-designed semi structured performa. Interviews focused on assessment of severity of TBI, insomnia and depression using GCS, ISI and PHQ-9 respectively. Results: Total 204 patients were included, mean age was 33.34 years. 40.2% participants were found to have insomnia. None of the demographic variables were associated with insomnia except severity and duration of TBI. Moderate TBI patient (70.73%) had significantly higher occurrence of insomnia than the mild cases (19.67%) (P = 0.000, df 1). First three month after TBI witnessed more than half (63.41%) of those patient who had insomnia. This was found statistically significant (P < 0.017). Neuroanatomical localization was also correlated with insomnia. Cerebral contusion was the most common (40.24%) site of impact. Almost half (42.42%) of the patients with insomnia had multiple contusions. 32.84% of the study population had depression. No significant correlation could be established between depression and insomnia. Conclusion: Insomnia is a prevalent condition after TBI requiring more clinical and scientific attention as it may have important repercussions on rehabilitation. (C) 2014 Elsevier B.V. All rights reserved.	[Jain, Akhilesh] ESIC Model Hosp, Jaipur, Rajasthan, India; [Mittal, R. S.; Sharma, Achal; Sharma, Anand; Gupta, I. D.] Sawai Man Singh Med Coll, Jaipur, Rajasthan, India		Jain, A (corresponding author), 67-39 Heera Path,New Sanganer Rd, Jaipur 302020, Rajasthan, India.	akhilesic@gmail.com; Dranandsharma100123@gmail.com					Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; BUYSSE DJ, 1994, SLEEP, V17, P630, DOI 10.1093/sleep/17.7.630; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Graham T., 1974, LANCET, V304, P81; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lahan Vivekananda, 2011, Indian J Psychol Med, V33, P172, DOI 10.4103/0253-7176.92060; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; PARSONS LC, 1982, NURS RES, V31, P260; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; Ravesloot C, 1997, REHABIL PSYCHOL, V42, P3, DOI 10.1037/0090-5550.42.1.3; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sierra JC, 2008, REV NEUROLOGIA, V47, P566, DOI 10.33588/rn.4711.2008221; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004; Yu DSF, 2010, J ADV NURS, V66, P2350, DOI 10.1111/j.1365-2648.2010.05394.x; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	31	12	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1876-2018	1876-2026		ASIAN J PSYCHIATR	Asian J. Psychiatr.	APR	2014	8						99	103		10.1016/j.ajp.2013.12.017			5	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	V3K8R	WOS:000218348000021	24655637				2022-02-06	
J	Karam, O; Tucci, M; Lacroix, J; Rimensberger, PC				Karam, Oliver; Tucci, Marisa; Lacroix, Jacques; Rimensberger, Peter C.		Canadian Critical Care Trials Grp; Pediatric Acute Lung Injury Sepsis	International survey on plasma transfusion practices in critically ill children	TRANSFUSION			English	Article							FRESH-FROZEN PLASMA; ORGAN FAILURE; POSTINJURY COMPLICATIONS; GUIDELINES; ASSOCIATION; CLINICIAN; REDUCTION; PROTOCOLS; RISK	BackgroundStudies have shown heterogeneity in red blood cell transfusion practices. Although plasma transfusion is common in intensive care, there are no data on plasma transfusion practices in pediatric critical care units. Study Design and MethodsA scenario-based survey was sent to 718 pediatric critical care physicians working in Europe, North America, Australia, and New Zealand. Respondents were asked to report their decisions regarding plasma transfusion practice with respect to four scenarios: pneumonia, septic shock, traumatic brain injury (TBI), and postoperative care after a Tetralogy of Fallot correction. ResultsThe response rate was 187 of 718 (26%); half of the responders worked in North America. The proportion of physicians who transfused plasma to nonbleeding patients, solely based on abnormal international normalized ratio (INR), varied from 66% for pneumonia to 84% for TBI (p<0.001). In such nonbleeding patients, the median INR threshold that would trigger plasma transfusion was 2.5 for pneumonia and septic shock patients and 2.0 for TBI and the cardiac postoperative patients (p<0.001). Minor bleeding, minor surgery, insertion of a femoral line, hypotension, abnormal activated partial thromboplastin time, thrombocytopenia, and anemia levels were important determinants of plasma transfusion, whereas none of the respondents' demographic characteristics were important. ConclusionMore than two-thirds of responding pediatric critical care physicians prescribe plasma transfusions for nonbleeding critically ill children. Additionally, there is a significant variation in transfusion practice patterns with respect to plasma transfusion thresholds.	[Karam, Oliver; Rimensberger, Peter C.] Univ Hosp Geneva, Pediat Crit Care Unit, CH-1211 Geneva, Switzerland; [Tucci, Marisa; Lacroix, Jacques] Univ Montreal, Hop St Justine, Pediat Crit Care Unit, Montreal, PQ H3T 1C5, Canada		Karam, O (corresponding author), Univ Hosp Geneva, Pediat Crit Care Unit, 6 Rue Willy Donze, CH-1211 Geneva, Switzerland.	oliver.karam@hcuge.ch	Karam, Oliver/N-6216-2014	Karam, Oliver/0000-0001-6606-1736	Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec [24460]	Supported by the Fonds de la Recherche en Sante du Quebec (Grant 24460).	Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; [Anonymous], 2010, RAPP ANN HEM 2010, V2011, P68; [Anonymous], 2011, REP US DEP HLTH HUM; Arnold DM, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2011.02.005; BOLTONMAGGS PHB, 2012, ANN SHOT REPORT 2011; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Church GD, 2009, PEDIATR CRIT CARE ME, V10, P297, DOI 10.1097/PCC.0b013e3181988952; Cotton BA, 2009, J TRAUMA, V66, P41, DOI 10.1097/TA.0b013e31819313bb; Dara SI, 2005, CRIT CARE MED, V33, P2667, DOI [10.1097/01.CCM.0000186745.53059.F0, 10.1097/01.CCM.0000151062.00501.60]; Dellinger R Phillip, 2008, Crit Care Med, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dillman DA, 1978, MAIL TELEPHONE SURVE, V19; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Karam O, 2013, VOX SANG, V104, P342, DOI 10.1111/vox.12009; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; Lauzier F, 2007, CRIT CARE MED, V35, P1655, DOI 10.1097/01.CCM.0000269370.59214.97; Laverdiere Caroline, 2002, Pediatr Crit Care Med, V3, P335, DOI 10.1097/00130478-200210000-00001; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P132, DOI 10.2450/2009.0005-09; Luk C, 2002, CAN MED ASSOC J, V166, P1539; NAT'L OCEANIC & ATMOSPHERIC ADMIN, 2010, APP SECR COMM COAST, P1; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Puetz J, 2012, J PEDIATR-US, V160, P210, DOI 10.1016/j.jpeds.2011.08.013; Roback JD, 2010, TRANSFUSION, V50, P1227, DOI 10.1111/j.1537-2995.2010.02632.x; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Stanworth SJ, 2007, TRANSFUS CLIN BIOL, V14, P551, DOI 10.1016/j.tracli.2008.03.008; Watson DM, 2011, TRANSFUSION MED, V21, P124, DOI 10.1111/j.1365-3148.2010.01049.x; Watson GA, 2009, J TRAUMA, V67, P221, DOI 10.1097/TA.0b013e3181ad5957	26	12	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	APR	2014	54	4					1125	1132		10.1111/trf.12393			8	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	AE7DF	WOS:000334156200024	24032693				2022-02-06	
J	Kowoll, CM; Dohmen, C; Kahmann, J; Dziewas, R; Schirotzek, I; Sakowitz, OW; Bosel, J				Kowoll, C. M.; Dohmen, C.; Kahmann, J.; Dziewas, R.; Schirotzek, I.; Sakowitz, O. W.; Boesel, J.		IGNITE	Standards of Scoring, Monitoring, and Parameter Targeting in German Neurocritical Care Units: A National Survey	NEUROCRITICAL CARE			English	Article						Neurological/neurosurgical intensive care unit; Neurocritical care unit; NICU; Monitoring; Scores; Parameters	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEUROLOGICAL INTENSIVE-CARE; OPTIMAL GLYCEMIC CONTROL; VENTILATED PATIENTS; GRADING SCALES; RELIABILITY; PREDICTORS; MICRODIALYSIS; VARIABILITY	Optimal management of physiological parameters in neurological/neurosurgical intensive care units (NICUs) is largely unclear as high-quality evidence is lacking. The aim of this survey was to investigate if standards exist in the use of clinical scores, systemic and cerebral monitoring and the targeting of physiology values and in what way this affects clinical management in German NICUs. National survey, on-line anonymized questionnaire. German departments stating to run a neurological, neurosurgical or interdisciplinary neurological/neurosurgical intensive care unit were identified by a web-based search of all German hospitals and contacted via email. Responses from 78 German NICUs were obtained. Of 19 proposed clinical/laboratory/radiological scores only 5 were used regularly by > 60 %. Bedside neuromonitoring (NM) predominantly consisted of transcranial Doppler sonography (94 %), electroencephalography (92 %) and measurement of intracranial pressure (ICP) (90 %), and was installed if patients had or were threatened by elevated ICP (86 %), had specific diseases like subarachnoid hemorrhage (51 %) or were comatose (35 %). Although mean trigger values for interventions complied with guidelines or wide-spread customs, individual trigger values varied widely, e.g., for hyperglycemia (maximum blood glucose between 120 and 250 mg/dl) or for anemia (minimum hemoglobin values between 5 and 10 g/dl). Although apparently aiming for standardization in neurocritical care, German NICUs show substantial differences in NM and monitoring-associated interventions. In terms of scoring and monitoring methods, German NICUs seem to be quite conservative. These survey results suggest a need of prospective and randomized interventional trials in neurocritical care to help define standards and target values.	[Kowoll, C. M.; Dohmen, C.] Univ Hosp Koln, Dept Neurol, Cologne, Germany; [Kahmann, J.] Fac Med Heidelberg, Dept Evaluat & Training Med Educ, Heidelberg, Germany; [Dziewas, R.] Univ Hosp Munster, Dept Neurol, Munster, Germany; [Schirotzek, I.] Univ Hosp Giessen, Dept Neurol, Giessen, Germany; [Sakowitz, O. W.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany; [Boesel, J.] Univ Heidelberg Hosp, Dept Neurol, Kopfklin, D-69120 Heidelberg, Germany		Bosel, J (corresponding author), Univ Heidelberg Hosp, Dept Neurol, Kopfklin, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	julian.boesel@med.uni-heidelberg.de	Dziewas, Rainer/AAX-9505-2020	Dziewas, Rainer/0000-0003-1592-8461; Sakowitz, Oliver/0000-0003-3248-6335			Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bilotta F, 2012, CRIT CARE, V16, DOI 10.1186/cc11521; Bosel J, 2012, NERVENARZT, V83, P1609, DOI 10.1007/s00115-012-3541-6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BURN JPS, 1992, STROKE, V23, P438, DOI 10.1161/str.23.3.438b; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Degen LAR, 2011, STROKE, V42, P1546, DOI 10.1161/STROKEAHA.110.601211; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Egea-Guerrero JJ, 2012, TRANSPL P, V44, P2050, DOI 10.1016/j.transproceed.2012.07.070; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fleig V, 2011, ANAESTHESIST, V60, P963, DOI 10.1007/s00101-011-1942-8; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Harms L, 1998, NERVENARZT, V69, P1123, DOI 10.1007/s001150050392; Helbok R, 2011, NEUROCRIT CARE, V14, P433, DOI 10.1007/s12028-011-9503-1; Helbok R, 2011, NEUROCRIT CARE, V14, P162, DOI 10.1007/s12028-010-9472-9; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; Jauss M, 2001, J NEUROIMAGING, V11, P268, DOI 10.1111/j.1552-6569.2001.tb00045.x; Johnston KC, 2009, STROKE, V40, P3804, DOI 10.1161/STROKEAHA.109.561498; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; LINDSAY KW, 1983, J NEUROSURG, V58, P57, DOI 10.3171/jns.1983.58.1.0057; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Oshiro EM, 1997, NEUROSURGERY, V41, P140, DOI 10.1097/00006123-199707000-00029; Ramsay MAE, 2000, JAMA-J AM MED ASSOC, V284, P441, DOI 10.1001/jama.284.4.441; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Schiefecker AJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12714; Szeder V, 2010, NEUROCRIT CARE, V13, P40, DOI 10.1007/s12028-010-9346-1; Szmudo T, 2011, NEUROL NEUROCHIR POL, V45, P543, DOI 10.1016/S0028-3843(14)60121-3; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vespa PM, 2009, STROKE, V40, P1547, DOI 10.1161/STROKEAHA.108.542803; Wijman CAC, 2012, NEUROCRIT CARE, V16, P42, DOI 10.1007/s12028-011-9609-5; Young P, 2012, CRIT CARE RESUSC, V14, P14	46	12	13	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2014	20	2					176	186		10.1007/s12028-013-9893-3			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD0XA	WOS:000332956400002	23979795				2022-02-06	
J	Kurinsky, RM; Rochette, LM; Smith, GA				Kurinsky, Rachel M.; Rochette, Lynne M.; Smith, Gary A.			Pediatric Injuries Associated With High Chairs and Chairs in the United States, 2003-2010	CLINICAL PEDIATRICS			English	Article						injury; high chair; booster seat; chair; fall; child; infant		This study describes the epidemiology of injuries among children 3 years old associated with high chairs compared with chairs by retrospectively analyzing data from the National Electronic Injury Surveillance System from 2003 to 2010. An estimated 402 479 (95% confidence interval = 335 116-469 842) injuries associated with high chairs and chairs were treated in United States emergency departments, with an average of 9421 high chair-related injuries and 40 889 chair-related injuries annually. The number of high chair-related injuries significantly increased by 22.4% from 8926 injuries in 2003 to 10 930 injuries in 2010. Falling was the most common injury mechanism associated with high chairs (92.8%) and chairs (87.3%). Closed head injury was the most common diagnosis associated with high chairs (37.3%), and increased in number (P = .005) and rate (P = .006) from 2003 to 2010. Child caregivers should properly engage high chair safety restraint systems and encourage appropriate behaviors by young children when using chairs.	[Kurinsky, Rachel M.; Rochette, Lynne M.; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Kurinsky, Rachel M.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Rochette, Lynne M.] US Army Res Inst Behav & Social Sci, Ft Belvoir, VA USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org			National Medical Student Injury Research Training Program of the Center for Injury Research and Policy; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001172]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: A student research scholarship was provided by the National Medical Student Injury Research Training Program of the Center for Injury Research and Policy and funded by the Centers for Disease Control and Prevention (grant# 1R49CE001172) to RMK while she worked on this study.	American Society for Testing and Materials International, 2010, F264010 ASTM INT; American Society for Testing and Materials International, 2010, F40410 ASTM INT; Drago DA, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e59; Mayr JM, 1999, ACTA PAEDIATR, V88, P319, DOI 10.1080/08035259950170105; Ozanne-Smith J, 12 MON U ACC RES CTR; Powell EC, 2002, AMBUL PEDIATR, V2, P276, DOI 10.1367/1539-4409(2002)002<0276:IADOHC>2.0.CO;2; Schalamon J, 2006, EUR J PEDIATR, V165, P732, DOI 10.1007/s00431-006-0130-3; Souheil M, 2011, J FORENSIC SCI, V56, P534, DOI 10.1111/j.1556-4029.2010.01656.x; Watson W, 1998, VICTORIAN INJURY SUR, V37, P1; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	10	12	13	2	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	APR	2014	53	4					372	379		10.1177/0009922813510599			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AC0SU	WOS:000332205900011	24322954				2022-02-06	
J	Matsui, T; Yoshida, Y; Yanagihara, M; Suenaga, H				Matsui, Tomohiro; Yoshida, Yusuke; Yanagihara, Masashi; Suenaga, Hiromi			Hypothermia at 35 A degrees C Reduces the Time-Dependent Microglial Production of Pro-inflammatory and Anti-inflammatory Factors that Mediate Neuronal Cell Death	NEUROCRITICAL CARE			English	Article						Microglia; Hypothermia at 35 degrees C; Tumor necrosis factor-alpha; Interleukin-10; Neuronal cell death; Nitric oxide; Temporal change; Optimum temperature; PC12 cells	TRAUMATIC BRAIN-INJURY; HOSPITAL CARDIAC-ARREST; MODERATE HYPOTHERMIA; NITRIC-OXIDE; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; HEAD-INJURY; INTERLEUKIN-10; TEMPERATURE	Therapeutic hypothermia protects neurons after severe brain damage. This effect has been mainly achieved at the core temperatures of 32-34 A degrees C; however, the optimum temperature of therapeutic hypothermia is not fully defined. Here we studied whether hypothermic culture at 35 A degrees C had the same effects on the decrease of time-dependent expression of tumor necrosis factor (TNF)-alpha, interleukin (IL)-10, and nitric oxide (NO) by stimuli-activated microglia as that at 33 A degrees C, as determined in our previous reports, and whether these factors directly induced neuronal cell death. We determined the levels of cytokines and NO produced by microglia cultured with adenosine triphosphate (ATP), a toll-like receptor (TLR)2 agonist (N-palmitoyl-S-(2,3-bis(palmitoyloxy)-(2R,S)-propyl)-(R)-cysteinyl-seryl-(lysyl)3-lysine, Pam(3)CSK(4)), or a TLR4 agonist (lipopolysaccharide) under mild hypothermic (33 A degrees C), minimal hypothermic (35 A degrees C), and normothermic (37 A degrees C) conditions. We also determined the viability of rat neuronal pheochromocytoma PC12 cells treated with recombinant TNF-alpha or IL-10 or (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide (NOR3, an NO donor). Production of TNF-alpha, as well as that of IL-10 and NO were decreased by minimal hypothermia at 1.5-6, and 24-48 h, respectively, compared with normothermia, although some effects were diminished as compared with those by mild hypothermia. Exposure to TNF-alpha, IL-10, and NOR3 caused the death of PC12 cells in a concentration-dependent manner after 24 h. Hypothermic culture at 35 A degrees C decreased the production of early-phase TNF-alpha and late-phase IL-10 and NO from ATP- and TLR-activated microglia as observed at 33 A degrees C, albeit with diminished effects. Moreover, these factors caused the death of neuronal cells in a concentration-dependent manner. These results suggest that the attenuation of microglial production of TNF-alpha, IL-10, and NO by therapeutic hypothermia leads to the inhibition of neuronal cell death. Minimal hypothermia at 35 A degrees C may be sufficient to elicit neuroprotective effect.	[Matsui, Tomohiro; Yanagihara, Masashi; Suenaga, Hiromi] Yamaguchi Univ, Dept Lab Sci, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Yoshida, Yusuke] ACEL Inc, Dept Res & Dev, Midori Ku, Sagamihara, Kanagawa 2520131, Japan		Matsui, T (corresponding author), Yamaguchi Univ, Dept Lab Sci, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22791435]	This research was supported in part by Grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Young Scientists (B), No. 22791435 to T. M.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Ceulemans AG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-60; CHADD MA, 1972, ARCH DIS CHILD, V47, P819, DOI 10.1136/adc.47.255.819; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dedoni S, 2010, J NEUROCHEM, V115, P1421, DOI 10.1111/j.1471-4159.2010.07046.x; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Gal R, 2009, BRATISL MED J, V110, P222; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Logue ES, 2007, ACAD EMERG MED, V14, P293, DOI 10.1197/j.aem.2006.10.097; Loidl CF, 1998, BRAIN RES, V791, P303, DOI 10.1016/S0006-8993(98)00195-4; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/00003246-200212000-00014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Matsui T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/436263; Matsui T, 2012, NEUROCRIT CARE, V17, P293, DOI 10.1007/s12028-011-9639-z; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Pappas TC, 2003, AGING CELL, V2, P83, DOI 10.1046/j.1474-9728.2003.00039.x; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Si QS, 1997, NEUROSCIENCE, V81, P223, DOI 10.1016/S0306-4522(97)00172-3; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yamaguchi S, 2000, NEUROL RES, V22, P657; Yamamoto T, 2000, EUR J PHARMACOL, V397, P25, DOI 10.1016/S0014-2999(00)00244-2; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x	47	12	13	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2014	20	2					301	310		10.1007/s12028-013-9911-5			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD0XA	WOS:000332956400018	24072458				2022-02-06	
J	Meltzer, CC; Sze, G; Rommelfanger, KS; Kinlaw, K; Banja, JD; Wolpe, PR				Meltzer, C. C.; Sze, G.; Rommelfanger, K. S.; Kinlaw, K.; Banja, J. D.; Wolpe, P. R.			Guidelines for the Ethical Use of Neuroimages in Medical Testimony: Report of a Multidisciplinary Consensus Conference	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EXPERT WITNESS; INCIDENTAL FINDINGS; LITIGATION; DISORDER; QUALIFICATIONS; FAVORITISM; PHYSICIANS; TRUTH; FMRI	With rapid advances in neuroimaging technology, there is growing concern over potential misuse of neuroradiologic imaging data in legal matters. On December 7 and 8, 2012, a multidisciplinary consensus conference, Use and Abuse of Neuroimaging in the Courtroom, was held at Emory University in Atlanta, Georgia. Through this interactive forum, a highly select group of experts-including neuroradiologists, neurologists, forensic psychiatrists, neuropsychologists, neuroscientists, legal scholars, imaging statisticians, judges, practicing attorneys, and neuroethicists-discussed the complex issues involved in the use of neuroimaging data entered into legal evidence and for associated expert testimony. The specific contexts of criminal cases, child abuse, and head trauma were especially considered. The purpose of the conference was to inform the development of guidelines on expert testimony for the American Society of Neuroradiology and to provide principles for courts on the ethical use of neuroimaging data as evidence. This report summarizes the conference and resulting recommendations.	[Meltzer, C. C.] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA USA; [Meltzer, C. C.; Rommelfanger, K. S.] Emory Univ, Dept Neurol, Atlanta, GA USA; [Meltzer, C. C.; Wolpe, P. R.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Banja, J. D.] Emory Univ, Dept Rehabil Med, Atlanta, GA USA; [Kinlaw, K.; Wolpe, P. R.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Wolpe, P. R.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Wolpe, P. R.] Emory Univ, Dept Sociol, Atlanta, GA USA; [Sze, G.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA		Meltzer, CC (corresponding author), Emory Univ, Sch Med, Emory Univ Hosp, D-112,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	cmeltze@emory.edu			American Society of Neuroradiology; American College of RadiologyGeneral Electric; Emory Neuroscience Initiative; Emory Center for Ethics; Atlanta Clinical and Translational Institute; ASNR; Atlanta Clinical and Translational Science Institute [NIH U54 UL1RR02500]; Emory University Neuroscience Initiative; Atlanta Clinical and Translational Science Institute; National Center for Advancing Translational Science (of the National Institutes of Health)	Carolyn C. Meltzer-RELATED: Grant: American Society of Neuroradiology,* UNRELATED: Board Membership: Image Matrix of the American College of Radiology,* General Electric-Association of University Radiologists Award Board,* Association of University Radiologists,* ASNR executive committee,* Comments: travel reimbursement only; Consultancy: Thomas Jefferson University, University of Arizona, Comments: review of radiology department. Gordon Sze-RELATED: Support for Travel to Meetings for the Study or Other Purposes: ASNR, American College of Radiology, Emory Neuroscience Initiative, Emory Center for Ethics, Atlanta Clinical and Translational Institute, Comments: Plane flights and ground transportation were provided to all participants outside of Atlanta to attend the symposium, UNRELATED: Board Membership: Guerbet Advisory Board, Expert Testimony: scattered law firms, Grants/Grants Pending: National Institutes of Health,* Remedy Pharmaceuticals,* Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: ASNR. Kathy Kinlaw-RELATED: Grant: Support for the conference was provided by the ASNR, the Atlanta Clinical and Translational Science Institute (NIH U54 UL1RR02500), and the Emory University Neuroscience Initiative. This support was for the consensus conference overall, not to support my direct participation in the project or writing. John D. Banja-RELATED: Grant: ASNR,* Atlanta Clinical and Translational Science Institute,* American College of Radiology,* Comments: These entities supported a consensus conference from which the article was derived; UNRELATED: Board Membership: American Society of Cataract and Refractive Surgery, Comments: I amthe public member of the governing board. That affiliation has nothing to do, however, with issues in forensic neuroradiology, Other: Atlanta Clinical and Translational Science Institute,* Comments: I direct the ethics program of the Atlanta Clinical and Translational Science Institute, which is made possible by a grant from the National Center for Advancing Translational Science (of the National Institutes of Health). This speaks to the (dual) use of translational technologies. However, I do not see how that role would suggest a "conflict" bearing on this article. Paul R. Wolpe-RELATED: GRANT: ASNR,* Comments: They helped fund the consensus conference on which the article was based. * Money paid to the institution.	Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; [Anonymous], 1996, J NUCL MED, V37, P1256; [Anonymous], 2009, SCIENCEINSIDER; [Anonymous], 2002, PEDIATRICS, V109, P974; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barnes Patrick D, 2002, Top Magn Reson Imaging, V13, P85, DOI 10.1097/00002142-200204000-00004; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Berlin L, 2000, AM J ROENTGENOL, V174, P1215, DOI 10.2214/ajr.174.5.1741215; Berlin Leonard, 2006, J Am Coll Radiol, V3, P252, DOI 10.1016/j.jacr.2005.12.013; Brown T, 2010, STANFORD LAW REV, V62, P1119; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Feigl GC, 2013, WORLD NEUROSURG; Feld AD, 2005, AM J GASTROENTEROL, V100, P991, DOI 10.1111/j.1572-0241.2005.50180.x; Field A, 2012, ASFNR GUIDELINES CLI, P5; Findley KA, 2012, HOUSTON J HLTH POLIC; Ganis G, 2011, NEUROIMAGE, V55, P312, DOI 10.1016/j.neuroimage.2010.11.025; Hugh TB, 2009, J LAW MED, V16, P846; Janower Murray L, 2005, J Am Coll Radiol, V2, P424, DOI 10.1016/j.jacr.2004.09.003; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jukuri T, 2013, SCHIZOPHR RES, V143, P239, DOI 10.1016/j.schres.2012.11.020; Karim AA, 2010, CEREB CORTEX, V20, P205, DOI 10.1093/cercor/bhp090; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kesselheim AS, 2006, OBSTET GYNECOL, V108, P273, DOI 10.1097/01.AOG.0000225969.08432.75; Konrad KA, 2012, J THEOR BIOL, V306, P61, DOI 10.1016/j.jtbi.2012.04.013; Korgaonkar MS, 2013, NEUROPSYCHOPHARMACOL, V38, P863, DOI 10.1038/npp.2012.252; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kulich R, 2009, PAIN MED, V10, P373, DOI 10.1111/j.1526-4637.2009.00567.x; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Maggiore WA, 2011, PREHOSP EMERG CARE, V15, P426, DOI 10.3109/10903127.2011.561413; McCabe DP, 2008, COGNITION, V107, P343, DOI 10.1016/j.cognition.2007.07.017; Mohamed FB, 2006, RADIOLOGY, V238, P679, DOI 10.1148/radiol.2382050237; Moriarty JC, 2008, BEHAV SCI LAW, V26, P29, DOI 10.1002/bsl.795; Morse S, 2011, FUTURE EVIDENCE SCI, P137; Morse SJ, 2006, OHIO STATE J CRIMINA, V3, P397; Nakamura M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-213; Sato JR, 2012, J PSYCHIATR RES, V46, P1126, DOI 10.1016/j.jpsychires.2012.05.008; Shore S, 1971, Med Trial Tech Q, V18, P121; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P617, DOI 10.1007/s00431-011-1611-6; Snead OC, 2007, NEW YORK U LAW REV, V82, P1265; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Williams MA, 2006, NEUROLOGY, V66, P13, DOI 10.1212/01.wnl.0000190568.69950.11; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056	49	12	12	0	9	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2014	35	4					632	637		10.3174/ajnr.A3711			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AG3TP	WOS:000335343000005	23988754	hybrid, Green Published			2022-02-06	
J	Moore, M; Winkelman, A; Kwong, S; Segal, SP; Manley, GT; Shumway, M				Moore, Megan; Winkelman, Amy; Kwong, Sharon; Segal, Steven P.; Manley, Geoffrey T.; Shumway, Martha			The emergency department social work intervention for mild traumatic brain injury (SWIFT-Acute): A pilot study	BRAIN INJURY			English	Article						Brain injury; implementation; intervention study; treatment outcome	HEAD-INJURY; RANDOMIZED-TRIAL; RISK-FACTORS; SYMPTOMS; RECOMMENDATIONS; MANAGEMENT	Objective: To determine acceptability and preliminary effectiveness of Emergency Department (ED) Social Work Intervention for Mild Traumatic Brain Injury (SWIFT-Acute) on alcohol use, community functioning, depression, anxiety, post-concussive symptoms, post-traumatic stress disorder and service use. Methods: This study enrolled 64 patients who received head CT after mild traumatic brain injury (mTBI) and were discharged <24 hours from a Level 1 trauma centre ED. The cohort study compared outcomes for SWIFT-Acute (n = 32) and Usual Care (n = 32) 3 months post-injury. SWIFT-Acute includes education about symptoms and decreasing alcohol use, coping strategies, reassurance and education about recovery process and follow-up guidelines and resources. Measures: Alcohol Use Disorders Identification Test (AUDIT), Community Integration Questionnaire (CIQ), Patient Health Questionnaire-4, Rivermead Post-concussion Symptoms Questionnaire, PTSD Checklist-Civilian, acceptability and service use surveys. Results: Paired t-test revealed SWIFT-Acute group maintained pre-injury community functioning; Usual Care significantly declined in functioning on the CIQ. Both groups reported 'hazardous' pre-injury drinking on AUDIT. Wilcoxon Signed Rank test showed the SWIFT-Acute group significantly reduced alcohol use; the Usual Care group did not. Both groups significantly increased medical service use. No statistically significant differences were found on other measures. Acceptability ratings were extremely high. Conclusions: SWIFT-Acute was acceptable to patients. There is preliminary evidence of effectiveness for reducing alcohol use and preventing functional decline. Future randomized studies are needed.	[Moore, Megan] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Winkelman, Amy; Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Cord Injury Ctr, San Francisco, CA 94143 USA; [Winkelman, Amy; Manley, Geoffrey T.] San Francisco Gen Hosp & Trauma Ctr, Dept Neurosurg, San Francisco, CA USA; [Kwong, Sharon] San Francisco Gen Hosp & Trauma Ctr, Dept Social Serv 4, San Francisco, CA USA; [Segal, Steven P.] Univ Calif Berkeley, Sch Social Welf, Berkeley, CA 94720 USA; [Shumway, Martha] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA.	mm99@uw.edu	Segal, Steven/AAY-6932-2020	Segal, Steven/0000-0001-6204-6950	San Francisco Hearts and Heroes Foundation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. The production of the patient educational materials was supported by a grant from the San Francisco Hearts and Heroes Foundation.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Dijkers M., 2000, COMMUNITY INTEGRATIO; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moore M, 2012, SOC WORK HEALTH CARE, V51, P140, DOI 10.1080/00981389.2011.610872; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Ruff RM, 2009, PSYCHOL INJ LAW, V2, P34, DOI 10.1007/s12207-009-9029-4; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soo C, 2007, COCHRANE DB SYST REV, V3; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	47	12	13	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					448	455		10.3109/02699052.2014.890746			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900008	24702522				2022-02-06	
J	Oyetunji, TA; Haider, AH; Obirieze, AC; Fisher, M; Cornwell, EE; Qureshi, FG; Abdullah, F; Nwomeh, BC				Oyetunji, Tolulope A.; Haider, Adil H.; Obirieze, Augustine C.; Fisher, Michael; Cornwell, Edward E., III; Qureshi, Faisal G.; Abdullah, Fizan; Nwomeh, Benedict C.			Epidemiology of 577 Pediatric Firearm Fatalities: A 2-year Review of the National Trauma Data Bank	AMERICAN SURGEON			English	Article; Proceedings Paper	43rd Annual Meeting of the American-Pediatric-Surgical-Association (APSA)	MAY 20-23, 2012	San Antonio, TX	Amer Pediat Surg Assoc			INJURY-RELATED MORTALITY; TEACHING SAFETY SKILLS; AFRICAN-AMERICAN MEN; PREVENT GUN PLAY; STORAGE PRACTICES; CHILDREN; ASSOCIATION; CARE; ADOLESCENTS; OWNERSHIP	The purpose of this study was to delineate the epidemiology of pediatric firearm injuries, including ethno-demographic patterns with impact on years of potential life lost (YPLL). A 2-year review of the National Trauma Data Bank (2007 to 2008) was conducted. Firearm fatalities in records of patients younger than 18 years were identified. Data were analyzed by demographic and injury characteristics and YPLL was calculated by ethnicity. A total of 577 deaths were identified in the pediatric group. Blacks accounted for 49.7 per cent of the fatalities; Hispanics, 19.2 per cent; whites, 17.7 per cent, and other ethnicity, 13.4 per cent. Median Injury Severity Score was 25 with a median Glasgow Coma Scale score of 3. Traumatic brain injury was present in 84.2 per cent of the records. Assault accounted for 72.8 per cent, self-inflicted injury 12.7 per cent, and unintentional injuries were 8.2 per cent. Most firearm fatalities occurred at home (33.6%). By emergency department (ED) disposition, 29.3 per cent died in the ED, 32.9 per cent were admitted to the intensive care unit, and 30.0 per cent taken to the operating room. Blacks had a total of 17,446 YPLL, Hispanics 6,776 YPLL, and whites 6,718 YPLL. Pediatric firearm fatalities still remain an important public health concern. Inclusive gun control policies focused on primary prevention of accidental injuries may be more effective in mitigating its impact.	[Oyetunji, Tolulope A.; Obirieze, Augustine C.; Fisher, Michael; Cornwell, Edward E., III] Howard Univ, Coll Med, Dept Surg, Washington, DC 20060 USA; [Haider, Adil H.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Abdullah, Fizan] Johns Hopkins Univ, Sch Med, Div Pediat Surg, Baltimore, MD 21205 USA; [Qureshi, Faisal G.] Childrens Natl Med Ctr, Dept Gen & Thorac Surg, Washington, DC 20010 USA; [Nwomeh, Benedict C.] Ohio State Univ, Coll Med, Div Pediat Surg, Columbus, OH 43210 USA		Oyetunji, TA (corresponding author), Howard Univ, Coll Med, Dept Surg, 2041 Georgia Ave NW, Washington, DC 20060 USA.	toyetunji@howard.edu	Nwomeh, Benedict/E-3771-2011	Nwomeh, Benedict/0000-0001-6665-2077; Oyetunji, Tolulope/0000-0003-3039-7195			Baxley F, 2006, ARCH PEDIAT ADOL MED, V160, P542, DOI 10.1001/archpedi.160.5.542; BEAVER BL, 1990, J PEDIATR SURG, V25, P97, DOI 10.1016/S0022-3468(05)80171-X; Bryant WW, 2011, J BLACK STUD, V42, P690, DOI 10.1177/0021934710393243; CHRISTOFFEL KK, 1991, PEDIATRICS, V88, P294; Connor SM, 2005, PEDIATRICS, V115, pE38, DOI 10.1542/peds.2004-1105; Coyne-Beasley T, 2002, ARCH PEDIAT ADOL MED, V156, P763, DOI 10.1001/archpedi.156.8.763; Coyne-Beasley T, 2001, ARCH PEDIAT ADOL MED, V155, P659, DOI 10.1001/archpedi.155.6.659; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; Darras Kyle M, 2002, Adv Nurse Pract, V10, P51; Earls F, 1991, J Health Care Poor Underserved, V2, P156; Earls F., 1991, J HEALTH CARE POOR U, V2, P165; Everett SA, 1997, J COMMUN HEALTH, V22, P313, DOI 10.1023/A:1025172903135; Farah MM, 1999, PEDIATRICS, V104, P1059, DOI 10.1542/peds.104.5.1059; Freed LH, 1998, PEDIATR CLIN N AM, V45, P427, DOI 10.1016/S0031-3955(05)70017-1; Garbarino J, 2002, FUTURE CHILD, V12, P73; Gatheridge BJ, 2004, PEDIATRICS, V114, pE294, DOI 10.1542/peds.2003-0635-L; Glatt Kathleen, 2005, J Pediatr Nurs, V20, P448, DOI 10.1016/j.pedn.2005.08.006; Grossman DC, 1999, ARCH PEDIAT ADOL MED, V153, P875, DOI 10.1001/archpedi.153.8.875; Grossman DC, 2000, PEDIATRICS, V106, P22, DOI 10.1542/peds.106.1.22; HAMMOND WR, 1993, AM PSYCHOL, V48, P142, DOI 10.1037/0003-066X.48.2.142; Hardy MS, 2002, FUTURE CHILD, V12, P101, DOI 10.2307/1602741; Hepburn L, 2006, J TRAUMA, V61, P423, DOI 10.1097/01.ta.0000226396.51850.fc; Himle MB, 2004, J APPL BEHAV ANAL, V37, P1, DOI 10.1901/jaba.2004.37-1; Jostad CM, 2008, J APPL BEHAV ANAL, V41, P117, DOI 10.1901/jaba.2008.41-117; Katcher M L, 1994, Wis Med J, V93, P511; Kunz Howard P, 2001, J Emerg Nurs, V27, P485, DOI 10.1067/men.2001.118613; Li GH, 1996, ARCH PEDIAT ADOL MED, V150, P1160, DOI 10.1001/archpedi.1996.02170360050008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MARTIN JR, 1991, ANN EMERG MED, V20, P58, DOI 10.1016/S0196-0644(05)81120-5; MAY JP, 1993, J GEN INTERN MED, V8, P380, DOI 10.1007/BF02600078; McGee Z T, 2001, J Cult Divers, V8, P94; Miltenberger RG, 2005, J APPL BEHAV ANAL, V38, P395, DOI 10.1901/jaba.2005.130-04; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; NAURECKAS SM, 1995, ARCH PEDIAT ADOL MED, V149, P1318, DOI 10.1001/archpedi.1995.02170250024003; ORNATO JP, 1985, J TRAUMA, V25, P575, DOI 10.1097/00005373-198507000-00001; Schwab W, 2000, J TRAUMA, V48, P30; Senturia YD, 1996, ARCH PEDIAT ADOL MED, V150, P265, DOI 10.1001/archpedi.1996.02170280035006; Solomon BS, 2002, ARCH PEDIAT ADOL MED, V156, P769, DOI 10.1001/archpedi.156.8.769; Teret SP, 2002, FUTURE CHILD, V12, P119, DOI 10.2307/1602742; Tongren JE, 2009, JAMA-J AM MED ASSOC, V301, P2213, DOI 10.1001/jama.2009.746; US Census Bureau, THE 2012 STATISTICAL; WINTEMUTE GJ, 1987, JAMA-J AM MED ASSOC, V257, P3107, DOI 10.1001/jama.257.22.3107; ZAVOSKI RW, 1995, PEDIATRICS, V96, P278	43	12	12	0	8	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	APR	2014	80	4					366	371					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	AJ5RL	WOS:000337744400018	24887667				2022-02-06	
J	Cohn, B; Keim, SM; Sanders, AB				Cohn, Brian; Keim, Samuel M.; Sanders, Arthur B.			CAN ANTICOAGULATED PATIENTS BE DISCHARGED HOME SAFELY FROM THE EMERGENCY DEPARTMENT AFTER MINOR HEAD INJURY?	JOURNAL OF EMERGENCY MEDICINE			English	Article						head injury; anticoagulation; medical imaging; prognosis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; OLDER-ADULTS; MILD; RISK; MANAGEMENT; MORTALITY	Background: Anticoagulated patients have increased risk for bleeding, and serious outcomes could occur after head injury. Controversy exists regarding the utility of head computed tomography (CT) in allowing safe discharge dispositions for anticoagulated patients suffering minor head injury. Clinical Question: What is the risk of delayed intracranial hemorrhage in anticoagulated patients with minor head injury and a normal initial head CT scan? Evidence Review: Four observational studies were reviewed that investigated the outcomes of anticoagulated patients who presented after minor head injury. Results: Overall incidence of death or neurosurgical intervention ranged from 0 to 1.1% among the patients investigated. The studies did not clarify which patients were at highest risk. Conclusion: The literature does not support mandatory admission for all anticoagulated patients after minor head injury, but further studies are needed to identify the higher-risk patients for delayed bleeding to determine appropriate management. (C) 2014 Elsevier Inc.	[Cohn, Brian] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA; [Keim, Samuel M.; Sanders, Arthur B.] Univ Arizona, Coll Med, Dept Emergency Med, Tucson, AZ 85724 USA		Keim, SM (corresponding author), Univ Arizona, Coll Med, Dept Emergency Med, POB 245057, Tucson, AZ 85724 USA.						Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Carpenter CR, 2011, WEST J EMERG MED, V12, P489, DOI 10.5811/westjem.2011.1.1962; Carpenter CR, 2011, ANN EMERG MED, V57, P653, DOI 10.1016/j.annemergmed.2010.06.560; Carpenter Christopher R, 2009, Ann Emerg Med, V53, P398, DOI 10.1016/j.annemergmed.2008.04.020; Caterino JM, 2012, J AM GERIATR SOC, V60, P304, DOI 10.1111/j.1532-5415.2011.03823.x; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; ELIASTAM M, 1989, ANN EMERG MED, V18, P1222, DOI 10.1016/S0196-0644(89)80064-2; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P1787, DOI 10.1136/jnnp.2004.041384; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Han JH, 2010, EMERG MED CLIN N AM, V28, P611, DOI 10.1016/j.emc.2010.03.005; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hastings SN, 2008, AM J EMERG MED, V26, P454, DOI 10.1016/j.ajem.2007.07.005; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Johnson SG, 2007, CHEST, V131, P1500, DOI 10.1378/chest.06-2374; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Temple RJ, 1995, CLIN MEASUREMENT DRU, P3; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	35	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAR	2014	46	3					410	416		10.1016/j.jemermed.2013.08.107			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AC3BZ	WOS:000332391300036	24360352				2022-02-06	
J	Gordon, KE; Do, MT; Thompson, W; McFaull, S				Gordon, Kevin E.; Do, Minh T.; Thompson, Wendy; McFaull, Steven		Canadian Paediat Surveillance Prog	Concussion management by paediatricians: A national survey of Canadian paediatricians	BRAIN INJURY			English	Article						Brain concussion; child; clinical medicine; physicians practice patterns; guideline adherence	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONSENSUS STATEMENT; KNOWLEDGE TRANSFER; CHILDREN; ADOLESCENTS; EDUCATION; MILD	Objective: To assess the use of concussion/mild traumatic brain injury (mTBI) guidelines, criteria used in the initiation of return-to-play (RTP) and management of RTP for brain injured children and youth by Canadian paediatricians. Methods: A cross-sectional survey was mailed through the Canadian Paediatric Surveillance Program to similar to 2600 paediatric specialists and sub-specialists. Results: Of 809 respondents (31%), 503 encountered newly diagnosed paediatric concussion/mTBI within the past 12 months, reporting similar to 6900 cases. Of the respondents, 96.7% (95% CI = 94.7-98.6%) reported using one or more of the presented concussion/mTBI guidelines in the management of their patients. The most frequently reported criteria (> 50%) used to determine asymptomatic status were: free from all concussion symptoms, by patient report (92%), by proxy report (76%), normal physical examination (65%), in school full-time, with usual school performance (53%). Most respondents (84.9%) did not initiate RTP immediately after their patients became asymptomatic. The median time waiting before initiating RTP was 7 days. The median duration of the RTP sequence was 7 days, with considerable variation reported. Conclusions: Canadian paediatricians frequently encounter patients with concussion/mTBI. Their concussion/mTBI care appears to be consistent with current guidelines,	[Gordon, Kevin E.] Canadian Paediat Soc, Ottawa, ON, Canada; [Gordon, Kevin E.] Dalhousie Univ, Dept Pediat, Div Pediat Neurol, Halifax, NS B3K 6R8, Canada; [Do, Minh T.; Thompson, Wendy; McFaull, Steven] Publ Hlth Agcy Canada, Ottawa, ON, Canada		Gordon, KE (corresponding author), Dalhousie Univ, IWK Hlth Ctr, Div Pediat Neurol, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	kegor@dal.ca			Public Health Agency of Canada	Funding Source: Public Health Agency of Canada.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Aubry M, 2001, BRIT J SPORT MED, V36, P6, DOI DOI 10.1136/BJSM.36.1.6; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Bergman DA, 1999, PEDIATRICS, V104, P1407; Broshek DK, 2012, J CHILD NEUROLOGY; *CAN PED SOC, 2006, PEDIAT CHILD HLTH, V11, P420; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Faul M, 2010, TRAUMATIC BRAIN INJU; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Grenier D, 2004, Paediatr Child Health, V9, P379; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Sosin DM, 1996, BRAIN INJURY, V10, P47; Standaert CJ, 2007, ARCH PHYS MED REHAB, V88, P1077, DOI 10.1016/j.apmr.2007.06.002; StataCorp, 2011, STAT STAT SOFTW REL; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	38	12	12	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2014	28	3					311	317		10.3109/02699052.2013.862740			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AC0RI	WOS:000332202100007	24354430				2022-02-06	
J	Sarubbo, S; Latini, F; Ceruti, S; Chieregato, A; d'Esterre, C; Lee, TY; Cavallo, M; Fainardi, E				Sarubbo, Silvio; Latini, Francesco; Ceruti, Stefano; Chieregato, Arturo; d'Esterre, Christopher; Lee, Ting-Yim; Cavallo, Michele; Fainardi, Enrico			Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: a pilot study	NEURORADIOLOGY			English	Article						Cranioplasty; CT perfusion; decompressive craniectomy; traumatic brain injury	CEREBRAL-BLOOD-FLOW; SINKING SKIN FLAP; COMPUTED-TOMOGRAPHY; HEMODYNAMIC-CHANGES; CRANIECTOMY; HEMICRANIECTOMY; SURGERY	Little is known about hemodynamic disturbances affecting cerebral hemispheres in traumatic brain injury (TBI) after cranioplasty. We prospectively investigated six stable TBI patients who underwent cranioplasty more than 90 days after effective decompressive craniectomy. Computerized tomography perfusion (CTP) studies and evaluation of clinical outcome were performed for each patient before cranioplasty and at 7 days and 3 months after surgery. Cerebral blood flow (CBF), cerebral blood volume (CBV) and mean transit time (MTT) were measured in multiple cortical circular regions positioned in cranioplasty-treated and contralateral hemispheres. Neither complications associated with cranioplasty nor changes in outcome were observed. On the treated side, CBF and CBV values were higher before and 7 days after cranioplasty than at 3 months after surgery, whereas MTT values were lower at 7 days than at 3 months after surgical treatment. Our results indicate that cortical perfusion progressively declines in the cranioplasty treated hemisphere but remains stable in the contralateral hemisphere after surgery and suggest that CTP can represent a promising tool for a longitudinal analysis of hemodynamic abnormalities occurring in TBI patients after cranioplasty. In addition, these data imply a possible role of cranioplasty in restoring flow to meet the prevailing metabolic demand.	[Sarubbo, Silvio] Santa Chiara Hosp, APSS Trento, Dept Neurosci, Neurosurg Unit, Trento, Italy; [Sarubbo, Silvio] S Anna Univ Hosp, Dept Med & Surg Sci Commun & Behav, Neurol Clin, Ferrara, Italy; [Latini, Francesco; Cavallo, Michele] S Anna Univ Hosp, Dept Neurosci & Rehabil, Neurosurg Unit, Ferrara, Italy; [Ceruti, Stefano; Fainardi, Enrico] S Anna Univ Hosp, Dept Neurosci & Rehabil, Neuroradiol Unit, Ferrara, Italy; [Chieregato, Arturo] Careggi Univ Hosp, Dept Neurosci, Neurocrit Care Unit, Florence, Italy; [d'Esterre, Christopher] Univ Calgary, Foothills Med Ctr, Calgary, AB, Canada; [d'Esterre, Christopher; Lee, Ting-Yim] Univ Western Ontario, Robarts Res Inst, Imaging Res Lab, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Imaging program, Lawson Hlth Res Inst, London, ON, Canada; [Fainardi, Enrico] Azienda Ospedaliera Univ, Dipartimento Neurosci, Unita Operat Neuroradiol, I-44124 Ferrara, Italy		Fainardi, E (corresponding author), Azienda Ospedaliera Univ, Dipartimento Neurosci, Unita Operat Neuroradiol, I-44124 Ferrara, Italy.	henryfai@tin.it	Sarubbo, Silvio/AAT-4312-2020; Lee, Ting-Yim/M-1721-2013; Sarubbo, Silvio/AAL-1592-2020; Sarubbo, Silvio/AAZ-7072-2020; Sarubbo, Silvio/F-7986-2012	Sarubbo, Silvio/0000-0003-1113-3717; Latini, Francesco/0000-0002-4702-526X			Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chieregato A, 2006, INTENS CARE MED, V32, P1668, DOI 10.1007/s00134-006-0302-7; d'Esterre CD, 2012, TRANSL STROKE RES, V3, P205, DOI 10.1007/s12975-012-0178-5; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; JENNETT B, 1975, LANCET, V1, P480; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Laidlaw J, 2000, OPERATIVE NEUROSURGE, VI, P303; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Maekawa M, 1999, NEUROL SURG TOKYO, V27, P717; Maeshima S, 2005, EUR NEUROL, V53, P164, DOI 10.1159/000086129; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Sinclair AG, 2010, RADIOGRAPHICS, V30, P461, DOI 10.1148/rg.302095115; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; TEASDALE G, 1974, LANCET, V2, P81; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Wintermark M, 2006, J NEURORADIOLOGY, V33, P27, DOI 10.1016/S0150-9861(06)77225-X; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	43	12	14	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAR	2014	56	3					237	243		10.1007/s00234-014-1318-2			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AC3ZO	WOS:000332460500007	24430116				2022-02-06	
J	Yan, HQ; Shin, SS; Ma, XC; Li, YM; Dixon, CE				Yan, Hong Q.; Shin, Samuel S.; Ma, Xiecheng; Li, Youming; Dixon, C. Edward			Differential effect of traumatic brain injury on the nuclear factor of activated T Cells C3 and C4 isoforms in the rat hippocampus	BRAIN RESEARCH			English	Article						Nuclear factor of activated T cells (NFAT); Immunohistochemistry; Rat; Traumatic brain injury (TBI); Calcineurin	FLUID PERCUSSION INJURY; DELAYED NEURONAL DEATH; GENE-EXPRESSION; TRANSCRIPTION FACTORS; TYROSINE-HYDROXYLASE; CALCINEURIN SUBUNIT; REACTIVE ASTROCYTES; FRONTAL-CORTEX; NFAT; APOPTOSIS	The interaction between the phosphatase calcineurin and transcription factor nuclear factor of activated T cells (NFAT) plays an important role numerous signaling and the regulatory events. Although NFAT is mostly known for its transcription function in the immune system, NFAT also has essential functions even in the central nervous system (CNS). The effects of traumatic brain injury (TBI) on NFAT are currently unknown. To determine if there is an alteration in NFAT after TBI, we examined NFATc3 and c4 levels at 6 h, 1 day, 1 week, 2 weeks and 4 weeks post injury. Rats were anesthetized and surgically prepared for controlled cortical impact (CCI) injury or sham surgery. Semi-quantitative measurements of NFATc3 and c4 in the hippocampal homogenates from injured and sham rats sacrificed at the appropriate time after injury were assessed using Western blot analysis. After TBI insult, in the hippocampus ipsilateral to the injury, NFATc3 expression levels were decreased both in the cytoplasmic and nuclear fractions. However, NFATc4 expression levels were increased in the cytoplasmic fraction but decreased in the nuclear fraction. Double labeling (with NeuN and GFAP) immunohistochemistry revealed that NFATc3 was expressed in subset of astrocytes and NFATc4 was expressed primarily in neurons. These differential responses in NFATc3 and c4 expression after TBI insult may indicate long-term changes in hippocampal excitability and may contribute to behavioral deficits. Further study is warranted to illustrate the role of NFATc3 and c4 in the setting of TBI. Published by Elsevier B.V.	[Yan, Hong Q.; Shin, Samuel S.; Ma, Xiecheng; Li, Youming; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Safar Ctr, 201 Hill Bldg,3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS33150, NS060672, NS079061]; Veterans Affairs grantUS Department of Veterans Affairs [B6761R]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033150, R01NS079061, P01NS030318, R01NS060672] Funding Source: NIH RePORTER	This work was supported by NIH/NINDS grants NS33150, NS060672 and NS079061; and the Veterans Affairs grant B6761R.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Bodor J, 2000, J LEUKOCYTE BIOL, V67, P774, DOI 10.1002/jlb.67.6.774; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Im SH, 2004, MOL CELLS, V18, P1; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Minematsu H, 2011, CELL SIGNAL, V23, P1785, DOI 10.1016/j.cellsig.2011.06.013; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Neria F, 2013, GLIA, V61, P1052, DOI 10.1002/glia.22494; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Quadrato G, 2012, P NATL ACAD SCI USA, V109, pE1499, DOI 10.1073/pnas.1202068109; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Serrano-Perez MC, 2011, GLIA, V59, P94, DOI 10.1002/glia.21079; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	50	12	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 22	2014	1548						63	72		10.1016/j.brainres.2013.12.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB6UM	WOS:000331925000006	24389074	Green Accepted			2022-02-06	
J	Ruis, C; van den Berg, E; van Stralen, HE; Wajer, IMCH; Biessels, GJ; Kappelle, LJ; Postma, A; van Zandvoort, MJE				Ruis, Carla; van den Berg, Esther; van Stralen, Haike E.; Wajer, Irene M. C. Huenges; Biessels, Geert Jan; Kappelle, L. Jaap; Postma, Albert; van Zandvoort, Martine J. E.			Symptom Checklist 90-Revised in neurological outpatients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Symptom Checklist 90-Revised; Complaints; Neurology; Psychopathology.; Questionnaire	TRAUMATIC BRAIN-INJURY; SCL 90-R; AFFECTIVE-DISORDERS; TUMOR; HEADACHE	The Symptom Checklist 90-Revised (SCL-90-R) is an international, widely used, self-report questionnaire of multidimensional complaints with normative data for healthy control subjects and psychiatric patients. The questionnaire is also often used in neurological patients. Little is known about the amount and pattern of complaints in this group, and normative data are lacking. We therefore analyzed self-reported symptoms on the SCL-90-R of a neurological population (N = 600). Moreover, we compared the answer patterns of five subgroups: neurodegenerative disease, cerebrovascular disease, epilepsy, brain tumor, and traumatic brain injury. Neurological outpatients scored significantly higher in comparison with normative data from healthy control subjects, with most pronounced scores on Inadequacy of Thinking and Acting, Depression, and Somatization (p < .01, effect sizes 1.69, 0.83, and 0.83). No differences between the various pathologies were found. Although it is difficult to determine whether the complaints arise directly from the neurological disease or more indirectly from psychiatric disturbances accompanying the disease, simply comparing a neurological patient to normative data for healthy control subjects can lead to inappropriate classifications. Complaints of our patients should not be directly interpreted as psychopathology. A two-step procedure in which scores on the SCL-90-R are first compared to healthy control subjects and secondly to neurological patients can be helpful in the interpretation.	[Ruis, Carla; van den Berg, Esther; Wajer, Irene M. C. Huenges; Biessels, Geert Jan; Kappelle, L. Jaap; van Zandvoort, Martine J. E.] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands; [Ruis, Carla; van den Berg, Esther; van Stralen, Haike E.; Postma, Albert; van Zandvoort, Martine J. E.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [van Stralen, Haike E.] Univ Med Ctr Utrecht, Dept Rehabil Med, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands		Ruis, C (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, G03-228,POB 85500, NL-3508 GA Utrecht, Netherlands.	c.ruis@umcutrecht.nl	van den Berg, Esther/ABD-8026-2020	van den Berg, Esther/0000-0002-8120-7366			Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Arrindell W.A., 2005, SYMPTOM CHECKLIST HA; Arrindell W. A., 1986, SYMPTOM CHECKLIST HA; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bornstein R. A., 1990, COGN BEHAV NEUROL, V3, P200; Caplan B., 1992, J CLIN EXPT NEUROPSY, V14, P78; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Derogatis L, 1977, SCL 90 ADM SCORING P; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; FORSYTH PA, 1993, NEUROLOGY, V43, P1678, DOI 10.1212/WNL.43.9.1678; Gass C. S., 2009, OXFORD HDB PERSONALI, P432; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; Glassmire DM, 2003, ASSESSMENT, V10, P299, DOI 10.1177/1073191103256129; Kaplan CP, 1998, J HEAD TRAUMA REHAB, V13, P94, DOI 10.1097/00001199-199806000-00009; Kaplan CP, 1998, BRAIN INJURY, V12, P977, DOI 10.1080/026990598122025; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; Leathem JM, 2000, J HEAD TRAUMA REHAB, V15, P1246, DOI 10.1097/00001199-200012000-00005; Leon-Carrion J, 2006, STUD NEUROPSYCH DEV, P275; Lezak M. D., 2012, NEUROPSYCHOLOGICAL A, P804; PIOTROWSKI C, 1990, PROF PSYCHOL-RES PR, V21, P99, DOI 10.1037/0735-7028.21.2.99; Schankin CJ, 2007, CEPHALALGIA, V27, P904, DOI 10.1111/j.1468-2982.2007.01368.x; Stang PE, 2005, NEUROLOGY, V64, P1573, DOI 10.1212/01.WNL.0000158326.31368.04; TATE DG, 1990, REHABIL PSYCHOL, V35, P211, DOI 10.1037/h0079062; Warlow C.P., 2011, STROKE PRACTICAL MAN; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; Woessner R., 1996, ASSESSMENT, V3, P291	29	12	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB 7	2014	36	2					170	177		10.1080/13803395.2013.875519			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AB2CN	WOS:000331600700006	24479727				2022-02-06	
J	Chabok, SY; Yazdanshenas, H; Naeeni, AF; Ziabakhsh, A; Bidar, SS; Reihanian, A; Bazargan-Hejazi, S				Chabok, S. Y.; Yazdanshenas, H.; Naeeni, A. F.; Ziabakhsh, A.; Bidar, S. S.; Reihanian, A.; Bazargan-Hejazi, S.			The impact of body mass index on treatment outcomes among traumatic brain injury patients in intensive care units	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Obesity; Body mass index; ICU; Traumatic brain injury; Mortality; Hospital length of stay; ICU length of stay	GLASGOW COMA SCALE; BLUNT TRAUMA; RESPIRATORY-FUNCTION; MORBIDLY OBESE; MORTALITY; RISK; ICU; LUNG	Obesity is a risk factor in treatment outcomes of critically ill patients. This study was conducted to determine the impact of obesity on the likelihood of recovery from traumatic brain injury (TBI) in intensive care unit (ICU) patients. We carried out a prospective study on 115 head injury patients who were admitted to the ICU of Poursina Hospital, Rasht, in the one-year period between July 2006 and June 2007. Obese patients (body mass index [BMI] a parts per thousand yen 30 kg/m(2)) were compared with non-obese patients (BMI < 30 kg/m(2)). Demographic information, acute physiology and chronic health evaluation scores, Injury Severity Scores (ISS), Glasgow Coma Scale scores, and ICU mortality incidences were recorded. Obese patients had significantly higher ICU mortality rates compared to non-obese patients (p = 0.02). Furthermore, we observed a trend towards a higher ICU mortality rate in obese patients with ISS > 25 (p = 0.04). Moreover, obesity was associated with prolonged mechanical ventilation, ICU length of stay (ILOS), and hospital length of stay (HLOS) (p < 0.001). Obesity was associated with increased ICU mortality and prolonged dependency on mechanical ventilation, ILOS, and HLOS in patients with TBI. However, further prospective studies with larger sample sizes are needed to substantiate these findings.	[Chabok, S. Y.; Naeeni, A. F.] Guilan Univ Med Sci, Rasht, Iran; [Yazdanshenas, H.] Charles R Drew Univ Med & Sci, Coll Med, Los Angeles, CA 90059 USA; [Ziabakhsh, A.; Reihanian, A.] Guilan Univ Med Sci, Rd Trauma Res Ctr, Rasht, Iran; [Bidar, S. S.] Univ Tehran Med Sci, Tehran, Iran; [Bazargan-Hejazi, S.] Charles R Drew Univ, Coll Med, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		Bazargan-Hejazi, S (corresponding author), Charles R Drew Univ, Coll Med, 1731 East 120th St, Los Angeles, CA 90059 USA.	sh.yousefzadeh@gmail.com; Hamedyazdanshenas@cdrewu.edu; fadaenaeeni@yahoo.com; aziabakhsh@yahoo.com; s.shabbidar@yahoo.com; atossa73@yahoo.com; shahrzadbazargan@cdrewu.edu	Shab-Bidar, Sakineh/H-9525-2017	Shab-Bidar, Sakineh/0000-0002-0167-7174; Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015	Guilan Road Trauma Research Center (GTRC); Clinical Research Development Unit of Poursina Hospital; National Institutes of Health, National Institute on Minority Health and Health Disparities (NIH-NIMHD) [U54RR026138]	Research supported in part by: Guilan Road Trauma Research Center (GTRC); Clinical Research Development Unit of Poursina Hospital, and the National Institutes of Health, National Institute on Minority Health and Health Disparities (NIH-NIMHD Grant U54MD007598-formerly U54RR026138).	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Alban RF, 2006, AM SURGEON, V72, P966; ALPERT MA, 1993, AM J MED SCI, V306, P117, DOI 10.1097/00000441-199308000-00011; Anzueto A, 2011, THORAX, V66, P66, DOI 10.1136/thx.2010.145086; Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08; Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Ciesla DJ, 2006, J AM COLL SURGEONS, V203, P539, DOI 10.1016/j.jamcollsurg.2006.06.029; Duane TM, 2006, J TRAUMA, V61, P1218, DOI 10.1097/01.ta.0000241022.43088.e1; El-Solh A, 2001, CHEST, V120, P1989, DOI 10.1378/chest.120.6.1989; Evans DC, 2011, AM SURGEON, V77, P1003; Farshchian N, 2012, J INJ VIOLENCE RES, V4, P44; Frat JP, 2008, INTENS CARE MED, V34, P1991, DOI 10.1007/s00134-008-1245-y; Frezza E E, 2005, Minerva Chir, V60, P391; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Goulenok C, 2004, CHEST, V125, P1441, DOI 10.1378/chest.125.4.1441; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; Liu T, 2012, INJURY; Livingston DH, 2013, AM SURGEON, V79, P247; Lown DJ, 2013, CRIT CARE RESUSC, V15, P49; Margot S, 2011, NCHS DATA BRIEF 2011; Marik PE, 2006, CRIT CARE MED, V34, P1251, DOI 10.1097/01.CCM.0000209142.99742.0B; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Pelosi P, 1996, CHEST, V109, P144, DOI 10.1378/chest.109.1.144; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; Shakeri M, 2012, J INJ VIOLENCE RES, V4, P11; SHARP JT, 1964, J CLIN INVEST, V43, P728, DOI 10.1172/JCI104957; Sifri ZC, 2008, J TRAUMA, V65, P396, DOI 10.1097/TA.0b013e31817f97fd; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; THOMAS PS, 1989, THORAX, V44, P382, DOI 10.1136/thx.44.5.382; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Varon J, 2001, CRIT CARE CLIN, V17, P187, DOI 10.1016/S0749-0704(05)70159-7; WHO, 2012, OB OV; Zali Ali Reza, 2012, Glob J Health Sci, V4, P179, DOI 10.5539/gjhs.v4n3p179; Zimmerman DW, 2004, BRIT J MATH STAT PSY, V57, P173, DOI 10.1348/000711004849222	43	12	12	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2014	40	1					51	55		10.1007/s00068-013-0314-2			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AA2VV	WOS:000330953200007	26815777				2022-02-06	
J	Coffey, L; Gallagher, P; Desmond, D				Coffey, Laura; Gallagher, Pamela; Desmond, Deirdre			A prospective study of the importance of life goal characteristics and goal adjustment capacities in longer term psychosocial adjustment to lower limb amputation	CLINICAL REHABILITATION			English	Article						Amputation; depression; goal importance; goal adjustment; prospective studies	ADAPTIVE SELF-REGULATION; TRAUMATIC BRAIN-INJURY; ANXIETY SYMPTOMS; REHABILITATION; PEOPLE; DEPRESSION; DISENGAGEMENT; DISABILITY	Objective: To explore the life goal characteristics and goal adjustment capacities of persons with lower limb amputation on admission to rehabilitation, and to examine their efficacy as predictors of psychosocial outcomes six months post discharge. Design: Prospective, descriptive. Setting: Two specialist inpatient rehabilitation facilities in Ireland. Subjects: A consecutive sample of 64 patients with lower limb amputation. Main measures: On admission to rehabilitation, life goal characteristics (goal importance, goal disturbance) were assessed using the Goal Facilitation Index and goal adjustment capacities (goal disengagement, goal re-engagement) were measured using the Goal Adjustment Scale. The Beck Depression Inventory-II and the Trinity Amputation and Prosthesis Experience Scales-Revised assessed depressive symptomatology and psychosocial adjustment to amputation at six months post discharge. Results: The highest average importance ratings were assigned to goals associated with interpersonal relationships, independence and subjective well-being. Goals related to physical limitations and disruptions in daily activities received the highest hindrance ratings. Goal importance ( = -0.33) and goal disengagement ( = -0.29) on admission significantly predicted depressive symptomatology six months post discharge (P 0.05). Goal importance ( = 0.32), goal disturbance ( = -0.26), and goal re-engagement ( = -0.21) on admission significantly predicted general adjustment to lower limb amputation at six months post discharge (P 0.05), while goal importance ( = -0.32) and goal disturbance ( = 0.30) significantly predicted social adjustment (P 0.05). Conclusions: Life goal characteristics and goal adjustment capacities on admission to rehabilitation predicted psychosocial outcomes six months post discharge among individuals with lower limb amputation.	[Coffey, Laura; Gallagher, Pamela] Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland; [Coffey, Laura; Gallagher, Pamela; Desmond, Deirdre] Dublin Psychoprosthet Grp, Dublin, Ireland; [Desmond, Deirdre] Natl Univ Ireland, Dept Psychol, Maynooth, Kildare, Ireland		Gallagher, P (corresponding author), Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland.	pamela.gallagher@dcu.ie	Coffey, Laura/N-1783-2015; Desmond, Deirdre/P-5625-2015	Coffey, Laura/0000-0001-5946-377X; Desmond, Deirdre/0000-0002-6746-7006	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	This research was partly funded by the Irish Research Council.	[Anonymous], 2009, BRIEF PAIN INVENTORY; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bloom LF, 2006, AM J PHYS MED REHAB, V85, P807, DOI 10.1097/01.phm.0000237871.91829.30; Boerner K, 2005, CLIN REHABIL, V19, P790, DOI 10.1191/0269215505cr893oa; Boersma SN, 2005, BRIT J HEALTH PSYCH, V10, P615, DOI 10.1348/135910705X52525; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Burger H, 2007, DISABIL REHABIL, V29, P1323, DOI 10.1080/09638280701320797; Carver C.S., 1998, SELF REGULATION BEHA; Carver CS, 2000, SOC SCI MED, V50, P1715, DOI 10.1016/S0277-9536(99)00412-8; Conrad N, 2010, CLIN REHABIL, V24, P431, DOI 10.1177/0269215509358930; Coppack RJ, 2012, CLIN REHABIL, V26, P1032, DOI 10.1177/0269215512436613; Dillingham TR, 2003, ARCH PHYS MED REHAB, V84, P1662, DOI 10.1053/S0003-9993(03)00291-0; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Dunne E, 2011, HEALTH PSYCHOL, V30, P763, DOI 10.1037/a0024019; EMMONS RA, 1986, J PERS SOC PSYCHOL, V51, P1058, DOI 10.1037/0022-3514.51.5.1058; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher P, 2011, PROSTHET ORTHOT INT, V35, P278, DOI 10.1177/0309364611407108; Gallagher P, 2010, AM J PHYS MED REHAB, V89, P487, DOI 10.1097/PHM.0b013e3181dd8cf1; Garnefski N, 2012, INT J AUDIOL, V51, P545, DOI 10.3109/14992027.2012.675628; Geertzen JHB, 2009, DISABIL REHABIL, V31, P522, DOI 10.1080/09638280802240589; Hayes SC., 1999, ACCEPTANCE COMMITMEN; Johnson RB., 2004, EDUC RESEARCHER, V33, P14, DOI [10.3102/0013189X033007014, DOI 10.3102/0013189X033007014]; Kraaij V, 2008, AIDS PATIENT CARE ST, V22, P395, DOI 10.1089/apc.2007.0145; Kraaij V, 2010, J HEALTH PSYCHOL, V15, P876, DOI 10.1177/1359105309357251; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Maester S, 2002, GOAL FACILITATION IN; McGrath J.R., 1999, TOP STROKE REHABIL, V6, P43, DOI [10.1310/J2G9-UVA8-UE5D-N693, DOI 10.1310/J2G9-UVA8-UE5D-N693]; McNamara P, 2006, CLIN REHABIL, V20, P818, DOI 10.1177/0269215506070811; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Nair KPS, 2003, CLIN REHABIL, V17, P521, DOI 10.1191/0269215503cr645oa; Nair KPS, 2003, CLIN REHABIL, V17, P192, DOI 10.1191/0269215503cr599oa; Phelps LF, 2008, REHABIL PSYCHOL, V53, P28, DOI 10.1037/0090-5550.53.1.28; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; Schroevers M, 2008, BRIT J HEALTH PSYCH, V13, P551, DOI 10.1348/135910707X241497; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Singh R, 2009, CLIN REHABIL, V23, P281, DOI 10.1177/0269215508094710; Stuifbergen Alexa K, 2003, J Neurosci Nurs, V35, P94; TZELGOV J, 1991, PSYCHOL BULL, V109, P524, DOI 10.1037/0033-2909.109.3.524; van Velzen JM, 2006, CLIN REHABIL, V20, P999, DOI 10.1177/0269215506070700; Williams R, 2004, DISABIL REHABIL, V26, P862, DOI 10.1080/09638280410001708878; Wrosch C, 2003, PERS SOC PSYCHOL B, V29, P1494, DOI 10.1177/0146167203256921; Wrosch C, 2013, PSYCHO-ONCOLOGY, V22, P581, DOI 10.1002/pon.3037; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	45	12	12	1	19	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2014	28	2					196	205		10.1177/0269215513497736			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	290QS	WOS:000329774000010	23945162	Green Accepted			2022-02-06	
J	Gu, JW; Yang, T; Kuang, YQ; Huang, HD; Kong, B; Shu, HF; Yu, SX; Zhang, JH				Gu, Jian-wen; Yang, Tao; Kuang, Yong-qin; Huang, Hai-dong; Kong, Bin; Shu, Hai-feng; Yu, Si-xun; Zhang, Jun-hai			Comparison of the safety and efficacy of propofol with midazolam for sedation of patients with severe traumatic brain injury: A meta-analysis	JOURNAL OF CRITICAL CARE			English	Article						Propofol; Midazolam; Traumatic brain injury; Sedation	CRITICALLY ILL PATIENTS; LONG-TERM SEDATION; ADULTS	Objective: To perform a meta-analysis to compare the safety and efficacy of propofol with midazolam for sedation of patients with severe traumatic brain injury. Materials and Methods: Studies were included in the meta-analysis if they met the following criteria: randomized controlled trial of sedative-hypnotic agents including propofol and midazolam; patients had severe traumatic brain injury; the primary outcome was the Glasgow Outcome Scale score; secondary outcomes included mortality, therapeutic failure, intracranial pressure, and cerebral perfusion pressure. The data were analyzed using software for meta-analysis. Results: Seven relevant studies were identified. Three of these studies were excluded: one was a single-arm study, one compared morphine and propofol, and for one the full text article could not be obtained. The remaining 4 studies were included in the meta-analysis. The results of the meta-analysis showed that propofol and midazolam have similar effects on the Glasgow Outcome Scale score, mortality, intracranial pressure, and cerebral perfusion pressure. Conclusion: Our meta-analysis of 4 studies showed that there are no important differences between propofol and midazolam when administered to provide sedation for patients with severe traumatic brain injury. Further randomized, controlled trials comparing propofol with midazolam for sedation of such patients are needed. (C) 2014 Elsevier Inc. All rights reserved.	[Gu, Jian-wen; Yang, Tao; Kuang, Yong-qin; Huang, Hai-dong; Kong, Bin; Shu, Hai-feng; Yu, Si-xun; Zhang, Jun-hai] Chengdu Mil Gen Hosp, Dept Neurosurg, Chengdu 610083, Peoples R China		Gu, JW (corresponding author), Chengdu Mil Gen Hosp, Dept Neurosurg, Chengdu 610083, Peoples R China.	gujianwen5000@gmail.com					Camps AS, 2000, CRIT CARE MED, V28, P3612, DOI 10.1097/00003246-200011000-00009; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; FLOWER O, 2012, EMERG MED INT, V2012, DOI DOI 10.1155/2012/637171; Ghori Kamran A, 2007, Crit Care Resusc, V9, P166; Ho KM, 2008, INTENS CARE MED, V34, P1969, DOI 10.1007/s00134-008-1186-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magarey J M, 2001, Aust Crit Care, V14, P147, DOI 10.1016/S1036-7314(05)80056-6; Roberts DJ, 2012, DRUGS, V72, P1881, DOI 10.2165/11636220-000000000-00000; Sanchez-Izquierdo-Riera JA, 1998, ANESTH ANALG, V86, P1219, DOI 10.1097/00000539-199806000-00016; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tanguy M, 2012, J NEUROTRAUM, V29, P1105, DOI 10.1089/neu.2011.1817; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Walder B, 2001, ANESTH ANALG, V92, P975, DOI 10.1097/00000539-200104000-00033	14	12	13	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2014	29	2					287	290		10.1016/j.jcrc.2013.10.021			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3IB	WOS:000332409400020	24360821				2022-02-06	
J	Mahmood, A; Wu, HT; Qu, CS; Mahmood, S; Xiong, Y; Kaplan, D; Chopp, M				Mahmood, Asim; Wu, Hongtao; Qu, Changsheng; Mahmood, Selina; Xiong, Ye; Kaplan, David; Chopp, Michael			Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats	BRAIN RESEARCH			English	Article						Bone marrow stromal cells; Nogo-A; Axonal regeneration; Traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; NEURITE GROWTH; ADULT-RATS; NEONATAL LESIONS; EXPRESSION; TRANSPLANTATION; MYELIN; PROTEOGLYCANS; INHIBITION	Nogo-A is a major form of growth inhibitory molecule (growth-IM) which inhibits axonal regeneration and neurite regrowth after neural injury. Bone marrow stromal cells (MSCs) have been shown to inhibit Nogo-A expression in vitro and in cerebral ischemic animal models. The present study was designed to investigate the effects of treatment with human MSCs (hMSCs) impregnated into collagen scaffolds on the expression of Nogo-A and axonal plasticity after traumatic brain injury (TBI). Adult male Wistar rats were injured with controlled cortical impact and treated either with saline, hMSCs-alone or hMSCs impregnated into collagen scaffolds (scaffold+hMSC) transplanted into the lesion cavity 7 days after TBI. Rats were sacrificed 14 days after TBI and brain tissues were harvested for immunohistochemical studies, Western blot analysis, laser capture microdissections and qRT-PCR to evaluate axonal density and Nogo-A protein and gene expressions. Our data showed that treatment of TBI with scaffold+hMSC significantly decreased TBI-induced Nogo-A protdin expression and increased axonal density compared to saline and hMSCalone treatments. In addition, scaffold+hMSC transplantation decreased Nogo-A transcription in oligodendrocytes after TBI. Scaffold+hMSC treatment was superior to hMSC-alone treatment in suppressing Nogo-A expression and enhancing axonal regeneration after TBI. Our data suggest that transplanting hMSCs with scaffolds down-regulates Nogo-A transcription and protein expression which may partially contribute to the enhanced axonal regeneration after TBI. (C) 2013 Elsevier B.V. All rights reserved.	[Mahmood, Asim; Wu, Hongtao; Qu, Changsheng; Mahmood, Selina; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Kaplan, David] Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, Boston, MA 02155 USA		Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799W Grand Blvd, Detroit, MI 48202 USA.	amahmoo1@hfhs.org; hwu1@hfhs.org; cqu1@hfhs.org; selina_117@hotmail.com; yxiong1@hfhs.org; david.kaplan@tufts.edu; mchopp1@hfhs.org		Xiong, Ye/0000-0001-9770-6031			Al Halabiah H, 2005, GENE EXPR PATTERNS, V5, P561, DOI 10.1016/j.modgep.2004.10.010; Bonilla C, 2012, J TRAUMA ACUTE CARE, V72, P1203, DOI 10.1097/TA.0b013e318248bdcf; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Condic ML, 2002, NEUROREPORT, V13, pA37, DOI 10.1097/00001756-200203040-00002; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Huber AB, 2002, J NEUROSCI, V22, P3553; KARTJETILLOTSON G, 1986, J COMP NEUROL, V250, P206, DOI 10.1002/cne.902500207; KOLB H, 1992, J COMP NEUROL, V318, P147, DOI 10.1002/cne.903180204; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; LEONG SK, 1973, BRAIN RES, V62, P218, DOI 10.1016/0006-8993(73)90630-6; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahrnood A., 2013, J NEUROSURG, V118, P381; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; Mihailoff G.A., 1981, NEUROSCI LETT, V21; MURAKAMI F, 1988, BRAIN RES, V447, P98, DOI 10.1016/0006-8993(88)90969-9; NAH SH, 1976, BRAIN RES, V107, P433, DOI 10.1016/0006-8993(76)90242-0; Ordway GA, 2009, J NEUROSCI RES, V87, P2430, DOI 10.1002/jnr.22078; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Properzi F, 2003, BIOCHEM SOC T, V31, P335, DOI 10.1042/BST0310335; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Wang XX, 2002, J NEUROSCI, V22, P5505; Wang YL, 2012, LIFE SCI J, V9, P733; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wright KT, 2007, BIOCHEM BIOPH RES CO, V354, P559, DOI 10.1016/j.bbrc.2007.01.013; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000	46	12	17	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 13	2014	1542						41	48		10.1016/j.brainres.2013.10.045			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299UF	WOS:000330420500005	24177046				2022-02-06	
J	Arbour, C; Choiniere, M; Topolovec-Vranic, J; Loiselle, CG; Gelinas, C				Arbour, Caroline; Choiniere, Manon; Topolovec-Vranic, Jane; Loiselle, Carmen G.; Gelinas, Celine			Can Fluctuations in Vital Signs Be Used for Pain Assessment in Critically Ill Patients with a Traumatic Brain Injury?	PAIN RESEARCH AND TREATMENT			English	Article							SEVERITY; RELIABILITY; VALIDITY; SCALE; ADULT; SCORE; COMA	Background. Many critically ill patients with a traumatic brain injury (TBI) are unable to communicate. While observation of behaviors is recommended for pain assessment in nonverbal populations, they are undetectable in TBI patients who are under the effects of neuroblocking agents. Aim. This study aimed to validate the use of vital signs for pain detection in critically ill TBI patients. Methods. Using a repeated measure within subject design, participants (N= 45) were observed for 1 minute before (baseline), during, and 15 minutes after two procedures: noninvasive blood pressure: NIBP (nonnociceptive) and turning (nociceptive). At each assessment, vital signs (e.g., systolic, diastolic, mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), capillary saturation (SpO(2)), end-tidal CO2, and intracranial pressure (ICP)) were recorded. Results. Significant fluctuations (P< 0.05) in diastolic (F= 6.087), HR (F= 3.566), SpO(2) (F= 5.740), and ICP (F= 3.776) were found across assessments, but they were similar during both procedures. In contrast, RR was found to increase exclusively during turning (t= 3.933;p< 0.001) and was correlated to participants' self-report. Conclusions. Findings from this study support previous ones that vital signs are not specific for pain detection. While RR could be a potential pain indicator in critical care, further research is warranted to support its validity in TBI patients with different LOC.	[Arbour, Caroline; Loiselle, Carmen G.; Gelinas, Celine] McGill Univ, Ingram Sch Nursing, Montreal, PQ H3A 2A7, Canada; [Arbour, Caroline; Loiselle, Carmen G.; Gelinas, Celine] Jewish Gen Hosp, Ctr Nursing Res, Montreal, PQ H3T 1E2, Canada; [Arbour, Caroline; Loiselle, Carmen G.; Gelinas, Celine] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Arbour, Caroline; Loiselle, Carmen G.; Gelinas, Celine] Quebec Nursing Intervent Res Network RRISIQ, Montreal, PQ H3A 2A7, Canada; [Arbour, Caroline; Gelinas, Celine] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 0G1, Canada; [Choiniere, Manon] Univ Montreal, CRCHUM, Dept Anaesthesiol, Montreal, PQ H2X 0A9, Canada; [Topolovec-Vranic, Jane] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada		Gelinas, C (corresponding author), McGill Univ, Ingram Sch Nursing, Montreal, PQ H3A 2A7, Canada.	celine.gelinas@mcgill.ca	Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Loiselle, Carmen/0000-0002-1981-2645	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [258 867]; Fonds de la Recherche du Quebec-Sante (FRQ-S) [25 094]; Louise and Alan Edwards Foundation; Quebec Nursing Intervention Research Network (RRISIQ); Quebec Ministry of Education (FRESIQ-MELS Program)	This study is part of a larger Research Program funded by the Canadian Institutes of Health Research (CIHR), no. 258 867, and the Fonds de la Recherche du Quebec-Sante (FRQ-S), no. 25 094. In addition to a pilot research Grant offered by the Louise and Alan Edwards Foundation, part of this study was also funded by a research Grant from the Quebec Nursing Intervention Research Network (RRISIQ) and three Ph. D. studentship awards from the Louise and Alan Edwards, the FRQ-S, and by the Quebec Ministry of Education (FRESIQ-MELS Program). The authors wish also to thank the ICU nurse manager, the assistant nurse managers, and the ICU nurses of the Montreal General Hospital for supporting and participating in data collection. The institution at which the work was performed: Montreal General Hospital department of Neurosurgery and Intensive Care Unit, affiliated with McGill University Health Center1650 Cedar Avenue, Montreal, Quebec, Canada, H3G 1A4.	American Pain Society, 2003, PRINC AN US TREATM A; Arbour C, 2010, INTENS CRIT CARE NUR, V26, P83, DOI 10.1016/j.iccn.2009.11.003; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Cohen BH, 2008, EXPLAINING PSYCHOL S; Donaldson GW, 2003, PAIN, V102, P97, DOI 10.1016/S0304-3959(02)00351-2; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fowler M, 2011, J TRAUMA, V71, pS87, DOI 10.1097/TA.0b013e3182218df8; Gelinas Celine, 2007, Perspect Infirm, V4, P12; Gelinas C, 2007, CLIN J PAIN, V23, P497, DOI 10.1097/ajp.0b013e31806a23fb; Herr K, 2011, PAIN MANAG NURS, V12, P230, DOI 10.1016/j.pmn.2011.10.002; Kehlet H, 2006, REGION ANESTH PAIN M, V31, P47, DOI 10.1016/j.rapm.2005.10.005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li D, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.07.005; Martin-Du Pan RC, 2004, SWISS MED WKLY, V134, P543; McHugh ML, 2011, BIOCHEM MEDICA, V21, P203; Nasraway SA, 2001, SEM RESP CRIT CARE M, V22, P165, DOI 10.1055/s-2001-13830; Neideen T, 2012, SURG CLIN N AM, V92, P1387, DOI 10.1016/j.suc.2012.08.010; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; PRKACHIN KM, 1995, J NONVERBAL BEHAV, V19, P191, DOI 10.1007/BF02173080; Puntillo K A, 2001, Am J Crit Care, V10, P238; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Stanik-Hutt J A, 2001, Am J Crit Care, V10, P252; Streiner DL., 2008, HLTH MEASUREMENT SCA; Tabachnick BG, 2007, USING MULTIVARIATES, V5th; TEASDALE G, 1974, LANCET, V2, P81; Young J. A., 2006, PHYS MED REHABILITAT, V17, P145; Young Jeanne, 2006, Intensive Crit Care Nurs, V22, P32, DOI 10.1016/j.iccn.2005.04.004	29	12	13	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1542	2090-1550		PAIN RES TREAT	Pain Res. Treat.		2014	2014								175794	10.1155/2014/175794			11	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V33KN	WOS:000215764400003	24639895	Green Submitted, Green Published, gold			2022-02-06	
J	Beskind, DL; Stolz, U; Gross, A; Earp, R; Mitchelson, J; Judkins, D; Bowlby, P; Guillen-Rodriguez, JM				Beskind, Daniel L.; Stolz, Uwe; Gross, Austin; Earp, Ryan; Mitchelson, Justin; Judkins, Dan; Bowlby, Paul; Guillen-Rodriguez, Jose M.			A COMPARISON OF THE PREHOSPITAL MOTOR COMPONENT OF THE GLASGOW COMA SCALE (MGCS) TO THE PREHOSPITAL TOTAL GCS (TGCS) AS A PREHOSPITAL RISK ADJUSTMENT MEASURE FOR TRAUMA PATIENTS	PREHOSPITAL EMERGENCY CARE			English	Article						Glasgow coma scale; motor score of the GCS; out-of-hospital care; prehospital emergency care; risk adjustment measure	BRAIN-INJURY OUTCOMES; MULTIPLE IMPUTATION; MISSING DATA; EMERGENCY-DEPARTMENT; ADVANCED STATISTICS; CLINICAL-RESEARCH; FIELD TRIAGE; PREDICTION; SCORE; RECOMMENDATIONS	Objective. This study compared the prehospital motor component subscale of the Glasgow Coma Scale (mGCS) to the prehospital total GCS (tGCS) score for its ability to predict the need for intubation, survival to hospital discharge, and neurosurgical intervention in trauma patients. Methods. This is a retrospective analysis of an urban level 1 trauma registry. All trauma patients presenting to the trauma center emergency department via emergency medical services from July 2008 through June 2010 were included. The area under the receiver operating characteristics curve (AUC) analysis was used to compare the predictive ability of the prehospital mGCS to tGCS for three outcomes: intubation, survival to hospital discharge, and neurosurgical intervention. Two subgroups (patients with injury severity score [ISS] >= 16 and traumatic brain injury [TBI] [head abbreviated injury score (AIS) >= 3]) were analyzed. An a priori statistically significant absolute difference of 0.050 in AUC between mGCS and tGCS for these clinical outcomes was used as a clinically significant difference. Multiple imputation was used for missing prehospital GCS data. Results. There were 9,816 patients, of which 4% were intubated, 3.8% had neurosurgical intervention, and 97.1% survived to hospital discharge. The absolute difference in AUC (prehospital tGCS minus mGCS) for all cases was statistically significant for all three outcomes but did not reach the clinical significance threshold: survival = 0.010 (95% CI: 0.002-0.018), intubation = 0.018 (95% CI: 0.011-0.024), and neurosurgical intervention = 0.019 (95% CI: 0.007-0.029). The difference in AUC between tGCS and mGCS for the subgroups ISS >= 16 (n = 1,151) and TBI (n = 1,165) did not reach clinical significance for the three outcomes. The discriminatory ability of the prehospital mGCS was good for survival (AUC: all patients = 0.89, ISS >= 16 = 0.84, traumatic brain injury = 0.86) excellent for intubation (AUC: all patients = 0.95, ISS >= 16 = 0.91, traumatic brain injury = 0.91), and poor for neurosurgical intervention (AUC: all patients = 0.67, ISS >= 16 = 0.57, traumatic brain injury = 0.60). Conclusion. The prehospital mGCS appears have good discriminatory power and is equivalent to the prehospital tGCS for predicting intubation and survival to hospital discharge in this trauma population as a whole, those with ISS >= 16, or TBI.	[Beskind, Daniel L.; Stolz, Uwe; Gross, Austin; Earp, Ryan; Mitchelson, Justin] Univ Arizona, Dept Emergency Med, Arizona Emergency Med Res Ctr, Tucson, AZ 85724 USA; [Judkins, Dan; Bowlby, Paul] Univ Arizona, Dept Surg, Tucson, AZ 85724 USA; [Earp, Ryan] Kaiser Permanente, Kaiser Permanente Med Ctr, Sacramento, CA USA; [Mitchelson, Justin] Kaiser Permanente, San Diego Med Ctr, Kaiser Fdn Hosp, San Diego, CA USA; [Guillen-Rodriguez, Jose M.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA		Beskind, DL (corresponding author), Univ Arizona, Dept Emergency Med, Arizona Emergency Med Res Ctr, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	dbeskind@aemrc.arizona.edu					Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; Beskind DL, 2011, ACAD EMERG MED, V18, P988, DOI 10.1111/j.1553-2712.2011.01148.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Garrison HG, 2002, ANN EMERG MED, V40, P81, DOI 10.1067/mem.2002.124758; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heron R, 2001, Aust Crit Care, V14, P100, DOI 10.1016/S1036-7314(01)80026-6; Martinez R., 2009, BUREAU EMERGENCY MED; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Newgard CD, 2006, ACAD EMERG MED, V13, P314, DOI 10.1197/j.aem.2005.09.011; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Rubin C., 1988, MULTIPLE IMPUTATION; Rubin D.B., 1988, P SURV RES METH SECT, P79; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Vivien B, 2012, AM J EMERG MED, V30, P1032, DOI 10.1016/j.ajem.2011.06.022; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	27	12	12	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN-MAR	2014	18	1					68	75		10.3109/10903127.2013.844870			8	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	270OO	WOS:000328328200010	24329032				2022-02-06	
J	Ciaramella, A; Della Vedova, C; Salani, F; Viganotti, M; D'Ippolito, M; Caltagirone, C; Formisano, R; Sabatini, U; Bossu, P				Ciaramella, Antonio; Della Vedova, Cecilia; Salani, Francesca; Viganotti, Mara; D'Ippolito, Mariagrazia; Caltagirone, Carlo; Formisano, Rita; Sabatini, Umberto; Bossu, Paola			Increased Levels of Serum IL-18 Are Associated with the Long-Term Outcome of Severe Traumatic Brain Injury	NEUROIMMUNOMODULATION			English	Article						Interleukin-18; Chronic traumatic brain injury; Long-term outcome; Cognitive impairment; Disability severity	ACUTE ISCHEMIC-STROKE; ALZHEIMERS-DISEASE; HEAD-INJURY; PRACTICAL SCALE; INTERLEUKIN-18; CYTOKINES; INFLAMMATION; NEUROINFLAMMATION; CHEMOKINES; DISABILITY	Objective: A long-lasting neuroinflammatory cascade may lead to the progression of brain damage, favoring neurodegeneration and cognitive impairment in patients with traumatic brain injury (TBI), but the potential mechanisms underlying this sequence of events remain elusive. Here we aimed to evaluate the impact of interleukin (IL)-18, a proinflannmatory cytokine elevated in post-acute head injury and associated with neurodegeneration, on the long-term outcome of patients with chronic TBI. Methods: The serum content of IL-18 was evaluated in 16 patients with severe TBI, during their rehabilitation phase, and in a matched group of 16 healthy controls. The disability of the enrolled patients was evaluated by means of the Glasgow Outcome Scale, Levels of Cognitive Functioning, and the Disability Rating Scale. Results: The circulating levels of IL-18 were significantly increased in chronic TBI patients, as compared to healthy subjects, and correlated with the patients' cognitive impairment and disability severity. Conclusions: IL-18 may contribute to the long-term outcome and neurodegeneration in TBI patients. Even though further studies are needed to understand the molecular mechanisms underlying the effects of IL-18 on TBI progression and its associated drop in cognitive function, a possible role of this cytokine as a therapeutic target in TBI can be envisaged. (C) 2013 S. Karger AG, Basel	[Ciaramella, Antonio; Salani, Francesca; Viganotti, Mara; Caltagirone, Carlo; Bossu, Paola] IRCCS Santa Lucia Fdn, Rome, Italy; [Della Vedova, Cecilia; D'Ippolito, Mariagrazia; Formisano, Rita] IRCCS Santa Lucia Fdn, Postcoma Unit, Rome, Italy; [Sabatini, Umberto] IRCCS Santa Lucia Fdn, Dept Radiol, Rome, Italy		Bossu, P (corresponding author), IRCCS Fdn Santa Lucia, Dept Clin & Behav Neurol, Expt Neuropsychobiol Lab, Via Ardeatina 306, IT-00179 Rome, Italy.	p.bossu@hsantalucia.it	Bosso, Paola/E-4832-2014; Nacmias, Benedetta/J-5084-2018; ciaramella, antonio/F-1170-2011; SALANI, FRANCESCA/I-1314-2012; ciaramella, antonio/P-9009-2019; D'Ippolito, Mariagrazia/K-4010-2016; Sabatini, Umberto/K-4659-2016	Bosso, Paola/0000-0002-1432-0078; Nacmias, Benedetta/0000-0001-9338-9040; ciaramella, antonio/0000-0001-9888-8156; SALANI, FRANCESCA/0000-0002-6901-6057; D'Ippolito, Mariagrazia/0000-0001-7818-7352; Sabatini, Umberto/0000-0001-5321-8626	Italian Ministry of HealthMinistry of Health, Italy [RC-11-12-13]	This work was supported by grants from the Italian Ministry of Health (RC-11-12-13) (P.B., R.F.).	Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Bossu P, 2008, BRAIN BEHAV IMMUN, V22, P487, DOI 10.1016/j.bbi.2007.10.001; Bossu P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-101; Bossu P, 2010, CURR PHARM DESIGN, V16, P4213, DOI 10.2174/138161210794519147; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Fassbender K, 1999, NEUROLOGY, V53, P1104, DOI 10.1212/WNL.53.5.1104; Felderhoff-Mueser U, 2005, TRENDS NEUROSCI, V28, P487, DOI 10.1016/j.tins.2005.06.008; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hagen C, 1979, REHABILITATION HEAD; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jander S, 2002, J CEREBR BLOOD F MET, V22, P62, DOI 10.1097/00004647-200201000-00008; JENNETT B, 1975, LANCET, V1, P480; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Menge T, 2001, J NEUROSCI RES, V65, P332, DOI 10.1002/jnr.1158; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Ojala J, 2009, NEUROBIOL AGING, V30, P198, DOI 10.1016/j.neurobiolaging.2007.06.006; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yuen CM, 2007, CIRC J, V71, P1691, DOI 10.1253/circj.71.1691; Zaremba J, 2003, NEUROL SCI, V24, P117, DOI 10.1007/s10072-003-0096-0; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	31	12	12	0	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2014	21	1					8	12		10.1159/000354764			5	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	265AQ	WOS:000327922500002	24080899				2022-02-06	
J	Clark-Wilson, J; Giles, GM; Baxter, DM				Clark-Wilson, Jo; Giles, Gordon Muir; Baxter, Doreen M.			Revisiting the neurofunctional approach: Conceptualizing the core components for the rehabilitation of everyday living skills	BRAIN INJURY			English	Article						Brain injury; cognition; learning; neurofunctional approach	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; TOTAL TASK PRESENTATION; COGNITIVE REHABILITATION; HEAD-INJURY; MULTIDISCIPLINARY REHABILITATION; THERAPEUTIC ALLIANCE; IMPAIRED AWARENESS; FUNCTIONAL SKILLS; WORKING ALLIANCE	Background: Introduced in the 1980s, the neurofunctional approach (NFA) is one of the few interventions designed primarily for clients with severe deficits following traumatic brain injury (TBI). Specifically the NFA was intended for those individuals who were limited in their ability to solve novel problems or generalize skills from one setting to another and whose lack of insight limited their engagement in the rehabilitative process. Description of the approach: The NFA is a client-centred, goal-driven approach that incorporates the principles of skill learning and promotes the development of routines and competencies in practical activities required for everyday living. Programmes based on the NFA are developed specifically to meet each client's unique needs, using a range of evidence-based interventions. Recent evidence: Recently the NFA has been found to be more effective than cognitive-retraining for some individuals with moderate-to-severe TBI who have deficits in activities of daily living. This paper aims to define the core features of the NFA, outline the theoretical basis on which it is founded and consider implications of the findings for rehabilitation after TBI in general. The NFA is highly relevant for clients living in the community who require a case manager to direct an integrated, rehabilitation programme or provide structured input for the long-term maintenance of skills.	[Clark-Wilson, Jo; Baxter, Doreen M.] Head First, Hawkhurst, Kent, England; [Giles, Gordon Muir] Crestwood Treatment Ctr, Neurobehav Serv, Fremont, CA USA; [Giles, Gordon Muir] Samuel Merritt Univ, Dept Occupat Therapy, Oakland, CA USA		Giles, GM (corresponding author), Crestwood Treatment Ctr, 2171 Mowry Ave, Fremont, CA 94538 USA.	jo.clarkwilson@head-first.org					ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bandura A., 1977, SOCIAL LEARNING THEO; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Campbell C H, 1988, Rehabil Nurs, V13, P320; Carkhuff R.R., 1977, COUNSELING THERAPY, V2nd Edn; Castonguay LG, 1996, J CONSULT CLIN PSYCH, V64, P497, DOI 10.1037/0022-006X.64.3.497; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Draganski D, 2004, NATURE, V427, P311; DRISKELL JE, 1992, J APPL PSYCHOL, V77, P615, DOI 10.1037/0021-9010.77.5.615; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans JJ, 2010, HDB CLIN NEUROPSYCHO, P15, DOI DOI 10.1093/ACPROF:OSO/9780199234110.003.02; Finfgeld-Connett D, 2009, CLIN NURS RES, V18, P272, DOI 10.1177/1054773809337577; Follette WC, 1996, BEHAV THER, V27, P623, DOI 10.1016/S0005-7894(96)80047-5; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Giles G. M., 2011, COGNITION OCCUPATION, P351; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; Giles GM, 2005, COGNITION OCCUPATION, P139; GILES GM, 1993, BRAIN INJURY REHABIL; Giles GM, 2010, AM J OCCUP THER, V64, P182, DOI 10.5014/ajot.64.1.182; Giles GM, 2009, ARCH PHYS MED REHAB, V90, P530, DOI 10.1016/j.apmr.2009.01.004; Giuffrida CG, 2009, AM J OCCUP THER, V63, P398, DOI 10.5014/ajot.63.4.398; Goldenberg G, 1998, NEUROPSYCHOL REHABIL, V8, P123; Goldenberg G, 2001, NEUROPSYCHOL REHABIL, V11, P147, DOI 10.1080/09602010042000204; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; HAYESROTH B, 1977, PSYCHOL REV, V84, P260, DOI 10.1037/0033-295X.84.3.260; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Holloway M, 2012, SOCIAL CARE NEURODIS, V3, P122, DOI DOI 10.1108/20420911211268740; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P563, DOI 10.1080/09602011.2012.676284; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Kazdin AE, 1994, BEHAV MODIFICATION A; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; KRAMER AF, 1990, J EXP PSYCHOL HUMAN, V16, P505; LATHAM GP, 1988, J APPL PSYCHOL, V73, P753, DOI 10.1037/0021-9010.73.4.753; LATHAM GP, 1994, J ORGAN BEHAV, V15, P49, DOI 10.1002/job.4030150106; Liao B, 2013, J EXP PSYCHOPATHOL, V4, P148, DOI 10.5127/jep.026612; LLOYD LF, 1994, BRAIN INJURY, V8, P529, DOI 10.3109/02699059409151005; Locke EA, 1997, RES PERS H, V15, P293; Lovden M, 2013, NEUROSCI BIOBEHAV R, V37, P2296, DOI 10.1016/j.neubiorev.2013.02.014; LUBORSKY L, 1985, ARCH GEN PSYCHIAT, V42, P602; Manchester D, 2001, BRAIN DAM B, P157; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Martelli MF, 2008, NEUROREHABILITATION, V23, P115; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; MARTIN G, 1981, BEHAV RES SEVERE DEV, V2, P117; Mastos M, 2007, CLIN REHABIL, V21, P47, DOI 10.1177/0269215506073494; MCDONNELL J, 1989, EDUC TRAIN MENT RET, V24, P230; McEwen SE, 2009, BRAIN INJURY, V23, P1041, DOI 10.3109/02699050903421107; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Mehrabian A., 1972, NONVERBAL COMMUNICAT; Miller W.R., 2002, MOTIVATIONAL INTERVI; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Newell A., 1981, COGN SKILLS ACQUISIT, V1, P1; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Polatajko H. J., 2005, COGNITION OCCUPATION, P237; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; ROGERS CR, 1957, J CONSULT PSYCHOL, V21, P95, DOI 10.1037/0022-006X.60.6.827; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rotenberg-Shpigelman S, 2012, NEUROPSYCHOL REHABIL, V22, P532, DOI 10.1080/09602011.2012.665610; Rothwell NA, 1999, BRAIN INJURY, V13, P521; SALOMON G, 1989, EDUC PSYCHOL-US, V24, P113, DOI 10.1207/s15326985ep2402_1; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; SchmitterEdgecombe M, 1997, NEUROPSYCHOLOGY, V11, P296, DOI 10.1037/0894-4105.11.2.296; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; SHIFFRIN RM, 1981, COGNITIVE SKILLS THE, P111; Sohlberg M. M., 1987, APT ATTENTION PROCES; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SPOONER F, 1984, EDUC TRAIN MENT RET, V19, P15; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Truax C. B., 1967, EFFECTIVE COUNSELING; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V20; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Vanderploeg RD, 2006, J HEAD TRAUMA REHAB, V21, P179, DOI 10.1097/00001199-200603000-00010; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P47, DOI 10.1017/CBO9780511581083.006; Woody SR, 2002, BEHAV THER, V33, P5, DOI 10.1016/S0005-7894(02)80003-X; Wulf G, 2002, PSYCHON B REV, V9, P185, DOI 10.3758/BF03196276; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Yuen HK, 1994, OCCUPATIONAL THERAPY, V12, P31; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553	115	12	12	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	13-14					1646	1656		10.3109/02699052.2014.946449			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT1LY	WOS:000344696600003	25153760	Green Published			2022-02-06	
J	Kim, DR; Yang, SH; Sung, JH; Lee, SW; Son, BC				Kim, Deok-ryeong; Yang, Seung-Ho; Sung, Jae-hoon; Lee, Sang-won; Son, Byung-chul			Significance of Intracranial Pressure Monitoring after Early Decompressive Craniectomy in Patients with Severe Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain injuries; Intracranial pressure monitoring; Decompressive craniectomy; Mortality	SEVERE HEAD-INJURY; MANAGEMENT; CLASSIFICATION; GUIDELINES; PROGNOSIS; OUTCOMES; IMPACT; DEATH	Objective : Early decompressive craniectomy (DC) has been used as the first stage treatment to prevent secondary injuries in cases of severe traumatic brain injury (TBI). Postoperative management is the major factor that influences outcome. The aim of this study is to investigate the effect of postoperative management, using intracranial pressure (ICP) monitoring and including consecutive DC on the other side, on the two-week mortality in severe TBI patients treated with early DC. Methods : Seventy-eight patients with severe TBI [Glasgow Coma Scale (GCS) score <9] underwent early DC were retrospectively investigated. Among 78 patients with early DC, 53 patients were managed by conventional medical treatments and the other, 25 patients were treated under the guidance of ICP monitoring, placed during early DC. In the ICP monitoring group, consecutive DC on the other side were performed on 11 patients due to a high ICP of greater than 30 mm Hg and failure to respond to any other medical treatments. Results : The two-week mortality rate was significantly different between two groups [50.9% (27 patients) and 24% (6 patients), respectively, p=0.025]. After adjusting for confounding factors, including sex, low GCS score, and pupillary abnormalities, ICP monitoring was associated with a 78% lower likelihood of 2-week mortality (p=0.021). Conclusion : ICP monitoring in conjunction with postoperative treatment, after early DC, is associated with a significantly reduced risk of death.	[Kim, Deok-ryeong] Eulji Univ, Sch Med, Eulji Gen Hosp, Dept Neurosurg, Seoul, South Korea; [Yang, Seung-Ho; Sung, Jae-hoon; Lee, Sang-won] Catholic Univ Korea, St Vincents Hosp, Dept Neurosurg, Coll Med, Suwon, South Korea; [Son, Byung-chul] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Neurosurg, Seoul 137701, South Korea		Son, BC (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Neurosurg, 222 Banpo Daero, Seoul 137701, South Korea.	sbc@catholic.ac.kr					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McKinely BA, 1999, J TRAUMA, V46, P271, DOI 10.1097/00005373-199902000-00013; Miyazaki Y, 1966, Shujutsu, V20, P845; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Roberts Susan R, 2004, Crit Care Nurs Clin North Am, V16, P537, DOI 10.1016/S0899-5885(04)00068-1; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	37	12	12	0	8	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JAN	2014	55	1					26	31		10.3340/jkns.2014.55.1.26			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AB1ZN	WOS:000331592900005	24570814	Green Published, gold, Green Submitted			2022-02-06	
J	Krause, M; Richards, S				Krause, Miriam; Richards, Stephanie			Prevalence of traumatic brain injury and access to services in an undergraduate population: A pilot study	BRAIN INJURY			English	Article						College; concussion; survey	POSTCONCUSSION-LIKE SYMPTOMS; DEPRESSION; STUDENTS; DEFICITS	Objectives: The aim of this pilot study was to identify the prevalence of traumatic brain injury (TBI) among undergraduate college students, compare common TBI symptoms reported by students with and without a history of TBI and explore how often students with and without TBI access campus services. Methods: A campus-wide email recruited participants to an online survey containing questions about their history of TBI, experience of TBI symptoms and use of services. Results: Of 201 undergraduates, 55.7% reported no history of TBI or hospitalization, 27.9% reported a history of hospitalization but not TBI and 16.4% reported a history of TBI. Significant differences were seen among groups in their experience of some physical and psychosocial symptoms such as dizziness and difficulty with relationships. Healthy and TBI groups reported significantly more symptoms than the hospitalized group, but did not differ from each other. Most participants reported using no services and there were no significant differences in the average number of symptoms experienced by those seeking vs not seeking services. Conclusions: A substantial proportion of undergraduates reported a history of TBI and the experience of symptoms that could negatively impact academic performance. Further study is needed to examine factors influencing their use of available services.	[Krause, Miriam] Bowling Green State Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA; [Richards, Stephanie] Cent Michigan Univ, Dept Commun Disorders, Mt Pleasant, MI 48859 USA		Krause, M (corresponding author), Bowling Green State Univ, Bowling Green, OH 43403 USA.	miriamk@bgsu.edu	Krause, Miriam/AAD-1197-2022	Krause, Miriam/0000-0002-6798-3991			Alvarez L, 2008, NY TIMES; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; JOHNSTONE B, 1994, J CLIN PSYCHOL MED S, V1, P375, DOI 10.1007/BF01991080; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; ORGEL SA, 1967, J CONSULT PSYCHOL, V31, P77, DOI 10.1037/h0024216; POWELL BD, 1995, PERCEPT MOTOR SKILL, V81, P227, DOI 10.2466/pms.1995.81.1.227; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Schwartz Alan, 2011, NY TIMES; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Wagner M., 2005, HIGH SCH 1 LOOK POST; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Woods AJ, 2011, PM&R, V3, P426, DOI 10.1016/j.pmrj.2011.02.018; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	28	12	12	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1301	1310		10.3109/02699052.2014.916416			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900011	24865186				2022-02-06	
J	Leibach, GG; Trapp, SK; Perrin, PB; Everhart, RS; Cabrera, TV; Jimenez-Maldonado, M; Arango-Lasprilla, JC				Leibach, Gillian G.; Trapp, Stephen K.; Perrin, Paul B.; Everhart, Robin S.; Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam; Carlos Arango-Lasprilla, Juan			Family needs and TBI caregiver mental health in Guadalajara, Mexico	NEUROREHABILITATION			English	Article						TBI caregivers; Latin America; mental health; family needs	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ROSENBERG SELF-ESTEEM; PSYCHOMETRIC PROPERTIES; INDIVIDUALS; DEPRESSION; PATIENT; SATISFACTION; PREDICTORS; TRANSITION	BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death in Mexico, and Mexican TBI caregivers have been shown to experience significant mental health problems and high levels of family needs. OBJECTIVE: This study investigated the associations between family needs and Mexican TBI caregiver mental health. METHODS: Ninety TBI caregivers from Guadalajara, Mexico completed measures assessing their own mental health (depression, anxiety, burden, satisfaction with life, and self-esteem) and family needs (physical health, informational, financial, social support, and household). RESULTS: Family health needs were uniquely associated with all indices of caregiver mental health, and household needs were uniquely associated with caregiver depression, burden, and anxiety. Additionally, social support needs were related to caregiver satisfaction with life, informational needs to burden, and financial needs to self-esteem. CONCLUSIONS: Interventions for TBI caregivers in Mexico-and likely in other global regions with high levels of familism-should include an emphasis on overall family health, the delineation of family roles regarding household responsibilities, the improvement of social support networks and the social presence of family members, and the provision of complete and relevant information regarding TBI. When these needs are more comprehensively met, caregiver mental health will likely improve.	[Leibach, Gillian G.; Trapp, Stephen K.; Perrin, Paul B.; Everhart, Robin S.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Villasenor Cabrera, Teresita; Jimenez-Maldonado, Miriam] Univ Guadalajara, Dept Neurosci, Guadalajara 44430, Jalisco, Mexico; [Jimenez-Maldonado, Miriam] Hosp Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, IKERBASQUE, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, IKERBASQUE, Basque Fdn Sci, Bilbao, Spain.	jcarango@deusto.es	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P83, DOI 10.3233/NRE-2010-0583; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Atienza FL, 2000, PSICOTHEMA, V12, P314; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Campbell C H, 1988, Rehabil Nurs, V13, P320; Covinsky KE, 2003, J GEN INTERN MED, V18, P1006, DOI 10.1111/j.1525-1497.2003.30103.x; Coy A.E., ARCH PHYS MED REHABI; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Delgado M, 1997, SOC WORK, V42, P125, DOI 10.1093/sw/42.2.125; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Engli M, 1993, J Neurosci Nurs, V25, P78; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839; Folkman S., 1984, STRESS; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Grant JS, 1992, FAM COMMUNITY HEALTH, V15, P49; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; Hardway C, 2006, DEV PSYCHOL, V42, P1246, DOI 10.1037/0012-1649.42.6.1246; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; Karlikaya G, 2005, INT J NEUROL, V4, P12; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lezak M.D., 1987, J HEAD TRAUMA REHABI; Marin G, 1991, RES HISPANIC POPULAT; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Martin M., 1996, REV GERONTOLOGIA, V6, P338; Mathis M, 1984, J Neurosurg Nurs, V16, P36; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; NAGEL J, 1994, SOC PROBL, V41, P152, DOI 10.1525/sp.1994.41.1.03x0430n; Napoles AM, 2010, AM J ALZHEIMERS DIS, V25, P389, DOI 10.1177/1533317510370957; NOVY DM, 1995, HISPANIC J BEHAV SCI, V17, P209, DOI 10.1177/07399863950172005; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Perrin P.B., NEUROREHABILITATION; Perrin PB, 2010, REHABIL PSYCHOL, V55, P372, DOI 10.1037/a0021486; Phinney JS, 2011, J SOC ISSUES, V67, P599, DOI 10.1111/j.1540-4560.2011.01716.x; Phinney JS, 1996, AM PSYCHOL, V51, P918, DOI 10.1037/0003-066X.51.9.918; Puvanachandra P., 2008, SALUD PUBLICA MEX S1, V50; Rivera D., PSICOLOGIA IN PRESS; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rosenberg M., 1965, SOC ADOLESCENT CHILD; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sanchez B, 2010, J ADOLESCENT RES, V25, P858, DOI 10.1177/0743558410376831; Sato A, 1996, J Community Health Nurs, V13, P31, DOI 10.1207/s15327655jchn1301_3; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; SKAFF MM, 1992, GERONTOLOGIST, V32, P656, DOI 10.1093/geront/32.5.656; SPIELBERGER C, 2010, ENCY PSYCHOL; Spielberger C.D., 1975, INVENTARIO ANSIED RA; Spielberger G, 1983, MANUAL STATE TRAIT A; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; VIRELLA B, 1994, J PERS ASSESS, V63, P401, DOI 10.1207/s15327752jpa6303_1; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Waters LE, 2002, J EMPLOYMENT COUNS, V39, P171, DOI 10.1002/j.2161-1920.2002.tb00848.x; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zniga Carrasco, 2008, VIGILANCIA EPIDEMIOL, V26, P1	73	12	13	1	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	1					167	175		10.3233/NRE-131013			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AA4JN	WOS:000331062000018	24284459				2022-02-06	
J	Liu, RZ; Li, SM; Su, BL; Tan, CL; Leong, TY; Pang, BC; Lim, CCT; Lee, CK				Liu, Ruizhe; Li, Shimiao; Su, Bolan; Tan, Chew Lim; Leong, Tze-Yun; Pang, Boon Chuan; Lim, C. C. Tchoyoson; Lee, Cheng Kiang			Automatic detection and quantification of brain midline shift using anatomical marker model	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						Brain midline shift; Brain CT diagnosis; Midline shift detection and quantification; Anatomatic marker model	HEAD TRAUMA; CONSCIOUSNESS; RESTORATION; INJURY	Brain midline shift (MLS) is a significant factor in brain CT diagnosis. In this paper, we present a new method of automatically detecting and quantifying brain midline shift in traumatic injury brain CT images. The proposed method automatically picks out the CT slice on which midline shift can be observed most clearly and uses automatically detected anatomical markers to delineate the deformed midline and quantify the shift. For each anatomical marker, the detector generates five candidate points. Then the best candidate for each marker is selected based on the statistical distribution of features characterizing the spatial relationships among the markers. Experiments show that the proposed method outperforms previous methods, especially in the cases of large intra-cerebral hemorrhage and missing ventricles. A brain CT retrieval system is also developed based on the brain midline shift quantification results. (C) 2013 Elsevier Ltd. All rights reserved.	[Liu, Ruizhe; Tan, Chew Lim; Leong, Tze-Yun] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Li, Shimiao; Su, Bolan] Inst Infocomm Res, Singapore, Singapore; [Pang, Boon Chuan; Lim, C. C. Tchoyoson; Lee, Cheng Kiang] Tan Tack Seng Hosp, Natl Inst Neurosci, Singapore, Singapore		Su, BL (corresponding author), Inst Infocomm Res, Singapore, Singapore.	subl@i2r.a-star.edu.sg	LEONG, Tze Yun/H-1142-2015	Lim, CC Tchoyoson/0000-0001-9355-6988; Leong, Tze Yun/0000-0002-1139-803X	MOEMinistry of Education, SingaporeMinistry of Higher Education & Scientific Research (MHESR) [MOE2011-T2-2-146 (R252-000-480-112)]	This research is supported in part by MOE Grant MOE2011-T2-2-146 (R252-000-480-112).	Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Boone JM, 2007, MED PHYS, V34, P4173, DOI 10.1118/1.2789501; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen W, 2010, P INT C PATT REC ICP, V2010, P2552; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Forsyth David A, 2002, COMPUTER VISION MODE; Gong TX, 2007, LECT NOTES COMPUT SC, V4774, P401; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Liao CC, 2006, BIOMED ENG-APP BAS C, V18, DOI 10.4015/S1016237206000452; Liu R, 2009, IEEE INT C IM PROC I, V2009, P2637; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall LF, 1991, J NEUROSURG S, V75, P14; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; RAMACHANDRAN K, 1980, P IEEE, V68, P813, DOI 10.1109/PROC.1980.11747; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; Sucu HK, 2006, SURG NEUROL, V66, P178, DOI 10.1016/j.surneu.2005.12.036; Sullivan DC, 2008, RADIOLOGY, V248, P328, DOI 10.1148/radiol.2482080242; Zheng Ye-feng, 2002, Journal of Software, V13, P790; [No title captured]	19	12	12	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	JAN	2014	38	1					1	14		10.1016/j.compmedimag.2013.11.001			14	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	293EJ	WOS:000329953900001	24332442				2022-02-06	
J	Ma, HP; Ou, JC; Yeh, CT; Wu, D; Tsai, SH; Chiu, WT; Hu, CJ				Ma, Hon-Ping; Ou, Ju-Chi; Yeh, Chun-Ting; Wu, Dean; Tsai, Shin-Han; Chiu, Wen-Ta; Hu, Chaur-Jong			Recovery from sleep disturbance precedes that of depression and anxiety following mild traumatic brain injury: a 6-week follow-up study	BMJ OPEN			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHINESE VERSION; QUALITY INDEX; INVENTORY; SEQUELAE; SCALE	Objectives: The detailed course of mental disorders at the acute and subacute stages of mild traumatic brain injury (mTBI), especially with regard to recovery from sleep disturbances, has not been well characterised. The aim of this study was to determine the course of depression, anxiety and sleep disturbance, following an mTBI. Setting: We recruited patients with mTBI from three university hospitals in Taipei and healthy participants as control group for this study. Participants: 100 patients with mTBI (35 men) who were older than 20 years, with a Glasgow Coma Scale score of 13-15 and loss of consciousness for <30 min, completed the baseline and 6-week follow-up assessments. 137 controls (47 men) without TBI were recruited in the study. None of the participants had a history of cerebrovascular disease, mental retardation, previous TBI, epilepsy or severe systemic medical illness. Primary outcome measures: The Beck Anxiety Inventory (BAI), the Beck Depression Inventory II (BDI), the Epworth Sleepiness Scale (ESS) and the Pittsburgh Sleep Quality Index (PSQI) were assessed for the patients with mTBI at baseline and 6 weeks after mTBI and for the controls. Results: The ESS scores were not significantly different between the mTBI at baseline or at 6 weeks after mTBI and controls. Although the BAI, BDI and PSQI scores of the mTBI group were significantly different than those of the control group at baseline, all had improved significantly 6 weeks later. However, only the PSQI score improved to a level that was not significantly different from that of the control group. Conclusions: Daytime sleepiness is not affected by mTBI. However, mTBI causes depression and anxiety and diminished sleep quality. Although all these conditions improve significantly within 6 weeks post-mTBI, only sleep quality improves to a pre-mTBI level. Thus, recovery from mTBI-induced sleep disturbance occurs more rapidly than that of mTBI-induced depression and anxiety.	[Ma, Hon-Ping; Ou, Ju-Chi; Yeh, Chun-Ting; Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei City, Taiwan; [Ma, Hon-Ping; Yeh, Chun-Ting; Tsai, Shin-Han] Taipei Med Univ, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Wu, Dean; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan; [Wu, Dean; Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Sleep Ctr, New Taipei City, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chiu, Wen-Ta] Minist Hlth & Welf, Taipei, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Hu, Chaur-Jong] Natl Def Med Ctr, Dept Neurol, Taipei, Taiwan		Hu, CJ (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan.	chaurjongh@s.tmu.edu.tw			National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2321-B-038-005-MY3, NSC 101-2321-B-038-005, DOH 101-TD-B-111-003]	This study was supported by grants from the National Science Council, Taiwan (NSC 98-2321-B-038-005-MY3, NSC 101-2321-B-038-005, DOH 101-TD-B-111-003).	Access Economics Pty Limited, 2009, THE ECONOMIC COST OF; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beck A. T., 1996, MANUAL FOR THE BECK; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MCFARLANE AC, 1992, J NERV MENT DIS, V180, P498, DOI 10.1097/00005053-199208000-00004; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Palagini L, 2013, SLEEP MED REV, P1; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUTHERFORD WH, 1977, LANCET, V1, P1; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; U. S. Department of Veterans Affairs, 2009, VA DOD CLINICAL PRAC; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZHENG YP, 1988, COMPR PSYCHIAT, V29, P484, DOI 10.1016/0010-440X(88)90063-6	29	12	12	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2014	4	1							e004205	10.1136/bmjopen-2013-004205			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0RP	WOS:000337363700039	24459040	Green Published, gold			2022-02-06	
J	Mutschler, M; Nienaber, U; Munzberg, M; Fabian, T; Paffrath, T; Wolfl, C; Bouillon, B; Maegele, M				Mutschler, Manuel; Nienaber, Ulrike; Muenzberg, Matthias; Fabian, Tobias; Paffrath, Thomas; Woelfl, Christoph; Bouillon, Bertil; Maegele, Marc			Assessment of hypovolaemic shock at scene: is the PHTLS classification of hypovolaemic shock really valid?	EMERGENCY MEDICINE JOURNAL			English	Article						Trauma; triage; prehospital care; major trauma management	SYSTOLIC BLOOD-PRESSURE; INCREASED MORTALITY; TRAUMA PATIENTS; 110 MMHG; HYPOTENSION; RISK	Objective Validation of the classification of hypovolaemic shock suggested by the prehospital trauma life support (PHTLS) in its sixth student course manual. Methods Adults, entered into the TraumaRegister DGU((R)) database between 2002 and 2011, were classified into reference ranges for heart rate (HR), systolic blood pressure (SBP) and Glasgow coma scale (GCS) according to the PHTLS classification of hypovolaemic shock. First, patients were grouped by a combination of all three parameters (HR, SBP and GCS) as suggested by PHTLS. Second, patients were classified by only one parameter (HR, SBP or GCS) according to PHTLS and alterations in the remaining two parameters were assessed. Furthermore, subgroup analysis for trauma mechanism and traumatic brain injury (TBI) were performed. Results Out of 46689 patients, only 12432 (26.5%) could be adequately classified according to PHTLS if a combination of all three criteria was assessed. In TBI patients, only 12.2% could be classified adequately, whereas trauma mechanism had no significant influence. When patients were grouped by HR, there was only a slight reduction in SBP. When grouped by SBP, GCS dropped from 14 to 8, while no significant tachycardia was observed in any group. In patients with a GCS less than 12, HR was unaltered whereas SBP was slightly reduced to 114 (42)mmHg. On average, GCS in TBI patients was lower within all shock groups. In penetrating trauma patients, changes in HR and SBP were more distinct, but still less than predicted by PHTLS. Conclusions The PHTLS classification of hypovolaemic shock displays substantial deficits in adequately risk-stratifying trauma patients.	[Mutschler, Manuel; Fabian, Tobias; Paffrath, Thomas; Bouillon, Bertil; Maegele, Marc] Univ Witten Herdecke, CMMC, Dept Trauma & Orthoped Surg, D-51109 Cologne, Germany; [Nienaber, Ulrike] Acad Trauma Surg, Berlin, Germany; [Muenzberg, Matthias; Woelfl, Christoph] BG Hosp Ludwigshafen, Dept Trauma & Orthoped Surg, Ludwigshafen, Germany		Mutschler, M (corresponding author), Univ Witten Herdecke, CMMC, Dept Trauma & Orthoped Surg, Ostmerheimerstr 200, D-51109 Cologne, Germany.	manuelmutschler@web.de					Baker SP, 1974, J TRAUMA, V14, P87; BARDENHEUE M, 1994, UNFALLCHIRURG, V97, P230; Brasel KJ, 2007, J TRAUMA, V62, P812, DOI 10.1097/TA.0b013e31803245a1; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Committee on Trauma American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Guly HR, 2010, RESUSCITATION, V81, P1142, DOI 10.1016/j.resuscitation.2010.04.007; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Jansen TC, 2008, CRIT CARE, V12, DOI 10.1186/cc7159; Ley EJ, 2009, J TRAUMA, V67, P1051, DOI 10.1097/TA.0b013e3181bba222; Meregalli A, 2004, CRIT CARE, V8, pR60, DOI 10.1186/cc2423; Mutschler M, 2012, RESUSCITATION; National Association of Emergency Medical Technicians (U.S.) Prehospital Trauma Life Support Committee A.C.o.S.-C. o.T., 2007, PREH TRAUM LIF SUPP; Parks JK, 2006, AM J SURG, V192, P727, DOI 10.1016/j.amjsurg.2006.08.034; TEASDALE G, 1974, LANCET, V2, P81; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5	21	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2014	31	1					35	39		10.1136/emermed-2012-202130			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	276JB	WOS:000328745500011	23302502				2022-02-06	
J	Pogoda, TK; Iverson, KM; Meterko, M; Baker, E; Hendricks, AM; Stolzmann, KL; Krengel, M; Charns, MP; Amara, J; Kimerling, R; Lew, HL				Pogoda, Terri K.; Iverson, Katherine M.; Meterko, Mark; Baker, Errol; Hendricks, Ann M.; Stolzmann, Kelly L.; Krengel, Maxine; Charns, Martin P.; Amara, Jomana; Kimerling, Rachel; Lew, Henry L.			Concordance of clinician judgment of mild traumatic brain injury history with a diagnostic standard	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						American Congress of Rehabilitation Medicine guidelines; blast injuries; comprehensive traumatic brain injury evaluation; diagnosis; mild traumatic brain injury; neurobehavioral manifestations; non-blast injuries; posttraumatic stress disorder; psychological factors; Veterans	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; IRAQ; AFGHANISTAN; DEPLOYMENT; MILITARY; VETERANS; ASSOCIATION; PREVALENCE; CHALLENGES	The concordance of Department of Veterans Affairs (VA) clinician judgment of mild traumatic brain injury (mTBI) history with American Congress of Rehabilitation Medicine (ACRM)-based criteria was examined for Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) Veterans. In order to understand inconsistencies in agreement, we also examined the associations between evaluation outcomes and conceptually relevant patient characteristics, deployment-related events, current self-reported health symptoms, and suspected psychiatric conditions. The Veteran sample comprised 14,026 OIF/OEF VA patients with deployment-related mTBI history (n = 9,858) or no history of mTBI (n = 4,168) as defined by ACRM-based criteria. In the majority of cases (76.0%), clinician judgment was in agreement with the ACRM-based criteria. The most common inconsistency was between clinician judgment (no) and ACRM-based criteria (yes) for 21.3% of the patients. Injury etiology, current self-reported health symptoms, and suspected psychiatric conditions were additional factors associated with clinician diagnosis and ACRM-based criteria disagreement. Adherence to established diagnostic guidelines is essential for accurate determination of mTBI history and for understanding the extent to which mTBI symptoms resolve or persist over time in OIF/OEF Veterans.	[Pogoda, Terri K.; Meterko, Mark; Baker, Errol; Stolzmann, Kelly L.; Charns, Martin P.] Dept Vet Affairs VA Boston Hlthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, Terri K.; Meterko, Mark; Hendricks, Ann M.; Charns, Martin P.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Boston, MA 02130 USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Pogoda, Terri K.; Hendricks, Ann M.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Krengel, Maxine] VA Boston Healthcare Syst, Res & Dev Serv, Boston, MA 02130 USA; [Krengel, Maxine] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Amara, Jomana] Naval Postgrad Sch, Def Resource Management Inst, Monterey, CA USA; [Kimerling, Rachel] VA Palo Alto Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Palo Alto, CA USA; [Kimerling, Rachel] VA Palo Alto Healthcare Syst, Ctr Hlth Care Evaluat, Palo Alto, CA USA; [Lew, Henry L.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Def & Vet Brain Injury Ctr, Richmond, VA USA; [Lew, Henry L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Commun Sci & Disorders, Honolulu, HI 96822 USA		Pogoda, TK (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave 152M, Boston, MA 02130 USA.	terri.pogoda@va.gov	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780; Kimerling, Rachel/0000-0003-0996-4212; Krengel, Maxine/0000-0001-7632-590X; Charns, Martin/0000-0002-7102-5331	VA Office of Research and Development, Health Services Research and Development ServiceUS Department of Veterans Affairs [SDR 08-405]; Health Services Research and Development Service Career Development Award [CDA-2, 10-029]	This material was based on work supported by the VA Office of Research and Development, Health Services Research and Development Service (grant SDR 08-405). Dr. Iverson's contribution was supported by a Health Services Research and Development Service Career Development Award (CDA-2; 10-029).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2011, DEPRESS ANXIETY, V28, P802, DOI 10.1002/da.20737; Bryant RA, 2011, J CLIN PSYCHIAT, V72, P233, DOI 10.4088/JCP.09r05072blu; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrin A, 2013, C GAO TAKE AIM DOD V; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T, 2008, INVISIBLE WOUNDS WAR, P492; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; U. S. Department of the Army Office of the Surgeon General Traumatic Brain Injury Task Force, 2008, REP SURG GEN; U. S. Government Accountability Office, 2008, VA HLTH CAR MILD TRA, P1; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	43	12	12	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	3					363	375		10.1682/JRRD.2013.05.0115			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AL5KL	WOS:000339172400005	25019660	Bronze			2022-02-06	
J	Tuma, M; El-Menyar, A; Abdelrahman, H; Al-Thani, H; Zarour, A; Parchani, A; Khoshnaw, S; Peralta, R; Latifi, R				Tuma, Mazin; El-Menyar, Ayman; Abdelrahman, Husham; Al-Thani, Hassan; Zarour, Ahmad; Parchani, Ashok; Khoshnaw, Sherwan; Peralta, Ruben; Latifi, Rifat			Prehospital Intubation in Patients with Isolated Severe Traumatic Brain Injury: A 4-Year Observational Study	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; VENTILATION; HYPOTENSION; OUTCOMES; IMPACT; MANAGEMENT; SURVIVAL; MODERATE; HYPOXIA	Objectives. To study the effect of prehospital intubation (PHI) on survival of patients with isolated severe traumatic brain injury (ISTBI). Method. Retrospective analyses of all intubated patients with ISTBI between 2008 and 2011 were studied. Comparison was made between those who were intubated in the PHI versus in the trauma resuscitation unit (TRU). Results. Among 1665 TBI patients, 160 met the inclusion criteria (105 underwent PHI, and 55 patients were intubated in TRU). PHI group was younger in age and had lower median scene motor GCS (P = 0.001). Ventilator days and hospital length of stay (P = 0.01 and 0.006, resp.) were higher in TRUI group. Mean ISS, length of stay, initial blood pressure, pneumonia, and ARDS were comparable among the two groups. Mortality rate was higher in the PHI group (54% versus 31%,P = 0.005). On multivariate regression analysis, scene motor GCS (OR 0.55; 95% CI 0.41-0.73) was an independent predictor for mortality. Conclusion. PHI did not offer survival benefit in our group of patients with ISTBI based on the head AIS and the scene motor GCS. However, more studies are warranted to prove this finding and identify patients who may benefit from this intervention.	[Tuma, Mazin; Abdelrahman, Husham; Al-Thani, Hassan; Zarour, Ahmad; Parchani, Ashok; Khoshnaw, Sherwan; Peralta, Ruben; Latifi, Rifat] Hamad Gen Hosp, Dept Surg, Sect Trauma Surg, POB 3050, Doha, Qatar; [El-Menyar, Ayman] HGH, Sect Trauma Surg, Clin Res, Doha, Qatar; [El-Menyar, Ayman; Latifi, Rifat] Weill Cornell Med Sch, Clin Med, Doha, Qatar; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA		Tuma, M (corresponding author), Hamad Gen Hosp, Dept Surg, Sect Trauma Surg, POB 3050, Doha, Qatar.	mazin615@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; Latifi, Rifat/0000-0003-1091-3682			[Anonymous], 2007, J NEUROTRAUMA S1, V24; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Bozeman WP, 2005, J TRAUMA, V58, P278, DOI 10.1097/01.TA.0000152536.71932.85; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P567, DOI 10.1097/TA.0b013e31824baddf; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Raatiniemi L, 2013, ACTA ANAESTH SCAND, V57, P654, DOI 10.1111/aas.12101; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; Vandromme MJ, 2011, J TRAUMA, V71, P1615, DOI 10.1097/TA.0b013e31822a30a1; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	27	12	12	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2014	2014								135986	10.1155/2014/135986			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V33WQ	WOS:000215795900003	24527211	Green Published, gold, Green Submitted			2022-02-06	
J	Wu, X; Du, ZY; Yu, J; Sun, YR; Pei, BB; Lu, X; Tang, ZY; Yin, M; Zhou, LF; Hu, J				Wu, Xing; Du, Zhuoying; Yu, Jian; Sun, Yirui; Pei, Bingbing; Lu, Xin; Tang, Zhengyu; Yin, Mao; Zhou, Liangfu; Hu, Jin			Activity of factor VII in patients with isolated blunt traumatic brain injury: Association with coagulopathy and progressive hemorrhagic injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Factor VII; isolated traumatic brain injury; coagulopathy; progressive hemorrhagic injury	RECOMBINANT FACTOR VIIA; HEAD TRAUMA; INTRACEREBRAL HEMORRHAGE; COAGULATION DISORDERS; HYPOPERFUSION; RISK	BACKGROUND: Given the importance of factor VII (FVII) in extrinsic pathway of coagulation cascade, we sought to elucidate the relationship between FVII and traumatic brain injury-induced coagulopathy and progressive hemorrhagic injury (PHI). METHODS: Eighty-one patients with isolated traumatic brain injury, 16 years or older, were recruited between 2010 and 2012. Blood was collected on arrival in the emergency department and analyzed with activated partial thromboplastic time, international normalized ratio, platelet count, and activity of FVII. Coagulopathy was defined as thrombocytopenia (platelet count < 120,000/KL) or elevated international normalized ratio of greater than 1.2 or prolonged activated partial thromboplastin time greater than 40 seconds at admission. PHI was present when the follow-up computed tomographic scan reported any increase in size or number of the hemorrhagic lesions. Logistic regression examined the risks for coagulopathy and PHI. RESULTS: Mean (SD) FVII activity in patients with coagulopathy was 85.69% (34.88%), which was significantly lower than patients without coagulopathy (99.57% [29.37%], p = 0.04). Isolated traumatic brain injury patients with FVII activity less than 77.5% have an odds ratio for coagulopathy of 5.52 (95% confidence interval, 1.82-16.68; p = 0.03) relative to patients with FVII activity of 77.5% or greater. Mean (SD) FVII activity in patients with PHI was 70.76% (18.21%), which was significantly lower than patients without PHI (105.76% [32.27%], p < 0.001). A stepwise logistic regression analysis identified FVII less than 77.5% (odds ratio, 4.53; 95% confidence interval, 1.62-12.67; p = 0.004) as a predisposing risk factors independently associated with the presence of PHI. The overall mortality rate in the study population was 7.4% (n = 6). The plasma FVII in death patients (91.44% [47.19%]) was slightly lower than that in survival patients (92.01% [32.04%]). However, there was no statistical difference between the two groups (p = 0.95). CONCLUSION: A decrease of FVII activity significantly contributes to the coagulopathy and PHI in patients with isolated traumatic brain injury. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Wu, Xing; Du, Zhuoying; Yu, Jian; Sun, Yirui; Yin, Mao; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Tang, Zhengyu] Chinese Acad Sci, Shanghai Adv Res Inst, SARI Ctr Stem Cell & NanoMed, Shanghai, Peoples R China; [Pei, Bingbing] Xinxiang Med Univ, Henan Prov Peoples Hosp, Dept Neurosurg, Xinxiang City, Henan Province, Peoples R China; [Lu, Xin] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	xggbtt@gmail.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, 08dj1400503]; National Basic Research ProgramNational Basic Research Program of China [2009CB941100, 2010CB945500, 2012CB966300]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [10JC1402300]; Shanghai Nature Science Foundation [08411952000]	This work is supported, in part, by funds from the National Natural Science Foundation of China (NSFC Grants 30870805, 81271003, 90919002, 30770824, 81000518, 81171133, 81271375, and 08dj1400503), the National Basic Research Program (2009CB941100, 2010CB945500, 2012CB966300), The Science and Technology Commission of Shanghai Municipality Project (10JC1402300), and the Shanghai Nature Science Foundation (08411952000).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; Corral J, 2001, BLOOD, V97, P2979, DOI 10.1182/blood.V97.10.2979; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Indrayan A., 2012, MED BIOSTATISTICS; Jansen JO, 2011, J TRAUMA, V71, pS435, DOI 10.1097/TA.0b013e318232e5cb; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Letarte PB, 2008, J TRAUMA, V64, P627; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Schurr MJ, 2004, J TRAUMA, V57, P718; Shaz BH, 2011, J TRAUMA, V70, P1401, DOI 10.1097/TA.0b013e31821266e0; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Vaslef SN, 2002, J TRAUMA, V53, P291, DOI 10.1097/00005373-200208000-00017; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	32	12	22	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2014	76	1					114	120		10.1097/TA.0b013e3182a8fe48			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AH8JN	WOS:000336384200023	24368365				2022-02-06	
J	Yoo, JS; Kim, OL; Kim, SH; Kim, MS; Jang, SH				Yoo, Jin-Sun; Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Su; Jang, Sung Ho			Relation between cognition and neural connection from injured cingulum to brainstem cholinergic nuclei in chronic patients with traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; brainstem cholinergic nuclei; cingulum; cognition; traumatic diffusion tensor imaging	DIFFUSION TENSOR TRACTOGRAPHY; AXONAL INJURY; ANTERIOR; SYSTEM; BUNDLE; FORNIX; CORTEX	Background: This study investigated the relation between cognition and the neural connection from injured cingulum to brainstem cholinergic nuclei in patients with traumatic brain injury (TBI), using diffusion tensor tractography (DTT). Methods: Among 353 patients with TBI, 20 chronic patients who showed discontinuation of both anterior cingulums from the basal forebrain on DTT were recruited for this study. The Wechsler Intelligence Scale and the Memory Assessment Scale (MAS; short-term, verbal, visual and total memory) were used for assessment of cognition. Patients were divided into two groups according to the presence of a neural connection between injured cingulum and brainstem cholinergic nuclei. Results: Eight patients who had a neural connection between injured cingulum and brainstem cholinergic nuclei showed better short-term memory on MAS than 12 patients who did not (p<0.05). However, other results of neuropsychological testing showed no significant difference (p>0.05). Conclusions: Better short-term memory in patients who had the neural connection between injured cingulum and brainstem cholinergic nuclei appears to have been attributed to the presence of cholinergic innervation to the cerebral cortex through the neural connection instead of the injured anterior cingulum. The neural connection appears to compensate for the injured anterior cingulum in obtaining cholinergic innervation.	[Yoo, Jin-Sun; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Oh Lyong; Kim, Seong Ho; Kim, Min Su] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - by the Ministry of Education, Science and Technology [2012R1A1A4A01001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Gazzaniga M.S., 2009, COGNITIVE NEUROSCIEN, V3; Harding L., 1996, ASSESSMENT NEUROPSYC; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Jackson O, 2004, NEUROIMAGE, V21, P456, DOI 10.1016/j.neuroimage.2003.09.050; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Miranda MI, 2003, NEUROBIOL LEARN MEM, V80, P211, DOI 10.1016/S1074-7427(03)00061-3; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Naidich TP, 2009, DUVERNOYS ATLAS HUMA; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; van Huijzen, 2008, HUMAN CENTRAL NERVOU; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D, 1981, WECHSLER ADULT INTEL; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williams JM., 1991, MAS MEMORY ASSESSMEN; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2012, NEUROREHABILITATION, V31, P143, DOI 10.3233/NRE-2012-0783; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	36	12	12	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	10					1257	1261		10.3109/02699052.2014.901557			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AN2ZZ	WOS:000340455900004	24926814				2022-02-06	
J	Jiang, Y; Rumble, JL; Gleixner, AM; Unnithan, AS; Pulugulla, SH; Posimo, JM; Choi, HJH; Crum, TS; Pant, DB; Leak, RK				Jiang, Y.; Rumble, J. L.; Gleixner, A. M.; Unnithan, A. S.; Pulugulla, S. H.; Posimo, J. M.; Choi, H. J. H.; Crum, T. S.; Pant, D. B.; Leak, R. K.			N-ACETYL CYSTEINE BLUNTS PROTEOTOXICITY IN A HEAT SHOCK PROTEIN-DEPENDENT MANNER	NEUROSCIENCE			English	Article						Parkinson's disease; Alzheimer's disease; heat shock protein 70; heat shock cognate 70; chaperone; N-acetylcysteine	UBIQUITIN-PROTEASOME PATHWAY; BULBAR MUSCULAR-ATROPHY; OXIDATIVE STRESS; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISORDERS; PARKINSONS-DISEASE; INDUCED APOPTOSIS; CELL-DEATH; RHEUMATOID-ARTHRITIS; NEUROBLASTOMA-CELLS	N-Acetyl cysteine, a glutathione precursor, has been shown to benefit patients with Alzheimer's disease and reduce the symptoms of traumatic brain injury in soldiers. Parkinson's and Alzheimer's disease are both characterized by stress from protein misfolding, or proteotoxicity. We have developed a high-throughput model of proteotoxicity by treating neuroblastoma N2a cells with the proteasome inhibitor MG132 and performing three independent assays for viability. Our previous study showed that N-acetyl cysteine protects N2a cells against two sequential treatments of MG132 and raises glutathione levels in a two-hit model of synergistic neurodegeneration. In the present study, however, N-acetyl cysteine was found to reduce the toxicity of a single hit of MG132 independent of its effect on glutathione. All three viability assays confirmed this protection. We measured heat shock protein 70 (Hsp70) levels because Hsp70 is a protective chaperone that helps refold proteins or guides ubiquitinated proteins toward degradation by the proteasome. Hsp70 levels were higher in MG132-treated cells when N-acetyl cysteine was applied. No parallel change in heat shock cognate 70 (Hsc70) was elicited. Inhibition of Hsp70/Hsc70 activity with VER 155008 attenuated the protection afforded by N-acetyl cysteine in a dose-responsive manner. MG132 induced a large rise in ubiquitinated proteins and N-acetyl cysteine reduced this effect. Consistent with the chaperone functions of Hsp70, VER 155008 also prevented the reduction in ubiquitin-conjugated proteins by N-acetyl cysteine. These data reveal a new role for N-acetyl cysteine: this compound may reduce misfolded protein levels and ameliorate proteotoxicity through heat shock proteins. These findings broaden the potential mechanisms of action for this dietary supplement in neurodegenerative proteinopathies. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Jiang, Y.; Rumble, J. L.; Gleixner, A. M.; Unnithan, A. S.; Pulugulla, S. H.; Posimo, J. M.; Choi, H. J. H.; Crum, T. S.; Pant, D. B.; Leak, R. K.] Duquesne Univ, Div Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15282 USA		Leak, RK (corresponding author), Duquesne Univ, Div Pharmaceut Sci, 600 Forbes Ave, Pittsburgh, PA 15282 USA.	leakr@duq.edu	Pulugulla, Sree/AAV-5319-2021; Leak, Rehana K/I-2607-2019	Leak, Rehana K/0000-0003-2817-7417	Pennsylvania Department of Health (Commonwealth Universal Research Enhancement program); Mylan School of Pharmacy at the Duquesne University	R.K.L. designed the experiments and wrote the manuscript. Y.J., J.R., A.M.G., A.S.U., S.P., J.M.P., T.C., and D.P. performed the experiments, analyzed the data, provided technical support, and proofread the article. This work was supported by a Grant from the Pennsylvania Department of Health (Commonwealth Universal Research Enhancement program) and by a startup award to R.K.L. from the Mylan School of Pharmacy at the Duquesne University. We are especially grateful for the superb administrative assistance of Deb Wilson, Mary Caruso, and Jackie Farrer. None of the authors have any conflicts to disclose.	Adachi H, 2003, J NEUROSCI, V23, P2203; Adair JC, 2001, NEUROLOGY, V57, P1515, DOI 10.1212/WNL.57.8.1515; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Beere HM, 2001, SCI STKE, V93, P1; Besche HC, 2009, CELL, V138, P25, DOI 10.1016/j.cell.2009.06.035; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P249, DOI 10.1177/0960327109363973; Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001; Calabrese EJ, 2001, TOXICOL SCI, V62, P330, DOI 10.1093/toxsci/62.2.330; Chacko SK, 2010, EXP CLIN ENDOCR DIAB, V118, P64, DOI 10.1055/s-0029-1225647; Chao PL, 2007, ANN NY ACAD SCI, V1122, P276, DOI 10.1196/annals.1403.020; Chatterjee M, 2013, HAEMATOLOGICA, V98, P1132, DOI 10.3324/haematol.2012.066175; Clark J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012333; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Fenteany G, 1996, CHEM BIOL, V3, P905, DOI 10.1016/S1074-5521(96)90179-9; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Giordano J, 2008, CRIT REV TOXICOL, V38, P623, DOI 10.1080/10408440802026356; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Han YH, 2010, ANTICANCER RES, V30, P2107; Han YH, 2010, INT J MOL MED, V25, P657, DOI 10.3892/ijmm_00000389; Hineno A, 2011, NEUROCHEM RES, V36, P2127, DOI 10.1007/s11064-011-0537-8; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kaneko K, 2008, NEUROSCI LETT, V446, P56, DOI 10.1016/j.neulet.2008.08.089; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Leak RK, 2008, J NEUROCHEM, V106, P860, DOI 10.1111/j.1471-4159.2008.05459.x; Leak RK, 2010, J NEUROSCI METH, V191, P234, DOI 10.1016/j.jneumeth.2010.06.023; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee HZ, 2009, FOOD CHEM TOXICOL, V47, P561, DOI 10.1016/j.fct.2008.12.013; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; Loeffler DA, 2001, FREE RADICAL RES, V35, P111, DOI 10.1080/10715760100300651; Louro MO, 2000, J TRACE ELEM MED BIO, V14, P174, DOI 10.1016/S0946-672X(00)80007-3; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Macias AT, 2011, J MED CHEM, V54, P4034, DOI 10.1021/jm101625x; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2004, INT REV NEUROBIOL, V62, P95, DOI 10.1016/S0074-7742(04)62003-4; Memisogullari R, 2004, J DIABETES COMPLICAT, V18, P193, DOI 10.1016/S1056-8727(03)00032-1; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Mezzetti A, 1996, J AM GERIATR SOC, V44, P823, DOI 10.1111/j.1532-5415.1996.tb03741.x; Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Muller JM, 1997, EUR J BIOCHEM, V244, P45, DOI 10.1111/j.1432-1033.1997.00045.x; Mustafi SB, 2009, CELL STRESS CHAPERON, V14, P579, DOI 10.1007/s12192-009-0109-x; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nollen EAA, 2002, J CELL SCI, V115, P2809; Ohtsuka K, 2000, INT J HYPERTHER, V16, P231, DOI 10.1080/026567300285259; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; Petersen AC, 2012, ACTA PHYSIOL, V204, P382, DOI 10.1111/j.1748-1716.2011.02344.x; Pocernich CB, 2000, NEUROCHEM INT, V36, P185, DOI 10.1016/S0197-0186(99)00126-6; Pocernich CB, 2012, BBA-MOL BASIS DIS, V1822, P625, DOI 10.1016/j.bbadis.2011.10.003; Posimo JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058596; Posimo JM, 2013, J VIS EXP IN PRESS; Putics A, 2008, ANTIOXID REDOX SIGN, V10, P65, DOI 10.1089/ars.2007.1866; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; Sawada H, 2004, J BIOL CHEM, V279, P10710, DOI 10.1074/jbc.M308434200; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Seok SH, 2007, TOXICOL IN VITRO, V21, P870, DOI 10.1016/j.tiv.2007.02.011; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Sun LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032503; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; Texel SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025077; Texel SJ, 2008, BIOCHEM SOC T, V36, P1277, DOI 10.1042/BST0361277; Titler AM, 2013, CELL TISSUE RES, V352, P427, DOI 10.1007/s00441-013-1571-4; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Tucker Stephanie, 2006, Current Alzheimer Research, V3, P221, DOI 10.2174/156720506777632835; Unnithan AS, 2012, NEUROCHEM INT, V61, P356, DOI 10.1016/j.neuint.2012.06.001; Xie WJ, 2010, J NEUROCHEM, V115, P188, DOI 10.1111/j.1471-4159.2010.06914.x; Yan CYI, 1998, J NEUROSCI, V18, P4042; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhu YG, 2007, NEUROCHEM INT, V50, P671, DOI 10.1016/j.neuint.2006.12.013; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	84	12	12	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 26	2013	255						19	32		10.1016/j.neuroscience.2013.09.049			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	302GR	WOS:000330591500002	24096134				2022-02-06	
J	Schmid, GHS; Eisenmenger-Sittner, C				Schmid, G. H. S.; Eisenmenger-Sittner, C.			A method for uniformly coating powdery substrates by magnetron sputtering	SURFACE & COATINGS TECHNOLOGY			English	Article						Magnetron sputtenng; Powder substrate; Particle coating; Thin films; Powder behaviour under vacuum conditions	SMALL SIO2 PARTICLES; CENOSPHERE PARTICLES; HYDROGEN GENERATION; SURFACE MODIFICATION; ALUMINUM-OXIDE; THIN-FILM; FABRICATION; HYDROLYSIS; DEPOSITION; METHANOL	DC magnetron sputtering was used to coat fine-grained powders, i.e. hollow glass microspheres (particle diameter approx. 2-70 mu m). To accomplish the exposure of the whole surface of each powder particle the powder was put into a rotating vessel which makes the particles tumble so that they are coated uniformly. However, there are problems of sticking and cluster formation of the powder during the sputtering process, which prevent the complete coating of the particles. To resolve this issue a concussion mechanism had been used which now was completely redesigned for better upscalability. This newly designed mechanism is based on gravity and will be described in this work as well as its ability to deposit metal and oxide films on powder particles. For the better understanding of the trickling behaviour of the used particles (glass microspheres), experiments addressing this behaviour with regard to different particle size distributions have been carried out in vacuum with the concussion mechanism and without it. Furthermore the influence of the sputter beam is taken into account. It will be shown that it is possible to coat powders, which strongly tend to agglutinate in vacuum and even more under sputter conditions, by using the new concussion mechanism. (C) 2013 Elsevier B.V. All rights reserved.	[Schmid, G. H. S.; Eisenmenger-Sittner, C.] Vienna Univ Technol, Inst Solid State Phys, A-1040 Vienna, Austria		Schmid, GHS (corresponding author), Vienna Univ Technol, Inst Solid State Phys, Wiedner Hauptstr 8-10, A-1040 Vienna, Austria.	gerwin.schmid@tuwien.ac.at			Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P-22718]; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [P 22718] Funding Source: researchfish	This work was supported by the Austrian Science Fund (FWF), project "CatSphere", grant number P-22718. The electron microscopy was carried out at the service centre for electron microscopy of the Vienna University of Technology (USTEM).	Abe T, 2005, J ALLOY COMPD, V402, P227, DOI 10.1016/j.jallcom.2005.02.097; Abe T, 2004, J ALLOY COMPD, V377, P194, DOI 10.1016/j.jallcom.2003.12.053; Abe T, 2007, J ALLOY COMPD, V441, P157, DOI 10.1016/j.jallcom.2006.07.132; Akamaru S, 2006, THIN SOLID FILMS, V513, P103, DOI 10.1016/j.tsf.2006.01.056; Andersson J, 2003, WEAR, V254, P1070, DOI 10.1016/S0043-1648(03)00336-3; Andrieux J, 2009, INT J HYDROGEN ENERG, V34, P938, DOI 10.1016/j.ijhydene.2008.09.102; Bennici S, 2011, INT J HYDROGEN ENERG, V36, P7431, DOI 10.1016/j.ijhydene.2011.03.148; Boulle A, 2001, ACTA MATER, V49, P811, DOI 10.1016/S1359-6454(00)00366-9; Brauer G, 2010, VACUUM, V84, P1354, DOI 10.1016/j.vacuum.2009.12.014; Ensinger W, 1998, NUCL INSTRUM METH B, V141, P693, DOI 10.1016/S0168-583X(98)00173-6; Ensinger W, 2003, SURF COAT TECH, V163, P281, DOI 10.1016/S0257-8972(02)00490-5; Fedotov AA, 2013, INT J HYDROGEN ENERG, V38, P426, DOI 10.1016/j.ijhydene.2012.09.121; Haraguchi M, 2004, SURF SCI, V548, P59, DOI 10.1016/j.susc.2003.10.037; Hell J, 2009, VACUUM, V84, P453, DOI 10.1016/j.vacuum.2009.09.007; Keding M, 2008, International Patent, Patent No. [WO2008019414 A2, 2008019414]; Kelly PJ, 2000, VACUUM, V56, P159, DOI 10.1016/S0042-207X(99)00189-X; Kojima Y, 2002, INT J HYDROGEN ENERG, V27, P1029, DOI 10.1016/S0360-3199(02)00014-9; MAKOWIECKI DM, 2002, Patent No. 6355146; Poelman H, 2007, APPL CATAL A-GEN, V325, P213, DOI 10.1016/j.apcata.2007.02.028; Safi I, 2000, SURF COAT TECH, V127, P203, DOI 10.1016/S0257-8972(00)00566-1; Schmid G, 2010, SURF COAT TECH, V205, P1929, DOI 10.1016/j.surfcoat.2010.08.076; SCHMID G, 2012, Patent No. 201250406; Shukla S, 2002, MATER LETT, V57, P151, DOI 10.1016/S0167-577X(02)00722-X; Suffredini HB, 2006, J POWER SOURCES, V158, P124, DOI 10.1016/j.jpowsour.2005.09.040; Suffredini HB, 2004, ELECTROCHEM COMMUN, V6, P1025, DOI 10.1016/j.elecom.2004.08.008; Taguchi A, 2007, J ALLOY COMPD, V441, P162, DOI 10.1016/j.jallcom.2006.07.131; Taguchi A, 2008, VACUUM, V83, P575, DOI 10.1016/j.vacuum.2008.04.023; TAKESHIMA E, 1990, Patent No. 4940523; TOTH RE, 2006, Patent No. 20060193978; Vahlas C, 2006, MAT SCI ENG R, V53, P1, DOI 10.1016/j.mser.2006.05.001; Xu J, 1997, WEAR, V202, P165, DOI 10.1016/S0043-1648(96)07274-2; Xu Q, 2007, J ALLOY COMPD, V446, P729, DOI 10.1016/j.jallcom.2007.01.040; Yu XZ, 2007, APPL SURF SCI, V253, P7082, DOI 10.1016/j.apsusc.2007.02.059; Yu XH, 2007, J PHYS D APPL PHYS, V40, P2894, DOI 10.1088/0022-3727/40/9/034; Yu XZ, 2011, VACUUM, V85, P1026, DOI 10.1016/j.vacuum.2011.03.010; Yu XZ, 2008, POWDER TECHNOL, V187, P239, DOI 10.1016/j.powtec.2008.02.017; Yu XZ, 2009, VACUUM, V83, P1438, DOI 10.1016/j.vacuum.2009.05.021; Yu XZ, 2009, J MAGN MAGN MATER, V321, P2890, DOI 10.1016/j.jmmm.2009.04.040	38	12	13	0	20	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0257-8972			SURF COAT TECH	Surf. Coat. Technol.	DEC 15	2013	236						353	360		10.1016/j.surfcoat.2013.10.012			8	Materials Science, Coatings & Films; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Physics	292EF	WOS:000329884300050					2022-02-06	
J	Palacios, EM; Sala-Llonch, R; Junque, C; Roig, T; Tormos, JM; Bargallo, N; Vendrell, P				Palacios, Eva M.; Sala-Llonch, Roser; Junque, Carme; Roig, Teresa; Tormos, Jose M.; Bargallo, Nuria; Vendrell, Pere			White Matter/Gray Matter Contrast Changes in Chronic and Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive deficits; diffusion tensor imaging (DTI); traumatic brain injury; white matter/gray matter signal-intensity contrast	HUMAN CEREBRAL-CORTEX; INTEGRITY; THICKNESS; NETWORKS	Signal-intensity contrast of T1-weighted magnetic resonance imaging scans has been associated with tissue integrity and reported as a sign of neurodegenerative changes in diseases such as Alzheimer's disease. After severe traumatic brain injury (TBI), progressive structural changes occur in white (WM) and gray matter (GM). In the current study, we assessed the signal-intensity contrast of GM and WM in patients with diffuse TBI in the chronic stage to (1) characterize the regional pattern of WM/GM changes in intensity contrast associated with traumatic axonal injury, (2) evaluate possible associations between this measure and diffusion tensor image (DTI)/fractional anisotropy (FA) for detecting WM damage, and (3) investigate the correlates of both measures with cognitive outcomes. Structural T1 scans were processed with FreeSurfer software to identify the boundary and calculate the WM/GM contrast maps. DTIs were processed with the FMRIB software library to obtain FA maps. The WM/GM contrast in TBI patients showed a pattern of reduction in almost all of the brain, except the visual and motor primary regions. Global FA values obtained from DTI correlated with the intensity contrast of all associative cerebral regions. WM/GM contrast correlated with memory functions, whereas FA global values correlated with tests measuring memory and mental processing speed. In conclusion, tissue-contrast intensity is a very sensitive measure for detecting structural brain damage in chronic, severe and diffuse TBI, but is less sensitive than FA for reflecting neuropsychological sequelae, such as impaired mental processing speed.	[Palacios, Eva M.; Sala-Llonch, Roser; Junque, Carme; Vendrell, Pere] Univ Barcelona, Dept Psychiat & Clin Psychobiol, E-08036 Barcelona, Spain; [Roig, Teresa; Tormos, Jose M.] Neurorehabil Hosp, Inst Guttmann, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imatge Hosp Clin Barcelona CDIC, Barcelona, Spain		Junque, C (corresponding author), Univ Barcelona, Dept Psychiat & Clin Psychobiol, C Casanova 143, E-08036 Barcelona, Spain.	cjunque@ub.edu	Sala-Llonch, Roser/L-4135-2015; Junque, Carme/B-4400-2011; Vendrell, Pere/B-4392-2011; Sala-Llonch, Roser/E-7882-2012; Bargallo, Nuria/G-6854-2016	Sala-Llonch, Roser/0000-0003-3576-0475; Junque, Carme/0000-0002-6381-3063; Vendrell, Pere/0000-0001-8918-5440; Sala-Llonch, Roser/0000-0003-3576-0475; Bargallo, Nuria/0000-0001-6284-5402; Tormos Munoz, Jose Maria/0000-0002-8764-2289			Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grydeland H, 2013, HUM BRAIN MAPP, V34, P2775, DOI 10.1002/hbm.22103; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024	14	12	12	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1991	1994		10.1089/neu.2012.2836			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400008	23822854	Green Published			2022-02-06	
J	Rostami, E; Davidsson, J; Gyorgy, A; Agoston, DV; Risling, M; Bellander, BM				Rostami, Elham; Davidsson, Johan; Gyorgy, Andrea; Agoston, Denes V.; Risling, Marten; Bellander, Bo-Michael			The Terminal Pathway of the Complement System Is Activated in Focal Penetrating But Not in Mild Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						C1q; C3; C5b-9; complement; synaptic stripping; TBI	C-REACTIVE PROTEIN; AXONAL INJURY; WALLERIAN DEGENERATION; ALZHEIMERS-DISEASE; GLIAL-CELLS; RAT; INFLAMMATION; EXPRESSION; ABSENCE; NEURODEGENERATION	The complement system plays an important role in the inflammatory response activated by many central nervous system disorders. However, its significance in traumatic diffuse traumatic axonal injury (TAI) is not fully known. Here we analyze the complement activity in two rat models of traumatic brain injury (TBI); a focal penetration injury (pen-TBI) and a rotational acceleration injury (rot-TBI) that leads to a mild TAI. We used in situ hybridization to examine the distribution of mRNA for C1q and C3 and immunohistochemistry to examine the presence of the C3 protein and C5b-9 complex at 1-5 days after injury. We found a time-dependent complement activity in both models. However, the responses caused by the two models were different. We detected C5b-9 surrounding the cavity in pen-TBI, but C5b-9 was not found in the rot-TBI. Our findings suggest that the terminal complement pathway is progressed to the formation of the C5b-9 membrane attack complex only in the penetrating TBI but not in isolated TAI model. This indicates that the complement activation does not lead to membrane-damaging effects and a subsequent secondary axotomy in TAI by the terminal complex C5b-9. The role of complement activation in TAI is unclear, but might indicate an alternative function following rot-TBI, such as opsonizing the synapses for elimination.	[Rostami, Elham; Risling, Marten] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden; [Davidsson, Johan] Chalmers, Div Vehicle Safety, S-41296 Gothenburg, Sweden; [Gyorgy, Andrea; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA		Rostami, E (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	Elham.rostami@ki.se	Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514	Karolinska InstitutetKarolinska Institutet; Swedish Armed Forces; Vinnova, SwedenVinnova	The study was funded by Karolinska Institutet and the Swedish Armed Forces and Vinnova, Sweden. We thank Viktoria Hammarstedt for editorial help and Dr Christine Mossinger for her generosity in contributing antibody GADPH.	Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; BURGER W, 1987, AGENTS ACTIONS, V21, P93; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Davidsson J, 2009, INT IRCOBI C BIOM IN, P43; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GASQUE P, 1995, J IMMUNOL, V154, P4726; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Graham D.I., 2002, GREENFIELDS NEUROPAT; Gyorgy AB, 2010, J NEUROSCI METH, V192, P96, DOI 10.1016/j.jneumeth.2010.07.029; Holbourn AHS, 1943, LANCET, V2, P438; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; KOSKI CL, 1985, J IMMUNOL, V134, P1810; Koski CL, 1996, J NEUROCHEM, V66, P303; Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Padilla ND, 2003, IMMUNOLOGY, V109, P564, DOI 10.1046/j.1365-2567.2003.01681.x; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Qiao F, 2010, AM J PATHOL, V177, P3061, DOI 10.2353/ajpath.2010.100158; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; SVENSSON M, 1995, MOL CHEM NEUROPATHOL, V24, P53, DOI 10.1007/BF03160112; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Webster S, 1997, AM J PATHOL, V150, P1531; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0	47	12	13	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2013	30	23					1954	1965		10.1089/neu.2012.2583			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI0FA	WOS:000336520400004	23808389				2022-02-06	
J	Bryan, CJ				Bryan, Craig J.			Multiple traumatic brain injury and concussive symptoms among deployed military personnel	BRAIN INJURY			English	Article						Concussion; depression; PTSD; TBI	IRAQ; TBI	Objective: To identify if concussive symptoms occur with greater frequency among military personnel with multiple lifetime TBIs and if a history of TBI increases risk for subsequent TBI. Patients: One hundred and sixty-one military personnel referred to a TBI clinic for evaluation and treatment of suspected head injury at a military clinic in Iraq. Methods: Military patients completed standardized self-report measures of concussion, depression and post-traumatic stress symptoms; clinical interview; and physical examination. Group comparisons were made according to number of lifetime TBIs and logistic regression was utilized to determine the association of past TBIs on current TBI. Results: Patients with one or more previous TBIs were more likely to report concussion symptoms immediately following a recent injury and during the evaluation. Although differences between single and multiple TBI groups were observed, these did not reach the level of statistical significance. A history of any TBI increased the likelihood of current TBI diagnosis, but this relationship was no longer significant when adjusting for injury mechanism, depression and post-traumatic stress symptoms. Conclusion: Among deployed military personnel, the relationship of previous TBI with recent TBI and concussive symptoms may be largely explained by the presence of psychological symptoms.	Natl Ctr Vet Studies, Salt Lake City, UT 84112 USA		Bryan, CJ (corresponding author), Natl Ctr Vet Studies, 260 S Cent Campus Dr,Room 205, Salt Lake City, UT 84112 USA.	craig.bryan@utah.edu		Bryan, Craig/0000-0002-9714-0733			Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Blount TH, 2010, ANN M ASS BEH COGN T; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, 2007, MIL AC CONC EV; Defense and Veterans Brain Injury Center [Internet], 2012, TBI FACTS; Department of Defense/Department of Veterans Affairs Traumatic Brain Injury Task Force, 2008, REP SURG GEN TRAUM B; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F.W., 1993, ANN CONV INT SOC TRA	17	12	12	1	20	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1333	1337		10.3109/02699052.2013.823651			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500001	24070144				2022-02-06	
J	Donders, J; Elzinga, B; Kuipers, D; Helder, E; Crawford, JR				Donders, Jacobus; Elzinga, Brianne; Kuipers, David; Helder, Emily; Crawford, John R.			Development of an eight-subtest short form of the WISC-IV and evaluation of its clinical utility in children with traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Assessment; Intelligence; Psychometrics; Short form	WECHSLER-INTELLIGENCE-SCALE; HIGHER-ORDER; VALIDITY; EDITION; SAMPLE; SCORES	This study evaluated the degree to which an 8-subtest short form of the Wechsler Intelligence Scale for ChildrenFourth Edition would yield acceptable estimates of the long-form Full-Scale IQ index while clarifying the underlying factor structure in a sample of 100 children and adolescents with traumatic brain injury. The short-form Full-Scale IQ had sufficient (i.e., at least two thirds) nonerror covariance with its full-length counterpart. In addition, a sufficient proportion (i.e., > 80%) of these short-form estimates fell within the 90% confidence interval of the respective full-length scores. Importantly, the elimination of 2 subtests, and in particular the Picture Concepts subtest, resulted in a factor structure where each remaining subtest was fairly specifically associated with its intended scale. It is concluded that this short form can be used clinically in children with traumatic brain injury without sacrificing reliability and with more straightforward interpretability at the level of the factor index scores.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; [Elzinga, Brianne; Kuipers, David; Helder, Emily] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA; [Crawford, John R.] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com	Crawford, John R/A-4165-2008	Crawford, John R/0000-0003-3403-3428	Campbell Foundation [1.1099.0014]	This research was supported by a grant from the Campbell Foundation (#1.1099.0014).	Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Bodin D, 2009, CHILD NEUROPSYCHOL, V15, P417, DOI 10.1080/09297040802603661; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Crawford JR, 2010, BRIT J CLIN PSYCHOL, V49, P235, DOI 10.1348/014466509X455470; Delis DC, 2003, J INT NEUROPSYCH SOC, V9, P936, DOI 10.1017/S1355617703960139; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Donders J, 1996, CHILD NEUROPSYCHOL, V2, P227, DOI 10.1080/09297049608402255; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Kaufman, 1994, INTELLIGENT TESTING; Keith TZ, 2006, SCHOOL PSYCHOL REV, V35, P108; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Ryan JJ, 2007, J CLIN PSYCHOL, V63, P309, DOI 10.1002/jclp.20343; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Watkins MW, 2010, PSYCHOL ASSESSMENT, V22, P782, DOI 10.1037/a0020043; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2011, WASI 2 WECHSLER ABBR; [No title captured]	20	12	12	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	NOV 1	2013	19	6					662	670		10.1080/09297049.2012.723681			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	240BY	WOS:000326070900009	22950806				2022-02-06	
J	Fares, Y; Ayoub, F; Fares, J; Khazim, R; Khazim, M; Gebeily, S				Fares, Youssef; Ayoub, Fouad; Fares, Jawad; Khazim, Rabi; Khazim, Mahmoud; Gebeily, Souheil			Pain and neurological sequelae of cluster munitions on children and adolescents in South Lebanon	NEUROLOGICAL SCIENCES			English	Article						Cluster bombs; Cluster munitions; Neurological effects; Psychological effects; Pain	UNEXPLODED ORDNANCE; LAND MINES	This paper aims at evaluating the neurological repercussions arising from injuries sustained due to cluster munitions in children up to 18 years in South Lebanon following the 2006 conflict. Data on neurological and pain symptoms suffered during and after treatment because of sub-munitions in South Lebanon from August 2006 till late 2011 were prospectively recorded. Patients were divided into subcategories; children aged 12 and under and adolescents aged between 13 and 18. During the study period, there were 407 casualties, 122 (30 %) of which were aged 18 years or younger. There were 116 (95 %) males and six (5 %) females. Average age was 14 years. 10 (8.2 %), all males, died as a result of their injuries. 42 (34.4 %) were children and 80 (65.6 %) were adolescents. 112 had surgical treatments for their injuries. 83 out of 112 patients (74 %) with non-lethal injuries had amputations, 67 % children and 78 % adolescents. Among those who had amputations, 31 (37.4 %) suffered from phantom limb pain and 71 % suffered from stump/residual limb pain. 88 % of patients were diagnosed with post-traumatic stress disorder (44 % children and 77 % adolescents) and 41 % were diagnosed with post-concussion syndrome. Four patients (3.6 %) suffered from traumatic brain injuries, both penetrating and closed. Pain syndromes were found in all patients who had amputation. The injury related comorbidities together with many post-concussion syndrome cases, and fewer traumatic brain injuries lead into a high level of physical, psychosocial and economic burdens on the community.	[Fares, Youssef] Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon; [Ayoub, Fouad] Lebanese Univ, Fac Med Dent, Dept Basic Sci, Beirut, Lebanon; [Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Khazim, Rabi] Southend Univ Hosp, Westcliff On Sea, Essex, England; [Khazim, Mahmoud] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gebeily, Souheil] Lebanese Univ, Fac Med Sci, Div Neurol, Beirut, Lebanon		Fares, Y (corresponding author), Lebanese Univ, Fac Med Sci, Div Neurosurg, Beirut, Lebanon.	yfares@ul.edu.lb; jyf04@mail.aub.edu	Fares, Jawad/X-4341-2018	Fares, Jawad/0000-0002-5368-8764; GEBEILY, SOUHEIL/0000-0001-8476-2149			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 2010, INT CAMP BAN LANDM; [Anonymous], 2011, CHILDR LANDM DEADL L; Bandak FA, 1996, TRAUMATIC BRAIN INJU, P167; Beehner L, 2006, CAMPAIGN BAN CLUSTER; Bendinelli C, 2009, WORLD J SURG, V33, P1070, DOI 10.1007/s00268-009-9978-5; Borrie J, 2006, CLUST MUNITIONS, V4, P5; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Fares Y, 2013, NEUROL SCI, V34, P2095, DOI 10.1007/s10072-013-1343-7; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; Jaber H, 2009, CLUSTER BOMBS LEAVE; Kalauokalani DAK, 1999, EPIDEMIOLOGY PAIN, P143; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Nixon R, 2007, CULT CRIT, P160; Roth W, 2011, GLOBALIZATIONS; Sherman RA, 1984, PAIN, V8, P85; Walsh NE, 2003, B WORLD HEALTH ORGAN, V81, P665; Watts HG, 2009, J PEDIATR REHAB MED, V2, P217, DOI 10.3233/PRM-2009-0083; Williamson B, 2011, J ERW MINE ACTION, V15, P29	20	12	12	0	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	NOV	2013	34	11					1971	1976		10.1007/s10072-013-1427-4			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250OJ	WOS:000326861800013	23563862				2022-02-06	
J	Johnston, BD; Ebel, BE				Johnston, Brian D.; Ebel, Beth E.			Child Injury Control: Trends, Themes, and Controversies	ACADEMIC PEDIATRICS			English	Article						concussion; drowning; injury prevention; road traffic injury; surveillance	UNEXPECTED INFANT DEATHS; HIGH-SCHOOL; RECREATIONAL BOATERS; COST-EFFECTIVENESS; YOUTH SUICIDE; UNITED-STATES; HEALTH; CONCUSSION; PREVENTION; SAFETY	Injury is a major cause of morbidity and mortality among US children, and an important driver of health status globally. Despite its enormous burden, injury is preventable. Over the last 10 years, significant progress has been made in the reduction of unintentional injury among US children. However, aggregate trends mask important disparities by age group, region, and injury mechanism. Basic and translation research is needed to develop and test prevention strategies to address these new or recalcitrant problems. Motor vehicle occupant injury has fallen to historic lows, but challenges remain in protecting novice drivers and managing the distraction of new technologies. Injury to pedestrians has also declined, but likely as a result of decreased exposure as fewer children walk. This calls for a broader public health perspective to promote activity while enhancing safety. Deaths due to drowning are common and illustrate the difficulty in measuring and promoting appropriate supervision. Environmental modification and use of protective products may be a more appropriate response. Concussion in sport is another challenging issue: public health laws promote identification and appropriate management of concussed athletes, but less progress has been made on primary prevention of these injuries. Unintentional poisoning is on the rise, attributable to misuse of, and overdose with, prescription opioids. Injury deaths to infants are also increasing. This trend is driven in part by better death investigation that classifies more sleep-related deaths as suffocation events. Finally, we examine a sample of cross-cutting themes and controversies in injury control that might be amenable to empiric evaluation.	[Johnston, Brian D.; Ebel, Beth E.] Univ Washington, Dept Pediat, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359774, Seattle, WA 98104 USA		Johnston, BD (corresponding author), Univ Washington, Dept Pediat, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359774, Seattle, WA 98104 USA.	bdj@uw.edu					Ackaah W, INJ PREV IN PRESS; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; [Anonymous], 2012, CONCUSSION LEGISLATI; [Anonymous], 2010, GLOB PLAN DEC ACT RO; Barber C, 2011, ACCIDENT ANAL PREV, V43, P724, DOI 10.1016/j.aap.2010.10.018; Benden ME, 2012, J HLTH BEHAV PUB HLT, V2, P20; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bonnie RJ, 2004, US NATL RES COUNCIL; Brach RM, 2011, COLLISION, P6; Brenner RA, 2009, ARCH PEDIAT ADOL MED, V163, P203, DOI 10.1001/archpediatrics.2008.563; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Cash SJ, 2009, CURR OPIN PEDIATR, V21, P613, DOI 10.1097/MOP.0b013e32833063e1; Centers for Disease Contro and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P270; Centers for Disease Control and Prevention, 2012, WEB BAS INJ STAT QUE; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Cooper Gregory D, 2011, Issues Ment Health Nurs, V32, P696, DOI 10.3109/01612840.2011.597911; Covington TM, 2011, INJURY PREV, V17, P34, DOI 10.1136/ip.2010.031203; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; Cummings P, 2011, INJURY PREV, V17, P156, DOI 10.1136/ip.2010.028688; Dalziel K, 2012, ARCH DIS CHILD, V97, P787, DOI 10.1136/archdischild-2011-300795; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; DiGuiseppi C, 1997, BRIT MED J, V314, P710, DOI 10.1136/bmj.314.7082.710; Durbin DR, 2011, PEDIATRICS, V127, pE1050, DOI 10.1542/peds.2011-0215; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Ebel BE, 2009, INJURY PREV, V15, P212, DOI 10.1136/ip.2009.022475; Eng HL, 2008, IEEE T CIRC SYST VID, V18, P196, DOI 10.1109/TCSVT.2007.913960; Fagan AA, RES SOCIAL IN PRESS; Farmer CM, 2010, J SAFETY RES, V41, P39, DOI 10.1016/j.jsr.2009.12.002; Farrington DP, 2009, CRIME JUSTICE, V38, P281, DOI 10.1086/599198; Feng ZY, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.024646; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fischer B, 2010, ADDICTION, V105, P2062, DOI 10.1111/j.1360-0443.2010.03092.x; Foss RD, 2009, ACCIDENT ANAL PREV, V41, P419, DOI 10.1016/j.aap.2009.01.004; Garcia-Espana JF, 2012, AM J PUBLIC HEALTH, V102, P1128, DOI 10.2105/AJPH.2011.300493; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hosking SG, 2009, HUM FACTORS, V51, P582, DOI 10.1177/0018720809341575; Jacobsen PL, 2015, INJURY PREV, V21, P271, DOI 10.1136/ip.9.3.205rep; Jimenez-Mejias E, INJURY PREV, DOI DOI 10.1136/INJURYPREV-2012-040467.ACCESSED; Johnston BD, 2008, INJURY PREV, V14, P145, DOI 10.1136/ip.2008.019265; Johnston BD, 2011, INJURY PREV, V17, P1, DOI 10.1136/ip.2010.031161; Johnston BD, 2010, INJURY PREV, V16, P1, DOI 10.1136/ip.2009.026096; Johnston BD, 2008, J URBAN DES, V13, P141, DOI 10.1080/13574800701803407; Johnston BD, 2009, INJURY PREV, V15, P73, DOI 10.1136/ip.2009.021790; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Koepsell TD, 2011, AM J PREV MED, V40, P191, DOI 10.1016/j.amepre.2010.10.022; Laosee Orapin C., 2012, Morbidity and Mortality Weekly Report, V61, P344; Lee SE, 2011, ACCIDENT ANAL PREV, V43, P1472, DOI 10.1016/j.aap.2011.02.026; Linnan HA, 2011, INJURY PREV, V17, P74, DOI 10.1136/ip.2010.026443; Linnan M, 2007, SPECIAL SERIES CHILD, V3; Liu X, 2009, INJURY PREV, V15, P105, DOI 10.1136/ip.2008.019877; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyon JD, 2012, J SAFETY RES, V43, P29, DOI 10.1016/j.jsr.2011.10.007; Mangione TW, 2012, J PUBLIC HEALTH POL, V33, P59, DOI 10.1057/jphp.2011.55; Martinotti G, 2011, J PUBLIC HEALTH-HEID, V19, P545, DOI 10.1007/s10389-011-0422-6; Matjasko JL, 2012, AGGRESS VIOLENT BEH, V17, P540, DOI 10.1016/j.avb.2012.06.006; McAndrews C, 2011, INJURY PREV, V17, P204, DOI 10.1136/ip.2010.029306; McCartt AT, 2010, TRAFFIC INJ PREV, V11, P361, DOI 10.1080/15389588.2010.486428; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; McDonald NC, 2011, AM J PREV MED, V41, P146, DOI 10.1016/j.amepre.2011.04.006; McGehee DV, 2007, J SAFETY RES, V38, P215, DOI 10.1016/j.jsr.2007.02.009; Merolli ML, 2011, COLLISION, P6; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Molcho M, 2011, INJURY PREV, V17, P147, DOI 10.1136/ip.2010.030023; Morrongiello BA, 2006, INJURY PREV, V12, P19, DOI 10.1136/ip.2005.008862; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mytton JA, 2012, INJURY PREV, V18, P334, DOI 10.1136/injuryprev-2012-040343; Naci H, 2009, INJURY PREV, V15, P55, DOI 10.1136/ip.2008.018721; O'Brien NP, ACCIDENT AN IN PRESS; Office of Statistics and Programming, 2012, COST INJ REP; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Peden M, 2008, WORLD REPORT CHILD I; Petrass LA, 2011, INJURY PREV, V17, P244, DOI 10.1136/ip.2010.031062; Pless IB, 2012, INJURY PREV, V18, P285, DOI 10.1136/injuryprev-2012-040449; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Pucher J, 2003, AM J PUBLIC HEALTH, V93, P1509, DOI 10.2105/AJPH.93.9.1509; Quan LA, 2011, INJURY PREV, V17, P28, DOI 10.1136/ip.2010.026849; Rahman A, 2010, INJURY PREV, V16, P21, DOI 10.1136/ip.2008.021311; Rahman F, PEDIATRICS IN PRESS; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Sanders MR, 2003, CHILD ABUSE REV J BR, V12, P155, DOI [10.1002/car.798., DOI 10.1002/CAR.798]; Schnitzer PG, 2012, AM J PUBLIC HEALTH, V102, P1204, DOI 10.2105/AJPH.2011.300613; Shain BN, 2007, PEDIATRICS, V120, P669, DOI 10.1542/peds.2007-1908; Shalini RT, 2011, POLICY POLIT, V39, P221, DOI 10.1332/030557310X501767; Shapiro-Mendoza CK, 2009, PEDIATRICS, V123, P533, DOI 10.1542/peds.2007-3746; Shapiro-Mendoza CK, 2006, AM J EPIDEMIOL, V163, P762, DOI 10.1093/aje/kwj117; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shope JT, 2008, AM J PREV MED, V35, pS261, DOI 10.1016/j.amepre.2008.06.022; Sidman EA, 2005, PEDIATRICS, V115, pE654, DOI 10.1542/peds.2004-1625; Sivak M, 2009, INJURY PREV, V15, P205, DOI 10.1136/ip.2009.021964; Starfield B, 2012, ANNU REV PUBL HEALTH, V33, P89, DOI 10.1146/annurev-publhealth-031811-124528; Sullivan MD, 2010, CLIN J PAIN, V26, P512, DOI 10.1097/AJP.0b013e3181dc7adc; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; U.S. Department of Health and Human Services Administration for Children and Families Children'sBureau, 2011, CHILD MALTREATMENT; UNICEF, 2001, LEAG TABL CHILD DEAT; US Department of Transportation. National Highway Traffic Safety Administration, 2012, 811680 DOT HS NAT HI; Virginia Tech Transportation Institute, 2009, NEW DAT VTT PROV INS; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Warner M, 2011, NCHS DATA BRIEF, V81, P1; Washington State Department of Health, CONC MAN SCH; Weiss J, 2010, PEDIATRICS, V126, P178, DOI 10.1542/peds.2010-1264; Williams A, 2012, TENNAGE DRIVER FATAL; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2	109	12	12	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1876-2859	1876-2867		ACAD PEDIATR	Acad. Pediatr.	NOV-DEC	2013	13	6					499	507		10.1016/j.acap.2013.04.016			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	261TX	WOS:000327688600005	24021529				2022-02-06	
J	Leonard, AV; Thornton, E; Vink, R				Leonard, Anna V.; Thornton, Emma; Vink, Robert			Substance P as a Mediator of Neurogenic Inflammation after Balloon Compression Induced Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood spinal cord barrier; edema; neurogenic inflammation; spinal cord injury; substance P	BLOOD-BRAIN-BARRIER; EDEMA FORMATION; FUNCTIONAL DEFICITS; TRAUMATIC INJURY; MODEL; RAT; PATHOPHYSIOLOGY; NEUROTOXICITY; PERMEABILITY; TRANSECTION	Although clinical spinal cord injury (SCI) occurs within a closed environment, most experimental models of SCI create an open injury. Such an open environment precludes the measurement of intrathecal pressure (ITP), whose increase after SCI has been linked to the development of greater tissue damage and functional deficits. Raised ITP may be potentiated by edema, which we have recently shown to be associated with substance P (SP) induced neurogenic inflammation in both traumatic brain injury and stroke. The present study investigates whether SP plays a similar role as a mediator of neurogenic inflammation after SCI. A closed balloon compression injury was induced at T10 in New Zealand white rabbits. Animals were thereafter assessed for blood spinal cord barrier (BSCB) permeability, edema, ITP, histological outcome, and functional outcome from 5h to 2 weeks post-SCI. The balloon compression model produced significant increases in BSCB permeability, edema, and ITP along with significant functional deficits that persisted for 2 weeks. Histological assessment demonstrated decreased SP immunoreactivity in the injured spinal cord while NK1 receptor immunoreactivity initially increased before returning to sham levels. In addition, aquaporin 4 immunoreactivity increased early post-SCI, implicating this water channel in the development of edema after SCI. The changes described in the present study support a role for SP as a mediator of neurogenic inflammation after SCI.	[Leonard, Anna V.; Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Med Sch South, Adelaide, SA 5005, Australia		Leonard, AV (corresponding author), Univ Adelaide, Sch Med Sci, Level Med Sch South 4, Frome Rd, Adelaide, SA 5005, Australia.	anna.leonard@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	Neil Sacshe Foundation, Australia	Supported in part by the Neil Sacshe Foundation, Australia.	Aslan A, 2009, EUR SPINE J, V18, P1442, DOI 10.1007/s00586-009-1033-6; Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Austin JW, 2012, J NEUROTRAUM, V29, P1838, DOI 10.1089/neu.2012.2354; Batchelor PE, 2011, J NEUROTRAUM, V28, P809, DOI 10.1089/neu.2010.1622; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; CHAO CC, 1992, J IMMUNOL, V149, P2736; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Demediuk P, 1990, Adv Neurol, V52, P225; Detloff MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3247; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; FADEN AI, 1985, NEUROPEPTIDES, V6, P215, DOI 10.1016/0143-4179(85)90092-7; Fukuda S, 2005, BRAIN RES PROTOC, V14, P171, DOI 10.1016/j.brainresprot.2005.01.001; GOODMAN JH, 1976, J NEUROSURG, V44, P418, DOI 10.3171/jns.1976.44.4.0418; GRIFFITHS IR, 1975, J NEUROSURG, V42, P155, DOI 10.3171/jns.1975.42.2.0155; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Horn EM, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E12; HUGHES JT, 1984, PARAPLEGIA, V22, P131, DOI 10.1038/sc.1984.25; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; Mao L, 2011, BRAIN INJURY, V25, P300, DOI 10.3109/02699052.2010.542432; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; MARTIN SH, 1973, J NEUROSURG, V39, P75, DOI 10.3171/jns.1973.39.1.0075; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; NEMECEK S, 1977, ACTA NEUROCHIR, V37, P7, DOI 10.1007/BF01401922; Nesathurai S, 2006, J MED PRIMATOL, V35, P401, DOI 10.1111/j.1600-0684.2006.00162.x; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Pan WH, 1999, J NEUROSCI, V19, P3649; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Poon PC, 2007, SPINE, V32, P2853, DOI 10.1097/BRS.0b013e31815b7e6b; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rybarova S, 1999, Gen Physiol Biophys, V18 Suppl 1, P75; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Schwartz ED, 2005, AM J NEURORADIOL, V26, P1609; SHARMA HS, 1993, NEUROSCIENCE, V57, P443, DOI 10.1016/0306-4522(93)90076-R; SHARMA HS, 1990, NEUROSCIENCE, V38, P205, DOI 10.1016/0306-4522(90)90386-I; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHARMA HS, 1991, J NEUROL SCI, V102, P150, DOI 10.1016/0022-510X(91)90063-D; SYPERT GW, 1990, CLIN NEUR, V36, P186; TARLOV IM, 1953, AMA ARCH NEUROL PSY, V70, P813, DOI 10.1001/archneurpsyc.1953.02320360128010; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034138, 10.1371/journal.pone.0042630]; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Vink R, 2003, ACT NEUR S, V86, P257; VITA G, 1990, NEUROPEPTIDES, V17, P147, DOI 10.1016/0143-4179(90)90078-D; WANG R, 1993, SURG NEUROL, V39, P348, DOI 10.1016/0090-3019(93)90198-A; WINKLER T, 1994, NEUROSCI RES, V21, P91, DOI 10.1016/0168-0102(94)90072-8; WOIE K, 1993, CIRC RES, V73, P839, DOI 10.1161/01.RES.73.5.839	59	12	14	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2013	30	21					1812	1823		10.1089/neu.2013.2993			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	236UN	WOS:000325825000004	23924052	Green Published			2022-02-06	
J	Li, N; Zhao, WG; Xu, FL; Zhang, WF; Gu, WT				Li, Ning; Zhao, Wei-Guo; Xu, Fu-Lin; Zhang, Wei-Feng; Gu, Wei-Ting			Neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury in patients with traumatic brain injury	JOURNAL OF NEPHROLOGY			English	Article						Acute kidney injury; Neutrophil gelatinase-associated lipocalin; Traumatic brain injury	ACUTE-RENAL-FAILURE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ORGAN DYSFUNCTION; CARDIAC-SURGERY; NGAL; BIOMARKER; THERAPY	Background: Recent studies have shown that urinary neutrophil gelatinase-associated lipocalin (NGAL) is rapidly up-regulated early after murine renal injury, and in patients after cardiac Surgery or patients critically ill with multiple trauma. In this study, we evaluated urinary NGAL levels as a potential biomarker of early acute kidney injury (AKI) in patients with severe traumatic brain injury (TBI). Methods: All patients with severe TBI admitted to our neurosurgical intensive care unit from March to September 2011 were enrolled prospectively: Urinary NGAL was measured using a chemiluminescent microparticle immunoassay upon admission and at 24 and, 48 hours after TBI. The presence of AKI was defined by 1 the Acute Kidney Injury Network (AKIN) criteria. Results: Using AKIN criteria, a total of 13 patients were identified with AKI, an incidence of 24%. Those who subsequently developed AKI had a striking rise in urinary NGAL early after TBI and a sustained increase over the entire duration of the study. The urinary NGAL level of the AKI group was significantly higher than the group without AKI at all time points. Using a cutoff value of 53.9 ng/mL, the area under the receiver-operating characteristic curve for urinary NGAL at 48 hours was 0.876 with a sensitivity of 0.69 and specificity of 0.95. Conclusions: Increased urinary NGAL is associated with an increased occurrence of AKI in patients with severe TBI. It is possible that urinary NGAL could provide a screening tool for AKI immediately after severe TBI, and this may in turn allow early intervention to ameliorate the adverse effects of AKI.	[Li, Ning; Zhao, Wei-Guo; Zhang, Wei-Feng; Gu, Wei-Ting] Rui Jin Hosp, Shanghai 200025, Peoples R China; [Xu, Fu-Lin] Ming Hang Dist Cent Hosp, Shanghai, Peoples R China		Gu, WT (corresponding author), Rui Jin Hosp, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	rjneurosurgeon@yahoo.com.cn					Bachorzewska-Gajewska H, 2006, AM J NEPHROL, V26, P287, DOI 10.1159/000093961; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Brunner HI, 2006, ARTHRITIS RHEUM, V54, P2577, DOI 10.1002/art.22008; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Ding HL, 2007, CLIN IMMUNOL, V123, P227, DOI 10.1016/j.clim.2007.01.010; Endre ZH, 2008, NEPHROLOGY, V13, P91, DOI 10.1111/j.1440-1797.2007.00905.x; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Makris K, 2009, CLIN CHEM LAB MED, V47, P79, DOI 10.1515/CCLM.2009.004; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra J, 2006, PEDIATR NEPHROL, V21, P856, DOI 10.1007/s00467-006-0055-0; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Molitoris BA, 2003, J AM SOC NEPHROL, V14, P265, DOI 10.1097/01.ASN.0000048852.53881.D9; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Tuladhar SM, 2009, J CARDIOVASC PHARM, V53, P261, DOI 10.1097/FJC.0b013e31819d6139; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Zacharia BE, 2009, STROKE, V40, P2375, DOI 10.1161/STROKEAHA.108.545210; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007	27	12	12	0	4	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	NOV-DEC	2013	26	6					1083	1088		10.5301/jn.5000282			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	AB5UI	WOS:000331853800015	24249209				2022-02-06	
J	Morse, CL; Douglas-Newman, K; Mandel, S; Swirsky-Sacchetti, T				Morse, Chelsea L.; Douglas-Newman, Kara; Mandel, Steven; Swirsky-Sacchetti, Thomas			Utility of the Rey-15 Recognition Trial to Detect Invalid Performance in a Forensic Neuropsychological Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Rey Fifteen Item Test; Rey-15; Performance validity testing; Malingering; Neuropsychology	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; DIGIT SPAN SUBTEST; SYMPTOM VALIDITY; 15-ITEM TEST; TESTS; IMPAIRMENT; RATES; TOMM	The current study sought to address the utility of the Rey Fifteen Item Test (Rey-15), with the use of a combined score [recall correct + (recognition correct - false positives)], to distinguish between valid and invalid performance among a sample of litigating persons referred for neuropsychological evaluation. Scores on the Rey-15 were analyzed across four comparison groups: (1) litigating persons with evidence of invalid performance (n = 29), (2) litigating persons with valid performance (n = 63), (3) learning-disabled patients (n = 36), and (4) a mixed clinical neuropsychological sample not involved in litigation (n = 54). A Rey-15 combined cutoff score of < 21 yielded the highest sensitivity (70%) and specificity (92.8%) rates. If the Rey-15 is to be used in clinical practice to detect invalid performance, the recognition trial with combined score < 21 should be used. Findings support the use of the combined Rey-15 score in place of the previously used recall Rey-15 score to improve sensitivity and specificity rates for detection of invalid performance in litigating neuropsychological referrals.	[Morse, Chelsea L.; Douglas-Newman, Kara; Swirsky-Sacchetti, Thomas] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Mandel, Steven; Swirsky-Sacchetti, Thomas] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA		Swirsky-Sacchetti, T (corresponding author), Drexel Univ, Dept Psychol, 2028 Chancellor St, Philadelphia, PA 19104 USA.	tomswisac@gmail.com					ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Delis D.C., 2000, CALIFORNIA VERBAL LE; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; Iverson Grant L, 2007, Pain Pract, V7, P94, DOI 10.1111/j.1533-2500.2007.00116.x; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; King C., 1992, THESIS CALIFORNIA SC; LaDuke C, 2012, PROF PSYCHOL-RES PR, V43, P503, DOI 10.1037/a0028161; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nitch S. R., 2007, ASSESSMENT FEIGNED C, P78; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Stimmel M, 2012, INT J FORENSIC MENT, V11, P51, DOI 10.1080/14999013.2012.676148; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 2008, WECHSLER ADULT INTEL; Wolfe P. L., 2012, CLIN NEUROPSYCHOL, V24, P153	41	12	12	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 1	2013	27	8					1395	1407		10.1080/13854046.2013.832385			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	273KW	WOS:000328534700012	23998436				2022-02-06	
J	Wan, CH; Jiang, JK; Mao, H; Cao, JH; Wu, XH; Cui, G				Wan, Chunhua; Jiang, Junkang; Mao, Hui; Cao, Jianhua; Wu, Xiaohong; Cui, Gang			Involvement of Upregulated P53-Induced Death Domain Protein (PIDD) in Neuronal Apoptosis after Rat Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						PIDD; Traumatic brain injury; Neuronal apoptosis; Rat	TUMOR-SUPPRESSOR GENE; ADULT BRAIN; ACTIVATION; P53; CASPASE-2; STRESS; PIDDOSOME; PATHWAYS; PRODEATH; COMPLEX	Traumatic brain injury (TBI) initiates a series of complicated pathological events that could eventually lead to neuronal apoptosis. Recent studies indicated that p53 played a crucial role in neuronal apoptosis and regeneration following TBI. However, the detailed mechanism of p53-induced neuronal apoptosis in TBI remains largely elusive. In this study, we identified that p53-induced death domain protein (PIDD), whose transcription could be rapidly induced by p53 activation, was significantly upregulated after TBI. Western blot and immunohistochemistrical analyses revealed that the expression of PIDD was gradually increased, reached a peak at 3 days, and then decreased gradually to basal level after brain trauma. Further, double immunofluorescent analysis showed that PIDD was distributed predominantly in neurons, and the number of PIDD-positive neurons was significantly elevated in injured brain cortex. In addition, we found that PIDD was mainly distributed in active caspase-3-positive neurons, implicating a possible involvement of PIDD in the regulation of neuronal apoptosis during TBI. Finally, we showed that the expressions of p53 and Bax were altered correlatively with PIDD after brain trauma, implying that the upregulation of PIDD after TBI might be a result of p53 activation. Taken together, these findings suggested that PIDD might be an important regulator and potential therapeutic target of TBI.	[Wan, Chunhua; Jiang, Junkang] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China; [Mao, Hui; Cao, Jianhua; Wu, Xiaohong; Cui, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China		Cui, G (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shixin St, Suzhou 215006, Peoples R China.	cui_gang123@163.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	Administration of Science and Technology of Nantong [BK2012090]	This work was supported by a grant of the Administration of Science and Technology of Nantong (BK2012090).	Ando K, 2012, MOL CELL, V47, P681, DOI 10.1016/j.molcel.2012.06.024; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Conti AC, 1998, J NEUROSCI, V18, P5663; Cregan SP, 1999, J NEUROSCI, V19, P7860; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kiryu-Seo S, 2005, J NEUROSCI, V25, P1442, DOI 10.1523/JNEUROSCI.4041-04.2005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Martin LJ, 2001, INT J MOL MED, V7, P455; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Qiu JH, 2002, J NEUROSCI, V22, P3504; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; Tomasevic G, 2010, J NEUROSCI RES, V88, P3414, DOI 10.1002/jnr.22491; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	27	12	12	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2013	51	3					695	702		10.1007/s12031-013-0050-4			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	235IH	WOS:000325710500008	23797734				2022-02-06	
J	Williams, G; Weragoda, N; Paterson, K; Clark, R				Williams, Gavin; Weragoda, Natasha; Paterson, Kade; Clark, Ross			Cardiovascular Fitness Is Unrelated to Mobility Limitations in Ambulant People With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activity levels; brain trauma; cardiovascular fitness; mobility limitations	ASSESSMENT-TOOL HIMAT; CARDIORESPIRATORY FITNESS; SUBMAXIMAL EXERCISE; RETEST RELIABILITY; WALKING SPEED; VALIDITY; INDIVIDUALS; IMPAIRMENT; CAPACITY; OUTCOMES	Objective: The aim of this study was to evaluate the relationship between mobility, activity levels, and cardiovascular fitness in patients with traumatic brain injury (TBI) currently undergoing rehabilitation, and to determine whether mobility and cardiovascular fitness differs between people with TBI and matched healthy controls (HCs). Design: Cross-sectional cohort study. Participants: Twenty-eight people with TBI and 28 matched HCs. Outcome Measures: The primary outcome measure for mobility was the high-level mobility assessment tool. Steps per day was the outcome measure for activity level, and the physical work capacity at 130 (PWC130) submaximal VO2 Monark bike test was the primary outcome measure for cardiovascular fitness. Results: Results revealed no relationship (P > .05) between mobility, activity levels, and cardiovascular fitness in the TBI cohort. Participants with TBI had significantly reduced capacity for mobility (P <.001) and performed less physical activity (P =.002) than matched HCs; however, there was no significant difference in cardiovascular fitness (P =.094) between groups. Conclusions: Despite reduced physical activity and a wide range in capacity to mobilize, no relationship was identified between mobility and cardiovascular fitness following TBI.	[Williams, Gavin; Weragoda, Natasha] Epworth Healthcare, Melbourne, Vic, Australia; [Williams, Gavin; Clark, Ross] Univ Melbourne, Melbourne, Vic, Australia; [Paterson, Kade] Australian Catholic Univ, Ctr Phys Act Across Lifespan COPAAL, Sch Exercise Sci, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	Paterson, Kade L/G-4715-2012; Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019	Paterson, Kade L/0000-0002-0323-6129; Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Williams, Gavin/0000-0003-2758-7473			Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Cink R E, 1981, Br J Sports Med, V15, P182; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DAUGHTON DM, 1982, ARCH PHYS MED REHAB, V63, P620; Davidson M, 2007, CLIN REHABIL, V21, P151, DOI 10.1177/0269215506069475; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Eng JJ, 2002, STROKE, V33, P756, DOI 10.1161/hs0302.104195; Fix A. J., 1988, HUMAN ACTIVITY PROFI; Harrison G. G. B. E, 1988, ANTHROPOMETRIC STAND, P55; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; Hillier SL, 1997, BRAIN INJURY, V11, P661; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LaMonte MJ, 2000, CIRCULATION, V102, P1623, DOI 10.1161/01.CIR.102.14.1623; Macsween A, 2001, J SPORT MED PHYS FIT, V41, P312; Marshall S, 2007, BRAIN INJURY, V21, P133, DOI 10.1080/02699050701201383; MCLENNAN W, 1997, AUSTR STANDARD CLASS; McTigue DM, 2007, EXP NEUROL, V205, P396, DOI 10.1016/j.expneurol.2007.02.009; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Noonan V, 2000, PHYS THER REHABIL J, V80, P782, DOI 10.1093/ptj/80.8.782; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; State Government of Victoria, BOD MASS IND BMI; Thomas MD, 2009, BRAIN INJURY, V23, P516, DOI 10.1080/02699050902926333; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Williams G, 2009, INT J THER REHABIL, V16, P2; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	41	12	12	3	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					E1	E7		10.1097/HTR.0b013e318279536d			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200001	23348405				2022-02-06	
J	Zeng, JS; Tong, WS; Zheng, P				Zeng, Jingsong; Tong, Wusong; Zheng, Ping			Decreased risk of acute kidney injury with intracranial pressure monitoring in patients with moderate or severe brain injury Clinical article	JOURNAL OF NEUROSURGERY			English	Article						intracranial pressure; traumatic brain injury; acute kidney injury; mannitol; cystatin C; creatinine	INTENSIVE-CARE; MANNITOL; COMPLICATIONS; THERAPY; FAILURE; TRAUMA; IMPACT	Object. The authors undertook this study to evaluate the effects of continuous intracranial pressure (ICP) monitoring directed mannitol treatment on kidney function in patients with moderate or severe traumatic brain injury (TBI). Methods. One hundred sixty-eight patients with TBI were prospectively assigned to an ICP monitoring group or a conventional treatment control group based on the Brain Trauma Foundation guidelines. Clinical data included the dynamic changes of patients' blood concentrations of cystatin C, creatinine (Cr), and blood urea nitrogen (BUN); mannitol use; and 6-month Glasgow Outcome Scale (GOS) scores. Results. There were no statistically significant differences with respect to hospitalized injury, age, or sex distribution between the 2 groups. The incidence of acute kidney injury (AKI) was higher in the control group than in the ICP monitoring group (p < 0.05). The mean mannitol dosage in the ICP monitoring group (443 133 g) was significantly lower than in the control group (820 412 g) (p < 0.01), and the period of mannitol use in the ICP monitoring group (3 3.8 days) was significantly shorter than in the control group (7 2.3 days) (p < 0.01). The 6-month GOS scores in the ICP monitoring group were significantly better than in the control group (p < 0.05). On the 7th, 14th, and 21st days after injury, the plasma cystatin C and Cr concentrations in the ICP-monitoring group were significantly higher than the control group (p < 0.05). Conclusions. In patients with moderate and severe TBI, ICP-directed mannitol treatment demonstrated a beneficial effect on reducing the incidence of AKI compared with treatment directed by neurological signs and physiological indicators.	[Zeng, Jingsong; Tong, Wusong] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zheng, Ping] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia		Zheng, P (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia.	jojo_ras@hotmail.com					Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Bilotta F, 2012, NEUROCRIT CARE, V16, P280, DOI 10.1007/s12028-011-9652-2; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Forsyth RJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub2; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; GADALLAH MF, 1995, AM J MED SCI, V309, P219, DOI 10.1097/00000441-199504000-00006; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hirsch KG, 2012, NEUROCRIT CARE, V17, P388, DOI 10.1007/s12028-012-9676-2; Lane PL, 2000, CAN J SURG, V43, P442; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Perez-Perez AJ, 2002, AM J NEPHROL, V22, P573, DOI 10.1159/000065279; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Tommasino C, 2007, BEST PRACT RES-CLIN, V21, P497, DOI 10.1016/j.bpa.2007.07.002; Tsai SF, 2010, CLIN NEPHROL, V74, P70; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	28	12	14	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2013	119	5					1228	1232		10.3171/2013.7.JNS122131			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	238OB	WOS:000325956200025	23909252				2022-02-06	
J	Zheng, KB; Li, CH; Shan, XS; Liu, HP; Fan, WF; Wang, ZS; Zheng, P				Zheng, Kebin; Li, Chunhui; Shan, Xiaosong; Liu, Haipeng; Fan, Wufang; Wang, Zhenshan; Zheng, Ping			Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury	NEUROLOGY INDIA			English	Article						Cerebrospinal fluid; matrix metalloproteinase; tissue inhibitor of metalloproteinase; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; NEURODEGENERATIVE DISEASES; BLOOD; MATRIX-METALLOPROTEINASE-9; INCREASE; RAT; MENINGITIS; DIAGNOSIS; DAMAGE	Objective: In this study, we investigated matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMPs) in cerebrospinal fluid (CSF) and plasma of traumatic brain injury (TBI) patients. Patients and Methods: A total of 30 patients with moderate and severe TBI and 15 age-matched controls were enrolled in this study. Plasma and CSF samples were collected within 24 h (as the initial value), at 72 and 120 h post injury. CSF and plasma MMP-9, MMP-2, TIMP-1 and TIMP-2 were estimated using ELISA. Different levels of these indexes were compared in the two groups and further investigated the correlation between each other. Results: There was a significant elevation in the levels of the initial MMP-9 in the CSF (P < 0.05), which lasted for 72 h post injury. TIMP-1 kept increasing within 120 h post injury and it was different compared with TIMP-1 at 24 and 72 h post injury. Plasma levels of MMP-9, MMP-2, TIMP-1 and TIMP-2 in TBI patients were also significantly different from those in controls. Furthermore the CSF MMP-9 in patients with severe TBI was higher than that in patients with moderate TBI. In addition, there was a positive relationship between the initial MMP-9 and TIMP-1 at 120 h post injury (r = 0.614, P < 0.01). Conclusion: MMPs and TIMPs are increased in both CSF and plasma of TBI patients. TIMP-1 has a positive correlation with MMP-9 and the initial MMP-9 is associated with the neurological outcomes.	[Zheng, Kebin; Fan, Wufang; Wang, Zhenshan] Hebei Univ, Coll Life Sci, Dept Neurosci, Baoding 071000, Hebei Province, Peoples R China; [Li, Chunhui; Shan, Xiaosong; Liu, Haipeng] Hebei Univ, Affiliated Hosp, Dept Neurosurg, Baoding 071000, Hebei Province, Peoples R China; [Zheng, Ping] Shanghai Pudong New Area Peoples Hosp, Shanghai 201299, Peoples R China		Wang, ZS (corresponding author), Hebei Univ, Coll Life Sci, Baoding 071000, Hebei Province, Peoples R China.	jiwen0008@126.com		Li, Chunhui/0000-0003-4055-1248	Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [2012201136]; Medical Science Special Foundation of Hebei University [2012B2004]; Hebei postdoctoral fund	Supported by the Natural Science Foundation of Hebei Province (No. 2012201136) and Medical Science Special Foundation of Hebei University (No. 2012B2004), Conflict of Interest: Hebei postdoctoral fund (No. 111867).	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Azeh I, 1998, NEUROSCI LETT, V256, P127, DOI 10.1016/S0304-3940(98)00776-9; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Jiang JY, 2012, INJURY IN PRESS; Johanson M, 2013, J PERIODONTOL, V84, P634, DOI 10.1902/jop.2012.120224; Kanoh Y, 2008, INFLAMMATION, V31, P99, DOI 10.1007/s10753-007-9054-y; Kavalci C, 2011, BRATISL MED J, V112, P398; Khrestchatisky Michel, 2003, Journal de la Societe de Biologie, V197, P133; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lorenzl S, 2003, J NEUROL SCI, V207, P71, DOI 10.1016/S0022-510X(02)00398-2; Niebroj-Dobosz I, 2010, EUR J NEUROL, V17, P226, DOI 10.1111/j.1468-1331.2009.02775.x; Renaud S, 2007, MUSCLE NERVE, V36, P1, DOI 10.1002/mus.20772; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang JJ, 2013, ARCH MED SCI, V9, P332, DOI 10.5114/aoms.2012.30949; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000	24	12	13	0	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2013	61	6					606	609		10.4103/0028-3886.125258			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB3OS	WOS:000331700700008	24441327				2022-02-06	
J	Schwer, CI; Lehane, C; Guelzow, T; Zenker, S; Strosing, KM; Spassov, S; Erxleben, A; Heimrich, B; Buerkle, H; Humar, M				Schwer, Christian I.; Lehane, Cornelius; Guelzow, Timo; Zenker, Simone; Strosing, Karl M.; Spassov, Sashko; Erxleben, Anika; Heimrich, Bernd; Buerkle, Hartmut; Humar, Matjaz			Thiopental Inhibits Global Protein Synthesis by Repression of Eukaryotic Elongation Factor 2 and Protects from Hypoxic Neuronal Cell Death	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; FACTOR-II; RAT HIPPOCAMPAL; NMDA RECEPTORS; KINASE PATHWAY; NUCLEAR-FACTOR; EEF2 KINASE; IN-VITRO	Ischemic and traumatic brain injury is associated with increased risk for death and disability. The inhibition of penumbral tissue damage has been recognized as a target for therapeutic intervention, because cellular injury evolves progressively upon ATP-depletion and loss of ion homeostasis. In patients, thiopental is used to treat refractory intracranial hypertension by reducing intracranial pressure and cerebral metabolic demands; however, therapeutic benefits of thiopental-treatment are controversially discussed. In the present study we identified fundamental neuroprotective molecular mechanisms mediated by thiopental. Here we show that thiopental inhibits global protein synthesis, which preserves the intracellular energy metabolite content in oxygen-deprived human neuronal SK-N-SH cells or primary mouse cortical neurons and thus ameliorates hypoxic cell damage. Sensitivity to hypoxic damage was restored by pharmacologic repression of eukaryotic elongation factor 2 kinase. Translational inhibition was mediated by calcium influx, activation of the AMP-activated protein kinase, and inhibitory phosphorylation of eukaryotic elongation factor 2. Our results explain the reduction of cerebral metabolic demands during thiopental treatment. Cycloheximide also protected neurons from hypoxic cell death, indicating that translational inhibitors may generally reduce secondary brain injury. In conclusion our study demonstrates that therapeutic inhibition of global protein synthesis protects neurons from hypoxic damage by preserving energy balance in oxygen-deprived cells. Molecular evidence for thiopental-mediated neuroprotection favours a positive clinical evaluation of barbiturate treatment. The chemical structure of thiopental could represent a pharmacologically relevant scaffold for the development of new organ-protective compounds to ameliorate tissue damage when oxygen availability is limited.	[Schwer, Christian I.; Lehane, Cornelius; Strosing, Karl M.; Spassov, Sashko; Buerkle, Hartmut; Humar, Matjaz] Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany; [Guelzow, Timo] Univ Med Ctr Freiburg, Dept Gen Neurosurg Cellular Neurophysiol, Freiburg, Germany; [Erxleben, Anika] Univ Freiburg, Inst Pharmaceut Sci, D-79106 Freiburg, Germany; [Zenker, Simone; Heimrich, Bernd] Univ Freiburg, Dept Anat & Cell Biol, D-79106 Freiburg, Germany		Humar, M (corresponding author), Univ Med Ctr Freiburg, Dept Anesthesiol & Crit Care Med, Freiburg, Germany.	matjaz.humar@uniklinik-freiburg.de	Buerkle, Hartmut/I-5785-2014; Spassov, Sashko/C-2105-2013	Spassov, Sashko/0000-0002-3585-3682; Lehane, Cornelius/0000-0001-5173-5216; Erxleben, Anika/0000-0002-7427-6478	Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany	This work was funded by the Department of Anesthesiology and Critical Care Medicine, University Medical Center Freiburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; ALDRIDGE WN, 1960, BIOCHEM J, V76, P47, DOI 10.1042/bj0760047; Almaas R, 2000, ANESTHESIOLOGY, V92, P764, DOI 10.1097/00000542-200003000-00020; Anderson CM, 2002, J NEUROSCI, V22, P9203; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; BECKER KE, 1976, ANESTHESIOLOGY, V45, P656, DOI 10.1097/00000542-197612000-00013; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Bouaziz N, 2002, EUR J PHARMACOL, V441, P35, DOI 10.1016/S0014-2999(02)01490-5; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Cole DJ, 2001, CAN J ANAESTH, V48, P807, DOI 10.1007/BF03016699; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; DESSI F, 1992, BRAIN RES, V581, P323, DOI 10.1016/0006-8993(92)90726-P; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; DOENICKE A, 1965, ACTA ANAESTH SCAND, P11; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; GOTO K, 1990, BRAIN RES, V534, P299, DOI 10.1016/0006-8993(90)90144-Z; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hidaka Ikuhiro, 2009, Hiroshima Journal of Medical Sciences, V58, P9; Hizli AA, 2013, MOL CELL BIOL, V33, P596, DOI 10.1128/MCB.01270-12; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Humar M, 2009, MOL PHARMACOL, V75, P667, DOI 10.1124/mol.108.052183; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Lin CC, 2013, CELL MOL LIFE SCI; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Park WS, 2006, J KOREAN MED SCI, V21, P337, DOI 10.3346/jkms.2006.21.2.337; Pizzi M, 2002, EUR J NEUROSCI, V16, P2342, DOI 10.1046/j.1460-9568.2002.02403.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; Roesslein M, 2008, J PHARMACOL EXP THER, V325, P217, DOI 10.1124/jpet.107.133108; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Shibuta S, 1998, BRIT J PHARMACOL, V124, P804, DOI 10.1038/sj.bjp.0701884; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; SMITH DS, 1980, ACTA PHYSIOL SCAND, P129; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; YASUDA T, 1993, INT J LEGAL MED, V105, P239, DOI 10.1007/BF01642801; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; ZAGER EL, 1988, J NEUROSURG, V69, P568, DOI 10.3171/jns.1988.69.4.0568; Zhan RZ, 1998, BRIT J ANAESTH, V81, P932, DOI 10.1093/bja/81.6.932; Zhan RZ, 1998, ANESTHESIOLOGY, V89, P456, DOI 10.1097/00000542-199808000-00023; Zhang XL, 2010, NEUROCHEM RES, V35, P1281, DOI 10.1007/s11064-010-0186-3	69	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77258	10.1371/journal.pone.0077258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	WOS:000326034500026	24167567	Green Submitted, Green Published, gold			2022-02-06	
J	Gu, SJ; Xuan, HF; Lu, M; Chen, XZ; Dong, WF; Yan, XF; Si, Y; Gao, GL; Hu, DX; Miao, JQ				Gu, Shui-Jun; Xuan, Hong-Fei; Lu, Ming; Chen, Xin-Zhi; Dong, Wei-Feng; Yan, Xiao-Feng; Si, Yun; Gao, Guo-Liang; Hu, Dian-Xiang; Miao, Jian-Qing			Admission plasma visfatin level strongly correlates with hematoma growth and early neurologic deterioration in patients with acute spontaneous basal ganglia hemorrhage	CLINICA CHIMICA ACTA			English	Article						Intracerebral hemorrhage; Hematoma growth; Early neurologic deterioration; Visfatin; Biomarker	COLONY-ENHANCING FACTOR; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; PROGNOSTIC-SIGNIFICANCE; ISCHEMIC-STROKE; INFLAMMATION; PREDICTORS; MORTALITY; PROTEIN	Background: Visfatin, a proinflammatory mediator has been associated with poor clinical outcomes after acute brain injury. The present study is designed to investigate the potential association between plasma visfatin levels and the risk of hematoma growth (HG) and early neurologic deterioration (END) after intracerebral hemorrhage. Methods: There were 85 patients as cases who presented with first-time hemorrhagic stroke that were assessed within 6 h after the incident The control group consisted of 85 healthy volunteers. HG was defined as hematoma enlargement >33% at 24 h. END was defined as an increase of >= 4 points in National Institute of Health Stroke Scale score at 24 h from symptoms onset Plasma visfatin levels were determined using enzyme immunoassay. Results: Plasma visfatin levels were significantly higher in patients compared to controls. Plasma visfatin level emerged as an independent predictor of HG [odds ratio (OR), 1.154; 95% confidence interval (CI), 1.046-3.108; P = 0.009] and END (OR, 1.195; 95% CI, 1.073-3516; P = 0.005). For predicting HG, area under curve (AUC) of plasma visfatin level (0.814; 95% CI: 0.715-0.890) was similar to that of hematoma volume (0.839; 95% CI, 0.743-0.909) (P = 0.703). For predicting END, AUC of plasma visfatin level (0.828; 95% CI: 0.730-0.901) was similar to that of hematoma volume (0.863; 95% CI, 0.771-0.928) (P = 0.605). Visfatin did not improve AUC of hematoma volume for predicting HG and END (both P > 0.05). Conclusion: Plasma visfatin level represents a novel biomarker for predicting HG and END. (C) 2013 Elsevier B.V. All rights reserved.	[Gu, Shui-Jun; Xuan, Hong-Fei; Lu, Ming; Chen, Xin-Zhi; Dong, Wei-Feng; Yan, Xiao-Feng; Si, Yun; Gao, Guo-Liang; Hu, Dian-Xiang; Miao, Jian-Qing] First Peoples Hosp Xiaoshan Dist Hangzhou City, Dept Neurosurg, Hangzhou 311200, Zhejiang, Peoples R China		Lu, M (corresponding author), First Peoples Hosp Xiaoshan Dist Hangzhou City, Dept Neurosurg, 199 Shixin South Rd, Hangzhou 311200, Zhejiang, Peoples R China.	sjghxml@163.com			Hangzhou Science and Technology Research Fund Project [20120533Q43]	The authors thank all staffs in Department of Neurosurgery, The First People's Hospital of Xiaoshan District of Hangzhou City (Hangzhou, China) for their technical support. This study was supported by a grant from Hangzhou Science and Technology Research Fund Project (no. 20120533Q43).	Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Chen J, 2012, PEPTIDES, V38, P8, DOI 10.1016/j.peptides.2012.08.016; Chen WP, 2010, CLIN CHEM LAB MED, V48, P1141, DOI 10.1515/CCLM.2010.230; Dahl TB, 2012, ANNU REV NUTR, V32, P229, DOI 10.1146/annurev-nutr-071811-150746; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; Fan JS, 2012, ACAD EMERG MED, V19, P133, DOI 10.1111/j.1553-2712.2011.01285.x; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Hu W, 2013, PEPTIDES, V43, P8, DOI 10.1016/j.peptides.2013.02.017; Huang Q, 2013, PEPTIDES, V39, P55, DOI 10.1016/j.peptides.2012.11.006; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lee KA, 2011, CHEST, V140, P382, DOI 10.1378/chest.10-3100; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; Mazaherioun M, 2012, ARCH IRAN MED, V15, P688, DOI 0121511/AIM.008; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Sonoli SS, 2011, EUR REV MED PHARMACO, V15, P9; Stofkova A, 2010, Endocr Regul, V44, P25; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Weng JF, 2013, PEPTIDES, V40, P8, DOI 10.1016/j.peptides.2012.12.017; Yin CG, 2013, PEPTIDES, V42, P101, DOI 10.1016/j.peptides.2013.01.005	31	12	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	OCT 21	2013	425						85	89		10.1016/j.cca.2013.07.025			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	270GE	WOS:000328306100015	23916712				2022-02-06	
J	Kontos, AP; Elbin, RJ; Appaneal, RN; Covassin, T; Collins, MW				Kontos, Anthony P.; Elbin, R. J.; Appaneal, Renee Newcomer; Covassin, Tracey; Collins, Michael W.			A Comparison of Coping Responses Among High School and College Athletes With Concussion, Orthopedic Injuries, and Healthy Controls	RESEARCH IN SPORTS MEDICINE			English	Article						coping; mild traumatic brain injury; sport-related concussion; orthopedic injury; psychology of sport injury	SPORT-RELATED CONCUSSION; EMOTIONAL RESPONSE; SOCIAL SUPPORT; BRIEF-COPE; GENDER; METAANALYSIS; ASSOCIATION; STRATEGIES; STRESS; MODEL	This study compared the coping responses of concussed athletes with those with an orthopedic injury and healthy controls and explored sex differences in coping behaviors following sport injury. Sixty-eight athletes with a concussion (CONCUSS), 42 with an orthopedic injury (ORTHO), and 33 healthy controls (CONTROL) completed the Brief COPE approximately 1 week following sport injury. The CONCUSS group reported lower active, planning, acceptance, religion, self-distraction, venting, and self-blame coping than the ORTHO group. The ORTHO group reported lower acceptance, venting, and substance use coping than CONTROLS. Females reported higher levels of planning, humor, instrumental support, and venting than males. Females reported more venting than males in the ORTHO and CONTROL groups, but not in the CONCUSS group. In conclusion, concussed athletes may not engage in coping to the same extent as athletes with other injuries.	[Kontos, Anthony P.; Elbin, R. J.; Collins, Michael W.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15261 USA; [Appaneal, Renee Newcomer] Univ N Carolina, Greensboro, NC 27412 USA; [Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA		Kontos, AP (corresponding author), UPMC Ctr Sports Med, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310; Appaneal, Renee/0000-0003-3971-8303			Aldridge AA, 2007, J BEHAV MED, V30, P115, DOI 10.1007/s10865-006-9087-y; American Academy of Orthopaedic Surgeons (AAOS), 1991, ATHL TRAIN SPORTS ME; Anshel MH, 2010, SCAND J PSYCHOL, V51, P341, DOI 10.1111/j.1467-9450.2009.00796.x; Bianco T, 1999, RES Q EXERCISE SPORT, V70, P157, DOI 10.1080/02701367.1999.10608033; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Deroche T, 2011, ANXIETY STRESS COPIN, V24, P579, DOI 10.1080/10615806.2011.552717; Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6; Folkman S., 1984, STRESS; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goyen MJ, 1998, J APPL DEV PSYCHOL, V19, P469, DOI 10.1016/S0193-3973(99)80051-3; Granito V. J. Jr., 2001, Journal of Sport Behavior, V24, P63; HAMMERMEISTER J, 2004, J APPL SPORT PSYCHOL, V27, P148, DOI DOI 10.1080/02640410600630654; [黄峥 HUANG Zheng], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P5; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Johnson U, 1997, SCAND J MED SCI SPOR, V7, P367; Johnston LH, 2000, J SPORT REHABIL, V9, P290, DOI 10.1123/jsr.9.4.290; Kapsou M, 2010, J HEALTH PSYCHOL, V15, P215, DOI 10.1177/1359105309346516; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; National Collegiate Athletic Association (NCAA), 1996, ALL SPORT INJ SUMM; Nicholls AR, 2007, J SPORT SCI, V25, P1521, DOI 10.1080/02640410701230479; Noyes F R, 1988, Am J Sports Med, V16 Suppl 1, pS65; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Quinn AM, 1999, J APPL SPORT PSYCHOL, V11, P210, DOI 10.1080/10413209908404201; Shultz SJ, 2000, ASSESSMENT ATHLETIC; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; STONE AA, 1995, HEALTH PSYCHOL, V14, P341, DOI 10.1037/0278-6133.14.4.341; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Udry E, 1997, J SPORT EXERCISE PSY, V19, P229, DOI 10.1123/jsep.19.3.229; Udry E, 1997, J SPORT EXERCISE PSY, V19, P71, DOI 10.1123/jsep.19.1.71; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Williams JM, 1998, J APPL SPORT PSYCHOL, V10, P5, DOI 10.1080/10413209808406375	38	12	12	2	36	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1543-8627			RES SPORTS MED	Res. Sports Med.	OCT 1	2013	21	4					367	379		10.1080/15438627.2013.825801			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	223GN	WOS:000324792800007	24067122				2022-02-06	
J	Rossi, JL; Todd, T; Bazan, NG; Belayev, L				Rossi, Janet L.; Todd, Tracey; Bazan, Nicolas G.; Belayev, Ludmila			Inhibition of Myosin Light-Chain Kinase Attenuates Cerebral Edema after Traumatic Brain Injury in Postnatal Mice	JOURNAL OF NEUROTRAUMA			English	Article						BBB; brain injury; closed head injury model; edema; mice	BARRIER DYSFUNCTION; LUNG INJURY; RHO-KINASE; CHILDREN; DIFFUSE; STRESS; VULNERABILITY; ACTIVATION; PLASTICITY; AQUAPORIN	Traumatic brain injury (TBI) in children less than 8 years of age leads to decline in intelligence and executive functioning. Neurological outcomes after TBI correlate to development of cerebral edema, which affect survival rates after TBI. It has been shown that myosin light-chain kinase (MLCK) increases cerebral edema and that pretreatment with an MLCK inhibitor (ML-7) reduces cerebral edema. The aim of this study was to determine whether inhibition of MLCK after TBI in postnatal day 24 (PND-24) mice would prevent breakdown of the blood-brain barrier (BBB) and development of cerebral edema and improve neurological outcome. We used a closed head injury model of TBI. ML-7 or saline treatment was administered at 4h and every 24h until sacrifice or 5 days after TBI. Mice were sacrificed at 24h, 48h, and 72h and 7 days after impact. Mice treated with ML-7 after TBI had decreased levels of MLCK-expressing cells (20.7 +/- 4.8 vs. 149.3 +/- 40.6), less albumin extravasation (28.3 +/- 11.2 vs. 116.2 +/- 60.7mm(2)) into surrounding parenchymal tissue, less Evans Blue extravasation (339 +/- 314 vs. 4017 +/- 560ng/g), and showed a significant difference in wet/dry weight ratio (1.9 +/- 0.07 vs. 2.2 +/- 0.05g), compared to saline-treated groups. Treatment with ML-7 also resulted in preserved neurological function measured by the wire hang test (57 vs. 21sec) and two-object novel recognition test (old vs. new, 10.5 touches). We concluded that inhibition of MLCK reduces cerebral edema and preserves neurological function in PND-24 mice.	[Rossi, Janet L.; Bazan, Nicolas G.; Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA 70112 USA; [Rossi, Janet L.; Todd, Tracey] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Div Crit Care,Sch Med, New Orleans, LA 70112 USA; [Rossi, Janet L.] Childrens Hosp New Orleans, New Orleans, LA USA		Rossi, JL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Lions Eye Ctr, Neurosci Ctr Excellence, 2020 Gravier 8th Floor, New Orleans, LA 70112 USA.	jross5@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	Department of Pediatrics; Neuroscience Center of Excellence; Louisiana State University Health Sciences Center (New Orleans, LA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103340] Funding Source: NIH RePORTER	Funding for this work was provided by the Department of Pediatrics (to R.S.) and the Neuroscience Center of Excellence (to N.G.B.), Louisiana State University Health Sciences Center (New Orleans, LA).	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Chen S., 2012, PLOS ONE, V7; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; EDELMAN AM, 1992, MOL BRAIN RES, V14, P27, DOI 10.1016/0169-328X(92)90006-W; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gourgiotis I, 2012, PHARMACOL BIOCHEM BE, V102, P507, DOI 10.1016/j.pbb.2012.06.013; Haorah J, 2005, ALCOHOL CLIN EXP RES, V29, P999, DOI 10.1097/01.ALC.0000166944.79914.0A; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haorah J, 2007, J NEUROCHEM, V100, P324, DOI 10.1111/j.1471-4159.2006.04245.x; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Higgins JNP, 2008, J NEUROSURG, V108, P372, DOI 10.3171/JNS/2008/108/2/0372; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kudryashov DS, 2004, EXP CELL RES, V298, P407, DOI 10.1016/j.yexcr.2004.04.025; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2000, ACT NEUR S, V76, P349; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Nadal A, 1996, J PHYSIOL-LONDON, V492, P737, DOI 10.1113/jphysiol.1996.sp021342; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Rossi JL, 2011, J NEUROSCI RES, V89, P852, DOI 10.1002/jnr.22600; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100	51	12	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1672	1679		10.1089/neu.2013.2898			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800008	23984869	Green Published			2022-02-06	
J	Teixeira, PG; Karamanos, E; Okoye, OT; Talving, P; Inaba, K; Lam, L; Demetriades, D				Teixeira, Pedro G.; Karamanos, Efstathios; Okoye, Obi T.; Talving, Peep; Inaba, Kenji; Lam, Lydia; Demetriades, Demetrios			Splenectomy in patients with traumatic brain injury: Protective or harmful? A National Trauma Data Bank analysis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; splenectomy; complications; outcomes; mortality	PROXIMAL SPLENIC ANGIOEMBOLIZATION; NONOPERATIVE MANAGEMENT; ARTERY EMBOLIZATION; IMPROVE OUTCOMES; COHORT ANALYSIS; INFLAMMATION; PATHOPHYSIOLOGY; MULTICENTER; ACTIVATION; INCREASES	BACKGROUND: Experimental data have demonstrated a potential survival benefit for animals undergoing splenectomy immediately after traumatic brain injury. The aim of this study was to investigate the effect of splenectomy on survival in patients with moderate or severe traumatic brain injury (TBI). METHODS: This is a National Trauma Data Bank (2002-2009) analysis and included patients sustaining moderate or severe blunt head trauma (head Abbreviated Injury Scale [AIS] score, 3-5), with an associated splenic injury and an exploratory laparotomy. The population was divided into two arms: those that had a splenectomy and those who did not. The primary outcome was in-hospital mortality. Logistic regression was performed to adjust for factors that were significantly different between the study groups. RESULTS: During the 9-year study period, 2,625 patients met the criteria for inclusion in the analysis. Of these, 1,450 (55%) had a splenectomy, and 1,175 (45%) did not. Mortality was 13% for the splenectomized compared with 9% for the nonsplenectomized population (p = 0.001). After logistic regression, mortality remained significantly higher in the splenectomized population (adjusted odds ratio [AOR], 1.62; 95% confidence interval [CI], 1.16-2.26; p = 0.005). After stratification according to the severity of brain injury, the association between splenectomy and increased mortality persisted for both patients with moderate head injury (8% vs. 6%; AOR, 2.43; 95% CI, 1.26-4.71; p = 0.008) and for patients with severe head injury (17% vs. 10%; AOR, 1.49; 95% CI, 1.03-2.19; p = 0.036). CONCLUSION: Splenectomy was independently associated with increased mortality in patients with moderate or severe TBI. This finding warrants further investigation regarding splenic preservation in patients with TBI. Copyright (C) 2013 by Lippincott Williams & Wilkins	[Teixeira, Pedro G.; Karamanos, Efstathios; Okoye, Obi T.; Talving, Peep; Inaba, Kenji; Lam, Lydia; Demetriades, Demetrios] Los Angeles Cty Univ So Calif, Med Ctr, Los Angeles, CA USA		Demetriades, D (corresponding author), Univ So Calif, LAC USC Med Ctr, Div Trauma & Crit Care, IPT, 2051 Marengo St,C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	INABA, KENJI/AAC-8532-2020; Teixeira, Pedro/H-2239-2011; Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015; Karamanos, Efstathios/AAU-8082-2020	Teixeira, Pedro/0000-0002-7258-7977; Talving, Peep/0000-0002-9741-2073; Karamanos, Efstathios/0000-0002-5118-4642; Okoye, Obi/0000-0003-4794-4335			Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Bessoud B, 2006, AM J ROENTGENOL, V186, P779, DOI 10.2214/AJR.04.1800; Demetriades D, 2012, J TRAUMA ACUTE CARE, V72, P229, DOI 10.1097/TA.0b013e31823fe0b6; Di Sabatino A, 2011, LANCET, V378, P86, DOI 10.1016/S0140-6736(10)61493-6; Duchesne JC, 2008, J TRAUMA, V65, P1346, DOI 10.1097/TA.0b013e31818c29ea; Haan J, 2008, J TRAUMA, V65, P1351; Harbrecht BG, 2007, J TRAUMA, V63, P44, DOI 10.1097/TA.0b013e3180686531; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Marshall L F, 2000, Clin Neurosurg, V46, P105; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Nakae H, 2009, J TRAUMA, V67, P557, DOI 10.1097/TA.0b013e3181af6ca9; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Perl M, 2012, SHOCK, V37, P210, DOI 10.1097/SHK.0b013e31823f1776; Sabe AA, 2009, J TRAUMA, V67, P565, DOI 10.1097/TA.0b013e3181b17010; Velmahos GC, 2010, ARCH SURG-CHICAGO, V145, P456, DOI 10.1001/archsurg.2010.58; Walusimbi MS, 2012, INJURY, V43, P180, DOI 10.1016/j.injury.2011.05.028; Wiseman J, 2006, AM SURGEON, V72, P947; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	21	12	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2013	75	4					596	601		10.1097/TA.0b013e31829bb976			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	300IK	WOS:000330457400008	24064871				2022-02-06	
J	Huang, E; Ngo, M; Yee, S; Held, L; Norman, K; Scremin, AME; Scremin, O				Huang, Emerald; Ngo, Mai; Yee, Stuart; Held, Laura; Norman, Keith; Scremin, A. M. Erika; Scremin, Oscar			Repeated blast exposure alters open field behavior recorded under low illumination	BRAIN RESEARCH			English	Article						Brain injury; Blast injury; Rat	TRAUMATIC BRAIN-INJURY; RAT; HEADACHE; MODELS; AGE	Blast-induced traumatic brain injury (bTBI) can have devastating behavioral consequences. This study was designed to evaluate the behavioral consequences of single or repeated bTBI, as evaluated by an open field (OF) test conducted in near-darkness to avoid confounding effects of illumination and photophobia. Sprague-Dawley rats under isoflurane anesthesia were exposed to a series of 3 sub-lethal blasts into a compressed air-driven blast chamber separated by 2 week intervals (n=11). Sham controls received anesthesia but without blast exposure (n=11). OF tests were performed 1 or 7 days after each blast using a computerized video tracking system in near-darkness to monitor spontaneous activity. Spatial and temporal variables calculated for both blast and sham groups were: Distance moved (cm) and time (s) spent in the center or periphery zones of the field, total distance traveled, speed in center and periphery zones, rearing events and non-linear regressions of distance moved and rearing events on time. Results showed that the sham group expressed the expected decrease (habituation) in total distance walked, and distance walked as well as speed in center and periphery in successive exposures to the OF while the blast group did not, a sign of impaired learning. The blast group also walked more and faster and demonstrated more rearing behavior, both considered OF signs of anxiety. These results indicate that OF outcomes of bTBI in animals have resemblance to alterations observed in human subjects with this condition and might be useful in evaluating the response of behavioral outcomes of bTBI to experimental treatments. Published by Elsevier B.V.	[Huang, Emerald; Ngo, Mai; Yee, Stuart] Univ Calif Los Angeles, VA Multicampus Residency Program, Los Angeles, CA USA; [Held, Laura; Scremin, A. M. Erika] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA 90073 USA; [Norman, Keith; Scremin, Oscar] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA; [Scremin, A. M. Erika] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Scremin, Oscar] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA		Scremin, O (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Dept Res, 11301 Wilshire Blvd,Bldg 115,Room 319, Los Angeles, CA 90073 USA.	oscremin@ucla.edu			Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARRD)US Department of Veterans Affairs [B5089R]; VA RR&D Research Career Scientist award	This work was supported by Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VARR&D) #B5089R, and a VA RR&D Research Career Scientist award (to O.U.S.).	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BIRCH D, 1975, VISION RES, V15, P687, DOI 10.1016/0042-6989(75)90285-0; BLIZARD DA, 1971, BRIT J PSYCHOL, V62, P245, DOI 10.1111/j.2044-8295.1971.tb02034.x; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cryan JF, 2011, BRIT J PHARMACOL, V164, P1129, DOI 10.1111/j.1476-5381.2011.01362.x; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DIXON LK, 1968, J COMP PHYSIOL PSYCH, V66, P803, DOI 10.1037/h0026533; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; LIVESEY PJ, 1970, J COMP PHYSIOL PSYCH, V73, P93, DOI 10.1037/h0030018; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; RUSSELL RW, 1990, PHARMACOL BIOCHEM BE, V37, P811, DOI 10.1016/0091-3057(90)90567-2; RUSSELL RW, 1982, ANNU REV PHARMACOL, V22, P435, DOI 10.1146/annurev.pa.22.040182.002251; Sartori SB, 2011, FUTUR NEUROL, V6, P531, DOI 10.2217/FNL.11.34; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Spelman J.F., 2012, J GEN INTERN MED; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Tanielan T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; VALLE FP, 1970, AM J PSYCHOL, V83, P103, DOI 10.2307/1420860; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	29	12	12	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 5	2013	1529						125	133		10.1016/j.brainres.2013.06.042			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221KQ	WOS:000324658200013	23850767				2022-02-06	
J	Hirose, T; Matsumoto, N; Tasaki, O; Nakamura, H; Akagaki, F; Shimazu, T				Hirose, Tomoya; Matsumoto, Naoya; Tasaki, Osamu; Nakamura, Hajime; Akagaki, Fuyuko; Shimazu, Takeshi			Delayed Progression of Edema Formation Around a Hematoma Expressing High Levels of VEGF and MMP-9 in a Patient With Traumatic Brain Injury: Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic brain injury; hematoma; vascular endothelial growth factor; matrix metalloproteinase-9; brain edema	ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; CEREBRAL-ISCHEMIA; BLOOD; BARRIER; MATRIX-METALLOPROTEINASE-9	The mechanisms accounting for the development of tissue damage following traumatic brain injury (TBI) have been studied for several decades. A variety of mediators, such as vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9), which play a crucial role in edema formation after TB!, have been identified. We experienced a case of brain edema that progressed continuously at least until 13 days after head injury. The brain edema occurred around the hemorrhage from an intracerebral contusion. The evacuated hematoma was investigated based on the inference that the unexpected expansion of edema was induced by the mediators within the hematoma itself. A 64-year-old woman was admitted to our hospital following a traffic injury. Left brain contusion was revealed by head computed tomography (CT) on admission. Three hours later, formation of an intracerebral hematoma became evident. Serial CT examination revealed that brain edema had developed progressively till 13 days after the injury. A hematoma removal operation was performed on Day 13. The hematoma was centrifuged and the supernatant was analyzed for the expression of VEGF and MMP-9. The values of both (4400 pg/ml and 920 ng/ml, respectively) were extremely high compared with values reported previously in serum and cerebrospinal fluid collected from patients with intracranial infection or injury. This case suggested that the delayed exacerbation of edema following traumatic intracranial hemorrhage was possibly induced by secretory factors such as VEGF and MMP-9 released from within and around the hematoma.	[Hirose, Tomoya; Matsumoto, Naoya; Akagaki, Fuyuko; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan; [Nakamura, Hajime] Osaka Univ, Grad Sch Med, Dept Neurosurg, Suita, Osaka 5650871, Japan; [Tasaki, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Unit Clin Med, Dept Emergency Med, Nagasaki 852, Japan		Hirose, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	htomoya1979@hp-emerg.med.osaka-u.ac.jp					Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Coenjaerts FEJ, 2004, J INFECT DIS, V190, P1310, DOI 10.1086/423849; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hohenstein A, 2005, J NEUROTRAUM, V22, P518, DOI 10.1089/neu.2005.22.518; LaFleur M, 1996, J EXP MED, V184, P2311; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Marmarou A, 2003, ACT NEUR S, V86, P7; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Suzuki R, 2003, ACTA NEUROCHIR SUPPL, V86, P277; Suzuki R, 1997, CEREB BLOOD FLOW MET, V17, pS416; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253	15	12	13	1	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	SEP	2013	53	9					609	612					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	295EX	WOS:000330100500007	24067772				2022-02-06	
J	Leung, YY; Lee, TCP; Ho, SMY; Cheung, LK				Leung, Yiu Yan; Lee, Terence Chak Pui; Ho, Samuel Mun Yin; Cheung, Lim Kwong			Trigeminal Neurosensory Deficit and Patient Reported Outcome Measures: The Effect on Life Satisfaction and Depression Symptoms	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SCALE; SURGERY	Objectives: To investigate the effect of persistent neurosensory disturbance of the lingual nerve (LN) or inferior alveolar nerve (IAN) on life satisfaction and depression symptoms. Methods: This study recruited patients with persistent LN or IAN deficit as a consequence of lower third molar surgery for 12 months or more to form the study group. A control group was formed by matching age and gender of recruited subjects in the study group with patients without the neurosensory complications. Life satisfaction was assessed with Satisfaction With Life Scale (SWLS) and depression symptoms were assessed with 20-item Center for Epidemiological Studies Depression scale (CESD-20). Results: Fourty-eight participants (24 cases and 24 controls) were recruited. Patients with LN or IAN deficits after lower third molar surgery were less satisfied with their lives when compared to the control group (p<0.001). They were presenting with more depression symptoms (p = 0.001). 45.8% of the study group subjects had a CESD-20 score of 16 or above. Older patients presented with more depression symptoms among the subjects with neurosensory disturbance after lower third molar surgery (p = 0.02). Conclusions: Individuals with permanent trigeminal neurosensory deficit after lower third molar surgery have worse life satisfaction and more depressive symptoms when compared to those who did not suffer from the surgical complication.	[Leung, Yiu Yan; Cheung, Lim Kwong] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Lee, Terence Chak Pui] Hong Kong Baptist Univ, Fac Social Sci, Psychol Unit, Hong Kong, Hong Kong, Peoples R China; [Ho, Samuel Mun Yin] City Univ Hong Kong, Dept Appl Social Studies, Hong Kong, Hong Kong, Peoples R China		Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk	Ho, Samuel M.Y. M.Y./D-2454-2014	Ho, Samuel M.Y. M.Y./0000-0001-7803-1657; /0000-0001-7038-3279; Cheung, Lim Kwong/0000-0002-2248-286X			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arrindell WA, 1999, PERS INDIV DIFFER, V26, P815, DOI 10.1016/S0191-8869(98)00180-9; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P775, DOI 10.1016/j.apmr.2011.12.020; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314; Cheung LK, 2010, INT J ORAL MAX SURG, V39, P320, DOI 10.1016/j.ijom.2009.11.010; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Ferrus-Torres E, 2011, J ORAL MAXIL SURG, V69, P54, DOI 10.1016/j.joms.2010.05.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Khanna D, 2011, ARTHRIT CARE RES, V63, pS486, DOI 10.1002/acr.20581; Latoo J, 2012, BRIT J HOSP MED, V73, P331, DOI 10.12968/hmed.2012.73.6.331; Leung YY, PLOS ONE UNPUB; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; Tonack M, 2008, SPINAL CORD, V46, P380, DOI 10.1038/sj.sc.3102088	21	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72891	10.1371/journal.pone.0072891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	WOS:000323734600041	24009712	Green Published, Green Submitted, gold			2022-02-06	
J	Easter, JS; Haukoos, JS; Claud, J; Wilbur, L; Hagstrom, MT; Cantrill, S; Mestek, M; Symonds, D; Bakes, K				Easter, Joshua S.; Haukoos, Jason S.; Claud, Jonathan; Wilbur, Lee; Hagstrom, Michelle Tartalgia; Cantrill, Stephen; Mestek, Michael; Symonds, David; Bakes, Katherine			Traumatic Intracranial Injury in Intoxicated Patients With Minor Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							GLASGOW COMA SCALE; COMPUTED-TOMOGRAPHY; BRAIN-INJURY; MANAGEMENT; GUIDELINES; ALCOHOL; ADULTS	Objectives Studies focusing on minor head injury in intoxicated patients report disparate prevalences of intracranial injury. It is unclear if the typical factors associated with intracranial injury in published clinical decision rules for computerized tomography (CT) acquisition are helpful in differentiating patients with and without intracranial injuries, as intoxication may obscure particular features of intracranial injury such as headache and mimic other signs of head injury such as altered mental status. This study aimed to estimate the prevalence of intracranial injury following minor head injury (Glasgow Coma Scale [GCS] score 14) in intoxicated patients and to assess the performance of established clinical decision rules in this population. Methods This was a prospective cohort study of consecutive intoxicated adults presenting to the emergency department (ED) following minor head injury. Historical and physical examination features included those from the Canadian CT Head Rule, National Emergency X-Radiography Utilization Study (NEXUS), and New Orleans Criteria. All patients underwent head CT. Results A total of 283 patients were enrolled, with a median age of 40years (interquartile range [IQR]=28 to 48years) and median alcohol concentration of 195mmol/L (IQR=154 to 256mmol/L). A total of 238 of 283 (84%) were male, and 225 (80%) had GCS scores of 15. Clinically important injuries (injuries requiring admission to the hospital or neurosurgical follow-up) were identified in 23 patients (8%; 95% confidence interval [CI]=5% to 12%); one required neurosurgical intervention (0.4%, 95% CI=0% to 2%). Loss of consciousness and headache were associated with clinically important intracranial injury on CT. The Canadian CT Head Rule had a sensitivity of 70% (95% CI=47% to 87%) and NEXUS criteria had a sensitivity of 83% (95% CI=61% to 95%) for clinically important injury in intoxicated patients. Conclusions In this study, the prevalence of clinically important injury in intoxicated patients with minor head injury was significant. While the presence of the common features associated with intracranial injury in nonintoxicated patients should raise clinical suspicion for intracranial injury in intoxicated patients, the Canadian CT Head Rule and NEXUS criteria do not have adequate sensitivity to be applied in intoxicated patients with minor head injury. (C) 2013 by the Society for Academic Emergency Medicine	[Easter, Joshua S.; Haukoos, Jason S.; Claud, Jonathan; Wilbur, Lee; Hagstrom, Michelle Tartalgia; Cantrill, Stephen; Bakes, Katherine] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA; [Easter, Joshua S.; Haukoos, Jason S.; Bakes, Katherine] Univ Colorado, Sch Med, Aurora, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Claud, Jonathan] Legacy Salmon Creek Hosp, Dept Emergency Med, Vancouver, WA USA; [Wilbur, Lee] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Hagstrom, Michelle Tartalgia] St Marys Hlth Ctr, Richmond Hts, MO USA; [Mestek, Michael; Symonds, David] Denver Hlth Med Ctr, Dept Radiol, Denver, CO USA		Bakes, K (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA.	Katherine.Bakes@dhha.org			Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS019464-01]; AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K02 HS017526]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS019464, K02HS017526] Funding Source: NIH RePORTER	Supported, in part, by a Physician Scientist Award (K12HS019464-01) from the Agency for Healthcare Research and Quality (AHRQ) to Dr. Easter and an Independent Scientist Award (K02 HS017526) from the AHRQ to Dr. Haukoos. Dr. Wilbur, an associate editor of this journal, had no role in the peer review process and publication decision for this paper. The other authors have no conflicts of interest to declare.	Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bracken ME, 2007, ANN EMERG MED, V49, P45, DOI 10.1016/j.annemergmed.2006.04.013; Cook L S, 1994, Acad Emerg Med, V1, P227; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Godbout BJ, 2011, EMERG RADIOL, V18, P381, DOI 10.1007/s10140-011-0966-3; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; REINUS WR, 1994, ANN EMERG MED, V23, P1271, DOI 10.1016/S0196-0644(94)70351-5; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Taylor TR, 2009, BRIT J NEUROSURG, V23, P622, DOI 10.3109/02688690903215666; Yates D, 2007, BMJ-BRIT MED J, V335, P719, DOI 10.1136/bmj.39331.702951.47	17	12	13	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	AUG	2013	20	8					753	760		10.1111/acem.12184			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	201IQ	WOS:000323134300002	24033617				2022-02-06	
J	Roscigno, CI; Savage, TA; Grant, G; Philipsen, G				Roscigno, Cecelia I.; Savage, Teresa A.; Grant, Gerald; Philipsen, Gerry			How healthcare provider talk with parents of children following severe traumatic brain injury is perceived in early acute care	SOCIAL SCIENCE & MEDICINE			English	Article						United States; Place; Provider-parent interaction; Communication; Culture; Severe traumatic brain injury; Ethnography of speaking	DECISION-MAKING; COMMUNICATION; UNIT; PREDICTORS; DOCTORS; PLACE; VIEWS; TRUST	Healthcare provider talk with parents in early acute care following children's severe traumatic brain injury (TBI) affects parents' orientations to these locales, but this connection has been minimally studied. This lack of attention to this topic in previous research may reflect providers' and researchers' views that these locales are generally neutral or supportive to parents' subsequent needs. This secondary analysis used data from a larger descriptive phenomenological study (2005-2007) with parents of children following moderate to severe TBI recruited from across the United States. Parents of children with severe TBI consistently had strong negative responses to the early acute care talk processes they experienced with providers, while parents of children with moderate TBI did not. Transcript data were independently coded using discourse analysis in the framework of ethnography of speaking. The purpose was to understand the linguistic and paralinguistic talk factors parents used in their meta-communications that could give a preliminary understanding of their cultural expectations for early acute care talk in these settings. Final participants included 27 parents of children with severe TBI from 23 families. We found the human constructed talk factors that parents reacted to were: a) access to the child, which is where information was; b) regular discussions with key personnel; c) updated information that is explained; d) differing expectations for talk in this context; and, e) perceived parental involvement in decisions. We found that the organization and nature of providers' talk with parents was perceived by parents to positively or negatively shape their early acute care identities in these locales, which influenced how they viewed these locales as places that either supported them and decreased their workload or discounted them and increased their workload for getting what they needed. (c) 2013 Elsevier Ltd. All rights reserved.	[Roscigno, Cecelia I.; Savage, Teresa A.] Univ Illinois, Coll Nursing, Chicago, IL USA; [Grant, Gerald] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA; [Philipsen, Gerry] Univ Washington, Dept Commun, Seattle, WA 98195 USA		Roscigno, CI (corresponding author), Univ N Carolina, Sch Nursing, Carrington Hall,CB 7460, Chapel Hill, NC 27599 USA.	croscign@email.unc.edu			Irving B. Harris Foundation Faculty Scholars Initiative at the College of Nursing, University of Illinois at Chicago; National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness [5T32NR007091-17]; NINR Ruth L. Kirschstein Predoctoral Research Fellowship [1 F31 NR009599-02]; Psi Chapter of Sigma Theta Tau Grant; American Nurses Foundation Martha E. Brill Scholars Award; University of Washington School of Nursing Hester McLaws Scholarship Fund; University of Washington LEND Training Grant [6 T73 MC 00041-11-03]; University of Washington Gatzert Child Welfare Fellowship; Integra Lifesciences Grant; Society of Pediatric Nurses; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR009599, T32NR007091] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, training, or authorship of this article: This secondary analysis was funded by the Society of Pediatric Nurses. The first author's training during the analysis was funded by the Irving B. Harris Foundation Faculty Scholars Initiative at the College of Nursing, University of Illinois at Chicago (PI: R. White-Traut, PhD), and the authorship of the manuscript was funded by a National Institutes of Nursing Research postdoctoral fellowship Interventions for Preventing and Managing Chronic Illness (5T32NR007091-17; PI: M. Mishel, PhD).; The original research study and training was funded by an NINR Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02); a Psi Chapter of Sigma Theta Tau Grant; a 2006 American Nurses Foundation Martha E. Brill Scholars Award; a University of Washington School of Nursing Hester McLaws Scholarship Fund; a University of Washington LEND Training Grant (TG # 6 T73 MC 00041-11-03); a University of Washington Gatzert Child Welfare Fellowship; and an Integra Lifesciences Grant. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of any of the funders.	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Basso KeithH., 1996, WISDOM SITS PLACES L; Berger CR, 2005, J COMMUN, V55, P415, DOI 10.1111/j.1460-2466.2005.tb02680.x; Boos Virginia D, 2010, Adv Neonatal Care, V10, P301, DOI 10.1097/ANC.0b013e3181f36e4c; BOURHIS RY, 1989, SOC SCI MED, V28, P339, DOI 10.1016/0277-9536(89)90035-X; Bronner MB, 2010, J PEDIATR PSYCHOL, V35, P966, DOI 10.1093/jpepsy/jsq004; Collins S, 2005, SOC SCI MED, V61, P2611, DOI 10.1016/j.socscimed.2005.04.047; Conway J., 2006, PARTNERING PATIENTS; Coulter A, 2002, BRIT MED J, V325, P668, DOI 10.1136/bmj.325.7366.668; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; DeLemos D, 2010, PEDIATR CRIT CARE ME, V11, P378, DOI 10.1097/PCC.0b013e3181b8088b; Edwards D, 2000, RES LANG SOC INTERAC, V33, P347, DOI 10.1207/S15327973RLSI3304_01; Gillotti C, 2002, SOC SCI MED, V54, P1011, DOI 10.1016/S0277-9536(01)00073-9; Gordon Cynthia, 2009, Commun Med, V6, P177; Gustafson P, 2001, J ENVIRON PSYCHOL, V21, P5, DOI 10.1006/jevp.2000.0185; Hoonakker P., 2008, HUMAN FACTORS ORG DE, P715; Hymes D., 1972, DIRECTIONS SOCIOLING, P35; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jee RA, 2012, PEDIATR CRIT CARE ME, V13, pE166, DOI 10.1097/PCC.0b013e31823893ad; Karnieli-Miller O, 2009, SOC SCI MED, V69, P1, DOI 10.1016/j.socscimed.2009.04.030; Kearns R. A., 1998, PUTTING HLTH PLACE L; Madrigal VN, 2012, CRIT CARE MED, V40, P2876, DOI 10.1097/CCM.0b013e31825b9151; Meadors P, 2008, J PEDIATR HEALTH CAR, V22, P24, DOI 10.1016/j.pedhc.2007.01.006; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Philipsen G, 2005, LEA COMMUN SER, P355; Philipsen G., 2005, THEORIZING INTERCULT, P55; Potter J., 2004, HDB DATA ANAL HDB DATA ANAL, P607, DOI DOI 10.4135/9781848608184.N27; Revenson T. A., 2012, HDB HLTH PSYCHOL, P193; Roscigno CI, 2012, QUAL HEALTH RES, V22, P1232, DOI 10.1177/1049732312449210; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; THORNE SE, 1993, NEGOTIATING HLTH CAR; Ularntinon S, 2010, CURR PSYCHIATRY REV, V6, P261, DOI 10.2174/157340010793499422	33	12	13	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	AUG	2013	90						32	39		10.1016/j.socscimed.2013.04.017			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	174RX	WOS:000321174200004	23746606	Green Accepted			2022-02-06	
J	Smith, HL; Chrischilles, E; Janus, TJ; Sidwell, RA; Ramirez, M; Peek-Asa, C; Sahr, SM				Smith, Hayden L.; Chrischilles, Elizabeth; Janus, Todd J.; Sidwell, Richard A.; Ramirez, Marizen; Peek-Asa, Corinne; Sahr, Sheryl M.			Clinical indicators of midface fracture in patients with trauma	DENTAL TRAUMATOLOGY			English	Article						diagnosis; etiology; examination; soft tissue; trauma; midface	FACIAL FRACTURES; CONCOMITANT INJURIES; COMPUTED-TOMOGRAPHY; RISK-FACTORS; HEAD; SCALE; SCANS; CARE	Background/Aim: Midface fractures are commonly present and difficult to diagnose in trauma patients. The objective of this study was to determine clinically accessible indicators of midface fracture. Material and Methods: A case-control study design was used to determine clinical indicators of midface fracture. Population source was a level I trauma center registry for years 2007-2009. Cases had a documented midface fracture. Patient and trauma characteristics were compared between cases and controls. Multivariate logistic regression analysis determined significant indicators of midface fracture. Results: Study sample included 83 cases and 83 frequency-matched controls. Cases had a total of 211 fractures with a median of two midface fractures per person. Common fractures were orbital (41%), malar and maxillary (28%), and nasal bones (19%). Patients with midface fracture were significantly different than patients without midface fracture in severity of injury and were more likely to have a traumatic brain injury. Significant clinical indicators of fracture were maxillary sinus opacification, ethmoid sinus opacification, forehead laceration, periorbital contusion, epistaxis, and injury mechanism (P < 0.05). Patients with midface fracture had a 63 times greater odds for maxillary sinus opacification. The multivariable model correctly classified the presence and absence of midface fracture in 95% of study sample. Conclusions: Determined indicators of midface fracture provided a high level of discrimination in fracture status. Indicators can be used by clinicians to help detect possible midface fractures. Future prospective research on midface fracture indicators can assist in establishing their generalizability and impact on fracture detection, care, and outcomes.	[Smith, Hayden L.; Janus, Todd J.; Sidwell, Richard A.; Sahr, Sheryl M.] Iowa Methodist Med Ctr, Des Moines, IA 50309 USA; [Chrischilles, Elizabeth; Ramirez, Marizen; Peek-Asa, Corinne] Univ Iowa, Iowa City, IA USA		Smith, HL (corresponding author), Iowa Methodist Med Ctr, Med Educ Serv, 1415 Woodland Ave,Suite 140, Des Moines, IA 50309 USA.	smithhl@ihs.org		Chrischilles, Elizabeth/0000-0002-1843-1955			Adkinson JM, 2011, ANN PLAS SURG, V66, P472, DOI 10.1097/SAP.0b013e318214532c; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brant WE, 2007, FUNDAMENTALS DIAGNOS, P1559; BUCHANAN RT, 1983, PLAST RECONSTR SURG, V71, P768, DOI 10.1097/00006534-198306000-00003; Daffner R H, 1997, Curr Probl Diagn Radiol, V26, P153; DOLAN KD, 1978, SEMIN ROENTGENOL, V13, P37, DOI 10.1016/S0037-198X(78)80017-0; ELLIS E, 1985, J ORAL MAXIL SURG, V43, P417, DOI 10.1016/S0278-2391(85)80049-5; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gonen M., 2007, ANAL RECEIVER OPERAT; Harrel F. E., 2001, REGRESSION MODELING; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Hohlrieder M, 2003, INTENS CARE MED, V29, P1095, DOI 10.1007/s00134-003-1804-1; Holmgren EP, 2004, J ORAL MAXIL SURG, V62, P913, DOI 10.1016/j.joms.2003.12.026; Laine F J, 1993, Curr Probl Diagn Radiol, V22, P145; Marinaro J, 2007, AM J EMERG MED, V25, P616, DOI 10.1016/j.ajem.2006.11.029; McAuley Clyde E., 1992, Journal of Trauma, V33, P948; McMullin BT, 2009, ARCH FACIAL PLAST S, V11, P165, DOI 10.1001/archfacial.2009.11; MOILANEN A, 1987, INT J ORAL MAX SURG, V16, P572, DOI 10.1016/S0901-5027(87)80108-X; Raby N, 1998, CLIN RADIOL, V53, P218, DOI 10.1016/S0009-9260(98)80105-0; Reed, 2007, ESSENTIAL SURG PROBL; REHM CG, 1995, J ORAL MAXIL SURG, V53, P522, DOI 10.1016/0278-2391(95)90063-2; Leles JLR, 2010, J APPL ORAL SCI, V18, P23, DOI 10.1590/S1678-77572010000100006; SCHERER M, 1989, J TRAUMA, V29, P388, DOI 10.1097/00005373-198903000-00020; Shapiro AJ, 2001, INJURY, V32, P353, DOI 10.1016/S0020-1383(00)00245-X; SHOCKLEY WW, 1988, LARYNGOSCOPE, V98, P18; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; TEASDALE G, 1974, LANCET, V2, P81; University Of Washington. Department of Radiology, 2007, MUSC RAD FAC MAND FR	31	12	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	AUG	2013	29	4					313	318		10.1111/edt.12006			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	178GO	WOS:000321433900010	23067335				2022-02-06	
J	Yang, CC; Huang, SJ; Lin, WC; Tsai, YH; Hua, MS				Yang, Chi-Cheng; Huang, Sheng-Jean; Lin, Wei-Chi; Tsai, Yi-Hsin; Hua, Mau-Sun			Divergent manifestations of irritability in patients with mild and moderate-to-severe traumatic brain injury: Perspectives of awareness and neurocognitive correlates	BRAIN INJURY			English	Article						Awareness; information processing; irritability; traumatic brain injury	HEAD-INJURY; AGGRESSION; SEQUELAE; CAREGIVERS; SYMPTOMS; MEMORY	Primary objectives: To evaluate irritability in patients with mild traumatic brain injury (mTBI) and moderate-to-severe traumatic brain injury (msTBI), respectively. Research design: A prospective study was conducted at a level I trauma centre. Methods and procedures: A total of 160 participants, which included 80 healthy subjects and 80 patients with TBI, were recruited. Irritability was assessed by the National Taiwan University Irritability Scale and other cognitive functions, which included memory, executive function and information processing, were also evaluated. Main outcomes and results: The results showed post-injury self-reported irritability in patients with mTBI and family-reported irritability in patients with msTBI were significantly higher than irritability reported by healthy participants. Irritability was significantly associated with information processing ability in patients with mTBI, but it was not associated with any cognitive functions in patients with msTBI. Conclusions: Irritability was found to be prominent after TBI. Divergent causes of irritability seemed apparent in patients with mTBI and msTBI. Irritability after mTBI appeared might be related to the cognitive functions disrupted after the injury, whereas irritability after msTBI appeared to result directly from the brain lesions involved.	[Yang, Chi-Cheng; Lin, Wei-Chi] Chang Gung Univ, Div Clin Psychol, Dept Occupat Therapy, Coll Med, Tao Yuan, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ Hosp, Jin Shan Branch, New Taipei City, Taiwan; [Huang, Sheng-Jean] Natl Taiwan Univ, Dept Surg, Coll Med, Taipei 10764, Taiwan; [Tsai, Yi-Hsin] Far Eastern Mem Hosp, Div Neurosurg, New Taipei City, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan		Yang, CC (corresponding author), Chang Gung Univ, Div Clin Psychol, Dept Occupat Therapy, Coll Med, Tao Yuan, Taiwan.	ccyang@mail.cgu.edu.tw; huams@ntu.edu.tw			National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2410-H-182-012-MY2]	This study was supported by the National Science Council of Taiwan (NSC 99-2410-H-182-012-MY2).	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Department of Health, 2005, HLTH NAT HLTH INS AN; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Eslinger PJ, 2000, BEHAVIOR AND MOOD DISORDERS IN FOCAL BRAIN LESIONS, P217; Eslinger PJ, 2007, BRAIN INJURY MED PRI, P779; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Granacher Jr RP, 2003, TRAUMATIC BRAIN INJU, P25; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hua M.-S., 1986, WORD SEQUENCE UNPUB; Hua MS, 1997, NEUROPSYCHOLOGY, V11, P156, DOI 10.1037/0894-4105.11.1.156; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Levin H. S., 1983, PACED AUDITORY UNPUB; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roberts RJ, 1983, WORD SEQUENCE LEARNI; Salmon DP, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P114; Starkstein S. E., 1991, FRONTAL LOBE FUNCTIO; Stuss DT, 1987, NEUROBEHAVIORAL RECO; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Watt S, 1999, NEUROPSYCHOLOGY, V13, P338, DOI 10.1037/0894-4105.13.3.338; Yang CC, 2005, ARCH CLIN PSYCHOL, V2, P49; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Yang CC, 2011, BRAIN IMPAIR, V12, P200	49	12	12	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1008	1015		10.3109/02699052.2013.794975			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100004	23662733				2022-02-06	
J	Kitagawa, R; Yokobori, S; Mazzeo, AT; Bullock, R				Kitagawa, Ryan; Yokobori, Shoji; Mazzeo, Anna T.; Bullock, Ross			Microdialysis in the Neurocritical Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Microdialysis; Neuromonitoring; Traumatic brain injury; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; INTRACEREBRAL MICRODIALYSIS; CEREBRAL MICRODIALYSIS; NEUROLOGICAL DEFICITS; METABOLIC CRISIS; HEAD-INJURY; VASOSPASM; LACTATE; ISCHEMIA	Effective monitoring is critical for neurologically compromised patients, and several techniques are available. One of these tools, cerebral microdialysis (MD), was designed to detect derangements in cerebral metabolism. Although this monitoring device began as a research instrument, favorable results and utility have broadened its clinical applications. Combined with other brain monitoring techniques, MD can be used to estimate cerebral vulnerability, to assess tissue outcome, and possibly to prevent secondary ischemic injury by guiding therapy. This article reviews the literature regarding the past, present, and future uses of MD along with its advantages and disadvantages in the intensive care unit setting.	[Kitagawa, Ryan; Yokobori, Shoji; Bullock, Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1130083, Japan; [Mazzeo, Anna T.] Univ Turin, Dept Anesthesia & Crit Care, Azienda Osped Citta Salute & Sci Torino Presidio, I-10126 Turin, Italy		Bullock, R (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, 1095 Northwest 14th Terrace, Miami, FL 33136 USA.	rbullock@med.miami.edu		Mazzeo, Anna Teresa/0000-0002-8454-7243			Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; AMBERG G, 1989, J PHARMACOL METHOD, V22, P157, DOI 10.1016/0160-5402(89)90012-0; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bjerring PN, 2008, NEUROCRIT CARE, V9, P3, DOI 10.1007/s12028-008-9060-4; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen Jeff W, 2012, Surg Neurol Int, V3, P57, DOI 10.4103/2152-7806.96868; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dhawan V, 2012, J NEUROINTERV SURG, V4, P407, DOI 10.1136/neurintsurg-2011-010158; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fried I, 2001, NAT NEUROSCI, V4, P201, DOI 10.1038/84041; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Jones DA, 2000, J NEUROCHEM, V75, P1703, DOI 10.1046/j.1471-4159.2000.0751703.x; Khaldi A, 2001, NEUROSURGERY, V49, P33; Kim DH, 2006, NEUROCRIT CARE, V4, P83, DOI 10.1385/NCC:4:1:083; Kolias AG, 2009, J NEUROSCI RES, V87, P1, DOI 10.1002/jnr.21823; Lee GJ, 2008, NEUROL RES, V30, P661, DOI 10.1179/174313208X289570; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Maurer MH, 2007, J CEREBR BLOOD F MET, V27, P1675, DOI 10.1038/sj.jcbfm.9600466; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2006, J NEUROSURG ANESTH, V18, P170, DOI 10.1097/01.ana.0000210999.18033.f6; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Miller CM, 2012, CURR NEUROL NEUROSCI, V12, P474, DOI 10.1007/s11910-012-0274-7; Nagel A, 2009, NEUROCRIT CARE, V11, P384, DOI 10.1007/s12028-009-9269-x; Noske DP, 2005, SURG NEUROL, V64, P109, DOI 10.1016/j.surneu.2004.09.036; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; Paraforou Theoniki, 2011, BMC Res Notes, V4, P540, DOI 10.1186/1756-0500-4-540; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sakowitz OW, 2001, J CEREBR BLOOD F MET, V21, P1067, DOI 10.1097/00004647-200109000-00004; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; Wu CT, 2011, ANESTH ANALG, V112, P666, DOI 10.1213/ANE.0b013e318207c51f; Yokobori S, 2001, NEUROL MED CHIR TOKY, V51, P265; Yokobori S, 2011, J TRAUMA, V71, P1235, DOI 10.1097/TA.0b013e3182140dd7; Zetterling M, 2009, ACTA NEUROCHIR, V151, P771, DOI 10.1007/s00701-009-0384-4	57	12	12	1	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					417	+		10.1016/j.nec.2013.02.002			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100010	23809035				2022-02-06	
J	Kleffelgaard, I; Roe, C; Sandvik, L; Hellstrom, T; Soberg, HL				Kleffelgaard, Ingerid; Roe, Cecile; Sandvik, Leiv; Hellstrom, Torgeir; Soberg, Helene L.			Measurement Properties of the High-Level Mobility Assessment Tool for Mild Traumatic Brain Injury	PHYSICAL THERAPY			English	Article							POST-CONCUSSION SYMPTOMS; INTERRATER RELIABILITY; CONCURRENT VALIDITY; WALKING SPEED; HEAD-INJURY; SELF-REPORT; HIMAT; QUALITY; PEOPLE; GAIT	Background. The High-Level Mobility Assessment Tool (HiMAT) was developed to quantify balance and mobility problems after traumatic brain injury (TBI). Measurement properties of the HiMAT have not been tested in the mild TBI (MTBI) population. Objective. The aim of this study was to examine the reliability, validity, and responsiveness of the HiMAT in a sample of the MTBI population. Design. A cohort, pretest-posttest, comparison study was conducted. Methods. Ninety-two patients (69% men, 31% women) with a mean age of 37.1 years (SD=13.8) and a mean Glasgow Coma Scale score of 14.7 (SD=0.7) were recruited from Oslo University Hospital. All patients were tested with the HiMAT (range of scores=0 [worst] to 54 [best]) at 3 months postinjury. Fifty-one patients were retested at 6 months. A subgroup of 25 patients was selected for the reliability testing. Balance function reported on the Rivermead Post Concussion Symptoms Questionnaire was chosen as a criterion and anchor. Criterion-related validity was studied with correlation analysis. Intraclass correlation coefficients (ICCs) were used for assessing interrater and intrarater reliability Minimal detectable change (MDC) for the HiMAT was estimated. Responsiveness was assessed with receiver operating characteristic curve analyses. Results. The mean HiMAT sum score was 46.2 (95% confidence interval=44.4 to 48.1). The HiMAT had a ceiling effect of 22.8%. The correlation between HiMAT scores and self-reported balance problems was large (r=-.63, P<.001). Interrater and intrarater reliability of the HiMAT sum score was high (interrater ICC=.99, intrarater ICC=.95). The MDC was -3 to +4 points. Responsiveness was good, and the HiMAT discriminated well between patients with self-perceived improved balance function versus unchanged balance function (area under the curve=0.86). Limitations. The small sample size, a ceiling effect, and lack of a gold standard were limitations of the study. Conclusions. The HiMAT demonstrated satisfactory measurement properties for patients with MTBI. The HiMAT can be used as an outcome measure of balance and mobility problems in patients with MTBI.	[Kleffelgaard, Ingerid; Roe, Cecile; Hellstrom, Torgeir; Soberg, Helene L.] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Kleffelgaard, Ingerid] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth Sci, Dept Physiotherapy, Oslo, Norway; [Roe, Cecile] Univ Oslo, Fac Med, N-0316 Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Unit Biostat & Epidemiol, N-0424 Oslo, Norway		Kleffelgaard, I (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4956, N-0424 Oslo, Norway.	inff@live.no	Hellstrom, Torgeir/AAY-6043-2021; Hellstrom, Torgeir/AAW-4301-2021	Hellstrom, Torgeir/0000-0003-0831-3274; 	Norwegian Fund for Postgraduate Training in Physiotherapy	This study was financially supported by the Norwegian Fund for Postgraduate Training in Physiotherapy.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Collen F M, 1991, Int Disabil Stud, V13, P50; Coman L, 2006, CAN J AGING, V25, P253, DOI 10.1353/cja.2007.0001; Finch E, 2002, PHYS REHABILITATION, Vix, P320; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Quinn B, 2000, BRAIN INJURY, V14, P1063; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; ROSNER B, 2005, FUNDAMENTALS BIOSTAT; Shumway-Cook A, 2000, MOTOR CONTROL THEORY, p[x, 614]; Soberg HL, 2011, J TRAUMA, V71, P425, DOI 10.1097/TA.0b013e3181eff54f; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Stauffer ME, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/231926; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, HIGH LEVEL MOBILITY; Williams GP, 2009, INT J THER REHABIL, V16, P370, DOI 10.12968/ijtr.2009.16.7.43046; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0	34	12	12	0	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2013	93	7					900	910		10.2522/ptj.20120381			11	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	176QU	WOS:000321320000005	23504342	Green Published, Bronze			2022-02-06	
J	Ranson, C; Peirce, N; Young, M				Ranson, Craig; Peirce, Nicholas; Young, Mark			Batting head injury in professional cricket: a systematic video analysis of helmet safety characteristics	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							ICE HOCKEY; BASEBALL; IMPACT	Background Batters in cricket are continuing to sustain head and facial injuries despite wearing protective helmets. Objective To gain an understanding of the types and mechanisms of head injuries sustained by batters wearing a helmet. Methods Injury type, location and mechanism were categorised via analysis of 35 videos of National or International cricketers sustaining a head injury while batting. Results 53% of the injuries occurred following ball impact to either the helmet faceguard and peak, or the faceguard alone. Ten injuries (29%) resulted from the ball penetrating the gap between the helmet peak and faceguard. 29% of the injuries involved the ball contacting the face following penetration of the gap between the helmet peak and faceguard. Fractures, lacerations and contusions were the most common injuries associated with face or faceguard impacts while concussion was more commonly associated with impacts to the side or rear of the helmet shell. Many of the injuries described resulted in prolonged or permanent absence from cricket. Conclusions Significant head and facial injuries occur in cricket batters despite wearing of helmets. Cricket helmet design and associated National and International Safety Standards should be improved to provide increased protection against head injury related to ball impact to the faceguard and shell of the helmet.	[Ranson, Craig] Cardiff Metropolitan Univ UWIC, Cardiff Sch Sport, Cardiff CF23 6XD, S Glam, Wales; [Peirce, Nicholas; Young, Mark] England & Wales Cricket Board, Sci & Med Dept, Loughborough, Leics, England		Ranson, C (corresponding author), Cardiff Metropolitan Univ UWIC, Cardiff Sch Sport, Cardiff CF23 6XD, S Glam, Wales.	cranson@cardiffmet.ac.uk	Ranson, Craig/AAQ-5452-2020	peirce, nicholas/0000-0002-3272-5060; Ranson, Craig/0000-0002-3783-0505	ICC; ICC Medical Committee	The authors acknowledge the ICC and ICC Medical Committee for their support of the project. Thanks also go to project collaborators at the Loughborough Sports Technology Institute, Nikunj Velani, Dr Andy Harland and Will Sach.	Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; British Standards Institute B, 1998, 7927 BS I; Caswell SV, 2012, AM J SPORTS MED; [Council for Standards Australia New New Zealand SS], 449913 ASNZS; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; Dick R, 2007, J ATHL TRAINING, V42, P255; Echlin PS, 2005, BRIT J SPORT MED, V39, P254, DOI 10.1136/bjsm.2004.013128; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; National Operating Committee on Standards for Athletic Equipment N, 2010, 024 NOCSAE; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P63; Orchard JW, 2006, J SCI MED SPORT, V9, P459, DOI 10.1016/j.jsams.2006.05.001; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25	15	12	12	0	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	JUL	2013	47	10					644	648		10.1136/bjsports-2012-091898			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	161AP	WOS:000320162600014	23418269				2022-02-06	
J	Pastore, V; Colombo, K; Villa, F; Galbiati, S; Adduci, A; Poggi, G; Massimino, M; Recla, M; Liscio, M; Strazzer, S				Pastore, Valentina; Colombo, Katia; Villa, Federica; Galbiati, Susanna; Adduci, Annarita; Poggi, Geraldina; Massimino, Maura; Recla, Monica; Liscio, Mariarosaria; Strazzer, Sandra			Psychological and adjustment problems due to acquired brain lesions in pre-school-aged patients	BRAIN INJURY			English	Article						Acquired brain injury; children; psychological problems	TERM-FOLLOW-UP; HEAD-INJURY; PSYCHIATRIC-DISORDERS; SOCIAL COMPETENCE; TUMOR SURVIVORS; CHILDREN; CHILDHOOD; ADOLESCENTS; RECOVERY; OUTCOMES	Objective: To describe and compare psychological, behavioural and adjustment problems in pre-school patients with acquired brain lesions of different aetiology. Methods: Three groups of patients with acquired brain lesions (14 patients post-TBI, 18 brain tumour survivors and 23 patients with vascular or infectious brain lesions), ranging in age between 24-47 months, received a psychological evaluation, including the Child Behavior Checklist for Ages 2-3 (CBCL) and the Vineland Adaptive Behavior Scales (VABS). Results: About half of the total sample (47.2%) showed psychological and behavioural problems. Difficulties vary according to the aetiology of the brain lesions. Brain tumour survivors showed more marked internalizing problems, whereas children with vascular or infectious brain lesions scored higher on the CBCL externalizing scales. Children with traumatic brain injury reported intermediate scores on most of the CBCL scales. Conclusions: Psychological and behavioural difficulties are very common, not only among school-aged children and adolescents, but also among pre-schoolers with acquired brain lesions. The relevance and the impact of these difficulties must necessarily be considered when developing psychological treatment and rehabilitation plans and planning for social re-entry.	[Pastore, Valentina; Colombo, Katia; Villa, Federica; Galbiati, Susanna; Adduci, Annarita; Poggi, Geraldina; Recla, Monica; Liscio, Mariarosaria; Strazzer, Sandra] IRCCS Eugenio Medea, I-23842 Bosisio Parini, LC, Italy; [Massimino, Maura] Natl Tumor Inst, Milan, Italy		Pastore, V (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, LC, Italy.	valentina.pastore@bp.lnf.it	Poggi, Geraldina/K-4490-2016; Colombo, Katia/ABE-5754-2020; Strazzer, Sandra/AAH-5712-2019; Galbiati, Susanna/AAH-6883-2019; massimino, maura/K-7310-2016; Pastore, Valentina/AAH-6831-2019; Recla, Monica/ABG-1905-2020	Poggi, Geraldina/0000-0003-0589-6347; Colombo, Katia/0000-0002-5390-106X; Strazzer, Sandra/0000-0001-8414-6565; Galbiati, Susanna/0000-0001-7209-4251; massimino, maura/0000-0002-5506-2001; Pastore, Valentina/0000-0002-3170-3070; Recla, Monica/0000-0002-3001-8872			Achenbach T., 1991, ATTENTION PROBLEMS C MANUAL CHILD BEHAV C; Adduci A, 2012, PEDIATR BLOOD CANCER, V59, P290, DOI 10.1002/pbc.24165; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Barbero P, 2003, REV NEUROLOGIA, V36, P143; Berg S, 2002, EUR J PEDIATR, V161, P330, DOI 10.1007/s00431-002-0957-1; BOONYAPRAKOB V, 1981, J MED ASSOC THAILAND, V64, P249; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CAPLAN R, 1987, J AM ACAD CHILD PSY, V26, P440, DOI 10.1097/00004583-198705000-00029; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; DANOFF BF, 1982, CANCER, V48, P1580, DOI 10.1002/1097-0142(19820415)49:8<1580::AID-CNCR2820490810>3.0.CO;2-7; Daseking M, 2008, FORTSCHR NEUROL PSYC, V76, P662, DOI 10.1055/s-2008-1038262; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fossen A, 1998, PEDIATR HEMAT ONCOL, V15, P479, DOI 10.3109/08880019809018309; Fuemmeler BF, 2002, CLIN PSYCHOL REV, V22, P547, DOI 10.1016/S0272-7358(01)00120-9; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Griffiths R, 1996, GRIFFITHS MENTAL DEV; Gualtieri CT, 1999, NEUROREHABILITATION, V13, P103; Halket S, 2003, ARCH DIS CHILD, V88, P395, DOI 10.1136/adc.88.5.395; Hooper L, 2007, NEUROPSYCHOL REHABIL, V17, P621, DOI 10.1080/09602010601137054; JENNETT B, 1975, LANCET, V1, P480; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MULHERN RK, 1993, J PEDIATR PSYCHOL, V18, P339, DOI 10.1093/jpepsy/18.3.339; MULHERN RK, 1989, PEDIATRICS, V83, P18; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; Nybo T, 1999, BRAIN INJURY, V13, P759; Pastore V, 2011, DISABIL REHABIL, V33, P675, DOI 10.3109/09638288.2010.506239; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Poggi G, 2005, BRAIN INJURY, V19, P777, DOI 10.1080/0269905500110132; Poggi G, 2005, PSYCHO-ONCOLOGY, V14, P386, DOI 10.1002/pon.855; Poggi G, 2009, DISABIL REHABIL, V31, P1066, DOI 10.1080/09638280802509546; Thompson JR, 1999, ADAPTIVE BEHAVIOR AND ITS MEASUREMENT, P15; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; WIDAMAN KF, 1996, MANUAL DIAGNOSIS PRO; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	44	12	12	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					677	684		10.3109/02699052.2013.775482			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500006	23560501				2022-02-06	
J	Saxena, MK; Taylor, CB; Hammond, NE; Young, PJ; Seppelt, IM; Glass, P; Myburgh, JA				Saxena, Manoj K.; Taylor, Colman B.; Hammond, Naomi E.; Young, Paul J.; Seppelt, Ian M.; Glass, Parisa; Myburgh, John A.		George Inst Global Hlth; ANZICS Clinical Trials Grp	Temperature management in patients with acute neurological lesions: an Australian and New Zealand point prevalence study	CRITICAL CARE AND RESUSCITATION			English	Article							PERCUSSION BRAIN-INJURY; LENGTH-OF-STAY; BODY-TEMPERATURE; PARACETAMOL ACETAMINOPHEN; SUBARACHNOID HEMORRHAGE; CRITICALLY-ILL; PROTEIN-LEVELS; HYPERTHERMIA; STROKE; HYPOTHERMIA	Background: Given the scientific uncertainty of the efficacy and safety of normothermia (36.0 degrees C to 37.5 degrees C) on disability and death after acute neurological lesions, we sought to understand how temperature is managed in usual clinical care for this patient population in Australia and New Zealand. Objective: To describe temperature management in patients with acute neurological lesions. Design: Prospective, observational, multicentre, single-day point-prevalence study. Participants, setting and methods: Observational data of usual practice were recorded for all patients with an intensive care admission diagnosis of acute neurological lesions and who were present in 33 intensive care units at 10:00 on the study day. Data were collected prospectively for the ensuing 24-hour period. Main outcome measures: Achieved temperature, interventions used to modify temperature and target temperature. Results: There were 106 patients with acute neurological lesions (61% with either stroke or traumatic brain injury) with a mean APACHE (Acute Physiology and Chronic Health Evaluation) II score of 19.3 +/- 7.4, age of 53.5 +/- 19.0 years and median time from intensive care admission to data capture of 3 days (interquartile range, 1-9). A target temperature was specified in 24% of patients. Although paracetamol was commonly used (56%), it was infrequently used at the maximum licensed dose and there was no use recorded of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors. Physical cooling was used in 25% of patients and core temperature was measured in 32%. Measured temperature often exceeded 37.0 degrees C (62% of readings), 37.5 degrees C (43%) and 38.0 degrees C (22%). Conclusions: Temperature readings above 37.5 degrees C are common. Further cohort studies are required to validate these preliminary, exploratory findings.	[Saxena, Manoj K.; Myburgh, John A.] St George Hosp, Dept Intens Care Med, Sydney, NSW, Australia; [Saxena, Manoj K.; Taylor, Colman B.; Hammond, Naomi E.; Seppelt, Ian M.; Glass, Parisa; Myburgh, John A.] George Inst Global Hlth, Sydney, NSW, Australia; [Saxena, Manoj K.; Myburgh, John A.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia; [Young, Paul J.] Med Res Inst New Zealand, Wellington, New Zealand; [Young, Paul J.] Wellington Reg Hosp, Intens Care Unit, Wellington, New Zealand; [Seppelt, Ian M.] Australian & New Zealand Intens Care Soc Clin Tri, Melbourne, Vic, Australia; [Seppelt, Ian M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia		Saxena, MK (corresponding author), St George Hosp, Dept Intens Care Med, Sydney, NSW, Australia.	m.saxena@unsw.edu.au		Hammond, Naomi/0000-0002-6559-7747; Young, Paul/0000-0002-3428-3083; Micallef, Sharon/0000-0002-8496-2324; Glass, Parisa/0000-0002-1334-7156; Saxena, Manoj/0000-0002-0385-6731	Intensive Care Foundation; St George Honda Critical Care; Trauma Fellowship	The Point Prevalence Program is funded by the Intensive Care Foundation. Manoj Saxena and John Myburgh are recipients of an unrestricted grant from the St George Honda Critical Care and Trauma Fellowship.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS53; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Childs Charmaine, 2010, Front Neurol, V1, P146, DOI 10.3389/fneur.2010.00146; *CURR CONTR TRIALS, EUR SOC INT CAR MED; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Den Hertog HM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001247.pub2; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Drennan K, 2010, INTENSIVE CARE RESOU; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Harris B, 2011, J ADV NURS, V67, P1173, DOI 10.1111/j.1365-2648.2011.05703.x; Huschak G, 2008, J NEUROSURG ANESTH, V20, P105, DOI 10.1097/ANA.0b013e31815f528c; Jefferies S, 2011, CRIT CARE RESUSC, V13, P194; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jorgensen HS, 2001, CEREBROVASC DIS, V11, P207, DOI 10.1159/000047640; KATO H, 1991, NEUROSCI LETT, V126, P21, DOI 10.1016/0304-3940(91)90361-V; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Manno EM, 2004, CRIT CARE MED, V32, P1611, DOI 10.1097/01.CCM.0000131864.83506.86; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Mcilvoy Laura, 2007, J Neurosci Nurs, V39, P324; Moran JL, 2007, CRIT CARE MED, V35, P155, DOI 10.1097/01.CCM.0000250318.31453.CB; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Saxena M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub2; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Suehiro E, 1999, J NEUROTRAUM, V16, P285, DOI 10.1089/neu.1999.16.285; TAKAGI K, 1994, AM J PHYSIOL-HEART C, V267, pH1770, DOI 10.1152/ajpheart.1994.267.5.H1770; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C	41	12	12	0	4	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2013	15	2					110	118					9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151UJ	WOS:000319485400007	23931042				2022-02-06	
J	Zampolini, M; Corea, F; Avesani, R; Boldrini, P; De Tanti, A; Di Stefano, MG; Formisano, R; Lamberti, G; Lombardi, F; Mazzucchi, A; Pistarini, C; Taricco, M; Citterio, A				Zampolini, M.; Corea, F.; Avesani, R.; Boldrini, P.; De Tanti, A.; Di Stefano, M. G.; Formisano, R.; Lamberti, G.; Lombardi, F.; Mazzucchi, A.; Pistarini, C.; Taricco, M.; Citterio, A.		Giscar Grp	Rehabilitation of acquired brain injuries: a multicentric prospective survey	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Rehabilitation; Brain injuries; Health surveys		Background. The rehabilitation of the persons with Severe Acquired Brain Injury (ABI) is an important concern to be approached with a comprehensive program aimed to improve the recovery of patients. The efficacy of an early and intensive rehabilitation program has been shown in large number of studies. Few studies focused on the prevalence of TBI and the data are often extrapolated in indirect ways. Aim. An analysis of the demographic characteristics of the population included in the GISCAR (Gruppo Italian per lo Studio delle Gravi Cerebrolesioni Acquisite e Riabilitazione- Italian Group for the Study of the severe ABI) database, type and conditions associated to the index event; the treatment administered during hospitalization; and the prognosis according to outcome measures. Design. The study was an observational prospective survey looking at management of ABI (both traumatic and non-traumatic). Setting. In hospital rehabilitation. Population. Patients consecutively admitted in each of the 52 GISCAR centres. Methods. Every centre included a consecutive cohort and recorded demographic data and index event characteristics. Results. In the study population were included 2626 subjects suffering of a severe ABI. The difference of length of stay (LOS) was significantly different with 67.5 days for traumatic patients compared to the 80 days of non traumatic ones. In the study population the probability of discharge at home is significantly greater for the traumatic condition (odds ratio 0,4587; CI 0.3671-0.5731). The overall benefit of the rehabilitative treatment was encountered in a net gain in all disability scores taken into account: LCF classes; DRS as well as GOS scores. At discharge the main destination for severe ABI patients was home (67.2%). Conclusions. A large number of patients admitted in Italian rehabilitative facilities for a severe ABI suffered from a TBI, more often these subjects were young male victims of road accident. The majority of subjects during the rehabilitative hospitalization demonstrated a significant recovery. Clinical Rehabilitation Impact. Considering the evidence of an early treatment benefit the delay of-the rehabilitation program start is far from being satisfactory. The high frequency of the home discharge indicate a good compliance of national family network.	[Zampolini, M.; Corea, F.] Severe Acquired Brain Les, Operat Unit, Perugia, Italy; [Avesani, R.] Don Calabria Hosp, Dept Funct Reeduc, Verona, Italy; [Boldrini, P.] Ferrara Hosp, Operat Unito Rehabil Med F, Ferrara, Italy; [De Tanti, A.] Ctr Cardinal Ferrari, Parma, Italy; [Di Stefano, M. G.] Cuasso al Monte Hosp, Operat Unit Recovery & Funct Reeduc, Cuasso Al Monte, Varese, Italy; [Formisano, R.] Santa Lucia IRCCS Fdn, Rome, Italy; [Lamberti, G.] Severe Brain Les Unit, Caraglio, Cuneo, Italy; [Lombardi, F.] Correggio Hosp, Dept Intens Care Unit, Correggio, Reggio Emilia, Italy; [Mazzucchi, A.] ELIAS Neuroriabilitaz, Parma, Italy; [Pistarini, C.] Fdn Clin Lavoro S Maugeri, Pavia, Italy; [Taricco, M.] S Orsola Univ Hospitalm, Operat Unit Rehabil Med, Bologna, Italy; [Citterio, A.] Ist Mondino, Pavia, Italy		Zampolini, M (corresponding author), Severe Acquired Brain Les, Operat Unit, ASL 3 Umbria, Foligno, Italy.	m.zampo1ini@asl3.umbria.it	corea, francesco/ABH-1776-2020; Pistarini, CATERINA/K-5234-2018	corea, francesco/0000-0002-5864-9991; Pistarini, CATERINA/0000-0001-8925-0484; LOMBARDI, Francesco/0000-0002-7184-6391			Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; CALDWELL MTP, 1993, IRISH J MED SCI, V162, P309, DOI 10.1007/BF02960726; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; FREEMAN J, 1981, REV INFECT DIS, V3, P658; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoffmann B, 2002, ACT NEUR S, V79, P33; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Mammi P, 2006, Eura Medicophys, V42, P17; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Mazaux JM, 2001, J REHABIL MED, V33, P99; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taricco M, 2006, Eura Medicophys, V42, P73; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	30	12	12	0	4	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	JUN	2013	49	3					365	372					8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	200UD	WOS:000323095500010	23389644				2022-02-06	
J	Cao, P; Liang, Y; Gao, X; Zhao, MG; Liang, GB				Cao, Peng; Liang, Yong; Gao, Xu; Zhao, Ming-Guang; Liang, Guo-Biao			RETRACTED: Administration of MS-275 Improves Cognitive Performance and Reduces Cell Death Following Traumatic Brain Injury in Rats (Retracted article. See vol. 20, pg. 1011, 2014)	CNS NEUROSCIENCE & THERAPEUTICS			English	Article; Retracted Publication						Hippocampus; Histone deacetylase; Inflammation; Morris water maze; MS-275; Traumatic brain injury	LATERAL FLUID-PERCUSSION; HISTONE DEACETYLASE INHIBITORS; ACUTE NEURONAL DEGENERATION; HDAC INHIBITORS; BEHAVIORAL DEFICITS; HUNTINGTONS-DISEASE; FLUORO-JADE; MOUSE MODEL; HEAD-INJURY; IN-VIVO	Aims The MS-275 is a selective inhibitor of class I histone deacetylases (HDACs), which has been reported as a potential strategy in some central nervous system diseases associated with neurodegeneration and disturbed learning. However, its role in traumatic brain injury is not well defined. In this study, we examined the behavioralcognitive performance as well as histology outcome in adult rats to evaluate whether postinjury administration of MS-275 (15 and 45mg/kg) would provide neuroprotection benefits and ameliorate cognitive deficits following fluid percussion injury. Methods Traumatic brain injury (2.15 ATMs) was produced using a fluid percussion device with the lateral orientation. MS-275 was administered (15 and 45mg/kg) systemically once daily for 7days starting at 30min after lateral fluid percussion TBI. Acquisition of spatial learning and memory retention was assessed using the Morris water maze (MWM) on days 1014 after TBI. Brain tissues were collected and stained with Fluoro-Jade B histofluorescence (for degenerating neurons) at 24h after injury and cresyl violet (for long-term neuronal survival) on day 14 postinjury. Results Behavioral outcome after TBI revealed MS-275 treatment groups, at all doses examined, performed significantly better in the Morris Water Maze (P<0.001). Acute histology analysis demonstrated that 45mg/kg MS-275 significantly reduced the number of degenerating neurons in the ipsilateral CA23 hippocampus at 24h postinjury (P=0.007). There was a trend for MS-275 to increase the survival of neurons in the CA23 hippocampus on 14days after TBI (P=0.164). Conclusion Our present data highlight the fact that MS-275 may provide neuroprotective effect and improve cognitive performance after TBI. We concluded that MS-275 is a potential novel treatment and will have an ameliorative effect on some of the pathological features associated with TBI.	[Cao, Peng; Liang, Yong; Gao, Xu; Zhao, Ming-Guang; Liang, Guo-Biao] Shenyang Northern Hosp, Dept Neurosurg, 83 Wenhua Rd, Shenyang 110018, Liaoning Provin, Peoples R China		Liang, GB (corresponding author), Shenyang Northern Hosp, Dept Neurosurg, 83 Wenhua Rd, Shenyang 110018, Liaoning Provin, Peoples R China.	liangguobiaosy@gmail.com					Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Bin Z, 2008, BRAIN RES, V1226, P181; Butler KV, 2008, CURR PHARM DESIGN, V14, P505; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kozikowski AP, 2007, J MED CHEM, V50, P3054, DOI 10.1021/jm070178x; Kwon SH, 2002, J BIOL CHEM, V277, P2073, DOI 10.1074/jbc.M106699200; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Lin HS, 2007, BRIT J PHARMACOL, V150, P862, DOI 10.1038/sj.bjp.0707165; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Riba-Bosch A, 2004, NEUROSCIENCE, V125, P803, DOI 10.1016/j.neuroscience.2004.02.017; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Simonini MV, 2006, P NATL ACAD SCI USA, V103, P1587, DOI 10.1073/pnas.0510341103; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomas EA, 2009, MOL NEUROBIOL, V40, P33, DOI 10.1007/s12035-009-8067-y; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang ZY, 2010, NEUROSCIENCE, V169, P370, DOI 10.1016/j.neuroscience.2010.04.074; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	52	12	12	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	MAY	2013	19	5					337	345		10.1111/cns.12082			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	133BQ	WOS:000318112800007	23551690	Green Published			2022-02-06	
J	Cegla, J; Jones, B; Seyani, L; Papadoulou, D; Wynne, K; Martin, NM; Meeran, K; Chapman, R; Donaldson, M; Goldstone, AP; Tan, T				Cegla, Jaimini; Jones, Ben; Seyani, Lata; Papadoulou, Deborah; Wynne, Katie; Martin, Niamh M.; Meeran, Karim; Chapman, Richard; Donaldson, Mandy; Goldstone, Anthony P.; Tan, Tricia			Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism	CLINICAL ENDOCRINOLOGY			English	Article							PITUITARY-ADRENAL AXIS; INSULIN HYPOGLYCEMIA; GROWTH-HORMONE; CORTISOL RESPONSES; ACTH; SURGERY; ADRENOCORTICOTROPIN; INSUFFICIENCY; DYSFUNCTION	Objective The insulin tolerance test (ITT) is contraindicated in a proportion of patients with suspected ACTH deficiency. The aim of this study was to investigate the diagnostic accuracy of the glucagon stress test (GST) compared with the overnight metyrapone test (OMT) in patients with contraindications to ITT. Design This was a prospective comparison of the GST to the OMT in patients with suspected ACTH deficiency and contraindications to the ITT. The OMT was used as the standard for comparison. The study was conducted at two tertiary referral centres for pituitary disease. Patients Seventy-eight patients underwent contemporaneous OMT and GST of whom 61 had sufficient suppression of cortisol during the OMT to be included in the comparison. Forty had suffered traumatic brain injury, 36 had organic pituitary disorders and two were classified as other'. Measurements ACTH sufficiency was defined as 0800h 11-deoxycortisol200nmol/l on OMT and peak cortisol440nmol/l on GST, as per local reference ranges. Results There was significant discrepancy between the proportion of patients diagnosed with ACTH deficiency using the OMT (39%) and GST (89%). From our data, a GST peak cortisol cut-off of 350nm provides the combination of optimal sensitivity (71%) and specificity (57%), compared with a higher sensitivity (88%) but poor specificity (11%) using a cut-off of 440nm. Conclusions The GST should be used with caution as a diagnostic test of ACTH reserve. The OMT should be used in preference to the GST to assess the hypothalamic pituitary adrenal axis where ITT is contraindicated.	[Cegla, Jaimini; Jones, Ben; Papadoulou, Deborah; Wynne, Katie; Martin, Niamh M.; Meeran, Karim; Tan, Tricia] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Diabet Endocrinol & Metab, London W12 0NN, England; [Cegla, Jaimini; Jones, Ben; Seyani, Lata; Chapman, Richard; Donaldson, Mandy; Tan, Tricia] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Healthcare NHS Trust, Dept Clin Biochem, Hammersmith Hosp, London, England; [Goldstone, Anthony P.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, Metab & Mol Imaging Grp, London W12 0NN, England		Tan, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Diabet Endocrinol & Metab, 6th Floor,Commonwealth Bldg,Du Cane Rd, London W12 0NN, England.	t.tan@imperial.ac.uk	Tan, Tricia/ABD-5502-2020; Tan, Tricia M.M./C-7140-2011; Wynne, Katie/P-9465-2019	Tan, Tricia/0000-0001-5873-3432; Wynne, Katie/0000-0002-7980-3337; Jones, Benjamin/0000-0003-0461-2584; Goldstone, Anthony/0000-0001-8179-7071	NIHRNational Institute for Health Research (NIHR); Wellcome TrustWellcome TrustEuropean Commission	NMM is supported by an NIHR Clinical Senior Lectureship award. JC is supported by a Wellcome Trust Clinical Ph.D. Fellowship.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Berg C, 2010, EUR J ENDOCRINOL, V162, P477, DOI 10.1530/EJE-09-0824; Berneis K, 2002, J CLIN ENDOCR METAB, V87, P5470, DOI 10.1210/jc.2001-011959; Courtney CH, 2004, J CLIN ENDOCR METAB, V89, P1712, DOI 10.1210/jc.2003-031577; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P309; DOLMAN LI, 1979, JAMA-J AM MED ASSOC, V241, P1251, DOI 10.1001/jama.241.12.1251; FAHY TJ, 1968, PSYCHOPHARMACOLOGIA, V12, P367, DOI 10.1007/BF00401416; FIAD TM, 1994, CLIN ENDOCRINOL, V40, P603, DOI 10.1111/j.1365-2265.1994.tb03011.x; Gibney J, 2008, J CLIN ENDOCR METAB, V93, P3763, DOI 10.1210/jc.2008-0154; Giordano R, 2008, CLIN ENDOCRINOL, V68, P935, DOI 10.1111/j.1365-2265.2007.03141.x; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; John K, 1985, Padiatr Grenzgeb, V24, P391; LANDON J, 1966, J CLIN INVEST, V45, P437, DOI 10.1172/JCI105358; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; LITTLEY MD, 1989, CLIN ENDOCRINOL, V31, P527, DOI 10.1111/j.1365-2265.1989.tb01276.x; Mukherjee JJ, 1997, CLIN ENDOCRINOL, V47, P51, DOI 10.1046/j.1365-2265.1997.2151035.x; Orme SM, 1996, CLIN ENDOCRINOL, V45, P135, DOI 10.1046/j.1365-2265.1996.d01-1562.x; PERUCCA E, 1982, CLIN PHARMACOKINET, V7, P57, DOI 10.2165/00003088-198207010-00004; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; Rasmussen E, 1998, CLIN PHARMACOL THER, V64, P150, DOI 10.1016/S0009-9236(98)90148-5; SPRUNT JG, 1968, ACTA ENDOCRINOL-COP, V59, P447, DOI 10.1530/acta.0.0590447; STEINER H, 1994, EXP CLIN ENDOCRINOL, V102, P33, DOI 10.1055/s-0029-1211262	23	12	14	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	MAY	2013	78	5					738	742		10.1111/cen.12043			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	126KX	WOS:000317615300016	22998100				2022-02-06	
J	Dams-O'Connor, K; Gordon, WA				Dams-O'Connor, Kristen; Gordon, Wayne A.			Integrating Interventions after Traumatic Brain Injury: A Synergistic Approach to Neurorehabilitation	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; neurorehabilitation; executive functioning	OF-THE-LITERATURE; COGNITIVE REHABILITATION; NEUROPSYCHOLOGIC REHABILITATION; EXECUTIVE DYSFUNCTION; CORTICAL PLASTICITY; PROCESSING SPEED; ATTENTION; INDIVIDUALS; DEFICITS; MEMORY	Deficits in attention, processing speed and executive functioning are among the most commonly reported and functionally limiting cognitive impairments among individuals with TBI. Changes in mood can exacerbate cognitive deficits and reduce life quality. Contemporary hierarchical models of cognitive functioning suggest that attention/arousal processes underlie and support higher-order functions. Building on decades of clinical research, a synergistic, integrative approach to neurorehabilitation is described, which combines bottom-up and top-town cognitive interventions in addition to psychotherapeutic interventions for mood. This approach is intended to address directly impairments in both foundational (i.e., attention) and higher-order (i.e., executive functions) processes. Executive dysfunction is addressed in a top-down fashion through the application of a series of problem-solving and emotional regulation modules that teach and integrate strategies that can be generalised across situations with practice. Attention, arousal and information processing are necessary prerequisites of successful higher-order thinking, attention skills, and are addressed in a bottom-up fashion through intensive individualised attention and processing training tasks. Combining top-down and bottom-up approaches within a comprehensive day-treatment programme can effect a synergistic improvement of overall functioning.	[Dams-O'Connor, Kristen; Gordon, Wayne A.] Ichan Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Dams-O'Connor, K (corresponding author), Ichan Sch Med Mt Sinai, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	Kristen.dams-o'connor@mountsinai.org			National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133B040033]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5R49-CE-001171]	This work was supported by Grant No. H133B040033, National Institute on Disability and Rehabilitation Research, US Department of Education; Grant No. 5R49-CE-001171, Centers for Disease Control and Prevention. The authors report no conflict of interests.	Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ashman TA, 2006, MT SINAI J MED, V73, P999; Barnes DE, 2009, ALZ DIS ASSOC DIS, V23, P205, DOI 10.1097/WAD.0b013e31819c6137; Benson D.F., 1986, FRONTAL LOBES; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; D'Zurilla T. J., 1988, HDB COGNITIVE BEHAV; D'Zurilla TJ, 2001, HANDBOOK OF COGNITIVE-BEHAVIORAL THERAPIES, SECOND EDITION, P211; Dijkers M. P., 2004, ARCH PHYS MED REHAB, V85, pE12; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; FOXX RM, 1989, BEHAV THER, V20, P61, DOI 10.1016/S0005-7894(89)80118-2; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Hibbard M. R., 2005, COGNITIVE BEHAV THER, P189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Honda Tetsumi, 1999, Top Stroke Rehabil, V6, P15, DOI 10.1310/CN46-B2WU-NGVN-37YJ; HUX K, 1994, APPL COGNITIVE PSYCH, V8, P259, DOI 10.1002/acp.2350080305; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1990, TRAUMATIC BRAIN INJU, P365; LURIA AR, 1964, NEUROPSYCHOLOGIA, V2, P95, DOI 10.1016/0028-3932(64)90015-6; Luria AR, 1963, RESTORATION FUNCTION; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MEICHENBAUM D, 1974, PSYCHOTHER-THEOR RES, V11, P103, DOI 10.1037/h0086326; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Merzenich MM, 1999, RES PER NEUROSCI, P169; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; O'Callaghan ME, 1998, COGNITIVE THER RES, V22, P91, DOI 10.1023/A:1018720120738; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SCHERZER BP, 1986, ARCH PHYS MED REHAB, V67, P366; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; SHALLICE T, 1981, BRIT MED BULL, V37, P187, DOI 10.1093/oxfordjournals.bmb.a071699; Simon D, 2001, REHABIL PSYCHOL, V46, P330; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Sohlberg M. M., 2003, J MED SPEECH LANGUAG, V11; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Sun R., 2004, Cognitive Systems Research, V5, P63, DOI 10.1016/j.cogsys.2003.07.001; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P655; [No title captured]	86	12	12	1	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2013	14	1			SI		51	62		10.1017/BrImp.2013.9			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	189EY	WOS:000322251300006					2022-02-06	
J	Stout, EE; Beloozerova, IN				Stout, Erik E.; Beloozerova, Irina N.			Differential responses of fast- and slow-conducting pyramidal tract neurons to changes in accuracy demands during locomotion	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							CAT MOTOR CORTEX; PRIMATE CORTICOMOTONEURONAL CELLS; VOLUNTARY GAIT MODIFICATIONS; MULTIJOINT ARM MOVEMENTS; DORSAL PREMOTOR CORTEX; CEREBRAL-CORTEX; CORTICOSPINAL PROJECTIONS; DISCHARGE PATTERNS; REACHING MOVEMENTS; CORTICAL ACTIVITY	Key points center dot The motor cortex is highly involved in performing complex movements including skilled locomotion. center dot Slow-conducting pyramidal tract neurons (PTNs) in the motor cortex are much more numerous than fast-conducting PTNs, but little is known about their function during movements. center dot We find here that slow-conducting PTNs show vigorous and concerted changes to their activities during accurate targeted stepping versus simple locomotion over a flat surface, while changes to the activities of fast-conducting PTNs vary. center dot This suggests that slow-conducting PTNs are involved to a greater extent in control of accuracy during locomotion. center dot The results may be relevant to developing therapies for stroke and traumatic brain injury. Abstract Most movements need to be accurate. The neuronal mechanisms controlling accuracy during movements are poorly understood. In this study we compare the activity of fast- and slow-conducting pyramidal tract neurons (PTNs) of the motor cortex in cats as they walk over both a flat surface, a task that does not require accurate stepping and can be accomplished without the motor cortex, as well as along a horizontal ladder, a task that requires accuracy and the activity of the motor cortex to be successful. Fast- and slow-conducting PTNs are known to have distinct biophysical properties as well as different afferent and efferent connections. We found that while the activity of all PTNs changes substantially upon transition from simple locomotion to accurate stepping on the ladder, slow-conducting PTNs respond in a much more concerted manner than fast-conducting ones. As a group, slow-conducting PTNs increase discharge rate, especially during the late stance and early swing phases, decrease discharge variability, have a tendency to shift their preferred phase of the discharge into the swing phase, and almost always produce a single peak of activity per stride during ladder locomotion. In contrast, the fast-conducting PTNs do not display such concerted changes to their activity. In addition, upon transfer from simple locomotion to accurate stepping on the ladder slow-conducting PTNs more profoundly increase the magnitude of their stride-related frequency modulation compared with fast-conducting PTNs. We suggest that slow-conducting PTNs are involved in control of accuracy of locomotor movements to a greater degree than fast-conducting PTNs.	[Stout, Erik E.; Beloozerova, Irina N.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA		Beloozerova, IN (corresponding author), St Josephs Hosp, Barrow Neurol Inst, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	ibelooz@chw.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS-39340, R01 NS-058659]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058659, R01NS039340] Funding Source: NIH RePORTER	The authors are thankful to Dr Zinaida Tamarova for help with data acquisition, to Mr Peter Wettenstein for excellent engineering assistance, and to Drs Mikhail Sirota and Vladimir Marlinski for valuable suggestions and discussions. The research reported in this paper was supported by NIH grants R01 NS-39340 and R01 NS-058659 to I.N.B.	AMOS A, 1990, NEUROSCI LETT, V109, P107, DOI 10.1016/0304-3940(90)90546-L; ANTAL M, 1984, J HIRNFORSCH, V25, P647; ARMSTRONG DM, 1984, J PHYSIOL-LONDON, V346, P471, DOI 10.1113/jphysiol.1984.sp015036; ARMSTRONG DM, 1985, J PHYSIOL-LONDON, V367, P309, DOI 10.1113/jphysiol.1985.sp015826; ARMSTRONG DM, 1984, J PHYSIOL-LONDON, V346, P497, DOI 10.1113/jphysiol.1984.sp015037; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Bastian AJ, 2000, J NEUROPHYSIOL, V83, P3019, DOI 10.1152/jn.2000.83.5.3019; Batshelet E, 1981, CIRCULAR STAT BIOL; Beer RF, 2000, EXP BRAIN RES, V131, P305, DOI 10.1007/s002219900275; BELOOZEROVA I N, 1985, Neirofiziologiya, V17, P406; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P27, DOI 10.1113/jphysiol.1993.sp019499; Beloozerova IN, 2005, J NEUROPHYSIOL, V93, P1831, DOI 10.1152/jn.00577.2004; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P1; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; Beloozerova IN, 1988, STANCE MOTION FACTS, P163; Beloozerova IN, 2007, 2007 NEUR M PLANN; Beloozerova IN, 2010, J NEUROPHYSIOL, V103, P2285, DOI 10.1152/jn.00360.2009; BISHOP PO, 1962, J PHYSIOL-LONDON, V162, P409, DOI 10.1113/jphysiol.1962.sp006942; Bishop PO, 1953, J PHYSL, V5, P537; BROOKHART J M, 1952, Res Publ Assoc Res Nerv Ment Dis, V30, P157; BROOKHART JM, 1948, J NEUROPHYSIOL, V11, P387, DOI 10.1152/jn.1948.11.4.387; CALVIN WH, 1976, J NEUROPHYSIOL, V39, P420, DOI 10.1152/jn.1976.39.2.420; Canedo A, 1997, PROG NEUROBIOL, V51, P287, DOI 10.1016/S0301-0082(96)00058-5; CHAMBERS WW, 1957, J COMP NEUROL, V108, P23, DOI 10.1002/cne.901080103; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Criado JM, 1997, PFLUG ARCH EUR J PHY, V434, P91, DOI 10.1007/s004240050367; DESCHENES M, 1979, BRAIN RES, V178, P251, DOI 10.1016/0006-8993(79)90693-0; DESCHENES M, 1982, NEUROSCIENCE, V7, P2149, DOI 10.1016/0306-4522(82)90126-9; Dounskaia N, 2005, EXP BRAIN RES, V166, P1, DOI 10.1007/s00221-005-2339-1; Dounskaia N, 2005, EXP BRAIN RES, V164, P505, DOI 10.1007/s00221-005-2271-4; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; DREW T, 1991, J NEUROSCI METH, V38, P171, DOI 10.1016/0165-0270(91)90167-X; DREW T, 1993, J NEUROPHYSIOL, V70, P179, DOI 10.1152/jn.1993.70.1.179; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; DYACHKOVA LN, 1971, EXP BRAIN RES, V12, P105; Efron B., 1993, INTRO BOOTSTRAP; EVARTS EV, 1965, J NEUROPHYSIOL, V28, P216, DOI 10.1152/jn.1965.28.2.216; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; Fisher NI, 1993, STAT ANAL CIRCULAR D; Friel KM, 2007, J NEUROPHYSIOL, V97, P3396, DOI 10.1152/jn.00750.2006; FROMM C, 1984, EXP BRAIN RES, V54, P177; FROMM C, 1977, NEUROSCI LETT, V5, P259, DOI 10.1016/0304-3940(77)90076-3; FROMM C, 1981, J NEUROSCI, V1, P453; FULLER JH, 1976, BRAIN RES, V112, P283, DOI 10.1016/0006-8993(76)90284-5; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; GHOSH S, 1988, J PHYSIOL-LONDON, V400, P593, DOI 10.1113/jphysiol.1988.sp017138; Ghosh S, 1997, J COMP NEUROL, V388, P371, DOI 10.1002/(SICI)1096-9861(19971124)388:3<371::AID-CNE3>3.0.CO;2-Y; Ghosh S, 1997, J COMP NEUROL, V380, P191, DOI 10.1002/(SICI)1096-9861(19970407)380:2<191::AID-CNE4>3.0.CO;2-Z; Gomez JE, 2000, EUR J NEUROSCI, V12, P3748, DOI 10.1046/j.1460-9568.2000.00232.x; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; HASSLER R, 1964, J Hirnforsch, V7, P377; Hoff EC, 1934, BRAIN, V57, P454, DOI 10.1093/brain/57.4.454; HUMPHREY DR, 1978, J NEUROPHYSIOL, V41, P216, DOI 10.1152/jn.1978.41.1.216; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; LABELLE A, 1979, BRAIN RES, V164, P309, DOI 10.1016/0006-8993(79)90027-1; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; Lassek AM, 1940, J COMP NEUROL, V72, P417, DOI 10.1002/cne.900720209; LEMON RNP, 1993, CORTICOSPINAL FUNCTI; Liddell EGT, 1944, BRAIN, V67, P1, DOI 10.1093/brain/67.1.1; Lloyd DPC, 1941, J NEUROPHYSIOL, V4, P525; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Marlinski V, 2012, J NEUROPHYSIOL, V107, P455, DOI 10.1152/jn.01113.2010; MARPLEHORVAT DE, 1993, J PHYSIOL-LONDON, V462, P87, DOI 10.1113/jphysiol.1993.sp019545; MARTIN JH, 1993, EXP BRAIN RES, V94, P429; MATSUNAMI K, 1980, NEUROSCI LETT, V16, P245, DOI 10.1016/0304-3940(80)90005-1; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Mihaltchev P, 2005, EXP BRAIN RES, V163, P468, DOI 10.1007/s00221-004-2202-9; Myasnikov AA, 1997, BRAIN RES, V750, P95, DOI 10.1016/S0006-8993(96)01337-6; NIEOULLON A, 1976, BRAIN RES, V105, P405, DOI 10.1016/0006-8993(76)90590-4; Novak KE, 2002, EXP BRAIN RES, V144, P351, DOI 10.1007/s00221-002-1060-6; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Prilutsky BI, 2005, J NEUROPHYSIOL, V94, P2959, DOI 10.1152/jn.00704.2004; Pryor K., 1975, LADS WIND; REITBOECK HJ, 1983, J NEUROSCI METH, V8, P249, DOI 10.1016/0165-0270(83)90038-9; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; Sakai H, 1982, Nihon Seirigaku Zasshi, V44, P199; Sirota MG, 2005, J NEUROSCI, V25, P5915, DOI 10.1523/JNEUROSCI.0489-05.2005; Skinner BF, 1938, BEHAV ORGANISMS; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Stout EE, 2010, 2010 NEUR M PLANN; Stout EE, 2012, J NEUROPHYSIOL, V107, P1890, DOI 10.1152/jn.00650.2011; TAKAHASHI K, 1965, J NEUROPHYSIOL, V28, P908, DOI 10.1152/jn.1965.28.5.908; TANJI J, 1978, J PHYSIOL-PARIS, V74, P293; TOWE AL, 1963, EXP NEUROL, V8, P220, DOI 10.1016/0014-4886(63)90033-5; TOWE AL, 1968, EXP NEUROL, V20, P497, DOI 10.1016/0014-4886(68)90105-2; TOYOSHIMA K, 1982, J HIRNFORSCH, V23, P257; Trendelenburg W, 1911, PFLUG ARCH GES PHYS, V137, P515, DOI 10.1007/BF01680423; TSUKAHARA N, 1968, J NEUROPHYSIOL, V31, P467, DOI 10.1152/jn.1968.31.3.467; UDO M, 1982, EXP BRAIN RES, V46, P438; VICARIO DS, 1983, EXP BRAIN RES, V51, P351; Vigneswaran G, 2011, J NEUROSCI, V31, P14235, DOI 10.1523/JNEUROSCI.3142-11.2011; WIDAJEWICZ W, 1994, J NEUROPHYSIOL, V72, P2070, DOI 10.1152/jn.1994.72.5.2070; Wiesendanger M, 1981, HDB BEHAV NEUROBIOLO, V5, P401; WISE SP, 1992, J NEUROPHYSIOL, V68, P969, DOI 10.1152/jn.1992.68.3.969; Woodworth RS, 1899, ACCURACY VOLUNTARY M	100	12	12	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	MAY	2013	591	10					2647	2666		10.1113/jphysiol.2012.232538			20	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	145LB	WOS:000319016200022	23381901	Green Published			2022-02-06	
J	Liu, YQ; Zhang, ZY; Luo, BW; Schluesener, HJ; Zhang, ZR				Liu, Yuqi; Zhang, Zhiyuan; Luo, Bangwei; Schluesener, Hermann J.; Zhang, Zhiren			Lesional accumulation of heme oxygenase-1 (+) microglia/macrophages in rat traumatic brain injury	NEUROREPORT			English	Article						heme oxygenase-1; macrophages; microglia; traumatic brain injury	EXPRESSION; MACROPHAGES/MICROGLIA; INFLAMMATION; INDUCTION; SYSTEM; HO-1	Heme oxygenase-1 (HO-1) is an inducible rate-limiting enzyme for heme degradation. Here, we studied the HO-1 expression in an open-skull weight-drop-induced traumatic brain injury, with a focus on the early phase, most amenable to therapy. In normal rat brains of our study, HO-1 (+) cells were rarely observed. Significant parenchymal accumulation of HO-1 (+) non-neuron cells was observed 18 h post-traumatic brain injury and increased continuously during the investigating time. We also observed that the accumulated HO-1 (+) non-neuron cells were mainly distributed in the perilesional areas and showed activated microglia/macrophage phenotypes with ramified or amoeboid morphologic characteristics. Further double-labeling experiments showed that most HO-1 (+) non-neuron cells coexpressed CD68 and CD163, but not glial fibrillary acid protein. Our data suggest that HO-1 expression defines a subtype of activated microglia/macrophages involved in the early processes following traumatic brain injury. NeuroReport 24:281-286 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Liu, Yuqi; Luo, Bangwei; Zhang, Zhiren] Third Mil Med Univ PLA, Inst Immunol, Chongqing 400038, Peoples R China; [Zhang, Zhiyuan; Schluesener, Hermann J.] Univ Tubingen, Inst Brain Res, Tubingen, Germany		Zhang, ZR (corresponding author), Third Mil Med Univ PLA, Inst Immunol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China.	zhangzhiren@yahoo.com	zhang, zhiren/I-1046-2014; Zhang, Zhiren/O-1012-2019	zhang, zhiren/0000-0002-5238-2835; Zhang, Zhiren/0000-0002-5238-2835	Natural Science Foundation Project of CQ CSTCNatural Science Foundation Project of CQ CSTC [2010BB5025]; National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070954]	This research was partly supported by the Natural Science Foundation Project of CQ CSTC (contract no. 2010BB5025) and the National Nature Science Foundation of China (no. 81070954).	Bergeron M, 1998, DEV BRAIN RES, V105, P181, DOI 10.1016/S0165-3806(97)00169-7; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bortscher S, 2012, J SURG RES, V178, P866, DOI 10.1016/j.jss.2012.07.064; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Orihara Yoshiyuki, 2003, Leg Med (Tokyo), V5 Suppl 1, pS278; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; Petersen B, 2011, XENOTRANSPLANTATION, V18, P355, DOI 10.1111/j.1399-3089.2011.00674.x; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Schluesener HJ, 2000, J NEUROIMMUNOL, V110, P114, DOI 10.1016/S0165-5728(00)00352-0; Shen XD, 2011, LIVER TRANSPLANT, V17, P201, DOI 10.1002/lt.22214; Snyder SH, 2001, NEUROPSYCHOPHARMACOL, V25, P294, DOI 10.1016/S0893-133X(01)00275-5; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Wagener FADTG, 2010, CURR DRUG TARGETS, V11, P1571; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038	25	12	12	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 17	2013	24	6					281	286		10.1097/WNR.0b013e32835f2810			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114KE	WOS:000316739000003	23470432				2022-02-06	
J	Cook, RS; Gillespie, GL; Kronk, R; Daugherty, MC; Moody, SM; Allen, LJ; Shebesta, KB; Falcone, RA				Cook, Rebecca S.; Gillespie, Gordon L.; Kronk, Rebecca; Daugherty, Margot C.; Moody, Suzanne M.; Allen, Lesley J.; Shebesta, Kaaren B.; Falcone, Richard A., Jr.			Effect of an Educational Intervention on Nursing Staff Knowledge, Confidence, and Practice in the Care of Children With Mild Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						knowledge; mild traumatic brain injury; nurse	PEDIATRIC EMERGENCY-DEPARTMENT; CLOSED-HEAD INJURIES; POSTCONCUSSIVE SYMPTOMS; CONCUSSION; MANAGEMENT; IDENTIFICATION; ADOLESCENTS; POPULATION; DIAGNOSIS; IMPACT	Background: Nurses are key providers in the care of children with mild traumatic brain injury (mTBI). New treatment recommendations emphasize symptom assessment and brain rest guidelines to optimize recovery. This study compared pediatric trauma core nurses' knowledge, degree of confidence, and perceived change in practice following mTBI education. Methods: Twenty-eight trauma core nurses were invited to participate in this voluntary quasiexperimental, one-group pretest-posttest study. Multiple choice questions were developed to assess knowledge, and self-report Likert scale statements were used to evaluate confidence and change in practice. Baseline data of 25 trauma core nurses were assessed and then reassessed 1 month postintervention. Results: Paired samples analysis showed significant improvement in knowledge (mean pretest: 33.6% vs. mean posttest score: 79.2%; 95% CI [35.6, 55.6]; t = 9.368; p < .001). All but two test questions yielded a significant increase in the number of participants with correct responses. Preintervention confidence was low (0-32% per question) and significantly increased postintervention (26%-84% per question). Despite increased administration of the symptom assessment and identification of interventions for symptom resolution posteducation (chi(2) = 6.125, p = .001), these scores remained low. Conclusion: Findings demonstrate that educational intervention effectively increased trauma core nurses' knowledge and confidence in applying content into practice. Postintervention scores did not uniformly increase, and not all trauma core nurses consistently transferred content into practice. Further research is recommended to evaluate which teaching method and curriculum content are most effective to educate trauma core nurses and registered nurses caring for patients with mTBI and to identify barriers to incorporating this knowledge in practice.	[Cook, Rebecca S.; Falcone, Richard A., Jr.] Cincinnati Childrens Hosp Med Ctr, Trauma Serv, Cincinnati, OH USA; [Gillespie, Gordon L.] Univ Cincinnati, Coll Nursing, Cincinnati, OH USA; [Kronk, Rebecca] Duquesne Univ, Sch Nursing, Pittsburgh, PA 15219 USA		Cook, RS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Trauma Serv, Cincinnati, OH USA.	becky.cook@cchmc.org	Gillespie, Gordon Lee/I-5649-2019	Gillespie, Gordon Lee/0000-0002-0231-1123; Kronk, Rebecca/0000-0001-5209-7180			American Association of Neuroscience Nurses & Association of Rehabilitation Nurses, 2011, CARE OF THE PATIENT; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay E, 2011, ADV EMERG NURS J, V33, P181, DOI 10.1097/TME.0b013e318217c958; Bay E, 2011, ADV EMERG NURS J, V33, P71, DOI 10.1097/TME.0b013e318207e851; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2011, HEADS UP FACTS FOR P; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Daley BJ, 2001, ADULT EDUC QUART, V52, P39, DOI 10.1177/07417130122087386; Faul M, 2010, TRAUMATIC BRAIN INJU; Fisher J, 2004, TOP EMERG MED, V26, P260; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Helmick KM, 2007, FEDERAL PRACTITIONER, V24, P58; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Kaddoura MA, 2011, INT J SCHOLARSHIP TE, V5, pn2, DOI [10.20429/ijsotl.2011.050220, DOI 10.20429/IJSOTL.2011.050220]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Mateo Magdalena A, 2003, Lippincotts Case Manag, V8, P203, DOI 10.1097/00129234-200309000-00005; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Melnyk Bernadette Mazurek, 2002, Pediatr Nurs, V28, P159; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Pieper P., 2011, J TRAUMA NURS, V18, P11, DOI [10.1097/JTN.0b013e31820e3f31, DOI 10.1097/JTN.0B013E31820E3F31]; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ragoo M, 2005, SCOT MED J, V50, P99, DOI 10.1177/003693300505000303; Rosenal T, 2009, ST HEAL T, V143, P487, DOI 10.3233/978-1-58603-979-0-487; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Sharpe S, 2012, J PAEDIATR CHILD H, V48, P170, DOI 10.1111/j.1440-1754.2011.02068.x; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stevens PK, 2010, J TRAUMA NURS, V17, P183; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	44	12	12	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2013	45	2					108	118		10.1097/JNN.0b013e318282906e			11	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	093KV	WOS:000315191700009	23422697				2022-02-06	
J	Davis, JJ; Axelrod, BN; McHugh, TS; Hanks, RA; Millis, SR				Davis, Jeremy J.; Axelrod, Bradley N.; McHugh, Tara S.; Hanks, Robin A.; Millis, Scott R.			Number of impaired scores as a performance validity indicator	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Performance validity; Effort assessment; Forensic neuropsychology; Impaired scores	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TESTS; NONCLINICAL SAMPLE; TEST BATTERIES; SUSPECT EFFORT; DIGIT SPAN; SPECIFICITY; SENSITIVITY; CLAIMANTS	This study examined embedded performance validity indicators (PVI) based on the number of impaired scores in an evaluation and the overall test battery mean (OTBM). Adult participants (N=175) reporting traumatic brain injury were grouped using eight PVI. Participants who passed all PVI (n=67) demonstrated fewer impaired scores and higher OTBM than those who failed two or more PVI (n=66). Impairment was defined at three levels: T scores < 40, 35, and 30. With specificity .90, sensitivity ranged from .51 to .71 for number of impaired scores and .74 for OTBM.	[Davis, Jeremy J.] Univ Utah, Sch Med, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA; [Axelrod, Bradley N.] John Dingell VA Med Ctr, Detroit, MI USA; [McHugh, Tara S.] Ottawa Hosp, Ottawa, ON, Canada; [Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA		Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2008, APPL NEUROPSYCHOL, V15, P170, DOI 10.1080/09084280802324184; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gladsjo JA, 1999, NORMS LETT CATEGORY; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Matthews CG., 1964, INSTRUCTION MANUAL A; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rohling ML, 2000, ARCH CLIN NEUROPSYCH, V15, P821, DOI 10.1016/S0887-6177(00)80311-X; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	40	12	12	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR 1	2013	35	4					413	420		10.1080/13803395.2013.781134			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	129LR	WOS:000317841600007	23514206				2022-02-06	
J	Osuka, A; Uno, T; Nakanishi, J; Hinokiyama, H; Takahashi, Y; Matsuoka, T				Osuka, Akinori; Uno, Taeko; Nakanishi, Jun; Hinokiyama, Hiromi; Takahashi, Yoshiaki; Matsuoka, Tetsuya			Energy expenditure in patients with severe head injury: Controlled normothermia with sedation and neuromuscular blockade	JOURNAL OF CRITICAL CARE			English	Article						Energy expenditure; Neuromuscular blockade; Indirect calorimetry; Head injury	MECHANICALLY VENTILATED PATIENTS; TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; OXYGEN-CONSUMPTION; INDIRECT CALORIMETRY; CARDIAC-SURGERY; RESUSCITATION; VALIDATION; GUIDELINES; PARALYSIS	Objectives: Providing optimal caloric intake is important for patients with severe traumatic brain injury. Insufficient nutrition worsens prognosis, and excessive nutrition may lead to complications such as weaning delay from mechanical ventilation. However, using controlled normothermia with sedation and neuromuscular blockade for patients with anticipated severe brain edema, the optimal caloric intake is still unclear. Methods: Ten patients with severe traumatic brain injury were studied. All patients received midazolam and vecuronium or pancuronium to control body temperature to 36.0 degrees C. Energy expenditure was measured using indirect calorimetry. Age, body height, body weight, heart rate, blood pressure, body temperature, and minute ventilation volume were evaluated at the time of the study. Differences between the mean measured energy expenditures (MEEs) and predicted basal energy expenditures (PEEs from the Harris-Benedict equation) were analyzed using paired t test. Furthermore, the relationships between these variables and MEEs were analyzed with multiple regression analysis. Results: The result of MEE was 1279 +/- 244 kcal/d. When compared with PEE, MEE/PEE was 87.2% +/- 10%. Multiple regression analysis showed that age, body height, body weight, heart rate, and minute ventilation volume were related with MEE. Conclusions: Energy expenditure in patients with severe traumatic brain injury who need mechanical ventilation and have received controlled normothermia with sedation and neuromuscular blockade was 13% less than predicted basal levels. Energy expenditure might be obtained from age, body height, body weight, heart rate, and minute ventilation. (C) 2013 Elsevier Inc. All rights reserved.	[Osuka, Akinori; Uno, Taeko; Nakanishi, Jun; Hinokiyama, Hiromi; Takahashi, Yoshiaki; Matsuoka, Tetsuya] Osaka Prefectural Senshu Crit Care Med Ctr, Izumisano, Osaka 5980048, Japan		Osuka, A (corresponding author), Osaka Prefectural Senshu Crit Care Med Ctr, Izumisano, Osaka 5980048, Japan.	akinori@sccmc.izumisano.osaka.jp	Osuka, Akinori/S-1936-2017	Osuka, Akinori/0000-0002-7575-7927			Barton Richard G., 1997, Journal of Burn Care and Rehabilitation, V18, P461, DOI 10.1097/00004630-199709000-00019; BRADFIELD RB, 1971, AM J CLIN NUTR, V24, P1148; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P539; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Brosh A, 2007, J ANIM SCI, V85, P1213, DOI 10.2527/jas.2006-298; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; DAMASK MC, 1982, ANESTHESIOLOGY, V57, P213, DOI 10.1097/00000542-198209000-00011; Epstein CD, 2000, CRIT CARE MED, V28, P1363, DOI 10.1097/00003246-200005000-00017; Faisy C, 2003, AM J CLIN NUTR, V78, P241, DOI 10.1093/ajcn/78.2.241; Frankenfield David, 2006, Nutr Clin Pract, V21, P430, DOI 10.1177/0115426506021005430; Giner M, 1996, NUTRITION, V12, P23, DOI 10.1016/0899-9007(95)00015-1; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lemson J, 2008, INTENS CARE MED, V34, P2268, DOI 10.1007/s00134-008-1252-z; Livingstone MBE, 1997, BRIT J NUTR, V78, P869, DOI 10.1079/BJN19970205; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P210, DOI 10.1164/ajrccm.151.1.7812556; Marik PE, 1996, CHEST, V109, P1038, DOI 10.1378/chest.109.4.1038; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; PALMISANO BW, 1984, ANESTHESIOLOGY, V61, P518, DOI 10.1097/00000542-198411000-00007; PAYNE PR, 1971, AM J CLIN NUTR, V24, P1164; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; Savard JF, 2008, CRIT CARE MED, V36, P1175, DOI 10.1097/CCM.0b013e3181691502; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Sunderland PM, 1992, NEUROSURGERY, V31, P252; Terao Y, 2003, CRIT CARE MED, V31, P830, DOI 10.1097/01.CCM.0000054868.93459.E1; Vernon DD, 2000, CRIT CARE MED, V28, P1569, DOI 10.1097/00003246-200005000-00051; WARNOLD I, 1977, AM J CLIN NUTR, V30, P304, DOI 10.1093/ajcn/30.3.304; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005	34	12	13	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	APR	2013	28	2							218.e9	10.1016/j.jcrc.2012.05.012			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110TF	WOS:000316468100024	22835423				2022-02-06	
J	Schiaveto-de-Souza, A; da-Silva, CA; Defino, HLA; Del Bel, EA				Schiaveto-de-Souza, A.; da-Silva, C. A.; Defino, H. L. A.; Del Bel, E. A.			Effect of melatonin on the functional recovery from experimental traumatic compression of the spinal cord	BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH			English	Article						Spinal cord injury; Melatonin; Functional recovery	NITRIC-OXIDE SYNTHASE; OCCLUSION STROKE MODEL; LIPID-PEROXIDATION; MOTOR FUNCTION; RATING-SCALE; INJURY; RATS; DAMAGE; METHYLPREDNISOLONE; BRAIN	Spinal cord injury is an extremely severe condition with no available effective therapies. We examined the effect of melatonin on traumatic compression of the spinal cord. Sixty male adult Wistar rats were divided into three groups: sham-operated animals and animals with 35 and 50% spinal cord compression with a polycarbonate rod spacer. Each group was divided into two subgroups, each receiving an injection of vehicle or melatonin (2.5 mg/kg, intraperitoneal) 5 min prior to and 1, 2, 3, and 4 h after injury. Functional recovery was monitored weekly by the open-field test, the Basso, Beattie and Bresnahan locomotor scale and the inclined plane test. Histological changes of the spinal cord were examined 35 days after injury. Motor scores were progressively lower as spacer size increased according to the motor scale and inclined plane test evaluation at all times of assessment. The results of the two tests were correlated. The open-field test presented similar results with a less pronounced difference between the 35 and 50% compression groups. The injured groups presented functional recovery that was more evident in the first and second weeks. Animals receiving melatonin treatment presented more pronounced functional recovery than vehicle-treated animals as measured by the motor scale or inclined plane. NADPH-d histochemistry revealed integrity of the spinal cord thoracic segment in sham-operated animals and confirmed the severity of the lesion after spinal cord narrowing. The results obtained after experimental compression of the spinal cord support the hypothesis that melatonin may be considered for use in clinical practice because of its protective effect on the secondary wave of neuronal death following the primary wave after spinal cord injury.	[Schiaveto-de-Souza, A.] Univ Fed Mato Grosso do Sul, Dept Morfofisiol, Campo Grande, MS, Brazil; [da-Silva, C. A.; Del Bel, E. A.] Univ Sao Paulo, Fac Odontol Ribeirao Preto, Dept Morfol Estomatol & Fisiol, BR-14049904 Ribeirao Preto, SP, Brazil; [Defino, H. L. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Orthopedia & Traumatol, BR-14049904 Ribeirao Preto, SP, Brazil		Del Bel, EA (corresponding author), Univ Sao Paulo, Fac Odontol Ribeirao Preto, Dept Morfol Estomatol & Fisiol, BR-14049904 Ribeirao Preto, SP, Brazil.	eadelbel@usp.br	Del Bel, Elaine/ABH-1331-2020; Del Bel, Elaine A/E-2308-2012; Defino, Helton L A/O-1928-2013	Del Bel, Elaine/0000-0003-3483-8074; Del Bel, Elaine A/0000-0002-4158-7376; Defino, Helton L A/0000-0003-4274-0130	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Don Bosco Universidade, Mato Grosso do Sul (A. Schiaveto-de-Souza fellowship)	The authors are indebted to Luciana N. Nascimento for skillful assistance during the study and to Prof. F.S. Guimaraes (Departamento de Farmacologia, FMRP-USP) for advice concerning statistical analysis and text revision. This article was taken from the thesis for the PhD in Sciences of A. Schiaveto-de-Souza. Research supported by CNPq, FAPESP, and Don Bosco Universidade, Mato Grosso do Sul (A. Schiaveto-de-Souza fellowship).	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Cheung RTF, 2003, J PINEAL RES, V34, P153, DOI 10.1034/j.1600-079X.2003.00034.x; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; Diaz-Ruiz A, 2002, NEUROSCI LETT, V319, P129, DOI 10.1016/S0304-3940(01)02540-X; Dimar JR, 1999, SPINE, V24, P1623, DOI 10.1097/00007632-199908150-00002; Escames G, 1997, NEUROSCI LETT, V230, P147, DOI 10.1016/S0304-3940(97)00498-9; Fujimoto T, 2000, SPINE, V25, P769, DOI 10.1097/00007632-200004010-00003; Giglio CA, 2006, BRAZ J MED BIOL RES, V39, P1613, DOI 10.1590/S0100-879X2006001200013; Guizar-Sahagun G, 2009, SPINAL CORD, V47, P156, DOI 10.1038/sc.2008.85; Hu WH, 2000, J CHEM NEUROANAT, V17, P183, DOI 10.1016/S0891-0618(99)00039-3; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; KERLINGER F, 1966, J PERS SOC PSYCHOL, V4, P391, DOI 10.1037/h0023731; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lahiri DK, 1999, ANN NY ACAD SCI, V893, P325, DOI 10.1111/j.1749-6632.1999.tb07847.x; Liu DX, 2000, J NEUROCHEM, V75, P2144, DOI 10.1046/j.1471-4159.2000.0752144.x; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Metz GAS, 2000, BRAIN RES, V883, P165, DOI 10.1016/S0006-8993(00)02778-5; Muir GD, 2000, EUR J NEUROSCI, V12, P3079, DOI 10.1046/j.1460-9568.2000.00205.x; Nakahara S, 2002, J NEUROTRAUM, V19, P1467, DOI 10.1089/089771502320914697; Pagliaro P, 2003, LIFE SCI, V73, P2137, DOI 10.1016/S0024-3205(03)00593-9; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Pei Z, 2003, J PINEAL RES, V34, P110, DOI 10.1034/j.1600-079X.2003.00014.x; Pei Z, 2002, NEUROSCI LETT, V318, P141, DOI 10.1016/S0304-3940(01)02503-4; Ramon-Cueto A, 1999, BRAIN RES, V815, P213, DOI 10.1016/S0006-8993(98)01092-0; Reiter R, 1997, LIFE SCI, V60, P2255, DOI 10.1016/S0024-3205(97)00030-1; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Reiter RJ, 1998, ACTA PHARMACOL SIN, V19, P575; Reiter RJ, 2008, SAUDI MED J, V29, P1537; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rogerio F, 2002, BRAIN RES, V926, P33, DOI 10.1016/S0006-8993(01)03286-3; Samantaray S, 2008, J PINEAL RES, V44, P348, DOI 10.1111/j.1600-079X.2007.00534.x; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Teixeira A, 2003, J PINEAL RES, V35, P262, DOI 10.1034/j.1600-079X.2003.00085.x; Topsakal C, 2003, SPINE, V28, P1643, DOI 10.1097/00007632-200308010-00004; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4; Xu M, 2000, EXP NEUROL, V161, P472, DOI 10.1006/exnr.1999.7278	40	12	14	0	7	ASSOC BRAS DIVULG CIENTIFICA	SAO PAULO	FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL	0100-879X	1678-4510		BRAZ J MED BIOL RES	Brazilian J. Med. Biol. Res.	APR	2013	46	4					348	358		10.1590/1414-431X20132322			11	Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine	158WK	WOS:000320004500004	23579633	Green Published, gold, Green Submitted			2022-02-06	
J	Shen, J; Fan, ZX; Ji, T; Pan, JW; Zhou, YQ; Zhan, RY				Shen, Jian; Fan, Zuoxu; Ji, Tao; Pan, Jianwei; Zhou, Yongqing; Zhan, Renya			Contralateral Acute Subdural Hematoma Following Traumatic Acute Subdural Hematoma Evacuation-Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						acute subdural hematoma; decompressive craniectomy; postoperative hemorrhage	DECOMPRESSIVE SURGERY; CRANIECTOMY; MORTALITY; INJURY	Contralateral acute subdural hematoma (ASDH) occurring after removal of traumatic ASDH is a rare, but nearly devastating postoperative complication. We treated a 26-year-old male who developed a contralateral ASDH shortly after craniectomy for evacuation of a traumatic ASDH. Burr-hole craniotomy was performed before decompressive craniectomy, and the bleeding source was a cortex artery within the frontal lobe contusion. Despite supportive therapy with barbiturate and mild hypothermia he expired 3 days later of brain death. Literature review suggests that the old are more susceptible to contralateral ASDH following evacuation of traumatic ASDH. Contralateral ASDH following evacuation of traumatic ASDH is a rare but potentially lethal complication, so neurosurgeons should try to detect such contralateral hematoma formation and prevent clinical deterioration.	[Shen, Jian; Fan, Zuoxu; Ji, Tao; Pan, Jianwei; Zhou, Yongqing; Zhan, Renya] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China		Zhan, RY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.			Pan, Jianwei/0000-0001-6353-1843			BAN M, 1991, Neurologia Medico-Chirurgica, V31, P927, DOI 10.2176/nmc.31.927; Brisman MH, 1996, NEUROSURGERY, V39, P1114, DOI 10.1097/00006123-199612000-00009; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Fridley J, 2011, J CLIN NEUROSCI, V18, P422, DOI 10.1016/j.jocn.2010.05.004; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; Harada Katsuhiko, 1992, Neurologia Medico-Chirurgica, V32, P969, DOI 10.2176/nmc.32.969; Huang APH, 2011, J TRAUMA, V70, P1578, DOI 10.1097/TA.0b013e3182178c71; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; MODESTI LM, 1982, NEUROSURGERY, V10, P689, DOI 10.1227/00006123-198206010-00002; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Moon KS, 2007, J CLIN NEUROSCI, V14, P283, DOI 10.1016/j.jocn.2005.11.016; Murzin V E, 1979, Zh Vopr Neirokhir Im N N Burdenko, P43; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Su TM, 2001, J TRAUMA, V50, P557, DOI 10.1097/00005373-200103000-00025; Tomycz Nestor D, 2010, J Trauma, V68, pE11, DOI 10.1097/TA.0b013e31811eaaf5; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	20	12	12	0	4	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2013	53	4					221	224		10.2176/nmc.53.221			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	128WT	WOS:000317801100005	23615411	Bronze			2022-02-06	
J	Liu, NK; Zhang, YP; O'Connor, J; Gianaris, A; Oakes, E; Lu, QB; Verhovshek, T; Walker, CL; Shields, CB; Xu, XM				Liu, Nai-Kui; Zhang, Yi-Ping; O'Connor, Jeremy; Gianaris, Alexander; Oakes, Eddie; Lu, Qing-Bo; Verhovshek, Tom; Walker, Chandler L.; Shields, Christopher B.; Xu, Xiao-Ming			A bilateral head injury that shows graded brain damage and behavioral deficits in adult mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; Controlled cortical impact; Closed head injury; Behavior; Histology	CONTROLLED CORTICAL IMPACT; COGNITIVE DEFICITS; MODEL; HISTOPATHOLOGY; MOUSE; RATS	Reliable animal models of traumatic brain injury (TBI) are essential to test novel hypotheses and therapeutic interventions. In this study, based on advantages of both the closed head injury (CHI) and controlled cortical impact (CCI) models, we developed a bilateral head injury model in mice. C57BL/6 mice were used in this study. A midline craniotomy (5 mm diameter) was performed extending 2 mm anteriorly and 3 mm posteriorly from the bregma, centered over the sagittal suture. The skull flap was left in place. A cortical impact on the surface of the skull flap was performed using an electromagnetic impactor. Here we report that the injury significantly decreased the neuroscore and increased foot drops in a severity-dependent manner. Severity-related deficits in performance on a rotarod device were also found at both slow and fast accelerations. These findings suggest that our TBI model can produce graded motor deficits. In addition, Morris water maze testing showed increased latency to locate a hidden platform in a severity-dependent manner, suggesting that our model can also produce graded memory deficits. Furthermore, an adhesive removal test revealed significant increases in time-to-contact and time-to-remove the adhesive tape from the paw in a severity-dependent manner, indicating that our TBI model produced graded somatosensory and motor deficits. Histological analysis presented a clear gradation in brain tissue damage following graded brain injuries. These findings collectively suggest that the current model may offer a sensitive, reliable and clinically-relevant model for assessments of therapeutic strategies for TBI. (C) 2012 Elsevier B.V. All rights reserved.	[Liu, Nai-Kui; O'Connor, Jeremy; Gianaris, Alexander; Oakes, Eddie; Lu, Qing-Bo; Verhovshek, Tom; Walker, Chandler L.; Xu, Xiao-Ming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Dept Neurol Surg & Goodman Campbell Brain & Spine, Indianapolis, IN 46202 USA; [Zhang, Yi-Ping; Shields, Christopher B.] Norton Healthcare, Norton Neurosci Inst, Louisville, KY 40202 USA		Liu, NK (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, 950 West Walnut St,R2 Bldg,Room 402, Indianapolis, IN 46202 USA.	nailiu@iupui.edu	Walker, Chandler L./D-2256-2014	Walker, Chandler L./0000-0002-8616-8263; Xu, Xiao-ming/0000-0002-7229-0081; O'Connor, Jeremy/0000-0002-7907-6432	Indiana Spinal Cord and Brain Injury Research Foundation; Mari Hulman George Endowment; State of Indiana (ISDH) [A70-2-079609, A70-9-079138]	This work was supported by Indiana Spinal Cord and Brain Injury Research Foundation and Mari Hulman George Endowment (XMX), and by the State of Indiana (ISDH, Grant # A70-2-079609 and A70-9-079138) (NKL).	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; MARKLUND N, 2010, BR J PHARM; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116	24	12	12	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 7	2013	1499						121	128		10.1016/j.brainres.2012.12.031			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	113ZX	WOS:000316710300011	23276498				2022-02-06	
J	Akelma, AZ; Celik, A; Ozdemir, O; Akelma, FK; Abaci, A; Razi, CH; Kislal, FM; Akin, O				Akelma, Ahmet Zulfikar; Celik, Aydin; Ozdemir, Osman; Akelma, Fatma Kavak; Abaci, Ayhan; Razi, Cem Hasan; Kislal, Fatih Mehmet; Akin, Okhan			Neuron-specific enolase and S100B protein in children with carbon monoxide poisoning: children are not just small adults	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MARKERS; DAMAGE; S-100; RATS; NSE	Introduction: The aim of this study was to evaluate the role of S100B protein and neuron-specific enolase (NSE) in children with carbon monoxide (CO) poisoning. Methods: In this prospective, case-controlled study, children with CO poisoning were recruited. Patient demographics features and Glasgow Coma Scale (GCS) were recorded. Blood samples were collected from all children with CO poisoning at their admission to the hospital and at 3 and 6 hours after admission. Levels of NSE and S100B were measured. The control group consisted of age-matched healthy children. Results: A total of 30 children with CO poisoning (mean age, 7.88 +/- 3.75 years; 17 boys) and 30 healthy children (mean age, 8.16 +/- 3.05 years; 7 boys) were enrolled in the study. Mean carboxyhemoglobin level (%) measured at admission was 30.05 +/- 8.00. Serum NSE levels of the children with CO poisoning were significantly higher than those of children from the control group at 0 hour and also at 3 and 6 hours (P < .001, P = .001, and P = .005, respectively). Serum S100B protein levels were similar between the 2 groups at 0 and 3 and 6 hours (P > .05). Serum NSE levels of patients with CO poisoning demonstrated a negative correlation with the admission GCS scores. No correlation was found between GCS scores and S100B protein levels. Conclusion: We have shown that NSE levels increase in CO-associated hypoxic brain damage in accordance with clinical findings. We have also found that, contrary to the studies conducted on adults, S100B protein levels do not increase in response to hypoxic brain damage. (C) 2013 Elsevier Inc. All rights reserved.	[Akelma, Ahmet Zulfikar] Fatih Univ, Sch Med, Dept Pediat, Ankara, Turkey; [Celik, Aydin; Ozdemir, Osman; Razi, Cem Hasan; Kislal, Fatih Mehmet] Kecioren Teaching & Res Hosp, Dept Pediat, Ankara, Turkey; [Akelma, Fatma Kavak] Ankara Zubeyde Hanim Etlik Matern & Gynecol Teach, Dept Anesthesiol, Ankara, Turkey; [Abaci, Ayhan] Dokuz Eylul Univ, Sch Med, Dept Pediat, Izmir, Turkey; [Akin, Okhan] Kecioren Teaching & Res Hosp, Dept Biochem, Ankara, Turkey		Akelma, AZ (corresponding author), Alparslan Turkes Cad 57, TR-06510 Ankara, Turkey.	akelma@gmail.com	Abaci, Ayhan/A-4356-2016; RAZI, CEM/AAY-1772-2020	Abaci, Ayhan/0000-0002-1812-0321; RAZI, CEM/0000-0003-0005-1409			Andiran N, 2004, TURKISH J PEDIATR, V46, P147; [Anonymous], 2008, MMWR MORB MORTAL WKL, V57, P896; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Brvar M, 2004, CRIT CARE MED, V32, P2128, DOI 10.1097/01.CCM.0000142702.39718.A0; Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Brvar M, 2006, CRIT CARE MED, V34, P2228, DOI 10.1097/01.CCM.0000228913.61710.9D; Cakir Z, 2010, AM J EMERG MED, V28, P61, DOI 10.1016/j.ajem.2008.10.032; DEGIORGIO CM, 1995, NEUROLOGY, V45, P1134, DOI 10.1212/WNL.45.6.1134; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Ide T, 2008, AM J EMERG MED, V26, P908, DOI 10.1016/j.ajem.2007.11.021; Ide T, 2012, AM J EMERG MED, V30, P222, DOI 10.1016/j.ajem.2010.11.025; Kao LW, 2005, MED CLIN N AM, V89, P1161, DOI 10.1016/j.mcna.2005.06.007; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Prockop LD, 2005, J NEUROIMAGING, V15, P144, DOI 10.1177/1051228404273819; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P469, DOI 10.1111/j.1399-6576.2004.00362.x; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016	21	12	13	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	MAR	2013	31	3					524	528		10.1016/j.ajem.2012.10.009			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	110SU	WOS:000316466800012	23380091				2022-02-06	
J	Anakwenze, OA; Namdari, S; Hsu, JE; Benham, J; Keenan, MA				Anakwenze, Oke A.; Namdari, Surena; Hsu, Jason E.; Benham, Joshua; Keenan, Mary Ann			Myotendinous lengthening of the elbow flexor muscles to improve active motion in patients with elbow spasticity following brain injury	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Elbow spasticity; fractional lengthening; outcomes; upper motor neuron syndrome; flexor release; arc of motion	UPPER EXTREMITY; DYNAMIC ELECTROMYOGRAPHY; ORTHOPEDIC MANAGEMENT; FLEXION; DYSFUNCTION; DEFORMITY; STROKE	Background: The objective of this study was to evaluate the outcomes of a novel technique of fractional myotendinous lengthening of the elbow flexors in patients with volitional motor control and spastic elbow flexion deformities after brain injury. Methods: A retrospective review of 42 consecutive patients with spastic elbow flexion deformities and upper motor neuron (UMN) syndrome was performed. Each patient had volitional motor control but limited elbow extension and underwent myotendinous lengthening of the elbow flexor muscles. Outcome measures included pre and post-operative active and passive arc of motion, Modified Ashworth Scale (MAS) of spasticity, and complications. Results: There were 26 men and 16 women. The etiologies of UMN syndrome were stroke (30 patients), traumatic brain injury (11 patients), and cerebral palsy (1 patient). Average duration between injury and surgery was 6.6 years. At an average follow-up of 14 months, improvements were noted in active extension (42 degrees to 20 degrees; P < .001). In addition, active arc of motion increased from 77 degrees (range of motion [ROM]: 42 degrees to 119 degrees) to 113 degrees (ROM: 20 degrees to 133 degrees) (P < .001) and passive arc of motion increased from 103 degrees (ROM: 24 degrees-127 degrees ) to 131 degrees (ROM: 8 degrees-139 degrees) (P < .001). Significant improvement in MAS was also noted after surgery (2.7 to 1.9; P < .001). Superficial wound dehiscence occurred in 2 patients and was successfully treated nonoperatively. Conclusion: In patients with spastic elbow flexion deformities and active motor control, fractional myotendinous lengthening of the elbow flexors safely improves active extension and the overall arc of motion while affording immediate postoperative elbow motion. Level of evidence: Level IV, Case Series, Treatment Study. (C) 2013 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Anakwenze, Oke A.; Namdari, Surena; Hsu, Jason E.; Keenan, Mary Ann] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19102 USA; [Benham, Joshua] Univ Penn, Sch Med, Philadelphia, PA 19102 USA		Anakwenze, OA (corresponding author), Univ Penn, 3400 Spruce St, Philadelphia, PA 19102 USA.	oanakwenze@gmail.com	Keenan, Mary Ann/ABB-1551-2020				Barus D, 2006, J HAND THER, V19, P192, DOI 10.1197/j.jht.2006.02.012; Flowers K R, 1994, J Hand Ther, V7, P150; Francis HP, 2004, J NEUROL NEUROSUR PS, V75, P1547, DOI 10.1136/jnnp.2003.025551; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P108, DOI 10.2106/00004623-198062010-00016; KAPLAN PE, 1977, ARCH PHYS MED REHAB, V58, P415; Keenan MA, 1996, J HEAD TRAUMA REHAB, V11, P57, DOI 10.1097/00001199-199608000-00008; Keenan MA, 2003, ARCH PHYS MED REHAB, V84, P291, DOI 10.1053/apmr.2003.50099; Keenan MA, 2010, GREENS OPERATIVE HAN, P1173; Keenan MAE, 2004, J HEAD TRAUMA REHAB, V19, P143, DOI 10.1097/00001199-200403000-00006; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P340, DOI 10.1016/0363-5023(90)90120-G; KOZIN SH, 1993, CLIN ORTHOP RELAT R, P109; MCCLURE PW, 1994, PHYS THER, V74, P1101, DOI 10.1093/ptj/74.12.1101; MITAL MA, 1979, J BONE JOINT SURG AM, V61, P515, DOI 10.2106/00004623-197961040-00005; Namdari S, 2012, J SHOULDER ELB SURG, V21, P1357, DOI 10.1016/j.jse.2011.09.029; Namdari S, 2012, J SHOULDER ELB SURG, V21, P691, DOI 10.1016/j.jse.2011.03.026; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Tafti MA, 2008, J AM ACAD ORTHOP SUR, V16, P462, DOI 10.5435/00124635-200808000-00005; [No title captured]	19	12	12	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAR	2013	22	3					318	322		10.1016/j.jse.2012.10.043			5	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	123UT	WOS:000317417400008	23352184				2022-02-06	
J	Dambinova, SA; Shikuev, AV; Weissman, JD; Mullins, JD				Dambinova, Svetlana A.; Shikuev, Alexey V.; Weissman, Joseph D.; Mullins, John D.			AMPAR Peptide Values in Blood of Nonathletes and Club Sport Athletes With Concussions	MILITARY MEDICINE			English	Article								Objectives: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) peptide, a product of the proteolytic degradation of AMPA receptors in healthy nonathletes and athletes with concussions, is assessed. The detection of AMPAR peptide in conjunction with neuropsychological testing and neuroimaging is undertaken. Subjects: Persons (n = 124, 19-23 years) are enrolled in the pilot-blinded study according to approved Institutional Review Board protocols at Kennesaw State University and DeKalb Medical. Methods: AMPAR peptide plasma assay was performed using magnetic particles-enzyme-linked immunosorbent assay. All participants had neurocognitive tests (ImPACT); selected subjects with concussions were followed-up with magnetic resonance imaging and neurologic consultations. Results: Athletes (n = 33) with clinically defined single or multiple concussions were compared to 91 age and gender matched controls without a history of concussion. AMPAR peptide values of 0.05-0.40 ng/mL for controls and 1.0-8.5 ng/mL for concussions are found. The biomarker sensitivity of 91% and a specificity of 92% (0.4 ng/mL cut off) to assess concussions are calculated. Poorer ImPACT scores correlated with abnormal levels of the biomarker. In athletes with multiple concussions, increased AMPAR peptide values (2.0-12.0 ng/mL) were associated with minor findings on magnetic resonance imaging. Conclusion: AMPAR peptide assay combined with ImPACT and neuroimaging is a promising tool for assessment of concussions. Additional clinical validation studies are required.	[Dambinova, Svetlana A.; Shikuev, Alexey V.] Kennesaw State Univ, WellStar Coll Hlth & Human Serv, Kennesaw, GA 30144 USA; [Weissman, Joseph D.] DeKalb Med, Decatur, GA 30033 USA; [Mullins, John D.] Headquarters Georgia Natl Guards SAS, Atlanta, GA 30309 USA		Dambinova, SA (corresponding author), Kennesaw State Univ, WellStar Coll Hlth & Human Serv, 1000 Chastain Rd,MD 4101,HS,Bldg 41,4211, Kennesaw, GA 30144 USA.		Dambinova, Svetlana A/G-1724-2017	Dambinova, Svetlana A/0000-0003-4411-5726	KSU Foundation; U.S. Army Medical Research and Materiel Command grantU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-2-0081]	The study was partly supported by KSU Foundation and U.S. Army Medical Research and Materiel Command grant no. W81XWH-11-2-0081.	Beneyto M, 2004, J COMP NEUROL, V468, P530, DOI 10.1002/cne.10981; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Dambinova SA, 2007, IVD TECHNOLOGY, V3, P3; Dambinova SA, 2012, RSC DRUG DISCOV, V24, P66, DOI 10.1039/9781849734745-00066; Enders J, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-4; Eng J, 2012, ROC ANAL JROCFIT COM; Faul M, 2006, TRAUMATIC BRAIN INJU; Gill S, 2010, EXCITATORY TRANSMISS, P3; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; Klinke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031766; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Siuda Edward R., 2007, V403, P37, DOI 10.1007/978-1-59745-529-9_3; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	19	12	12	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2013	178	3					285	290		10.7205/MILMED-D-12-00368			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7TX	WOS:000340805000009	23707115	Bronze			2022-02-06	
J	Mayers, LB				Mayers, Lester B.			Outcomes of Sport-Related Concussion Among College Athletes	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SCHOOL FOOTBALL PLAYERS; NEUROPSYCHOLOGISTS RESPONSE; INTERNATIONAL-CONFERENCE; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; DARK-AGES; RETURN; 1ST-CONCUSSION; CONVOLUTIONS; PERFORMANCE	The author collected and analyzed data for all student-athletes diagnosed with concussion between 1998 and 2011. Outcome measurements were post-concussion symptom duration, time interval until return-to-play, and clinical outcomes self-reported by athletes and by athlete's parent/guardian 1 year post-injury. A total of 98 concussions occurred in 95 student athletes among a cohort averaging 350 athletes competing yearly. Athletes were managed according to expert-consensus guidelines. Forty-one (43%) of the athletes had experienced a previously-diagnosed concussion (range: 1-3). Eight athletes (10.4%), retired from their sport for concussion-related issues. Six athletes (6.3%) with completed follow-up experienced memory and/or concentration impairment(s) lasting more than 1 year.	Pace Univ, Div Sports Med, Pleasantville, NY USA		Mayers, LB (corresponding author), Pace Univ, Div Sports Med, Pleasantville, NY USA.	lmayers@pace.edu					Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Casson IR, 2009, ARCH NEUROL-CHICAGO, V66, P419, DOI 10.1001/archneurol.2008.592; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Klossner D, 2008, 2008 09 NCAA SPORTS; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; Mayers L, 2009, ARCH NEUROL-CHICAGO, V66, P421, DOI 10.1001/archneurol.2008.593; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2005, NEUROSURGERY, P90; Shuttleworth-Edwards AB, 2009, ARCH NEUROL-CHICAGO, V66, P421; Shuttleworth-Edwards AB, 2009, ARCH NEUROL-CHICAGO, V66, P420, DOI 10.1001/archneurol.2009.9; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008	24	12	12	1	13	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2013	25	2					115	119		10.1176/appi.neuropsych.11120374			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	156FX	WOS:000319808300044	23686028				2022-02-06	
J	Sabuncuoglu, O				Sabuncuoglu, Osman			Understanding the relationships between breastfeeding, malocclusion, ADHD, sleep-disordered breathing and traumatic dental injuries	MEDICAL HYPOTHESES			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; NONNUTRITIVE SUCKING HABITS; IRON-DEFICIENCY; RISK-FACTORS; CHILDREN; APNEA; PREVALENCE; DIAGNOSIS; SYMPTOMS	Attention-deficit/hyperactivity disorder (ADHD), one of the most common neuropsychiatric disorders that present at young age, may occasionally be associated with physical problems and disorders. Among them exists a group of oral-pharyngeal conditions with considerable clinical morbidity. Previous research that identified absence or short duration of breastfeeding in ADHD children has been reviewed. Essential nutritional factors in breast milk can affect brain development and regulate the manifestation of ADHD symptoms. Low ferritin levels caused by insufficient breastfeeding may contribute to ADHD susceptibility because of the role of iron in dopaminergic activity. Insufficient breast feeding and subsequently excessive bottle-feeding may lead to increased rates of non-nutritive sucking habits, such as pacifier use and thumb-sucking, all of which are associated with the risk of development of malocclusions. Malocclusion refers to an unacceptable deviation from the ideal relationship of the upper and lower teeth and necessitates orthodontic treatment. Sleep-disordered breathing in children may present with neurocognitive symptoms that resemble ADHD and abnormal craniofacial developments, as well as malocclusions, have been cited as part of the syndrome. Obesity, which is an outcome of insufficient breastfeeding, is a shared comorbidity of ADHD and sleep-disordered breathing. The risk of traumatic dental injury is higher in children with ADHD and presence of malocclusions further increases the likelihood of dental injuries. In this review, certain oral-pharyngeal conditions relating to ADHD have been reviewed and links among them have been highlighted in a tentative explanatory model. More research that will provide increased awareness and clinical implications is needed. (C) 2012 Elsevier Ltd. All rights reserved.	[Sabuncuoglu, Osman] Marmara Univ, Sch Med, Dept Child & Adolescent Psychiat, Istanbul, Turkey		Sabuncuoglu, O (corresponding author), Halk Cad Emin Ongan Sok 11-15, TR-34672 Istanbul, Turkey.	sabuncuoglu2004@yahoo.com					Alonge OK, 2001, DENT TRAUMATOL, V17, P218; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Assis AMO, 2004, REV SAUDE PUBL, V38, P543, DOI 10.1590/S0034-89102004000400010; Atmetlla Gabriela, 2006, J Clin Pediatr Dent, V30, P183; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Banabilh SM, 2010, ANGLE ORTHOD, V80, P37, DOI 10.2319/011509-26.1; Schutza TCB, 2011, ANGLE ORTHOD, V81, P222, DOI 10.2319/052710-233.1; Bimstein E, 2008, SPEC CARE DENT, V28, P107, DOI 10.1111/j.1754-4505.2008.00021.x; Borum M K, 2001, Int J Paediatr Dent, V11, P249; Brooks LJ, 2008, ANN ACAD MED SINGAP, V37, P701; Brotanek JM, 2005, ARCH PEDIAT ADOL MED, V159, P1038, DOI 10.1001/archpedi.159.11.1038; Calarge C, 2010, J CHILD ADOL PSYCHOP, V20, P495, DOI 10.1089/cap.2010.0053; Callen Jennifer, 2005, Adv Neonatal Care, V5, P72, DOI 10.1016/j.adnc.2004.12.003; Camurdan AD, 2008, PUBLIC HEALTH NUTR, V11, P1173, DOI 10.1017/S1368980008001742; Carrascoza Karina Camillo, 2006, J. Pediatr. (Rio J.), V82, P395, DOI [10.1590/S0021-75572006000600015, 10.2223/JPED.1536]; Cazzolla AP, 2010, EUR J PAEDIATR DENT, V11, P189; Chaparro CM, 2008, J NUTR, V138, P2529, DOI 10.1093/jn/138.12.2529; Chervin RD, 2005, SLEEP, V28, P885, DOI 10.1093/sleep/28.7.885; Chervin RD, 2002, PEDIATRICS, V109, P449, DOI 10.1542/peds.109.3.449; Cortese S, 2008, CRIT REV FOOD SCI, V48, P524, DOI 10.1080/10408390701540124; Cortese S, 2007, J PSYCHOSOM RES, V63, P587, DOI 10.1016/j.jpsychores.2007.08.005; Cortese S, 2009, J AM ACAD CHILD PSY, V48, P894, DOI 10.1097/CHI.0b013e3181ac09c9; Daley D, 2009, CHILD CARE HLTH DEV, V35, P754, DOI 10.1111/j.1365-2214.2009.00938.x; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; Davis C, 2010, CURR PSYCHIAT REP, V12, P389, DOI 10.1007/s11920-010-0133-7; de Oliveira AS, 2010, CAD SAUDE PUBLICA, V26, P409, DOI 10.1590/S0102-311X2010000200020; Diouf JS, 2010, INT ORTHOD, V8, P372, DOI 10.1016/j.ortho.2010.10.001; Fewtrell MS, 2011, P NUTR SOC, V70, P472, DOI 10.1017/S0029665111000589; Floet AMW, 2010, PEDIATR REV, V31, P56, DOI 10.1542/pir.31-2-56; FRIED I, 1995, J DENT CHILD, V62, P256; Gelgor Ibrahim Erhan, 2007, Eur J Dent, V1, P125; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Gozal D, 2008, CURR OPIN PEDIATR, V20, P654, DOI 10.1097/MOP.0b013e328316ec2d; Guilleminault C, 2005, ARCH PEDIAT ADOL MED, V159, P775, DOI 10.1001/archpedi.159.8.775; Heasman P, 2003, MASTER DENT RESTORAT; Howard CR, 2003, PEDIATRICS, V111, P511, DOI 10.1542/peds.111.3.511; Huang YS, 2007, SLEEP MED, V8, P18, DOI 10.1016/j.sleep.2006.05.016; Hultcrantz E, 2009, INT J PEDIATR OTORHI, V73, P1234, DOI 10.1016/j.ijporl.2009.05.012; Julvez J, 2007, ACTA PAEDIATR, V96, P842, DOI 10.1111/j.1651-2227.2007.00273.x; Kadziela-Olech H, 2005, Rocz Akad Med Bialymst, V50, P302; Katz-Sagi H, 2010, J CLIN PEDIATR DENT, V34, P287, DOI 10.17796/jcpd.34.4.p6714ln2g658322u; Kikuchi Makoto, 2005, Sleep Breath, V9, P146, DOI 10.1007/s11325-005-0028-8; Kim HW, 2009, PSYCHIAT INVEST, V6, P278, DOI 10.4306/pi.2009.6.4.278; Konofal E, 2008, PEDIATR NEUROL, V38, P20, DOI 10.1016/j.pediatrneurol.2007.08.014; Lalloo R, 2003, DENT TRAUMATOL, V19, P12, DOI 10.1034/j.1600-9657.2003.00139.x; Li HY, 2006, LARYNGOSCOPE, V116, P1142, DOI 10.1097/01.mlg.0000217542.84013.b5; Li SH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-144; Medeiros Ana Paula Magalhães, 2009, Pró-Fono R. Atual. Cient., V21, P315, DOI 10.1590/S0104-56872009000400009; Miano S, 2011, CLIN NEUROPHYSIOL, V122, P311, DOI 10.1016/j.clinph.2010.06.019; Miyao E, 2008, INTERNAL MED, V47, P1573, DOI 10.2169/internalmedicine.47.0717; Montaldo L, 2011, INT J PAEDIATR DENT, V21, P68, DOI 10.1111/j.1365-263X.2010.01092.x; Montgomery-Downs HE, 2007, PEDIATRICS, V120, P1030, DOI 10.1542/peds.2007-0722; O'Brien LM, 2003, PEDIATRICS, V111, P554, DOI 10.1542/peds.111.3.554; Oddy Wendy H, 2012, Breastfeed Rev, V20, P7; Oliveira Maria A. A., 2005, J. Pediatr. (Rio J.), V81, P361, DOI 10.1590/S0021-75572005000600004; Oner P, 2008, CHILD PSYCHIAT HUM D, V39, P323, DOI 10.1007/s10578-007-0095-0; Owens JA, 2009, PEDIATR PULM, V44, P417, DOI 10.1002/ppul.20981; Perinetti G, 2008, ORAL HLTH PREV DENT, V6, P119; Pessah Stephanie, 2009, Orthod Fr, V80, P331, DOI 10.1051/orthodfr/2009024; Ray R Mark, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P360, DOI 10.1097/01.moo.0000186076.53986.71; Rizwanulla T, 2009, THESIS R GANDHI U HL; Sabuncuoglu O, 2005, DENT TRAUMATOL, V21, P249, DOI 10.1111/j.1600-9657.2005.00317.x; Sabuncuoglu O, 2007, DENT TRAUMATOL, V23, P137, DOI 10.1111/j.1600-9657.2005.00431.x; Sanchez-Molins M, 2010, EUR J PAEDIATR DENT, V11, P87; Schmied K, 2009, ZWR, V118, P26; Sever Y, 1997, NEUROPSYCHOBIOLOGY, V35, P178, DOI 10.1159/000119341; Sidlauskas A, 2009, MEDICINA-LITHUANIA, V45, P147, DOI 10.3390/medicina45020019; Stettler N, 2011, NESTLE NUTR WORKS SE, V68, P215, DOI 10.1159/000325884; STEVENS LJ, 1995, AM J CLIN NUTR, V62, P761, DOI 10.1093/ajcn/62.4.761; Surman Craig B H, 2006, J Atten Disord, V9, P550, DOI 10.1177/1087054705282121; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Trawitzki Luciana Vitaliano Voi, 2005, Braz J Otorhinolaryngol, V71, P747; TurgeonOBrien H, 1996, J DENT CHILD, V63, P321; Viggiano D, 2004, ARCH DIS CHILD, V89, P1121, DOI 10.1136/adc.2003.029728; Vlastos IM, 2010, EUR J PEDIATR, V169, P261, DOI 10.1007/s00431-009-1019-8; Weber Silke Anna Thereza, 2006, Braz J Otorhinolaryngol, V72, P124; Wei JL, 2007, ARCH OTOLARYNGOL, V133, P974, DOI 10.1001/archotol.133.10.974; World Health Organization, 2009, INF YOUNG CHILD FEED; Yoon SYR, 2012, SLEEP MED REV, V16, P371, DOI 10.1016/j.smrv.2011.07.001; Yorbik O, 2003, TURK J CHILD ADOLESC, V10, P115	81	12	14	0	40	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAR	2013	80	3					315	320		10.1016/j.mehy.2012.12.017			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	102GZ	WOS:000315834400023	23306004				2022-02-06	
J	Schulte, S; Schiffer, T; Sperlich, B; Knicker, A; Podlog, LW; Struder, HK				Schulte, Stefanie; Schiffer, Thorsten; Sperlich, Billy; Knicker, Axel; Podlog, Leslie W.; Strueder, Heiko K.			The impact of increased blood lactate on serum S100B and prolactin concentrations in male adult athletes	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Blood lactate; Lactate clamp; Serum S100B; Prolactin; Sodium lactate	SEROTONERGIC NEURONS; PLASMA PROLACTIN; SODIUM-LACTATE; S-100B PROTEIN; ELITE PLAYERS; BRAIN-INJURY; EXERCISE; INFUSION; S100-BETA; RELEASE	S100B is an astroglial protein that is increased in the peripheral bloodstream after traumatic brain injury (TBI). Elevated serum levels of S100B have been shown to be predictive of mild TBI. Furthermore, physical activity (PA) can affect S100B levels. Interestingly, increased serum S100B concentrations have been detected in athletes without apparent TBI. Such increases could be attributed to tissue hypoperfusion reflected by blood lactate concentrations [BLa-] and/or increased serotonergic activity reflected by prolactin (PRL). The impact of increased blood lactates on peripheral S100B levels per se are yet unknown. The purpose of our study was to investigate if increased blood lactate induced by sodium lactate infusion, without the "side effects" of PA, resulted in changes in serum S100B and PRL. Twelve male adults were given a sodium lactate infusion for a period of 24 min by a perfusor with an infusion rate of 0.01 mL kg(-1) min(-1), increased every 3 min. The main outcome measures showed no increase in serum S100B (p > 0.05). Prolactin increased significantly (p < 0.05) after [BLa-] exceeded a concentration of 4 mmol L-1. Furthermore, the expected values of blood lactate achieved peak values ranging from 11 to 15 mmol L-1. We conclude that neither increased blood lactate nor serum PRL play an exclusive role in the regulation of S100B. Nevertheless, PA should be surveyed in medical history and critically assessed in determining the severity of TBI, especially in sports. Further studies are needed to clarify the impact of PA on the biomarker S100B.	[Schulte, Stefanie; Podlog, Leslie W.] Univ Utah, Dept Exercise & Sport Sci, Coll Hlth, HPER N, Salt Lake City, UT 84112 USA; [Schiffer, Thorsten] Outpatient Clin Sports Traumatol & Publ Hlth Cons, Cologne, Germany; [Sperlich, Billy] Univ Wuppertal, Dept Sport Sci, Wuppertal, Germany; [Knicker, Axel; Strueder, Heiko K.] German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany		Schulte, S (corresponding author), Univ Utah, Dept Exercise & Sport Sci, Coll Hlth, HPER N, 250 S 1850 E, Salt Lake City, UT 84112 USA.	schulte.research@yahoo.com	Knicker, Axel/I-4912-2019	Knicker, Axel/0000-0002-6286-5961; Podlog, Leslie/0000-0001-5012-9118			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Buckley JD, 2001, EUR J APPL PHYSIOL, V85, P412, DOI 10.1007/s004210100492; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; HARING JH, 1993, BRAIN RES, V631, P119, DOI 10.1016/0006-8993(93)91195-X; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; LUGER A, 1992, NEUROENDOCRINOLOGY, V56, P112, DOI 10.1159/000126912; Martins RO, 2006, ARQ NEURO-PSIQUIAT, V64, P24, DOI 10.1590/S0004-282X2006000100006; MDE OD, 2004, CLIN J SPORT MED, V14, P368; Miller BF, 2005, J APPL PHYSIOL, V98, P856, DOI 10.1152/japplphysiol.00753.2004; Mustafa I, 2002, SHOCK, V18, P306, DOI 10.1097/00024382-200210000-00003; Nishi M, 2000, BRAIN RES, V868, P113, DOI 10.1016/S0006-8993(00)02201-0; Nishi M, 1996, SYNAPSE, V23, P1, DOI 10.1002/(SICI)1098-2396(199605)23:1<1::AID-SYN1>3.0.CO;2-E; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pitchot W, 2002, PSYCHOPHARMACOLOGY, V164, P27, DOI 10.1007/s00213-002-1177-0; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Snyder-Ramos SA, 2004, ANAESTHESIA, V59, P344, DOI 10.1111/j.1365-2044.2004.03663.x; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Struder HK, 1999, ACTA PHYSIOL SCAND, V165, P265; Struder HK, 2001, INT J SPORTS MED, V22, P467, DOI 10.1055/s-2001-17605; Struder HK, 1996, EUR J APPL PHYSIOL O, V74, P443; VandeKar LD, 1996, BEHAV BRAIN RES, V73, P203; VANDERMOLEN GM, 1988, PSYCHOSOM MED, V50, P439, DOI 10.1097/00006842-198807000-00011; Vega SR, 2012, J NEUROENDOCRINOL, V24, P395, DOI 10.1111/j.1365-2826.2011.02266.x; Vega SR, 2006, MED SCI SPORT EXER, V38, P675, DOI 10.1249/01.mss.0000210195.94952.50; Vega SR, 2003, HORM METAB RES, V35, P598, DOI 10.1055/s-2003-43506; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004; Watson P, 2006, MED SCI SPORT EXER, V38, P2118, DOI 10.1249/01.mss.0000235356.31932.0a; WHITAKERAZMITIA PM, 1990, BRAIN RES, V528, P155, DOI 10.1016/0006-8993(90)90210-3; WHITAKERAZMITIA PM, 1989, BRAIN RES, V497, P80, DOI 10.1016/0006-8993(89)90972-4; Woertgen C, 2002, J CLIN NEUROSCI, V9, P51, DOI 10.1054/jocn.2001.0904; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143	37	12	12	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319			EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAR	2013	113	3					811	817		10.1007/s00421-012-2503-9			7	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	087PF	WOS:000314773500028	23053124				2022-02-06	
J	Avraham, Y; Dayan, M; Lassri, V; Vorobiev, L; Davidi, N; Chernoguz, D; Berry, E; Leker, RR				Avraham, Y.; Dayan, M.; Lassri, V.; Vorobiev, L.; Davidi, N.; Chernoguz, D.; Berry, E.; Leker, R. R.			Delayed leptin administration after stroke induces neurogenesis and angiogenesis	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						angiogenesis; cerebrovascular disease; leptin; neurogenesis; neuroprotection; stroke	ACTIVATED PROTEIN-KINASE; CLOSED-HEAD-INJURY; VEGF EXPRESSION; CELL-PROLIFERATION; ISCHEMIA; FGF-2	Leptin is a potent AMP kinase (AMPK) inhibitor that induces neuroprotection, neurogenesis, and angiogenesis when administered immediately after stroke. To dissociate these effects, we explored the effects of delayed administration of leptin, at 10 days after stroke onset, on neurogenesis and angiogenesis after stroke. Sabra mice underwent photothrombotic stroke and were treated with vehicle or leptin given either as a single dose or in triple dosing, 10 days later. Newborn cells were labeled with bromodeoxyuridine. Functional outcome was studied with the neurological severity score for 90 days poststroke, and the brains were then evaluated via immunohistochemistry. Final infarct volumes did not differ between the groups. Exogenous leptin led to significant increments in the number of proliferating BrdU+ cells in the subventricular zone and in the cortex abutting the lesion (2.5-fold and 1.4-fold, respectively). There were significant increments in the number of newborn neurons and glia (4- and 3.4-fold, respectively) in leptin-treated animals. Leptin also significantly increased the number of blood vessels in the perilesioned cortex. However, animals treated with leptin failed to demonstrate significantly better functional states. In conclusion, leptin induces neurogenesis and angiogenesis even when given late after stroke but does not lead to better functional outcome in this delayed-treatment paradigm. These results suggest that the main beneficial effects of leptin after stroke are associated with its early neuroprotective role rather than with its proneurogenic or proangiogenic effects. (C) 2012 Wiley Periodicals, Inc.	[Leker, R. R.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neurol, Stroke Serv, IL-91120 Jerusalem, Israel; [Avraham, Y.; Dayan, M.; Vorobiev, L.; Davidi, N.; Berry, E.] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel		Leker, RR (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neurol, Stroke Serv, POB 12000, IL-91120 Jerusalem, Israel.	leker@hadassah.org.il	Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334	Israeli Science FoundationIsrael Science Foundation [1327/07]; Peritz and Chantal Scheinberg Cerebrovascular Research Fund; Sol Irwin Juni Trust Fund	Contract grant sponsor: Israeli Science Foundation; Contract grant number: 1327/07; Contract grant sponsor: Peritz and Chantal Scheinberg Cerebrovascular Research Fund; Contract grant sponsor: Sol Irwin Juni Trust Fund.	Avraham Y, 2011, CURR NEUROV IN PRESS; Avraham Y, 2010, CURR NEUROVASC RES, V7, P136, DOI 10.2174/156720210791184943; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Dagon Y, 2005, J BIOL CHEM, V280, P42142, DOI 10.1074/jbc.M507607200; Eichenbaum JW, 2002, J PHARMACOL TOXICOL, V47, P67, DOI 10.1016/S1056-8719(02)00215-0; Forsberg-Nilsson K, 1998, J NEUROSCI RES, V53, P521, DOI 10.1002/(SICI)1097-4547(19980901)53:5<521::AID-JNR2>3.0.CO;2-B; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Lee JK, 2007, SURG NEUROL, V67, P620, DOI 10.1016/j.surneu.2006.08.077; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Li J, 2010, J CEREBR BLOOD F MET, V30, P480, DOI 10.1038/jcbfm.2009.255; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Neurath KM, 2006, GLIA, V53, P733, DOI 10.1002/glia.20326; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019	21	12	18	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB	2013	91	2					187	195		10.1002/jnr.23147			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	056JS	WOS:000312485300004	23152300				2022-02-06	
J	Blomster, LV; Cowin, GJ; Kurniawan, ND; Ruitenberg, MJ				Blomster, Linda V.; Cowin, Gary J.; Kurniawan, Nyoman D.; Ruitenberg, Marc J.			Detection of endogenous iron deposits in the injured mouse spinal cord through high-resolution ex vivo and in vivo MRI	NMR IN BIOMEDICINE			English	Article						neurotrauma; secondary injury; astrogliosis; neural scar; neurodegeneration; haemorrhage; oxidative stress	MAGNETIC-RESONANCE; QUANTITATIVE MRI; NERVOUS-SYSTEM; WHITE-MATTER; DEGENERATION; CELLS; RAT; TRANSPLANTATION; HISTOLOGY; BRAIN	The main aim of this study was to employ high-resolution MRI to investigate the spatiotemporal development of pathological features associated with contusive spinal cord injury (SCI) in mice. Experimental mice were subjected to either sham surgery or moderate contusive SCI. A 16.4-T small-animal MR system was employed for nondestructive imaging of post-mortem, fixed spinal cord specimens at the subacute (7?days) and more chronic (2835 days) stages post-injury. Routine histological techniques were used for subsequent investigation of the observed neuropathology at the microscopic level. The central core of the lesion appeared as a dark hypo-intense area on MR images at all time points investigated. Small focal hypo-intense spots were also observed spreading through the dorsal funiculi proximal and distal to the site of impact, an area that is known to undergo gliosis and Wallerian degeneration in response to injury. Histological examination revealed these hypo-intense spots to be high in iron content as determined by Prussian blue staining. Quantitative image analysis confirmed the increased presence of iron deposits at all post-injury time points investigated (p < 0.05). Distant iron deposits were also detectable through live imaging without the use of contrast-enhancing agents, enabling the longitudinal investigation of this pathology in individual animals. Further immunohistochemical evaluation showed that intracellular iron deposits localised to macrophages/microglia, astrocytes and oligodendrocytes in the subacute phase of SCI, but predominantly to glial fibrillary acidic protein-positive, CC-1-positive astrocytes at later stages of recovery. Progressive, widespread intracellular iron accumulation is thus a normal feature of SCI in mice, and high-resolution MRI can be effectively used to detect and monitor these neuropathological changes with time. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Blomster, Linda V.; Ruitenberg, Marc J.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia; [Blomster, Linda V.] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA, Australia; [Cowin, Gary J.; Kurniawan, Nyoman D.] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld 4072, Australia; [Ruitenberg, Marc J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia		Ruitenberg, MJ (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	m.ruitenberg@uq.edu.au	Kurniawan, Nyoman/D-9764-2011; Cowin, Gary J/E-6147-2011; Blomster, Linda V./L-6368-2018; Cowin, Gary/U-8721-2019	Kurniawan, Nyoman/0000-0001-6340-182X; Cowin, Gary J/0000-0002-3400-3109; Blomster, Linda V./0000-0002-7611-9740; Cowin, Gary/0000-0002-3400-3109; Ruitenberg, Marc/0000-0002-6917-0708	School of Biomedical Sciences (The University of Queensland); office of the DVC(R) of The University of Queensland; International Postgraduate Research Scholarship of Australian Government; Australian National Imaging Facility; Queensland NMR network	This work was financially supported by the School of Biomedical Sciences (The University of Queensland) and an Enabling Grant from the office of the DVC(R) of The University of Queensland. LVB is supported by an International Postgraduate Research Scholarship of the Australian Government. Additional support was received through the Australian National Imaging Facility and the Queensland NMR network.	Ahrens ET, 2011, BIOTECHNIQUES, V50, P229, DOI 10.2144/000113652; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bilgen M, 2008, BIOMARK MED, V2, P113, DOI 10.2217/17520363.2.2.113; Blackwell ML, 2009, NEUROIMAGE, V46, P382, DOI 10.1016/j.neuroimage.2009.01.030; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; BUNGE RP, 1993, ADV NEUROL, V59, P75; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cowin GJ, 2011, NEUROIMAGE, V58, P69, DOI 10.1016/j.neuroimage.2011.06.003; David BT, 2010, EXP NEUROL, V226, P128, DOI 10.1016/j.expneurol.2010.08.014; Do-Dai DD, 2010, CURR PROBL DIAGN RAD, V39, P160, DOI 10.1067/j.cpradiol.2009.05.004; Dunning MD, 2006, NEUROIMAGE, V31, P172, DOI 10.1016/j.neuroimage.2005.11.050; Dunning MD, 2004, J NEUROSCI, V24, P9799, DOI 10.1523/JNEUROSCI.3126-04.2004; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Ellingson BM, 2010, J NEUROSURG-SPINE, V13, P181, DOI 10.3171/2010.3.SPINE09523; Gaviria M, 2006, NEUROBIOL DIS, V22, P694, DOI 10.1016/j.nbd.2006.01.011; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Gonzalez-Lara LE, 2011, MOL IMAGING BIOL, V13, P702, DOI 10.1007/s11307-010-0393-y; Gonzalez-Lara LE, 2009, J NEUROTRAUM, V26, P753, DOI 10.1089/neu.2008.0704; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; HEYE N, 1994, ARCH GERONTOL GERIAT, V18, P181, DOI 10.1016/0167-4943(94)90012-4; Hu SL, 2009, J CELL BIOCHEM, V108, P529, DOI 10.1002/jcb.22283; Izawa T, 2010, BRAIN RES, V1349, P105, DOI 10.1016/j.brainres.2010.06.030; Johnson GA, 2002, RADIOLOGY, V222, P789, DOI 10.1148/radiol.2223010531; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Koszyca B, 2002, J CLIN NEUROSCI, V9, P298, DOI 10.1054/jocn.2001.0969; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Liu Jin-bo, 2004, Chin J Traumatol, V7, P229; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Paterniti I, 2010, FREE RADICAL RES, V44, P694, DOI 10.3109/10715761003742993; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Schonberg DL, 2009, EXP NEUROL, V218, P64, DOI 10.1016/j.expneurol.2009.04.005; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Ullmann JFP, 2010, NMR BIOMED, V23, P341, DOI 10.1002/nbm.1465; Wang MY, 2011, MAGN RESON IMAGING, V29, P365, DOI 10.1016/j.mri.2010.10.016	47	12	12	2	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480			NMR BIOMED	NMR Biomed.	FEB	2013	26	2					141	150		10.1002/nbm.2829			10	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	075LC	WOS:000313886500005	22730180	Green Submitted			2022-02-06	
J	Millett, PJ; Schoenahl, JY; Allen, MJ; Motta, T; Gaskill, TR				Millett, Peter J.; Schoenahl, Jean-Yves; Allen, Matthew J.; Motta, Tatiana; Gaskill, Trevor R.			An association between the inferior humeral head osteophyte and teres minor fatty infiltration: evidence for axillary nerve entrapment in glenohumeral osteoarthritis	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Humeral osteophytes; goat's beard; teres minor fatty infiltration; axillary neurovascular bundle	QUADRILATERAL SPACE SYNDROME; TENDON RELEASE; SHOULDER; INJURIES; MUSCLE; PERSPECTIVE; SPORTS; CYST	Background: Glenohumeral osteoarthritis often results in inferior humeral osteophytes. Anatomic studies suggest that the axillary neurovascular bundle is in close proximity to the glenohumeral capsule. We therefore hypothesize that an inferior humeral osteophyte of sufficient magnitude could encroach on the axillary nerve and result in measurable fatty infiltration of the teres minor muscle. Materials and methods: Preoperative magnetic resonance imaging studies of 91 consecutive arthritic shoulders were retrospectively reviewed. Two cohorts were established based on the presence of a humeral osteophyte. The distances from the axillary neurovascular bundle to various osseous structures were measured using calibrated software. Objective quantitative measurements of the degree of fatty infiltration of the teres minor muscles were obtained with image analysis software. Results were compared between cohorts. Results: The distance between the inferior humerus and axillary neurovascular bundle was inversely correlated to the size of the inferior humeral osteophyte (rho = -0.631, P < .001). Fatty infiltration of the teres minor was greater when an inferior osteophyte was present (11.9%) than when an osteophyte was not present (4.4%) (P = .004). A statistically significant correlation between the size of the humeral head spur and quantity of fat in the teres minor muscle belly (rho = 0.297, P = .005) was identified. Conclusion: These data are consistent with our hypothesis that the axillary nerve may be entrapped by the inferior humeral osteophyte often presenting with glenohumeral osteoarthritis. Entrapment may affect axillary nerve function and lead to changes in the teres minor muscle. Axillary neuropathy from an inferior humeral osteophyte may represent a contributing and treatable cause of pain in patients with glenohumeral osteoarthritis. Level of evidence: Level III, Case-Control Study, Epidemiology Study. (C) 2013 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Millett, Peter J.; Schoenahl, Jean-Yves; Gaskill, Trevor R.] Steadman Philippon Res Inst, Vail, CO 81657 USA; [Allen, Matthew J.; Motta, Tatiana] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA		Millett, PJ (corresponding author), Steadman Philippon Res Inst, 181 W Meadow Dr, Vail, CO 81657 USA.	drmillett@steadmanclinic.net			Steadman Philippon Research Institute; Arthrex; Ossur; Smith Nephew; ArthroCare; OrthroRehab; SiemensSiemens AG	Dr Millett is a consultant for and receives payments from Arthrex and has stock options in Game Ready, which are related to the subject of this work. Dr Millett also receives support from the Steadman Philippon Research Institute. Companies that support the Steadman Philippon Research Institute include Arthrex, Ossur, Smith & Nephew, ArthroCare, OrthroRehab, and Siemens.	Amin MF, 2006, SKELETAL RADIOL, V35, P956, DOI 10.1007/s00256-006-0092-6; Apaydin N, 2010, SURG RADIOL ANAT, V32, P193, DOI 10.1007/s00276-009-0594-8; Aval SM, 2007, J AM ACAD ORTHOP SUR, V15, P281, DOI 10.5435/00124635-200705000-00006; Ball CM, 2003, J BONE JOINT SURG AM, V85A, P1497, DOI 10.2106/00004623-200308000-00010; BATEMAN JE, 1967, J BONE JOINT SURG AM, VA 49, P785, DOI 10.2106/00004623-196749040-00025; Bonnard C, 1999, J BONE JOINT SURG BR, V81B, P212, DOI 10.1302/0301-620X.81B2.8301; BRYAN WJ, 1986, AM J SPORT MED, V14, P113, DOI 10.1177/036354658601400203; Burkhead W Z Jr, 1992, J Shoulder Elbow Surg, V1, P31, DOI 10.1016/S1058-2746(09)80014-1; CAHILL BR, 1983, J HAND SURG-AM, V8, P65, DOI 10.1016/S0363-5023(83)80056-2; Duparc F, 1997, SURG RADIOL ANAT, V19, P127, DOI 10.1007/s00276-997-0127-2; Eakin CL, 1998, AM J SPORT MED, V26, P505, DOI 10.1177/03635465980260040501; ENGEL WK, 1966, ANN NY ACAD SCI, V138, P160; Gerber C, 2004, J BONE JOINT SURG AM, V86A, P1973, DOI 10.2106/00004623-200409000-00016; LOOMER R, 1989, CLIN ORTHOP RELAT R, P100; McCarty EC, 2004, AM J SPORT MED, V32, P909, DOI 10.1177/0363546503260064; McFarland EG, 2002, AM J SPORT MED, V30, P601, DOI 10.1177/03635465020300042101; McMinn R, 1966, NATURE, V195, P509; Meyer DC, 2004, J ORTHOPAED RES, V22, P1004, DOI 10.1016/j.orthres.2004.02.009; Millett PJ, 2011, ARTHROSCOPY, V27, P1296, DOI 10.1016/j.arthro.2011.03.089; PETRUCCI FS, 1982, J HAND SURG-AM, V7, P271, DOI 10.1016/S0363-5023(82)80178-0; Price MR, 2004, J BONE JOINT SURG AM, V86A, P2135, DOI 10.2106/00004623-200410000-00003; Robinson P, 2000, AM J ROENTGENOL, V175, P1103, DOI 10.2214/ajr.175.4.1751103; Safran MR, 2004, AM J SPORT MED, V32, P803, DOI 10.1177/0363546504264582; Sanders TG, 1999, ARTHROSCOPY, V15, P632, DOI 10.1053/ar.1999.v15.015063; Steinmann S P, 2001, J Am Acad Orthop Surg, V9, P328; Yoo JC, 2007, ARTHROSCOPY, V23, P1271, DOI 10.1016/j.arthro.2007.07.011	26	12	12	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	FEB	2013	22	2					215	221		10.1016/j.jse.2012.05.030			7	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	100DG	WOS:000315675400020	22939404				2022-02-06	
J	Yang, SG; Ma, YH; Liu, Y; Que, HP; Zhu, CQ; Liu, SJ				Yang, Shuguang; Ma, Yanhong; Liu, Yong; Que, Haiping; Zhu, Changqiang; Liu, Shaojun			Elevated serum haptoglobin after traumatic brain injury is synthesized mainly in liver	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						serum; haptoglobin; proteomics; rat; traumatic brain injury	HUMAN CEREBROSPINAL-FLUID; CELL-LINE; EXPRESSION; GENE; INTERLEUKIN-6; ELEMENT; TISSUE; RATS; MICE	Haptoglobin (Hp), an acute-phase response protein, is typically increased in the serum of adults after acute tissue injury. It is an antioxidant and may function as an injury-induced neuroprotective protein. However, the source of increased Hp is not clear. To investigate its source, we compared its time course expression profile in serum from rats with or without traumatic brain injury (TBI). Elevated Hp levels revealed by proteomic analysis were confirmed by Western blot, semiquantitative PCR, and real-time PCR. We found that Hp protein and mRNA levels were increased after TBI in both serum and liver, especially in liver. Both in vivo and in vitro data showed that Hp expression was increased in rat and human (HL7702) liver cells upon treatment with TBI serum. Addition of anti-interleukin-6 (IL-6) antibody downregulated the expression of Hp in liver cells induced by serum derived from rats and in liver of rats after TBI. These findings suggest that the increased Hp in serum came from the liver in response to TBI and that IL-6 is an important mediator of this induction. (C) 2012 Wiley Periodicals, Inc.	[Yang, Shuguang; Ma, Yanhong; Liu, Yong; Que, Haiping; Zhu, Changqiang; Liu, Shaojun] Inst Basic Med Sci, State Key Lab Prote, Beijing 100850, Peoples R China; [Yang, Shuguang; Ma, Yanhong; Liu, Yong; Que, Haiping; Zhu, Changqiang; Liu, Shaojun] Inst Basic Med Sci, Dept Neurobiol, Beijing 100850, Peoples R China; [Ma, Yanhong] 261th Hosp Chinese PLA, Dept Cardiol, Beijing, Peoples R China		Yang, SG (corresponding author), Inst Basic Med Sci, State Key Lab Prote, Beijing 100850, Peoples R China.	lionfmmu@yahoo.com.cn			Chinese National Key Project of Basic ResearchNational Basic Research Program of China [2009CB918301]; Chinese National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81000797]	Contract grant sponsor: Chinese National Key Project of Basic Research; Contract grant number: 2009CB918301; Contract grant sponsor: Chinese National Natural Science Foundation; Contract grant number: 81000797.	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Arredouani M, 2003, IMMUNOLOGY, V108, P144, DOI 10.1046/j.1365-2567.2003.01569.x; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; DArmiento J, 1997, GENE, V195, P19, DOI 10.1016/S0378-1119(97)00123-6; Ding QX, 2003, PROTEOMICS, V3, P1313, DOI 10.1002/pmic.200300452; El-Ghmati SM, 2002, SCAND J IMMUNOL, V55, P352, DOI 10.1046/j.1365-3083.2002.01067.x; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Johnson Ginger, 1992, Applied and Theoretical Electrophoresis, V3, P47; Kim IS, 2001, BIOCHEM BIOPH RES CO, V284, P738, DOI 10.1006/bbrc.2001.5041; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Lewis E J, 1992, Mediators Inflamm, V1, P39, DOI 10.1155/S0962935192000085; Lim YK, 2000, KIDNEY INT, V58, P1033, DOI 10.1046/j.1523-1755.2000.00261.x; MARINKOVIC S, 1990, MOL CELL BIOL, V10, P1573, DOI 10.1128/MCB.10.4.1573; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sanchez DJ, 2001, NEUROSCI LETT, V303, P181, DOI 10.1016/S0304-3940(01)01748-7; SEVALJEVIC LJ, 1995, INT J BIOCHEM CELL B, V27, P185, DOI 10.1016/1357-2725(94)00073-K; Smeets MB, 2002, FEBS LETT, V529, P221, DOI 10.1016/S0014-5793(02)03343-4; Vejda S, 2002, MOL CELL PROTEOMICS, V1, P387, DOI 10.1074/mcp.M200004-MCP200; WADA T, 1970, J RETICULOENDOTH SOC, V8, P185; YANG FM, 1995, LAB INVEST, V73, P433; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012; Zhang ZY, 2009, WORLD J GASTROENTERO, V15, P4150, DOI 10.3748/wjg.15.4150	29	12	12	1	20	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	FEB	2013	91	2					230	239		10.1002/jnr.23159			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	056JS	WOS:000312485300008	23172820				2022-02-06	
J	Anderson, GD; Peterson, TC; Farin, FM; Bammler, TK; Beyer, RP; Kantor, ED; Hoane, MR				Anderson, G. D.; Peterson, T. C.; Farin, F. M.; Bammler, T. K.; Beyer, R. P.; Kantor, E. D.; Hoane, M. R.			The effect of nicotinamide on gene expression in a traumatic brain injury model	FRONTIERS IN NEUROSCIENCE			English	Article						nicotinamide; gene expression; cortical contusion model; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; IMPROVES FUNCTIONAL RECOVERY; CORTICAL CONTUSION INJURY; FLUID PERCUSSION INJURY; NEUROTRANSMITTER RELEASE; WISTAR RATS; RECEPTOR; NEUROPROTECTION; PROGESTERONE; APOPTOSIS	Microarray-based transcriptional profiling was used to determine the effect of nicotinamide on gene expression in an experimental traumatic brain injury (TBI) model. Ingenuity Pathway Analysis (IPA) was used to evaluate the effect on relevant functional categories and canonical pathways. At 24 h, 72 h, and 7 days, respectively, 70, 58, and 76%, of the differentially expressed genes were up-regulated in the vehicle treated compared to the sham animals. At 24 h post-TBI, there were 150 differentially expressed genes in the nicotinamide treated animals compared to vehicle; the majority (82%) down-regulated. IPA analysis identified a significant effect of nicotinamide on the functional categories of cellular movement, cell-to-cell-signaling, antigen presentation and cellular compromise, function, and maintenance and cell death. The canonical pathways identified were signaling pathways primarily involved with the inflammatory process. At 72 h post-cortical contusion injury, there were 119 differentially expressed genes in the nicotinamide treated animals compared to vehicle; the majority (90%) was up-regulated. IPA analysis identified a significant effect of nicotinamide on cell signaling pathways involving neurotransmitters, neuropeptides, growth factors, and ion channels with little to no effect on inflammatory pathways. At 7 days post-TBI, there were only five differentially expressed genes with nicotinamide treatment compared to vehicle. Overall, the effect of nicotinamide on counteracting the effect of TBI resulted in significantly decreased number of genes differentially expressed by TBI. In conclusion, the mechanism of the effect of nicotinamide on secondary injury pathways involves effects on inflammatory response, signaling pathways, and cell death.	[Anderson, G. D.; Kantor, E. D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Peterson, T. C.; Hoane, M. R.] So Illinois Univ, Dept Psychol, Carbondale, IL 62901 USA; [Farin, F. M.; Bammler, T. K.; Beyer, R. P.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Box 357630,Hlth Sci Complex H-361A, Seattle, WA 98195 USA.	gaila@washington.edu		Hoane, Michael/0000-0001-7779-2657	National Institutes of Health/National Institute of Child, Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 HD061944-01]; UW NIEHS sponsored Center for Ecogenetics and Environmental Health [P30ES07033]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER	This research was supported by a grant from the National Institutes of Health/National Institute of Child, Health and Development (R01 HD061944-01). This work was also supported in part by the UW NIEHS sponsored Center for Ecogenetics and Environmental Health (P30ES07033).	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Bourke E, 2003, J IMMUNOL, V170, P5999, DOI 10.4049/jimmunol.170.12.5999; CANTONI O, 1987, BIOCHEM INT, V15, P329; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; De Smedt T., 2007, CNS DRUG REV, V13, P3; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng GB, 2009, J MOL NEUROSCI, V39, P354, DOI 10.1007/s12031-009-9288-2; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Gunther E, 2001, IMMUNOGENETICS, V53, P520, DOI 10.1007/s002510100361; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hansen H, 2008, AROMA AFFYMETRIX GEN; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; HORSMAN MR, 1993, RADIOTHER ONCOL, V27, P131, DOI 10.1016/0167-8140(93)90133-S; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; Leung YM, 2010, LIFE SCI, V86, P775, DOI 10.1016/j.lfs.2010.04.004; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Sakakibara Y, 2002, BRAIN RES, V931, P68, DOI 10.1016/S0006-8993(02)02263-1; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Smyth GK., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tallent MK, 2008, MOL CELL ENDOCRINOL, V286, P96, DOI 10.1016/j.mce.2007.12.004; VEZZANI A, 1991, NEUROPHARMACOLOGY, V30, P345, DOI 10.1016/0028-3908(91)90059-K; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang J, 2002, MINI-REV MED CHEM, V2, P125, DOI 10.2174/1389557024605483; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; YANG J, 2004, DRUG DESIGN REV, V1, P43; Zhang GL, 2011, INFLAMM RES, V60, P11, DOI 10.1007/s00011-010-0216-2	56	12	12	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.		2013	7								21	10.3389/fnins.2013.00021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AW9HF	WOS:000346567300021	23550224	Green Published, gold			2022-02-06	
J	Pereira, JLB; de Albuquerque, LAF; Dellaretti, M; Teles, G; de Carvalho, C; Vieira, G; Brochado, VM; Drummond, AV; de Morais, JE; Ferreira, LM; Miranda, PAC; de Sousa, AA				Barbosa Pereira, Julio Leonardo; Freitas de Albuquerque, Lucas Alverne; Dellaretti, Marcos; Teles, Gervasio; de Carvalho, Cardoso; Vieira, Gerival, Jr.; Brochado, Vitor Michelstaedter; Drummond, Austen Venancio; de Morais, Joyce Espeschit; Ferreira, Leticia Maia; Carvalho Miranda, Paulo Augusto; de Sousa, Atos Alves			Pituitary deficiency after aneurysmal subarachnoid hemorrhage	CLINICS			English	Article						Subarachnoid Hemorrhage; Endocrine Dysfunction; Aneurysm	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROENDOCRINE DYSFUNCTION; HYPOPITUITARISM	OBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patients in the first 15 days after aneurysmal subarachnoid hemorrhage. The following were measured in all patients: thyroid-stimulating hormone, free thyroxine, triiodothyronine, luteinizing hormone, follicle-stimulating hormone, total testosterone (in males), estradiol (in females), prolactin, serum cortisol, plasma adrenocorticotropic hormone, growth hormone and insulin growth factor. RESULTS: The endocrine assessment was made at a mean of 7.4 days (standard deviation +/- 6.6) after subarachnoid hemorrhage. Forty-four (66.7%) female and 22 (33.3%) male patients were evaluated. Thirty-nine patients (59.1%) had some type of pituitary dysfunction. Follicle-stimulating hormone/luteinizing hormone deficiency was the most frequent disorder (34.8%), followed by growth hormone/insulin growth factor (28.7%), adrenocorticotropic hormone (18.1%) and thyroid-stimulating hormone (9%). Seventeen (25.7%) patients showed deficiencies in more than one axis. A greater incidence of hormone deficiency was observed in patients with a Glasgow Coma Scale score <= 13 (t test, p = 0.008), Hunt-Hess grade >= 4 (t test, p<0.001), or Fisher grade 4 (t test, p = 0.039). Hormone deficiency was not significantly associated (p>0.05) with increased hospitalization or clinical outcome. CONCLUSION: Pituitary dysfunction was identified in a substantial portion of patients with previous aneurysmal subarachnoid hemorrhage, but no association was found between this dysfunction and poor clinical outcome.	[Barbosa Pereira, Julio Leonardo; Freitas de Albuquerque, Lucas Alverne; Dellaretti, Marcos; Teles, Gervasio; de Carvalho, Cardoso; Vieira, Gerival, Jr.; Brochado, Vitor Michelstaedter; Drummond, Austen Venancio; de Morais, Joyce Espeschit; Ferreira, Leticia Maia; Carvalho Miranda, Paulo Augusto; de Sousa, Atos Alves] Santa Casa Belo Horizonte, Dept Neurosurg, Belo Horizonte, MG, Brazil		Pereira, JLB (corresponding author), Santa Casa Belo Horizonte, Dept Neurosurg, Belo Horizonte, MG, Brazil.	lucasalverne@yahoo.com.br	Pereira, Julio/H-3324-2011; Dellaretti, Marcos/G-4664-2012	Pereira, Julio/0000-0003-0303-7506; 			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Darzy K H, 2005, J Endocrinol Invest, V28, P78; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Inagawa T, 1997, SURG NEUROL, V47, P47, DOI 10.1016/S0090-3019(96)00370-9; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Mangieri P, 2003, ARQ NEURO-PSIQUIAT, V61, P14, DOI 10.1590/S0004-282X2003000100003; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sharshar T, 2011, CRIT CARE, V15, DOI 10.1186/cc10010; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732	19	12	13	0	0	HOSPITAL CLINICAS, UNIV SAO PAULO	SAO PAULO	FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL	1807-5932			CLINICS	Clinics		2013	68	6					745	749		10.6061/clinics/2013(06)04			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165DS	WOS:000320463800004	23778478	Green Published, gold, Green Submitted			2022-02-06	
S	Barlow, KM		Dulac, O; Lassonde, M; Sarnat, HB		Barlow, Karen Maria			Traumatic brain injury	PEDIATRIC NEUROLOGY, PT II	Handbook of Clinical Neurology		English	Article; Book Chapter							INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; PEDIATRIC HEAD-INJURY; YOUNG-CHILDREN; POSTCONCUSSION SYNDROME; COMA SCALE; RECOVERY; MICRODIALYSIS; EPIDEMIOLOGY; ADOLESCENTS		[Barlow, Karen Maria] Univ Calgary, Fac Med, Div Pediat Neurol, Alberta Childrens Hosp, Calgary, AB T3B 6A8, Canada		Barlow, KM (corresponding author), Univ Calgary, Fac Med, Alberta Childrens Hosp, C4-335,2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	karen.barlow@albertahealthservices.ca	Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; BARLOW B, 1983, J PEDIATR SURG, V18, P509, DOI 10.1016/S0022-3468(83)80210-3; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; Chadwick DL, 1998, PEDIATRICS, V101, P321, DOI 10.1542/peds.101.2.321; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; TEASDALE G, 1974, LANCET, V2, P81; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	46	12	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-444-62699-8; 978-0-444-52910-7	HAND CLINIC			2013	112						891	904					14	Clinical Neurology; Pediatrics	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Pediatrics	BA6KI	WOS:000337167400013	23622299				2022-02-06	
J	Ciuffreda, KJ; Yadav, NK; Ludlam, DP				Ciuffreda, Kenneth J.; Yadav, Naveen K.; Ludlam, Diana P.			Effect of binasal occlusion (BNO) on the visual-evoked potential (VEP) in mild traumatic brain injury (mTBI)	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); binasal occlusion; visual-evoked potential amplitude; visual-evoked potential latency; visual motion sensitivity; disinhibition	POPULATION; CONCUSSION; PROTOCOL; TBI	Primary objective: The purpose of the experiment was to assess the effect of binasal occlusion (BNO) on the visually-evoked potential (VEP) in visually-normal (VN) individuals and in those with mild traumatic brain injury (mTBI) for whom BNO frequently reduces their primary symptoms related to abnormally-increased visual motion sensitivity (VMS). Design and methods: Subjects were comprised of asymptomatic VN adults (n = 10) and individuals with mTBI (n = 10) having the symptom of VMS. Conventional full-field VEP testing was employed under two conditions: without BNO and with opaque BNO which blocked regions on either side of the VEP test stimulus. Subjective impressions were also assessed. Results: In VN, the mean VEP amplitude decreased significantly with BNO in all subjects. In contrast, in mTBI, the mean VEP amplitude increased significantly with BNO in all subjects. Latency was normal and unaffected in all cases. Repeat VEP testing in three subjects from each group revealed similar test-re-test findings. Visuomotor activities improved, with reduced symptoms, with BNO in the mTBI group. Conclusions: It is speculated that individuals with mTBI habitually attempt to suppress visual information in the near retinal periphery to reduce their abnormal VMS, with addition of the BNO negating the suppressive influence and thus producing a widespread disinhibition effect and resultant increase in VEP amplitude.	[Ciuffreda, Kenneth J.; Yadav, Naveen K.; Ludlam, Diana P.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu					Ciuffreda K. J., 2012, VISUAL DIAGNOSIS CAR, P95; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda KJ, 1999, CLIN EYE VIS CARE, V11, P41, DOI DOI 10.1016/S0953-4431(99)00010-7; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Gallop S, 1998, J BEHAV OPTOM, V9, P31; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; JAMPOLSKY A, 1955, ARCH OPHTHALMOL-CHIC, V54, P683; KAUFMAN LLOYD, 1963, VISION RES, V3, P401, DOI 10.1016/0042-6989(63)90092-0; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Proctor A, 1974, OPTOMETRY VISION DEV, V40, P45; Semrud-Clikeman M., 2001, TRAUMATIC BRAIN INJU, P28; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Winkler PA, 2009, OPTOMETRY, V80, P502, DOI 10.1016/j.optm.2009.01.014	20	12	12	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2013	27	1					41	47		10.3109/02699052.2012.700088			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300005	22900490				2022-02-06	
J	El-Maraghi, S; Yehia, H; Hossam, H; Yehia, A; Mowafy, H				El-Maraghi, Sameh; Yehia, Heba; Hossam, Hazem; Yehia, Ahmed; Mowafy, Hossam			The prognostic value of neuron specific enolase in head injury	EGYPTIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Neuron specific enclose; Brain injury; GCS; Mortality		Background: The development and the use of biochemical markers for assessment of brain injury severity have been of considerable interest. The most promising marker of brain damage is considered to be neuron-specific enolase (NSE); predominantly located in neurons and neuroectodermal cells. Purpose: To investigate the serum levels of NSE in patients with head injury admitted to ICU and to correlate them with their outcome and other clinical parameters. Methods: A total of 20 patients admitted to the critical care unit, MISR University for science and technology Hospital with head injury; including traumatic brain injury and those with stroke either ischemic or hemorrhagic stroke were included in the study. NSE was measured in venous blood samples collected on ICU admission and at 48 h of admission. Clinical data and final outcome of survival/mortality rates were recorded for all patients. Results: Patients age ranged from 20 to 80 years with a mean (50.8 +/- 16.5), 18 of them were males (90%) and two were females (10%). There were no statistical significant difference between NSE level in traumatic (8.8 +/- 8.1) or non traumatic patients (10.9 +/- 7.9) (p value = 0.3). There was a significant correlation between NSE level and the progression of CT findings. Moreover, NSE showed statistically significant higher level estimation in those patients with moderate and severe brain injury (17.2 +/- 13.5) than in mild brain injury (7.1 +/- 4.8) (p = 0.04) together with significant negative correlation between NSE and GCS on admission (p = 0.01 & r = -0.564) as well as the changes in GCS assessment after 48 h. Upon estimating the prognostic role of NSE and its ability in detecting outcome; NSE was significantly higher in non survivors (20 +/- 14) than in survivors (8.9 +/- 6.7) (p < 0.05). Also, it was significantly higher in those with bad outcome (severe disability) than those who recover or with mild disability (p < 0.05). By statistical analysis; an optimal cutoff value of NSE level of 18 mu g/L was determined to predict ICU mortality and 7.9 mu g/L to predict bad outcome with a high sensitivity and specificity. Conclusion: Neuron specific enclose can be used as a potentially useful marker for brain damage and can be considered to be a relevant parameter for assessing the prognosis of brain injury. (C) 2012 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V.	[Yehia, Heba; Hossam, Hazem; Yehia, Ahmed; Mowafy, Hossam] Cairo Univ, Fac Med, Crit Care Dept, Cairo, Egypt; [El-Maraghi, Sameh] Beni Suef Univ, Fac Med, Crit Care Dept, Bani Suwayf, Egypt		El-Maraghi, S (corresponding author), Beni Suef Univ, Fac Med, Crit Care Dept, Bani Suwayf, Egypt.	sameh_elmaraghi@yahoo.com					Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Berg J. M., 2006, BIOCHEMISTRY; Casmiro M, 2005, EUR J NEUROL, V12, P369, DOI 10.1111/j.1468-1331.2004.01021.x; David B, 2009, CLIN CHEM LAB MED, V47, P1513; de Boussard N, 2005, J REHABIL MED, V53, P37; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Ergun R, 1998, NEUROL RES, V20, P418; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Johnsson P, 1996, J CARDIOTHOR VASC AN, V10, P120, DOI 10.1016/S1053-0770(96)80187-X; Manfred H, 2003, RESTOR NEUROL NEUROS, V21, P177; Mehta Samit Satish, 2010, Clin Neurosurg, V57, P134; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; REILLY PL, 1975, LANCET, V2, P375; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Rothoerl RD, 2000, ACT NEUR S, V76, P97; Sawaughi S, 2005, NEUROL SURG TOKYO, V33, P1073; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Sogut O, 2010, J INT MED RES, V38, P1708, DOI 10.1177/147323001003800516; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zahra S, 2006, BRAIN INJURY, V20, P463	28	12	13	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2090-7303			EGYPT J CRIT CARE ME	Egypt. J. Crit. Care Med.	JAN	2013	1	1					25	32		10.1016/j.ejccm.2012.12.002			8	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V24WV	WOS:000215188000005		gold			2022-02-06	
J	Huang, XJ; Mao, Q; Lin, Y; Feng, JF; Jiang, JY				Huang, Xian-jian; Mao, Qing; Lin, Yong; Feng, Jun-feng; Jiang, Ji-yao			Expression of Voltage-Gated Sodium Channel Nav1.3 Is Associated with Severity of Traumatic Brain Injury in Adult Rats	JOURNAL OF NEUROTRAUMA			English	Article						Nav1.3; rat; sodium channel; TBI	SPINAL SENSORY NEURONS; NEUROPATHIC PAIN; MESSENGER-RNAS; ISCHEMIA; MODEL; NA(V)1.3; MUTATION	During the secondary injury period after traumatic brain injury (TBI), depolarization of neurons mediated by voltage-gated sodium channels (VGSCs) leads to cellular abnormalities and neurological dysfunction. Alterations in expression of different alpha subunits of VGSCs can affect early brain pathology following TBI. This study detected the expression of Nav1.3 mRNA and protein in the rat cortex post-TBI. Adult male Sprague-Dawley rats were randomly assigned to sham-TBI, mild-TBI (mTBI), or severe-TBI (sTBI) groups. TBI was induced using a fluid percussion device at magnitudes of 1.5-1.6 atm (mTBI) and 2.9-3.0 atm (sTBI). Nav1.3 mRNA and protein levels in the ipsilateral-injured cortex were examined at 2 h, 12 h, 24 h, and 72 h post-TBI by real-time reverse transcriptase quantitative polymerase chain reaction and Western blot. Brains were collected at 24 h, 72 h, and 7 days post-TBI for TUNEL staining and cell count analysis. Immunofluorescence was performed to localize expression of Nav1.3 protein in the ipsilateral-injured cortex. Expression of Nav1.3 mRNA and protein were significantly upregulated in mTBI and sTBI groups when compared with the sham-TBI group at 2 h and 12 h post-TBI. Nav1.3 mRNA and protein levels in the sTBI group were much higher than in the mTBI group at 12 h post-TBI. TUNEL-positive cell numbers were significantly higher in the sTBI group than in the mTBI at 24 h, 72 h, and 7 days post-TBI. Expression of Nav1.3 was observed predominantly in neurons of the cortex. These findings indicated significant upregulation in the expression of Nav1.3 mRNA and protein in the rat ipsilateral-injured cortex at the very early stage post-TBI, and were also correlated with TBI severity.	[Huang, Xian-jian; Mao, Qing; Lin, Yong; Feng, Jun-feng; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	Jiangjyb@online.sh.cn			National Science and Nature Grant [30973086, 30901543]; National Health Science Grant [200802093]; National Key Basic Research ProjectNational Basic Research Program of China [2012CB518100]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [10JC1409800, 08411951900]; Program for Shanghai Outstanding Medical Academic Leaders	This work was supported by grants from National Science and Nature Grant (No. 30973086 and No. 30901543), National Health Science Grant (No. 200802093), National Key Basic Research Project (No. 2012CB518100), Science and Technology Committee of Shanghai (No. 10JC1409800 and No. 08411951900), and Program for Shanghai Outstanding Medical Academic Leaders. We thank Dr. Bruce G. Lyeth and Ken C. Van, Department of Neurological Surgery, University of California Davis, for their editorial support and critical review of the article.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aronica E, 2001, EUR J NEUROSCI, V13, P1261, DOI 10.1046/j.0953-816x.2001.01502.x; Blumenfeld H, 2009, EPILEPSIA, V50, P44, DOI 10.1111/j.1528-1167.2008.01710.x; Bragge P, 2012, J NEUROTRAUM, V29, P1539, DOI 10.1089/neu.2011.2193; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cheng KI, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-71; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; Guo F, 2008, J ELECTRON MATER, V37, P1, DOI 10.1007/s11664-007-0302-6; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hains BC, 2004, J NEUROSCI, V24, P4832, DOI 10.1523/JNEUROSCI.0300-04.2004; Hains BC, 2003, J NEUROSCI, V23, P8881; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Holland KD, 2008, NEUROSCI LETT, V433, P65, DOI 10.1016/j.neulet.2007.12.064; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ostlund G, 2012, GENE, V497, P228, DOI 10.1016/j.gene.2012.01.029; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Siqueira SRDT, 2009, NEUROSCIENCE, V164, P573, DOI 10.1016/j.neuroscience.2009.08.037; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3; Wix-Ramos R, 2011, CAN J PHYSIOL PHARM, V89, P753, DOI [10.1139/y11-073, 10.1139/Y11-073]	30	12	12	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2013	30	1					39	46		10.1089/neu.2012.2508			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	061GU	WOS:000312837300007	22928478	Green Published			2022-02-06	
J	Ilodigwe, D; Murray, GD; Kassell, NF; Torner, J; Kerr, RSC; Molyneux, AJ; Macdonald, RL				Ilodigwe, Don; Murray, Gordon D.; Kassell, Neal F.; Torner, James; Kerr, Richard S. C.; Molyneux, Andrew J.; Macdonald, R. Loch			Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials Clinical article	JOURNAL OF NEUROSURGERY			English	Article						clinical trial; statistical analysis; vascular disorders; subarachnoid hemorrhage; vasospasm	RUPTURED INTRACRANIAL ANEURYSMS; VEHICLE-CONTROLLED TRIAL; DOSE TIRILAZAD MESYLATE; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; ENDOVASCULAR COILING; RANDOMIZED-TRIAL; NORTH-AMERICA; STROKE TRIALS; NEW-ZEALAND	Object. In randomized clinical trials of subarachnoid hemorrhage (SAH) in which the primary clinical outcomes are ordinal, it has been common practice to dichotomize the ordinal outcome scale into favorable versus unfavorable outcome. Using this strategy may increase sample sizes by reducing statistical power. Authors of the present study used SAH clinical trial data to determine if a sliding dichotomy would improve statistical power. Methods. Available individual patient data from tirilazad (3552 patients), clazosentan (the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage trial [CONSCIOUS-1], 413 patients), and subarachnoid aneurysm trials (the International Subarachnoid Aneurysm Trial [ISAT], 2089 patients) were analyzed. Treatment effect sizes were examined using conventional fixed dichotomy, sliding dichotomy (logical or median split methods), or proportional odds modeling. Whether sliding dichotomy affected the difference in outcomes between the several age and neurological grade groups was also evaluated. Results. In the tirilazad data, there was no significant effect of treatment on outcome (fixed dichotomy: OR = 0.92, 95% CI 0.80-1.07; and sliding dichotomy: OR = 1.02, 95% CI 0.87-1.19). Sliding dichotomy reversed and increased the difference in outcome in favor of the placebo over clazosentan (fixed dichotomy: OR = 1.06, 95% CI 0.65-1.74; and sliding dichotomy: OR = 0.85, 95% CI 0.52-1.39). In the ISAT data, sliding dichotomy produced identical odds ratios compared with fixed dichotomy (fixed dichotomy vs sliding dichotomy, respectively: OR = 0.67, 95% CI 0.55-0.82 vs OR = 0.67, 95% CI 0.53-0.85). When considering the tirilazad and CONSCIOUS-1 groups based on age or World Federation of Neurosurgical Societies grade, no consistent effects of sliding dichotomy compared with fixed dichotomy were observed. Conclusions. There were differences among fixed dichotomy, sliding dichotomy, and proportional odds models in the magnitude and precision of odds ratios, but these differences were not as substantial as those seen when these methods were used in other conditions such as head injury. This finding suggests the need for different outcome scales for SAH. (http://thejns.org/doi/abs/10.3171/2012.9.JNS111383)	[Ilodigwe, Don; Macdonald, R. Loch] Univ Toronto, St Michaels Hosp,Div Neurosurg, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr,Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Ilodigwe, Don; Macdonald, R. Loch] Univ Toronto, Inst Med Sci, Dept Surg, Toronto, ON M5B 1W8, Canada; [Kassell, Neal F.] Univ Virginia, Sch Med, Dept Neurol Surg, Charlottesville, VA 22908 USA; [Torner, James] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Murray, Gordon D.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kerr, Richard S. C.] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England; [Molyneux, Andrew J.] Univ Oxford, Oxford Neurovasc & Neuroradiol Res Unit, Oxford OX1 2JD, England		Macdonald, RL (corresponding author), Univ Toronto, St Michaels Hosp,Div Neurosurg, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr,Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	macdonaldlo@smh.ca		Murray, Gordon/0000-0001-9866-4734	Actelion Pharmaceuticals, Ltd.; Physicians Services Incorporated Foundation; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Cerecyte Coil Trial (Micrus Endovascular); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700479, G0800803] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700479, G0800803] Funding Source: UKRI	Actelion Pharmaceuticals, Ltd., was the sponsor of the CONSCIOUS-1 trial and they provided financial support for the exploratory analysis described in this article. The data analysis and writing are the work of the authors. Dr. Macdonald is the chief scientific officer for and has direct stock ownership in Edge Therapeutics, Inc.; is a consultant for Actelion Pharmaceuticals, Ltd.; and receives grant funding from Physicians Services Incorporated Foundation and the Heart and Stroke Foundation of Canada. Dr. Kassell has ownership in InSightec. Dr. Molyneux is a consultant for Actelion Pharmaceuticals, Ltd., and Micrus Endovascular Corp. and receives grant support from the Medical Research Council UK and Cerecyte Coil Trial (Micrus Endovascular).	Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bolland K, 1998, STAT MED, V17, P2835, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2835::AID-SIM933>3.3.CO;2-#; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; HALEY EC, 1995, J NEUROSURG, V82, P786, DOI 10.3171/jns.1995.82.5.0786; JENNETT B, 1975, LANCET, V1, P480; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; Lanzino G, 1999, J NEUROSURG, V90, P1011, DOI 10.3171/jns.1999.90.6.1011; Lanzino G, 1999, J NEUROSURG, V90, P1018, DOI 10.3171/jns.1999.90.6.1018; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Mendelow AD, 2005, LANCET, V365, P387; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	22	12	12	1	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JAN	2013	118	1					3	12		10.3171/2012.9.JNS111383			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	062UQ	WOS:000312948800003	23039145	Bronze			2022-02-06	
J	Lei-Rivera, L; Sutera, J; Galatioto, JA; Hujsak, BD; Gurley, JM				Lei-Rivera, Laura; Sutera, John; Galatioto, Jessica A.; Hujsak, Bryan D.; Gurley, James M.			Special tools for the assessment of balance and dizziness in individuals with mild traumatic brain injury	NEUROREHABILITATION			English	Article						Vestibular rehabilitation; traumatic brain injury; concussion; outcomes measures	ERROR SCORING SYSTEM; DWELLING OLDER-ADULTS; PAROXYSMAL POSITIONAL VERTIGO; FUNCTIONAL GAIT ASSESSMENT; SENSORY INTERACTION; POSTURAL STABILITY; FALL RISK; CLINICAL-TEST; FOLLOW-UP; CONCUSSION	INTRODUCTION: Although a majority of patients following minor traumatic brain injury recover to their pre-morbid functional level, persistent activity and participation limitations can occur in the refractory patient. These long-term consequences of brain injury may only become apparent months to years after the injury. In order to quantify these long-term sequella, laboratory, clinical and functional outcome measures may not only identify needed areas of treatment, but may also assist in determining the impact of the treatment on the individuals function. PURPOSE: The aim of this manuscript is to review the clinical utility of vestibular laboratory testing and the bedside vestibular examination in patients following mild traumatic brain injury. In addition, the validity and inter-observer reliability of functional outcome measures commonly used in individuals with mTBI will also be reviewed. SUMMARY: Because of the diffuse pathology seen with mTBI, multiple tests are needed to determine the resultant impairment and their impact on the patient's activity level and participation level. Laboratory test and bedside tests of vestibular impairment are reviewed. Functional outcome measures including the Dynamic Gait Index, the Functional Gait Assessment, the Balance Error Scoring System, and Dual Task Performance are reviewed for their appropriateness in quantifying the effect of mTBI at activity level and participation level of the individual. CONCLUSION: TBI rehabilitation services are increasingly exemplified by the needs of patients, rather than by the underlying pathology or diagnosis. Basing treatment decisions and treatment timing on laboratory, clinical, and functional testing can optimize the rehabilitation outcome.	[Lei-Rivera, Laura; Sutera, John; Hujsak, Bryan D.] New York Eye & Ear Infirm, Vestibular Rehabil Dept, New York, NY USA; [Galatioto, Jessica A.] New York Eye & Ear Infirm, Ctr Hearing & Balance Disorders, New York, NY USA; [Gurley, James M.] Mercy Coll, Phys Therapy Program, Dobbs Ferry, NY 10522 USA; [Gurley, James M.] James J Peters VAMC, Dept Otololaryngol, Bronx, NY USA		Gurley, JM (corresponding author), Mercy Coll, Phys Therapy Program, 555 Broadway, Dobbs Ferry, NY 10522 USA.	jgurley@mercy.edu					Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Foley JA, 2010, BRAIN INJURY, V24, P851, DOI 10.3109/02699051003789278; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Guidetti G, 2002, CLIN OTOLARYNGOL, V27, P124, DOI 10.1046/j.1365-2273.2002.00545.x; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Jacobson G. P., 2008, BALANCE FUNCTION ASS, V179, p[148, 339]; Kisilevski V., 2001, INT TINNITUS J, V7; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKinnon B. J., NEUROOTOLOGIC TEST C; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Meltzer I., 2004, J AM GERIATR SOC, V52, P1255; Minor LB, 1999, NEUROLOGY, V53, P2158, DOI 10.1212/WNL.53.9.2158; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Nuti D, 2005, Acta Otorhinolaryngol Ital, V25, P271; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pickett T. C., 2007, J REHABILITATION RES, V44; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Schrodt LA, 2004, GAIT POSTURE, V19, P279, DOI 10.1016/S0966-6362(03)00067-5; Schubert M., 2008, BALANCE FUNCTION ASS, p[148, 179, 339]; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Schubert MC, 2006, JARO-J ASSOC RES OTO, V7, P329, DOI 10.1007/s10162-006-0047-6; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; ShumwayCook A, 1997, PHYS THER, V77, P46, DOI 10.1093/ptj/77.1.46; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Susco TM, 2004, J ATHL TRAINING, V39, P241; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; Walker MF, 1999, NEUROLOGY, V53, P1576, DOI 10.1212/WNL.53.7.1576; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; World Health Organization, 1997, ICIDH 2 INT CLASS IM; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wrisley DM, 2004, ARCH PHYS MED REHAB, V85, P335, DOI 10.1016/j.apmr.2003.03.005; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; Wulf G, 2007, RES Q EXERCISE SPORT, V78, P384, DOI 10.5641/193250307X13082505158336; Zwergal A, 2009, NEUROLOGY, V72, P1689, DOI 10.1212/WNL.0b013e3181a55ecf	61	12	13	0	29	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	3					463	472		10.3233/NRE-130869			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200005	23648601				2022-02-06	
J	Li, YS; Chavko, M; Slack, JL; Liu, B; McCarron, RM; Ross, JD; Lucca, JJD				Li, Yansong; Chavko, Mikulas; Slack, Jessica L.; Liu, Bin; McCarron, Richard M.; Ross, James D.; Lucca, Jurandir J. Dalle			` Protective effects of decay-accelerating factor on blast-induced neurotrauma in rats	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Blast overpressure; Blast-induced neurotrauma; Complement activation; Blood-brain barrier; Tauopathy; Decay-accelerating factor		Background: Blast-induced neurotrauma (BINT) is the signature life threatening injury of current military casualties. Neuroinflammation is a key pathological occurrence of secondary injury contributing to brain damage after blast injury. We have recently demonstrated that blast-triggered complement activation and cytokine release are associated with BINT. Here, we evaluated if administration of the complement inhibitor recombinant human decay-accelerating factor (rhDAF) is beneficial on neuroinflammation and neurodegeneration in a rat model of moderate BINT. Administration of rhDAF after exposure to moderate blast overpressure (BOP, 120 kPa) mitigated brain injury characterized by neuronal degeneration. rhDAF treatment reduced complement hemolytic activity at 3 hours and tissue complement deposition at 3, 24, and 48 hours as well as systemic and local cytokine release at 24 hours post BOP. Furthermore, rhDAF protected blood-brain barrier (BBB) integrity and reduced cytotoxic edema. Interaction between complement cleavage component, C3a and C3a receptor and tau phosphorylation were also attenuated in rhDAF treated animals at 3 and 24 hours after BOP. These novel findings suggest early complement targeted inhibition as a new therapeutic strategy to decrease neuroinflammation and neurodegeneration after blast TBI. Result: Administration of rhDAF after exposure to moderate blast overpressure (BOP, 120 kPa) mitigated brain injury characterized by neuronal degeneration. rhDAF treatment reduced complement hemolytic activity at 3 hours and tissue complement deposition at 3, 24, and 48 hours as well as systemic and local cytokine release at 24 hours post BOP. Furthermore, rhDAF protected blood-brain barrier (BBB) integrity and reduced cytotoxic edema. Interaction between complement cleavage component, C3a and C3a receptor and tau phosphorylation were also attenuated in rhDAF treated animals at 3 and 24 hours after BOP. Conclusion: These novel findings suggest early complement targeted inhibition as a new therapeutic strategy to decrease neuroinflammation and neurodegeneration after blast TBI.	[Li, Yansong; Slack, Jessica L.; Liu, Bin; Lucca, Jurandir J. Dalle] US Army Inst Surg Res, Immunomodulat Trauma Program, 3650 Chambers Pass,BHT2-Bldg 3610, Fort Sam Houston, TX 78234 USA; [Chavko, Mikulas; McCarron, Richard M.] Naval Med Res Ctr, Dept Trauma & Resuscitat Med, Silver Spring, MD 20910 USA; [Ross, James D.] Trauma & Clin Care Res 59th Med Wing, Wilford Hall Ambulatory Surg Ctr, Sci & Technol Off, San Antonio, TX USA		Lucca, JJD (corresponding author), US Army Inst Surg Res, Immunomodulat Trauma Program, 3650 Chambers Pass,BHT2-Bldg 3610, Fort Sam Houston, TX 78234 USA.	Jurandir.dallelucca@us.army.mil			Defense Medical Research and Development Program	The authors wish to thank Mr. Jason Lankasky and Michael Falabella for assisting in animal blast experiments and sampling, Dr. Manojkumar Valiyaveettil for manuscript revision, and the Defense Medical Research and Development Program for supporting this work.	Asai H, 2013, CELL MOL NEUROBIOL, V33, P393, DOI 10.1007/s10571-013-9905-z; Barnum SR, 2002, GLIA, V38, P169, DOI 10.1002/glia.10069; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Britschgi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-220; Crehan H., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/983640; Davoust N, 1999, GLIA, V26, P201, DOI 10.1002/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fonseca MI, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-25; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Garrett MC, 2009, BRAIN RES, V1298, P171, DOI 10.1016/j.brainres.2009.04.047; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Harris CL, 2000, IMMUNOLOGY, V100, P462, DOI 10.1046/j.1365-2567.2000.00066.x; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Killick R, 2013, NEUROSCI LETT, V533, P96, DOI 10.1016/j.neulet.2012.11.008; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Lu XY, 2011, J SURG RES, V167, pE103, DOI 10.1016/j.jss.2009.10.021; Lucca JJD, 2013, J SURG RES, V179, P153, DOI 10.1016/j.jss.2012.10.017; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Lucca JJD, 2011, J TRAUMA, V71, pS151, DOI 10.1097/TA.0b013e318221aa4c; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; Monsinjon T, 2001, FEBS LETT, V487, P339, DOI 10.1016/S0014-5793(00)02320-6; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Shen Y, 2001, NEUROSCI LETT, V305, P165, DOI 10.1016/S0304-3940(01)01842-0; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Tenuta Joachim J, 2006, J Am Acad Orthop Surg, V14, pS45; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Wang Y, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-24; Weeks C, 2007, CLIN IMMUNOL, V124, P311, DOI 10.1016/j.clim.2007.05.010; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang SX, 2006, J CEREBR BLOOD F MET, V26, P1490, DOI 10.1038/sj.jcbfm.9600305; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497	47	12	15	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.		2013	1								52	10.1186/2051-5960-1-52			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V9K2F	WOS:000422387200042	24252631	Green Published, gold			2022-02-06	
J	Matsui, T; Motoki, Y; Yoshida, Y				Matsui, Tomohiro; Motoki, Yukari; Yoshida, Yusuke			Hypothermia Reduces Toll-Like Receptor 3-Activated Microglial Interferon-beta and Nitric Oxide Production	MEDIATORS OF INFLAMMATION			English	Article							CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; DOUBLE-STRANDED-RNA; NF-KAPPA-B; CEREBROSPINAL-FLUID; MESSENGER-RNA; IFN-BETA; ACTIVATION; CELLS; INNATE	Therapeutic hypothermia protects neurons after injury to the central nervous system (CNS). Microglia express toll-like receptors (TLRs) that play significant roles in the pathogenesis of sterile CNS injury. To elucidate the possible mechanisms involved in the neuroprotective effect of therapeutic hypothermia, we examined the effects of hypothermic culture on TLR3-activated microglial release of interferon (IFN)-beta and nitric oxide (NO), which are known to be associated with neuronal cell death. When rat or mouse microglia were cultured under conditions of hypothermia (33 degrees C) and normothermia (37 degrees C) with a TLR3 agonist, polyinosinic-polycytidylic acid, the production of IFN-beta and NO in TLR3-activated microglia at 48 h was decreased by hypothermia compared with that by normothermia. In addition, exposure to recombinant IFN-beta and sodium nitroprusside, an NO donor, caused death of rat neuronal pheochromocytoma PC12 cells in a concentration-dependent manner after 24 h. Taken together, these results suggest that the attenuation of microglial production of IFN-beta and NO by therapeutic hypothermia leads to the inhibition of neuronal cell death.	[Matsui, Tomohiro; Motoki, Yukari] Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, Ube, Yamaguchi 7558505, Japan; [Yoshida, Yusuke] ACEL Inc, Midori Ku, Sagamihara, Kanagawa 2520131, Japan		Matsui, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	giants@yamaguchi-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22791435]	This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-Aid for Young Scientists (B), no. 22791435 to T. Matsui. The authors would like to thank Enago (http://www.enago.jp/) for the English language review.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akwa Y, 1998, J IMMUNOL, V161, P5016; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Bsibsi M, 2010, J IMMUNOL, V184, P6929, DOI 10.4049/jimmunol.0902419; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Dedoni S, 2010, J NEUROCHEM, V115, P1421, DOI 10.1111/j.1471-4159.2010.07046.x; Gibbons H, 2003, MOL BRAIN RES, V110, P63, DOI 10.1016/S0169-328X(02)00585-5; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Hua LWL, 2000, GLIA, V30, P74, DOI 10.1002/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Liu AX, 2005, J NEUROSCI, V25, P737, DOI 10.1523/JNEUROSCI.4174-04.2005; Loidl CF, 1998, BRAIN RES, V791, P303, DOI 10.1016/S0006-8993(98)00195-4; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/00003246-200212000-00014; Makar TK, 2008, J NEUROIMMUNOL, V196, P67, DOI 10.1016/j.jneuroim.2008.02.014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Matsui T, 2012, NEUROCRIT CARE, V17, P293, DOI 10.1007/s12028-011-9639-z; Matsui T, 2012, INTENS CARE MED, V38, P1392, DOI 10.1007/s00134-012-2591-3; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Melton LM, 2003, GLIA, V44, P1, DOI 10.1002/glia.10276; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Patro IK, 2010, INDIAN J EXP BIOL, V48, P104; Reyes-Vazquez C, 2012, BRAIN RES, V1442, P76, DOI 10.1016/j.brainres.2011.09.061; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Si QS, 1997, NEUROSCIENCE, V81, P223, DOI 10.1016/S0306-4522(97)00172-3; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wada K, 1996, NEUROCHEM INT, V29, P461, DOI 10.1016/0197-0186(96)82655-6; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yamaguchi S, 2000, NEUROL RES, V22, P657; Zhang LJ, 2012, NEUROCHEM INT, V61, P1220, DOI 10.1016/j.neuint.2012.09.002; Zhang ZR, 2005, J NEUROIMMUNOL, V164, P154, DOI 10.1016/j.jneuroim.2005.03.014; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	62	12	12	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2013	2013								436263	10.1155/2013/436263			7	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	121CP	WOS:000317220600001	23589665	Green Published, gold			2022-02-06	
J	Negahban, H; Fattahizadeh, P; Ghasemzadeh, R; Salehi, R; Majdinasab, N; Mazaheri, M				Negahban, Hossein; Fattahizadeh, Parastoo; Ghasemzadeh, Roya; Salehi, Reza; Majdinasab, Nastaran; Mazaheri, Masood			The Persian Version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis	DISABILITY AND REHABILITATION			English	Article						Community integration questionnaire; multiple sclerosis; Persian version; psychometric properties	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; CONCURRENT VALIDITY; QUALITY	Purpose: To culturally translate and validate the Community Integration Questionnaire (CIQ) in persons with multiple sclerosis (MS). Methods: After a forward-backward translation, 105 persons with MS completed the Persian versions of the CIQ and MS Quality of Life (MSQOL) questionnaires in the first visit. The CIQ was re-administered to a sample of 45 persons with MS 7-10 days after the first session. Test-retest reliability and internal consistency were assessed using intraclass correlation coefficient (ICC) and Cronbach's a coefficient, respectively. Construct validity was assessed by measuring associations between subscales of the Persian CIQ (including Home Integration (HI), Social Integration (SI), and Productivity (P)) and MSQOL (including Physical and Mental Components). Dimensionality was assessed through two methods of corrected item-subscale correlation and factor analysis. Results: The acceptable level of test-retest reliability (ICC >= 0.70) was obtained for the Persian CIQ. However, Cronbach's a coefficient of >= 0.70 was only seen for the HI. The correlations between the Persian CIQ and the Physical MSQOL were higher than those of Persian CIQ and the Mental MSQOL. The corrected item-subscale Spearman's correlation coefficient of 0.40 was exceeded by most items of the HI and 2 items of P. A total of four factors were detected and similar to the results of item-subscale correlation, the most variability was seen for the items of SI which loaded on different factors. Conclusions: Persian CIQ seems to be a reliable and valid instrument for monitoring the level of community integration following rehabilitation in persons with MS. Some modifications need to be made in the SI of the Persian CIQ to improve extraction of information regarding community integration of persons with MS.	[Negahban, Hossein; Fattahizadeh, Parastoo; Ghasemzadeh, Roya; Salehi, Reza] Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran; [Majdinasab, Nastaran] Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Dept Neurol, Ahvaz, Iran; [Mazaheri, Masood] Isfahan Univ Med Sci, Musculoskeletal Res Ctr, Esfahan, Iran		Negahban, H (corresponding author), Ahvaz Jundishapur Univ Med Sci, Musculoskeletal Rehabil Res Ctr, Ahvaz, Iran.	honegahban@yahoo.com	Ghasemzadeh, Roya/S-8225-2017; Mazaheri, Masood/V-9739-2019; Negahban, Hossein/O-7405-2018; Salehi, Reza/Q-5721-2017; Majdinasab, Nastaran/M-8218-2017; Mazaheri, Masood/A-8207-2018	Ghasemzadeh, Roya/0000-0002-1402-4025; Negahban, Hossein/0000-0001-8387-1781; Salehi, Reza/0000-0001-6793-7293; Majdinasab, Nastaran/0000-0001-5163-7210; 	Ahvaz Jundishapur University of Medical Sciences [pht-9008]	This study is part of M.Sc thesis of Mrs Fattahizadeh. Special thanks to Ahvaz Jundishapur University of Medical Sciences for the financial support (Master thesis grant no: pht-9008). Also, we thank Prof. Willer for permitting us to validate the Persian-version of this instrument in our country, Iran. Finally, we would like to thank the two anonymous reviewers (especially reviewer# 1) for providing us with constructive comments and suggestions.	Bennell K, 2000, PHYS THER SPORT, V1, P32, DOI DOI 10.1054/PTSP.2000.0009; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dijkers M., 1998, TOP SPINAL CORD INJ, V4, P1, DOI DOI 10.1310/BJJA-2018-45KL-0VTL; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Fayer P. M., 2000, QUALITY LIFE ASSESSM; Field A., 2005, DISCOVERING STAT USI; Ghaem H, 2007, NEUROL INDIA, V55, P369, DOI 10.4103/0028-3886.33316; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mazaheri M, 2011, DISABIL REHABIL, V33, P1737, DOI 10.3109/09638288.2010.544838; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Negahban H, 2011, DISABIL REHABIL, V33, P2305, DOI 10.3109/09638288.2011.570409; Negahban H, 2010, CLIN RHEUMATOL, V29, P479, DOI 10.1007/s10067-009-1344-3; Rintala DH, 2002, REHABIL PSYCHOL, V47, P144, DOI 10.1037//0090-5550.47.2.144; Saeki S, 2006, J REHABIL MED, V38, P333, DOI 10.1080/16501970600780245; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638	29	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	17					1453	1459		10.3109/09638288.2012.741653			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	186IW	WOS:000322037800005	23330593				2022-02-06	
J	Sigurta, A; Zanaboni, C; Canavesi, K; Citerio, G; Beretta, L; Stocchetti, N				Sigurta, A.; Zanaboni, C.; Canavesi, K.; Citerio, G.; Beretta, L.; Stocchetti, N.			Intensive care for pediatric traumatic brain injury	INTENSIVE CARE MEDICINE			English	Article						Neurotrauma; Pediatrics; Intracranial pressure; Cerebral perfusion pressure; Outcome	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; CASE VOLUME; COMA SCALE; CHILDREN; MORTALITY; HYPERTENSION; MANAGEMENT; DATABASE	Purposes: The aims of this study are to describe a cohort of head-injured pediatric patients, focusing on current practice for intracranial pressure (ICP) monitoring and treatment and to verify the relationship between clinical and radiological parameters and the six-month outcome in a multivariable statistical model. Methods: A retrospective review was done of a prospectively collected database considering patients younger than 19 years admitted to three neuro-intensive care units (ICU). Patients were divided into four age groups: 0-5 (infant), 6-12 (children), 13-16 (pre-adolescent) and 17-18 years (adolescent). The ICP and cerebral perfusion pressure (CPP) were analyzed calculating average data and values exceeding thresholds for more than 5 min. Outcome was assessed 6 months after trauma using the Glasgow Outcome Score. Results: There were 199 patients, 155 male, included. Sixty percent had extracranial injuries. Pupils were abnormal in 38 %. Emergency evacuation of intracranial hematomas was necessary in 81 cases. The ICP was monitored in 117 patients; in 87 cases ICP was higher than 20 mmHg, with no differences among age groups. All but six patients received therapy to prevent raised ICP; barbiturates, deep hyperventilation or surgical decompression were used in 31 cases. At 6 months, mortality was 21 % and favorable outcome was achieved by 72 %. Significant predictors of outcome in the multivariable model were the Glasgow Coma Scale (GCS) motor score, pupils and ICP. Conclusions: Pediatric head injury is associated with a high incidence of intracranial hypertension. Early surgical treatment and intensive care may achieve favorable outcome in the majority of cases.	[Sigurta, A.; Canavesi, K.; Stocchetti, N.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Neurointens Care Unit, Milan, Italy; [Sigurta, A.; Canavesi, K.; Stocchetti, N.] Univ Milan, Milan, Italy; [Zanaboni, C.] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Citerio, G.] Azienda Osped San Gerardo, Neurointens Care Unit, Monza, Italy; [Beretta, L.] Fdn San Raffaele, Neurointens Care Unit, Milan, Italy		Sigurta, A (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Neurointens Care Unit, Milan, Italy.	anna.sigurta@unimi.it	Citerio, Giuseppe/B-1839-2015; Stocchetti, Nino/O-7444-2017; Viani, Rafael/V-1196-2018	Citerio, Giuseppe/0000-0002-5374-3161; Stocchetti, Nino/0000-0003-3250-6834; 			Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cross DT, 2003, J NEUROSURG, V99, P810, DOI 10.3171/jns.2003.99.5.0810; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hartman M, 2008, PEDIATRICS, V122, pE172, DOI 10.1542/peds.2007-3399; Heros RC, 2003, J NEUROSURG, V99, P805, DOI 10.3171/jns.2003.99.5.0805; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	29	12	14	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JAN	2013	39	1					129	136		10.1007/s00134-012-2748-0			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052JK	WOS:000312193700018	23179331				2022-02-06	
J	Volman, V; Bazhenov, M; Sejnowski, TJ				Volman, Vladislav; Bazhenov, Maxim; Sejnowski, Terrence J.			Divide and Conquer: Functional Segregation of Synaptic Inputs by Astrocytic Microdomains Could Alleviate Paroxysmal Activity Following Brain Trauma	PLOS COMPUTATIONAL BIOLOGY			English	Article							NECROSIS-FACTOR-ALPHA; V PYRAMIDAL NEURONS; TNF-ALPHA; SEIZURES; RELEASE; MODEL; HYPEREXCITABILITY; ENDOCANNABINOIDS; EPILEPTOGENESIS; HIPPOCAMPUS	Traumatic brain injury often leads to epileptic seizures. Among other factors, homeostatic synaptic plasticity (HSP) mediates posttraumatic epileptogenesis through unbalanced synaptic scaling, partially compensating for the trauma-incurred loss of neural excitability. HSP is mediated in part by tumor necrosis factor alpha (TNF alpha), which is released locally from reactive astrocytes early after trauma in response to chronic neuronal inactivity. During this early period, TNFa is likely to be constrained to its glial sources; however, the contribution of glia-mediated spatially localized HSP to post-traumatic epileptogenesis remains poorly understood. We used computational model to investigate the reorganization of collective neural activity early after trauma. Trauma and synaptic scaling transformed asynchronous spiking into paroxysmal discharges. The rate of paroxysms could be reduced by functional segregation of synaptic input into astrocytic microdomains. Thus, we propose that trauma-triggered reactive gliosis could exert both beneficial and deleterious effects on neural activity.	[Volman, Vladislav; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Volman, Vladislav; Sejnowski, Terrence J.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Volman, Vladislav] L 3 Appl Technol Simulat Engn & Testing, San Diego, CA USA; [Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, La Jolla, CA USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA		Volman, V (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA.	volman@salk.edu	Sejnowski, Terrence/AAV-5558-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS059740, R01 NS060870]; Howard Hughes Medical InstituteHoward Hughes Medical Institute; NSF-sponsored Center for Theoretical Biological Physics at UCSD [NSF PHY-0822283]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS059740, R01NS060870] Funding Source: NIH RePORTER	This study was supported by NIH grants R01 NS059740 and R01 NS060870 and the Howard Hughes Medical Institute. Numerical simulations were performed using computational resources of NSF-sponsored Center for Theoretical Biological Physics at UCSD, grant NSF PHY-0822283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Yanez I, 2006, NEUROSCIENCE, V138, P403, DOI 10.1016/j.neuroscience.2005.11.038; Balosso S, 2009, NEUROSCIENCE, V161, P293, DOI 10.1016/j.neuroscience.2009.03.005; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Coiret G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037320; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; de Lanerolle NC, 2010, NEUROTHERAPEUTICS, V7, P424, DOI 10.1016/j.nurt.2010.08.002; De Pitta M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002293; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Frohlich F, 2010, J NEUROSCI, V30, P10734, DOI 10.1523/JNEUROSCI.1239-10.2010; Frohlich F, 2008, J NEUROSCI, V28, P1709, DOI 10.1523/JNEUROSCI.4263-07.2008; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Ichiyama T, 2000, BRAIN RES, V857, P246, DOI 10.1016/S0006-8993(99)02439-7; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; NADKARNI S, 2003, PHYS REV LETT, V91, P1; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Otani N, 2003, ACTA NEUROCHIR SUPPL, V86, P267; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Probert L, 1997, J NEUROIMMUNOL, V72, P137, DOI 10.1016/S0165-5728(96)00184-1; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Shandra AA, 2002, NEUROSCI RES, V42, P147, DOI 10.1016/S0168-0102(01)00309-1; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Silchenko AN, 2008, BIOL CYBERN, V98, P61, DOI 10.1007/s00422-007-0196-7; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2002, J NEUROSCI, V25, P3219; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Turrigiano GG, 2006, TRENDS MOL MED, V12, P458, DOI 10.1016/j.molmed.2006.08.002; Volman V, 2007, NEURAL COMPUT, V19, P303, DOI 10.1162/neco.2007.19.2.303; Volman V, 2011, J NEUROPHYSIOL, V106, P1933, DOI 10.1152/jn.00458.2011; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; Yuhas Y, 1999, INFECT IMMUN, V67, P1455, DOI 10.1128/IAI.67.3.1455-1460.1999	65	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	JAN	2013	9	1							e1002856	10.1371/journal.pcbi.1002856			16	Biochemical Research Methods; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Mathematical & Computational Biology	085ED	WOS:000314595600015	23357960	gold, Green Submitted, Green Published			2022-02-06	
J	Yeo, SS; Kim, SH; Jang, SH				Yeo, Sang Seok; Kim, Seong Ho; Jang, Sung Ho			Proximal weakness due to injury of the corticoreticular pathway in a patient with traumatic brain injury	NEUROREHABILITATION			English	Article						Diffusion tensor imaging; corticoreticulospinal tract; corticoreticular pathway; corticospinal tract; stroke	DIFFUSE AXONAL INJURY; PREMOTOR CORTEX; CORTICOSPINAL TRACT; MAGNETIC STIMULATION; STROKE PATIENTS; MOTOR RECOVERY; GAIT; WALKING; CAT	BACKGROUND: The corticoreticular pathway (CRP) innervates the proximal muscles of extremities and axial muscles; therefore, it is involved in postural control and gait. We report on a patient who exhibited proximal weakness due to a CRP injury, which was evaluated using diffusion tensor tractography (DTT). METHODS: A 62-year-old male patient who had been injured in a traffic accident underwent conservative management for a contusional hemorrhage in the right frontotemporal lobes, and a subdural and epidural hematoma in the right temporoparietal lobes. The patient exhibited right proximal weakness (shoulder: 3(+), hip: 3(+)) at two weeks after onset. Findings on brain MRI revealed encephalomalactic lesions in both frontal lobes. RESULTS: Findings on DTT of the left CRP showed discontinuation at the midbrain level; in contrast, the integrities of the corticospinal tract in both hemispheres were maintained from the cerebral cortex to the medulla along the known pathway of the corticospinal tract. CONCLUSION: The proximal weakness of the right shoulder and hip observed in this patient appeared to be attributed to injury of the left CRP.	[Yeo, Sang Seok; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea(NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A0 1001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A0 1001873).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chang WH, 2010, GAIT POSTURE, V32, P487, DOI 10.1016/j.gaitpost.2010.07.007; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; FREUND HJ, 1985, BRAIN, V108, P697, DOI 10.1093/brain/108.3.697; FREUND HJ, 1985, BEHAV BRAIN RES, V18, P187, DOI 10.1016/0166-4328(85)90074-9; FREUND HJ, 1984, EXP BRAIN RES, V53, P479; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; Jang SH, 2010, INT J REHABIL RES, V33, P285, DOI 10.1097/MRR.0b013e32833f0500; Jang SH, 2009, NEUROREHABILITATION, V24, P285, DOI 10.3233/NRE-2009-0480; Jo HM, 2012, NEUROREHABILITATION, V31, P207, DOI 10.3233/NRE-2012-0790; Kably B, 1998, J NEUROPHYSIOL, V80, P389, DOI 10.1152/jn.1998.80.1.389; Kably B, 1998, J NEUROPHYSIOL, V80, P406, DOI 10.1152/jn.1998.80.1.406; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Medical Research Council (Great Britain), 1976, AIDS EX PER NERV SYS, Vvi, P62; Mendoza J., 2007, CLIN NEUROANATOMY NE; Miyai I, 1999, STROKE, V30, P1380, DOI 10.1161/01.STR.30.7.1380; Miyai I, 2002, ANN NEUROL, V52, P188, DOI 10.1002/ana.10274; Miyai I, 2003, STROKE, V34, P2866, DOI 10.1161/01.STR.0000100166.81077.8A; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Smania N, 2007, STROKE, V38, P1088, DOI 10.1161/01.STR.0000258077.88064.a3; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Suzuki M, 2008, NEUROIMAGE, V39, P600, DOI 10.1016/j.neuroimage.2007.08.044; Yeo SS, 2013, NEUROREHABILITATION, V32, P305, DOI 10.3233/NRE-130848; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	31	12	12	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2013	32	3					665	669		10.3233/NRE-130889			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200025	23648621				2022-02-06	
J	Bin, J; Wang, Q; Zhuo, YY; Xu, JP; Zhang, HT				Bin, Juan; Wang, Qian; Zhuo, Ye-Ye; Xu, Jiang-Ping; Zhang, Han-Ting			Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via neuroprotection associated with anti-apoptotic activity	METABOLIC BRAIN DISEASE			English	Article						Piperphentonamine hydrochloride (PPTA); Cerebral ischemia; Memory; Apoptosis; PC12 cells; Rats	DELAYED NEURONAL DEATH; GLOBAL BRAIN ISCHEMIA; ACETYL-L-CARNITINE; IN-VITRO MODEL; CALCIUM; INJURY; DAMAGE; MITOCHONDRIAL; LEVOSIMENDAN; MECHANISMS	The calcium sensitizers levosimendan and piperphentonamine hydrochloride (PPTA) are used as cardiovascular drugs for treatment of heart failure. Given that levosimendan has been reported to exhibit a neuroprotective profile in a model of traumatic brain injury, it was interesting to know whether PPTA, a new calcium sensitizer recently developed in China, exerts a similar effect. The objective of this study was to determine whether PPTA exhibited neuroprotective effects and whether these properties were associated with memory. Four-vessel occlusion (4-VO) was used to induce global cerebral ischemia/reperfusion injury in rats treated with or without PPTA (5, 10 mg/kg, i.p., 2 h after the onset of reperfusion and then once a day for 15 consecutive days). Memory was measured using the step-through passive avoidance test. Neurochemical changes were examined in rat PC12 cells treated with oxygen-glucose deprivation (OGD) for 4 h followed by reoxygenation (OGD-R) for 24 h, in the absence or presence of PPTA. In vehicle-treated animals, 4-VO for 10 min produced memory deficits, as demonstrated by decreased retention in step-through passive avoidance, and massive neuron loss in the hippocampal CA1 subregion. These effects were attenuated by PPTA. The results were consistent with those observed in PC12 cells. PPTA treatment increased cell viability, as indicated by MTT assay, inhibited apoptosis, and decreased extracellular lactate dehydrogenase levels in Na2S2O4-treated PC12 cells. These results provide novel demonstration for the ability of PPTA to attenuate cerebral ischemia-induced memory deficits via neuroprotection in the hippocampus. The neuroprotective effect of PPTA appears to be associated with its anti-apoptotic activity. PPTA has the therapeutic potential for ischemic stroke.	[Bin, Juan; Wang, Qian; Zhuo, Ye-Ye; Xu, Jiang-Ping; Zhang, Han-Ting] So Med Univ, Dept Pharmacol, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Han-Ting] W Virginia Univ, Dept Behav Med & Psychiat, Hlth Sci Ctr, Morgantown, WV 26506 USA; [Zhang, Han-Ting] W Virginia Univ, Dept Physiol & Pharmacol, Hlth Sci Ctr, Morgantown, WV 26506 USA		Xu, JP (corresponding author), So Med Univ, Dept Pharmacol, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China.	jpx@smu.edu.com; Hzhang@hsc.wvu.edu	Xu, Jiangping/D-1456-2012		National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2011ZX09101-002-03]	This work was supported by the National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (No. 2011ZX09101-002-03 to JPX).	Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Annunziato L, 2007, ANN NY ACAD SCI, V1099, P413, DOI 10.1196/annals.1387.050; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Bartl J, 2010, ADHD-ATTEND DEFICIT, V2, P225, DOI 10.1007/s12402-010-0039-6; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Block F, 1997, PHARMACOL BIOCHEM BE, V56, P755, DOI 10.1016/S0091-3057(96)00484-4; Block F, 1997, BRAIN RES, V754, P279, DOI 10.1016/S0006-8993(97)00096-6; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Burda J, 2005, NEUROCHEM RES, V30, P1397, DOI 10.1007/s11064-005-8510-z; Cao BY, 2010, J ETHNOPHARMACOL, V131, P122, DOI 10.1016/j.jep.2010.06.009; Chen J, 1998, J NEUROSCI, V18, P4914; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Gao YA, 2010, BRAIN RES, V1358, P239, DOI 10.1016/j.brainres.2010.08.043; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Gong LW, 2002, EUR J NEUROSCI, V15, P779, DOI 10.1046/j.1460-9568.2002.01908.x; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Hamada N, 2009, J NEURAL TRANSM, V116, P841, DOI 10.1007/s00702-009-0250-9; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hickenbottom SL, 2000, NEUROL CLIN, V18, P379, DOI 10.1016/S0733-8619(05)70198-5; Honisch A, 2010, BASIC RES CARDIOL, V105, P155, DOI 10.1007/s00395-009-0064-9; Iqbal S, 2002, BRAIN RES, V946, P162, DOI 10.1016/S0006-8993(02)02871-8; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Langdon KD, 2008, EUR J NEUROSCI, V28, P2310, DOI 10.1111/j.1460-9568.2008.06513.x; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Li RB, 2012, CHINA PHARM, V15, P219; McCranor BJ, 2012, J BIOENERG BIOMEMBR, V44, P253, DOI 10.1007/s10863-012-9427-2; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Miao YF, 2010, INT J MOL SCI, V11, P140, DOI 10.3390/ijms11010140; Nanri M, 1998, JPN J PHARMACOL, V76, P23, DOI 10.1254/jjp.76.23; Ottani A, 2004, EUR J PHARMACOL, V485, P183, DOI 10.1016/j.ejphar.2003.11.072; Ozturk T, 2010, J CARDIOTHOR VASC AN, V24, P624, DOI 10.1053/j.jvca.2009.08.003; Phan TG, 2002, CLIN EXP PHARMACOL P, V29, P1, DOI 10.1046/j.1440-1681.2002.03609.x; Pisani A, 2004, CELL CALCIUM, V36, P277, DOI 10.1016/j.ceca.2004.02.010; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Roberts GG, 2007, ANTIOXID REDOX SIGN, V9, P2265, DOI 10.1089/ars.2007.1786; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Seta KA, 2004, CELL CALCIUM, V36, P331, DOI 10.1016/j.ceca.2004.02.006; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Virmani A, 2011, CURR NEUROPHARMACOL, V9, P195, DOI 10.2174/157015911795017182; Wang C, 2012, INT J NEUROPSYCHOPH, V15, P749, DOI 10.1017/S1461145711000836; Xu Bing, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1041; Yang XF, 2011, CELL MOL NEUROBIOL, V31, P303, DOI 10.1007/s10571-010-9622-9; [杨小龙 Yang Xiaolong], 2010, [湖南大学学报. 自然科学版, Journal of Hunan University. Natural Sciences], V37, P32; Yasa H, 2008, J SURG RES, V147, P138, DOI 10.1016/j.jss.2007.08.002; Zapater P, 1997, BRAIN RES, V772, P57, DOI 10.1016/S0006-8993(97)00838-X; Zeiger SLH, 2010, BBA-MOL BASIS DIS, V1802, P1095, DOI 10.1016/j.bbadis.2010.07.013; Zhang H, 2010, J BIOCHEM, V148, P413, DOI 10.1093/jb/mvq074; Zhang HT, 2000, NEUROPSYCHOPHARMACOL, V23, P198, DOI 10.1016/S0893-133X(00)00108-1; Zhang R, 2012, INT J MOL SCI, V13, P2078, DOI 10.3390/ijms13022078; Zhu Han-yi, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1858; [朱汉祎 ZHU Hanyi], 2011, [军事医学, Military Medical Sciences], V35, P286; Zhu JR, 2010, ACTA PHARMACOL SIN, V31, P273, DOI 10.1038/aps.2010.9	64	12	14	0	15	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	DEC	2012	27	4					495	505		10.1007/s11011-012-9330-x			11	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	040CT	WOS:000311298300011	22843383				2022-02-06	
J	Cortes, DF; Landis, MK; Ottens, AK				Cortes, Diego F.; Landis, Miranda K.; Ottens, Andrew K.			High-capacity peptide-centric platform to decode the proteomic response to brain injury	ELECTROPHORESIS			English	Article						Data-independent; Label free; Neuroproteomics; Neurotrauma; TBI	PROTEINS; NEUROFASCIN-155; IDENTIFICATION; PROTEOLYSIS; MS	Traumatic brain injury (TBI) is a progressive disease process underlain by dynamic and interactive biochemical mechanisms; thus, large-scale and unbiased assessments are needed to fully understand its highly complex pathobiology. Here, we report on a new high-capacity label-free proteomic platform to evaluate the post-TBI neuroproteome. Six orthogonal separation stages and data-independent MS were employed, affording reproducible quantitative assessment on 18 651 peptides across biological replicates. From these data 3587 peptides were statistically responsive to TBI of which 18% were post-translationally modified. Results revealed as many as 484 proteins in the post-TBI neuroproteome, which was fully nine times the number determined from our prior study of focal cortical injury. Yet, these data were generated using 25 times less brain tissue per animal relative to former methodology, permitting greater anatomical specificity and proper biological replication for increased statistical power. Exemplified by these data, we discuss benefits of peptide-centric differential analysis to more accurately infer novel biological findings testable in future hypothesis-driven research. The high-capacity label-free proteomic platform is designed for multi-factor studies aimed at expanding our knowledge on the molecular underpinnings of TBI and to develop better diagnostics and therapeutics.	[Cortes, Diego F.; Landis, Miranda K.; Ottens, Andrew K.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Richmond, VA 23298 USA		Ottens, AK (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, POB 980709, Richmond, VA 23298 USA.	akottens@vcu.edu		Ottens, Andrew/0000-0002-2118-3796	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS055012]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25NS055012] Funding Source: NIH RePORTER	We thank M. Fox and L. Phillips for gifted antibodies; P. Ottens for programming expertise; S. Tenzer for providing and assisting with Isoquant Software. This work was funded in part by the National Institutes of Health grant NS055012.	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Blackburn K, 2010, J PROTEOME RES, V9, P3621, DOI 10.1021/pr100144z; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Carlstrom LP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-82; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Chich JF, 2007, J CHROMATOGR B, V849, P261, DOI 10.1016/j.jchromb.2006.09.033; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; Doneanu CE, 2012, MABS-AUSTIN, V4, P24, DOI 10.4161/mabs.4.1.18748; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Fuller BF, 2012, ENVIRON HEALTH PERSP, V120, P1684, DOI 10.1289/ehp.1104857; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karpievitch Y, 2009, BIOINFORMATICS, V25, P2028, DOI 10.1093/bioinformatics/btp362; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Liao ZP, 2012, ANAL CHEM, V84, P4535, DOI 10.1021/ac300510t; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Maier O, 2006, EXP CELL RES, V312, P500, DOI 10.1016/j.yexcr.2005.11.014; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Pomicter AD, 2010, BRAIN, V133, P389, DOI 10.1093/brain/awp341; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; Yang XY, 2009, BRAIN INJURY, V23, P830, DOI 10.1080/02699050903196670	35	12	12	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	DEC	2012	33	24			SI		3712	3719		10.1002/elps.201200341			8	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	057FT	WOS:000312548900014	23160985	Green Accepted			2022-02-06	
J	Sturiale, CL; De Bonis, P; Rigante, L; Calandrelli, R; D'Arrigo, S; Pompucci, A; Mangiola, A; D'Apolito, G; Colosimo, C; Anile, C				Sturiale, Carmelo Lucio; De Bonis, Pasquale; Rigante, Luigi; Calandrelli, Rosalinda; D'Arrigo, Sonia; Pompucci, Angelo; Mangiola, Annunziato; D'Apolito, Gabriella; Colosimo, Cesare; Anile, Carmelo			Do Traumatic Brain Contusions Increase in Size after Decompressive Craniectomy?	JOURNAL OF NEUROTRAUMA			English	Article						brain contusions; decompressive craniectomy; hemorrhagic contusion; traumatic brain injury	HEAD-INJURY; INTRACEREBRAL HEMATOMA; HEMORRHAGE; PROGRESSION; CRANIOTOMY; LESIONS; EDEMA	Hemorrhagic contusions (HC) represent a common consequence of traumatic brain injury (TBI) and usually evolve during the first 12 h after trauma. The relationship between decompressive craniectomy (DC) and evolution of the post-traumatic HC is still unclear. The aim of the present study was to evaluate the impact of DC on HC evolution. Fifty-seven patients with the evidence of at least one HC at admission CT scan were analyzed. Twenty-five patients (Group 1) underwent DC and 32 patients underwent medical therapy alone (Group 2). Fisher's exact test was used to compare categorical variables. Logistic regression model was used to assess the independent contribution of predictive factors (age, <= 50 years; treatment received, DC vs. medical; anticoagulant/antiplatelet drugs intake; Rotterdam CT score, 1-3 vs. 4-6) to the evolution/new appearance of an HC. A significant increase (>= 2 cc) of any HC during the observation period was detected in 8 patients (14%): 4/25 patients (16%) of Group 1 and 4/32 patients (12.5%) of Group 2 (Fisher exact test two-sided p = 0.72). Univariate and multivariate analyses showed that none of the analyzed factors was associated with increased or de novo appearance of any HC. DC does not seem to constitute a risk factor for the evolution of HC.	[Sturiale, Carmelo Lucio; De Bonis, Pasquale; Rigante, Luigi; Pompucci, Angelo; Mangiola, Annunziato; Anile, Carmelo] Catholic Univ, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [Calandrelli, Rosalinda; D'Apolito, Gabriella; Colosimo, Cesare] Catholic Univ, Sch Med, Dept Bio Imaging, I-00168 Rome, Italy; [D'Arrigo, Sonia] Catholic Univ, Sch Med, Dept Anaesthesiol & Intens Care, I-00168 Rome, Italy		De Bonis, P (corresponding author), Catholic Univ, Sch Med, Inst Neurosurg, Lgo F Vito 1, I-00168 Rome, Italy.	debonisvox@gmail.com	de bonis, pasquale/K-8200-2016; Rigante, Luigi/K-7260-2016; D'Arrigo, Sonia/K-8792-2018; Sturiale, Carmelo Lucio/K-6412-2016	de bonis, pasquale/0000-0002-9879-8940; D'Arrigo, Sonia/0000-0001-6740-3195; Sturiale, Carmelo Lucio/0000-0002-4080-2492; Calandrelli, Rosalinda/0000-0003-4517-3477; Rigante, Luigi/0000-0003-0539-526X; Colosimo, Cesare/0000-0003-3800-3648			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Csokay A, 2001, NEUROSURG REV, V24, P209, DOI 10.1007/s101430100158; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; Doughty R.G., 1938, SOUTH MED J, V31, P254; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; JAIMOVICH R, 1992, PEDIATR NEUROSURG, V17, P25, DOI 10.1159/000120562; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MERTOL T, 1991, British Journal of Neurosurgery, V5, P491, DOI 10.3109/02688699108998478; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P507; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	27	12	14	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2723	2726		10.1089/neu.2012.2556			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800001	22873699				2022-02-06	
J	Forbes, CE; Cameron, KA; Grafman, J; Barbey, A; Solomon, J; Ritter, W; Ruchkin, DS				Forbes, Chad E.; Cameron, Katherine A.; Grafman, Jordan; Barbey, Aron; Solomon, Jeffrey; Ritter, Walter; Ruchkin, Daniel S.			Identifying temporal and causal contributions of neural processes underlying the Implicit Association Test (IAT)	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						event-related brain potentials; traumatic brain injuries; EEG coherence; implicit association test; automaticity; gender stereotypes; extra-striate visual cortex; prefrontal cortex	SOCIAL COGNITIVE NEUROSCIENCE; EVENT-RELATED-POTENTIALS; FRONTOTEMPORAL DEMENTIA; ATTITUDES; BRAIN; RACE; STEREOTYPES; LESIONS; CORTEX; MALLEABILITY	The Implicit Association Test (IAT) is a popular behavioral measure that assesses the associative strength between outgroup members and stereotypical and counterstereotypical traits. Less is known, however, about the degree to which the IAT reflects automatic processing. Two studies examined automatic processing contributions to a gender-IAT using a data driven, social neuroscience approach. Performance on congruent (e.g., categorizing male names with synonyms of strength) and incongruent (e.g., categorizing female names with synonyms of strength) IAT blocks were separately analyzed using EEG (event-related potentials, or ERPs, and coherence; Study 1) and lesion (Study 2) methodologies. Compared to incongruent blocks, performance on congruent IAT blocks was associated with more positive ERPs that manifested in frontal and occipital regions at automatic processing speeds, occipital regions at more controlled processing speeds and was compromised by volume loss in the anterior temporal lobe (ATL), insula and medial PFC. Performance on incongruent blocks was associated with volume loss in supplementary motor areas, cingulate gyrus and a region in medial PFC similar to that found for congruent blocks. Greater coherence was found between frontal and occipital regions to the extent individuals exhibited more bias. This suggests there are separable neural contributions to congruent and incongruent blocks of the IAT but there is also a surprising amount of overlap. Given the temporal and regional neural distinctions, these results provide converging evidence that stereotypic associative strength assessed by the IAT indexes automatic processing to a degree.	[Forbes, Chad E.] Univ Delaware, Dept Psychol, Social Neurosci Lab, Newark, DE 19716 USA; [Cameron, Katherine A.] Coppin State Univ, Dept Appl Psychol & Rehabil Counseling, Baltimore, MD USA; [Grafman, Jordan] Kessler Fdn, Traumat Brain Injury Res Lab, Res Ctr, W Orange, NJ USA; [Barbey, Aron] Univ Illinois, Beckman Inst Adv Sci & Technol, Decis Neurosci Lab, Champaign, IL USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; [Ritter, Walter] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ruchkin, Daniel S.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA		Forbes, CE (corresponding author), Univ Delaware, Dept Psychol, Social Neurosci Lab, 222 Wolf Hall, Newark, DE 19716 USA.	cforbes@psych.udel.edu			Support of Mentors and their Students (SOMAS) [1205]; National Science FoundationNational Science Foundation (NSF) [DUE-0426266]; National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	This research was supported in part by a Support of Mentors and their Students (SOMAS) Grant # 1205 awarded to Katherine A. Cameron, funded through the National Science Foundation (Grant No. DUE-0426266). Drs. Grafman and Ruchkin were supported through the National Institute of Neurological Disorders and Stroke Intramural Research Program. We thank Jonathan M. Fallica and Jessica L. Hobbs for their assistance and Fei'i L. Atualevao for her important contributions to the project during the SOMAS summer research program. We thank Dr. Marta Gozzi for making available data from her investigation of the effects of cortical lesions on stereotypical gender associations. We also thank Dr. William Gehring for his helpful comments on an earlier version of this manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ardid S, 2010, J NEUROSCI, V30, P2856, DOI 10.1523/JNEUROSCI.4222-09.2010; Banfield JF, 2006, NEUROIMAGE, V31, P1841, DOI 10.1016/j.neuroimage.2006.02.017; Bargh J.A., 1997, ADV SOCIAL COGNITION; Barnes Holmes D., 2004, INT J PSYCHOL PSYCHO, V4, P215; Barnes-Holmes D, 2008, PSYCHOL REC, V58, P497, DOI 10.1007/BF03395634; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Bartholow B.D., 2007, SOCIAL NEUROSCIENCE, P376; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Bluemke M, 2006, J EXP SOC PSYCHOL, V42, P163, DOI 10.1016/j.jesp.2005.03.004; Brazier MAB., 1977, ELECT ACTIVITY NERVO; Coates M. A., 2011, EVENT RELATED POTENT; Cunningham W.A., 2007, SOC NEUROSCI-UK, P227; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Cunningham WA, 2007, TRENDS COGN SCI, V11, P97, DOI 10.1016/j.tics.2006.12.005; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; Dasgupta N, 2001, J PERS SOC PSYCHOL, V81, P800, DOI 10.1037/0022-3514.81.5.800; De Houwer J, 2007, J EXP SOC PSYCHOL, V43, P972, DOI 10.1016/j.jesp.2006.10.007; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; EdwardsLee T, 1997, BRAIN, V120, P1027, DOI 10.1093/brain/120.6.1027; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Forbes CE, 2012, SOC COGN AFFECT NEUR, V7, P771, DOI 10.1093/scan/nsr052; Forbes CE, 2010, J PERS SOC PSYCHOL, V99, P740, DOI 10.1037/a0020971; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Gregg AP, 2006, J PERS SOC PSYCHOL, V90, P1, DOI 10.1037/0022-3514.90.1.1; He Y, 2009, SOC NEUROSCI-UK, V4, P426, DOI 10.1080/17470910902949184; Kim DY, 2003, SOC PSYCHOL QUART, V66, P83, DOI 10.2307/3090143; KLEIST K, 1922, GEISTES NERVENKRANKH; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lins Otavio G., 1993, Brain Topography, V6, P65, DOI 10.1007/BF01234128; Lins Otavio G., 1993, Brain Topography, V6, P51, DOI 10.1007/BF01234127; Luo Q, 2010, J NEUROSCI, V30, P5825, DOI 10.1523/JNEUROSCI.BC-5668-09.2010; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Mitchell JP, 2003, J EXP PSYCHOL GEN, V132, P455, DOI 10.1037/0096-3445.132.3.455; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Nelson, 2009, HDB PREJUDICE STEREO, P61; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; O'Toole C, 2009, PSYCHOL REC, V59, P207, DOI 10.1007/BF03395659; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Posner M.I., 1975, ATTENTION PERFORMANC, V41, P509; Posner MI, 1975, INFORM PROCESSING CO, P55; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Regan, 1989, HUMAN BRAIN ELECTROP; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Rothermund K, 2001, Z EXP PSYCHOL, V48, P94, DOI 10.1026//0949-3946.48.2.94; Ruchkin DS, 1997, COGNITIVE BRAIN RES, V6, P95, DOI 10.1016/S0926-6410(97)00021-9; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Siegel M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00021; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Steffens MC, 2001, Z EXP PSYCHOL, V48, P123; Williams JK, 2011, SOC COGN AFFECT NEUR, V6, P468, DOI 10.1093/scan/nsq065; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	74	12	13	3	44	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 30	2012	6								320	10.3389/fnhum.2012.00320			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	045TF	WOS:000311719000001		Green Published, gold			2022-02-06	
J	Cernea, CR; Hojaij, FC; De Carlucci, D; Tavares, MR; Araujo, VJ; Silva, GBE; Brandao, LG				Cernea, Claudio R.; Hojaij, Flavio C.; De Carlucci, Dorival, Jr.; Tavares, Marcos R.; Araujo-Filho, Vergilius J.; Britto e Silva-Filho, Gilberto; Brandao, Lenine G.			Abdominal compression: A new intraoperative maneuver to detect chyle fistulas during left neck dissections that include level IV	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK			English	Article						neck dissection; chyle fistula; lymphatic fistula; neck dissection complications; neck metastases	THORACIC-DUCT; MANAGEMENT; LEAKAGE	Background Chyle fistulas may occur after left neck dissections that include level IV, due to injury of the thoracic duct or of 1 of its major branches. Despite being unusual, this complication carries substantial postoperative morbidity and even mortality. So far, no effective intraoperative maneuver has been reported to detect this fistula at the end of a neck dissection. In this cohort study, we sought to describe a simple new maneuver, intraoperative abdominal compression, which can effectively help to identify an open major lymphatic duct on level IV at the end of a neck dissection. Patients and Methods From March 1989 to September 2010, 206 patients underwent neck dissections involving left level IV, and underwent intraoperative abdominal compression. There were 119 men and 87 women, with ages ranging from 18 to 81 years (median, 52 years). One hundred forty-four patients had squamous cell carcinomas, 54 had thyroid carcinomas, 5 had malignant melanomas, and 3 had salivary cancers. Distribution by type of left neck dissection was: selective including levels II, III, and IV (73 cases; 35.4%), selective including levels II, III, IV, and V (55 cases; 26.6%), selective including levels I, II, III, and IV (12 cases; 5.8%), modified radical (47 cases; 22.8%), and radical (19 cases; 9.2%). In all cases, at the end of the procedure, the endotracheal tube was temporarily disconnected from the ventilator. Keeping the dissected level IV area under clear visualization, an abdominal compression was performed. At this moment, any detected lymphatic leak was carefully clamped and tied with nonabsorbable sutures. After ventilating the patient, the intraoperative abdominal compression was repeated to reassure complete occlusion of the lymphatic vessel. Results In 13 cases (6.3%), a chyle leak was detected after performing the intraoperative abdominal compression. All leaks except for 2 were successfully controlled after 1 attempt. In these 2 patients, a patch of muscle and fat tissue was applied with fibrin glue on the top. In 1 of these patients, another chyle leak in a different location was detected only at the second intraoperative abdominal compression, and was also effectively closed. Postoperatively, there were 2 (1%) chyle fistulas, both among these 13 cases, and all were successfully managed with clinical measures only. No fistulas occurred among the remaining 193 patients in whom intraoperative abdominal compression did not demonstrate lymphatic leak. Conclusion To our knowledge, this is the first description of a specific maneuver to actively detect a lymphatic fistula at the end of a left neck dissection involving level IV. In this study, intraoperative abdominal compression was able to detect an open lymphatic vessel in 6.3% of the cases, as well as to assure its effective sealing in the remaining 93.7% of the patients. Moreover, no life-threatening high-volume fistula was noted in this study. (C) 2012 Wiley Periodicals, Inc. Head Neck, 2012	[Cernea, Claudio R.; De Carlucci, Dorival, Jr.; Tavares, Marcos R.; Araujo-Filho, Vergilius J.; Britto e Silva-Filho, Gilberto; Brandao, Lenine G.] Univ Sao Paulo, Sch Med, Dept Head & Neck Surg, Sao Paulo, Brazil; [Cernea, Claudio R.; Hojaij, Flavio C.; De Carlucci, Dorival, Jr.; Tavares, Marcos R.; Araujo-Filho, Vergilius J.; Britto e Silva-Filho, Gilberto; Brandao, Lenine G.] Univ Fed Sao Paulo, Dept Head & Neck Surg, Sao Paulo, Brazil		Cernea, CR (corresponding author), Univ Sao Paulo, Sch Med, Dept Head & Neck Surg, Sao Paulo, Brazil.	cerneamd@uol.com.br	Tavares, Marcos R/J-8202-2012; Cernea, Claudio Roberto/F-5610-2016; Brandao, Lenine/J-5334-2013; de Araujo Filho, Vergilius Jose Furtado/AAW-5771-2020; Carlucci, Dorival/AAD-8268-2020	Tavares, Marcos R/0000-0002-9244-7058; Cernea, Claudio Roberto/0000-0001-5899-0535; de Araujo Filho, Vergilius Jose Furtado/0000-0001-7027-5681; Carlucci, Dorival/0000-0002-3894-9997			Erisen L, 2002, OTOLARYNG HEAD NECK, V126, P172, DOI 10.1067/mhn.2002.121859; Eufinger H, 2001, Mund Kiefer Gesichtschir, V5, P193, DOI 10.1007/s100060100292; Gregor RT, 2000, OTOLARYNG HEAD NECK, V122, P434, DOI 10.1016/S0194-5998(00)70061-1; HAREL G, 1985, HEAD NECK SURG, V7, P225, DOI 10.1002/hed.2890070307; HAVAS TE, 1987, AUST NZ J SURG, V57, P851, DOI 10.1111/j.1445-2197.1987.tb01279.x; JABBAR ASA, 1995, HEAD NECK-J SCI SPEC, V17, P69, DOI 10.1002/hed.2880170115; Jortay A, 2001, Acta Otorhinolaryngol Belg, V55, P285; Li ZJ, 2007, J ORAL MAXIL SURG, V65, P1430, DOI 10.1016/j.jams.2005.10.061; LUCENTE FE, 1981, OTOLARYNG HEAD NECK, V89, P575, DOI 10.1177/019459988108900413; Nussenbaum B, 2000, OTOLARYNG HEAD NECK, V122, P31, DOI 10.1016/S0194-5998(00)70140-9; Roh JL, 2008, ANN SURG ONCOL, V15, P2576, DOI 10.1245/s10434-008-0017-9; Roh JL, 2008, ANN SURG ONCOL, V15, P424, DOI 10.1245/s10434-007-9692-1; Santaolalla F, 2010, EUR J CANCER CARE, V19, P510, DOI 10.1111/j.1365-2354.2009.01086.x; Scorza LB, 2008, OTOLARYNG CLIN N AM, V41, P1231, DOI 10.1016/j.otc.2008.06.004; SPIRO JD, 1990, LARYNGOSCOPE, V100, P771; Van Natta TL, 2009, JSLS-J SOC LAPAROEND, V13, P430	16	12	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1043-3074	1097-0347		HEAD NECK-J SCI SPEC	Head Neck-J. Sci. Spec. Head Neck	NOV	2012	34	11					1570	1573		10.1002/hed.21956			4	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	027FR	WOS:000310337800009	22290583				2022-02-06	
J	Hanell, A; Clausen, F; Djupsjo, A; Vallstedt, A; Patra, K; Israelsson, C; Larhammar, M; Bjork, M; Paixao, S; Kullander, K; Marklund, N				Hanell, Anders; Clausen, Fredrik; Djupsjo, Anders; Vallstedt, Anna; Patra, Kalicharan; Israelsson, Charlotte; Larhammar, Martin; Bjork, Maria; Paixao, Sonia; Kullander, Klas; Marklund, Niklas			Functional and Histological Outcome after Focal Traumatic Brain Injury Is Not Improved in Conditional EphA4 Knockout Mice	JOURNAL OF NEUROTRAUMA			English	Article						axonal regeneration; behavior; traumatic brain injury	SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; RECEPTOR TYROSINE KINASES; EPHRIN-A LIGANDS; AXONAL REGENERATION; CORTICOSPINAL TRACT; UP-REGULATION; ADULT-RAT; POSTTRAUMATIC EPILEPSY; SUBVENTRICULAR ZONE	We investigated the role of the axon guidance molecule EphA4 following traumatic brain injury (TBI) in mice. Neutralization of EphA4 improved motor function and axonal regeneration following experimental spinal cord injury (SCI). We hypothesized that genetic absence of EphA4 could improve functional and histological outcome following TBI. Using qRT-PCR in wild-type (WT) mice, we evaluated the EphA4 mRNA levels following controlled cortical impact (CCI) TBI or sham injury and found it to be downregulated in the hippocampus (p < 0.05) but not the cortex ipsilateral to the injury at 24 h post-injury. Next, we evaluated the behavioral and histological outcome following CCI using WT mice and Emx1-Cre-driven conditional knockout (cKO) mice. In cKO mice, EphA4 was completely absent in the hippocampus and markedly reduced in the cortical regions from embryonic day 16, which was confirmed using Western blot analysis. EphA4 cKO mice had similar learning and memory abilities at 3 weeks post-TBI compared to WT controls, although brain-injured animals performed worse than sham-injured controls (p < 0.05). EphA4 cKO mice performed similarly to WT mice in the rotarod and cylinder tests of motor function up to 29 days post-injury. TBI increased cortical and hippocampal astrocytosis (GFAP immunohistochemistry, p < 0.05) and hippocampal sprouting (Timm stain, p < 0.05) and induced a marked loss of hemispheric tissue (p < 0.05). EphA4 cKO did not alter the histological outcome. Although our results may argue against a beneficial role for EphA4 in the recovery process following TBI, further studies including post-injury pharmacological neutralization of EphA4 are needed to define the role for EphA4 following TBI.	[Hanell, Anders; Clausen, Fredrik; Djupsjo, Anders; Bjork, Maria; Marklund, Niklas] Uppsala Univ, Neurosurg Sect, Dept Neurosci, Uppsala, Sweden; [Vallstedt, Anna; Patra, Kalicharan; Larhammar, Martin; Kullander, Klas] Uppsala Univ, Sect Dev Genet, Dept Neurosci, Uppsala, Sweden; [Israelsson, Charlotte] Uppsala Univ, Sect Dev Neurosci, Dept Neurosci, Uppsala, Sweden; [Paixao, Sonia] Max Planck Inst Neurobiol, Dept Mol Neurobiol, Martinsried, Germany		Marklund, N (corresponding author), Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, Entrance 85,2nd Floor, S-75185 Uppsala, Sweden.	niklas.marklund@neuro.uu.se	Hanell, Anders/E-4776-2011	Hanell, Anders/0000-0001-9369-3886; Clausen, Fredrik/0000-0003-3592-4417; Kullander, Klas/0000-0001-6418-5460; Marklund, Niklas/0000-0002-9797-5626	Upplandsstiftelsen; Uppsala University; Jeanssons Foundation; Swedish Brain Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation	The authors wish to thank Elaine Astrand and Moritz Mayerle for excellent technical support. This study was supported by Upplandsstiftelsen, Uppsala University, Jeanssons Foundation, and the Swedish Brain Foundation. Dr. Kullander is a Royal Swedish Academy of Sciences Research Fellow and is supported by a grant from the Knut and Alice Wallenberg Foundation.	Arocho LC, 2011, CELL MOL NEUROBIOL, V31, P1057, DOI 10.1007/s10571-011-9705-2; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Biervert C, 2001, NEUROSCI LETT, V315, P25, DOI 10.1016/S0304-3940(01)02312-6; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Castellani V, 1998, J NEUROSCI, V18, P4663; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Coonan JR, 2001, J COMP NEUROL, V436, P248; Cruz-Orengo L, 2007, NEUROSCI LETT, V418, P49, DOI 10.1016/j.neulet.2007.03.015; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Herrmann JE, 2010, EXP NEUROL, V223, P582, DOI 10.1016/j.expneurol.2010.02.005; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Irie F, 2008, P NATL ACAD SCI USA, V105, P12307, DOI 10.1073/pnas.0801302105; Irizarry-Ramirez M, 2005, J NEUROTRAUM, V22, P929, DOI 10.1089/neu.2005.22.929; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Knoll B, 2001, MECH DEVELOP, V106, P119, DOI 10.1016/S0925-4773(01)00431-2; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nissinen J, 2001, HIPPOCAMPUS, V11, P299, DOI 10.1002/hipo.1044; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Tremblay ME, 2009, J COMP NEUROL, V512, P798, DOI 10.1002/cne.21922; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wakenhorst J., 2000, MOL CELL NEUROSCI, V16, P365; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Xu B, 2003, MOL CELL NEUROSCI, V24, P984, DOI 10.1016/j.mcn.2003.08.003; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zorner B, 2010, ANN NY ACAD SCI, V1198, pE22, DOI 10.1111/j.1749-6632.2010.05566.x	82	12	12	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2660	2671		10.1089/neu.2012.2376			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400007	22985250				2022-02-06	
J	Schonenberger, A; Billeter, AT; Seifert, B; Neuhaus, V; Trentz, O; Turina, M				Schoenenberger, Amadea; Billeter, Adrian T.; Seifert, Burkhardt; Neuhaus, Valentin; Trentz, Otmar; Turina, Matthias			Opportunities for improved trauma care of the elderly - A single center analysis of 2090 severely injured patients	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Trauma; Injury; Mortality; Elderly; Age; Brain	MULTIPLE-ORGAN FAILURE; BRAIN-INJURY; AGE; OUTCOMES; PREDICTORS; MORTALITY; ADULTS; SCORE	Purpose: Western trauma centers are increasingly confronted with elderly trauma patients in parallel to an increase of the elderly population. The purpose of this study was to identify shortcomings and opportunities for improvement in the treatment of elderly trauma patients. Materials and methods: Retrospective analysis of a prospectively collected single-center trauma database. Patients were grouped according to age and analyzed using univariate and multivariate analysis. Results: 158 patients (7.6%) were older than 75 years, and 604 patients (28.9%) were between 50 and 75 years. Although comparable with respect to injury severity (injury severity score (ISS) 29-33) and age-adjusted Acute Physiologic and Chronic Health Evaluation (APACHE) score, there was a significant increase in mortality beyond the age of 50 (>75 years: 63.9%), with age being an independent predictor of mortality. Despite a similar rate and severity of head injuries (affecting 71% of all patients), mortality of head injuries was highest in patients >75 years (70.2%), accounting for the increased mortality in this group. Patients >75 years old were less likely to undergo craniotomy, and withdrawal of medical support occurred five times more frequently. Surviving patients >50 years required shorter ICU care than patients below 50 years (7.8 vs. 12.4 days). Conclusions: With increasing life expectancy and sustained independence, elderly trauma patients have become a regular occurrence in trauma services. Despite comparable injury severity and physiologic status upon admission, these patients suffer from disproportionately high mortality rates. Closed head injuries account for the majority of fatalities, regardless of the extent of therapeutic measures applied. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Turina, Matthias] Cleveland Clin, Dept Colorectal Surg, Inst Digest Dis, Cleveland, OH 44195 USA; [Schoenenberger, Amadea; Billeter, Adrian T.; Neuhaus, Valentin; Trentz, Otmar; Turina, Matthias] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland; [Billeter, Adrian T.] Univ Louisville Hosp, Price Inst Surg Res, Louisville, KY 40201 USA; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, Div Biostat, CH-8001 Zurich, Switzerland; [Neuhaus, Valentin] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA		Turina, M (corresponding author), Cleveland Clin, Dept Colorectal Surg, Inst Digest Dis, Main Campus,Mail Code A-30,9500 Euclid Ave, Cleveland, OH 44195 USA.	mturina73@hotmail.com	Billeter, Adrian/O-2185-2019	Billeter, Adrian/0000-0001-8724-4793; Seifert, Burkhardt/0000-0002-5829-2478; Neuhaus, Valentin/0000-0003-4012-5628			Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Bennett KM, 2010, J SURG RES, V163, P127, DOI 10.1016/j.jss.2010.04.031; Billeter A, 2009, WORLD J SURG, V33, P558, DOI 10.1007/s00268-008-9896-y; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; FOGELHOLM R, 1975, J NEUROSURG, V42, P43, DOI 10.3171/jns.1975.42.1.0043; Gennarelli T.A., 2001, ABBREVIATED INJURY S; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109; Haub C., 2011, 2010 WORLD POPULATIO; JOHNSON CL, 1994, AM SURGEON, V60, P899; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Meldon, 2000, Acad Emerg Med, V7, P1166; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7	26	12	12	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	NOV-DEC	2012	55	3					660	666		10.1016/j.archger.2012.02.013			7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	004GC	WOS:000308667900022	22465302				2022-02-06	
J	Wu, C; Orringer, DA; Lau, D; Fletcher, JJ				Wu, Chris; Orringer, Daniel A.; Lau, Darryl; Fletcher, Jeffrey J.			Cumulative incidence and predictors of neurosurgical interventions following nonsevere traumatic brain injury with mildly abnormal head imaging findings	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Mild traumatic brain injury; moderate traumatic brain injury; neurosurgical intervention	NATIONAL-SURVEY; MANAGEMENT; GUIDELINES; CENTERS	BACKGROUND: Incidence and predictors of neurosurgical interventions following nonsevere traumatic brain injury (TBI) with mildly abnormal head computed tomographic (CT) findings are poorly defined. Despite this, neurosurgical consultation is routinely requested in this patient population. Our objective was to determine incidence of neurosurgical intervention in this patient population and identify clinical and radiographic features predicting the subsequent need for these interventions. METHODS: We identified all consecutive adult patients with nonsevere TBI admitted from January 1, 2001, through December 31, 2010. The definitions of "mildly abnormal initial head CT findings'' and "neurosurgical interventions'' were determined a priori by author consensus. Cumulative incidence of neurosurgical interventions was determined, and multivariate logistic regression was used to identify independent predictors of neurosurgical intervention. RESULTS: Of 677 patients, 51 underwent neurosurgical intervention for a cumulative incidence of 7.5%. Only 1.6% required an intracranial procedure. In adjusted analysis, presence of coagulopathy (odds ratio [OR], 2.21; 95% confidence interval [CI], 1.13-4.3; p = 0.02), suspected cerebrospinal fluid leak (OR, 11.36; 95% CI, 2.83-45.58; p = 0.001), any basal cistern or sylvian fissure subarachnoid hemorrhage (OR, 2.94; 95% CI, 1.56-5.57; p = 0.001), depressed skull fracture (OR, 2.84; 95% CI, 1.29-6.28; p = 0.01), or unstable repeated head CT findings (OR, 2.81; 95% CI, 1.52-5.2; p = 0.001) remained an independent predictor of the need for subsequent neurosurgical intervention. CONCLUSION: Among patients with nonsevere TBI and mildly abnormal head imaging findings in which routine neurosurgical consultation is obtained, there is a low incidence of neurosurgical interventions. Our findings suggest that routine early neurosurgical consultation in this patient population may not be necessary; however, this should be tested in a prospective, comparative study. (J Trauma Acute Care Surg. 2012;73:1247-1253. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Wu, Chris; Orringer, Daniel A.; Lau, Darryl; Fletcher, Jeffrey J.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA		Fletcher, JJ (corresponding author), Univ Michigan Hlth Syst, Dept Neurosurg, 1500 E Med Ctr Dr,Room 3552 Taubman Ctr, Ann Arbor, MI 48109 USA.	jeffletc@med.umich.edu		Orringer, Daniel/0000-0001-6427-8376	Michigan Institute for Clinical and Health Research [CTSA: UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024986] Funding Source: NIH RePORTER	The authors have no conflicts of interest to report pertaining to the materials or methods used in this study or the findings specified in this article. This project was supported in part by a grant from the Michigan Institute for Clinical and Health Research (CTSA: UL1RR024986).	[Anonymous], 2009, VA DOD CLIN PRACTICE; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huynh T, 2006, AM SURGEON, V72, P1162; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Manessiez O, 2007, J RADIOL, V88, P567, DOI 10.1016/S0221-0363(07)89856-8; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Stein SC, 1996, NEUROSURG QUART, V6, P108, DOI 10.1097/00013414-199606000-00004	14	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2012	73	5					1247	1253		10.1097/TA.0b013e318265d24e			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	043VF	WOS:000311577100038	23064607				2022-02-06	
J	Alam, HB; Pusateri, AE; Kindzelski, A; Egan, D; Hoots, K; Andrews, MT; Rhee, P; Tisherman, S; Mann, K; Vostal, J; Kochanek, PM; Scalea, T; Deal, V; Sheppard, F; Sopko, G				Alam, Hasan B.; Pusateri, Anthony E.; Kindzelski, Andrei; Egan, Debra; Hoots, Keith; Andrews, Matthew T.; Rhee, Peter; Tisherman, Samuel; Mann, Kenneth; Vostal, Jaroslav; Kochanek, Patrick M.; Scalea, Thomas; Deal, Virgil; Sheppard, Forest; Sopko, George		HYPOSTAT Workshop Participants	Hypothermia and hemostasis in severe trauma: A new crossroads workshop report	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Hypothermia; trauma; coagulopathy; injury; protection	SWINE MODEL; PROFOUND HYPOTHERMIA; CARDIAC-ARREST; HEMORRHAGIC-SHOCK; CIRCULATORY ARREST; BRAIN-INJURY; EMERGENCY PRESERVATION; CARDIOPULMONARY BYPASS; BETA-HYDROXYBUTYRATE; FLUID RESUSCITATION	OBJECTIVE: The hypothermia and hemostasis in severe trauma (HYPOSTAT): a new crossroads workshop was convened to evaluate the interplay among hypothermia, hemostasis, and severe trauma/hemorrhage. Trauma is the major cause of death in young individuals in the United States, with uncontrolled hemorrhage representing the major cause of preventable deaths. DATA SOURCES: This workshop organized by the National Heart, Lung, and Blood Institute and the US Army Medical Research and Material Command as a forum for exchange of ideas among experts from diverse fields. The specific workshop goals were to (1) identify state-of-the-art and needs in knowledge of biology of hypothermia and hemostasis in the setting of significant traumatic injury; (2) provide an interdisciplinary forum to enhance knowledge regarding early detection of traumatic shock and monitoring of the level and effect of controlled hypothermia in severe trauma settings; and (3) identify future research directions of the role of therapeutic-oriented hypothermia and hemostasis in trauma with severe blood loss. STUDY SELECTION: Not applicable. DATA EXTRACTION: Expert opinion and literature review. CONCLUSION: This document provides a summary of the expert opinion and highlights the recommendations that came out of the discussions at this workshop to guide scientific efforts in basic, translational, and clinical research in this area. (J Trauma Acute Care Surg. 2012;73:809-817. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Alam, Hasan B.] Harvard Univ, Sch Med, Boston, MA USA; [Pusateri, Anthony E.; Deal, Virgil; Sheppard, Forest] US Dept Def, Washington, DC 20305 USA; [Kindzelski, Andrei; Egan, Debra; Hoots, Keith; Sopko, George] NIH, Bethesda, MD 20892 USA; [Vostal, Jaroslav] US FDA, Silver Spring, MD USA; [Scalea, Thomas] Univ Maryland, College Pk, MD 20742 USA; [Andrews, Matthew T.] Univ Minnesota, Duluth, MN 55812 USA; [Rhee, Peter] Univ Arizona, Tucson, AZ USA; [Tisherman, Samuel; Kochanek, Patrick M.] Univ Pittsburgh, Pittsburgh, PA USA; [Mann, Kenneth] Univ Vermont, Burlington, VT USA		Alam, HB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	hbalam@partners.org	Kochanek, Patrick M/D-2371-2015; Tisherman, Samuel A./AAK-9377-2020	Kochanek, Patrick M/0000-0002-2627-913X; Tisherman, Samuel A./0000-0003-3810-3729			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alam HB, 2012, BRIT J SURG, V99, P29, DOI 10.1002/bjs.7756; Alam HB, 2008, J TRAUMA, V64, P912, DOI 10.1097/TA.0b013e3181659e7f; Alam HB, 2006, SURGERY, V140, P307, DOI 10.1016/j.surg.2006.03.015; Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Alam HB, 2006, J TRAUMA, V60, P134, DOI 10.1097/01.ta.0000198469.95292.ec; Alam HB, 2005, J SURG RES, V126, P172, DOI 10.1016/j.jss.2005.01.019; Alam HB, 2004, J TRAUMA, V57, P961, DOI 10.1097/01.TA.0000149549.72389.3F; Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Behringer W, 2003, CRIT CARE MED, V31, P1523, DOI 10.1097/01.CCM.0000063450.73967.40; Behringer W, 2000, ANESTHESIOLOGY, V93, P1491, DOI 10.1097/00000542-200012000-00022; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; Capone A, 1996, J TRAUMA, V40, P388, DOI 10.1097/00005373-199603000-00011; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Z, 2005, RESUSCITATION, V66, P209, DOI 10.1016/j.resuscitation.2005.01.021; COLE SL, 1956, JAMA-J AM MED ASSOC, V161, P1454, DOI 10.1001/jama.1956.02970150022005; Conrad MF, 2007, ANN THORAC SURG, V83, pS856, DOI 10.1016/j.athoracsur.2006.10.096; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; deMeis L, 1997, FEBS LETT, V406, P201, DOI 10.1016/S0014-5793(97)00244-5; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; EHRLICH M, 1995, TEX HEART I J, V22, P250; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Fries D, 2010, BRIT J ANAESTH, V105, P116, DOI 10.1093/bja/aeq161; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; Haman F, 2006, J APPL PHYSIOL, V100, P1702, DOI 10.1152/japplphysiol.01088.2005; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Henry PG, 2007, J NEUROCHEM, V101, P1505, DOI 10.1111/j.1471-4159.2007.04514.x; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Iida Y, 2001, THER DRUG MONIT, V23, P192, DOI 10.1097/00007691-200106000-00002; JENNINGS RB, 1988, CRIT CARE MED, V16, P988, DOI 10.1097/00003246-198810000-00010; Jonas Richard A, 2002, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V5, P76, DOI 10.1053/pcsu.2002.31493; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; KADAR D, 1982, CAN ANAESTH SOC J, V29, P16, DOI 10.1007/BF03007942; Kheirbek T, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-65; Klein AH, 2010, SHOCK, V34, P565, DOI 10.1097/SHK.0b013e3181e15063; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MATTOX KL, 1982, J TRAUMA, V22, P934, DOI 10.1097/00005373-198211000-00008; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Mulier KE, 2012, RESUSCITATION, V83, P253, DOI 10.1016/j.resuscitation.2011.08.003; PUIG MM, 1987, BRIT J ANAESTH, V59, P1459, DOI 10.1093/bja/59.11.1459; RADOVSKY A, 1995, STROKE, V26, P2127, DOI 10.1161/01.STR.26.11.2127; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Rothoerl Ralf Dirk, 2006, Neurosurg Focus, V20, pE5; Sailhamer EA, 2007, J AM COLL SURGEONS, V204, P642, DOI 10.1016/j.jamcollsurg.2007.01.017; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scribner DM, 2010, J SURG RES, V164, pE131, DOI 10.1016/j.jss.2010.07.046; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; TAYLOR MJ, 1995, CIRCULATION, V91, P431, DOI 10.1161/01.CIR.91.2.431; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; Tisherman SA, 2004, CRIT CARE MED, V32, pS46, DOI 10.1097/01.CCM.0000110736.31246.C5; TISHERMAN SA, 1990, J TRAUMA, V30, P836, DOI 10.1097/00005373-199007000-00014; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; WONG KC, 1983, WESTERN J MED, V138, P227; Wu XR, 2008, J CEREBR BLOOD F MET, V28, P302, DOI 10.1038/sj.jcbfm.9600524; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	87	12	13	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2012	73	4					809	817		10.1097/TA.0b013e318265d1b8			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	029OL	WOS:000310505100003	23026915				2022-02-06	
J	Chung, SW; Park, YS; Nam, TK; Kwon, JT; Min, BK; Hwang, N				Chung, Sang Won; Park, Yong Sook; Nam, Taek Kyun; Kwon, Jeong Taik; Min, Byung Kook; Hwang, Nam			Locations and Clinical Significance of Non-Hemorrhagic Brain Lesions in Diffuse Axonal Injuries	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Diffuse axonal injury; Magnetic resonance imaging; Corpus callosum; Non-hemorrhagic	CEREBRAL WHITE MATTER; CORPUS-CALLOSUM; HEAD-INJURY; TRAUMA	Objective : Detection of focal non-hemorrhagic lesion (NHL) has become more efficient in diffuse axonal injury (DAI) patients using an MRI. The aims of this study are to find out the radiological distribution, progress of NHL and its clinical significance. Methods : Between September 2005 and October 2011, 32 individuals with NHLs on brain MRI were enrolled. NHLs were classified by brain location into 4 major districts and 13 detailed locations including cortical and subcortical, corpus callosum, deep nuclei and adjacent area, and brain-szem. The severity of NHL was scored from grades 1 to 4, according to the number of districts involved. Fourteen patients with NHL were available for MRI follow-up and an investigation of the changes was conducted. Results : Thirty-two patients had 59 NHLs. The most common district of NHL was cortical and subcortical area; 15 patients had 20 NHSs. However the most common specific location was the splenium of the corpus callosum; 14 patients had 14 lesions. The more lesions patients had, the lower the GCS, however, this was not a statistically meaningful difference. On follow-up MRI in 14 patients, out of 24 lesions, 13 NHLs resolved, 5 showed cystic change, and 6 showed atrophic changes. Conclusion : NHLs were located most commonly in the splenium and occur frequently in the thalamus and the mesial temporal lobe. Because most NHS occur concomitantly with hemorrhagic lesions, it was difficult to determine their effects on prognosis. Since most NHLs resolve completely, they are probably less significant to prognosis than hemorrhagic lesions.	[Chung, Sang Won; Park, Yong Sook; Nam, Taek Kyun; Kwon, Jeong Taik; Min, Byung Kook; Hwang, Nam] Chung Ang Univ Hosp, Dept Neurosurg, Seoul 156755, South Korea		Park, YS (corresponding author), Chung Ang Univ Hosp, Dept Neurosurg, 102 Heukseok Ro, Seoul 156755, South Korea.	cuttage@cau.ac.kr			Chung-Ang University Research Grants	This research was supported by the Chung-Ang University Research Grants in 2008.	Adams J H, 1988, Curr Top Pathol, V76, P1; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, INJURY, V13, P444, DOI 10.1016/0020-1383(82)90105-X; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Gem AD, 2011, YOUMANS NEUROLOGICAL, V4, P3342; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GRCEVIC N, 1988, SCAND J REHABIL MED, P25; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hardman J M, 1979, Adv Neurol, V22, P15; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; Lindenberg R, 1964, Clin Neurosurg, V12, P129; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meaney DF, 2001, J NEUROSURG, V95, P1108; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Povlishock J T, 2000, Clin Neurosurg, V46, P113; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rhoton AL, 2000, NEUROSURGERY, V47, pS131, DOI 10.1097/00006123-200009001-00015; Strich S J, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P166; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393	30	12	12	0	5	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	OCT	2012	52	4					377	383		10.3340/jkns.2012.52.4.377			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	029FO	WOS:000310480400016	23133728	Green Published, gold, Green Submitted			2022-02-06	
J	Grape, S; Ravussin, P				Grape, Sina; Ravussin, Patrick			PRO: Osmotherapy for the Treatment of Acute Intracranial Hypertension	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						osmotherapy; mannitol; hypertonic saline; intracranial hypertension	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; ASSOCIATION-STROKE-COUNCIL; HYPERTONIC SALINE; VOLUME REGULATION; LUND CONCEPT; PHYSIOLOGICAL PRINCIPLES; CEREBROSPINAL-FLUID; BRIEF EPISODES	Persisting severe brain edema causes intracranial hypertension and is associated with poor patient outcome. The treatment of acute intracranial hypertension is complex and multimodal. The most important options for medical treatment include controlled ventilation and osmotherapy, maintenance of brain and body homeostasis, and sedation. Osmotherapy is recommended in all relevant guidelines. The 2 osmotic agents most frequently used are mannitol and hypertonic saline. Both reduce intracranial pressure and improve cerebral perfusion and cerebral oxygen delivery. However, hypertonic saline seems advantageous over mannitol in many situations. In multitrauma patients, hypertonic saline contributes to hemodynamic stabilization and to the prevention of secondary insults. In addition, hypertonic saline has neurohumoral and immunologic effects, which may be beneficial in cerebral resuscitation.	[Ravussin, Patrick] Hop Sion, Dept Anesthesiol & Reanimat, CHCVs, CH-1950 Sion, Switzerland		Ravussin, P (corresponding author), Hop Sion, Dept Anesthesiol & Reanimat, CHCVs, Av Grand Champsec 80, CH-1950 Sion, Switzerland.	patrick.ravussin@hopitalvs.ch					Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Andrews PJD, 2006, INTENS CARE MED, V32, P1461, DOI 10.1007/s00134-006-0295-2; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bereczki D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001153.pub2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Chang Y, 2006, J APPL PHYSIOL, V100, P1445, DOI 10.1152/japplphysiol.00763.2005; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Diringer MN, 2012, NEUROSURGERY, V70, P1215, DOI 10.1227/NEU.0b013e3182417bc2; Ditillo M, 2011, J TRAUMA, V71, P373; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; DONATO T, 1994, ANESTH ANALG, V78, P58; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2011, J NEUROSURG ANESTH, V23, P251, DOI 10.1097/ANA.0b013e31821a8f10; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Korenkov AI, 2000, NEUROSURG REV, V23, P145, DOI 10.1007/PL00011946; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P131; Liu Chang-Wen, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P610; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Oreopoulos GD, 2000, SHOCK, V14, P409, DOI 10.1097/00024382-200014030-00029; Palma L, 2006, J Neurosurg Sci, V50, P63; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Sankar T, 2008, J NEUROSURG, V108, P1010, DOI 10.3171/JNS/2008/108/5/1010; SCALFANI MT, 2011, J CRIT CARE; SCHEGA H W, 1955, Langenbecks Arch Klin Chir Ver Dtsch Z Chir, V280, P479, DOI 10.1007/BF01441411; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; SUTHERLAND G, 1988, STROKE, V19, P571, DOI 10.1161/01.STR.19.5.571; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Torre-Healy A, 2011, NEUROCRIT CARE; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; WISE BL, 1963, J NEUROSURG, V20, P961, DOI 10.3171/jns.1963.20.11.0961; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zeng HK, 2010, NEUROSCIENCE, V166, P878, DOI 10.1016/j.neuroscience.2009.12.076; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853	56	12	13	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2012	24	4					402	406					5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	013GR	WOS:000309294400022	22955194				2022-02-06	
J	Kruer, RM; Ensor, CR				Kruer, Rachel M.; Ensor, Christopher R.			Colloids in the intensive care unit	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article							HYDROXYETHYL STARCH; INFLAMMATORY RESPONSE; SEVERE SEPSIS; ALBUMIN; RESUSCITATION; METAANALYSIS; HEMOSTASIS; SURGERY; THERAPY; RELEASE	Purpose. The most recent published evidence on the use of colloids versus crystalloids in critical care is reviewed, with a focus on population-dependent differences in safety and efficacy. Summary. Colloids offer a number of theoretical advantages over crystalloids for fluid resuscitation, but some colloids (e.g., hydroxyethyl starch solutions, dextrans) can have serious adverse effects, and albumin products entail higher costs. The results of the influential Saline Versus Albumin Fluid Evaluation (SAFE) trial and a subsequent SAFE subgroup analysis indicated that colloid therapy should not be used in patients with traumatic brain injury and other forms of trauma due to an increased mortality risk relative to crystalloid therapy. With regard to patients with severe sepsis, two meta-analyses published in 2011, which collectively evaluated 82 trials involving nearly 10,000 patients, indicated comparable outcomes with the use of either crystalloids or albumins. For patients requiring extracorporeal cardiopulmonary bypass (CPB) during heart surgery, the available evidence supports the use of a colloid, particularly albumin, for CPB circuit priming and postoperative volume expansion. In select patients with burn injury, the published evidence supports the use of supplemental colloids if adequate urine output cannot be maintained with a crystalloid-only rescue strategy. Conclusion. The results of the SAFE trial and a subgroup analysis of SAFE data suggest that colloids should be avoided in patients with trauma and traumatic brain injury. There are minimal differences in outcome between crystalloids and hypo-oncotic or iso-oncotic albumin for fluid resuscitation in severe sepsis; in select populations, such as patients undergoing cardiac surgery, the use of iso-oncotic albumin may confer a survival advantage and should be considered a first-line alternative. Am 1 Health-Syst Pharm. 2012; 69:1635-42	[Kruer, Rachel M.] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Ensor, Christopher R.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA		Kruer, RM (corresponding author), Johns Hopkins Univ Hosp, Dept Pharm, 600 N Wolfe St,Carnegie 180, Baltimore, MD 21287 USA.	rkruerl@jhmi.edu					Beck R, 1998, CIRC RES, V83, P923; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Cochran A, 2007, BURNS, V33, P25, DOI 10.1016/j.burns.2006.10.005; Cope JT, 1997, ANN THORAC SURG, V63, P78; de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dellinger R Phillip, 2008, Crit Care Med, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Horstick G, 2002, CRIT CARE MED, V30, P851, DOI 10.1097/00003246-200204000-00023; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Martin GS, 2004, AM J RESP CRIT CARE, V170, P1247, DOI 10.1164/rccm.200208-909ST; MCCANDLESS BK, 1991, AM J PHYSIOL, V260, pL571, DOI 10.1152/ajplung.1991.260.6.L571; Miller BE, 1997, J CARDIOTHOR VASC AN, V11, P355, DOI 10.1016/S1053-0770(97)90106-3; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nielsen VG, 1997, CRIT CARE MED, V25, P1565, DOI 10.1097/00003246-199709000-00026; Niemi TT, 2006, ANESTH ANALG, V102, P998, DOI 10.1213/01.ane.0000200285.20510.b6; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Perner A, 2012, NEW ENGL J MED, V367, P481; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Rioux JP, 2009, CRIT CARE MED, V37, P1293, DOI 10.1097/CCM.0b013e31819cc1a0; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Russell JA, 2004, J CARDIOTHOR VASC AN, V18, P429, DOI 10.1053/j.jvca.2004.05.019; SAFE study investigators, 2011, INTENS CARE MED, V37, P89; Schortgen F, 2008, INTENS CARE MED, V34, P2157, DOI 10.1007/s00134-008-1225-2; Sedrakyan A, 2003, CHEST, V123, P1853, DOI 10.1378/chest.123.6.1853; Vlachou E, 2010, BURNS, V36, P984, DOI 10.1016/j.burns.2010.04.001; Wilkes MM, 2001, ANN THORAC SURG, V72, P527, DOI 10.1016/S0003-4975(01)02745-X	29	12	12	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	OCT 1	2012	69	19					1635	1642		10.2146/ajhp110414			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	015ZF	WOS:000309486200010	22997116				2022-02-06	
J	Lynch, KM; Brett, F				Lynch, Karen M.; Brett, Francesca			Headaches that kill: A retrospective study of incidence, etiology and clinical features in cases of sudden death	CEPHALALGIA			English	Article						Fatal headache; death; autopsy; red flag features		Objective: The study objective was to analyze cases of sudden death that presented to the National Deptartment of Clinical Neurosciences, Ireland, over a 10-year period (1997-2006) where headache was the presenting symptom. Background: Headache is a common yet challenging presentation in clinical neurology. In the vast majority of cases, the cause is trivial and reversible-however, in a few patients it may be indicative of a more sinister intracranial process. Recognizing associated "red flag'' features and identifying possible life-threatening causes are crucial in ensuring prompt and appropriate intervention. Design/methods: A retrospective study/database of all autopsy cases presenting to the Neuropathology Department in Beaumont Hospital, Dublin, was carried out for the period 1997-2006. Cases were selected with headache as the presenting clinical feature. Traumatic head injuries or known central nervous system (CNS) disorders were excluded. Autopsy and medical reports were reviewed to identify associated red flag features at initial presentation according to the International Classification of Headache Diseases, second edition (ICHD-II) criteria. Results: Fifty-five autopsy cases out of a total of 499 complying with selection criteria were reviewed. Over the 10-year-study period, the number of cases of fatal headaches over time were negatively correlated. The most commonly associated red flag symptoms included age over 50: loss of consciousness and collapse, and worst/thunderclap character of headache. Cause of death at autopsy comprised vascular events 60.4% (N = 29), primary brain tumours/cysts 16.7% (N = 8) and meningitis 6.25% (N = 3). Aneurysms accounted for the majority of vascular cases 22.9% (N = 11), with loss of consciousness, occipital headache, neck pain and a focal neurological deficit seen more commonly in this subset of cases. Conclusions: Sudden-onset headache is a common and often alarming presentation. The majority of cases are of a benign nature; however, a small proportion may be indicative of a catastrophic etiology. Documenting "red flags'' on initial presentation is crucial to acutely identify and treat those at highest risk. The results demonstrate an improving trend among clinicians in recognizing and initiating appropriate interventions in these patients, and highlights particular red flag features common in cases of fatal headaches.	[Lynch, Karen M.] Tufts Univ, Tufts Med Ctr, Dept Neurol, Boston, MA 02111 USA; [Brett, Francesca] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland		Lynch, KM (corresponding author), Tufts Univ, Tufts Med Ctr, Dept Neurol, 800 Washington St, Boston, MA 02111 USA.	klynch1@tuftsmedicalcenter.org		Brett, Francesca/0000-0002-7453-4027			Dodick D, 1997, POSTGRAD MED, V101, P46, DOI 10.3810/pgm.1997.05.217; DUMAS MD, 1994, CAN MED ASSOC J, V151, P1447; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Locker T, 2004, EMERG MED J, V21, P327, DOI 10.1136/emj.2003.012351; Marks DR, 1997, SEMIN NEUROL, V17, P307, DOI 10.1055/s-2008-1040943; Medina LS, 2003, NEUROIMAG CLIN N AM, V13, P225, DOI 10.1016/S1052-5149(03)00026-1; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sobri M, 2003, BRIT J RADIOL, V76, P532, DOI 10.1259/bjr/89012738; Spears Roderick C, 2004, Curr Pain Headache Rep, V8, P297, DOI 10.1007/s11916-004-0011-2; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354	10	12	12	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2012	32	13					972	978		10.1177/0333102412455706			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	013CQ	WOS:000309283700005	22875877				2022-02-06	
J	Sun, JH; Xie, CC; Liu, W; Lu, DY; Qiao, WD; Huang, Q; Huo, ZH; Shen, H; Lin, ZG				Sun, Jiahang; Xie, Chuncheng; Liu, Wei; Lu, Dunyue; Qiao, Weidong; Huang, Qi; Huo, Zhihui; Shen, Hong; Lin, Zhiguo			The effects of simvastatin on hippocampal caspase-3 and Bcl-2 expression following kainate-induced seizures in rats	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						simvastatin; status epilepticus; B-cell leukemia-2; cysteinyl aspartate-specific protease-3; kainic acid; hippocampus	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; EXPERIMENTAL STATUS EPILEPTICUS; INDUCED NEURONAL NECROSIS; CELL-DEATH; DENTATE GYRUS; REDUCTASE INHIBITORS; ALZHEIMERS-DISEASE; DNA FRAGMENTATION; LIMBIC SEIZURES	Status epilepticus (SE) causes neuronal loss and apoptosis by inducing several apoptosis-regulatory genes. Two such genes, cysteinyl aspartate-specific protease-3 (caspase-3), an apoptosis activator, and B-cell leukemia-2 (Bcl-2), an apoptosis suppressor, are tightly regulated for their expression and activation. Statins, inhibitors of HMG-CoA reductase, have been recently recognized as neuroprotective drugs. However, their underlying mechanisms are still unclear. In this study, we examined the neuroprotective effects of simvastatin in a rat model of SE induced by kainic acid (KA). Feeding of simvastatin for 3 days after kainate injection rescued SE-induced neuronal apoptosis, as determined by histological examination of brain sections at the level of the dorsal hippocampus. Semi-quantitative RT-PCR showed that SE treatment markedly increased caspase-3 mRNA expression and reduced Bcl-2 mRNA expression in the hippocampus. Similarly, western blot analysis and immunohistochemical analysis of the rat hippocampus demonstrated that under SE treatment, caspase-3 protein levels significantly increased and peaked at 72 h, whereas Bcl-2 protein levels decreased from 6-24 h following SE. Interestingly, simvastatin could reverse the aforementioned SE-induced changes, suggesting that the neuroprotective effects of simvastatin against neuronal apoptosis may be achieved by inhibiting caspase-3 expression and increasing Bcl-2 expression.	[Xie, Chuncheng; Qiao, Weidong; Huo, Zhihui; Shen, Hong; Lin, Zhiguo] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150000, Peoples R China; [Sun, Jiahang; Liu, Wei] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin 150000, Peoples R China; [Lu, Dunyue] SUNY Hlth Sci Ctr, Dept Psychiat, Brooklyn, NY 11203 USA; [Huang, Qi] Harbin Med Univ, Dept Anat, Harbin, Peoples R China		Lin, ZG (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150000, Peoples R China.	linzhiguo@hotmail.com					Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ananth C, 2001, J NEUROSCI RES, V66, P177, DOI 10.1002/jnr.1210; Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Benarroch EE, 2007, NEUROLOGY, V69, P1635, DOI 10.1212/01.wnl.0000279590.22544.c3; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bengzon J, 2002, PROG BRAIN RES, V135, P111; BOTTI RE, 1991, CLIN NEUROPHARMACOL, V14, P256, DOI 10.1097/00002826-199106000-00010; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; DEGIORGIO CM, 1992, EPILEPSIA, V33, P23, DOI 10.1111/j.1528-1157.1992.tb02278.x; Dolga AM, 2009, J ALZHEIMERS DIS, V17, P327, DOI 10.3233/JAD-2009-1052; Dumas TC, 2000, EXP NEUROL, V166, P180, DOI 10.1006/exnr.2000.7500; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ekdahl CT, 2001, EUR J NEUROSCI, V14, P937, DOI 10.1046/j.0953-816x.2001.01713.x; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Faherty CJ, 1999, MOL BRAIN RES, V70, P159, DOI 10.1016/S0169-328X(99)00143-6; Fujikawa DG, 2002, J NEUROCHEM, V83, P229, DOI 10.1046/j.1471-4159.2002.01152.x; Fujikawa DG, 2000, EPILEPSIA, V41, pS9, DOI 10.1111/j.1528-1157.2000.tb01549.x; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Henshall DC, 2000, NEUROLOGY, V55, P250, DOI 10.1212/WNL.55.2.250; Henshall DC, 2000, J NEUROCHEM, V74, P1215; Hoglund K, 2007, CNS DRUGS, V21, P449; Huang XM, 2007, MOVEMENT DISORD, V22, P377, DOI 10.1002/mds.21290; Kondratyev A, 2000, MOL BRAIN RES, V75, P216, DOI 10.1016/S0169-328X(99)00292-2; Kovacs R, 2002, J NEUROPHYSIOL, V88, P2909, DOI 10.1152/jn.00149.2002; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Marz P, 2007, GLIA, V55, P1, DOI 10.1002/glia.20422; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Murphy B, 2007, AM J PATHOL, V171, P1258, DOI 10.2353/ajpath.2007.070269; Narkilahti S, 2003, EUR J NEUROSCI, V18, P1486, DOI 10.1046/j.1460-9568.2003.02874.x; Niquet J, 2007, EPILEPSIA, V48, P1203, DOI 10.1111/j.1528-1167.2007.01102.x; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; PAN HY, 1993, ANN PHARMACOTHER, V27, P1029, DOI 10.1177/106002809302700902; Phillips RG, 2000, BRAIN RES, V859, P202, DOI 10.1016/S0006-8993(99)02453-1; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Radley JJ, 2003, BRAIN RES, V966, P1, DOI 10.1016/S0006-8993(02)03989-6; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Tokuhara D, 2007, BRAIN DEV-JPN, V29, P2, DOI 10.1016/j.braindev.2006.05.003; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Weiss S, 1996, NEUROSCIENCE, V74, P541, DOI 10.1016/0306-4522(96)00148-0; Wolazin B, 2006, ACTA NEUROL SCAND, V114, P63; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiang ZM, 2009, EXP NEUROL, V215, P41, DOI 10.1016/j.expneurol.2008.09.010; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Zipp F, 2007, TRENDS PHARMACOL SCI, V28, P342, DOI 10.1016/j.tips.2007.05.001	54	12	18	1	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	OCT	2012	30	4					739	746		10.3892/ijmm.2012.1076			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	013IB	WOS:000309298000003	22842798	Bronze			2022-02-06	
J	Xie, ZY; Lei, B; Huang, Q; Deng, JM; Wu, MJ; Shen, WW; Cheng, Y				Xie, Zongyi; Lei, Bo; Huang, Qin; Deng, Jinmu; Wu, Mingjun; Shen, Weiwei; Cheng, Yuan			Neuroprotective effect of Cyclosporin A on the development of early brain injury in a subarachnoid hemorrhage model: A pilot study	BRAIN RESEARCH			English	Article						Cyclosporin A; Early brain injury; Subarachnoid hemorrhage; Apoptosis	MITOCHONDRIAL PERMEABILITY TRANSITION; CEREBRAL-BLOOD-FLOW; CELL-DEATH; SIGNALING PATHWAYS; DOSE-RESPONSE; ISCHEMIA; MECHANISMS; VASOSPASM; APOPTOSIS; INHIBITION	Cyclosporin A (CsA) has been demonstrated to be neuroprotective in ischemic and traumatic brain injuries by inhibiting mitochondrial permeability transition pore (mPTP) opening, thereby maintaining mitochondrial homeostasis and inhibiting pro-apoptotic protein release. The effects of CsA on early brain injury (EBI) after subarachnoid hemorrhage (SAH), however, have not been investigated. This study was designed to explore the effects of CsA on apoptotic signaling pathways and EBI after experimental SAH using four equal groups (n=36) of adult male SD rats, including the sham group, SAH+vehicle group, SAH+CsA2 group, and SAH+CsA10 group. The rat SAH model was induced by injection of 0.3 ml non-heparinized arterial blood into the prechiasmatic cistern. In the SAH+CsA2 and SAH+CsA10 groups, a dose of 2 mg/kg and 10 mg/kg CsA was directly administered by intercarotid injection at 15 min and again 24 h after SAH induction. Cerebral tissue samples were extracted 48 h after SAH. Increased expressions of Cytochrome C, apoptosis-inducing factor (AIF), and cleaved caspase-3 were observed in the cerebral cortex after SAH. Treatment with high dose (10 mg/kg) CsA markedly decreased expressions of Cytochrome C, AIF, and cleaved caspase-3, and inhibited apoptosis pathways. Administration of CsA following SAH significantly ameliorated EBI, including cortical apoptosis, brain edema, blood-brain barrier (BBB) impairment, and neurobehavioral deficits. These findings suggest that early administration of CsA may ameliorate EBI and provide neuroprotection in the SAH model through potential mechanisms that include blockage of mPTP opening and inhibition of apoptotic cell death pathways. (C) 2012 Elsevier B.V. All rights reserved.	[Xie, Zongyi; Lei, Bo; Huang, Qin; Deng, Jinmu; Cheng, Yuan] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing 400010, Peoples R China; [Wu, Mingjun] Chongqing Med Univ, Inst Biol Sci, Chongqing 400016, Peoples R China; [Shen, Weiwei] Sixth Peoples Hosp Chongqing City, Dept Internal Med, Chongqing 400060, Peoples R China		Xie, ZY (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing 400010, Peoples R China.	zongyixie@yahoo.com.cn; chengyuancq023@yahoo.cn		Lei, Bo/0000-0002-5497-0905	Chongqing Natural Science FoundationNatural Science Foundation of Chongqing [CSTC, 2008BB5234]	This work was supported by the Chongqing Natural Science Foundation Project to Z.Y.X (no. CSTC, 2008BB5234). The authors are appreciative of Daqiang Li, M.D. and Ph.D. from Department of Biochemistry and Molecular Biology, George Washington University, for revising the manuscript.	Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Bulsara Ketan R, 2006, Neurosurg Focus, V21, pE11; Cahill J, 2007, NEUROSURGERY, V60, P531, DOI 10.1227/01.NEU.0000249287.99878.9B; Cahill J, 2009, STROKE, V40, pS86, DOI 10.1161/STROKEAHA.108.533315; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Cheng G., 2009, BMC NEURSOCI; Cho BB, 2008, J INVEST SURG, V21, P141, DOI 10.1080/08941930802029945; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Friedrich V, 2012, NEUROSCI LETT, V512, P6, DOI 10.1016/j.neulet.2012.01.036; Gabryel B, 2009, CELL BIOL INT, V33, P739, DOI 10.1016/j.cellbi.2009.04.006; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gao C, 2010, VASC PHARMACOL, V52, P77, DOI 10.1016/j.vph.2009.12.001; Gules I, 2003, ACT NEUR S, V86, P483; HANDA Y, 1991, NEUROSURGERY, V28, P380, DOI 10.1227/00006123-199103000-00007; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Ibarra A., 2002, IMMUNOSUPPRESSANT AN, P283; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Manno EM, 1997, NEUROSURGERY, V40, P289, DOI 10.1097/00006123-199702000-00010; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Nau R, 2002, BRAIN PATHOL, V12, P329; Nicholson DW, 2003, SCIENCE, V299, P214, DOI 10.1126/science.1081274; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; PETERSON JW, 1990, STROKE, V21, P133, DOI 10.1161/01.STR.21.1.133; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; RYBA M, 1991, ACTA NEUROCHIR, V108, P81, DOI 10.1007/BF01407672; RYBA M, 1991, ACTA NEUROCHIR, V112, P25, DOI 10.1007/BF01402450; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sun J, 2012, BRAIN RES, V1436, P101, DOI 10.1016/j.brainres.2011.11.055; Tsuboi H, 2001, NEUROIMMUNOMODULAT, V9, P1, DOI 10.1159/000049001; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wang L, 2005, ANN CLIN LAB SCI, V35, P79; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Yamaguchi M, 2004, STROKE, V35, P1750, DOI 10.1161/01.STR.0000129898.68350.9f; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	56	12	15	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 7	2012	1472						113	123		10.1016/j.brainres.2012.06.053			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	005TI	WOS:000308772600013	22796593				2022-02-06	
J	Desai, A; Bekelis, K; Zhao, WY; Ball, PA				Desai, Atman; Bekelis, Kimon; Zhao, Wenyan; Ball, Perry A.			Increased population density of neurosurgeons associated with decreased risk of death from motor vehicle accidents in the United States Clinical article	JOURNAL OF NEUROSURGERY			English	Article						motor vehicle crash; area resource file; trauma neurosurgeon population density	TRAUMA SYSTEMS; MORTALITY; CRASHES; INJURY	Object. Motor vehicle accidents (MVAs) are a leading cause of death and disability in young people. Given that a major cause of death from MVAs is traumatic brain injury, and neurosurgeons hold special expertise in this area relative to other members of a trauma team, the authors hypothesized that neurosurgeon population density would be related to reduced mortality from MVAs across US counties. Methods. The Area Resource File (2009-2010), a national health resource information database, was retrospectively analyzed. The primary outcome variable was the 3-year (2004-2006) average in MVA deaths per million population for each county. The primary independent variable was the density of neurosurgeons per million population in the year 2006. Multiple regression analysis was performed, adjusting for population density of general practitioners, urbanicity of the county, and socioeconomic status of the county. Results. The median number of annual MVA deaths per million population, in the 3141 counties analyzed, was 226 (interquartile range [IQR] 151-323). The median number of neurosurgeons per million population was 0 (IQR 0-0), while the median number of general practitioners per million population was 274 (IQR 175-410). Using an unadjusted analysis, each increase of I neurosurgeon per million population was associated with 1.90 fewer MVA deaths per million population (p < 0.001). On multivariate adjusted analysis, each increase of 1 neurosurgeon per million population was associated with 1.01 fewer MVA deaths per million population (p < 0.001), with a respective decrease in MVA deaths of 0.03 per million population for an increase in I general practitioner (p = 0.007). Rural location, persistent poverty, and low educational level were all associated with significant increases in the rate of MVA deaths. Conclusions. A higher population density of neurosurgeons is associated with a significant reduction in deaths from MVAs, a major cause of death nationally. This suggests that the availability of local neurosurgeons is an important factor in the overall likelihood of survival from an MVA, and therefore indicates the importance of promoting neurosurgical education and practice throughout the country. (http://thejns.org/doi/abs/10.3171/2012.6.JNS111281)	[Desai, Atman; Bekelis, Kimon; Ball, Perry A.] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03756 USA; [Zhao, Wenyan] Dartmouth Hitchcock Med Ctr, Dept Orthopaed, Lebanon, NH 03756 USA		Desai, A (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Neurosurg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	atman.desai@hitchcock.org	Bekelis, Kimon/Y-3402-2019				Adekoya N., 2009, Morbidity and Mortality Weekly Report, V58, P161; BAKER SP, 1988, J TRAUMA, V28, P741, DOI 10.1097/00005373-198806000-00003; BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; Center for the Evaluative Clinical Sciences, 2006, SPIN SURG REP DARTM; Chang DC, 2011, J AM COLL SURGEONS, V212, P862, DOI 10.1016/j.jamcollsurg.2011.01.057; Clark DE, 1999, ACAD EMERG MED, V6, P125, DOI 10.1111/j.1553-2712.1999.tb01050.x; Committee on Trauma Research, 1985, INJ AM CONT PUBL HLT; Crompton JG, 2010, AM J SURG, V200, P191, DOI 10.1016/j.amjsurg.2009.07.047; Dartmouth Atlas Working Group, 2000, DARTM ATL MUSC HLTH; Donaldson AE, 2006, ACCIDENT ANAL PREV, V38, P723, DOI 10.1016/j.aap.2006.01.002; Fingerhut LA., 1997, INJURY CHARTBOOK HLT; Gardner R, 2007, ARCH PEDIAT ADOL MED, V161, P889, DOI 10.1001/archpedi.161.9.889; Gonzalez RP, 2006, J TRAUMA, V61, P404, DOI 10.1097/01.ta.0000229816.16305.94; Gonzalez RP, 2009, AM J SURG, V197, P30, DOI 10.1016/j.amjsurg.2007.11.018; Li MD, 2008, J SAFETY RES, V39, P623, DOI 10.1016/j.jsr.2008.10.008; Maio RF, 1996, J TRAUMA, V41, P83, DOI 10.1097/00005373-199607000-00013; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; Marson AC, 2001, J TRAUMA, V50, P917; Melton SM, 2003, J TRAUMA, V54, P273, DOI 10.1097/01.TA.0000038506.54819.11; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Rice DP, 1989, COST INJURY US REPOR; Shafi S, 2006, J TRAUMA, V61, P1374, DOI 10.1097/01.ta.0000246698.07125.c0; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017	25	12	12	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2012	117	3					599	603		10.3171/2012.6.JNS111281			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	990JP	WOS:000307627100028	22827590	Bronze			2022-02-06	
J	Kendrick, D; Silverberg, ND; Barlow, S; Miller, WC; Moffat, J				Kendrick, Denise; Silverberg, Noah D.; Barlow, Susan; Miller, William C.; Moffat, Jacqui			Acquired brain injury self-management programme: A pilot study	BRAIN INJURY			English	Article						Mild traumatic brain injury; concussion; rehabilitation; self-efficacy; occupational performance	OCCUPATIONAL PERFORMANCE-MEASURE; COGNITIVE-BEHAVIORAL THERAPY; CHRONIC DISEASE; REHABILITATION; OUTCOMES; EDUCATION; SYMPTOMS; ILLNESS; ADULTS; CARE	Primary objective: Traditional rehabilitation is not well suited to individuals with chronic mild symptoms following an acquired brain injury. To address this, this study adapted a supported self-management programme (SMP) for this population. The aim of this study was to evaluate the potential effectiveness of this novel SMP. Research design: Retrospective case series with repeated measures. Methods and procedures: Fifty-three participants with chronic mild symptoms following an acquired brain injury (primarily mild traumatic brain injury) completed an SMP. The intervention involved eight coaching sessions with each an occupational therapist and psychologist, carried out in the community and based on SMP principles. The Canadian Occupational Performance Measure was administered at baseline, discharge and 3- and 9-month follow-up. This measure yielded scores for performance and satisfaction with daily functioning, covering the domains of self-care, productivity and leisure. Main outcomes and results: A complete case analysis of programme completers revealed that participants' ratings of their occupational performance and satisfaction improved markedly between baseline and discharge from the SMP. This set of outcome measures remained stable between discharge and the two follow-up points. Conclusions: This pilot study suggests that SMPs may improve daily functioning in individuals with chronic mild ABI symptoms. More methodologically robust clinical trials are warranted.	[Barlow, Susan] GF Strong Rehabil Ctr, Vancouver, BC V5Z 2G9, Canada; [Kendrick, Denise] Vancouver Gen Hosp, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Fac Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Moffat, Jacqui] Ridge Meadows Child Dev Ctr, Vancouver, BC, Canada		Barlow, S (corresponding author), GF Strong Rehabil Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	susan.barlow@vch.ca	Miller, William/S-7407-2019	Kendrick, Denise/0000-0003-3603-6542			Bandura A, 1986, SOCIAL FDN THOUGHT A; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cadilhac DA, 2011, STROKE, V42, P1673, DOI 10.1161/STROKEAHA.110.601997; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dedding C, 2004, CLIN REHABIL, V18, P660, DOI 10.1191/0269215504cr746oa; Dixon G, 2007, CLIN REHABIL, V21, P230, DOI 10.1177/0269215506071784; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Law M, 1990, Can J Occup Ther, V57, P82; Law M, 1994, Can J Occup Ther, V61, P191; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; McColl M A, 2000, Can J Occup Ther, V67, P22; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Muenchberger H, 2011, BRAIN INJURY, V25, P23, DOI 10.3109/02699052.2010.531689; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Nolte S, 2007, PATIENT EDUC COUNS, V65, P351, DOI 10.1016/j.pec.2006.08.016; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Pollock N, 1998, CANADIAN OCCUPATIONA; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640	33	12	12	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1243	1249		10.3109/02699052.2012.672787			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600009	22658076				2022-02-06	
J	Lee, TTC; Graham, JR; Sellbom, M; Gervais, RO				Lee, Tayla T. C.; Graham, John R.; Sellbom, Martin; Gervais, Roger O.			Examining the Potential for Gender Bias in the Prediction of Symptom Validity Test Failure by MMPI-2 Symptom Validity Scale Scores	PSYCHOLOGICAL ASSESSMENT			English	Article						Minnesota Multiphasic Personality Inventory-2; Symptom Validity scale (FBS); symptom validity tests; gender bias	FAKE BAD SCALE; MEMORY MALINGERING TOMM; TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; CHRONIC PAIN; CLASSIFICATION ACCURACY; INCREMENTAL VALIDITY; METAANALYSIS; PERFORMANCE; LITIGANTS	Using a sample of individuals undergoing medico-legal evaluations (690 men, 519 women), the present study extended past research on potential gender biases for scores of the Symptom Validity (FBS) scale of the Minnesota Multiphasic Personality Inventory-2 by examining score- and item-level differences between men and women and determining the extent to which FBS scores were able to correctly identify men and women who were divided into credible responders (n = 837) and noncredible responders (n = 372) on the basis of performance on symptom validity tests. Results indicated that women had slightly higher raw FBS scores than men (d = .29), and significant differences between men and women in item endorsement were demonstrated for 14 FBS items. Step-down hierarchical logistic regression procedures indicated predictive bias (chi(2)Delta = 23.72, p < .001). Follow-up analyses indicated intercept bias (chi(2)Delta = 23.51, p < .001) but not slope bias (chi(2)Delta = 0.22, p = .64). However, using the test publisher's recommended FBS cutoff scores (Ben-Porath, Graham, & Tellegen, 2009), classification accuracies were similar for women and men (T > 80, h = -.02; T > 100, h = -.22, respectively). On the basis of these results, we conclude there is no evidence of clinically meaningful bias in predictions of symptom validity test failure made using FBS scores for men and women.	[Lee, Tayla T. C.; Graham, John R.] Kent State Univ, Dept Psychol, Kent, OH 44242 USA; [Sellbom, Martin] Univ Alabama, Dept Psychol, Tuscaloosa, AL 35487 USA; [Gervais, Roger O.] Univ Alberta, Dept Educ Psychol, Edmonton, AB T6G 2E1, Canada; [Gervais, Roger O.] Neurobehav Associates, Edmonton, AB, Canada		Lee, TTC (corresponding author), Kent State Univ, Dept Psychol, Kent Hall, Kent, OH 44242 USA.	tconnerl@gmail.com	Sellbom, Martin/I-9302-2014				Allen L., 1997, CARB 97 MANUAL COMPU; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arbisi PA, 2002, PSYCHOL ASSESSMENT, V14, P3, DOI 10.1037//1040-3590.14.1.3; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Ben-Porath YS, 2009, PSYCHOL INJ LAW, V2, P62, DOI 10.1007/s12207-009-9037-4; Ben-Porath YS., 2009, MMPI 2 SYMPTOM VALID; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bury AS, 2002, PSYCHOL ASSESSMENT, V14, P472, DOI 10.1037//1040-3590.14.4.472; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Butcher JN, 2008, PSYCHOL INJ LAW, V1, P191, DOI 10.1007/s12207-007-9002-z; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Cohen J., 1988, STAT POWER BEHAV SCI; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Efendov AA, 2008, PSYCHOL ASSESSMENT, V20, P317, DOI 10.1037/a0013870; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2009, CLIN NEUROPSYCHOL, V23, P996, DOI 10.1080/13854040902748249; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Gierok SD, 2005, ARCH CLIN NEUROPSYCH, V20, P755, DOI 10.1016/j.acn.2005.04.008; Green P., 2003, GREENS WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Green P., 2004, MEMORY COMPLAINTS IN; Green P, 1995, MANUAL ORAL WORD MEM; GREENE RL, 1987, J CONSULT CLIN PSYCH, V55, P497, DOI 10.1037/0022-006X.55.4.497; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; LAUTENSCHLAGER GJ, 1986, APPL PSYCH MEAS, V10, P133, DOI 10.1177/014662168601000202; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Nichols D., 2009, SOC PERS ASS ANN M C; PRITCHARD DA, 1980, J CONSULT CLIN PSYCH, V48, P263; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R., 2008, CLIN ASSESSMENT MALI; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tellegen A., 2008, MMPI 2 RF TECHNICAL; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Williams CL, 2009, PSYCHOL INJ LAW, V2, P182, DOI 10.1007/s12207-009-9046-3; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027	57	12	12	2	15	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2012	24	3					618	627		10.1037/a0026458			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	999AI	WOS:000308281100009	22309000				2022-02-06	
J	Monea, AG; Verpoest, I; Vander Sloten, J; Van der Perre, G; Goffin, J; Depreitere, B				Monea, Aida Georgeta; Verpoest, Ignaas; Vander Sloten, Jos; Van der Perre, Georges; Goffin, Jan; Depreitere, Bart			Assessment of Relative Brain-Skull Motion in Quasistatic Circumstances by Magnetic Resonance Imaging	JOURNAL OF NEUROTRAUMA			English	Article						brain motion; brain deformation; cerebral contusion; magnetic resonance imaging; traumatic brain injury	INJURY; DEFORMATION; MR; DISPLACEMENT; CT	Brain-skull relative motion plays a pivotal role in the etiology of traumatic brain injury (TBI). The present study aims to assess brain-skull relative motion in quasistatic circumstances, and to correlate cortical regions with high motion amplitudes with sites prone to cerebral contusions. The study includes 30 healthy volunteers scanned using a clinical 3-T MR scanner in four different head positions. Through image processing and 3D model registration, pairwise comparisons were performed to calculate the brain shift between sagittal and coronal head positional change. Next, local brain deformation was evaluated by comparison between cortical and ventricular amplitudes. Finally, the influence of age, sex, and skull geometry on the cortical and ventricular motion was investigated. The results describe complex brain shift patterns, with high regional and inter-individual variations, outweighing age and sex patterns. Regions with maximum motion amplitudes were identified at the inferolateral aspects of the frontal and temporal lobes, congruent with predilection sites for contusions. No significant influences of age and sex on the cortical shift amplitudes were detected. The 3D cortical deviations varied from -7.86 mm to +5.71 mm for the sagittal head movement, and from -11.46 mm to + 7.30 mm for head movement in the coronal plane, for a 95% confidence interval. The present study contributes to a better understanding of the mechanopathogenesis of frontotemporal contusions, and is useful for the optimization of finite-element head models and neurosurgical navigation procedures. Moreover, our results prove that in vivo MRI allows for accurate assessment of brain-skull relative motion in quasistatic conditions.	[Monea, Aida Georgeta; Goffin, Jan; Depreitere, Bart] Katholieke Univ Leuven, Div Expt Neurosurg & Neuroanat, B-3001 Heverlee, Belgium; [Verpoest, Ignaas] Katholieke Univ Leuven, Dept Mat Engn, B-3001 Heverlee, Belgium; [Vander Sloten, Jos; Van der Perre, Georges] Katholieke Univ Leuven, Biomech Sect, B-3001 Heverlee, Belgium		Monea, AG (corresponding author), Katholieke Univ Leuven, Div Expt Neurosurg & Neuroanat, Celestijnenlaan 300,Box 2419, B-3001 Heverlee, Belgium.	aidageorgeta.asiminei@med.kuleuven.be	Depreitere, Bart/AAA-9846-2020	Depreitere, Bart/0000-0002-7458-0648	FWO Vlaanderen (Funds for Scientific Research from Flanders, Belgium) [G.0001.08]	This research was performed within the framework of the FWO Vlaanderen (Funds for Scientific Research from Flanders, Belgium), Project Levenslijn G.0001.08: "Improving head protection for child and adult pedal cyclists: approach based on lesion-specific mechanogenesis." We would like to acknowledge Prof. Stefan Sunaert and Mr. Stefan Ghysels from the Radiology Section, University Hospital Gasthuisberg, for technical assistance offered during the MRI sessions.	Aiello L., 1990, INTRO HUMAN EVOLUTIO; Al-Bsharat A.S., 2002, P 43 STAPP CAR CRASH, P321; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Bowers ME, 2008, OSTEOARTHR CARTILAGE, V16, P1167, DOI 10.1016/j.joca.2008.03.005; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Depreitere B., 2004, THESIS KATHOLIEKE U; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Gelaude F, 2008, COMPUT AIDED SURG, V13, P188, DOI 10.3109/10929080802195783; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GOSCH H H, 1969, Surgical Forum (Chicago), V20, P425; Gur RC, 2002, AM J GERIAT PSYCHIAT, V10, P72, DOI 10.1176/appi.ajgp.10.1.72; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hardy W.N., 1997, ASME PUBLICATION AMD, V225, P241; Hardy WN, 2001, P 45 STAPP CAR CRASH, P1; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ji Songbai, 2004, Stapp Car Crash J, V48, P227; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; McIntosh TK, 1996, LAB INVEST, V74, P315; Miyagi Y, 2007, J NEUROSURG, V107, P989, DOI 10.3171/JNS-07/11/0989; Nusholtz G.S., 1984, 841657 SAE, P41; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	31	12	12	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2012	29	13					2305	2317		10.1089/neu.2011.2271			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	000PU	WOS:000308399900006	22663153				2022-02-06	
J	Turner, RC; Seminerio, MJ; Naser, ZJ; Ford, JN; Martin, SJ; Matsumoto, RR; Rosen, CL; Huber, JD				Turner, Ryan C.; Seminerio, Michael J.; Naser, Zachary J.; Ford, J. Neal; Martin, Samantha J.; Matsumoto, Rae R.; Rosen, Charles L.; Huber, Jason D.			Effects of aging on behavioral assessment performance: implications for clinically relevant models of neurological disease Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						aging; behavior; neurological injury; stroke	TRAUMATIC BRAIN INJURY; RISK-FACTORS; STROKE; MOTOR; RATS; AGE; ISCHEMIA; DEFICITS; RECOMMENDATIONS	Object. Despite the role of aging in development of neurological and neurodegenerative diseases, the effects of age are often disregarded in experimental design of preclinical studies. Functional assessment increases the clinical relevance of animal models of neurological disease and adds value beyond traditional histological measures. However, the relationship between age and functional impairment has not been systematically assessed through a battery of functional tests. Methods. In this study, various sensorimotor and behavioral tests were used to evaluate effects of aging on functional performance in naive animals. Sensorimotor measures included locomotor activity; Rotarod, inclined plane, and grip-strength testing; and modified Neurological Severity Score. The Morris water maze was used to examine differences in learning and memory, and the elevated plus maze and forced swim test were used to assess anxiety-like and depressive-like behaviors, respectively. Results. Older Sprague-Dawley rats (18-20 months) were found to perform significantly worse on the inclined plane tests, and they exhibited alterations in elevated-plus maze and forced swim test compared with young adult rats (3-4 months). Specifically, older rats exhibited reduced exploration of open arms in elevated plus maze and higher immobility time in forced swim test. Spatial acquisition and reference memory were diminished in older rats compared with those in young adult rats. Conclusions. This study demonstrates clear differences between naive young adult and older animals, which may have implications in functional assessment for preclinical models of neurological disease. (http://thejns.org/doi/abs/10.3171/2012.5.JNS112224)	[Rosen, Charles L.] W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; [Turner, Ryan C.; Seminerio, Michael J.; Matsumoto, Rae R.; Rosen, Charles L.; Huber, Jason D.] W Virginia Univ, Ctr Neurosci, Sch Med, Morgantown, WV 26506 USA; [Seminerio, Michael J.; Ford, J. Neal; Martin, Samantha J.; Matsumoto, Rae R.; Huber, Jason D.] W Virginia Univ, Dept Basic Pharmaceut Sci, Sch Med, Morgantown, WV 26506 USA		Rosen, CL (corresponding author), W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Neurosurg, 1 Med Ctr Dr,POB 9183, Morgantown, WV 26506 USA.	crosen@hsc.wvu.edu		Turner, Ryan/0000-0001-5523-0645	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01-NS061954, 5T32GM08174]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [S06GM008174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061954] Funding Source: NIH RePORTER	This work would not have been possible without NIH support provided to J.D.H. (NIH Grant No. 5R01-NS061954), and R.C.T. and M.J.S. (NIH Grant No. 5T32GM08174).	[Anonymous], 1999, STROKE, V30, P2752; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hunter AJ, 1998, TRENDS PHARMACOL SCI, V19, P59, DOI 10.1016/S0165-6147(97)01157-7; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Mehan N. D., 2011, NEUROBIOL AGING; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Pan WH, 2006, EXP NEUROL, V198, P222, DOI 10.1016/j.expneurol.2005.11.020; PITSIKAS N, 1990, NEUROBIOL AGING, V11, P417, DOI 10.1016/0197-4580(90)90008-N; Popa-Wagner A, 2009, ROM J MORPHOL EMBRYO, V50, P155; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Porsolt R. D., 2001, CURR PROTOC NEUROSCI, V14, p10A1; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rosen CL, 2005, J NEUROSURG, V103, P687, DOI 10.3171/jns.2005.103.4.0687; Sacco RL, 1997, NEUROLOGY, V49, pS39, DOI 10.1212/WNL.49.5_Suppl_4.S39; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Watanabe T, 2004, J CEREBR BLOOD F MET, V24, P1205, DOI 10.1097/01.WCB.0000136525.75839.41	24	12	13	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2012	117	3					629	637		10.3171/2012.5.JNS112224			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	990JP	WOS:000307627100032	22746378				2022-02-06	
J	Li, CY; Wu, PM; Hartings, JA; Wu, ZZ; Cheyuo, C; Wang, P; LeDoux, D; Shutter, LA; Ramaswamy, BR; Ahn, CH; Narayan, RK				Li, Chunyan; Wu, Pei-Ming; Hartings, Jed A.; Wu, Zhizhen; Cheyuo, Cletus; Wang, Ping; LeDoux, David; Shutter, Lori A.; Ramaswamy, Bharat Ram; Ahn, Chong H.; Narayan, Raj K.			Micromachined lab-on-a-tube sensors for simultaneous brain temperature and cerebral blood flow measurements	BIOMEDICAL MICRODEVICES			English	Article						Lab-on-a-tube; Temperature sensor; Cerebral blood flow sensor; Smart catheter; Traumatic brain injury	SECONDARY INSULTS; INJURED PATIENTS; PATHOPHYSIOLOGY; AUTOREGULATION; MANAGEMENT	This work describes the development of a micromachined lab-on-a-tube device for simultaneous measurement of brain temperature and regional cerebral blood flow. The device consists of two micromachined gold resistance temperature detectors with a 4-wire configuration. One is used as a temperature sensor and the other as a flow sensor. The temperature sensor operates with AC excitation current of 500 mu A and updates its outputs at a rate of 5 Hz. The flow sensor employs a periodic heating and cooling technique under constant-temperature mode and updates its outputs at a rate of 0.1 Hz. The temperature sensor is also used to compensate for temperature changes during the heating period of the flow sensor to improve the accuracy of flow measurements. To prevent thermal and electronic crosstalk between the sensors, the temperature sensor is located outside the "thermal influence" region of the flow sensor and the sensors are separated into two different layers with a thin-film Copper shield. We evaluated the sensors for accuracy, crosstalk and long-term drift in human blood-stained cerebrospinal fluid. These in vitro experiments showed that simultaneous temperature and flow measurements with a single lab-on-a-tube device are accurate and reliable over the course of 5 days. It has a resolution of 0.013 A degrees C and 0.18 ml/100 g/min; and achieves an accuracy of 0.1 A degrees C and 5 ml/100 g/min for temperature and flow sensors respectively. The prototype device and techniques developed here establish a foundation for a multi-sensor lab-on-a-tube, enabling versatile multimodality monitoring applications.	[Li, Chunyan; Wu, Pei-Ming; Narayan, Raj K.] N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Hartings, Jed A.; Shutter, Lori A.] Univ Cincinnati UC, Dept Neurosurg, Inst Neurosci, UC Coll Med, Cincinnati, OH 45219 USA; [Wu, Zhizhen; Ramaswamy, Bharat Ram; Ahn, Chong H.] Univ Cincinnati, Microsyst & BioMEMS Lab, Dept Elect & Comp Engn, Cincinnati, OH 45221 USA; [Cheyuo, Cletus; Wang, Ping] N Shore Long Isl Jewish Hlth Syst, Dept Surg, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [LeDoux, David] N Shore Univ Hosp, Neurosurg Intens Care Unit, Manhasset, NY 11030 USA; [Narayan, Raj K.] Hofstra N Shore LIJ Sch Med, Cushing Neurosci Inst, Hempstead, NY 11549 USA		Li, CY (corresponding author), N Shore Long Isl Jewish Hlth Syst, Cushing Neuromonitoring Lab, Feinstein Inst Med Res, Manhasset, NY 11030 USA.	cli11@nshs.edu	Cheyuo, Cletus/AAM-5785-2021; Shutter, Lori A/G-2957-2013	Hartings, Jed/0000-0001-8583-3471; Wang, Ping/0000-0002-1557-0394; Shutter, Lori/0000-0002-1390-0628	US Department of DefenseUnited States Department of Defense [PT090526P4 (W81XWH-10-1-0978)]	This work was supported by the US Department of Defense under project No. PT090526P4 (W81XWH-10-1-0978). The authors gratefully acknowledge Mr. Melvin O. Gonzalez at the North Shore University Hospital for performing polyethylene gas sterilization.	Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Chen J, 2003, J MICROELECTROMECH S, V12, P979, DOI 10.1109/JMEMS.2003.820261; Chunyan Li, 2012, 2012 IEEE 25th International Conference on Micro Electro Mechanical Systems (MEMS), P1021, DOI 10.1109/MEMSYS.2012.6170188; Dagal A, 2011, CURR OPIN ANESTHESIO, V24, P131, DOI 10.1097/ACO.0b013e3283445898; Elf K, 2008, NEUROL RES, V30, P1097, DOI 10.1179/174313208X319125; Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534; Haga Y, 2004, P IEEE, V92, P98, DOI 10.1109/JPROC.2003.820545; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169; Hassler C, 2010, J BIOMED MATER RES B, V93B, P266, DOI 10.1002/jbm.b.31584; Hayward E, 2011, ANAEST INTENS CARE M, V12, P198, DOI 10.1016/j.mpaic.2011.02.004; Hsu JM, 2009, IEEE T BIO-MED ENG, V56, P23, DOI 10.1109/TBME.2008.2002155; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Keller E, 2003, NEUROIMAGE, V20, P828, DOI 10.1016/S1053-8119(03)00315-X; Krajewski KL, 2011, ACTA NEUROCHIR SUPPL, V110, P125, DOI 10.1007/978-3-7091-0353-1_22; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Li C., 2011, APPL PHYS LETT, V99; Li CY, 2008, BIOMED MICRODEVICES, V10, P671, DOI 10.1007/s10544-008-9178-3; Li CY, 2011, IEEE SENSOR, P1417; Li CY, 2012, BIOMED MICRODEVICES, V14, P109, DOI 10.1007/s10544-011-9589-4; Li CY, 2010, LAB CHIP, V10, P1476, DOI 10.1039/c000897d; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Liptak B.G., 1995, PROCESS MEASUREMENT, P690; Menon P R, 2009, 15th International Conference on Solid-State Sensors, Actuators and Microsystems. Transducers 2009, P1892, DOI 10.1109/SENSOR.2009.5285687; Mette D, 2011, TRANSL STROKE RES, V2, P152, DOI 10.1007/s12975-010-0064-y; Michalski, 2001, TEMPERATURE MEASUREM, P88; Mohamed G., 2001, MEMS HDB, P2615; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Rubehn B, 2010, BIOMATERIALS, V31, P3449, DOI 10.1016/j.biomaterials.2010.01.053; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Schramm P, 2007, NEURORADIOLOGY, V49, pS35, DOI 10.1007/s00234-007-1471-3; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; THALAYASINGAM S, 1989, MED BIOL ENG COMPUT, V27, P394, DOI 10.1007/BF02441431; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Vidgeon S. D., 2011, J INTENSIVE CARE SOC, V12, P126, DOI DOI 10.1177/175114371101200208; Wester BA, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/024002; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	42	12	12	0	14	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-2176	1572-8781		BIOMED MICRODEVICES	Biomed. Microdevices	AUG	2012	14	4					759	768		10.1007/s10544-012-9646-7			10	Engineering, Biomedical; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics	968BH	WOS:000305951500015	22552801				2022-02-06	
J	McFadden, KL; Healy, KM; Hoversten, KP; Ito, TA; Hernandez, TD				McFadden, Kristina L.; Healy, Kyle M.; Hoversten, Kate P.; Ito, Tiffany A.; Hernandez, Theresa D.			Efficacy of acupressure for non-pharmacological stress reduction in college students	COMPLEMENTARY THERAPIES IN MEDICINE			English	Article						Placebo-controlled; Randomised; Blinded; Skin conductance; Heart rate variability	HEART-RATE-VARIABILITY; BISPECTRAL INDEX; MENTAL STRESS; HABITUATION; ANXIETY; REACTIVITY; NEUROENDOCRINE; RESPONSES; THERAPY	Objectives: Identifying a non-pharmacological intervention to reduce the stress response could be particularly beneficial to college students, a group prone to considerable stress. Acupressure has shown some efficacy in reducing stress in adults following stroke or traumatic brain injury (TBI), but multiple treatments were required. Results from single treatments in healthy populations have been mixed. Design: The current study used a randomised, placebo-controlled, single-blind design to investigate the use of a single acupressure treatment for stress reduction in healthy college students (n= 109) during a stressor. Interventions: Participants were randomly assigned to one of three single, 40-min interventions: active acupressure, placebo acupressure, or a relaxation CD control. A math task stressor administered before and after the intervention assessed intervention effects on stressor responsivity. Main outcome measures: Stress responses were measured by physiological (heart rate (HR), heart rate variability (HRV), skin conductance response (SCR)) and subjective measures (State Anxiety Inventory, nine-item Psychological Stress Measure) of anxiety and stress. Results: All interventions were associated with the following changes during the post-intervention stressor compared to the pre-intervention stressor: reduced HR (p < 0.001), increased HRV (p < 0.024), reduced SCR (p < 0.001), reduced subjective stress scores (p < 0.001), and increased correct answers (p < 0.001). Although all groups demonstrated stress reduction, there were no significant group differences after a single treatment. Conclusions: All interventions significantly reduced the stress response, although not differently. The lack of active acupressure-associated treatment effects appears to be due to insufficient dosing. (c) 2012 Elsevier Ltd. All rights reserved.	[McFadden, Kristina L.; Healy, Kyle M.; Hoversten, Kate P.; Ito, Tiffany A.; Hernandez, Theresa D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA		Hernandez, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, UCB 345,1905 Colorado Ave, Boulder, CO 80309 USA.	Theresa.Hernandez@colorado.edu	Legget, Kristina/AAU-8563-2020	Legget, Kristina/0000-0002-2948-506X	Graduate School at the University of Colorado	Study funding was made available from the Innovative Grant Program from the Graduate School at the University of Colorado.; With appreciation to Jin Shin (acupressure) practitioner Christine Palafox, B.A., C.M.T., N.C.T.M.B. and to all study participants. We also thank undergraduate research assistants Samantha Kile, B.A. and Amanda Stahl, B.A. for help with data acquisition/entry, undergraduate research assistants D. Frank Distel and Nathan Faes for help with data entry, and James A. Kole, Ph.D. for statistical support. Study funding was made available from the Innovative Grant Program from the Graduate School at the University of Colorado.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Agarwal A, 2005, ANAESTHESIA, V60, P978, DOI 10.1111/j.1365-2044.2005.04332.x; Burleson MH, 2003, PSYCHOPHYSIOLOGY, V40, P358, DOI 10.1111/1469-8986.00039; Burmeister A, 1997, JIN SHIN JYUTSU TOUC; CACIOPPO JT, 1995, PSYCHOSOM MED, V57, P154, DOI 10.1097/00006842-199503000-00008; Camm AJ, 1996, CIRCULATION, V93, P1043; Castro MN, 2008, SCHIZOPHR RES, V99, P294, DOI 10.1016/j.schres.2007.08.025; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; Fassoulaki A, 2003, ANESTH ANALG, V96, P885, DOI 10.1213/01.ANE.0000048713.41657.D3; Fassoulaki A, 2007, ANESTH ANALG, V104, P312, DOI 10.1213/01.ane.0000250911.43942.4e; Felhendler D, 1999, Complement Ther Med, V7, P231, DOI 10.1016/S0965-2299(99)80007-7; Hamer M, 2006, BRAIN BEHAV IMMUN, V20, P456, DOI 10.1016/j.bbi.2006.01.001; Ice GH, 2007, CAM S BIO EVOL ANTHR, V49, P3; Jonsson P, 2010, PSYCHONEUROENDOCRINO, V35, P1397, DOI 10.1016/j.psyneuen.2010.04.003; KELSEY RM, 1993, CARDIOVASCULAR REACTIVITY TO PSYCHOLOGICAL STRESS & DISEASE, P135, DOI 10.1037/10125-006; Kober A, 2003, ANESTHESIOLOGY, V98, P1328, DOI 10.1097/00000542-200306000-00005; Lemyre Louise, 2009, Physiotherapy Theory and Practice, V25, P453, DOI 10.1080/09593980902886321; LYKKEN DT, 1988, PSYCHOPHYSIOLOGY, V25, P4, DOI 10.1111/j.1469-8986.1988.tb00949.x; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; McFadden KL, 2011, J NEUROTRAUM, V28, P21, DOI 10.1089/neu.2010.1515; McFadden KL, 2010, EXPLORE-NY, V6, P380, DOI 10.1016/j.explore.2010.08.004; McFadden KL, 2010, COMPLEMENT THER MED, V18, P42, DOI 10.1016/j.ctim.2010.01.001; Mines S, 1982, WELLSPRING, V11, P16; Munck A, 2010, STRESS SCI NEUROENDO, P162; Myers SS, 2008, J GEN INTERN MED, V23, P148, DOI 10.1007/s11606-007-0460-5; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SHAPIRO DA, 1981, BRIT J CLIN PSYCHOL, V20, P111, DOI 10.1111/j.2044-8260.1981.tb00504.x; Spielberger CD., 1970, STATE TRAIT ANXIETY; Sugiura Toshifumi, 2007, Journal of Physiological Anthropology, V26, P257, DOI 10.2114/jpa2.26.257; SZABO A, 1992, PHYSIOL BEHAV, V51, P501, DOI 10.1016/0031-9384(92)90171-W; Tosevski DL, 2010, CURR OPIN PSYCHIATR, V23, P48, DOI 10.1097/YCO.0b013e328333d625; Tsay SL, 2005, J ADV NURS, V52, P142, DOI 10.1111/j.1365-2648.2005.03576.x; von Kanel R, 2006, BRAIN BEHAV IMMUN, V20, P40, DOI 10.1016/j.bbi.2005.03.013; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Wang SM, 2005, ANESTH ANALG, V101, P666, DOI 10.1213/01.ANE.0000175212.17642.45; WATTS JMJ, 1975, PSYCHOPHYSIOLOGY, V12, P596, DOI 10.1111/j.1469-8986.1975.tb00053.x	38	12	12	1	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0965-2299	1873-6963		COMPLEMENT THER MED	Complement. Ther. Med.	AUG	2012	20	4					175	182		10.1016/j.ctim.2011.12.003			8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	951NF	WOS:000304726600002	22579428				2022-02-06	
J	Pinto, TF; Rocha, R; Paula, CA; de Jesus, RP				Pinto, Tatiana Fuchs; Rocha, Raquel; Paula, Cristiane Assis; de Jesus, RosAngela Passos			Tolerance to enteral nutrition therapy in traumatic brain injury patients	BRAIN INJURY			English	Article						Enteral nutrition; traumatic brain injury; gastrointestinal complications; pro-kinetics	CRITICALLY ILL PATIENTS; METOCLOPRAMIDE; INTOLERANCE; GUIDELINES; MODERATE; TRIAL	Objective: To evaluate the tolerance to enteral nutrition (EN) and the effects of pro-kinetic drugs in critical traumatic brain injury (TBI) patients. Methods: Transversal observational study. A total of 32 out of 45 TBI patients of both genders receiving EN were evaluated in a trauma referral hospital intensive care unit (ICU). Data from each patient were collected for a period of 10 consecutive days after initiation of enteral feeding: gastric residue, presence of vomiting, abdominal distension, Glasgow coma scale and the use of pro-kinetic agents. Results: In 20 of the 32 patients high levels of gastric residue were found. Of these 20 patients, half could not tolerate the diet within the first 72 hours following infusion. However, no association was found between disease severity and occurrence of gastrointestinal complications (p>0.05). Feeding intolerance was observed in 75.0% (n = 24) of patients, even with the systematic use of metaclopramide from the outset of nutritional therapy. All patients with feeding intolerance who used erythromycin by nasogastric tube showed improvement. Conclusions: The high level of gastric residue was the most common feeding intolerance and the delivery of erythromycin by nasogastric tube seems to control gastrointestinal disorders in TBI patients.	[Pinto, Tatiana Fuchs; Rocha, Raquel; de Jesus, RosAngela Passos] Univ Fed Bahia, Sch Nutr, Dept Nutr Sci, BR-40110150 Salvador, BA, Brazil; [Paula, Cristiane Assis] Hosp Geral Estado Bahia, Unit Nutr, Salvador, BA, Brazil		Rocha, R (corresponding author), Univ Fed Bahia, Sch Nutr, Dept Nutr Sci, Ave Araujo Pinho,32 Canela, BR-40110150 Salvador, BA, Brazil.	raquelrocha2@yahoo.com.br	Rocha, Raquel/G-3924-2012	Rocha, Raquel/0000-0002-2687-2080			Acosta Escribano J A, 2001, Nutr Hosp, V16, P262; Bell RM, 1999, ANN EMERG MED, V34, P233, DOI 10.1016/S0196-0644(99)70238-6; Berne JD, 2002, J TRAUMA, V53, P422, DOI 10.1097/00005373-200209000-00004; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Davies Andrew R, 2004, Curr Opin Crit Care, V10, P156, DOI 10.1097/00075198-200404000-00013; Davies AR, 2002, CRIT CARE MED, V30, P586, DOI 10.1097/00003246-200203000-00016; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Madroszkiewicz D, 2003, NEUROLOGIA I NEUROCH, V39, P41; Marino LV, 2003, BRIT J NEUROSURG, V17, P24, DOI 10.1080/026889031000093708; Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Nursal TZ, 2007, J CLIN NEUROSCI, V14, P344, DOI 10.1016/j.jocn.2005.11.011; Rhoney DH, 2002, NEUROL RES, V24, P613, DOI 10.1179/016164102101200456; Ritz MA, 2005, INTENS CARE MED, V31, P949, DOI 10.1007/s00134-005-2663-8; Ritz MA, 2001, CRIT CARE MED, V29, P1744, DOI 10.1097/00003246-200109000-00015; Stroud M, 2003, GUT, V52, P1; Tack J, 2007, BEST PRACT RES CL GA, V21, P379, DOI 10.1016/j.bpg.2007.01.002; Thor Piotr J, 2003, Neurol Neurochir Pol, V37, P1037; Thor PJ, 2003, MED SCI MONITOR, V9, P392; Todd S Rob, 2006, Nutr Clin Pract, V21, P421, DOI 10.1177/0115426506021005421; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668	25	12	24	0	16	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1113	1117		10.3109/02699052.2012.666369			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400008	22571511				2022-02-06	
J	Sullivan, KA; Edmed, SL				Sullivan, Karen A.; Edmed, Shannon L.			The good-old-days bias and post-concussion syndrome symptom reporting in a non-clinical sample	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion syndrome; good-old-days bias; assessment	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION-LIKE SYMPTOMS; MILD HEAD-INJURY; CHRONIC PAIN; BASE RATES; ETIOLOGY; EXPECTATION; DEPRESSION	Primary objective: To investigate the good-old-days bias, a psychosocial factor associated with post-concussion syndrome (PCS). Study design: Repeated measures comparison of PCS symptoms reported 6 months prior (retrospectively) and currently. A non-clinical sample was used to determine if this bias is a general recall bias. Methods and procedures: Fifty-seven university students with no history of brain injury or neurological disease completed the British Columbia Post-concussion Symptom Inventory. Symptoms were reported on two occasions, spaced 1 week apart, commencing with current symptoms. Main outcomes and results: Using PCS symptom frequency by severity product scores, there was no significant difference in the 13 PCS symptoms reported across occasions, nor the relevant summary score (p = 0.199). These data do not support the presence of a general recall bias. However, significant differences emerged when analysed using a simple count of the total number of endorsed symptoms (p = 0.002, d = 0.39, small-to-medium effect) or the sample percentage that endorsed each symptom (four symptoms were endorsed by fewer participants retrospectively than currently). Conclusions: There is only weak evidence of a general recall bias in this non-clinical sample. Further consideration of the methods used to study this bias and its role clinically is needed.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, O Block B Wing Room 523,Kelvin Grove Campus,Victo, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The authors report no conflicts of interest. This work was conducted and written by the authors. This research was funded by the School of Psychology and Counselling, Queensland University of Technology.	Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cohen J., 1988, STAT POWER ANAL OFR; Edmed S.L., APPL NEUROP IN PRESS; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lovibond P.F., 1995, MANUAL DESPRESSION A; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Panayiotou A, AUSTR PSYCH IN PRESS; Panayiotou A, 2011, AUST PSYCHOL, V46, P210, DOI 10.1111/j.1742-9544.2010.00018.x; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Steinber WJ., 2011, STAT ALIVE; Sullivan KA, 2010, J HEAD TRAUMA REHAB, V17, P1; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006	29	12	12	1	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1098	1104		10.3109/02699052.2012.666367			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400006	22624800				2022-02-06	
J	Onifer, SM; Quintero, JE; Gerhardt, GA				Onifer, Stephen M.; Quintero, Jorge E.; Gerhardt, Greg A.			Cutaneous and electrically evoked glutamate signaling in the adult rat somatosensory system	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Amperometry; Cutaneous stimulation; Dorsal column nuclei; Electrical stimulation; Microelectrode array; Spinal cord	SPINAL-CORD-INJURY; WHEAT-GERM-AGGLUTININ; DORSAL COLUMN NUCLEI; CUNEATE NUCLEUS; PREFRONTAL CORTEX; WGA-HRP; SOMATOTOPIC ORGANIZATION; CENTRAL PROJECTIONS; TRANSGANGLIONIC TRANSPORT; HORSERADISH-PEROXIDASE	Glutamate neurotransmission plays critical roles in normal central nervous system (CNS) function, neurodegenerative diseases, and neurotrauma. We determined whether glutamate signaling could be evoked within the anesthetized normal adult rat CNS with clinically relevant peripheral stimulation and recorded (at >1 Hz) with glutamate-sensitive, ceramic microelectrode arrays (MEAs). Basal glutamate levels and both forelimb cutaneous and electrical stimulation-evoked glutamate release were measured within the cuneate nucleus, a relay of the mammalian dorsal columns somatosensory system. The MEAs with triangular, sharp-point tips were more effective at tissue penetration than the flat, blunt tips. Basal glutamate levels of 2.1 +/- 4.4 mu M (mean +/- SD, n = 10 animals) were detected from 150 mu m to 1200 mu m below the brainstem dorsal surface. Cutaneous evoked glutamate signals showed an amplitude of 1.1 +/- 1.1 mu M and a duration of 7.3 +/- 6.5 s (26 signals, n = 6). Electrically evoked signals, like cutaneous ones, were both rapid and slowly rising. Electrically evoked signals, especially those evoked by stimulation trains, were more reproducible and had an amplitude of 1.2 +/- 1.4 mu M, duration of 19.4 +/- 17.3s, and latency from stimulus onset of 21.3 +/- 21.5 s (25 signals, n = 4). In contrast to cutaneous stimulation, glutamate signals evoked by electrical stimulation had longer durations and were recorded primarily in the middle and ventral cuneate nuclei. Importantly, both cutaneous and electrical stimulation of the contralateral forelimb and hindlimbs did not evoke glutamate signaling. With the use of MEAs, these results show, for the first time, somatosensory-pathway specific changes in glutamate levels during peripheral cutaneous and electrical stimulation. (C) 2012 Elsevier B.V. All rights reserved.	[Onifer, Stephen M.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Onifer, Stephen M.; Quintero, Jorge E.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Quintero, Jorge E.; Gerhardt, Greg A.] Univ Kentucky, Coll Med, Ctr Microelectrode Technol, Lexington, KY 40536 USA		Onifer, SM (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, B457 Biomed & Biol Sci Res Bldg,741 S Limestone S, Lexington, KY 40536 USA.	smonif2@email.uky.edu; george.quintero@uky.edu; gregg@uky.edu			Kentucky Spinal Cord and Head Injury Research Trust [9-9]; USPHSUnited States Department of Health & Human ServicesUnited States Public Health Service [DA 017186]; NSFNational Science Foundation (NSF) [EEC-0310723]; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-2080]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA017186] Funding Source: NIH RePORTER	This research was supported by the Kentucky Spinal Cord and Head Injury Research Trust Grant 9-9 (Stephen M. Onifer) and by USPHS Grant DA 017186, NSF Grant EEC-0310723, DARPA Grant N66001-09-2080 (Greg A. Gerhardt). The funding source had no involvement in study design. Greg A. Gerhardt is sole proprietor of and Jorge E. Quintero serves as a consultant to Quanteon LLC. The technical and artistic expertises of Laura Whitnel-Smith, Joshua Eason, Daisy Ramos, and David Onifer are gratefully appreciated.	American Spinal Injury Association, 2002, INT STAND NEUR CLASS; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; ARVIDSSON J, 1990, J COMP NEUROL, V292, P349, DOI 10.1002/cne.902920303; BASBAUM AI, 1973, J COMP NEUROL, V148, P347, DOI 10.1002/cne.901480304; BECK CHM, 1981, BRAIN RES BULL, V6, P503, DOI 10.1016/S0361-9230(81)80025-1; Bermejo PE, 2003, J COMP NEUROL, V463, P419, DOI 10.1002/cne.10747; BROMAN J, 1994, ANAT EMBRYOL, V189, P181; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Cook CJ, 1997, J NEUROSCI METH, V72, P161, DOI 10.1016/S0165-0270(96)02175-9; Cook CJ, 1996, PHYSIOL BEHAV, V60, P741; CROCKETT DP, 1993, BRAIN RES, V612, P41, DOI 10.1016/0006-8993(93)91642-6; Darvesh AS, 2011, EXPERT OPIN DRUG DIS, V6, P109, DOI 10.1517/17460441.2011.547189; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; DEBIASI S, 1990, J HISTOCHEM CYTOCHEM, V38, P1745, DOI 10.1177/38.12.1701456; Garifoli A, 2010, ARCH ITAL BIOL, V148, P339, DOI 10.4449/aib.v148i4.1022; Greene E, 1935, T AM PHILOS SOC, V27, pii; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Hascup KN, 2008, J PHARMACOL EXP THER, V324, P725, DOI 10.1124/jpet.107.131698; Hascup KN, 2011, NEUROPSYCHOPHARMACOL, V36, P1769, DOI 10.1038/npp.2011.60; Hascup KN, 2007, ELECTROCHEMICAL METH; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; IMAMURA J, 1986, NEUROSCI LETT, V70, P46, DOI 10.1016/0304-3940(86)90435-0; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; MASLANY S, 1991, BRAIN RES, V564, P56, DOI 10.1016/0006-8993(91)91351-Z; MASLANY S, 1990, BRAIN RES, V507, P164, DOI 10.1016/0006-8993(90)90539-N; MASLANY S, 1992, NEUROSCI LETT, V139, P130, DOI 10.1016/0304-3940(92)90874-7; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Mattinson CE, 2011, J NEUROSCI METH, V202, P199, DOI 10.1016/j.jneumeth.2011.08.020; NATHAN PW, 1986, BRAIN, V109, P1003, DOI 10.1093/brain/109.5.1003; NORD SG, 1967, J COMP NEUROL, V130, P343, DOI 10.1002/cne.901300406; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Onifer SM, 2005, EXP NEUROL, V192, P25, DOI 10.1016/j.expneurol.2004.10.016; Onifer SM, 2007, EXP NEUROL, V207, P238, DOI 10.1016/j.expneurol.2007.06.012; Onifer SM, 2011, RESTOR NEUROL NEUROS, V29, P275, DOI [10.3233/RNN-2011-598, 10.3233/RNN-2011-0598]; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Paxinos G, 1997, RAT BRAIN STEREOTAXI; PFALLER K, 1988, J COMP NEUROL, V268, P91, DOI 10.1002/cne.902680110; Quintero JE, 2007, EXP NEUROL, V208, P238, DOI 10.1016/j.expneurol.2007.08.002; Rutherford EC, 2007, J NEUROCHEM, V102, P712, DOI 10.1111/j.1471-4159.2007.04596.x; Stephens ML, 2011, NEUROBIOL AGING, V32, P811, DOI 10.1016/j.neurobiolaging.2009.05.009; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; WEBSTER KE, 1987, NEUROSCI LETT, V76, P18, DOI 10.1016/0304-3940(87)90185-6; Xie J, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E11; YGGE J, 1989, J COMP NEUROL, V279, P199, DOI 10.1002/cne.902790204	48	12	12	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JUL 15	2012	208	2					146	154		10.1016/j.jneumeth.2012.05.013			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	980GY	WOS:000306882800008	22627377				2022-02-06	
J	Bay, E; Kalpakjian, C; Giordani, B				Bay, Esther; Kalpakjian, Claire; Giordani, Bruno			Determinants of subjective memory complaints in community-dwelling adults with mild-to-moderate traumatic brain injury	BRAIN INJURY			English	Article						Chronic stress; brain injury; rehabilitation; depression; memory	COGNITIVE COMPLAINTS; NATURAL-HISTORY; STRESS; DEPRESSION; IMPACT; SYMPTOMS; CORTISOL; RECOVERY; OUTCOMES; TERM	Primary objective: This study sought to determine to what extent chronic stress, depression and neurobehavioural consequences explained post-TBI subjective memory complaints (SMC). Research design: An observational, cross-sectional design was used. Methods and procedures: One hundred and fifty-nine persons who were 1-36 months post-injury provided data using interviews, chart reviews and surveys. Predictor variables included the Center for Epidemiological Studies-Depression Scale (CES-D), Perceived Stress Scale (PSS-14) and sub-scales of the NFI. Main outcomes and results: SMC, according to the Neurobehavioural Functioning Inventory (NFI), was the main outcome variable. SMC could best be explained by increased age, months-since-injury, chronic situational stress and the frequency of somatic and communication difficulties, not depression (R-2 = 0.780, F = 97.39, [8, 152], p < 0.001). These findings suggest that, for persons in the chronic phase of recovery from their TBI, specific determinants other than general adjustment issues may apply. These include: increased chronic stress, age, somatic symptoms and communication difficulties. Conclusion: Self-reported chronic situational stress is positively associated with self-reported memory complaints, as well as somatic and communication difficulties. The causal ordering of these relationships would be best understood with prospective designs using biological correlates of chronic stress to advance understanding of post-TBI depression in older adults.	[Bay, Esther] Univ MI, Sch Nursing, Ann Arbor, MI 48109 USA; [Kalpakjian, Claire] Univ MI, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Giordani, Bruno] Univ MI, Dept Psychiat, Ann Arbor, MI 48109 USA; [Giordani, Bruno] Univ MI, Dept Psychol, Neuropsychol Sect, Ann Arbor, MI 48109 USA		Bay, E (corresponding author), Univ MI, Sch Nursing, 400 N Ingalls Bldg Div 1, Ann Arbor, MI 48109 USA.	pdq@med.umich.edu	Giordani, Bruno/AAR-1910-2021	Kalpakjian, Claire/0000-0001-6652-1245; Giordani, Bruno/0000-0001-5921-3455	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422] Funding Source: NIH RePORTER	The project described was supported by Award Number T32HD007422 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E, 2009, RES THEORY NURSING P, V23, P43; Bay E, 2012, NEUROCOGNITIVE UNPUB; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S. C. R., 1995, MEASURING STRESS GUI, P1; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Garrett DD, 2010, PSYCHOL AGING, V25, P74, DOI 10.1037/a0017726; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hook JN, 2007, J INT NEUROPSYCH SOC, V13, P21, DOI 10.1017/S1355617707070051; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2009, MILD TRAUMATIC BRAIN, P285; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kreutzer J, 1999, NEUROBEHAVIORAL FUNC, P1; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lavretsky H, 2010, AM J PSYCHIAT, V167, P589, DOI 10.1176/appi.ajp.2009.09020280; Lee BK, 2007, ARCH GEN PSYCHIAT, V64, P810, DOI 10.1001/archpsyc.64.7.810; Lupien SJ, 2005, PSYCHONEUROENDOCRINO, V30, P225, DOI 10.1016/j.psyneuen.2004.08.003; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McEwen BS, 2000, NEUROCHEM RES, V25, P1219, DOI 10.1023/A:1007687911139; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Radley JJ, 2008, J COMP NEUROL, V507, P1141, DOI 10.1002/cne.21588; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yehuda Rachel, 2004, Psychoneuroendocrinology, V29, P1212, DOI 10.1016/j.psyneuen.2004.01.006	52	12	12	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					941	949		10.3109/02699052.2012.666365			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100005	22571456				2022-02-06	
J	Gura, M; Silav, G; Isik, N; Elmaci, I				Gura, Melek; Silav, Gokalp; Isik, Nejat; Elmaci, Ilhan			Noninvasive Estimation of Cerebral Perfusion Pressure with Transcranial Doppler Ultrasonography in Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Cerebral perfusion pressure; Estimated cerebral perfusion pressure; Transcranial doppler ultrasonography; Traumatic brain injury	CRITICAL CLOSING PRESSURE; ZERO-FLOW PRESSURE; INTRACRANIAL HYPERTENSION; HEAD-INJURY; BLOOD-FLOW; AUTOREGULATION; CIRCULATION; MANAGEMENT; VELOCITY; ABSENCE	AIM: In traumatic brain injury (TBI) patients, to overcome the secondary insults, cerebral perfusion pressure (CPP) oriented therapy is recommended. The study is assigned to estimate CPP values with middle cerebral artery (MCA) flow velocities measured noninvasively using transcranial Doppler ultrasonography (TCD). MATERIAL and METHODS: Forty-seven TBI patients were studied. Intracranial pressure (ICP), mean arterial pressure (MAP) and MCA flow velocities of the patients were monitored. Invasive CPP was calculated as the difference between MAP and ICP. The formula : 'MAP x FVd/FVm +14' was used to estimate CPP noninvasively. Correlation of the noninvasive and invasive values were analysed. RESULTS: The mean values of noninvasive CPP and invasive CPP were 66.10 +/- 10.55 mmHg and 65.40 +/- 10.03 mmHg respectively. The correlation between noninvasive and invasive CPP measurements was strongly significant (p < 0.001) with a correlation coefficient of r = 0.920. CONCLUSION: With ICP monitoring systems, CPP is calculated and the therapy is guided according to these values. As it is recognized that brain perfusion can be assessed with TCD waveforms, noninvasive CPP estimation with MCA flow velocities may help to observe the trends in CPP values.	[Silav, Gokalp; Elmaci, Ilhan] Acibadem Maslak Hosp, Dept Neurosurg, Istanbul, Turkey; [Gura, Melek] MH Istanbul Medeniyet Univ, Goztepe Educ & Res Hosp, Dept Anesthesiol & Reanimat, Istanbul, Turkey; [Isik, Nejat] MH Istanbul Medeniyet Univ, Goztepe Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey		Silav, G (corresponding author), Acibadem Maslak Hosp, Dept Neurosurg, Istanbul, Turkey.	gsilav@yahoo.com	Elmaci, Ilhan/AAF-3459-2021; ISIK, NEJAT/E-9316-2013; Isik, Nejat/AAG-1716-2020	Elmaci, Ilhan/0000-0001-9433-0307; 			Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Aaslid R., 1986, INTRACRANIAL PRESSUR, P226; Belfort MA, 1999, AM J OBSTET GYNECOL, V181, P402, DOI 10.1016/S0002-9378(99)70569-7; Buhre W, 2003, BRIT J ANAESTH, V90, P291, DOI 10.1093/bja/aeg073; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; Edaudard AR, 2005, BRIT J ANAESTH, V94, P216; Hancock SM, 2003, ANESTH ANALG, V96, P847, DOI 10.1213/01.ANE.0000047273.85729.A7; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Ling GSF, 2005, NEUROCRIT CARE, V2, P75, DOI 10.1385/NCC:2:1:075; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin N A, 1993, Neurosurgery, V33, P761; MICHEL E, 1995, NEUROL RES, V17, P149, DOI 10.1080/01616412.1995.11740304; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Moreno J, 2000, NEUROSURG FOCUS, V8, P1; Nagai H, 1997, STROKE, V28, P603, DOI 10.1161/01.STR.28.3.603; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Sorteberg A, 2007, CONT NEUROSURGERY, V29, P1; Stacey M, 2002, BRIT J ANAESTH, V89, p96P; Steiner L A, 2003, Br J Anaesth, V90, P396, DOI 10.1093/bja/aeg532; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; The Brain Trauma Foundation, 2007, J NEUROTRAUM, pS45; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Umamaheswara R, 2008, SAARC J ANAESTH, P58; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; ZURYNSKI Y, 1991, Neurological Research, V13, P248	35	12	13	1	5	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JUL	2012	22	4					411	415		10.5137/1019-5149.JTN.4201-11.1			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	983RW	WOS:000307137400003	22843455	Bronze			2022-02-06	
J	Richards, D; Carroll, J				Richards, David; Carroll, Jolyon			Relationship between types of head injury and age of pedestrian	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Road safety; Pedestrian; Traumatic brain injury; Risk; Age; Traffic accident		This paper explores the relationship between age and the different types of head injury received by pedestrians in traffic accidents with cars. The analysis is based on information collected by hospitals in England, and is supported by in-depth case examples. The principle result is that the risk of intracranial injury increases with age, whilst the risk of fracture to the head or facial bones remains relatively constant. This agrees with previous findings for other groups of casualties, which have reported that that the decrease in brain size leads to an increase in the relative motion of the skull and brain in an impact, with a corresponding increase in the risk of traumatic brain injury. Intracranial injuries have also been found to place the greatest burden on hospitals, which may have implications on automotive design if prevention of these injuries is to be prioritised over fractures of the skull. (C) 2012 Jolyon Carroll. Published by Elsevier Ltd. All rights reserved.	[Richards, David; Carroll, Jolyon] TRL, Wokingham RG40 3GA, Berks, England		Carroll, J (corresponding author), TRL, Crowthorne House, Wokingham RG40 3GA, Berks, England.	jcarroll@trl.co.uk					Anderson T., 2010, NATL TRAVEL SURVEY 2; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Connecting for Health, 2011, DAT DICT ATTR PRIM D; Cuerden R., 2008, 73 DEP TRANSP; Dawodu S.T., 2003, TRAUMATIC BRAIN INJU; Department for Transport, 2010, NAT TRAV SURV 2009 N; Department for Transport, 2007, ROAD CAS GREAT BRIT; Department for Transport, 2006, ROAD ACC CAS COMP ST; Department for Transport, 2009, ROAD CAS GREAT BRIT; Department of Health, 2005, NHS REF COSTS 2004 A; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Goldstein FC, 1999, J NEUROPSYCH CLIN N, V11, P38, DOI 10.1176/jnp.11.1.38; Hardy B.J., 2009, APSP33024R APROSYS E; Hardy B.J., 2008, APSP33018R APROSYS E; Hodgson V.R., 1979, P 23 STAPP CAR CRASH; Hodgson V.R., 1969, P 13 STAPP CAR CRASH, P18; Holbourn AHS, 1943, LANCET, V2, P438; Jennet W.B., 1989, P REC 1 FEBR 1989 RO; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Office for National Statistics, 2010, MID POP EST 2008; Office of National Statistics, 2011, CONS PRIC IND; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Richards D., 2009, P INT RES COUNC BIOM; Richards D.C., 2009, ENHANCED MED ENG LIN; Sarkar SN, 2009, TRAUMA, V11, P157, DOI 10.1177/1460408609335937; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Wismans, 1997, P 41 STAPP CAR CRASH, V41, P315, DOI DOI 10.4271/973338; World Health Organization, 2009, GLOB STAT REP ROAD S; Zhang J., 2006, 50 ANN P ASS ADV AUT	31	12	12	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2012	47						16	23		10.1016/j.aap.2012.01.009			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	921WJ	WOS:000302508500003	22405234				2022-02-06	
J	Lin, C; Huang, SJ; Wang, N; Shen, ZP				Lin, Chao; Huang, Shou-Jiang; Wang, Ning; Shen, Zhi-Peng			Relationship between plasma leptin levels and clinical outcomes of pediatric traumatic brain injury	PEPTIDES			English	Article						Leptin; Traumatic brain injury; Functional outcome; Mortality	ADIPOKINE GENE-EXPRESSION; POTENTIAL ROLE; INFLAMMATION; CYTOKINES; WEIGHT; STROKE; OBESE	High plasma leptin level has been associated with mortality after adult intracerebral hemorrhage. The present study was undertaken to investigate the plasma leptin concentrations in children with traumatic brain injury and to analyze the correlation of leptin with pediatric traumatic brain injury outcome. Plasma leptin concentration of eighty-nine healthy children and 142 children with acute severe traumatic brain injury was measured by enzyme-linked immunosorbent assay. Twenty-six patients (18.3%) died and 42 patients (29.6%) had an unfavorable outcome (Glasgow outcome scale score of 1-3) at 6 months after traumatic brain injury. Upon admission, plasma leptin level in patients was substantially higher than that in healthy controls. A forward stepwise logistic regression selected plasma leptin level as an independent predictor for 6-month mortality and unfavorable outcome of patients. A receiver operating characteristic curve analysis showed plasma leptin level better predicted 6-month mortality and unfavorable outcome. The prognostic value of leptin was similar to that of Glasgow Coma scale score for 6-month clinical outcomes. Thus, plasma leptin level represents a novel biomarker for predicting 6-month clinical outcome in children with traumatic brain injury. (c) 2012 Elsevier Inc. All rights reserved.	[Lin, Chao; Huang, Shou-Jiang; Wang, Ning; Shen, Zhi-Peng] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurosurg, Hangzhou 310000, Peoples R China		Huang, SJ (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurosurg, 57 Zhugan Lane, Hangzhou 310000, Peoples R China.	hzshoujianghuang@163.com					Ahima RS, 2006, PROG BRAIN RES, V153, P155, DOI 10.1016/S0079-6123(06)53009-2; Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arnalich F, 1999, J INFECT DIS, V180, P908, DOI 10.1086/314963; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Czlonkowska A, 2011, J NEUROIMMUNOL, V231, P78, DOI 10.1016/j.jneuroim.2010.09.020; De Rosa S, 2009, J VASC RES, V46, P609, DOI 10.1159/000226229; Dong XQ, 2010, WORLD NEUROSURG, V74, P286, DOI 10.1016/j.wneu.2010.02.019; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; JENNETT B, 1975, LANCET, V1, P480; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Sarraf P, 1997, J EXP MED, V185, P171, DOI 10.1084/jem.185.1.171; Sierra-Johnson J, 2007, AM J CARDIOL, V100, P234, DOI 10.1016/j.amjcard.2007.02.088; Soderberg S, 1999, STROKE, V30, P328, DOI 10.1161/01.STR.30.2.328; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Wilkinson M, 2007, NEUROENDOCRINOLOGY, V86, P191, DOI 10.1159/000108635; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0	36	12	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JUN	2012	35	2					166	171		10.1016/j.peptides.2012.03.024			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	953TG	WOS:000304895500004	22764368				2022-02-06	
J	Selig, HF; Hupfl, M; Trimmel, H; Voelckel, WG; Nagele, P				Selig, Harald F.; Huepfl, Michael; Trimmel, Helmut; Voelckel, Wolfgang G.; Nagele, Peter			Pediatric Trauma in the Austrian Alps: The Epidemiology of Sport-Related Injuries in Helicopter Emergency Medical Service	HIGH ALTITUDE MEDICINE & BIOLOGY			English	Article						pediatric; trauma; sports; alpine; mountain rescue; air ambulance; epidemiology	SNOWBOARDING INJURIES; MOUNTAIN RESCUE; AIR-RESCUE; CHILDREN; TRANSPORT; PATTERNS; SYSTEM; HEAD	Selig, Harald F., Michael Hupfl, Helmut Trimmel, Wolfgang G. Voelckel, Peter Nagele. Pediatric trauma in the Austrian Alps: The epidemiology of sport-related injuries in helicopter emergency medical service. High Alt. Med. Biol. 13: 112-117.-Background/Purpose: We aimed to examine the epidemiological characteristics and injury patterns of pediatric trauma in helicopter emergency medical service (HEMS) caused by sports/outdoor activities in alpine environment. Methods: This retrospective cohort study analyzed 912 primary HEMS missions for pediatric trauma (0-14 years of age) in Austrian Alps between 1 January 2006 and 30 June 2007. Children were stratified by age into toddlers (3-5 years), children in early (6-9 years), and late school age (10-14 years). Results: The majority of pediatric sports-related trauma in alpine environment was caused by skiing (82.1%; n = 749). Pediatric patients were predominately in late school age and boys (72.8%, n = 664 and 61.0%, n = 556, respectively) and a minority (16.0%, n = 146) was severely injured. Overall, fracture (47.0%, n = 429), contusion (17.9%, n = 163), and traumatic brain injury (17.0%, n = 155) were the most common prehospital diagnoses. The most frequent pattern of injury was related to the head/face and spine (36.3%, n = 331). Conclusions: The knowledge about epidemiological characteristics of HEMS use for injured children in alpine environment may be essential for training requirements of HEMS crews and operational considerations of HEMS providers. The incidence of head and spinal injuries requires support for initiatives to promote helmet wear and appropriate risk behavior amongst skiers and snowboarders.	[Selig, Harald F.; Huepfl, Michael] Med Univ Vienna, Dept Anesthesiol & Gen Intens Care & Pain Therapy, Vienna, Austria; [Trimmel, Helmut] Wiener Neustadt Gen Hosp, Dept Anesthesiol & Gen Intens Care, Vienna, Austria; [Trimmel, Helmut; Voelckel, Wolfgang G.] OEAMTC Christophorus Air Rescue Serv, Vienna, Austria; [Voelckel, Wolfgang G.] AUVA Trauma Ctr, Dept Anesthesiol & Crit Care Med, Salzburg, Austria; [Nagele, Peter] Washington Univ, Dept Anesthesiol, St Louis, MO USA		Selig, HF (corresponding author), Rhoen Clinicum AG, Clin Hand Surg Bad Neustadt, D-97616 Bad Neustadt an der Saale, Germany.	harald.se@gmx.at	Nagele, Peter/ABA-5189-2020; Nagele, Peter/A-2922-2008; Nagele, Peter/AAW-1651-2020	Nagele, Peter/0000-0001-8369-3858; Nagele, Peter/0000-0001-8369-3858			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Corra Stefano, 2004, Inj Control Saf Promot, V11, P281, DOI 10.1080/156609704/233/289788; Damore DT, 2003, PEDIATR EMERG CARE, V19, P65, DOI 10.1097/00006565-200304000-00001; DEMARTINES N, 1991, HELV CHIR ACTA, V58, P223; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; Hagel B, 2005, MED SPORT SCI, V48, P74, DOI 10.1159/000084284; Hayes JR, 2008, J PEDIATR SURG, V43, P928, DOI 10.1016/j.jpedsurg.2007.12.041; Heggie TW, 2010, BRIT J SPORT MED, V44, P50, DOI 10.1136/bjsm.2009.068049; Kaufmann M, 2006, WILD ENVIRON MED, V17, P8, DOI 10.1580/1080-6032(2006)17[8:CIIPAS]2.0.CO;2; Lischke V, 2001, WILD ENVIRON MED, V12, P74, DOI 10.1580/1080-6032(2001)012[0074:MAITEA]2.0.CO;2; MACNAB AJ, 1991, J TRAUMA, V31, P205, DOI 10.1097/00005373-199131020-00009; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Marsigny B, 1999, WILD ENVIRON MED, V10, P152, DOI 10.1580/1080-6032(1999)010[0152:MMRITM]2.3.CO;2; McCowan Christy L, 2006, Air Med J, V25, P26, DOI 10.1016/j.amj.2005.10.005; Moront ML, 1996, J PEDIATR SURG, V31, P1183, DOI 10.1016/S0022-3468(96)90114-1; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Selig HF, 2011, WIEN KLIN WOCHENSCHR, V123, P552, DOI 10.1007/s00508-011-0006-z; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Skokan EG, 2003, AM J EMERG MED, V21, P95, DOI 10.1053/ajem.2003.50032; Taylor BL, 2000, ACAD EMERG MED, V7, P1376, DOI 10.1111/j.1553-2712.2000.tb00495.x; Tomazin I, 2003, HIGH ALT MED BIOL, V4, P479, DOI 10.1089/152702903322616236; Voelckel WG, 2008, NOTFALL RETTUNGSMED, V11, P240, DOI 10.1007/s10049-008-1056-2	25	12	12	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1527-0297			HIGH ALT MED BIOL	High Alt. Med. Biol.	JUN	2012	13	2					112	117		10.1089/ham.2011.1082			6	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	965JR	WOS:000305764400007	22724614				2022-02-06	
J	Tansey, KE; McKay, WB; Kakulas, BA				Tansey, Keith E.; McKay, William Barry; Kakulas, Byron A.			Restorative neurology: Consideration of the new anatomy and physiology of the injured nervous system	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Neurotrauma; Neural plasticity; Functional recovery	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; SYNAPTIC PLASTICITY; ASSESSMENTS; MECHANISMS; RECOVERY; THERAPY	The adult human nervous system is an incredibly complex set of thousands to tens of thousands of connections between a hundred billion neurons that develops via an intricate spatial-temporal process and is shaped by experience. In addition, any one anatomical arrangement of neural circuits is usually capable of multiple physiological states. Following neurological injury, a new anatomy, and consequently a new spectrum of physiology, emerges within this nervous system with its mix of both injured and uninjured parts. It is this new combination of neural components that determines the extent to which natural functional recovery can occur and the extent to which clinical interventions can further that recovery. Detecting the new anatomy and physiology of the injured human nervous system is difficult but not impossible and some methods can track over time changes in neural structure or, more often, functions that correlate with neurological improvement. The goal of restorative neurology is to make best use of this new anatomy and physiology to facilitate neurological recovery. While we are still learning about how neurorehabilitation interventions generate functional recovery, we can begin to test hypothesis regarding the underlying mechanisms of neural plasticity and attempt to augment those processes. Published by Elsevier B.V.	[Tansey, Keith E.] Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Neurol, Atlanta, GA 30309 USA; [Tansey, Keith E.] Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Physiol, Atlanta, GA 30309 USA; [McKay, William Barry] Norton Neurosci Inst, Louisville, KY 40203 USA; [Kakulas, Byron A.] Univ Western Australia, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Crawley, WA 6009, Australia		Tansey, KE (corresponding author), Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Neurol, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	keith_tansey@shepherd.org; william.mckay@nortonhealthcare.org; bkakulas@meddent.uwa.edu.au					Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dimitrijevic M R, 1997, Adv Neurol, V72, P335; DIMITRIJEVIC MR, 1992, J NEUROTRAUM, V9, pS293; Dimitrijevic MR, 2012, RESTORATIVE NEUROLOG; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; Ellaway PH, 2011, BRAIN RES BULL, V84, P343, DOI 10.1016/j.brainresbull.2010.08.007; Ellaway PH, 2004, SPINAL CORD, V42, P325, DOI 10.1038/sj.sc.3101596; Enoka RM, 1997, MUSCLE NERVE, pS66; Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011; Field-Fote EC, 2011, PHYS THER, V91, P48, DOI 10.2522/ptj.20090359; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Ghez C, 1991, Curr Opin Neurobiol, V1, P664, DOI 10.1016/S0959-4388(05)80046-7; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Knikou M, 2010, CLIN NEUROPHYSIOL, V121, P1655, DOI 10.1016/j.clinph.2010.01.039; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Looby S, 2011, RADIOL CLIN N AM, V49, P129, DOI 10.1016/j.rcl.2010.07.019; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Munakata Y, 2004, DEVELOPMENTAL SCI, V7, P141, DOI 10.1111/j.1467-7687.2004.00331.x; Nguyen DK, 1998, CAN J NEUROL SCI, V25, P5, DOI 10.1017/S0317167100033424; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Park DH, 2010, THESCIENTIFICWORLDJO, V10, P470, DOI 10.1100/tsw.2010.39; Reggia JA, 2004, MED ENG PHYS, V26, P711, DOI 10.1016/j.medengphy.2004.06.010; Scott SH, 2003, CURR OPIN NEUROL, V16, P693, DOI 10.1097/00019052-200312000-00008; Sterr A, 2006, COGN BEHAV NEUROL, V19, P48, DOI 10.1097/00146965-200603000-00006; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Winchester P, 2005, NEUROREHAB NEURAL RE, V19, P313, DOI 10.1177/1545968305281515	38	12	14	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2012	114	5			SI		436	440		10.1016/j.clineuro.2012.01.010			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	941EN	WOS:000303946600004	22300890				2022-02-06	
J	Bechi, A; Nucera, MP; Olivotto, I; Manetti, R; Fabbri, LP				Bechi, A.; Nucera, M. P.; Olivotto, I.; Manetti, R.; Fabbri, L. P.			Complete neurological recovery after systemic air embolism during endoscopic retrograde cholangiopancreatography	MINERVA ANESTESIOLOGICA			English	Article						Endoscopy Embolism, complications; Pancreas, surgery	DIAGNOSIS; PATIENT	Systemic air embolisms are a rare but often a fatal complication of endoscopic retrograde cholangiopancreatography (ERCP). Only few cases have been reported in scientific studies. This paper concerns a case of a systemic air embolism that occurred during endoscopic sphincterotomy for gallstone removal in a 79-year-old-woman and discusses possible mechanisms. The basic vital and neurologic signs of the woman deteriorated abruptly towards the end of the procedure. It was believed to be an air embolism and an urgent transthoracic echocardiography was ordered which confirmed the etiological diagnosis. Supportive measures were initiated: she was administered 100% oxygen, she was placed head down, left lateral position and fluid resuscitation was started to increase venous pressure. We considered hyperbaric oxygen therapy for neurological injury but, despite the severe initial presentation, she had a complete clinical recovery with only conservative treatment. Present experience stresses the importance of the awareness of this uncommon complication: a close vigilance of the anesthetists during ERCP is critical to ensure early diagnosis and a timely intervention. (Minerva Anestesiol 2012;78:622-5)	[Bechi, A.; Nucera, M. P.; Fabbri, L. P.] Careggi Hosp, Dept Anesthesia & Intens Care, Florence, Italy; [Olivotto, I.] Careggi Hosp, Dept Cardiol, Florence, Italy; [Manetti, R.] Careggi Hosp, Dept Gen Surg, Florence, Italy		Bechi, A (corresponding author), Careggi Hosp, Dept Anesthesia & Intens Care, Via Oblate 1, Florence, Italy.	annalisabechi@libero.it	Olivotto, Iacopo/AAC-5950-2022	Olivotto, Iacopo/0000-0003-1751-9266			Garcia BA, 2009, GASTROENTEROL HEPATO, V32, P614, DOI 10.1016/j.gastrohep.2009.06.001; Bisceglia M, 2009, ADV ANAT PATHOL, V16, P255, DOI 10.1097/PAP.0b013e3181aab793; Cha ST, 2010, YONSEI MED J, V51, P287, DOI 10.3349/ymj.2010.51.2.287; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Di Pisa M, 2011, MINERVA ANESTESIOL, V77, P90; Finsterer J, 2010, EUR J GASTROEN HEPAT, V22, P1157, DOI 10.1097/MEG.0b013e32833c5459; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Mohammedi I, 2002, J TRAUMA, V53, P1170, DOI 10.1097/00005373-200212000-00023; Natal BL., VENOUS AIR EMBOLISM; Nayagam J, 2004, ANAESTH INTENS CARE, V32, P260, DOI 10.1177/0310057X0403200217; Nesher E, 2002, Eur J Emerg Med, V9, P163, DOI 10.1097/00063110-200206000-00012; Siddiqui J, 2005, GASTROINTEST ENDOSC, V61, P153, DOI 10.1016/S0016-5107(04)02448-4; Sviri S, 2004, Crit Care Resusc, V6, P271; Tan BK, 2008, ANN FR ANESTH, V27, P240, DOI 10.1016/j.annfar.2007.12.015	14	12	14	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393			MINERVA ANESTESIOL	Minerva Anestesiol.	MAY	2012	78	5					622	625					4	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	941KL	WOS:000303962000014	22240610				2022-02-06	
J	Charland-Verville, V; Lassonde, M; Frasnelli, J				Charland-Verville, Vanessa; Lassonde, Maryse; Frasnelli, Johannes			Olfaction in athletes with concussion	AMERICAN JOURNAL OF RHINOLOGY & ALLERGY			English	Article							MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; OF-PENNSYLVANIA SMELL; ODOR IDENTIFICATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; POSTTRAUMATIC ANOSMIA; RECURRENT CONCUSSION; SPORTS CONCUSSION	Background: Moderate to severe traumatic brain injuries (TBIs) commonly lead to olfactory dysfunction; it is, however, unclear whether and to what degree mild TBI such as concussions, which are common sports injuries, affect olfactory function. We therefore aimed to evaluate smell function in athletes who sustained one or more sport concussions in a cross-sectional design. Methods: Twenty-two University-level football players with one or multiple concussions and 13 control athletes without a history of concussion participated. We measured olfactory function by using the Sniffin' Sticks test to assess subjects' ability to discriminate and identify odors as well as their detection thresholds. In addition, we assessed odor intensity and pleasantness. Results: We used number of concussions and time since the last concussion as independent variables and measure of olfactory function as dependent variables. Although we did not observe any significant effect of the number of concussions, athletes with a longer delay from time of concussion scored significantly weaker than more recently concussed subjects on the odor identification test and on an aggregate olfactory score. Accordingly, we observed a significant negative linear correlation between the odor identification score and the time elapsed since the last concussion. Conclusion: These findings suggest a possible degenerative effect of concussions on olfactory function. (Am J Rhinol Allergy 26, 222-226, 2012; doi: 10.2500/ajra.2012.26.3769)	[Frasnelli, Johannes] Univ Montreal, Dept Psychol, Ctr Rech Neuropsycholgie & Cognit, Montreal, PQ H2V 2S9, Canada; [Charland-Verville, Vanessa] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Charland-Verville, Vanessa] Univ Liege, Dept Neurol, Liege, Belgium; [Charland-Verville, Vanessa] Univ Hosp Liege, Liege, Belgium		Frasnelli, J (corresponding author), Univ Montreal, Dept Psychol, Ctr Rech Neuropsycholgie & Cognit, Salle F-475,Pavillon Marie Victorin,90 Ave, Montreal, PQ H2V 2S9, Canada.	frasnelli@yahoo.com		Frasnelli, Johannes/0000-0002-8863-3982	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR)	Funded by the NSERC and CIHR	Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Eibenstein A, 2005, NEUROL SCI, V26, P156, DOI 10.1007/s10072-005-0453-2; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Fusetti M, 2010, J OTOLARYNGOL-HEAD N, V39, P175, DOI 10.2310/7070.2009.090046; Gaines AD, 2010, ALLERGY ASTHMA PROC, V31, P185, DOI 10.2500/aap.2010.31.3357; Graves AB, 1999, NEUROLOGY, V53, P1480, DOI 10.1212/WNL.53.7.1480; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Haehner A, 2009, CHEM SENSES, V34, P705, DOI 10.1093/chemse/bjp057; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jiang RS, 2009, AM J RHINOL ALLERGY, V23, P582, DOI 10.2500/ajra.2009.23.3370; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Lehrner J, 2009, CLIN NEUROPSYCHOL, V23, P818, DOI 10.1080/13854040802585030; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Royall DR, 2002, NEUROEPIDEMIOLOGY, V21, P68, DOI 10.1159/000048619; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sela L, 2009, J NEUROSCI, V29, P12059, DOI 10.1523/JNEUROSCI.2114-09.2009; Sobel N, 2001, P NATL ACAD SCI USA, V98, P4154, DOI 10.1073/pnas.071061598; Sommer U, 2004, MOVEMENT DISORD, V19, P1196, DOI 10.1002/mds.20141; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P802, DOI 10.1001/archpsyc.64.7.802; Wilson RS, 2009, ANN NY ACAD SCI, V1170, P730, DOI 10.1111/j.1749-6632.2009.04013.x	53	12	12	0	22	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1945-8924			AM J RHINOL ALLERGY	Am. J. Rhinol. Allergy	MAY-JUN	2012	26	3					222	226		10.2500/ajra.2012.26.3769			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	955AF	WOS:000304988800019	22643951				2022-02-06	
J	Kramer, C; Freeman, WD; Larson, JS; Hoffman-Snyder, C; Wellik, KE; Demaerschalk, BM; Wingerchuk, DM				Kramer, Christopher; Freeman, William D.; Larson, Joel S.; Hoffman-Snyder, Charlene; Wellik, Kay E.; Demaerschalk, Bart M.; Wingerchuk, Dean M.			Therapeutic Hypothermia for Severe Traumatic Brain Injury A Critically Appraised Topic	NEUROLOGIST			English	Article						brain injury; traumatic brain injury; head injury; induced hypothermia; therapeutic hypothermia; critically appraised topic	TERM MILD HYPOTHERMIA; INTRACRANIAL-PRESSURE	Background: Traumatic brain injury (TBI) is common and confers a high rate of disability and mortality. Current treatments are primarily supportive. Therapeutic hypothermia has been proposed for severe TBI because of its ability to reduce intracranial pressure and putative neuroprotective effects. Objective: To critically appraise the current evidence concerning the efficacy of therapeutic hypothermia in the treatment of severe TBI. Methods: The objective was addressed through the development of a structured, critically appraised topic. This incorporated a clinical scenario, background information, a structured question, literature search strategy, critical appraisal, results, evidence summary, commentary, and bottom line conclusions. Participants included consultant and resident neurologists, a medical librarian, clinical epidemiologists, and critical care and neurocritical care content experts. Results: A recent multicenter randomized controlled trial was selected for critical assessment; meta-analyses were also reviewed. Subjects with severe TBI were randomized to either rapid cooling to 33 degrees C for 48 hours (treatment, n = 52) or normothermia (control, n = 45). Outcome assessments included mortality and disability at 6 months as measured by the Glasgow Outcome Scale. Initiation of hypothermia began within 2.5 hours of injury and patients were rewarmed over a mean of 17.2 hours. The study was terminated for futility; no difference in outcome or mortality was detected between treatment groups. Post hoc subgroup analysis showed that among subjects who required hematoma evacuation, hypothermia was associated with a lower rate of poor clinical outcome (number needed to treat = 2.8; 95% confidence interval, 1.4-78.3, P = 0.02) and a trend toward a decrease in mortality (P = 0.16). Conclusions: Current cumulative evidence does not support general use of therapeutic hypothermia for acute severe TBI. However, further investigation of the role of therapeutic hypothermia may be warranted for specific TBI subgroups.	[Kramer, Christopher; Hoffman-Snyder, Charlene; Demaerschalk, Bart M.; Wingerchuk, Dean M.] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; [Larson, Joel S.] Mayo Clin, Dept Crit Care Med, Scottsdale, AZ 85259 USA; [Wellik, Kay E.] Mayo Clin, Dept Lib Serv, Scottsdale, AZ 85259 USA; [Freeman, William D.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Kramer, Christopher; Hoffman-Snyder, Charlene; Demaerschalk, Bart M.; Wingerchuk, Dean M.] Mayo Clin, Dept Neurol, Phoenix, AZ USA; [Larson, Joel S.] Mayo Clin, Dept Crit Care Med, Phoenix, AZ USA; [Wellik, Kay E.] Mayo Clin, Dept Lib Serv, Phoenix, AZ USA		Wingerchuk, DM (corresponding author), Mayo Clin, Dept Neurol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	wingerchuk.dean@mayo.edu		Freeman, M.D., William D./0000-0003-2326-0633	Mayo Clinic College of Medicine	D.M.W. and B.M.D., Co-Directors of Mayo Clinic Evidence Based Clinical Practice, Research, Informatics, and Training (MERIT) Center were supported by Clinician Educator grants from the Mayo Clinic College of Medicine.	Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Takeuchi S, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70083-7; Zollman FS, 2011, MANUAL OF TRAUMATIC BRAIN INJURY MANAGEMENT, P1	20	12	14	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1074-7931			NEUROLOGIST	Neurologist	MAY	2012	18	3					173	177		10.1097/NRL.0b013e318253f8ef			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	937IT	WOS:000303652900015	22549362				2022-02-06	
J	Papageorgiou, E; Hardiess, G; Wietholter, H; Ackermann, H; Dietz, K; Mallot, HA; Schiefer, U				Papageorgiou, Eleni; Hardiess, Gregor; Wiethoelter, Horst; Ackermann, Hermann; Dietz, Klaus; Mallot, Hanspeter A.; Schiefer, Ulrich			The neural correlates of impaired collision avoidance in hemianopic patients	ACTA OPHTHALMOLOGICA			English	Article						cerebrovascular damage; driving; fusiform gyrus; homonymous visual field defects; lesion analysis; parieto-occipital area; posterior cingulate gyrus; virtual reality	VISUAL-FIELD DEFECTS; TRAUMATIC BRAIN-INJURY; DRIVING PERFORMANCE; RIGHT-HEMISPHERE; WORKING-MEMORY; BEHAVIOR; ACTIVATION; HETEROGENEITY; LESIONS; UPDATE	. Purpose: The aim of this study was to assess the brain regions associated with impaired performance in a virtual, dynamic collision avoidance task, in a group of patients with homonymous visual field defects (HVFDs) because of unilateral vascular brain lesions. Methods: Overall task performance was quantitatively assessed as the number of collisions while crossing an intersection at two levels of traffic density. Twenty-six patients were divided into two subgroups using the median split method: patients with performance above average (HVFDA, i.e. lower number of collisions) and patients with performance below average (HVFDB, i.e. higher number of collisions). In order to identify the anatomical structures that might be specifically affected in HVFDB patients but spared in HVFDA patients, overlap, subtraction and voxel-based lesion-symptom mapping analyses were performed using the MRIcron software. Results: No significant difference in collision avoidance between patients with left- and right-hemispheric lesions was revealed. Separate lesion analysis in 12 patients with right- and 14 patients with left-hemispheric lesions showed that the cortical structures associated with impaired collision avoidance were the parieto-occipital region and posterior cingulate gyrus in the right hemisphere and the inferior occipital cortex and parts of the fusiform (occipito-temporal) gyrus in the left hemisphere. Conclusion: In the present collision avoidance paradigm, impaired performance of patients with right-hemispheric lesions is associated with damage in the dorsal processing stream and potential impact on the visual spatial working memory (WM), while impaired performance of patients with left-hemispheric lesions is associated with damage in the ventral stream and potential impact on the visual object WM.	[Papageorgiou, Eleni; Schiefer, Ulrich] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Hardiess, Gregor; Mallot, Hanspeter A.] Cognit Neurosci Lab, Dept Neurobiol, Tubingen, Germany; [Wiethoelter, Horst] Burger Hosp, Dept Neurol, Stuttgart, Germany; [Ackermann, Hermann] Rehabil Ctr, Bad Urach, Germany; [Dietz, Klaus] Univ Tubingen, Dept Med Biometry, D-72076 Tubingen, Germany		Papageorgiou, E (corresponding author), Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Schleichstr 12-16, D-72076 Tubingen, Germany.	e_papage@yahoo.com	Dietz, Klaus/R-9268-2016; Mallot, Hanspeter A/H-7888-2016	Dietz, Klaus/0000-0001-8503-9737; Papageorgiou, Eleni/0000-0003-1931-4168	European Union (PERACT-Marie Curie Early Stage Research Training) [MEST-CT-2004-504321]; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 550-A4, Graduiertenkolleg 778]	This study was supported by the following grants: European Union (PERACT-Marie Curie Early Stage Research Training, MEST-CT-2004-504321), Deutsche Forschungsgemeinschaft (SFB 550-A4) and Graduiertenkolleg 778. The authors are indebted to Regina Hofer and Elke Krapp (Department & Institute for Ophthalmology, Tubingen, Germany) for expert assistance with graphics.	Baddeley A.D., 1986, WORKING MEMORY; Bartolomeo P, 2006, ARCH NEUROL-CHICAGO, V63, P1238, DOI 10.1001/archneur.63.9.1238; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P158, DOI 10.1002/hbm.10032; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goodale MA, 2005, PROG BRAIN RES, V149, P269, DOI 10.1016/S0079-6123(05)49019-6; Hardiess G, 2010, VISION RES, V50, P1158, DOI 10.1016/j.visres.2010.04.004; Henriksson L, 2007, J NEUROL NEUROSUR PS, V78, P74, DOI 10.1136/jnnp.2006.099374; Horikawa E, 2005, BRAIN COGNITION, V58, P166, DOI 10.1016/j.bandc.2004.10.002; Jeong M, 2006, ANN NUCL MED, V20, P623, DOI 10.1007/BF02984660; Lobjois R, 2008, EXP BRAIN RES, V184, P457, DOI 10.1007/s00221-007-1117-7; Machner B, 2009, NEUROPSYCHOLOGIA, V47, P2704, DOI 10.1016/j.neuropsychologia.2009.05.016; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; MEERWALDT JD, 1982, J NEUROL NEUROSUR PS, V45, P586, DOI 10.1136/jnnp.45.7.586; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Milner DA, 1995, VISUAL BRAIN ACTION; Mitchell M., 2010, RES DESIGN EXPLAINED; Nelles G, 2007, NEUROSCI LETT, V426, P34, DOI 10.1016/j.neulet.2007.08.028; Papageorgiou E, 2011, VISION RES; Papageorgiou E, 2007, GRAEF ARCH CLIN EXP, V245, P1749, DOI 10.1007/s00417-007-0644-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; RATCLIFF G, 1973, J NEUROL NEUROSUR PS, V36, P448, DOI 10.1136/jnnp.36.3.448; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sala J, 2003, NEUROPSYCHOLOGIA, V41, P341, DOI 10.1016/S0028-3932(02)00166-5; Schulte T, 1999, AM J PHYS MED REHAB, V78, P136, DOI 10.1097/00002060-199903000-00010; Spiers HJ, 2007, NEUROIMAGE, V36, P245, DOI 10.1016/j.neuroimage.2007.02.032; SZLYK JP, 1993, OPTOMETRY VISION SCI, V70, P1031, DOI 10.1097/00006324-199312000-00007; Tant MLM, 2002, VISION RES, V42, P1339, DOI 10.1016/S0042-6989(02)00044-5; Tant MLM, 2002, NEUROPSYCHOL REHABIL, V12, P419, DOI 10.1080/09602010244000183; Tucker DM, 1995, ANN NY ACAD SCI, V769, P213, DOI 10.1111/j.1749-6632.1995.tb38141.x; Uchiyama Y, 2003, NEUROSCI LETT, V352, P199, DOI 10.1016/j.neulet.2003.08.072; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Ungerleider LG., 1982, ANAL VISUAL BEHAV; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walter H, 2001, NEUROREPORT, V12, P1763, DOI 10.1097/00001756-200106130-00049; Wood JM, 2009, INVEST OPHTH VIS SCI, V50, P577, DOI 10.1167/iovs.08-2506; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; ZIHL J, 1994, ST HEAL T, V11, P287; Zihl J, 2003, NEUROPSYCHCOLOGY OF VISION, P319	45	12	12	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	MAY	2012	90	3					e198	e205		10.1111/j.1755-3768.2011.02315.x			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	932SS	WOS:000303311400006	22176680	Bronze			2022-02-06	
J	Arun, P; Abu-Taleb, R; Valiyaveettil, M; Wang, Y; Long, JB; Nambiar, MP				Arun, Peethambaran; Abu-Taleb, Rania; Valiyaveettil, Manojkumar; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.			Transient changes in neuronal cell membrane permeability after blast exposure	NEUROREPORT			English	Article						blast exposure; fluorescence release; fluorescence uptake; membrane integrity; SH-SY5Y cells; traumatic brain injury	NEUROTRAUMA	The biochemical mechanisms of explosive blast-induced traumatic brain injury and the subsequent long-term neurobehavioral abnormalities are still not completely understood. We studied the biochemical mechanism of blast traumatic brain injury using our recently reported in-vitro model system with a shock tube. Primary blast exposure of in-vitro models leads to neurobiological changes in an overpressure dose-dependent and time-dependent manner. Lactate dehydrogenase was released significantly into the extracellular medium without cell death after blast exposure, indicating compromised cell membrane integrity. We further explored the integrity of cell membrane after blast exposure by fluorescent dye uptake/release techniques in SH-SY5Y human neuroblastoma cells. Our data indicate that blast exposure leads to an overpressure-dependent transient increase in the release of preloaded calcein AM into the culture medium with proportional intracellular decrease. Uptake of an extracellular nucleic acid-binding dye TO-PRO-3 iodide was also increased significantly after blast exposure, indicating that the increased molecular transport is bidirectional and nuclear membrane integrity is also affected by blast exposure. These results suggest that blast exposure perturbs the integrity of the neuronal cell membrane, leading to increased bidirectional transport of molecules - a potential mechanism that can lead to traumatic brain injury. NeuroReport 23:342-346 (c) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Arun, Peethambaran; Abu-Taleb, Rania; Valiyaveettil, Manojkumar; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Nambiar, MP (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	madhusoodana.nambiar@amedd.army.mil			Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research	Support from COL Paul Bliese, Director, Center for Military Psychiatry and Neurosciences, Walter Reed Army Institute of Research, is greatly acknowledged.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P985, DOI 10.1152/jn.1976.39.5.985; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Song ZL, 2007, AM J PHYSIOL-REG I, V292, pR423, DOI 10.1152/ajpregu.00495.2006; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Zhang X, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-84; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7	12	12	12	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	APR 18	2012	23	6					342	346		10.1097/WNR.0b013e328351b58d			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	922CU	WOS:000302525200002	22426026				2022-02-06	
J	Wang, YX; Gu, JX; Wang, JC; Feng, XM; Tao, YP; Jiang, BC; He, JS; Wang, Q; Yang, JD; Zhang, SF; Cai, J; Sun, Y				Wang, Yongxiang; Gu, Jiaxiang; Wang, Jingcheng; Feng, Xingmin; Tao, Yuping; Jiang, Baichuan; He, Jinshan; Wang, Qiang; Yang, Jiandong; Zhang, Shenfei; Cai, Jun; Sun, Yu			BDNF and NT-3 expression by using glucocorticoid-induced bicistronic expression vector pGC-BDNF-IRES-NT3 protects apoptotic cells in a cellular injury model	BRAIN RESEARCH			English	Article						Spinal cord injury; BDNF; Neurotrophin-3; Bicistronic expression vector, Apoptosis	SPINAL-CORD INJURY; UP-REGULATION; SURVIVAL; REGENERATION; MUSCLE	Spinal cord injury (SCI) is a severe traumatic disease in the central nervous system with high incidence and high morbidity. Recent study demonstrated that cell transplantation therapy may improve local microenvironment of the injury site and promote nerve regeneration to restore spinal cord functions. In this study, we constructed a glucocorticoid-induced bicistronic eukaryotic expression vector pGC-BDNF-IRES-NT3 by using molecular cloning techniques and examined the protective effect of neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF) expressed by this vector in a rat spinal cord injury (SCI) model. We first connected glucocorticoid response element (GRE) to cytomegalovirus (CMV) promoter and then the GRE-CMV gene was inserted into pEGFP-1 vector to construct the eukaryotic expression vector pGC-EGFP. Western blot analysis was used to confirm the expression of EGFP by transfecting this vector in RN-DSC cells. The IRES was used to connect BDNF gene and NT-3 gene and replaced the EGFP gene in pGC-EGFP plasmid to form the bicistronic expression vector-pGC-BDNF-IRES-NT3. After RN-DSC cells were transfected with the plas mid and treated with glucocorticoid, BDNF and NT-3 expression in the culture medium were measured by ELISA method. Finally, we found that combination therapy with the transfection of this vector and glucocorticoid had an anti-apoptotic effect in a cellular SCI model of RN-DSC cells. Therefore, the co-expression of BDNF and NT-3 by using this vector rescued the injured cells. This provided useful information for the gene-modification cell transplantation combined with glucocorticoid for the treatment of SCI. (C) 2012 Elsevier B.V. All rights resented.	[Wang, Yongxiang; Gu, Jiaxiang; Wang, Jingcheng; Feng, Xingmin; Tao, Yuping; Jiang, Baichuan; He, Jinshan; Wang, Qiang; Yang, Jiandong; Zhang, Shenfei; Cai, Jun; Sun, Yu] Univ Yangzhou, Clin Med Coll Yangzhou, Dept Orthoped Surg, Yangzhou City 225001, Jiangsu, Peoples R China		Wang, JC (corresponding author), Univ Yangzhou, Clin Med Coll Yangzhou, Dept Orthoped Surg, 98 W Nantong Rd, Yangzhou City 225001, Jiangsu, Peoples R China.	001wjc@sina.com					Allera-Moreau C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-74; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104; Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275; Ikeda O, 2002, J NEUROPATH EXP NEUR, V61, P142, DOI 10.1093/jnen/61.2.142; Ikeda O, 2001, ACTA NEUROPATHOL, V102, P239; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Que HP, 2011, IN VITRO CELL DEV-AN, V47, P558, DOI 10.1007/s11626-011-9443-2; Shinoda M, 1996, BRAIN RES, V722, P153, DOI 10.1016/0006-8993(96)00208-9; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9	13	12	13	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	APR 11	2012	1448						137	143		10.1016/j.brainres.2012.02.007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	926OO	WOS:000302840900015	22373651				2022-02-06	
J	Furutani, R; Kibayashi, K				Furutani, Rui; Kibayashi, Kazuhiko			Morphological Alteration and Reduction of MAP2-Immunoreactivity in Pyramidal Neurons of Cerebral Cortex in a Rat Model of Focal Cortical Compression	JOURNAL OF NEUROTRAUMA			English	Article						apical and basilar dendrites; dendritic spine; focal cortical compression; microtubule-associated protein 2; pyramidal neuron	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; EXCITATORY AMINO-ACIDS; VISUAL-CORTEX; PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; DENDRITIC BUNDLES; NMDA RECEPTORS; PROTEIN; MAP2	Subdural hematoma causes cortical damage including brain tissue disruption, often resulting in neuronal dysfunction and neurological impairment. The aim of the present study was to identify the relationship between cerebral compression and neuronal injury. In this report, we investigated time-dependent morphological alterations within layers II, III, and V pyramidal neurons in the cerebral cortex, using Golgi-Cox staining and immunohistochemistry for microtubule-associated protein 2 (MAP2) in a rat model of focal cortical compression. An acryl pole was used to experimentally induce chronic cerebral compression by continuous pressure on the cortical surface. Changes in cellular morphology were examined at five survival time periods: 12 h and 1, 2, 3, and 4 weeks. The Golgi-Cox method revealed time-dependent alterations in dendritic length of apical and basilar dendrites of pyramidal neurons. The number of dendritic branch segments and spines of basilar dendrites were decreased in cells in layers II, III, and V. Immunohistochemical staining for MAP2 revealed changes in the intracellular distribution of immunoreactive materials. A significant reduction in MAP2 immunostaining was found in nerve cell bodies and apical dendrites of ipsilateral cortical neurons. The number of MAP2-immunoreactive neurons was significantly decreased at 12 h compared with the contralateral cerebral cortex in the same animal. Dendritic changes in layers II, III, and V pyramidal neurons were accompanied by reductions in intracellular MAP2-immunoreactive materials. The present results suggest that cortical compression causes alteration of cellular morphology as a consequence of injury, and that these morphological changes may be related to reductions in MAP2-immunoreactive materials.	[Furutani, Rui] Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan		Furutani, R (corresponding author), Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	furutani@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215			Akulinin VA, 2003, NEUROCHEM RES, V28, P373, DOI 10.1023/A:1022401922669; Audesirk G, 1997, DEV BRAIN RES, V102, P247, DOI 10.1016/S0165-3806(97)00100-4; Camilli P.D., 1984, NEUROSCIENCE, V11, P819; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Curtetti R, 2002, MECH AGEING DEV, V123, P473, DOI 10.1016/S0047-6374(01)00357-8; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; DERYCK M, 1992, BRAIN RES, V573, P44; Eijkenboom M, 2004, NEUROSCIENCE, V124, P523, DOI 10.1016/j.neuroscience.2003.11.019; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GABBOTT PLA, 1987, J COMP NEUROL, V259, P364, DOI 10.1002/cne.902590305; GHOSH S, 1987, J COMP NEUROL, V259, P424, DOI 10.1002/cne.902590309; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; Hoskison MM, 2006, EXP NEUROL, V202, P302, DOI 10.1016/j.expneurol.2006.06.010; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Ichinohe N, 2003, EUR J NEUROSCI, V18, P1764, DOI 10.1046/j.1460-9568.2003.02900.x; KISVARDAY ZF, 1992, NEUROSCIENCE, V46, P275, DOI 10.1016/0306-4522(92)90050-C; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; LaBerge D, 2007, NEURAL NETWORKS, V20, P1004, DOI 10.1016/j.neunet.2007.09.006; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Li GL, 2000, APMIS, V108, P98; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Perez-Cruz C, 2009, EUR J NEUROSCI, V29, P738, DOI 10.1111/j.1460-9568.2009.06622.x; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Sweet RA, 2007, BIOL PSYCHIAT, V61, P854, DOI 10.1016/j.biopsych.2006.07.033; Takahashi H, 2003, J NEUROSCI, V23, P6586; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Vercelli AE, 2004, EUR J NEUROSCI, V20, P495, DOI 10.1111/j.1460-9568.2004.03483.x; Vespa P., 2003, NEUROSURG FOCUS, V15, pA4; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	45	12	13	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1266	1276		10.1089/neu.2010.1630			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100027	21401443				2022-02-06	
J	John, CA; Day, MW				John, Cynthia (Cindi) A.; Day, Michael W.			Central Neurogenic Diabetes Insipidus, Syndrome of Inappropriate Secretion of Antidiuretic Hormone, and Cerebral Salt-Wasting Syndrome in Traumatic Brain Injury	CRITICAL CARE NURSE			English	Article								Central neurogenic diabetes insipidus, syndrome of inappropriate secretion of antidiuretic hormone, and cerebral salt-wasting syndrome are secondary events that affect patients with traumatic brain injury. All 3 syndromes affect both sodium and water balance; however, they have differences in pathophysiology, diagnosis, and treatment. Differentiating between hypernatremia (central neurogenic diabetes insipidus) and the 2 hyponatremia syndromes (syndrome of inappropriate secretion of antidiuretic hormone, and cerebral salt-wasting syndrome) is critical for preventing worsening neurological outcomes in patients with head injuries. (Critical Care Nurse. 2012;32[2]:e1-e8)	[John, Cynthia (Cindi) A.; Day, Michael W.] Providence Sacred Heart Med Ctr, Spokane, WA USA; [John, Cynthia (Cindi) A.; Day, Michael W.] Childrens Hosp, Spokane, WA USA		Day, MW (corresponding author), 12915 E Main Ave, Spokane Valley, WA 99216 USA.	cnsd_ccrn@yahoo.com					Boughey JC, 2004, AM SURGEON, V70, P500; Byrum D, 2009, AACN ADV CRITICAL CA, P939; Cooperman M, DIABETES INSIPIDUS; Faul M, 2010, TRAUMATIC BRAIN INJU; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Hickey J, 2009, CLIN PRACTICE NEUROL, P195; Klein MJ, POSTHEAD INJURY ENDO; Momi Jasminder, 2010, Perm J, V14, P62; Mortimer Diane Schretzman, 2006, J Neurosci Nurs, V38, P142; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; Pangilinan PH, CLASSIFICATION COMPL; Urdan L, 2006, THELANS CRITICAL CAR, P918; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; Zhang WC, 2010, J EMERG MED, V39, P151, DOI 10.1016/j.jemermed.2008.01.027	14	12	15	0	8	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	APR	2012	32	2					E1	E8		10.4037/ccn2012904			8	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	025OV	WOS:000310201700001	22467619	Bronze			2022-02-06	
J	Mala, H; Castro, MR; Pearce, H; Kingod, SC; Nedergaard, SK; Scharff, Z; Zandersen, M; Mogensen, J				Mala, Hana; Castro, Maria Rodriguez; Pearce, Hadley; Kingod, Siff Camilla; Nedergaard, Signe Kjoer; Scharff, Zakaryiah; Zandersen, Maja; Mogensen, Jesper			Delayed intensive acquisition training alleviates the lesion-induced place learning deficits after fimbria-fornix transection in the rat	BRAIN RESEARCH			English	Article						Neurotrauma; Functional recovery; Place learning; Intensive training; Fimbria-fornix; Rat	INDUCED MOVEMENT THERAPY; PRIMARY MOTOR CORTEX; LONG-TERM-MEMORY; ALLOCENTRIC SPATIAL MEMORY; CONSTRAINT-INDUCED APHASIA; USE-DEPENDENT EXAGGERATION; BRAIN-INJURY; WATER-MAZE; BEHAVIORAL RECOVERY; STRATEGY SELECTION	This study evaluates the effects of two learning paradigms, intensive vs. baseline, on the posttraumatic acquisition of a water maze based place learning task. Rats were subjected either to a control operation (Sham) or to a fimbria-fornix (FF) transection, which renders the hippocampus dysfunctional and disrupts the acquisition of allocentric place learning. All animals were administered 30 post-lesion acquisition sessions, which spanned either 10 or 30 days. The acquisition period was followed by a 7 day pause after which a retention probe was administered. The lesioned animals were divided into 3 groups: i) Baseline Acquisition Paradigm (BAP) once daily for 30 days starting 1 week post-surgery; ii) Early Intensive Acquisition Paradigm (EIAP) 3 times daily for 10 days starting 1 week post-surgery; and Late Intensive Acquisition Paradigm (LIAP) 3 times daily for 10 days starting 3 weeks post-surgery. Within the control animals, one group followed the schedule of BAP, and one group followed the schedule of Intensive Acquisition Paradigm (IAP). All lesioned animals showed an impaired task acquisition. LIAP was beneficial in FF animals, in that it led to a better acquisition of the place learning task than the two other acquisition paradigms. The FF/EIAP group did not show improved acquisition compared to the FF/BAP group. The control animals were not differentially affected by the two learning schedules. The findings have implications for cognitive rehabilitation after brain injury and support the assumption that intensive treatment can lead to an improved learning, even when the neural structures underlying such a process are compromised. However, the timing of intensive treatment needs to be considered further. (C) 2012 Elsevier B.V. All rights reserved.	[Mala, Hana; Castro, Maria Rodriguez; Pearce, Hadley; Kingod, Siff Camilla; Nedergaard, Signe Kjoer; Scharff, Zakaryiah; Zandersen, Maja; Mogensen, Jesper] Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, DK-1353 Copenhagen K, Denmark		Mogensen, J (corresponding author), Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, Oester Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	jesper.mogensen@psy.ku.dk		Rytter, Hana Mala/0000-0002-2910-372X; Mogensen, Jesper/0000-0003-1959-581X	Danish Research CouncilDet Frie Forskningsrad (DFF)	The present study was supported by a grant from the Danish Research Council.	Alaei H, 2006, EUR J PHARMACOL, V536, P138, DOI 10.1016/j.ejphar.2006.02.025; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Boake C, 2007, NEUROREHAB NEURAL RE, V21, P14, DOI 10.1177/1545968306291858; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brasted PJ, 2003, BRAIN, V126, P1202, DOI 10.1093/brain/awg103; Briones TL, 2004, BRAIN RES, V997, P137, DOI 10.1016/j.brainres.2003.10.030; BUCHAN AM, 1990, BRAIN RES, V512, P7, DOI 10.1016/0006-8993(90)91163-B; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cain CK, 2003, J EXP PSYCHOL ANIM B, V29, P323, DOI 10.1037/0097-7403.29.4.323; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Comeau WL, 2010, BEHAV BRAIN RES, V214, P91, DOI 10.1016/j.bbr.2010.04.033; Commins S, 2003, BEHAV BRAIN RES, V139, P215, DOI 10.1016/S0166-4328(02)00270-X; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; de Araujo FLB, 2008, NEUROSCI LETT, V431, P179, DOI 10.1016/j.neulet.2007.11.038; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Farah CA, 2009, J NEUROSCI, V29, P10281, DOI 10.1523/JNEUROSCI.1533-09.2009; Friel KM, 2000, NEUROREHAB NEURAL RE, V14, P187, DOI 10.1177/154596830001400304; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; GOODRICK CL, 1973, J EXP PSYCHOL, V98, P344, DOI 10.1037/h0034421; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hasselmo ME, 2010, BEHAV BRAIN RES, V215, P261, DOI 10.1016/j.bbr.2009.12.010; Herrera-Morales W, 2007, EUR J NEUROSCI, V25, P1581, DOI 10.1111/j.1460-9568.2007.05391.x; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Janis LS, 1998, BEHAV BRAIN RES, V90, P23; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Kolb B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00204; Kornell N, 2008, PSYCHOL SCI, V19, P585, DOI 10.1111/j.1467-9280.2008.02127.x; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; LAHTINEN H, 1993, BRAIN RES BULL, V31, P311, DOI 10.1016/0361-9230(93)90223-X; Lavenex P, 2011, HIPPOCAMPUS, V21, P142, DOI 10.1002/hipo.20730; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; MacLellan CL, 2005, BRAIN RES, V1063, P40, DOI 10.1016/j.brainres.2005.09.027; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Mark VW, 2004, RESTOR NEUROL NEUROS, V22, P317; Masini CV, 2008, BEHAV NEUROSCI, V122, P210, DOI 10.1037/0735-7044.122.1.210; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Meinzer M, 2008, NEUROIMAGE, V39, P2038, DOI 10.1016/j.neuroimage.2007.10.008; Meinzer M, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-28; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Meinzer M, 2010, NEUROIMAGE, V53, P283, DOI 10.1016/j.neuroimage.2010.06.004; Meinzer M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-20; Menke R, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-118; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Mogensen J, 2002, NEUROBIOL LEARN MEM, V78, P139, DOI 10.1006/nlme.2001.4055; Mogensen J, 2011, J CONSCIOUSNESS STUD, V18, P13; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; Mogensen J, 2009, SCAND J PSYCHOL, V50, P561, DOI 10.1111/j.1467-9450.2009.00781.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murata Y, 2008, J NEUROPHYSIOL, V99, P773, DOI 10.1152/jn.01001.2007; Musicco M, 2003, ARCH PHYS MED REHAB, V84, P551, DOI 10.1053/apmr.2003.50084; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Nadeau SE, 2006, NEUROREHABILITATION, V21, P107; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Parslow DM, 2005, ACTA PSYCHOL, V118, P123, DOI 10.1016/j.actpsy.2004.10.006; Parslow DM, 2004, NEUROPSYCHOLOGY, V18, P450, DOI 10.1037/0894-4105.18.3.450; Philips GT, 2007, J NEUROSCI, V27, P13701, DOI 10.1523/JNEUROSCI.4262-07.2007; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Rogers JL, 2006, BEHAV NEUROSCI, V120, P852, DOI 10.1037/0735-7044.120.4.852; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Seo HG, 2010, J KOREAN MED SCI, V25, P1638, DOI 10.3346/jkms.2010.25.11.1638; Shapiro ML, 2006, P NATL ACAD SCI USA, V103, P4287, DOI 10.1073/pnas.0508688103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Spreng M, 2002, BEHAV BRAIN RES, V128, P103, DOI 10.1016/S0166-4328(01)00266-2; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Sterr A, 2003, NEUROLOGY, V61, P842, DOI 10.1212/WNL.61.6.842; Sterr A, 2006, COGN BEHAV NEUROL, V19, P48, DOI 10.1097/00146965-200603000-00006; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Sziklas V, 2002, HIPPOCAMPUS, V12, P543, DOI 10.1002/hipo.10030; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; Taub E, 2003, J REHABIL MED, V35, P34, DOI 10.1080/16501960310010124; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Taub E, 1999, J REHABIL RES DEV, V36, P237; Taub E, 2006, NEUROREHABILITATION, V21, P93; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; Toppino TC, 2010, J EXP PSYCHOL LEARN, V36, P1480, DOI 10.1037/a0020949; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van der Lee JH, 2001, CURR OPIN NEUROL, V14, P741, DOI 10.1097/00019052-200112000-00010; Wais PE, 2011, HIPPOCAMPUS, V21, P9, DOI 10.1002/hipo.20716; WHISHAW IQ, 1988, BEHAV NEUROSCI, V102, P662, DOI 10.1037/0735-7044.102.5.662; Wilson BA, 2002, NEUROREHAB NEURAL RE, V16, P207, DOI 10.1177/0888439002016002003; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Yamaguchi Yoko, 2004, Journal of Integrative Neuroscience, V3, P143, DOI 10.1142/S0219635204000488; Zhao CS, 2009, TOHOKU J EXP MED, V218, P301, DOI 10.1620/tjem.218.301	113	12	12	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 22	2012	1445						40	51		10.1016/j.brainres.2012.01.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	926KV	WOS:000302830800005	22322151				2022-02-06	
J	Yang, DM; Han, YX; Zhang, JF; Seyda, A; Chopp, M; Seyfried, DM				Yang, Dongmei; Han, Yuxia; Zhang, Jianfeng; Seyda, Agnieszka; Chopp, Michael; Seyfried, Donald M.			Therapeutic effect of human umbilical tissue-derived cell treatment in Rats with experimental intracerebral hemorrhage	BRAIN RESEARCH			English	Article						Intracerebral hemorrhage; Stem cells; Neurogenesis; Synaptogenesis	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; RODENT MODEL; BLOOD-CELLS; STROKE; CORD; RECOVERY; BENEFIT	Background and purpose: The present study examines whether human umbilical tissue-derived cells (hUTC) have a neuro-restorative effect and improve functional recovery after intracerebral hemorrhage (ICH) in rats. Methods: Primary ICH was induced in male Wistar rats by stereotactic injection of 100 mu L of autologous blood into the striatal region adjacent to the subventricular zone. Briefly, the rats were randomly divided into six groups, each group was intravenously injected either with 2 mL phosphate-buffered saline (PBS) or 3 million hUTC in PBS at 1, 3 or 7 days after ICH (n=8/group). To evaluate neurological functional outcome, each animal was subjected to the modified neurological severity score (mNSS) and corner turn tests at different time points after ICH. At four weeks post treatment, each group was anesthetized intraperitoneally, sacrificed, and brain tissues were processed histologically. Immunohistochemistry was employed to measure vascularity (vWF), neurogenesis (BrdU TUJ1, DCX and NeuN), synaptogenesis (synaptophysin) and apoptosis (TUNEL). Results: The hUTC-treated animals showed significantly improved neurological functional outcomes as assessed by mNSS and corner turn tests at 14, 21 and 28 days post-injection in each treatment group (P<0.05) as compared to the PBS controls. Animals treated with hUTC were seen to have significantly increased cell proliferation, vascularity and synaptogenesis, as well as reduced apoptosis in the hematoma rim compared to the corresponding control group (P<0.05). Conclusions: Intravenously infused hUTC have a beneficial effect after experimental ICH by functional and histochemical measurements of neural cell proliferation and synaptogenesis in the ICH border zone. This brain region also shows correlative evidence of neuronal recovery with increased vascularity. (C) 2012 Elsevier B.V. All rights reserved.	[Yang, Dongmei; Han, Yuxia; Zhang, Jianfeng; Seyfried, Donald M.] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Seyda, Agnieszka] Adv Technol & Regenerat Med LLC, Somerville, NJ 08876 USA		Seyfried, DM (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsdos@neuro.hfh.edu			Advanced Technologies and Regenerative Medicine, LLC	The research presented here was funded by Advanced Technologies and Regenerative Medicine, LLC, a Johnson & Johnson Affiliate.	Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Cheung RTF, 2007, REV RECENT CLIN TRIA, V2, P174, DOI 10.2174/157488707781662751; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Gomicka-Pawlak el B., ACTA NEUROBIOL EXP W, V71, P46; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Gorski JA, 2003, J NEUROSCI, V23, P6856; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hua Y, 2002, J CEREBR BLOOD F MET, V22, P55, DOI 10.1097/00004647-200201000-00007; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Liao WB, 2009, CELL PHYSIOL BIOCHEM, V24, P307, DOI 10.1159/000233255; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Matsuoka N, 2003, STROKE, V34, P1519, DOI 10.1161/01.STR.0000070840.56414.3B; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Seyfried DM, 2009, INT J STROKE, V4, P250, DOI 10.1111/j.1747-4949.2009.00292.x; Seyfried DM, 2008, BRAIN RES, V1224, P12, DOI 10.1016/j.brainres.2008.05.080; Seyfried DM, 2010, J NEUROSURG, V112, P329, DOI 10.3171/2009.2.JNS08907; Skidmore CT, 2002, NEUROSURG CLIN N AM, V13, P281, DOI 10.1016/S1042-3680(02)00019-0; Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	38	12	13	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAR 20	2012	1444						1	10		10.1016/j.brainres.2012.01.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914PD	WOS:000301962600001	22341873				2022-02-06	
J	Ackery, AD; Tator, CH; Snider, C				Ackery, Alun D.; Tator, Charles H.; Snider, Carolyn			Violence in Canadian Amateur Hockey: The Experience of Referees in Ontario	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						hockey; violence; referee; concussion; injury prevention	PERCEIVED PSYCHOLOGICAL STRESS; MENS ICE HOCKEY; DECISION-MAKING; HOME ADVANTAGE; CROWD SIZE; CONCUSSION; INJURIES; OFFICIALS; PLAYERS; SOCCER	Objective: To determine the perceptions and roles of referees about violence and injury in hockey games. Design: Questionnaire. Setting: Web-based survey. Participants: We contacted referees across Canada from various leagues and all levels of play, with the majority of respondents from Ontario (92%). Main Outcome Measures: We gathered demographic information anonymously and posed questions on aggression and experience in hockey games. Results: The majority of referees (n = 632) indicated that violence is a serious concern to both players and referees at all levels of hockey. More than 90% of referees responded that they were the recipients of aggression and anger (92.1%, 95% confidence interval, 90.0-94.2), 55% had been involved in hockey games where aggressive behavior resulted in the referee losing control of the game, and 71% said that this increased aggression leads to injury. Referees' opinions are that the coach is the most responsible for managing on-ice safety (63%). To improve hockey safety, referees suggest education and more rigorous enforcement of discipline for all participants. Conclusions: Referees are important for hockey safety and need to be appropriately supported. Referees believe that increased aggression can lead to injury and that rules need to be enforced more diligently. Referees recommend that increased education about safety is needed to guide parents, coaches, and players to make hockey safer.	[Ackery, Alun D.] Univ Toronto, Div Emergency Med, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Ackery, Alun D.; Tator, Charles H.] ThinkFirst Fdn Canada, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Div Neurosurg, Toronto, ON M4N 3M5, Canada; [Tator, Charles H.] Toronto Western Hosp, Univ Hlth Network, Toronto, ON M5T 2S8, Canada; [Snider, Carolyn] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada		Ackery, AD (corresponding author), Univ Toronto, Div Emergency Med, Dept Med, Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave,C7-53, Toronto, ON M4N 3M5, Canada.	alun.ackery@utoronto.ca	Snider, Carolyn/AAB-7183-2019; Ackery, Alun/B-6634-2016				Ackery A, 2009, CAN J NEUROL SCI, V36, P207, DOI 10.1017/S0317167100120281; Anderson SD, 2004, CAN MED ASSOC J, V170, P16; Anderson SD, 2004, CMAJ; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blake C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-74; Brooks DA, 2007, NEUROREHABILITATION, V22, P169; Canovas S, 2008, PSYCHOL REP, V102, P99, DOI 10.2466/PRO.102.1.99-110; Catteeuw P, 2010, J SPORT SCI, V28, P471, DOI 10.1080/02640410903518184; Catteeuw P, 2009, J SPORT SCI, V27, P1125, DOI 10.1080/02640410903079179; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; COOPER E R, 1961, J Med Soc N J, V58, P54; Cribb R., 2009, TORONTO STAR, pA1; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Dillman D.A., 2009, INTERNET MAIL MIXED, V3rd ed.; Downward P, 2007, J SPORT SCI, V25, P1541, DOI 10.1080/02640410701275193; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Gordon KE, 2006, CLIN J SPORT MED, V16, P195, DOI 10.1097/00042752-200605000-00001; Johnston KM, 2003, CAN J NEUROL SCI, V30, P183, DOI 10.1017/S0317167100002559; Johnston R, 2008, J SPORT SCI, V26, P563, DOI 10.1080/02640410701736780; Kis M, 2004, CAN J NEUROL SCI, V31, P499, DOI 10.1017/S031716710000370X; Leicht AS, 2008, J SCI MED SPORT, V11, P357, DOI 10.1016/j.jsams.2007.05.006; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Rainey D, 1995, PERCEPT MOTOR SKILL, V81, P1241, DOI 10.2466/pms.1995.81.3f.1241; Rainey DW, 1997, PERCEPT MOTOR SKILL, V84, P728, DOI 10.2466/pms.1997.84.3.728; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Saleh F, 2008, CATASTROPHIC INJURIE, P291; Seckin A, 2008, PERCEPT MOTOR SKILL, V107, P51, DOI 10.2466/PMS.107.1.51-54; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Stewart MJ, 2004, PERCEPT MOTOR SKILL, V99, P463, DOI 10.2466/PMS.99.5.463-469; Stewart MJ, 1998, PERCEPT MOTOR SKILL, V87, P1275, DOI 10.2466/pms.1998.87.3f.1275; Tator CH, 2009, CAN J NEUROL SCI, V36, P269, DOI 10.1017/S0317167100006922; Tsorbatzoudis H, 2005, PERCEPT MOTOR SKILL, V100, P821, DOI 10.2466/PMS.100.3.821-830; Unkelbach C, 2010, J SPORT EXERCISE PSY, V32, P483, DOI 10.1123/jsep.32.4.483; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2009, PHYS MED REH CLIN N, V20, px; Wennberg RA, 2008, NEUROL CLIN, V26, pxi; Wennberg RA, 2009, PHYS MED REH CLIN N, V20, P215, DOI 10.1016/j.pmr.2008.10.005; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Werinberg RA, 2008, NEUROL CLIN, V26, P243, DOI 10.1016/j.ncl.2007.12.002	47	12	14	1	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2012	22	2					86	90		10.1097/JSM.0b013e3182342b69			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	908RG	WOS:000301507200003	22252162				2022-02-06	
J	Mirzayan, MJ; Probst, C; Samii, M; Krettek, C; Gharabaghi, A; Pape, HC; van Griensven, M; Samii, A				Mirzayan, M. J.; Probst, C.; Samii, M.; Krettek, C.; Gharabaghi, A.; Pape, H. C.; van Griensven, M.; Samii, A.			Histopathological features of the brain, liver, kidney and spleen following an innovative polytrauma model of the mouse	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article						Brain injury; Controlled cortical impact; Fracture; Mouse; Neuroprotection; Neurotrauma; Polytrauma	NEUROGENIC PULMONARY-EDEMA; HEAD-INJURY; FLUID PERCUSSION; EPINEPHRINE; PRESSURE; TRAUMA	Object: Among the various introduced experimental traumatic brain injury models, there is a clear paucity of proper experimental polytrauma models. To overcome this experimental gap we introduced such a polytrauma model in the mouse including traumatic brain injury. Here, we report on the histopathological features of the brain, lung, kidney, spleen and liver. Materials and methods: 20 male C57BL mice with a mean weight of 23 g were anesthetized with ketamine and xylazine. The anaesthetized animals were subjected to a controlled cortical impact (CCI) over the left parieto-temporal cortex using rounded-tip impounder for application of a standardized brain injury. Following fracture of the right femur using a guillotine, a volume-controlled hemorrhagic shock was induced. The control groups included animals with CCI only (n = 20) and animals with femur fracture plus hemorrhagic shock without CCI (n = 20). Subjects were sacrified at 96h following trauma. Brain, lung, kidney, spleen and liver of the animals underwent histopathological examinations. Results: The mortality rate at 96 h was 25% in the polytrauma group versus 10% in the control groups. Within the histopathological investigations, polytraumatized animals differ from those with a single trauma (traumatic brain injury or femur fracture with hemorrhagic shock) with various severity. Conclusion: The findings of this study show that such a polytrauma model can be standardized resulting in a reproducible damage. This model fulfills the requirements of a standardized animal model. It allows adequate analogies and inferences to the clinical situation of a polytrauma in humans. (C) 2010 Elsevier GmbH. All rights reserved.	[Mirzayan, M. J.] Hannover Med Sch, Dept Neurosurg, D-30625 Hannover, Germany; [Probst, C.; Krettek, C.] Hannover Med Sch, Dept Traumatol, D-30625 Hannover, Germany; [Samii, M.; Samii, A.] Int Neurosci Inst Hannover, Hannover, Germany; [Gharabaghi, A.] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Pape, H. C.] Univ Penn, Dept Orthopaed Trauma, Pittsburgh, PA USA; [van Griensven, M.] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria		Mirzayan, MJ (corresponding author), Hannover Med Sch, Dept Neurosurg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mirzayan@hotmail.com	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Krettek, Christian/0000-0001-9807-0020			Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; ASANO T, 1989, MOL CHEM NEUROPATHOL, V10, P101, DOI 10.1007/BF03159717; BOGGS DR, 1975, CLIN HAEMATOL, V4, P535; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CRITTENDEN DJ, 1982, J TRAUMA, V22, P766, DOI 10.1097/00005373-198209000-00008; DAVIS JM, 1991, J TRAUMA, V31, P725, DOI 10.1097/00005373-199106000-00001; GARCIAURIA J, 1981, J NEUROSURG, V54, P632, DOI 10.3171/jns.1981.54.5.0632; Haljamae H, 1988, Prog Clin Biol Res, V264, P17; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HILTUNEN A, 1993, J ORTHOP RES, V11, P305, DOI 10.1002/jor.1100110219; Hinshaw LB, 1996, CRIT CARE MED, V24, P1072, DOI 10.1097/00003246-199606000-00031; Hofstetter T, 2007, J NEUROSURG, V106, P701, DOI 10.3171/jns.2007.106.4.701; Jiang J, 1997, Chin Med Sci J, V12, P41; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; MARON MB, 1979, J APPL PHYSIOL, V47, P153, DOI 10.1152/jappl.1979.47.1.153; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; Morken JJ, 2002, SHOCK, V18, P46, DOI 10.1097/00024382-200207000-00009; Pace N, 1977, BIOCHEM BIOPH RES CO, V56, P129; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; REGEL G, 1993, UNFALLCHIRURG, V96, P350; SINGBARTL G, 1981, ANAESTHESIST, V30, P431; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stahel P, 2004, UNFALLCHIRURGIE; van Griensven M, 1999, SHOCK, V11, P259, DOI 10.1097/00024382-199904000-00006; van Griensven M, 2002, EXP TOXICOL PATHOL, V54, P203, DOI 10.1078/0940-2993-00247; WAUCHOB TD, 1984, ANAESTHESIA, V39, P529, DOI 10.1111/j.1365-2044.1984.tb07355.x; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141	30	12	13	0	5	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	MAR	2012	64	3					133	139		10.1016/j.etp.2010.07.007			7	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Toxicology	922QG	WOS:000302562200001	20688496				2022-02-06	
J	Shimada, R; Nakao, K; Furutani, R; Kibayashi, K				Shimada, Ryo; Nakao, Ken-ichiro; Furutani, Rui; Kibayashi, Kazuhiko			A rat model of changes in dural mast cells and brain histamine receptor H3 expression following traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Dura; Head trauma; Histamine receptor; Mast cell	TRYPTASE; EDEMA	Mast cells can secrete histamine in response to extrinsic stimuli. Histamine plays a role in the development of brain edema and can induce histamine receptor H3 (HRH3) expression in the brain to provide protective feedback effects against histamine neurotoxicity. We investigated time-dependent changes in dural mast cell numbers and HRH3 expression in the brain for one to 14 days after traumatic brain injury in a controlled cortical impact model in the rat. The number of tryptase-immunoreactive dural mast cells at the site of impact was significantly decreased one and four days after the injury. Furthermore, immunoreactivity and messenger RNA (mRNA) expression of HRH3 at the underlying cortical contusion site were significantly increased one and four days after the injury. These data suggest that histamine released from degranulated unstainable mast cells induces a transient increase in presynaptic autoinhibitory HRH3 immunoreactivity and mRNA expression as a mechanism to counteract histamine neurotoxicity. (C) 2011 Elsevier Ltd. All rights reserved.	[Shimada, Ryo; Nakao, Ken-ichiro; Furutani, Rui; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, Tokyo 1628666, Japan		Shimada, R (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	shimada@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [19390186, 21659177]	This work was supported by grants to Kazuhiko Kibayashi from the Japan Society for the Promotion of Science (no. 19390186 and 21659177).	ARRANG JM, 1987, NEUROSCIENCE, V23, P149, DOI 10.1016/0306-4522(87)90279-X; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; BUTT AM, 1992, BRAIN RES, V569, P100, DOI 10.1016/0006-8993(92)90374-I; Santos PPD, 2011, ARCH ORAL BIOL, V56, P231, DOI 10.1016/j.archoralbio.2010.09.020; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Kibayashi K, 2011, AM J FORENSIC MED PA; MOHANTY S, 1989, J NEUROL SCI, V90, P87, DOI 10.1016/0022-510X(89)90048-8; Nakao K, 2010, J NEUROTRAUM, V27, P1925, DOI 10.1089/neu.2010.1379; Nuutinen S, 2011, NEUROPHARMACOLOGY, V60, P1193, DOI 10.1016/j.neuropharm.2010.10.027; Onodera K, 1999, Nihon Yakurigaku Zasshi, V114, P89; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WALLS AF, 1990, J PATHOL, V162, P119, DOI 10.1002/path.1711620204	15	12	13	2	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2012	19	3					447	451		10.1016/j.jocn.2011.06.033			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	904AD	WOS:000301165100022	22277566				2022-02-06	
J	Sinski, JB				Sinski, Jennifer Blevins			Classroom Strategies for Teaching Veterans with Post-Traumatic Stress Disorder and Traumatic Brain Injury	JOURNAL OF POSTSECONDARY EDUCATION AND DISABILITY			English	Article						Veterans; traumatic brain injury; post-traumatic stress disorder; classroom strategies; teaching; learning		Postsecondary institutions currently face the largest influx of veteran students since World War II. As the number of veteran students who may experience learning problems caused by Post-Traumatic Stress Disorder and/or Traumatic Brain Injury continues to rise, the need for instructional strategies that address their needs increases. Educators may unwittingly expose these students to uncomfortable or distressing situations. Equipped with basic knowledge about the brain and memory, college faculty can provide instruction and assessment in ways that allow all students in the classroom to feel successful, including "wounded warriors." This article provides suggestions for research-supported strategies that postsecondary faculty can use to promote wider access for an increasingly diverse student population.	[Sinski, Jennifer Blevins] Elizabethtown Community & Tech Coll, Dept English, Elizabethtown, PA 42701 USA		Sinski, JB (corresponding author), Elizabethtown Community & Tech Coll, Dept English, Elizabethtown, PA 42701 USA.	jsinski0001@kctcs.edu	Sinski, Jennifer/ABD-9326-2020	Sinski, Jennifer/0000-0002-2823-2968			Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; Barker-Collo Suzanne, 2008, N Z Med J, V121, pU2903; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; BRUNNING HR, 1999, COGNITIVE PSYCHOL IN; Ceci S. J, 1987, HDB COGNITIVE SOCIAL; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Church TE, 2009, J POSTSECOND EDUC DI, V22, P43; De Bellis MD, 2009, J INT NEUROPSYCH SOC, V15, P868, DOI 10.1017/S1355617709990464; Department of Veterans Affairs, 2010, VET BEN ADM ANN VET; Dye, 2000, TEACHING EXCEPTIONAL, V32, P1, DOI [10.1177/004005990003200311, DOI 10.1177/004005990003200311]; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Harris JL, 2000, APHASIOLOGY, V14, P515, DOI 10.1080/026870300401289; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Johnsen GE, 2009, PSYCHIAT RES, V165, P68, DOI 10.1016/j.psychres.2008.01.001; Kim Y., 2009, SOLDIER STUDENT EASI; Kinjo H, 2000, AM J PSYCHOL, V113, P95, DOI 10.2307/1423462; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Moshfeghi F., 1998, J ED PSYCHOL RES, V1, P1; National Survey of Student Engagement, 2010, MAJ DIFF EX STUD ENG; Nijenhuis E., 2004, TRAUMA RELATED STRUC; Odom S, 2009, INT J TEACHING LEARN, V21, P108; Papgno C., 1996, HDB MEMORY DISORDERS, P135; Perry B.D., 2001, TXB CHILD ADOLESCENT, P221; Perry BD, 1997, CHILDREN VIOLENT SOC, P124; PRESSLEY M, 1987, HDB COGNITIVE SOCIAL, P175; Pressley M., 2008, J ED, V189, P77; Samuelson KW, 2009, J INT NEUROPSYCH SOC, V15, P853, DOI 10.1017/S1355617709990282; Schore AN, 2002, AUST NZ J PSYCHIAT, V36, P9, DOI 10.1046/j.1440-1614.2002.00996.x; Sharifian F., 2002, TESL EJ, V6; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Snodgrass JG, 1998, J EXP PSYCHOL LEARN, V24, P645, DOI 10.1037/0278-7393.24.3.645; Steele J. L., 2010, MILITARY VETERANS EX; Washbourn P., 1996, LIBERAL EDUC, V82, P1	34	12	12	0	0	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD	COLUMBUS	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD, COLUMBUS, OH 00000 USA	2379-7762	2328-3343		J POSTSECOND EDUC DI	J. Postsecond. Educ. Disabil.	SPR	2012	25	1					87	95					9	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VE7EZ	WOS:000440145600008					2022-02-06	
J	Bonilla, C; Zurita, M; Otero, L; Aguayo, C; Rico, MA; Rodriguez, A; Vaquero, J				Bonilla, Celia; Zurita, Mercedes; Otero, Laura; Aguayo, Concepcion; Rico, Miguel A.; Rodriguez, Alicia; Vaquero, Jesus			Failure of Delayed Intravenous Administration of Bone Marrow Stromal Cells after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bone marrow stromal cells; cell therapy; traumatic brain injury	PROMOTES FUNCTIONAL RECOVERY; CHRONIC PARAPLEGIC RATS; THERAPEUTIC BENEFIT; ADULT RATS; STEM-CELLS; TRANSPLANTATION; DIFFERENTIATION; INCREASES	Traumatic brain injury (TBI) is a leading cause of mortality and morbidity worldwide. Currently, there is no effective strategy to treat the functional sequelae associated with TBI. Experimental evidence shows that the intravenous administration of bone marrow stromal cells (BMSC) during the first week after TBI prevents neurological deficits, but no experimental studies have shown evidence of the effect of intravenous BMSC on chronic brain injury sequelae. Here we studied the effect of intravenous administration of BMSC on functional outcomes 2 months after experimental TBI in rats. Adult Wistar rats were subjected to weight-drop impact causing severe brain injury, and 2 months later BMSC in saline, or saline alone, was intravenously injected. All experimental groups were evaluated by means of the modified Neurological Severity Score (mNSS), and internal zone Permanence Time (izPT) after video-tracking box (VTB) analysis, over the following 2 months to test the efficacy of BMSC therapy. At the end of the study period the animals were sacrificed and their brains were studied to evaluate possible differences between groups. Two months after BMSC administration no significant differences were detected in the motor and sensory evaluation between animals treated with BMSC and controls, and no differences were detected after histological study of the brains. Our present results suggest that intravenous administration of BMSC after TBI, when the neurological deficits are well established, has no beneficial effect in neurological outcomes or on brain tissue.	[Bonilla, Celia; Zurita, Mercedes; Otero, Laura; Aguayo, Concepcion; Rico, Miguel A.; Rodriguez, Alicia; Vaquero, Jesus] Puerta Hierro Majadahonda Hosp, Neurosci Res Unit, Madrid, Spain; [Vaquero, Jesus] Puerta Hierro Hosp, Serv Neurosurg, Madrid 28222, Spain		Vaquero, J (corresponding author), Puerta Hierro Hosp, Neurosci Res Unit, Joaquin Rodrigo 2, Madrid 28222, Spain.	jvaqueroc@telefonica.net		Otero Ortega, Laura/0000-0001-8765-6341	Mapfre Foundation; MM Foundation; Rafael del Pino Chair for Neuroscience Research; Institute of Health Carlos IIIInstituto de Salud Carlos III [FIS PI060650]	This study was made possible by grants received from the Mapfre Foundation, the MM Foundation, the Rafael del Pino Chair for Neuroscience Research, and the Institute of Health Carlos III (FIS PI060650).	Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Benayahu D, 2007, CURR MED CHEM, V14, P173, DOI 10.2174/092986707779313363; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Kotobuki N, 2004, ARTIF ORGANS, V28, P33, DOI 10.1111/j.1525-1594.2004.07320.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Otero L, 2010, J NEUROSCI METH, V188, P53, DOI 10.1016/j.jneumeth.2010.01.036; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zurita M, 2004, NEUROREPORT, V15, P1105, DOI 10.1097/00001756-200405190-00004; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f; Zurita M, 2008, NEUROSCI RES, V60, P275, DOI 10.1016/j.neures.2007.11.006; Zurita M, 2007, NEUROREPORT, V18, P1713, DOI 10.1097/WNR.0b013e3282f0d3b0; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069	32	12	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					394	400		10.1089/neu.2011.2101			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300018	21999525				2022-02-06	
J	Amato, S; Resan, M; Mion, L				Amato, Shelly; Resan, Marian; Mion, Lorraine			The Feasibility, Reliability, and Clinical Utility of the Agitated Behavior Scale in Brain-Injured Rehabilitation Patients	REHABILITATION NURSING			English	Article						brain injury; research: quantitative; safety issues	PHYSICAL RESTRAINT USE; PREVALENCE	Patients with traumatic brain injury often experience physical and cognitive impairments as well as agitation requiring additional care to maintain a safe and therapeutic environment. Purpose: The aim of this study was to determine the feasibility, reliability and clinical utility of the Agitated Behavior Scale (ABS) as part of routine rehabilitation nursing assessment. Method: A prospective descriptive study was conducted on a brain injury rehabilitation unit consisting of a sample of 51 patients who were consecutively admitted over 4 months to a rehabilitation unit. Findings: Results showed that the tool was completed on the majority of nursing shifts, had high interrater agreement, and distinguished patients who were on constant observation or physically restrained. Conclusion and Clinical Relevance: The ABS can be used as an objective measure for nurses to guide the initiation and evaluate the effectiveness of various care strategies.	[Amato, Shelly] MetroHlth Rehabil Inst Ohio, Brain Injury & Stroke Rehabil Unit, Cleveland, OH USA; [Resan, Marian] MetroHlth Med Ctr Rehabil Nursing, Traumat Brain Injury Unit, Cleveland, OH USA; [Mion, Lorraine] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA		Amato, S (corresponding author), MetroHlth Rehabil Inst Ohio, Brain Injury & Stroke Rehabil Unit, Cleveland, OH USA.	samato@metrohealth.org					Bailey M, 2009, REHABIL NURS, V34, P11, DOI 10.1002/j.2048-7940.2009.tb00242.x; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; Gordon V, 1999, Outcomes Manag Nurs Pract, V3, P153; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Levy M, 2005, NEUROREHABILITATION, V20, P279; Minnick AF, 1998, J NURS ADMIN, V28, P19, DOI 10.1097/00005110-199811000-00007; Minnick AF, 2007, J NURS SCHOLARSHIP, V39, P30, DOI 10.1111/j.1547-5069.2007.00140.x; Montgomery P, 1997, Rehabil Nurs, V22, P20; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114	17	12	12	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	JAN-FEB	2012	37	1					19	24		10.1002/RNJ.00001			6	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	998GG	WOS:000308224900004	22271217				2022-02-06	
J	Colantonio, A; Comper, P				Colantonio, A.; Comper, P.			Post-injury symptoms after work related traumatic brain injury in Canadian population	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Work; post-concussion syndrome; return to work; rehabilitation	POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; FOLLOW-UP; RELIABILITY; RETURN	Objectives: To examine the nature and extent of persistent post-injury symptoms of persons who have experienced a work-related traumatic brain injury (WrTBI) in Ontario, Canada. Methods: Using a retrospective case series design, post-injury symptoms, occupation, and work factors were examined for WrTBIs among an adult population. Data were abstracted from medical records of individuals who sustained a WrTBI and were discharged from a referral-based outpatient neurology service between the years of 1998 and 2001. Results: Of the 435 individuals who sustained a WrTBI, most were >= 45 years of age and male. Approximately 50% had injuries to the head only, while others had multiple injuries. The most common post-injury symptoms were headaches (85.1%), memory changes (74.3%), and mood/personality changes (68.3%). A small subset of individuals reported very long-term post-injury symptoms, and a majority of individuals had not yet returned to work. Conclusions: This study profiles the demographic and clinical characteristics of an outpatient injured worker population with a history of WrTBI which provides a basis for the planning and implementation of assessment and treatment programs for this clinical population.	[Colantonio, A.] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Colantonio, A.; Comper, P.] Toronto Rehabil Inst UHN, Toronto, ON, Canada; [Colantonio, A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765			Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Centers for Disease Control and Prevention, TRAUM BRAIN INJ; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; Health Canada, 2002, EC BURD ILLN CAN; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kim H, 2006, NEUROREHABILITATION, V21, P269; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ray SL, 2008, ARCH PSYCHIAT NURS, V22, P217, DOI 10.1016/j.apnu.2007.08.005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	31	12	13	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815			WORK	Work		2012	43	2					195	201		10.3233/WOR-2012-1377			7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	012CX	WOS:000309214100009	22927617				2022-02-06	
J	de Joode, E; Proot, I; Slegers, K; van Heugten, C; Verhey, F; van Boxtel, M				de Joode, Elisabeth; Proot, Ireen; Slegers, Karin; van Heugten, Caroline; Verhey, Frans; van Boxtel, Martin			The use of standard calendar software by individuals with acquired brain injury and cognitive complaints: a mixed methods study	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Cognitive rehabilitation; stroke; traumatic brain injury		Purpose: To explore the actual use of standard calendar software by people with acquired brain injury (ABI) and healthy individuals. Method: Mixed methods design with qualitative and quantitative analyses of the respondents' use of calendar software. Fifteen individuals with ABI and 15 healthy participants were enrolled. Participants were asked to execute five consecutive tasks using standard calendar software, which resembled everyday use of an electronic calendar. Results: The core processes "task execution" and "information processing" were influenced by internal factors (cognitive and emotional processes and fatigue) as well as environmental factors (software features and distractions). Results obtained by qualitative and quantitative methods showed similar reaction patterns in both groups. However, ABI patients had more cognitive problems and showed stronger emotions during task performance than healthy participants. Healthy participants were more successful and needed less time and mental effort to perform a task. Conclusions: Although ABI patients were able to use standard calendar software, they became upset more easily, needed more effort, became tired sooner and more suddenly. Strategies to support ABI patients in the use of calendar software are suggested from multi-disciplinary perspectives.	[de Joode, Elisabeth; van Heugten, Caroline; Verhey, Frans; van Boxtel, Martin] Maastricht Univ, Psychiat & Neuropsychol, Maastricht, Netherlands; [Proot, Ireen] Maastricht Univ, Clin Genet Governor Kremers Ctr, Maastricht, Netherlands; [Slegers, Karin] Katholieke Univ Leuven, Ctr User Experience Res, Leuven, Belgium; [van Heugten, Caroline] Maastricht Univ, Neuropsychol & Psychopharmacol, Maastricht, Netherlands		van Heugten, C (corresponding author), Maastricht Univ, Psychiat & Neuropsychol, Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl	de Joode, Elsbeth/AAT-3805-2020	Slegers, Karin/0000-0003-3368-2282	Netherlands Organization for Health Research and Development (ZonMW) The Hague, The NetherlandsNetherlands Organization for Health Research and DevelopmentNetherlands Government [14350052]	This project was supported by a grant (grant no. 14350052) from the Netherlands Organization for Health Research and Development (ZonMW) The Hague, The Netherlands. The authors report no conflicts of interest.	Abilia, 2011, HAND; Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; De Joode EA, USE ASSISTIVE UNPUB; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; DEBIE SE, 1987, STANDARD QUESTIONS 1; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Friese S., 2004, ATLAS TI; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1988, NEUROPSYCHOLOGIA, V26, P173, DOI 10.1016/0028-3932(88)90041-3; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kroll Thilo, 2005, Rehabil Nurs, V30, P106; Levinson R, 1997, J HEAD TRAUMA REHAB, V12, P85, DOI 10.1097/00001199-199704000-00010; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Nygard L, 2007, AGING MENT HEALTH, V11, P144, DOI 10.1080/13607860600844168; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Scherer MJ, 2005, DISABIL REHABIL, V27, P731, DOI 10.1080/09638280400014816; Shneiderman B., 1992, DESIGNING USER INTER; Sohlberg MM, 2005, APHASIOLOGY, V19, P651, DOI 10.1080/02687030544000100; Starkstein SE, 2010, CAN J PSYCHIAT, V55, P355, DOI 10.1177/070674371005500604; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van Boxtel M., 2006, TIJDSCHRIFT NEUROPSY, V1, P37; Van der Elst W, 2006, PSYCHOL ASSESSMENT, V18, P424, DOI 10.1037/1040-3590.18.4.424; van Doorn L., 1985, TECHNICAL REPORT	34	12	12	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2012	7	5					389	398		10.3109/17483107.2011.644623			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V06SM	WOS:000213959900007	22204657	Green Published			2022-02-06	
J	Drebing, CE; Bell, M; Campinell, EA; Fraser, R; Malec, J; Penk, W; Pruitt-Stephens, L				Drebing, Charles E.; Bell, Morris; Campinell, E. Anthony; Fraser, Robert; Malec, James; Penk, Walter; Pruitt-Stephens, Laura			Vocational services research: Recommendations for next stage of work	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						design; employment; measurement; methodology outcomes; rehabilitation; research; vocational rehabilitation; vocational services work	TRAUMATIC BRAIN-INJURY; SEVERE MENTAL-ILLNESS; RANDOMIZED CONTROLLED-TRIAL; NEUROCOGNITIVE ENHANCEMENT THERAPY; COGNITIVE-BEHAVIORAL THERAPY; SUPPORTED EMPLOYMENT; FIDELITY SCALE; JOB PLACEMENT; OUTCOMES; REHABILITATION	As the field of vocational services (VS) research matures, it is necessary to review its progress and identify any important gaps in measurement and methodology that may hamper future efforts. To encourage progress, we have identified (1) ways to increase consistency in measuring employment outcomes, (2) emerging patterns and lingering gaps in the range of variables and measures commonly used in VS research, (3) broader methodological patterns and needs in the area of study design and sampling, (4) interventions that warrant additional study, and (5) broad strategies to increase the overall amount and quality of VS research. The goal of this article is to assist the field in achieving clearer coherence in shared expectations and standards for research so that the field can consolidate its gains as it helps people successfully return to rewarding jobs in the community.	[Drebing, Charles E.] Bedford Dept Vet Affairs Med Ctr, Psychol Serv, Bedford, MA USA; [Bell, Morris] Yale Univ, Dept Psychiat, West Haven, CT USA; [Campinell, E. Anthony] Vet Hlth Adm, Off Mental Hlth Serv, Lowell, MA USA; [Fraser, Robert] Univ Washington, Dept Neurol Neurol Surg & Rehabil Med, Seattle, WA 98195 USA; [Malec, James] Indiana Univ Sch Med, Indianapolis, IN USA; [Malec, James] Rehabil Hosp Indiana, Indianapolis, IN USA; [Penk, Walter] Texas A&M Univ Hlth Sci Ctr, Coll Med, Bryan, TX USA; [Pruitt-Stephens, Laura] Texas A&M Univ, College Stn, TX USA		Drebing, CE (corresponding author), Bedford VAMC, 200 Springs Rd 116B, Bedford, MA 01730 USA.	charles.drebing@va.gov			VHA Office of Research and Development; New England Mental Illness Research Education and Clinical Center	This material is based on work supported by the VHA Office of Research and Development and the New England Mental Illness Research Education and Clinical Center.	[Anonymous], 2001, INT CLASS FUNCT DIS; [Anonymous], 2002, DIAGN STAT MAN MENT; [Anonymous], 2002, PRES NEW FREED COMM; Becker DR, 1993, WORKING LIFE INDIVID; Bedell JR, 1998, PSYCHIATR REHABIL J, V21, P279, DOI 10.1037/h0095301; BELL M, 2003, J VOCATIONAL REHABIL, V18, P43; Bell MD, 2007, J NORWEGIAN PSYCHOL, V44, P606; Bell MD, 2008, SCHIZOPHR RES, V105, P18, DOI 10.1016/j.schres.2008.06.026; Bell MD, 2005, J REHABIL RES DEV, V42, P829, DOI 10.1682/JRRD.2005.03.0061; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Black W., 2004, BRIT J OCCUP THER, V67, P526, DOI [10.1177/030802260406701202, DOI 10.1177/030802260406701202]; Bond GR, 2007, J CONSULT CLIN PSYCH, V75, P968, DOI 10.1037/0022-006X.75.6.968; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Bond GR, 2010, RES SOCIAL WORK PRAC, V20, P493, DOI 10.1177/1049731509358085; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Bruyere SM, 2006, REHABIL COUNS BULL, V50, P46, DOI 10.1177/00343552060500010601; Bush PW, 2009, PSYCHIAT SERV, V60, P1024, DOI 10.1176/appi.ps.60.8.1024; Campbell K, 2007, J VOCAT REHABIL, V27, P3; Chalamat M, 2005, AUST NZ J PSYCHIAT, V39, P693, DOI 10.1111/j.1440-1614.2005.01653.x; Chan ASM, 2009, AM J OCCUP THER, V63, P238, DOI 10.5014/ajot.63.3.238; Chandler D, 1999, PSYCHIATR REHABIL J, V23, P24, DOI 10.1037/h0095198; Cimera RE, 2009, J APPL REHABILITATIO, V40, P28; Conley R, 2009, J VOCAT REHABIL, V31, P19, DOI 10.3233/JVR-2009-0468; Connors SH, 2001, RESOURCE FACILITATIO; Cook JA, 2006, J VOCAT REHABIL, V25, P71; Cook JA, 2008, PSYCHIATR REHABIL J, V31, P291, DOI 10.2975/31.4.2008.291.295; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corthell DW, 1990, TRAUMATIC BRAIN INJU; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; CURL RM, 1993, J VOCATIONAL REHABIL, V3, P72; Drebing C.E., 2006, PSYCHOL SERV, V3, P181, DOI DOI 10.1037/1541-1559.3.3.181; Drebing CE, 2005, J APPL BEHAV ANAL, V38, P359, DOI 10.1901/jaba.2005.100-03; Drebing CE, 2004, REHABIL COUNS BULL, V47, P162, DOI 10.1177/00343552040470030501; Drebing CE, 2005, P ANN CONV AM PSYCH; Drebing CE, 2007, J REHABIL RES DEV, V44, P851, DOI 10.1682/JRRD.2006.09.0123; Evans R W, 1991, J Insur Med, V23, P192; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fraser VV, 2008, PSYCHIATR REHABIL J, V31, P332, DOI 10.2975/31.4.2008.332.339; Gowdy EA, 2004, PSYCHIATR REHABIL J, V28, P150, DOI 10.2975/28.2004.150.156; Greenberg GA, 2007, MIL MED, V172, P162, DOI 10.7205/MILMED.172.2.162; Griffin C, 2008, J VOCAT REHABIL, V28, P135; Gutman SA, 2009, AM J OCCUP THER, V63, P245, DOI 10.5014/ajot.63.3.245; Hagner D, 2000, REHABIL COUNS BULL, V44, P22, DOI 10.1177/003435520004400104; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hser YI, 2004, PSYCHIAT SERV, V55, P767, DOI 10.1176/appi.ps.55.7.767; Humphreys K, 1997, J STUD ALCOHOL, V58, P231, DOI 10.15288/jsa.1997.58.231; Koop JI, 2004, PSYCHIATR REHABIL J, V28, P16, DOI 10.2975/28.2004.16.24; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lawer L, 2009, J AUTISM DEV DISORD, V39, P487, DOI 10.1007/s10803-008-0649-4; Liberman, 2008, RECOVERY DISABILITY; Lysaker PH, 2009, SCHIZOPHR RES, V107, P186, DOI 10.1016/j.schres.2008.10.018; Lysaker PH, 2005, J REHABIL RES DEV, V42, P673, DOI 10.1682/JRRD.2004.12.0157; Macias C, 2009, ADM POLICY MENT HLTH, V36, P331, DOI 10.1007/s10488-009-0224-0; Magura S, 2007, SUBST USE MISUSE, V42, P811, DOI 10.1080/10826080701202403; Malec J, 2005, REHABILITATION TRAUM; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; McGurk SR, 2009, SCHIZOPHRENIA BULL, V35, P319, DOI 10.1093/schbul/sbn182; McKay C, 2005, PSYCHIATR REHABIL J, V29, P25, DOI 10.2975/29.2005.25.33; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; McQuilken M, 2003, J VOCATIONAL REHABIL, V18, P59; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; Mueller L, 2008, P 117 ANN M AM PSYCH; Mueser KT, 1997, J NERV MENT DIS, V185, P419, DOI 10.1097/00005053-199707000-00001; Noone W, 2002, COMMUNITY BASED EMPL; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Penk W, 2009, PSYCHIATR REHABIL J, V33, P297, DOI 10.2975/33.4.2010.297.307; Pinsk J, 2008, P VA C TRANSF MENT H; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Prochaska J.O., 1986, TREATING ADDICTIVE B; Resnick S.G., 2006, PSYCHOL SERV, V3, P239; Rudnick A, 2009, PSYCHIAT SERV, V60, P1690, DOI 10.1176/ps.2009.60.12.1690; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schneider J, 2009, HEALTH SOC CARE COMM, V17, P151, DOI 10.1111/j.1365-2524.2008.00810.x; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shankar J, 2008, SOC WORK MENT HEALTH, V7, P271, DOI 10.1080/15332980802072603; Silverman K, 2007, J APPL BEHAV ANAL, V40, P387, DOI 10.1901/jaba.2007.40-387; Siu PSK, 2010, J VOCAT REHABIL, V32, P15, DOI 10.3233/JVR-2010-0491; Stewart M, 2000, J FAM PRACTICE, V49, P796; THOMAS DF, 1993, COMMUNITY BASED EMPL; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; Warburton J, 2008, EUR J AGEING, V5, P129, DOI 10.1007/s10433-008-0081-9; Warner R, 2006, PSYCHIAT SERV, V57, P1488, DOI 10.1176/appi.ps.57.10.1488; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WEHMAN P, 1993, COMMUNITY BASED EMPL; Wong CJ, 2004, EXP CLIN PSYCHOPHARM, V12, P39, DOI 10.1037/1064-1297.12.1.39; Wong CJ, 2007, SUBST USE MISUSE, V42, P1127, DOI 10.1080/10826080701407952; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946	92	12	12	2	19	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	1					101	119		10.1682/JRRD.2010.06.0105			19	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149ES	WOS:000319302400011	22492342	Bronze			2022-02-06	
J	Gill, PS; Gill, TS; Kamath, A; Whisnant, B				Gill, Preetinder S.; Gill, Tejkaran S.; Kamath, Ashwini; Whisnant, Billy			Readability assessment of concussion and traumatic brain injury publications by Centers for Disease Control and Prevention	INTERNATIONAL JOURNAL OF GENERAL MEDICINE			English	Article						readability; usability; suitability; CDC health literature; concussion; traumatic brain injury	PATIENT EDUCATION MATERIALS; INFORMED-CONSENT FORMS; HEALTH LITERACY; INFORMATION LEAFLETS; AMERICAN-ACADEMY; COMPREHENSION; INTERNET; QUALITY	Health literacy is associated with a person's capacity to find, access, contextualize, and understand information needed for health care-related decisions. The level of health literacy thus has an influence on an individual's health status. It can be argued that low health literacy is associated with poor health status. Health care literature (eg,pamphlets, brochures, postcards, posters, forms) are published by public and private organizations worldwide to provide - information to the general public. The ability to read, use, and understand is critical to the successful application of knowledge disseminated by this literature. This study assessed the readability, suitability, and usability of health care literature associated with concussion and traumatic brain injury published by the United States Centers for Disease Control and Prevention. The Flesch-Kincaid Grade Level, Flesch Reading Ease, Gunning Fog, Simple Measure of Gobbledygook, and Suitability Assessment of Materials indices were used to assess 40 documents obtained from the Centers for Disease Control and Prevention website. The documents analyzed were targeted towards the general public. It was found that in order to be read properly, on average, these documents needed more than an eleventh grade/high school level education. This was consistent with the findings of other similar studies. However, the qualitative Suitability Assessment of - Materials index showed that, on average, usability and suitability of these documents was superior. Hence, it was concluded that formatting, - illustrations, layout, and graphics play a pivotal role in improving health care-related literature and, in turn, - promoting health literacy. Based on the comprehensive literature review and assessment of the 40 documents associated with concussion and traumatic brain injury, recommendations have been made for improving the readability, suitability, and usability of health care- related - documents. The recommendations are presented in the form of an incremental improvement process cycle and a list of dos and don'ts.	[Gill, Preetinder S.; Whisnant, Billy] Eastern Michigan Univ, Coll Technol, 159 Sill Hall, Ypsilanti, MI 48197 USA; [Gill, Tejkaran S.] Univ Michigan, Coll Engn, Ann Arbor, MI 48109 USA; [Kamath, Ashwini] Univ Texas Austin, Sch Informat, Austin, TX 78712 USA		Gill, PS (corresponding author), Eastern Michigan Univ, Coll Technol, 159 Sill Hall, Ypsilanti, MI 48197 USA.	pgill1@emich.edu					Amini H, 2007, PEDIATR DENT, V29, P431; Badarudeen S, 2010, CLIN ORTHOP RELAT R, V468, P2572, DOI 10.1007/s11999-010-1380-y; Banasiak N, 2011, J PEDIATR HEALTH CAR, V25, pe24; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Breese P, 2005, JAMA-J AM MED ASSOC, V293, P1593, DOI 10.1001/jama.293.13.1593; Calderon JL, 2006, AM J MED QUAL, V21, P49, DOI 10.1177/1062860605283572; CDC, 2010, CDC CDC HIST OUR STO; Centers for Disease Control and Prevention, 2012, AB CDC; Centers for Disease Control and Prevention, 2011, AB CDC; Clauson KA, 2010, J ALTERN COMPLEM MED, V16, P119, DOI 10.1089/acm.2008.0611; Collins Nina, 2006, J Allied Health, V35, P223; Davis TC, 1998, PATIENT EDUC COUNS, V33, P25, DOI 10.1016/S0738-3991(97)00053-0; DAVIS TC, 1994, PEDIATRICS, V93, P460; Davis TC, 1996, PEDIATRICS, V97, P804; Doak CC, 1996, TEACHING PATIENTS LO; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; Hay L, 2009, PERSPECT PUBLIC HEAL, V129, P156, DOI 10.1177/17579139091290040305; HealthyPeople.gov, 2012, HLTH COMM HLTH INF T; Hendrickson Rachel L, 2006, BMC Oral Health, V6, P14, DOI 10.1186/1472-6831-6-14; Herman Steve, 2000, GLOBAL COSMETIC IND, V167, P34; Herreid CF, 2002, J COLL SCI TEACH, V31, P288; Jukkala AM, 2011, J NURS CARE QUAL, V26, P186, DOI 10.1097/NCQ.0b013e318209fa2f; Kasabwala K, 2012, OTOLARYNG HEAD NECK, V147, P466, DOI 10.1177/0194599812442783; Kolstad, 2002, ADULT LITERACY AM 1; Lagasse LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023583; Lauder B., 2008, HOME HEALTHCARE NURS, V26, P253; McCray AT, 2005, J AM MED INFORM ASSN, V12, P152, DOI 10.1197/jamia.M1687; McKinney J, 2006, FAMILY HLTH LITERACY; MCLAUGHLIN GH, 1969, J READING, V12, P639; MedLinePlus, 2011, HLTH LIT; MedlinePlus, 2007, ADV DIR; MedlinePlus, 2011, WRIT EASY TO READ HL; MELMAN ST, 1994, ARCH PEDIAT ADOL MED, V148, P642, DOI 10.1001/archpedi.1994.02170060096019; Merchant RC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-238; Mumford ME, 1997, J ADV NURS, V26, P985, DOI 10.1046/j.1365-2648.1997.00455.x; MURPHY J, 1994, NEW ZEAL MED J, V107, P509; Naidu A., 2008, WHITIREIA NURS J, P39; NICOLL A, 1984, DEV MED CHILD NEUROL, V26, P596; Nore GWE, 1991, CLEAR LINES COMPOSE; O'Reilly K. B., 2012, AM MED NEWS; OATES MS, 1989, AUST PAEDIATR J, V25, P35; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Osborne H, 1999, Hosp Top, V77, P4; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Parker RM, 2003, HEALTH AFFAIR, V22, P147, DOI 10.1377/hlthaff.22.4.147; Pizur-Barnekow K, 2011, TOP EARLY CHILD SPEC, V31, P58, DOI 10.1177/0271121410387676; Reinhard SC, 2007, ISSUE BRIEF CTR MED, V1, P1; Schneider Janet M, 2006, J HOSP LIBRARIANSHIP, V6, P99; SPARKS BI, 1993, OPTOMETRY VISION SCI, V70, P127, DOI 10.1097/00006324-199302000-00008; Sugerman DE, 2012, J HEALTH COMMUN, V17, P698, DOI 10.1080/10810730.2011.635777; Terblanche M, 2010, OPEN ACCESS J CLIN T, V2, P157, DOI 10.2147/OAJCT.S13608; Walsh TM, 2008, RESP CARE, V53, P1310; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Williams MV, 2002, FAM MED, V34, P383; Wilson JF, 2003, ANN INTERN MED, V139, P875, DOI 10.7326/0003-4819-139-10-200311180-00038; Wilson M, 2009, CLIN NURSE SPEC, V23, P33, DOI 10.1097/01.NUR.0000343079.50214.31; Wong ICK, 1999, SEIZURE-EUR J EPILEP, V8, P35, DOI 10.1053/seiz.1998.0220	58	12	12	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-7074			INT J GEN MED	Int. J. Gen. Med.		2012	5						923	933		10.2147/IJGM.S37110			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V05IK	WOS:000213866100127	23204856	Green Submitted, Green Published, gold			2022-02-06	
J	Hassett, LM; Moseley, AM; Whiteside, B; Barry, S; Jones, T				Hassett, Leanne M.; Moseley, Anne M.; Whiteside, Bhavini; Barry, Siobhan; Jones, Taryn			Circuit class therapy can provide a fitness training stimulus for adults with severe traumatic brain injury: a randomised trial within an observational study	JOURNAL OF PHYSIOTHERAPY			English	Article						Brain Injuries; Physiotherapy (Specialty); Exercise; Heart rate; Feedback	HEART-RATE; EXERCISE; DEPRESSION; INTENSITY; MODERATE; PROGRAM; INDUCE	Questions: Can circuit class therapy provide sufficient exercise dosage (at least 20 minutes at >= 50% heart rate reserve or total caloric expenditure >= 300 kilocalories) to induce a cardiorespiratory fitness effect in adults with traumatic brain injury? Can feedback from heart rate monitors influence exercise intensity? Design: Randomised controlled trial within an observational study. Participants: Fifty-three people with severe traumatic brain injury, of whom 40 progressed into the trial. Intervention: All participants undertook circuit class therapy. Participants allocated to the experimental group received exercise intensity feedback from a heart rate monitor and the control group received no feedback. Outcome measures: Proportion of participants exercising at >= 50% heart rate reserve for at least 20 minutes or expending >= 300 kilocalories during circuit class therapy. The primary outcome measure for the trial was the time spent in the heart rate training zone (ie, at >= 50% heart rate reserve) during the intervention and re-assessment periods. Results: Circuit class therapy provided sufficient cardiorespiratory exercise dosage for 28% (95% CI 18 to 42) of the cohort according to the heart rate reserve criteria and 62% (95% CI 49 to 74) according to the caloric criteria. Feedback did not increase the time in the training zone during the intervention (mean difference 4.8 minutes, 95% CI -1.4 to 10.9) or re-assessment (1.9 minutes, -4.4 to 8.3) periods. Conclusion: The low intensity, long duration structure of circuit class therapy can provide sufficient exercise dosage for a fitness training effect for 62% of people with traumatic brain injury. Feedback from heart rate monitors does not necessarily influence exercise intensity. Trial registration: ACTRN12607000522415. [Hassett LM, Moseley AM, Whiteside B, Barry S, Jones T (2012) Circuit class therapy can provide a fitness training stimulus for adults with severe traumatic brain injury: a randomised trial within an observational study. Journal of Physiotherapy 58: 105-112]	[Hassett, Leanne M.; Whiteside, Bhavini; Barry, Siobhan; Jones, Taryn] S Western Sydney Local Hlth Dist, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Moseley, Anne M.] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Musculoskeletal Div, Sydney, NSW 2006, Australia		Hassett, LM (corresponding author), S Western Sydney Local Hlth Dist, Liverpool Brain Injury Rehabil Unit, Locked Bag 7103,Liverpool BC 1871, Sydney, NSW, Australia.	Leanne.hassett@sswahs.nsw.gov.au	; Jones, Taryn/C-8333-2013	Hassett, Leanne/0000-0002-3546-1822; Jones, Taryn/0000-0003-3809-2126	Menzies Foundation	The Menzies Foundation.	American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Carr J. H., 1998, NEUROLOGICAL REHABIL; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Dunton GF, 2009, MED SCI SPORT EXER, V41, P1698, DOI 10.1249/MSS.0b013e3181a06c9b; English C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007513.pub2; Fann JR, 2003, PSYCHOSOMATICS, V44, P161; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; Katz-Leurer M, 2010, BRAIN INJURY, V24, P110, DOI 10.3109/02699050903508234; Kuys S, 2006, PHYSIOTHER RES INT, V11, P219, DOI 10.1002/pri.344; Lamberts RP, 2009, J STRENGTH COND RES, V23, P1005, DOI 10.1519/JSC.0b013e3181a2dcdc; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1378, DOI 10.1053/apmr.2002.35089; McManus AM, 2008, PREV MED, V47, P402, DOI 10.1016/j.ypmed.2008.06.001; Moore, 2009, ACSMS EXERCISE MANAG, P287; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pfaff A, 2004, MANUAL MODIFIED OXFO; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; SALTIN B, 1968, CIRCULATION       S7, V38, P1, DOI DOI 10.1161/01.CIR.38.6.1104; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Swain D. P., 2007, EXERCISE PRESCRIPTIO; Swain David P, 2005, Prev Cardiol, V8, P55, DOI 10.1111/j.1520-037X.2005.02791.x; Yamashita S, 2006, J SPORT MED PHYS FIT, V46, P425	26	12	12	0	15	AUSTRALIAN PHYSIOTHERAPY ASSOC	ST KILDA	LEVEL 3, 201  FITZROY ST, ST KILDA, 3182, AUSTRALIA	1836-9553	1836-9561		J PHYSIOTHER	J. Physiother.		2012	58	2					105	112		10.1016/S1836-9553(12)70090-5			8	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	946UO	WOS:000304383200006	22613240	gold			2022-02-06	
J	Hsieh, MY; Ponsford, J; Wong, D; Schonberger, M; McKay, A; Haines, K				Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; Schoenberger, Michael; McKay, Adam; Haines, Kerrie			Development of a motivational interviewing programme as a prelude to CBT for anxiety following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Anxiety; Motivational interviewing; Cognitive behaviour therapy; Traumatic brain injury	WORKING ALLIANCE INVENTORY; SCHEDULED TELEPHONE INTERVENTION; COGNITIVE-BEHAVIORAL THERAPY; CASE EXPERIMENTAL-DESIGN; PSYCHOTHERAPY-RESEARCH; PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; EMOTIONAL STATUS; SELF-GENERATION	A brief preparatory programme, based on the principles of motivational interviewing (MI), was developed as a way of engaging clients with traumatic brain injury (TBI) and preparing them for a cognitive behaviour therapy (CBT) programme for anxiety. The MI + CBT programme was delivered to a male client in his early 40s with severe TBI at four months post-injury, using a single-subject design with repeated measures pre- and post-treatment. The client received three sessions of manualised MI, followed by nine sessions of CBT. The MI sessions focused on helping the client to develop more realistic goals and supporting his self-efficacy about his ability to cope with anxiety. Specific strategies were used to accommodate the client's cognitive limitations, such as the use of personally meaningful metaphors and role plays. Re-assessments were conducted at the end of MI, CBT and nine weeks post-treatment, using a semi-structured clinical interview and self-report measures of anxiety, mood and change expectancy. The client showed significant improvement in anxiety following treatment and a significant reduction in subjective units of distress (SUDS) between the MI and CBT phases. The results suggest the potential utility of MI in people with TBI, and the need to evaluate treatment protocols in a controlled trial.	[Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; McKay, Adam; Haines, Kerrie] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Hsieh, Ming-Yun; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [McKay, Adam] Epworth Med Fdn, Melbourne, Vic, Australia; [Hsieh, Ming-Yun] Arbias, Melbourne, Vic, Australia; [Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	McKay, Adam JD/M-6003-2017; Wong, Dana/AAD-3410-2020	McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929	Monash UniversityMonash University; Victorian Brain Injury Recovery Association	This study was supported by a grant from Monash University, and a scholarship from the Victorian Brain Injury Recovery Association. The funding sources had no role in study design, data collection or analysis. The authors alone were responsible for the content and writing of the paper. A portion of the preliminary findings of this paper was presented at the Australian Association of Cognitive and Behaviour Therapy conference in Melbourne, April 2010. The data reported herein are from the first author's doctoral thesis, which was supervised by the second, third and fourth authors. The authors would like to thank all participants who helped to make this work possible. Special thanks to the staff members at the Monash-Epworth Rehabilitation Research Unit, Epworth Hospital and The Victorian Rehabilitation Centre. We gratefully acknowledge Dr Henny Westra and Dr David Dozois, who generously provided us with their MI treatment manual for adaptation.	Andrews G., 2003, TREATMENT ANXIETY DI; Arkowitz H., 2008, MOTIVATIONAL INTERVI; Beck J.S., 1995, COGNITIVE THERAPY BA; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Borckardt JJ, 2008, AM PSYCHOL, V63, P77, DOI 10.1037/0003-066X.63.2.77; Borckardt JJ, 2006, SMA SIMULATION MODEL; Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burke B. L., 2004, J COGN PSYCHOTHER, V18, P309, DOI [10.1891/jcop.18.4.309.64002, DOI 10.1891/JC0P.18.4.309.64002]; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Busseri MA, 2003, PSYCHOL ASSESSMENT, V15, P193, DOI 10.1037/1040-3590.15.2.193; Coughlin A, 2007, MEMORY INFORM PROCES; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Devilly GJ, 2005, RELIABLE CLIN CHANGE, V4.0; Dozois DJA, 2005, BEHAV RES THER, V43, P1655, DOI 10.1016/j.brat.2004.12.001; Dozois DJA, 2004, BEHAV RES THER, V42, P711, DOI 10.1016/S0005-7967(03)00193-1; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; First M, 2007, STRUCTURED CLIN INTE; Fleming JM, 1996, BRAIN INJURY, V10, P1; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Hatcher RL, 2006, PSYCHOTHER RES, V16, P12, DOI 10.1080/10503300500352500; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kertes A, 2011, COGN BEHAV PRACT, V18, P55, DOI 10.1016/j.cbpra.2009.06.005; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; Manchester D, 2001, BRAIN DAM B, P157; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Mendel E., 2002, BRIT J LEARN DISABIL, V30, P153, DOI DOI 10.1046/J.1468-3156.2002.00209.X; Miller W.R., 2002, MOTIVATIONAL INTERVI; Moyers T. B., 2006, PERSONAL GOALS VALUE; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; PsycBITE Committee, 2010, RAT MAN SINGL UNPUB; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Westra H. A., 2003, MOTIVATIONAL INTERVI; Westra HA, 2007, J CONSULT CLIN PSYCH, V75, P363, DOI 10.1037/0022-006X.75.3.363; Westra HA, 2006, COGNITIVE THER RES, V30, P481, DOI 10.1007/s10608-006-9016-y; Westra HA, 2010, TREATMENT RESISTANT ANXIETY DISORDERS: RESOLVING IMPASSES TO SYMPTOM REMISSION, P199; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	12	13	3	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	4					563	584		10.1080/09602011.2012.676284			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	995SC	WOS:000308031600006	22632450				2022-02-06	
J	Prakash, A; Parelkar, SV; Oak, SN; Gupta, RK; Sanghvi, BV; Bachani, M; Patil, R				Prakash, Advait; Parelkar, Sandesh V.; Oak, Sanjay N.; Gupta, Rahul K.; Sanghvi, Beejal V.; Bachani, Mitesh; Patil, Rajashekhar			Role of hyperbaric oxygen therapy in severe head injury in children	JOURNAL OF PEDIATRIC NEUROSCIENCES			English	Article						Children; head injury; hyperbaric oxygen therapy		Aim: A brain injury results in a temporary or permanent impairment of cognitive, emotional, and/or physical function. Predicting the outcome of pediatric brain injury is difficult. Prognostic instruments are not precise enough to reliably predict individual patient's mortality and long-term functional status. The purpose of this article is to provide a guide to the strengths and limitations of the use of hyperbaric oxygen therapy (HBOT) in treating pediatric patients with severe brain injury. Materials and Methods: We studied total 56 patients of head injury. Out of them 28 received HBOT. Only cases with severe head injury [Glasgow Coma Scale (GCS) < 8] with no other associated injury were included in the study group. After an initial period of resuscitation and conservative management (10-12 days), all were subjected to three sessions of HBOT at 1-week interval. This study group was compared with a control group of similar severity of head injury (GCS < 8). Results: The study and control groups were compared in terms of duration of hospitalization, GCS, disability reduction, and social behavior. Patients who received HBOT were significantly better than the control group on all the parameters with decreased hospital stay, better GCS, and drastic reduction in disability. Conclusion: In children with traumatic brain injury, the addition of HBOT significantly improved outcome and quality of life and reduced the risk of complications.	[Prakash, Advait; Parelkar, Sandesh V.; Oak, Sanjay N.; Gupta, Rahul K.; Sanghvi, Beejal V.; Bachani, Mitesh; Patil, Rajashekhar] King Edward Mem Hosp, Dept Pediat Surg, Mumbai, Maharashtra, India		Prakash, A (corresponding author), 302,Nirmal Kunj,Parel Village, Mumbai, Maharashtra, India.	drprakashadvait@rediffmail.com					Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Barrett K, 1998, UNDERSEA HYPERBAR M, V25, P9; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CHESNUT R, 1999, EVIDENCE REPORT REHA, P1; Clark DE, 2002, HEALTH SERV RES, V37, P631, DOI 10.1111/1475-6773.00041; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; Harch P. G., 1999, TXB HYPERBARIC MED; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 1998, PROGNOSIS NEUROLOGY, P31; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kindwall EP., 1999, HYPERBARIC MED PRACT, V2nd ed; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Miljkovic-Lolic M, 2003, BRAIN RES, V971, P90, DOI 10.1016/S0006-8993(03)02364-3; Neubauer R, 1998, 8 INT CHILD NEUR C; NEUBAUER RA, 1990, LANCET, V335, P1217, DOI 10.1016/0140-6736(90)92736-2; NEUBAUER RA, 1992, CLIN NUCL MED, V17, P477, DOI 10.1097/00003072-199206000-00010; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Rosenthal RE, 2003, STROKE, V34, P1311, DOI 10.1161/01.STR.0000066868.95807.91; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; Scheinkestel CD, 1999, MED J AUSTRALIA, V170, P203, DOI 10.5694/j.1326-5377.1999.tb140318.x; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tolias CM, 2009, J NEUROSURG, V110, P607, DOI 10.3171/JNS.2009.110.3.0607a; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	40	12	15	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1817-1745	1998-3948		J PEDIATR NEUROSCI	J. Pediatr. Neurosci.	JAN-APR	2012	7	1					4	8		10.4103/1817-1745.97610			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V4Q6B	WOS:000219173200002	22837768	Green Published			2022-02-06	
J	Seo, JP; Kim, OL; Kim, SH; Chang, MC; Kim, MS; Son, SM; Jang, SH				Seo, Jeong Pyo; Kim, Oh Lyong; Kim, Seong Ho; Chang, Min Cheol; Kim, Min-Su; Son, Su Min; Jang, Sung Ho			Neural injury of uncinate fasciculus in patients with diffuse axonal injury	NEUROREHABILITATION			English	Article						Diffusion tensor imaging; brain injury; diffuse axonal injury; uncinate fasciculus	TRAUMATIC BRAIN-INJURY; LONGITUDINAL CHANGES; TENSOR; TRACTOGRAPHY; IMPAIRMENT; TRACKING; MR	The recent development of diffusion tensor imaging (DTI) allows visualization and estimation of the uncinate fascicul us (UF). We investigated injuries of the UF in patients with diffuse axonal injury (DAI) who showed no specific lesions except for DAI lesions on conventional brain MRI. Twenty-one chronic patients with DAI, and 21 age- and sex-matched normal control subjects were recruited for this study. Diffusion tensor images were acquired using a sensitivity-encoding head coil at 1.5 T and the UF was reconstructed using DTI-Studio software. Fractional anisotropy (FA), apparent diffusion coefficient (ADC) value, and fiber number of the UF were measured. In the DAI group, the FA values and fiber numbers were significantly decreased compared to those of the control group (P < 0.05). The FA value and fiber number decreased 8.4% and 26.5% in the DAI group compared to those of the control group. By contrast, the ADC value did not show any difference between the DAI and control groups (P > 0.05). Changes in the DTI parameters of the DAI group appeared to indicate neural injury of the UF. We believe that DTI can be a useful evaluation tool for detecting hidden neural injuries of UF in patients with DAI.	[Seo, Jeong Pyo; Chang, Min Cheol; Son, Su Min; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Kim, Oh Lyong; Kim, Seong Ho; Kim, Min-Su] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Ministry of Education, Science and Technology of KoreaMinistry of Education, Science and Technology, Republic of Korea [11-1T-01]	This work was supported by the DGIST R&D Program of the Ministry of Education, Science and Technology of Korea (11-1T-01).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Holl N, 2011, SURG RADIOL ANAT, V33, P713, DOI 10.1007/s00276-011-0816-8; Hong JH, 2012, J HEAD TRAUMA REHAB, V27, P172, DOI 10.1097/HTR.0b013e318217192d; Hong JH, 2010, EUR NEUROL, V63, P252, DOI 10.1159/000277477; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Marchina S, 2011, STROKE, V42, P2251, DOI 10.1161/STROKEAHA.110.606103; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Nestor PG, 2004, NEUROPSYCHOLOGY, V18, P629, DOI 10.1037/0894-4105.18.4.629; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Sato K, 2010, NEURORADIOLOGY, V52, P729, DOI 10.1007/s00234-010-0653-1; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN, P654; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stadlbauer A, 2008, EUR RADIOL, V18, P130, DOI 10.1007/s00330-007-0733-8; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler, 1997, WECHSLER ADULT INTEL; Williams JM, 1991, MAS MEMORY ASSESSMEN, P127	40	12	12	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	4					323	328		10.3233/NRE-2012-0762			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	980HQ	WOS:000306884600010	22672947				2022-02-06	
S	Sullivan, KW; Quinn, JE; Pramuka, M; Sharkey, LA; French, LM		Wiederhold, BK; Riva, G		Sullivan, Katherine W.; Quinn, Julia E.; Pramuka, Michael; Sharkey, Laura A.; French, Louis M.			Outcomes from a Pilot Study using Computer-Based Rehabilitative Tools in a Military Population	ANNUAL REVIEW OF CYBERTHERAPY AND TELEMEDICINE 2012: ADVANCED TECHNOLOGIES IN THE BEHAVIORAL, SOCIAL AND NEUROSCIENCES	Studies in Health Technology and Informatics		English	Article; Book Chapter						Neurorehabilitation; Cognitive Rehabilitation & Therapy; Traumatic Brain Injury; Military Medicine	TRAUMATIC BRAIN-INJURY	Novel therapeutic approaches and outcome data are needed for cognitive rehabilitation for patients with a traumatic brain injury; computer-based programs may play a critical role in filling existing knowledge gaps. Brain-fitness computer programs can complement existing therapies, maximize neuroplasticity, provide treatment beyond the clinic, and deliver objective efficacy data. However, these approaches have not been extensively studied in the military and traumatic brain injury population. Walter Reed National Military Medical Center established its Brain Fitness Center (BFC) in 2008 as an adjunct to traditional cognitive therapies for wounded warriors. The BFC offers commercially available "brain-training" products for military Service Members to use in a supportive, structured environment. Over 250 Service Members have utilized this therapeutic intervention. Each patient receives subjective assessments pre and post BFC participation including the Mayo-Portland Adaptability Inventory-4 (MPAI-4), the Neurobehavioral Symptom Inventory (NBSI), and the Satisfaction with Life Scale (SWLS). A review of the first 29 BFC participants, who finished initial and repeat measures, was completed to determine the effectiveness of the BFC program. Two of the three questionnaires of self-reported symptom change completed before and after participation in the BFC revealed a statistically significant reduction in symptom severity based on MPAI and NBSI total scores (p < .05). There were no significant differences in the SWLS score. Despite the typical limitations of a retrospective chart review, such as variation in treatment procedures, preliminary results reveal a trend towards improved self-reported cognitive and functional symptoms.	[Sullivan, Katherine W.; Quinn, Julia E.; Pramuka, Michael; Sharkey, Laura A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA; [Quinn, Julia E.; Sharkey, Laura A.; French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA		French, LM (corresponding author), Walter Reed Natl Mil Med Ctr, Bethesda, MD 20889 USA.	louis.French@med.navy.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Galante E, 2007, G Ital Med Lav Ergon, V29, pB26; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Tieming J., 2011, ENT SOFTW COGN NEUR; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805	10	12	12	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0926-9630		978-1-61499-121-2	STUD HEALTH TECHNOL			2012	181						71	77		10.3233/978-1-61499-121-2-71			7	Computer Science, Cybernetics; Health Care Sciences & Services; Medical Informatics	Book Citation Index – Science (BKCI-S)	Computer Science; Health Care Sciences & Services; Medical Informatics	BA9IV	WOS:000339449900015	22954831				2022-02-06	
J	Yeo, SS; Chang, MC; Kim, SH; Son, S; Jang, SH				Yeo, Sang Seok; Chang, Min Cheol; Kim, Seong Ho; Son, Sumin; Jang, Sung Ho			Neural connection between injured cingulum and pedunculopontine nucleus in a patient with traumatic brain injury	NEUROREHABILITATION			English	Article						Cingulum; axonal injury; head trauma; diffusion tensor imaging; brain plasticity	DIFFUSION-TENSOR; CHOLINERGIC PATHWAYS; MILD; TRACTOGRAPHY; RAT	We report on a patient with traumatic brain injury who showed neural connection between injured cingulum and pedunculopontine nucleus on diffusion tensor tractography (DTT). A 74-year-old male who had suffered a traffic accident underwent conservative management for subarachnoid haemorrhage. Brain MRI which was performed 6 months after onset showed no specific lesions. On 6-month DTTs for cingulum of the patient, we observed discontinuations of both cingulums above the genu of corpus callosum. However, the left cingulum was connected to the left PPN via a neural tract that passed through the anterior corona radiata and thalamus. The neural connection between the injured cingulum and PPN seems to be a compensatory phenomenon for the destruction of cholinergic pathways from basal forebrain. We believe that this result might suggest one of recovery mechanisms of injured cingulum following brain injury.	[Yeo, Sang Seok; Chang, Min Cheol; Son, Sumin; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A0100 1873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A0100 1873).	Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Butcher L. L, 2004, RAT NERVOUS SYSTEM, P1257, DOI [DOI 10.1016/B978-012547638-6/50036-5, 10.1016/B978-012547638-6/50036-5]; Concha L, 2005, AM J NEURORADIOL, V26, P2267; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hong J. H., 2011, J HEAD TRAU IN PRESS; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Huijzen Cv, 2008, HUMAN CENTRAL NERVOU, Vxiv, P967; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee WT, 2008, MED NEUROANATOMY; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Mendoza JE, 2007, CLIN NEUROANATOMY NE, pix; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Nestler E. J., 2001, MOL NEUROPHARMACOLOG, Vxvi, P539; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Paxinos G., 1990, HUMAN NERVOUS SYSTEM, Vxi, P1195; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Wechsler, 1997, WECHSLER ADULT INTEL; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	21	12	12	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	2					143	146		10.3233/NRE-2012-0783			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	003IN	WOS:000308604700006	22951708				2022-02-06	
J	Yoshikawa, T; Hayashi, N; Tajiri, Y; Satake, Y; Ohtomo, K				Yoshikawa, Takeharu; Hayashi, Naoto; Tajiri, Yasuhito; Satake, Yoshirou; Ohtomo, Kuni			Brain Reorganization in Patients with Brachial Plexus Injury: A Longitudinal Functional MRI Study	SCIENTIFIC WORLD JOURNAL			English	Article							MUSCULOCUTANEOUS NERVE TRANSFER; PRIMARY SENSORIMOTOR CORTEX; CERVICAL ROOT-AVULSION; MOTOR CORTEX; CORTICAL REPRESENTATION; INTERCOSTAL NERVE; HAND MOVEMENT; BICEPS MUSCLE; STROKE; FMRI	The aim of this study is to assess plastic changes of the sensorimotor cortex (SMC) in patients with traumatic brachial plexus injury (BPI) using functional magnetic resonance imaging (fMRI). Twenty patients with traumatic BPI underwent fMRI using blood oxygen level-dependent technique with echo-planar imaging before the operation. Sixteen patients underwent their second fMRI at approximately one year after injury. The subjects performed two tasks: a flexion-extension task of the affected elbow and a task of the unaffected elbow. After activation, maps were generated, the number of significantly activated voxels in SMC contralateral to the elbow movement in the affected elbow task study (N-af) and that in the unaffected task study (N-unaf) were counted. An asymmetry index (AI) was calculated, where AI = (N-af - N-unaf)/(N-af + N-unaf). Ten healthy volunteers were also included in this fMRI study. The AI of the first fMRI of the patients with BPI was significantly lower than that of the healthy subjects (P = 0.035). The AI of the second fMRI significantly decreased compared with that of the first fMRI (P = 0.045). Brain reorganization associates with peripheral nervous changes after BPI and after operation for functional reconstruction.	[Yoshikawa, Takeharu; Hayashi, Naoto] Tokyo Univ Hosp, Dept Computat Diagnost Radiol & Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan; [Tajiri, Yasuhito] Tokyo Metropolitan Hiroo Gen Hosp, Dept Orthoped Surg, Shibuya Ku, Tokyo 1500013, Japan; [Satake, Yoshirou; Ohtomo, Kuni] Tokyo Univ Hosp, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan		Yoshikawa, T (corresponding author), Tokyo Univ Hosp, Dept Computat Diagnost Radiol & Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	takeharu-yoshikawa@umin.ac.jp					Alkadhi H, 2000, AM J NEURORADIOL, V21, P1423; Belzberg AJ, 2004, J NEUROSURG, V101, P365, DOI 10.3171/jns.2004.101.3.0365; Cheng H, 1997, J COMP NEUROL, V380, P155, DOI 10.1002/(SICI)1096-9861(19970407)380:2<155::AID-CNE1>3.0.CO;2-2; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cramer SC, 2000, NEUROPHARMACOLOGY, V39, P842, DOI 10.1016/S0028-3908(99)00258-0; Cramer SC, 2000, STROKE, V31, P668, DOI 10.1161/01.STR.31.3.668; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Dettmers C, 1999, NEUROSCI LETT, V263, P41, DOI 10.1016/S0304-3940(99)00105-6; Ersland L, 1996, NEUROREPORT, V8, P207, DOI 10.1097/00001756-199612200-00042; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1997, HUMAN BRAIN FUNCTION, P25; GLASBY MA, 1995, PARAPLEGIA, V33, P359, DOI 10.1038/sc.1995.80; Hayashi N, 2002, RADIOLOGY, V223, P397, DOI 10.1148/radiol.2232010857; Hayashi N, 1998, RADIOLOGY, V206, P817, DOI 10.1148/radiology.206.3.9494507; Hsieh JC, 2002, ANN NEUROL, V51, P381, DOI 10.1002/ana.10149; Iwase Y, 2001, J Orthop Sci, V6, P397, DOI 10.1007/s007760170005; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; KAWAI H, 1994, J BONE JOINT SURG BR, V76B, P666; Kinomoto K, 2003, NEUROREPORT, V14, P1671, DOI 10.1097/00001756-200309150-00003; Malessy MJA, 1998, J NEUROSURG, V88, P266, DOI 10.3171/jns.1998.88.2.0266; Malessy MJA, 2003, J NEUROSURG, V98, P261, DOI 10.3171/jns.2003.98.2.0261; Malessy MJA, 1998, NEUROSURGERY, V42, P787, DOI 10.1097/00006123-199804000-00062; Malessy MJA, 1998, J NEUROSURG, V89, P568, DOI 10.3171/jns.1998.89.4.0568; MANO Y, 1995, ANN NEUROL, V38, P15, DOI 10.1002/ana.410380106; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Millesi H., 1991, FLYNNS HAND SURG, P457; NAGANO A, 1989, J HAND SURG-AM, V14A, P980, DOI 10.1016/S0363-5023(89)80047-4; Nagano A, 1998, J Orthop Sci, V3, P71, DOI 10.1007/s007760050024; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Pineiro R, 2002, STROKE, V33, P103, DOI 10.1161/hs0102.100482; Pineiro R, 2001, STROKE, V32, P1134, DOI 10.1161/01.STR.32.5.1134; POLINE JB, 1995, J COMPUT ASSIST TOMO, V19, P788, DOI 10.1097/00004728-199509000-00017; Reddy H, 2002, STROKE, V33, P502, DOI 10.1161/hs0202.103337; Reddy H, 2002, BRAIN, V125, P2646, DOI 10.1093/brain/awf283; Reddy H, 2002, J NEUROL NEUROSUR PS, V72, P203, DOI 10.1136/jnnp.72.2.203; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Roux FE, 2001, NEUROSURGERY, V49, P736	42	12	13	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1537-744X			SCI WORLD J	Sci. World J.		2012									501751	10.1100/2012/501751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960ZQ	WOS:000305433100001	22623904	Green Published, gold, Green Submitted			2022-02-06	
J	Zahid, M; Bin Sabir, A; Asif, N; Julfiqar, M; Khan, AQ; Ahmad, S; Siddiqui, YS				Zahid, Mohammad; Bin Sabir, Aamir; Asif, Naiyer; Julfiqar, Mohammad; Khan, A. Q.; Ahmad, Sohail; Siddiqui, Yasir S.			Fixation using cannulated screws and fibular strut grafts for fresh femoral neck fractures with posterior comminution	JOURNAL OF ORTHOPAEDIC SURGERY			English	Article						bone screws; bone transplantation; femoral neck fractures; fibula		Purpose. To evaluate the use of fibular grafting for fresh femoral neck fractures with posterior comminution. Methods. 18 women and 15 men aged 20 to 60 years underwent osteosynthesis and fibular strut grafting supplemented with 7.0-mm cannulated hip screws for Garden grades III (n=21) and IV (n=12) femoral neck fractures associated with posterior comminution. All fractures were reduced by closed methods, and no hip was aspirated. Clinical and radiological outcomes were evaluated. Results. The mean delay in presentation after injury was 3.2 (range, 1-12) days. The mean delay in operation was 8.8 (range, 5-21) days. The mean follow-up period was 2 (range, 1-4) years. According to the Harris hip score, outcome was good to excellent in 20 patients, fair in 7, and poor in 6. 27 of the 33 patients achieved bone union after a mean of 4.7 (range, 4.2-7) months. In 5 patients, the bone was united with a mean of 10 degrees of varus collapse and a mean of 1 cm of shortening. Six patients had nonunion. Other complications included screw migration in the joint space (n=1), graft migration into the joint space (n=3), and screw pullout (n=5). No patient had avascular necrosis of the femoral head. Conclusion. Osteosynthesis and fibular grafting for freshly displaced femoral neck fractures with posterior comminution is an inexpensive and technically less demanding procedure for retaining a stable, painless, mobile, and functional hip.	[Zahid, Mohammad; Bin Sabir, Aamir; Asif, Naiyer; Julfiqar, Mohammad; Khan, A. Q.; Ahmad, Sohail; Siddiqui, Yasir S.] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Orthopaed Surg, Aligarh 202002, Uttar Pradesh, India		Julfiqar, M (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Orthopaed Surg, Aligarh 202002, Uttar Pradesh, India.	drzulfiqar1983@rediffmail.com					BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; Cho MR, 2007, J ORTHOP TRAUMA, V21, P158, DOI 10.1097/BOT.0b013e31803773ae; DOOLEY BJ, 1982, AUST NZ J SURG, V52, P134, DOI 10.1111/j.1445-2197.1982.tb06087.x; Estrada LS, 2002, CLIN ORTHOP RELAT R, P110; GARDEN RS, 1964, J BONE JOINT SURG BR, V46, P630, DOI 10.1302/0301-620X.46B4.630; GARDEN RS, 1974, ORTHOP CLIN N AM, V5, P683; HARGADON EJ, 1963, J BONE JOINT SURG BR, V45, P305; Hirata T, 2001, CLIN ORTHOP RELAT R, P294; Krastman P, 2006, ARCH ORTHOP TRAUM SU, V126, P297, DOI 10.1007/s00402-006-0143-4; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; Mathews V, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000118700.22681.50; MEYERS MH, 1973, J BONE JOINT SURG AM, VA 55, P257, DOI 10.2106/00004623-197355020-00002; MEYERS MH, 1975, J BONE JOINT SURG AM, V57, P718, DOI 10.2106/00004623-197557050-00034; Mishra D, 1998, INDIAN J ORTHOP, V32, P32; Nagi ON, 1998, J BONE JOINT SURG BR, V80B, P798, DOI 10.1302/0301-620X.80B5.8703; NAGI ON, 1986, J BONE JOINT SURG BR, V68, P387, DOI 10.1302/0301-620X.68B3.3733802; PARKER MJ, 1993, HIP FRACTURE MANAGEM, P273; Roshan A, 2006, CLIN ORTHOP RELAT R, P152, DOI 10.1097/01.blo.0000203483.13583.c8; SCHECK M, 1980, CLIN ORTHOP RELAT R, P138; STEWART MJ, 1956, J BONE JOINT SURG AM, V38, P33, DOI 10.2106/00004623-195638010-00004; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003	21	12	20	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2309-4990			J ORTHOP SURG-HONG K	J. Orthop. Surg.		2012	20	2					191	195		10.1177/230949901202000211			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	V35TN	WOS:000209171100011	22933677	gold			2022-02-06	
J	Jeong, E; Lesiuk, TL				Jeong, Eunju; Lesiuk, Teresa L.			Development and Preliminary Evaluation of a Music-based Attention Assessment for Patients with Traumatic Brain Injury	JOURNAL OF MUSIC THERAPY			English	Article							SELECTIVE ATTENTION; DIVIDED ATTENTION; HEAD-INJURY; PERCEPTION ASSESSMENT; PREFRONTAL CORTEX; TASK; CONSISTENCY; TIME	Impairments in attention are commonly seen in individuals with traumatic brain injury (TBI). While visual attention assessment measurements have been rigorously developed and frequently used in cognitive neurorehabilitation, there is a paucity of auditory attention assessment measurements for patients with TBI. The purpose of this study was to field test a researcher-developed Music-based Attention Assessment (MAA), a melodic contour identification test designed to assess three different types of attention (i.e., sustained attention, selective attention, and divided attention), for patients with TBI. Additionally, this study aimed to evaluate the readability and comprehensibility of the test items and to examine the preliminary psychometric properties of the scale and test items. Fifteen patients diagnosed with TBI completed 3 different series of tasks in which they were required to identify melodic contours. The resulting data showed that (a) test items in each of the 3 subtests were found to have an easy to moderate level of item difficulty and an acceptable to high level of item discrimination, and (b) the musical characteristics (i.e., contour, congruence, and pitch interference) were found to be associated with the level of item difficulty, and (c) the internal consistency of the MAA as computed by Cronbach's alpha was .95. Subsequent studies using a larger sample of typical participants, along with individuals with TBI, are needed to confirm construct validity and internal consistency of the MAA. In addition, the authors recommend examination of criterion validity of the MAA as correlated with current neuropsychological attention assessment measurements.	[Jeong, Eunju; Lesiuk, Teresa L.] Univ Miami, Frost Sch Mus, Dept Mus Educ & Mus Therapy, Coral Gables, FL 33124 USA		Jeong, E (corresponding author), 5545 NW 112th Path, Doral, FL USA.	e.jeong@umiami.edu	Jeong, Eunju/L-2185-2017	Jeong, Eunju/0000-0002-5064-5419			ANDREWS MW, 1991, MUSIC PERCEPT, V8, P349; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bigand E, 2000, INT J PSYCHOL, V35, P270, DOI 10.1080/002075900750047987; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1971, J EXP PSYCHOL, V89, P244, DOI 10.1037/h0031163; BREGMAN AS, 1973, PERCEPT PSYCHOPHYS, V13, P308, DOI 10.3758/BF03214144; Crawley EJ, 2002, J EXP PSYCHOL HUMAN, V28, P367, DOI 10.1037//0096-1523.28.2.367; Cusack R, 2004, J EXP PSYCHOL HUMAN, V30, P643, DOI 10.1037/0096-1523.30.4.643; Davison LL, 2003, MUSIC PERCEPT, V21, P3, DOI 10.1525/mp.2003.21.1.3; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Deutsch D., 1982, PSYCHOL MUSIC, P99; DOWLING WJ, 1973, COGNITIVE PSYCHOL, V5, P322, DOI 10.1016/0010-0285(73)90040-6; Franzen M. D., 1984, HDB PSYCHOL ASSESSME, P19; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Furr R. M., 2008, PSYCHOMETRICS INTRO; Fyk J., 1995, B COUNCIL RES MUSIC, V127, P72; Gallun FJ, 2007, PERCEPT PSYCHOPHYS, V69, P757, DOI 10.3758/BF03193777; GARRETT HE, 1966, STAT PSYCHOL ED; Gordon E.E., 1998, INTRO RES PSYCHOL MU; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Henson RK, 2001, MEAS EVAL COUNS DEV, V34, P177, DOI 10.1080/07481756.2002.12069034; HUNTER LL, 1989, J MUSIC THER, V26, P79, DOI 10.1093/jmt/26.2.79; Janata P, 2002, COGN AFFECT BEHAV NE, V2, P121, DOI 10.3758/CABN.2.2.121; Johnson JA, 2007, J COGNITIVE NEUROSCI, V19, P907, DOI 10.1162/jocn.2007.19.6.907; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; JONES MR, 1984, ANN NY ACAD SCI, V423, P158, DOI 10.1111/j.1749-6632.1984.tb23426.x; JONES RE, 1986, J MUSIC THER, V23, P166, DOI 10.1093/jmt/23.3.166; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; Kim K., 2005, THESIS U MINNESOTA; Klein JM, 1996, PERCEPT PSYCHOPHYS, V58, P34, DOI 10.3758/BF03205473; Kline T.J.B., 2005, PSYCHOL TESTING PRAC; KRUMHANSL CL, 1986, MUSIC PERCEPT, V4, P153; LIPE A, 1995, J MUSIC THER, V32, P137, DOI 10.1093/jmt/32.3.137; Lipe AW, 2007, J MUSIC THER, V44, P369, DOI 10.1093/jmt/44.4.369; Lipscomb S. D., 1996, HDB MUSIC PSYCHOL, P83; Loose R., 2000, NEUROIMAGE, V11, P2; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; Macken WJ, 2003, J EXP PSYCHOL HUMAN, V29, P43, DOI 10.1037/0096-1523.29.1.43; Magee WL, 2007, NEUROREHABILITATION, V22, P319; Mateer CA, 1990, COGNITIVE REHABILITA, P68; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Oosterhof A., 2001, CLASSROOM APPL ED ME; OSTERLIND SJ, 2006, MODERN MEASUREMENT T; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P59; Ponsford J., 2008, COGNITIVE NEUROREHAB, P507; Radocy, 1987, MEASUREMENT EVALUATI; Reitan RM, 1985, HALSTEADREITAN NEURO; RIDER MS, 1981, J MUSIC THER, V18, P110, DOI 10.1093/jmt/18.3.110; Schmidt KM, 2003, HDB PSYCHOL, V2, P429; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; SHINNCUNNINGHAM B, 2004, P ICAD 04 10 M INT C; Sloboda J., 1981, PSYCHOL MUSIC, V9, P39, DOI [10.1177/03057356810090010701, DOI 10.1177/03057356810090010701]; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Stephan KM, 2002, NEUROIMAGE, V15, P345, DOI 10.1006/nimg.2001.0929; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Talland G.A., 1965, DERANGED MEMORY; Talsma D, 2001, PSYCHOPHYSIOLOGY, V38, P736, DOI 10.1017/S0048577201000798; Trainor LJ, 2002, J COGNITIVE NEUROSCI, V14, P430, DOI 10.1162/089892902317361949; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Noorden L. P. A. S., 1975, THESIS U TECHNOLOGY; Waldon EG, 2006, J MUSIC THER, V43, P356, DOI 10.1093/jmt/43.4.356; Wechsler D., 2008, WECHSLER ADULT INTEL; YORK E, 1994, J MUSIC THER, V31, P280, DOI 10.1093/jmt/31.4.280; York E, 2000, PSYCHOL MUSIC, V28, P174, DOI [DOI 10.1177/0305735600282006, 10.1177/0305735600282006]	75	12	12	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	WIN	2011	48	4					551	572		10.1093/jmt/48.4.551			22	Music; Rehabilitation	Social Science Citation Index (SSCI)	Music; Rehabilitation	872RN	WOS:000298827100007	22506304				2022-02-06	
J	Maeir, A; Krauss, S; Katz, N				Maeir, Adina; Krauss, Shim; Katz, Noomi			Ecological Validity of the Multiple Errands Test (MET) on Discharge From Neurorehabilitation Hospital	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						executive functions; multitasking; community participation	PORTLAND ADAPTABILITY INVENTORY; FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; SIMPLIFIED VERSION; REHABILITATION; PARTICIPATION; RELIABILITY; AWARENESS; PEOPLE	The purpose of this prospective study was to examine the predictive and ecological validity of the Multiple Errands Test (MET) on discharge from neurorehabilitation hospital to the community. The specific objective was to examine the relationships between discharge MET scores and follow-up scores on the Participation Index (M2PI). The study sample included 30 participants with acquired brain injury who were independent in basic activities of daily living 1 week prior to discharge from a neurorehabilitation unit. The MET Hospital-Version was administered at discharge and the M2PI was administered to participants and their caregivers during a home visit 3 months after discharge. Moderate significant correlations were found between the MET and the M2PI scores (self and caregiver MET total error score with total M2PI r = .403, r = .510), with a greater correlation coefficient for caregiver ratings than for self ratings. Partial correlation analysis demonstrated the stability of this relationship while controlling for basic cognitive status scores. The results provide supporting evidence for the ecological validity of the MET at discharge from neurorehabilitation. In addition, the findings highlight the need for community-based rehabilitation that will reduce the impact of executive function deficits on participation in daily life.	[Maeir, Adina; Krauss, Shim; Katz, Noomi] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; [Katz, Noomi] Ono Acad Coll, Res Inst Hlth & Med Profess, Jerusalem, Israel			amaeir@mscc.huji.ac.il		Maeir, Adina/0000-0002-3356-5847			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Anderson V., 2008, EXECUTIVE FUNCTIONS; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Dawson D. R., 2005, AM C REH MED CHIC IL; Dawson D. R., 2005, M INT NEUR SOC ST LO; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Edwards, 2003, EXECUTIVE FUNCTION P; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fischer, 2004, NEUROPSYCHOL ASSESSM; FLEMING J, 2009, INT ENCY REHABILITAT; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; KATZ N, 2005, COGNITION OCCUPATION, pR13; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; LEVAV M, 2005, WORLD FED OCC THER S; MALEC J, 2005, MAYOPORTLAND ADAPTAB; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Ones Kadriye, 2005, J Stroke Cerebrovasc Dis, V14, P261, DOI 10.1016/j.jstrokecerebrovasdis.2005.07.003; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Roth RM, 2005, BRIEF BEHAV RATING I; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; Segal, 2003, NATURALISTIC ACTION; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SOHLBERG MM, 2001, COGNITIVE REHABILITA, P230; Tranel D, 2007, J CLIN EXP NEUROPSYC, V29, P319, DOI 10.1080/13803390600701376; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Wilson BA, 2010, STUD NEUROPSYCHOL NE, P385; World Health Organization, 2007, INT CLASS FUNCT DIS; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641; [No title captured]	47	12	12	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	WIN	2011	31	1		S	SI		S38	S46		10.3928/15394492-20101108-07			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	707ME	WOS:000286289900007	24650263				2022-02-06	
J	McDonald, S; Rosenfeld, J; Henry, JD; Togher, L; Tate, R; Bornhofen, C				McDonald, Skye; Rosenfeld, Julia; Henry, Julie D.; Togher, Leanne; Tate, Robyn; Bornhofen, Cristina			Emotion Perception and Alexithymia in People With Severe Traumatic Brain Injury: One Disorder or Two? A Preliminary Investigation	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; emotion perception; alexithymia	POSTTRAUMATIC-STRESS-DISORDER; DIFFUSE AXONAL INJURY; HEAD-INJURY; SOCIAL-PERCEPTION; FACIAL EMOTION; ORGANIC ALEXITHYMIA; GENERAL-POPULATION; EATING-DISORDERS; FRONTAL-LOBE; SELF-REPORT	Primary objective: Recent research studies attest to the presence of deficits in emotion perception following severe traumatic brain injury (TBI). Additionally, a growing number of studies report significant levels of alexithymia (disorder of emotional cognition) following TBI. This research aimed to examine the relation between the two, while assessing the influence of posttraumatic stress disorder (PTSD). Design: Cross-sectional study examining levels of alexithymia, emotion perception disorders and PTSD and their association, in 20 people with severe, chronic TBI and 20 adults without brain injuries. Methods: Participants were assessed on the Toronto Alexithymia - 20 Scale, the Posttraumatic Diagnostic Scale and on two emotion perception tasks: matching and labelling of photos depicting the 6 basic emotions. Results:The group with TBI were impaired relative to controls when matching facial expressions. Their performance on 'fear' was especially poor. Performance on labelling was similar in pattern, although failed to reach significance. There was no association between poor performance on fear, or other negative expressions, and either PTSD or alexithymia symptoms in the TBI group. Conclusions: Alexithymia, as assessed by the TAS-20, taps a constellation of difficulties that do not appear to include difficulties with emotion perception in people with traumatic brain injuries.	[McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; Univ Sydney, Sydney, NSW 2006, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Togher, Leanne/AAC-7083-2019; McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Henry, Julie/0000-0002-2081-3717; Togher, Leanne/0000-0002-4518-6748	Australian Research CouncilAustralian Research Council; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was supported by grants from the Australian Research Council and the National Health and Medical Research Council. We would like to thank the Royal Rehabilitation Centre, Sydney, for assisting with participant recruitment. We are indebted to the people with traumatic brain injuries and other members of the community who gave their time freely to assist with this research.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Allerdings MD, 2001, BRAIN COGNITION, V47, P304; Badura AS, 2003, J ANXIETY DISORD, V17, P349, DOI 10.1016/S0887-6185(02)00201-3; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; BERENBAUM H, 1994, COGNITION EMOTION, V8, P231, DOI 10.1080/02699939408408939; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; BIRD K, 2001, PSY PROGRAM CONTRAST; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Cohen J., 2013, STAT POWER ANAL BEHA; Connelly M, 2007, J PSYCHOSOM RES, V62, P649, DOI 10.1016/j.jpsychores.2006.12.008; Courville C. B., 1945, PATHOLOGY NERVOUS SY; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Eizaguirre AE, 2004, PERS INDIV DIFFER, V36, P321, DOI 10.1016/S0191-8869(03)00099-0; Ekman P., 1976, PICTURES FACIAL AFFE; Felmingham KL, 2003, NEUROREPORT, V14, P777, DOI 10.1097/00001756-200304150-00024; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Frewen PA, 2008, J ABNORM PSYCHOL, V117, P171, DOI 10.1037/0021-843X.117.1.171; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Hale WW, 1998, J AFFECT DISORDERS, V47, P63, DOI 10.1016/S0165-0327(97)00112-2; HARRIS RJ, 1994, ANOVA ANAL VARIANCE; Haviland MG, 1996, J PSYCHOSOM RES, V41, P597, DOI 10.1016/S0022-3999(96)00223-1; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Hintikka J, 2001, COMPR PSYCHIAT, V42, P234, DOI 10.1053/comp.2001.23147; Honkalampi K, 2001, PSYCHOTHER PSYCHOSOM, V70, P247, DOI 10.1159/000056262; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Lorenzo, 2002, THESIS; MANDAL MK, 1985, PERCEPT MOTOR SKILL, V61, P13, DOI 10.2466/pms.1985.61.1.13; MAYER JD, 1990, J PERS ASSESS, V54, P772, DOI 10.1207/s15327752jpa5403&4_29; MCDONALD PW, 1990, PSYCHOSOM MED, V52, P199, DOI 10.1097/00006842-199003000-00007; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S., 2011, INT J PSYCHOPHYSIOLO; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Monson CM, 2004, J TRAUMA STRESS, V17, P275, DOI 10.1023/B:JOTS.0000029271.58494.05; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rastam M, 1997, ACTA PSYCHIAT SCAND, V95, P385, DOI 10.1111/j.1600-0447.1997.tb09650.x; Rosenthal R., 2000, CONTRASTS EFFECT SIZ; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Sheeran T, 2002, J CONSULT CLIN PSYCH, V70, P961, DOI 10.1037//0022-006X.70.4.000; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spitzer R. L., 1990, STRUCTURED CLIN INTE; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Taylor G. J., 1997, DISORDERS AFFECT REG; Taylor GJ, 1996, J PSYCHOSOM RES, V41, P561, DOI 10.1016/S0022-3999(96)00224-3; Taylor GJ, 2004, PSYCHOTHER PSYCHOSOM, V73, P68, DOI 10.1159/000075537; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams KR, 2001, BRAIN INJURY, V15, P349, DOI 10.1080/026990501750111319; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Zech E, 1999, EUR J PERSONALITY, V13, P511; Zeitlin S.B., 1993, AM J PSYCHIAT, V60, P150; Zlotnick C, 2001, J TRAUMA STRESS, V14, P177, DOI 10.1023/A:1007899918410	88	12	12	0	29	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2011	12	3					165	178					14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	887FJ	WOS:000299912000001					2022-02-06	
J	Pan, Y; Shreiber, DI; Pelegri, AA				Pan, Yi; Shreiber, David I.; Pelegri, Assimina A.			A Transition Model for Finite Element Simulation of Kinematics of Central Nervous System White Matter	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Finite element methods; kinematics; transition kinematic model; white matter	DIFFUSE AXONAL INJURY; ELASTIC PROPERTIES; SPINAL-CORD; HUMAN HEAD; TISSUE; DAMAGE	Mechanical damage to axons is a proximal cause of deficits following traumatic brain injury and spinal cord injury. Axons are injured predominantly by tensile strain, and identifying the strain experienced by axons is a critical step toward injury prevention. White matter demonstrates complex nonlinear mechanical behavior at the continuum level that evolves from even more complex, dynamic, and composite behavior between axons and the "glial matrix" at the microlevel. In situ, axons maintain an undulated state that depends on the location of the white matter and the stage of neurodevelopment. When exposed to tissue strain, axons do not demonstrate pure affine or non-affine behavior, but instead transition from non-affine-dominated kinematics at low stretch levels to affine kinematics at high stretch levels. This transitional and predominant kinematic behavior has been linked to the natural coupling of axons to each other via the glial matrix. In this paper, a transitional kinematic model is applied to a micromechanics finite element model to simulate the axonal behavior within a white matter tissue subjected to uniaxial tensile stretch. The effects of the transition parameters and the volume fraction of axons on axonal behavior is evaluated and compared to previous experimental data and numerical simulations.	[Pan, Yi; Pelegri, Assimina A.] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA; [Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA		Pelegri, AA (corresponding author), Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA.	yipan@rci.rutgers.edu; shreiber@rci.rutgers.edu; pelegri@jove.rutgers.edu	Shreiber, David/ABE-8254-2021	Pelegri, Assimina/0000-0003-1145-8175; Shreiber, David/0000-0001-8248-419X	New Jersey Commission on Brain Injury [10-3219-BIR-E-0]; NSFNational Science Foundation (NSF) [1000450]; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1000450] Funding Source: National Science Foundation	Manuscript received April 9, 2011; revised June 20, 2011; accepted July 14, 2011. Date of publication July 29, 2011; date of current version November 18, 2011. This work was supported by the New Jersey Commission on Brain Injury Research Postdoctoral Fellowship Grant under Award 10-3219-BIR-E-0 and by NSF under Grant 1000450. Asterisk indicates corresponding author.	Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; *DASS SYST, 2007, ABAQUS 6 7; Hao H, 2007, J BIOMECH ENG-T ASME, V129, P511, DOI 10.1115/1.2746372; Iorga L, 2008, J MECH MATER STRUCT, V3, P1279, DOI 10.2140/jomms.2008.3.1279; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Maikos JT, 2008, J NEUROTRAUM, V25, P795, DOI 10.1089/neu.2007.0423; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; PAN Y, 2011, AM SOC MECH ENG 2011; Pan Y, 2008, COMPOS SCI TECHNOL, V68, P2792, DOI 10.1016/j.compscitech.2008.06.007; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009	18	12	12	0	12	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294			IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	DEC	2011	58	12	2				3443	3446		10.1109/TBME.2011.2163189			4	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	852FR	WOS:000297341500004	21803674				2022-02-06	
J	Chao, OY; Huston, JP; von Bothmer, A; Pum, ME				Chao, O. Y.; Huston, J. P.; von Bothmer, A.; Pum, M. E.			CHRONIC PROGESTERONE TREATMENT OF MALE RATS WITH UNILATERAL 6-HYDROXYDOPAMINE LESION OF THE DORSAL STRIATUM EXASPERATES PARKINSONIAN SYMPTOMS	NEUROSCIENCE			English	Article						Parkinson's disease; progesterone; 6-OHDA; turning behavior; foot slips; forelimb use	TRAUMATIC BRAIN-INJURY; INDUCED DOPAMINE DEPLETION; SPINAL-CORD-INJURY; NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; IN-VIVO; OVARIECTOMIZED RATS; GENE-EXPRESSION; CELL-LINE	Progesterone (PROG) shows neuroprotective effects in numerous lesion models, including a mouse model of Parkinson's disease (PD) induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). However, the possible beneficial effects of PROG on the behavioral and neurochemical impairments incurred in the hemiparkinsonian 6-hydroxydopamine (6-OHDA) model have not been investigated. Vehicle or PROG (4 mg/kg or 8 mg/kg) was daily applied over 13 days after unilateral injection of 6-OHDA into the dorsal striatum of male rats. Turning behavior, foot slips on a horizontal grid, and forelimb use during rearing in a cylinder were observed on days 4, 5, 9, 10, 13, and 14 postlesion, and then the brain samples were analyzed by HPLC-EC. Chronic 8 mg/kg of PROG administration increased the DOPAC/dopamine (DA) ratio in the lesioned striatum, ipsiversive turnings, and the number of hind limb slips and decreased the symmetrical use of forelimbs. Thus, contrary to hypothesis, the chronic treatment with PROG exasperated rather than alleviated the motor impairments in the hemiparkinsonian rats. Because previous studies with the MPTP model had shown protective effects when PROG treatment was administrated before the lesion, our results do not rule out such potential neuroprotective action with prelesion PROG treatment. However, our results raise the question of possible negative interactions between PROG and parkinsonian symptoms in males. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Chao, O. Y.; Huston, J. P.; von Bothmer, A.; Pum, M. E.] Univ Dusseldorf, Ctr Behav Neurosci, D-40225 Dusseldorf, Germany		Huston, JP (corresponding author), Univ Dusseldorf, Ctr Behav Neurosci, Univ Str 1, D-40225 Dusseldorf, Germany.	Huston@uni-duesseldorf.de			Forschungskommission of the Medical Faculty of the University of Dusseldorf; DAADDeutscher Akademischer Austausch Dienst (DAAD)European Commission	This research was supported by the Forschungskommission of the Medical Faculty of the University of Dusseldorf and the DAAD.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Aron L, 2011, TRENDS NEUROSCI, V34, P88, DOI 10.1016/j.tins.2010.11.001; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Baron MS, 2002, J NEUROSCI, V22, P592, DOI 10.1523/JNEUROSCI.22-02-00592.2002; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Baulieu EE, 1996, CELL MOL NEUROBIOL, V16, P143, DOI 10.1007/BF02088173; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Brooks David J, 2008, Neuropsychiatr Dis Treat, V4, P39; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; DIPAOLO T, 1986, EUR J PHARMACOL, V125, P11, DOI 10.1016/0014-2999(86)90077-4; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Dluzen D, 1997, BRAIN RES, V767, P340, DOI 10.1016/S0006-8993(97)00630-6; Dluzen DE, 1996, NEUROTOXICOL TERATOL, V18, P603, DOI 10.1016/0892-0362(96)00086-4; Ferraz AC, 2008, NEUROCHEM RES, V33, P1238, DOI 10.1007/s11064-007-9575-7; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Giachino C, 2003, ANN NY ACAD SCI, V1007, P335, DOI 10.1196/annals.1286.032; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gillies GE, 2004, PHARMACOL BIOCHEM BE, V78, P513, DOI 10.1016/j.pbb.2004.04.022; Gillies GE, 2010, HORM BEHAV, V57, P23, DOI 10.1016/j.yhbeh.2009.06.002; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; KURTZKE JF, 1988, NEUROLOGY, V38, P1558, DOI 10.1212/WNL.38.10.1558; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Magnaghi V, 2006, J PERIPHER NERV SYST, V11, P111, DOI 10.1111/j.1085-9489.2006.00075.x; Marder K, 1996, NEUROLOGY, V47, P155, DOI 10.1212/WNL.47.1.155; MAYEUX R, 1992, ARCH NEUROL-CHICAGO, V49, P492, DOI 10.1001/archneur.1992.00530290076015; Mehta A, 2005, EXP NEUROL, V193, P110, DOI 10.1016/j.expneurol.2005.01.001; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; MORISSETTE M, 1993, J NEUROCHEM, V60, P1876, DOI 10.1111/j.1471-4159.1993.tb13415.x; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; PETITCLERC M, 1995, PROG NEURO-PSYCHOPH, V19, P491, DOI 10.1016/0278-5846(95)00029-U; Ramirez AD, 2003, NEUROENDOCRINOLOGY, V77, P223, DOI 10.1159/000070277; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rubin Susan M, 2007, Dis Mon, V53, P206, DOI 10.1016/j.disamonth.2007.02.002; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert T, 2000, CONT NEUROS, P131; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; SCHWARTING RKW, 1993, J NEUROSCI METH, V49, P199, DOI 10.1016/0165-0270(93)90125-B; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Silva MAD, 2008, NEUROSCIENCE, V157, P196, DOI 10.1016/j.neuroscience.2008.09.003; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Walsh S, 2011, NEUROSCIENCE, V175, P251, DOI 10.1016/j.neuroscience.2010.12.005; Woodlee MT, 2008, EXP NEUROL, V211, P511, DOI 10.1016/j.expneurol.2008.02.024; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamada M, 1999, P NATL ACAD SCI USA, V96, P4078, DOI 10.1073/pnas.96.7.4078; Yang LC, 1998, J NEUROSCI, V18, P8145; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yu L, 2000, J NEURAL TRANSM, V107, P1139, DOI 10.1007/s007020070027	79	12	12	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 24	2011	196						228	236		10.1016/j.neuroscience.2011.08.043			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	837OO	WOS:000296213300020	21888950				2022-02-06	
J	Erickson, JA; Grenache, DG				Erickson, J. Alan; Grenache, David G.			Comparison of three assays for quantifying S-100B in serum	CLINICA CHIMICA ACTA			English	Article						S-100B; ELISA; Melanoma; Brain injury	PROGNOSTIC VALUE; PROTEIN; MARKER; INJURY; PREDICTION; S100B	Background: Serum S-100B has clinical value in monitoring malignant melanoma and in monitoring and predicting outcomes in patients with traumatic brain injury. Methods: Analytical performance characteristic and split-sample method comparison studies for three commercial S-100B immunoassays (CanAg (R) S100, Sangtec (R) 100, YK150 Human S-100 beta) were performed. Reference intervals (97.5th percentile) for each assay were established by non-parametric analysis of results from healthy volunteers. Results: Linearity results were slope = 1.014, intercept = 65.1, r(2) = 0.999 for the Sangtec assay; slope = 1.038, intercept = 31.1. r(2) = 0.999 for the CanAg assay; slope = 1.123, intercept = -105.4, r(2) = 0.997 for the YK150 assay. Within-run CVs were <= 5.7, <= 63 and <= 10.8 for the Sangtec. CanAg and YK150 ELISAs. respectively. Between-run CVs were <= 113, <= 5.9 and <= 9.5, respectively. Upper reference interval limits of 141,96 and 735 ng/I S-100B were established for the Sangtec, CanAg and YK150 ELISAs, respectively. Deming regression generated the following: CanAg vs. Sangtec, slope = 0.339, intercept =24.1, r(2) = 0.932; YK150 vs. Sangtec, slope = 0.266, intercept = -140.0, r(2) = 0.690; YK150 vs. CanAg, slope = 1.376, intercept= -13.1, r(2) = 0.860. Conclusions: The configurations, procedures and performance characteristics of the Sangtec and CanAg S-100B ELISAs are comparable and better than those of the YK150 assay. Poor agreement and large biases prevent interchangeable use of results. (C) 2011 Elsevier B.V. All rights reserved.	[Erickson, J. Alan; Grenache, David G.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Grenache, David G.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA		Erickson, JA (corresponding author), ARUP Labs, 500 Chipeta Way, Salt Lake City, UT 84108 USA.	ericksja@aruplab.com			ARUP Institute for Clinical and Experimental Pathology	Financial support was provided by the ARUP Institute for Clinical and Experimental Pathology.	Andres R, 2004, TUMORI J, V90, P607, DOI 10.1177/030089160409000613; Bertsch T, 2001, CLIN CHEM LAB MED, V39, P319, DOI 10.1515/CCLM.2001.050; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Boni R, 1997, BRIT J DERMATOL, V137, P39, DOI 10.1046/j.1365-2133.1997.17651853.x; Chen Da-qing, 2005, Chin J Traumatol, V8, P245; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; DiaSorin Inc, 2004, SANGT 100 ELISA INST; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fujirebio Diagnostics AB, 2006, CANAG S100 EIA INSTR; Hallen M, 2008, CLIN CHEM LAB MED, V46, P1025, DOI 10.1515/CCLM.2008.190; Hamberg AP, 2003, MELANOMA RES, V13, P45, DOI 10.1097/00008390-200302000-00008; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Nakamura K, 2005, CYTOKINE, V29, P95, DOI 10.1016/j.cyto.2004.10.002; Prohl J, 2007, CRIT CARE MED, V35, P1230, DOI 10.1097/01.CCM.0000261892.10559.85; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Smit LHM, 2008, ANTICANCER RES, V28, P2297; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Stigbrand T, 2000, INT J BIOL MARKER, V15, P33, DOI 10.1177/172460080001500106; Stranjalis G, 2007, ACTA NEUROCHIR, V149, P231, DOI 10.1007/s00701-006-1106-9; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Yanaihara Institute Inc, 2007, YK150 HUM S 100 BET	26	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV 20	2011	412	23-24					2122	2127		10.1016/j.cca.2011.07.020			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	843QC	WOS:000296686100017	21824469				2022-02-06	
J	Adler, RH				Adler, Richard H.			Youth Sports and Concussions: Preventing Preventable Brain Injuries. One Client, One Cause, and A New Law	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Youth; Sports; Concussion; Brain		Effective concussion prevention and management for youth athletes requires both education and legislation. Education alone effectively begins the awareness of an issue, but does not change behavior. Education and legislation are required to prevent preventable concussion and brain injuries in youth athletes.	[Adler, Richard H.] Adler Giersch PS, Seattle, WA 98109 USA; [Adler, Richard H.] Brain Injury Assoc Washington, Seattle, WA 98122 USA		Adler, RH (corresponding author), Adler Giersch PS, 300 Taylor Ave N, Seattle, WA 98109 USA.	radler@adlergiersch.com					Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Wiersma LD, 2005, RES Q EXERCISE SPORT, V76, P324	2	12	12	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651			PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					721	+		10.1016/j.pmr.2011.08.010			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	858SI	WOS:000297822600011	22050945				2022-02-06	
J	Lantz, PE; Couture, DE				Lantz, Patrick E.; Couture, Daniel E.			Fatal Acute Intracranial Injury, Subdural Hematoma, and Retinal Hemorrhages Caused by Stairway Fall	JOURNAL OF FORENSIC SCIENCES			English	Article; Proceedings Paper	62nd Annual Meeting of the American-Academy-of-Forensic-Sciences	FEB 22-27, 2010	Seattle, WA	Amer Acad Forens Sci		forensic science; retinal hemorrhages; subdural hematoma; shaken baby syndrome; child abuse; accidental fall; abusive head trauma; stairway fall; short fall	NONACCIDENTAL HEAD-INJURY; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; CHILDHOOD; INFANTS; POPULATION	We describe an infant with an acute subdural hematoma, a fatal head injury, and severe hemorrhagic retinopathy caused by a stairway fall. His cerebral and ocular findings are considered diagnostic of abusive head trauma by many authors. Our literature search of serious injuries or fatalities from stairway or low-height falls involving young children yielded 19 articles of primary data. These articles are discrepant, making the classification of a young child's death following a reported short fall problematic. This case report contradicts the prevalent belief of many physicians dealing with suspected child abuse that low-height falls by young children are without exception benign occurrences and cannot cause fatal intracranial injuries and severe retinal hemorrhages. The irreparable harm to a caregiver facing an erroneous allegation of child abuse requires physicians to thoroughly investigate and correctly classify pediatric accidental head injuries.	[Lantz, Patrick E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27157 USA; [Couture, Daniel E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurosurg, Winston Salem, NC 27157 USA		Lantz, PE (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	plantz@wfubmc.edu					ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; Bechtel K, 2005, PEDIATRICS, V115, P192, DOI 10.1542/peds.2004-2150; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Behera C, 2010, MED SCI LAW, V50, P22, DOI 10.1258/msl.2009.009010; Betz P, 1996, FORENSIC SCI INT, V78, P71, DOI 10.1016/0379-0738(95)01866-2; Betz P, 1996, FORENSIC SCI INT, V82, P255; Block RW, 1999, CURR PROBL PEDIATR, V29, P253; Case M, 2002, AM J FOREN MED PATH, V23, P105, DOI 10.1097/00000433-200203000-00025; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; Chadwick DL, 2008, PEDIATR NEUROSURG, V44, P517, DOI 10.1159/000187129; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; Chadwick DL, 1992, J TRAUMA, V32, P672; Chadwick DL, 2007, PEDIATR NEUROSURG, V43, P433; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; David TJ, 1999, J ROY SOC MED, V92, P556, DOI 10.1177/014107689909201105; Denton S, 2004, AM J FOREN MED PATH, V25, P270, DOI 10.1097/01.paf.0000136663.52750.59; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Docherty E, 2010, EMERG MED J, V27, P207, DOI 10.1136/emj.2008.069179; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ehsani JP, 2010, AM J FOREN MED PATH, V31, P287, DOI 10.1097/PAF.0b013e3181db7eb5; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Ganesh A, 2003, BR J OPHTHALMOL, V87, P9; Ganesh A, 2007, BRIT J OPHTHALMOL, V91, P396, DOI 10.1136/bjo.2006.099481; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; GUTIERREZ FA, 1975, CHILD BRAIN, V1, P269; Hall J R, 1992, J Trauma, V32, P672, DOI 10.1097/00005373-199205000-00027; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hall JR, 1990, J TRAUMA, V30, P1421; Hall JR, 1991, J TRAUMA, V31, P1353; Hall JR, 1991, J TRAUMA, V31, P1350; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 1999, JAMA-J AM MED ASSOC, V282, P29; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P657; Jenny C, 1999, JAMA-J AM MED ASSOC, V282, P1421; JOFFE M, 1988, PEDIATRICS, V82, P457; JOHNSON DL, 1993, NEUROSURGERY, V33, P231; Kairys SW, 2001, PEDIATRICS, V108, P206; Laposata Martha E, 2005, Am J Clin Pathol, V123 Suppl, pS119; Levin AV, 2009, EYE, V23, P1758, DOI 10.1038/eye.2009.199; Levin AV, 2009, PEDIATR CLIN N AM, V56, P333, DOI 10.1016/j.pcl.2009.02.003; Levin AV, 2002, NEUROSURG CLIN N AM, V13, P201, DOI 10.1016/S1042-3680(02)00004-9; Levin AV, 2009, CHILD ABUSE MED DIAG, P211; LEVIN AV, 2000, RECENT ADV PAEDIAT, V18, P151; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; Pierre-Kahn V, 2004, OPHTHALMOLOGY, V111, P1794, DOI 10.1016/j.ophtha.2004.06.009; Plunkett J, 2002, AM J FOREN MED PATH, V23, P103, DOI 10.1097/00000433-200203000-00023; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Plunkett J, 2001, AM J FOREN MED PATH, V22, P332; Plunkett J, 2001, AM J FOREN MED PATH, V22, P415; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; Reiber GD, 2000, AM J FOREN MED PATH, V21, P198; Reyes HM, 1990, J TRAUMA, V30, P1422; RIVARA FP, 1993, PEDIATRICS, V92, P61; Rorke-Adams L, 2009, CHILD ABUSE MED DIAG, P53; Steinbok P, 2007, NEUROSURGERY, V60, P689, DOI 10.1227/01.NEU.0000255398.00410.6B; Stray-Pedersen A, 2011, FORENSIC SCI MED PAT, V7, P37, DOI 10.1007/s12024-010-9176-7; Sturm V, 2009, EYE, V23, P1535, DOI 10.1038/eye.2008.317; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Vincent AL, 2010, CLIN EXP OPHTHALMOL, V38, P521, DOI 10.1111/j.1442-9071.2010.02324.x; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005; Williams RA, 1992, J TRAUMA, V32, P672; Wygnanski-Jaffe T, 2009, FORENSIC SCI MED PAT, V5, P291, DOI 10.1007/s12024-009-9134-4	70	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	NOV	2011	56	6					1648	1653		10.1111/j.1556-4029.2011.01892.x			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Legal Medicine	848MK	WOS:000297055500035	21827475				2022-02-06	
J	Wiseman-Hakes, C; Victor, JC; Brandys, C; Murray, BJ				Wiseman-Hakes, Catherine; Victor, J. Charles; Brandys, Clare; Murray, Brian J.			Impact of post-traumatic hypersomnia on functional recovery of cognition and communication	BRAIN INJURY			English	Article						Sleep disturbance; hypersomnia; excessive day-time sleepiness; traumatic brain injury; cognition; cognitive-communication; mood disturbance	TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCE; INSOMNIA; PREVALENCE; REHABILITATION; SCALE	Primary objective: To assess aspects of cognition and communication, in response to the treatment of post-traumatic hypersomnia and mood disturbance. Research design: A single case study; pre-post intervention. Methods and procedures: The participant was a male with severe TBI and cognitive-communication impairments, who subsequently developed sleep and mood disturbance and excessive daytime sleepiness. The Daily Cognitive-Communication and Sleep Profile (D-CCASP), Clinical Interview, Epworth and Stanford Sleepiness Scales and polysomnography assessed sleep and wakefulness. Cognitive-communication was also assessed by the D-CCASP. His sleep, wake and mood difficulties were pharmacologically managed. Main outcomes and results: Baseline polysomnography indicated abnormal sleep. There was a clear positive relationship between quality of sleep, language processing, attention and memory, seen across the phases of the medication intervention (p < 0.01). Conclusions: A comprehensive pharmacological management programme addressing the multi-factorial underlying aetiology was successful in improving sleep, arousal and mood. The D-CCASP was found to be clinically and statistically sensitive to reported changes in cognitive-communication function in relation to improvements in sleep and daytime arousal. These findings suggest that management of sleep/wake disturbances and mood post-traumatic brain injury can potentially facilitate improvements in cognitive-communication function which may, in turn, facilitate participation in rehabilitation and community integration.	[Wiseman-Hakes, Catherine] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Victor, J. Charles] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada; [Brandys, Clare] Univ Toronto, Dept Psychiat, Toronto, ON M5G 1V7, Canada; [Murray, Brian J.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada		Wiseman-Hakes, C (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	catherinew.hakes@utoronto.ca	Victor, J Charles/F-8765-2011; Wiseman-Hakes, Catherine/AAC-8303-2021; Murray, Brian/E-6786-2016	Victor, J Charles/0000-0003-1720-9356; Wiseman-Hakes, Catherine/0000-0001-8441-884X; Murray, Brian/0000-0001-5085-0909	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ministry of Health and Long-Term Care in Ontario, Canada	This work was conducted at Sunnybrook Health Sciences Centre, Toronto, Canada and was financially supported by Canadian Institutes for Health Research (CIHR) through a Fellowship in Clinical Research, and the Toronto Rehabilitation Institute who receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario, Canada. The views expressed do not necessarily reflect those of the Ministry.	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Burke DT, 2004, J APPL RES, V4, P239; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Doghramji K, 1997, ELECTROEN CLIN NEURO, V103, P554, DOI 10.1016/S0013-4694(97)00010-2; Fellus J, 2007, BRAIN INJURY MED, P545; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; Francisco GE, 1996, AM J PHYS MED REHAB, V75, P63, DOI 10.1097/00002060-199601000-00016; Fung C, 2011, CAN ASS OCC THER CAO; Giglio P., 2007, REV SLEEP MED, P29; Greenwald BD, 2009, PHYS MED REHABILITAT, P347; Hartley L. L, 1995, COGNITIVE COMMUNICAT; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; MacLean, 1992, J Sleep Res, V1, P35; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Repchinsky C, 2010, COMPENDIUM PHARM SPE; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; SAS Institute Inc, 2008, SAS SYST WIND V9 2; Seyone C, 2006, SLEEP SLEEP DISORDER; Stickgold R, 2003, SLEEP BRAIN PLASTICI, P41; Stickgold R., 2003, SLEEP BRAIN PLASTICI; STICKGOLD R, 2003, SLEEP BRAIN PLASTICI, P17; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; VANBEMMEL AL, 1993, PSYCHOPHARMACOLOGY, V113, P225, DOI 10.1007/BF02245702; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Winokur A, 2001, DEPRESS ANXIETY, V14, P19, DOI 10.1002/da.1043; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]	41	12	12	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1256	1265		10.3109/02699052.2011.608215			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200013	21961569				2022-02-06	
J	Alvsaker, K; Walther, SM; Kleffelgard, I; Mongs, M; Draegebo, RA; Keller, A				Alvsaker, Kristin; Walther, Sten M.; Kleffelgard, Ingerid; Mongs, Malin; Draegebo, Randi Aas; Keller, Anne			INTER-RATER RELIABILITY OF THE EARLY FUNCTIONAL ABILITIES SCALE	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; rehabilitation outcome; assessment	TRAUMATIC BRAIN-INJURY; EARLY INTERVENTION; HEAD-INJURY; REHABILITATION; COMA; COEFFICIENT; TOMOGRAPHY	Objective: To investigate the inter-rater reliability of the Early Functional Abilities (EFA) scale. Design: An observational study of inter-rater reliability in an open cohort. Patients: Twenty-four patients with traumatic brain injury in need of medical or surgical intervention in the early rehabilitation section of the intensive care unit. Methods: The EFA was assessed by 4 different professions in the rehabilitation team. Inter-rater reliability was assessed using linear weighted kappa statistics. Results: The overall weighted kappa values of the different EFA items varied from 0.27 to 0.60. The items in the sensorimotor functional area had the highest pairwise agreement, with a mean kappa range of 0.68-0.76. The vegetative stability, position tolerance and wakefulness items had the lowest mean kappa values (0.49, 0.33 and 0.49, respectively). Agreement was good to excellent between the occupational therapist and physiotherapist across the majority of the items, whereas the physician and nurse agreed less with one another. Conclusion: The inter-rater reliability of the EFA scale was good for most items among all the raters. The scale may be used by all members of the interdisciplinary team after training in administration and scoring. A reduction in the number of items in the vegetative functional domain is recommended.	[Alvsaker, Kristin; Keller, Anne] Univ Oslo, Ulleval Hosp, Dept Phys Med & Rehabil, NO-0407 Oslo, Norway; [Alvsaker, Kristin; Walther, Sten M.; Kleffelgard, Ingerid; Mongs, Malin; Draegebo, Randi Aas] Univ Oslo, Ulleval Hosp, Intens Care Unit, NO-0407 Oslo, Norway; [Walther, Sten M.] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth, Div Cardiovasc Med, S-58183 Linkoping, Sweden		Alvsaker, K (corresponding author), Univ Oslo, Ulleval Hosp, Dept Phys Med & Rehabil, NO-0407 Oslo, Norway.	Kristin.Alvsaker@oslo-universitetssykehus.no					Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COOMBES K, 2001, FACIAL ORAL TRACT TH, P47; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DAVIS JZ, 1992, OCCUP THER PRACT, V3, P30; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Fleiss J.L., 1981, STAT METHODS RATES P; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; FRANK U, 2008, TREATING TRACHEOTOMI; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gjelsvik BEB, 2008, BOBATH CONCEPT ADULT; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hanoa Rolf, 2008, Tidsskr Nor Laegeforen, V128, P66; Heck G, 2000, NEUROL REHABIL, V6, P125; Huber Lisa, 2010, AORN J, V92, P345, DOI 10.1016/j.aorn.2010.06.011; KLEFFELGARD I, 2008, 7 WORLD C BRAIN INJ; KRISTENSEN KS, TRANSLATION EARLY FU; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Lorentzen J, 2005, EVALUATION EARLY FUN; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MAHONEY F I, 1965, Md State Med J, V14, P61; McCluggage WG, 1996, J CLIN PATHOL, V49, P833, DOI 10.1136/jcp.49.10.833; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; NORUP A, 2011, NEUROPSYCHOL REHABIL, P1; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; SALLING B, 2000, DANISH TRANSLATION E; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TEASDALE G, 1974, LANCET, V2, P81; *US DEP HHS, 1998, REH PERS TRAUM BRAIN, V16, P1; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; 2005, REHABILITATION PERSO	35	12	12	0	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	OCT	2011	43	10					892	899		10.2340/16501977-0855			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	844KF	WOS:000296745400004	21879231	gold			2022-02-06	
J	Wright, KM; Britt, TW; Bliese, PD; Adler, AB				Wright, Kathleen M.; Britt, Thomas W.; Bliese, Paul D.; Adler, Amy B.			Insomnia Severity, Combat Exposure and Mental Health Outcomes	STRESS AND HEALTH			English	Article						insomnia; combat disorders; stress disorders; post-traumatic reactions; alcohol related disorders	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; POOR SLEEP QUALITY; PRIMARY-CARE; SOLDIERS; IRAQ; DEPRIVATION; PERFORMANCE; ADAPTATION; MORBIDITY	Few studies have examined insomnia severity as a moderator of the impact of combat experiences on posttraumatic stress disorder (PTSD) and alcohol problems, such that combat exposure is expected to have more negative consequences for soldiers who report insomnia. In this study, a sample of 522 military personnel completed measures of PTSD and alcohol problems prior to a 12-month deployment to Iraq, and then completed measures assessing insomnia severity, combat exposure, PTSD, alcohol problems and overall distress 3 months post-deployment. Results of a moderated multiple regression indicated that insomnia severity interacted with combat exposure to predict PTSD and alcohol problems after controlling for pre-deployment baseline measures of these outcomes, such that the relationship between combat exposure and the mental health symptoms was stronger when insomnia severity was greater. Results are discussed from the perspective of the role of insomnia in the development of PTSD and alcohol problems, as well as from an occupational health perspective where insomnia may deprive individuals of the resources they need to recover from the effects of severe occupational stressors found in high risk occupations. Published in 2010 by John Wiley & Sons, Ltd.	[Wright, Kathleen M.; Britt, Thomas W.; Adler, Amy B.] Walter Reed Army Inst Res, Heidelberg, Germany; [Bliese, Paul D.] Walter Reed Army Inst Res, Silver Spring, MD USA		Wright, KM (corresponding author), US Army Med Res Unit Europe, Nachrichten Kaserne Postfach 103180, D-69021 Heidelberg, Germany.	kathleen.wright@us.army.mil		Bliese, paul/0000-0002-5384-8879			Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson C, 2010, STRESS HEALTH, V26, P194, DOI 10.1002/smi.1301; Babor T.F., 2001, AUDIT THE ALCOHOL US; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Barber LK, 2010, STRESS HEALTH, V26, P200, DOI 10.1002/smi.1311; Barber LK, 2010, STRESS HEALTH, V26, P186, DOI 10.1002/smi.1292; Barton J, 1995, WORK STRESS, V9, P109, DOI 10.1080/02678379508256545; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Benham G, 2010, STRESS HEALTH, V26, P204, DOI 10.1002/smi.1304; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese P.D., 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Blumenthal SJ, 1996, J PRACTICAL PSYCHIAT, V2, P67; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Cooper CL., 2001, ORG STRESS REV CRITI; De Koninck J, 1997, CAN PSYCHOL, V38, P191, DOI 10.1037/0708-5591.38.3.191; Doi Y, 2003, SLEEP, V26, P467, DOI 10.1093/sleep/26.4.467; Dolan CA, 2005, MIL PSYCHOL, V17, P157, DOI 10.1207/s15327876mp1703_3; Gillin JC, 1998, ACTA PSYCHIAT SCAND, V98, P39, DOI 10.1111/j.1600-0447.1998.tb05965.x; Gregg R L, 2002, Work, V18, P133; Hagger MS, 2010, STRESS HEALTH, V26, P181, DOI 10.1002/smi.1345; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Harvey AG, 2001, CLIN PSYCHOL REV, V21, P1037, DOI 10.1016/S0272-7358(00)00083-0; Hobfoll SE, 2002, REV GEN PSYCHOL, V6, P307, DOI 10.1037//1089-2680.6.4.307; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; JOHNSON LC, 1983, MIL MED, V148, P727; King DW, 2004, EARLY INTERVENTION FOR TRAUMA AND TRAUMATIC LOSS, P34; Knudsen HK, 2007, SOC SCI MED, V64, P1997, DOI 10.1016/j.socscimed.2007.02.020; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Linton SJ, 2004, BRIT J HEALTH PSYCH, V9, P127, DOI 10.1348/135910704773891005; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P1659; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Morin CM, 2003, INSOMNIA CLIN GUIDE; NAITOH P, 1990, OCCUP MED, V5, P209; *NIAAA, 1998, 41 NIAAA; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Philip P, 2001, J SLEEP RES, V10, P111, DOI 10.1046/j.1365-2869.2001.00253.x; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; PLOYHART RE, 2005, ITEM RESPONSE THEORY; ROEHRS T, 1995, ALCOHOL HEALTH RES W, V19, P130; Roth T, 1999, SLEEP, V22, pS354; Scott BA, 2006, J MANAGE, V32, P622, DOI 10.1177/0149206306289762; Sonnentag S, 2008, J APPL PSYCHOL, V93, P674, DOI 10.1037/0021-9010.93.3.674; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vitiello MV, 1997, ADDICT BIOL, V2, P151, DOI 10.1080/13556219772697; Weathers F.W., 1993, ANN CONV INT SOC TRA; Weissman MM, 1997, GEN HOSP PSYCHIAT, V19, P245, DOI 10.1016/S0163-8343(97)00056-X; WESENSTEN NJ, 2006, MILITARY LIFE PSYCHO, V1, P81; WESTMAN M, 2005, RES OCCUPATIONAL STR, V4, P167; Wright KM, 2007, J TRAUMA STRESS, V20, P965, DOI 10.1002/jts.20279; Wright RA, 2010, STRESS HEALTH, V26, P198, DOI 10.1002/smi.1302; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	59	12	12	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1532-3005	1532-2998		STRESS HEALTH	Stress Health	OCT	2011	27	4					325	333		10.1002/smi.1373			9	Psychology, Applied; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	833IB	WOS:000295876000006					2022-02-06	
J	Mahajan, H; Spaeth, DM; Dicianno, BE; Collins, DM; Boninger, ML; Cooper, RA				Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Collins, Diane M.; Boninger, Michael L.; Cooper, Rory A.			Comparison of Virtual Wheelchair Driving Performance of People With Traumatic Brain Injury Using an Isometric and a Conventional Joystick	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Assistive technology; Brain injuries, traumatic; Rehabilitation; User-computer interface; Wheelchairs, computer simulation	TARGET ACQUISITION; TECHNOLOGY; INDIVIDUALS	Mahajan H, Spaeth DM, Dicianno BE, Collins DM, Boninger ML, Cooper RA. Comparison of virtual wheelchair driving performance of people with traumatic brain injury using an isometric and a conventional joystick. Arch Phys Med Rehabil 2011;92:1298-304. Objective: To compare wheelchair driving performance in a driving simulator using a conventional joystick and an isometric joystick. Design: Randomized, cohort study. Setting: A research facility based in a hospital or in an independent living center. Participants: Participants (N=20; 12 men, 8 women; mean age +/- SD, 30.62 +/- 10.91y) who were at least 1 year post-TBI. Interventions: Driving performance using an isometric joystick compared with a conventional movement joystick. Main Outcome Measures: Average trial completion time, and trajectory-specific measures measured orthogonal to the center of driving tasks: root mean squared error, movement offset, movement error, and number of significant changes in heading. Results: After statistically controlling for driving speed, participants were able to complete the driving tasks faster with an isometric joystick than while using a conventional movement joystick. Compared with the conventional joystick, an isometric joystick used for driving forward demonstrated fewer driving errors. During reverse driving the conventional joystick performed better. Conclusions: The customizable isometric joystick seems to be a promising interface for driving a powered wheelchair for individuals with TBI.	[Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Boninger, Michael L.; Cooper, Rory A.] VA Pittsburgh HealthCare Syst, Human Engn Res Lab, Pittsburgh, PA 15206 USA; [Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Boninger, Michael L.; Cooper, Rory A.] VA Pittsburgh HealthCare Syst, Ctr Excellence Wheelchairs & Related Technol, Pittsburgh, PA 15206 USA; [Dicianno, Brad E.; Boninger, Michael L.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Mahajan, Harshal; Spaeth, Donald M.; Dicianno, Brad E.; Collins, Diane M.; Boninger, Michael L.; Cooper, Rory A.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Dicianno, Brad E.; Boninger, Michael L.; Cooper, Rory A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA		Cooper, RA (corresponding author), VA Pittsburgh HealthCare Syst, Human Engn Res Lab, 7180 Highland Dr,Bldg 4,2nd Fl E,151R1-H, Pittsburgh, PA 15206 USA.	rcooper@pitt.edu	Dicanno, Brad/AAC-5918-2019	Dicanno, Brad/0000-0003-0738-0192; Boninger, Michael/0000-0001-6966-919X; Collins, Diane/0000-0003-0646-0457	National Institute on Disability and Rehabilitation Research; U.S. Department of EducationUS Department of Education [H133A020502]; Human Engineering Research Laboratories, VA Pittsburgh HealthCare System; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD048465] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grant no. H133A020502), and with resources and facilities by the Human Engineering Research Laboratories, VA Pittsburgh HealthCare System. The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government.	Bellolio MF, 2008, INT J EMERG MED, V1, P197, DOI 10.1007/s12245-008-0061-z; Cooper RA, 2000, IEEE T CONTR SYST T, V8, P112, DOI 10.1109/87.817696; Cooper RA, 2000, IEEE T BIO-MED ENG, V47, P902, DOI 10.1109/10.846684; Cooper RA, 2005, ASSIST TECHNOL, V17, P159, DOI 10.1080/10400435.2005.10132105; Cooper RA, 2002, MED ENG PHYS, V24, P703, DOI 10.1016/S1350-4533(02)00111-X; Dicianno BE, 2007, IEEE T NEUR SYS REH, V15, P144, DOI 10.1109/TNSRE.2007.891394; Dicianno BE, 2006, AM J PHYS MED REHAB, V85, P631, DOI 10.1097/01.phm.0000228519.54763.b4; Douglas S. A., 1999, P SIGCHI C HUM FACT, P215, DOI DOI 10.1145/302979.303042; Fehr L, 2000, J REHABIL RES DEV, V37, P353; Guiard Y, 2004, INT J HUM-COMPUT ST, V61, P875, DOI 10.1016/j.ijhcs.2004.09.005; Jones DK, 1998, PROCEEDINGS OF THE IEEE 24TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P130, DOI 10.1109/NEBC.1998.664901; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; MacKenzie I. S., 2001, CHI 2001 Conference Proceedings. Conference on Human Factors in Computing Systems, P9; Niemeier J P, 2001, Top Stroke Rehabil, V8, P10; Phillips B, 1993, Assist Technol, V5, P36; Rao RS, 2000, IEEE T REHABIL ENG, V8, P118, DOI 10.1109/86.830956; Riemer-Reiss ML, 2000, J REHABIL, V66, P44; Roduit P, 2006, LECT NOTES COMPUT SC, V4095, P819; Scherer MJ, 2001, DISABIL REHABIL, V23, P387; Spaeth DM, 2008, ARCH PHYS MED REHAB, V89, P996, DOI 10.1016/j.apmr.2007.11.030; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Zhai SM, 2004, PRESENCE-TELEOP VIRT, V13, P113, DOI 10.1162/1054746041382393	25	12	12	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2011	92	8					1298	1304		10.1016/j.apmr.2011.03.011			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	803WL	WOS:000293612800016	21807150	Green Accepted			2022-02-06	
J	Pecha, T; Sharma, D; Hoffman, NG; Sookplung, P; Curry, P; Vavilala, MS				Pecha, Travis; Sharma, Deepak; Hoffman, Noah G.; Sookplung, Pimwan; Curry, Parichat; Vavilala, Monica S.			Hyperglycemia During Craniotomy for Adult Traumatic Brain Injury	ANESTHESIA AND ANALGESIA			English	Article							INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; RISK-FACTORS; HEAD-INJURY; GLUCOSE; IMPACT; MICRODIALYSIS	BACKGROUND: Hyperglycemia after traumatic brain injury (TBI) is associated with poor outcome, but previous studies have not addressed intraoperative hyperglycemia in adult TBI. In this study, we examined glucose value variability and risk factors for hyperglycemia during craniotomy in adults with TBI. METHODS: A retrospective cohort study of patients >= 18 years who underwent urgent or emergent craniotomy for TBI at Harborview Medical Center (level 1 adult and pediatric trauma center) between October 2007 and May 2010 was performed. Preoperative (within 24 hours of anesthesia start) and intraoperative (during anesthesia) glucose values for each patient were retrieved. The prevalence of intraoperative hyperglycemia (glucose >= 200 mg/dL), hypoglycemia (glucose <60 mg/dL), and glycemic trends was determined. Generalized Estimating Equations was used to determine the independent predictors of intraoperative hyperglycemia. Data are presented as adjusted odds ratio (AOR) (95% confidence interval [CI]), and P < 0.05 reflects significance. RESULTS: Intraoperative hyperglycemia was common (26 [15%]) and intraoperative hypoglycemia was not observed. Independent risk factors of intraoperative hyperglycemia were age >= 65 years (AOR 3.9 [95% CI: 1.4-10.3]; P = 0.007), Glasgow Coma Scale score <9 (AOR 4.9 [95% CI: 1.6-15.1]; P = 0.006), preoperative hyperglycemia (AOR 4.4 [95% CI: 1.7-11.6]; P = 0.003), and subdural hematoma (AOR 5.6 [95% CI: 1.4-22.2]; P = 0.02). Mean intraoperative glucose was highest in severe TBI patients (P = 0.02). There was both between-patient (79.5% variance; P < 0.001) and within-patient (20.5% variance; P < 0.001) intraoperative glucose value variability. Patients with intraoperative hyperglycemia had higher in-hospital mortality (8 [31%] vs 20 [13%]; P < 0.02). CONCLUSION: Intraoperative hyperglycemia was common in adults undergoing urgent/emergent craniotomy for TBI and was predicted by severe TBI, the presence of subdural hematoma, preoperative hyperglycemia, and age >= 65 years. However, there was significant variability in intraoperative glucose values. (Anesth Analg 2011;113:336-42)	[Pecha, Travis; Sharma, Deepak; Sookplung, Pimwan; Curry, Parichat; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Sch Med, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@uw.edu			University of WashingtonUniversity of Washington; University of Washington Department of Anesthesiology and Pain MedicineUniversity of Washington	Supported by the University of Washington Medical Student Research Training Program, and University of Washington Department of Anesthesiology and Pain Medicine departmental sources.	Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bower WF, 2010, AM J SURG, V199, P240, DOI 10.1016/j.amjsurg.2009.04.010; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Lipshutz AKM, 2009, ANESTHESIOLOGY, V110, P408, DOI 10.1097/ALN.0b013e3181948a80; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salim A, 2009, AM SURGEON, V75, P25; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; SIEBER F, 1986, ANESTHESIOLOGY, V64, P453, DOI 10.1097/00000542-198604000-00007; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	23	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	AUG	2011	113	2					336	342		10.1213/ANE.0b013e31821d3dde			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	796PQ	WOS:000293064500021	21596888				2022-02-06	
J	Stokell, R; Yu, AN; Williams, K; Treleaven, J				Stokell, Raina; Yu, Annie; Williams, Katrina; Treleaven, Julia			Dynamic and functional balance tasks in subjects with persistent whiplash: A pilot trial	MANUAL THERAPY			English	Article						Balance; Functional; Whiplash; Neck pain	JOINT POSITION ERROR; STANDING BALANCE; STEPPING TEST; NECK PAIN; DIZZINESS; STABILITY; INJURY	Disturbances in static balance have been demonstrated in subjects with persistent whiplash. Some also report loss of balance and falls. These disturbances may contribute to difficulties in dynamic tasks. The aim of this study was to determine whether subjects with whiplash had deficits in dynamic and functional balance tasks when compared to a healthy control group. Twenty subjects with persistent pain following a whiplash injury and twenty healthy controls were assessed in single leg stance with eyes open and closed, the step test, Fukuda stepping test, tandem walk on a firm and soft surface, Singleton test with eyes open and closed, a stair walking test and the timed 10 m walk with and without head movement. Subjects with whiplash demonstrated significant deficits (p < 0.01) in single leg stance with eyes closed, the step test, tandem walk on a firm and soft surface, stair walking and the timed 10 m walk with and without head movement when compared to the control subjects. Specific assessment and rehabilitation directed towards improving these deficits may need to be considered in the management of patients with persistent whiplash if these results are confirmed in a larger cohort. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.	[Stokell, Raina; Yu, Annie; Williams, Katrina; Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia		Treleaven, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia.	j.treleaven@uq.edu.au	Treleaven, Julia/N-1379-2019; Treleaven, Julia M/F-8734-2010; Williams, Katrina/H-6511-2013	Treleaven, Julia/0000-0002-6258-3972; Treleaven, Julia M/0000-0002-6258-3972; Williams, Katrina/0000-0001-5096-7752			Alpini D, 2005, GAIT POSTURE, V22, P308, DOI 10.1016/j.gaitpost.2004.10.003; Berkovits, 1996, PHYSIOTHER CAN, V48, P257, DOI [10.3138/ptc.48.4.257, DOI 10.3138/PTC.48.4.257]; BOHANNON R, 1984, PHYS THER, V64, P1037; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; BONNANI M, 1998, PHYSIOTHERAPY RES IN, V3, P58; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Herdman S, 2000, VESTIBULAR REHABILIT; Honaker JA, 2009, J AM ACAD AUDIOL, V20, P311, DOI 10.3766/jaaa.20.5.4; LowChoy N, 2006, AUST J PHYSIOTHER, V52, P211; Michaelson P, 2003, J REHABIL MED, V35, P229, DOI 10.1080/16501970306093; Poole E, 2008, MANUAL THER, V13, P317, DOI 10.1016/j.math.2007.02.002; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; Tesio L, 1999, AM J PHYS MED REHAB, V78, P233, DOI 10.1097/00002060-199905000-00009; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Vernon H, 1996, J MUSCULOSKELET PAIN, V4, P95, DOI DOI 10.1300/J094V04N04_	18	12	12	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1356-689X			MANUAL THER	Man. Ther.	AUG	2011	16	4					394	398		10.1016/j.math.2011.01.012			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	798XH	WOS:000293245000015	21367648				2022-02-06	
J	Connell, S; Gao, J; Chen, J; Shi, RY				Connell, Sean; Gao, Jian; Chen, Jun; Shi, Riyi			Novel Model to Investigate Blast Injury in the Central Nervous System	JOURNAL OF NEUROTRAUMA			English	Article						axolemma; axonal injury; electrophysiology; military injury; neuronal cell death	MAMMALIAN SPINAL-CORD; IN-VITRO; BRAIN; CONDUCTION; DISRUPTION; MAGNITUDE; DYNAMICS; DEFICITS; NEURONS; STRAIN	Blast-induced neurotrauma (BINT) is a common injury modality associated with the current war efforts and increasing levels of terrorist activity. Exposure to the primary blast wave generated by explosive devices causes significant neurological deficits and is responsible for many of the war-related pathologies. Despite research efforts, the mechanism of injury is still poorly understood. To this end, we have established a novel ex vivo model for the direct observation and quantification of BINT at the tissue level. The model provides a quantifiable and reproducible method to illustrate the mechanism of BINT. Isolated sections of guinea pig spinal cord white matter were exposed to a supersonic shockwave using a blast generator with small-scaled explosives. The blast wave impact with isolated tissue was observed using focused shadowgraphy with a high-speed camera recording at 90,000 fps. Concurrently, functional deficits were measured by monitoring the production of compound action potentials using a double sucrose gap-recording chamber. Additionally, anatomical deficits were measured after blast exposure with a dye exclusion assay to visualize axonal membrane permeability. Our findings demonstrate that direct exposure to the blast wave compressed nervous tissue at a rate of 60 m/sec and led to significant functional deficits. Damage to the isolated spinal cord was marked by increased axonal permeability, suggesting rapid compression from the shockwave-generated high strain rates that resulted in membrane disruption. The model provides new insight into the mechanism of BINT and permits direct observation that may contribute to the development of appropriate treatment regimens.	[Shi, Riyi] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47906 USA; [Connell, Sean; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47906 USA; [Gao, Jian; Chen, Jun] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47906 USA		Shi, RY (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, 408 S Univ St, W Lafayette, IN 47906 USA.	riyi@purdue.edu	Gao, Jian/Q-6457-2016	Gao, Jian/0000-0003-3744-453X			Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Luo J, 2007, BRAIN RES, V1155, P10, DOI 10.1016/j.brainres.2007.03.091; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ouyang Hui, 2009, J Neurosurg Spine, V10, P161, DOI 10.3171/2008.10.SPI08495; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Settles G.S., 2001, EXP FLUID MECH, DOI 10.1007/978-3-642-56640-0; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shi RY, 2004, J NEUROCYTOL, V33, P203, DOI 10.1023/B:NEUR.0000030695.76840.19; Simon CM, 2005, J NEUROTRAUM, V22, P1173; Simon C, 2007, J NEUROTRAUM, V24, P1282; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; STUHMILLER JH, 1991, CONVENTIONAL WARFARE; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060	31	12	13	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1229	1236		10.1089/neu.2011.1832			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600011	21529318				2022-02-06	
J	Gupta, B; Kaur, M; D'souza, N; Dey, CK; Shende, S; Kumar, A; Gamangatti, S				Gupta, Babita; Kaur, Manpreet; D'souza, Nita; Dey, Chandan Kumar; Shende, Seema; Kumar, Atin; Gamangatti, Shivanand			Cerebral Fat Embolism: A diagnostic challenge	SAUDI JOURNAL OF ANAESTHESIA			English	Article						Cerebral fat embolism; fat embolism syndrome; magnetic resonance imaging		Fat embolism syndrome (FES) is a rare but a serious clinical catastrophe occurring after traumatic injury to long bones. Cerebral involvement in the absence of pulmonary or dermatological manifestation on initial presentation may delay the diagnosis of cerebral fat embolism (CFE). We discuss a case series of CFE which posed a challenge in diagnosis. The clinical presentations of these patients did not satisfy the commonly used clinical criteria for aiding the diagnosis of FES. Early MRI brain (DWI and T2 weighted sequences) in patients with neurological symptoms after trauma even in the absence of pulmonary and dermatological findings should be the goal.	[Gupta, Babita; Kaur, Manpreet; D'souza, Nita; Dey, Chandan Kumar; Shende, Seema] All India Inst Med Sci, JPNA Trauma Ctr, Dept Anaesthesia & Crit Care, New Delhi, India; [Kumar, Atin; Gamangatti, Shivanand] All India Inst Med Sci, JPNA Trauma Ctr, Dept Radiodiag, New Delhi, India		Kaur, M (corresponding author), AIIMS, 426 Masjid Moth Resident Doctors Hostel, New Delhi 110029, India.	manpreetkaurrajpal@yahoo.com	Kaur, Manpreet/ABE-7810-2021; D'souza, Nita/AAK-8295-2020; Gamanagatti, Shivanand/ABC-8486-2020	Kaur, Manpreet/0000-0003-3069-1562; 			Bulger EM, 1997, ARCH SURG-CHICAGO, V132, P435; Eguia P, 2007, J NEUROIMAGING, V17, P78, DOI 10.1111/j.1552-6569.2006.00068.x; Gregorakos L, 2000, J ACCID EMERG MED, V17, P144; Guillevin R, 2005, ANN NEUROL, V57, P434, DOI 10.1002/ana.20388; GURD AR, 1974, J BONE JOINT SURG BR, VB 56, P408, DOI 10.1302/0301-620X.56B3.408; JACOBSON DM, 1986, NEUROLOGY, V36, P847, DOI 10.1212/WNL.36.6.847; LESSELLS AM, 1981, BRIT MED J, V282, P1586, DOI 10.1136/bmj.282.6276.1586; Parizel PM, 2001, STROKE, V32, P2942, DOI 10.1161/str.32.12.2942; Ryu CW, 2005, ACTA RADIOL, V46, P528, DOI 10.1080/02841850510021481; Shaikh N, 2008, INDIAN J CRIT CARE M, V12, P32, DOI 10.4103/0972-5229.40948; Stoeger A, 1998, EUR RADIOL, V8, P1590, DOI 10.1007/s003300050592; Takahashi M, 1999, J TRAUMA, V46, P324, DOI 10.1097/00005373-199902000-00021; Yoshida A, 1996, J TRAUMA, V40, P437, DOI 10.1097/00005373-199603000-00019	13	12	13	0	2	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1658-354X	0975-3125		SAUDI J ANAESTH	Saudi J. Anaesth.	JUL-SEP	2011	5	3					348	352		10.4103/1658-354X.84122			5	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V4N1X	WOS:000219084400027	21957425	Green Published, gold			2022-02-06	
J	Mahmood, A; Qu, CS; Ning, RZ; Wu, HT; Goussev, A; Xiong, Y; Irtenkauf, S; Li, Y; Chopp, M				Mahmood, Asim; Qu, Changsheng; Ning, Riuzuo; Wu, Hongtao; Goussev, Anton; Xiong, Ye; Irtenkauf, Susan; Li, Yi; Chopp, Michael			Treatment of TBI with Collagen Scaffolds and Human Marrow Stromal Cells Increases the Expression of Tissue Plasminogen Activator	JOURNAL OF NEUROTRAUMA			English	Article						collagen scaffolds; marrow stromal cells; tissue plasminogen activator; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERIPHERAL-NERVE REGENERATION; FUNCTIONAL RECOVERY; ADULT RATS; TRANSPLANTATION; INDUCTION; SEIZURE; DEFICIT; BENEFIT; MODEL	This study examines the effects of combination therapy of collagen scaffolds and human marrow stromal cells (hMSCs) on the expression of tissue plasminogen activator (tPA) after traumatic brain injury (TBI) in rats. Adult male Wistar rats (n=48) were injured with controlled cortical impact and treated either with scaffolds suffused with hMSCs (3 x 10(6)) or hMSCs (3 x 10(6)) alone transplanted into the lesion cavity 1 week after TBI. A control group was treated with saline. Neurological function was assessed using the Morris Water Maze test (MWM) and modified Neurological Severity Scores (mNSS). The rats were sacrificed 14 days after TBI and brain samples were processed for immunohistochemical analysis and quantitative Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) studies. Enhanced functional improvement was observed on both the mNSS and MWM tests in the scaffold + hMSC-treated group compared to the other two groups. Immunostaining with anti-human mitochondrial antibody (E5204) showed more hMSCs in the injury zone of the scaffold + hMSC group compared to the hMSC-alone group. Triple staining showed that more neurons were tPA-positive in the scaffold + hMSC group compared to the other two groups (p<0.05). Western blot analysis and qRT-PCR showed that scaffold + hMSC and hMSC-alone treatment enhanced the expression of tPA compared to controls (p<0.05), but tPA expression was significantly greater in the scaffold + hMSC group. The induction of tPA by hMSCs after TBI may be one of the mechanisms involved in promoting functional improvement after TBI.	[Mahmood, Asim; Qu, Changsheng; Ning, Riuzuo; Wu, Hongtao; Goussev, Anton; Xiong, Ye; Irtenkauf, Susan] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Li, Yi; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Mahmood, A (corresponding author), Henry Ford Hlth Syst, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu	ning, ruizhuo/E-6401-2012	Xiong, Ye/0000-0001-9770-6031	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS066041] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066041] Funding Source: NIH RePORTER		BARNES P, 2008, PLOS, V3, P1; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Day LB, 1996, BEHAV NEUROSCI, V110, P998; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellis V, 2003, PLASMINOGEN: STRUCTURE, ACTIVATION AND REGULATION, P19; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu DY, 2003, J HEAD TRAUMA REHAB, V18, P357, DOI 10.1097/00001199-200307000-00006; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; MOONEN G, 1982, NATURE, V298, P753, DOI 10.1038/298753a0; Nagai Nobuo, 2008, P314, DOI 10.1007/978-4-431-78847-8_22; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Teesalu T, 2003, PLASMINOGEN: STRUCTURE, ACTIVATION AND REGULATION, P251; WARE JH, 1995, J NEUROBIOL, V28, P9, DOI 10.1002/neu.480280103; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	48	12	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1199	1207		10.1089/neu.2010.1694			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600008	21355820	Green Published			2022-02-06	
J	Suarez, EP; Gonzalez, AS; Diaz, CP; Salido, AG; Garde, AMD; Flores, JC				Perez Suarez, Esther; Serrano Gonzalez, Ana; Perez Diaz, Carlos; Garcia Salido, Alberto; de Azagra Garde, Amelia Martinez; Casado Flores, Juan			Decompressive Craniectomy in 14 Children With Severe Head Injury: Clinical Results With Long-Term Follow-Up and Review of the Literature	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Decompressive craniectomy; Severe head injury; Traumatic brain injury; Intracranial pressure	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CRANIOTOMY; MANAGEMENT; PRESSURE	Background: Decompressive craniectomy (DC) is a controversial therapeutic measure used in patients with intractable intracranial hypertension after severe head injury. This study describes the morbidity and mortality of DC in 14 children with a mean follow-up of 3.2 years. We review published evidence from the past 10 years on the indications for DC in pediatric brain trauma. We also examine timing, surgical technique, and the results of this procedure. Method: We retrospectively reviewed patients who underwent DC from 2002 to 2010. Clinical data were collected at admission, as were data on the indication for craniectomy, timing, and surgical technique. Perioperative intracranial pressure (ICP), complications of craniectomy, and Glasgow Outcome Scale score at 2 years were recorded as outcome variables. Results: Fourteen craniectomies were performed. The median presenting Glasgow Coma Scale score was 6.5 (range, 4-15). Ten patients were presented with anisocoria. In 13 patients, craniectomy initially decreased ICP to <25 mm Hg. Two patients (14%) had a poor prognosis on admission and died. The most frequent complications were hygroma (8 patients) and infections (3 patients). The mean Glasgow Outcome Scale score at the 2-year follow-up visit was 4.4 (range, 4-5). Behavioral and psychiatric abnormalities and poor academic performance were frequent (82%). Conclusions: DC reduces ICP in pediatric patients with traumatic brain injury. The mortality rate is low and long-term prognosis in survivors is good. Complications related to surgery are frequent. Wide craniectomy with duraplasty seems to be the most common technique. Defining the most appropriate indications and timing for DC in pediatric patients should be the objective of future prospective studies.	[Perez Suarez, Esther; Serrano Gonzalez, Ana; Garcia Salido, Alberto; de Azagra Garde, Amelia Martinez; Casado Flores, Juan] Childrens Hosp, Pediat Intens Care Unit, Madrid, Spain; [Perez Diaz, Carlos] Childrens Hosp, Pediat Neurosurg Serv, Madrid, Spain		Suarez, EP (corresponding author), Nino Jesus Pediat Univ Hosp, Pediat Intens Care Unit, Avda Menendez Pelayo 65, Madrid 28009, Spain.	eperez221981@hotmail.com	Garcia-Salido, Alberto/D-2294-2019	Garcia-Salido, Alberto/0000-0002-8038-7430			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Cambra FJ, 2010, AN PEDIATR, V73, P12, DOI 10.1016/j.anpedi.2010.02.011; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; GERL A, 1980, Zentralblatt fuer Neurochirurgie, V41, P125; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JENNETT B, 1975, LANCET, V1, P480; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; SAHUQUILLO J, 2007, COCHRANE DB SYST REV, V1; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Wechsler D., 2005, WISC 4 ESCALA WECHSL; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	25	12	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					133	140		10.1097/TA.0b013e318211071f			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	790RR	WOS:000292607400033	21818021				2022-02-06	
J	Avesani, R; Fedeli, M; Ferraro, C; Khansefid, M				Avesani, R.; Fedeli, M.; Ferraro, C.; Khansefid, M.			Use of early indicators in rehabilitation process to predict functional outcomes in subjects with acquired brain injury	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Rehabilitation; Outcomes; Evaluation studies	DISABILITY RATING-SCALE; TBI	Background. The use of Evaluation Scales in ABI is necessary for measure of outcome, but not always they are used as predictor factors for rehabilitation processes and organization. Aim. The aim of this study was to evaluate the effectiveness and efficiency of an inpatient rehabilitation program for patients with traumatic brain injury through the use of selected indicators and to identify predictive factors for functional outcome. Design. This was a retrospective database analysis. Setting. Patients admitted to an Intensive Rehabilitation Unit as inpatient (Sacro Cuore-Don Calabria Hospital, Negrar-Verona). Population. The population included patients with traumatic brain injury. Methods. The study enrolled 175 patients admitted to an Intensive Rehabilitation Unit between 2004 and 2007. Data collected included demographic characteristics, first 24-hours worst GCS, length of acute and rehabilitative stay at admission and discharge FIM, DRS, LCF and GOS. Results. There was a statistically significant recovery over the course of admission for all assessment tools (P < 0.000). When patients were subdivided on the basis of admission DRS categories a linear correlation among variables could be observed, with most disabled patients showing the longest acute and rehabilitation stays and the lowest functional gains. Within each DRS category age appeared to affect improvement (P < 0.005) while final outcome was influenced not only by age but also by initial functional status (P < 0.000) and time from injury to admission (P < 0.004). Conclusions and Clinical Rehabilitation Impact. Systematic data collection in intensive rehabilitation is of great importance to monitor recovery and plan appropriate programs on the basis of admission functional status.	[Avesani, R.; Khansefid, M.] Sacra Cuore Hosp, Dept Rehabil Med, I-37024 Verona, Italy; [Fedeli, M.; Ferraro, C.] Univ Padua, Dept Rehabil Med, Padua, Italy		Avesani, R (corresponding author), Sacra Cuore Hosp, Dept Rehabil Med, I-37024 Verona, Italy.	renato.avesani@sacrocuore.it					Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Novack TA, 2000, BRAIN INJURY, V14, P987; Poon WS, 2005, ACT NEUR S, V93, P207; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stineman MG, 2001, ARCH PHYS MED REHAB, V82, P553, DOI 10.1053/apmr.2001.24088; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Wright J., 2000, CTR OUTCOME MEASUREM; Wright J, CTR OUTCOME MEASUREM; WRIGHT J, GLASGOW OUTCOME SCAL; ZAFONTE RD, 1996, AM J PHYS REHABIL, V75, P346	21	12	12	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	JUN	2011	47	2					203	212					10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	774TW	WOS:000291410500003	21364510				2022-02-06	
J	Kamp, MA; Slotty, P; Sarikaya-Seiwert, S; Steiger, HJ; Hanggi, D				Kamp, Marcel A.; Slotty, Philipp; Sarikaya-Seiwert, Sevgi; Steiger, Hans-Jakob; Haenggi, Daniel			Traumatic brain injuries in illustrated literature: experience from a series of over 700 head injuries in the Asterix comic books	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Illustrated literature risk factors; Ancient Roman Empire; Asterix		The goal of the present study was to analyze the epidemiology and specific risk factors of traumatic brain injury (TBI) in the Asterix illustrated comic books. Among the illustrated literature, TBI is a predominating injury pattern. A retrospective analysis of TBI in all 34 Asterix comic books was performed by examining the initial neurological status and signs of TBI. Clinical data were correlated to information regarding the trauma mechanism, the sociocultural background of victims and offenders, and the circumstances of the traumata, to identify specific risk factors. Seven hundred and four TBIs were identified. The majority of persons involved were adult and male. The major cause of trauma was assault (98.8%). Traumata were classified to be severe in over 50% (GCS 3-8). Different neurological deficits and signs of basal skull fractures were identified. Although over half of head-injury victims had a severe initial impairment of consciousness, no case of death or permanent neurological deficit was found. The largest group of head-injured characters was constituted by Romans (63.9%), while Gauls caused nearly 90% of the TBIs. A helmet had been worn by 70.5% of victims but had been lost in the vast majority of cases (87.7%). In 83% of cases, TBIs were caused under the influence of a doping agent called "the magic potion". Although over half of patients had an initially severe impairment of consciousness after TBI, no permanent deficit could be found. Roman nationality, hypoglossal paresis, lost helmet, and ingestion of the magic potion were significantly correlated with severe initial impairment of consciousness (p a parts per thousand currency signaEuro parts per thousand 0.05).	[Kamp, Marcel A.; Slotty, Philipp; Sarikaya-Seiwert, Sevgi; Steiger, Hans-Jakob; Haenggi, Daniel] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany		Kamp, MA (corresponding author), Univ Dusseldorf, Dept Neurosurg, Moorenstr 5, D-40225 Dusseldorf, Germany.	marcelalexander.kamp@uni-duesseldorf.de	Steiger, Hans-Jakob/AAN-8307-2021; Sarikaya-Seiwert, Sevgi/AAH-4859-2020	Steiger, Hans-Jakob/0000-0002-8249-2998; Kamp, Marcel/0000-0002-1252-2944			Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Kanz F, 2006, FORENSIC SCI INT, V160, P207, DOI 10.1016/j.forsciint.2005.10.010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenartz D, 2000, ANTICANCER RES, V20, P2073; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Rose F C, 1997, J Hist Neurosci, V6, P154; Sanchez Gonzalo Moreno, 2007, Neurosurg Focus, V23, pE5; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; WILKINS RH, 1964, J NEUROSURG, V21, P240, DOI 10.3171/jns.1964.21.3.0240	11	12	12	0	31	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2011	153	6					1351	1355		10.1007/s00701-011-0993-6			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	766OV	WOS:000290795700028	21472486				2022-02-06	
J	Stein, DG; Cekic, MM				Stein, Donald G.; Cekic, Milos M.			Progesterone and Vitamin D Hormone as a Biologic Treatment of Traumatic Brain Injury in the Aged	PM&R			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; D-RECEPTOR; SYNDROME SCORE; 1,25-DIHYDROXYVITAMIN D-3; ORGAN DYSFUNCTION; HYPOVITAMINOSIS-D; GROWTH-HORMONE; UNITED-STATES; D DEFICIENCY; HEAD-INJURY	There is growing recognition that traumatic brain injury is a highly variable and complex systemic disorder that is refractory to therapies that target individual mechanisms. It is even more complex in elderly persons, in whom frailty, previous comorbidities, altered metabolism, and a long history of medication use are likely to complicate the secondary effects of brain trauma. Progesterone, one of the few neuroprotective agents that has shown promise for the treatment of acute brain injury, is now in national and international phase 3 multicenter trials. New findings show that vitamin D hormone (VDH) and VDH deficiency in the aging process (and across the developmental spectrum) may interact with progesterone and treatment for traumatic brain injury. In this article we review the use of progesterone and VDH as biologics-based therapies along with recent studies demonstrating that the combination of progesterone and VDH may promote better functional outcomes than either treatment independently. PM R 2011;3:S100-5110	[Stein, Donald G.; Cekic, Milos M.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	DsteiO4@emory.edu	Stein, Donald/AAJ-5139-2020; Cekic, Milos/AAR-8250-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R015R01NS048451, 5R01HD61971-02]; H. Allen and Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048451] Funding Source: NIH RePORTER	4A, royalties from the products of BHR Pharma related to some of the research described in this presentation; 7, BHR; 2A, consultant, BHR. The terms of this arrangement have been reviewed and approved by Emory University, which receives the principal share of any royalties and benefits. In accordance with its conflict of interest policies, the University itself is not required to disclose any similar information; 8B, NIH grants R015R01NS048451 and 5R01HD61971-02; 7, gift in support of research from H. Allen and Company	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298; Bochicchio GV, 2001, J TRAUMA, V50, P817, DOI 10.1097/00005373-200105000-00007; Boxer RS, 2008, J AM GERIATR SOC, V56, P454, DOI 10.1111/j.1532-5415.2007.01601.x; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bulati Matteo, 2008, Immun Ageing, V5, P9, DOI 10.1186/1742-4933-5-9; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Cekic M, NEUROBIOL A IN PRESS; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Chatfield SM, 2007, INTERN MED J, V37, P377, DOI 10.1111/j.1445-5994.2007.01339.x; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Corino A, 2007, CALCIFIED TISSUE INT, V80, P76, DOI 10.1007/s00223-006-0189-x; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dang J, BRAIN BEHAV IN PRESS; DeLuca HF, 1998, NUTR REV, V56, pS4; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Elmadfa I, 2008, ANN NUTR METAB, V52, P2, DOI 10.1159/000115339; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Ferrucci L, 2004, AGING CLIN EXP RES, V16, P240, DOI 10.1007/BF03327390; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; Gruber CJ, 2003, MATURITAS, V46, pS71, DOI 10.1016/j.maturitas.2003.09.021; Guo O, 2004, J NEUROTRAUM, V21, P1303; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Hewison M, 2000, J MOL ENDOCRINOL, V25, P141, DOI 10.1677/jme.0.0250141; Hirashima Y, 1997, NEUROCHEM RES, V22, P1249, DOI 10.1023/A:1021985030331; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holmoy T, 2010, ACTA NEUROL SCAND, V122, P88, DOI 10.1111/j.1600-0404.2010.01383.x; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jiang C, 2009, INFLAMM RES, V58, P619, DOI 10.1007/s00011-009-0032-8; Jiang M, 2004, EXP GERONTOL, V39, P1603, DOI 10.1016/j.exger.2004.06.017; Kalueff AV, 2004, NEUROREPORT, V15, P1271, DOI 10.1097/01.wnr.0000129370.04248.92; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Lanfranco F, 2003, J ENDOCRINOL INVEST, V26, P861, DOI 10.1007/BF03345237; Larrosa M, 2001, MED CLIN-BARCELONA, V117, P611, DOI 10.1016/S0025-7753(01)72195-1; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luoma JI, STEROIDS IN PRESS; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; Malone DL, 2001, J TRAUMA, V51, P458, DOI 10.1097/00005373-200109000-00006; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; McCarty MF, 2005, MED HYPOTHESES, V64, P1022, DOI 10.1016/j.mehy.2004.03.041; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; McGrath JJ, 2004, J STEROID BIOCHEM, V89-90, P557, DOI 10.1016/j.jsbmb.2004.03.070; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Melamed ML, 2008, ARTERIOSCL THROM VAS, V28, P1179, DOI 10.1161/ATVBAHA.108.165886; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Miller RR, 2007, J GERONTOL A-BIOL, V62, P1402, DOI 10.1093/gerona/62.12.1402; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nadziejko C, 2004, INHAL TOXICOL, V16, P373, DOI 10.1080/08958370490439533; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Napolitano LM, 2000, J TRAUMA, V49, P647, DOI 10.1097/00005373-200010000-00011; Napolitano LM, 2000, J TRAUMA, p[49, 652]; NastKolb D, 1997, J TRAUMA, V42, P446, DOI 10.1097/00005373-199703000-00012; Norman AW, 2010, EXP BIOL MED, V235, P1034, DOI 10.1258/ebm.2010.010014; NUYTINCK HKS, 1988, ARCH SURG-CHICAGO, V123, P1519; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pape HC, 2007, INJURY, V38, P1358, DOI 10.1016/j.injury.2007.09.026; PERRY VH, 1993, GLIA, V7, P60, DOI 10.1002/glia.440070111; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pfeifer M, 2002, OSTEOPOROSIS INT, V13, P187, DOI 10.1007/s001980200012; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Priego T, 2003, J ENDOCRINOL, V179, P107, DOI 10.1677/joe.0.1790107; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rammos G, 2008, INT UROL NEPHROL, V40, P419, DOI 10.1007/s11255-007-9244-4; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Schwartz N, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.012; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sheffield LG, 1998, NEUROBIOL AGING, V19, P47, DOI 10.1016/S0197-4580(97)00168-1; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Straub RH, 2000, J NEUROIMMUNOL, V109, P10, DOI 10.1016/S0165-5728(00)00296-4; Sullivan SS, 2005, J AM DIET ASSOC, V105, P971, DOI 10.1016/j.jada.2005.03.002; Tait AS, 2008, J LEUKOCYTE BIOL, V84, P924, DOI 10.1189/jlb.0208104; Talhouk RS, 2004, PROG NEURO-PSYCHOPH, V28, P625, DOI 10.1016/j.pnpbp.2004.01.012; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Townsend K, 2005, J STEROID BIOCHEM, V97, P103, DOI 10.1016/j.jsbmb.2005.06.004; Van den Berghe G, 2003, J CLIN ENDOCR METAB, V88, P4623, DOI 10.1210/jc.2003-030358; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; VERMEULEN A, 1995, HORM RES, V43, P25, DOI 10.1159/000184233; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vodovotz Y, 2010, IMMUNOPHARM IMMUNOT, V32, P181, DOI 10.3109/08923970903369867; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	150	12	12	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2011	3	6		S			S100	S110		10.1016/j.pmrj.2011.03.010			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	961BB	WOS:000305437800017	21703565	Green Accepted			2022-02-06	
J	Harr, ME; Heskestad, B; Ingebrigtsen, T; Romner, B; Ronning, P; Helseth, E				Harr, Marianne Efskind; Heskestad, Ben; Ingebrigtsen, Tor; Romner, Bertil; Ronning, Pal; Helseth, Eirik			Alcohol consumption, blood alcohol concentration level and guideline compliance in hospital referred patients with minimal, mild and moderate head injuries	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; EPIDEMIOLOGY; MANAGEMENT; SEVERITY	Background: In 2000 the Scandinavian Neurotrauma Committee published guidelines for safe and cost-effective management of minimal, mild and moderate head injured patients. The aims of this study were to investigate to what extent the head injury population is under the influence of alcohol, and to evaluate whether the physicians' compliance to the guidelines is affected when patients are influenced by alcohol. Methods: This study included adult patients (>= 15 years) referred to a Norwegian University Hospital with minimal, mild and moderate head injuries classified according to the Head Injury Severity Scale (HISS). Information on alcohol consumption was recorded, and in most of these patients blood alcohol concentration (BAC) was measured. Compliance with the abovementioned guidelines was registered. Results: The study includes 860 patients. 35.8% of the patients had consumed alcohol, and 92.1% of these patients had a BAC >= 1.00 parts per thousand. Young age, male gender, trauma occurring during the weekends, mild and moderate head injuries were independent factors significantly associated with being under the influence of alcohol. Guideline compliance was 60.5%, and over-triage was the main violation. The guideline compliance showed no significant correlation to alcohol consumption or to BAC-level. Conclusions: This study confirms that alcohol consumption is common among patients with head injuries. The physicians' guideline compliance was not affected by the patients' alcohol consumption, and alcohol influence could therefore not explain the low guideline compliance.	[Harr, Marianne Efskind; Heskestad, Ben; Ronning, Pal; Helseth, Eirik] Oslo Univ Hosp Ulleval, Dept Neurosurg, N-0424 Oslo, Norway; [Harr, Marianne Efskind; Heskestad, Ben; Helseth, Eirik] Univ Oslo, Fac Med, N-0315 Oslo, Norway; [Heskestad, Ben] Stavanger Univ Hosp, Dept Neurosurg, N-4068 Stavanger, Norway; [Ingebrigtsen, Tor; Romner, Bertil] Univ Tromso, Dept Neurosurg, Fac Hlth Sci, Inst Clin Med, N-9038 Tromso, Norway; [Ingebrigtsen, Tor; Romner, Bertil] Univ Hosp N Norway, N-9038 Tromso, Norway; [Romner, Bertil] Rigshosp, Dept Neurosurg, DK-2100 Copenhagen O, Denmark		Harr, ME (corresponding author), Oslo Univ Hosp Ulleval, Dept Neurosurg, POB 4950 Nydalen, N-0424 Oslo, Norway.	marianne.efskind@gmail.com	Helseth, Eirik/AAH-2466-2020	Ingebrigtsen, Tor/0000-0001-5966-9786			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Moskowitz H., 2000, REV LIT EFFECTS LOW; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; R Development Core Team, 2010, R LANG ENV STAT COMP; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vonghia L, 2008, EUR J INTERN MED, V19, P561, DOI 10.1016/j.ejim.2007.06.033; WHO, 2007, ALC INJ EM DEP SUMM; [No title captured], DOI DOI 10.1016/J.INJURY.2010.01.098; [No title captured]; [No title captured]	27	12	12	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 17	2011	19								25	10.1186/1757-7241-19-25			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	767QH	WOS:000290870600001	21496318	gold, Green Published			2022-02-06	
